PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Yan, SM; Huse, DA; White, SR				Yan, Simeng; Huse, David A.; White, Steven R.			Spin-Liquid Ground State of the S=1/2 Kagome Heisenberg Antiferromagnet	SCIENCE			English	Article							QUANTUM RENORMALIZATION-GROUPS; VALENCE-BOND STATE; EXCITATIONS; LATTICE; GAP	We use the density matrix renormalization group to perform accurate calculations of the ground state of the nearest-neighbor quantum spin S = 1/2 Heisenberg antiferromagnet on the kagome lattice. We study this model on numerous long cylinders with circumferences up to 12 lattice spacings. Through a combination of very-low-energy and small finite-size effects, our results provide strong evidence that, for the infinite two-dimensional system, the ground state of this model is a fully gapped spin liquid.	[Yan, Simeng; White, Steven R.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92617 USA; [Huse, David A.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Huse, David A.] Inst Adv Study, Princeton, NJ 08540 USA	University of California System; University of California Irvine; Princeton University; Institute for Advanced Study - USA	White, SR (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92617 USA.	srwhite@uci.edu	White, Steven R/B-4760-2008	White, Steven R/0000-0003-3496-0707	NSF [DMR-0907500, DMR-0819860]	NSF(National Science Foundation (NSF))	We thank A. Lauchli for Lanczos results; R. Singh for series results; and C. Lhuillier, M. P. A. Fisher, T. Senthil, E. Sorensen, S. Sondhi, G. Vidal, X.-G. Wen, O. Tchernyshyov, and M. Stoudenmire for discussions. This work was supported by NSF grants DMR-0907500 and DMR-0819860.	Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; ELSER V, 1989, PHYS REV LETT, V62, P2405, DOI 10.1103/PhysRevLett.62.2405; Evenbly G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.187203; Jiang HC, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.117203; KIVELSON SA, 1987, PHYS REV B, V35, P8865, DOI 10.1103/PhysRevB.35.8865; LEUNG PW, 1993, PHYS REV B, V47, P5459, DOI 10.1103/PhysRevB.47.5459; LIEB E, 1961, ANN PHYS-NEW YORK, V16, P407, DOI 10.1016/0003-4916(61)90115-4; MARSTON JB, 1991, J APPL PHYS, V69, P5962, DOI 10.1063/1.347830; Misguich G, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.214413; Moessner R, 2001, PHYS REV LETT, V86, P1881, DOI 10.1103/PhysRevLett.86.1881; Poilblanc D, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.180402; Ran Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.117205; READ N, 1989, PHYS REV B, V40, P7133, DOI 10.1103/PhysRevB.40.7133; READ N, 1991, PHYS REV LETT, V66, P1773, DOI 10.1103/PhysRevLett.66.1773; SACHDEV S, 1992, PHYS REV B, V45, P12377, DOI 10.1103/PhysRevB.45.12377; Sindzingre P, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/27009; Singh RRP, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.144415; Singh RRP, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.180407; Waldtmann C, 1998, EUR PHYS J B, V2, P501, DOI 10.1007/s100510050274; WEN XG, 1991, PHYS REV B, V44, P2664, DOI 10.1103/PhysRevB.44.2664; WHITE SR, 1992, PHYS REV LETT, V69, P2863, DOI 10.1103/PhysRevLett.69.2863	24	811	817	8	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1173	1176		10.1126/science.1201080	http://dx.doi.org/10.1126/science.1201080			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21527676	Green Submitted			2022-12-28	WOS:000291205200041
J	Blumberg, LJ				Blumberg, Linda J.			High-Risk Pools - Merely a Stopgap Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Urban Inst, Washington, DC 20037 USA	Urban Institute	Blumberg, LJ (corresponding author), Urban Inst, Washington, DC 20037 USA.							*HEALTHCARE, 2011, STAT STAT ENR PREEX; HIGH RISK POOL	2	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2011	364	19								10.1056/NEJMP1100112	http://dx.doi.org/10.1056/NEJMP1100112			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MM	21524232				2022-12-28	WOS:000290483000005
J	Schiff, GD				Schiff, Gordon D.			Medical Error A 60-Year-Old Man With Delayed Care for a Renal Mass	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPROVING PATIENT SAFETY; TOYOTA PRODUCTION SYSTEM; HEALTH-CARE; HIGH-RELIABILITY; FOLLOW-UP; INATTENTIONAL BLINDNESS; INFORMATION-TECHNOLOGY; HANDOFFS; ORGANIZATIONS; HOSPITALS	Mr B, a 60-year-old man with back pain, was not informed of an incidental finding of a renal mass suggestive of cancer on a magnetic resonance imaging scan. Failure and delays in test follow-up are a frequent problem in medicine, occurring in more than 5% of significantly abnormal ambulatory test results. Rather than simply blaming involved clinicians, systems for managing tests need to be reengineered using methods from reliability sciences. These begin with investigations into the systemic causes of the failures, then application of approaches such as heightened situational awareness, closed-loop systems, improved handoffs, just-in-time work, culture and practices of stopping to fix problems, forcing functions and simplification, enhanced visual cues, and cautious use of information technology and redundancy, all while avoiding suboptimization. Emerging test management systems and critical test follow-up recommendations illustrate how applying these principles can enhance this important aspect of patient safety. JAMA. 2011;305(18):1890-1898 www.jama.com	[Schiff, Gordon D.] Brigham & Womens Hosp, Div Gen Internal Med, Ctr Patient Safety Res & Practice, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Schiff, GD (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med, Ctr Patient Safety Res & Practice, 1620 Tremont St,3rd Floor, Boston, MA 02120 USA.	gschiff@partners.org						[Anonymous], 2005, BUILDING BETTER DELI; Arora VM, 2009, J HOSP MED, V4, P433, DOI 10.1002/jhm.573; Bagian James P, 2002, Jt Comm J Qual Improv, V28, P531; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Battles JB, 2006, HEALTH SERV RES, V41, P1555, DOI 10.1111/j.1475-6773.2006.00565.x; Berlin L, 2006, LANCET, V367, P373, DOI 10.1016/S0140-6736(06)68114-2; BERWICK DM, 1989, NEW ENGL J MED, V320, P53, DOI 10.1056/NEJM198901053200110; Boston-Fleischhauer C, 2008, J NURS ADMIN, V38, P84, DOI 10.1097/01.NNA.0000295637.03216.26; Browne AM, 2004, COMMON CAUSE ANAL FO; Buesa RJ, 2009, ANN DIAGN PATHOL, V13, P322, DOI 10.1016/j.anndiagpath.2009.06.005; Carnahan SJ, 2007, J LAW MED ETHICS, V35, P211, DOI 10.1111/j.1748-720X.2007.00125.x; Carrim ZI, 2003, CLIN RADIOL, V58, P626, DOI 10.1016/S0009-9260(03)00165-X; Casalino LP, 2009, ARCH INTERN MED, V169, P1123, DOI 10.1001/archinternmed.2009.130; Clancy CM, 2007, AM J MED QUAL, V22, P463, DOI 10.1177/1062860607308146; Cohen MD, 2010, QUAL SAF HEALTH CARE, V19, P493, DOI 10.1136/qshc.2009.033480; Cram P, 2005, JT COMM J QUAL PATIE, V31, P90, DOI 10.1016/S1553-7250(05)31013-0; DAVENPORT TH, 1990, SLOAN MANAGE REV, V31, P11; Deming WE, 2000, OUT CRISIS; Dixon NM, 2006, HEALTH SERV RES, V41, P1618, DOI 10.1111/j.1475-6773.2006.00568.x; Edelman David, 2002, Eff Clin Pract, V5, P11; Elder NC, 2009, ANN FAM MED, V7, P343, DOI 10.1370/afm.961; Fei Kerri, 2008, J Healthc Qual, V30, P37; Furman C, 2007, JT COMM J QUAL PATIE, V33, P376, DOI 10.1016/S1553-7250(07)33043-2; Gandhi TK, 2006, ANN INTERN MED, V145, P488, DOI 10.7326/0003-4819-145-7-200610030-00006; Gandhi TK, 2005, ANN INTERN MED, V142, P352, DOI 10.7326/0003-4819-142-5-200503010-00010; Garvey CH, 2006, LANCET, V367, P443, DOI 10.1016/S0140-6736(06)68145-2; Gordon JRS, 2009, ANN INTERN MED, V151, P21, DOI 10.7326/0003-4819-151-1-200907070-00005; GRIMSHAW JM, 2001, MED CARE S2, V39, P2, DOI DOI 10.1097/00005650-200108002-00002; Grout JR, 2006, QUAL SAF HEALTH CARE, V15, pI44, DOI 10.1136/qshc.2005.016030; Hanna D, 2005, JT COMM J QUAL PATIE, V31, P68, DOI 10.1016/S1553-7250(05)31011-7; Hibbard JH, 2005, MED CARE RES REV, V62, P601, DOI 10.1177/1077558705279313; Hines S, 2008, BECOMING HIGH RELIAB; Hines S, 2008, BECOMING HIGH RELIAB; Institute for Healthcare Improvement, IMPR WORK FLOW REM W; Israel GM, 2005, UROLOGY, V66, P484, DOI 10.1016/j.urology.2005.04.003; Jackson Cheryl, 2009, Healthc Q, V12 Spec No Patient, P116; Kern LM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-87; Kissane JM, 1976, CYSTIC DIS KIDNEY; LAUCKS SP, 1981, BRIT J RADIOL, V54, P12, DOI 10.1259/0007-1285-54-637-12; Leder R A, 1999, Curr Opin Urol, V9, P129, DOI 10.1097/00042307-199903000-00007; Liker J. K., 2004, TOYOTA WAY 14 MANAGE; Luria JW, 2006, PEDIATR CLIN N AM, V53, P1121, DOI 10.1016/j.pcl.2006.09.007; Mack A, 2003, CURR DIR PSYCHOL SCI, V12, P180, DOI 10.1111/1467-8721.01256; Nazareno J, 2007, CAN J GASTROENTEROL, V21, P285, DOI 10.1155/2007/628408; Nepple KG, 2008, MAYO CLIN PROC, V83, P439, DOI 10.4065/83.4.439; Pasquale Frank, 2010, Ann Health Law, V19, P269; Patterson ES, 2010, JT COMM J QUAL PATIE, V36, P52, DOI 10.1016/S1553-7250(10)36011-9; Pham HH, 2009, ANN INTERN MED, V150, P236, DOI 10.7326/0003-4819-150-4-200902170-00004; Poon EG, 2004, ARCH INTERN MED, V164, P2223, DOI 10.1001/archinte.164.20.2223; Poon EG, 2003, J BIOMED INFORM, V36, P80, DOI 10.1016/S1532-0464(03)00061-3; POWSNER SM, 1994, LANCET, V344, P386, DOI 10.1016/S0140-6736(94)91406-0; Pronovost PJ, 2006, HEALTH SERV RES, V41, P1599, DOI 10.1111/j.1475-6773.2006.00567.x; Pronovost PJ, 2004, J CRIT CARE, V19, P121, DOI 10.1016/j.jcrc.2004.07.004; Raab SS, 2006, AM J OBSTET GYNECOL, V194, P57, DOI 10.1016/j.ajog.2005.06.069; Raab SS, 2004, CLIN LAB MED, V24, P849, DOI 10.1016/j.cll.2004.05.014; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Ruoff G, 1999, Fam Med, V31, P331; SCHIFF G, 2006, GETTING RESULTS RELI; Schiff GD, 2000, AM J MED, V109, P494, DOI 10.1016/S0002-9343(00)00546-5; Schiff GD, 2005, ARCH INTERN MED, V165, P574, DOI 10.1001/archinte.165.5.574; SCHIFF GD, 1991, ANN INTERN MED, V114, P748, DOI 10.7326/0003-4819-114-9-748; Schiff GD, 2006, RESPECTING REFLECTIN; Schiff GD, 2008, AM J MED, V121, P38, DOI 10.1016/j.amjmed.2008.02.004; Schoen C, 2005, HLTH AFF MILLWOOD S; Shapiro MJ, 2003, QUAL SAF HEALTH CARE, V12, P238, DOI 10.1136/qhc.12.4.238; Silvestre AL, 2009, HEALTH AFFAIR, V28, P334, DOI 10.1377/hlthaff.28.2.334; Simons DJ, 2000, TRENDS COGN SCI, V4, P147, DOI 10.1016/S1364-6613(00)01455-8; Singh H, 2010, JT COMM J QUAL PATIE, V36, P226, DOI 10.1016/S1553-7250(10)36037-5; Singh H, 2009, ARCH INTERN MED, V169, P1578, DOI 10.1001/archinternmed.2009.263; Singh H, 2009, AM J GASTROENTEROL, V104, P942, DOI 10.1038/ajg.2009.55; Solet DJ, 2005, ACAD MED, V80, P1094, DOI 10.1097/00001888-200512000-00005; Spear S, 1999, HARVARD BUS REV, V77, P96; Spear SJ, 2005, ANN INTERN MED, V142, P627, DOI 10.7326/0003-4819-142-8-200504190-00011; Spear SJ, 2009, HIGH VELOCITY EDGE M; Sweitzer Stormy C, 2005, J Healthc Qual, V27, P11; Tamuz M, 2006, HEALTH SERV RES, V41, P1654, DOI 10.1111/j.1475-6773.2006.00570.x; Tucker AL, 2008, HEALTH SERV RES, V43, P1807, DOI 10.1111/j.1475-6773.2008.00868.x; US Postal Service, Q PERF SINGL PIEC 1; Vaughan D, 1999, ANNU REV SOCIOL, V25, P271, DOI 10.1146/annurev.soc.25.1.271; Vest JR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-35; Wahls TL, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-32; Weingart SN, 2006, J AM MED INFORM ASSN, V13, P91, DOI 10.1197/jamia.M1833	82	9	9	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2011	305	18					1890	1898		10.1001/jama.2011.496	http://dx.doi.org/10.1001/jama.2011.496			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761YH	21486963				2022-12-28	WOS:000290438800026
J	Schmitz, L; Motani, R				Schmitz, Lars; Motani, Ryosuke			Nocturnality in Dinosaurs Inferred from Scleral Ring and Orbit Morphology	SCIENCE			English	Article							ACTIVITY PATTERNS; EVOLUTION; CATHEMERALITY; EYEBALLS; FEATURES; MAMMALS; BRAIN; SIZE	Variation in daily activity patterns facilitates temporal partitioning of habitat and resources among species. Knowledge of temporal niche partitioning in paleobiological systems has been limited by the difficulty of obtaining reliable information about activity patterns from fossils. On the basis of an analysis of scleral ring and orbit morphology in 33 archosaurs, including dinosaurs and pterosaurs, we show that the eyes of Mesozoic archosaurs were adapted to all major types of dig activity (that is, nocturnal, diurnal, and cathemeral) and provide concrete evidence of temporal niche partitioning in the Mesozoic. Similar to extant amniotes, flyers were predominantly diurnal; terrestrial predators, at least partially, nocturnal; and large herbivores, cathemeral. These similarities suggest that ecology drives the evolution of diet activity patterns.	[Schmitz, Lars] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Schmitz, Lars; Motani, Ryosuke] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Schmitz, L (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	lschmitz@ucdavis.edu	Schmitz, Lars/G-2928-2010; Motani, Ryosuke/K-2607-2015	Schmitz, Lars/0000-0003-0210-4383; Motani, Ryosuke/0000-0001-5022-1053	NSF [EAR 0551024]; Department of Geology, University of California Davis; Royal Ontario Museum; German Academic Exchange Service; German Research Foundation	NSF(National Science Foundation (NSF)); Department of Geology, University of California Davis; Royal Ontario Museum; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation(German Research Foundation (DFG))	We thank D. Brinkmann, S. Carlson, I. Schwab, G. Vermeij, and P. Wainwright for comments. C. Cicero, A. Engilis, I. Engilis, D. Evans, M. Flannery, P. Holroyd, M. Koelbl-Ebert, J. McGuire., C. Mehling, M. Norell, R. Papendieck, O. Rauhut, M. Sander, K. Seymour, B. Shaffer, D. Unwin, X. Xu, and Z. Zhou granted specimen access. The project was supported by NSF grant EAR 0551024 to R.M. and Darrell Funds of the Department of Geology, University of California Davis, an M. A. Fritz Award of Royal Ontario Museum, a doctoral stipend of German Academic Exchange Service, and a postdoctoral fellowship of German Research Foundation to L.S.	Bennett SC, 2007, PALAEONTOL Z, V81, P376, DOI 10.1007/BF02990250; Carpenter Kenneth, 2000, Gaia (Lisboa), V15, P135; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483, DOI 10.1093/oxfordjournals.molbev.a004211; Chure Daniel J., 2000, Gaia (Lisboa), V15, P233; CROMPTON AW, 1978, NATURE, V272, P333, DOI 10.1038/272333a0; Curtis DJ, 2006, FOLIA PRIMATOL, V77, P178, DOI 10.1159/000089703; GITTLEMAN JL, 1986, J MAMMAL, V67, P23, DOI 10.2307/1380998; Hall MI, 2009, ANAT REC, V292, P798, DOI 10.1002/ar.20889; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Kundrat M, 2007, NATURWISSENSCHAFTEN, V94, P769, DOI 10.1007/s00114-007-0258-7; Kurochkin EN, 2007, BIOL LETTERS, V3, P309, DOI 10.1098/rsbl.2006.0617; Lee MSY, 2004, ASSEMBLING THE TREE OF LIFE, P451; Longrich Nick, 2010, P308; Maloney SK, 2005, J COMP PHYSIOL A, V191, P1055, DOI 10.1007/s00359-005-0030-4; McNab BK, 2009, P NATL ACAD SCI USA, V106, P12184, DOI 10.1073/pnas.0904000106; MCNEIL R, 1992, BIOL REV, V67, P381, DOI 10.1111/j.1469-185X.1992.tb01188.x; Motani R, 1999, NATURE, V402, P747, DOI 10.1038/45435; MOTANI R, EVOLUTION, DOI DOI 10.1111/J.1558-5646.2011.01271; Mougeot F, 2000, J AVIAN BIOL, V31, P376, DOI 10.1034/j.1600-048X.2000.310314.x; OWENSMITH RN, 1988, MEGULLERBIVORES INFL; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schmitz L, 2010, VISION RES, V50, P936, DOI 10.1016/j.visres.2010.03.009; Schmitz L, 2009, J MORPHOL, V270, P759, DOI 10.1002/jmor.10720; Seebacher F, 1999, J EXP BIOL, V202, P77; Sellwood BW, 2006, SEDIMENT GEOL, V190, P269, DOI 10.1016/j.sedgeo.2006.05.013; Swingland I. R., 1979, HDB BIOTELEMETRY RAD, P611; Tattersall I, 2006, FOLIA PRIMATOL, V77, P7, DOI 10.1159/000089692; Weishampel DB., 2004, DINOSAURIA; WIENS JA, 1961, COMMUNITY ECOLOGY, P145	30	101	102	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					705	708		10.1126/science.1200043	http://dx.doi.org/10.1126/science.1200043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21493820				2022-12-28	WOS:000290265800039
J	Fitzgerald, CM				Fitzgerald, Colleen M.			It's Never Too Late	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												cfitzgerald@ric.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1742	1743		10.1001/jama.2011.553	http://dx.doi.org/10.1001/jama.2011.553			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758HZ	21540412				2022-12-28	WOS:000290156200001
J	Buyx, A; Tait, J				Buyx, Alena; Tait, Joyce			Ethical Framework for Biofuels	SCIENCE			English	Editorial Material									[Buyx, Alena] Nuffield Council Bioeth, London WC1B 3JS, England; [Tait, Joyce] Univ Edinburgh, Econ & Social Res Council, Innogen Ctr, Edinburgh EH1 1LZ, Midlothian, Scotland	Innogenetics NV; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of Edinburgh	Buyx, A (corresponding author), Nuffield Council Bioeth, London WC1B 3JS, England.	abuyx@nuffieldbio-ethics.org			ESRC [ES/F028180/1] Funding Source: UKRI; Economic and Social Research Council [ES/F028180/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Amnesty International, 2008, BRAZ AMN INT REP 200; Dobson A., 1998, JUSTICE ENV; *EC, 2010, COMM COMM VOL SCHEM; *FOEI, 2008, MAL PALM OIL GREEN G; Humphreys S., 2009, AHRCRES104 UN; IEA International Energy Agency, 2010, WORLD EN OUTL 2010; Kaswan A., 2003, N CAROLINA LAW REV, V81, P1031; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Lapola DM, 2010, P NATL ACAD SCI USA, V107, P3388, DOI 10.1073/pnas.0907318107; Nuffield Council on Bioethics, 2011, BIOF ETH ISS; *OECD, 2006, GUID LIC GEN INV; Pogge T., 2002, WORLD POVERTY HUMAN; Rawls J., 1971, THEORY JUSTICE; Rawls John, 1993, POLITICAL LIBERALISM, pxviii; *REN FUELS AG, 2010, GALL REV IND EFF BIO; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; US Environmental Protection Agency, 2011, REN FUEL STAND RFS; World Bank, 2010, RISING GLOBAL INTERE	18	46	46	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					540	541		10.1126/science.1206064	http://dx.doi.org/10.1126/science.1206064			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756DE	21487119				2022-12-28	WOS:000289991100029
J	Chafe, R; Born, KB; Slutsky, AS; Laupacis, A				Chafe, Roger; Born, Karen B.; Slutsky, Arthur S.; Laupacis, Andreas			The rise of people power	NATURE			English	Editorial Material							CEREBROSPINAL VENOUS INSUFFICIENCY; MULTIPLE-SCLEROSIS		[Chafe, Roger] Mem Univ Newfoundland, St John, NF A1B 3V6, Canada; [Born, Karen B.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada; [Slutsky, Arthur S.; Laupacis, Andreas] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Slutsky, Arthur S.; Laupacis, Andreas] King Saud Univ, Riyadh, Saudi Arabia	Memorial University Newfoundland; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; King Saud University	Chafe, R (corresponding author), Mem Univ Newfoundland, St John, NF A1B 3V6, Canada.	roger.chafe@med.mun.ca	Slutsky, Arthur/M-3325-2019					[Anonymous], 2009, CTV NEWS        1121; Canadian Institute of Health Research, 2010, JOINT INV M MULT SCL; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; LERNER IJ, 1984, CANCER, V53, P815, DOI 10.1002/1097-0142(19840201)53:3+<815::AID-CNCR2820531334>3.0.CO;2-U; Rudick RA, 2010, NAT REV NEUROL, V6, P472, DOI 10.1038/nrneurol.2010.117; Sundstrom P, 2010, ANN NEUROL, V68, P255, DOI 10.1002/ana.22132; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2009, J VASC SURG, V50, P1348, DOI 10.1016/j.jvs.2009.07.096	8	48	49	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					410	411		10.1038/472410a	http://dx.doi.org/10.1038/472410a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	755QC	21525907	Bronze			2022-12-28	WOS:000289949600010
J	Watkins, H; Ashrafian, H; Redwood, C				Watkins, Hugh; Ashrafian, Houman; Redwood, Charles			MECHANISMS OF DISEASE Inherited Cardiomyopathies	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; RIGHT-VENTRICULAR CARDIOMYOPATHY; BINDING-PROTEIN-C; CAUSES DILATED CARDIOMYOPATHY; CARDIAC TROPONIN-T; LAMIN A/C GENE; ALPHA-TROPOMYOSIN; PHENOTYPE CORRELATIONS; MYOCARDIAL FIBROSIS; MISSENSE MUTATIONS		[Watkins, Hugh; Ashrafian, Houman; Redwood, Charles] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Watkins, H (corresponding author), John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.	hugh.watkins@cardiov.ox.ac.uk	Raju, Hariharan/E-2081-2011; Towbin, Jeffrey A./J-5595-2019	Raju, Hariharan/0000-0003-0000-7520; Towbin, Jeffrey A./0000-0002-6585-714X; Watkins, Hugh/0000-0002-5287-9016; Ashrafian, Houman/0000-0003-3988-378X	British Heart Foundation Centre of Excellence at Oxford; Wellcome Trust; European Commission [241577]; Oxford Partners National Institute for Health Research Comprehensive Biomedical Research Centre; British Heart Foundation [RG/07/012/24110] Funding Source: researchfish	British Heart Foundation Centre of Excellence at Oxford; Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Oxford Partners National Institute for Health Research Comprehensive Biomedical Research Centre; British Heart Foundation(British Heart Foundation)	Supported by the British Heart Foundation Centre of Excellence at Oxford, Wellcome Trust, European Commission Framework Programme Grant (241577), and Oxford Partners National Institute for Health Research Comprehensive Biomedical Research Centre.	Abozguia K, 2010, CIRCULATION, V122, P1562, DOI 10.1161/CIRCULATIONAHA.109.934059; Andersen PS, 2009, HUM MUTAT, V30, P363, DOI 10.1002/humu.20862; Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; Asimaki A, 2009, NEW ENGL J MED, V360, P1075, DOI 10.1056/NEJMoa0808138; Baig MK, 1998, J AM COLL CARDIOL, V31, P195, DOI 10.1016/S0735-1097(97)00433-6; Banerjee SK, 2010, BBA-MOL BASIS DIS, V1802, P284, DOI 10.1016/j.bbadis.2009.12.001; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; Belus A, 2008, J PHYSIOL-LONDON, V586, P3639, DOI 10.1113/jphysiol.2008.155952; Bers DM, 2005, ANN NY ACAD SCI, V1047, P86, DOI 10.1196/annals.1341.008; Blair E, 2003, CIRCULATION, V108, pE24, DOI 10.1161/01.CIR.0000081440.49766.A6; Blair E, 2001, J MED GENET, V38, P385, DOI 10.1136/jmg.38.6.385; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Bowles NE, 2000, HERZ, V25, P168, DOI 10.1007/s000590050003; Chiu C, 2010, J AM COLL CARDIOL, V55, P1127, DOI 10.1016/j.jacc.2009.11.016; Cinquetti R, 2008, HUM MUTAT, V29, P468, DOI 10.1002/humu.20711; Crilley JG, 2003, J AM COLL CARDIOL, V41, P1776, DOI 10.1016/S0735-1097(02)03009-7; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; DELLEFAVE L, 2010, CURR OPIN CARDI 0224; DeWitt MM, 2006, J AM COLL CARDIOL, V48, P1396, DOI 10.1016/j.jacc.2006.07.016; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Dietz HC, 2010, NEW ENGL J MED, V363, P852, DOI 10.1056/NEJMra0907180; Djouadi F, 2009, CARDIOVASC RES, V84, P83, DOI 10.1093/cvr/cvp183; Duboscq-Bidot L, 2009, EUR HEART J, V30, P2128, DOI 10.1093/eurheartj/ehp225; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Geier C, 2008, HUM MOL GENET, V17, P2753, DOI 10.1093/hmg/ddn160; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Girolami F, 2010, J AM COLL CARDIOL, V55, P1444, DOI 10.1016/j.jacc.2009.11.062; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Hayashi T, 2004, J AM COLL CARDIOL, V44, P2192, DOI 10.1016/j.jacc.2004.08.058; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; Huke S, 2010, J MOL CELL CARDIOL, V48, P824, DOI 10.1016/j.yjmcc.2010.01.011; Ingles J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033886; JARCHO JA, 1989, NEW ENGL J MED, V321, P1372, DOI 10.1056/NEJM198911163212005; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Kaplan SR, 2004, HEART RHYTHM, V1, P3, DOI 10.1016/j.hrthm.2004.01.001; Kataoka A, 2007, J BIOMECH, V40, P2044, DOI 10.1016/j.jbiomech.2006.09.026; Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x; Kirchhof P, 2006, CIRCULATION, V114, P1799, DOI 10.1161/CIRCULATIONAHA.106.624502; Klaassen S, 2008, CIRCULATION, V117, P2893, DOI 10.1161/CIRCULATIONAHA.107.746164; Knollmann BC, 2003, CIRC RES, V92, P428, DOI 10.1161/01.RES.0000059562.91384.1A; Kubo T, 2007, J AM COLL CARDIOL, V49, P2419, DOI 10.1016/j.jacc.2007.02.061; Lakdawala NK, 2010, J AM COLL CARDIOL, V55, P320, DOI 10.1016/j.jacc.2009.11.017; Landstrom AP, 2007, J MOL CELL CARDIOL, V42, P1026, DOI 10.1016/j.yjmcc.2007.04.006; Lofiego C, 2007, HEART, V93, P65, DOI 10.1136/hrt.2006.088229; Lombardi R, 2009, CIRC RES, V104, P1076, DOI 10.1161/CIRCRESAHA.109.196899; Malhotra R, 2009, CURR OPIN CARDIOL, V24, P203, DOI 10.1097/HCO.0b013e32832a11c6; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Maron BJ, 2009, JAMA-J AM MED ASSOC, V301, P1253, DOI 10.1001/jama.2009.371; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Maron BJ, 2001, J AM COLL CARDIOL, V38, P315, DOI 10.1016/S0735-1097(01)01386-9; Marston S, 2009, CIRC RES, V105, P219, DOI 10.1161/CIRCRESAHA.109.202440; Matkovich SJ, 2010, J CLIN INVEST, V120, P280, DOI 10.1172/JCI39085; Matolweni LO, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-29; Merner ND, 2008, AM J HUM GENET, V82, P809, DOI 10.1016/j.ajhg.2008.01.010; Meune C, 2006, NEW ENGL J MED, V354, P209, DOI 10.1056/NEJMc052632; Miller MK, 2004, TRENDS CELL BIOL, V14, P119, DOI 10.1016/j.tcb.2004.01.003; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Monserrat L, 2007, J AM COLL CARDIOL, V50, P2399, DOI 10.1016/j.jacc.2007.06.062; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Noutsias M, 2001, CIRCULATION, V104, P275; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Oechslin EN, 2000, J AM COLL CARDIOL, V36, P493, DOI 10.1016/S0735-1097(00)00755-5; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Osio A, 2007, CIRC RES, V100, P766, DOI 10.1161/01.RES.0000263008.66799.aa; Pasotti M, 2008, J AM COLL CARDIOL, V52, P1250, DOI 10.1016/j.jacc.2008.06.044; Penicka M, 2009, J MOL DIAGN, V11, P35, DOI 10.2353/jmoldx.2009.080082; Petersen SE, 2007, CIRCULATION, V115, P2418, DOI 10.1161/CIRCULATIONAHA.106.657023; Redwood CS, 1999, CARDIOVASC RES, V44, P20, DOI 10.1016/S0008-6363(99)00213-8; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Schmitt JP, 2006, P NATL ACAD SCI USA, V103, P14525, DOI 10.1073/pnas.0606383103; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Semsarian C, 2002, J CLIN INVEST, V109, P1013, DOI 10.1172/JCI200214677; Sen-Chowdhry S, 2010, ANNU REV MED, V61, P233, DOI 10.1146/annurev.med.052208.130419; Smith GA, 2000, BIOCHEM J, V346, P393, DOI 10.1042/0264-6021:3460393; Spindler M, 1998, J CLIN INVEST, V101, P1775, DOI 10.1172/JCI1940; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Troughton RW, 2004, CIRCULATION, V109, pE325; Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; Van Driest SL, 2003, CIRCULATION, V108, P445, DOI 10.1161/01.CIR.0000080896.52003.DF; van Spaendonck-Zwarts KY, 2010, CIRCULATION, V121, P2169, DOI 10.1161/CIRCULATIONAHA.109.929646; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Watkins H, 2008, HEART, V94, P1264, DOI 10.1136/hrt.2008.154104; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; Wolf CM, 2008, J MOL CELL CARDIOL, V44, P293, DOI 10.1016/j.yjmcc.2007.11.008; Wordsworth S, 2010, EUR HEART J, V31, P926, DOI 10.1093/eurheartj/ehq067; Xiong DD, 2002, NAT MED, V8, P872, DOI 10.1038/nm737; Xu TH, 2010, J AM COLL CARDIOL, V55, P587, DOI 10.1016/j.jacc.2009.11.020	99	322	330	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1643	1656		10.1056/NEJMra0902923	http://dx.doi.org/10.1056/NEJMra0902923			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755NW	21524215	Bronze			2022-12-28	WOS:000289940400011
J	Wu, H; Siegel, RM				Wu, Hao; Siegel, Richard M.			Progranulin Resolves Inflammation	SCIENCE			English	Editorial Material							COLLAGEN-INDUCED ARTHRITIS; HOST-DEFENSE; MICE		[Wu, Hao] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Siegel, Richard M.] NIAMSD, NIH, Bethesda, MD 20814 USA	Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Wu, H (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA.	siegelr@mail.nih.gov			NIAID NIH HHS [R01 AI045937] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041133] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Mori L, 1996, J IMMUNOL, V157, P3178; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Tada Y, 2001, CLIN IMMUNOL, V99, P325, DOI 10.1006/clim.2001.5027; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	9	45	47	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					427	428		10.1126/science.1205992	http://dx.doi.org/10.1126/science.1205992			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512023	Green Accepted			2022-12-28	WOS:000289784900030
J	Gadde, KM; Allison, DB; Ryan, DH; Peterson, CA; Troupin, B; Schwiers, ML; Day, WW				Gadde, Kishore M.; Allison, David B.; Ryan, Donna H.; Peterson, Craig A.; Troupin, Barbara; Schwiers, Michael L.; Day, Wesley W.			Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial	LANCET			English	Article							LIFE-STYLE INTERVENTION; DOUBLE-BLIND; PHYSICAL-ACTIVITY; EFFICACY; SAFETY; MULTICENTER; ADIPOSITY	Background Obesity is associated with a reduction in life expectancy and an increase in mortality from cardiovascular diseases, cancer, and other causes. We therefore assessed the efficacy and safety of two doses of phentermine plus topiramate controlled-release combination as an adjunct to diet and lifestyle modification for weight loss and metabolic risk reduction in individuals who were overweight and obese, with two or more risk factors. Methods In this 56-week phase 3 trial, we randomly assigned overweight or obese adults (aged 18-70 years), with a body-mass index of 27-45 kg/m(2) and two or more comorbidities (hypertension, dyslipidaemia, diabetes or prediabetes, or abdominal obesity) to placebo, once-daily phentermine 7.5 mg plus topiramate 46.0 mg, or once-daily phentermine 15.0 mg plus topiramate 92.0 mg in a 2:1:2 ratio in 93 centres in the USA. Drugs were administered orally. Patients were randomly assigned by use of a computer-generated algorithm that was implemented through an interactive voice response system, and were stratified by sex and diabetic status. Investigators, patients, and study sponsors were masked to treatment. Primary endpoints were the percentage change in bodyweight and the proportion of patients achieving at least 5% weight loss. Analysis was by intention to treat. This study is registered with Clinical Trials.gov, number NCT00553787. Findings Of 2487 patients, 994 were assigned to placebo, 498 to phentermine 7.5 mg plus topiramate 46.0 mg, and 995 to phentermine 15.0 mg plus topiramate 92.0 mg; 979, 488, and 981 patients, respectively, were analysed. At 56 weeks, change in bodyweight was -1.4 kg (least-squares mean -1.2%, 95% CI -1.8 to -0.7), -8.1 kg (-7.8%, -8.5 to -7.1; p<0.0001), and -10.2 kg (-9.8%, -10.4 to -9.3; p<0.0001) in the patients assigned to placebo, phentermine 7.5 mg plus topiramate 46.0 mg, and phentermine 15.0 mg plus topiramate 92.0 mg, respectively. 204 (21%) patients achieved at least 5% weight loss with placebo, 303 (62%; odds ratio 6.3, 95% CI 4.9 to 8.0; p<0.0001) with phentermine 7.5 mg plus topiramate 46.0 mg, and 687 (70%; 9.0, 7.3 to 11.1; p<0.0001) with phentermine 15.0 mg plus topiramate 92.0 mg; for >= 10% weight loss, the corresponding numbers were 72 (7%), 182 (37%; 7.6, 5.6 to 10.2; p<0.0001), and 467 (48%; 11.7, 8.9 to 15.4; p<0.0001). The most common adverse events were dry mouth (24 [2%], 67 [13%], and 207 [21%] in the groups assigned to placebo, phenterrnine 7.5 mg plus topiramate 46.0 mg, and phentermine 15.0 mg plus topiramate 92.0 mg, respectively), paraesthesia (20 [2%], 68 [14%], and 204 [21%], respectively), constipation (59 [6%],75 [15%], and 173 [17%], respectively), insomnia (47 [5%],29 [6%], and 102 [10%], respectively), dizziness (31 [3%], 36 [7%], 99 [10%], respectively), and dysgeusia (11 [1%], 37 [7%], and 103 [10%], respectively). 38 (4%) patients assigned to placebo, 19 (4%) to phentermine 7.5 mg, plus topiramate 46.0 mg, and 73 (7%) to phentermine 15.0 mg plus topiramate 92.0 mg had depression-related adverse events; and 28 (3%), 24 (5%), and 77 (8%), respectively, had anxiety-related adverse events. Interpretation The combination of phentermine and topiramate, with office-based lifestyle interventions, might be a valuable treatment for obesity that can be provided by family doctors.	[Gadde, Kishore M.] Duke Univ, Med Ctr, Obes Clin Trials Programme, Durham, NC 27710 USA; [Allison, David B.] Univ Alabama Birmingham, Birmingham, AL USA; [Ryan, Donna H.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Schwiers, Michael L.] Medpace, Cincinnati, OH USA; [Peterson, Craig A.; Troupin, Barbara; Day, Wesley W.] Vivus, Mountain View, CA USA	Duke University; University of Alabama System; University of Alabama Birmingham; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Gadde, KM (corresponding author), Duke Univ, Med Ctr, Obes Clin Trials Programme, Box 3292, Durham, NC 27710 USA.	gadde001@mc.duke.edu	Gadde, Kishore/N-1963-2017	Gadde, Kishore/0000-0002-1856-5574; Ryan, Donna/0000-0001-8374-2277; Allison, David/0000-0003-3566-9399	Bristol Myers Squibb; Forest Labs; National Institute of Diabetes and Digestive and Kidney Diseases; Pfizer; Vivus; GlaxoSmithKline; Merck; Merck (SciMed); Merck (Gray Consulting); Eli Lilly; Abbott Laboratories; SlimFast Foods; Ipsos Health; Calorie Control Council; Dunn Group; Duke University; Datamonitor; Ideo; Medifast; Wolters Kluwer Pharma Solutions; Paul Weiss Rifkind Wharton and Garrison (Weight Watchers); National Institutes of Health; Arena Pharmaceuticals; Arena; NutriSystem; Sanofi Aventis; Abbott; Shionogi	Bristol Myers Squibb(Bristol-Myers Squibb); Forest Labs; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Pfizer(Pfizer); Vivus; GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Merck (SciMed)(Merck & Company); Merck (Gray Consulting)(Merck & Company); Eli Lilly(Eli Lilly); Abbott Laboratories(Abbott Laboratories); SlimFast Foods; Ipsos Health; Calorie Control Council; Dunn Group; Duke University; Datamonitor; Ideo; Medifast; Wolters Kluwer Pharma Solutions; Paul Weiss Rifkind Wharton and Garrison (Weight Watchers); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arena Pharmaceuticals; Arena(Australian Renewable Energy Agency (ARENA)); NutriSystem; Sanofi Aventis(Sanofi-Aventis); Abbott(Abbott Laboratories); Shionogi	In the past 3 years, KMG received research support from Bristol Myers Squibb, Forest Labs, National Institute of Diabetes and Digestive and Kidney Diseases, Pfizer, and Vivus. Before November, 2008, he served on the scientific advisory boards of Arena and Merck, and as a consultant for Vivus. He owns stocks in Orexigen, and has been awarded several patents for inventions related to obesity and weight loss interventions that are unrelated to the interventions tested in the current investigation. DBA has received grants, honoraria, donations, and consulting fees from the following with related interests Vivus, GlaxoSmithKline, Merck, Merck (SciMed), Merck (Gray Consulting), Pfizer, Eli Lilly, Abbott Laboratories, SlimFast Foods, Ipsos Health, Calorie Control Council, Dunn Group, Duke University, Datamonitor, Ideo, Medifast, Wolters Kluwer Pharma Solutions, Paul Weiss Rifkind Wharton and Garrison (Weight Watchers), National Institutes of Health, and Arena Pharmaceuticals. DHR has not accepted compensation from industrial ties since January, 2008, and, before that, she received consulting fees from Arena, NutriSystem, Merck, Sanofi Aventis, Abbott, and Shionogi. WWD, BT, and CAP are employees of Vivus. MLS was an employee of Medpace.	Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Bray GA, 2003, OBES RES, V11, P722, DOI 10.1038/oby.2003.102; Brownell K. D., 2000, LEARN PROGRAM WEIGHT; Center for Drug Evaluation and Research Food and Drug Administration US Department of Health and Human Services, 2007, GUID IND DEV PROD WE; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Espeland M, 2007, DIABETES CARE, V30, P1374; Gadde Kishore M, 2007, Expert Rev Neurother, V7, P17, DOI 10.1586/14737175.7.1.17; Gadde KM, 2009, CURR OPIN ENDOCRINOL, V16, P353, DOI 10.1097/MED.0b013e3283304f90; Gadde KM, 2006, OBES RES, V14, pA17; Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolotkin RL, 2002, QUAL LIFE RES, V11, P157, DOI 10.1023/A:1015081805439; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Melnikova I, 2006, NAT REV DRUG DISCOV, V5, P369, DOI 10.1038/nrd2037; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Posner K., COLUMBIA SUICIDE SEV; Rosenstock J, 2007, DIABETES CARE, V30, P1480, DOI 10.2337/dc06-2001; Rothman RB, 2001, SYNAPSE, V39, P32, DOI 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; STAMLER R, 1978, JAMA-J AM MED ASSOC, V240, P1607, DOI 10.1001/jama.240.15.1607; Stenlof K, 2007, DIABETES OBES METAB, V9, P360, DOI 10.1111/j.1463-1326.2006.00618.x; Tonstad S, 2005, AM J CARDIOL, V96, P243, DOI 10.1016/j.amjcard.2005.03.053; Toplak H, 2007, INT J OBESITY, V31, P138, DOI 10.1038/sj.ijo.0803382; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Wadden TA, 2006, OBESITY, V14, P737; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilding J, 2004, INT J OBESITY, V28, P1399, DOI 10.1038/sj.ijo.0802783	33	564	584	0	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2011	377	9774					1341	1352		10.1016/S0140-6736(11)60205-5	http://dx.doi.org/10.1016/S0140-6736(11)60205-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UE	21481449				2022-12-28	WOS:000289962900035
J	Cao, P; Maximov, A; Sudhof, TC				Cao, Peng; Maximov, Anton; Suedhof, Thomas C.			Activity-Dependent IGF-1 Exocytosis Is Controlled by the Ca2+-Sensor Synaptotagmin-10	CELL			English	Article							GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; RAT OLFACTORY-BULB; CA2+ SENSORS; PC12 CELLS; SYNAPTIC-TRANSMISSION; MESSENGER-RNA; NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; DISTINCT CA2+	Synaptotagmins Syt1, Syt2, Syt7, and Syt9 act as Ca2+-sensors for synaptic and neuroendocrine exocytosis, but the function of other synaptotagmins remains unknown. Here, we show that olfactory bulb neurons secrete IGF-1 by an activity-dependent pathway of exocytosis, and that Syt10 functions as the Ca2+-sensor that triggers IGF-1 exocytosis in these neurons. Deletion of Syt10 impaired activity-dependent IGF-1 secretion in olfactory bulb neurons, resulting in smaller neurons and an overall decrease in synapse numbers. Exogenous IGF-1 completely reversed the Syt10 knockout phenotype. Syt10 colocalized with IGF-1 in somatodendritic vesicles of olfactory bulb neurons, and Ca2+-binding to Syt10 caused these vesicles to undergo exocytosis, thereby secreting IGF-1. Thus, Syt10 controls a previously unrecognized pathway of Ca2+-dependent exocytosis that is spatially and temporally distinct from Ca2+-dependent synaptic vesicle exocytosis controlled by Syt1. Our findings thereby reveal that two different synaptotagmins can regulate functionally distinct Ca2+-dependent membrane fusion reactions in the same neuron.	[Cao, Peng; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94305 USA; [Cao, Peng; Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94305 USA; [Maximov, Anton; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci & Mol Genet, Dallas, TX 75390 USA; [Maximov, Anton; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, 1050 Arastradero Rd, Palo Alto, CA 94305 USA.	tcs1@stanford.edu	Karakhanov, Edward/P-1660-2015		Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R01 MH085776] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085776] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGUADO F, 1993, J MOL ENDOCRINOL, V11, P231, DOI 10.1677/jme.0.0110231; Babity JM, 1997, P NATL ACAD SCI USA, V94, P2638, DOI 10.1073/pnas.94.6.2638; BARTLETT WP, 1991, DEV BIOL, V147, P239, DOI 10.1016/S0012-1606(05)80021-1; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Bhalla A, 2008, J BIOL CHEM, V283, P21799, DOI 10.1074/jbc.M709628200; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Cheng CM, 2003, J NEUROSCI RES, V73, P1, DOI 10.1002/jnr.10634; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Flannery AR, 2010, J CELL BIOL, V191, P599, DOI 10.1083/jcb.201003021; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GIACOBINI MMJ, 1995, DEV BRAIN RES, V84, P67, DOI 10.1016/0165-3806(94)00154-R; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; Li JL, 2009, SCI CHINA SER C, V52, P1156, DOI 10.1007/s11427-009-0160-y; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Lynch KL, 2007, J CELL SCI, V120, P617, DOI 10.1242/jcs.03375; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mittelsteadt T, 2009, J COMP NEUROL, V512, P514, DOI 10.1002/cne.21908; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Scolnick JA, 2008, NEURON, V57, P847, DOI 10.1016/j.neuron.2008.01.027; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106; Sorensen JB, 2003, J GEN PHYSIOL, V122, P265, DOI 10.1085/jgp.200308855; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; TROMBLEY PQ, 1990, J NEUROPHYSIOL, V64, P598, DOI 10.1152/jn.1990.64.2.598; Vicario-Abejon C, 2003, J NEUROSCI, V23, P895; Vrljic M, 2010, NAT STRUCT MOL BIOL, V17, P325, DOI 10.1038/nsmb.1764; Wang P, 2005, MOL CELL BIOL, V25, P8693, DOI 10.1128/MCB.25.19.8693-8702.2005; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004	47	99	104	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					300	311		10.1016/j.cell.2011.03.034	http://dx.doi.org/10.1016/j.cell.2011.03.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496647	Bronze, Green Accepted			2022-12-28	WOS:000289549900017
J	Ferrari, R				Ferrari, Raffaele			A Frontal Challenge for Climate Models	SCIENCE			English	Editorial Material							MESOSCALE		MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Ferrari, R (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	rferrari@mit.edu	Ferrari, Raffaele/C-9337-2013	Ferrari, Raffaele/0000-0002-3736-1956				Capet X, 2008, J PHYS OCEANOGR, V38, P44, DOI 10.1175/2007JPO3672.1; D'Asaro E, 2011, SCIENCE, V332, P318, DOI 10.1126/science.1201515; Fox-Kemper B, 2008, J PHYS OCEANOGR, V38, P1145, DOI 10.1175/2007JPO3792.1; Klein P, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038359; Klein P, 2009, ANNU REV MAR SCI, V1, P351, DOI 10.1146/annurev.marine.010908.163704; Sen A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033407; Taylor JR, 2010, J PHYS OCEANOGR, V40, P1222, DOI 10.1175/2010JPO4365.1; Wunsch C, 2004, ANNU REV FLUID MECH, V36, P281, DOI 10.1146/annurev.fluid.36.050802.122121	8	67	68	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					316	317		10.1126/science.1203632	http://dx.doi.org/10.1126/science.1203632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493851				2022-12-28	WOS:000289516600034
J	Newton-Cheh, C; Lin, AE; Baggish, AL; Wang, H				Newton-Cheh, Christopher; Lin, Angela E.; Baggish, Aaron L.; Wang, He			Case 11-2011: A 47-Year-Old Man with Systemic Lupus Erythematosus and Heart Failure Cardiac intracellular deposition disorder, consistent with hydroxychloroquine toxicity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ULTRASTRUCTURAL FINDINGS; CHLOROQUINE; CARDIOMYOPATHY; CLASSIFICATION; CARDIOLOGY		[Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Newton-Cheh, Christopher] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Baggish, Aaron L.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Lin, Angela E.] Massachusetts Gen Hosp, MassGen Hosp Children, Dept Pediat, Genet Unit, Boston, MA 02114 USA; [Wang, He] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Baggish, Aaron L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Lin, Angela E.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Wang, He] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Newton-Cheh, C (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.			Wang, He/0000-0001-9736-8028				AUGUST C, 1995, J MOL MED-JMM, V73, P73, DOI 10.1007/BF00270580; Chen CY, 2006, CLIN TOXICOL, V44, P173, DOI 10.1080/15563650500514558; Colan SD, 2007, PROG PEDIATR CARDIOL, V23, P5, DOI 10.1016/j.ppedcard.2007.05.003; Costedoat-Chalumeau N, 2007, RHEUMATOLOGY, V46, P808, DOI 10.1093/rheumatology/kel402; Costedoat-Chalumeau N, 2007, CARDIOLOGY, V107, P73, DOI 10.1159/000094079; Cotroneo J, 2007, EUR J ECHOCARDIOGR, V8, P247, DOI 10.1016/j.euje.2006.02.002; Cushing DJ, 2009, CARDIOVASC TOXICOL, V9, P126, DOI 10.1007/s12012-009-9044-4; Estes M L, 1987, Am J Med, V82, P447, DOI 10.1016/0002-9343(87)90444-X; FAUCHIER JP, 1993, ARCH MAL COEUR VAISS, V86, P757; Guedira N, 1998, REV RHUM, V65, P58; HARRIS L, 1988, CAN J CARDIOL, V4, P295; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; Keating Richard J, 2005, J Am Soc Echocardiogr, V18, P981; Macfarlane DE, 1998, J IMMUNOL, V160, P1122; Manohar VA, 2009, J RHEUMATOL, V36, P440, DOI 10.3899/jrheum.080305; Maron Barry J., 2003, Journal of the American College of Cardiology, V42, P1687, DOI 10.1016/S0735-1097(03)00941-0; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Nord JE, 2004, SEMIN ARTHRITIS RHEU, V33, P336, DOI 10.1016/j.semarthrit.2003.09.012; RATLIFF NB, 1987, NEW ENGL J MED, V316, P191, DOI 10.1056/NEJM198701223160405; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Sachdev B, 2002, CIRCULATION, V105, P1407, DOI 10.1161/01.CIR.0000012626.81324.38; Sanchez-Capula JA, 2001, J PHARMACOL EXP THER, V297, P437; Soong TR, 2007, HUM PATHOL, V38, P1858, DOI 10.1016/j.humpath.2007.06.013; Stein M, 2000, J RHEUMATOL, V27, P2927; TETT SE, 1989, BRIT J CLIN PHARMACO, V27, P771, DOI 10.1111/j.1365-2125.1989.tb03439.x	26	19	20	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1450	1460		10.1056/NEJMcpc1011319	http://dx.doi.org/10.1056/NEJMcpc1011319			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LD	21488768				2022-12-28	WOS:000289467200011
J	Perencevich, EN; Lautenbach, E				Perencevich, Eli N.; Lautenbach, Ebbing			Infection Prevention and Comparative Effectiveness Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTERVENTION; RESISTANCE; STATEMENT		[Perencevich, Eli N.] Iowa City VA Med Ctr, Ctr Comprehens Access & Delivery Res & Evaluat, Iowa City, IA 52246 USA; [Perencevich, Eli N.] Univ Iowa, Carver Coll Med, Div Gen Internal Med, Iowa City, IA USA; [Lautenbach, Ebbing] Univ Penn, Sch Med, Dept Med & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Pennsylvania; Pennsylvania Medicine	Perencevich, EN (corresponding author), Iowa City VA Med Ctr, Ctr Comprehens Access & Delivery Res & Evaluat, 601 Hwy 6 W 3E21, Iowa City, IA 52246 USA.	eli-perencevich@uiowa.edu		Perencevich, Eli/0000-0002-3721-3355	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI080942] Funding Source: NIH RePORTER; NIAID NIH HHS [K24AI080942] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cook TD, 2008, J POLICY ANAL MANAG, V27, P724, DOI 10.1002/pam.20375; Harris AD, 2005, CLIN INFECT DIS, V41, P77, DOI 10.1086/430713; Harris AD, 2004, CLIN INFECT DIS, V38, P1586, DOI 10.1086/420936; Lautenbach E, 2010, CLIN INFECT DIS, V50, P523, DOI 10.1086/650169; McGinnis JM., 2010, REDESIGNING CLIN EFF; Platt R, 2010, MED CARE, V48, pS52, DOI 10.1097/MLR.0b013e3181dbebcf; Saginur R, 2009, CLIN INFECT DIS, V49, P1254, DOI 10.1086/605666; Shardell M, 2007, CLIN INFECT DIS, V45, P901, DOI 10.1086/521255; Stone SP, 2007, LANCET INFECT DIS, V7, P282, DOI 10.1016/S1473-3099(07)70082-8; Weber SG, 2007, INFECT CONT HOSP EP, V28, P249, DOI 10.1086/512261	10	16	18	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1482	1483		10.1001/jama.2011.450	http://dx.doi.org/10.1001/jama.2011.450			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486981				2022-12-28	WOS:000289424100027
J	Hopson, J; Holmes, J				Hopson, Jackie; Holmes, Jeremy			Through the wasteland: chronic depression	BRITISH MEDICAL JOURNAL			English	Editorial Material												jh@byfleet.org							0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 11	2011	342								d93	10.1136/bmj.d93	http://dx.doi.org/10.1136/bmj.d93			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752UT	21482596	Bronze			2022-12-28	WOS:000289721100016
J	Wu, YQ; Lin, YM; Bol, AA; Jenkins, KA; Xia, FN; Farmer, DB; Zhu, Y; Avouris, P				Wu, Yanqing; Lin, Yu-ming; Bol, Ageeth A.; Jenkins, Keith A.; Xia, Fengnian; Farmer, Damon B.; Zhu, Yu; Avouris, Phaedon			High-frequency, scaled graphene transistors on diamond-like carbon	NATURE			English	Article							FIELD-EFFECT TRANSISTORS; CUTOFF FREQUENCY	Owing to its high carrier mobility and saturation velocity, graphene has attracted enormous attention in recent years(1-5). In particular, high-performance graphene transistors for radio-frequency (r.f.) applications are of great interest(6-13). Synthesis of large-scale graphene sheets of high quality and at low cost has been demonstrated using chemical vapour deposition (CVD) methods(14). However, very few studies have been performed on the scaling behaviour of transistors made from CVD graphene for r.f. applications, which hold great potential for commercialization. Here we report the systematic study of top-gated CVD-graphene r.f. transistors with gate lengths scaled down to 40 nm, the shortest gate length demonstrated on graphene r.f. devices. The CVD graphene was grown on copper film and transferred to a wafer of diamond-like carbon. Cut-off frequencies as high as 155 GHz have been obtained for the 40-nm transistors, and the cut-off frequency was found to scale as 1/(gate length). Furthermore, we studied graphene r.f. transistors at cryogenic temperatures. Unlike conventional semiconductor devices where low-temperature performance is hampered by carrier freeze-out effects, the r.f. performance of our graphene devices exhibits little temperature dependence down to 4.3 K, providing a much larger operation window than is available for conventional devices.	[Wu, Yanqing; Lin, Yu-ming; Bol, Ageeth A.; Jenkins, Keith A.; Xia, Fengnian; Farmer, Damon B.; Zhu, Yu; Avouris, Phaedon] IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Lin, YM (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.	yming@us.ibm.com; avouris@us.ibm.com	WU, Yanqing/C-9737-2009; Xia, Fengnian/O-2637-2015; Xia, Fengnian/D-1003-2012; Bol, Ageeth A/E-3071-2014	Xia, Fengnian/0000-0001-5176-368X; Bol, Ageeth A/0000-0002-1259-6265; Avouris, Phaedon/0000-0001-9902-8000	DARPA [FA8650-08-C-7838]	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	We thank T. Graham, B. Ek, J. Bucchignano, C. V. Jahnes and S. Han for technical assistance, and C. Y. Sung, V. Perebeinos, A. Valdes-Garcia, C. Dimitrakopoulos, W. Zhu and H.-Y. Chiu for discussions. This work was supported in part by DARPA through the CERA programme (contract FA8650-08-C-7838). The views, opinions and findings contained in this Letter are those of the authors and should not be interpreted as representing the official views or policies, either expressed or implied, of DARPA or the US Department of Defense.	Avouris P, 2010, NANO LETT, V10, P4285, DOI 10.1021/nl102824h; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Chen ZH, 2007, PHYSICA E, V40, P228, DOI 10.1016/j.physe.2007.06.020; GUMMEL HK, 1969, P IEEE, V57, P2159, DOI 10.1109/PROC.1969.7509; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Huard B, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.236803; Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384; Kim DH, 2008, IEEE ELECTR DEVICE L, V29, P830, DOI 10.1109/LED.2008.2000794; Lee BK, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2928228; LEE J, 2010, IEDM, P568, DOI DOI 10.1109/IEDM.2010.5703422; Lee T. H., 2004, DESIGN CMOS RADIO FR; Lemme MC, 2007, IEEE ELECTR DEVICE L, V28, P282, DOI 10.1109/LED.2007.891668; Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Liao L, 2010, NATURE, V467, P305, DOI 10.1038/nature09405; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Lin YM, 2009, INT EL DEVICES MEET, P216, DOI 10.1109/iedm.2009.5424378; Lin YM, 2009, NANO LETT, V9, P422, DOI 10.1021/nl803316h; Meric I, 2008, INT EL DEVICES MEET, P513; Moon JS, 2009, IEEE ELECTR DEVICE L, V30, P650, DOI 10.1109/LED.2009.2020699; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/NNANO.2010.89, 10.1038/nnano.2010.89]; Sze S. M., 2006, PHYS SEMICONDUCTOR D; Wang XR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206803; Xia FN, 2010, NANO LETT, V10, P715, DOI 10.1021/nl9039636; Young AF, 2009, NAT PHYS, V5, P222, DOI 10.1038/NPHYS1198; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	28	728	754	8	616	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					74	78		10.1038/nature09979	http://dx.doi.org/10.1038/nature09979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475197				2022-12-28	WOS:000289199400039
J	Krupitsky, E; Nunes, EV; Ling, W; Illeperuma, A; Gastfriend, DR; Silverman, BL				Krupitsky, Evgeny; Nunes, Edward V.; Ling, Walter; Illeperuma, Ari; Gastfriend, David R.; Silverman, Bernard L.			Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial	LANCET			English	Article							ALCOHOL; ABSTINENT; EFFICACY	Background Opioid dependence is associated with low rates of treatment-seeking, poor adherence to treatment, frequent relapse, and major societal consequences. We aimed to assess the efficacy, safety, and patient-reported outcomes of an injectable, once monthly extended-release formulation of the opioid antagonist naltrexone (XR-NTX) for treatment of patients with opioid dependence after detoxification. Methods We did a double-blind, placebo-controlled, randomised, 24-week trial of patients with opioid dependence disorder. Patients aged 18 years or over who had 30 days or less of inpatient detoxification and 7 days or more off all opioids were enrolled at 13 clinical sites in Russia. We randomly assigned patients (1:1) to either 380 mg XR-NTX or placebo by an interactive voice response system, stratified by site and gender in a centralised, permuted-block method. Participants also received 12 biweekly counselling sessions. Participants, investigators, staff, and the sponsor were masked to treatment allocation. The primary endpoint was the response profile for confirmed abstinence during weeks 5-24, assessed by urine drug tests and self report of non-use. Secondary endpoints were self-reported opioid-free days, opioid craving scores, number of days of retention, and relapse to physiological opioid dependence. Analyses were by intention to treat. This trial is registered at ClinicalTrials.gov, NCT00678418. Findings Between July 3, 2008, and Oct 5, 2009, 250 patients were randomly assigned to XR-NTX (n=126) or placebo (n=124). The median proportion of weeks of confirmed abstinence was 90.0% (95% CI 69.9-92.4) in the XR-NTX group compared with 35.0% (11.4-63.8) in the placebo group (p=0.0002). Patients in the XR-NTX group self-reported a median of 99.2% (range 89.1-99.4) opioid-free days compared with 60.4% (46.2-94.0) for the placebo group (p=0.0004). The mean change in craving was -10.1 (95% CI -12.3 to -7.8) in the XR-NTX group compared with 0.7 (-3.1 to 4.4) in the placebo group (p<0.0001). Median retention was over 168 days in the XR-NTX group compared with 96 days (95% CI 63-165) in the placebo group (p=0-0042). Naloxone challenge confirmed relapse to physiological opioid dependence in 17 patients in the placebo group compared with one in the XR-NTX group (p<0.0001). XR-NTX was well tolerated. Two patients in each group discontinued owing to adverse events. No XR-NTX-treated patients died, overdosed, or discontinued owing to severe adverse events. Interpretation XR-NTX represents a new treatment option that is distinct from opioid agonist maintenance treatment. XR-NTX in conjunction with psychosocial treatment might improve acceptance of opioid dependence pharmacotherapy and provide a useful treatment option for many patients.	[Krupitsky, Evgeny] Pavlov State Med Univ St Petersburg, VM Bekhterev Psychoneurol Res Inst, St Petersburg, Russia; [Nunes, Edward V.] Columbia Univ, New York State Psychiat Inst, New York, NY USA; [Nunes, Edward V.] Columbia Univ, Dept Psychiat, New York, NY USA; [Ling, Walter] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Illeperuma, Ari; Gastfriend, David R.; Silverman, Bernard L.] Alkermes, Waltham, MA USA	Pavlov First Saint Petersburg State Medical University; V.M. Bekhterev National Research Medical Center Psychiatry & Neurology; Columbia University; New York State Psychiatry Institute; Columbia University; University of California System; University of California Los Angeles; Alkermes	Krupitsky, E (corresponding author), St Petersburg Bekhterev Psychoneurol Res Inst, Dept Addict, Bekhtereva St 3, St Petersburg 192019, Russia.	kruenator@gmail.com	Krupitsky, Evgeny/M-5935-2016	Krupitsky, Evgeny/0000-0002-0529-4525; , Walter/0000-0003-0664-5099	National Institute on Drug Abuse [R43DA013531]; National Institute on Alcohol Abuse and Alcoholism [N43AA001002]; Alkermes; Titan Pharmaceuticals; Hythiam	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Alkermes; Titan Pharmaceuticals; Hythiam	The Medisorb preparation used in XR-NTX was developed with support from the National Institute on Drug Abuse (grant R43DA013531) and National Institute on Alcohol Abuse and Alcoholism (grant N43AA001002). EK is a consultant for Alkermes and received research funding for this study from Alkermes. EVN was a member of the Alkermes advisory board that designed this trial and was an unpaid consultant to an expert panel convened by Alkermes, with approval from the Columbia University Department of Psychiatry. WL has been an advisory board member for Alkermes and US World Med, has received research funding from Titan Pharmaceuticals, investigator initiated research funding from Hythiam, and research support, an unrestricted educational grant, and speaker support from Reckitt Benckiser. AI, DRG, and BLS are full-time employees of Alkermes.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; AMIRDJANOVA VN, 2008, RHEUMATOL SCI PRACT, V1, P36; Ball J.C., 2012, EFFECTIVENESS METHAD; Comer SD, 2006, ARCH GEN PSYCHIAT, V63, P210, DOI 10.1001/archpsyc.63.2.210; Cook C., 2010, GLOBAL STATE HARM RE; Dean RL, 2008, PHARMACOL BIOCHEM BE, V89, P515, DOI 10.1016/j.pbb.2008.02.006; Dijkstra BAG, 2007, ADDICT BIOL, V12, P176, DOI 10.1111/j.1369-1600.2007.00067.x; Dunbar JL, 2006, ALCOHOL CLIN EXP RES, V30, P480, DOI 10.1111/j.1530-0277.2006.00052.x; Garbutt JC, 2005, JAMA-J AM MED ASSOC, V293, P1617, DOI 10.1001/jama.293.13.1617; Gastfriend DR, 2011, ANN NY ACAD SCI, V1216, P144, DOI 10.1111/j.1749-6632.2010.05900.x; Guy W., 1976, ECDEU ASSESSMENT PSY; HOLM S, 1979, SCAND J STAT, V6, P65; HSER YI, 1993, ARCH GEN PSYCHIAT, V50, P577; Hulse GK, 2009, ARCH GEN PSYCHIAT, V66, P1108, DOI 10.1001/archgenpsychiatry.2009.130; Kleber Herbert D, 2007, Dialogues Clin Neurosci, V9, P455; Krupitsky EM, 2004, J SUBST ABUSE TREAT, V26, P285, DOI 10.1016/j.jsat.2004.02.002; Kunoe N, 2009, BRIT J PSYCHIAT, V194, P541, DOI 10.1192/bjp.bp.108.055319; Lobmaier P, 2010, EUR J CLIN PHARMACOL, V66, P537, DOI 10.1007/s00228-010-0793-6; Marsch LA, 1998, ADDICTION, V93, P515, DOI 10.1046/j.1360-0443.1998.9345157.x; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; MCLELLAN AT, 2003, PRINCIPLES ADDICTION, P429; MERCER DE, 1999, THERAPY MANUALS DRUG; Metzger DS, 2001, ENCY DRUGS ALCOHOL A; Minozzi S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001333.pub2; *NAT I DRUG AB, 2005, NIDA RES REP HER AB; Nunes EV, 2006, AM J DRUG ALCOHOL AB, V32, P503, DOI 10.1080/00952990600918973; O'Malley SS, 2007, J CLIN PSYCHOPHARM, V27, P507, DOI 10.1097/jcp.0b013e31814ce50d; *PAR PACT IN, 2008, ILL DRUG TRENDS RUSS; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; *UNODC, WORLD DRUG REP 2010; VANDERWAERDEN BL, 1953, P K NED AKAD WET A, V564, P303; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; Wilcox HC, 2004, DRUG ALCOHOL DEPEN, V76, pS11, DOI 10.1016/j.drugalcdep.2004.08.003; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	35	364	380	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2011	377	9776					1506	1513		10.1016/S0140-6736(11)60358-9	http://dx.doi.org/10.1016/S0140-6736(11)60358-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761RX	21529928				2022-12-28	WOS:000290419400028
J	Siegel, M				Siegel, Michael			A Lost Opportunity for Public Health - The FDA Advisory Committee Report on Menthol	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA 02215 USA	Boston University	Siegel, M (corresponding author), Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA 02215 USA.			Siegel, Michael/0000-0002-2573-9616				MULLINS B, 2004, ROLL CALL       1005; SIEGEL M, 2007, REST STORY TOBACCO N; Tobacco Products Scientific Advisory Committee to the Food and Drug Administration, 2011, MENTH CIG PUBL HLTH; Young A., 2008, ATLANTA J CONST 0529	4	12	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2177	2179		10.1056/NEJMp1103403	http://dx.doi.org/10.1056/NEJMp1103403			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	774NA	21542736				2022-12-28	WOS:000291392100001
J	Rhind, N; Chen, ZH; Yassour, M; Thompson, DA; Haas, BJ; Habib, N; Wapinski, I; Roy, S; Lin, MF; Heiman, DI; Young, SK; Furuya, K; Guo, YB; Pidoux, A; Chen, HM; Robbertse, B; Goldberg, JM; Aoki, K; Bayne, EH; Berlin, AM; Desjardins, CA; Dobbs, E; Dukaj, L; Fan, L; FitzGerald, MG; French, C; Gujja, S; Hansen, K; Keifenheim, D; Levin, JZ; Mosher, RA; Muller, CA; Pfiffner, J; Priest, M; Russ, C; Smialowska, A; Swoboda, P; Sykes, SM; Vaughn, M; Vengrova, S; Yoder, R; Zeng, QD; Allshire, R; Baulcombe, D; Birren, BW; Brown, W; Ekwall, K; Kellis, M; Leatherwood, J; Levin, H; Margalit, H; Martienssen, R; Nieduszynski, CA; Spatafora, JW; Friedman, N; Dalgaard, JZ; Baumann, P; Niki, H; Regev, A; Nusbaum, C				Rhind, Nicholas; Chen, Zehua; Yassour, Moran; Thompson, Dawn A.; Haas, Brian J.; Habib, Naomi; Wapinski, Ilan; Roy, Sushmita; Lin, Michael F.; Heiman, David I.; Young, Sarah K.; Furuya, Kanji; Guo, Yabin; Pidoux, Alison; Chen, Huei Mei; Robbertse, Barbara; Goldberg, Jonathan M.; Aoki, Keita; Bayne, Elizabeth H.; Berlin, Aaron M.; Desjardins, Christopher A.; Dobbs, Edward; Dukaj, Livio; Fan, Lin; FitzGerald, Michael G.; French, Courtney; Gujja, Sharvari; Hansen, Klavs; Keifenheim, Dan; Levin, Joshua Z.; Mosher, Rebecca A.; Mueller, Carolin A.; Pfiffner, Jenna; Priest, Margaret; Russ, Carsten; Smialowska, Agata; Swoboda, Peter; Sykes, Sean M.; Vaughn, Matthew; Vengrova, Sonya; Yoder, Ryan; Zeng, Qiandong; Allshire, Robin; Baulcombe, David; Birren, Bruce W.; Brown, William; Ekwall, Karl; Kellis, Manolis; Leatherwood, Janet; Levin, Henry; Margalit, Hanah; Martienssen, Rob; Nieduszynski, Conrad A.; Spatafora, Joseph W.; Friedman, Nir; Dalgaard, Jacob Z.; Baumann, Peter; Niki, Hironori; Regev, Aviv; Nusbaum, Chad			Comparative Functional Genomics of the Fission Yeasts	SCIENCE			English	Article							SCHIZOSACCHAROMYCES-POMBE; REPLICATION ORIGINS; GENES; HETEROCHROMATIN; CENTROMERE; RNAI; TRANSCRIPTOME; EXPRESSION; INTEGRITY; PROTEINS	The fission yeast clade-comprising Schizosaccharomyces pombe, S. octosporus, S. cryophilus, and S. japonicus-occupies the basal branch of Ascomycete fungi and is an important model of eukaryote biology. A comparative annotation of these genomes identified a near extinction of transposons and the associated innovation of transposon-free centromeres. Expression analysis established that meiotic genes are subject to antisense transcription during vegetative growth, which suggests a mechanism for their tight regulation. In addition, trans-acting regulators control new genes within the context of expanded functional modules for meiosis and stress response. Differences in gene content and regulation also explain why, unlike the budding yeast of Saccharomycotina, fission yeasts cannot use ethanol as a primary carbon source. These analyses elucidate the genome structure and gene regulation of fission yeast and provide tools for investigation across the Schizosaccharomyces clade.	[Rhind, Nicholas; Dukaj, Livio; Keifenheim, Dan] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Chen, Zehua; Haas, Brian J.; Heiman, David I.; Young, Sarah K.; Goldberg, Jonathan M.; Berlin, Aaron M.; Desjardins, Christopher A.; Fan, Lin; FitzGerald, Michael G.; Gujja, Sharvari; Levin, Joshua Z.; Pfiffner, Jenna; Priest, Margaret; Russ, Carsten; Sykes, Sean M.; Zeng, Qiandong; Birren, Bruce W.; Nusbaum, Chad] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02141 USA; [Yassour, Moran; Thompson, Dawn A.; Wapinski, Ilan; Roy, Sushmita; Kellis, Manolis; Regev, Aviv] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Yassour, Moran; Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02139 USA; [Yassour, Moran; Habib, Naomi; Friedman, Nir] Hebrew Univ Jerusalem, Sch Engn & Comp Sci, IL-91904 Jerusalem, Israel; [Habib, Naomi; French, Courtney; Margalit, Hanah] Hebrew Univ Jerusalem, Fac Med, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel; [Wapinski, Ilan] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Roy, Sushmita; Lin, Michael F.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Furuya, Kanji; Aoki, Keita; Niki, Hironori] Res Org Informat & Syst, Genet Strains Res Ctr, Natl Inst Genet, Microbial Genet Lab, Mishima, Shizuoka 4118540, Japan; [Guo, Yabin; Levin, Henry] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [Pidoux, Alison; Bayne, Elizabeth H.; Dobbs, Edward; Allshire, Robin] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Chen, Huei Mei; Leatherwood, Janet] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Robbertse, Barbara; Yoder, Ryan; Spatafora, Joseph W.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Hansen, Klavs; Vaughn, Matthew; Martienssen, Rob] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Mosher, Rebecca A.; Baulcombe, David] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Mueller, Carolin A.; Brown, William; Nieduszynski, Conrad A.] Univ Nottingham, Queens Med Ctr, Ctr Genet & Genom, Nottingham NG7 2UH, England; [Smialowska, Agata; Swoboda, Peter; Ekwall, Karl] Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, S-14138 Huddinge, Sweden; [Smialowska, Agata; Ekwall, Karl] Sodertorns Hgsk, Dept Life Sci, S-14189 Huddinge, Sweden; [Vengrova, Sonya; Dalgaard, Jacob Z.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Friedman, Nir] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; [Baumann, Peter] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Baumann, Peter] Univ Kansas, Sch Med, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Baumann, Peter; Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Edinburgh; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Oregon State University; Cold Spring Harbor Laboratory; University of Cambridge; University of Nottingham; Karolinska Institutet; Sodertorn University; University of Warwick; Hebrew University of Jerusalem; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Howard Hughes Medical Institute	Rhind, N (corresponding author), Univ Massachusetts, Sch Med, 364 Plantat St, Worcester, MA 01605 USA.	nick.rhind@umassmed.edu; aregev@broad.mit.edu; chad@broadinstitute.org	Nieduszynski, Conrad/B-2170-2010; Mosher, Rebecca/F-4800-2010; Margalit, Hanah/H-1651-2013; Chen, Zehua/E-6356-2011; Friedman, Nir/H-9692-2012; Habib, Naomi/AAA-8937-2020; Kellis, Manolis/ABE-7385-2020; Zeng, Qiandong/AAF-3305-2019; Bayne, Elizabeth H/G-5411-2010; Berlin, Aaron M/AFY-6549-2022; chen, zehua/H-1260-2011; Yassour, Moran/ABE-7415-2020; Guo, Yabin/AAS-9022-2021	Nieduszynski, Conrad/0000-0003-2001-076X; Mosher, Rebecca/0000-0003-2195-0825; Friedman, Nir/0000-0002-9678-3550; Kellis, Manolis/0000-0001-7113-9630; Bayne, Elizabeth H/0000-0001-8775-999X; Berlin, Aaron M/0000-0002-0714-2808; Yassour, Moran/0000-0002-7344-5188; Guo, Yabin/0000-0001-8316-8527; Baumann, Peter/0000-0003-4892-1485; Keifenheim, Daniel/0000-0002-4235-8903; Desjardins, Christopher/0000-0002-3160-4734; Rhind, Nicholas/0000-0003-1758-7736; Niki, Hironori/0000-0002-5391-6595; Swoboda, Peter/0000-0001-6416-8572; Allshire, Robin/0000-0002-8005-3625; Baulcombe, David/0000-0003-0780-6878; Brown, William RA/0000-0001-5340-3645; Heiman, David/0000-0001-7895-4259; Aoki, Keita/0000-0003-2079-4031; Dalgaard, Jacob/0000-0001-9545-7254; Vaughn, Matthew/0000-0002-1384-4283; Sykes, Sean/0000-0001-8344-5176; Levin, Joshua/0000-0002-0170-3598; Ekwall, Karl/0000-0002-3029-4041	National Human Genome Research Institute (NHGRI), NIH; NHGRI; Clore Fellowship; NSF; NIH; Danish Research Council; Biotechnology and Biological Science Research Council; Stowers Institute; HHMI; National Institute of Child Health and Human Development, NIH; Sloan Foundation; Human Frontier Science Program; Career Award at the Scientific Interface from the Burroughs Wellcome Fund; BBSRC [BB/E023754/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E023754/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001009] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069957, R01GM076396] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23131515] Funding Source: KAKEN	National Human Genome Research Institute (NHGRI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Clore Fellowship; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Research Council(Det Frie Forskningsrad (DFF)); Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Stowers Institute; HHMI(Howard Hughes Medical Institute); National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Sloan Foundation(Alfred P. Sloan Foundation); Human Frontier Science Program(Human Frontier Science Program); Career Award at the Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Assemblies and annotations are available at GenBank (S. octosporus, ABHY04000000; S. cryophilus, ACQJ02000000; S. japonicus, AATM02000000), the Broad Institute's Schizosaccharomyces Web site (www.broadinstitute.org/annotation/genome/schizosaccharomyces_group), which provides search and visualization tools and pomBase (www.pombase.org). The RNA-Seq and single-nucleotide polymorphism (SNP) data are at the National Center for Biological Information (NCBI), NIH, Sequence Read Archive (see table S42). The S. japonicus siRNA data sets are at NCBI GEO as GSE26902 and GSE27837. This work was supported by the National Human Genome Research Institute (NHGRI), NIH. C.N. and M.F.L. were supported by NHGRI; M.Y. was supported by a Clore Fellowship; I.W. is the Howard Hughes Medical Institute (HHMI) fellow of the Damon Runyon Cancer Research Foundation; S.R. was supported by NSF; R.M. was supported by NIH; K.H. was supported by Danish Research Council; C.A.N and C.A.M were supported by the Biotechnology and Biological Science Research Council; P.B. was supported by the Stowers Institute and HHMI; Y.G. and H.L. were supported by the National Institute of Child Health and Human Development, NIH; M.K. was supported by the NIH, an NSF CAREER award, and the Sloan Foundation; A.R. was supported by the Human Frontier Science Program, a Career Award at the Scientific Interface from the Burroughs Wellcome Fund, the Sloan Foundation, an NIH Director's PIONEER award and HHMI. We thank the Broad Institute Sequencing Platform; A. Fujiyama and A. Toyoda for generating DNA sequence; M. Lara and N. Stange-Thomann for developing molecular biology protocols; J. Robinson, M. Garber, and P. Muller for technical advice and support; A. Klar for providing S. pombe var. kambucha (SPK1820); L. Gaffney for assistance with the figures; K. Mar and J. Mwangi for administrative support; and C. Cuomo for comments on the manuscript.	Abe H, 2000, GENETICS, V154, P1497; ARCANGIOLI B, 1991, EMBO J, V10, P3025, DOI 10.1002/j.1460-2075.1991.tb07853.x; Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; BEACH DH, 1983, NATURE, V305, P682, DOI 10.1038/305682a0; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; Casola C, 2008, MOL BIOL EVOL, V25, P29, DOI 10.1093/molbev/msm221; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Eaton ML, 2010, GENE DEV, V24, P748, DOI 10.1101/gad.1913210; EGEL R, 1984, CURR GENET, V8, P205, DOI 10.1007/BF00417817; Flores CL, 2000, FEMS MICROBIOL REV, V24, P507, DOI 10.1111/j.1574-6976.2000.tb00553.x; Forsburg SL, 1999, TRENDS GENET, V15, P340, DOI 10.1016/S0168-9525(99)01798-9; Gomez M, 1999, EMBO J, V18, P5683, DOI 10.1093/emboj/18.20.5683; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Grewal SIS, 1997, GENETICS, V146, P1221; Ishii K, 2008, SCIENCE, V321, P1088, DOI 10.1126/science.1158699; Kaufer NF, 2000, NUCLEIC ACIDS RES, V28, P3003, DOI 10.1093/nar/28.16.3003; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; LIN MF, NATURE PRECEDINGS; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Matsuzawa T, 2010, APPL MICROBIOL BIOT, V87, P715, DOI 10.1007/s00253-010-2586-3; Moldon A, 2008, NATURE, V455, P997, DOI 10.1038/nature07325; Ni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015271; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; Sayrac S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001328; Singh G, 2002, GENETICS, V162, P591; STEINER NC, 1993, MOL CELL BIOL, V13, P4578, DOI 10.1128/MCB.13.8.4578; Uo T, 2001, J BACTERIOL, V183, P2226, DOI 10.1128/JB.183.7.2226-2233.2001; Vengrova S, 2004, GENE DEV, V18, P794, DOI 10.1101/gad.289404; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wong LH, 2004, TRENDS GENET, V20, P611, DOI 10.1016/j.tig.2004.09.011; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Zaratiegui M, 2011, NATURE, V469, P112, DOI 10.1038/nature09608; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	43	337	793	4	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					930	936		10.1126/science.1203357	http://dx.doi.org/10.1126/science.1203357			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21511999	Green Accepted, Green Submitted			2022-12-28	WOS:000290766600034
J	Beasley, BN; Unger, EF; Temple, R				Beasley, B. Nhi; Unger, Ellis F.; Temple, Robert			Anticoagulant Options - Why the FDA Approved a Higher but Not a Lower Dose of Dabigatran	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ATRIAL-FIBRILLATION; WARFARIN		[Beasley, B. Nhi] US FDA, Div Cardiovasc & Renal Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Unger, Ellis F.; Temple, Robert] US FDA, Off Drug Evaluat 1, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Beasley, BN (corresponding author), US FDA, Div Cardiovasc & Renal Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							[Anonymous], 2010, GUIDANCE IND NONINFE; Birman-Deych E, 2006, STROKE, V37, P1070, DOI 10.1161/01.STR.0000208294.46968.a4; Connolly SJ, 2010, NEW ENGL J MED, V363, P1877; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; fda, FDA APPR DRUG PROD; *FOOD DRUG ADM CTR, DAB PROP IND PREV ST	6	190	200	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2011	364	19					1788	1790		10.1056/NEJMp1103050	http://dx.doi.org/10.1056/NEJMp1103050			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MM	21488759				2022-12-28	WOS:000290483000003
J	Darmstadt, GL				Darmstadt, Gary L.			Stillbirths: missing from the family and from family health	LANCET			English	Editorial Material							SURVIVAL; NEWBORN; INTERVENTIONS; STRATEGIES; MORTALITY; IMPACT		Bill & Melinda Gates Fdn, Global Hlth Program, Family Hlth Div, Seattle, WA 98102 USA	Bill & Melinda Gates Foundation	Darmstadt, GL (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, Family Hlth Div, Seattle, WA 98102 USA.	gary.darmstadt@gatesfoundation.org	Darmstadt, Gary/AAU-7488-2020	Darmstadt, Gary/0000-0002-7522-5824				BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Haws RA, 2010, SOC SCI MED, V71, P1764, DOI 10.1016/j.socscimed.2010.03.051; Kumar V, 2010, SEMIN PERINATOL, V34, P446, DOI 10.1053/j.semperi.2010.09.006; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Lee ACC, 2008, PEDIATRICS, V121, pE1381, DOI 10.1542/peds.2007-1966; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Rubens CE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S7; Yakoob MY, 2010, SEMIN PERINATOL, V34, P387, DOI 10.1053/j.semperi.2010.09.010	14	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 7	2011	377	9777					1550	1551		10.1016/S0140-6736(11)60099-8	http://dx.doi.org/10.1016/S0140-6736(11)60099-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	763IJ	21496909				2022-12-28	WOS:000290549700007
J	Kim, HJ; Ruszczycky, MW; Choi, SH; Liu, YN; Liu, HW				Kim, Hak Joong; Ruszczycky, Mark W.; Choi, Sei-hyun; Liu, Yung-nan; Liu, Hung-wen			Enzyme-catalysed [4+2] cycloaddition is a key step in the biosynthesis of spinosyn A	NATURE			English	Article							DIELS-ALDER REACTION; MACROPHOMATE SYNTHASE; SACCHAROPOLYSPORA-SPINOSA; SUGAR BIOSYNTHESIS; MECHANISM	The Diels-Alder reaction is a [4+2] cycloaddition reaction in which a cyclohexene ring is formed between a 1,3-diene and an electron-deficient alkene via a single pericyclic transition state(1). This reaction has been proposed as a key transformation in the biosynthesis of many cyclohexene-containing secondary metabolites(2-5). However, only four purified enzymes have thus far been implicated in biotransformations that are consistent with a Diels-Alder reaction, namely solanapyrone synthase(6), LovB(7,8), macrophomate synthase(9,10), and riboflavin synthase(11,12). Although the stereochemical outcomes of these reactions indicate that the product formation could be enzyme-guided in each case, these enzymes typically demonstrate more than one catalytic activity, leaving their specific influence on the cycloaddition step uncertain. In our studies of the biosynthesis of spinosyn A, a tetracyclic polyketide-derived insecticide from Saccharopolyspora spinosa(13,14), we identified a cyclase, SpnF, that catalyses a transannular [4+2] cycloaddition to form the cyclohexene ring in spinosyn A. Kinetic analysis demonstrates that SpnF specifically accelerates the ring formation reaction with an estimated 500-fold rate enhancement. A second enzyme, SpnL, was also identified as responsible for the final cross-bridging step that completes the tetracyclic core of spinosyn A in a manner consistent with a Rauhut-Currier reaction(15). This work is significant because SpnF represents the first example characterized in vitro of a standalone enzyme solely committed to the catalysis of a [4+2] cycloaddition reaction. In addition, the mode of formation of the complex perhydro-as-indacene moiety in spinosyn A is now fully established.	[Kim, Hak Joong; Choi, Sei-hyun; Liu, Hung-wen] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Ruszczycky, Mark W.; Liu, Yung-nan; Liu, Hung-wen] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Liu, HW (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	h.w.liu@mail.utexas.edu	Kim, Hak Joong/D-1117-2013		National Institutes of Health [GM035906, F32AI082906]; Texas Higher Education Coordination Board [ARP-003658-0093-2007]; Welch Foundation [F-1511]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI082906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040541, R01GM035906, R37GM035906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Higher Education Coordination Board; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Whitman for review of the manuscript, L. Hong for carrying out the early cloning work, B. Shoulders and S. Sorey for assistance with the interpretation of the NMR spectra, and S. Mansoorabadi and E. Isiorho for discussions on the reaction mechanisms and structural modelling of SpnF. This work is supported in part by grants from the National Institutes of Health (GM035906, F32AI082906), the Texas Higher Education Coordination Board (ARP-003658-0093-2007), and the Welch Foundation (F-1511).	Aroyan CE, 2009, TETRAHEDRON, V65, P4069, DOI 10.1016/j.tet.2009.02.066; Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; Chen YL, 2009, J BIOL CHEM, V284, P7352, DOI 10.1074/jbc.M808441200; Draper NR., 1998, WILEY SERIES PROBABI, V3rd ed.; Eberhardt S, 2001, EUR J BIOCHEM, V268, P4315, DOI 10.1046/j.1432-1327.2001.02351.x; FRIEDEN C, 1994, METHOD ENZYMOL, V240, P311; Guimaraes CRW, 2005, J AM CHEM SOC, V127, P3577, DOI 10.1021/ja043905b; HUISGEN R, 1968, ANGEW CHEM INT EDIT, V7, P321, DOI 10.1002/anie.196803211; Kelly WL, 2008, ORG BIOMOL CHEM, V6, P4483, DOI 10.1039/b814552k; Kim HJ, 2007, J AM CHEM SOC, V129, P14582, DOI 10.1021/ja076580i; Kim HJ, 2010, J AM CHEM SOC, V132, P2901, DOI 10.1021/ja910223x; Kim RR, 2010, J AM CHEM SOC, V132, P2983, DOI 10.1021/ja908395r; KIRST HA, 1991, TETRAHEDRON LETT, V32, P4839, DOI 10.1016/S0040-4039(00)93474-9; Kirst HA, 2010, J ANTIBIOT, V63, P101, DOI 10.1038/ja.2010.5; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Martin CJ, 2003, ORG BIOMOL CHEM, V1, P4144, DOI 10.1039/b310740j; Mergott DJ, 2004, P NATL ACAD SCI USA, V101, P11955, DOI 10.1073/pnas.0401247101; Oikawa H, 2005, B CHEM SOC JPN, V78, P537, DOI 10.1246/bcsj.78.537; Oikawa H, 2003, J ORG CHEM, V68, P3552, DOI 10.1021/jo0267596; OIKAWA H, 1995, J CHEM SOC CHEM COMM, P1321, DOI 10.1039/c39950001321; Oikawa H, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 8: ENZYMES AND ENZYME MECHANISMS, P277; Ose T, 2003, NATURE, V422, P185, DOI 10.1038/nature01454; Serafimov JM, 2008, J AM CHEM SOC, V130, P7798, DOI 10.1021/ja8017994; Stocking EM, 2003, ANGEW CHEM INT EDIT, V42, P3078, DOI 10.1002/anie.200200534; Tenenbaum M., 1985, ORDINARY DIFFERENTIA; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Waldron C, 2001, CHEM BIOL, V8, P487, DOI 10.1016/S1074-5521(01)00029-1; Watanabe K, 2000, J BIOL CHEM, V275, P38393, DOI 10.1074/jbc.M003119200	29	223	223	8	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					109	112		10.1038/nature09981	http://dx.doi.org/10.1038/nature09981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544146	Green Accepted			2022-12-28	WOS:000290218300041
J	Prud'homme, B; Minervino, C; Hocine, M; Cande, JD; Aouane, A; Dufour, HD; Kassner, VA; Gompel, N				Prud'homme, Benjamin; Minervino, Caroline; Hocine, Melanie; Cande, Jessica D.; Aouane, Aicha; Dufour, Heloise D.; Kassner, Victoria A.; Gompel, Nicolas			Body plan innovation in treehoppers through the evolution of an extra wing-like appendage	NATURE			English	Article							BEETLE TRIBOLIUM-CASTANEUM; INSECT WINGS; GENE; CONSTRAINTS; ORIGIN	Body plans, which characterize the anatomical organization of animal groups of high taxonomic rank(1), often evolve by the reduction or loss of appendages (limbs in vertebrates and legs and wings in insects, for example). In contrast, the addition of new features is extremely rare and is thought to be heavily constrained, although the nature of the constraints remains elusive(2-4). Here we show that the treehopper (Membracidae) 'helmet' is actually an appendage, a wing serial homologue on the first thoracic segment. This innovation in the insect body plan is an unprecedented situation in 250 Myr of insect evolution. We provide evidence suggesting that the helmet arose by escaping the ancestral repression of wing formation imparted by a member of the Hox gene family, which sculpts the number and pattern of appendages along the body axis(5-8). Moreover, we propose that the exceptional morphological diversification of the helmet was possible because, in contrast to the wings, it escaped the stringent functional requirements imposed by flight. This example illustrates how complex morphological structures can arise by the expression of ancestral developmental potentials and fuel the morphological diversification of an evolutionary lineage.	[Prud'homme, Benjamin; Minervino, Caroline; Hocine, Melanie; Cande, Jessica D.; Aouane, Aicha; Gompel, Nicolas] CNRS, UMR 6216, Inst Biol Dev Marseille Luminy, F-13288 Marseille 9, France; [Dufour, Heloise D.; Kassner, Victoria A.] Univ Wisconsin, Madison, WI 53706 USA; [Dufour, Heloise D.; Kassner, Victoria A.] Howard Hughes Med Inst, Bock Labs, Madison, WI 53706 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute	Prud'homme, B (corresponding author), CNRS, UMR 6216, Inst Biol Dev Marseille Luminy, Case 907,Parc Sci Luminy, F-13288 Marseille 9, France.	benjamin.prudhomme@univmed.fr; nicolas.gompel@univmed.fr		Hocine, Melanie/0000-0003-2830-9918; Dufour, Heloise/0000-0001-7934-7549; Gompel, Nicolas/0000-0003-3358-7963	EURYI award; Human Frontier Science Program; CNRS	EURYI award(European Science Foundation (ESF)); Human Frontier Science Program(Human Frontier Science Program); CNRS(Centre National de la Recherche Scientifique (CNRS))	We are grateful to G. Moragues for inspiring the project and the loan of specimens. We thank S. B. Carroll for discussions and support during the early stage of the project; M. Morgan and S. Morgan for access to their field property; J. P. Chauvin for assistance with SEM; S. McKamey and C. Dietrich for help with bibliography; D. Milo for discussions; and D. Andrews, M. Averof, S. B. Carroll, A. Kopp, A. Salzberg and Y. Tomoyasu for sharing reagents. We used FlyBase for information support. We also thank F. Leulier, T. Lecuit, M. Averof, C. Desplan and S. B. Carroll for comments on the manuscript. This work was supported by a EURYI award, a Human Frontier Science Program Career Development Award and the CNRS. J.D.C. was supported by a Human Frontier Science Program Long-term fellowship.	Angelini DR, 2005, ANNU REV GENET, V39, P95, DOI 10.1146/annurev.genet.39.073003.112310; [Anonymous], 1861, ORIGIN SPECIES MEANS; Averof M, 1997, NATURE, V385, P627, DOI 10.1038/385627a0; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; Boulard M., 1973, Bulletin Mus Natn Hist nat Paris, V83, P145; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; Chesebro J, 2009, DEV BIOL, V329, P142, DOI 10.1016/j.ydbio.2009.01.032; Cifuentes FJ, 1997, P NATL ACAD SCI USA, V94, P11405, DOI 10.1073/pnas.94.21.11405; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Comstock JH, 1918, WINGS INSECTS; Di-Poi N, 2010, NATURE, V464, P99, DOI 10.1038/nature08789; Dietrich Christopher H., 2002, Denisia, V4, P155; Fowler W. W, 1894, BIOL CENTRALI AM, P1; Grimaldi David, 2005, pi; KUKALOVAPECK J, 1978, J MORPHOL, V156, P53, DOI 10.1002/jmor.1051560104; Moczek AP, 2006, DEV GENES EVOL, V216, P655, DOI 10.1007/s00427-006-0087-2; Pavlopoulos A, 2009, P NATL ACAD SCI USA, V106, P13897, DOI 10.1073/pnas.0902804106; Poinar Jr. G.O., 1999, AMBER FOREST; POULTON EB, 1903, MONOGRAPH MEMBRACIDA, P273; Raff R. A., 1996, SHAPE LIFE GENES DEV; Richter L., 1953, Lozania, Vno. 7, P1; RIEDL R, 1977, Q REV BIOL, V52, P351, DOI 10.1086/410123; Rogers BT, 1997, DEVELOPMENT, V124, P149; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Snodgrass Robert Evans, 1909, Proceedings of the United States National Museum Smithsonian Institution Washington, V36; Stegmann UE, 1998, J MORPHOL, V238, P157, DOI 10.1002/(SICI)1097-4687(199811)238:2<157::AID-JMOR3>3.0.CO;2-H; Tomoyasu Y, 2005, NATURE, V433, P643, DOI 10.1038/nature03272	29	65	68	0	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					83	86		10.1038/nature09977	http://dx.doi.org/10.1038/nature09977			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544145				2022-12-28	WOS:000290218300035
J	Rogal, SS; Ukomadu, C; Levy, BD; Loscalzo, J				Rogal, Shari S.; Ukomadu, Chinweike; Levy, Bruce D.; Loscalzo, Joseph			A Sweet Source of Abdominal Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RHEUMATOID-ARTHRITIS; HEPATIC GLYCOGENOSIS; DIABETES-MELLITUS; LIVER-DISEASE; METHOTREXATE; TESTS		[Levy, Bruce D.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Dept Med, Harvard Inst Med Bldg,Ave Louis Pasteur HIM855, Boston, MA 02115 USA.	blevy@partners.org	Loscalzo, Joseph/ABD-8980-2021					Abaci A, 2008, J DIABETES COMPLICAT, V22, P325, DOI 10.1016/j.jdiacomp.2007.11.002; Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Amital H, 2009, RHEUMATOLOGY, V48, P1107, DOI 10.1093/rheumatology/kep176; Cersosimo E, 1997, AM J PHYSIOL-ENDOC M, V272, pE756, DOI 10.1152/ajpendo.1997.272.5.E756; Chatila R, 1996, MEDICINE, V75, P327, DOI 10.1097/00005792-199611000-00003; Hashkes PJ, 1999, J PEDIATR-US, V134, P47, DOI 10.1016/S0022-3476(99)70371-9; KREMER JM, 1994, ARTHRITIS RHEUM-US, V37, P316, DOI 10.1002/art.1780370304; Mauriac P., 1930, GAX HEBD MED BORDEAU, V26, P402; Munns CFJ, 2000, J PAEDIATR CHILD H, V36, P449, DOI 10.1046/j.1440-1754.2000.00547.x; Nakamuta Makoto, 1993, Fukuoka Acta Medica, V84, P354; OLSSON R, 1989, J CLIN GASTROENTEROL, V11, P541, DOI 10.1097/00004836-198910000-00010; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sayuk GS, 2007, DIGEST DIS SCI, V52, P936, DOI 10.1007/s10620-006-9430-8; Torbenson M, 2006, AM J SURG PATHOL, V30, P508, DOI 10.1097/00000478-200604000-00012; WALKER AM, 1993, ARTHRITIS RHEUM, V36, P329, DOI 10.1002/art.1780360307	15	9	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1762	1767		10.1056/NEJMcps0905921	http://dx.doi.org/10.1056/NEJMcps0905921			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759DC	21542747				2022-12-28	WOS:000290219800014
J	Chiu, JC; Ko, HW; Edery, I				Chiu, Joanna C.; Ko, Hyuk Wan; Edery, Isaac			NEMO/NLK Phosphorylates PERIOD to Initiate a Time-Delay Phosphorylation Circuit that Sets Circadian Clock Speed	CELL			English	Article							SLEEP PHASE SYNDROME; DROSOPHILA CLOCK; PROTEIN; GENE; MELANOGASTER; MUTATION; KINASE; NEUROSPORA; DOUBLETIME; MUTANTS	The speed of circadian clocks in animals is tightly linked to complex phosphorylation programs that drive daily cycles in the levels of PERIOD (PER) proteins. Using Drosophila, we identify a time-delay circuit based on hierarchical phosphorylation that controls the daily downswing in PER abundance. Phosphorylation by the NEMO/NLK kinase at the "per-short" domain on PER stimulates phosphorylation by DOUBLETIME (DBT/CK1 delta/epsilon) at several nearby sites. This multisite phosphorylation operates in a spatially oriented and graded manner to delay progressive phosphorylation by DBT at other more distal sites on PER, including those required for recognition by the F box protein SLIMB/beta-TrCP and proteasomal degradation. Highly phosphorylated PER has a more open structure, suggesting that progressive increases in global phosphorylation contribute to the timing mechanism by slowly increasing PER susceptibility to degradation. Our findings identify NEMO as a clock kinase and demonstrate that long-range interactions between functionally distinct phospho-clusters collaborate to set clock speed.	[Chiu, Joanna C.; Ko, Hyuk Wan; Edery, Isaac] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Chiu, Joanna C.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Rutgers State University New Brunswick; University of California System; University of California Davis	Edery, I (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	edery@cabm.rutgers.edu		KO, HYUK WAN/0000-0003-1753-1900; Chiu, Joanna/0000-0001-7613-8127	NIH [R01NS03498, K99/R00NS061952]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS061952, K99NS061952, R01NS034958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Paul Hardin (Texas A&M, USA) for communicating unpublished results (Yu et al., 2011), Thomas Kusch (Rutgers University, USA) for Sfx cells, and the VDRC (Vienna, Austria) for RNAi lines. We thank Axel Diernfellner and Michael Brunner (Heidelberg University, Germany) for conditions for limited proteolysis. This work was supported by NIH grant (R01NS03498) to I. E. and NIH grant (K99/R00NS061952) to J.C.C.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Bae K, 2006, J BIOCHEM, V140, P609, DOI 10.1093/jb/mvj198; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; BAYLIES MK, 1992, NEURON, V9, P575, DOI 10.1016/0896-6273(92)90194-I; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; Brunner M, 2006, GENE DEV, V20, P1061, DOI 10.1101/gad.1410406; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Hamblen MJ, 1998, GENETICS, V149, P165; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Kadener S, 2008, PLOS BIOL, V6, P965, DOI 10.1371/journal.pbio.0060119; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kim EY, 2007, MOL CELL BIOL, V27, P5014, DOI 10.1128/MCB.02339-06; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Ko HW, 2005, METHOD ENZYMOL, V393, P394, DOI 10.1016/S0076-6879(05)93018-8; Ko HW, 2007, J BIOL RHYTHM, V22, P488, DOI 10.1177/0748730407306929; Ko HW, 2010, J NEUROSCI, V30, P12664, DOI 10.1523/JNEUROSCI.1586-10.2010; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1994, J BIOL RHYTHM, V9, P189, DOI 10.1177/074873049400900303; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Markson JS, 2009, FEBS LETT, V583, P3938, DOI 10.1016/j.febslet.2009.11.021; Marrus SB, 1996, EMBO J, V15, P6877, DOI 10.1002/j.1460-2075.1996.tb01080.x; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Nawathean P, 2007, MOL CELL BIOL, V27, P5002, DOI 10.1128/MCB.02338-06; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; RUTILA JE, 1992, J NEUROGENET, V8, P101, DOI 10.3109/01677069209084155; Schibler U, 2006, PROG BRAIN RES, V153, P271, DOI 10.1016/S0079-6123(06)53016-X; Sidote D, 1998, MOL CELL BIOL, V18, P2004, DOI 10.1128/MCB.18.4.2004; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; YU Q, 1987, P NATL ACAD SCI USA, V84, P784, DOI 10.1073/pnas.84.3.784; Yu WJ, 2011, CURR BIOL, V21, P756, DOI 10.1016/j.cub.2011.02.037; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177	52	125	128	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					357	370		10.1016/j.cell.2011.04.002	http://dx.doi.org/10.1016/j.cell.2011.04.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21514639	Green Accepted, Bronze			2022-12-28	WOS:000290022900006
J	Maillard, RA; Chistol, G; Sen, M; Righini, M; Tan, JY; Kaiser, CM; Hodges, C; Martin, A; Bustamante, C				Maillard, Rodrigo A.; Chistol, Gheorghe; Sen, Maya; Righini, Maurizio; Tan, Jiongyi; Kaiser, Christian M.; Hodges, Courtney; Martin, Andreas; Bustamante, Carlos			ClpX(P) Generates Mechanical Force to Unfold and Translocate Its Protein Substrates	CELL			English	Article							GREEN FLUORESCENT PROTEIN; OPERATING PRINCIPLES; RNA-POLYMERASE; MOLECULE; DEGRADATION; MACHINE; THERMODYNAMICS; PROTEOLYSIS; RESOLUTION; PROTEASES	AAA(+) unfoldases denature and translocate polypeptides into associated peptidases. We report direct observations of mechanical, force-induced protein unfolding by the ClpX unfoldase from E. coli, alone, and in complex with the ClpP peptidase. ClpX hydrolyzes ATP to generate mechanical force and translocate polypeptides through its central pore. Threading is interrupted by pauses that are found to be off the main translocation pathway. ClpX's translocation velocity is force dependent, reaching a maximum of 80 aa/s near-zero force and vanishing at around 20 pN. ClpX takes 1, 2, or 3 nm steps, suggesting a fundamental step-size of 1 nm and a certain degree of intersubunit coordination. When ClpX encounters a folded protein, it either overcomes this mechanical barrier or slips on the polypeptide before making another unfolding attempt. Binding of ClpP decreases the slip probability and enhances the unfolding efficiency of ClpX. Under the action of ClpXP, GFP unravels cooperatively via a transient intermediate.	[Maillard, Rodrigo A.; Righini, Maurizio; Kaiser, Christian M.; Martin, Andreas; Bustamante, Carlos] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Maillard, Rodrigo A.; Chistol, Gheorghe; Sen, Maya; Righini, Maurizio; Tan, Jiongyi; Kaiser, Christian M.; Hodges, Courtney; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Maillard, Rodrigo A.; Chistol, Gheorghe; Kaiser, Christian M.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Sen, Maya; Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Martin, Andreas; Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Martin, A (corresponding author), Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA.	a.martin@berkeley.edu; carlos@alice.berkeley.edu		Chistol, Gheorghe/0000-0003-4868-3667; Hodges, H. Courtney/0000-0003-4441-497X; Bustamante, Carlos/0000-0002-2970-0073; Martin, Andreas/0000-0003-0923-3284; Righini, Maurizio/0000-0002-8454-8887	NSF; QB3 Institute; NIH [5K99GM086516, R01-GM0325543]; Searle Scholars Program; Lawrence Berkeley National Laboratory; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094497, K99GM086516, R01GM032543] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); QB3 Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lacramioara Bintu, Craig Hetherington, and Phillip Elms for helpful discussions. M.S. acknowledges support from the NSF Graduate Research Fellowship. C.M.K. acknowledges support from the QB3 Institute (Distinguished Postdoctoral Fellowship) and the NIH K99 Award (5K99GM086516). This research was supported in part by the Searle Scholars Program (A.M.), the NIH grant R01-GM0325543, the Lawrence Berkeley National Laboratory, and the Howard Hughes Medical Institute (C.B.).	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Bertz M, 2008, ANGEW CHEM INT EDIT, V47, P8192, DOI 10.1002/anie.200802987; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Bustamante C, 2001, ACCOUNTS CHEM RES, V34, P412, DOI 10.1021/ar0001719; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Bustamante C, 2011, CELL, V144, P480, DOI 10.1016/j.cell.2011.01.033; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Horwich AL, 1999, P NATL ACAD SCI USA, V96, P11033, DOI 10.1073/pnas.96.20.11033; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Mickler M, 2007, P NATL ACAD SCI USA, V104, P20268, DOI 10.1073/pnas.0705458104; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Shin Y, 2009, P NATL ACAD SCI USA, V106, P19340, DOI 10.1073/pnas.0910484106; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yildiz A, 2005, TRENDS CELL BIOL, V15, P112, DOI 10.1016/j.tcb.2004.12.007; Yin J, 2005, P NATL ACAD SCI USA, V102, P15815, DOI 10.1073/pnas.0507705102	35	196	201	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					459	469		10.1016/j.cell.2011.04.010	http://dx.doi.org/10.1016/j.cell.2011.04.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529717	Green Accepted, Bronze			2022-12-28	WOS:000290022900014
J	Bollinger, AT; Dubuis, G; Yoon, J; Pavuna, D; Misewich, J; Bozovic, I				Bollinger, A. T.; Dubuis, G.; Yoon, J.; Pavuna, D.; Misewich, J.; Bozovic, I.			Superconductor-insulator transition in La2-xSrxCuO4 at the pair quantum resistance	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTIVITY; INTERFACE SUPERCONDUCTIVITY; 2-DIMENSIONAL LIMIT; SUPERFLUID DENSITY; GROUND-STATE; LIQUID; FILMS	High-temperature superconductivity in copper oxides arises when a parent insulator compound is doped beyond some critical concentration; what exactly happens at this superconductor-insulator transition is a key open question(1). The cleanest approach is to tune the carrier density using the electric field effect(2-7); for example, it was learned in this way(5) that weak electron localization transforms superconducting SrTiO3 into a Fermi-glass insulator. But in the copper oxides this has been a long-standing technical challenge(3), because perfect ultrathin films and huge local fields (>10(9) V m(-1)) are needed. Recently, such fields have been obtained using electrolytes or ionic liquids in the electric double-layer transistor configuration(8-10). Here we report synthesis of epitaxial films of La2 - xSrxCuO4 that are one unit cell thick, and fabrication of double-layer transistors. Very large fields and induced changes in surface carrier density enable shifts in the critical temperature by up to 30 K. Hundreds of resistance versus temperature and carrier density curves were recorded and shown to collapse onto a single function, as predicted for a two-dimensional superconductor-insulator transition(11-14). The observed critical resistance is precisely the quantum resistance for pairs, R-Q = h/(2e)(2) = 6.45 k Omega, suggestive of a phase transition driven by quantum phase fluctuations, and Cooper pair (de) localization.	[Bollinger, A. T.; Dubuis, G.; Yoon, J.; Misewich, J.; Bozovic, I.] Brookhaven Natl Lab, Upton, NY 11973 USA; [Dubuis, G.; Pavuna, D.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	United States Department of Energy (DOE); Brookhaven National Laboratory; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Bozovic, I (corresponding author), Brookhaven Natl Lab, Upton, NY 11973 USA.	bozovic@bnl.gov	Dubuis, Guy/A-6849-2012	Dubuis, Guy/0000-0002-8199-4953	US Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division; US DOE, Energy Frontier Research Center; Laboratory for Physics of Complex Matter (EPFL); Swiss National Science Foundation	US Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); US DOE, Energy Frontier Research Center(United States Department of Energy (DOE)); Laboratory for Physics of Complex Matter (EPFL); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work at BNL was supported by the US Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division. A. T. B. was supported by the US DOE, Energy Frontier Research Center. D. P. and G. D. were supported by the Laboratory for Physics of Complex Matter (EPFL) and the Swiss National Science Foundation. We are grateful to A. Tsvelik, J. C. Davis, A. Balatsky, P. N. Armitage, A. Goldman, V. Gantmakher, I. Herbut, Z. Tesanovic, A. Chubukov, J. Mannhart, J.-M. Triscone, N. Markovic, N. Mason and M. Norman for comments and suggestions and to R. Adzic, G. Logvenov, J. Pereiro, J. Sadovsky and R. Sundling for technical help.	Ahn CH, 2006, REV MOD PHYS, V78, P1185, DOI 10.1103/RevModPhys.78.1185; Bell C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.226802; Bilbro LS, 2011, NAT PHYS, V7, P298, DOI [10.1038/nphys1912, 10.1038/NPHYS1912]; Biscaras J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1084; Broun DM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.237003; Caviglia AD, 2008, NATURE, V456, P624, DOI 10.1038/nature07576; Dhoot AS, 2010, ADV MATER, V22, P2529, DOI 10.1002/adma.200904024; FISHER MPA, 1990, PHYS REV LETT, V64, P587, DOI 10.1103/PhysRevLett.64.587; Gantmakher VF, 2010, PHYS-USP+, V53, P1, DOI 10.3367/UFNe.0180.201001a.0003; Goldman AM, 1998, PHYS TODAY, V51, P39, DOI 10.1063/1.882069; Gozar A, 2008, NATURE, V455, P782, DOI 10.1038/nature07293; Herbut IF, 2000, PHYS REV B, V61, P14723, DOI 10.1103/PhysRevB.61.14723; Hetel I, 2007, NAT PHYS, V3, P700, DOI 10.1038/nphys707; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Li L, 2007, NAT PHYS, V3, P311, DOI 10.1038/nphys563; Logvenov G, 2009, SCIENCE, V326, P699, DOI 10.1126/science.1178863; Mason N, 1999, PHYS REV LETT, V82, P5341, DOI 10.1103/PhysRevLett.82.5341; Matthey D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057002; Parendo KA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197004; Phillips P, 2003, SCIENCE, V302, P243, DOI 10.1126/science.1088253; Smadici S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.107004; Sondhi SL, 1997, REV MOD PHYS, V69, P315, DOI 10.1103/RevModPhys.69.315; Steiner MA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.212501; Tesanovic Z, 2008, NAT PHYS, V4, P408, DOI 10.1038/nphys910; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Valla T, 2006, SCIENCE, V314, P1914, DOI 10.1126/science.1134742; WANG T, 1991, PHYS REV B, V43, P8623, DOI 10.1103/PhysRevB.43.8623; YAZDANI A, 1995, PHYS REV LETT, V74, P3037, DOI 10.1103/PhysRevLett.74.3037; Ye JT, 2010, NAT MATER, V9, P125, DOI [10.1038/NMAT2587, 10.1038/nmat2587]	30	379	383	13	389	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					458	460		10.1038/nature09998	http://dx.doi.org/10.1038/nature09998			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525929				2022-12-28	WOS:000289949600031
J	Turner, MR; Camacho, X; Fischer, HD; Austin, PC; Anderson, GM; Rochon, PA; Lipscombe, LL				Turner, Marci R.; Camacho, Ximena; Fischer, Hadas D.; Austin, Peter C.; Anderson, Geoff M.; Rochon, Paula A.; Lipscombe, Lorraine L.			Levothyroxine dose and risk of fractures in older adults: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							THYROID-STIMULATING HORMONE; BONE-MINERAL DENSITY; SEROTONIN-REUPTAKE INHIBITORS; SUBCLINICAL HYPERTHYROIDISM; HIP-FRACTURES; ADMINISTRATIVE DATA; HYPOTHYROID PATIENTS; SUBSEQUENT FRACTURE; ATRIAL-FIBRILLATION; LONG-TERM	Objective To quantify the effect of levothyroxine dose on risk of fractures in older adults. Design Nested case-control study. Setting Population based health databases, Ontario, Canada. Participants Adults aged 70 or more prescribed levothyroxine between 1 April 2002 and 31 March 2007 and followed for fractures until 31 March 2008. Cases were cohort members admitted to hospital for any fracture, matched with up to five controls from within the cohort who had not yet had a fracture. Main outcome measure Primary outcome was fracture (wrist or forearm, shoulder or upper arm, thoracic spine, lumbar spine and pelvis, hip or femur, or lower leg or ankle) in relation to levothyroxine use (current, recent past, remote). Risk among current users was compared between those prescribed high, medium, and low cumulative levothyroxine doses in the year before fracture. Results Of 213 511 prevalent levothyroxine users identified, 22 236 (10.4%) experienced a fracture over a mean 3.8 years of follow-up, 18 108 (88%) of whom were women. Compared with remote levothyroxine use, current use was associated with a significantly higher risk of fracture (adjusted odds ratio 1.88, 95% confidence interval 1.71 to 2.05), despite adjustment for numerous risk factors. Among current users, high and medium cumulative doses (>0.093 mg/day and 0.044-0.093 mg/day) were associated with a significantly increased risk of fracture compared with low cumulative doses (<0.044 mg/day): 3.45 (3.27 to 3.65) and 2.62 (2.50 to 2.76), respectively. Conclusion Among adults aged 70 or more, current levothyroxine treatment was associated with a significantly increased risk of fracture, with a strong dose-response relation. Ongoing monitoring of levothyroxine dose is important to avoid overtreatment in this population.	[Rochon, Paula A.; Lipscombe, Lorraine L.] Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada; [Turner, Marci R.] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Camacho, Ximena; Fischer, Hadas D.; Austin, Peter C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Anderson, Geoff M.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University of Toronto	Lipscombe, LL (corresponding author), Womens Coll Res Inst, 790 Bay St, Toronto, ON M5G 1N8, Canada.	lorraine.lipscombe@wchospital.ca	Rochon, Paula A/J-2918-2016	Rochon, Paula A/0000-0002-5973-4151	Canadian Institutes of Health Research (CIHR) [OTG-88591, HOA-80075]; Canadian Diabetes Association/CIHR; Heart and Stroke Foundation of Ontario; University of Toronto	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association/CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); University of Toronto(University of Toronto)	This work was supported by a team grant (OTG-88591) from the Canadian Institutes of Health Research (CIHR) and by a CIHR interdisciplinary capacity enhancement grant (HOA-80075). LLL is supported by a Canadian Diabetes Association/CIHR clinician scientist award. PCA is supported by a career investigator award from the Heart and Stroke Foundation of Ontario. GMA is supported by the University of Toronto chair in health management strategies.	Acotto CG, 1998, OSTEOPOROSIS INT, V8, P455, DOI 10.1007/s001980050091; Alibhai SMH, 2010, J UROLOGY, V184, P918, DOI 10.1016/j.juro.2010.04.068; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Auer J, 2001, AM HEART J, V142, P838, DOI 10.1067/mhj.2001.119370; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Bauer DC, 2001, ANN INTERN MED, V134, P561, DOI 10.7326/0003-4819-134-7-200104030-00009; Brennan MD, 2006, THYROID, V16, P375, DOI 10.1089/thy.2006.16.375; Canadian Institute of Health Information, 2010, DRUG US SEN PUBL DRU; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Center JR, 2007, JAMA-J AM MED ASSOC, V297, P387, DOI 10.1001/jama.297.4.387; CHRISCHILLES EA, 1991, ARCH INTERN MED, V151, P2026, DOI 10.1001/archinte.151.10.2026; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Dennis MS, 2002, STROKE, V33, P728, DOI 10.1161/hs0302.103621; DEWHALLEY P, 1995, BRIT J GEN PRACT, V45, P93; DUNCAN WE, 1994, THYROID, V4, P183, DOI 10.1089/thy.1994.4.183; ERIKSEN EF, 1985, BONE, V6, P421, DOI 10.1016/8756-3282(85)90218-2; ERNSTER VL, 1994, PREV MED, V23, P587, DOI 10.1006/pmed.1994.1093; Essebag V, 2003, AM HEART J, V146, P581, DOI 10.1016/S0002-8703(03)00512-X; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Flynn RW, 2010, J CLIN ENDOCR METAB, V95, P186, DOI 10.1210/jc.2009-1625; GRANT DJ, 1993, CLIN ENDOCRINOL, V39, P529, DOI 10.1111/j.1365-2265.1993.tb02404.x; Guidelines and Protocols Advisory Committee, 2010, THYR FUNCT TESTS DIA; Hadji P, 2000, EUR J ENDOCRINOL, V142, P445, DOI 10.1530/eje.0.1420445; HALL R, 1979, CLIN ENDOCRINOL META, V8, P29, DOI 10.1016/S0300-595X(79)80007-9; Hall S, 2006, J CLIN EPIDEMIOL, V59, P67, DOI 10.1016/j.jclinepi.2005.05.001; Hawker GA, 1997, J CLIN EPIDEMIOL, V50, P265, DOI 10.1016/S0895-4356(96)00368-X; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hoogendoorn EH, 2004, POSTGRAD MED J, V80, P394, DOI 10.1136/pgmj.2003.017095; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Joseph KS, 2009, CHRONIC DIS CAN, V29, P96; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; KOPEC JA, 1990, J EPIDEMIOL COMMUN H, V44, P179, DOI 10.1136/jech.44.3.179; Lee JS, 2010, ARCH INTERN MED, V170, P1876, DOI 10.1001/archinternmed.2010.424; Leslie WD, 2007, BONE, V40, P991, DOI 10.1016/j.bone.2006.11.008; Leslie WD, 2009, JAMA-J AM MED ASSOC, V302, P883, DOI 10.1001/jama.2009.1231; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Liu B, 1998, LANCET, V351, P1303, DOI 10.1016/S0140-6736(97)09528-7; Mamdani M, 2007, OSTEOPOROSIS INT, V18, P1595, DOI 10.1007/s00198-007-0446-5; MANDEL SJ, 1993, ANN INTERN MED, V119, P492, DOI 10.7326/0003-4819-119-6-199309150-00009; Mazziotti G, 2010, BONE, V46, P747, DOI 10.1016/j.bone.2009.10.031; Meier C, 2004, OSTEOPOROSIS INT, V15, P209, DOI 10.1007/s00198-003-1527-8; MOORADIAN AD, 1995, CLIN GERIATR MED, V11, P159, DOI 10.1016/S0749-0690(18)30288-X; OKOSIEME OE, 2010, QJM; Pouwels S, 2009, STROKE, V40, P3281, DOI 10.1161/STROKEAHA.109.554055; Rejnmark L, 2007, OSTEOPOROSIS INT, V18, P409, DOI 10.1007/s00198-006-0250-7; RICHARDS J, 2001, P STAT CAN S STAT CA; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; RIGGS BL, 1982, J CLIN INVEST, V70, P716, DOI 10.1172/JCI110667; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; ROBBINS J, 1981, ENVIRON HEALTH PERSP, V38, P65, DOI 10.2307/3429363; Roberts CGP, 2004, LANCET, V363, P793, DOI 10.1016/S0140-6736(04)15696-1; ROSS DS, 1989, J CLIN ENDOCR METAB, V69, P684, DOI 10.1210/jcem-69-3-684; SAWIN CT, 1989, JAMA-J AM MED ASSOC, V261, P2653, DOI 10.1001/jama.261.18.2653; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; SAWIN CT, 1983, AM J MED, V75, P206, DOI 10.1016/0002-9343(83)91192-0; SCHNEIDER DL, 1994, JAMA-J AM MED ASSOC, V271, P1245, DOI 10.1001/jama.271.16.1245; Sheppard MC, 2002, ARCH INTERN MED, V162, P338, DOI 10.1001/archinte.162.3.338; Somwaru LL, 2009, J CLIN ENDOCR METAB, V94, P1342, DOI 10.1210/jc.2008-1696; STALL GM, 1990, ANN INTERN MED, V113, P265, DOI 10.7326/0003-4819-113-4-265; Suissa S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P811; Surks MI, 2010, J CLIN ENDOCR METAB, V95, P496, DOI 10.1210/jc.2009-1845; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Trimpou P, 2010, OSTEOPOROSIS INT, V21, P409, DOI 10.1007/s00198-009-0961-7; *US THYR FUNCT TES, 2006, UK GUID US THYR FUNC; Vestergaard P, 2005, CALCIFIED TISSUE INT, V77, P139, DOI 10.1007/s00223-005-0068-x; Vestergaard P, 2000, THYROID, V10, P335, DOI 10.1089/thy.2000.10.335; WEJDA B, 1995, J INTERN MED, V237, P241, DOI 10.1111/j.1365-2796.1995.tb01172.x; Weller I, 2004, ANN EPIDEMIOL, V14, P319, DOI 10.1016/j.annepidem.2003.08.005	70	77	79	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2011	342								d2238	10.1136/bmj.d2238	http://dx.doi.org/10.1136/bmj.d2238			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759BV	21527461	Green Published, hybrid			2022-12-28	WOS:000290215900002
J	Brophy, J				Brophy, James			Review: Varenicline is better than placebo or bupropion, but not clearly different from the nicotine patch, for smoking abstinence	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McGill Univ, Montreal, PQ, Canada	McGill University	Brophy, J (corresponding author), McGill Univ, Montreal, PQ, Canada.		brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875					0	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8							JC4-4	10.7326/0003-4819-154-8-201104190-02004	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502642				2022-12-28	WOS:000289622000003
J	Morris, A				Morris, Andrew			Review: CURB65, CRB65, and Pneumonia Severity Index similarly predict mortality in community-acquired pneumonia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Morris, Andrew] Univ Toronto, Mt Sinai Hosp, Univ Hlth Network, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto	Morris, A (corresponding author), Univ Toronto, Mt Sinai Hosp, Univ Hlth Network, Toronto, ON M5G 1X5, Canada.							Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; Robenshtok E, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004418.pub3	3	6	8	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8							JC4-13	10.7326/0003-4819-154-8-201104190-02013	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502639				2022-12-28	WOS:000289622000012
J	Flenady, V; Koopmans, L; Middleton, P; Froen, JF; Smith, GC; Gibbons, K; Coory, M; Gordon, A; Ellwood, D; McIntyre, HD; Fretts, R; Ezzati, M				Flenady, Vicki; Koopmans, Laura; Middleton, Philippa; Froen, J. Frederik; Smith, Gordon C.; Gibbons, Kristen; Coory, Michael; Gordon, Adrienne; Ellwood, David; McIntyre, Harold David; Fretts, Ruth; Ezzati, Majid			Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis	LANCET			English	Review							FOR-GESTATIONAL-AGE; ADVANCED MATERNAL AGE; ASSISTED REPRODUCTIVE TECHNOLOGY; ADVERSE PREGNANCY OUTCOMES; WOMEN DELAYING INITIATION; FETAL-GROWTH RESTRICTION; NEW-SOUTH-WALES; PERINATAL OUTCOMES; UNITED-STATES; PRENATAL-CARE	Background Stillbirth rates in high-income countries have shown little or no improvement over the past two decades. Prevention strategies that target risk factors could be important in rate reduction. This systematic review and meta-analysis was done to identify priority areas for stillbirth prevention relevant to those countries. Methods Population-based studies addressing risk factors for stillbirth were identified through database searches. The factors most frequently reported were identified and selected according to whether they could potentially be reduced through lifestyle or medical intervention. The numbers attributable to modifiable risk factors were calculated from data relating to the five high-income countries with the highest numbers of stillbirths and where all the data required for analysis were available. Odds ratios were calculated for selected risk factors, from which population-attributable risk (PAR) values were calculated. Findings Of 6963 studies initially identified, 96 population-based studies were included. Maternal overweight and obesity (body-mass index >25 kg/m(2)) was the highest ranking modifiable risk factor, with PARs of 8-18% across the five countries and contributing to around 8000 stillbirths (>= 22 weeks' gestation) annually across all high-income countries. Advanced maternal age (>35 years) and maternal smoking yielded PARs of 7-11% and 4-7%, respectively, and each year contribute to more than 4200 and 2800 stillbirths, respectively, across all high-income countries. In disadvantaged populations maternal smoking could contribute to 20% of stillbirths. Primiparity contributes to around 15% of stillbirths. Of the pregnancy disorders, small size for gestational age and abruption are the highest PARs (23% and 15%, respectively), which highlights the notable role of placental pathology in stillbirth. Pre-existing diabetes and hypertension remain important contributors to stillbirth in such countries. Interpretation The raising of awareness and implementation of effective interventions for modifiable risk factors, such as overweight, obesity, maternal age, and smoking, are priorities for stillbirth prevention in high-income countries.	[Flenady, Vicki] Mater Hlth Serv, Mater Med Res Inst, Brisbane, Qld 4101, Australia; [Flenady, Vicki; Koopmans, Laura; Middleton, Philippa; Ellwood, David] Australia & New Zealand Stillbirth Alliance, Brisbane, Qld, Australia; [Flenady, Vicki; McIntyre, Harold David] Univ Queensland, Brisbane, Qld, Australia; [Middleton, Philippa] Univ Adelaide, Adelaide, SA, Australia; [Froen, J. Frederik] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Smith, Gordon C.] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Coory, Michael] Queensland Hlth, Hlth Informat Ctr, Brisbane, Qld, Australia; [Gordon, Adrienne] Univ Sydney, Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Ellwood, David] Canberra Hosp, Canberra, ACT, Australia; [Ellwood, David] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Fretts, Ruth] Harvard Vanguard Med Associates, Boston, MA USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England	Mater Health Services; Mater Research; University of Queensland; University of Adelaide; Norwegian Institute of Public Health (NIPH); University of Cambridge; Queensland Health; University of Sydney; Australian National University; Canberra Hospital; Australian National University; Harvard Vanguard Medical Associates; Imperial College London	Flenady, V (corresponding author), Mater Hlth Serv, Mater Med Res Inst, Brisbane, Qld 4101, Australia.	vicki.flenady@mmri.mater.org.au	Ellwood, David Alan/GNW-4485-2022; Frøen, J. Frederik/C-3271-2009; Gibbons, Kristen/J-3429-2014; Smith, Gordon/A-8070-2008; Gibbons, Kristen/AAW-6321-2020; McIntyre, Harold D/F-1888-2010; Flenady, Vicki Jane/O-9609-2014	Ellwood, David Alan/0000-0003-4512-6443; Gibbons, Kristen/0000-0002-5679-0932; Smith, Gordon/0000-0003-2124-0997; Gibbons, Kristen/0000-0002-5679-0932; McIntyre, Harold D/0000-0001-8819-5794; Flenady, Vicki Jane/0000-0001-8114-7677; Gordon, Adrienne/0000-0002-2328-1066; Froen Froen, Jahn Frederik/0000-0001-9390-8509	Australian and New Zealand Stillbirth Alliance; International Stillbirth Alliance; Stillbirth Foundation Australia; Department of Health and Ageing, Canberra, Australia; Mater Foundation, Brisbane, Australia; Medical Research Council [G0801056B] Funding Source: researchfish	Australian and New Zealand Stillbirth Alliance; International Stillbirth Alliance; Stillbirth Foundation Australia; Department of Health and Ageing, Canberra, Australia; Mater Foundation, Brisbane, Australia; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Dominique Rossouw, Elizabeth Flenady, and Madeleine Elder for assistance with literature searches and reference management. We also thank Yuan Lu for help with calculations of the PAR values. We particularly thank Ibinabo Ibiebele for assistance with searches, data extraction, and analysis. The study was undertaken under the auspices of the Australian and New Zealand Stillbirth Alliance, in collaboration with the International Stillbirth Alliance.; The Stillbirth Foundation Australia, the Department of Health and Ageing, Canberra, Australia, and the Mater Foundation, Brisbane, Australia.	Ahlenius I, 1999, ACTA OBSTET GYN SCAN, V78, P408; Alexander GR, 2005, OBSTET GYN CLIN N AM, V32, P1, DOI 10.1016/j.ogc.2004.10.005; Alexander MR, 2004, AM J OBSTET GYNECOL, V191, P2097, DOI 10.1016/j.ajog.2004.05.023; Aliyu MH, 2005, OBSTET GYNECOL, V106, P446, DOI 10.1097/01.AOG.0000165825.65203.69; Aliyu MH, 2008, ALCOHOL, V42, P369, DOI 10.1016/j.alcohol.2008.04.003; Allen Victoria M, 2004, BMC Pregnancy Childbirth, V4, P17, DOI 10.1186/1471-2393-4-17; Ananth CV, 1995, ACTA OBSTET GYN SCAN, V74, P788, DOI 10.3109/00016349509021198; Andersen AMN, 2004, AM J EPIDEMIOL, V160, P1214, DOI 10.1093/aje/kwh332; Armitage B, 2001, STAT METHODS MED RES, P682; Arntzen A, 1996, SCAND J SOC MED, V24, P36, DOI 10.1177/140349489602400106; *ASS 1 NAT 1 NAT I, 2007, 1 NAT REG LONG HLTH; Astolfi P, 2005, REV EPIDEMIOL SANTE, V53, p2S97; Astolfi P, 2002, PAEDIATR PERINAT EP, V16, P67, DOI 10.1046/j.1365-3016.2002.00375.x; Basso O, 2006, JAMA-J AM MED ASSOC, V296, P1357, DOI 10.1001/jama.296.11.1357; Bateman BT, 2006, AM J OBSTET GYNECOL, V194, P840, DOI 10.1016/j.ajog.2005.08.038; Bech BH, 2005, AM J EPIDEMIOL, V162, P983, DOI 10.1093/aje/kwi317; Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; Black M, 2008, BJOG-INT J OBSTET GY, V115, P269, DOI 10.1111/j.1471-0528.2007.01562.x; Borrell C, 2003, EUR J EPIDEMIOL, V18, P5, DOI 10.1023/A:1022524914396; Canterino J C, 2004, J Matern Fetal Neonatal Med, V15, P193, DOI 10.1080/14767050410001668301; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chen J, 1998, Health Rep, V10, P53; CHEN J, 1998, HLTH REP, V10, P57; Clausson B, 1999, OBSTET GYNECOL, V94, P758, DOI 10.1016/S0029-7844(99)00387-7; Cnattingius S, 1998, BRIT MED J, V316, P1483, DOI 10.1136/bmj.316.7143.1483; Cnattingius S, 2002, SEMIN PERINATOL, V26, P286, DOI 10.1053/sper.2002.34771; Craig ED, 2004, AUST NZ J OBSTET GYN, V44, P530, DOI 10.1111/j.1479-828X.2004.00309.x; Delbaere I, 2007, EUR J OBSTET GYN R B, V135, P41, DOI 10.1016/j.ejogrb.2006.10.030; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhont M, 1999, AM J OBSTET GYNECOL, V181, P688, DOI 10.1016/S0002-9378(99)70514-4; Divon MY, 1998, AM J OBSTET GYNECOL, V178, P726, DOI 10.1016/S0002-9378(98)70482-X; Flegal KM, 2004, AM J EPIDEMIOL, V160, P331, DOI 10.1093/aje/kwh222; FLENADY V, 2008, PAEDIAT CHILD HLTH, P2; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Fretts RC, 2005, AM J OBSTET GYNECOL, V193, P1923, DOI 10.1016/j.ajog.2005.03.074; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; Gardosi J, 1998, BRIT J OBSTET GYNAEC, V105, P524, DOI 10.1111/j.1471-0528.1998.tb10153.x; Gardosi J, 2011, PAEDIATR PERINAT EP, V25, P2, DOI 10.1111/j.1365-3016.2010.01166.x; Getahun D, 2007, AM J OBSTET GYNECOL, V196, P499, DOI 10.1016/j.ajog.2006.09.017; Gilbert WM, 2007, J REPROD MED, V52, P1046; Goldenberg R L, 2004, J Matern Fetal Neonatal Med, V16, P79; Goy J, 2008, PAEDIATR PERINAT EP, V22, P314, DOI 10.1111/j.1365-3016.2008.00947.x; Graham S, 2007, MED J AUSTRALIA, V186, P509, DOI 10.5694/j.1326-5377.2007.tb01024.x; Gray R, 2007, BJOG-INT J OBSTET GY, V114, P264, DOI 10.1111/j.1471-0528.2006.01249.x; GUENDELMAN S, 1994, J COMMUN HEALTH, V19, P319, DOI 10.1007/BF02260402; Hansen M, 2009, HUM REPROD, V24, P2321, DOI 10.1093/humrep/dep173; HARVEY SM, 1993, FAM PLANN PERSPECT, V25, P32, DOI 10.2307/2135990; Hogberg L, 2007, BJOG-INT J OBSTET GY, V114, P699, DOI 10.1111/j.1471-0528.2007.01340.x; Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be; Jacquemyn Y, 2006, J PERINAT MED, V34, P28, DOI 10.1515/JPM.2006.004; Jolly M, 2000, HUM REPROD, V15, P2433, DOI 10.1093/humrep/15.11.2433; Kallen B, 2005, FERTIL STERIL, V84, P611, DOI 10.1016/j.fertnstert.2005.02.038; Kennare R, 2005, AUST NZ J OBSTET GYN, V45, P220, DOI 10.1111/j.1479-828X.2005.00379.x; Kennare R, 2007, OBSTET GYNECOL, V109, P270, DOI 10.1097/01.AOG.0000250469.23047.73; Khashan AS, 2009, EUR J EPIDEMIOL, V24, P697, DOI 10.1007/s10654-009-9375-2; KLIEWER EV, 1993, J PAEDIATR CHILD H, V29, P43, DOI 10.1111/j.1440-1754.1993.tb00439.x; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Laws P, 2009, PERINATAL STAT SERIE; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; Luo ZC, 2006, CAN MED ASSOC J, V174, P1415, DOI 10.1503/cmaj.051096; Luo ZC, 2008, PAEDIATR PERINAT EP, V22, P341, DOI 10.1111/j.1365-3016.2008.00938.x; Luo ZC, 2010, CAN MED ASSOC J, V182, P235, DOI 10.1503/cmaj.082042; Lykke JA, 2009, OBSTET GYNECOL, V113, P1217, DOI 10.1097/AOG.0b013e3181a66f2d; McDonald SD, 2007, J OBSTET GYNAECOL CA, V29, P556, DOI 10.1016/S1701-2163(16)32511-7; Measey MA, 2009, AUST NZ J OBSTET GYN, V49, P151, DOI 10.1111/j.1479-828X.2009.00982.x; Mohsin M, 2006, J BIOSOC SCI, V38, P643, DOI 10.1017/S002193200502701X; Nabukera SK, 2008, J OBSTET GYNAECOL RE, V34, P941, DOI 10.1111/j.1447-0756.2008.00808.x; Nabukera SK, 2009, MATERN CHILD HLTH J, V13, P81, DOI 10.1007/s10995-008-0330-8; O'Leary CM, 2007, PAEDIATR PERINAT EP, V21, P541, DOI 10.1111/j.1365-3016.2007.00849.x; Olesen AW, 2003, AM J OBSTET GYNECOL, V189, P222, DOI 10.1067/mob.2003.446; Ombelet W, 2006, HUM REPROD, V21, P1025, DOI 10.1093/humrep/dei419; Ombelet W, 2005, REPROD BIOMED ONLINE, V11, P244; Persson M, 2009, DIABETES CARE, V32, P2005, DOI 10.2337/dc09-0656; Peticca P, 2009, J OBSTET GYNAECOL CA, V31, P487, DOI 10.1016/S1701-2163(16)34210-4; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Reime B, 2009, ACTA OBSTET GYN SCAN, V88, P1276, DOI 10.3109/00016340903295584; Reinold C, 2009, PREGNANCY NUTR SURVE; Richter R, 2007, EUR J OBSTET GYN R B, V132, P51, DOI 10.1016/j.ejogrb.2006.06.002; Roberts CL, 2000, AUST NZ J PUBL HEAL, V24, P291, DOI 10.1111/j.1467-842X.2000.tb01571.x; Robson S, 2006, AUST NZ J OBSTET GYN, V46, P305, DOI 10.1111/j.1479-828X.2006.00597.x; Rydhstroem H, 2001, Twin Res, V4, P227, DOI 10.1375/twin.4.4.227; Salihu HM, 2008, J OBSTET GYNAECOL RE, V34, P843, DOI 10.1111/j.1447-0756.2008.00855.x; Salihu HM, 2008, NICOTINE TOB RES, V10, P159, DOI 10.1080/14622200701705431; Salihu HM, 2007, OBSTET GYNECOL, V110, P552, DOI 10.1097/01.AOG.0000270159.80607.10; Salihu HM, 2006, OBSTET GYNECOL, V107, P851, DOI 10.1097/01.AOG.0000206185.55324.5b; Salihu HM, 2006, OBSTET GYNECOL, V107, P383, DOI 10.1097/01.AOG.0000195103.46999.32; Salihu HM, 2006, J PEDIATR-US, V148, P522, DOI 10.1016/j.jpeds.2005.11.018; Salihu HM, 2009, J NATL MED ASSOC, V101, P582, DOI 10.1016/S0027-9684(15)30944-5; Salihu HM, 2005, AM J OBSTET GYNECOL, V193, P198, DOI 10.1016/j.ajog.2005.05.021; Salihu HM, 2004, AM J PERINAT, V21, P121, DOI 10.1055/s-2004-823776; Salihu HM, 2003, OBSTET GYNECOL, V102, P1006, DOI 10.1016/S0029-7844(03)00739-7; Sebire NJ, 2001, BRIT J OBSTET GYNAEC, V108, P61, DOI 10.1111/j.1471-0528.2001.00021.x; Sharma PP, 2007, PAEDIATR PERINAT EP, V21, P24, DOI 10.1111/j.1365-3016.2007.00834.x; Shevell T, 2005, OBSTET GYNECOL, V106, P1039, DOI 10.1097/01.AOG.0000183593.24583.7c; Smith GCS, 2007, BJOG-INT J OBSTET GY, V114, P705, DOI 10.1111/j.1471-0528.2007.01343.x; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; Smith GCS, 2003, BRIT MED J, V327, P313, DOI 10.1136/bmj.327.7410.313; Smith GCS, 2007, AM J EPIDEMIOL, V165, P194, DOI 10.1093/aje/kwj354; Stephansson O, 2003, OBSTET GYNECOL, V102, P101, DOI 10.1016/S0029-7844(03)00366-1; Stephansson O, 2001, AM J OBSTET GYNECOL, V184, P463, DOI 10.1067/mob.2001.109591; Strandberg-Larsen K, 2008, OBSTET GYNECOL, V111, P602, DOI 10.1097/AOG.0b013e3181661431; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Surkan PJ, 2004, NEW ENGL J MED, V350, P777, DOI 10.1056/NEJMoa031587; Taylor LK, 2005, MED J AUSTRALIA, V183, P515, DOI 10.5694/j.1326-5377.2005.tb07152.x; Villadsen SF, 2009, J EPIDEMIOL COMMUN H, V63, P106, DOI 10.1136/jech.2008.078741; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Vintzileos AM, 2002, OBSTET GYNECOL, V99, P483, DOI 10.1016/S0029-7844(01)01758-6; Wells GA., 2003, NEWCASTLE OTTAWA SCA; Wilczynski Nancy L, 2003, AMIA Annu Symp Proc, P719; Willinger M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.057; Wilson RE, 2008, ARCH GYNECOL OBSTET, V278, P231, DOI 10.1007/s00404-007-0557-4; Wingate MS, 2006, ANN EPIDEMIOL, V16, P485, DOI 10.1016/j.annepidem.2005.04.001; Wisborg K, 2001, AM J EPIDEMIOL, V154, P322, DOI 10.1093/aje/154.4.322; Wolfe Ellen L, 2005, J Perinatol, V25, P93, DOI 10.1038/sj.jp.7211214; WOOD S, 2008, BJOG, V11, P726; Wood SL, 2003, DIABETIC MED, V20, P703, DOI 10.1046/j.1464-5491.2003.01015.x; World Bank, 2009, COUNTR LEND GROUPS; World Health Organization, 2000, WHO TECHN REP SER, V894; Xiong X, 2001, INT J GYNECOL OBSTET, V75, P221, DOI 10.1016/S0020-7292(01)00496-9; YUDKIN PL, 1987, LANCET, V1, P1192; Zetterstrom K, 2008, BJOG-INT J OBSTET GY, V115, P1436, DOI 10.1111/j.1471-0528.2008.01844.x	123	757	770	7	128	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2011	377	9774					1331	1340		10.1016/S0140-6736(10)62233-7	http://dx.doi.org/10.1016/S0140-6736(10)62233-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21496916				2022-12-28	WOS:000289962900034
J	Hochberg, T				Hochberg, Todd			Moments held-photographing perinatal loss	LANCET			English	Editorial Material												todd@toddhochberg.com							0	4	5	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1310	1311		10.1016/S0140-6736(11)60528-X	http://dx.doi.org/10.1016/S0140-6736(11)60528-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21504088				2022-12-28	WOS:000289962900017
J	Tsutakawa, SE; Classen, S; Chapados, BR; Arvai, AS; Finger, LD; Guenther, G; Tomlinson, CG; Thompson, P; Sarker, AH; Shen, BH; Cooper, PK; Grasby, JA; Tainer, JA				Tsutakawa, Susan E.; Classen, Scott; Chapados, Brian R.; Arvai, Andrew S.; Finger, L. David; Guenther, Grant; Tomlinson, Christopher G.; Thompson, Peter; Sarker, Altaf H.; Shen, Binghui; Cooper, Priscilla K.; Grasby, Jane A.; Tainer, John A.			Human Flap Endonuclease Structures, DNA Double-Base Flipping, and a Unified Understanding of the FEN1 Superfamily	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-SPECIFICITY; POLYMERASE-BETA; 3'-FLAP POCKET; BINDING; REPLICATION; EXONUCLEASE; CATALYSIS; PCNA	Flap endonuclease (FEN1), essential for DNA replication and repair, removes RNA and DNA 5' flaps. FEN1 5' nuclease superfamily members acting in nucleotide excision repair (XPG), mismatch repair (EXO1), and homologous recombination (GEN1) paradoxically incise structurally distinct bubbles, ends, or Holliday junctions, respectively. Here, structural and functional analyses of human FEN1: DNA complexes show structure-specific, sequence-independent recognition for nicked dsDNA bent 100 degrees with unpaired 3' and 5' flaps. Above the active site, a helical cap over a gateway formed by two helices enforces ssDNA threading and specificity for free 5' ends. Crystallographic analyses of product and substrate complexes reveal that dsDNA binding and bending, the ssDNA gateway, and double-base unpairing flanking the scissile phosphate control precise flap incision by the two-metal-ion active site. Superfamily conserved motifs bind and open dsDNA; direct the target region into the helical gateway, permitting only nonbase-paired oligonucleotides active site access; and support a unified understanding of superfamily substrate specificity.	[Tomlinson, Christopher G.; Thompson, Peter; Grasby, Jane A.] Univ Sheffield, Dept Chem, Ctr Chem Biol, Krebs Inst, Sheffield S3 7HF, S Yorkshire, England; [Tsutakawa, Susan E.; Finger, L. David; Sarker, Altaf H.; Cooper, Priscilla K.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Classen, Scott] Scripps Res Inst, Phys Biosci Div, La Jolla, CA 92037 USA; [Chapados, Brian R.; Arvai, Andrew S.; Guenther, Grant; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Chapados, Brian R.; Arvai, Andrew S.; Guenther, Grant; Tainer, John A.] Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Finger, L. David; Shen, Binghui] City Hope Natl Med Ctr, Div Radiat Biol, Duarte, CA 91010 USA; [Finger, L. David; Shen, Binghui] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Shen, Binghui] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	University of Sheffield; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; City of Hope; City of Hope; Beckman Research Institute of City of Hope; Zhejiang University	Grasby, JA (corresponding author), Univ Sheffield, Dept Chem, Ctr Chem Biol, Krebs Inst, Sheffield S3 7HF, S Yorkshire, England.	j.a.grasby@sheffield.ac.uk; jat@scripps.edu	Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429; Shen, Binghui/0000-0002-4408-407X; Finger, L. David/0000-0002-2342-9569; Thompson, Peter/0000-0002-4688-3414; Tsutakawa, Susan/0000-0002-4918-4571	NIH/NCI [RO1CA081967, R01CA073764, P01 CA092584]; BBSRC [BBF0147321]; ALS [DE-AC02-05CH11231]; DOE; DOE, OBER; NIH; NCRR; Biomedical Technology Program; NIGMS; NATIONAL CANCER INSTITUTE [R01CA073764, R01CA081967, P01CA092584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F014732/1, B19316] Funding Source: researchfish; BBSRC [BB/F014732/1] Funding Source: UKRI	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ALS; DOE(United States Department of Energy (DOE)); DOE, OBER(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work on FEN1 is supported by the NIH/NCI through RO1CA081967, R01CA073764, and P01 CA092584 (SBDR) and by BBSRC (BBF0147321). Crystal data was collected at the SIBYLS beamline 12.3.1 (ALS, Contract DE-AC02-05CH11231) and beamline 11-1 (SSRL, supported by DOE, OBER, NIH, NCRR, Biomedical Technology Program, and the NIGMS). Morphing movies were produced with CHIMERA (NIH P41 RR-01081). We thank Hong Xu and Chiharu Hitomi for technical assistance and Gareth Williams, James Holton, Mike Pique, Elizabeth Getzoff, David Moiani, Cliff Ng, and Peter Burgers for contributing to the analyses.	Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; FINGER LD, 2010, FEN1 FLAP STRUCTURE; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Friedrich-Heineken E, 2004, NUCLEIC ACIDS RES, V32, P2520, DOI 10.1093/nar/gkh576; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Hohl M, 2003, J BIOL CHEM, V278, P19500, DOI 10.1074/jbc.M213155200; Hohl M, 2007, NUCLEIC ACIDS RES, V35, P3053, DOI 10.1093/nar/gkm092; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Ivanov I, 2007, P NATL ACAD SCI USA, V104, P1465, DOI 10.1073/pnas.0603468104; Kalifa L, 2009, DNA REPAIR, V8, P1242, DOI 10.1016/j.dnarep.2009.07.008; Kim CY, 2001, BIOCHEMISTRY-US, V40, P3208, DOI 10.1021/bi002100n; Krahn JM, 2004, STRUCTURE, V12, P1823, DOI 10.1016/j.str.2004.08.001; Kuppuraj G, 2009, J PHYS CHEM B, V113, P2952, DOI 10.1021/jp807972e; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lyamichev V, 1999, P NATL ACAD SCI USA, V96, P6143, DOI 10.1073/pnas.96.11.6143; Matsuzaki Y, 2002, NUCLEIC ACIDS RES, V30, P3273, DOI 10.1093/nar/gkf440; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Navarro MS, 2007, GENETICS, V176, P1391, DOI 10.1534/genetics.107.073056; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Qiu JZ, 2002, J BIOL CHEM, V277, P24659, DOI 10.1074/jbc.M111941200; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; ROBERTS VA, 1991, J BIOL CHEM, V266, P13431; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Schroeder GK, 2006, P NATL ACAD SCI USA, V103, P4052, DOI 10.1073/pnas.0510879103; Sengerova B, 2010, BIOCHEMISTRY-US, V49, P8085, DOI 10.1021/bi100895j; Shen BH, 1996, J BIOL CHEM, V271, P9173, DOI 10.1074/jbc.271.16.9173; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Singh P, 2007, J BIOL CHEM, V282, P3465, DOI 10.1074/jbc.M606582200; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; Storici F, 2002, EMBO J, V21, P5930, DOI 10.1093/emboj/cdf587; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Tomlinson CG, 2010, BIOCHEM SOC T, V38, P433, DOI 10.1042/BST0380433; Tumey LN, 2005, BIOORG MED CHEM LETT, V15, P277, DOI 10.1016/j.bmcl.2004.10.086; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Xu Y, 2001, J BIOL CHEM, V276, P30167, DOI 10.1074/jbc.M100985200; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	50	195	201	9	144	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					198	211		10.1016/j.cell.2011.03.004	http://dx.doi.org/10.1016/j.cell.2011.03.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496641	Green Accepted, Bronze			2022-12-28	WOS:000289549900010
J	Berger, T; Testa, P; Hillier, A; Boerner, P; Low, BC; Shibata, K; Schrijver, C; Tarbell, T; Title, A				Berger, Thomas; Testa, Paola; Hillier, Andrew; Boerner, Paul; Low, Boon Chye; Shibata, Kazunari; Schrijver, Carolus; Tarbell, Ted; Title, Alan			Magneto-thermal convection in solar prominences	NATURE			English	Article							QUIESCENT PROMINENCE; HELICAL FLUX; MASS EJECTIONS; HINODE; EMERGENCE; CONFINEMENT; TELESCOPE; CORONA; FLOWS; SOHO	Coronal cavities are large low-density regions formed by hemispheric-scale magnetic flux ropes suspended in the Sun's outer atmosphere(1). They evolve over time, eventually erupting as the dark cores of coronal mass ejections(2,3). Although coronal mass ejections are common and can significantly affect planetary magnetospheres, the mechanisms by which cavities evolve to an eruptive state remain poorly understood. Recent optical observations(4) of high-latitude 'polar crown' prominences within coronal cavities reveal dark, low-density(5) 'bubbles' that undergo Rayleigh-Taylor instabilities(6,7) to form dark plumes rising into overlying coronal cavities. These observations offered a possible mechanism for coronal cavity evolution, although the nature of the bubbles, particularly their buoyancy, was hitherto unclear. Here we report simultaneous optical and extreme-ultraviolet observations of polar crown prominences that show that these bubbles contain plasma at temperatures in the range (2.5-12) x 10(5) kelvin, which is 25-120 times hotter than the overlying prominence. This identifies a source of the buoyancy, and suggests that the coronal cavity-prominence system supports a novel form of magneto-thermal convection in the solar atmosphere, challenging current hydromagnetic concepts of prominences and their relation to coronal cavities.	[Berger, Thomas; Boerner, Paul; Schrijver, Carolus; Tarbell, Ted; Title, Alan] Lockheed Martin Adv Technol Ctr, Solar & Astrophys Lab, Palo Alto, CA 94304 USA; [Testa, Paola] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Hillier, Andrew; Shibata, Kazunari] Kyoto Univ, Grad Sch Sci, Kwasan Observ, Kyoto 6078471, Japan; [Hillier, Andrew; Shibata, Kazunari] Kyoto Univ, Grad Sch Sci, Hida Observ, Kyoto 6078471, Japan; [Low, Boon Chye] Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA	Lockheed Martin; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Kyoto University; Kyoto University; National Center Atmospheric Research (NCAR) - USA	Berger, T (corresponding author), Lockheed Martin Adv Technol Ctr, Solar & Astrophys Lab, O ADBS B 252,3251 Hanover St, Palo Alto, CA 94304 USA.	berger@lmsal.com	Berger, Thomas E./AAD-1010-2020	Berger, Thomas E./0000-0002-4989-475X; Hillier, Andrew/0000-0002-0851-5362; Schrijver, Carolus/0000-0002-6010-8182	JAXA and NAOJ (Japan); STFC (UK); NASA; ESA; NSC (Norway); Universality and Emergence	JAXA and NAOJ (Japan); STFC (UK)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NASA(National Aeronautics & Space Administration (NASA)); ESA(European Space Agency); NSC (Norway); Universality and Emergence	Hinode is a Japanese mission developed and launched by ISAS/JAXA, in collaboration with NAOJ as a domestic partner, and with NASA and STFC (UK) as international partners. Scientific operation of the Hinode mission is conducted by the Hinode science team organized at ISAS/JAXA. Support for the post-launch operation is provided by JAXA and NAOJ (Japan), STFC (UK), NASA, ESA and NSC (Norway). The Solar Dynamics Observatory is part of NASA's Living with a Star programme. K.S. and A.H. are supported by the Grant-in-Aid for the Global COE Program 'The Next Generation of Physics, Spun from Universality and Emergence'. We thank J. Martinez-Sykora for discovering the 2 July 2010 prominence bubble event in the AIA database.	Berger TE, 2008, ASTROPHYS J LETT, V676, pL89, DOI 10.1086/587171; Berger TE, 2010, ASTROPHYS J, V716, P1288, DOI 10.1088/0004-637X/716/2/1288; Cirigliano D, 2004, SOL PHYS, V223, P95, DOI 10.1007/s11207-004-5101-0; de Toma G, 2008, ASTROPHYS J LETT, V687, pL123, DOI 10.1086/593326; Fan Y, 2007, ASTROPHYS J, V668, P1232, DOI 10.1086/521335; FOUKAL P, 1978, ASTROPHYS J, V223, P1046, DOI 10.1086/156338; Golub L, 2007, SOL PHYS, V243, P63, DOI 10.1007/s11207-007-0182-1; GOSLING JT, 1974, J GEOPHYS RES, V79, P4581, DOI 10.1029/JA079i031p04581; Heinzel P, 2008, ASTROPHYS J, V686, P1383, DOI 10.1086/591018; Isobe H, 2005, NATURE, V434, P478, DOI 10.1038/nature03399; Janse AM, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3474943; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Lemen J. R., 2010, SOL PHYS UNPUB; Lites BW, 2010, ASTROPHYS J, V718, P474, DOI 10.1088/0004-637X/718/1/474; Marsch E, 2008, ASTROPHYS J, V685, P1262, DOI 10.1086/591038; Matsumoto T, 2010, ASTROPHYS J, V710, P1857, DOI 10.1088/0004-637X/710/2/1857; Okamoto TJ, 2008, ASTROPHYS J LETT, V673, pL215, DOI 10.1086/528792; Okamoto TJ, 2010, ASTROPHYS J, V719, P583, DOI 10.1088/0004-637X/719/1/583; PNEUMAN GW, 1972, ASTROPHYS J, V177, P793, DOI 10.1086/151756; Ryutova M, 2010, SOL PHYS, V267, P75, DOI 10.1007/s11207-010-9638-9; Schmit DJ, 2009, ASTROPHYS J LETT, V700, pL96, DOI 10.1088/0004-637X/700/2/L96; SHIBATA K, 1989, ASTROPHYS J, V345, P584, DOI 10.1086/167932; STELLMACHER G, 1973, ASTRON ASTROPHYS, V24, P321; Suematsu Y, 2008, SOL PHYS, V249, P197, DOI 10.1007/s11207-008-9129-4; WITHBROE GL, 1977, ANNU REV ASTRON ASTR, V15, P363, DOI 10.1146/annurev.aa.15.090177.002051; Zhang M, 2005, ANNU REV ASTRON ASTR, V43, P103, DOI 10.1146/annurev.astro.43.072103.150602; Zhang M, 2006, ASTROPHYS J, V644, P575, DOI 10.1086/503353	27	108	108	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					197	200		10.1038/nature09925	http://dx.doi.org/10.1038/nature09925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21490669				2022-12-28	WOS:000289469100037
J	Gin, DL; Noble, RD				Gin, Douglas L.; Noble, Richard D.			Designing the Next Generation of Chemical Separation Membranes	SCIENCE			English	Editorial Material							IONIC LIQUIDS; PERMEATION; TRANSPORT		[Gin, Douglas L.; Noble, Richard D.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Gin, DL (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	douglas.gin@colorado.edu	Gin, Douglas/AAW-5360-2021	GIN, DOUGLAS/0000-0002-6215-668X; NOBLE, RICHARD/0000-0002-2712-3700				Bae TH, 2010, ANGEW CHEM INT EDIT, V49, P9863, DOI 10.1002/anie.201006141; Bara JE, 2010, ACCOUNTS CHEM RES, V43, P152, DOI 10.1021/ar9001747; Czaplewski KF, 2001, ADV MATER, V13, P1895, DOI 10.1002/1521-4095(200112)13:24<1895::AID-ADMA1895>3.0.CO;2-C; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Hudiono YC, 2011, J MEMBRANE SCI, V370, P141, DOI 10.1016/j.memsci.2011.01.012; Koros W. J., 1995, CHEM ENG PROG, V91, P10; Newton MR, 2005, J AM CHEM SOC, V127, P7268, DOI 10.1021/ja043275d; Olson DA, 2008, CHEM MATER, V20, P869, DOI 10.1021/cm702239k; Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030; Simons K, 2010, J MEMBRANE SCI, V360, P202, DOI 10.1016/j.memsci.2010.05.018; Voss BA, 2009, CHEM MATER, V21, P3027, DOI 10.1021/cm900726p; Wirtz M., 2002, INT J NANOSCI, V1, P255; Xu T, 2011, ACS NANO, V5, P1376, DOI 10.1021/nn103083t; Yan X, 2002, J AM CHEM SOC, V124, P10962, DOI 10.1021/ja0274305; Zhou MJ, 2007, J AM CHEM SOC, V129, P9574, DOI 10.1021/ja073067w	15	528	546	19	514	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					674	676		10.1126/science.1203771	http://dx.doi.org/10.1126/science.1203771			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551053				2022-12-28	WOS:000290265800030
J	Moskovits, M				Moskovits, Marlin			Hot Electrons Cross Boundaries	SCIENCE			English	Editorial Material									Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Moskovits, M (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	moskovits@chem.ucsb.edu						Knight MW, 2011, SCIENCE, V332, P702, DOI 10.1126/science.1203056; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Shalaev VM, 1996, PHYS REV B, V53, P11388, DOI 10.1103/PhysRevB.53.11388	3	62	63	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					676	677		10.1126/science.1205312	http://dx.doi.org/10.1126/science.1205312			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551054				2022-12-28	WOS:000290265800031
J	Powell, J; Bhat, J; Orpin, S				Powell, James; Bhat, Jaideep; Orpin, Stephen			CASE REPORT Plastered in pustules	BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-PATTERN; AGEP		[Powell, James; Bhat, Jaideep; Orpin, Stephen] Solihull Hosp, Dept Dermatol, Solihull B91 2JL, W Midlands, England	Heart of England NHS Foundation Trust	Powell, J (corresponding author), Solihull Hosp, Dept Dermatol, Solihull B91 2JL, W Midlands, England.	jbpowell@doctors.org.uk						Beltraminelli HS, 2005, BRIT J DERMATOL, V152, P780, DOI 10.1111/j.1365-2133.2005.06393.x; Guevara-Gutierrez E, 2009, INT J DERMATOL, V48, P253, DOI 10.1111/j.1365-4632.2009.03908.x; Kardaun SH, 2007, BRIT J DERMATOL, V156, P609, DOI 10.1111/j.1365-2133.2006.07704.x; Millard LG, 2010, ROOKS TXB DERMATOLOG, P1; Mockenhaupt M, 2009, J DTSCH DERMATOL GES, V7, P142, DOI 10.1111/j.1610-0387.2008.06878.x; Sidoroff A, 2007, BRIT J DERMATOL, V157, P989, DOI 10.1111/j.1365-2133.2007.08156.x; Sidoroff A, 2001, J CUTAN PATHOL, V28, P113, DOI 10.1034/j.1600-0560.2001.028003113.x	7	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2011	342								d926	10.1136/bmj.d926	http://dx.doi.org/10.1136/bmj.d926			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762MB	21543398				2022-12-28	WOS:000290481700015
J	Gershon, A; Croxford, R; To, T; Stanbrook, MB; Upshur, R; Sanchez-Romeu, P; Stukel, T				Gershon, Andrea; Croxford, Ruth; To, Teresa; Stanbrook, Matthew B.; Upshur, Ross; Sanchez-Romeu, Paula; Stukel, Therese			Comparison of Inhaled Long-Acting beta-Agonist and Anticholinergic Effectiveness in Older Patients With Chronic Obstructive Pulmonary Disease A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR EVENTS; COPD; PREVALENCE; TIOTROPIUM; MORTALITY; TRENDS; RISK; METAANALYSIS; REDUCTION; BROMIDE	Background: Chronic obstructive pulmonary disease (COPD), a largely preventable and manageable respiratory condition, affects an estimated 12% to 20% of adults. Long-acting inhaled beta-agonists and anticholinergics have both been shown to improve COPD outcomes and are recommended for moderate to severe disease; however, little is known about their comparative effectiveness. Objective: To compare survival in older patients with COPD who initially receive inhaled long-acting beta-agonists with that of patients who receive anticholinergics. Design: Population-based, retrospective cohort study. Setting: Ontario, Canada. Patients: Patients aged 66 years or older (who carry the largest burden of COPD and for whom data were available) who met a validated case definition of COPD on the basis of health administrative data and were newly prescribed an inhaled long-acting beta-agonist or a long-acting anticholinergic (but not both) between 2003 and 2007. Patients were followed for up to 5.5 years. Measurements: The primary outcome was all-cause mortality. Results: A total of 46 403 patients with COPD (mean age, 77 years; 49% women) were included. Overall mortality was 38.2%. Mortality was higher in patients initially prescribed a long-acting anticholinergic than in those initially prescribed a long-acting inhaled beta-agonist (adjusted hazard ratio, 1.14 [95% CI, 1.09 to 1.19]). Rates of hospitalizations and emergency department visits were also higher in those initially prescribed a long-acting anticholinergic. Limitation: Patients were classified as having COPD on the basis of health administrative records, which did not contain information about lung function. Conclusion: Older adults initially prescribed long-acting inhaled beta-agonists for the management of moderate COPD seem to have lower mortality than those initially prescribed long-acting anticholinergics. Further research is needed to confirm these findings in younger patients and in a randomized, controlled trial.	[Gershon, Andrea] Hosp Sick Children, Sunnybrook Hlth Sci Ctr, Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Univ Toronto, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Hospital for Sick Children (SickKids); Sunnybrook Health Science Center; University of Toronto	Gershon, A (corresponding author), Hosp Sick Children, Sunnybrook Hlth Sci Ctr, Inst Clin Evaluat Sci, G106,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	andrea.gershon@ices.on.ca		Stukel, Therese/0000-0002-2951-1360; Upshur, Ross/0000-0003-1128-0557	Government of Ontario, Canada; Government of Ontario; Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research; Institute of Population and Public Health; Public Health Agency of Canada; University of Toronto	Government of Ontario, Canada; Government of Ontario; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Population and Public Health; Public Health Agency of Canada; University of Toronto(University of Toronto)	Primary Funding Source: Government of Ontario, Canada.r By the Government of Ontario; a Career Scientist Award from the Ontario Ministry of Health and Long-Term Care and a Research Fellowship from the Canadian Institutes of Health Research, Institute of Population and Public Health, and The Public Health Agency of Canada (Dr. Gershon); and the Dales Award in Medical Research from the University of Toronto, (Dr. To). Support was also provide by the Institute for Clinical Evaluative Sciences, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care.	[Anonymous], 2006, J HOPK U ACG CAS MIX; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P333, DOI 10.1164/rccm.2110093; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Baker WL, 2009, PHARMACOTHERAPY, V29, P891, DOI 10.1592/phco.29.8.891; Barr RG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002876.pub2; *BOEHR ING, TIOTR ONC DAIL 18 MC; *BOEHR ING, TIOTR SPIR RESP EV F; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Celli B, 2010, CHEST, V137, P20, DOI 10.1378/chest.09-0011; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Durham Martha C, 2004, Proc (Bayl Univ Med Cent), V17, P366; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon AS, 2010, AM J EPIDEMIOL, V172, P728, DOI 10.1093/aje/kwq189; Gershon AS, 2010, ARCH INTERN MED, V170, P560, DOI 10.1001/archinternmed.2010.17; Global Initiative for Chronic Obstructive Lung Disease, 2008, GLOB STRAT DIAGN MAN; Hux JE, 1997, ONTARIO DRUG BENEFIT; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Joo MJ, 2009, TRANSL RES, V154, P103, DOI 10.1016/j.trsl.2009.06.003; Lee TA, 2008, ANN INTERN MED, V149, P380, DOI 10.7326/0003-4819-149-6-200809160-00004; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Ogale SS, 2010, CHEST, V137, P13, DOI 10.1378/chest.08-2367; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Puhan MA, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-2; Reid RJ, 2001, MED CARE, V39, P86, DOI 10.1097/00005650-200101000-00010; Rodrigo GJ, 2008, CHEST, V133, P1079, DOI 10.1378/chest.07-1167; Salpeter SR, 2006, CLIN REV ALLERG IMMU, V31, P219, DOI 10.1385/CRIAI:31:2:219; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Sturmer T, 2005, AM J EPIDEMIOL, V162, P279, DOI 10.1093/aje/kwi192; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Travers J, 2007, RESP MED, V101, P1313, DOI 10.1016/j.rmed.2006.10.011; Wilkins R, 2004, PCCF VERSION 4D USER	34	34	35	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					583	592		10.7326/0003-4819-154-9-201105030-00003	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21536937				2022-12-28	WOS:000290112300002
J	Fiete, GA				Fiete, Gregory A.			How Do You Want That Insulator?	SCIENCE			English	Editorial Material							TOPOLOGICAL INSULATORS		Univ Texas Austin, Dept Phys, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Fiete, GA (corresponding author), Univ Texas Austin, Dept Phys, Austin, TX 78712 USA.	fiete@physics.utexas.edu		Fiete, Gregory/0000-0001-9477-0804	Direct For Mathematical & Physical Scien [0955778] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Essin AM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.146805; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hsieh D, 2009, NATURE, V460, P1101, DOI 10.1038/nature08234; Kargarian M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165112; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; Pesin D, 2010, NAT PHYS, V6, P376, DOI 10.1038/NPHYS1606; Qi XL, 2010, PHYS TODAY, V63, P33, DOI 10.1063/1.3293411; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Seradjeh B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.066402; Shitade A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.256403; Wen X.G., 2004, QUANTUM FIELD THEORY; Witczak-Krempa W, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165122; Xu SY, 2011, SCIENCE, V332, P560, DOI 10.1126/science.1201607	14	7	7	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					546	547		10.1126/science.1205251	http://dx.doi.org/10.1126/science.1205251			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527703	Green Submitted			2022-12-28	WOS:000289991100033
J	Morikawa, T; Kuchiba, A; Yamauchi, M; Meyerhardt, JA; Shima, K; Nosho, K; Chan, AT; Giovannucci, E; Fuchs, CS; Ogino, S				Morikawa, Teppei; Kuchiba, Aya; Yamauchi, Mai; Meyerhardt, Jeffrey A.; Shima, Kaori; Nosho, Katsuhiko; Chan, Andrew T.; Giovannucci, Edward; Fuchs, Charles S.; Ogino, Shuji			Association of CTNNB1 (beta-Catenin) Alterations, Body Mass Index, and Physical Activity With Survival in Patients With Colorectal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISLAND METHYLATOR PHENOTYPE; MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; COLON-CANCER; MICROSATELLITE INSTABILITY; E-CADHERIN; PROGNOSTIC-SIGNIFICANCE; ACTIVITY QUESTIONNAIRE; NUCLEAR ACCUMULATION; PIK3CA MUTATION; RECTAL-CANCER	Context Alterations of the WNT signaling pathway and cadherin-associated protein beta 1 (CTNNB1 or beta-catenin) have been implicated in colorectal carcinogenesis and metabolic diseases. Objective To test the hypothesis that CTNNB1 activation in colorectal cancer modifies prognostic associations of body mass index (BMI) and level of postdiagnosis physical activity. Design, Setting, and Patients Two US prospective cohort studies (Nurses' Health Study and the Health Professionals Follow-up Study) were used to evaluate CTNNB1 localization by immunohistochemistry in 955 patients with stage I, II, III, or IV colon and rectal cancer from 1980 through 2004. A Cox proportional hazards model was used to compute the hazard ratio (HR) for mortality, adjusting for clinical and tumor features, including microsatellite instability, CpG island methylator phenotype, level of long interspersed nucleotide element 1 methylation, mutations in KRAS, BRAF, or PIK3CA, and tumor protein p53. Main Outcome Measures Colorectal cancer-specific mortality and overall mortality through June 30, 2009. Results In obese patients (BMI >= 30), positive status for nuclear CTNNB1 was associated with significantly better colorectal cancer-specific survival (adjusted HR, 0.24 [95% confidence interval {CI}, 0.12-0.49], P<.001 for interaction; 5-year survival: 0.85 for patients with positive nuclear CTNNB1 status vs 0.78 for those with negative status) and overall survival (adjusted HR, 0.56 [95% CI, 0.35-0.90], P=.03 for interaction; 5-year survival: 0.77 for patients with positive nuclear CTNNB1 status vs 0.74 for those with negative status), while CTNNB1 status was not associated with prognosis among nonobese patients (BMI <30). Among patients with negative status for nuclear CTNNB1 and cancer in stages I, II, or III, postdiagnosis physical activity was associated with better colorectal cancer-specific survival (adjusted HR, 0.33 [95% CI, 0.13-0.81], P=.05 for interaction; 5-year survival: 0.97 for >= 18 vs 0.89 for <18 metabolic equivalent task hours/week), while postdiagnosis physical activity was not associated with colorectal cancer-specific survival among patients with positive status for nuclear CTNNB1 (adjusted HR, 1.07 [95% CI, 0.50-2.30]). Conclusions Among obese patients only, activation of CTNNB1 was associated with better colorectal cancer-specific survival and overall survival. Postdiagnosis physical activity was associated with better colorectal cancer-specific survival only among patients with negative status for nuclear CTNNB1. These molecular pathological epidemiology findings suggest that the effects of alterations in the WNT-CTNNB1 pathway on outcome are modified by BMI and physical activity. JAMA. 2011;305(16):1685-1694 www.jama.com	[Ogino, Shuji] Harvard Univ, Sch Med, Brigham & Womens Hosp,Dept Med Oncol, Dana Farber Canc Inst,Ctr Mol Oncol Pathol, Boston, MA 02215 USA; [Chan, Andrew T.; Giovannucci, Edward; Fuchs, Charles S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA 02215 USA; [Ogino, Shuji] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02215 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Ogino, S (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp,Dept Med Oncol, Dana Farber Canc Inst,Ctr Mol Oncol Pathol, 450 Brookline Ave,Room JF-215C, Boston, MA 02215 USA.	shuji_ogino@dfci.harvard.edu	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767; Ogino, Shuji/0000-0002-3909-2323	US National Institute of Health [P01CA87969, P01CA55075, P50CA127003, K07CA122826, R01CA151993, R01CA137178]; Bennett Family Fund; Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; Japan Society for Promotion of Science; NATIONAL CANCER INSTITUTE [R01CA151993, R01CA137178, K07CA122826, P50CA127003, R01CA050385, P01CA087969, P01CA055075] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bennett Family Fund; Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institute of Health grants P01CA87969, P01CA55075, P50CA127003, K07CA122826, R01CA151993, and R01CA137178 and by grants from the Bennett Family Fund and the Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance. Dr Morikawa was supported by a fellowship grant from the Japan Society for Promotion of Science. Dr Chan is a Damon Runyon Clinical Investigator.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Arango NA, 2005, DEV BIOL, V288, P276, DOI 10.1016/j.ydbio.2005.09.045; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Cheah PY, 2002, CANCER-AM CANCER SOC, V95, P2479, DOI 10.1002/cncr.10986; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Chung GG, 2001, CLIN CANCER RES, V7, P4013; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Doria-Rose VP, 2006, CANCER CAUSE CONTROL, V17, P63, DOI 10.1007/s10552-005-0360-0; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Elzagheid A, 2008, WORLD J GASTROENTERO, V14, P3866, DOI 10.3748/wjg.14.3866; Fang QX, 2010, J SURG ONCOL, V102, P433, DOI 10.1002/jso.21537; Filiz AI, 2010, COLORECTAL DIS, V12, P1223, DOI 10.1111/j.1463-1318.2009.01994.x; Gunther K, 1998, DIS COLON RECTUM, V41, P1256, DOI 10.1007/BF02258226; Han QF, 2006, CANCER LETT, V231, P129, DOI 10.1016/j.canlet.2005.01.026; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hugh TJ, 1999, BRIT J CANCER, V80, P1046, DOI 10.1038/sj.bjc.6690461; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Kawada M, 2006, CANCER RES, V66, P2913, DOI 10.1158/0008-5472.CAN-05-3460; Kawasaki T, 2007, NEOPLASIA, V9, P569, DOI 10.1593/neo.07334; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Lugli A, 2007, HISTOPATHOLOGY, V50, P453, DOI 10.1111/j.1365-2559.2007.02620.x; Martensson A, 2007, ONCOL REP, V17, P447; Maruyama K, 2000, ONCOLOGY-BASEL, V59, P302, DOI 10.1159/000012187; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3527, DOI 10.1200/JCO.2006.06.0855; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Meyerhardt JA, 2009, ARCH INTERN MED, V169, P2102, DOI 10.1001/archinternmed.2009.412; Meyerhardt JA, 2009, CLIN CANCER RES, V15, P5931, DOI 10.1158/1078-0432.CCR-09-0496; Miyamoto S, 2004, ONCOL REP, V12, P245; Norwood MGA, 2010, HISTOPATHOLOGY, V57, P101, DOI 10.1111/j.1365-2559.2010.03587.x; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Nosho K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003698; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2006, NEOPLASIA, V8, P458, DOI 10.1593/neo.06247; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Ogino S, 2008, J CLIN ONCOL, V26, P5713, DOI [10.1200/JCO.2008.18.2675, 10.1200/JCO.2009.22.8858]; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Roca F, 2006, J SURG ONCOL, V93, P151, DOI 10.1002/jso.20413; Schinner S, 2009, HORM METAB RES, V41, P159, DOI 10.1055/s-0028-1119408; Sinicrope FA, 2010, CLIN CANCER RES, V16, P1884, DOI 10.1158/1078-0432.CCR-09-2636; Waldman SA, 2009, JAMA-J AM MED ASSOC, V301, P745, DOI 10.1001/jama.2009.141; Wanitsuwan W, 2008, WORLD J GASTROENTERO, V14, P6052, DOI 10.3748/wjg.14.6052; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Wong SCC, 2004, CLIN CANCER RES, V10, P1401, DOI 10.1158/1078-0432.CCR-0157-03; Wong SCC, 2003, J CLIN PATHOL-MOL PA, V56, P347, DOI 10.1136/mp.56.6.347; Zhang W, 2008, ONCOL REP, V20, P1013, DOI 10.3892/or_00000103; Zhao JX, 2010, BIOCHEM BIOPH RES CO, V395, P146, DOI 10.1016/j.bbrc.2010.03.161	58	147	149	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1685	1694		10.1001/jama.2011.513	http://dx.doi.org/10.1001/jama.2011.513			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521850	Bronze, Green Accepted			2022-12-28	WOS:000289890500022
J	Wang, EA; Wildeman, C				Wang, Emily A.; Wildeman, Christopher			Studying Health Disparities by Including Incarcerated and Formerly Incarcerated Individuals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DESIGN; ATHEROSCLEROSIS; OBJECTIVES; RISK		[Wang, Emily A.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Wildeman, Christopher] Yale Univ, Dept Sociol, New Haven, CT 06510 USA	Yale University; Yale University	Wang, EA (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Harkness Hall Bldg A,367 Cedar St,Ste 410A, New Haven, CT 06510 USA.	emily.wang@yale.edu			NHLBI NIH HHS [K23 HL103720] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL103720] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; CUTTER G R, 1991, Controlled Clinical Trials, V12, p1S; Gostin LO, 2006, ETHICAL CONSIDERATIO; Greifinger Robert, 2007, PUBLIC HLTH BARS; Lerner BH, 2007, NEW ENGL J MED, V356, P1806, DOI 10.1056/NEJMp068280; Taylor HA, 2005, ETHNIC DIS, V15, pS4; Wang EA, 2009, ARCH INTERN MED, V169, P687, DOI 10.1001/archinternmed.2009.26; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	9	23	23	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1708	1709		10.1001/jama.2011.532	http://dx.doi.org/10.1001/jama.2011.532			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521854	Green Accepted			2022-12-28	WOS:000289890500027
J	Fearing, MK; Israel, EJ; Sahai, I; Rapalino, O; Lisovsky, M				Fearing, Marsha Kay; Israel, Esther J.; Sahai, Inderneel; Rapalino, Otto; Lisovsky, Mikhail			Case 12-2011: A 9-Month-Old Boy with Acute Liver Failure Microvesicular hepatic steatosis due to CACT deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; SJOGREN-LARSSON-SYNDROME; MR SPECTROSCOPY; MYELINATION; DISORDERS; DIAGNOSIS; DISEASE; BRAIN		[Fearing, Marsha Kay; Israel, Esther J.; Sahai, Inderneel] Massachusetts Gen Hosp, Serv Pediat, Boston, MA 02114 USA; [Rapalino, Otto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Fearing, Marsha Kay; Israel, Esther J.; Sahai, Inderneel] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Rapalino, Otto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Lisovsky, Mikhail] Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03766 USA; [Lisovsky, Mikhail] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pathol, Hanover, NH 03756 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Dartmouth College; Dartmouth College	Fearing, MK (corresponding author), Massachusetts Gen Hosp, Serv Pediat, Boston, MA 02114 USA.			Rapalino, Otto/0000-0002-5038-4183				Adamsbaum C, 1996, PEDIATR RADIOL, V26, P759, DOI 10.1007/BF01396195; Badizadegan K, 1997, HEPATOLOGY, V26, P365, DOI 10.1002/hep.510260217; Barker PB, 2004, J CHILD NEUROL, V19, P559, DOI 10.1177/088307380401900801; Blau N, 2002, PHYS GUIDE LAB DIAGN; Boldrini R, 2004, PATHOL RES PRACT, V200, P231, DOI 10.1016/j.prp.2003.11.001; Browning MF, 2006, OBSTET GYNECOL, V107, P115, DOI 10.1097/01.AOG.0000191297.47183.bd; BRUHN H, 1992, J COMPUT ASSIST TOMO, V16, P335, DOI 10.1097/00004728-199205000-00001; Burt AD, 1998, SEMIN DIAGN PATHOL, V15, P246; Campo JV, 2002, J AM ACAD CHILD PSY, V41, P631, DOI 10.1097/00004583-200206000-00001; Cochran JB, 2007, PEDIATR EMERG CARE, V23, P129, DOI 10.1097/PEC.0b013e3180308f4b; Costa C, 2003, MOL GENET METAB, V78, P68, DOI 10.1016/S1096-7192(02)00205-6; Fernandes J., 2006, INBORN METABOLIC DIS, V4th; Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5; Groenendaal F, 2001, NEUROPEDIATRICS, V32, P23, DOI 10.1055/s-2001-12218; Kaminaga T, 2001, MAGNET RESON MED, V45, P1112, DOI 10.1002/mrm.1146; Korman SH, 2004, MOL GENET METAB, V82, P121, DOI 10.1016/j.ymgme.2004.03.002; LAMONT P, 1995, PEDIATRICS, V95, P409; Lee WM, 2008, HEPATOLOGY, V47, P1401, DOI 10.1002/hep.22177; Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087; LUONGO MA, 1954, NEW ENGL J MED, V251, P995, DOI 10.1056/NEJM195412162512501; Mahler H, 1997, NEW ENGL J MED, V336, P1142, DOI 10.1056/NEJM199704173361604; Mann MY, 2006, PEDIATRICS, V117, pS296, DOI 10.1542/peds.2005-26331; Mano T, 1999, AM J NEURORADIOL, V20, P1671; MCKIERNAN SH, 1991, HUM REPROD, V6, P64, DOI 10.1093/oxfordjournals.humrep.a137260; Narkewicz MR, 2009, J PEDIAT, V155; PORTMANN BC, 2006, MACSWEENS PATHOLOGY, P199; RHJR S, 2006, J PEDIAT, V148, P652; Roomets E, 2006, NEUROLOGY, V67, P1516, DOI 10.1212/01.wnl.0000240118.82937.ed; Rubio-Gozalbo M. E., 2004, Molecular Aspects of Medicine, V25, P521, DOI 10.1016/j.mam.2004.06.007; Scriver C.R., 2001, METABOLIC MOL BASES; Sijens PE, 2009, MOL GENET METAB, V98, P367, DOI 10.1016/j.ymgme.2009.07.009; Stone JA, 1998, AM J NEURORADIOL, V19, P1378; Therrell BL, 2006, PEDIATRICS, V117, pS212, DOI 10.1542/peds.2005-2633C; Unay B, 2005, CLIN DYSMORPHOL, V14, P165; Weller S, 2008, J INHERIT METAB 0414; Wilcken B, 2010, J INHERIT METAB DIS, V33, P501, DOI 10.1007/s10545-009-9001-1; Willemsen MAAP, 2004, AM J NEURORADIOL, V25, P649; Willemsen MAAP, 2001, BRAIN, V124, P1426, DOI 10.1093/brain/124.7.1426; Wilson JMG, 1968, PRINCIPLES PRACTICE; Yagishita A, 1998, NEURORADIOLOGY, V40, P734, DOI 10.1007/s002340050674; Yang Z, 2007, PEDIATR INT, V49, P883, DOI 10.1111/j.1442-200X.2007.02478.x; 2008, CHANGING MORAL FOCUS	42	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1545	1556		10.1056/NEJMcpc1013928	http://dx.doi.org/10.1056/NEJMcpc1013928			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21506744				2022-12-28	WOS:000289722700014
J	Welch, JS; Westervelt, P; Ding, L; Larson, DE; Klco, JM; Kulkarni, S; Wallis, J; Chen, K; Payton, JE; Fulton, RS; Veizer, J; Schmidt, H; Vickery, TL; Heath, S; Watson, MA; Tomasson, MH; Link, DC; Graubert, TA; DiPersio, JF; Mardis, ER; Ley, TJ; Wilson, RK				Welch, John S.; Westervelt, Peter; Ding, Li; Larson, David E.; Klco, Jeffery M.; Kulkarni, Shashikant; Wallis, John; Chen, Ken; Payton, Jacqueline E.; Fulton, Robert S.; Veizer, Joelle; Schmidt, Heather; Vickery, Tammi L.; Heath, Sharon; Watson, Mark A.; Tomasson, Michael H.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.; Mardis, Elaine R.; Ley, Timothy J.; Wilson, Richard K.			Use of Whole-Genome Sequencing to Diagnose a Cryptic Fusion Oncogene	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; RAR-ALPHA-PML; POLYMERASE-CHAIN-REACTION; RETINOIC ACID RECEPTOR; IN-SITU HYBRIDIZATION; INTERSTITIAL INSERTION; CLASSIC T(15/17); GENE; MUTATIONS	Context Whole-genome sequencing is becoming increasingly available for research purposes, but it has not yet been routinely used for clinical diagnosis. Objective To determine whether whole-genome sequencing can identify cryptic, actionable mutations in a clinically relevant time frame. Design, Setting, and Patient We were referred a difficult diagnostic case of acute promyelocytic leukemia with no pathogenic X-RARA fusion identified by routine metaphase cytogenetics or interphase fluorescence in situ hybridization (FISH). The case patient was enrolled in an institutional review board-approved protocol, with consent specifically tailored to the implications of whole-genome sequencing. The protocol uses a "movable firewall" that maintains patient anonymity within the entire research team but allows the research team to communicate medically relevant information to the treating physician. Main Outcome Measures Clinical relevance of whole-genome sequencing and time to communicate validated results to the treating physician. Results Massively parallel paired-end sequencing allowed identification of a cytogenetically cryptic event: a 77-kilobase segment from chromosome 15 was inserted en bloc into the second intron of the RARA gene on chromosome 17, resulting in a classic bcr3 PML-RARA fusion gene. Reverse transcription polymerase chain reaction sequencing subsequently validated the expression of the fusion transcript. Novel FISH probes identified 2 additional cases of t(15;17)-negative acute promyelocytic leukemia that had cytogenetically invisible insertions. Whole-genome sequencing and validation were completed in 7 weeks and changed the treatment plan for the patient. Conclusion Whole-genome sequencing can identify cytogenetically invisible oncogenes in a clinically relevant time frame. JAMA. 2011; 305(15): 1577-1584	[Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Welch, John S.; Westervelt, Peter; Heath, Sharon; Tomasson, Michael H.; Link, Daniel C.; Graubert, Timothy A.; DiPersio, John F.; Ley, Timothy J.] Washington Univ, Dept Med, St Louis, MO 63108 USA; [Klco, Jeffery M.; Kulkarni, Shashikant; Payton, Jacqueline E.; Watson, Mark A.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Kulkarni, Shashikant; Mardis, Elaine R.; Ley, Timothy J.; Wilson, Richard K.] Washington Univ, Dept Genet, St Louis, MO 63108 USA; [Kulkarni, Shashikant] Washington Univ, Dept Pediat, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wilson, RK (corresponding author), Washington Univ, Sch Med, Genome Inst, 4444 Forest Pk Blvd,POB 8501, St Louis, MO 63108 USA.	rwilson@wustl.edu	Klco, Jeffery/M-9717-2018; Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019; Chen, Ken/AAU-1432-2021	Klco, Jeffery/0000-0003-2961-6960; Wilson, Richard K./0000-0002-1992-1358; Chen, Ken/0000-0003-4013-5279; Tomasson, Michael/0000-0003-4518-7123; Graubert, Timothy/0000-0002-7710-1171; Larson, David/0000-0001-7934-5906	Celgene; Novartis; Genzyme; Washington University Cancer Genome Initiative; National Institutes of Health (NIH) [PO1 CA101937, U54 HG003079]; Barnes-Jewish Hospital Foundation [00335-0505-02]; NATIONAL CANCER INSTITUTE [R01CA083962, P01CA101937] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL103975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	Celgene(Bristol-Myers SquibbCelgene Corporation); Novartis(Novartis); Genzyme(Sanofi-AventisGenzyme Corporation); Washington University Cancer Genome Initiative; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Westervelt reported receiving lecture fees from Celgene and Novartis; Dr DiPersio reported receiving consulting and lecture fees from Genzyme. No other authors reported disclosures.; This study was supported by the Washington University Cancer Genome Initiative, by National Institutes of Health (NIH) grant PO1 CA101937, by Barnes-Jewish Hospital Foundation grant 00335-0505-02 (Dr Ley), and by NIH grant U54 HG003079 (Dr Wilson). Dr Welch is a fellow of the Leukemia Lymphoma Society.	Abe S, 2008, CANCER GENET CYTOGEN, V184, P44, DOI 10.1016/j.cancergencyto.2008.03.006; ALCALAY M, 1992, P NATL ACAD SCI USA, V89, P4840, DOI 10.1073/pnas.89.11.4840; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; Burnett AK, 2010, BLOOD, V115, P948, DOI 10.1182/blood-2009-08-236588; Catalano A, 2007, BLOOD, V110, P4073, DOI 10.1182/blood-2007-06-095554; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Dong S, 2002, BLOOD, V99, P2637, DOI 10.1182/blood.V99.8.2637; Goldschmidt N, 2010, HEMATOLOGY, V15, P332, DOI 10.1179/102453310X12647083621083; Grimwade D, 2000, BLOOD, V96, P1297; Grimwade D, 1997, BLOOD, V90, P4876; Hill BT, 2010, CURR HEMATOL MALIG R, V5, P101, DOI 10.1007/s11899-010-0042-1; HIORNS LR, 1995, CANCER GENET CYTOGEN, V83, P136, DOI 10.1016/0165-4608(95)00048-T; HIORNS LR, 1994, BLOOD, V83, P2946, DOI 10.1182/blood.V83.10.2946.2946; Jurcic Joseph G, 2007, Curr Oncol Rep, V9, P337, DOI 10.1007/s11912-007-0045-9; Kim MJ, 2010, CANCER GENET CYTOGEN, V203, P278, DOI 10.1016/j.cancergencyto.2010.08.026; Kondo T, 2008, HAEMATOL-HEMATOL J, V93, P1414, DOI 10.3324/haematol.12854; LAFAGEPOCHITALOFF M, 1995, BLOOD, V85, P1169, DOI 10.1182/blood.V85.5.1169.1169; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; May PC, 2010, CANCER GENET CYTOGEN, V198, P71, DOI 10.1016/j.cancergencyto.2009.12.010; PANDOLFI PP, 1992, EMBO J, V11, P1397, DOI 10.1002/j.1460-2075.1992.tb05185.x; Park TS, 2009, CANCER GENET CYTOGEN, V188, P103, DOI 10.1016/j.cancergencyto.2008.09.002; Pollock JL, 1999, P NATL ACAD SCI USA, V96, P15103, DOI 10.1073/pnas.96.26.15103; Powell BL, 2010, BLOOD, V116, P3751, DOI 10.1182/blood-2010-02-269621; Reiter A, 2003, GENE CHROMOSOME CANC, V36, P175, DOI 10.1002/gcc.10154; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Such E, 2011, BLOOD, V117, P242, DOI 10.1182/blood-2010-06-291658; Tallman MS, 2002, BLOOD, V100, P4298, DOI 10.1182/blood-2002-02-0632; Walter MJ, 2007, BLOOD, V109, P1237, DOI 10.1182/blood-2006-07-037465; Walz C, 2010, GENE CHROMOSOME CANC, V49, P471, DOI 10.1002/gcc.20757; Yamamoto Y, 2010, BLOOD, V116, P4274, DOI 10.1182/blood-2010-01-264432	32	182	188	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1577	1584		10.1001/jama.2011.497	http://dx.doi.org/10.1001/jama.2011.497			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21505136	Green Accepted, Bronze			2022-12-28	WOS:000289683000027
J	[Anonymous]				[Anonymous]			PERSONAL VIEW Private alcohol detox clinics should be regulated	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 20	2011	342								d2399	10.1136/bmj.d2399	http://dx.doi.org/10.1136/bmj.d2399			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755ON	21508046				2022-12-28	WOS:000289942900007
J	Gilbert, J; Saheecha, SY; Oguntolu, V				Gilbert, Jackie; Saheecha, Saad Yousif; Oguntolu, Victor			CASE REPORT Acute global limb weakness	BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPOKALEMIC PERIODIC PARALYSIS; MUTATIONS; CHANNEL		[Gilbert, Jackie; Saheecha, Saad Yousif] Kings Coll Hosp NHS Fdn Trust, London SE9 5RS, England; [Oguntolu, Victor] Univ Hosp Lewisham, London, England	King's College Hospital NHS Foundation Trust; University of London; King's College London	Gilbert, J (corresponding author), Kings Coll Hosp NHS Fdn Trust, London SE9 5RS, England.	jackiegilbert@nhs.net						Ahlawat SK, 1999, POSTGRAD MED J, V75, P193, DOI 10.1136/pgmj.75.882.193; Bresolin NL, 2005, PEDIATR NEPHROL, V20, P818, DOI 10.1007/s00467-005-1833-9; JEN J, 2001, METABOLIC MOL BASES, P5223; Lapie P, 1997, NEUROMUSCULAR DISORD, V7, P234, DOI 10.1016/S0960-8966(97)00435-5; Lin SH, 2001, QJM-MON J ASSOC PHYS, V94, P133, DOI 10.1093/qjmed/94.3.133; LINKS TP, 1988, J NEUROL NEUROSUR PS, V51, P1142, DOI 10.1136/jnnp.51.9.1142; Manoukian MA, 1999, ARCH INTERN MED, V159, P601, DOI 10.1001/archinte.159.6.601; Soule Benjamin R, 2008, Cases J, V1, P256, DOI 10.1186/1757-1626-1-256; STEDWELL RE, 1992, AM J EMERG MED, V10, P143, DOI 10.1016/0735-6757(92)90048-3; Sternberg D, 2001, BRAIN, V124, P1091, DOI 10.1093/brain/124.6.1091; Venance SL, 2006, BRAIN, V129, P8, DOI 10.1093/brain/awh639	11	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 18	2011	342								d1516	10.1136/bmj.d1516	http://dx.doi.org/10.1136/bmj.d1516			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755OG	21502257				2022-12-28	WOS:000289941800001
J	Howard, GCW; Nairn, M				Howard, G. C. W.; Nairn, M.			GUIDELINES Management of adult testicular germ cell tumours: summary of updated SIGN guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER; TESTIS		[Nairn, M.] Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland; [Howard, G. C. W.] Western Gen Hosp, Edinburgh Canc Ctr, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Nairn, M (corresponding author), Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland.	moray.nairn@nhs.net		Nairn, Moray/0000-0001-6474-4410				ALBERS P, 2009, GUIDELINES TESTICULA; CHILVERS CED, 1989, BRIT J CANCER, V59, P126, DOI 10.1038/bjc.1989.25; Feldman DR, 2008, JAMA-J AM MED ASSOC, V299, P672, DOI 10.1001/jama.299.6.672; GIWERCMAN A, 1993, EUR UROL, V23, P104; Harland SJ, 1998, J UROLOGY, V160, P1353, DOI 10.1016/S0022-5347(01)62535-7; Howard GCW, 2005, CLIN ONCOL-UK, V17, P435, DOI 10.1016/j.clon.2005.03.011; HOWARD GCW, 1995, BRIT J CANCER, V72, P1307, DOI 10.1038/bjc.1995.506; *INF STAT DIV SCOT, MAL GEN ORG CANC; *INF STAT DIV SCOT, CANC MAL GEN ORG; *INF STAT DIV SCOT, CHILDH AD YOUNG AD C; Mead GM, 1997, J CLIN ONCOL, V15, P594; *SCOTT INT GUID NE, 2011, SIGN PUBL, V124	12	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2011	342								d2005	10.1136/bmj.d2005	http://dx.doi.org/10.1136/bmj.d2005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752UZ	21493673				2022-12-28	WOS:000289721700004
J	Kim, LT				Kim, Lawrence T.			Surgical Site Infection Still Waiting on the Revolution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRIAL	Objective: To determine if an evidenced-based practice bundle would result in a significantly lower rate of surgical site infections (SSIs) when compared with standard practice. Design: Single-institution, randomized controlled trial with blinded assessment of main outcome. The trial opened in April 2007 and was closed in January 2010. Setting: Veterans Administration teaching hospital. Patients: Patients who required elective transabdominal colorectal surgery were eligible. A total of 241 subjects were approached, 211 subjects were randomly allocated to 1 of 2 interventions, and 197 were included in an intention-to-treat analysis. Interventions: Subjects received either a combination of 5 evidenced-based practices (extended arm) or were treated according to our current practice (standard arm). The interventions in the extended arm included (1) omission of mechanical bowel preparation; (2) preoperative and intraoperative warming; (3) supplemental oxygen during and immediately after surgery; (4) intraoperative intravenous fluid restriction; and (5) use of a surgical wound protector. Main Outcome Measure: Overall SSI rate at 30 days assessed by blinded infection control coordinators using standardized definitions. Results: The overall rate of SSI was 45% in the extended arm of the study and 24% in the standard arm (P=.003). Most of the increased number of infections in the extended arm were superficial incisional SSIs (36% extended arm vs 19% standard arm; P=.004). Multivariate analysis suggested that allocation to the extended arm of the trial conferred a 2.49-fold risk (95% confidence interval, 1.36-4.56; P=.003) independent of other factors traditionally associated with SSI. Conclusions: An evidenced-based intervention bundle did not reduce SSIs. The bundling of interventions, even when the constituent interventions have been individually tested, does not have a predictable effect on outcome. Formal testing of bundled approaches should occur prior to implementation.	[Kim, Lawrence T.] Univ Texas SW Med Ctr Dallas, Surg Serv, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Kim, LT (corresponding author), 4300 W 7th St, Little Rock, AR 72205 USA.	KimLawrence@uams.edu						Anthony T, 2011, ARCH SURG-CHICAGO, V146, P263, DOI 10.1001/archsurg.2010.249; Guenaga KKFG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001544.pub3; Institute for Healthcare Improvement, PROGR TOP CRIT CAR I; Meyhoff CS, 2009, JAMA-J AM MED ASSOC, V302, P1543, DOI 10.1001/jama.2009.1452; Stulberg JJ, 2010, JAMA-J AM MED ASSOC, V303, P2479, DOI 10.1001/jama.2010.841	5	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1478	1479		10.1001/jama.2011.447	http://dx.doi.org/10.1001/jama.2011.447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21491663				2022-12-28	WOS:000289424100025
J	Petrou, S; Gray, A				Petrou, Stavros; Gray, Alastair			Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH TECHNOLOGY-ASSESSMENT; COST-EFFECTIVENESS; CARE; CANCER; TRIAL		[Petrou, Stavros] Univ Warwick, Warwick Med Sch, Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Gray, Alastair] Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford, England	University of Warwick; University of Oxford	Petrou, S (corresponding author), Univ Warwick, Warwick Med Sch, Clin Trials Unit, Coventry CV4 7AL, W Midlands, England.	S.Petrou@warwick.ac.uk	Petrou, Stavros/ABD-8323-2021	Petrou, Stavros/0000-0003-3121-6050	National Institute of Health Research; UK Medical Research Council; MRC [G0501681] Funding Source: UKRI; Medical Research Council [G0501681] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10206] Funding Source: researchfish	National Institute of Health Research(National Institute for Health Research (NIHR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The Warwick Clinical Trials Unit benefited from facilities funded through the Birmingham Science City Translational Medicine Clinical Research and Infrastructure Trials Platform, with support from Advantage West Midlands. The Health Economics Research Centre receives funding from the National Institute of Health Research. SP started working on this article while employed by the National Perinatal Epidemiology Unit, University of Oxford, and the Health Economics Research Centre, University of Oxford, and funded by a UK Medical Research Council senior non-clinical research fellowship. AG is an NIHR senior investigator. They have no other relationships or activities that could appear to have influenced the submitted work.	Ades AE, 2002, MED DECIS MAKING, V22, P359, DOI 10.1177/027298902400448920; Ades AE, 2006, J R STAT SOC A STAT, V169, P5, DOI 10.1111/j.1467-985X.2005.00377.x; Barton Pelham, 2004, J Health Serv Res Policy, V9, P110, DOI 10.1258/135581904322987535; Bojke L, 2007, PHARMACOECONOMICS, V25, P829, DOI 10.2165/00019053-200725100-00003; Bojke L, 2009, VALUE HEALTH, V12, P739, DOI 10.1111/j.1524-4733.2008.00502.x; Brennan A, 2006, HEALTH ECON, V15, P1295, DOI 10.1002/hec.1148; BRIGGS A, 2006, DECIS MODELLING HLTH; Brisson M, 2003, MED DECIS MAKING, V23, P76, DOI 10.1177/0272989X02239651; Castelnuovo E, 2006, HEALTH TECHNOL ASSES, V10, P1; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Claxton K, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8310; Cooper K, 2007, J OPER RES SOC, V58, P168, DOI 10.1057/palgrave.jors.2602230; Coyle D, 1998, PHARMACOECONOMICS, V14, P357, DOI 10.2165/00019053-199814040-00003; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; DRUMMOND MF, 2005, METHODS ECON EVALUA; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Golder S, 2005, INT J TECHNOL ASSESS, V21, P305, DOI 10.1017/S0266462305050403; GRAY A, 2010, APPL METHODS COST; Legood R, 2006, BMJ-BRIT MED J, V332, P79, DOI 10.1136/bmj.38698.458866.7C; Mihaylova B, 2005, LANCET, V365, P1779, DOI 10.1016/S0140-6736(05)63014-0; Mihaylova B, 2006, BMJ-BRIT MED J, V333, P1145, DOI 10.1136/bmj.38993.731725.BE; *NHS CTR REV DISS, 2001, UNDERTAKING SYSTEM; Palmer AJ, 2007, DIABETES CARE, V30, P1638, DOI 10.2337/dc07-9919; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1548; Philips Z, 2006, PHARMACOECONOMICS, V24, P355, DOI 10.2165/00019053-200624040-00006; Philips Z, 2004, HEALTH TECHNOL ASSES, V8, P1; Philips Z, 2008, MED DECIS MAKING, V28, P287, DOI 10.1177/0272989X07312724; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Sculpher MJ, 2006, HEALTH ECON, V15, P677, DOI 10.1002/hec.1093; Speight PM, 2006, HEALTH TECHNOL ASSES, V10, P1; Stout NK, 2009, PHARMACOECONOMICS, V27, P533, DOI 10.2165/11314830-000000000-00000; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; Weinstein MC, 2006, PHARMACOECONOMICS, V24, P1043, DOI 10.2165/00019053-200624110-00002	34	151	143	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2011	342								d1766	10.1136/bmj.d1766	http://dx.doi.org/10.1136/bmj.d1766			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752UT	21482590	Green Submitted, Bronze			2022-12-28	WOS:000289721100018
J	Cox, C				Cox, Caroline			The Art of Medicine Elizabeth Evans Hughes-surviving starvation therapy for diabetes	LANCET			English	Editorial Material									Univ Pacific, Dept Hist, Stockton, CA 95211 USA	University of the Pacific	Cox, C (corresponding author), Univ Pacific, Dept Hist, Stockton, CA 95211 USA.	ccox@pacific.edu						Cox Caroline., 2009, FIGHT SURVIVE YOUNG; Davidson CathyN., 2004, REVOLUTION WORD RISE; HUGHES E, LETT ELIZABETH HUGHE; Kleinman A., 1988, ILLNESS NARRATIVE SU; Lawrence C., 2003, BITTERSWEET DIABETES, V1st, P89	5	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1232	1233		10.1016/S0140-6736(11)60490-X	http://dx.doi.org/10.1016/S0140-6736(11)60490-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	751DI	21495276				2022-12-28	WOS:000289597300016
J	Serour, GI; Cabral, SA; Lynch, B				Serour, Gamal I.; Cabral, Sergio A.; Lynch, Bridget			Stillbirths: the professional organisations' perspective	LANCET			English	Editorial Material							RECURRENCE; PREGNANCY; RISK		[Serour, Gamal I.] Al Azhar Univ, Int Islamic Ctr Populat Studies & Res, Cairo, Egypt; [Cabral, Sergio A.] Estacio de Sa Univ, Int Pediat Assoc, Rio De Janeiro, Brazil; [Lynch, Bridget] Canadian Assoc Midwives, Montreal, PQ, Canada	Egyptian Knowledge Bank (EKB); Al Azhar University	Serour, GI (corresponding author), Al Azhar Univ, Int Islamic Ctr Populat Studies & Res, Cairo, Egypt.	giserour1@link.net						BHATTACHARYA S, 2010, BJOG, V117, P1234; Black M, 2008, BJOG-INT J OBSTET GY, V115, P269, DOI 10.1111/j.1471-0528.2007.01562.x; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Herring AH, 2010, BJOG-INT J OBSTET GY, V117, P1173, DOI 10.1111/j.1471-0528.2010.02655.x; Serour GI, 2010, INT J GYNECOL OBSTET, V108, P93, DOI 10.1016/j.ijgo.2009.11.001; SEROUR GI, 2009, BRAIN, V106, P175; Sharma PP, 2007, PAEDIATR PERINAT EP, V21, P24, DOI 10.1111/j.1365-3016.2007.00834.x; WHO, WORK TOG HLTH WORLD; WHO UNICEF, 2010, COUNTD 2015 DEC REP; World Health Organization (WHO), 2009, GLOB HLTH ATL	10	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2011	377	9776					1471	1472		10.1016/S0140-6736(10)62357-4	http://dx.doi.org/10.1016/S0140-6736(10)62357-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761RX	21496908				2022-12-28	WOS:000290419400007
J	Tipton, K; Launders, JH; Inamdar, R; Miyamoto, C; Schoelles, K				Tipton, Kelley; Launders, Jason H.; Inamdar, Rohit; Miyamoto, Curtis; Schoelles, Karen			Stereotactic Body Radiation Therapy: Scope of the Literature	ANNALS OF INTERNAL MEDICINE			English	Review							CELL LUNG-CANCER; TIME TUMOR-TRACKING; PRIMARY HEPATOCELLULAR-CARCINOMA; PROSPECTIVE PHASE-II; MEDICALLY INOPERABLE PATIENTS; SINGLE-DOSE RADIOTHERAPY; RISK PROSTATE-CANCER; STAGE-I; LIVER METASTASES; CYBERKNIFE RADIOSURGERY	Stereotactic body radiation therapy (SBRT) is derived from the techniques of stereotactic radiosurgery used to treat lesions in the brain and spine. It combines multiple finely collimated radiation beams and stereotaxy to deliver a high dose of radiation to an extracranial target in the body in a single dose or a few fractions. This review provides a broad overview of the current state of SBRT for solid malignant tumors. Reviewers identified a total of 124 relevant studies. To our knowledge, no published comparative studies address the relative effectiveness and safety of SBRT versus other forms of external-beam radiation therapy. Stereotactic body radiation therapy seems to be widely diffused as a treatment of various types of cancer, although most studies have focused only on its use for treating thoracic tumors. Comparative studies are needed to provide evidence that the theoretical advantages of SBRT over other radiation therapies actually occur in the clinical setting; this area is currently being studied in only 1 small trial.	[Schoelles, Karen] ECRI Inst, Evidence Based Practice Ctr, Plymouth Meeting, PA 19462 USA; Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Schoelles, K (corresponding author), ECRI Inst, Evidence Based Practice Ctr, 5200 Butler Pike, Plymouth Meeting, PA 19462 USA.	kschoelles@ecri.org			Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [290-02-0019]	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was supported by the ECRI Institute Evidence-based Practice Center with funding from the Agency for Healthcare Research and Quality under contract 290-02-0019, U.S. Department of Health and Human Services.	Ahn SH, 2009, ONCOL REP, V21, P693, DOI 10.3892/or_00000273; Aluwini S, 2010, J ENDOUROL, V24, P865, DOI 10.1089/end.2009.0438; American Hospital Association, 2014, GUID US HOSP HLTH CA; [Anonymous], 2010, MEDCAC M RAD THER LO; Aoki Masahiko, 2007, Radiat Med, V25, P289, DOI 10.1007/s11604-007-0141-7; Baumann P, 2008, RADIOTHER ONCOL, V88, P359, DOI 10.1016/j.radonc.2008.07.019; Baumann P, 2006, ACTA ONCOL, V45, P787, DOI 10.1080/02841860600904862; Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; Bolzicco G, 2010, TECHNOL CANCER RES T, V9, P473, DOI 10.1177/153303461000900505; Bradley JD, 2010, INT J RADIAT ONCOL, V77, P1146, DOI 10.1016/j.ijrobp.2009.06.017; Brock J, 2008, CLIN ONCOL-UK, V20, P666, DOI 10.1016/j.clon.2008.06.005; Brown WT, 2007, COMPUT AIDED SURG, V12, P253, DOI 10.1080/10929080701684754; Bucci MK, 2005, CA-CANCER J CLIN, V55, P117, DOI 10.3322/canjclin.55.2.117; Diaz-Santos NC, 2008, RADIOTHER ONCOL, V89, P245, DOI 10.1016/j.radonc.2008.07.022; Cardenes HR, 2010, CLIN TRANSL ONCOL, V12, P218, DOI 10.1007/s12094-010-0492-x; Casamassima F, 2008, INT J RADIAT ONCOL, V71, P145, DOI 10.1016/j.ijrobp.2007.09.036; Chang BK, 2007, AM J CLIN ONCOL-CANC, V30, P637, DOI 10.1097/COC.0b013e3180ca7cb1; Chang DT, 2009, CANCER-AM CANCER SOC, V115, P665, DOI 10.1002/cncr.24059; Chang JY, 2008, INT J RADIAT ONCOL, V72, P967, DOI 10.1016/j.ijrobp.2008.08.001; Chawla S, 2009, INT J RADIAT ONCOL, V75, P71, DOI 10.1016/j.ijrobp.2008.10.079; Chi A, 2010, RADIOTHER ONCOL, V94, P1, DOI 10.1016/j.radonc.2009.12.008; Cho CW, 2009, INT J RADIAT ONCOL, V74, P147, DOI 10.1016/j.ijrobp.2008.07.020; Choi BO, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-351; Collins BT, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-1; Coon D, 2008, CLIN LUNG CANCER, V9, P217, DOI 10.3816/CLC.2008.n.032; Crabtree TD, 2010, J THORAC CARDIOV SUR, V140, P377, DOI 10.1016/j.jtcvs.2009.12.054; Dawson LA, 2006, ACTA ONCOL, V45, P856, DOI 10.1080/02841860600936369; Dunlap NE, 2010, INT J RADIAT ONCOL, V76, P796, DOI 10.1016/j.ijrobp.2009.02.027; Ernst-Stecken A, 2006, STRAHLENTHER ONKOL, V182, P696, DOI 10.1007/s00066-006-1577-x; Freeman DE, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-3; Fritz P, 2008, LUNG CANCER, V60, P193, DOI 10.1016/j.lungcan.2007.10.005; Goodman KA, 2010, INT J RADIAT ONCOL, V78, P486, DOI 10.1016/j.ijrobp.2009.08.020; Grills IS, 2010, J CLIN ONCOL, V28, P928, DOI 10.1200/JCO.2009.25.0928; Guckenberger M, 2007, RADIOTHER ONCOL, V85, P435, DOI 10.1016/j.radonc.2007.10.044; Guckenberger M, 2010, RADIOTHER ONCOL, V94, P53, DOI 10.1016/j.radonc.2009.12.004; Guckenberger M, 2009, INT J RADIAT ONCOL, V74, P47, DOI 10.1016/j.ijrobp.2008.06.1939; Gunven P, 2003, HEPATO-GASTROENTEROL, V50, P1201; Haasbeek CJA, 2009, CANCER, V115, P587, DOI 10.1002/cncr.24068; Hamamoto Y, 2010, JPN J CLIN ONCOL, V40, P125, DOI 10.1093/jjco/hyp129; Harada T, 2002, CANCER, V95, P1720, DOI 10.1002/cncr.10856; Hodge W, 2006, ACTA ONCOL, V45, P890, DOI 10.1080/02841860600907329; Hof H, 2007, STRAHLENTHER ONKOL, V183, P673, DOI 10.1007/s00066-007-1724-z; Hof H, 2007, CANCER-AM CANCER SOC, V110, P148, DOI 10.1002/cncr.22763; Hoyer M, 2005, RADIOTHER ONCOL, V76, P48, DOI 10.1016/j.radonc.2004.12.022; Hoyer M, 2006, ACTA ONCOL, V45, P823, DOI 10.1080/02841860600904854; Ishimori T, 2004, ANN NUCL MED, V18, P669, DOI 10.1007/BF02985960; Jereczek-Fossa BA, 2008, STRAHLENTHER ONKOL, V184, P36, DOI 10.1007/s00066-008-1783-9; Jorcano S, 2010, TECHNOL CANCER RES T, V9, P509, DOI 10.1177/153303461000900509; Joyner M, 2006, ACTA ONCOL, V45, P802, DOI 10.1080/02841860600915322; Kang JK, 2010, CLIN EXP METASTAS, V27, P273, DOI 10.1007/s10585-010-9325-0; Katoh N, 2008, RADIOTHER ONCOL, V87, P418, DOI 10.1016/j.radonc.2008.03.013; Khrizman P, 2010, CLIN COLORECTAL CANC, V9, P136, DOI 10.3816/CCC.2010.n.018; Kim JH, 2010, OTOLARYNG HEAD NECK, V142, P338, DOI 10.1016/j.otohns.2009.12.034; Kim MS, 2008, JPN J CLIN ONCOL, V38, P695, DOI 10.1093/jjco/hyn083; Kim MS, 2009, ONCOLOGY-BASEL, V76, P212, DOI 10.1159/000201932; King CR, 2009, INT J RADIAT ONCOL, V73, P1043, DOI 10.1016/j.ijrobp.2008.05.059; Kopek N, 2010, RADIOTHER ONCOL, V94, P47, DOI 10.1016/j.radonc.2009.11.004; Kopek N, 2009, RADIOTHER ONCOL, V93, P402, DOI 10.1016/j.radonc.2009.06.002; Koto M, 2007, RADIOTHER ONCOL, V85, P429, DOI 10.1016/j.radonc.2007.10.017; Kunos C, 2008, TECHNOL CANCER RES T, V7, P375, DOI 10.1177/153303460800700504; Lagerwaard FJ, 2008, INT J RADIAT ONCOL, V70, P685, DOI 10.1016/j.ijrobp.2007.10.053; Lanni Jr TB, 2010, AM J CLIN ONCOL; Le QT, 2006, J THORAC ONCOL, V1, P802, DOI 10.1097/01243894-200610000-00008; Lee MT, 2009, J CLIN ONCOL, V27, P1585, DOI 10.1200/JCO.2008.20.0600; Lee SW, 2003, LUNG CANCER, V40, P309, DOI 10.1016/S0169-5002(03)00040-0; Louis C, 2010, TECHNOL CANCER RES T, V9, P479, DOI 10.1177/153303461000900506; Mahadevan A, 2010, INT J RADIAT ONCOL, V78, P735, DOI 10.1016/j.ijrobp.2009.08.046; McCammon R, 2009, INT J RADIAT ONCOL, V73, P112, DOI 10.1016/j.ijrobp.2008.03.062; Romero AM, 2006, ACTA ONCOL, V45, P831, DOI 10.1080/02841860600897934; Meyer JL, 2007, FRONT RADIAT THER ON, V40, P1, DOI 10.1159/000106025; Milano MT, 2010, AM J CLIN ONCOL-CANC, V33, P157, DOI 10.1097/COC.0b013e3181979238; Milano MT, 2009, RADIOTHER ONCOL, V91, P301, DOI 10.1016/j.radonc.2009.03.005; Milano MT, 2009, INT J RADIAT ONCOL, V73, P832, DOI 10.1016/j.ijrobp.2008.04.073; Molla M, 2005, INT J RADIAT ONCOL, V62, P118, DOI 10.1016/j.ijrobp.2004.09.028; Nakagawa K, 2000, INT J RADIAT ONCOL, V48, P449, DOI 10.1016/S0360-3016(00)00617-9; Nguyen NP, 2008, CANCER TREAT REV, V34, P719, DOI 10.1016/j.ctrv.2008.06.001; Norihisa Y, 2008, INT J RADIAT ONCOL, V72, P398, DOI 10.1016/j.ijrobp.2008.01.002; Nuyttens JJ, 2007, TECHNOL CANCER RES T, V6, P605, DOI 10.1177/153303460700600603; Nuyttens JJ, 2006, ACTA ONCOL, V45, P961, DOI 10.1080/02841860600902205; Oermann EK, 2010, TECHNOL CANCER RES T, V9, P453, DOI 10.1177/153303461000900503; Onimaru R, 2008, INT J RADIAT ONCOL, V70, P374, DOI 10.1016/j.ijrobp.2007.06.043; Onishi H, 2004, LUNG CANCER, V45, P45, DOI 10.1016/j.lungcan.2004.01.004; Pennathur A, 2009, J THORAC CARDIOV SUR, V137, P597, DOI 10.1016/j.jtcvs.2008.06.046; Polistina F, 2010, ANN SURG ONCOL, V17, P2092, DOI 10.1245/s10434-010-1019-y; Ponsky LE, 2007, SURG INNOV, V14, P265, DOI 10.1177/1553350607310546; Ricardi U, 2007, J THORAC ONCOL, V2, pS47, DOI 10.1097/01.JTO.0000268645.86568.a4; Rusthoven KE, 2009, J CLIN ONCOL, V27, P1572, DOI 10.1200/JCO.2008.19.6329; Rusthoven KE, 2009, J CLIN ONCOL, V27, P1579, DOI 10.1200/JCO.2008.19.6386; Salazar OM, 2008, INT J RADIAT ONCOL, V72, P707, DOI 10.1016/j.ijrobp.2008.01.054; Sawrie SM, 2010, CANCER CONTROL, V17, P111, DOI 10.1177/107327481001700206; Schellenberg D, 2008, INT J RADIAT ONCOL, V72, P678, DOI 10.1016/j.ijrobp.2008.01.051; Seo YS, 2010, J SURG ONCOL, V102, P209, DOI 10.1002/jso.21593; Shin YJ, 2010, TUMORI J, V96, P65, DOI 10.1177/030089161009600111; Shioyama Yoshiyuki, 2005, Radiat Med, V23, P407; Sinha B, 2006, INT J RADIAT ONCOL, V66, P1120, DOI 10.1016/j.ijrobp.2006.06.042; Siva S, 2010, J THORAC ONCOL, V5, P1091, DOI 10.1097/JTO.0b013e3181de7143; Son SH, 2010, INT J RADIAT ONCOL, V78, P1073, DOI 10.1016/j.ijrobp.2009.09.009; Song DY, 2005, AM J CLIN ONCOL-CANC, V28, P591, DOI 10.1097/01.coc.0000182428.56184.af; Song SY, 2009, LUNG CANCER, V66, P89, DOI 10.1016/j.lungcan.2008.12.016; Stephans KL, 2009, J THORAC ONCOL, V4, P976, DOI 10.1097/JTO.0b013e3181adf509; Stephans KL, 2009, J THORAC ONCOL, V4, P838, DOI 10.1097/JTO.0b013e3181a99ff6; Stintzing S, 2010, EUR J CANCER, V46, P1026, DOI 10.1016/j.ejca.2010.01.008; Stintzing S, 2010, ANN SURG ONCOL, V17, P2877, DOI 10.1245/s10434-010-1187-9; Svedman C, 2008, ACTA ONCOL, V47, P1578, DOI 10.1080/02841860802123196; Svedman C, 2006, ACTA ONCOL, V45, P870, DOI 10.1080/02841860600954875; Takeda A, 2010, INT J RADIAT ONCOL, V77, P685, DOI 10.1016/j.ijrobp.2009.06.001; Takeda A, 2009, INT J RADIAT ONCOL, V73, P442, DOI 10.1016/j.ijrobp.2008.04.043; Teh BS, 2007, TECHNOL CANCER RES T, V6, P347, DOI 10.1177/153303460700600412; Timmerman R, 2006, J CLIN ONCOL, V24, P4833, DOI 10.1200/JCO.2006.07.5937; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Tipton K.N, 2011, STEREOTACTIC BODY RA; Townsend NC, 2011, AM J CLIN ONCOL-CANC, V34, P6, DOI 10.1097/COC.0b013e3181c4c7c4; Trovo M, 2010, LUNG CANCER, V69, P77, DOI 10.1016/j.lungcan.2009.09.006; Tse RV, 2008, J CLIN ONCOL, V26, P657, DOI 10.1200/JCO.2007.14.3529; Uematsu M, 2001, INT J RADIAT ONCOL, V51, P666, DOI 10.1016/S0360-3016(01)01703-5; Unger K, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-39; Vahdat S, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-6; van Zyp NCV, 2009, RADIOTHER ONCOL, V91, P296, DOI 10.1016/j.radonc.2009.02.011; Whyte RI, 2003, ANN THORAC SURG, V75, P1097, DOI 10.1016/S0003-4975(02)04681-7; Wulf J, 2001, STRAHLENTHER ONKOL, V177, P645, DOI 10.1007/PL00002379; Wulf J, 2006, ACTA ONCOL, V45, P838, DOI 10.1080/02841860600904821; Xia TY, 2006, INT J RADIAT ONCOL, V66, P117, DOI 10.1016/j.ijrobp.2006.04.013; Yamashita H, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-32; Yang ZX, 2010, J CANCER RES CLIN, V136, P625, DOI 10.1007/s00432-009-0701-6; Yoon SM, 2006, ACTA ONCOL, V45, P1108, DOI 10.1080/02841860600812685; Zimmermann FB, 2006, ACTA ONCOL, V45, P796, DOI 10.1080/02841860600913210	126	29	29	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11					737	+		10.7326/0003-4819-154-11-201106070-00343	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-00343			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MV	21536933				2022-12-28	WOS:000291312300004
J	Selmi, C; Bowlus, CL; Gershwin, ME; Coppel, RL				Selmi, Carlo; Bowlus, Christopher L.; Gershwin, M. Eric; Coppel, Ross L.			Primary biliary cirrhosis	LANCET			English	Article							URSODEOXYCHOLIC-ACID THERAPY; RANDOMIZED CONTROLLED-TRIALS; LONG-TERM SURVIVAL; REGULATORY T-CELLS; ANTIMITOCHONDRIAL ANTIBODIES; CLINICAL-FEATURES; ANTINUCLEAR ANTIBODIES; BIOCHEMICAL RESPONSE; NATURAL-HISTORY; LIVER-DISEASE	Primary biliary cirrhosis is a chronic liver disease characterised by intrahepatic bile-duct destruction, cholestasis, and, in some cases, cirrhosis. Evidence supporting the autoimmune nature of this disorder includes the appearance of highly specific antimitochondrial antibodies (AMAs) and autoreactive T cells. Concordance rates in monozygotic twins, familial prevalence, and genetic associations underscore the importance of genetic factors, whereas findings of epidemiological studies and murine models suggest a possible role for exogenous chemicals and infectious agents through molecular mimicry. The incidence of primary biliary cirrhosis has increased over recent decades, possibly attributable to augmented testing of liver biochemistry rather than a rise in disease incidence. AMAs remain the hallmark of diagnosis in most cases and allow detection of asymptomatic patients. Symptomatic individuals usually present with either pruritus or fatigue and, more rarely, with either jaundice or complications of cirrhosis. The prognosis of primary biliary cirrhosis has improved because of early diagnosis and use of ursodeoxycholic acid, the only established medical treatment for this disorder. Although not a cure, treatment can slow disease progression and delay the need for liver transplantation. However, some patients do not respond adequately to ursodeoxycholic acid and might need alternative therapeutic approaches.	[Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Selmi, Carlo] Univ Milan, Dept Translat Med, IRCCS Ist Clin Humanitas, Milan, Italy; [Bowlus, Christopher L.] Univ Calif Davis, Div Gastroenterol & Hepatol, Davis, CA 95616 USA; [Gershwin, M. Eric] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA	Monash University; Humanitas University; IRCCS Humanitas Research Hospital; University of Milan; University of California System; University of California Davis; University of California System; University of California Davis	Coppel, RL (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.	ross.coppel@monash.edu	Selmi, Carlo/ABG-4899-2021; Bowlus, Christopher/N-9276-2016; Coppel, Ross L/A-6626-2008	Selmi, Carlo/0000-0002-0323-0376; Bowlus, Christopher/0000-0002-3906-6811; Coppel, Ross L/0000-0002-4476-9124	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067003] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK090019, R01 DK067003] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHRENS EH, 1950, MEDICINE, V29, P299, DOI 10.1097/00005792-195012000-00002; Al-Harthy N, 2010, HEPATOLOGY, V52, P562, DOI 10.1002/hep.23683; Ala A, 2006, HEPATOLOGY, V43, P525, DOI 10.1002/hep.21076; Allocca M, 2006, GUT, V55, P1795, DOI 10.1136/gut.2005.079814; Benetti A, 2008, J CLIN GASTROENTEROL, V42, P306, DOI 10.1097/01.mcg.0000248017.31386.39; Berg CP, 2009, LIVER INT, V29, P797, DOI 10.1111/j.1478-3231.2008.01942.x; Bergasa NV, 2008, CLIN LIVER DIS, V12, P385, DOI 10.1016/j.cld.2008.02.013; Bergasa NV, 1998, HEPATOLOGY, V27, P679, DOI 10.1002/hep.510270307; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Bogdanos DP, 2009, CLIN REV ALLERG IMMU, V36, P30, DOI 10.1007/s12016-008-8087-9; Bruggraber SFA, 2003, GASTROENTEROLOGY, V125, P1705, DOI 10.1053/j.gastro.2003.09.034; BURROUGHS AK, 1984, GUT, V25, P133, DOI 10.1136/gut.25.2.133; Cerri G, 2010, CLIN NEUROPHYSIOL, V121, P1321, DOI 10.1016/j.clinph.2009.12.040; CHA S, 1993, P NATL ACAD SCI USA, V90, P2527, DOI 10.1073/pnas.90.6.2527; Charatcharoenwitthaya P, 2007, LIVER TRANSPLANT, V13, P1236, DOI 10.1002/lt.21124; Chazouilleres O, 1998, HEPATOLOGY, V28, P296, DOI 10.1002/hep.510280203; Chuang YH, 2006, J AUTOIMMUN, V26, P232, DOI 10.1016/j.jaut.2006.04.001; Corpechot C, 2005, GASTROENTEROLOGY, V128, P297, DOI 10.1053/j.gastro.2004.11.009; CROSIGNANI A, 1991, HEPATOLOGY, V14, P1000, DOI 10.1016/0270-9139(91)90119-G; Dahlan Y, 2003, GASTROENTEROLOGY, V125, P1476, DOI 10.1016/j.gastro.2003.08.022; DATTA DV, 1966, GASTROENTEROLOGY, V50, P323; de Rave S, 2005, TRANSPL INT, V18, P937, DOI 10.1111/j.1432-2277.2005.00161.x; DICKSON ER, 1989, HEPATOLOGY, V10, P1, DOI 10.1002/hep.1840100102; Fukushima N, 2002, HEPATOLOGY, V36, P1383, DOI 10.1053/jhep.2002.37140; FUSSEY SPM, 1988, P NATL ACAD SCI USA, V85, P8654, DOI 10.1073/pnas.85.22.8654; Garcia RFL, 2001, HEPATOLOGY, V33, P22, DOI 10.1053/jhep.2001.20894; Garrido MC, 1996, J CLIN PATHOL, V49, P556, DOI 10.1136/jcp.49.7.556; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; GLUUD C, 2002, COCHRANE DB SYST REV, V1; Goldblatt J, 2002, GASTROENTEROLOGY, V122, P1235, DOI 10.1053/gast.2002.32993; Gong Y, 2008, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000551.PUB2; Gong Y, 2007, AM J GASTROENTEROL, V102, P1799, DOI 10.1111/j.1572-0241.2007.01235.x; Goulis J, 1999, LANCET, V354, P1053, DOI 10.1016/S0140-6736(98)11293-X; Granito A, 2007, ALIMENT PHARM THER, V26, P831, DOI 10.1111/j.1365-2036.2007.03433.x; Granito A, 2006, ALIMENT PHARM THER, V24, P1575, DOI 10.1111/j.1365-2036.2006.03172.x; Guanabens N, 2005, J HEPATOL, V42, P573, DOI 10.1016/j.jhep.2004.11.035; Hardy T, 2010, LIVER INT, V30, P1551, DOI 10.1111/j.1478-3231.2010.02288.x; Heathcote EJ, 2000, HEPATOLOGY, V31, P1005, DOI 10.1053/he.2000.5984; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hollingsworth KG, 2008, CLIN GASTROENTEROL H, V6, P1041, DOI 10.1016/j.cgh.2008.04.013; Hollingsworth KG, 2009, J MAGN RESON IMAGING, V29, P780, DOI 10.1002/jmri.21555; Holtmeier J, 2001, DIGESTION, V64, P137, DOI 10.1159/000048854; Huet PM, 2008, GASTROENTEROLOGY, V135, P1552, DOI 10.1053/j.gastro.2008.07.019; Invernizzi P, 2005, SEMIN LIVER DIS, V25, P298, DOI 10.1055/s-2005-916321; Invernizzi P, 1997, HEPATOLOGY, V25, P1090, DOI 10.1002/hep.510250507; James OFW, 1999, HEPATOLOGY, V30, P390, DOI 10.1002/hep.510300213; Jones DEJ, 2007, ALIMENT PHARM THER, V25, P471, DOI 10.1111/j.1365-2036.2006.03223.x; Jones DE, 2010, J HEPATOL, V53, P911, DOI 10.1016/j.jhep.2010.05.026; Jones DEJ, 2007, GUT, V56, P1615, DOI 10.1136/gut.2007.122150; Jones DEJ, 2006, GUT, V55, P536, DOI 10.1136/gut.2005.080317; Kikuchi K, 2005, GASTROENTEROLOGY, V128, P304, DOI 10.1053/j.gastro.2004.11.005; Kim WR, 2000, GASTROENTEROLOGY, V119, P1631, DOI 10.1053/gast.2000.20197; Kita H, 2002, GASTROENTEROLOGY, V123, P1031, DOI 10.1053/gast.2002.36020; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Kuiper EMM, 2009, GASTROENTEROLOGY, V136, P1281, DOI 10.1053/j.gastro.2009.01.003; Lan RY, 2006, HEPATOLOGY, V43, P729, DOI 10.1002/hep.21123; Lee J, 2007, CLIN GASTROENTEROL H, V5, P1313, DOI 10.1016/j.cgh.2007.07.015; Leslie WD, 2003, GASTROENTEROLOGY, V125, P941, DOI 10.1016/S0016-5085(03)01062-X; Leung PSC, 2007, J IMMUNOL, V179, P2651, DOI 10.4049/jimmunol.179.4.2651; LEUSCHNER U, 1994, J HEPATOL, V21, P624, DOI 10.1016/S0168-8278(94)80111-8; Lindor KD, 1996, GASTROENTEROLOGY, V110, P1515, DOI 10.1053/gast.1996.v110.pm8613058; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Lleo A, 2008, AUTOIMMUN REV, V7, P626, DOI 10.1016/j.autrev.2008.06.009; Lleo A, 2010, HEPATOLOGY, V52, P987, DOI 10.1002/hep.23783; Lleo A, 2009, HEPATOLOGY, V49, P871, DOI 10.1002/hep.22736; Lleo A, 2008, J AUTOIMMUN, V31, P257, DOI 10.1016/j.jaut.2008.04.009; Locke GR, 1996, HEPATOLOGY, V23, P52, DOI 10.1002/hep.510230108; Longhi MS, 2008, HEPATOLOGY, V47, P581, DOI 10.1002/hep.22071; Longo M, 2002, GUT, V51, P265, DOI 10.1136/gut.51.2.265; LOZANO F, 1988, HEPATOLOGY, V8, P930, DOI 10.1002/hep.1840080438; LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479; Mackay IR, 2009, J AUTOIMMUN, V33, P170, DOI 10.1016/j.jaut.2009.09.006; MacQuillan Gerry C, 2003, Clin Liver Dis, V7, P941, DOI 10.1016/S1089-3261(03)00099-0; Mao TK, 2005, HEPATOLOGY, V42, P802, DOI 10.1002/hep.20859; Marasini B, 2001, ANN RHEUM DIS, V60, P1046, DOI 10.1136/ard.60.11.1046; Marzioni M, 2007, J HEPATOL, V46, P583, DOI 10.1016/j.jhep.2007.01.006; Mason A, 2010, J HEPATOL, V52, pS1, DOI 10.1016/S0168-8278(10)60004-9; Mattalia A, 1998, HEPATOLOGY, V27, P656, DOI 10.1002/hep.510270303; Mayo MJ, 2008, HEPATOLOGY, V48, P1549, DOI 10.1002/hep.22517; McNally RJQ, 2009, HEPATOLOGY, V50, P1169, DOI 10.1002/hep.23139; Metcalf JV, 1996, LANCET, V348, P1399, DOI 10.1016/S0140-6736(96)04410-8; Miyachi K, 1996, MOL BIOL REP, V23, P227, DOI 10.1007/BF00351173; Miyakawa H, 1999, AUTOIMMUNITY, V30, P11, DOI 10.3109/08916939908994755; Miyakawa H, 2001, HEPATOLOGY, V34, P243, DOI 10.1053/jhep.2001.26514; Moteki S, 1996, HEPATOLOGY, V24, P97; Muratori P, 2004, CLIN EXP IMMUNOL, V135, P154, DOI 10.1111/j.1365-2249.2004.02332.x; Muratori P, 2003, AM J GASTROENTEROL, V98, P431, DOI 10.1016/S0002-9270(02)05925-7; MUTIMER DJ, 1989, HEPATOLOGY, V10, P403, DOI 10.1002/hep.1840100402; MYSZOR M, 1990, Q J MED, V75, P377; Nakamura M, 2005, J HEPATOL, V42, P386, DOI 10.1016/j.jhep.2004.11.016; Nakamura M, 2007, HEPATOLOGY, V45, P118, DOI 10.1002/hep.21472; Newton JL, 2007, HEPATOLOGY, V45, P1496, DOI 10.1002/hep.21609; Newton JL, 2006, HEPATOLOGY, V44, P91, DOI 10.1002/hep.21230; Odin JA, 2001, J CLIN INVEST, V108, P223, DOI 10.1172/JCI200110716; Oertelt S, 2007, HEPATOLOGY, V45, P659, DOI 10.1002/hep.21583; Padgett KA, 2005, J AUTOIMMUN, V24, P209, DOI 10.1016/j.jaut.2005.01.012; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088; Pla X, 2007, EUR J GASTROEN HEPAT, V19, P859, DOI 10.1097/MEG.0b013e328277594a; Poupon RE, 1997, GASTROENTEROLOGY, V113, P884, DOI 10.1016/S0016-5085(97)70183-5; Prince M, 2002, GASTROENTEROLOGY, V123, P1044, DOI 10.1053/gast.2002.36027; PRINCE M, 2005, COCHRANE DB SYST REV, V2; Prince MI, 2010, GUT, V59, P508, DOI 10.1136/gut.2009.184218; Prince MI, 2004, GUT, V53, P865, DOI 10.1136/gut.2003.023937; Ramos-Casals M, 2005, J VIRAL HEPATITIS, V12, P648, DOI 10.1111/j.1365-2893.2005.00642.x; Ray-Chadhuri D, 2001, GUT, V48, P42; Reuben A, 2003, HEPATOLOGY, V37, P225, DOI 10.1002/hep.510370134; Rieger R, 2007, J AUTOIMMUN, V28, P76, DOI 10.1016/j.jaut.2007.02.003; Rieger R, 2006, J AUTOIMMUN, V27, P7, DOI 10.1016/j.jaut.2006.06.002; Rigamonti C, 2006, GUT, V55, P388, DOI 10.1136/gut.2005.075002; ROLL J, 1983, NEW ENGL J MED, V308, P1, DOI 10.1056/NEJM198301063080101; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; SCHEUER PJ, 1967, P ROY SOC MED, V60, P1257, DOI 10.1177/003591576706001205; Selmi C, 2005, SEMIN LIVER DIS, V25, P265, DOI 10.1055/s-2005-916319; Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/j.gastro.2004.05.005; Selmi C, 2004, GASTROENTEROLOGY, V127, P493, DOI 10.1053/j.gastro.2004.05.033; Selmi C, 2003, HEPATOLOGY, V38, P1250, DOI 10.1053/jhep.2003.50446; SHERLOCK S, 1968, Acta Gastro-Enterologica Belgica, V31, P416; Shimoda S, 2003, GASTROENTEROLOGY, V124, P1915, DOI 10.1016/S0016-5085(03)00387-1; Shimoda S, 2008, J AUTOIMMUN, V31, P110, DOI 10.1016/j.jaut.2008.05.003; Silveira MG, 2008, HEPATOLOGY, V48, P1149, DOI 10.1002/hep.22458; Silveira MG, 2007, AM J GASTROENTEROL, V102, P1244, DOI 10.1111/j.1572-0241.2007.01136.x; Sood S, 2004, GASTROENTEROLOGY, V127, P470, DOI 10.1053/j.gastro.2004.04.064; Springer J, 1999, AM J GASTROENTEROL, V94, P47; Stojakovic T, 2007, HEPATOLOGY, V46, P776, DOI 10.1002/hep.21741; Sylvestre PB, 2003, LIVER TRANSPLANT, V9, P1086, DOI 10.1053/jlts.2003.50213; Tanaka A, 2007, ANN NY ACAD SCI, V1107, P259, DOI 10.1196/annals.1381.028; Telesca D, 2008, BIOMETRICS, V64, P10, DOI 10.1111/j.1541-0420.2007.00825.x; TRIGER DR, 1980, BRIT MED J, V281, P772, DOI 10.1136/bmj.281.6243.772; van Hoogstraten HJE, 1999, J HEPATOL, V31, P256, DOI 10.1016/S0168-8278(99)80222-0; Wakabayashi K, 2009, CLIN EXP IMMUNOL, V155, P577, DOI 10.1111/j.1365-2249.2008.03837.x; Wakabayashi K, 2008, HEPATOLOGY, V48, P531, DOI 10.1002/hep.22390; Walden HR, 2008, HEPATOLOGY, V48, P1874, DOI 10.1002/hep.22540; WALKER JG, 1965, LANCET, V1, P827; Wesierska-Gadek J, 2006, HEPATOLOGY, V43, P1135, DOI 10.1002/hep.21172; Xu LZ, 2003, P NATL ACAD SCI USA, V100, P8454, DOI 10.1073/pnas.1433063100; Yang GX, 2008, HEPATOLOGY, V47, P1974, DOI 10.1002/hep.22226; Zuchner D, 1997, HEPATOLOGY, V26, P1123	139	216	239	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1600	1609		10.1016/S0140-6736(10)61965-4	http://dx.doi.org/10.1016/S0140-6736(10)61965-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763IJ	21529926				2022-12-28	WOS:000290549700034
J	Dunn, M; Greenhill, SJ; Levinson, SC; Gray, RD				Dunn, Michael; Greenhill, Simon J.; Levinson, Stephen C.; Gray, Russell D.			Evolved structure of language shows lineage-specific trends in word-order universals	NATURE			English	Article								Languages vary widely but not without limit. The central goal of linguistics is to describe the diversity of human languages and explain the constraints on that diversity. Generative linguists following Chomsky have claimed that linguistic diversity must be constrained by innate parameters that are set as a child learns a language(1,2). In contrast, other linguists following Greenberg have claimed that there are statistical tendencies for co-occurrence of traits reflecting universal systems biases(3-5), rather than absolute constraints or parametric variation. Here we use computational phylogenetic methods to address the nature of constraints on linguistic diversity in an evolutionary framework(6). First, contrary to the generative account of parameter setting, we show that the evolution of only a few word-order features of languages are strongly correlated. Second, contrary to the Greenbergian generalizations, we show that most observed functional dependencies between traits are lineage-specific rather than universal tendencies. These findings support the view that-at least with respect to word order-cultural evolution is the primary factor that determines linguistic structure, with the current state of a linguistic system shaping and constraining future states.	[Dunn, Michael; Levinson, Stephen C.] Max Planck Inst Psycholinguist, NL-6500 AH Nijmegen, Netherlands; [Dunn, Michael; Levinson, Stephen C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands; [Greenhill, Simon J.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland 1142, New Zealand; [Greenhill, Simon J.] Univ Auckland, Computat Evolut Grp, Auckland 1142, New Zealand	Max Planck Society; Radboud University Nijmegen; University of Auckland; University of Auckland	Dunn, M (corresponding author), Max Planck Inst Psycholinguist, POB 310, NL-6500 AH Nijmegen, Netherlands.	michael.dunn@mpi.nl	Dunn, Michael/F-1077-2012; Greenhill, Simon/I-3554-2019; Gray, Russell/H-2078-2015; Galantucci, Bruno/E-5770-2010; Greenhill, Simon J/B-3114-2011	Dunn, Michael/0000-0001-5349-5252; Greenhill, Simon/0000-0001-7832-6156; Gray, Russell/0000-0002-9858-0191; Greenhill, Simon J/0000-0001-7832-6156				Baker M., 2001, ATOMS LANGUAGE; BAKKER P, 2010, OXFORD HDB LINGUISTI; CAMPBELL L, 1997, AM INDIAN LANGUAGES, P133; Cela-Conde C. J., 1998, SYNTAX, V1, P19, DOI DOI 10.1111/1467-9612.00002; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky Noam, 1981, LECT GOVT BINDING; Croft W, 2008, ANNU REV ANTHROPOL, V37, P219, DOI 10.1146/annurev.anthro.37.081407.085156; Cysouw M, 2005, HANDB SPRACH KOMMUN, V27, P554; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Dryer M.S., 2007, LANGUAGE TYPOLOGY AN, P61, DOI DOI 10  1017/CBO9780511619427.002; Dryer Matthew S., 2008, WORLD ATLAS LANGUAGE; DRYER MS, 1992, LANGUAGE, V68, P81, DOI 10.2307/416370; DYEN I, 1992, T AM PHILOS SOC, V82, P1; Evans N, 2009, BEHAV BRAIN SCI, V32, P429, DOI 10.1017/S0140525X0999094X; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Greenberg Joseph, 1963, UNIVERSALS LANG, P73; Greenhill SJ, 2008, EVOL BIOINFORM, V4, P271; Guthrie M., 1971, COMP BANTU, V2; Hawkins J. A., 2009, LANGUAGE UNIVERSALS, P54, DOI DOI 10.1093/ACPROF:OSO/9780195305432.003.0004; Holden CJ, 2002, P ROY SOC B-BIOL SCI, V269, P793, DOI 10.1098/rspb.2002.1955; Kemp BM, 2010, P NATL ACAD SCI USA, V107, P6759, DOI 10.1073/pnas.0905753107; LIGHTFOOT DW, 1989, BEHAV BRAIN SCI, V12, P321, DOI 10.1017/S0140525X00048883; MACE R, 1994, CURR ANTHROPOL, V35, P549, DOI 10.1086/204317; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Raftery AE, 1996, BIOMETRIKA, V83, P251, DOI 10.1093/biomet/83.2.251; Reesink G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000241	29	252	255	6	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					79	82		10.1038/nature09923	http://dx.doi.org/10.1038/nature09923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	759CQ	21490599	Green Published			2022-12-28	WOS:000290218300034
J	Plikus, MV; Baker, RE; Chen, CC; Fare, C; de la Cruz, D; Andl, T; Maini, PK; Millar, SE; Widelitz, R; Chuong, CM				Plikus, Maksim V.; Baker, Ruth E.; Chen, Chih-Chiang; Fare, Clyde; de la Cruz, Damon; Andl, Thomas; Maini, Philip K.; Millar, Sarah E.; Widelitz, Randall; Chuong, Cheng-Ming			Self-Organizing and Stochastic Behaviors During the Regeneration of Hair Stem Cells	SCIENCE			English	Article							SKIN; MORPHOGENESIS; FOLLICLES; PATTERNS; WNT	Stem cells cycle through active and quiescent states. Large populations of stem cells in an organ may cycle randomly or in a coordinated manner. Although stem cell cycling within single hair follicles has been studied, less is known about regenerative behavior in a hair follicle population. By combining predictive mathematical modeling with in vivo studies in mice and rabbits, we show that a follicle progresses through cycling stages by continuous integration of inputs from intrinsic follicular and extrinsic environmental signals based on universal patterning principles. Signaling from the WNT/bone morphogenetic protein activator/inhibitor pair is coopted to mediate interactions among follicles in the population. This regenerative strategy is robust and versatile because relative activator/inhibitor strengths can be modulated easily, adapting the organism to different physiological and evolutionary needs.	[Plikus, Maksim V.; Chen, Chih-Chiang; de la Cruz, Damon; Widelitz, Randall; Chuong, Cheng-Ming] Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA; [Baker, Ruth E.; Maini, Philip K.] Math Inst, Ctr Math Biol, Oxford OX1 3LB, England; [Chen, Chih-Chiang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Chih-Chiang] Natl Yang Ming Univ, Dept Dermatol, Taipei 112, Taiwan; [Chen, Chih-Chiang] Taipei Vet Gen Hosp, Dept Dermatol, Taipei, Taiwan; [Fare, Clyde] Life Sci Interface Doctoral Training Ctr, Oxford OX1 3QD, England; [Andl, Thomas] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Maini, Philip K.] Oxford Ctr Integrat Syst Biol, Dept Biochem, Oxford OX1 3QU, England; [Millar, Sarah E.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Chuong, Cheng-Ming] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan	University of Southern California; University of Oxford; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; University of Oxford; Vanderbilt University; University of Oxford; University of Pennsylvania; National Taiwan University	Chuong, CM (corresponding author), Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA.	cmchuong@usc.edu		Millar, Sarah/0000-0001-8792-6890; Plikus, Maksim/0000-0002-8845-2559; Andl, Thomas/0000-0002-5555-468X; Baker, Ruth/0000-0002-6304-9333	National Institute of Arthritis and Musculoskeletal and Skin Diseases [RO1-AR42177, AR60306, AR47364]; UK Engineering and Physical Sciences Research Council; Royal Society; California Institute for Regenerative Medicine;  [RO1-AR47709]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060306, R01AR047364, R01AR042177, R01AR047709] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	C.-M.C. is supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases RO1-AR42177, AR60306, and AR47364; S.E.M. by RO1-AR47709; R.E.B. by a UK Engineering and Physical Sciences Research Council First grant; P.K.M. by a Royal Society Wolfson Research Merit Award; and M.V.P. by a California Institute for Regenerative Medicine postdoctoral grant. There is a USC patent application partially based on the work in this study on the compositions and methods to modulate hair growth.	Antaya RJ, 2005, J AM ACAD DERMATOL, V53, pS130, DOI 10.1016/j.jaad.2004.12.029; Chuong CM, 2009, INT J DEV BIOL, V53, P653, DOI 10.1387/ijdb.082594cc; Cutrone M, 2005, EUR J PEDIATR, V164, P630, DOI 10.1007/s00431-005-1707-y; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Halloy J, 2000, P NATL ACAD SCI USA, V97, P8328, DOI 10.1073/pnas.97.15.8328; Jiang TX, 1999, DEVELOPMENT, V126, P4997; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Plikus MV, 2008, J INVEST DERMATOL, V128, P1071, DOI 10.1038/sj.jid.5701180; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P9680, DOI 10.1073/pnas.1731184100; WHITELEY HJ, 1958, NATURE, V181, P850, DOI 10.1038/181850a0; Wolfram S., 2002, NEW KIND SCI	17	144	151	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					586	589		10.1126/science.1201647	http://dx.doi.org/10.1126/science.1201647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527712	Green Accepted			2022-12-28	WOS:000289991100048
J	Beal, LM; De Ruijter, WPM; Biastoch, A; Zahn, R				Beal, Lisa M.; De Ruijter, Wilhelmus P. M.; Biastoch, Arne; Zahn, Rainer		SCOR WCRP IAPSO Working Grp 136	On the role of the Agulhas system in ocean circulation and climate	NATURE			English	Review							ATLANTIC INTEROCEAN EXCHANGE; MERIDIONAL OVERTURNING CIRCULATION; MULTIPLE EQUILIBRIA REGIME; FRESH-WATER FLUX; SOUTH-ATLANTIC; ATMOSPHERE INTERACTION; BOUNDARY-LAYER; SEA-ICE; MADAGASCAR; RETROFLECTION	The Atlantic Ocean receives warm, saline water from the Indo-Pacific Ocean through Agulhas leakage around the southern tip of Africa. Recent findings suggest that Agulhas leakage is a crucial component of the climate system and that ongoing increases in leakage under anthropogenic warming could strengthen the Atlantic overturning circulation at a time when warming and accelerated meltwater input in the North Atlantic is predicted to weaken it. Yet in comparison with processes in the North Atlantic, the overall Agulhas system is largely overlooked as a potential climate trigger or feedback mechanism. Detailed modelling experiments-backed by palaeoceanographic and sustained modern observations-are required to establish firmly the role of the Agulhas system in a warming climate.	[Beal, Lisa M.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [De Ruijter, Wilhelmus P. M.] Univ Utrecht, Inst Marine & Atmospher Res, NL-3584 CC Utrecht, Netherlands; [Biastoch, Arne] Leibniz Inst Meereswissensch IFM GEOMAR, D-24105 Kiel, Germany; [Zahn, Rainer] Univ Autonoma Barcelona, Dept Fis, ICREA, ICTA, E-08193 Barcelona, Spain	University of Miami; Utrecht University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Autonomous University of Barcelona; ICREA	Beal, LM (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	lbeal@rsmas.miami.edu	Cronin, Meghan F/M-3155-2018; Biastoch, Arne/B-5219-2014; Penven, Pierrick/A-6665-2008; Tozuka, Tomoki/A-1805-2009; Cipollini, Paolo/B-5294-2012; Hall, Ian R/C-2755-2009; Park, Wonsun/J-8097-2012; Quartly, Graham D/A-4834-2013; de Ruijter, Wilhelmus/I-2541-2016; Bornman, Thomas G/V-7794-2019; Zinke, Jens/G-5026-2011	Cronin, Meghan F/0000-0002-4703-8132; Biastoch, Arne/0000-0003-3946-4390; Penven, Pierrick/0000-0001-6456-3142; Tozuka, Tomoki/0000-0001-6738-1299; Cipollini, Paolo/0000-0002-3682-5675; Hall, Ian R/0000-0001-6960-1419; Park, Wonsun/0000-0002-6345-8428; Quartly, Graham D/0000-0001-9132-9511; Bornman, Thomas G/0000-0003-1868-479X; Zinke, Jens/0000-0002-0634-8281; Peeters, Frank J.C./0000-0002-5678-9288; Beal, Lisa/0000-0003-3678-5367	US National Science Foundation [OCE-0850891, OCE-0938349]; Netherlands Organization for Scientific Research [839.08.430]; Ministerio de Ciencia e Innovacion, Spain [CGL2007-61579/CLI]; EC; Natural Environment Research Council [noc010012] Funding Source: researchfish; ICREA Funding Source: Custom; Directorate For Geosciences [0938349, 1038217] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EC(European CommissionEuropean Commission Joint Research Centre); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ICREA(ICREA); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Fig. 1 was produced by E. Van Sebille and Fig. 2 was produced by H. Van Aken. We thank D. leBars for discussions. L. M. B. is funded by the US National Science Foundation through the ACT project, award no. OCE-0850891. W. P. M. D. R. is funded by the Netherlands Organization for Scientific Research through the INATEX program, ZKO no. 839.08.430. R.Z. receives funding from the Ministerio de Ciencia e Innovacion, Spain, through grant CGL2007-61579/CLI. A. B. and R.Z. acknowledge funding by the EC FP7 Marie Curie ITN GATEWAYS. This document is based on work partially supported by the US National Science Foundation under Grant OCE-0938349 to the Scientific Committee on Oceanic Research.	Alory G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028044; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Banks HT, 2007, J CLIMATE, V20, P5815, DOI 10.1175/2007JCLI1688.1; Bard E, 2009, NATURE, V460, P380, DOI 10.1038/nature08189; Beal LM, 2006, J PHYS OCEANOGR, V36, P2060, DOI 10.1175/JPO2964.1; Beal LM, 2009, J PHYS OCEANOGR, V39, P2436, DOI 10.1175/2009JPO4195.1; Behera SK, 2001, GEOPHYS RES LETT, V28, P327, DOI 10.1029/2000GL011451; Berger WH, 1996, SOUTH ATLANTIC, P363; Biastoch A, 2008, NATURE, V456, P489, DOI 10.1038/nature07426; Biastoch A, 2009, NATURE, V462, P495, DOI 10.1038/nature08519; Biastoch A, 2009, J PHYS OCEANOGR, V39, P2417, DOI 10.1175/2009JPO4184.1; Boebel O, 2003, DEEP-SEA RES PT II, V50, P57, DOI 10.1016/S0967-0645(02)00379-X; Bryden HL, 2005, J OCEANOGR, V61, P479, DOI 10.1007/s10872-005-0057-8; Cai W, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024911; Chiessi CM, 2008, GEOLOGY, V36, P919, DOI 10.1130/G24979A.1; Cortese G, 2002, PALAEOGEOGR PALAEOCL, V182, P259, DOI 10.1016/S0031-0182(01)00499-0; Cunningham SA, 2007, SCIENCE, V317, P935, DOI 10.1126/science.1141304; de Ruijter WPM, 1999, J GEOPHYS RES-OCEANS, V104, P20885, DOI 10.1029/1998JC900099; de Ruijter WPM, 2004, DEEP-SEA RES PT I, V51, P383, DOI 10.1016/j.dsr.2003.10.011; de Vries P, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021450; DERUIJTER W, 1982, J PHYS OCEANOGR, V12, P361, DOI 10.1175/1520-0485(1982)012<0361:AAOTAA>2.0.CO;2; Dijkstra HA, 2001, J PHYS OCEANOGR, V31, P2971, DOI 10.1175/1520-0485(2001)031<2971:OTPOTA>2.0.CO;2; Dijkstra HA, 2007, TELLUS A, V59, P695, DOI 10.1111/j.1600-0870.2007.00267.x; Donlon C, 2007, B AM METEOROL SOC, V88, P1197, DOI 10.1175/BAMS-88-8-1197; Donners J, 2004, J PHYS OCEANOGR, V34, P1019, DOI 10.1175/1520-0485(2004)034<1019:TLVOSA>2.0.CO;2; Donohue KA, 2003, DEEP-SEA RES PT II, V50, P1893, DOI 10.1016/S0967-0645(03)00039-0; Farneti R, 2010, J PHYS OCEANOGR, V40, P2348, DOI 10.1175/2010JPO4480.1; Flores JA, 1999, MAR MICROPALEONTOL, V37, P1, DOI 10.1016/S0377-8398(99)00012-2; Franzese AM, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001706; Garabato ACN, 2007, NATURE, V447, P194, DOI 10.1038/nature05832; Gordon AL, 2003, NATURE, V421, P904, DOI 10.1038/421904a; GORDON AL, 1992, J GEOPHYS RES-OCEANS, V97, P7223, DOI 10.1029/92JC00485; GORDON AL, 1986, J GEOPHYS RES-OCEANS, V91, P5037, DOI 10.1029/JC091iC04p05037; Gregory JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023209; Haarsma RJ, 2011, CLIM DYNAM, V36, P989, DOI 10.1007/s00382-009-0692-7; Hermes JC, 2005, J CLIMATE, V18, P2864, DOI 10.1175/JCLI3422.1; Hughes GO, 2009, J PHYS OCEANOGR, V39, P3130, DOI 10.1175/2009JPO4162.1; Huisman SE, 2010, J PHYS OCEANOGR, V40, P551, DOI 10.1175/2009JPO4215.1; JURY M, 1988, J GEOPHYS RES-OCEANS, V93, P647, DOI 10.1029/JC093iC01p00647; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; Kuhlbrodt T, 2007, REV GEOPHYS, V45, DOI 10.1029/2004RG000166; Large W. G., 2004, NCARTN460 STR CGD DI, DOI [10.5065/D6KK98Q6, DOI 10.5065/D6KK98Q6]; Lisiecki LE, 2008, NATURE, V456, P85, DOI 10.1038/nature07425; Liu WT, 2007, J CLIMATE, V20, P5784, DOI 10.1175/2007JCLI1732.1; LUTJEHARMS JRE, 1988, DEEP-SEA RES, V35, P2045, DOI 10.1016/0198-0149(88)90124-0; Lutjeharms JRE, 2006, AGULHAS CURRENT; Marsh R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027815; Martinez-Mendez G, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001879; McDonagh EL, 2005, J PHYS OCEANOGR, V35, P109, DOI 10.1175/JPO-2666.1; Mix A.C., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P839, DOI 10.2973/odp.proc.sr.138.160.1995; Nakamura H, 2004, J CLIMATE, V17, P1828, DOI 10.1175/1520-0442(2004)017<1828:SVITSH>2.0.CO;2; Nauw JJ, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004639; Palastanga V, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003081; Palastanga V, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2005JC003395; Palastanga V, 2009, J PHYS OCEANOGR, V39, P465, DOI 10.1175/2008JPO3872.1; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; Quartly GD, 2006, J MARINE SYST, V63, P115, DOI 10.1016/j.jmarsys.2006.06.001; Quartly GD, 2002, J PHYS OCEANOGR, V32, P1585, DOI 10.1175/1520-0485(2002)032<1585:SOOTAA>2.0.CO;2; Rahmstorf S, 1996, CLIM DYNAM, V12, P799, DOI 10.1007/s003820050144; Rau A, 2006, QUATERN INT, V148, P65, DOI 10.1016/j.quaint.2005.11.007; Reason CJC, 2001, J CLIMATE, V14, P2769, DOI 10.1175/1520-0442(2001)014<2769:EFTIOT>2.0.CO;2; Richardson PL, 2007, DEEP-SEA RES PT I, V54, P1361, DOI 10.1016/j.dsr.2007.04.010; Ridderinkhof H, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005619; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; RINTOUL SR, 1991, J GEOPHYS RES-OCEANS, V96, P2675, DOI 10.1029/90JC02422; Rojas M, 2009, CLIM DYNAM, V32, P525, DOI 10.1007/s00382-008-0421-7; Romanova V, 2010, TELLUS A, V62, P435, DOI 10.1111/j.1600-0870.2010.00447.x; Rouault M, 2002, WEATHER FORECAST, V17, P655, DOI 10.1175/1520-0434(2002)017<0655:OAIITA>2.0.CO;2; Rouault M, 2000, J PHYS OCEANOGR, V30, P40, DOI 10.1175/1520-0485(2000)030<0040:TABLAT>2.0.CO;2; Rouault M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037987; Schouten MW, 2000, J GEOPHYS RES-OCEANS, V105, P21913, DOI 10.1029/1999JC000046; Schouten MW, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000804; Sen Gupta A, 2009, J CLIMATE, V22, P3047, DOI 10.1175/2008JCLI2827.1; Siedler G, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004921; Sijp WP, 2009, J CLIMATE, V22, P1277, DOI 10.1175/2008JCLI2310.1; Sloyan BM, 2001, J PHYS OCEANOGR, V31, P143, DOI 10.1175/1520-0485(2001)031<0143:TSOLOT>2.0.CO;2; Song Q, 2004, J PHYS OCEANOGR, V34, P772, DOI 10.1175/1520-0485(2004)034<0772:SOTITI>2.0.CO;2; Speer K, 2000, J PHYS OCEANOGR, V30, P3212, DOI 10.1175/1520-0485(2000)030<3212:TDDC>2.0.CO;2; Speich S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027157; Speich S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031583; Stammer D, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC004079; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; SWALLOW J, 1988, J GEOPHYS RES-OCEANS, V93, P4951, DOI 10.1029/JC093iC05p04951; THORNALLEY DJR, GLOBAL PLAN IN PRESS; TOGGWEILER JR, 1995, DEEP-SEA RES PT I, V42, P477, DOI 10.1016/0967-0637(95)00012-U; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Tschumi T, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001592; Tsugawa M, 2010, J PHYS OCEANOGR, V40, P1597, DOI 10.1175/2010JPO4347.1; van Aken HM, 2003, DEEP-SEA RES PT II, V50, P167, DOI 10.1016/S0967-0645(02)00383-1; van Sebille E, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036614; van Sebille E, 2007, J PHYS OCEANOGR, V37, P2305, DOI 10.1175/JPO3108.1; VELLINGA M, 2005, CLIMATIC CHANGE, V54, P251; Watson AJ, 2006, TELLUS B, V58, P73, DOI 10.1111/j.1600-0889.2005.00167.x; Weijer W, 2002, GLOBAL PLANET CHANGE, V34, P293, DOI 10.1016/S0921-8181(02)00121-2; Weijer W, 1999, J PHYS OCEANOGR, V29, P2266, DOI 10.1175/1520-0485(1999)029<2266:IOIEOT>2.0.CO;2; Weijer W, 2001, J PHYS OCEANOGR, V31, P2385, DOI 10.1175/1520-0485(2001)031<2385:SOTAOC>2.0.CO;2; Wunsch C, 2004, ANNU REV FLUID MECH, V36, P281, DOI 10.1146/annurev.fluid.36.050802.122121; Zahn R, 2009, NATURE, V460, P335, DOI 10.1038/460335a; Zharkov V, 2008, OCEAN SCI, V4, P293, DOI 10.5194/os-4-293-2008; Zinke J, 2004, EARTH PLANET SC LETT, V228, P177, DOI 10.1016/j.epsl.2004.09.028	100	386	392	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					429	436		10.1038/nature09983	http://dx.doi.org/10.1038/nature09983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525925				2022-12-28	WOS:000289949600026
J	Truman, RW; Singh, P; Sharma, R; Busso, P; Rougemont, J; Paniz-Mondolfi, A; Kapopoulou, A; Brisse, S; Scollard, DM; Gillis, TP; Cole, ST				Truman, Richard W.; Singh, Pushpendra; Sharma, Rahul; Busso, Philippe; Rougemont, Jacques; Paniz-Mondolfi, Alberto; Kapopoulou, Adamandia; Brisse, Sylvain; Scollard, David M.; Gillis, Thomas P.; Cole, Stewart T.			Probable Zoonotic Leprosy in the Southern United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYCOBACTERIUM-LEPRAE; ARMADILLO EXPOSURE; DASYPUS-NOVEMCINCTUS; 9-BANDED ARMADILLO; HANSENS-DISEASE; WILD ARMADILLOS; CONTACT; ASSOCIATION; ORIGIN	BACKGROUND In the southern region of the United States, such as in Louisiana and Texas, there are autochthonous cases of leprosy among native-born Americans with no history of foreign exposure. In the same region, as well as in Mexico, wild armadillos are infected with Mycobacterium leprae. METHODS Whole-genome resequencing of M. leprae from one wild armadillo and three U. S. patients with leprosy revealed that the infective strains were essentially identical. Comparative genomic analysis of these strains and M. leprae strains from Asia and Brazil identified 51 single-nucleotide polymorphisms and an 11-bp insertion-deletion. We genotyped these polymorphic sites, in combination with 10 variable-number tandem repeats, in M. leprae strains obtained from 33 wild armadillos from five southern states, 50 U. S. outpatients seen at a clinic in Louisiana, and 64 Venezuelan patients, as well as in four foreign reference strains. RESULTS The M. leprae genotype of patients with foreign exposure generally reflected their country of origin or travel history. However, a unique M. leprae genotype (3I-2-v1) was found in 28 of the 33 wild armadillos and 25 of the 39 U. S. patients who resided in areas where exposure to armadillo-borne M. leprae was possible. This genotype has not been reported elsewhere in the world. CONCLUSIONS Wild armadillos and many patients with leprosy in the southern United States are infected with the same strain of M. leprae. Armadillos are a large natural reservoir for M. leprae, and leprosy may be a zoonosis in the region.	[Truman, Richard W.; Sharma, Rahul; Scollard, David M.; Gillis, Thomas P.] Louisiana State Univ, Sch Vet Med, Bur Primary Hlth Care,Natl Hansens Dis Program, Hlth Resources & Serv Adm,Dept Hlth & Human Serv, Baton Rouge, LA 70803 USA; [Singh, Pushpendra; Busso, Philippe; Rougemont, Jacques; Kapopoulou, Adamandia; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland; [Rougemont, Jacques; Kapopoulou, Adamandia] Swiss Inst Bioinformat, Lausanne, Switzerland; [Paniz-Mondolfi, Alberto] Inst Biomed, Caracas, Venezuela; [Brisse, Sylvain] Inst Pasteur, Paris, France	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; United States Health Resources & Service Administration (HRSA); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Truman, RW (corresponding author), Louisiana State Univ, Sch Vet Med, Bur Primary Hlth Care,Natl Hansens Dis Program, Hlth Resources & Serv Adm,Dept Hlth & Human Serv, Skip Bertman Dr, Baton Rouge, LA 70803 USA.	rtruman@hrsa.gov	SHARMA, RAHUL/F-2691-2013; Singh, Pushpendra/J-6484-2015; Brisse, Sylvain/M-8723-2013; Truman, Richard/E-3025-2013	Singh, Pushpendra/0000-0001-9453-8669; Brisse, Sylvain/0000-0002-2516-2108; 	Fondation Raoul Follereau; American Leprosy Missions; Society of Saint Lazarus; IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) Consortium; Health Resources and Services Administration; National Institutes of Health, National Institute of Allergy and Infectious Diseases [RO1-AI47197-01A1, NIAID IAA-2646]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047197] Funding Source: NIH RePORTER	Fondation Raoul Follereau; American Leprosy Missions; Society of Saint Lazarus; IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) Consortium; Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Fondation Raoul Follereau, the American Leprosy Missions, the Society of Saint Lazarus, the IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) Consortium, the Health Resources and Services Administration, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases (grants RO1-AI47197-01A1 and NIAID IAA-2646).; Funded by the National Institute of Allergy and Infectious Diseases and others	Abide JM, 2008, SOUTH MED J, V101, P635, DOI 10.1097/SMJ.0b013e31816f8610; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMEZCUA ME, 1984, INT J LEPROSY, V52, P254; Badger LF, 1955, PUBLIC HEALTH REP, V70, P525, DOI 10.2307/4589124; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Bruce S, 2000, J AM ACAD DERMATOL, V43, P223, DOI 10.1067/mjd.2000.106368; Clark BM, 2008, AM J TROP MED HYG, V78, P962, DOI 10.4269/ajtmh.2008.78.962; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; *DEP HLTH HUM SERV, 2009, SUMM HANS DIS US 200; Deps PD, 2008, INDIAN J DERMATOL VE, V74, P338, DOI 10.4103/0378-6323.42897; FILICE GA, 1977, AM J TROP MED HYG, V26, P137, DOI 10.4269/ajtmh.1977.26.137; Gillis T, 2009, LEPROSY REV, V80, P250; Hall BG, 2010, J CLIN MICROBIOL, V48, P1997, DOI 10.1128/JCM.00149-10; Hamilton HK, 2008, INT J DERMATOL, V47, P545, DOI 10.1111/j.1365-4632.2008.03722.x; KIRCHHEIMER W F, 1971, International Journal of Leprosy and Other Mycobacterial Diseases, V39, P693; Lane JE, 2006, J AM ACAD DERMATOL, V55, P714, DOI 10.1016/j.jaad.2006.02.070; Li HT, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/2/025006; Loughry WJ, 2009, J WILDLIFE DIS, V45, P144, DOI 10.7589/0090-3558-45.1.144; LUMPKIN LR, 1983, J AM ACAD DERMATOL, V9, P899, DOI 10.1016/S0190-9622(83)70206-9; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Taulman JF, 1996, J BIOGEOGR, V23, P635, DOI 10.1111/j.1365-2699.1996.tb00024.x; THOMAS DA, 1987, J INFECT DIS, V156, P990, DOI 10.1093/infdis/156.6.990; Truman R, 2005, LEPROSY REV, V76, P198; TRUMAN RW, 1986, AM J TROP MED HYG, V35, P588, DOI 10.4269/ajtmh.1986.35.588; TRUMAN RW, 1991, EPIDEMIOL INFECT, V106, P549, DOI 10.1017/S0950268800067613; WALSH GP, 1986, J LEUKOCYTE BIOL, V40, P645, DOI 10.1002/jlb.40.5.645; Weir B.S., 1996, GENETIC DATA ANAL; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P333; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	34	208	218	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1626	1633		10.1056/NEJMoa1010536	http://dx.doi.org/10.1056/NEJMoa1010536			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755NW	21524213	Green Accepted, Bronze			2022-12-28	WOS:000289940400009
J	Jernberg, T; Johanson, P; Held, C; Svennblad, B; Lindback, J; Wallentin, L				Jernberg, Tomas; Johanson, Per; Held, Claes; Svennblad, Bodil; Lindback, Johan; Wallentin, Lars		SWEDEHEART RIKS-HIA	Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							THERAPY; METAANALYSIS; REPERFUSION; OUTCOMES; DISEASE; TRENDS; STATIN	Context Only limited information is available on the speed of implementation of new evidence-based and guideline-recommended treatments and its association with survival in real life health care of patients with ST-elevation myocardial infarction (STEMI). Objective To describe the adoption of new treatments and the related chances of short-and long-term survival in consecutive patients with STEMI in a single country over a 12-year period. Design, Setting, and Participants The Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA) records baseline characteristics, treatments, and outcome of consecutive patients with acute coronary syndrome admitted to almost all hospitals in Sweden. This study includes 61 238 patients with a first-time diagnosis of STEMI between 1996 and 2007. Main Outcome Measures Estimated and crude proportions of patients treated with different medications and invasive procedures and mortality over time. Results Of evidence based-treatments, reperfusion increased from 66% (95%, confidence interval [CI], 52%-79%) to 79% (95% CI, 69%-89%; P<.001), primary percutaneous coronary intervention from 12% (95% CI, 11%-14%) to 61% (95% CI, 45%-77%; P<.001), and revascularization from 10% (96% CI, 6%-14%) to 84% (95% CI, 73%-95%; P<.001). The use of aspirin, clopidogrel, beta-blockers, statins, and angiotensin-converting enzyme (ACE) inhibitors all increased: clopidogrel from 0% to 82% (95% CI, 69%-95%; P<.001), statins from 23% (95% CI, 12%-33%) to 83% (95% CI, 75%-91%; P<.001), and ACE inhibitor or angiotensin II receptor blockers from 39% (95% CI, 26%-52%) to 69% (95% CI, 58%-70%; P<.001). The estimated in-hospital, 30-day and 1-year mortality decreased from 12.5% (95% CI, 4.3%-20.6%) to 7.2% (95% CI, 1.7%-12.6%; P<.001); from 15.0% (95% CI, 6.2%-23.7%) to 8.6% (95% CI, 2.7%-14.5%; P<.001); and from 21.0% (95% CI, 11.0%-30.9%) to 13.3% (95% CI, 6.0%-20.4%; P<.001), respectively. After adjustment, there was still a consistent trend with lower standardized mortality over the years. The 12-year survival analyses showed that the decrease of mortality was sustained over time. Conclusion In a Swedish registry of patients with STEMI, between 1996 and 2007, there was an increase in the prevalence of evidence-based treatments. During this same time, there was a decrease in 30-day and 1-year mortality that was sustained during long-term follow-up. JAMA. 2011;305(16):1677-1684 www.jama.com	[Jernberg, Tomas] Dept Med, Cardiol Sect, Huddinge, Sweden; [Jernberg, Tomas] Karolinska Inst, Karolinska Univ Hosp, S-14186 Huddinge, Sweden; [Johanson, Per] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden; [Held, Claes; Svennblad, Bodil; Lindback, Johan; Wallentin, Lars] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Sahlgrenska University Hospital; Uppsala University	Jernberg, T (corresponding author), Karolinska Univ Hosp, Dept Cardiol, Huddinge, Sweden.	tomas.jernberg@karolinska.se	Lindbäck, Johan/R-2900-2017; Held, Claes/AAA-3973-2021	Lindbäck, Johan/0000-0002-6473-8798; Held, Claes/0000-0001-9402-7404; Johanson, Per/0000-0001-9802-4147; Jernberg, Tomas/0000-0003-1695-379X	Swedish Heart Lung Foundation; Swedish Association of Local Authorities and Regions	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Association of Local Authorities and Regions	This study was supported by the Swedish Heart Lung Foundation. Financial support for the registry is provided by the Swedish Association of Local Authorities and Regions.	Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; De Luca G, 2005, JAMA-J AM MED ASSOC, V293, P1759, DOI 10.1001/jama.293.14.1759; Fang J, 2010, AM J MED, V123, P259, DOI 10.1016/j.amjmed.2009.08.018; Floyd KC, 2009, CIRC-CARDIOVASC QUAL, V2, P88, DOI 10.1161/CIRCOUTCOMES.108.811828; Flynn MR, 2005, EUR HEART J, V26, P308, DOI 10.1093/eurheartj/ehi079; Franzosi MG, 1998, CIRCULATION, V97, P2202, DOI 10.1161/01.CIR.97.22.2202; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Go AS, 2006, ANN INTERN MED, V144, P229, DOI 10.7326/0003-4819-144-4-200602210-00004; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kushner, 2010, CIRCULATION, V121, pE257, DOI 10.1161/CIR.0b013e3181d7a65e; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Peterson ED, 2010, HEART, V96, P1798, DOI 10.1136/hrt.2010.200261; R Core Team, 2020, R LANG ENV STAT COMP; Roger VL, 2010, CIRCULATION, V121, P863, DOI 10.1161/CIRCULATIONAHA.109.897249; Stenestrand U, 2005, AM HEART J, V149, P82, DOI 10.1016/j.ahj.2004.07.018; Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430; Thygesen K, 2007, EUR HEART J, V28, P2525; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Yusuf S, 2001, NEW ENGL J MED, V345, P494; 2000, EUR HEART J, V21, P1502, DOI 10.1053/eurj.2000.2305	30	279	292	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1677	1684		10.1001/jama.2011.522	http://dx.doi.org/10.1001/jama.2011.522			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521849	Bronze			2022-12-28	WOS:000289890500021
J	Lavine, JE; Schwimmer, JB; Van Natta, ML; Molleston, JP; Murray, KF; Rosenthal, P; Abrams, SH; Scheimann, AO; Sanyal, AJ; Chalasani, N; Tonascia, J; Unalp, A; Clark, JM; Brunt, EM; Kleiner, DE; Hoofnagle, JH; Robuck, PR				Lavine, Joel E.; Schwimmer, Jeffrey B.; Van Natta, Mark L.; Molleston, Jean P.; Murray, Karen F.; Rosenthal, Philip; Abrams, Stephanie H.; Scheimann, Ann O.; Sanyal, Arun J.; Chalasani, Naga; Tonascia, James; Uenalp, Aynur; Clark, Jeanne M.; Brunt, Elizabeth M.; Kleiner, David E.; Hoofnagle, Jay H.; Robuck, Patricia R.		Nonalcoholic Steatohepatitis Clini	Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents The TONIC Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STEATOHEPATITIS; HISTOPATHOLOGY; THERAPY	Context Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in US children and adolescents and can present with advanced fibrosis or nonalcoholic steatohepatitis (NASH). No treatment has been established. Objective To determine whether children with NAFLD would improve from therapeutic intervention with vitamin E or metformin. Design, Setting, and Patients Randomized, double-blind, double-dummy, placebo-controlled clinical trial conducted at 10 university clinical research centers in 173 patients (aged 8-17 years) with biopsy-confirmed NAFLD conducted between September 2005 and March 2010. Interventions Daily dosing of 800 IU of vitamin E (58 patients), 1000 mg of metformin (57 patients), or placebo (58 patients) for 96 weeks. Main Outcome Measures The primary outcome was sustained reduction in alanine aminotransferase (ALT) defined as 50% or less of the baseline level or 40 U/L or less at visits every 12 weeks from 48 to 96 weeks of treatment. Improvements in histological features of NAFLD and resolution of NASH were secondary outcome measures. Results Sustained reduction in ALT level was similar to placebo (10/58; 17%; 95% CI, 9% to 29%) in both the vitamin E (15/58; 26%; 95% CI, 15% to 39%; P=.26) and metformin treatment groups (9/57; 16%; 95% CI, 7% to 28%; P=.83). The mean change in ALT level from baseline to 96 weeks was -35.2 U/L (95% CI, -56.9 to -13.5) with placebo vs -48.3 U/L (95% CI, -66.8 to -29.8) with vitamin E (P=.07) and -41.7 U/L (95% CI, -62.9 to -20.5) with metformin (P=.40). The mean change at 96 weeks in hepatocellular ballooning scores was 0.1 with placebo (95% CI, -0.2 to 0.3) vs -0.5 with vitamin E (95% CI, -0.8 to -0.3; P=.006) and -0.3 with metformin (95% CI, -0.6 to -0.0; P=.04); and in NAFLD activity score, -0.7 with placebo (95% CI, -1.3 to -0.2) vs -1.8 with vitamin E (95% CI, -2.4 to -1.2; P=.02) and -1.1 with metformin (95% CI, -1.7 to -0.5; P=.25). Among children with NASH, the proportion who resolved at 96 weeks was 28% with placebo (95% CI, 15% to 45%; 11/39) vs 58% with vitamin E (95% CI, 42% to 73%; 25/43; P=.006) and 41% with metformin (95% CI, 26% to 58%; 16/39; P=.23). Compared with placebo, neither therapy demonstrated significant improvements in other histological features. Conclusion Neither vitamin E nor metformin was superior to placebo in attaining the primary outcome of sustained reduction in ALT level in patients with pediatric NAFLD.	[Lavine, Joel E.] Columbia Univ, Med Ctr, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, New York, NY 10032 USA; [Schwimmer, Jeffrey B.] Univ Calif San Diego, Dept Pediat, Div Gastroenterol Hepatol & Nutr, San Diego, CA 92103 USA; [Van Natta, Mark L.; Uenalp, Aynur] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Clark, Jeanne M.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Scheimann, Ann O.] Johns Hopkins Univ, Dept Pediat, Div Gastroenterol & Nutr, Baltimore, MD 21218 USA; [Tonascia, James] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Molleston, Jean P.] Indiana Univ, James Whitcomb Riley Hosp Children, Dept Pediat, Sect Pediat Gastroenterol, Indianapolis, IN USA; [Murray, Karen F.] Univ Washington, Sch Med, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Rosenthal, Philip] Univ Calif San Francisco, Dept Pediat, Div Gastroenterol Hepatol & Nutr, San Francisco, CA 94143 USA; [Abrams, Stephanie H.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Sect Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Sanyal, Arun J.] Virginia Commonwealth Univ, Dept Med, Virginia Commonwealth Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, Richmond, VA 23298 USA; [Chalasani, Naga] Indiana Univ, Dept Med, Div Gastroenterol Hepatol, Indianapolis, IN USA; [Brunt, Elizabeth M.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Kleiner, David E.] NCI, Dept Labs, NIH, Bethesda, MD 20892 USA; [Hoofnagle, Jay H.; Robuck, Patricia R.] NIDDK, NIH, Bethesda, MD USA	Columbia University; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Baylor College of Medicine; Virginia Commonwealth University; Indiana University System; Indiana University-Purdue University Indianapolis; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Lavine, JE (corresponding author), Columbia Univ, Med Ctr, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, 3959 Broadway,CHN 7-702, New York, NY 10032 USA.	jl3553@columbia.edu	Clark, Jeanne/AGG-8199-2022; Vaughn, Ivana/B-6138-2016; Buse, John Bernard/J-9742-2019; Kleiner, David E/N-2770-2013	Clark, Jeanne/0000-0003-1194-0092; Vaughn, Ivana/0000-0002-7201-0289; Buse, John Bernard/0000-0002-9723-3876; Kleiner, David E/0000-0003-3442-4453; Schwimmer, Jeffrey/0000-0001-8538-2877	Schering; Roche; Bristol-Myers Squibb; GlaxoSmithKline; Takeda; Salix; Gore; Astellas; Exalenz; Norgine; Gore Associates; Gilead Sciences; Mochida; Karo Bio; Johnson Johnson; Gilead; Abbott; Medpace; Astra-Zeneca; Teva; Amylin; Phenomix; Lilly; National Institute of Diabetes and Digestive and Kidney Diseases [U01DK061718, U01DK061728, U01DK061731, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, U01DK061713]; National Cancer Institute; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health General Clinical Research Centers [UL1RR024989, UL1RR024128, M01RR000750, UL1RR024131, M01RR000827, UL1RR02501401, M01RR000065, M01RR00188, M01RR020359]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD061221] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014, M01RR000827, M01RR000188, M01RR000750, UL1RR024128, UL1RR024131, M01RR000065, M01RR020359, UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061718, U01DK061730, U01DK061734, U01DK061732, U01DK061737, U01DK061728, U01DK061731, K24DK069290, U01DK061713, U01DK061738] Funding Source: NIH RePORTER	Schering; Roche(Roche Holding); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Takeda(Takeda Pharmaceutical Company Ltd); Salix; Gore; Astellas(Astellas Pharmaceuticals); Exalenz; Norgine; Gore Associates; Gilead Sciences(Gilead Sciences); Mochida; Karo Bio; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Gilead(Gilead Sciences); Abbott(Abbott Laboratories); Medpace; Astra-Zeneca(AstraZeneca); Teva(Teva Pharmaceutical Industries); Amylin; Phenomix; Lilly(Eli Lilly); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health General Clinical Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Molleston reported receiving grant support from Schering and Roche. Dr Rosenthal reported receiving consulting fees from Roche, grant support from Bristol-Myers Squibb and Roche, and speaking fees from GlaxoSmithKline. Dr Sanyal reported receiving consulting fees from Takeda, Salix, Gore, Astellas, Exalenz, and Norgine; grant support from Salix, Gore & Associates, Gilead Sciences, Exalenz, Roche, and Mochida; royalties from UptoDate; and travel and meeting expenses from Salix and Astellas. Dr Chalasani reported receiving consulting fees from Merck, Karo Bio, Johnson & Johnson, Gilead, Abbott, Medpace, Astra-Zeneca, Teva, Salix, Amylin, and Phenomix and grant support from Amylin and Lilly. Dr Brunt reported receiving consulting fees from Amylin and Pfizer. The other authors reported no conflicts of interest.; The Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) is supported by the National Institute of Diabetes and Digestive and Kidney Diseases grants U01DK061718, U01DK061728, U01DK061731, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, and U01DK061713. This study was supported in part by the Intramural Research Program of the National Cancer Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Other grant support included the following National Institutes of Health General Clinical Research Centers or Clinical and Translational Science Awards: UL1RR024989, UL1RR024128, M01RR000750, UL1RR024131, M01RR000827, UL1RR02501401, M01RR000065, M01RR00188, and M01RR020359. The vitamin E soft gels and matching placebo were provided by Pharmavite through a Clinical Trial Agreement with the National Institutes of Health.	Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Caldwell S, 2010, J HEPATOL, V53, P719, DOI 10.1016/j.jhep.2010.04.031; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lavine JE, 2000, J PEDIATR-US, V136, P734, DOI 10.1016/S0022-3476(00)05040-X; Lavine JE, 2010, CONTEMP CLIN TRIALS, V31, P62, DOI 10.1016/j.cct.2009.09.001; Loomba R, 2009, HEPATOLOGY, V50, P1282, DOI 10.1002/hep.23119; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Molleston JP, 2002, AM J GASTROENTEROL, V97, P2460; Nobili V, 2008, HEPATOLOGY, V48, P119, DOI 10.1002/hep.22336; Patton HM, 2008, GASTROENTEROLOGY, V135, P1961, DOI 10.1053/j.gastro.2008.08.050; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schwimmer JB, 2005, ALIMENT PHARM THER, V21, P871, DOI 10.1111/j.1365-2036.2005.02420.x; Schwimmer JB, 2003, J PEDIATR-US, V143, P500, DOI 10.1067/S0022-3476(03)00325-1; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Schwimmer JB, 2008, CIRCULATION, V118, P277, DOI 10.1161/CIRCULATIONAHA.107.739920; Schwinnner JB, 2005, HEPATOLOGY, V42, P641, DOI 10.1002/hep.20842	20	694	728	1	63	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1659	1668		10.1001/jama.2011.520	http://dx.doi.org/10.1001/jama.2011.520			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521847	Bronze, Green Accepted			2022-12-28	WOS:000289890500019
J	Beyrer, C				Beyrer, Chris			Safe injection facilities save lives	LANCET			English	Editorial Material							DRUG-USERS; COST-EFFECTIVENESS; HARM REDUCTION; MORTALITY; COHORT		Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21202 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21202 USA.	cbeyrer@jhsph.edu						Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; Christie T, 2003, INT J DRUG POLICY, V16, P56; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Guinness L, 2010, ADDICTION, V105, P319, DOI 10.1111/j.1360-0443.2009.02755.x; HALL N, 2010, VANCOUVER SUN   0115; Marshall BDL, 2011, LANCET, V377, P1429, DOI 10.1016/S0140-6736(10)62353-7; Padian NS, 2011, JAIDS-J ACQ IMM DEF, V56, P199, DOI 10.1097/QAI.0b013e31820bb448; Palmateer N, 2010, ADDICTION, V105, P844, DOI 10.1111/j.1360-0443.2009.02888.x; Small D, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-23; Stoove MA, 2008, DRUG ALCOHOL DEPEN, V96, P281, DOI 10.1016/j.drugalcdep.2008.03.006; Vickerman P, 2006, SEX TRANSM DIS, V33, pS89, DOI 10.1097/01.olq.0000221335.80508.fa	11	4	4	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 23	2011	377	9775					1385	1386		10.1016/S0140-6736(11)60132-3	http://dx.doi.org/10.1016/S0140-6736(11)60132-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UF	21497899				2022-12-28	WOS:000289963000006
J	Heallen, T; Zhang, M; Wang, J; Bonilla-Claudio, M; Klysik, E; Johnson, RL; Martin, JF				Heallen, Todd; Zhang, Min; Wang, Jun; Bonilla-Claudio, Margarita; Klysik, Ela; Johnson, Randy L.; Martin, James F.			Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size	SCIENCE			English	Article							GROWTH; EXPRESSION; REGULATOR; LIVER	Genetic regulation of mammalian heart size is poorly understood. Hippo signaling represents an organ-size control pathway in Drosophila, where it also inhibits cell proliferation and promotes apoptosis in imaginal discs. To determine whether Hippo signaling controls mammalian heart size, we inactivated Hippo pathway components in the developing mouse heart. Hippo-deficient embryos had overgrown hearts with elevated cardiomyocyte proliferation. Gene expression profiling and chromatin immunoprecipitation revealed that Hippo signaling negatively regulates a subset of Wnt target genes. Genetic interaction studies indicated that beta-catenin heterozygosity suppressed the Hippo cardiomyocyte overgrowth phenotype. Furthermore, the Hippo effector Yap interacts with b-catenin on Sox2 and Snai2 genes. These data uncover a nuclear interaction between Hippo and Wnt signaling that restricts cardiomyocyte proliferation and controls heart size.	[Heallen, Todd; Zhang, Min; Wang, Jun; Bonilla-Claudio, Margarita; Klysik, Ela; Martin, James F.] Texas A&M Syst Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center	Martin, JF (corresponding author), Texas A&M Syst Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	jmartin@ibt.tamhsc.edu		Zhang, Min/0000-0001-7055-6790; Heallen, Todd/0000-0002-6003-8743	NIH [T32 DE15355-04, R01HD052785, R01HD060579, AHA09PRE2150024, AHA10POST4140029]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052785, R01HD060579] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE015355] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. Epstein, S. Sasakura, T. Gridley, M. Sudol, F. Long, and B. Amendt for reagents. Supported by NIH grants (J. F. M. and R. L. J.), T32 DE15355-04 (M. B. C.), R01HD052785 and R01HD060579 (R. L. J.), AHA09PRE2150024 (J. W.), and AHA10POST4140029 (T. H.). Microarray data (accession number GSE27259) can be accessed at the Gene Expression Omnibus (GEO) repository (www.ncbi.nlm.nih.gov/geo/).	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Islam A, 2000, ONCOGENE, V19, P617, DOI 10.1038/sj.onc.1203358; Koyanagi M, 2010, CIRC RES, V106, P1290, DOI 10.1161/CIRCRESAHA.109.206045; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Tzahor E, 2007, DEV CELL, V13, P10, DOI 10.1016/j.devcel.2007.06.006; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007	15	719	753	3	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					458	461		10.1126/science.1199010	http://dx.doi.org/10.1126/science.1199010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512031	Green Accepted			2022-12-28	WOS:000289784900041
J	Rajab, TK; Shekar, P; Falk, RH				Rajab, Taufiek Konrad; Shekar, Prem; Falk, Rodney Howard			Myxoma, dyspnoea, tinnitus, scoliosis, and alopecia	LANCET			English	Editorial Material									[Rajab, Taufiek Konrad; Shekar, Prem] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Rajab, Taufiek Konrad; Shekar, Prem] Harvard Univ, Sch Med, Boston, MA USA; [Falk, Rodney Howard] Harvard Vanguard Med Associates, Dept Cardiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard Vanguard Medical Associates	Rajab, TK (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.	trajab@rics.bwh.harvard.edu						King TW, 1845, LANCET, V46, P428, DOI DOI 10.1016/S0140-6736(02)87782-0; Loche F, 1999, EUR J DERMATOL, V9, P650; Pinede L, 2001, MEDICINE, V80, P159, DOI 10.1097/00005792-200105000-00002; REYNEN K, 1995, NEW ENGL J MED, V333, P1610, DOI 10.1056/NEJM199512143332407	4	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2011	377	9774					1378	1378		10.1016/S0140-6736(11)60328-0	http://dx.doi.org/10.1016/S0140-6736(11)60328-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UE	21497702				2022-12-28	WOS:000289962900038
J	Kooijman, JDG; Meijaard, JP; Papadopoulos, JM; Ruina, A; Schwab, AL				Kooijman, J. D. G.; Meijaard, J. P.; Papadopoulos, Jim M.; Ruina, Andy; Schwab, A. L.			A Bicycle Can Be Self-Stable Without Gyroscopic or Caster Effects	SCIENCE			English	Article							DYNAMICS	A riderless bicycle can automatically steer itself so as to recover from falls. The common view is that this self-steering is caused by gyroscopic precession of the front wheel, or by the wheel contact trailing like a caster behind the steer axis. We show that neither effect is necessary for self-stability. Using linearized stability calculations as a guide, we built a bicycle with extra counter-rotating wheels (canceling the wheel spin angular momentum) and with its front-wheel ground-contact forward of the steer axis (making the trailing distance negative). When laterally disturbed from rolling straight, this bicycle automatically recovers to upright travel. Our results show that various design variables, like the front mass location and the steer axis tilt, contribute to stability in complex interacting ways.	[Kooijman, J. D. G.; Schwab, A. L.] Delft Univ Technol, Dept Mech Engn, NL-2628 CD Delft, Netherlands; [Meijaard, J. P.] Univ Twente, Dept Engn Technol, NL-7500 AE Enschede, Netherlands; [Papadopoulos, Jim M.] Univ Wisconsin Stout, Dept Engn & Technol, Menomonie, WI 54751 USA; [Ruina, Andy] Cornell Univ, Dept Mech Engn, Ithaca, NY 14853 USA	Delft University of Technology; University of Twente; University of Wisconsin System; University of Wisconsin Stout; Cornell University	Ruina, A (corresponding author), Delft Univ Technol, Dept Mech Engn, NL-2628 CD Delft, Netherlands.	ruina@cornell.edu	Ruina, Andy L/A-8725-2018; Schwab, Arend/Q-4387-2016	Ruina, Andy L/0000-0001-5493-6048; Schwab, Arend/0000-0001-5897-9790	NSF	NSF(National Science Foundation (NSF))	R.S. Hand helped with the theory and experiments; A. Dressel helped with the eigenvalue analysis; J. van Frankenhuyzen helped with designing the experimental machine; and J. Moore helped with conducting the experiments. The manuscript was improved by comments from M. Broide, M. Cook, A. Dressel, J. Guckenheimer, R. Klein, D. Limebeer, C. Miller, J. Moore, R. Pohl, L. Schaffer, and D. van Nouhuys. The research was initially supported by a NSF Presidential Young Investigators award to A. R. The original theory was mostly by J. M. P. with later refinement by A. L. S. J. P. M. found the error in (11). Experiments were performed mostly by J. D. G. K. and A. L. S. Writing was done mostly by A. R. and A.L.S.	Astrom KJ, 2005, IEEE CONTR SYST MAG, V25, P26, DOI 10.1109/MCS.2005.1499389; Carvallo E, 1899, THEORIE MOUVEMENT MO; Chateau C., 1892, LA NATURE, V20, P353; COLLINS RN, 1963, THESIS U WISCONSIN M; Griffiths J. A., 1886, P I MECH ENG, V37, P128; JONES DEH, 1970, PHYS TODAY, V23, P34, DOI 10.1063/1.3022064; KLEIN F, 1910, THEORIE KREISELS; Kooijman JDG, 2008, MULTIBODY SYST DYN, V19, P115, DOI 10.1007/s11044-007-9050-x; Meijaard JP, 2007, P ROY SOC A-MATH PHY, V463, P1955, DOI 10.1098/rspa.2007.1857; Neimark J. I., 1967, AM MATH SOC, V33; Papadopoulos J. M., 1987, BICYCLE STEERING DYN; Rankine W.J.M., 1869, ENGINEER, V28, P79; Routh E.J, 1873, P LOND MATH SOC, V5, p1873/74; Spencer C., 1876, MODERN BICYCLE, P23; Thomson W., 1889, POPULAR LECT ADDRESS, V1, P142; Whipple F., 1899, Q J PURE APPL MATH, V30, P312	16	110	120	9	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					339	342		10.1126/science.1201959	http://dx.doi.org/10.1126/science.1201959			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493856				2022-12-28	WOS:000289516600041
J	Sudo, K; Harada, H				Sudo, Kazumasa; Harada, Hiroshi			Calcification of the Aorta and Common Iliac Arteries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sudo, Kazumasa; Harada, Hiroshi] Sapporo City Gen Hosp, Sapporo, Hokkaido, Japan	Sapporo City General Hospital	Sudo, K (corresponding author), Sapporo City Gen Hosp, Sapporo, Hokkaido, Japan.	kazumasa.sudo@doc.city.sapporo.jp							0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1449	1449		10.1056/NEJMicm1007721	http://dx.doi.org/10.1056/NEJMicm1007721			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LD	21488767				2022-12-28	WOS:000289467200009
J	Herr, HW				Herr, Harry W.			Intravesical Bacille Calmette-Guerin in Patients With Asymptomatic Bacteriuria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Herr, HW (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Urol, 1275 York Ave, New York, NY 10021 USA.	herrh@mskcc.org						Billips BK, 2007, INFECT IMMUN, V75, P5353, DOI 10.1128/IAI.00922-07; Gross PA, 2007, CLIN INFECT DIS, V45, P1335, DOI 10.1086/522183; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; Schaeffer EM, 2006, NAT CLIN PRACT UROL, V3, P24, DOI 10.1038/ncpuro0357	4	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1413	1414		10.1001/jama.2011.428	http://dx.doi.org/10.1001/jama.2011.428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486973	Bronze			2022-12-28	WOS:000289424100016
J	Spong, CY; Reddy, UM; Willinger, M				Spong, Catherine Y.; Reddy, Uma M.; Willinger, Marian			Addressing the complexity of disparities in stillbirths	LANCET			English	Editorial Material							RISK-FACTORS		[Spong, Catherine Y.; Reddy, Uma M.; Willinger, Marian] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pregnancy & Perinatol Branch, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Spong, CY (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pregnancy & Perinatol Branch, NIH, Rockville, MD 20852 USA.	spongc@mail.nih.gov						COPPER RL, 1994, OBSTET GYNECOL, V84, P490; Dudley DJ, 2010, OBSTET GYNECOL, V116, P254, DOI 10.1097/AOG.0b013e3181e7d975; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Getahun D, 2007, AM J OBSTET GYNECOL, V196, P499, DOI 10.1016/j.ajog.2006.09.017; MacDorman Marian F, 2009, Natl Vital Stat Rep, V57, P1; Mathews T J, 2008, Natl Vital Stat Rep, V57, P1; Reddy UM, 2009, OBSTET GYNECOL, V114, P901, DOI 10.1097/AOG.0b013e3181b8f6e4; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Spong CY, 2011, OBSTET GYNECOL, V117, P948, DOI 10.1097/AOG.0b013e318211726f; Willinger M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.057	10	15	15	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2011	377	9778					1635	1636		10.1016/S0140-6736(11)60025-1	http://dx.doi.org/10.1016/S0140-6736(11)60025-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	766JF	21496913				2022-12-28	WOS:000290777700009
J	Windbichler, N; Menichelli, M; Papathanos, PA; Thyme, SB; Li, H; Ulge, UY; Hovde, BT; Baker, D; Monnat, RJ; Burt, A; Crisanti, A				Windbichler, Nikolai; Menichelli, Miriam; Papathanos, Philippos Aris; Thyme, Summer B.; Li, Hui; Ulge, Umut Y.; Hovde, Blake T.; Baker, David; Monnat, Raymond J., Jr.; Burt, Austin; Crisanti, Andrea			A synthetic homing endonuclease-based gene drive system in the human malaria mosquito	NATURE			English	Article							SPECIFICITY; BINDING; TRANSMISSION; DERIVATIVES; GENERATION; CONVERSION; PROTEIN	Genetic methods of manipulating or eradicating disease vector populations have long been discussed as an attractive alternative to existing control measures because of their potential advantages in terms of effectiveness and species specificity(1-3). The development of genetically engineered malaria-resistant mosquitoes has shown, as a proof of principle, the possibility of targeting the mosquito's ability to serve as a disease vector(4-7). The translation of these achievements into control measures requires an effective technology to spread a genetic modification from laboratory mosquitoes to field populations(8). We have suggested previously that homing endonuclease genes (HEGs), a class of simple selfish genetic elements, could be exploited for this purpose(9). Here we demonstrate that a synthetic genetic element, consisting of mosquito regulatory regions(10) and the homing endonuclease gene I-SceI(11-13), can substantially increase its transmission to the progeny in transgenic mosquitoes of the human malaria vector Anopheles gambiae. We show that the I-SceI element is able to invade receptive mosquito cage populations rapidly, validating mathematical models for the transmission dynamics of HEGs. Molecular analyses confirm that expression of I-SceI in the male germline induces high rates of site-specific chromosomal cleavage and gene conversion, which results in the gain of the I-SceI gene, and underlies the observed genetic drive. These findings demonstrate a new mechanism by which genetic control measures can be implemented. Our results also show in principle how sequence-specific genetic drive elements like HEGs could be used to take the step from the genetic engineering of individuals to the genetic engineering of populations.	[Windbichler, Nikolai; Menichelli, Miriam; Papathanos, Philippos Aris; Burt, Austin; Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Thyme, Summer B.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Thyme, Summer B.; Baker, David] Univ Washington, Grad Program Biomol Struct & Design, Seattle, WA 98195 USA; [Li, Hui; Ulge, Umut Y.; Monnat, Raymond J., Jr.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Ulge, Umut Y.; Monnat, Raymond J., Jr.] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Hovde, Blake T.; Monnat, Raymond J., Jr.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Burt, Austin] Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Crisanti, Andrea] Univ Perugia, Dept Expt Med, I-06122 Perugia, Italy	Imperial College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Imperial College London; University of Perugia	Crisanti, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, S Kensington Campus, London SW7 2AZ, England.	a.drcrisanti@imperial.ac.uk	Li, Hui/E-8866-2010; Papathanos, Philippos/ABE-4869-2021; Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Li, Hui/0000-0002-2980-2491; Ulge, Umut/0000-0002-3745-0668; Papathanos, Philippos Aris/0000-0001-8508-4554; Windbichler, Nikolai/0000-0001-9896-1165; Hovde, Blake/0000-0002-7112-3310; Thyme, Summer/0000-0003-3593-4148; Burt, Austin/0000-0001-5146-9640; Crisanti, Andrea/0000-0002-2406-4426	Foundation for the National Institutes of Health through Grand Challenges in Global Health initiative; NIH [GM084433, CA133831]; NATIONAL CANCER INSTITUTE [T32CA080416, RL1CA133831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084433] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through Grand Challenges in Global Health initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Ashburner, S. Russell, D. Huen and S. Chan for comments, assistance and for plasmids. We thank M. P. Calos for providing the pET11phiC31polyA plasmid. We thank M. J. Fraser Jr for providing the pBSII-IFP2-orf plasmid. We thank J. Meredith and P. Eggleston for providing the docking strain. We thank A. Hall, T. Nolan, K. Magnusson, D. Rogers and S. Fuchs for assistance. We thank S. Arshiya Quadri and M. Szeto for experimental support and the members of the laboratories of D. Baker, R. Monnat, A. Scharenberg and B. Stoddard for their collective support of HEG engineering. A. F. M. Hackmann provided graphics support. Funded by a grant from the Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative and by NIH RL1 awards GM084433 to D.B. and CA133831 to R.J.M.	Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; Argast GM, 1998, J MOL BIOL, V280, P345, DOI 10.1006/jmbi.1998.1886; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Bellaiche Y, 1999, GENETICS, V152, P1037; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Catteruccia F, 2005, NAT BIOTECHNOL, V23, P1414, DOI 10.1038/nbt1152; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja057519l; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Goddard MR, 2001, P ROY SOC B-BIOL SCI, V268, P2537, DOI 10.1098/rspb.2001.1830; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Jarjour J, 2009, NUCLEIC ACIDS RES, V37, P6871, DOI 10.1093/nar/gkp726; Li FW, 2005, J INFECT DIS, V192, P878, DOI 10.1086/432552; Li H, 2009, NUCLEIC ACIDS RES, V37, P1650, DOI 10.1093/nar/gkp004; Lobo NF, 2006, NAT PROTOC, V1, P1312, DOI 10.1038/nprot.2006.221; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Meredith JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014587; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; Munoz IG, 2011, NUCLEIC ACIDS RES, V39, P729, DOI 10.1093/nar/gkq801; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Rosen LE, 2006, NUCLEIC ACIDS RES, V34, P4791, DOI 10.1093/nar/gkl645; Scalley-Kim M, 2007, J MOL BIOL, V372, P1305, DOI 10.1016/j.jmb.2007.07.052; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thyme SB, 2009, NATURE, V461, P1300, DOI 10.1038/nature08508; Ulge UY, 2011, NUCLEIC ACIDS RES, V39, P4330, DOI 10.1093/nar/gkr022; Windbichler N, 2007, NUCLEIC ACIDS RES, V35, P5922, DOI 10.1093/nar/gkm632	40	237	254	1	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					212	+		10.1038/nature09937	http://dx.doi.org/10.1038/nature09937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21508956	Green Accepted, Green Submitted			2022-12-28	WOS:000290487200038
J	Schilcher, J; Michaelsson, K; Aspenberg, P				Schilcher, Jorg; Michaelsson, Karl; Aspenberg, Per			Bisphosphonate Use and Atypical Fractures of the Femoral Shaft	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIAPHYSEAL FEMUR FRACTURES; SUPPRESSED BONE TURNOVER; STRESS-FRACTURES; ALENDRONATE; COMPLICATION; WOMEN	BACKGROUND Studies show conflicting results regarding the possible excess risk of atypical fractures of the femoral shaft associated with bisphosphonate use. METHODS In Sweden, 12,777 women 55 years of age or older sustained a fracture of the femur in 2008. We reviewed radiographs of 1234 of the 1271 women who had a subtrochanteric or shaft fracture and identified 59 patients with atypical fractures. Data on medications and coexisting conditions were obtained from national registries. The relative and absolute risk of atypical fractures associated with bisphosphonate use was estimated by means of a nationwide cohort analysis. The 59 case patients were also compared with 263 control patients who had ordinary subtrochanteric or shaft fractures. RESULTS The age-adjusted relative risk of atypical fracture was 47.3 (95% confidence interval [CI], 25.6 to 87.3) in the cohort analysis. The increase in absolute risk was 5 cases per 10,000 patient-years (95% CI, 4 to 7). A total of 78% of the case patients and 10% of the controls had received bisphosphonates, corresponding to a multivariable-adjusted odds ratio of 33.3 (95% CI, 14.3 to 77.8). The risk was independent of coexisting conditions and of concurrent use of other drugs with known effects on bone. The duration of use influenced the risk (odds ratio per 100 daily doses, 1.3; 95% CI, 1.1 to 1.6). After drug withdrawal, the risk diminished by 70% per year since the last use (odds ratio, 0.28; 95% CI, 0.21 to 0.38). CONCLUSIONS These population-based nationwide analyses may be reassuring for patients who receive bisphosphonates. Although there was a high prevalence of current bisphosphonate use among patients with atypical fractures, the absolute risk was small.	[Schilcher, Jorg; Aspenberg, Per] Linkoping Univ, Fac Hlth Sci, Dept Expt & Clin Med, SE-58185 Linkoping, Sweden; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Sect Orthoped, Uppsala, Sweden; [Michaelsson, Karl] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden	Linkoping University; Uppsala University; Uppsala University	Aspenberg, P (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Expt & Clin Med, SE-58185 Linkoping, Sweden.	per.aspenberg@liu.se	Michaelsson, Karl/AAM-9094-2021	Michaelsson, Karl/0000-0003-2815-1217	Eli Lilly; Amgen; Swedish Research Council	Eli Lilly(Eli Lilly); Amgen(Amgen); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Dr. Aspenberg reports receiving consulting fees from Eli Lilly and Amgen and grant support to his institution, Linkoping University, from Eli Lilly and Amgen, as well as holding stock in AddBIO, a company trying to commercialize a method for bisphosphonate coating of implants to be inserted in bone, and holding a patent for this method. No other potential conflict of interest relevant to this article was reported.; Funded by the Swedish Research Council.	Abrahamsen B, 2010, J CLIN ENDOCR METAB, V95, P5258, DOI 10.1210/jc.2010-1571; Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/JBMR.081247, 10.1359/jbmr.081247]; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Calltorp J, 1996, LANCET, V347, P587, DOI 10.1016/S0140-6736(96)91278-7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Girgis CM, 2010, NEW ENGL J MED, V362, P1848, DOI 10.1056/NEJMc0910389; Ing-Lorenzini K, 2009, DRUG SAFETY, V32, P775, DOI 10.2165/00002018-200932090-00002; Kwek EBK, 2008, INJURY, V39, P224, DOI 10.1016/j.injury.2007.08.036; Lenart BA, 2009, OSTEOPOROSIS INT, V20, P1353, DOI 10.1007/s00198-008-0805-x; Lenart BA, 2008, NEW ENGL J MED, V358, P1304, DOI 10.1056/NEJMc0707493; NEER RM, 1995, BONE, V17, pS501, DOI 10.1016/8756-3282(95)00343-7; Neviaser AS, 2008, J ORTHOP TRAUMA, V22, P346, DOI 10.1097/BOT.0b013e318172841c; Odvina CV, 2010, CLIN ENDOCRINOL, V72, P161, DOI 10.1111/j.1365-2265.2009.03581.x; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schilcher J, 2009, ACTA ORTHOP, V80, P413, DOI 10.3109/17453670903139914; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Visekruna M, 2008, J CLIN ENDOCR METAB, V93, P2948, DOI 10.1210/jc.2007-2803	19	482	496	2	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1728	1737		10.1056/NEJMoa1010650	http://dx.doi.org/10.1056/NEJMoa1010650			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759DC	21542743				2022-12-28	WOS:000290219800009
J	Haque, A; Engwerda, CR				Haque, Ashraful; Engwerda, Christian R.			An Antioxidant Link between Sickle Cell Disease and Severe Malaria	CELL			English	Editorial Material							FALCIPARUM-MALARIA; HEMOGLOBIN; RESPONSES	Although a link between sickle cell disease and resistance to severe malaria is well established, the biochemical relationship between the two is unknown. Ferreira et al. (2011) show that carriers of the sickle cell mutation increase expression of the heme oxygenase-1 enzyme, which produces antioxidant molecules that may prevent severe disease symptoms.	[Haque, Ashraful; Engwerda, Christian R.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Haque, Ashraful; Engwerda, Christian R.] Australian Ctr Vaccine Dev, Herston, Qld 4006, Australia; [Engwerda, Christian R.] Univ Queensland, Sch Med, Herston, Qld 4006, Australia	QIMR Berghofer Medical Research Institute; University of Queensland	Engwerda, CR (corresponding author), Queensland Inst Med Res, Bramston Terrace, Herston, Qld 4006, Australia.	christian.engwerda@qimr.edu.au	Engwerda, Christian/I-3072-2015; Haque, Ashraful/H-8697-2014	Haque, Ashraful/0000-0003-2260-0026; Engwerda, Christian/0000-0003-2813-4804				ALLISON AC, 1954, T ROY SOC TROP MED H, V48, P312, DOI 10.1016/0035-9203(54)90101-7; Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; Cabrera G, 2005, J INFECT DIS, V191, P1631, DOI 10.1086/429832; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Hood AT, 1996, BLOOD, V87, P1600, DOI 10.1182/blood.V87.4.1600.bloodjournal8741600; Medana IM, 2001, NEUROPATH APPL NEURO, V27, P421, DOI 10.1046/j.0305-1846.2001.00360.x; MULLEREBERHARD U, 2007, NAT MED, V13, P703; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819	9	4	5	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					335	336		10.1016/j.cell.2011.04.004	http://dx.doi.org/10.1016/j.cell.2011.04.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529707	Bronze			2022-12-28	WOS:000290022900002
J	Esvelt, KM; Carlson, JC; Liu, DR				Esvelt, Kevin M.; Carlson, Jacob C.; Liu, David R.			A system for the continuous directed evolution of biomolecules	NATURE			English	Article							T7 RNA-POLYMERASE; START SITE SELECTION; PHAGE; TRANSCRIPTION; RECOGNITION; INITIATION; VECTORS; MUTANTS; YEAST; ASSAY	Laboratory evolution has generated many biomolecules with desired properties, but a single round of mutation, gene expression, screening or selection, and replication typically requires days or longer with frequent human intervention(1). Because evolutionary success is dependent on the total number of rounds performed(2), a means of performing laboratory evolution continuously and rapidly could dramatically enhance its effectiveness(3). Although researchers have accelerated individual steps in the evolutionary cycle(4-9), the only previous example of continuous directed evolution was the landmark study of Wright and Joyce(10), who continuously evolved RNA ligase ribozymes with an in vitro replication cycle that unfortunately cannot be easily adapted to other biomolecules. Here we describe a system that enables the continuous directed evolution of gene-encoded molecules that can be linked to protein production in Escherichia coli. During phage-assisted continuous evolution (PACE), evolving genes are transferred from host cell to host cell through a modified bacteriophage life cycle in a manner that is dependent on the activity of interest. Dozens of rounds of evolution can occur in a single day of PACE without human intervention. Using PACE, we evolved T7 RNA polymerase (RNAP) variants that recognize a distinct promoter, initiate transcripts with ATP instead of GTP, and initiate transcripts with CTP. In one example, PACE executed 200 rounds of protein evolution over the course of 8 days. Starting from undetectable activity levels in two of these cases, enzymes with each of the three target activities emerged in less than 1 week of PACE. In all three cases, PACE-evolved polymerase activities exceeded or were comparable to that of the wild-type T7 RNAP on its wild-type promoter, representing improvements of up to several hundred-fold. By greatly accelerating laboratory evolution, PACE may provide solutions to otherwise intractable directed evolution problems and address novel questions about molecular evolution.	[Carlson, Jacob C.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Esvelt, Kevin M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022	Esvelt, Kevin/0000-0001-8797-3945	National Institutes of Health/National Institute of General Medical Sciences [R01 GM065400]; HHMI; Hertz Foundation; National Science Foundation; Harvard Chemical Biology Graduate Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065400] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHMI(Howard Hughes Medical Institute); Hertz Foundation; National Science Foundation(National Science Foundation (NSF)); Harvard Chemical Biology Graduate Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/National Institute of General Medical Sciences R01 GM065400 and by HHMI. K. M. E. acknowledges graduate research fellowships from the Hertz Foundation and the National Science Foundation. J.C.C. was supported by the Harvard Chemical Biology Graduate Program. We thank B. Dorr for assistance with phage generation modelling, E. Curtis for suggestions and V. D'Souza for plasmid pT7-911Q.	Baker K, 2002, P NATL ACAD SCI USA, V99, P16537, DOI 10.1073/pnas.262420099; Brieba LG, 2002, BIOCHEMISTRY-US, V41, P5144, DOI 10.1021/bi016057v; Calendar R., 2006, BACTERIOPHAGES; Camps M, 2003, P NATL ACAD SCI USA, V100, P9727, DOI 10.1073/pnas.1333928100; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis JN, 2010, J VIROL, V84, P1625, DOI 10.1128/JVI.01747-09; Fijalkowska IJ, 1996, P NATL ACAD SCI USA, V93, P2856, DOI 10.1073/pnas.93.7.2856; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Husimi Y, 1989, Adv Biophys, V25, P1, DOI 10.1016/0065-227X(89)90003-8; Ichetovkin IE, 1997, J BIOL CHEM, V272, P33009, DOI 10.1074/jbc.272.52.33009; IKEDA RA, 1993, BIOCHEMISTRY-US, V32, P9115, DOI 10.1021/bi00086a016; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; Kuzmine I, 2003, J BIOL CHEM, V278, P2819, DOI 10.1074/jbc.M208405200; Makeyev EV, 2004, J VIROL, V78, P2114, DOI 10.1128/JVI.78.4.2114-2120.2004; MARTIN CT, 1987, BIOCHEMISTRY-US, V26, P2690, DOI 10.1021/bi00384a006; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; NELSON FK, 1981, VIROLOGY, V108, P338, DOI 10.1016/0042-6822(81)90442-6; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Rakonjac J, 1998, J MOL BIOL, V282, P25, DOI 10.1006/jmbi.1998.2006; RASKIN CA, 1993, P NATL ACAD SCI USA, V90, P3147, DOI 10.1073/pnas.90.8.3147; RASKIN CA, 1992, J MOL BIOL, V228, P506, DOI 10.1016/0022-2836(92)90838-B; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Vidal-Aroca F, 2006, BIOTECHNIQUES, V40, P433, DOI 10.2144/000112145; Voigt CA, 2001, ADV PROTEIN CHEM, V55, P79; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wright MC, 1997, SCIENCE, V276, P614, DOI 10.1126/science.276.5312.614; Yuan L, 2005, MICROBIOL MOL BIOL R, V69, P373, DOI 10.1128/MMBR.69.3.373-392.2005	32	360	433	26	431	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					499	U550		10.1038/nature09929	http://dx.doi.org/10.1038/nature09929			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21478873	Green Accepted			2022-12-28	WOS:000289949600040
J	Basinga, P; Gertler, PJ; Binagwaho, A; Soucat, ALB; Sturdy, J; Vermeersch, CMJ				Basinga, Paulin; Gertler, Paul J.; Binagwaho, Agnes; Soucat, Agnes L. B.; Sturdy, Jennifer; Vermeersch, Christel M. J.			Effect on maternal and child health services in Rwanda of payment to primary health-care providers for performance: an impact evaluation	LANCET			English	Article							ROUTINE ANTENATAL CARE; CONDITIONAL CASH TRANSFERS; RANDOMIZED-TRIAL; BIRTH-WEIGHT; CENTERS; QUALITY; OPORTUNIDADES; INTERVENTIONS; EXPERIENCE; COUNTRIES	Background Evidence about the best methods with which to accelerate progress towards achieving the Millennium Development Goals is urgently needed. We assessed the effect of performance-based payment of health-care providers (payment for performance; P4P) on use and quality of child and maternal care services in health-care facilities in Rwanda. Methods 166 facilities were randomly assigned at the district level either to begin P4P funding between June, 2006, and October, 2006 (intervention group; n=80), or to continue with the traditional input-based funding until 23 months after study baseline (control group; n=86). Randomisation was done by coin toss. We surveyed facilities and 2158 households at baseline and after 23 months. The main outcome measures were prenatal care visits and institutional deliveries, quality of prenatal care, and child preventive care visits and immunisation. We isolated the incentive effect from the resource effect by increasing comparison facilities' input-based budgets by the average P4P payments made to the treatment facilities. We estimated a multivariate regression specification of the difference-in-difference model in which an individual's outcome is regressed against a dummy variable, indicating whether the facility received P4P that year, a facility-fixed effect, a year indicator, and a series of individual and household characteristics. Findings Our model estimated that facilities in the intervention group had a 23% increase in the number of institutional deliveries and increases in the number of preventive care visits by children aged 23 months or younger (56%) and aged between 24 months and 59 months (132%). No improvements were seen in the number of women completing four prenatal care visits or of children receiving full immunisation schedules. We also estimate an increase of 0.157 standard deviations (95% CI 0.026-0.289) in prenatal quality as measured by compliance with Rwandan prenatal care clinical practice guidelines. Interpretation The P4P scheme in Rwanda had the greatest effect on those services that had the highest payment rates and needed the least effort from the service provider. P4P financial performance incentives can improve both the use and quality of maternal and child health services, and could be a useful intervention to accelerate progress towards Millennium Development Goals for maternal and child health.	[Gertler, Paul J.] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94705 USA; [Basinga, Paulin] Natl Univ Rwanda, Sch Publ Hlth, Kigali, Rwanda; [Binagwaho, Agnes] Minist Hlth, Kigali, Rwanda; [Soucat, Agnes L. B.; Sturdy, Jennifer; Vermeersch, Christel M. J.] World Bank, Washington, DC 20433 USA	University of California System; University of California Berkeley; University of Rwanda; The World Bank	Gertler, PJ (corresponding author), Univ Calif Berkeley, Haas Sch Business, MC1900, Berkeley, CA 94705 USA.	gertler@haas.berkeley.edu			World Bank's Bank-Netherlands Partnership Program; British Economic and Social Research Council; Government of Rwanda; World Bank's Spanish Impact Evaluation Fund; Global Development Network; MacNamara Foundation; Economic and Social Research Council [ES/E021832/1] Funding Source: researchfish	World Bank's Bank-Netherlands Partnership Program; British Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Government of Rwanda; World Bank's Spanish Impact Evaluation Fund; Global Development Network; MacNamara Foundation; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	We thank the World Bank's Bank-Netherlands Partnership Program, the British Economic and Social Research Council, the Government of Rwanda, and the World Bank's Spanish Impact Evaluation Fund for their financial support; Claude Sekabaraga, Louis Rusa, Rigobert Mpendwanzi, Kathy Kantengwa, Gyuri Fritsche, and Bruno Meesen for useful comments on the study design, discussions on programme design and implementation, and continued support of the study; the Rwandan Ministry of Health, Management Sciences for Health, the Belgian Technical Cooperation, Cordaid, GTZ, Healthnet, USAID, and the World Bank and their staff for their collaboration in the implementation of the P4P rollout plan and supporting the evaluation; Lia Fernald, Anastasia Gage, Paul Hutchinson, Benjamin Loevinsohn, Nancy Mock, and Nancy Padian for valuable comments on early drafts; the National University of Rwanda School of Public Health and CIEDEP for data collection; and Elena Samonte-Hinckley, Rosangela Bando, Rafael Ramirez, and Ricardo Cavazos for research assistance. PB thanks the Global Development Network and the MacNamara Foundation for their financial support.	[Anonymous], 2008, Stud Fam Plann, V39, P147; [Anonymous], 2010, MILL DEV GOALS REP; Barber SL, 2008, TROP MED INT HEALTH, V13, P1405, DOI 10.1111/j.1365-3156.2008.02157.x; BARHAM T, 2005, PROVIDING HLTH START; BASINGA P, 2008, SCALING INNOVATION S, P84; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; EICHLER R, 2007, 121 CTR GLOB DEV; Eldridge C, 2009, HEALTH POLICY PLANN, V24, P160, DOI 10.1093/heapol/czp002; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Fiszbein A, 2009, CONDITIONAL CASH TRA; Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109; *GOV RWAND, 2002 GEN CENS POP HO; Grosh E., 1996, LSM126 WORLD BANK; *HDP, 2008, RAPP ENQ CONTR VER C; Horton R, 2008, LANCET, V371, P1217, DOI 10.1016/S0140-6736(08)60533-4; KOGAN MD, 1994, JAMA-J AM MED ASSOC, V271, P1340, DOI 10.1001/jama.271.17.1340; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Leonard KL, 2005, SOC SCI MED, V61, P1944, DOI 10.1016/j.socscimed.2005.03.043; LEVINE R, 2009, PERFORMANCE INCENTIV; Meessen B, 2007, B WORLD HEALTH ORGAN, V85, P108, DOI 10.2471/BLT.06.032110; Meessen B, 2006, TROP MED INT HEALTH, V11, P1303, DOI 10.1111/j.1365-3156.2006.01680.x; *MIN HLTH REP RWAN, 2003, NORM DISTR SANT RWAN; *MIN HLTH REP RWAN, 2008, REF MOD FAM PLANN TR; *MIN HLTH REP RWAN, 2008, ANN REP 2007 PERF BA; *MIN HLTH REP RWAN, 2008, ANN REP 2007 MIN HLT; *MIN HLTH REP RWAN, 2006, GUID PERF BAS FIN TR; *MIN HLTH REP RWAN, 1993, STAND PREST SERV CTR, V1; *MIN HLTH REP RWAN, 1997, NORM DISTR SAN RWAND; *MIN HLTH REP RWAN, 2009, POL NORM SERV SANT, V1; *MIN HLTH RWAND, 2008, ANN REP 2007 PERF BA; MINALOC (Ministry of Local Government), 2006, MAK DEC SERV DEL WOR; Morris SS, 2004, LANCET, V364, P2030, DOI 10.1016/S0140-6736(04)17515-6; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; Rusa L, 2009, TROP MED INT HEALTH, V14, P830, DOI 10.1111/j.1365-3156.2009.02292.x; Schwartz JB, 2004, B WORLD HEALTH ORGAN, V82, P661; Soeters R, 2006, B WORLD HEALTH ORGAN, V84, P884; VERMEERSCH C, 2010, PERFORMANCE BASED CO; Villar J, 1997, ACTA OBSTET GYN SCAN, V76, P1, DOI 10.3109/00016349709047778; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X	42	327	330	0	76	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 23	2011	377	9775					1421	1428		10.1016/S0140-6736(11)60177-3	http://dx.doi.org/10.1016/S0140-6736(11)60177-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UF	21515164				2022-12-28	WOS:000289963000031
J	Lawn, JE; Blencowe, H; Pattinson, R; Cousens, S; Kumar, R; Ibiebele, I; Gardosi, J; Day, LT; Stanton, C				Lawn, Joy E.; Blencowe, Hannah; Pattinson, Robert; Cousens, Simon; Kumar, Rajesh; Ibiebele, Ibinabo; Gardosi, Jason; Day, Louise T.; Stanton, Cynthia		Lancet's Stillbirths Series Steeri	Stillbirths 2 Stillbirths: Where? When? Why? How to make the data count?	LANCET			English	Article							4-MILLION NEONATAL DEATHS; PERINATAL-MORTALITY; INTRAPARTUM STILLBIRTHS; MATERNAL MORTALITY; PRETERM BIRTH; SURVIVAL 1; HEALTH; CARE; CLASSIFICATION; FETAL	Despite increasing attention and investment for maternal, neonatal, and child health, stillbirths remain invisible not counted in the Millennium Development Goals, nor tracked by the UN, nor in the Global Burden of Disease metrics. At least 2.65 million stillbirths (uncertainty range 2.08 million to 3.79 million) were estimated worldwide in 2008 (>= 1000 g birthweight or >= 28 weeks of gestation). 98% of stillbirths occur in low-income and middle-income countries, and numbers vary from 2.0 per 1000 total births in Finland to more than 40 per 1000 total births in Nigeria and Pakistan. Worldwide, 67% of stillbirths occur in rural families, 55% in rural sub-Saharan Africa and south Asia, where skilled birth attendance and caesarean sections are much lower than that for urban births. In total, an estimated 1.19 million (range 0.82 million to 1.97 million) intrapartum stillbirths occur yearly. Most intrapartum stillbirths are associated with obstetric emergencies, whereas antepartum stillbirths are associated with maternal infections and fetal growth restriction. National estimates of causes of stillbirths are scarce, and multiple (>35) classification systems impede international comparison. Immediate data improvements are feasible through household surveys and facility audit, and improvements in vital registration, including specific perinatal certificates and revised International Classification of Disease codes, are needed. A simple, programme-relevant stillbirth classification that can be used with verbal autopsy would provide a basis for comparable national estimates. A new focus on all deaths around the time of birth is crucial to inform programmatic investment.	[Lawn, Joy E.] Saving Newborn Lives Save Children, Cape Town, South Africa; [Lawn, Joy E.] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Lawn, Joy E.] Inst Child Hlth, London, England; [Blencowe, Hannah; Cousens, Simon] London Sch Hyg & Trop Med, London WC1, England; [Pattinson, Robert] Univ Pretoria, Dept Obstet & Gynaecol, MRC, Maternal & Infant Hlth Care Strategies Res Unit, ZA-0002 Pretoria, South Africa; [Kumar, Rajesh] Postgrad Inst Med Educ & Res, Chandigarh 160012, India; [Ibiebele, Ibinabo] Mater Med Res Inst, Brisbane, Qld, Australia; [Gardosi, Jason] W Midlands Perinatal Inst, Birmingham, W Midlands, England; [Day, Louise T.] LAMB Hosp, Parbatipur, Bangladesh; [Stanton, Cynthia] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Save the Children; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of Pretoria; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Mater Research; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lawn, JE (corresponding author), 11 South Way, ZA-7405 Cape Town, South Africa.	joylawn@yahoo.co.uk	Lawn, Joy/ABE-6382-2020; Flenady, Vicki Jane/O-9609-2014; Gardosi, Jason/GXN-1375-2022; Blencowe, Hannah/K-7415-2012	Lawn, Joy/0000-0002-4573-1443; Flenady, Vicki Jane/0000-0001-8114-7677; Froen Froen, Jahn Frederik/0000-0001-9390-8509; Gardosi, Jason/0000-0002-3230-1292; Blencowe, Hannah/0000-0003-1556-3159; Ibiebele, Ibinabo/0000-0001-6024-2958	Bill & Melinda Gates Foundation; Global Alliance to Prevent Prematurity and Stillbirths	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Global Alliance to Prevent Prematurity and Stillbirths	Some of the technical work for this paper during 2010 was funded through a grant from the Bill & Melinda Gates Foundation to the International Stillbirth Alliance secretariat for this series. JELLS funded by the Bill & Melinda Gates Foundation via Saving Newborn Lives/Save the Children. CS was partly funded by the Global Alliance to Prevent Prematurity and Stillbirths. The views expressed herein are solely those of the authors. We thank the team involved in the stillbirth rate estimates (Doris Chou, Saifuddin Ahmed, Laura Steinhardt, Andreea A Creanga, Ozge Tuncalp, Zohra Patel Balsara, Shivam Gupta, and Lale Say); Vicki Flenady, J Frederik Froen, and their team for the stillbirth cause and condition data from high-income countries; Felicity Mussell as the perinatal audit coordinator at LAMB Hospital, Bangladesh; Mikkel Oestergaard and Florence Rusciano at WHO for assistance with figure 2, the 20 scorers for the GHNRI research priority setting exercise (Romano Byaruhanga, Hannah Blencowe, Simon Cousens, Gary L Darmstadt, Louise T Day, Karen Edmond, Vincent Fauveau, Alfredo Fort, J Frederik Froen, Ron Gray, Rachel Haws, G Justus Hofmeyr, Jane Hirst, Mary Kamb, Anne C C Lee, Elizabeth M McClure, Nafissa Bique Osman, Robert Pattinson, Sonia Lansky, and Dave Woods);	AbouZahr C, 2007, LANCET, V370, P1791, DOI 10.1016/S0140-6736(07)61310-5; ACOLET D, 2008, 7 CONF ENQ MAT CHILD; Aggarwal AK, 2011, B WORLD HEALTH ORGAN, V89, P31, DOI 10.2471/BLT.10.076828; Aisien AO, 2000, INT J GYNECOL OBSTET, V71, P171, DOI 10.1016/S0020-7292(00)00214-9; AKPALA CO, 1993, J ROY SOC HEALTH, V113, P124, DOI 10.1177/146642409311300306; Ananth CV, 2009, INT J EPIDEMIOL, V38, P480, DOI 10.1093/ije/dyn194; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; BARSON AJ, 1984, ARCH DIS CHILD, V59, P199, DOI 10.1136/adc.59.3.199; Bhutta Z, 2004, BRIT MED J, V328, P777, DOI 10.1136/bmj.328.7443.777; BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Campbell Oona, 2004, J Perinatol, V24, P284, DOI 10.1038/sj.jp.7211084; Costeloe K, 2006, BJOG-INT J OBSTET GY, V113, P10, DOI 10.1111/j.1471-0528.2006.01118.x; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; *CTR MAT CHILD ENQ, PER MORT 2008; DAVID RJ, 1983, PEDIATRICS, V71, P531; Doyal L, 2004, B WORLD HEALTH ORGAN, V82, P162; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P417, DOI 10.1111/j.1365-3016.2008.00962.x; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P430, DOI 10.1111/j.1365-3016.2008.00961.x; Edouard L, 1985, World Health Stat Q, V38, P289; Fauveau V, 2007, LANCET, V370, P1310, DOI 10.1016/S0140-6736(07)61571-2; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-58; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; Froen JF, 2001, AM J OBSTET GYNECOL, V184, P694, DOI 10.1067/mob.2001.110697; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gissler M, 2010, INFORM HEALTH SOC CA, V35, P64, DOI 10.3109/17538157.2010.492923; *GLOB ALL PREV PRE, 2010, BMC PREGNANCY CHI S1, V10, pS7; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Goldenberg RL, 2009, INT J GYNECOL OBSTET, V107, pS1, DOI 10.1016/j.ijgo.2009.07.014; Harvey SA, 2004, INT J GYNECOL OBSTET, V87, P203, DOI 10.1016/j.ijgo.2004.06.017; Harvey SA, 2007, B WORLD HEALTH ORGAN, V85, P783, DOI 10.2471/BLT.06.038455; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Huang DY, 2000, OBSTET GYNECOL, V95, P215, DOI 10.1016/S0029-7844(99)00536-0; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; Korteweg FJ, 2006, BJOG-INT J OBSTET GY, V113, P393, DOI 10.1111/j.1471-0528.2006.00881.x; Kramer MS, 2002, AM J EPIDEMIOL, V156, P493, DOI 10.1093/aje/kwf077; LanghoffRoos J, 1996, ACTA OBSTET GYN SCAN, V75, P820, DOI 10.3109/00016349609054710; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn Joy, OPPORTUNITIES AFRICA; Lawn JE, 2008, PAEDIATR PERINAT EP, V22, P410, DOI 10.1111/j.1365-3016.2008.00960.x; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lawn JE, 2010, INT J EPIDEMIOL, V39, P144, DOI 10.1093/ije/dyq031; Lawn JE, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S2; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Li XF, 1996, INT J GYNECOL OBSTET, V54, P1, DOI 10.1016/0020-7292(96)02667-7; Luo ZC, 2006, CAN MED ASSOC J, V174, P1415, DOI 10.1503/cmaj.051096; MacDorman Marian F, 2009, Natl Vital Stat Rep, V57, P1; Macfarlane A, 2003, EUR J OBSTET GYN R B, V111, pS15, DOI 10.1016/j.ejogrb.2003.09.003; *MAT CHILD HLTH RE, 1999, 7 MAT CHILD HLTH RES; *MRC MAT INF HLTH, SAV BAB 200 IN PRESS; Nuffield Council on Bioethics, 2006, CRIT CAR DEC FET NEO; Oyelese KO, 1998, AUST NZ J OBSTET GYN, V38, P391, DOI 10.1111/j.1479-828X.1998.tb03094.x; PARSONS L, 1990, BRIT J OBSTET GYNAEC, V97, P237, DOI 10.1111/j.1471-0528.1990.tb01788.x; PATTINSON RC, 1995, S AFR MED J, V85, P145; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Petersson K, 2002, ACTA OBSTET GYN SCAN, V81, P284; PITT C, 2010, LANCET, V371, P1268; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rani M, 2008, INT J QUAL HEALTH C, V20, P62, DOI 10.1093/intqhc/mzm052; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; ROSENFIELD A, 1985, LANCET, V2, P83; Rudan I, 2007, CROAT MED J, V48, P595; Say Lale, 2006, Reprod Health, V3, P1, DOI 10.1186/1742-4755-3-1; Shankar A, 2008, LANCET, V371, P1223, DOI 10.1016/S0140-6736(08)60536-X; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Shiffman Jeremy, 2004, Afr J Reprod Health, V8, P6, DOI 10.2307/3583389; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Spector JM, 2008, B WORLD HEALTH ORGAN, V86, P315, DOI 10.2471/BLT.07.049924; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; *STILLB RES CONS, 2010, GLOB RES AG RED STIL; Ticconi C, 2003, JAIDS-J ACQ IMM DEF, V34, P289, DOI 10.1097/00126334-200311010-00005; Vergani P, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.098; Wang H, 2001, Zhonghua Yi Xue Za Zhi, V81, P1424; WARD HRG, 1995, S AFR MED J, V85, P147; WHO, 2006, PER NEON MORT YEAR 2 PER NEON MORT YEAR 2; WHO, 1993, INT STAT CLASS DIS R, V2; WHO UNICEF, 2010, COUNTD 2015 DEC REP; Winbo IGB, 1998, INT J EPIDEMIOL, V27, P499, DOI 10.1093/ije/27.3.499; Winbo IGB, 1997, INT J EPIDEMIOL, V26, P1298, DOI 10.1093/ije/26.6.1298; Wood NS, 2003, ARCH DIS CHILD-FETAL, V88, pF492, DOI 10.1136/fn.88.6.F492; WOODS R, 2009, DEATH BIRTH 2009, P294; Woods R, 2008, B WORLD HEALTH ORGAN, V86, P460, DOI 10.2471/BLT.07.043471; World Health Organization, TRENDS MAT MORT 1990; World Health Organization, 1996, WHOFRHMSM967; Wu ZC, 2003, BRIT MED J, V327, P1319, DOI 10.1136/bmj.327.7427.1319; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608	101	489	505	1	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2011	377	9775					1448	1463		10.1016/S0140-6736(10)62187-3	http://dx.doi.org/10.1016/S0140-6736(10)62187-3			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UF	21496911	Green Accepted, Green Submitted			2022-12-28	WOS:000289963000034
J	Lowden, MR; Flibotte, S; Moerman, DG; Ahmed, S				Lowden, Mia Rochelle; Flibotte, Stephane; Moerman, Donald G.; Ahmed, Shawn			DNA Synthesis Generates Terminal Duplications That Seal End-to-End Chromosome Fusions	SCIENCE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; GENE AMPLIFICATION; CANCER GENOMES; COPY-NUMBER; HUMAN-CELLS; TELOMERES; REARRANGEMENTS; REPLICATION; DELETION	End-to-end chromosome fusions that occur in the context of telomerase deficiency can trigger genomic duplications. For more than 70 years, these duplications have been attributed solely to breakage-fusion-bridge cycles. To test this hypothesis, we examined end-to-end fusions isolated from Caenorhabditis elegans telomere replication mutants. Genome-level rearrangements revealed fused chromosome ends having interrupted terminal duplications accompanied by template-switching events. These features are very similar to disease-associated duplications of interstitial segments of the human genome. A model termed Fork Stalling and Template Switching has been proposed previously to explain such duplications, where promiscuous replication of large, noncontiguous segments of the genome occurs. Thus, a DNA synthesis-based process may create duplications that seal end-to-end fusions, in the absence of breakage-fusion-bridge cycles.	[Lowden, Mia Rochelle; Ahmed, Shawn] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Lowden, Mia Rochelle; Ahmed, Shawn] Univ N Carolina, Dept Biol, Chapel Hill, NC 27514 USA; [Flibotte, Stephane; Moerman, Donald G.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of British Columbia	Ahmed, S (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	shawn@med.unc.edu		Flibotte, Stephane/0000-0001-9613-7666	NIH [GM066228, GM072150]; Genome Canada; Genome British Columbia; Michael Smith Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066228, R01GM066228, F31GM072150] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Canada(Genome Canada); Genome British Columbia; Michael Smith Research Foundation(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Maydan for technical assistance; D. Reiner, J. Sekelsky, L. Shtessel, D. Shippen, and T. Petes for comments on the manuscript; and D. Ramsden for discussion. S. A. and M. L. were supported by NIH grants GM066228 and GM072150. D. G. M. was supported by funds from Genome Canada and Genome British Columbia and the Michael Smith Research Foundation. D. G. M. is a fellow of the Canadian Institute for Advanced Research.	Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Bailey SM, 2006, NUCLEIC ACIDS RES, V34, P2408, DOI 10.1093/nar/gkl303; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Bosco G, 1998, GENETICS, V150, P1037; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Cheung I, 2006, NUCLEIC ACIDS RES, V34, P96, DOI 10.1093/nar/gkj417; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Letsolo BT, 2010, NUCLEIC ACIDS RES, V38, P1841, DOI 10.1093/nar/gkp1183; Lowden MR, 2008, GENETICS, V180, P741, DOI 10.1534/genetics.108.089920; Mantripragada KK, 2004, INT J MOL MED, V13, P273; McClintock B, 1941, GENETICS, V26, P234; McVey M, 2004, GENETICS, V168, P2067, DOI 10.1534/genetics.104.033902; Meier B, 2006, PLOS GENET, V2, P187, DOI 10.1371/journal.pgen.0020018; MOERMAN DG, 1991, NUCLEIC ACIDS RES, V19, P5669, DOI 10.1093/nar/19.20.5669; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Raices M, 2008, CELL, V132, P745, DOI 10.1016/j.cell.2007.12.039; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stansel RM, 2001, EMBO J, V20, P5532; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645	26	39	39	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					468	471		10.1126/science.1199022	http://dx.doi.org/10.1126/science.1199022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512032	Green Accepted, Green Submitted			2022-12-28	WOS:000289784900044
J	Quagliarello, V				Quagliarello, Vincent			Dissemination of Neisseria meningitidis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA	Yale University	Quagliarello, V (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.							Butler D, 2010, NATURE, V468, P143, DOI 10.1038/468143a; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Murray CJL, 2001, GLOBAL BURDEN DIS 20; Sutherland TC, 2010, INFECT IMMUN, V78, P3832, DOI 10.1128/IAI.01377-09; Tan LKK, 2010, NEW ENGL J MED, V362, P1511, DOI 10.1056/NEJMra0906357	5	9	9	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1573	1575		10.1056/NEJMcibr1101564	http://dx.doi.org/10.1056/NEJMcibr1101564			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21506747				2022-12-28	WOS:000289722700019
J	Hargrove, LJ; Simon, AM; Lipschutz, RD; Finucane, SB; Kuiken, TA				Hargrove, Levi J.; Simon, Ann M.; Lipschutz, Robert D.; Finucane, Suzanne B.; Kuiken, Todd A.			Real-Time Myoelectric Control of Knee and Ankle Motions for Transfemoral Amputees	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Hargrove, Levi J.; Simon, Ann M.; Lipschutz, Robert D.; Finucane, Suzanne B.; Kuiken, Todd A.] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA	Shirley Ryan AbilityLab	Hargrove, LJ (corresponding author), Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA.	l-hargrove@northwestern.edu		Simon, Ann/0000-0002-6431-0329				Au S, 2008, NEURAL NETWORKS, V21, P654, DOI 10.1016/j.neunet.2008.03.006; Ha KH, 2011, IEEE T BIO-MED ENG, V58, P144, DOI 10.1109/TBME.2010.2070840; Hitt JK, 2010, J MED DEVICES, V4, DOI 10.1115/1.4001139; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Netter FH, 2010, ATLAS HUMAN ANATOMY, P511; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	6	47	57	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1542	1544		10.1001/jama.2011.465	http://dx.doi.org/10.1001/jama.2011.465			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21505133				2022-12-28	WOS:000289683000021
J	Williamson, OD				Williamson, Owen D.			Review: Ultrasonography is accurate for diagnosing rotator cuff tears in adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Monash Univ, Melbourne, Vic 3004, Australia	Monash University	Williamson, OD (corresponding author), Monash Univ, Melbourne, Vic 3004, Australia.								0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8							JC4-11	10.7326/0003-4819-154-8-201104190-02011	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502637				2022-12-28	WOS:000289622000010
J	Surjit, M; Ganti, KP; Mukherji, A; Ye, T; Hua, G; Metzger, D; Li, M; Chambon, P				Surjit, Milan; Ganti, Krishna Priya; Mukherji, Atish; Ye, Tao; Hua, Guoqiang; Metzger, Daniel; Li, Mei; Chambon, Pierre			Widespread Negative Response Elements Mediate Direct Repression by Agonist-Liganded Glucocorticoid Receptor	CELL			English	Article							REV-ERB-ALPHA; MOUSE KERATINOCYTES; GENE PROMOTER; BINDING; MICE; MECHANISMS; GROWTH; TRANSACTIVATION; TRANSREPRESSION; TRANSCRIPTION	The glucocorticoid (GC) receptor (GR), when liganded to GC, activates transcription through direct binding to simple (+)GRE DNA binding sequences (DBS). GC-induced direct repression via GR binding to complex "negative" GREs (nGREs) has been reported. However, GR-mediated transrepression was generally ascribed to indirect "tethered" interaction with other DNA-bound factors. We report that GC-induces direct transrepression via the binding of GR to simple DBS (IR nGREs) unrelated to (+) GRE. These DBS act on agonist-liganded GR, promoting the assembly of cis-acting GR-SMRT/NCoR repressing complexes. IR nGREs are present in over 1000 mouse/human ortho-log genes, which are repressed by GC in vivo. Thus variations in the levels of a single ligand can coordinately turn genes on or off depending in their response element DBS, allowing an additional level of regulation in GR signaling. This mechanism suits GR signaling remarkably well, given that adrenal secretion of GC fluctuates in a circadian and stress-related fashion.	[Surjit, Milan; Ganti, Krishna Priya; Mukherji, Atish; Ye, Tao; Hua, Guoqiang; Metzger, Daniel; Li, Mei; Chambon, Pierre] Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire, Coll France,Inserm U964,UMR7104, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chambon, P (corresponding author), Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire, Coll France,Inserm U964,UMR7104, F-67404 Illkirch Graffenstaden, France.	chambon@igbmc.fr	Ganti, Krishna Priya/AAV-2106-2021; Ye, Tao/D-8026-2011	Metzger, Daniel/0000-0002-5555-046X; Li, Mei/0000-0003-4225-6699	CNRS; INSERM; ANR [ANR 07-Physio 002-01]; Association pour la Recherche a l'IGBMC (ARI)	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); Association pour la Recherche a l'IGBMC (ARI)	This study is dedicated to the memory of Dr. Regine Losson, who died last year. She was a wonderful colleague and an outstanding scientist. We thank the staff of the animal and cell culture facilities of the IGBMC/ICS; Dr. H. Gronemeyer and Leo Pharmaceutical for kind gifts of RU24858 and MC903, respectively; Dr. S. Kato for floxed VDR mice; Dr. G. Richards for a critical reading of the manuscript; and Estelle Meyer for secretarial help. This work was supported by the CNRS, the INSERM, the ANR (No. ANR 07-Physio 002-01), and the Association pour la Recherche a l'IGBMC (ARI). M.S., A.M., G.H., and K.G. were supported by ARI fellowships.	Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Belvisi MG, 2001, J IMMUNOL, V166, P1975, DOI 10.4049/jimmunol.166.3.1975; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; BOAM DSW, 1990, J BIOL CHEM, V265, P8285; Carey M, 2001, TRANSCRIPTIONAL REGU, DOI Cold Spring Harbor Laboratory Pr; CARO JF, 1982, J CLIN INVEST, V69, P866, DOI 10.1172/JCI110526; Chen A, 2004, ENDOCRINOLOGY, V145, P2445, DOI 10.1210/en.2003-1570; Chen A, 2006, J NEUROSCI, V26, P5500, DOI 10.1523/JNEUROSCI.3955-05.2006; Chen SJ, 2000, J CELL PHYSIOL, V183, P381, DOI 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O; Cheng XP, 2010, CELL, V141, P331, DOI 10.1016/j.cell.2010.03.013; Chida D, 2007, P NATL ACAD SCI USA, V104, P18205, DOI 10.1073/pnas.0706953104; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743; Dostert A, 2004, CURR PHARM DESIGN, V10, P2807; Duez H, 2008, FEBS LETT, V582, P19, DOI 10.1016/j.febslet.2007.08.032; Fassler R, 1996, EXP CELL RES, V222, P111, DOI 10.1006/excr.1996.0014; Frank S, 1996, J BIOL CHEM, V271, P10188, DOI 10.1074/jbc.271.17.10188; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Goodman PA, 1996, MOL CELL ENDOCRINOL, V120, P139, DOI 10.1016/0303-7207(96)03830-0; Gross KL, 2008, TRENDS ENDOCRIN MET, V19, P331, DOI 10.1016/j.tem.2008.07.009; Karin M, 1998, CELL, V93, P487, DOI 10.1016/S0092-8674(00)81177-0; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Li SW, 2001, DEV DYNAM, V222, P141, DOI 10.1002/dvdy.1178; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Mocetti P, 2001, TISSUE CELL, V33, P1, DOI 10.1054/tice.2000.0144; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Neufeld-Cohen A, 2010, P NATL ACAD SCI USA, V107, P19020, DOI 10.1073/pnas.1013761107; Ochala J, 2007, J PHYSIOL-LONDON, V581, P1283, DOI 10.1113/jphysiol.2007.129759; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramot Y, 2009, BIOESSAYS, V31, P389, DOI 10.1002/bies.200800121; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ricketson D, 2007, J MOL BIOL, V368, P729, DOI 10.1016/j.jmb.2007.02.057; Rogatsky I, 1999, MOL CELL BIOL, V19, P5036; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sasaki N, 2001, NEPHROL DIAL TRANSPL, V16, P479, DOI 10.1093/ndt/16.3.479; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schakman O, 2008, ENDOCRINOLOGY, V149, P3900, DOI 10.1210/en.2008-0439; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Stewart PM, 1996, LANCET, V347, P88, DOI 10.1016/S0140-6736(96)90211-1; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; Torra IP, 2000, ENDOCRINOLOGY, V141, P3799, DOI 10.1210/en.141.10.3799; Tuckermann JP, 1999, J CELL BIOL, V147, P1365, DOI 10.1083/jcb.147.7.1365; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; Vayssiere BM, 1997, MOL ENDOCRINOL, V11, P1245, DOI 10.1210/me.11.9.1245; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; WRANGE O, 1989, J BIOL CHEM, V264, P5253; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324	60	370	376	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					224	241		10.1016/j.cell.2011.03.027	http://dx.doi.org/10.1016/j.cell.2011.03.027			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496643	Bronze			2022-12-28	WOS:000289549900012
J	Launay, O; van der Vliet, D; Rosenberg, AR; Michel, ML; Piroth, L; Rey, D; de Verdiere, NC; Slama, L; Martin, K; Lortholary, O; Carrat, F				Launay, Odile; van der Vliet, Diane; Rosenberg, Arielle R.; Michel, Marie-Louise; Piroth, Lionel; Rey, David; de Verdiere, Nathalie Colin; Slama, Laurence; Martin, Karine; Lortholary, Olivier; Carrat, Fabrice		ANRS HB03 VIHVAC-B Trial	Safety and Immunogenicity of 4 Intramuscular Double Doses and 4 Intradermal Low Doses vs Standard Hepatitis B Vaccine Regimen in Adults With HIV-1 A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTI-HBS; VIRUS; INFECTION; PREVALENCE; INJECTIONS; MORTALITY; SCHEDULE; EFFICACY; THERAPY; NUMBER	Context Alternative schedules more immunogenic than the standard hepatitis B vaccine regimen are needed in patients with human immunodeficiency virus 1 (HIV-1) infection. Objective To compare the safety and immunogenicity of 4 intramuscular double-dose and 4 intradermal low-dose regimens vs the standard hepatitis B vaccine regimen. Design, Setting, and Participants An open-label, multicenter, 1:1:1 parallel-group, randomized trial conducted between June 28, 2007, and October 23, 2008 (date of last patient visit, July 3, 2009) at 33 centers in France with patients enrolled in French National Agency for Research on AIDS and Viral Hepatitis trials in adults with HIV-1 infection who were hepatitis B virus (HBV) seronegative and having CD4 cell counts of more than 200 cells/mu L. Intervention Patients were randomly assigned to receive 3 intramuscular injections of the standard dose (20 mu g) of recombinant HBV vaccine at weeks 0, 4, and 24 (IM20 x 3 group, n=145); 4 intramuscular double doses (40 mu g [2 injections of 20 mu g]) of recombinant HBV vaccine at weeks 0, 4, 8, and 24 (IM40 x 4 group, n=148); or 4 intradermal injections of low doses (4 mu g [1/5 of 20 mu g]) of recombinant HBV vaccine at weeks 0, 4, 8, and 24 (ID4 x 4 group, n=144). Main Outcome Measures Percentage of responders at week 28, defined as patients with hepatitis B surface antibody (anti-HBs) of at least 10 mIU/mL in patients who received at least 1 dose of vaccine. Patients with missing anti-HBs titer measurement at the final follow-up visit at week 28 were considered as nonresponders in the primary (efficacy) analysis. Results A total of 437 patients were randomized to the 3 study groups, of whom 11 did not receive any vaccine. Of these, 396 had available anti-HBs titers at week 28. The percentage of responders at week 28 was 65% (95% confidence interval [CI], 56%-72%) in the IM20 x 3 group (n=91), 82% (95% CI, 77%-88%) in the IM40 x 4 group (n=119) (P < .001 vs IM20 x 3 group), and 77% (95% CI, 69%-84%) in the ID4 x 4 group (n=108) (P=.02 vs IM20 x 3 group). No safety signal and no effect on CD4 cell count or viral load were observed. Conclusion In adults with HIV-1, both the 4 intramuscular double-dose regimen and the 4 intradermal low-dose regimen improved serological response compared with the standard HBV vaccine regimen.	[Launay, Odile] Cochin Hosp, AP HP, CIC Vaccinol Cochin Pasteur, F-75679 Paris 14, France; [Launay, Odile; Rosenberg, Arielle R.; Lortholary, Olivier] Paris Descartes Univ, Paris, France; [Launay, Odile; van der Vliet, Diane] INSERM, CICBT505, Paris, France; [Michel, Marie-Louise] Inst Pasteur, Paris, France; [Michel, Marie-Louise] INSERM, U845, Paris, France; [Piroth, Lionel] Univ Hosp, Dijon, France; [Piroth, Lionel] Univ Bourgogne, Dijon, France; [Rey, David] Univ Hosp, Strasbourg, France; [de Verdiere, Nathalie Colin] St Louis Hosp, AP HP, Paris, France; [Slama, Laurence] Tenon Hosp, AP HP, Paris, France; [Martin, Karine; Carrat, Fabrice] INSERM, U707, Paris, France; [Lortholary, Olivier] Necker Enfants Malad Hosp, AP HP, Paris, France; [Carrat, Fabrice] Univ Paris 06, UMR S 707, Paris, France; [Carrat, Fabrice] St Antoine Hosp, AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Dijon Bourgogne; Universite de Bourgogne; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Launay, O (corresponding author), Cochin Hosp, AP HP, CIC Vaccinol Cochin Pasteur, Batiment Lavoisier,27 Rue Faubourg St Jacques, F-75679 Paris 14, France.	odile.launay@cch.aphp.fr	Carrat, Fabrice/AAU-8480-2020; Slama, Laurence/GYJ-7508-2022; Michel, Marie-Louise/N-4384-2017; Matheron, Sophie/D-7420-2017	Carrat, Fabrice/0000-0002-8672-7918; Matheron, Sophie/0000-0001-7879-6553; Rosenberg, Arielle/0000-0003-2085-8146; Touze, Emmanuel/0000-0002-7254-2162	Sanofi Pasteur-MSD; Pfizer; Astellas; Gilead Sciences; Schering Plough; Merck Sharp Dohme; French National Agency for Research on AIDS and Viral Hepatitis, Paris, France	Sanofi Pasteur-MSD; Pfizer(Pfizer); Astellas(Astellas Pharmaceuticals); Gilead Sciences(Gilead Sciences); Schering Plough(Merck & CompanySchering Plough Corporation); Merck Sharp Dohme(Merck & Company); French National Agency for Research on AIDS and Viral Hepatitis, Paris, France(ANRS)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Launay reported not having shares or paid employment with pharmaceutical companies, but reported being an investigator on vaccine studies sponsored by Sanofi Pasteur-MSD and other companies, and receiving travel support to attend scientific meetings from Sanofi Pasteur-MSD and other companies. Dr van der Vliet reported not having shares or paid employment with pharmaceutical companies during the conduct of the trial; however, is currently employed by Sanofi Pasteur. Dr Piroth reported not having shares or paid employment with pharmaceutical companies, but reported receiving honoraria from GlaxoSmithKline, Gilead, and Bristol-Myers Squibb. Dr Rey reported not having shares or paid employment with pharmaceutical companies, but reported receiving honoraria from Gilead Sciences and Bristol-Myers Squibb. Dr Colin de Verdiere reported not having shares or paid employment with pharmaceutical companies, but reported previously receiving honoraria for lectures from Wyeth. Dr Slama reported not having shares or paid employment with pharmaceutical companies, but reported receiving honoraria from Bristol-Myers Squibb and Merck Sharp & Dohme, and receiving travel support to attend scientific meetings from Bristol-Myers Squibb and GlaxoSmithKline. Dr Lortholary reported not having shares or paid employment with pharmaceutical companies, but reported receiving honoraria and research grants from Pfizer, Astellas, Gilead Sciences, Schering Plough, and Merck Sharp & Dohme. Dr Carrat reported not having shares or paid employment with pharmaceutical companies, but reported receiving honoraria from Novartis and GlaxoSmithKline, and receiving travel support to attend scientific meetings from Novartis. Drs Rosenberg, Michel, and Martin reported not having shares or paid employment with pharmaceutical companies.; This study was sponsored and funded by the French National Agency for Research on AIDS and Viral Hepatitis, Paris, France. Sanofi Pasteur-MSD provided the vaccines used in the study.	Alberti A, 2005, J HEPATOL, V42, P615, DOI 10.1016/j.jhep.2005.03.003; Cooper CL, 2008, CLIN INFECT DIS, V46, P1310, DOI 10.1086/533467; Cornejo-Juarez Patricia, 2006, AIDS Res Ther, V3, P9, DOI 10.1186/1742-6405-3-9; Cruciani M, 2009, VACCINE, V27, P17, DOI 10.1016/j.vaccine.2008.10.040; de Vries-Sluijs TEMS, 2008, J INFECT DIS, V197, P292, DOI 10.1086/524690; Fabrizi F, 2006, ALIMENT PHARM THER, V24, P497, DOI 10.1111/j.1365-2036.2006.03002.x; Fernandes SJ, 2008, VACCINE, V26, P1032, DOI 10.1016/j.vaccine.2007.12.020; Fischer Marc, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fonseca MO, 2005, VACCINE, V23, P2902, DOI 10.1016/j.vaccine.2004.11.057; GESEMANN M, 1995, VACCINE, V13, P443, DOI 10.1016/0264-410X(94)00010-K; HADLER SC, 1986, NEW ENGL J MED, V315, P209, DOI 10.1056/NEJM198607243150401; Kellerman SE, 2003, J INFECT DIS, V188, P571, DOI 10.1086/377135; Kim HN, 2008, INT J STD AIDS, V19, P600, DOI 10.1258/ijsa.2007.007197; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Lambert PH, 2008, VACCINE, V26, P3197, DOI 10.1016/j.vaccine.2008.03.095; Lemon SM, 1997, NEW ENGL J MED, V336, P196, DOI 10.1056/NEJM199701163360307; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Overton ET, 2005, CLIN INFECT DIS, V41, P1045, DOI 10.1086/433180; Pasricha N, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-65; Potsch DV, 2010, VACCINE, V28, P1447, DOI 10.1016/j.vaccine.2009.11.066; Rey D, 2000, VACCINE, V18, P1161, DOI 10.1016/S0264-410X(99)00389-8; Tedaldi EM, 2004, CLIN INFECT DIS, V38, P1483; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Veiga APR, 2006, VACCINE, V24, P7124, DOI 10.1016/j.vaccine.2006.06.079; Wiedmann M, 2000, HEPATOLOGY, V31, P230, DOI 10.1002/hep.510310134; Yeni P, FRENCH HIV GUIDELINE; Yu Andy S, 2004, Clin Liver Dis, V8, P283, DOI 10.1016/j.cld.2004.02.010	27	126	134	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1432	1440		10.1001/jama.2011.351	http://dx.doi.org/10.1001/jama.2011.351			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486976				2022-12-28	WOS:000289424100020
J	Mason, RJ				Mason, Rodney J.			Appendicitis: is surgery the best option?	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; APPENDECTOMY; MANAGEMENT		Univ So Calif, Keck Sch Med, Div Gen & Laparoscop Surg, Los Angeles, CA 90033 USA	University of Southern California	Mason, RJ (corresponding author), Univ So Calif, Keck Sch Med, Div Gen & Laparoscop Surg, Los Angeles, CA 90033 USA.	rjmason@med.usc.edu						Andersen BR, 2005, COCHRANE DB SYST REV, V3; Chautems RC, 2002, DIS COLON RECTUM, V45, P962, DOI 10.1007/s10350-004-6336-4; ERIKSSON S, 1995, BRIT J SURG, V82, P166, DOI 10.1002/bjs.1800820207; Hansson J, 2009, BRIT J SURG, V96, P473, DOI 10.1002/bjs.6482; Malik AA, 2009, J GASTROINTEST SURG, V13, P966, DOI 10.1007/s11605-009-0835-5; Oteo J, 2008, EMERG INFECT DIS, V14, P1259, DOI 10.3201/eid1408.071059; Powers JH, 2002, CLIN INFECT DIS, V34, P879, DOI 10.1086/339072; Solomkin JS, 2010, SURG INFECT, V11, P79, DOI 10.1089/sur.2009.9930; Styrud J, 2006, WORLD J SURG, V30, P1033, DOI 10.1007/s00268-005-0304-6; Vons C, 2011, LANCET, V377, P1573, DOI 10.1016/S0140-6736(11)60410-8	10	12	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1545	1546		10.1016/S0140-6736(11)60623-5	http://dx.doi.org/10.1016/S0140-6736(11)60623-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763IJ	21550468				2022-12-28	WOS:000290549700004
J	Goldberg, NH; Schneeweiss, S; Kowal, MK; Gagne, JJ				Goldberg, Nikolas H.; Schneeweiss, Sebastian; Kowal, Mary K.; Gagne, Joshua J.			Availability of Comparative Efficacy Data at the Time of Drug Approval in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRIALS	Context Comparative effectiveness is taking on an increasingly important role in US health care, yet little is known about the availability of comparative efficacy data for drugs at the time of their approval in the United States. Objective To quantify the availability of comparative efficacy data for new molecular entities (NMEs) approved in the United States. Data Sources Approval packages publicly available through the online database of drug products approved by the US Food and Drug Administration (FDA). Study Selection Identification of efficacy studies that supported approval of each NME approved by FDA between 2000 and 2010. Data Extraction We determined whether eligible studies were head-to-head active controlled trials and whether the results of such studies were available in the approval packages. We recorded the approved indication, whether the NME was an orphan product, whether the NME had undergone priority review, and whether the control group was a specific active comparator or standard care. Results Of 197 NMEs identified that met eligibility criteria, 100 (51% [95% confidence interval {CI}, 44%-58%]) met criteria for having comparative efficacy data available at the time of market authorization. After excluding NMEs designated as orphan products (n=37) and those approved for indications for which no alternative treatments existed (n=17), this proportion increased to 70% (95% CI, 62%-77%). The proportions of NMEs with available comparative efficacy data varied widely by therapeutic area, from 33% (95% CI, 9%-67%) for hormones and contraceptives to 89% (95% CI, 56%-99%) for diabetes medications. Conclusion Publicly available FDA approval packages contain comparative efficacy data for about half of NMEs recently approved in the United States and for more than two-thirds of NMEs for which alternative treatment options exist. We did not investigate the extent to which available comparative efficacy information is useful for clinical guidance. JAMA. 2011;305(17):1786-1789 www.jama.com	[Goldberg, Nikolas H.; Schneeweiss, Sebastian; Kowal, Mary K.; Gagne, Joshua J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gagne, JJ (corresponding author), Harvard Univ, Sch Med, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	jgagne1@partners.org	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X	Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham; Women's Hospital	Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham; Women's Hospital	This study was funded by internal resources of the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital.	Dreyer NA, 2010, HEALTH AFFAIR, V29, P1818, DOI 10.1377/hlthaff.2010.0666; Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211; European Medicines Agency, EU STAND MED PROD RE; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gagne JJ, 2011, JAMA-J AM MED ASSOC, V305, P711, DOI 10.1001/jama.2011.152; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; O'Connor AB, 2010, JAMA-J AM MED ASSOC, V303, P979, DOI 10.1001/jama.2010.257; Sox HC, 2010, ANN INTERN MED, V153, P469, DOI 10.7326/0003-4819-153-7-201010050-00269; Turner JA, 2010, MED CARE, V48, pS129, DOI 10.1097/MLR.0b013e3181d9e622; *US FDA, 225100010 MOU US FOO; US Food and Drug Administration, DRUGS FDA; van Luijn JCF, 2007, BRIT J CLIN PHARMACO, V63, P159, DOI 10.1111/j.1365-2125.2006.02812.x	12	50	51	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1786	1789		10.1001/jama.2011.539	http://dx.doi.org/10.1001/jama.2011.539			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758HZ	21540422	Bronze			2022-12-28	WOS:000290156200019
J	Rex, DK				Rex, Douglas K.			Effect of the Centers for Medicare & Medicaid Services Policy About Deep Sedation on Use of Propofol	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OUTPATIENT COLONOSCOPY; ENDOSCOPY; NURSES; GASTROENTEROLOGY	On 11 December 2009, the Centers for Medicare & Medicaid Services issued a policy stating that deep sedation can only be administered by an anesthesiologist, a certified registered nurse anesthetist, or a trained medical doctor or a doctor of osteopathy not involved in the performance of a medical procedure. Propofol is a popular sedation agent that is usually administered by anesthesia specialists in a service termed monitored anesthesia care (MAC). Monitored anesthesia care adds substantial new fees to procedural sedation. However, available evidence shows that propofol can be used safely by nonanesthesiologists for procedural sedation. The American Society of Anesthesiologists considers that propofol implies deep sedation and should only be administered by anesthesia specialists. The Centers for Medicare & Medicaid Services policy on deep sedation can be viewed as supporting an ongoing conversion to MAC to deliver propofol for procedural sedation. However, the absence of an evidence base supporting a need for MAC to deliver propofol, combined with its high cost, suggests that alternatives to MAC to deliver propofol deserve fair and balanced evaluation.	[Rex, Douglas K.] Indiana Univ Hosp, Indianapolis, IN 46202 USA	Indiana University System	Rex, DK (corresponding author), Indiana Univ Hosp, 4100,550 N Univ Blvd, Indianapolis, IN 46202 USA.	drex@iupui.edu						*AM ASS NURS AN FE, 2009, CMS REPL AN INT GUID; *AM MED ASS, 2010, CPT STAND ED 2010, P416; *AM SOC AN, STAT GRANT PRIV NON; *AM SOC AN, POL PROC GOV AN PRIV; American Society of Anesthesiologists, STAT SAF US PROP; Bhananker SM, 2006, ANESTHESIOLOGY, V104, P228, DOI 10.1097/00000542-200602000-00005; Brill Joel V, 2008, Gastrointest Endosc Clin N Am, V18, P665, DOI 10.1016/j.giec.2008.06.012; Byrne MF, 2008, CAN J GASTROENTEROL, V22, P457, DOI 10.1155/2008/268320; Chutkan R, 2004, GASTROINTEST ENDOSC, V60, P167, DOI 10.1016/S0016-5107(04)01699-2; *CMS, CMS PUBL; Cohen LB, 2006, AM J GASTROENTEROL, V101, P967, DOI 10.1111/j.1572-0241.2006.00500.x; Cohen LB, 2004, GASTROINTEST ENDOSC, V59, P795, DOI 10.1016/S0016-5107(04)00349-9; Cote GA, 2010, CLIN GASTROENTEROL H, V8, P137, DOI 10.1016/j.cgh.2009.07.008; Dumonceau JM, 2010, ENDOSCOPY, V42, P960, DOI 10.1055/s-0030-1255728; Gross JB, 2002, ANESTHESIOLOGY, V96, P1004; Inadomi JM, 2010, GASTROINTEST ENDOSC, V72, P580, DOI 10.1016/j.gie.2010.04.040; Jain R, 2010, GASTROINTEST ENDOSC, V72, P469, DOI 10.1016/j.gie.2010.02.017; KAYE JM, 2005, SURGISTRATEGIES; Knape JTA, 2007, EUR J ANAESTH, V24, P563, DOI 10.1017/S0265021506002092; Pambianco DJ, 2011, GASTROINTEST ENDOSC, V73, P765, DOI 10.1016/j.gie.2010.10.031; Patel S, 2005, AM J GASTROENTEROL, V100, P2689, DOI 10.1111/j.1572-0241.2005.00320.x; Rex DK, 2009, GASTROENTEROLOGY, V137, P1229, DOI 10.1053/j.gastro.2009.06.042; Riphaus A, 2009, ENDOSCOPY, V41, P787, DOI 10.1055/s-0029-1215035; Sharma VK, 2007, GASTROINTEST ENDOSC, V66, P27, DOI 10.1016/j.gie.2006.12.040; Sipe BW, 2002, GASTROINTEST ENDOSC, V55, P815, DOI 10.1067/mge.2002.124636; Symington L, 2006, EMERG MED J, V23, P89, DOI 10.1136/emj.2005.023713; Ulmer BJ, 2003, CLIN GASTROENTEROL H, V1, P425, DOI 10.1016/S1542-3565(03)00226-X; VanNatta ME, 2006, AM J GASTROENTEROL, V101, P2209, DOI 10.1111/j.1572-0241.2006.00760.x; Vargo JJ, 2009, GASTROENTEROLOGY, V137, P2161, DOI 10.1053/j.gastro.2009.09.050	29	36	36	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					622	626		10.7326/0003-4819-154-9-201105030-00007	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21536938				2022-12-28	WOS:000290112300005
J	Brook, RH				Brook, Robert H.			Health Services Research and Clinical Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RELIABILITY; JUDGMENTS		RAND Corp, Santa Monica, CA 90401 USA	RAND Corporation	Brook, RH (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	brook@rand.org						Al-Khatib SM, 2011, JAMA-J AM MED ASSOC, V305, P43, DOI 10.1001/jama.2010.1915; Brook R H, 1986, Int J Technol Assess Health Care, V2, P53; CHASSIN MR, 1987, JAMA-J AM MED ASSOC, V258, P2533, DOI 10.1001/jama.258.18.2533; Keehan S, 2008, HEALTH AFFAIR, V27, pW145, DOI 10.1377/hlthaff.27.2.w145; KORAN LM, 1975, NEW ENGL J MED, V293, P695, DOI 10.1056/NEJM197510022931405; KORAN LM, 1975, NEW ENGL J MED, V293, P642, DOI 10.1056/NEJM197509252931307; Leape LL, 2000, AM HEART J, V139, P106, DOI 10.1016/S0002-8703(00)90316-8; Lohr KN, 2002, HEALTH SERV RES, V37, P7	8	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1589	1590		10.1001/jama.2011.489	http://dx.doi.org/10.1001/jama.2011.489			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752HU	21505138				2022-12-28	WOS:000289683000030
J	Link, DC; Schuettpelz, LG; Shen, D; Wang, JL; Walter, MJ; Kulkarni, S; Payton, JE; Ivanovich, J; Goodfellow, PJ; Le Beau, M; Koboldt, DC; Dooling, DJ; Fulton, RS; Bender, RHF; Fulton, LL; Delehaunty, KD; Fronick, CC; Appelbaum, EL; Schmidt, H; Abbott, R; O'Laughlin, M; Chen, K; McLellan, MD; Varghese, N; Nagarajan, R; Heath, S; Graubert, TA; Ding, L; Ley, TJ; Zambetti, GP; Wilson, RK; Mardis, ER				Link, Daniel C.; Schuettpelz, Laura G.; Shen, Dong; Wang, Jinling; Walter, Matthew J.; Kulkarni, Shashikant; Payton, Jacqueline E.; Ivanovich, Jennifer; Goodfellow, Paul J.; Le Beau, Michelle; Koboldt, Daniel C.; Dooling, David J.; Fulton, Robert S.; Bender, R. Hugh F.; Fulton, Lucinda L.; Delehaunty, Kimberly D.; Fronick, Catrina C.; Appelbaum, Elizabeth L.; Schmidt, Heather; Abbott, Rachel; O'Laughlin, Michelle; Chen, Ken; McLellan, Michael D.; Varghese, Nobish; Nagarajan, Rakesh; Heath, Sharon; Graubert, Timothy A.; Ding, Li; Ley, Timothy J.; Zambetti, Gerard P.; Wilson, Richard K.; Mardis, Elaine R.			Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AML	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LI-FRAUMENI-SYNDROME; MYELOID-LEUKEMIA GENOME; BREAST-CANCER; FAMILIAL SYNDROME; P53 MUTATIONS; NEOPLASMS; SARCOMAS; RISK; GENE	Context The identification of patients with inherited cancer susceptibility syndromes facilitates early diagnosis, prevention, and treatment. However, in many cases of suspected cancer susceptibility, the family history is unclear and genetic testing of common cancer susceptibility genes is unrevealing. Objective To apply whole-genome sequencing to a patient without any significant family history of cancer but with suspected increased cancer susceptibility because of multiple primary tumors to identify rare or novel germline variants in cancer susceptibility genes. Design, Setting, and Participant Skin (normal) and bone marrow (leukemia) DNA were obtained from a patient with early-onset breast and ovarian cancer (negative for BRCA1 and BRCA2 mutations) and therapy-related acute myeloid leukemia (t-AML) and analyzed with the following: whole-genome sequencing using paired-end reads, single-nucleotide polymorphism (SNP) genotyping, RNA expression profiling, and spectral karyotyping. Main Outcome Measures Structural variants, copy number alterations, single-nucleotide variants, and small insertions and deletions (indels) were detected and validated using the described platforms. Results Whole-genome sequencing revealed a novel, heterozygous 3-kilobase deletion removing exons 7-9 of TP53 in the patient's normal skin DNA, which was homozygous in the leukemia DNA as a result of uniparental disomy. In addition, a total of 28 validated somatic single-nucleotide variations or indels in coding genes, 8 somatic structural variants, and 12 somatic copy number alterations were detected in the patient's leukemia genome. Conclusion Whole-genome sequencing can identify novel, cryptic variants in cancer susceptibility genes in addition to providing unbiased information on the spectrum of mutations in a cancer genome. JAMA. 2011; 305(15): 1568-1576	[Wilson, Richard K.] Washington Univ, Sch Med, Genome Ctr, Dept Genet, St Louis, MO 63108 USA; [Link, Daniel C.; Walter, Matthew J.; Bender, R. Hugh F.; Heath, Sharon; Graubert, Timothy A.; Ley, Timothy J.] Washington Univ, Dept Med, St Louis, MO 63108 USA; [Kulkarni, Shashikant; Payton, Jacqueline E.; Varghese, Nobish; Nagarajan, Rakesh] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Schuettpelz, Laura G.; Kulkarni, Shashikant] Washington Univ, Siteman Canc Ctr, Dept Pediat, St Louis, MO 63108 USA; [Ivanovich, Jennifer; Goodfellow, Paul J.] Washington Univ, Dept Surg, St Louis, MO 63108 USA; [Wang, Jinling; Zambetti, Gerard P.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Le Beau, Michelle] Univ Chicago, Comprehens Canc Ctr, Chicago, IL 60637 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital; Robert H. Lurie Comprehensive Cancer Center; University of Chicago	Wilson, RK (corresponding author), Washington Univ, Sch Med, Genome Ctr, Dept Genet, 4444 Forest Pk Blvd,Box 8501, St Louis, MO 63108 USA.	rwilson@wustl.edu	Zambetti, Gerard/N-8093-2018; Chen, Ken/AAU-1432-2021; Walter, Matthew J/S-7758-2018; Mardis, Elaine/W-2202-2019; Wilson, Richard K./AAF-4139-2019	Zambetti, Gerard/0000-0002-0929-5007; Chen, Ken/0000-0003-4013-5279; Wilson, Richard K./0000-0002-1992-1358; MCLELLAN, MICHAEL/0000-0002-2703-8784; Graubert, Timothy/0000-0002-7710-1171	National Human Genome Research Institute [U54 HG003079]; National Institutes of Health (NIH) [PO1 CA101937]; Barnes-Jewish Hospital Foundation [00335-0505-02]; NIH [GM083159, CA21765]; Pediatric Scientist Development Program; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K12-HD000850]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA101937, P30CA021765] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083159, T32GM007067] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Hospital Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Scientist Development Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Washington University Cancer Genome Initiative, U54 HG003079 from the National Human Genome Research Institute (R. K. W.), PO1 CA101937 from the National Institutes of Health (NIH) (T.J.L.), the Barnes-Jewish Hospital Foundation (00335-0505-02) (T.J.L.), GM083159 and CA21765 from the NIH (G.P.Z.), the Pediatric Scientist Development Program (L. G. S.), and award K12-HD000850 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (L.G.S.).	Anensen NA, 2006, LEUKEMIA, V20, P734, DOI 10.1038/sj.leu.2404117; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Felix CA, 1996, BLOOD, V87, P4376, DOI 10.1182/blood.V87.10.4376.bloodjournal87104376; Garber JE, 2005, J CLIN ONCOL, V23, P276, DOI 10.1200/JCO.2005.10.042; Godley LA, 2008, SEMIN ONCOL, V35, P418, DOI 10.1053/j.seminoncol.2008.04.012; Gonzalez KD, 2009, J MED GENET, V46, P689, DOI 10.1136/jmg.2008.058958; Gonzalez KD, 2009, J CLIN ONCOL, V27, P1250, DOI 10.1200/JCO.2008.16.6959; Hwang SJ, 2003, AM J HUM GENET, V72, P975, DOI 10.1086/374567; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kuribayashi K, 2005, INTERNAL MED, V44, P490, DOI 10.2169/internalmedicine.44.490; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Masciari S, 2008, JAMA-J AM MED ASSOC, V299, P1315, DOI 10.1001/jama.299.11.1315; Mouchawar J, 2010, CANCER RES, V70, P4795, DOI 10.1158/0008-5472.CAN-09-0851; Panizo C, 1998, MED PEDIATR ONCOL, V30, P165, DOI 10.1002/(SICI)1096-911X(199803)30:3<165::AID-MPO7>3.0.CO;2-F; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Talwalkar SS, 2010, ARCH PATHOL LAB MED, V134, P1010, DOI 10.1043/2009-0015-OA.1; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; West AN, 2006, CANCER RES, V66, P5056, DOI 10.1158/0008-5472.CAN-05-4580; ZAMBETTI GP, 1992, GENE DEV, V6, P1143, DOI 10.1101/gad.6.7.1143	23	114	126	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1568	1576		10.1001/jama.2011.473	http://dx.doi.org/10.1001/jama.2011.473			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21505135	Bronze, Green Accepted			2022-12-28	WOS:000289683000026
J	Peralta, CA; Shlipak, MG; Judd, S; Cushman, M; McClellan, W; Zakai, NA; Safford, MM; Zhang, XA; Muntner, P; Warnock, D				Peralta, Carmen A.; Shlipak, Michael G.; Judd, Suzanne; Cushman, Mary; McClellan, William; Zakai, Neil A.; Safford, Monika M.; Zhang, Xiao; Muntner, Paul; Warnock, David			Detection of Chronic Kidney Disease With Creatinine, Cystatin C, and Urine Albumin-to-Creatinine Ratio and Association With Progression to End-Stage Renal Disease and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; RACIAL-DIFFERENCES; CARDIOVASCULAR EVENTS; US ADULTS; ALL-CAUSE; REASONS; STROKE; RISK; GFR; POPULATION	Context A triple-marker approach for chronic kidney disease (CKD) evaluation has not been well studied. Objective To evaluate whether combining creatinine, cystatin C, and urine albumin-to-creatinine ratio (ACR) would improve identification of risks associated with CKD compared with creatinine alone. Design, Setting, and Participants Prospective cohort study involving 26 643 US adults enrolled in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study from January 2003 to June 2010. Participants were categorized into 8 groups defined by estimated glomerular filtration rate (GFR) determined by creatinine and by cystatin C of either <60 or >= 60 mL/min/1.73 m(2) and ACR of either <30 or >= 30 mg/g. Main Outcome Measures All-cause mortality and incident end-stage renal disease with median follow-up of 4.6 years. Results Participants had a mean age of 65 years, 40% were black, and 54% were women. Of 26 643 participants, 1940 died and 177 developed end-stage renal disease. Among participants without CKD defined by creatinine, 24% did not have CKD by either ACR or cystatin C. Compared with those with CKD defined by creatinine alone, the hazard ratio for death in multivariable-adjusted models was 3.3 (95% confidence interval [CI], 2.0-5.6) for participants with CKD defined by creatinine and ACR; 3.2 (95% CI, 2.2-4.7) for those with CKD defined by creatinine and cystatin C, and 5.6 (95% CI, 3.9-8.2) for those with CKD defined by all biomarkers. Among participants without CKD defined by creatinine, 3863 (16%) had CKD detected by ACR or cystatin C. Compared with participants who did not have CKD by any measure, the HRs for mortality were 1.7 (95% CI, 1.4-1.9) for participants with CKD defined by ACR alone, 2.2 (95% CI, 1.9-2.7) for participants with CKD defined by cystatin C alone, and 3.0 (95% CI, 2.4-3.7) for participants with CKD defined by both measures. Risk of incident end-stage renal disease was higher among those with CKD defined by all markers (34.1 per 1000 person-years; 95% CI, 28.7-40.5 vs 0.33 per 1000 person-years; 95% CI, 0.05-2.3) for those with CKD defined by creatinine alone. The second highest end-stage renal disease rate was among persons missed by the creatinine measure but detected by both ACR and cystatin C (rate per 1000 person-years, 6.4; 95% CI, 3.6-11.3). Net reclassification improvement for death was 13.3% (P<.001) and for end-stage renal disease was 6.4% (P<.001) after adding estimated GFR cystatin C in fully adjusted models with estimated GFR creatinine and ACR. Conclusion Adding cystatin C to the combination of creatinine and ACR measures improved the predictive accuracy for all-cause mortality and end-stage renal disease.	[Peralta, Carmen A.; Shlipak, Michael G.] San Francisco VA Med Ctr, Dept Med, San Francisco, CA USA; [Peralta, Carmen A.; Shlipak, Michael G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Judd, Suzanne; Zhang, Xiao] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL USA; [Muntner, Paul] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL USA; [Safford, Monika M.; Warnock, David] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA; [Cushman, Mary; Zakai, Neil A.] Univ Vermont, Dept Med, Burlington, VT 05405 USA; [Cushman, Mary; Zakai, Neil A.] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [McClellan, William] Emory Univ, Dept Med, Atlanta, GA 30322 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Vermont; University of Vermont; Emory University	Peralta, CA (corresponding author), 4150 Clement St,111A1, San Francisco, CA 94121 USA.	carmenalicia.peralta@ucsf.edu		Cushman, Mary/0000-0002-7871-6143	Amgen; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services [U01 NS041588]; Amgen Corp.; National Institutes of Diabetes and Digestive and Kidney Diseases [1K23SK082793-01]; Robert Wood Johnson Harold Amos award; American Heart Association [0640012N];  [R01AG034853];  [R01DK066488];  [R01HL085757];  [R01DK078124];  [R21HL091217]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091217, R01HL085757, R01HL080477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK095877, R01DK078124, R01DK066488, K23DK082793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034853] Funding Source: NIH RePORTER	Amgen(Amgen); National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Amgen Corp.; National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Robert Wood Johnson Harold Amos award; American Heart Association(American Heart Association); ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Warnock reported that he is a consultant for Amgen Corp and has received research support from Amgen. Dr Cushman reported receiving research support from Amgen. Dr McClellen reported receiving research support from Amgen. Otherwise, no other conflicts of interest were reported.; This research project is supported by cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services. Additional funding was provided by an investigator-initiated grant-in-aid from Amgen Corp. Dr Peralta is funded by the National Institutes of Diabetes and Digestive and Kidney Diseases grant 1K23SK082793-01 and a Robert Wood Johnson Harold Amos award. Dr Shlipak is funded by grants R01AG034853 (PI), R01DK066488 (PI), R01HL085757 (Co-Investigator), R01DK078124 (Co-Investigator), and R21HL091217 (Co-Investigator) and by an American Heart Association Established Investigator Award (0640012N; PI)	Bakris GL, 2010, LANCET, V375, P1173, DOI 10.1016/S0140-6736(09)62100-0; Bauer C, 2008, J AM SOC NEPHROL, V19, P844, DOI 10.1681/ASN.2008010110; Couser WG, 2007, J AM SOC NEPHROL, V18, P2803, DOI 10.1681/ASN.2007080964; de Jong PE, 2008, NEPHROL DIAL TRANSPL, V23, P1092, DOI 10.1093/ndt/gfn028; den Hartog JR, 2009, CLIN J AM SOC NEPHRO, V4, P419, DOI 10.2215/CJN.04080808; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foley RN, 2009, CLIN J AM SOC NEPHRO, V4, P965, DOI 10.2215/CJN.05281008; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Jaar BG, 2008, CLIN J AM SOC NEPHRO, V3, P601, DOI 10.2215/CJN.02540607; Kwong YT, 2010, AM J KIDNEY DIS, V56, P39, DOI 10.1053/j.ajkd.2010.02.347; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, AM J KIDNEY DIS, V53, pS4, DOI 10.1053/j.ajkd.2008.07.048; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McClellan W, 2007, J AM SOC NEPHROL, V18, P1344, DOI 10.1681/ASN.2006090952; Menon V, 2008, KIDNEY INT, V73, P1310, DOI 10.1038/ki.2008.67; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Peralta CA, 2011, J AM SOC NEPHROL, V22, P147, DOI 10.1681/ASN.2010050483; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Shlipak MG, 2006, ANN INTERN MED, V145, P237, DOI 10.7326/0003-4819-145-4-200608150-00003; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Tamura MK, 2008, AM J KIDNEY DIS, V52, P227, DOI 10.1053/j.ajkd.2008.05.004; Tonelli M, 2011, ANN INTERN MED, V154, P12, DOI 10.7326/0003-4819-154-1-201101040-00003; Warnock DG, 2010, AM J KIDNEY DIS, V56, P861, DOI 10.1053/j.ajkd.2010.05.017; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421	32	320	330	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1545	1552		10.1001/jama.2011.468	http://dx.doi.org/10.1001/jama.2011.468			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21482744	Green Accepted, Bronze			2022-12-28	WOS:000289683000023
J	Mitchell, R; Conley, JM; Davis, AM; Cadigan, RJ; Dobson, AW; Gladden, RQ				Mitchell, Robert; Conley, John M.; Davis, Arlene M.; Cadigan, R. Jean; Dobson, Allison W.; Gladden, Ryan Q.			Genomics, Biobanks, and the Trade-Secret Model	SCIENCE			English	Editorial Material									[Mitchell, Robert] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Mitchell, Robert] Duke Univ, Dept English, Durham, NC 27708 USA; [Conley, John M.; Davis, Arlene M.; Cadigan, R. Jean; Dobson, Allison W.; Gladden, Ryan Q.] Univ N Carolina, Sch Law, Dept Social Med, Chapel Hill, NC 27599 USA; [Conley, John M.; Davis, Arlene M.; Cadigan, R. Jean; Dobson, Allison W.; Gladden, Ryan Q.] Univ N Carolina, Ctr Genom & Soc, Chapel Hill, NC 27599 USA	Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Mitchell, R (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	rmitch@duke.edu			NHGRI NIH HHS [P50HG004488] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004488] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Cadigan R. J., 2009, GOVERNING BIOBANKS, P117; Caulfield T, 2008, PLOS BIOL, V6, P430, DOI 10.1371/journal.pbio.0060073; Caulfield Timothy, 2003, BMC Med Ethics, V4, pE1; Fullerton SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000361; Greely H T, 1999, Wake Forest Law Rev, V34, P737; Greely HT, 2007, ANNU REV GENOM HUM G, V8, P343, DOI 10.1146/annurev.genom.7.080505.115721; Jacobs KB, 2009, NAT GENET, V41, P1253, DOI 10.1038/ng.455; Longstaff H, 2010, PUBLIC UNDERST SCI, V19, P212, DOI 10.1177/0963662508097626; Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360; Minkler M., 2003, COMMUNITY BASED PART; Terry SF, 2007, NAT REV GENET, V8, P157, DOI 10.1038/nrg1991; U.S. Food and Drug Administration, PAYM RES SUBJ INF SH; U.S. Office for Human Research Protections (OHRP), 2008, GUID RES INV COD PRI; VANGELDEREN CEM, 1993, EUR J CLIN PHARMACOL, V45, P15, DOI 10.1007/BF00315344; Waldby Catherine, 2006, TISSUE EC; Winickoff DE, 2003, NEW ENGL J MED, V349, P1180, DOI 10.1056/NEJMsb030036	16	14	14	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					309	310		10.1126/science.1199554	http://dx.doi.org/10.1126/science.1199554			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	750AT	21493846				2022-12-28	WOS:000289516600029
J	Staton, TL; Lazarevic, V; Jones, DC; Lanser, AJ; Takagi, T; Ishii, S; Glimcher, LH				Staton, Tracy L.; Lazarevic, Vanja; Jones, Dallas C.; Lanser, Amanda J.; Takagi, Tsuyoshi; Ishii, Shunsuke; Glimcher, Laurie H.			Dampening of death pathways by schnurri-2 is essential for T-cell development	NATURE			English	Article							NEGATIVE SELECTION; POSITIVE SELECTION; THYMOCYTE DEVELOPMENT; BH3-ONLY PROTEINS; MURINE SCHNURRI-2; TRANSGENIC MICE; BCL-2 FAMILY; APOPTOSIS; ANTIGEN; BIM	Generation of a diverse and self-tolerant T-cell repertoire requires appropriate interpretation of T-cell antigen receptor (TCR) signals by CD4(+)CD8(+) double-positive thymocytes. Thymocyte cell fate is dictated by the nature of TCR-major-histocompatibility-complex (MHC)-peptide interactions, with signals of higher strength leading to death (negative selection) and signals of intermediate strength leading to differentiation (positive selection)(1). Molecules that regulate T-cell development by modulating TCR signal strength have been described but components that specifically define the boundaries between positive and negative selection remain unknown. Here we show in mice that repression of TCR-induced death pathways is critical for proper interpretation of positive selecting signals in vivo, and identify schnurri-2 (Shn2; also known as Hivep2) as a crucial death dampener. Our results indicate that Shn2(-/-) double-positive thymocytes inappropriately undergo negative selection in response to positive selecting signals, thus leading to disrupted T-cell development. Shn2(-/-) double-positive thymocytes are more sensitive to TCR-induced death in vitro and die in response to positive selection interactions in vivo. However, Shn2-deficient thymocytes can be positively selected when TCR-induced death is genetically ablated. Shn2 levels increase after TCR stimulation, indicating that integration of multiple TCR-MHC-peptide interactions may fine-tune the death threshold. Mechanistically, Shn2 functions downstream of TCR proximal signalling compenents to dampen Bax activation and the mitochondrial death pathway. Our findings uncover a critical regulator of T-cell development that controls the balance between death and differentiation.	[Staton, Tracy L.; Lazarevic, Vanja; Jones, Dallas C.; Lanser, Amanda J.; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Takagi, Tsuyoshi; Ishii, Shunsuke] RIKEN Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki 3050074, Japan; [Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Glimcher, Laurie H.] Ragon Inst MGH MIT & Harvard, Charlestown, MA 02129 USA	Harvard University; Harvard T.H. Chan School of Public Health; RIKEN; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu	Ishii, Shunsuke/A-5271-2016; Lazarevic, Vanja/B-1160-2009	Ishii, Shunsuke/0000-0002-6530-2478; Lazarevic, Vanja/0000-0002-5783-7130	National Institutes of Health [AI29673, K99AR055668]; NATIONAL CANCER INSTITUTE [ZIABC011431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, R01AI029673, P30AI060354, R37AI029673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR055668] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23370079, 23659244] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank R. Davis for providing Bim phospho-Thr-112 specific antibody; R. Germain for providing DAP3 and P139 cell lines; M. Winslow and E. Gallo for critical reading of the manuscript and valuable comments. T.L.S. is a Fellow of the Leukemia and Lymphoma Society and V.L. was a Fellow of the Irvington Institute. Supported by the National Institutes of Health grant AI29673 (L.H.G.) and K99AR055668 (D.C.J.).	ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Cainan B. J., 1995, IMMUNITY, V3, P273, DOI DOI 10.1016/1074-7613(95)90113-2; Cante-Barrett K, 2006, J IMMUNOL, V176, P2299, DOI 10.4049/jimmunol.176.4.2299; Ebert PJR, 2008, IMMUNITY, V29, P734, DOI 10.1016/j.immuni.2008.09.014; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; GLIMCHER LH, 1982, NATURE, V298, P283, DOI 10.1038/298283a0; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Jones DC, 2010, P NATL ACAD SCI USA, V107, P8254, DOI 10.1073/pnas.1003727107; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kimura MY, 2007, J IMMUNOL, V178, P4926, DOI 10.4049/jimmunol.178.8.4926; Kimura MY, 2005, J EXP MED, V201, P397, DOI 10.1084/jem.20040733; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Liang J, 2003, DEVELOPMENT, V130, P6453, DOI 10.1242/dev.00863; Lucas B, 2000, J IMMUNOL, V165, P1889, DOI 10.4049/jimmunol.165.4.1889; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Naeher D, 2007, J EXP MED, V204, P2553, DOI 10.1084/jem.20070254; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Takagi T, 2001, NAT IMMUNOL, V2, P1048, DOI 10.1038/ni728; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001	30	31	31	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					105	U138		10.1038/nature09848	http://dx.doi.org/10.1038/nature09848			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475200	Green Accepted			2022-12-28	WOS:000289199400046
J	Kranzer, K				Kranzer, Katharina			Improving tuberculosis diagnostics and treatment	LANCET			English	Editorial Material							CHLAMYDIA-TRACHOMATIS		Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Kranzer, K (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, Keppel St, London WC1E 7HT, England.	katharina.kranzer@lshtm.ac.uk	Kranzer, Katharina/O-8845-2014	Kranzer, Katharina/0000-0001-5691-7270				[Anonymous], 2010, MULTIDRUG EXTENSIVEL; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; BOEHME CC, 2011, LANCET, DOI DOI 10.1016/50140-6736(11)60438-8; Gift TL, 1999, SEX TRANSM DIS, V26, P232, DOI 10.1097/00007435-199904000-00010; Global Laboratory Initiative, 2010, ROADM ENS QUAL TUB D; Keshavjee S, 2010, NEW ENGL J MED, V363, P1781, DOI 10.1056/NEJMp1010023; Vickerman P, 2003, SEX TRANSM INFECT, V79, P363, DOI 10.1136/sti.79.5.363; WHO, 2010, GLOB TUB CONTR 2010; World Health Organization, 2009, GLOB TUB CONTR EP ST	9	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2011	377	9776					1467	1468		10.1016/S0140-6736(11)60513-8	http://dx.doi.org/10.1016/S0140-6736(11)60513-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761RX	21507476				2022-12-28	WOS:000290419400004
J	Lobell, DB; Schlenker, W; Costa-Roberts, J				Lobell, David B.; Schlenker, Wolfram; Costa-Roberts, Justin			Climate Trends and Global Crop Production Since 1980	SCIENCE			English	Article							YIELD; TEMPERATURE; FOOD	Efforts to anticipate how climate change will affect future food availability can benefit from understanding the impacts of changes to date. We found that in the cropping regions and growing seasons of most countries, with the important exception of the United States, temperature trends from 1980 to 2008 exceeded one standard deviation of historic year-to-year variability. Models that link yields of the four largest commodity crops to weather indicate that global maize and wheat production declined by 3.8 and 5.5%, respectively, relative to a counterfactual without climate trends. For soybeans and rice, winners and losers largely balanced out. Climate trends were large enough in some countries to offset a significant portion of the increases in average yields that arose from technology, carbon dioxide fertilization, and other factors.	[Lobell, David B.; Costa-Roberts, Justin] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Lobell, David B.; Costa-Roberts, Justin] Stanford Univ, Program Food Secur & Environm, Stanford, CA 94305 USA; [Schlenker, Wolfram] Columbia Univ, Dept Econ, New York, NY 10027 USA; [Schlenker, Wolfram] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA; [Schlenker, Wolfram] Natl Bur Econ Res, New York, NY 10016 USA	Stanford University; Stanford University; Columbia University; Columbia University; National Bureau of Economic Research	Lobell, DB (corresponding author), Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA.	dlobell@stanford.edu		Lobell, David/0000-0002-5969-3476	Rockefeller Foundation; NASA [NNX08AV25G]; NSF [SES-0962625]	Rockefeller Foundation; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We thank five anonymous reviewers for helpful comments. Supported by a grant from the Rockefeller Foundation, NASA new investigator grant NNX08AV25G (D.B.L.), and NSF grant SES-0962625.	Ainsworth EA, 2008, NEW PHYTOL, V179, P5, DOI 10.1111/j.1469-8137.2008.02500.x; Brisson N, 2010, FIELD CROP RES, V119, P201, DOI 10.1016/j.fcr.2010.07.012; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; Estrella N, 2007, GLOBAL CHANGE BIOL, V13, P1737, DOI 10.1111/j.1365-2486.2007.01374.x; Goswami BN, 2006, SCIENCE, V314, P1442, DOI 10.1126/science.1132027; Hertel TW, 2010, GLOBAL ENVIRON CHANG, V20, P577, DOI 10.1016/j.gloenvcha.2010.07.001; Kalra N, 2008, CURR SCI INDIA, V94, P82; Ladha JK, 2003, FIELD CROP RES, V81, P159, DOI 10.1016/S0378-4290(02)00219-8; Leakey ADB, 2009, P ROY SOC B-BIOL SCI, V276, P2333, DOI 10.1098/rspb.2008.1517; Liu YA, 2010, GLOBAL CHANGE BIOL, V16, P2287, DOI 10.1111/j.1365-2486.2009.02077.x; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034007; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Reilly J, 2000, CLIMATIC CHANGE, V45, P253, DOI 10.1023/A:1005669807945; Reilly J, 1996, CLIMATE CHANGE 1995, P429; Roberts M J, 2010, 15921 NBER; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Solomon S., 2007, PHYS SCI BASIS WORKI; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107	22	2205	2364	82	1412	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					616	620		10.1126/science.1204531	http://dx.doi.org/10.1126/science.1204531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21551030				2022-12-28	WOS:000293222400058
J	Vigny, C; Socquet, A; Peyrat, S; Ruegg, JC; Metois, M; Madariaga, R; Morvan, S; Lancieri, M; Lacassin, R; Campos, J; Carrizo, D; Bejar-Pizarro, M; Barrientos, S; Armijo, R; Aranda, C; Valderas-Bermejo, MC; Ortega, I; Bondoux, F; Baize, S; Lyon-Caen, H; Pavez, A; Vilotte, JP; Bevis, M; Brooks, B; Smalley, R; Parra, H; Baez, JC; Blanco, M; Cimbaro, S; Kendrick, E				Vigny, C.; Socquet, A.; Peyrat, S.; Ruegg, J-C; Metois, M.; Madariaga, R.; Morvan, S.; Lancieri, M.; Lacassin, R.; Campos, J.; Carrizo, D.; Bejar-Pizarro, M.; Barrientos, S.; Armijo, R.; Aranda, C.; Valderas-Bermejo, M-C; Ortega, I.; Bondoux, F.; Baize, S.; Lyon-Caen, H.; Pavez, A.; Vilotte, J. P.; Bevis, M.; Brooks, B.; Smalley, R.; Parra, H.; Baez, J-C; Blanco, M.; Cimbaro, S.; Kendrick, E.			The 2010 M-w 8.8 Maule Megathrust Earthquake of Central Chile, Monitored by GPS	SCIENCE			English	Article							INTERSEISMIC STRAIN ACCUMULATION; SOUTH-CENTRAL CHILE; SEISMIC GAP; SUBDUCTION ZONE; SLIP	Large earthquakes produce crustal deformation that can be quantified by geodetic measurements, allowing for the determination of the slip distribution on the fault. We used data from Global Positioning System (GPS) networks in Central Chile to infer the static deformation and the kinematics of the 2010 moment magnitude (M-w) 8.8 Maule megathrust earthquake. From elastic modeling, we found a total rupture length of similar to 500 kilometers where slip (up to 15 meters) concentrated on two main asperities situated on both sides of the epicenter. We found that rupture reached shallow depths, probably extending up to the trench. Resolvable afterslip occurred in regions of low coseismic slip. The low-frequency hypocenter is relocated 40 kilometers southwest of initial estimates. Rupture propagated bilaterally at about 3.1 kilometers per second, with possible but not fully resolved velocity variations.	[Vigny, C.; Metois, M.; Madariaga, R.; Morvan, S.; Lancieri, M.; Lyon-Caen, H.] Ecole Normale Super, CNRS, UMR 8538, Geol Lab, Paris, France; [Socquet, A.; Ruegg, J-C; Metois, M.; Lacassin, R.; Bejar-Pizarro, M.; Armijo, R.; Vilotte, J. P.] Inst Phys Globe, Paris, France; [Socquet, A.; Ruegg, J-C; Metois, M.; Lacassin, R.; Bejar-Pizarro, M.; Armijo, R.; Vilotte, J. P.] Univ Paris Diderot Sorbonne Paris Cite, CNRS, UMR 7154, Paris, France; [Peyrat, S.; Campos, J.; Barrientos, S.] Univ Chile, Dept Geofis, Santiago, Chile; [Carrizo, D.] Univ Chile, Adv Min Technol Ctr, Santiago, Chile; [Barrientos, S.; Aranda, C.; Valderas-Bermejo, M-C; Ortega, I.] Univ Chile, Serv Sismol Nacl, Santiago, Chile; [Bondoux, F.] Inst Rech & Dev, Lima, Peru; [Baize, S.] Inst Radioprotect & Surete Nucl, Fontenay Aux Roses, France; [Bevis, M.; Kendrick, E.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Brooks, B.] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Smalley, R.] Univ Memphis, Ctr Earthquake Res & Informat, Memphis, TN 38152 USA; [Parra, H.] Inst Geog Mil, Santiago, Chile; [Baez, J-C] Univ Concepcion, Los Angeles, Chile; [Blanco, M.] Univ Nacl Cuyo, RA-5500 Mendoza, Argentina	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universidad de Chile; Universidad de Chile; Universidad de Chile; Institut de Recherche pour le Developpement (IRD); University System of Ohio; Ohio State University; University of Hawaii System; University of Memphis; Universidad de Concepcion; University Nacional Cuyo Mendoza	Vigny, C (corresponding author), Ecole Normale Super, CNRS, UMR 8538, Geol Lab, Paris, France.	vigny@biotite.ens.fr	Pizarro, Marta Béjar/I-9372-2014; Armijo, Rolando/A-5715-2011; Vilotte, Jean-Pierre/H-1552-2017; Peyrat, Sophie/Y-5196-2018; Lancieri, Maria/E-5942-2010; Lacassin, Robin/A-6781-2011; Socquet, Anne/A-5698-2011; Madariaga, Raul/D-5304-2011; CAMPOS, Jaime/K-7358-2014; Carrizo, Daniel/M-9322-2019; Armijo, Rolando/P-5123-2019; Métois, Marianne/D-7019-2017; Lyon-Caen, Hélène/B-1825-2008; BAIZE, Stephane/H-7489-2015	Pizarro, Marta Béjar/0000-0001-7449-4048; Vilotte, Jean-Pierre/0000-0002-6085-6498; Lancieri, Maria/0000-0003-3992-5644; Lacassin, Robin/0000-0003-1424-325X; Socquet, Anne/0000-0002-9208-7136; CAMPOS, Jaime/0000-0002-5924-9009; Carrizo, Daniel/0000-0002-7205-7693; Métois, Marianne/0000-0002-1489-0513; Lyon-Caen, Hélène/0000-0002-6331-0108; Baez, Juan Carlos/0000-0002-7265-7402; BAIZE, Stephane/0000-0002-7656-1790; Armijo, Rolando/0000-0002-8258-2862	French Institut National des Sciences de l'Univers; Institut pour la Recherche et le Developpment; Agence Nationale pour la Recherche; Ministere des Affaires Etrangeres; Directorate For Geosciences [1118514, 1036252] Funding Source: National Science Foundation	French Institut National des Sciences de l'Univers; Institut pour la Recherche et le Developpment; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ministere des Affaires Etrangeres; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the International GNSS Service; Instituto Geografico Nacional, Argentina; Instituto Brasileiro de Geografia e Estatistica, Brasil; and Transportable Integrated Geodetic Observatory/Bundesamt fur Kartographie und Geodasie Frankfurt/Universidad de Concepcion for access to their cGPS data in South America. We are also thankful to the French Institut National des Sciences de l'Univers, the Institut pour la Recherche et le Developpment, the Agence Nationale pour la Recherche, and the Ministere des Affaires Etrangeres for providing financial support. We also thank members of the Laboratoire International Associe Montessus de Ballore and the many individuals who participated in field campaigns and network maintenance over the years. This is IPGP contribution #3161.	Altamimi Z, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB004949; Beck S, 1998, J S AM EARTH SCI, V11, P115, DOI 10.1016/S0895-9811(98)00005-4; BEJARPIZARRO M, 2010, GEOPHYS J INT; Bilham R, 2005, SCIENCE, V308, P1126, DOI 10.1126/science.1113363; Campos J, 2002, PHYS EARTH PLANET IN, V132, P177, DOI 10.1016/S0031-9201(02)00051-1; Darwin Charles, 1876, J RES NATURAL HIST G; de Ballore F. Montessus, 1916, HIST SISMICA ANDES M; Delouis B, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043899; Fitz-Roy Robert, 1839, NARRATIVE SURVEYING; Hyndman RD, 1997, ISL ARC, V6, P244, DOI 10.1111/j.1440-1738.1997.tb00175.x; Lay T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043379; Lomnitz C, 1971, GEOFIS PANAMERICANA, V1, P151; Lorito S, 2011, NAT GEOSCI, V4, P173, DOI [10.1038/ngeo1073, 10.1038/NGEO1073]; Madariaga R, 2010, SCIENCE, V328, P181, DOI 10.1126/science.1189197; Moreno M, 2010, NATURE, V467, P198, DOI 10.1038/nature09349; NISHENKO SP, 1985, J GEOPHYS RES-SOLID, V90, P3589, DOI 10.1029/JB090iB05p03589; Ruegg JC, 2009, PHYS EARTH PLANET IN, V175, P78, DOI 10.1016/j.pepi.2008.02.015; Ruegg JC, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013438; Tanimoto T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045244; Tong XP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045805; Vigny C, 2005, NATURE, V436, P201, DOI 10.1038/nature03937	21	305	313	0	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1417	1421		10.1126/science.1204132	http://dx.doi.org/10.1126/science.1204132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21527673				2022-12-28	WOS:000291689000038
J	Lord, C; Bhandari, D; Menon, S; Ghassemian, M; Nycz, D; Hay, J; Ghosh, P; Ferro-Novick, S				Lord, Christopher; Bhandari, Deepali; Menon, Shekar; Ghassemian, Majid; Nycz, Deborah; Hay, Jesse; Ghosh, Pradipta; Ferro-Novick, Susan			Sequential interactions with Sec23 control the direction of vesicle traffic	NATURE			English	Article							CASEIN KINASE-I; ENDOPLASMIC-RETICULUM; COPII VESICLE; INTERMEDIATE COMPARTMENT; NEGATIVE REGULATION; PROTEIN-TRANSPORT; GOLGI TRANSPORT; COAT; COMPLEX; BINDING	How the directionality of vesicle traffic is achieved remains an important unanswered question in cell biology. The Sec23p/Sec24p coat complex sorts the fusion machinery (SNAREs) into vesicles as they bud from the endoplasmic reticulum (ER). Vesicle tethering to the Golgi begins when the tethering factor TRAPPI binds to Sec23p. Where the coat is released and how this event relates to membrane fusion is unknown. Here we use a yeast transport assay to demonstrate that an ER-derived vesicle retains its coat until it reaches the Golgi. A Golgi-associated kinase, Hrr25p (CK1 delta orthologue), then phosphorylates the Sec23p/Sec24p complex. Coat phosphorylation and dephosphorylation are needed for vesicle fusion and budding, respectively. Additionally, we show that Sec23p interacts in a sequential manner with different binding partners, including TRAPPI and Hrr25p, to ensure the directionality of ER-Golgi traffic and prevent the back-fusion of a COPII vesicle with the ER. These events are conserved in mammalian cells.	[Lord, Christopher; Bhandari, Deepali; Menon, Shekar; Ferro-Novick, Susan] Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ghassemian, Majid] Univ Calif San Diego, Dept Chem & Biochem, Biomol & Prote Mass Spectrometry Facil, La Jolla, CA 92093 USA; [Nycz, Deborah; Hay, Jesse] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Ghosh, Pradipta] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Montana System; University of Montana; University of California System; University of California San Diego	Ferro-Novick, S (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	sfnovick@ucsd.edu	Lord, Christopher/AAX-7130-2021; Lord, Christopher/B-3295-2012	Lord, Christopher/0000-0003-0820-8298; Lord, Christopher/0000-0002-3226-0515	Howard Hughes Medical Institute; Burroughs Wellcome Fund; SRP Super Fund Research Program; National Institutes of Health [GM-059378, RR-015583]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059378] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); SRP Super Fund Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Schekman, M. Cyert, L. Miller, B. Glick, M. Lowe and E. Mizuno-Yamasaki for strains, constructs, purified protein and antibody; K. Reinisch for discussions; S. Chen, H. Cai and M. Garcia-Marcos for advice; W. Zhou and A. Lougheed for technical assistance. This work was supported by the Howard Hughes Medical Institute. Salary support for S.F.-N., D.B. and S.M. was provided by the Howard Hughes Medical Institute, P.G. was funded by the Burroughs Wellcome Fund and M.G. by the SRP Super Fund Research Program. Work at the University of Montana was supported by National Institutes of Health grant GM-059378 (to J.C.H.) and the National Institutes of Health COBRE Center grant RR-015583.	BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Chin HF, 2009, J MOL BIOL, V389, P275, DOI 10.1016/j.jmb.2009.03.068; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; Dudognon P, 2004, FEBS LETT, V561, P44, DOI 10.1016/S0014-5793(04)00109-7; Flanagan JJ, 2006, J BIOL CHEM, V281, P2281, DOI 10.1074/jbc.M511695200; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Gimeno RE, 1996, MOL BIOL CELL, V7, P1815, DOI 10.1091/mbc.7.11.1815; Guttman M, 2009, PROTEOMICS, V9, P5016, DOI 10.1002/pmic.200900457; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Lusk CP, 2007, TRAFFIC, V8, P647, DOI 10.1111/j.1600-0854.2007.00559.x; Mashhoon N, 2000, J BIOL CHEM, V275, P20052, DOI 10.1074/jbc.M001713200; Milne DM, 2001, EXP CELL RES, V263, P43, DOI 10.1006/excr.2000.5100; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Murakami A, 1999, J BIOL CHEM, V274, P3804, DOI 10.1074/jbc.274.6.3804; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; SARASTE J, 1991, J CELL SCI, V100, P415; SCHWEIZER A, 1990, EUR J CELL BIOL, V53, P185; Whyte JRC, 2002, J CELL SCI, V115, P2627; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; Yu S, 2002, MOL BIOL CELL, V13, P2559, DOI 10.1091/mbc.E02-04-0189	29	129	131	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					181	+		10.1038/nature09969	http://dx.doi.org/10.1038/nature09969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21532587	Bronze, Green Accepted			2022-12-28	WOS:000290487200031
J	Samandari, T; Agizew, TB; Nyirenda, S; Tedla, Z; Sibanda, T; Shang, N; Mosimaneotsile, B; Motsamai, OI; Bozeman, L; Davis, MK; Talbot, EA; Moeti, TL; Moffat, H; Kilmarx, PH; Castro, KG; Wells, CD				Samandari, Taraz; Agizew, Tefera B.; Nyirenda, Samba; Tedla, Zegabriel; Sibanda, Thabisa; Shang, Nong; Mosimaneotsile, Barudi; Motsamai, Oaitse I.; Bozeman, Lorna; Davis, Margarett K.; Talbot, Elizabeth A.; Moeti, Themba L.; Moffat, Howard; Kilmarx, Peter H.; Castro, Kenneth G.; Wells, Charles D.			6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ANTIRETROVIRAL THERAPY; ACTIVE TUBERCULOSIS; LATENT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; SOUTH-AFRICA; 3 REGIMENS; RISK; IMPACT; COHORT	Background In accordance with WHO guidelines, people with HIV infection in Botswana receive daily isoniazid preventive therapy against tuberculosis without obtaining a tuberculin skin test, but duration of prophylaxis is restricted to 6 months. We aimed to assess effectiveness of extended isoniazid therapy. Methods In our randomised, double-blind, placebo-controlled trial we enrolled adults infected with HIV aged 18 years or older at government HIV-care clinics in Botswana. Exclusion criteria included current illness such as cough and an abnormal chest radiograph without antecedent tuberculosis or pneumonia. Eligible individuals were randomly allocated (1:1) to receive 6 months' open-label isoniazid followed by 30 months' masked placebo (control group) or 6 months' open-label isoniazid followed by 30 months' masked isoniazid (continued isoniazid group) on the basis of a computer-generated randomisation list with permuted blocks of ten at each clinic. Antiretroviral therapy was provided if participants had CD4-positive lymphocyte counts of fewer than 200 cells per mu L. We used Cox regression analysis and the log-rank test to compare incident tuberculosis in the groups. Cox regression models were used to estimate the effect of antiretroviral therapy. The trial is registered at ClinicalTrials.gov, number NCT00164281. Findings Between Nov 26, 2004, and July 3, 2009, we recorded 34 (3.4%) cases of incident tuberculosis in 989 participants allocated to the control group and 20 (2.0%) in 1006 allocated to the continued isoniazid group (incidence 1.26% per year vs 0.72%; hazard ratio 0.57, 95% CI 0.33-0.99, p=0.047). Tuberculosis incidence in those individuals receiving placebo escalated approximately 200 days after completion of open-label isoniazid. Participants who were tuberculin skin test positive (ie, >= 5 mm induration) at enrolment received a substantial benefit from continued isoniazid treatment (0.26, 0.09-0.80, p=0.02), whereas participants who were tuberculin skin test-negative received no significant benefit (0 75, 0.38-1.46, p=0.40). By study completion, 946 (47%) of 1995 participants had initiated antiretroviral therapy. Tuberculosis incidence was reduced by 50% in those receiving 360 days of antiretroviral therapy compared with participants receiving no antiretroviral therapy (adjusted hazard ratio 0.50, 95% CI 0.26-0.97). Severe adverse events and death were much the same in the control and continued isoniazid groups. Interpretation In a tuberculosis-endemic setting, 36 months' isoniazid prophylaxis was more effective for prevention of tuberculosis than was 6-month prophylaxis in individuals with HIV infection, and chiefly benefited those who were tuberculin skin test positive.	[Samandari, Taraz; Agizew, Tefera B.; Nyirenda, Samba; Tedla, Zegabriel; Sibanda, Thabisa; Mosimaneotsile, Barudi; Davis, Margarett K.; Talbot, Elizabeth A.] Botswana USA Partnership BOTUSA, Gaborone, Botswana; [Samandari, Taraz; Agizew, Tefera B.; Nyirenda, Samba; Tedla, Zegabriel; Sibanda, Thabisa; Mosimaneotsile, Barudi; Davis, Margarett K.; Talbot, Elizabeth A.] Botswana USA Partnership BOTUSA, Francistown, Botswana; [Motsamai, Oaitse I.] Minist Hlth, Natl TB Programme, Gaborone, Botswana; [Samandari, Taraz; Shang, Nong; Bozeman, Lorna; Talbot, Elizabeth A.; Castro, Kenneth G.; Wells, Charles D.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Kilmarx, Peter H.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Samandari, T (corresponding author), 1600 Clifton Rd NE,Mailstop E-45, Atlanta, GA 30333 USA.	tts0@cdc.gov	Castro, Kenneth G/P-1882-2018	Castro, Kenneth G/0000-0001-7964-6354; Kilmarx, Peter/0000-0001-6464-3345; Tedla, Zegabriel/0000-0002-6272-3699	US Centers for Disease Control and Prevention; US Agency for International Development	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Agency for International Development(United States Agency for International Development (USAID))	Funding US Centers for Disease Control and Prevention and US Agency for International Development.	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 1999, WKLY EPIDEMIOL RECOR, V74, P385; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Charalambous S, 2008, INT J TUBERC LUNG D, V12, P942; Charalambous S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000391010.02774.6f; CHIRENDA J, 2009, INT J TUBERC LUNG S1, V13, pS3; Delgado JC, 2002, P NATL ACAD SCI USA, V99, P7576, DOI 10.1073/pnas.062056099; Easterbrook PJ, 2004, J CLIN MICROBIOL, V42, P4536, DOI 10.1128/JCM.42.10.4536-4544.2004; Elliott AM, 2004, T ROY SOC TROP MED H, V98, P660, DOI 10.1016/j.trstmh.2004.01.007; Gilks CF, 1997, AIDS, V11, P911, DOI 10.1097/00002030-199707000-00011; Glynn JR, 2005, J INFECT DIS, V192, P480, DOI 10.1086/431517; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Gordin FM, 1997, NEW ENGL J MED, V337, P315, DOI 10.1056/NEJM199707313370505; Harrington T., 2010, Morbidity and Mortality Weekly Report, V59, P224; Johnson JL, 2001, AIDS, V15, P2137, DOI 10.1097/00002030-200111090-00009; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lockman S, 2001, J CLIN MICROBIOL, V39, P1042, DOI 10.1128/JCM.39.3.1042-1047.2001; Martinson N, 2009, 16 C RETR OPP INF MO; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Mosimaneotsile B, 2003, LANCET, V362, P1551, DOI 10.1016/S0140-6736(03)14745-9; Mosimaneotsile B, 2010, JAIDS-J ACQ IMM DEF, V54, P71, DOI 10.1097/QAI.0b013e3181c3cbf0; Mwinga A, 1998, AIDS, V12, P2447, DOI 10.1097/00002030-199818000-00014; National Institute of Health, CANC THER EV PROGR C; Ojikutu Bisola, 2008, Curr HIV/AIDS Rep, V5, P94, DOI 10.1007/s11908-008-0012-0; PAPE JW, 1993, LANCET, V342, P268, DOI 10.1016/0140-6736(93)91817-6; Quigley MA, 2001, AIDS, V15, P215, DOI 10.1097/00002030-200101260-00011; Reid A, 2006, LANCET INFECT DIS, V6, P483, DOI 10.1016/S1473-3099(06)70549-7; Rieder HL, 2007, CLIN INFECT DIS, V44, P103, DOI 10.1086/510093; Rivero A, 2003, ENFERM INFEC MICR CL, V21, P287, DOI 10.1157/13048575; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; Tedla Z, 2010, AM J RESP CRIT CARE, V182, P278, DOI 10.1164/rccm.200911-1783OC; TSICOPOULOS A, 1992, J IMMUNOL, V148, P2058; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; Were W, 2009, INT J TUBERC LUNG D, V13, P47; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; Wilkinson D, 1998, BRIT MED J, V317, P625, DOI 10.1136/bmj.317.7159.625	41	266	272	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1588	1598		10.1016/S0140-6736(11)60204-3	http://dx.doi.org/10.1016/S0140-6736(11)60204-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763IJ	21492926				2022-12-28	WOS:000290549700032
J	Sakurai, Y; Itou, M; Barbiellini, B; Mijnarends, PE; Markiewicz, RS; Kaprzyk, S; Gillet, JM; Wakimoto, S; Fujita, M; Basak, S; Wang, YJ; Al-Sawai, W; Lin, H; Bansil, A; Yamada, K				Sakurai, Y.; Itou, M.; Barbiellini, B.; Mijnarends, P. E.; Markiewicz, R. S.; Kaprzyk, S.; Gillet, J-M; Wakimoto, S.; Fujita, M.; Basak, S.; Wang, Yung Jui; Al-Sawai, W.; Lin, H.; Bansil, A.; Yamada, K.			Imaging Doped Holes in a Cuprate Superconductor with High-Resolution Compton Scattering	SCIENCE			English	Article							MOMENTUM DENSITIES; POSITRON; LA2-XSRXCUO4; SYMMETRY; SPECTRA; PROFILE; ALLOYS; PLANE	The high-temperature superconducting cuprate La2-xSrxCuO4 (LSCO) shows several phases ranging from antiferromagnetic insulator to metal with increasing hole doping. To understand how the nature of the hole state evolves with doping, we have carried out high-resolution Compton scattering measurements at room temperature together with first-principles electronic structure computations on a series of LSCO single crystals in which the hole doping level varies from the underdoped (UD) to the overdoped (OD) regime. Holes in the UD system are found to primarily populate the O 2p(x)/p(y) orbitals. In contrast, the character of holes in the OD system is very different in that these holes mostly enter Cu d orbitals. High-resolution Compton scattering provides a bulk-sensitive method for imaging the orbital character of dopants in complex materials.	[Sakurai, Y.; Itou, M.] SPring 8, Japan Synchrotron Radiat Res Inst JASRI, Sayo, Hyogo 6795198, Japan; [Barbiellini, B.; Mijnarends, P. E.; Markiewicz, R. S.; Kaprzyk, S.; Basak, S.; Wang, Yung Jui; Al-Sawai, W.; Lin, H.; Bansil, A.] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Mijnarends, P. E.] Delft Univ Technol, Fac Sci Appl, Dept Radiat Radionuclides & Reactors, NL-2629 JB Delft, Netherlands; [Kaprzyk, S.] AGH Univ Sci & Technol, PL-30059 Krakow, Poland; [Gillet, J-M] Ecole Cent Paris, Lab Struct Proprietes & Modelisat Solides, CNRS, UMR 8580, F-92295 Chatenay Malabry, France; [Wakimoto, S.] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Naka, Ibaraki 31911195, Japan; [Fujita, M.; Yamada, K.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Yamada, K.] Tohoku Univ, Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Japan Synchrotron Radiation Research Institute; Northeastern University; Delft University of Technology; AGH University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Japan Atomic Energy Agency; Tohoku University; Tohoku University	Sakurai, Y (corresponding author), SPring 8, Japan Synchrotron Radiat Res Inst JASRI, 1-1-1 Kouto, Sayo, Hyogo 6795198, Japan.	sakurai@spring8.or.jp	Fujita, Masaki/D-8430-2013; Lin, Hsin/F-9568-2012; Yamada, Kazuyoshi/C-2728-2009; Wakimoto, Shuichi/V-8177-2019; Barbiellini, Bernardo/AAV-8522-2020; Barbiellini, Bernardo/K-3619-2015	Lin, Hsin/0000-0002-4688-2315; Barbiellini, Bernardo/0000-0002-3309-1362	Ministry of Education, Culture, Spurts, Science, mid Technology (MEXT), Japan [18340111, 16104005, 19340090, 22244039]; Division of Materials Science and Engineering, Office of Science, U.S. Department of Energy	Ministry of Education, Culture, Spurts, Science, mid Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Division of Materials Science and Engineering, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE))	The work at JASRI was supported by a Grant-in-Aid for Scientific Research (no. 18340111) from the Ministry of Education, Culture, Spurts, Science, mid Technology (MEXT), Japan, mid that at Tohoku University was supported by a Grant-in-Aid for Scientific Research (nos. 16104005, 19340090, and 22244039) from the MEXT, Japan. The work at Northeastern University (NU) was supported by the Division of Materials Science and Engineering, Office of Science, U.S. Department of Energy, and it benefited from the allocation of supercomputer time at the National Energy Research Scientific Computing Center, the NU's Advanced Scientific Computation Center (ASCC), and the Stichting Nationale Computerfaciliteiten (National Computing Facilities Foundation, NU). The Compton scattering experiments were performed with the approval of JASRI (proposals 2003B0762, 2004A0152, 2007B1413, 2008A1191, and 2010A1907).	BANSIL A, 1981, PHYS REV B, V23, P3608, DOI 10.1103/PhysRevB.23.3608; Bansil A, 1999, PHYS REV LETT, V83, P5154, DOI 10.1103/PhysRevLett.83.5154; BANSIL A, 1993, Z NATURFORSCH A, V48, P165; Barbiellini B, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.206402; BARBIELLINI B, 1994, PHYSICA C, V229, P113, DOI 10.1016/0921-4534(94)90819-2; BIANCONI A, 1987, SOLID STATE COMMUN, V63, P1009, DOI 10.1016/0038-1098(87)90650-8; CHEN CT, 1992, PHYS REV LETT, V68, P2543, DOI 10.1103/PhysRevLett.68.2543; Cooper M.J., 2004, XRAY COMPTON SCATTER; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Dugdale SB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.046406; GOODENOUGH JB, 1990, PHYS REV B, V42, P4276, DOI 10.1103/PhysRevB.42.4276; HARTHOORN R, 1978, J PHYS F MET PHYS, V8, P1147, DOI 10.1088/0305-4608/8/6/016; Hiraoka N, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121101; Koizumi A, 2001, PHYS REV LETT, V86, P5589, DOI 10.1103/PhysRevLett.86.5589; MIJNAREN.PE, 1973, PHYSICA, V63, P235, DOI 10.1016/0031-8914(73)90311-X; Nieminen J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.037001; NUCKER N, 1989, PHYS REV B, V39, P6619, DOI 10.1103/PhysRevB.39.6619; Peets DC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.087402; Sahrakorpi S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.157601; Sakakibara H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.057003; SAKURAI Y, 1995, PHYS REV LETT, V74, P2252, DOI 10.1103/PhysRevLett.74.2252; SMEDSKJAER LC, 1991, J PHYS CHEM SOLIDS, V52, P1541, DOI 10.1016/0022-3697(91)90138-P; UCHIDA S, 1991, PHYS REV B, V43, P7942, DOI 10.1103/PhysRevB.43.7942; Utfeld C, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.064509; WEYRICH W, 1979, CHEM PHYS, V41, P271, DOI 10.1016/0301-0104(79)80034-8; ZHANG FC, 1988, PHYS REV B, V37, P3759, DOI 10.1103/PhysRevB.37.3759	28	69	70	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					698	702		10.1126/science.1199391	http://dx.doi.org/10.1126/science.1199391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21527674				2022-12-28	WOS:000290265800037
J	Lamont, T; Beaumont, C; Fayaz, A; Healey, F; Huehns, T; Law, R; Lecko, C; Panesar, S; Surkitt-Parr, M; Stroud, M; Warner, B				Lamont, Tara; Beaumont, Catherine; Fayaz, Alan; Healey, Frances; Huehns, Tanya; Law, Robert; Lecko, Caroline; Panesar, Sukhmeet; Surkitt-Parr, Michael; Stroud, Mike; Warner, Bruce			SAFETY ALERTS Checking placement of nasogastric feeding tubes in adults (interpretation of x ray images): summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lamont, Tara; Beaumont, Catherine; Healey, Frances; Huehns, Tanya; Lecko, Caroline; Panesar, Sukhmeet; Surkitt-Parr, Michael; Warner, Bruce] Natl Patient Safety Agcy, London W1T 5HD, England; [Fayaz, Alan] London Deanery, London WC1B 5DN, England; [Law, Robert] N Bristol NHS Trust, Bristol BS16 1LE, Avon, England; [Stroud, Mike] Southampton Gen Hosp, Southampton SO16 6YD, Hants, England	North Bristol NHS Trust; University of Southampton	Lamont, T (corresponding author), Natl Patient Safety Agcy, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk	Fayaz, Alan/E-9967-2018	Fayaz, Alan/0000-0002-4643-4846				Bercik P, 2005, JPEN-PARENTER ENTER, V29, P305, DOI 10.1177/0148607105029004305; Hanna G, IMPROVING SAFETY NAS; May Sarah, 2007, Br J Nurs, V16, P414; Mayor S, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1263; Metheny NA, 2006, AM J CRIT CARE, V15, P360, DOI 10.4037/ajcc2006.15.4.360; *NAT I HLTH CLIN E, 2006, CLIN GUID NAT I HL G, V32; National Patient Safety Agency, 2005, RED HARM CAUS MISPL; National Patient Safety Agency, NEV EV ANN REP 2009; National Patient Safety Agency, 2011, RED HARM CAUS MISPL; National Patient Safety Agency, 2010, NAS TUB AUD JUN DOCT; Stroud M, 2003, GUT, V52, P1	11	21	21	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2011	342								d2586	10.1136/bmj.d2586	http://dx.doi.org/10.1136/bmj.d2586			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MC	21546422				2022-12-28	WOS:000290481800005
J	Moczek, AP				Moczek, Armin P.			EVOLUTIONARY BIOLOGY The origins of novelty	NATURE			English	Editorial Material							INSECT		Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Moczek, Armin P.] Natl Ctr Evolutionary Synth NESCent, Durham, NC 27705 USA	Indiana University System; Indiana University Bloomington; The National Evolutionary Synthesis Center	Moczek, AP (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	armin@indiana.edu						CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; Chesebro J, 2009, DEV BIOL, V329, P142, DOI 10.1016/j.ydbio.2009.01.032; Grimaldi David, 2005, pi; Prud'homme B, 2011, NATURE, V473, P83, DOI 10.1038/nature09977; Stegmann UE, 1998, J MORPHOL, V238, P157, DOI 10.1002/(SICI)1097-4687(199811)238:2<157::AID-JMOR3>3.0.CO;2-H	5	7	8	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					34	35		10.1038/473034a	http://dx.doi.org/10.1038/473034a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	759CQ	21544136				2022-12-28	WOS:000290218300022
J	Bester, AC; Roniger, M; Oren, YS; Im, MM; Sarni, D; Chaoat, M; Bensimon, A; Zamir, G; Shewach, DS; Kerem, B				Bester, Assaf C.; Roniger, Maayan; Oren, Yifat S.; Im, Michael M.; Sarni, Dan; Chaoat, Malka; Bensimon, Aaron; Zamir, Gideon; Shewach, Donna S.; Kerem, Batsheva			Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development	CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; PAPILLOMAVIRUS TYPE-16 E6; CELL-CYCLE CHECKPOINT; DNA-DAMAGE; CERVICAL-CANCER; REPLICATION STRESS; MAMMALIAN-CELLS; ORIGIN CHOICE; FRAGILE SITE; CARCINOGENESIS	Chromosomal instability in early cancer stages is caused by stress on DNA replication. The molecular basis for replication perturbation in this context is currently unknown. We studied the replication dynamics in cells in which a regulator of S phase entry and cell proliferation, the Rb-E2F pathway, is aberrantly activated. Aberrant activation of this pathway by HPV-16 E6/E7 or cyclin E oncogenes significantly decreased the cellular nucleotide levels in the newly transformed cells. Exogenously supplied nucleosides rescued the replication stress and DNA damage and dramatically decreased oncogene-induced transformation. Increased transcription of nucleotide biosynthesis genes, mediated by expressing the transcription factor c-myc, increased the nucleotide pool and also rescued the replication-induced DNA damage. Our results suggest a model for early oncogenesis in which uncoordinated activation of factors regulating cell proliferation leads to insufficient nucleotides that fail to support normal replication and genome stability.	[Bester, Assaf C.; Roniger, Maayan; Oren, Yifat S.; Sarni, Dan; Kerem, Batsheva] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91905 Jerusalem, Israel; [Chaoat, Malka; Zamir, Gideon] Hebrew Univ Jerusalem, Dept Surg, Hadassah Med Sch, IL-91905 Jerusalem, Israel; [Im, Michael M.; Shewach, Donna S.] Univ Michigan, Dept Pharmacol, Med Ctr, Ann Arbor, MI 48109 USA; [Bensimon, Aaron] Genom Vis, F-75014 Paris, France	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Michigan System; University of Michigan	Kerem, B (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, Edmond J Safra Campus, IL-91905 Jerusalem, Israel.	kerem@cc.huji.ac.il	Bester, Assaf/ABG-1707-2021		Nachmias Foundation of the Hebrew University; Israeli Ministry of Science; Israel Ministry of Health; NATIONAL CANCER INSTITUTE [R01CA076581, R01CA083081] Funding Source: NIH RePORTER	Nachmias Foundation of the Hebrew University; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Israel Ministry of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Prof. Levana Sherman for the LXSN vectors and for helpful advice, Dr. Tzipora Shlomai for the F1 cells, and Prof. Jiri Bartek for the pbabe-puro-cyclin E vector. This work was partially supported by a grant from the Nachmias Foundation of the Hebrew University, France-Israel program of the Israeli Ministry of Science, and the Israel Ministry of Health.	Akli S, 2003, CANCER BIOL THER, V2, pS38; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Bartkova J, 2010, ONCOGENE, V29, P5095, DOI 10.1038/onc.2010.249; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Coquelle A, 1998, MOL CELL, V2, P259, DOI 10.1016/S1097-2765(00)80137-9; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Duensing S, 2004, INT J CANCER, V109, P157, DOI 10.1002/ijc.11691; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Duensing S, 2003, CRIT REV EUKAR GENE, V13, P9, DOI 10.1615/CritRevEukaryotGeneExpr.v13.i1.20; Duensing S, 2002, CANCER RES, V62, P7075; Flanagan SA, 2007, MOL CANCER THER, V6, P1858, DOI 10.1158/1535-7163.MCT-07-0068; Frame FM, 2006, ONCOGENE, V25, P3258, DOI 10.1038/sj.onc.1209352; Garcia-Closas R, 2005, INT J CANCER, V117, P629, DOI 10.1002/ijc.21193; Garner-Hamrick PA, 2004, J VIROL, V78, P9041, DOI 10.1128/JVI.78.17.9041-9050.2004; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Gross-Mesilaty S, 1998, P NATL ACAD SCI USA, V95, P8058, DOI 10.1073/pnas.95.14.8058; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harris CP, 2003, GENE CHROMOSOME CANC, V36, P233, DOI 10.1002/gcc.10158; Herrick J, 1999, BIOCHIMIE, V81, P859, DOI 10.1016/S0300-9084(00)87170-9; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Klausner RD, 2002, CANCER CELL, V1, P3, DOI 10.1016/S1535-6108(02)00020-X; Lebofsky R, 2006, MOL BIOL CELL, V17, P5337, DOI 10.1091/mbc.E06-04-0298; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Narisawa-Saito M, 2008, CANCER RES, V68, P5699, DOI 10.1158/0008-5472.CAN-07-6862; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Pickering MT, 2006, ONCOGENE, V25, P746, DOI 10.1038/sj.onc.1209103; Plug-DeMaggio AW, 2004, ONCOGENE, V23, P3561, DOI 10.1038/sj.onc.1207388; Rampersaud GC, 2002, J AM DIET ASSOC, V102, P1273, DOI 10.1016/S0002-8223(02)90281-6; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; SHEWACH DS, 1992, ANAL BIOCHEM, V206, P178, DOI 10.1016/S0003-2697(05)80030-2; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Thompson DA, 1997, ONCOGENE, V15, P3025, DOI 10.1038/sj.onc.1201495; Tsantoulis PK, 2008, ONCOGENE, V27, P3256, DOI 10.1038/sj.onc.1210989; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; YAN ZA, 1987, J MED GENET, V24, P593, DOI 10.1136/jmg.24.10.593	44	576	587	4	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					435	446		10.1016/j.cell.2011.03.044	http://dx.doi.org/10.1016/j.cell.2011.03.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529715	Bronze, Green Accepted			2022-12-28	WOS:000290022900012
J	Gascoigne, KE; Takeuchi, K; Suzuki, A; Hori, T; Fukagawa, T; Cheeseman, IM				Gascoigne, Karen E.; Takeuchi, Kozo; Suzuki, Aussie; Hori, Tetsuya; Fukagawa, Tatsuo; Cheeseman, Iain M.			Induced Ectopic Kinetochore Assembly Bypasses the Requirement for CENP-A Nucleosomes	CELL			English	Article							OUTER KINETOCHORE; MICROTUBULE INTERFACE; DNA-BINDING; CENTROMERE; COMPLEX; PROTEIN; CHROMATIN; IDENTIFICATION; RECOGNITION; CHROMOSOME	Accurate chromosome segregation requires assembly of the multiprotein kinetochore complex at centromeres. Although prior work identified the centromeric histone H3-variant CENP-A as the important upstream factor necessary for centromere specification, in human cells CENP-A is not sufficient for kinetochore assembly. Here, we demonstrate that two constitutive DNA-binding kinetochore components, CENP-C and CENP-T, function to direct kinetochore formation. Replacing the DNA-binding regions of CENP-C and CENP-T with alternate chromosome-targeting domains recruits these proteins to ectopic loci, resulting in CENP-A-independent kinetochore assembly. These ectopic kinetochore-like foci are functional based on the stoichiometric assembly of multiple kinetochore components, including the microtubule-binding KMN network, the presence of microtubule attachments, the microtubule-sensitive recruitment of the spindle checkpoint protein Mad2, and the segregation behavior of foci-containing chromosomes. We additionally find that CENP-T phosphorylation regulates the mitotic assembly of both endogenous and ectopic kinetochores. Thus, CENP-C and CENP-T form a critical regulated platform for vertebrate kinetochore assembly.	[Gascoigne, Karen E.; Cheeseman, Iain M.] MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Gascoigne, Karen E.; Cheeseman, Iain M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Takeuchi, Kozo; Suzuki, Aussie; Hori, Tetsuya; Fukagawa, Tatsuo] Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan; [Takeuchi, Kozo; Suzuki, Aussie; Hori, Tetsuya; Fukagawa, Tatsuo] Grad Univ Adv Studies, Mishima, Shizuoka 4118540, Japan	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Cheeseman, IM (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA.	icheese@wi.mit.edu	Fukagawa, Tatsuo/AAK-3922-2021; Suzuki, Aussie/ABF-4170-2021	Suzuki, Aussie/0000-0001-7390-5116; Cheeseman, Iain/0000-0002-3829-5612; Takeuchi, Kozo/0000-0003-2531-9264	Massachusetts Life Sciences Center; Searle Scholars Program; NIH/National Institute of General Medical Sciences [GM088313]; EMBO long-term fellowship; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088313] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22570008] Funding Source: KAKEN	Massachusetts Life Sciences Center; Searle Scholars Program; NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Mike Lampson, Rick Young, Terry Orr-Weaver, David Page, Stephen Taylor, and members of the Cheeseman and Hochwagen labs for helpful discussions and critical reading of the manuscript and the anonymous reviewers for constructive suggestions. This work was supported by awards to I.M.C. from the Massachusetts Life Sciences Center and the Searle Scholars Program and a grant from the NIH/National Institute of General Medical Sciences to I.M.C. (GM088313). I.M.C. is a Thomas D. and Virginia W. Cabot Career Development Professor of Biology. K.E.G. is supported by an EMBO long-term fellowship. Work in the Fukagawa Lab was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to T.F.	Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Gascoigne KE, 2011, CURR OPIN CELL BIOL, V23, P102, DOI 10.1016/j.ceb.2010.07.007; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Masumoto H, 1998, CHROMOSOMA, V107, P406, DOI 10.1007/s004120050324; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Shang WH, 2010, GENOME RES, V20, P1219, DOI 10.1101/gr.106245.110; SUGIMOTO K, 1994, J BIOCHEM-TOKYO, V116, P877, DOI 10.1093/oxfordjournals.jbchem.a124610; Suzuki A, 2011, J CELL BIOL, V193, P125, DOI 10.1083/jcb.201012050; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Yang CH, 1996, MOL CELL BIOL, V16, P3576	35	247	252	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					410	422		10.1016/j.cell.2011.03.031	http://dx.doi.org/10.1016/j.cell.2011.03.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529714	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000290022900010
J	Bell, SL; Eveson, DJ				Bell, Sarah Louise; Eveson, David J			PICTURE QUIZ An unusual cause of stroke and hypoxia The likely underlying condition is hereditary haemorrhagic telangiectasia, also known as Osler-Weber-Rendu syndrome.	BRITISH MEDICAL JOURNAL			English	Editorial Material							PULMONARY ARTERIOVENOUS-MALFORMATIONS				Eveson, DJ (corresponding author), Univ Hosp Leicester, Leicester Gen Hosp, Dept Stroke Med, Leicester, Leics, England.	david.eveson@uhl-tr.nhs.uk						Govani FS, 2009, EUR J HUM GENET, V17, P860, DOI 10.1038/ejhg.2009.35; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Marchuk DA, 2003, HUM MOL GENET, V12, pR97, DOI 10.1093/hmg/ddg103; Shovlin C, 2008, BRIT DENT J, V205, P531, DOI 10.1038/sj.bdj.2008.978; Shovlin CL, 2008, THORAX, V63, P259, DOI 10.1136/thx.2007.087452; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 1999, THORAX, V54, P714, DOI 10.1136/thx.54.8.714; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001	8	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 27	2011	342								c7200	10.1136/bmj.c7200	http://dx.doi.org/10.1136/bmj.c7200			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759BT	21525101				2022-12-28	WOS:000290215600021
J	Roberts, TE; Tsourapas, A; Middleton, LJ; Champaneria, R; Daniels, JP; Cooper, KG; Bhattacharya, S; Barton, PM				Roberts, T. E.; Tsourapas, A.; Middleton, L. J.; Champaneria, R.; Daniels, J. P.; Cooper, K. G.; Bhattacharya, S.; Barton, P. M.			Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis	BRITISH MEDICAL JOURNAL			English	Article							5-YEAR FOLLOW-UP; QUALITY-OF-LIFE; RANDOMIZED-TRIAL; MENORRHAGIA; MANAGEMENT; MICROWAVE; SURGERY; DESTRUCTION; UNCERTAINTY; RESECTION	Objective To undertake a cost effectiveness analysis comparing first and second generation endometrial ablative techniques, hysterectomy, and the levonorgestrel releasing intrauterine system (Mirena) for treating heavy menstrual bleeding. Design Model based economic evaluation with data from an individual patient data meta-analysis supplemented with cost and outcome data from published sources taking an NHS (National Health Service) perspective. A state transition (Markov) model was developed, the structure being informed by the reviews of the trials and clinical input. A subgroup analysis, one way sensitivity analysis, and probabilistic sensitivity analysis were also carried out. Population Four hypothetical cohorts of women with heavy menstrual bleeding. Interventions One of four alternative strategies: Mirena, first or second generation endometrial ablation techniques, or hysterectomy. Main outcome measures Cost effectiveness based on incremental cost per quality adjusted life year (QALY). Results Hysterectomy is the preferred strategy for the first intervention for heavy menstrual bleeding. Although hysterectomy is more expensive, it produces more QALYs relative to other remaining strategies and is likely to be considered cost effective. The incremental cost effectiveness ratio for hysterectomy compared with Mirena is 1440 pound ((sic)1633, $2350) per additional QALY. The incremental cost effectiveness ratio for hysterectomy compared with second generation ablation is 970 pound per additional QALY. Conclusion In light of the acceptable thresholds used by the National Institute for Health and Clinical Excellence, hysterectomy would be considered the preferred strategy for the treatment of heavy menstrual bleeding. The results concur with those of other studies but are highly sensitive to utility values used in the analysis.	[Roberts, T. E.; Tsourapas, A.; Barton, P. M.] Univ Birmingham, Sch Hlth & Populat Sci, Hlth Econ Unit, Birmingham B15 2TT, W Midlands, England; [Middleton, L. J.; Champaneria, R.; Daniels, J. P.] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; [Cooper, K. G.] Aberdeen Royal Infirm, Dept Obstet & Gynaecol, Aberdeen AB25 2ZN, Scotland; [Bhattacharya, S.] Univ Aberdeen, Sch Med & Dent, Aberdeen Matern Hosp, Div Appl Hlth Sci,Sect Appl Clin Sci, Aberdeen, Scotland	University of Birmingham; University of Birmingham; University of Aberdeen; University of Aberdeen	Roberts, TE (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Hlth Econ Unit, Publ Hlth Bldg, Birmingham B15 2TT, W Midlands, England.	T.E.Roberts@bham.ac.uk	Roberts, Tracy/AAO-4610-2021	Roberts, Tracy/0000-0002-0624-0537; cooper, kevin/0000-0003-1486-0071; Middleton, Lee/0000-0003-4621-1922	National Institute for Health Research [05/45/02]	National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the National Institute for Health Research Health Technology Assessment Programme (05/45/02).	BHATTACHARYA S, HLTH TECHNO IN PRESS; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; Brown JS, 2000, LANCET, V356, P535, DOI 10.1016/S0140-6736(00)02577-0; Cameron IM, 1996, EUR J OBSTET GYN R B, V70, P87, DOI 10.1016/S0301-2115(96)02558-4; Clegg JP, 2007, CURR MED RES OPIN, V23, P1637, DOI 10.1185/030079907X199709; Cooper KG, 1997, BRIT J OBSTET GYNAEC, V104, P1360, DOI 10.1111/j.1471-0528.1997.tb11004.x; Cooper KG, 2001, BRIT J OBSTET GYNAEC, V108, P1222, DOI 10.1016/S0306-5456(01)00275-3; COULTER A, 1994, FAM PRACT, V11, P394, DOI 10.1093/fampra/11.4.394; Curtis L., 2008, UNIT COSTS HLTH SOCI; Garside R, 2004, HEALTH TECHNOL ASSES, V8, P1; *GOV ACT DEP, 2009, LIF TABL; Hurskainen R, 2004, JAMA-J AM MED ASSOC, V291, P1456, DOI 10.1001/jama.291.12.1456; Hurskainen R, 2001, LANCET, V357, P273, DOI 10.1016/S0140-6736(00)03615-1; MacLean-Fraser E, 2002, J AM ASSOC GYN LAP, V9, P175, DOI 10.1016/S1074-3804(05)60127-2; Maresh MJA, 2002, BJOG-INT J OBSTET GY, V109, P302, DOI 10.1111/j.1471-0528.2002.01282.x; Middleton LJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3929; *NAT STAT ONL, 2002, CENS 2001; *NIH CLIN EXC, 2007, IPG104 IMP CONTR BIP; Overton C, 1997, BRIT J OBSTET GYNAEC, V104, P1351, DOI 10.1111/j.1471-0528.1997.tb11003.x; Parkin DE, 2000, GYNAECOL ENDOSC, V9, P385, DOI 10.1046/j.1365-2508.2000.00381.x; REES MCP, 1991, BRIT J OBSTET GYNAEC, V98, P327, DOI 10.1111/j.1471-0528.1991.tb13406.x; Sambrook AM, 2010, BJOG-INT J OBSTET GY, V117, P493, DOI 10.1111/j.1471-0528.2009.02476.x; Sculpher M, 1998, INT J TECHNOL ASSESS, V14, P302, DOI 10.1017/S0266462300012277; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; VESSEY MP, 1992, BRIT J OBSTET GYNAEC, V99, P402, DOI 10.1111/j.1471-0528.1992.tb13758.x	27	57	58	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 26	2011	342								d2202	10.1136/bmj.d2202	http://dx.doi.org/10.1136/bmj.d2202			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759BO	21521730	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000290215100001
J	Gosling, R; Tickle, C; Running, SW; Yao, TD; Dinnyes, A; Osowole, AA; Cule, E				Gosling, Raymond; Tickle, Cheryll; Running, Steve W.; Yao Tandong; Dinnyes, Andras; Osowole, A. A.; Cule, Erika			Seven ages of the PhD	NATURE			English	Editorial Material									[Gosling, Raymond] Univ London, London WC1E 7HU, England; [Tickle, Cheryll] Univ Bath, Bath BA2 7AY, Avon, England; [Running, Steve W.] Univ Montana, Missoula, MT 59812 USA; [Yao Tandong] Inst Tibetan Plateau Res, Beijing, Peoples R China; [Dinnyes, Andras] Szent Istvan Univ, Godollo, Hungary; [Osowole, A. A.] Univ Ibadan, Dept Chem, Ibadan, Nigeria; [Cule, Erika] Imperial Coll London, London, England	University of London; University of Bath; University of Montana System; University of Montana; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Hungarian University of Agriculture & Life Sciences; University of Ibadan; Imperial College London	Gosling, R (corresponding author), Univ London, London WC1E 7HU, England.		Dinnyes, Andras/D-5131-2013	Dinnyes, Andras/0000-0003-3791-2583					0	1	1	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					283	286		10.1038/472283a	http://dx.doi.org/10.1038/472283a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752VW	21512550				2022-12-28	WOS:000289724600012
J	Hildebrandt, F; Benzing, T; Katsanis, N				Hildebrandt, Friedhelm; Benzing, Thomas; Katsanis, Nicholas			Mechanisms of Disease: Ciliopathies	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							POLYCYSTIC KIDNEY-DISEASE; JOUBERT-SYNDROME; DOMAIN PROTEIN; PRIMARY CILIA; JUVENILE NEPHRONOPHTHISIS; RETINAL DEGENERATION; CENTROSOMAL PROTEIN; MUTATION ANALYSIS; CYST FORMATION; SYNDROME GENE		[Hildebrandt, Friedhelm] Univ Michigan Hlth Syst, Howard Hughes Med Inst, Dept Pediat, Ann Arbor, MI 48109 USA; [Hildebrandt, Friedhelm] Univ Michigan Hlth Syst, Dept Human Genet, Ann Arbor, MI 48109 USA; [Benzing, Thomas] Univ Cologne, Div Renal, Dept Med, Ctr Mol Med, Cologne, Germany; [Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Cologne; Duke University; Duke University; Duke University	Hildebrandt, F (corresponding author), Univ Michigan Hlth Syst, Howard Hughes Med Inst, Dept Pediat, 8220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	fhilde@umich.edu	Katsanis, Nicholas/E-1837-2012; Benzing, Thomas/X-5476-2019	Katsanis, Nicholas/0000-0002-2480-0171	Novartis; Amgen; Shire; Beijing Genomics Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064614, R01DK069274, R01DK072301, R01DK068306] Funding Source: NIH RePORTER	Novartis(Novartis); Amgen(Amgen); Shire; Beijing Genomics Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Benzing reports receiving lecture fees from Novartis, Amgen, and Shire; and Dr. Katsanis, lecture fees from the Beijing Genomics Institute. No other potential conflict of interest relevant to this article was reported.	Adeva M, 2006, MEDICINE, V85, P1, DOI 10.1097/01.md.0000200165.90373.9a; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Bukanov NO, 2006, NATURE, V444, P949, DOI 10.1038/nature05348; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Consugar MB, 2007, HUM GENET, V121, P591, DOI 10.1007/s00439-007-0341-3; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Donaldson JC, 2002, J BIOL CHEM, V277, P29028, DOI 10.1074/jbc.M111697200; FANCONI G, 1951, Helv Paediatr Acta, V6, P1; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gleeson JG, 2004, AM J MED GENET A, V125A, P125, DOI 10.1002/ajmg.a.20437; Helou J, 2007, J MED GENET, V44, P657, DOI 10.1136/jmg.2007.052027; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Jauregui AR, 2008, J CELL BIOL, V180, P973, DOI 10.1083/jcb.200707090; Jauregui AR, 2005, EXP CELL RES, V305, P333, DOI 10.1016/j.yexcr.2005.01.008; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kaelin WG, 2003, J AM SOC NEPHROL, V14, P2703, DOI 10.1097/01.ASN.0000092803.69761.41; Khaddour Rana, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9489; Kim E, 2007, NAT MED, V13, P1409, DOI 10.1038/nm1207-1409; Kim IY, 2008, J AM SOC NEPHROL, V19, P455, DOI 10.1681/ASN.2007070770; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Liu SM, 2002, DEVELOPMENT, V129, P5839, DOI 10.1242/dev.00173; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nishio S, 2010, J AM SOC NEPHROL, V21, P295, DOI 10.1681/ASN.2009060603; Noor A, 2008, AM J HUM GENET, V82, P1011, DOI 10.1016/j.ajhg.2008.01.021; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto EA, 2009, J MED GENET, V46, P663, DOI 10.1136/jmg.2009.066613; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Otto EA, 2008, HUM MUTAT, V29, P418, DOI 10.1002/humu.20669; Otto EA, 2008, J AM SOC NEPHROL, V19, P587, DOI 10.1681/ASN.2007040490; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Sohara E, 2008, J AM SOC NEPHROL, V19, P469, DOI 10.1681/ASN.2006090985; Tallila J, 2008, AM J HUM GENET, V82, P1361, DOI 10.1016/j.ajhg.2008.05.004; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Valente EM, 2005, ANN NEUROL, V57, P513, DOI 10.1002/ana.20422; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; Wolf MTF, 2007, KIDNEY INT, V72, P1520, DOI 10.1038/sj.ki.5002630; Wolf MTF, 2005, J AM SOC NEPHROL, V16, P676, DOI 10.1681/ASN.2003121025; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25	83	886	912	2	108	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1533	1543		10.1056/NEJMra1010172	http://dx.doi.org/10.1056/NEJMra1010172			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21506742	Green Accepted			2022-12-28	WOS:000289722700010
J	Wiggermann, P; Stroszczynski, C				Wiggermann, Philipp; Stroszczynski, Christian			Ovarian-Vein Thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wiggermann, Philipp; Stroszczynski, Christian] Univ Med Ctr Regensburg, Regensburg, Germany	University of Regensburg	Wiggermann, P (corresponding author), Univ Med Ctr Regensburg, Regensburg, Germany.		Wiggermann, Philipp/AAY-6759-2021; WIGGERMANN, Philipp/AAX-6721-2021						0	6	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1544	1544		10.1056/NEJMicm1008247	http://dx.doi.org/10.1056/NEJMicm1008247			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21506743				2022-12-28	WOS:000289722700012
J	Talley, NJ				Talley, Nicholas J.			Rifaximin relieved global symptoms and bloating in the irritable bowel syndrome without constipation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Talley, NJ (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.		Talley, Nicholas J/D-5399-2013	Talley, Nicholas J/0000-0003-2537-3092				Brandt LJ, 2009, AM J GASTROENTEROL, V104, pS1, DOI 10.1038/ajg.2008.122; Pimentel M, 2006, ANN INTERN MED, V145, P557, DOI 10.7326/0003-4819-145-8-200610170-00004; Posserud I, 2007, GUT, V56, P802, DOI 10.1136/gut.2006.108712	3	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8							JC4-7	10.7326/0003-4819-154-8-201104190-02007	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502645				2022-12-28	WOS:000289622000006
J	Affolter, M; Basler, K				Affolter, Markus; Basler, Konrad			Cytonemes Show Their Colors	SCIENCE			English	Editorial Material							DROSOPHILA		[Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Basler, Konrad] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	University of Basel; University of Zurich	Affolter, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	affolter@unibas.ch; konrad.basler@imls.uzh.ch		Affolter, Markus/0000-0002-5171-0016; Basler, Konrad/0000-0003-3534-1529				Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Roy S, 2011, SCIENCE, V332, P354, DOI 10.1126/science.1198949; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2	7	7	7	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					312	313		10.1126/science.1205971	http://dx.doi.org/10.1126/science.1205971			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493848				2022-12-28	WOS:000289516600031
J	Verma, S; Lewis, D; Warne, G; Grossmann, M				Verma, Shilpa; Lewis, Diana; Warne, Garry; Grossmann, Mathis			An X-traordinary stroke	LANCET			English	Editorial Material							CONGENITAL ADRENAL-HYPERPLASIA		[Grossmann, Mathis] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic 3084, Australia; [Verma, Shilpa; Lewis, Diana; Grossmann, Mathis] Eastern Hlth, Endocrine Unit, Box Hill, Vic, Australia; [Warne, Garry] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Grossmann, M (corresponding author), Univ Melbourne, Dept Med, Austin Hlth, L7 LTB,Studley Rd, Heidelberg, Vic 3084, Australia.	mathisg@unimelb.edu.au						Albareda M M, 2000, Haematologica, V85, pE08; GOLD AP, 1959, PEDIATRICS, V23, P727; Nguyen An T. T., 2006, Indian Journal of Pediatrics, V73, P89, DOI 10.1007/BF02758268; Speiser PW, 2010, J CLIN ENDOCR METAB, V95, P4133, DOI 10.1210/jc.2009-2631	4	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 9	2011	377	9773					1288	1288		10.1016/S0140-6736(10)62266-0	http://dx.doi.org/10.1016/S0140-6736(10)62266-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751DI	21481709				2022-12-28	WOS:000289597300035
J	Ji, AL; Wang, F; Luo, WJ; Yang, RH; Chen, JY; Cai, TJ				Ji, Ailing; Wang, Feng; Luo, Wenjing; Yang, Ruihua; Chen, Jingyuan; Cai, Tongjian			Lead poisoning in China: a nightmare from industrialisation	LANCET			English	Editorial Material							EXPOSURE		[Luo, Wenjing; Chen, Jingyuan; Cai, Tongjian] Fourth Mil Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian 710032, Peoples R China; [Ji, Ailing; Wang, Feng; Yang, Ruihua] Fourth Mil Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Cai, TJ (corresponding author), Fourth Mil Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian 710032, Peoples R China.	ctjcsl@netease.com	Cai, Tong-Jian/AAX-6338-2021	Cai, Tong-Jian/0000-0003-3188-6265				Barbosa F, 2005, ENVIRON HEALTH PERSP, V113, P1669, DOI 10.1289/ehp.7917; CHEN G, 2009, CHINA NEWS AGEN 0815; Cheng HF, 2010, ENVIRON POLLUT, V158, P1134, DOI 10.1016/j.envpol.2009.12.028; CUI M, 2009, BEIJING NEWS    0823; GUO H, 2009, LEGAL DAILY     1021; He KM, 2009, SCI TOTAL ENVIRON, V407, P3986, DOI 10.1016/j.scitotenv.2009.03.018; JIA H, 2009, CHEM WORLD      0825; LE Y, 2009, MORE PARENTS PROTEST; Meyer PA, 2008, MUTAT RES-REV MUTAT, V659, P166, DOI 10.1016/j.mrrev.2008.03.003; *NAT DEV REF COMM, 2007, ACC COND LEAD ZINC I; *PEOPL REP CHIN NA, 2007, NEC ID RESP GOV DIFF; QIAN W, 2010, CHINA DAILY     0317; RAN J, 2010, SO WEEKLY       0324; Watts J, 2009, LANCET, V374, P868, DOI 10.1016/S0140-6736(09)61612-3; Zhang SM, 2009, BIOMED ENVIRON SCI, V22, P288, DOI 10.1016/S0895-3988(09)60058-1; 2010, SHENZHEN DAILY  0318	16	51	60	3	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2011	377	9776					1474	1476		10.1016/S0140-6736(10)60623-X	http://dx.doi.org/10.1016/S0140-6736(10)60623-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761RX	21492927				2022-12-28	WOS:000290419400009
J	Schwartz, L				Schwartz, Louis			The art of medicine 17th-century childbirth: "exquisite torment and infinite grace"	LANCET			English	Editorial Material									Univ Richmond, Dept English, Richmond, VA 23173 USA	University of Richmond	Schwartz, L (corresponding author), Univ Richmond, Dept English, Richmond, VA 23173 USA.	lschwart@richmond.edu						Becker L. M., 2003, DEATH EARLY MODERN E; Cressy David, 1997, BIRTH MARRIAGE DEATH; Greer Germaine, 1988, KISSING ROD ANTHOLOG; Milton John, 1629, COMPLETE POETRY ESSE, P18; Schwartz L, 2009, MILTON AND MATERNAL MORTALITY, P1, DOI 10.1017/CBO9780511581175	5	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2011	377	9776					1486	1487		10.1016/S0140-6736(11)60590-4	http://dx.doi.org/10.1016/S0140-6736(11)60590-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	761RX	21539009				2022-12-28	WOS:000290419400015
J	Boal, AK; Grove, TL; McLaughlin, MI; Yennawar, NH; Booker, SJ; Rosenzweig, AC				Boal, Amie K.; Grove, Tyler L.; McLaughlin, Monica I.; Yennawar, Neela H.; Booker, Squire J.; Rosenzweig, Amy C.			Structural Basis for Methyl Transfer by a Radical SAM Enzyme	SCIENCE			English	Article							23S RIBOSOMAL-RNA; CONFERS ANTIBIOTIC-RESISTANCE; CATECHOL O-METHYLTRANSFERASE; PYRUVATE FORMATE-LYASE; CRYSTAL-STRUCTURE; 5'-DEOXYADENOSYL RADICALS; FES CLUSTER; ADENOSYLMETHIONINE; MECHANISM; CFR	The radical S-adenosyl-L-methionine (SAM) enzymes RlmN and Cfr methylate 23S ribosomal RNA, modifying the C2 or C8 position of adenosine 2503. The methyl groups are installed by a two-step sequence involving initial methylation of a conserved Cys residue (RlmN Cys(355)) by SAM. Methyl transfer to the substrate requires reductive cleavage of a second equivalent of SAM. Crystal structures of RlmN and RlmN with SAM show that a single molecule of SAM coordinates the [4Fe-4S] cluster. Residue Cys(355) is S-methylated and located proximal to the SAM methyl group, suggesting the SAM that is involved in the initial methyl transfer binds at the same site. Thus, RlmN accomplishes its complex reaction with structural economy, harnessing the two most important reactivities of SAM within a single site.	[Grove, Tyler L.; McLaughlin, Monica I.; Booker, Squire J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Grove, Tyler L.; McLaughlin, Monica I.; Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Boal, Amie K.; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Boal, Amie K.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Yennawar, Neela H.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Northwestern University; Northwestern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Booker, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	squire@psu.edu; amyr@northwestern.edu		McLaughlin, Martin/0000-0003-4410-0786	NIH [GM58518, GM63847]; National Research Service Award; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063847, K99GM100011, R01GM058518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by NIH grants GM58518 (A. C. R.) and GM63847 (S.J.B.) and a National Research Service Award fellowship to A. K. B. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). GM/CA CAT has been funded in whole or in part with Federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 3RF9 (RlmN) and 3RFA (RlmN+SAM).	Allen BD, 2003, J AM CHEM SOC, V125, P9018, DOI 10.1021/ja034242l; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Cosper NJ, 2000, BIOCHEMISTRY-US, V39, P15668, DOI 10.1021/bi0022184; Fontecave M, 2001, CURR OPIN CHEM BIOL, V5, P506, DOI 10.1016/S1367-5931(00)00237-4; Frey P. A., 2007, ENZYMATIC REACTION M; Frey P. A., 1992, ENZYMES, V20, P142; Frey PA, 2001, ADV PROTEIN CHEM, V58, P1; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hardin JW, 2010, J MOL BIOL, V402, P412, DOI 10.1016/j.jmb.2010.07.040; HEGAZI MF, 1979, J AM CHEM SOC, V101, P4359, DOI 10.1021/ja00509a052; Iwig DF, 2004, BIOCHEMISTRY-US, V43, P13510, DOI 10.1021/bi048692h; Jarrett JT, 2003, CURR OPIN CHEM BIOL, V7, P174, DOI 10.1016/S1367-5931(03)00022-X; Kaminska KH, 2010, NUCLEIC ACIDS RES, V38, P1652, DOI 10.1093/nar/gkp1142; Kampmeier JA, 2010, BIOCHEMISTRY-US, V49, P10770, DOI 10.1021/bi101509u; Kehrenberg C, 2005, MOL MICROBIOL, V57, P1064, DOI 10.1111/j.1365-2958.2005.04754.x; Kimura S, 2010, NUCLEIC ACIDS RES, V38, P1341, DOI 10.1093/nar/gkp1073; KOWALAK JA, 1995, J BIOL CHEM, V270, P17758, DOI 10.1074/jbc.270.30.17758; LaMarre JM, 2011, ANTIMICROB AGENTS CH, V55, P2989, DOI 10.1128/AAC.00183-11; Larsson KM, 2001, STRUCTURE, V9, P739, DOI 10.1016/S0969-2126(01)00627-X; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Markham G. D., 2010, ENCY LIFE SCIENCES; Miller DJ, 2003, PROTEIN SCI, V12, P1432, DOI 10.1110/ps.0302403; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Nicolet Y, 2009, P NATL ACAD SCI USA, V106, P14867, DOI 10.1073/pnas.0904385106; Schwarz S, 2000, ANTIMICROB AGENTS CH, V44, P2530, DOI 10.1128/AAC.44.9.2530-2533.2000; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; Smith LK, 2008, ANTIMICROB AGENTS CH, V52, P1703, DOI 10.1128/AAC.01583-07; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Westler WM, 2011, J AM CHEM SOC, V133, P1310, DOI 10.1021/ja1049059; WOODARD RW, 1980, J BIOL CHEM, V255, P9124; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y	48	125	127	1	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1089	1092		10.1126/science.1205358	http://dx.doi.org/10.1126/science.1205358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21527678	Green Accepted			2022-12-28	WOS:000290996700046
J	Strother, PK; Battison, L; Brasier, MD; Wellman, CH				Strother, Paul K.; Battison, Leila; Brasier, Martin D.; Wellman, Charles H.			Earth's earliest non-marine eukaryotes	NATURE			English	Article							LIFE; OXYGENATION; EVOLUTION; ROCKS; LAND	The existence of a terrestrial Precambrian (more than 542 Myr ago) biota has been largely inferred from indirect chemical and geological evidence associated with palaeosols(1,2), the weathering of clay minerals(3) and microbially induced sedimentary structures in siliciclastic sediments(4). Direct evidence of fossils within rocks of nonmarine origin in the Precambrian is exceedingly rare(5,6). The most widely cited example comprises a single report of morphologically simple mineralized tubes and spheres interpreted as cyanobacteria, obtained from 1,200-Myr-old palaeokarst in Arizona(5). Organic-walled microfossils were first described from the non-marine Torridonian (1.2-1.0 Gyr ago) sequence of northwest Scotland in 1907(7). Subsequent studies(8-10) found few distinctive taxa-a century later, the Torridonian microflora is still being characterized as primarily nondescript "leiospheres''(11). We have comprehensively sampled grey shales and phosphatic nodules throughout the Torridonian sequence. Here we report the recovery of large populations of diverse organic-walled microfossils extracted by acid maceration, complemented by studies using thin sections of phosphatic nodules that yield exceptionally detailed three-dimensional preservation. These assemblages contain multicellular structures, complex-walled cysts, asymmetric organic structures, and dorsiventral, compressed organic thalli, some approaching one millimetre in diameter. They offer direct evidence of eukaryotes living in freshwater aquatic and subaerially exposed habitats during the Proterozoic era. The apparent dominance of eukaryotes in non-marine settings by 1 Gyr ago indicates that eukaryotic evolution on land may have commenced far earlier than previously thought.	[Strother, Paul K.] Boston Coll, Dept Earth & Environm Sci, Weston, MA 02493 USA; [Battison, Leila; Brasier, Martin D.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Wellman, Charles H.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Boston College; University of Oxford; University of Sheffield	Strother, PK (corresponding author), Boston Coll, Dept Earth & Environm Sci, Weston, MA 02493 USA.	Strother@bc.edu		Strother, Paul/0000-0003-0550-1704	NASA [NNX07AU79G]; NERC [NE/G015716/1, NE/G524060/1]; Natural Environment Research Council [NE/G015716/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	J. Rosenberg produced the confocal laser scanning image (Supplementary Fig. 6a); we thank O. Green for preparation of phosphatic nodules at Oxford. We thank J. Antcliffe, R. Callow and S. Moorhouse for field assistance and the people of Scoraig and Bill (the boatman) for access to Cailleach Head. This research was supported by NASA grant NNX07AU79G (P.K.S.), NERC NE/G015716/1 (C.H.W.) and NERC NE/G524060/1 (L.B.).	Blank CE, 2010, GEOBIOLOGY, V8, P1, DOI 10.1111/j.1472-4669.2009.00220.x; Butterfield NJ, 2009, PRECAMBRIAN RES, V173, P201, DOI 10.1016/j.precamres.2009.01.008; BUTTERFIELD NJ, 1992, PALAEONTOLOGY, V35, P943; CLOUD P, 1971, GEOL SOC AM BULL, V82, P3469, DOI 10.1130/0016-7606(1971)82[3469:NPNFTS]2.0.CO;2; Downie C., 1962, P GEOL SOC, V1600, P127; Gutzmer J, 1998, GEOLOGY, V26, P263, DOI 10.1130/0091-7613(1998)026<0263:ELAPEF>2.3.CO;2; HORODYSKI RJ, 1994, SCIENCE, V263, P494, DOI 10.1126/science.263.5146.494; HUTCHINSON G, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Jankauskas TV., 1989, MIKROFOSSILII DOKEMB, P190; Javaux EJ, 2001, NATURE, V412, P66, DOI 10.1038/35083562; Kennedy M, 2006, SCIENCE, V311, P1446, DOI 10.1126/science.1118929; Kinnaird TC, 2007, J GEOL SOC LONDON, V164, P541, DOI 10.1144/0016-76492005-096; Knauth LP, 2009, NATURE, V460, P728, DOI 10.1038/nature08213; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; KNOLL AH, 1984, J PALEONTOL, V58, P131; Lenton TM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018802; Meng FW, 2005, CHINESE SCI BULL, V50, P1230, DOI 10.1360/982004-543; Mikhailov KV, 2009, BIOESSAYS, V31, P758, DOI 10.1002/bies.200800214; Ohmoto H, 1996, GEOLOGY, V24, P1135, DOI 10.1130/0091-7613(1996)024<1135:EIPGPF>2.3.CO;2; Parnell J, 2010, NATURE, V468, P290, DOI 10.1038/nature09538; Prave AR, 2002, GEOLOGY, V30, P811, DOI 10.1130/0091-7613(2002)030<0811:LOLITP>2.0.CO;2; SCHOPF J.W., 1992, PROTEROZOIC BIOSPHER; Spinks SC, 2010, INT J ASTROBIOL, V9, P209, DOI 10.1017/S1473550410000273; Stewart A. D., 1962, GEOL MAG, V99, P399; Stewart A. D., 2002, MEMOIRS GEOLOGICAL S; STEWART AD, 1979, SEDIMENT GEOL, V22, P229, DOI 10.1016/0037-0738(79)90054-X; Sutton J., 1960, GEOL MAG, V97, P106; Teall J. J. H., 1907, MEMOIRS GEOLOGICAL S, P288; Turnbull MJM, 1996, J GEOL SOC LONDON, V153, P955, DOI 10.1144/gsjgs.153.6.0955; ZHANG ZY, 1982, PALAEONTOLOGY, V25, P443	30	126	130	3	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					505	509		10.1038/nature09943	http://dx.doi.org/10.1038/nature09943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21490597				2022-12-28	WOS:000290951300039
J	Arumugam, M; Raes, J; Pelletier, E; Le Paslier, D; Yamada, T; Mende, DR; Fernandes, GR; Tap, J; Bruls, T; Batto, JM; Bertalan, M; Borruel, N; Casellas, F; Fernandez, L; Gautier, L; Hansen, T; Hattori, M; Hayashi, T; Kleerebezem, M; Kurokawa, K; Leclerc, M; Levenez, F; Manichanh, C; Nielsen, HB; Nielsen, T; Pons, N; Poulain, J; Qin, JJ; Sicheritz-Ponten, T; Tims, S; Torrents, D; Ugarte, E; Zoetendal, EG; Wang, J; Guarner, F; Pedersen, O; de Vos, WM; Brunak, S; Dore, J; Weissenbach, J; Ehrlich, SD; Bork, P				Arumugam, Manimozhiyan; Raes, Jeroen; Pelletier, Eric; Le Paslier, Denis; Yamada, Takuji; Mende, Daniel R.; Fernandes, Gabriel R.; Tap, Julien; Bruls, Thomas; Batto, Jean-Michel; Bertalan, Marcelo; Borruel, Natalia; Casellas, Francesc; Fernandez, Leyden; Gautier, Laurent; Hansen, Torben; Hattori, Masahira; Hayashi, Tetsuya; Kleerebezem, Michiel; Kurokawa, Ken; Leclerc, Marion; Levenez, Florence; Manichanh, Chaysavanh; Nielsen, H. Bjorn; Nielsen, Trine; Pons, Nicolas; Poulain, Julie; Qin, Junjie; Sicheritz-Ponten, Thomas; Tims, Sebastian; Torrents, David; Ugarte, Edgardo; Zoetendal, Erwin G.; Wang, Jun; Guarner, Francisco; Pedersen, Oluf; de Vos, Willem M.; Brunak, Soren; Dore, Joel; Weissenbach, Jean; Ehrlich, S. Dusko; Bork, Peer		MetaHIT Consortium	Enterotypes of the human gut microbiome	NATURE			English	Article							BACTERIAL; DIVERSITY; PATHWAYS; CATALOG; GENES; MUCIN	Our knowledge of species and functional composition of the human gut microbiome is rapidly increasing, but it is still based on very few cohorts and little is known about variation across the world. By combining 22 newly sequenced faecal metagenomes of individuals from four countries with previously published data sets, here we identify three robust clusters (referred to as enterotypes hereafter) that are not nation or continent specific. We also confirmed the enterotypes in two published, larger cohorts, indicating that intestinal microbiota variation is generally stratified, not continuous. This indicates further the existence of a limited number of well-balanced host-microbial symbiotic states that might respond differently to diet and drug intake. The enterotypes are mostly driven by species composition, but abundant molecular functions are not necessarily provided by abundant species, highlighting the importance of a functional analysis to understand microbial communities. Although individual host properties such as body mass index, age, or gender cannot explain the observed enterotypes, data-driven marker genes or functional modules can be identified for each of these host properties. For example, twelve genes significantly correlate with age and three functional modules with the body mass index, hinting at a diagnostic potential of microbial markers.	[Arumugam, Manimozhiyan; Raes, Jeroen; Yamada, Takuji; Mende, Daniel R.; Fernandes, Gabriel R.; Tap, Julien; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Raes, Jeroen] Vrije Univ Brussel VIB, B-1050 Brussels, Belgium; [Pelletier, Eric; Le Paslier, Denis; Bruls, Thomas; Poulain, Julie; Ugarte, Edgardo; Weissenbach, Jean] CEA, F-91000 Evry, France; [Pelletier, Eric; Le Paslier, Denis; Bruls, Thomas; Weissenbach, Jean] CNRS, UMR8030, F-91000 Evry, France; [Pelletier, Eric; Le Paslier, Denis; Bruls, Thomas; Weissenbach, Jean] Univ Evry Val dEssone, F-91000 Evry, France; [Fernandes, Gabriel R.] Univ Fed Minas Gerais, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil; [Tap, Julien; Batto, Jean-Michel; Leclerc, Marion; Levenez, Florence; Pons, Nicolas; Dore, Joel; Ehrlich, S. Dusko] INRA, F-78350 Jouy En Josas, France; [Bertalan, Marcelo; Gautier, Laurent; Nielsen, H. Bjorn; Sicheritz-Ponten, Thomas; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Borruel, Natalia; Casellas, Francesc; Manichanh, Chaysavanh; Guarner, Francisco] Univ Hosp Vall Hebron, Digest Syst Res Unit, Barcelona 08035, Spain; [Fernandez, Leyden; Torrents, David] Barcelona Supercomp Ctr, Barcelona 08034, Spain; [Hansen, Torben; Nielsen, Trine; Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Sect Metab Genet, Marie Krogh Ctr Metab Res, DK-2100 Copenhagen, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, DK-5000 Odense, Denmark; [Hattori, Masahira] Univ Tokyo, Computat Biol Lab Bld, Chiba 2778561, Japan; [Hayashi, Tetsuya] Miyazaki Univ, Frontier Sci Res Ctr, Div Bioenvironm Sci, Miyazaki 8891692, Japan; [Kleerebezem, Michiel; Tims, Sebastian; Zoetendal, Erwin G.; de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6710 BA Ede, Netherlands; [Kurokawa, Ken] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Qin, Junjie; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Sicheritz-Ponten, Thomas] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark; [Torrents, David] Pg Lluis Co 23, ICREA, Barcelona 08010, Spain; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Inst Biomed Sci, DK-2200 Copenhagen, Denmark; [Pedersen, Oluf] Hagedom Res Inst, DK-2820 Gentofte, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [de Vos, Willem M.] Univ Helsinki, FI-00014 Helsinki, Finland; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universidade Federal de Minas Gerais; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Technical University of Denmark; Hospital Universitari Vall d'Hebron; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); University of Copenhagen; University of Southern Denmark; University of Tokyo; University of Miyazaki; Wageningen University & Research; Tokyo Institute of Technology; Beijing Genomics Institute (BGI); Technical University of Denmark; ICREA; University of Copenhagen; University of Copenhagen; Aarhus University; University of Helsinki; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	dusko.ehrlich@jouy.inra.fr; bork@embl.de	Borruel, Natalia/AFO-6891-2022; Kleerebezem, Michiel/AAT-2078-2021; Arumugam, Manimozhiyan/E-1211-2011; Knol, Jan/AAL-6487-2020; da Rocha Fernandes, Gabriel/A-5383-2010; InWeb, Inct/J-9839-2013; Bork, Peer/F-1813-2013; Hattori, Masahira/AAD-3785-2019; Förstner, Konrad U./B-1531-2010; Sunagawa, Shinichi/Q-5950-2019; Arumugam, Manimozhiyan/AAJ-2394-2020; Guarner, Francisco/ABF-1192-2020; Ehrlich, S./Y-2423-2019; Leclerc, Marion/AAZ-3950-2021; Muller, Jean/L-7412-2018; Shingakujyutsu, Kurokawaken/G-1378-2011; Wang, Jun/A-7261-2013; Tap, Julien/E-5760-2010; BLOTTIERE, Hervé M/C-6120-2011; Knol, Jan/A-2178-2010; Mende, Daniel R/I-3662-2019; Nielsen, Henrik/B-8961-2019; Pedersen, Oluf/AAG-8015-2020; Guedon, Eric/S-5635-2016; Chervaux, Christian/N-1972-2014; Zeller, Georg/M-6484-2013; Pedersen, Oluf/Z-1731-2019; Hayashi, Tetsuya/ABA-1074-2020; van Hylckama Vlieg, Johan/F-7887-2014; Casellas, Francesc/AAT-1018-2021; Rescigno, Maria/J-9704-2012; Hattori, Masahira/C-6958-2016; GUEDON, Eric/N-8624-2019; Dore, Joel/ABA-8921-2020; Duarte, Graziela Biude Silva/Q-7728-2016; Gautier, Laurent/F-9849-2012; raes, jeroen/D-7835-2018; de Melo-Minardi, Raquel C./AAG-6540-2021; Guédon, Eric/AAP-4143-2021; Parkhill, Julian/G-4703-2011; Brunak, Soren/O-6621-2016; Wang, Jun/C-8434-2016; Sicheritz-Ponten, Thomas/A-4325-2017; Wang, Jun/B-9503-2016; Torrents, David/G-5785-2015	Borruel, Natalia/0000-0002-4449-2292; Arumugam, Manimozhiyan/0000-0002-0886-9101; Knol, Jan/0000-0002-2103-5961; da Rocha Fernandes, Gabriel/0000-0002-4897-8521; Bork, Peer/0000-0002-2627-833X; Förstner, Konrad U./0000-0002-1481-2996; Sunagawa, Shinichi/0000-0003-3065-0314; Arumugam, Manimozhiyan/0000-0002-0886-9101; Guarner, Francisco/0000-0002-4051-0836; Ehrlich, S./0000-0002-7563-4046; Leclerc, Marion/0000-0001-8684-2847; Muller, Jean/0000-0002-7682-559X; Tap, Julien/0000-0001-8998-5413; BLOTTIERE, Hervé M/0000-0002-8390-0607; Knol, Jan/0000-0002-2103-5961; Mende, Daniel R/0000-0001-6831-4557; Nielsen, Henrik/0000-0003-2281-5713; Guedon, Eric/0000-0002-0901-4447; Chervaux, Christian/0000-0001-6812-0912; Zeller, Georg/0000-0003-1429-7485; Pedersen, Oluf/0000-0002-3321-3972; van Hylckama Vlieg, Johan/0000-0001-6656-8668; Casellas, Francesc/0000-0003-3196-039X; Rescigno, Maria/0000-0002-6464-509X; Hattori, Masahira/0000-0001-9467-0344; GUEDON, Eric/0000-0002-0901-4447; raes, jeroen/0000-0002-1337-041X; Parkhill, Julian/0000-0002-7069-5958; Le Paslier, Denis/0000-0003-4335-9956; Huber, Wolfgang/0000-0002-0474-2218; Brunak, Soren/0000-0003-0316-5866; Nielsen, Trine/0000-0002-2066-7895; Chaysavanh, Manichanh/0000-0002-2287-4003; Kleerebezem, Michiel/0000-0001-8552-2235; Poulain, Julie/0000-0002-8744-3116; Wang, Jun/0000-0002-8540-8931; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Hansen, Torben/0000-0001-8748-3831; Wang, Jun/0000-0002-2113-5874; Pelletier, Eric/0000-0003-4228-1712; C. de Melo-Minardi, Raquel/0000-0001-5190-100X; Varela Castro, Encarna/0000-0001-6334-9320; TORREJON, ANTONIO/0000-0002-3126-1532; Torrents, David/0000-0002-6086-9037; Delorme, Christine/0000-0002-5208-7238	European Community [HEALTH-F4-2007-201052]; Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCAMP); Novo Nordisk Foundation; International Science and Technology Cooperation Project in China [0806]; Agence Nationale de la Recherche (ANR); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Fund for Scientific Research Flanders (FWO); Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002800] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	European Community(European Commission); Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCAMP); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); International Science and Technology Cooperation Project in China; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Fund for Scientific Research Flanders (FWO)(FWO); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ICREA(ICREA)	The authors are grateful to C. Creevey, G. Falony and members of the Bork group at EMBL for discussions and assistance. We thank the EMBL IT core facility and Y. Yuan for managing the high-performance computing resources. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013): MetaHIT, grant agreement HEALTH-F4-2007-201052, EMBL, the Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCAMP), Novo Nordisk Foundation and the International Science and Technology Cooperation Project in China (0806). Obese/non-obese volunteers for the MicroObes study were recruited from the SU.VI.MAX cohort study coordinated by P. Galan and S. Hercberg, and metagenome sequencing was funded by Agence Nationale de la Recherche (ANR); volunteers for MicroAge study were recruited from the CROWNALIFE cohort study coordinated by S. Silvi and A. Cresci, and metagenome sequencing was funded by GenoScope. Ciberehd is funded by the Instituto de Salud Carlos III (Spain). J.R. is supported by the Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB) and the Odysseus programme of the Fund for Scientific Research Flanders (FWO). We are thankful to the Human Microbiome Project for generating the reference genomes from human gut microbes and the International Human Microbiome Consortium for discussions and exchange of data.	Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fujihashi K, 2009, TRENDS IMMUNOL, V30, P334, DOI 10.1016/j.it.2009.04.004; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; GIBSON GR, 1990, GUT, V31, P679, DOI 10.1136/gut.31.6.679; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kovacikova G, 2002, INFECT IMMUN, V70, P5355, DOI 10.1128/IAI.70.10.5355-5362.2002; KROGFELT KA, 1991, REV INFECT DIS, V13, P721; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; MetaHITConsortium, 2010, METAHIT DRAFT BACT G; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Walker A, 2007, NAT REV MICROBIOL, V5, P572, DOI 10.1038/nrmicro1720; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Wright DP, 2000, FEMS MICROBIOL LETT, V190, P73, DOI 10.1016/S0378-1097(00)00324-4; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	40	4083	4393	65	1668	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					174	180		10.1038/nature09944	http://dx.doi.org/10.1038/nature09944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21508958	Green Submitted, Green Accepted			2022-12-28	WOS:000290487200030
J	Castro, H; Judd, A; Gibb, DM; Butler, K; Lodwick, RK; van Sighem, A; Ramos, JT; Warsawski, J; Thorne, C; Noguera-Julian, A; Obel, N; Costagliola, D; Tookey, PA; Colin, C; Kjaer, J; Grarup, J; Chene, G; Phillips, A				Castro, Hannah; Judd, Ali; Gibb, Diana M.; Butler, Karina; Lodwick, Rebecca K.; van Sighem, Ard; Ramos, Jose T.; Warsawski, Josiane; Thorne, Claire; Noguera-Julian, Antoni; Obel, Niels; Costagliola, Dominique; Tookey, Pat A.; Colin, Celine; Kjaer, Jesper; Grarup, Jesper; Chene, Genevieve; Phillips, Andrew		COHERE	Risk of triple-class virological failure in children with HIV: a retrospective cohort study	LANCET			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INFECTED CHILDREN; ADHERENCE; MORTALITY; GUIDELINES; IRELAND; UK	Background In adults with HIV treated with antiretroviral drug regimens from within the three original drug classes (nucleoside or nucleotide reverse transcriptase inhibitors [NRTIs], non-NRTIs [NNRTIs], and protease inhibitors), virological failure occurs slowly, suggesting that long-term virological suppression can be achieved in most people, even in areas where access is restricted to drugs from these classes. It is unclear whether this is the case for children, the group who will need to maintain viral suppression for longest. We aimed to determine the rate and predictors of triple-class virological failure to the three original drugs classes in children. Methods In the Collaboration of Observational HIV Epidemiological Research Europe, the rate of triple-class virological failure was studied in children infected perinatally with HIV who were aged less than 16 years, starting antiretroviral therapy (ART) with three or more drugs, between 1998 and 2008. We used Kaplan-Meier and Cox regression methods to investigate the risk and predictors of triple-class virological failure after ART initiation. Findings Of 1007 children followed up for a median of 4.2 (IQR 2.4-6.5) years, 237 (24%) were triple-class exposed and 105 (10%) had triple-class virological failure, of whom 29 never had a viral-load measurement less than 500 copies per mL. Incidence of triple-class virological failure after ART initiation increased with time, and risk by 5 years after ART initiation was 12.0% (95% CI 9.4-14.6). In multivariate analysis, older age at ART initiation was associated with increased risk of failure (p=0.02). Of 686 children starting ART with NRTIs and either a NNRTI or ritonavir-boosted protease inhibitor, the rate of failure was higher than in adults with heterosexually transmitted HIV (hazard ratio 2.2 [95% CI 1.6-3.0, p<0.0001]). Interpretation Findings highlight the challenges of attaining long-term viral suppression in children who will be taking life-long ART Early identification of children not responding to ART, adherence support, particularly for children and adolescents aged 13 years or older starting ART, and ART simplification strategies are all needed to attain and sustain virological suppression.			Judd, A (corresponding author), MRC, Clin Trials Unit, 222 Euston Rd, London NW1 2DA, England.	a.judd@ctu.mrc.ac.uk	Phillips, Andrew N/B-4427-2008; Thorne, Claire/C-5943-2008; DEL AMO VALERO, JULIA/M-7020-2015; Costagliola, Dominique/H-5849-2011; Lodwick, Rebecca/B-7578-2015; Judd, Ali/B-5132-2009; Tookey, Pat A/G-2732-2010; Mocroft, Amanda/G-8748-2011; chene, genevieve/H-8665-2014; Matheron, Sophie/D-7420-2017	Phillips, Andrew N/0000-0003-2384-4807; Thorne, Claire/0000-0003-0389-1956; DEL AMO VALERO, JULIA/0000-0002-3104-540X; Costagliola, Dominique/0000-0003-0765-0869; Lodwick, Rebecca/0000-0003-2558-4762; Judd, Ali/0000-0003-3176-5295; Tookey, Pat A/0000-0001-6258-0387; Mocroft, Amanda/0000-0001-8316-1122; chene, genevieve/0000-0002-8368-6460; Noguera-Julian, Antoni/0000-0001-7485-0583; Casabona-Barbara, Jordi/0000-0003-4816-5536; Gibb, Diana/0000-0002-9738-5490; Matheron, Sophie/0000-0001-7879-6553; Obel, Niels/0000-0002-5031-0045; Castro, Hannah/0000-0001-9086-8687; Paraskevis, Dimitrios/0000-0001-6167-7152; Lo Caputo, Sergio/0000-0002-4729-7548	UK Medical Research Council [G0700832]; European Union [260694]; Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France; HIV Monitoring Foundation, Netherlands; Augustinus Foundation, Denmark; Swiss Bridge Foundation; MRC [G0700832, G0900274, MC_U122886353, G9620552] Funding Source: UKRI; Medical Research Council [MC_U122886353, G0900274, G9620552, G0700832] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France(ANRS); HIV Monitoring Foundation, Netherlands(Netherlands Government); Augustinus Foundation, Denmark; Swiss Bridge Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The PLATO II project is funded by UK Medical Research Council award G0700832. The COHERE study group has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement number 260694; Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France; HIV Monitoring Foundation, Netherlands; and the Augustinus Foundation, Denmark. The group has also received project specific funding from the UK Medical Research Council and the Swiss Bridge Foundation. A list of the funding sources of participating cohorts can be found on the regional coordinating centre websites.	Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Bangsberg David R, 2007, Curr HIV/AIDS Rep, V4, P65, DOI 10.1007/s11904-007-0010-0; Boyd K, 2010, PREVALENCE DARUNAVIR, P851; Brady MT, 2010, JAIDS-J ACQ IMM DEF, V53, P86, DOI 10.1097/QAI.0b013e3181b9869f; Butler L, 2010, 18 INT AIDS C VIENN; de Martino M, 2000, JAMA-J AM MED ASSOC, V284, P190, DOI 10.1001/jama.284.2.190; Deeks SG, 2000, CLIN INFECT DIS, V30, pS177, DOI 10.1086/313855; Giaquinto C, 2008, CLIN DRUG INVEST, V28, P375, DOI 10.2165/00044011-200828060-00005; Goetghebuer T, 2009, AIDS, V23, P597, DOI 10.1097/QAD.0b013e328326ca37; HIV-1 viral load CD4cellcountinuntreatedchildrenwithverticallyacquiredasymptomaticormilddisease, 1998, AIDS, V12, P1; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Kekitiinwa A, 2008, JAIDS-J ACQ IMM DEF, V49, P384, DOI 10.1097/QAI.0b013e31818cdef5; Kjaer J, 2004, ANTIVIR THER, V9, P631; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Lee KJ, 2006, 8 INT C DRUG THER HI; Lodwick R, 2010, ARCH INTERN MED, V170, P410, DOI 10.1001/archinternmed.2009.472; Martin S, 2007, PEDIATR INFECT DIS J, V26, P61, DOI 10.1097/01.inf.0000250625.80340.48; Melvin A, 2010, 18 INT AIDS C VIENN; Menson EN, 2006, BMJ-BRIT MED J, V332, P1183, DOI 10.1136/bmj.332.7551.1183; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Murphy DA, 2005, ARCH PEDIAT ADOL MED, V159, P764, DOI 10.1001/archpedi.159.8.764; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Reddington C, 2000, PEDIATR INFECT DIS J, V19, P1148, DOI 10.1097/00006454-200012000-00005; Sabin CA, 2008, AIDS, V22, P1463; Sharland M, 2004, HIV MED, V5, P61, DOI 10.1111/j.1468-1293.2004.00227.x; Swan J, 2007, PEDIATRICS, V119, P838, DOI 10.1542/peds.2007-0273; The PLATO II Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Group, 2009, EUR AIDS CLIN SOC C; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Walker AS, 2004, AIDS, V18, P1915, DOI 10.1097/00002030-200409240-00007; Welch S, 2009, HIV MED, V10, P591, DOI 10.1111/j.1468-1293.2009.00759.x; *WORK GROUP ANT TH, 2009, GUID US ANT AG PED H, P1; World Health Organization, 2010, ANT THER HIV INF INF	34	86	87	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1580	1587		10.1016/S0140-6736(11)60208-0	http://dx.doi.org/10.1016/S0140-6736(11)60208-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763IJ	21511330	Green Published			2022-12-28	WOS:000290549700031
J	Bollinger, JJ				Bollinger, John J.			METROLOGY Filtering noise with a quantum probe	NATURE			English	Editorial Material									Natl Inst Stand & Technol, Div Time & Frequency, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Bollinger, JJ (corresponding author), Natl Inst Stand & Technol, Div Time & Frequency, Boulder, CO 80305 USA.	john.bollinger@boulder.nist.gov						Bending SJ, 1999, ADV PHYS, V48, P449, DOI 10.1080/000187399243437; Biercuk MJ, 2009, NATURE, V458, P996, DOI 10.1038/nature07951; Chou CW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070802; HAEBERLEN U, 1976, ADV MAGN RES SER; HOROWITZ P, 1989, ART ELECT, V1031; Kotler S, 2011, NATURE, V473, P61, DOI 10.1038/nature10010; Ludlow AD, 2008, SCIENCE, V319, P1805, DOI 10.1126/science.1153341; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075	8	0	0	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					39	40		10.1038/473039a	http://dx.doi.org/10.1038/473039a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544140				2022-12-28	WOS:000290218300025
J	Srivastava, R				Srivastava, Ranjana			The Loneliness of Visiting	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Monash Med Ctr, Melbourne, Vic, Australia	Monash University	Srivastava, R (corresponding author), Monash Med Ctr, Melbourne, Vic, Australia.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1691	1693		10.1056/NEJMp1013909	http://dx.doi.org/10.1056/NEJMp1013909			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759DC	21542740				2022-12-28	WOS:000290219800004
J	Sackett, B; Sakel, M				Sackett, Brian; Sakel, Mohamed			A PATIENT'S JOURNEY Motor neurone disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sakel, Mohamed] E Kent Hosp Univ NHS Fdn Trust, Kent & Canterbury Hosp, Canterbury CT1 3NG, Kent, England	University of Kent		brian@sackett.go-plus.net							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 3	2011	342								d1661	10.1136/bmj.d1661	http://dx.doi.org/10.1136/bmj.d1661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762MA	21540256	Green Submitted, Bronze			2022-12-28	WOS:000290481600005
J	Ratcliff, WC; Denison, RF				Ratcliff, William Croft; Denison, Robert Ford			Alternative Actions for Antibiotics	SCIENCE			English	Editorial Material									[Ratcliff, William Croft; Denison, Robert Ford] Univ Minnesota, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Ratcliff, WC (corresponding author), Univ Minnesota, St Paul, MN 55108 USA.	denis036@umn.edu						Berleman JE, 2006, J BACTERIOL, V188, P5888, DOI 10.1128/JB.00559-06; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; Diggle SP, 2007, PHILOS T R SOC B, V362, P1241, DOI 10.1098/rstb.2007.2049; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; Gilg O, 2010, SCIENCE, V327, P276, DOI 10.1126/science.1184964; Jousset A, 2008, FUNCT ECOL, V22, P714, DOI 10.1111/j.1365-2435.2008.01411.x; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Nizak C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000212; Ratcliff WC, 2009, ISME J, V3, P870, DOI 10.1038/ismej.2009.38; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; SMITH J. M., 1964, Nature, V201, P1145, DOI 10.1038/2011145a0; Ward J., 2008, CONTROL BIOFILM INFE, P79; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044	16	43	43	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					547	548		10.1126/science.1205970	http://dx.doi.org/10.1126/science.1205970			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527704				2022-12-28	WOS:000289991100034
J	van den Elsen, JMH; Isenman, DE				van den Elsen, Jean M. H.; Isenman, David E.			A Crystal Structure of the Complex Between Human Complement Receptor 2 and Its Ligand C3d	SCIENCE			English	Article							EPSTEIN-BARR-VIRUS; STAPHYLOCOCCUS-AUREUS; BINDING-SITE; COMPONENT C3; CR-2; CD21; RESIDUES; ARTHRITIS; CR2/CD21; IMMUNITY	The interaction of complement receptor 2 (CR2)-which is present on B cells and follicular dendritic cells-with its antigen-bound ligand C3d results in an enhanced antibody response, thus providing an important link between the innate and adaptive immune systems. Although a cocrystal structure of a complex between C3d and the ligand-binding domains of CR2 has been published, several aspects of this structure, including the position in C3d of the binding interface, remained controversial because of disagreement with biochemical data. We now report a cocrystal structure of a CR2(SCR1-2):C3d complex at 3.2 angstrom resolution in which the interaction interfaces differ markedly from the previously published structure and are consistent with the biochemical data. It is likely that, in the previous structure, the interaction was influenced by the presence of zinc acetate additive in the crystallization buffer, leading to a nonphysiological complex. Detailed knowledge of the binding interface now at hand gives the potential to exploit the interaction in vaccine design or in therapeutics directed against autoreactive B cells.	[van den Elsen, Jean M. H.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Isenman, David E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Bath; University of Toronto	van den Elsen, JMH (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssjmhve@bath.ac.uk; d.isenman@utoronto.ca	van den Elsen, Jean/D-9274-2011	van den Elsen, Jean/0000-0002-0367-1956				Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; CAREL JC, 1990, J BIOL CHEM, V265, P12293; Clark EA, 2011, MOL IMMUNOL, V48, P452, DOI 10.1016/j.molimm.2010.09.017; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; Del Nagro CJ, 2005, J IMMUNOL, V175, P5379, DOI 10.4049/jimmunol.175.8.5379; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; DIEFENBACH RJ, 1995, J IMMUNOL, V154, P2303; Fang YF, 1998, J IMMUNOL, V160, P5273; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Hannan JP, 2005, J MOL BIOL, V346, P845, DOI 10.1016/j.jmb.2004.12.007; Isenman DE, 2010, J IMMUNOL, V184, P1946, DOI 10.4049/jimmunol.0902919; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; KALLI KR, 1991, J IMMUNOL, V147, P590; Kovacs JM, 2009, J BIOL CHEM, V284, P9513, DOI 10.1074/jbc.M808404200; Kuhn KA, 2008, MOL IMMUNOL, V45, P2808, DOI 10.1016/j.molimm.2008.01.036; LAMBRIS JD, 1985, P NATL ACAD SCI USA, V82, P4235, DOI 10.1073/pnas.82.12.4235; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; MOORE MD, 1989, J BIOL CHEM, V264, P20576; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Prota AE, 2002, P NATL ACAD SCI USA, V99, P10641, DOI 10.1073/pnas.162360499; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Shaw CD, 2010, J MOL BIOL, V404, P697, DOI 10.1016/j.jmb.2010.10.005; Szakonyi G, 2001, SCIENCE, V292, P1725, DOI 10.1126/science.1059118	26	56	64	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					608	611		10.1126/science.1201954	http://dx.doi.org/10.1126/science.1201954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527715				2022-12-28	WOS:000289991100054
J	Wendler, D				Wendler, David			How to Enroll Participants in Research Ethically	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Wendler, D (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	dwendler@nih.gov						[Anonymous], INF CONS FAQS WHAT I; Appelbaum Paul S, 2009, IRB, V31, P10; Appelbaum PS, 2009, HASTINGS CENT REP, V39, P30, DOI 10.1353/hcr.0.0103; BERG J, 2001, INFORMED CONSENT LEG, P279; Miller FG., 2010, ETHICS CONSENT THEOR, P79; Wendler D, 2004, ARCH INTERN MED, V164, P2201, DOI 10.1001/archinte.164.20.2201	6	13	13	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1587	1588		10.1001/jama.2011.421	http://dx.doi.org/10.1001/jama.2011.421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21505137				2022-12-28	WOS:000289683000029
J	Durand, S; Lykke-Andersen, J				Durand, Sebastien; Lykke-Andersen, Jens			SnapShot: Nonsense-Mediated mRNA Decay	CELL			English	Editorial Material									[Durand, Sebastien; Lykke-Andersen, Jens] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Durand, S (corresponding author), Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA.		Durand, Sebastien/Q-2138-2019	Durand, Sebastien/0000-0002-9960-9099; Lykke-Andersen, Jens/0000-0003-1821-0754				Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Franks TM, 2010, CELL, V143, P938, DOI 10.1016/j.cell.2010.11.043; Hogg JR, 2010, CELL, V143, P379, DOI 10.1016/j.cell.2010.10.005; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Kashima I, 2010, GENE DEV, V24, P2440, DOI 10.1101/gad.604610; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007	10	11	15	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					324	U2		10.1016/j.cell.2011.03.038	http://dx.doi.org/10.1016/j.cell.2011.03.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496649	Bronze			2022-12-28	WOS:000289549900020
J	Kononenko, NL; Haucke, V				Kononenko, Natalia L.; Haucke, Volker			An Exciting Calcium Sensor for Smell	CELL			English	Editorial Material							MEMBRANE-FUSION; MAP FORMATION; MECHANISMS; EXOCYTOSIS		[Kononenko, Natalia L.; Haucke, Volker] Free Univ Berlin, Charite Berlin, D-14195 Berlin, Germany; [Haucke, Volker] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Haucke, V (corresponding author), Free Univ Berlin, Charite Berlin, D-14195 Berlin, Germany.	volker.haucke@fu-berlin.de		Kononenko, Natalia/0000-0002-3425-6659; Haucke, Volker/0000-0003-3119-6993				BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Cao P, 2011, CELL, V145, P300, DOI 10.1016/j.cell.2011.03.034; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Kennedy MJ, 2011, NEURON, V69, P856, DOI 10.1016/j.neuron.2011.02.032; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; Scolnick JA, 2008, NEURON, V57, P847, DOI 10.1016/j.neuron.2008.01.027; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Trejo JI, 2007, MOL PSYCHIATR, V12, P1118, DOI 10.1038/sj.mp.4002076	10	0	0	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					175	177		10.1016/j.cell.2011.03.047	http://dx.doi.org/10.1016/j.cell.2011.03.047			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496639	Bronze			2022-12-28	WOS:000289549900007
J	Shetty, P				Shetty, Priya			Lunch with The Lancet Anne Johnson	LANCET			English	Editorial Material												priya4876@gmail.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1231	1231		10.1016/S0140-6736(11)60489-3	http://dx.doi.org/10.1016/S0140-6736(11)60489-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	751DI	21481694				2022-12-28	WOS:000289597300015
J	Fu, SN; Yang, L; Li, P; Hofmann, O; Dicker, L; Hide, W; Lin, XH; Watkins, SM; Ivanov, AR; Hotamisligil, GS				Fu, Suneng; Yang, Ling; Li, Ping; Hofmann, Oliver; Dicker, Lee; Hide, Winston; Lin, Xihong; Watkins, Steven M.; Ivanov, Alexander R.; Hotamisligil, Goekhan S.			Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity	NATURE			English	Article							GLUCOSE-HOMEOSTASIS; MASS-SPECTROMETRY; ADIPOSE-TISSUE; ER STRESS; MICE; CA2+-ATPASE; INSULIN; PHOSPHATIDYLETHANOLAMINE; CHOLESTEROL; ACTIVATION	The endoplasmic reticulum (ER) is the main site of protein and lipid synthesis, membrane biogenesis, xenobiotic detoxification and cellular calcium storage, and perturbation of ER homeostasis leads to stress and the activation of the unfolded protein response(1). Chronic activation of ER stress has been shown to have an important role in the development of insulin resistance and diabetes in obesity(2). However, the mechanisms that lead to chronic ER stress in a metabolic context in general, and in obesity in particular, are not understood. Here we comparatively examined the proteomic and lipidomic landscape of hepatic ER purified from lean and obese mice to explore the mechanisms of chronic ER stress in obesity. We found suppression of protein but stimulation of lipid synthesis in the obese ER without significant alterations in chaperone content. Alterations in ER fatty acid and lipid composition result in the inhibition of sarco/endoplasmic reticulum calcium ATPase (SERCA) activity and ER stress. Correcting the obesity-induced alteration of ER phospholipid composition or hepatic Serca overexpression in vivo both reduced chronic ER stress and improved glucose homeostasis. Hence, we established that abnormal lipid and calcium metabolism are important contributors to hepatic ER stress in obesity.	[Fu, Suneng; Yang, Ling; Li, Ping; Ivanov, Alexander R.; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Fu, Suneng; Yang, Ling; Li, Ping; Ivanov, Alexander R.; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hofmann, Oliver; Dicker, Lee; Hide, Winston; Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Watkins, Steven M.] Lip Technol Inc, W Sacramento, CA 95691 USA; [Hotamisligil, Goekhan S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Hide, Winston A/V-2727-2017; Yang, Ling/C-8000-2011; Hide, Winston/R-3815-2019; Hofmann, Oliver M/F-1800-2013; Hide, Winston Hide/C-7217-2009	Hide, Winston A/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; Hofmann, Oliver M/0000-0002-7738-1513; Hide, Winston Hide/0000-0002-8621-3271; Yang, Ling/0000-0002-3105-3063	National Institutes of Health [DK52539, 1RC4-DK090942]; Syndexa Pharmaceuticals; NIH/NIEHS [T32ES007155]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090942, R01DK052539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Syndexa Pharmaceuticals; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Porter, E. Freeman and R. Davis for technical assistance. The anti-HERP antibody is a gift of Y. Hirabayashi. We thank the members of the G.S.H. laboratory for scientific discussions and critical reading of the manuscript. This work was supported in part by the National Institutes of Health (DK52539 and 1RC4-DK090942) and a research grant from Syndexa Pharmaceuticals to G.S.H. S.F. was supported in part by the NIH/NIEHS postdoctoral training grant (T32ES007155).	Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; CHENG KH, 1986, J BIOL CHEM, V261, P5081; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Kim SJ, 2010, NEUROSCI LETT, V479, P292, DOI 10.1016/j.neulet.2010.05.083; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Li SY, 2006, DIABETOLOGIA, V49, P1434, DOI 10.1007/s00125-006-0229-0; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; LODISH HF, 1990, J BIOL CHEM, V265, P10893; Miyauchi Y, 2006, J BIOL CHEM, V281, P22882, DOI 10.1074/jbc.M601966200; MOORE L, 1975, J BIOL CHEM, V250, P4562; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schiller J, 2001, J LIPID RES, V42, P1501	24	683	706	11	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2011	473	7348					528	531		10.1038/nature09968	http://dx.doi.org/10.1038/nature09968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21532591	Green Accepted			2022-12-28	WOS:000290951300044
J	Kirby, T				Kirby, Tony			Profile Rebecca Ivers: driving down the toll of injury	LANCET			English	Biographical-Item												tony.kirby@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 7	2011	377	9777					1563	1563		10.1016/S0140-6736(11)60629-6	http://dx.doi.org/10.1016/S0140-6736(11)60629-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	763IJ	21550470				2022-12-28	WOS:000290549700013
J	Salo, H				Salo, Heikki			Twisted Disks	SCIENCE			English	Editorial Material							SYSTEM; RINGS		Univ Oulu, Dept Phys, Astron Div, FI-90014 Oulu, Finland	University of Oulu	Salo, H (corresponding author), Univ Oulu, Dept Phys, Astron Div, FI-90014 Oulu, Finland.	heikki.salo@oulu.fi						BINNEY J, 1992, ANNU REV ASTRON ASTR, V30, P51; BOSMA A, 1978, THESIS GRONINGEN U G; Cuzzi JN, 2010, SCIENCE, V327, P1470, DOI 10.1126/science.1179118; Hedman MM, 2011, SCIENCE, V332, P708, DOI 10.1126/science.1202238; Hedman MM, 2007, ICARUS, V188, P89, DOI 10.1016/j.icarus.2006.11.017; HUNTER C, 1969, ASTROPHYS J, V155, P747, DOI 10.1086/149908; Mouillet D, 1997, MON NOT R ASTRON SOC, V292, P896, DOI 10.1093/mnras/292.4.896; Ockert-Bell ME, 1999, ICARUS, V138, P188, DOI 10.1006/icar.1998.6072; OORT JH, 1958, MON NOT R ASTRON SOC, V118, P379; Pringle JE, 1996, MON NOT R ASTRON SOC, V281, P357, DOI 10.1093/mnras/281.1.357; SANCISI R, 1976, ASTRON ASTROPHYS, V53, P159; Showalter MR, 2011, SCIENCE, V332, P711, DOI 10.1126/science.1202241; SHU FH, 1983, ICARUS, V53, P185, DOI 10.1016/0019-1035(83)90141-0	13	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					672	673		10.1126/science.1205672	http://dx.doi.org/10.1126/science.1205672			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551051				2022-12-28	WOS:000290265800028
J	Price, D; Musgrave, SD; Shepstone, L; Hillyer, EV; Sims, EJ; Gilbert, RFT; Juniper, EF; Ayres, JG; Kemp, L; Blyth, A; Wilson, ECF; Wolfe, S; Freeman, D; Mugford, HM; Murdoch, J; Harvey, I				Price, David; Musgrave, Stanley D.; Shepstone, Lee; Hillyer, Elizabeth V.; Sims, Erika J.; Gilbert, Richard F. T.; Juniper, Elizabeth F.; Ayres, Jon G.; Kemp, Linda; Blyth, Annie; Wilson, Edward C. F.; Wolfe, Stephanie; Freeman, Daryl; Mugford, H. Miranda; Murdoch, Jamie; Harvey, Ian			Leukotriene Antagonists as First-Line or Add-on Asthma-Controller Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; MILD PERSISTENT ASTHMA; FLUTICASONE PROPIONATE; INHALED CORTICOSTEROIDS; CONTROLLED-TRIALS; ORAL MONTELUKAST; BUDESONIDE; BECLOMETHASONE; EXACERBATIONS; VALIDATION	BACKGROUND Most randomized trials of treatment for asthma study highly selected patients under idealized conditions. METHODS We conducted two parallel, multicenter, pragmatic trials to evaluate the real-world effectiveness of a leukotriene-receptor antagonist (LTRA) as compared with either an inhaled glucocorticoid for first-line asthma-controller therapy or a long-acting beta(2)-agonist (LABA) as add-on therapy in patients already receiving inhaled glucocorticoid therapy. Eligible primary care patients 12 to 80 years of age had impaired asthma-related quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score <= 6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score >= 1). We randomly assigned patients to 2 years of open-label therapy, under the care of their usual physician, with LTRA (148 patients) or an inhaled glucocorticoid (158 patients) in the first-line controller therapy trial and LTRA (170 patients) or LABA (182 patients) added to an inhaled glucocorticoid in the add-on therapy trial. RESULTS Mean MiniAQLQ scores increased by 0.8 to 1.0 point over a period of 2 years in both trials. At 2 months, differences in the MiniAQLQ scores between the two treatment groups met our definition of equivalence (95% confidence interval [CI] for an adjusted mean difference, -0.3 to 0.3). At 2 years, mean MiniAQLQ scores approached equivalence, with an adjusted mean difference between treatment groups of -0.11 (95% CI, -0.35 to 0.13) in the first-line controller therapy trial and of -0.11 (95% CI, -0.32 to 0.11) in the add-on therapy trial. Exacerbation rates and ACQ scores did not differ significantly between the two groups. CONCLUSIONS Study results at 2 months suggest that LTRA was equivalent to an inhaled glucocorticoid as first-line controller therapy and to LABA as add-on therapy for diverse primary care patients. Equivalence was not proved at 2 years. The interpretation of results of pragmatic research may be limited by the cross-over between treatment groups and lack of a placebo group.	[Price, David] Univ Aberdeen, Ctr Acad Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland; [Price, David; Musgrave, Stanley D.; Shepstone, Lee; Sims, Erika J.; Blyth, Annie; Wilson, Edward C. F.; Mugford, H. Miranda; Harvey, Ian] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Murdoch, Jamie] Univ E Anglia, Sch Nursing & Midwifery, Norwich NR4 7TJ, Norfolk, England; [Hillyer, Elizabeth V.; Kemp, Linda] Res Real Life, Norwich, Norfolk, England; [Gilbert, Richard F. T.] Castle Partnership, Norwich, Norfolk, England; [Wolfe, Stephanie] Thorpewood Surg, Norwich, Norfolk, England; [Ayres, Jon G.] Univ Birmingham, Sch Hlth & Populat Sci, Inst Occupat & Environm Med, Birmingham, W Midlands, England; [Freeman, Daryl] Sheringham Med Practice, Sheringham, England; [Juniper, Elizabeth F.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Aberdeen; University of East Anglia; University of East Anglia; University of Birmingham; McMaster University	Price, D (corresponding author), Univ Aberdeen, Ctr Acad Primary Care, Foresterhill Hlth Ctr, Westburn Rd, Aberdeen AB25 2AY, Scotland.	david@rirl.org	Murdoch, Jamie/ABE-3382-2020; Price, David/H-2837-2019; Wilson, Ed/P-4310-2019	Price, David/0000-0002-9728-9992; Wilson, Ed/0000-0002-8369-1577; Hillyer, Elizabeth/0000-0003-3022-5692; Murdoch, Jamie/0000-0002-9021-3629	Health Technology Assessment Programme [98/34/05]; Clement Clarke International for implementation of the study; Merck Sharp Dohme; AstraZeneca; Research in Real Life; Aerocrine; Boehringer Ingelheim; GlaxoSmithKline; Merck; Mundipharma; Novartis; Nycomed; Pfizer; Teva; Chiesi; Meda; AKL Technologies; University of East Anglia; QOL Technologies; National Coordinating Centre for Health Technology Assessment U.K.	Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Clement Clarke International for implementation of the study; Merck Sharp Dohme(Merck & Company); AstraZeneca(AstraZeneca); Research in Real Life; Aerocrine; Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Mundipharma; Novartis(Novartis); Nycomed; Pfizer(Pfizer); Teva(Teva Pharmaceutical Industries); Chiesi(Chiesi Pharmaceuticals Inc); Meda; AKL Technologies; University of East Anglia; QOL Technologies; National Coordinating Centre for Health Technology Assessment U.K.	Supported by the Health Technology Assessment Programme (project number 98/34/05), by Clement Clarke International for implementation of the study, and by unrestricted educational grants from Merck Sharp & Dohme, AstraZeneca, and Research in Real Life.; Dr. Price reports receiving grants and support for research in respiratory disease from Aerocrine, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, Mundipharma, Novartis, Nycomed, Pfizer, Teva, and Chiesi; consulting fees from Boehringer Ingelheim, GlaxoSmithKline, Meda, Merck, Mundipharma, Novartis, and Teva; lecture fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Merck, Mundipharma, Pfizer, and Teva; payment for developing educational presentations from Teva and Merck; and owning shares in AKL Technologies, a producer of phytopharmaceuticals; having a phytopharmaceuticals patent pending with AKL; and being the sole owner of Research in Real Life. Dr. Musgrave reports receiving institutional grant support from AKL Technologies, Chiesi, and Mundipharma. Dr. Hillyer reports receiving payment for manuscript preparation from the University of East Anglia, supported by an unrestricted grant from Merck; payment as a freelance medical writer from Aerocrine, Merck, and Teva Sante (France); and consulting fees from Research in Real Life. Dr. Sims reports receiving institutional grant support from Merck. Dr. Gilbert reports receiving lecture fees from Pfizer, Boehringer Ingelheim, AstraZeneca, and GlaxoSmithKline. Prof. Juniper reports receiving consulting fees from GlaxoSmithKline and AstraZeneca and being a board member for and receiving payment for copyrights from QOL Technologies. Ms. Wolfe reports being an advisory-board member for Merck Sharp & Dohme. Dr. Freeman reports receiving lecture fees from Boehringer Ingelheim, AstraZeneca, and Chiesi and support for conference attendance from Napp Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.; Funded by the National Coordinating Centre for Health Technology Assessment U.K. and others	Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Barnes N, 2001, RESP MED, V95, P379, DOI 10.1053/rmed.2001.1052; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Baumgartner RA, 2003, EUR RESPIR J, V21, P123, DOI 10.1183/09031936.03.00028803; Bleecker ER, 2000, J ALLERGY CLIN IMMUN, V105, P1123, DOI 10.1067/mai.2000.106043; British Guideline on the Management of Asthma, 2009, NAT CLIN GUID; British Thoracic Society, ASTHM GUID; Busse W, 2001, J ALLERGY CLIN IMMUN, V107, P461, DOI 10.1067/mai.2001.114657; Currie GP, 2005, CHEST, V128, P2954, DOI 10.1378/chest.128.4.2954; De Maeseneer JM, 2003, LANCET, V362, P1314, DOI 10.1016/S0140-6736(03)14576-X; Ducharme FM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003137.pub3; Haughney J, 2008, RESP MED, V102, P1681, DOI 10.1016/j.rmed.2008.08.003; Herland K, 2005, RESP MED, V99, P11, DOI 10.1016/j.rmed.2004.03.026; Israel E, 2002, J ALLERGY CLIN IMMUN, V110, P847, DOI 10.1067/mai.2002.129413; Joos S, 2008, THORAX, V63, P453, DOI 10.1136/thx.2007.081596; Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Juniper EF, 1999, EUR RESPIR J, V14, P1038, DOI 10.1183/09031936.99.14510389; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Juniper EF, 2000, CLIN EXP ALLERGY, V30, P132; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Meltzer EO, 2002, MAYO CLIN PROC, V77, P437; National Asthma Education and Prevention Program, 2007, EXP PAN REP 3 GUID D; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; Ogawa Y, 2006, J ALLERGY CLIN IMMUN, V118, P789, DOI 10.1016/j.jaci.2006.08.009; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Rawlins MD, 2008, HARVEIAN ORATION; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Reiss TF, 1998, ARCH INTERN MED, V158, P1213, DOI 10.1001/archinte.158.11.1213; Santanello NC, 1997, EUR RESPIR J, V10, P646; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Thomas Mike, 2009, Prim Care Respir J, V18, P83, DOI 10.3132/pcrj.2008.00045; Tinkelman DG, 2006, J ASTHMA, V43, P75, DOI 10.1080/02770900500448738; Zeiger RS, 2005, AM J MED, V118, P649, DOI 10.1016/j.amjmed.2005.03.003; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	40	183	191	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1695	1707		10.1056/NEJMoa1010846	http://dx.doi.org/10.1056/NEJMoa1010846			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759DC	21542741	Green Accepted, Bronze			2022-12-28	WOS:000290219800006
J	Malik, S				Malik, Sabreena			BMJ GROUP AWARDS Medical Team in a Crisis Zone: Medical responses to a clear and present danger	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Malik, S (corresponding author), BMJ, London WC1H 9JR, England.	smalik@bmj.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2011	342								d2719	10.1136/bmj.d2719	http://dx.doi.org/10.1136/bmj.d2719			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MB	21543408				2022-12-28	WOS:000290481700008
J	Neff, S; Goldschmidt, R				Neff, Sarah; Goldschmidt, Ronald			Centers for Disease Control and Prevention 2006 Human Immunodeficiency Virus Testing Recommendations and State Testing Laws	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Neff, Sarah; Goldschmidt, Ronald] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Neff, S (corresponding author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.	neffs@nccc.ucsf.edu						[Anonymous], 2011 COMP STAT HIV T; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1	2	28	28	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1767	1768		10.1001/jama.2011.564	http://dx.doi.org/10.1001/jama.2011.564			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758HZ	21540419	Bronze			2022-12-28	WOS:000290156200016
J	Kulkarni, S; Savan, R; Qi, Y; Gao, XJ; Yuki, Y; Bass, SE; Martin, MP; Hunt, P; Deeks, SG; Telenti, A; Pereyra, F; Goldstein, D; Wolinsky, S; Walker, B; Young, HA; Carrington, M				Kulkarni, Smita; Savan, Ram; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Bass, Sara E.; Martin, Maureen P.; Hunt, Peter; Deeks, Steven G.; Telenti, Amalio; Pereyra, Florencia; Goldstein, David; Wolinsky, Steven; Walker, Bruce; Young, Howard A.; Carrington, Mary			Differential microRNA regulation of HLA-C expression and its association with HIV control	NATURE			English	Article							SURFACE EXPRESSION; DEADENYLATION; ANTIGENS; GENOME; GENES	The HLA-C locus is distinct relative to the other classical HLA class I loci in that it has relatively limited polymorphism(1), lower expression on the cell surface(2,3), and more extensive ligand-receptor interactions with killer-cell immunoglobulin-like receptors(4). A single nucleotide polymorphism (SNP) 35 kb upstream of HLA-C (rs9264942; termed -35) associates with control of HIV5-7, and with levels of HLA-C messenger RNA transcripts(8) and cell-surface expression(7), but the mechanism underlying its varied expression is unknown. We proposed that the -35 SNP is not the causal variant for differential HLA-C expression, but rather is marking another polymorphism that directly affects levels of HLA-C-7. Here we show that variation within the 3' untranslated region (UTR) of HLA-C regulates binding of the microRNA hsa-miR-148 to its target site, resulting in relatively low surface expression of alleles that bind this microRNA and high expression of HLA-C alleles that escape post-transcriptional regulation. The 3' UTR variant associates strongly with control of HIV, potentially adding to the effects of genetic variation encoding the peptide-binding region of the HLA class I loci. Variation in HLA-C expression adds another layer of diversity to this highly polymorphic locus that must be considered when deciphering the function of these molecules in health and disease.	[Kulkarni, Smita; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Bass, Sara E.; Martin, Maureen P.; Carrington, Mary] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA; [Kulkarni, Smita; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Martin, Maureen P.; Pereyra, Florencia; Walker, Bruce; Carrington, Mary] Harvard Univ, Boston, MA 02114 USA; [Kulkarni, Smita; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Martin, Maureen P.; Pereyra, Florencia; Walker, Bruce; Carrington, Mary] MIT, Ragon Inst, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hunt, Peter; Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Aids, San Francisco, CA 94110 USA; [Telenti, Amalio] Univ Lausanne, Inst Microbiol, CH-1011 Lausanne, Switzerland; [Goldstein, David] Duke Univ, Inst Genome Sci & Policy, Ctr Human Genome Variat, Durham, NC 27708 USA; [Wolinsky, Steven] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Lausanne; Duke University; Northwestern University; Feinberg School of Medicine	Carrington, M (corresponding author), NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA.	carringm@mail.nih.gov	Wolinsky, Steven/B-2893-2012; Young, Howard/R-5140-2019; Telenti, Amalio/AAY-1674-2021; Goldstein, David/AAY-8125-2020; Hunt, Peter W./P-2976-2017; Young, Howard/A-6350-2008	Hunt, Peter W./0000-0002-4571-4870; Wolinsky, Steven/0000-0002-9625-6697; Young, Howard/0000-0002-3118-5111; Savan, Ram/0000-0002-3087-1355	National Cancer Institute, National Institutes of Health (NIH) [HHSN261200800001E, N02-CP-55504, R01-DA04334, R01-DA12568]; NIH, National Cancer Institute, Center for Cancer Research; Cancer Inflammation Program Project Award; Bill & Melinda Gates Foundation; Mark and Lisa Schwartz Foundation; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung and Blood Institute [UO1-AI-35042, 5-MO1-RR-00722, UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041]; Swiss HIV Cohort Study; Swiss National Science Foundation [33CSC0-108787];  [UL1 RR024131];  [P30 AI27763]; NATIONAL CANCER INSTITUTE [ZIABC010791] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Inflammation Program Project Award; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Mark and Lisa Schwartz Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Swiss HIV Cohort Study; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health (NIH), under contracts HHSN261200800001E, N02-CP-55504, R01-DA04334 and R01-DA12568. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research and the Cancer Inflammation Program Project Award for the year 2009, a grant from the Bill & Melinda Gates Foundation as part of the Collaboration for AIDS Vaccine Discovery, and the Mark and Lisa Schwartz Foundation. We would also like to thank the patients and investigators involved in the Multicenter AIDS Cohort Study (the MACS is funded by the National Institute of Allergy and Infectious Diseases, with supplemental funding from the National Cancer Institute and the National Heart, Lung and Blood Institute (grants UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613 and UO1-AI-35041), the Swiss HIV Cohort Study (see Supplementary Note 4 for the list of members), supported by the Swiss National Science Foundation grant number 33CSC0-108787, and the SCOPE study, which was funded by the UL1 RR024131 (Clinical and Translational Sciences Award) and P30 AI27763 (Center for AIDS Research) grants. We thank S. Anderson, G. O'Connor and R. Thomas for advice, A. Kronfli and K. Ramakrishnan for assistance in plasmid and genomic DNA preparations, A. McFarland for western blots, V. Braud for the DT9 antibody, R. Johnson and G. Nelson for statistical advice and T. Covell for administrative assistance.	Apps R, 2008, TRENDS IMMUNOL, V29, P313, DOI 10.1016/j.it.2008.02.012; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Castelli EC, 2009, HUM IMMUNOL, V70, P1020, DOI 10.1016/j.humimm.2009.07.028; Corrah TW, 2011, J VIROL, V85, P3367, DOI 10.1128/JVI.02276-10; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Kralovicova J, 2006, J IMMUNOL, V176, P2381, DOI 10.4049/jimmunol.176.4.2381; KRANGEL MS, 1986, J EXP MED, V163, P1173, DOI 10.1084/jem.163.5.1173; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HC, 2010, METHODS MOL BIOL, V612, P377, DOI 10.1007/978-1-60761-362-6_26; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; MCCUTCHEON JA, 1995, J EXP MED, V181, P2085, DOI 10.1084/jem.181.6.2085; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; PHAIR J, 1992, J ACQ IMMUN DEF SYND, V5, P490; Schaefer MR, 2008, J IMMUNOL, V180, P7804, DOI 10.4049/jimmunol.180.12.7804; Setini A, 1996, HUM IMMUNOL, V46, P69, DOI 10.1016/0198-8859(96)00011-0; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SNARY D, 1977, EUR J IMMUNOL, V7, P580, DOI 10.1002/eji.1830070816; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; TILANUS MGJ, 2002, IMMUNOBIOLOGY HUMAN, V1, P304; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; ZEMMOUR J, 1992, J EXP MED, V176, P937, DOI 10.1084/jem.176.4.937	27	267	280	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					495	U548		10.1038/nature09914	http://dx.doi.org/10.1038/nature09914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21499264	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000289949600039
J	Ploegh, H				Ploegh, Hidde			End the wasteful tyranny of reviewer experiments	NATURE			English	Editorial Material									MIT, Whitehead Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Ploegh, H (corresponding author), MIT, Whitehead Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ploegh@wi.mit.edu							0	32	35	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					391	391		10.1038/472391a	http://dx.doi.org/10.1038/472391a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	755QC	21525890	Bronze			2022-12-28	WOS:000289949600004
J	Solt, LA; Kumar, N; Nuhant, P; Wang, YJ; Lauer, JL; Liu, J; Istrate, MA; Kamenecka, TM; Roush, WR; Vidovic, D; Schurer, SC; Xu, JH; Wagoner, G; Drew, PD; Griffin, PR; Burris, TP				Solt, Laura A.; Kumar, Naresh; Nuhant, Philippe; Wang, Yongjun; Lauer, Janelle L.; Liu, Jin; Istrate, Monica A.; Kamenecka, Theodore M.; Roush, William R.; Vidovic, Dusica; Schuerer, Stephan C.; Xu, Jihong; Wagoner, Gail; Drew, Paul D.; Griffin, Patrick R.; Burris, Thomas P.			Suppression of T(H)17 differentiation and autoimmunity by a synthetic ROR ligand	NATURE			English	Article							TH17 CELL-DIFFERENTIATION; ORPHAN RECEPTOR-ALPHA; REV-ERB-ALPHA; GAMMA-T; NUCLEAR RECEPTORS; MASS-SPECTROMETRY; TARGET GENE; IDENTIFICATION; EXCHANGE; AGONIST	T-helper cells that produce interleukin-17 (T(H)17 cells) are a recently identified CD4(+) T-cell subset with characterized pathological roles in autoimmune diseases(1-3). The nuclear receptors retinoic-acid-receptor-related orphan receptors alpha and gamma t (ROR alpha and ROR gamma t, respectively) have indispensible roles in the development of this cell type(4-7). Here we present SR1001, a high-affinity synthetic ligand-the first in a new class of compound-that is specific to both ROR alpha and ROR gamma t and which inhibits T(H)17 cell differentiation and function. SR1001 binds specifically to the ligand-binding domains of ROR alpha and ROR gamma t, inducing a conformational change within the ligand-binding domain that encompasses the repositioning of helix 12 and leads to diminished affinity for co-activators and increased affinity for co-repressors, resulting in suppression of the receptors' transcriptional activity. SR1001 inhibited the development of murine T(H)17 cells, as demonstrated by inhibition of interleukin-17A gene expression and protein production. Furthermore, SR1001 inhibited the expression of cytokines when added to differentiated murine or human T(H)17 cells. Finally, SR1001 effectively suppressed the clinical severity of autoimmune disease in mice. Our data demonstrate the feasibility of targeting the orphan receptors ROR alpha and ROR gamma t to inhibit specifically T(H)17 cell differentiation and function, and indicate that this novel class of compound has potential utility in the treatment of autoimmune diseases.	[Solt, Laura A.; Kumar, Naresh; Wang, Yongjun; Lauer, Janelle L.; Liu, Jin; Istrate, Monica A.; Griffin, Patrick R.; Burris, Thomas P.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Kumar, Naresh; Istrate, Monica A.; Vidovic, Dusica; Schuerer, Stephan C.; Griffin, Patrick R.] Scripps Res Inst, Scripps Res Inst Mol Screening Ctr, Jupiter, FL 33458 USA; [Nuhant, Philippe; Roush, William R.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Kamenecka, Theodore M.; Griffin, Patrick R.] Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA; [Vidovic, Dusica; Schuerer, Stephan C.] Univ Miami, Ctr Computat Sci, Miami, FL 33136 USA; [Xu, Jihong; Wagoner, Gail; Drew, Paul D.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Little Rock, AR 72205 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Miami; University of Arkansas System; University of Arkansas Medical Sciences	Burris, TP (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA.	tburris@scripps.edu	Burris, Thomas/H-5078-2011; Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	NIH [DK080201, DK089984, MH084512, DK088499, GM084041]; National Multiple Sclerosis Society [RG389A2/1]; NIH Molecular Library Screening Center Network (MLSCN) [U54MH074404]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK088499, R24DK089984, R01DK080201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769, U54MH074404, U54MH084512] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH Molecular Library Screening Center Network (MLSCN); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants to T. P. B. (DK080201, DK089984 and MH084512), to L. A. S. (DK088499) and P. R. G. (GM084041) and a grant from the National Multiple Sclerosis Society to P. D. D. (RG389A2/1). Additionally, the efforts of P. R. G. and W. R. R. were supported by the NIH Molecular Library Screening Center Network (MLSCN) grant U54MH074404 (Hugh Rosen, Principal Investigator).	Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Delerive P, 2002, J BIOL CHEM, V277, P35013, DOI 10.1074/jbc.M202979200; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Pascal BD, 2009, J AM SOC MASS SPECTR, V20, P601, DOI 10.1016/j.jasms.2008.11.019; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Tamauchi H, 2004, INT IMMUNOL, V16, P179, DOI 10.1093/intimm/dxh026; Wada T, 2008, MOL PHARMACOL, V73, P891, DOI 10.1124/mol.107.040741; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Xu JH, 2007, J NEUROCHEM, V103, P1801, DOI 10.1111/j.1471-4159.2007.04875.x; Xu JH, 2009, J LEUKOCYTE BIOL, V86, P401, DOI 10.1189/jlb.1008600; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	25	372	419	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					491	U547		10.1038/nature10075	http://dx.doi.org/10.1038/nature10075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21499262	Green Accepted			2022-12-28	WOS:000289949600038
J	Bowen, GJ				Bowen, Gabriel J.			A Faster Water Cycle	SCIENCE			English	Editorial Material							PALEOGENE; BOUNDARY; CARBON		Purdue Univ, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Bowen, GJ (corresponding author), Purdue Univ, W Lafayette, IN 47907 USA.	gabe@purdue.edu	Bowen, Gabriel J/C-1708-2008					BARRON EJ, 1989, GLOBAL PLANET CHANGE, V75, P157; Bijl PK, 2009, NATURE, V461, P776, DOI 10.1038/nature08399; Bowen GJ, 2008, GEOLOGY, V36, P379, DOI 10.1130/G24597A.1; Clementz MT, 2011, SCIENCE, V332, P455, DOI 10.1126/science.1201182; Handley L, 2008, EARTH PLANET SC LETT, V275, P17, DOI 10.1016/j.epsl.2008.07.030; Held IM, 2000, ANNU REV ENERG ENV, V25, P441, DOI 10.1146/annurev.energy.25.1.441; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Huber M, 2008, SCIENCE, V321, P353, DOI 10.1126/science.1161170; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pagani M, 2006, NATURE, V442, P671, DOI 10.1038/nature05043; ROBERT C, 1994, GEOLOGY, V22, P211, DOI 10.1130/0091-7613(1994)022<0211:ASHEAT>2.3.CO;2; Trenberth KE, 1998, CLIMATIC CHANGE, V39, P667, DOI 10.1023/A:1005319109110	12	11	13	4	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					430	431		10.1126/science.1205253	http://dx.doi.org/10.1126/science.1205253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512025				2022-12-28	WOS:000289784900032
J	Tallis, R				Tallis, Raymond			Should the law on assisted dying be changed? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							OF-LIFE PRACTICES; NETHERLANDS		Univ Manchester, Manchester, Lancs, England	University of Manchester	Tallis, R (corresponding author), Univ Manchester, Manchester, Lancs, England.	raymond@rtallis.wanadoo.co.uk						Battin MP, 2007, J MED ETHICS, V33, P591, DOI 10.1136/jme.2007.022335; Bilsen J, 2009, NEW ENGL J MED, V361, P1119, DOI 10.1056/NEJMc0904292; Clery E., 2007, BRIT SOCIAL ATTITUDE, P35; Jackson A., 2009, DIGN CHOIC S END OF; KMEITOVICZ Z, 2002, BRIT MED J, V324, P11; McAndrew Siobhan, 2010, BRIT SOCIAL ATTITUDE, P87; *OR HLTH AUTH, DEATH DIGN ANN REP; *OR PUBL HLTH DIV, 1998, CHAR END OF LIF CAR; Seale C, 2009, PALLIATIVE MED, V23, P198, DOI 10.1177/0269216308102042; Seale C, 2010, J PAIN SYMPTOM MANAG, V39, P44, DOI 10.1016/j.jpainsymman.2009.06.007; van der Heide A, 2007, NEW ENGL J MED, V356, P1957, DOI 10.1056/NEJMsa071143; VANBEEK K, 2010, ASSESSING ORG IMPROV, P117	12	4	4	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2011	342								d2355	10.1136/bmj.d2355	http://dx.doi.org/10.1136/bmj.d2355			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OR	21511806				2022-12-28	WOS:000289943400009
J	Jarvinen, TLN; Sievanen, H; Kannus, P; Jokihaara, J; Khan, KM				Jarvinen, Teppo L. N.; Sievanen, Harri; Kannus, Pekka; Jokihaara, Jarkko; Khan, Karim M.			The true cost of pharmacological disease prevention	BRITISH MEDICAL JOURNAL			English	Editorial Material							OSTEOPOROTIC FRACTURES; CONTROLLED-TRIAL; FALLS; RISK		[Jarvinen, Teppo L. N.] Univ Tampere, Dept Orthopaed Surg, Tampere 33014, Finland; [Sievanen, Harri] Cent Finland Cent Hosp, Dept Surg, Jyvaskyla 40620, Finland; [Sievanen, Harri] UKK Inst, Bone Res Grp, Tampere 33500, Finland; [Kannus, Pekka] Tampere Univ Hosp, Div Orthopaed & Traumatol, Tampere 33520, Finland; [Jokihaara, Jarkko; Khan, Karim M.] Univ British Columbia, Ctr Hip Hlth & Mobil, Vancouver, BC V5Z 1M9, Canada	Tampere University; Central Finland Central Hospital; UKK Institute; Tampere University; Tampere University Hospital; University of British Columbia	Jarvinen, TLN (corresponding author), Univ Tampere, Dept Orthopaed Surg, Tampere 33014, Finland.	teppo.jarvinen@uta.fi	Jokihaara, Jarkko/C-5817-2017; Järvinen, Teppo/B-8189-2013	Jokihaara, Jarkko/0000-0001-6153-2180; Järvinen, Teppo/0000-0003-3713-956X				Borgstrom F, 2010, OSTEOPOROSIS INT, V21, P495, DOI 10.1007/s00198-009-0989-8; Compston JE, 2006, LANCET, V368, P973, DOI 10.1016/S0140-6736(06)69394-X; Cooper A, 2008, CLIN GUIDELINES EVID; Dawson J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c186; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; Inderjeeth CA, 2009, BONE, V44, P744, DOI 10.1016/j.bone.2008.12.003; Jarvinen TLN, 2008, BRIT MED J, V336, P124, DOI 10.1136/bmj.39428.470752.AD; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kannus P, 2006, J BONE MINER RES, V21, P1836, DOI 10.1359/JBMR.060815; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V299, P1651, DOI 10.1001/jama.299.14.1651; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; *NAT I HLTH CLIN E, 2006, NICE CLIN GUID, V34; *NICE, 2010, NICE TECHN APPR GUID, V160; Parikh S, 2009, J AM GERIATR SOC, V57, P327, DOI 10.1111/j.1532-5415.2008.02119.x; Relton C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1066; Robertson MC, 2001, BRIT MED J, V322, P701, DOI 10.1136/bmj.322.7288.701; Sawka AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009515; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; van Staa TP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000194; Yeaw J, 2009, J MANAGE CARE PHARM, V15, P728, DOI 10.18553/jmcp.2009.15.9.728	21	39	39	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2011	342								d2175	10.1136/bmj.d2175	http://dx.doi.org/10.1136/bmj.d2175			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OI	21505222				2022-12-28	WOS:000289942200004
J	Froen, JF; Cacciatore, J; McClure, EM; Kuti, O; Jokhio, AH; Islam, M; Shiffman, J				Froen, J. Frederik; Cacciatore, Joanne; McClure, Elizabeth M.; Kuti, Oluwafemi; Jokhio, Abdul Hakeem; Islam, Monir; Shiffman, Jeremy		Lancet's Stillbirths Series Steeri	Stillbirths 1 Stillbirths: why they matter	LANCET			English	Article							NEONATAL DEATH; CLASSIFICATION SYSTEMS; REPRODUCTIVE HEALTH; PERINATAL-MORTALITY; MATERNAL MORTALITY; PSYCHOSOCIAL CARE; SAFE MOTHERHOOD; GLOBAL HEALTH; RURAL MALAWI; PREGNANCY	In this first paper of The Lancet's Stillbirths Series we explore the present status of stillbirths in the world from global health policy to a survey of community perceptions in 135 countries. Our findings highlight the need for a strong call for action. In times of global focus on motherhood, the mother's own aspiration of a liveborn baby is not recognised on the world's health agenda. Millions of deaths are not counted; stillbirths are not in the Global Burden of Disease, nor in disability-adjusted life-years lost, and they are not part of the UN Millennium Development Goals. The grief of mothers might be aggravated by social stigma, blame, and marginalisation in regions where most deaths occur. Most stillborn babies are disposed of without any recognition or ritual, such as naming, funeral rites, or the mother holding or dressing the baby. Beliefs in the mother's sins and evil spirits as causes of stillbirth are rife, and stillbirth is widely believed to be a natural selection of babies never meant to live. Stillbirth prevention is closely linked with prevention of maternal and neonatal deaths. Knowledge of causes and feasible solutions for prevention is key to health professionals' priorities, to which this Stillbirths Series paper aims to contribute.	[Froen, J. Frederik] Norwegian Inst Publ Hlth, Div Epidemiol, N-0403 Oslo, Norway; [Cacciatore, Joanne] Arizona State Univ, Phoenix, AZ USA; [McClure, Elizabeth M.] Univ N Carolina Chapel Hill, Sch Publ Hlth, Dept Epidemiol, Res Triangle Inst, Durham, NC USA; [Kuti, Oluwafemi] Obafemi Awolowo Univ, Ife, Nigeria; [Jokhio, Abdul Hakeem] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Islam, Monir] WHO Reg Off SE Asia, New Delhi, India; [Shiffman, Jeremy] American Univ, Sch Publ Affairs, Washington, DC 20016 USA	Norwegian Institute of Public Health (NIPH); Arizona State University; Arizona State University-Downtown Phoenix; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; Obafemi Awolowo University; Aga Khan University; American University	Froen, JF (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, POB 4404 Nydalen, N-0403 Oslo, Norway.	frederik.froen@fhi.no	Flenady, Vicki Jane/O-9609-2014; Lawn, Joy/ABE-6382-2020; Frøen, J. Frederik/C-3271-2009	Flenady, Vicki Jane/0000-0001-8114-7677; Lawn, Joy/0000-0002-4573-1443; McClure, Elizabeth/0000-0001-8659-5444; Shiffman, Jeremy/0000-0002-1693-4671; Froen Froen, Jahn Frederik/0000-0001-9390-8509	Bill & Melinda Gates Foundation; International Stillbirth Alliance; e Norwegian Institute of Public Health	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); International Stillbirth Alliance; e Norwegian Institute of Public Health	We thank all parents and colleagues for their participation in the surveys, the many organisations for assisting us in recruiting participants, and Claudia Ravaldi and Alfredo Vannacci from CiaoLapo for translation and recruitment for the parental survey in Italy. We thank the Bill & Melinda Gates Foundation for a grant to support this work to the International Stillbirth Alliance administered by the Mater Medical Research Institute, Brisbane, Australia. Additionally, we thank the International Stillbirth Alliance and the Norwegian Institute of Public Health for seed funding to support meetings of the steering committee. We thank Laura Koopmans, Dominique Rossouw, and Madeleine Elder for technical assistance in the development of the report. The views expressed in this article do not necessarily represent the decisions, policy, or views of the authors' affiliations.	Adetunji JA, 1996, SOC SCI MED, V43, P1561, DOI 10.1016/S0277-9536(96)00052-4; Ahmed S, 2006, AM J PUBLIC HEALTH, V96, P1423, DOI 10.2105/AJPH.2005.066316; Arps S, 2009, SOC SCI MED, V69, P579, DOI 10.1016/j.socscimed.2009.06.005; Badenhorst W, 2006, J PSYCHOSOM OBST GYN, V27, P245, DOI 10.1080/01674820600870327; BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Cacciatore J, 2009, HEALTH SOC CARE COMM, V17, P167, DOI 10.1111/j.1365-2524.2008.00814.x; Cacciatore J, 2007, J SOC WORK END-LIFE, V3, P59, DOI 10.1300/J457v03n03_06; Cacciatore J, 2010, CLIN OBSTET GYNECOL, V53, P691, DOI 10.1097/GRF.0b013e3181eba1c6; Cacciatore J, 2008, BIRTH-ISS PERINAT C, V35, P313, DOI 10.1111/j.1523-536X.2008.00258.x; Carlo WA, 2010, NEW ENGL J MED, V362, P614, DOI 10.1056/NEJMsa0806033; Cecil R., 1996, ANTHR PREGNANCY LOSS; Chapman RR, 2003, SOC SCI MED, V57, P355, DOI 10.1016/S0277-9536(02)00363-5; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; DAGA S R, 1992, Indian Pediatrics, V29, P189; DARMSTADT G, 2009, BMC PREGNANCY CHILDB, V9, P6; Darmstadt GL, 2009, INT J GYNECOL OBSTET, V107, pS89, DOI 10.1016/j.ijgo.2009.07.010; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Erviti J, 2004, QUAL HEALTH RES, V14, P1058, DOI 10.1177/1049732304267693; Fellman J, 2006, TWIN RES HUM GENET, V9, P260, DOI 10.1375/183242706776382356; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Fottrell E, 2010, BRIT J PSYCHIAT, V196, P18, DOI 10.1192/bjp.bp.108.062489; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-58; Froen JF, 2001, AM J OBSTET GYNECOL, V184, P694, DOI 10.1067/mob.2001.110697; Gold KJ, 2008, OBSTET GYNECOL, V112, P29, DOI 10.1097/AOG.0b013e31817d0582; Gold KJ, 2010, PEDIATRICS, V125, pE1202, DOI 10.1542/peds.2009-3081; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Gordijn SJ, 2009, EUR J OBSTET GYN R B, V144, P99, DOI 10.1016/j.ejogrb.2009.01.012; Gottlieb Alma, 2004, AFTERLIFE IS WE COME; Grossmann-Kendall F, 2001, REPROD HEALTH MATTER, V9, P90, DOI 10.1016/S0968-8080(01)90095-3; Gulmezoglu AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945; Haws RA, 2010, SOC SCI MED, V71, P1764, DOI 10.1016/j.socscimed.2010.03.051; Heimstad R, 2007, ACTA OBSTET GYN SCAN, V86, P950, DOI 10.1080/00016340701416929; Horton R, 2007, LANCET, V370, P1526, DOI 10.1016/S0140-6736(07)61418-4; Hughes P, 2002, LANCET, V360, P114, DOI 10.1016/S0140-6736(02)09410-2; Kuti O, 2001, TROP J OBSTET GYNAEC, V18, P31; LAROCHE C, 1984, CAN J PSYCHIAT, V29, P14, DOI 10.1177/070674378402900104; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; LAYNE L.L., 2003, MOTHERHOOD LOST; MATHERS CD, 2008, GLOB BURDEN DIS 2004; McClure EM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.004; Meij LWD, 2005, J CONSULT CLIN PSYCH, V73, P617, DOI 10.1037/0022-006X.73.4.617; *MICR CORP, 2010, MSN ENC DICT; MIDDLETON P, 2010, J PAEDIATR CHILD H, V46, pA54; *NAT LIB MED, PUBMED HOM NAT CTR B; *NORW I PUBL HLTH, 2010, MED BIRTH REG NORW O; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Radestad I, 1996, BIRTH-ISS PERINAT C, V23, P209, DOI 10.1111/j.1523-536X.1996.tb00496.x; Radestad I, 1996, BRIT MED J, V312, P1505, DOI 10.1136/bmj.312.7045.1505; Radestad I, 2009, MIDWIFERY, V25, P422, DOI 10.1016/j.midw.2007.03.005; Rice PL, 2000, OMEGA-J DEATH DYING, V41, P39, DOI 10.2190/N95H-JTCQ-NCTJ-MM7R; Ronsmans C, 2010, B WORLD HEALTH ORGAN, V88, P289, DOI 10.2471/BLT.09.069385; Rosato M, 2006, LANCET, V368, P1180, DOI 10.1016/S0140-6736(06)69475-0; Roy K. K., 2006, Indian Journal of Pediatrics, V73, P669, DOI 10.1007/BF02898441; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Silverman JG, 2007, BJOG-INT J OBSTET GY, V114, P1246, DOI 10.1111/j.1471-0528.2007.01481.x; Spector JM, 2008, B WORLD HEALTH ORGAN, V86, P315, DOI 10.2471/BLT.07.049924; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; STOKES E, 2009, BJOG, V115, P1641; Turton P, 2009, ARCH WOMEN MENT HLTH, V12, P35, DOI 10.1007/s00737-008-0040-7; *UN, 2010, SUMM COMM WOM CHILDR; *UN DEV PROGR, 2010, HUM DEV REP UN DEV P; United Nations, 2010, MILL DEV GOALS REP 2; United Nations Statistics Division, 2010, STAT IND WOM MEN; van den Broek NR, 2003, BJOG-INT J OBSTET GY, V110, P902, DOI 10.1111/j.1471-0528.2003.02402.x; VANOTOO LA, 2010, J PEADIAT CHILD HLTH, V46, pA21; Warland J, 2011, MIDWIFERY, V27, pE163, DOI 10.1016/j.midw.2010.02.004; WHO, 2004, INT STAT CLASS DIS R, V2; *WHO, 2010, LIF TABL WHO MEMBR S; (WHO) WHO, 2020, LIST MEMB STAT WHO R; Winch PJ, 2005, LANCET, V366, P478, DOI 10.1016/S0140-6736(05)66836-5; World Health Organization (WHO), 2007, NEON PER MORT COUNTR; YUDKIN PL, 1987, LANCET, V1, P1192; 1999, TRANSFORMATIVE MOTHE	76	201	203	2	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2011	377	9774					1353	1366		10.1016/S0140-6736(10)62232-5	http://dx.doi.org/10.1016/S0140-6736(10)62232-5			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21496915				2022-12-28	WOS:000289962900036
J	Roy, S; Hsiung, F; Kornberg, TB				Roy, Sougata; Hsiung, Frank; Kornberg, Thomas B.			Specificity of Drosophila Cytonemes for Distinct Signaling Pathways	SCIENCE			English	Article							EGF RECEPTOR; EYE; PATTERN; INHIBITION; TRIGGERS; SPITZ; DISC	Cytonemes are types of filopodia in the Drosophila wing imaginal disc that are proposed to serve as conduits in which morphogen signaling proteins move between producing and target cells. We investigated the specificity of cytonemes that are made by target cells. Cells in wing discs made cytonemes that responded specifically to Decapentaplegic (Dpp) and cells in eye discs made cytonemes that responded specifically to Spitz (the Drosophila epidermal growth factor protein). Tracheal cells had at least two types: one made in response to Branchless (a Drosophila fibroblast growth factor protein, Bnl), to which they segregate the Bnl receptor, and another to which they segregate the Dpp receptor. We conclude that cells can make several types of cytonemes, each of which responds specifically to a signaling pathway by means of the selective presence of a particular signaling protein receptor that has been localized to that cytoneme.	[Kornberg, Thomas B.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kornberg, TB (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	tkornberg@ucsf.edu	Roy, Sougaya/I-5341-2019	Roy, Sougaya/0000-0002-2236-9277	Herbert Boyer Postdoctoral Fellowship; National Institute of General Medical Studies; National Heart, Lung, and Blood Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030637] Funding Source: NIH RePORTER	Herbert Boyer Postdoctoral Fellowship; National Institute of General Medical Studies(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Li and K. Kechris for help with data analysis; S. Liu for technical help; the Bloomington Drosophila Stock Center, I. Guerrero, E. Bier, M. Krasnow, J. Duffy, M. Sato, and K. Wharton for fly stocks; and T. Wunderlich for hCre*PR*. This work was supported in part by a Herbert Boyer Postdoctoral Fellowship (to S. R.) and by grants from the National Institute of General Medical Studies and the National Heart, Lung, and Blood Institute to T.B.K.	Alvarado D, 2004, GENETICS, V167, P187, DOI 10.1534/genetics.167.1.187; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Guha A, 2009, DEV BIOL, V335, P317, DOI 10.1016/j.ydbio.2009.09.005; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Jones C, 2004, SEMIN CELL DEV BIOL, V15, P75, DOI 10.1016/j.semcdb.2003.09.002; Kornberg TB, 2007, CURR OPIN GENET DEV, V17, P264, DOI 10.1016/j.gde.2007.05.010; Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(01)00265-3; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Reifegerste R, 1999, BIOESSAYS, V21, P275, DOI 10.1002/(SICI)1521-1878(199904)21:4<275::AID-BIES3>3.0.CO;2-5; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Schlesinger A, 2004, DEV CELL, V7, P535, DOI 10.1016/j.devcel.2004.09.001; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592	16	175	177	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					354	358		10.1126/science.1198949	http://dx.doi.org/10.1126/science.1198949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493861	Green Accepted			2022-12-28	WOS:000289516600046
J	Magklara, A; Yen, A; Colquitt, BM; Clowney, EJ; Allen, W; Markenscoff-Papadimitriou, E; Evans, ZA; Kheradpour, P; Mountoufaris, G; Carey, C; Barnea, G; Kellis, M; Lomvardas, S				Magklara, Angeliki; Yen, Angela; Colquitt, Bradley M.; Clowney, E. Josephine; Allen, William; Markenscoff-Papadimitriou, Eirene; Evans, Zoe A.; Kheradpour, Pouya; Mountoufaris, George; Carey, Catriona; Barnea, Gilad; Kellis, Manolis; Lomvardas, Stavros			An Epigenetic Signature for Monoallelic Olfactory Receptor Expression	CELL			English	Article							ODORANT RECEPTORS; GENE-EXPRESSION; BASAL-CELLS; STEM-CELLS; CHROMATIN; FAMILY; ONTOGENY; DOMAINS; NEURONS; PROTEIN	Constitutive heterochromatin is traditionally viewed as the static form of heterochromatin that silences pericentromeric and telomeric repeats in a cell cycle-and differentiation-independent manner. Here, we show that, in the mouse olfactory epithelium, olfactory receptor (OR) genes are marked in a highly dynamic fashion with the molecular hallmarks of constitutive heterochromatin, H3K9me3 and H4K20me3. The cell type and developmentally dependent deposition of these marks along the OR clusters are, most likely, reversed during the process of OR choice to allow for monogenic and monoallelic OR expression. In contrast to the current view of OR choice, our data suggest that OR silencing takes place before OR expression, indicating that it is not the product of an OR-elicited feedback signal. Our findings suggest that chromatin-mediated silencing lays a molecular foundation upon which singular and stochastic selection for gene expression can be applied.	[Magklara, Angeliki; Evans, Zoe A.; Mountoufaris, George; Carey, Catriona; Lomvardas, Stavros] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Colquitt, Bradley M.; Markenscoff-Papadimitriou, Eirene; Lomvardas, Stavros] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA; [Clowney, E. Josephine; Lomvardas, Stavros] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA; [Yen, Angela; Kheradpour, Pouya; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Yen, Angela; Kheradpour, Pouya; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Allen, William; Barnea, Gilad] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Brown University	Lomvardas, S (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA.	stavros.lomvardas@ucsf.edu	Colquitt, Bradley/AAR-7838-2021; Magklara, Angeliki/AAK-8347-2020; Kellis, Manolis/ABE-7385-2020	Colquitt, Bradley/0000-0001-5819-7924; Magklara, Angeliki/0000-0003-3408-6722; Kellis, Manolis/0000-0001-7113-9630; Lomvardas, Stavros/0000-0002-7668-3026; Clowney, Eleanor/0000-0002-9150-9464	National Science Foundation; Royce Fellowship; McKnight Endowment Fund for Neuroscience; Rett Syndrome Research Trust; Hellman Family Foundation; NIDCD [R03 DC010273]; Director's New Innovator Award Program [1DP2 OD006667]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030320] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006667] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Royce Fellowship; McKnight Endowment Fund for Neuroscience; Rett Syndrome Research Trust; Hellman Family Foundation; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Director's New Innovator Award Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Dr. Frank Margolis for the OMP-LacZ mouse strain, Dr. John Rubenstein for the Emx2 knockout mouse, Dr. James E. Schwob for the SUS4 antibody, Drs. Andrew Feinberg and Bo Wen for the primer sequences for the positive controls for the H3K9me2 ChIPs, and Dr. Richard Axel for the P2-IRES-GFP and OMP-IRES-GFP mice as well as for the helpful discussions and support. We would also like to thank Drs. Hiten Madhani, Barbara Panning, Nirao Shah, Dimitris Thanos, Tim Mcclintock, Kevin Monahan, and Keith Yamamoto for critical reading of the manuscript. B. M. C., E.J.C., and E. M.-P. are supported by fellowships from the National Science Foundation. W. A. is supported by a Royce Fellowship, G. B. is a Pew Scholar in the Biomedical Sciences, and S. L. is funded by the McKnight Endowment Fund for Neuroscience, Rett Syndrome Research Trust, Hellman Family Foundation, NIDCD (R03 DC010273), and Director's New Innovator Award Program (1DP2 OD006667).	Axel R, 2005, ANGEW CHEM INT EDIT, V44, P6110, DOI 10.1002/anie.200501726; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carter LA, 2004, J NEUROSCI, V24, P5670, DOI 10.1523/JNEUROSCI.0330-04.2004; Cau E, 2002, DEVELOPMENT, V129, P1871; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Duggan CD, 2007, NAT NEUROSCI, V10, P673, DOI 10.1038/nn0607-673; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Ghirlando R, 2004, J MOL BIOL, V336, P597, DOI 10.1016/j.jmb.2003.12.049; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Goldmit M, 2004, IMMUNOL REV, V200, P197, DOI 10.1111/j.0105-2896.2004.00158.x; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Imai T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001776; Jang WC, 2007, J COMP NEUROL, V502, P367, DOI 10.1002/cne.21328; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Larson JL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-557; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; McIntyre JC, 2008, CHEM SENSES, V33, P825, DOI 10.1093/chemse/bjn061; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Pyrski M, 2001, J NEUROSCI, V21, P4637, DOI 10.1523/JNEUROSCI.21-13-04637.2001; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; ROTHMAN A, 2008, CURR BIOL, V18, pR255; Sammeta N, 2007, J COMP NEUROL, V502, P1138, DOI 10.1002/cne.21365; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Walters E, 1996, INT J DEV NEUROSCI, V14, P813, DOI 10.1016/S0736-5748(96)00063-9; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297	48	199	200	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2011	145	4					555	570		10.1016/j.cell.2011.03.040	http://dx.doi.org/10.1016/j.cell.2011.03.040			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21529909	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-28	WOS:000290560800009
J	Pattinson, R; Kerber, K; Buchmann, E; Friberg, IK; Belizan, M; Lansky, S; Weissman, E; Mathai, M; Rudan, I; Walker, N; Lawn, JE				Pattinson, Robert; Kerber, Kate; Buchmann, Eckhart; Friberg, Ingrid K.; Belizan, Maria; Lansky, Sonia; Weissman, Eva; Mathai, Matthews; Rudan, Igor; Walker, Neff; Lawn, Joy E.		Lancet's Stillbirths Series Steeri	Stillbirths 4 Stillbirths: how can health systems deliver for mothers and babies?	LANCET			English	Article							MATERNAL MORTALITY; CHILD HEALTH; OBSTETRIC CARE; GLOBAL HEALTH; PRETERM BIRTH; NEWBORN; INTERVENTIONS; CHALLENGES; FACILITIES; CONTINUUM	The causes of stillbirths are inseparable from the causes of maternal and neonatal deaths. This report focuses on prevention of stillbirths by scale-up of care for mothers and babies at the health-system level, with consideration for effects and cost. In countries with high mortality rates, emergency obstetric care has the greatest effect on maternal and neonatal deaths, and on stillbirths. Syphilis detection and treatment is of moderate effect but of lower cost and is highly feasible. Advanced antenatal care, including induction for post-term pregnancies, and detection and management of hypertensive disease, fetal growth restriction, and gestational diabetes, will further reduce mortality, but at higher cost. These interventions are best packaged and provided through linked service delivery methods tailored to suit existing health-care systems. If 99% coverage is reached in 68 priority countries by 2015, up to 1.1 million (45%) third-trimester stillbirths, 201000 (54%) maternal deaths, and 1.4 million (43%) neonatal deaths could be saved per year at an additional total cost of US$10.9 billion or $2.32 per person, which is in the range of $0.96-2.32 for other ingredients-based intervention packages with only recurrent costs.	[Pattinson, Robert; Belizan, Maria] Univ Pretoria, Dept Obstet & Gynaecol, Med Res Council Maternal & Infant Hlth Care Strat, ZA-0001 Pretoria, South Africa; [Kerber, Kate; Lawn, Joy E.] Saving Newborn Lives Save Children, Cape Town, South Africa; [Buchmann, Eckhart] Chris Hani Baragwanath Hosp, Dept Obstet & Gynaecol, Johannesburg, South Africa; [Buchmann, Eckhart] Univ Witwatersrand, Johannesburg, South Africa; [Friberg, Ingrid K.; Walker, Neff] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Belizan, Maria] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Lansky, Sonia] Univ Fed Minas Gerais, Belo Horizonte Hlth Dept, Belo Horizonte, MG, Brazil; [Weissman, Eva] Futures Inst, New York, NY USA; [Mathai, Matthews] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Lawn, Joy E.] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Lawn, Joy E.] Inst Child Hlth, London, England	University of Pretoria; Save the Children; University of Witwatersrand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Minas Gerais; World Health Organization; University of Split; University of Edinburgh; University of London; University College London	Pattinson, R (corresponding author), Univ Pretoria, Dept Obstet & Gynaecol, Med Res Council Maternal & Infant Hlth Care Strat, POB 667, ZA-0001 Pretoria, South Africa.	robert.pattinson@up.ac.za	Lawn, Joy/ABE-6382-2020; Rudan, Igor/I-1467-2012; Flenady, Vicki Jane/O-9609-2014	Lawn, Joy/0000-0002-4573-1443; Rudan, Igor/0000-0001-6993-6884; Flenady, Vicki Jane/0000-0001-8114-7677; Belizan, Maria/0000-0002-8739-5249; Froen Froen, Jahn Frederik/0000-0001-9390-8509	Bill & Melinda Gates Foundation; Global Alliance to Prevent Prematurity and Stillbirth; Partnership for Maternal, Newborn and Child Health	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Global Alliance to Prevent Prematurity and Stillbirth; Partnership for Maternal, Newborn and Child Health	Some technical work and travel for this report during 2010 were funded through a grant for The Lancet's Series from the Bill & Melinda Gates Foundation to the International Stillbirth Alliance secretariat. JEL and KK are funded by the Bill & Melinda Gates Foundation through Saving Newborn Lives/Save the Children. Some meetings and travel were partially funded by the Global Alliance to Prevent Prematurity and Stillbirth and the Partnership for Maternal, Newborn and Child Health. The funding organisations had no role in the drafting or direction of this report. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of their employers. We thank Robert Goldenberg for helpful insights and thoughtful review of this paper; and scorers for the Child Health and Nutrition Research Initiative research priority setting exercise (in alphabetical order): Hassan Baaqeel, Zulfiqar A Bhutta, Betty Chacko, Evita Fernandez, Rajshree Jha, Ruby Jose, James Machoki M'Imunya, Suneeta Mittal, Nafissa Bique Osman, Zahida Qureshi, Gary L Darmstadt, Louise Day, Nighat Shah, Nilofer Babar, Shabnam Khowaja, and Sidrah Nausheen for low-income countries; and Hany Abdel-Aleem, Jose M Belizan, Jackie Ho, Ravindran Jegasothy, Tippawan Liabsuetrakul, Deepika Attygalle, Eckhart Buchmann, Jose Guilherme Cecatti, Yolanda Contreras Garcia, Glen Mola, Neil Moran, Metin Gulmezoglu, Matthews Mathai, Jose Ortiz-Segarra, Robert Pattinson, Alejandro Vargas, Paulino Vigil-De Gracia, and Juan Carlos Vazquez for middle-income countries.	Althabe F, 2008, PAEDIATR PERINAT EP, V22, P42, DOI 10.1111/j.1365-3016.2007.00912.x; Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; [Anonymous], INT DRUG PRIC IND GU; Bala M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004704.pub2; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; BLENCOWE H, INT J EPIDEMIOL S1, V39, P110; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Chivu CM, 2008, AM J HEALTH PROMOT, V22, P237, DOI 10.4278/06051566R2.1; Darmstadt GL, 2008, HEALTH POLICY PLANN, V23, P101, DOI 10.1093/heapol/czn001; Darmstadt GL, 2009, INT J GYNECOL OBSTET, V107, pS89, DOI 10.1016/j.ijgo.2009.07.010; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; *GUTTM I, FACTS INV FAM PLANN; Hodnett ED, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003766.pub2; Hofmeyr GJ, 2009, INT J GYNECOL OBSTET, V107, pS21, DOI 10.1016/j.ijgo.2009.07.017; Hounton S, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1947; *INT HLTH PARTN, 2009, TASKF INN INT FIN HL; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Lagarde M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008137; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; LAWN J, 2005, TRACKING PROGR CHILD; LAWN J, 2005, DIS CONTROL PRIORITI; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S12; Lee ACC, 2009, INT J GYNECOL OBSTET, V107, pS65, DOI 10.1016/j.ijgo.2009.07.012; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; McClure EM, 2007, INT J GYNECOL OBSTET, V96, P139, DOI 10.1016/j.ijgo.2006.10.010; MEADS CA, 2008, HEALTH TECHNOL ASSES, V12, pR3, DOI DOI 10.3310/hta12060; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; OPIYO N, 2010, COCHRANE DB SYST REV, V4; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; Rudan I, 2008, CROAT MED J, V49, P720, DOI 10.3325/cmj.2008.49.720; Shiffman J, 2007, AM J PUBLIC HEALTH, V97, P796, DOI 10.2105/AJPH.2006.095455; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Shiffman J, 2009, B WORLD HEALTH ORGAN, V87, P608, DOI 10.2471/BLT.08.060749; Singh S, 2009, ADDING IT COSTS BENE; *SKILL CAR IN, 2007, TEST APPR INCR SKILL; SOWDEN A, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001291; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; UNICEF, SUPPL CAT; Victora CG, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S4; Vidanapathirana J, 2005, COCHRANE DB SYST REV, V3; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; *WHO, 2009, REC INT IMPR MAT NEW; *WHO, 2010, CHOOSING INT AR COST; WHO, 2010, TRENDS MAT MORT 1990; *WHO COMM MACR HLT, 2002, IMPR HLTH OUTC POOR; World Health Organization, 2005, WORLD HLTH REP 2005	62	122	122	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1610	1623		10.1016/S0140-6736(10)62306-9	http://dx.doi.org/10.1016/S0140-6736(10)62306-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763IJ	21496910	Green Submitted			2022-12-28	WOS:000290549700035
J	Papadopoulou, M; Cassenaer, S; Nowotny, T; Laurent, G				Papadopoulou, Maria; Cassenaer, Stijn; Nowotny, Thomas; Laurent, Gilles			Normalization for Sparse Encoding of Odors by a Wide-Field Interneuron	SCIENCE			English	Article							MUSHROOM BODY; OLFACTORY SYSTEM; ANTENNAL LOBE; LOCUST; CORTEX; REPRESENTATIONS; NEURONS; OSCILLATIONS; SEQUENCES; SYNAPSES	Sparse coding presents practical advantages for sensory representations and memory storage. In the insect olfactory system, the representation of general odors is dense in the antennal lobes but sparse in the mushroom bodies, only one synapse downstream. In locusts, this transformation relies on the oscillatory structure of antennal lobe output, feed-forward inhibitory circuits, intrinsic properties of mushroom body neurons, and connectivity between antennal lobe and mushroom bodies. Here we show the existence of a normalizing negative-feedback loop within the mushroom body to maintain sparse output over a wide range of input conditions. This loop consists of an identifiable "giant" nonspiking inhibitory interneuron with ubiquitous connectivity and graded release properties.	[Papadopoulou, Maria; Cassenaer, Stijn; Laurent, Gilles] CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA; [Cassenaer, Stijn] CALTECH, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA; [Nowotny, Thomas] Univ Sussex, Sch Informat, CCNR, Brighton BN1 9QJ, E Sussex, England; [Laurent, Gilles] Max Planck Inst Brain Res, D-60528 Frankfurt, Germany	California Institute of Technology; California Institute of Technology; University of Sussex; Max Planck Society	Laurent, G (corresponding author), CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA.	gilles.laurent@brain.mpg.de	Nowotny, Thomas/C-3883-2012; Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Nowotny, Thomas/0000-0002-4451-915X	National Institute for Deafness and Communications Disorders; Lawrence Hanson Fund; Max Planck Society; Office of Naval Research [N00014-07-1-0741, N00014-10-1-0735]; Evolved Machines, Inc.; Research Council of UK; Biotechnology and Biological Sciences Research Council (UK) [BB/F005113/1]; Biotechnology and Biological Sciences Research Council [BB/F005113/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E500315/1] Funding Source: researchfish; BBSRC [BB/F005113/1] Funding Source: UKRI	National Institute for Deafness and Communications Disorders; Lawrence Hanson Fund; Max Planck Society(Max Planck SocietyFoundation CELLEX); Office of Naval Research(Office of Naval Research); Evolved Machines, Inc.; Research Council of UK; Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank G. Turner fur help with early locust experiments; V. Jayaraman, G. Turner, and G. Jefferis for help with the Drosophila recordings (fig. S9); and the Caltech Imaging Center for use of a confocal microscope. This work was funded by the National Institute for Deafness and Communications Disorders (G.L.), the Lawrence Hanson Fund (G.L.), the Max Planck Society the Office of Naval Research (grants N00014-07-1-0741 and N00014-10-1-0735 to G.L. and S.C.), a grant from Evolved Machines, Inc. (G.L. and M.P.), a Research Council of UK Academic Fellowship, and a grant from the Biotechnology and Biological Sciences Research Council (UK grant number BB/F005113/1) (T.N.).	Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; BURROWS M, 1978, J PHYSIOL-LONDON, V285, P231, DOI 10.1113/jphysiol.1978.sp012569; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; Kanerva P., 1988, SPARSE DISTRIBUTED M; LAURENT G, 1994, J NEUROSCI, V14, P2993; Leitch B, 1996, J COMP NEUROL, V372, P487; Li YS, 1997, J COMP NEUROL, V387, P631; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; WATSON AHD, 1985, J COMP NEUROL, V240, P219, DOI 10.1002/cne.902400302; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	21	132	132	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					721	725		10.1126/science.1201835	http://dx.doi.org/10.1126/science.1201835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551062	Green Accepted			2022-12-28	WOS:000290265800044
J	Pei, YZ; Shi, XY; LaLonde, A; Wang, H; Chen, LD; Snyder, GJ				Pei, Yanzhong; Shi, Xiaoya; LaLonde, Aaron; Wang, Heng; Chen, Lidong; Snyder, G. Jeffrey			Convergence of electronic bands for high performance bulk thermoelectrics	NATURE			English	Article							TRANSPORT PHENOMENA; LEAD-CHALCOGENIDES; PBTE; TELLURIDE; ALLOYS; FIGURE; MERIT; POWER	Thermoelectric generators, which directly convert heat into electricity, have long been relegated to use in space-based or other niche applications, but are now being actively considered for a variety of practical waste heat recovery systems-such as the conversion of car exhaust heat into electricity. Although these devices can be very reliable and compact, the thermoelectric materials themselves are relatively inefficient: to facilitate widespread application, it will be desirable to identify or develop materials that have an intensive thermoelectric materials figure of merit, zT, above 1.5 (ref. 1). Many different concepts have been used in the search for new materials with high thermoelectric efficiency, such as the use of nanostructuring to reduce phonon thermal conductivity(2-4), which has led to the investigation of a variety of complex material systems(5). In this vein, it is well known(6,7) that a high valley degeneracy (typically <= 6 for known thermoelectrics) in the electronic bands is conducive to high zT, and this in turn has stimulated attempts to engineer such degeneracy by adopting low-dimensional nanostructures(8-10). Here we demonstrate that it is possible to direct the convergence of many valleys in a bulk material by tuning the doping and composition. By this route, we achieve a convergence of at least 12 valleys in doped PbTe(1-x)Se(x) alloys, leading to an extraordinary zT value of 1.8 at about 850 kelvin. Band engineering to converge the valence (or conduction) bands to achieve high valley degeneracy should be a general strategy in the search for and improvement of bulk thermoelectric materials, because it simultaneously leads to a high Seebeck coefficient and high electrical conductivity.	[Pei, Yanzhong; LaLonde, Aaron; Wang, Heng; Snyder, G. Jeffrey] CALTECH, Pasadena, CA 91125 USA; [Shi, Xiaoya; Chen, Lidong] Chinese Acad Sci, Shanghai Inst Ceram, CAS Key Lab Mat Energy Convers, Shanghai 200050, Peoples R China	California Institute of Technology; Chinese Academy of Sciences; Shanghai Institute of Ceramics, CAS	Snyder, GJ (corresponding author), CALTECH, Pasadena, CA 91125 USA.	jsnyder@caltech.edu	Snyder, G. Jeffrey/E-4453-2011; Chen, Lidong/F-2705-2010; Pei, Yanzhong/M-7840-2019; Pei, Yanzhong/E-4708-2011; shi, xiaoya/A-4934-2013; Snyder, G J/I-2263-2015; Wang, Heng/O-5418-2014	Snyder, G. Jeffrey/0000-0003-1414-8682; Pei, Yanzhong/0000-0003-1612-3294; Chen, Lidong/0000-0002-9683-037X	NASA-JPL; DARPA; CAS	NASA-JPL(National Aeronautics & Space Administration (NASA)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); CAS(Defence Research & Development Organisation (DRDO)Chinese Academy of Sciences)	This work was supported by NASA-JPL and the DARPA Nano Materials programme; the work at SIC-CAS was supported by CAS. We thank J.-P. Fleurial, S. Bux, D. Zoltan and F. Harris for measurements of transport properties at NASA's Jet Propulsion Laboratory and at ZT Plus Inc.	ALEKSEEV.GT, 1971, SOV PHYS SEMICOND+, V4, P1122; Androulakis J, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115209; ASHCROFT NW, 1976, SOLID STATE PHYS, pCH1; Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; Bilc D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.146403; BLACHNIK R, 1974, Z NATURFORSCH B, VB 29, P625, DOI 10.1515/znb-1974-9-1012; CHERNIK IA, 1968, SOV PHYS SEMICOND+, V2, P645; Crocker A. J., 1968, Journal de Physique, V29, pc4, DOI 10.1051/jphyscol:1968418; DiSalvo FJ, 1999, SCIENCE, V285, P703, DOI 10.1126/science.285.5428.703; Dresselhaus MS, 2007, ADV MATER, V19, P1043, DOI 10.1002/adma.200600527; Fritts R.W., 1960, THERMOELECTRIC MAT D, P143; Goldsmid H.J., 1964, THERMOELECTRIC REFRI; Heremans JP, 2008, SCIENCE, V321, P554, DOI 10.1126/science.1159725; Kanatzidis MG, 2010, CHEM MATER, V22, P648, DOI 10.1021/cm902195j; Koga T, 1998, APPL PHYS LETT, V73, P2950, DOI 10.1063/1.122640; KUDMAN I, 1972, J MATER SCI, V7, P1027, DOI 10.1007/BF00550066; LYDEN HA, 1964, PHYS REV A-GEN PHYS, V135, pA514, DOI 10.1103/PhysRev.135.A514; Mahan GD, 1998, SOLID STATE PHYS, V51, P81; NIMTZ G, 1983, SPRINGER TRACTS MOD, V98, P27; Pei YZ, 2011, ENERG ENVIRON SCI, V4, P2085, DOI 10.1039/c0ee00456a; Pei YZ, 2011, ADV FUNCT MATER, V21, P241, DOI 10.1002/adfm.201000878; Poudeu PFR, 2006, ANGEW CHEM INT EDIT, V45, P3835, DOI 10.1002/anie.200600865; Rabina O, 2001, APPL PHYS LETT, V79, P81, DOI 10.1063/1.1379365; Ravich Y.I., 1970, SEMICONDUCTING LEAD; RAVICH YI, 1971, PHYS STATUS SOLIDI B, V43, P11, DOI 10.1002/pssb.2220430102; Ravich YI, 2003, LEAD CHALCOGENIDES P, P1; Slack G. A., 1995, CRC HDB THERMOELECTR, P406; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; STRAUSS AJ, 1968, T METALL SOC AIME, V242, P354; TAUBER RN, 1966, J APPL PHYS, V37, P4855, DOI 10.1063/1.1708150	30	2727	2770	96	1786	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					66	69		10.1038/nature09996	http://dx.doi.org/10.1038/nature09996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544143				2022-12-28	WOS:000290218300031
J	Mestres, CA; Toshani, A; Hemdan, A; Alewa, AM; Bernal, JM				Mestres, Carlos-A; Toshani, Abdulhafiz; Hemdan, Abdulsamee; Alewa, Alewa M.; Bernal, Jose M.			Hydatid pericardial tamponade: a grape soup	LANCET			English	Editorial Material									[Mestres, Carlos-A; Toshani, Abdulhafiz; Hemdan, Abdulsamee; Alewa, Alewa M.; Bernal, Jose M.] Natl Heart Ctr, Dept Cardiac Surg, Tripoli, Libya		Mestres, CA (corresponding author), Natl Heart Ctr, Dept Cardiovasc Surg, Tripoli, Libya.	14144cml@comb.es							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2011	377	9780					1862	1862		10.1016/S0140-6736(10)61154-3	http://dx.doi.org/10.1016/S0140-6736(10)61154-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774UI	21550108				2022-12-28	WOS:000291411700032
J	Bader, M; Benjamin, S; Wapinski, OL; Smith, DM; Goldberg, AL; Steller, H				Bader, Maya; Benjamin, Sigi; Wapinski, Orly L.; Smith, David M.; Goldberg, Alfred L.; Steller, Hermann			A Conserved F Box Regulatory Complex Controls Proteasome Activity in Drosophila	CELL			English	Article							MEIOTIC CELL-CYCLE; CASPASE ACTIVITY; 20S PROTEASOMES; SPERMATID DIFFERENTIATION; PROTEIN-DEGRADATION; 26S PROTEASOMES; ACTIVATOR PA28; BETA-TUBULIN; CYTOCHROME-C; MELANOGASTER	The ubiquitin-proteasome system catalyzes the degradation of intracellular proteins. Although ubiquitination of proteins determines their stabilities, there is growing evidence that proteasome function is also regulated. We report the functional characterization of a conserved proteasomal regulatory complex. We identified DmPI31 as a binding partner of the F box protein Nutcracker, a component of an SCF ubiquitin ligase (E3) required for caspase activation during sperm differentiation in Drosophila. DmPI31 binds Nutcracker via a conserved mechanism that is also used by mammalian FBXO7 and PI31. Nutcracker promotes DmPI31 stability, which is necessary for caspase activation, proteasome function, and sperm differentiation. DmPI31 can activate 26S proteasomes in vitro, and increasing DmPI31 levels suppresses defects caused by diminished proteasome activity in vivo. Furthermore, loss of DmPI31 function causes lethality, cell-cycle abnormalities, and defects in protein degradation, demonstrating that DmPI31 is physiologically required for normal proteasome activity.	[Bader, Maya; Benjamin, Sigi; Wapinski, Orly L.; Steller, Hermann] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Smith, David M.; Goldberg, Alfred L.] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA	Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard Medical School	Steller, H (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	steller@rockefeller.edu	Smith, David/AAL-7662-2020	Smith, David/0000-0002-1502-676X	Rockefeller University; NIH [RO1GM60124]; NIGMS; Multiple Myeloma Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060124] Funding Source: NIH RePORTER	Rockefeller University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Multiple Myeloma Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to C. Zucker, R. Lehmann, HD, Ryoo, L. Vosshall, and J. Belote for fly strains. R. Lehmann generously shared the Vasa antibody. B. Chait and M. Sekedat were a tremendous help in setting up the proteomic screen. E. Arama devised the original male-sterile screen. Members of the Vosshall lab consulted on generating homologous recombination mutants and provided materials. K. Sobczyk participated in the proteasome-activity experiments. We thank M. Garcia-Fernandez and M. Pratt for critically reading this manuscript. O. Wapinski was supported by The Rockefeller University SURF Program. H. Steller is an investigator of the Howard Hughes Medical Institute. This work was supported by NIH grant RO1GM60124 to H.S. and by grants from the NIGMS and the Multiple Myeloma Foundation to A.L.G.	Alessandrini A, 1997, LEUKEMIA, V11, P342, DOI 10.1038/sj.leu.2400581; Arama E, 2006, EMBO J, V25, P232, DOI 10.1038/sj.emboj.7600920; Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bader M, 2010, DEVELOPMENT, V137, P1679, DOI 10.1242/dev.050088; Baker CC, 2007, DEVELOPMENT, V134, P2863, DOI 10.1242/dev.003764; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Belote JM, 2002, GENESIS, V34, P80, DOI 10.1002/gene.10131; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fujimuro M, 1997, EUR J BIOCHEM, V249, P427, DOI 10.1111/j.1432-1033.1997.00427.x; Fuller MT, 1998, SEMIN CELL DEV BIOL, V9, P433, DOI 10.1006/scdb.1998.0227; Fuller MT., 1993, DEV DROSOPHILA MELAN, VI; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; GAUHAR Z, 2008, DROSOPHILA MELANOGAS; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Haas KF, 2007, BIOL CELL, V99, P615, DOI 10.1042/BC20070019; Hime GR, 1996, J CELL SCI, V109, P2779; HOYLE HD, 1995, DEV GENET, V16, P148, DOI 10.1002/dvg.1020160208; Jin ZG, 2005, DEVELOPMENT, V132, P4075, DOI 10.1242/dev.01965; KEMPHUES KJ, 1980, CELL, V21, P445, DOI 10.1016/0092-8674(80)90481-X; Kirk R, 2008, J BIOL CHEM, V283, P22325, DOI 10.1074/jbc.M709900200; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lin TY, 1996, DEVELOPMENT, V122, P1331; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303, DOI 10.1016/0167-4838(92)90218-3; MA CP, 1992, J BIOL CHEM, V267, P10515; Masson P, 2001, J BIOL CHEM, V276, P1383, DOI 10.1074/jbc.M007379200; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Noguchi T, 2003, DEVELOPMENT, V130, P1805, DOI 10.1242/dev.00406; ORRWEAVER TL, 1994, TRENDS GENET, V10, P321, DOI 10.1016/0168-9525(94)90035-3; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tanahashi N, 1997, GENES CELLS, V2, P195, DOI 10.1046/j.1365-2443.1997.d01-308.x; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Ventadour S, 2006, CURR OPIN RHEUMATOL, V18, P631, DOI 10.1097/01.bor.0000245731.25383.de; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Zaiss DMW, 1999, FEBS LETT, V457, P333, DOI 10.1016/S0014-5793(99)01072-8; Zaiss DMW, 2002, P NATL ACAD SCI USA, V99, P14344, DOI 10.1073/pnas.212257299; Zhong L, 2007, DEVELOPMENT, V134, P3517, DOI 10.1242/dev.004770	52	66	72	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					371	382		10.1016/j.cell.2011.03.021	http://dx.doi.org/10.1016/j.cell.2011.03.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529711	Bronze, Green Accepted			2022-12-28	WOS:000290022900007
J	Stubbe, J				Stubbe, JoAnne			The Two Faces of SAM	SCIENCE			English	Editorial Material							PYRUVATE FORMATE-LYASE; RADICAL-SAM; S-ADENOSYLMETHIONINE; RIBOSOMAL-RNA; SYNTHASE; BIOSYNTHESIS; SUPERFAMILY; ENZYME; ACID; CFR		[Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stubbe, JoAnne] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Stubbe, J (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	stubbe@mit.edu						Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; BOAL AK, SCIENCE, DOI DOI 10.1126/SCIENCE.1205358; BOOKER SJ, 2010, REP, V2, P1; Chatterjee A, 2010, ANGEW CHEM INT EDIT, V49, P8653, DOI 10.1002/anie.201003419; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Kaminska KH, 2010, NUCLEIC ACIDS RES, V38, P1652, DOI 10.1093/nar/gkp1142; KNAPPE J, 1976, BIOCHEM BIOPH RES CO, V71, P1110, DOI 10.1016/0006-291X(76)90768-3; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Walsby CJ, 2002, J AM CHEM SOC, V124, P11270, DOI 10.1021/ja027078v; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y	13	9	9	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					544	545		10.1126/science.1204209	http://dx.doi.org/10.1126/science.1204209			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527702				2022-12-28	WOS:000289991100032
J	Blaszkowsky, LS; Cusack, JC; Hong, TS; Chung, DC; Blake, MA; Lennerz, JK				Blaszkowsky, Lawrence S.; Cusack, James C., Jr.; Hong, Theodore S.; Chung, Daniel C.; Blake, Michael A.; Lennerz, Jochen K.			A Man with Adenocarcinoma of the Rectum Rectal adenocarcinoma associated with the Lynch syndrome (hereditary nonpolyposis colorectal cancer), due to an MSH6 mutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOTAL MESORECTAL EXCISION; PREOPERATIVE RADIOTHERAPY; POSTOPERATIVE CHEMORADIOTHERAPY; MICROSATELLITE INSTABILITY; LOCAL RECURRENCE; COLON-CANCER; PREDISPOSITION; FLUOROURACIL; CHEMOTHERAPY; LEUCOVORIN		[Blaszkowsky, Lawrence S.] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA; [Cusack, James C., Jr.] Massachusetts Gen Hosp, Div Surg Oncol, Boston, MA 02114 USA; [Chung, Daniel C.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Hong, Theodore S.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Blake, Michael A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Lennerz, Jochen K.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Blaszkowsky, Lawrence S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Cusack, James C., Jr.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Hong, Theodore S.] Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA 02115 USA; [Blake, Michael A.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Lennerz, Jochen K.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Blaszkowsky, LS (corresponding author), Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA.							ADAM IJ, 1994, LANCET, V344, P707, DOI 10.1016/S0140-6736(94)92206-3; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; [Anonymous], 1985, NEW ENGL J MED, V312, P1465; Aschele C, 2009, J CLIN ONCOL, V27; Baglietto L, 2010, JNCI-J NATL CANCER I, V102, P193, DOI 10.1093/jnci/djp473; Berends MJW, 2002, AM J HUM GENET, V70, P26, DOI 10.1086/337944; Birgisson H, 2005, J CLIN ONCOL, V23, P8697, DOI 10.1200/JCO.2005.02.9017; Boland CR, 1998, CANCER RES, V58, P5248; Bosset JF, 2007, NEW ENGL J MED, V357, P728; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Bosset JF, 2005, J CLIN ONCOL, V23, P5620, DOI 10.1200/JCO.2005.02.113; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Engstrom PF, 2009, J NATL COMPR CANC NE, V7, P838, DOI 10.6004/jnccn.2009.0057; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Gerard J, 2009, J CLIN ONCOL, V27; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Gualdi GF, 2000, DIS COLON RECTUM, V43, P338, DOI 10.1007/BF02258299; Heald RJ, 1998, SEMIN SURG ONCOL, V15, P66, DOI 10.1002/(SICI)1098-2388(199809)15:2<66::AID-SSU2>3.0.CO;2-3; HEALD RJ, 1979, BRIT J HOSP MED, V22, P277; Hermanek P, 2003, INT J COLORECTAL DIS, V18, P335, DOI 10.1007/s00384-002-0468-6; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; KROOK JE, 1991, NEW ENGL J MED, V324, P709, DOI 10.1056/NEJM199103143241101; Lindor NM, 2006, JAMA-J AM MED ASSOC, V296, P1507, DOI 10.1001/jama.296.12.1507; Malkhosyan S, 1996, NATURE, V382, P499, DOI 10.1038/382499a0; Marijnen CAM, 2001, J CLIN ONCOL, V19, P1976, DOI 10.1200/JCO.2001.19.7.1976; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Pahlman L, 1997, NEW ENGL J MED, V336, P1539; Pahlman L, 1997, NEW ENGL J MED, V336, P980; Parfitt JR, 2007, J CLIN PATHOL, V60, P849, DOI 10.1136/jcp.2006.043802; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Roh MS, 2009, J CLIN ONCOL, V27, P5124, DOI 10.1200/JCO.2009.22.0467; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; Suchy J, 2008, HERED CANCER CLIN PR, V6, P103, DOI 10.1186/1897-4287-6-2-103; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; WILLETT C, 2007, J CLIN ONCOL S, V25, pS173; Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771	39	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1658	1668		10.1056/NEJMcpc1011321	http://dx.doi.org/10.1056/NEJMcpc1011321			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755NW	21524217				2022-12-28	WOS:000289940400014
J	Geller, RJ				Geller, Robert J.			Shake-up time for Japanese seismology	NATURE			English	Editorial Material							EARTHQUAKE		Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 1130033, Japan	University of Tokyo	Geller, RJ (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 1130033, Japan.	bob@eps.s.u-tokyo.ac.jp	Geller, Robert J/A-1753-2009	Geller, Robert J/0000-0001-6628-9431				ANDO M, 1975, TECTONOPHYSICS, V25, P69, DOI 10.1016/0040-1951(75)90011-6; ANDO M, 1975, TECTONOPHYSICS, V27, P119, DOI 10.1016/0040-1951(75)90102-X; Geller RJ, 1997, GEOPHYS J INT, V131, P425, DOI 10.1111/j.1365-246X.1997.tb06588.x; Headquarters for Earthquake Research Promotion, 2005, NAT SEISM HAZ MAPS J; Kagan YY, 1996, B SEISMOL SOC AM, V86, P274; KAGAN YY, 1991, J GEOPHYS RES-SOL EA, V96, P21419, DOI 10.1029/91JB02210; Kanamori H., 1995, SEISMOL RES LETT, V66, P7; McCaffrey R, 2008, GEOLOGY, V36, P263, DOI 10.1130/G24402A.1; Newman A., 2001, SEISMOLOGICAL RES LE, V72, P647; 1973, NATURE, V245, P174	10	133	136	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					407	409		10.1038/nature10105	http://dx.doi.org/10.1038/nature10105			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	755QC	21490595	Bronze			2022-12-28	WOS:000289949600009
J	Sokol, DK				Sokol, Daniel K.			The lawyer's brief on ethics The parallels between legal and medical ethics are clear	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						MORTIMER J, 1995, 3 RUMPOLE OMNIBUS, P614	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 27	2011	342								d1815	10.1136/bmj.d1815	http://dx.doi.org/10.1136/bmj.d1815			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759BT	21525093				2022-12-28	WOS:000290215600001
J	Montagu, D; Yamey, G				Montagu, Dominic; Yamey, Gavin			Pay-for-performance and the Millennium Development Goals	LANCET			English	Editorial Material									[Montagu, Dominic; Yamey, Gavin] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94105 USA	University of California System; University of California San Francisco	Montagu, D (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94105 USA.	montagud@globalhealth.ucsf.edu						[Anonymous], 2009, PERFORMANCE INCENTIV; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Eichler R., 2007, PERFORMANCE BASED IN; Eldridge C, 2009, HEALTH POLICY PLANN, V24, P160, DOI 10.1093/heapol/czp002; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Lavis JN, 2009, HEALTH RES POLICY SY, V7, DOI [10.1186/1478-4505-7-S1-S1, 10.1186/1478-4505-7-S1-11, 10.1186/1478-4505-7-S1-S15, 10.1186/1478-4505-7-S1-I1]; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Oxman Andrew D, 2009, J Evid Based Med, V2, P70, DOI 10.1111/j.1756-5391.2009.01020.x; RUSA L, 2007, RWANDA PERFORMANCE B; Werner RM, 2011, HEALTH AFFAIR, V30, P690, DOI 10.1377/hlthaff.2010.1277	11	12	12	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 23	2011	377	9775					1383	1385		10.1016/S0140-6736(11)60544-8	http://dx.doi.org/10.1016/S0140-6736(11)60544-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UF	21515147	Green Submitted			2022-12-28	WOS:000289963000005
J	Bonnin, A; Goeden, N; Chen, K; Wilson, ML; King, J; Shih, JC; Blakely, RD; Deneris, ES; Levitt, P				Bonnin, Alexandre; Goeden, Nick; Chen, Kevin; Wilson, Melissa L.; King, Jennifer; Shih, Jean C.; Blakely, Randy D.; Deneris, Evan S.; Levitt, Pat			A transient placental source of serotonin for the fetal forebrain	NATURE			English	Article							NORMAL ANXIETY-LIKE; TRYPTOPHAN 2,3-DIOXYGENASE; AGGRESSIVE-BEHAVIOR; MONOAMINE-OXIDASE; BRAIN-SEROTONIN; EXPRESSION; MICE; TRANSPORTER; NEURONS; PREGNANCY	Serotonin (5-hydroxytryptamine or 5-HT) is thought to regulate neurodevelopmental processes through maternal-fetal interactions that have long-term mental health implications. It is thought that beyond fetal 5-HT neurons there are significant maternal contributions to fetal 5-HT during pregnancy(1,2) but this has not been tested empirically. To examine putative central and peripheral sources of embryonic brain 5-HT, we used Pet1(-/-) (also called Fev) mice in which most dorsal raphe neurons lack 5-HT3. We detected previously unknown differences in accumulation of 5-HT between the forebrain and hindbrain during early and late fetal stages, through an exogenous source of 5-HT which is not of maternal origin. Using additional genetic strategies, a new technology for studying placental biology ex vivo and direct manipulation of placental neosynthesis, we investigated the nature of this exogenous source. We uncovered a placental 5-HT synthetic pathway from a maternal tryptophan precursor in both mice and humans. This study reveals a new, direct role for placental metabolic pathways in modulating fetal brain development and indicates that maternal-placental-fetal interactions could underlie the pronounced impact of 5-HT on long-lasting mental health outcomes.	[Bonnin, Alexandre; Goeden, Nick; Levitt, Pat] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Bonnin, Alexandre; Levitt, Pat] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; [Chen, Kevin; Shih, Jean C.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Wilson, Melissa L.; King, Jennifer] Univ So Calif, Keck Sch Med, Dept OB GYN, Los Angeles, CA 90089 USA; [Wilson, Melissa L.; King, Jennifer] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Blakely, Randy D.] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37221 USA; [Blakely, Randy D.] Vanderbilt Univ, Ctr Mol Neurosci, Med Ctr, Nashville, TN 37221 USA; [Deneris, Evan S.] Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Vanderbilt University; Vanderbilt University; Case Western Reserve University	Bonnin, A (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA.	bonnin@usc.edu; plevitt@usc.edu	Wilson, Melissa/P-3100-2017; Chen, Kevin/GYU-8963-2022	Wilson, Melissa/0000-0001-7785-4221; 	NICHD [5R21HD065287]; NARSAD; NIMH [R01MH39085, 1P50MH078280A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039085, P50MH078028] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NARSAD(NARSAD); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank H. H. Wu and K. Eagleson for discussions and comments on the manuscript. We thank R. Johnson (Vanderbilt HPLC core facility), L. Zhang for technical help and E. Meng for discussions. This work was supported by the NICHD (grant 5R21HD065287 to A. B.), NARSAD (A. B.) and the NIMH (grant R01MH39085 to J.C.S. and 1P50MH078280A1 to R. D. B. and P.L.).	AITKEN AR, 1988, J COMP NEUROL, V274, P32, DOI 10.1002/cne.902740105; Anderson GM, 2002, MOL PSYCHIATR, V7, P831, DOI 10.1038/sj.mp.4001099; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; BALKOVETZ DF, 1989, J BIOL CHEM, V264, P2195; Bonnin A, 2006, NEUROSCIENCE, V141, P781, DOI 10.1016/j.neuroscience.2006.04.036; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; BRANCHEK TA, 1989, J COMP NEUROL, V285, P262, DOI 10.1002/cne.902850208; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Buznikov GA, 2001, CELL TISSUE RES, V305, P177, DOI 10.1007/s004410100408; Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; Chen K, 2007, J BIOL CHEM, V282, P115, DOI 10.1074/jbc.M609830200; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; HOWD RA, 1975, LIFE SCI, V17, P803, DOI 10.1016/0024-3205(75)90538-X; Jawerbaum A, 2010, ENDOCR REV, V31, P680, DOI 10.1210/er.2009-0038; JOHANSEN PA, 1995, J NEUROCHEM, V65, P882; Kanai M, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-8; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; KOE BK, 1966, J PHARMACOL EXP THER, V154, P499; KUHN DM, 1980, J BIOL CHEM, V255, P4137; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; Lebrand C, 1998, J COMP NEUROL, V401, P506; LIDOV HGW, 1982, BRAIN RES BULL, V9, P559, DOI 10.1016/0361-9230(82)90164-2; Lynn-Bullock CP, 2004, J CHEM NEUROANAT, V27, P129, DOI 10.1016/j.jchemneu.2004.02.003; Miller CL, 2009, SCHIZOPHR RES, V113, P259, DOI 10.1016/j.schres.2009.05.014; Nabi R, 2004, AM J MED GENET B, V125B, P63, DOI 10.1002/ajmg.b.20147; Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; ROBSON JM, 1964, BRIT J PHARM CHEMOTH, V22, P380, DOI 10.1111/j.1476-5381.1964.tb02043.x; Scott AL, 2008, NEUROREPORT, V19, P739, DOI 10.1097/WNR.0b013e3282fd6e88; Suzuki S, 2001, BIOCHEM J, V355, P425, DOI 10.1042/0264-6021:3550425; Taylor SE, 2006, BIOL PSYCHIAT, V60, P671, DOI 10.1016/j.biopsych.2006.04.019; YAVARONE MS, 1993, PLACENTA, V14, P149, DOI 10.1016/S0143-4004(05)80257-7	35	363	371	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					347	U246		10.1038/nature09972	http://dx.doi.org/10.1038/nature09972			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21512572	Green Accepted, Green Published			2022-12-28	WOS:000289724600039
J	Zwarenstein, M; Fairall, LR; Lombard, C; Mayers, P; Bheekie, A; English, RG; Lewin, S; Bachmann, MO; Bateman, E				Zwarenstein, Merrick; Fairall, Lara R.; Lombard, Carl; Mayers, Pat; Bheekie, Angeni; English, Rene G.; Lewin, Simon; Bachmann, Max O.; Bateman, Eric			Outreach education for integration of HIV/AIDS care, antiretroviral treatment, and tuberculosis care in primary care clinics in South Africa: PALSA PLUS pragmatic cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SUB-SAHARAN AFRICA; RESOURCE-POOR SETTINGS; EXPANDING ACCESS; HIV TREATMENT; HEALTH; THERAPY; DELIVERY; SERVICES; WILL; AIDS	Objective To investigate whether PALSA PLUS, an on-site educational outreach programme of non-didactic, case based, iterative clinical education of staff, led by a trainer, can increase access to and comprehensiveness of care for patients with HIV/AIDS. Design Cluster randomised trial. Setting Public primary care clinics offering HIV/AIDS care, antiretroviral treatment (ART), tuberculosis care, and ambulatory primary care in Free State province, South Africa. Participants Fifteen clinics all implementing decentralisation and task shifting were randomised. The clinics cared for 400 000 general primary care patients and 10 136 patients in an HIV/AIDS/ART programme. There were 150 nurses. Intervention On-site outreach education in eight clinics; no such education in seven (control). Main outcome measures Provision of co-trimoxazole prophylaxis among patients referred to the HIV/AIDS/ART programme, and detection of cases of tuberculosis among those in the programme. Proportion of patients in the programme enrolled through general primary care consultations. Results Patients referred to the HIV/AIDS programme through general primary care at intervention clinics were more likely than those at control clinics to receive co-trimoxazole prophylaxis (41%, (2253/5523) v 32% (1340/4210); odds ratio 1.95, 95% confidence interval 1.11 to 3.40), and tuberculosis was more likely to be diagnosed among patients with HIV/AIDS/ART (7% (417/5793) v 6% (245/4343); 1.25, 1.01 to 1.55). Enrolment in the HIV/AIDS and ART programme through HIV testing in general primary care was not significantly increased (53% v 50%; 1.19, 0.51 to 2.77). Secondary outcomes were similar, except for weight gain, which was higher in the intervention group (2.3 kg v 1.9 kg, P<0.001). Conclusion Though outreach education is an effective and feasible strategy for improving comprehensiveness of care and wellbeing of patients with HIV/AIDS, there is no evidence that it increases access to the ART programme. It is now being widely implemented in South Africa.	[Zwarenstein, Merrick] Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Zwarenstein, Merrick; Fairall, Lara R.; Mayers, Pat; English, Rene G.; Lewin, Simon; Bachmann, Max O.] Univ Cape Town, Lung Inst, Knowledge Translat Unit, ZA-7925 Cape Town, South Africa; [Lombard, Carl] MRC, Biostat Unit, Cape Town, South Africa; [Fairall, Lara R.; Bateman, Eric] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Mayers, Pat] Univ Cape Town, Div Nursing & Midwifery, ZA-7925 Cape Town, South Africa; [Bheekie, Angeni] Univ Western Cape, Sch Pharm, ZA-7535 Bellville, South Africa; [Lewin, Simon] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Zwarenstein, Merrick] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Bachmann, Max O.] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Zwarenstein, Merrick] Karolinska Inst, IHCAR, Stockholm, Sweden; [Lewin, Simon] MRC, Hlth Syst Res Unit, Cape Town, South Africa	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Cape Town; University of Cape Town; University of Cape Town; University of the Western Cape; Norwegian Knowledge Centre for Health Services; University of Toronto; University of East Anglia; Karolinska Institutet	Zwarenstein, M (corresponding author), Sunnybrook Res Inst, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	merrick.zwarenstein@ices.on.ca	Zwarenstein, Merrick F/P-5210-2014; Mayers, Pat M/B-7224-2016	Zwarenstein, Merrick F/0000-0003-0162-7027; Mayers, Pat M/0000-0002-2622-1624; Bachmann, Max Oscar/0000-0003-1770-3506; Lombard, Carl/0000-0002-2136-6533; Fairall, Lara/0000-0002-7460-4670	International Development Research Centre (IDRC) of Canada	International Development Research Centre (IDRC) of Canada	The study was funded by the International Development Research Centre (IDRC) of Canada, who had no role in study design, in the collection, analysis, and interpretation of data, in the writing of the article, or in the decision to submit it for publication. The researchers were completely independent of IDRC.	Assefa Y, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000056; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bendavid E, 2009, ANN INTERN MED, V150, P688, DOI 10.7326/0003-4819-150-10-200905190-00117; Bheekie A, 2006, INT NURS REV, V53, P261, DOI 10.1111/j.1466-7657.2006.00520.x; Calmy A, 2004, AIDS, V18, P2353; CAMPBELL M, 1999, CLUSTER SAMPLE SIZE; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chaisson RE, 2008, NEW ENGL J MED, V358, P1089, DOI 10.1056/NEJMp0800809; CHAPMAN R, 2003, PROPOSED PLAN IMPLEM; Coetzee D, 2004, TROP MED INT HEALTH, V9, pA11, DOI 10.1111/j.1365-3156.2004.01259.x; Colvin CJ, 2010, SAMJ S AFR MED J, V100, P210, DOI 10.7196/SAMJ.4124; *DEP HLTH, 2010, TUB HIV AIDS CLIN GU; Dong K, 2007, J INFECT DIS, V196, pS491, DOI 10.1086/521111; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Fairall LR, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-21; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Frenk J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000089; *GLOB FUND, GLOB FUND GRANTS PRO; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Groenewald P, 2005, AIDS, V19, P193, DOI 10.1097/00002030-200501280-00012; Harries AD, 2008, T ROY SOC TROP MED H, V102, P310, DOI 10.1016/j.trstmh.2008.01.005; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Kurowski C, 2007, HEALTH POLICY PLANN, V22, P113, DOI 10.1093/heapol/czm012; McCoy D, 2005, AM J PUBLIC HEALTH, V95, P18, DOI 10.2105/AJPH.2004.040121; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; Ovretveit J, 2009, DIR DEV, P35; Oxman AD, 2010, LANCET, V375, P427, DOI 10.1016/S0140-6736(09)61251-4; Pfeiffer J, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-3; Philips M, 2008, LANCET, V371, P682, DOI 10.1016/S0140-6736(08)60307-4; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; *S AFR GOV INF, 2003, OP PLAN COMPR HIV AI; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; SCHULL M, 2010, STRENGTHENING HUMAN; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Statistics South Africa, 2005, MORT CAUS DEATH S AF; Stein J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-240; Steinbrook R, 2007, NEW ENGL J MED, V357, P1996, DOI 10.1056/NEJMp0706918; Topp SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011522; *UNAIDS, 2006, ASS REP SCAL UN ACC; Van Damme W, 2008, SOC SCI MED, V66, P2108, DOI 10.1016/j.socscimed.2008.01.043; WEI LJ, 1988, CONTROL CLIN TRIALS, V9, P345, DOI 10.1016/0197-2456(88)90048-7; *WHO, 2006, HLTH SYST SERV TAK S; *WHO, 2008, TASK SHIFT RAT RED T, V1; *WHO, 2010, PROGR GLOB AIDS ACC; Wood R, 2007, J INFECT DIS, V196, pS497, DOI 10.1086/521118	46	60	61	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2011	342								d2022	10.1136/bmj.d2022	http://dx.doi.org/10.1136/bmj.d2022			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OR	21511783	hybrid, Green Published			2022-12-28	WOS:000289943400003
J	Cnattingius, S; Stephansson, O				Cnattingius, Sven; Stephansson, Olof			The challenges of reducing risk factors for stillbirths	LANCET			English	Editorial Material							PREGNANCY; OUTCOMES; EPIDEMIOLOGY; SWEDISH		[Cnattingius, Sven; Stephansson, Olof] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden	Karolinska Institutet	Cnattingius, S (corresponding author), Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden.	sven.cnattingius@ki.se		Stephansson, Olof/0000-0003-1528-4563				Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Fretts R, 2010, CLIN OBSTET GYNECOL, V53, P588, DOI 10.1097/GRF.0b013e3181eb63fc; Gissler M, 2009, ACTA OBSTET GYN SCAN, V88, P134, DOI 10.1080/00016340802603805; Kinnunen TI, 2007, EUR J CLIN NUTR, V61, P884, DOI 10.1038/sj.ejcn.1602602; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; Maggard MA, 2008, JAMA-J AM MED ASSOC, V300, P2286, DOI 10.1001/jama.2008.641; McDonald SD, 2005, J OBSTET GYNAECOL CA, V27, P449, DOI 10.1016/S1701-2163(16)30527-8; Nygren KG, 2007, ACTA OBSTET GYN SCAN, V86, P774, DOI 10.1080/00016340701446231; Official Statistics of Sweden National Board of Health and Welfare, 2009, SWED MED BIRTH REG 1; Smith GCS, 2010, CLIN OBSTET GYNECOL, V53, P597, DOI 10.1097/GRF.0b013e3181eb64a6; Surkan PJ, 2004, NEW ENGL J MED, V350, P777, DOI 10.1056/NEJMoa031587; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Wikstrom AK, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.003; Wikstrom AK, 2010, EPIDEMIOLOGY, V21, P772, DOI 10.1097/EDE.0b013e3181f20d7e	15	7	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2011	377	9774					1294	1295		10.1016/S0140-6736(11)60027-5	http://dx.doi.org/10.1016/S0140-6736(11)60027-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UE	21496918				2022-12-28	WOS:000289962900006
J	Morris, K				Morris, Kelly			Shershah Syed: improving maternal care in Pakistan	LANCET			English	Editorial Material												kellyvitalwriter@gmail.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1309	1309		10.1016/S0140-6736(11)60527-8	http://dx.doi.org/10.1016/S0140-6736(11)60527-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21497689	Bronze			2022-12-28	WOS:000289962900016
J	Mullan, Z; Horton, R				Mullan, Zoe; Horton, Richard			Bringing stillbirths out of the shadows	LANCET			English	Editorial Material									[Mullan, Zoe; Horton, Richard] The Lancet, London NW1 7BY, England		Mullan, Z (corresponding author), The Lancet, London NW1 7BY, England.	zoe.mullan@lancet.com						BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; *STILLB NEON DEATH, WHAT IS WHY 17; World Health Organization, GLOB BURD DIS GBD	10	43	46	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1291	1292		10.1016/S0140-6736(11)60098-6	http://dx.doi.org/10.1016/S0140-6736(11)60098-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21496920				2022-12-28	WOS:000289962900004
J	Aubin-Tam, ME; Olivares, AO; Sauer, RT; Baker, TA; Lang, MJ				Aubin-Tam, Marie-Eve; Olivares, Adrian O.; Sauer, Robert T.; Baker, Tania A.; Lang, Matthew J.			Single-Molecule Protein Unfolding and Translocation by an ATP-Fueled Proteolytic Machine	CELL			English	Article							PLUS CLPXP PROTEASE; OPERATING PRINCIPLES; DEPENDENT PROTEASES; DEGRADATION MACHINE; FORCE SPECTROSCOPY; RNA-POLYMERASE; PORE LOOPS; DENATURATION; RECOGNITION; BINDING	All cells employ ATP-powered proteases for protein-quality control and regulation. In the ClpXP protease, ClpX is a AAA+ machine that recognizes specific protein substrates, unfolds these molecules, and then translocates the denatured polypeptide through a central pore and into ClpP for degradation. Here, we use optical-trapping nanometry to probe the mechanics of enzymatic unfolding and translocation of single molecules of a multidomain substrate. Our experiments demonstrate the capacity of ClpXP and ClpX to perform mechanical work under load, reveal very fast and highly cooperative unfolding of individual substrate domains, suggest a translocation step size of 5-8 amino acids, and support a power-stroke model of denaturation in which successful enzyme-mediated unfolding of stable domains requires coincidence between mechanical pulling by the enzyme and a transient stochastic reduction in protein stability. We anticipate that single-molecule studies of the mechanical properties of other AAA+ proteolytic machines will reveal many shared features with ClpXP.	[Aubin-Tam, Marie-Eve; Olivares, Adrian O.; Sauer, Robert T.; Baker, Tania A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Aubin-Tam, Marie-Eve; Lang, Matthew J.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Lang, Matthew J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Baker, TA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tabaker@mit.edu; matt.lang@vanderbilt.edu	Aubin-Tam, Marie-Eve/J-3337-2013; Olivares, Adrian/D-7717-2012; Aubin-Tam, Marie-Eve/F-5253-2012	Aubin-Tam, Marie-Eve/0000-0001-9995-2623; Olivares, Adrian/0000-0002-0895-7988; Sauer, Robert/0000-0002-1719-5399	National Science Foundation [0643745]; Howard Hughes Medical Institute; National Institutes of Health [AI-15706, AI-82929]; Direct For Biological Sciences [1118490] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015706, F32AI082929, R37AI015706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101988] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Nakamura for filamin-A plasmids and S. Glynn, J. Kardon, A. Nager, B. Stinson, Y. Shin, and other members of our labs for advice and discussions. This study was supported by National Science Foundation Career Award 0643745 (M.J.L.), the Howard Hughes Medical Institute, and National Institutes of Health grants AI-15706 and AI-82929 (A.O.O.). T.A.B. is an employee of the Howard Hughes Medical Institute.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Aubin-Tam ME, 2011, J PHYS CHEM A, V115, P3657, DOI 10.1021/jp1031493; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Burton BM, 2001, MOL CELL, V8, P449, DOI 10.1016/S1097-2765(01)00307-0; Burton RE, 2003, PROTEIN SCI, V12, P893, DOI 10.1110/ps.0237603; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Ferrer JM, 2008, P NATL ACAD SCI USA, V105, P9221, DOI 10.1073/pnas.0706124105; Fucini P, 1997, NAT STRUCT BIOL, V4, P223, DOI 10.1038/nsb0397-223; Furuike S, 2001, FEBS LETT, V498, P72, DOI 10.1016/S0014-5793(01)02497-8; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Greenleaf WJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208102; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Hollien J, 1999, P NATL ACAD SCI USA, V96, P13674, DOI 10.1073/pnas.96.24.13674; Hwang W, 2009, CELL BIOCHEM BIOPHYS, V54, P11, DOI 10.1007/s12013-009-9049-4; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Los GV, 2007, METH MOL B, V356, P195; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schlierf M, 2007, BIOPHYS J, V93, P3989, DOI 10.1529/biophysj.107.114397; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shin Y, 2009, P NATL ACAD SCI USA, V106, P19340, DOI 10.1073/pnas.0910484106; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Taniguchi Y, 2010, LANGMUIR, V26, P10433, DOI 10.1021/la101658a; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200	49	189	191	1	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					257	267		10.1016/j.cell.2011.03.036	http://dx.doi.org/10.1016/j.cell.2011.03.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496645	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000289549900014
J	Rubbia, C				Rubbia, Carlo			Simon van der Meer (1925-2011) OBITUARY	NATURE			English	Biographical-Item									CERN, CH-1211 Geneva 23, Switzerland	European Organization for Nuclear Research (CERN)	Rubbia, C (corresponding author), CERN, CH-1211 Geneva 23, Switzerland.	carlo.rubbia@cern.ch						VANDERMEER S, PUBLICATION LIST	1	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					170	170		10.1038/472170a	http://dx.doi.org/10.1038/472170a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21490660	Bronze			2022-12-28	WOS:000289469100026
J	Nishtar, S; Mehboob, AB				Nishtar, Sania; Mehboob, Ahmed Bilal			Pakistan prepares to abolish Ministry of Health	LANCET			English	Editorial Material									[Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Mehboob, Ahmed Bilal] Pakistan Inst Legislat Dev & Transparency, Islamabad 44000, Pakistan		Nishtar, S (corresponding author), Heartfile, Islamabad, Pakistan.	sania@heartfile.org						[Anonymous], NTS WORKING PAPER SE; Clapham A., 2009, REALIZING RIGHT HLTH	2	21	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 20	2011	378	9792					648	649		10.1016/S0140-6736(11)60606-5	http://dx.doi.org/10.1016/S0140-6736(11)60606-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815EW	21549420				2022-12-28	WOS:000294509900009
J	Lee, H; Chah, OK; Sheen, J				Lee, Horim; Chah, Ok-Kyong; Sheen, Jen			Stem-cell-triggered immunity through CLV3p-FLS2 signalling	NATURE			English	Article							RECEPTOR-LIKE KINASE; BACTERIAL ELICITOR FLAGELLIN; RICH REPEAT DOMAIN; ARABIDOPSIS-THALIANA; INNATE IMMUNITY; PERCEPTION; FLS2; CLAVATA1; MERISTEM; RESISTANCE	Stem cells in the shoot apical meristem (SAM) of plants are the self-renewable reservoir for leaf, stem and flower organogenesis(1,2). In nature, disease-free plants can be regenerated from SAM despite infections elsewhere, which underlies a horticultural practice for decades(3). However, the molecular basis of the SAM immunity remains unclear. Here we show that the CLAVATA3 peptide (CLV3p), expressed and secreted from stem cells and functioning as a key regulator of stem-cell homeostasis in the SAM of Arabidopsis(1,2,4), can trigger immune signalling and pathogen resistance via the flagellin receptor kinase FLS2 (refs 5, 6). CLV3p-FLS2 signalling acts independently from the stem-cell signalling pathway mediated through CLV1 and CLV2 receptors(1,2,4), and is uncoupled from FLS2-mediated growth suppression(5,6). Endogenous CLV3p perception in the SAM by a pattern recognition receptor for bacterial flagellin, FLS2, breaks the previously defined self and non-self discrimination in innate immunity(6,7). The dual perception of CLV3p illustrates co-evolution of plant peptide and receptor kinase signalling for both development and immunity. The enhanced immunity in SAM or germ lines may represent a common strategy towards immortal fate in plants and animals(1,2,8).	[Lee, Horim; Chah, Ok-Kyong; Sheen, Jen] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Lee, Horim; Chah, Ok-Kyong; Sheen, Jen] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Lee, Horim; Chah, Ok-Kyong; Sheen, Jen] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, H (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	hrlee@molbio.mgh.harvard.edu; sheen@molbio.mgh.harvard.edu	Lee, Horim/I-6180-2019		NSF; NIH; MGH CCIB fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060493, R01GM070567] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH CCIB fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Laux for the pWUS::GUS line, Y. Matsubayashi for the purified Ara-CLV3 peptide and advice, A. Collmer for the GFP-labelled P. syringae pv. tomato DC3000, L. Shan and P. He for constructs, G. Tena, F. Ausubel, J. Bush, J. Plotnikova and ABRC for mutant seeds and bacterial strains, and Y. Xiong, M. McCormack, Y. Niu, M. Ramon and J. Li for critically reading of the manuscript. Funding was provided by the NSF, NIH and the MGH CCIB fund to J.S.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; Baurle I, 2005, PLANT CELL, V17, P2271, DOI 10.1105/tpc.105.032623; Baurle I, 2003, BIOESSAYS, V25, P961, DOI 10.1002/bies.10341; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Butenko MA, 2009, TRENDS PLANT SCI, V14, P255, DOI 10.1016/j.tplants.2009.02.002; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; Dievart A, 2003, PLANT CELL, V15, P1198, DOI 10.1105/tpc.010504; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fiers M, 2006, PLANT PHYSIOL, V141, P1284, DOI 10.1104/pp.106.080671; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Goldsby RA, 2006, KUBY IMMUNOLOGY; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; HOLLINGS M, 1965, ANNU REV PHYTOPATHOL, V3, P367, DOI 10.1146/annurev.py.03.090165.002055; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Jun JH, 2008, CELL MOL LIFE SCI, V65, P743, DOI 10.1007/s00018-007-7411-5; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; KOORNNEEF M, 1983, J HERED, V74, P265, DOI 10.1093/oxfordjournals.jhered.a109781; Miwa H, 2008, PLANT CELL PHYSIOL, V49, P1752, DOI 10.1093/pcp/pcn148; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182; Scheres B, 2005, CELL, V122, P499, DOI 10.1016/j.cell.2005.08.006; Schreiber K, 2008, PLANT J, V54, P522, DOI 10.1111/j.1365-313X.2008.03425.x; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yamamizo C, 2006, PLANT PHYSIOL, V140, P681, DOI 10.1104/pp.105.074906; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	40	57	61	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					376	U559		10.1038/nature09958	http://dx.doi.org/10.1038/nature09958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21499263	Green Accepted			2022-12-28	WOS:000290722400049
J	Knight, MW; Sobhani, H; Nordlander, P; Halas, NJ				Knight, Mark W.; Sobhani, Heidar; Nordlander, Peter; Halas, Naomi J.			Photodetection with Active Optical Antennas	SCIENCE			English	Article							SURFACE-PLASMONS; SILVER; PHOTOEMISSION; METALS; NANOPARTICLES; NANOCRYSTALS; NANORODS; FILMS; DECAY	Nanoantennas are key optical components for light harvesting; photodiodes convert light into a current of electrons for photodetection. We show that these two distinct, independent functions can be combined into the same structure. Photons coupled into a metallic nanoantenna excite resonant plasmons, which decay into energetic, "hot" electrons injected over a potential barrier at the nanoantenna-semiconductor interface, resulting in a photocurrent. This dual-function structure is a highly compact, wavelength-resonant, and polarization-specific tight detector, with a spectral response extending to energies well below the semiconductor band edge.	[Knight, Mark W.; Sobhani, Heidar; Nordlander, Peter; Halas, Naomi J.] Rice Univ, Dept Elect & Comp Engn, Houston, TX 77005 USA; [Knight, Mark W.; Sobhani, Heidar; Nordlander, Peter; Halas, Naomi J.] Rice Univ, Lab Nanophoton, Houston, TX 77005 USA; [Nordlander, Peter; Halas, Naomi J.] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA	Rice University; Rice University; Rice University	Halas, NJ (corresponding author), Rice Univ, Dept Elect & Comp Engn, Houston, TX 77005 USA.	halas@rice.edu	Knight, Mark W/E-3089-2010; Selopal, Gurpreet Singh/D-5801-2018; Halas, Naomi/D-2935-2011; Nordlander, Peter J. A./A-2560-2008	Knight, Mark W/0000-0001-7625-403X; Halas, Naomi/0000-0002-8461-8494; Nordlander, Peter J. A./0000-0002-1633-2937	NSF; U.S. Department of Defense [N00244-09-1-0067]; Robert A. Welch Foundation [C-1220, C-1222]; Office of Naval Research [N00014-10-1-0989]; Air Force Office of Scientific Research [F49620-03-C-0068]; U.S. Department of Energy	NSF(National Science Foundation (NSF)); U.S. Department of Defense(United States Department of Defense); Robert A. Welch Foundation(The Welch Foundation); Office of Naval Research(Office of Naval Research); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); U.S. Department of Energy(United States Department of Energy (DOE))	We thank J. B. Lassiter, J. Day, R. Huschka, A. Schlather, and S. Lal for their insight and input. Supported by NSF Integrative Graduate Research and Educational Training program in Nanophotonics grant DGE-0504425 (M.W.K.), National Security Science and Engineering Faculty Fellowship program of the U.S. Department of Defense grant N00244-09-1-0067, Robert A. Welch Foundation grants C-1220 and C-1222, Office of Naval Research grant N00014-10-1-0989, Air Force Office of Scientific Research grant F49620-03-C-0068, and the Center for Advanced Solar Photophysics, an Energy Frontier Research Center funded by the U.S. Department of Energy.	Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Brus L, 2008, ACCOUNTS CHEM RES, V41, P1742, DOI 10.1021/ar800121r; COWLEY AM, 1970, SOLID STATE ELECTRON, V13, P403, DOI 10.1016/0038-1101(70)90151-6; ENDRIZ JG, 1970, PHYS REV LETT, V24, P64, DOI 10.1103/PhysRevLett.24.64; Fowler RH, 1931, PHYS REV, V38, P45, DOI 10.1103/PhysRev.38.45; Gobin AM, 2007, NANO LETT, V7, P1929, DOI 10.1021/nl070610y; HOFMANN J, 1968, PHYS STATUS SOLIDI, V30, pK53, DOI 10.1002/pssb.19680300160; INAGAKI T, 1982, APPL OPTICS, V21, P949, DOI 10.1364/AO.21.000949; INAGAKI T, 1981, PHYS REV B, V24, P3644, DOI 10.1103/PhysRevB.24.3644; Ishi T, 2005, JPN J APPL PHYS 2, V44, pL364, DOI 10.1143/JJAP.44.L364; Jin RC, 2003, NATURE, V425, P487, DOI 10.1038/nature02020; Jin RC, 2001, SCIENCE, V294, P1901, DOI 10.1126/science.1066541; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Kreibig U., 1995, OPTICAL PROPERTIES M, P1, DOI [10.1007/978-3-662-09109-8_1, DOI 10.1007/978-3-662-09109-8_1]; Lal S, 2007, NAT PHOTONICS, V1, P641, DOI 10.1038/nphoton.2007.223; Laux S, 1998, THIN SOLID FILMS, V335, P1, DOI 10.1016/S0040-6090(98)00861-X; Lehmann J, 2000, PHYS REV LETT, V85, P2921, DOI 10.1103/PhysRevLett.85.2921; Muhlschlegel P, 2005, SCIENCE, V308, P1607, DOI 10.1126/science.1111886; Murphy CJ, 2002, ADV MATER, V14, P80, DOI 10.1002/1521-4095(20020104)14:1<80::AID-ADMA80>3.0.CO;2-#; Palik E.D, 1998, HDB OPTICAL CONSTANT, V3, DOI DOI 10.1080/716099804A; Perez-Juste J, 2005, COORDIN CHEM REV, V249, P1870, DOI 10.1016/j.ccr.2005.01.030; Redmond PL, 2007, J PHYS CHEM C, V111, P14849, DOI 10.1021/jp0741859; Scales C, 2010, IEEE J QUANTUM ELECT, V46, P633, DOI 10.1109/JQE.2010.2046720; Shalaev VM, 1996, PHYS REV B, V53, P11388, DOI 10.1103/PhysRevB.53.11388; STUCKLESS JT, 1989, PHYS REV B, V40, P9997, DOI 10.1103/PhysRevB.40.9997; Sze S. M., 2021, PHYS SEMICONDUCTOR D, DOI DOI 10.1002/0470068329; Tang L, 2008, NAT PHOTONICS, V2, P226, DOI 10.1038/nphoton.2008.30; Westphalen M, 2000, SOL ENERG MAT SOL C, V61, P97, DOI 10.1016/S0927-0248(99)00100-2; Wu XM, 2010, J PHYS CHEM C, V114, P12896, DOI 10.1021/jp102720r; Yu NF, 2008, NAT PHOTONICS, V2, P564, DOI 10.1038/nphoton.2008.152	30	1533	1575	43	981	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					702	704		10.1126/science.1203056	http://dx.doi.org/10.1126/science.1203056			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551059				2022-12-28	WOS:000290265800038
J	Liu, HK; Chen, WC				Liu, Hsiao-Kan; Chen, Wen-Chau			Fat Embolism Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Liu, Hsiao-Kan; Chen, Wen-Chau] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital	Liu, HK (corresponding author), Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan.								0	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1761	1761		10.1056/NEJMicm1006177	http://dx.doi.org/10.1056/NEJMicm1006177			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759DC	21542746				2022-12-28	WOS:000290219800012
J	Gheorghiade, M; Braunwald, E				Gheorghiade, Mihai; Braunwald, Eugene			A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OUTCOMES; ASSOCIATION; CARDIOLOGY; SOCIETY; LUNG		[Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Dept Med, Chicago, IL 60611 USA; [Braunwald, Eugene] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc Med, Sch Med,Dept Med,TIMI Study Grp, Boston, MA 02115 USA	Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Dept Med, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu						Flaherty JD, 2009, J AM COLL CARDIOL, V53, P254, DOI 10.1016/j.jacc.2008.08.072; Fonarow GC, 2008, ARCH INTERN MED, V168, P847, DOI 10.1001/archinte.168.8.847; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Gheorghiade M, 2010, EUR J HEART FAIL, V12, P423, DOI 10.1093/eurjhf/hfq045; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Peacock WF, 2010, J AM COLL CARDIOL, V56, P343, DOI 10.1016/j.jacc.2010.03.051	10	42	44	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1702	1703		10.1001/jama.2011.515	http://dx.doi.org/10.1001/jama.2011.515			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521852				2022-12-28	WOS:000289890500024
J	Quraishi, NA; Esler, C				Quraishi, Nasir A.; Esler, Claire			EASILY MISSED? Metastatic spinal cord compression	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SURGICAL-MANAGEMENT; CANCER; DISEASE; RADIOTHERAPY; DIAGNOSIS; RESECTION		[Quraishi, Nasir A.] Queens Med Ctr, Ctr Spine Studies & Surg, Nottingham NG7 2UH, England; [Esler, Claire] Leicester Royal Infirm, Dept Oncol, Leicester, Leics, England	University of Nottingham; University of Leicester	Quraishi, NA (corresponding author), Queens Med Ctr, Ctr Spine Studies & Surg, Nottingham NG7 2UH, England.	nasquraishi@hotmail.com						AARON AD, 1994, JAMA-J AM MED ASSOC, V272, P1206, DOI 10.1001/jama.272.15.1206; Baur A, 2002, RADIOLOGY, V225, P730, DOI 10.1148/radiol.2253011413; Chen YJ, 2007, SPINE, V32, pE413, DOI 10.1097/BRS.0b013e318074d6c7; Fung HS, 2003, RADIOGRAPHICS, V23, P179, DOI 10.1148/rg.231025043; Graham PH, 2006, CLIN ONCOL-UK, V18, P70, DOI 10.1016/j.clon.2005.08.015; HELWEGLARSEN S, 1994, EUR J CANCER, V30A, P396, DOI 10.1016/0959-8049(94)90263-1; Klimo PJ, 2003, NEUROSURG FOCUS, V15, P1; Kwok Y, 2006, HEMATOL ONCOL CLIN N, V20, P1297, DOI 10.1016/j.hoc.2006.09.008; Levack P, 2002, CLIN ONCOL-UK, V14, P472, DOI 10.1053/clon.2002.0098; Levack P, 2001, 9708 CRAG; Loblaw DA, 2003, CLIN ONCOL, V14, P472; Mannion RJ, 2007, BRIT J NEUROSURG, V21, P593, DOI 10.1080/02688690701593579; National Institute for Health and Clinical Excellence, 2008, CLIN GUID NAT I HLTH; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1; Prewett S, 2010, CLIN ONCOL-UK, V22, P222, DOI 10.1016/j.clon.2010.01.006; Quraishi NA, 2010, J BONE JOINT SURG BR, V92B, P1054, DOI 10.1302/0301-620X.92B8.22296; SCHABERG J, 1985, SPINE, V10, P19, DOI 10.1097/00007632-198501000-00003; Schiff D, 2003, NEUROL CLIN, V21, P67, DOI 10.1016/S0733-8619(02)00033-6; Sciubba DM, 2006, SURG ONCOL, V15, P141, DOI 10.1016/j.suronc.2006.11.002; Senel A, 2007, NEUROSURG REV, V30, P131, DOI 10.1007/s10143-007-0067-7; Shehadi JA, 2007, EUR SPINE J, V16, P1179, DOI 10.1007/s00586-007-0357-3; SORENSEN PS, 1994, EUR J CANCER, V30A, P22, DOI 10.1016/S0959-8049(05)80011-5; White BD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2538; Witham TF, 2006, NAT CLIN PRACT NEURO, V2, P87, DOI 10.1038/ncpneuro0116	24	14	15	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2011	342								d2402	10.1136/bmj.d2402	http://dx.doi.org/10.1136/bmj.d2402			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759BT	21525095				2022-12-28	WOS:000290215600004
J	Shah, K; Villareal, DT				Shah, Krupa; Villareal, Dennis T.			Combination treatment to CONQUER obesity?	LANCET			English	Editorial Material							OLDER-ADULTS; WEIGHT-LOSS; US ADULTS; OVERWEIGHT; TRIAL		[Shah, Krupa] Univ Rochester, Sch Med & Dent, Highland Hosp, Div Geriatr & Aging, Rochester, NY 14627 USA; [Villareal, Dennis T.] Univ New Mexico, Sch Med, New Mexico Vet Affairs Hlth Care Syst, Sect Geriatr, Albuquerque, NM 87108 USA; [Villareal, Dennis T.] Univ New Mexico, Sch Med, Div Geriatr, Albuquerque, NM 87108 USA	University of Rochester; University of New Mexico; University of New Mexico	Shah, K (corresponding author), Univ Rochester, Sch Med & Dent, Highland Hosp, Div Geriatr & Aging, Rochester, NY 14627 USA.							Astrup A, 2004, OBES RES, V12, P1658, DOI 10.1038/oby.2004.206; Bray GA, 2007, GASTROENTEROLOGY, V132, P2239, DOI 10.1053/j.gastro.2007.03.053; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Wadden TA, 2001, ARCH INTERN MED, V161, P218, DOI 10.1001/archinte.161.2.218	13	7	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1295	1297		10.1016/S0140-6736(11)60518-7	http://dx.doi.org/10.1016/S0140-6736(11)60518-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UE	21497686				2022-12-28	WOS:000289962900007
J	Kagaya, K; Takahata, M				Kagaya, Katsushi; Takahata, Masakazu			Sequential Synaptic Excitation and Inhibition Shape Readiness Discharge for Voluntary Behavior	SCIENCE			English	Article							CENTRAL NERVOUS SYSTEM; PROCAMBARUS-CLARKII; NEURAL ACTIVITY; CENTRAL COMPLEX; FRONTAL-CORTEX; MOTOR CORTEX; CRAYFISH; INITIATION; MOVEMENTS; WALKING	How do animals initiate voluntary behavior? A key phenomenon in neuroscience is the readiness or preparatory neural activity in specific regions of the animal brain. The neurons and synaptic mechanisms mediating this activity are unknown. We found that the readiness discharge is shaped by sequential synaptic excitation and inhibition in the brain of crayfish (Procambarus clarkii). The readiness discharge neurons extended axon collaterals that appeared to activate recurring local interneurons. Therefore, we propose that the readiness discharge is formed by sequential synaptic events within the brain without feedback signals from downstream ganglia. The circuit involved is suited for signal processing for self-generated voluntary initiation of behavior.	[Kagaya, Katsushi; Takahata, Masakazu] Hokkaido Univ, Dept Biol Sci, Fac Sci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University	Kagaya, K (corresponding author), Hokkaido Univ, Dept Biol Sci, Fac Sci, Sapporo, Hokkaido 0600810, Japan.	kagaya@sci.hokudai.ac.jp		Kagaya, Katsushi/0000-0003-3001-7690	Ministry of Education, Culture, Sports, Science and Technology, Japan [18657025, 20370028]; Grants-in-Aid for Scientific Research [23370031] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (18657025 and 20370028).	ATWOOD HL, 1967, J EXP BIOL, V46, P249; Bender JA, 2010, CURR BIOL, V20, P921, DOI 10.1016/j.cub.2010.03.054; BOWERMAN RF, 1974, J EXP BIOL, V60, P119; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chikamoto K, 2008, ZOOL SCI, V25, P783, DOI 10.2108/zsj.25.783; CHRACHRI A, 1990, J NEUROSCI, V10, P707; Hyland B, 1998, BEHAV BRAIN RES, V94, P255, DOI 10.1016/S0166-4328(97)00157-5; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Kagaya K, 2010, J NEUROSCI, V30, P1348, DOI 10.1523/JNEUROSCI.4885-09.2010; Maimon G, 2006, J NEUROSCI, V26, P2487, DOI 10.1523/JNEUROSCI.3590-05.2006; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; OKANO K, 1987, EXP BRAIN RES, V66, P155; Roskies AL, 2010, ANNU REV NEUROSCI, V33, P109, DOI 10.1146/annurev-neuro-060909-153151; SANDEMAN D, 1992, BIOL BULL, V183, P304, DOI 10.2307/1542217; SCHULTZ W, 1992, EXP BRAIN RES, V91, P363; WIERSMA CAG, 1958, J COMP NEUROL, V110, P421, DOI 10.1002/cne.901100306	16	12	12	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					365	368		10.1126/science.1202244	http://dx.doi.org/10.1126/science.1202244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493864				2022-12-28	WOS:000289516600049
J	McArthur, KS; Quinn, TJ; Higgins, P; Langhorne, P				McArthur, K. S.; Quinn, T. J.; Higgins, P.; Langhorne, P.			Post-acute care and secondary prevention after ischaemic stroke	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ASPIRIN; CLOPIDOGREL; DIPYRIDAMOLE; WARFARIN; EVENTS; ATTACK; TRIAL; RISK		[McArthur, K. S.; Quinn, T. J.; Higgins, P.; Langhorne, P.] Univ Glasgow, Western Infirm, Inst Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow	McArthur, KS (corresponding author), Univ Glasgow, Western Infirm, Inst Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, Scotland.	kate.mcarthur@glasgow.ac.uk	Quinn, Terence Joseph/H-7000-2019	Quinn, Terence Joseph/0000-0003-1401-0181	Bristol Myers Squibb; Sanofi; Pfizer	Bristol Myers Squibb(Bristol-Myers Squibb); Sanofi; Pfizer(Pfizer)	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no external support for the submitted work; KSMcA, PH, PL have no relationships with companies that might have an interest in the submitted work in the previous three years. TJQ has received modest speakers' fees and travel assistance from Bristol Myers Squibb, Sanofi, and Pfizer; no non-financial interests that may be relevant to the submitted work.	Algra A, 2006, COCHRANE DB SYST REV, V3; Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; [Anonymous], 2008, MAN PAT STROK TIA AS; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Clarke J, 2005, LANCET, V365, P764, DOI 10.1016/S0140-6736(05)17983-5; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dennis M, 2005, LANCET, V365, P755, DOI 10.1016/S0140-6736(05)17982-3; Dennis M, 2010, ANN INTERN MED, V153, P553, DOI 10.7326/0003-4819-153-9-201011020-00280; Dennis M, 2009, LANCET, V373, P1958, DOI 10.1016/S0140-6736(09)60941-7; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Ellis G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005066.pub2; Govan L, 2007, STROKE, V38, P2536, DOI 10.1161/STROKEAHA.106.478842; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hankey GJ, 2010, LANCET NEUROL, V9, P855, DOI 10.1016/S1474-4422(10)70187-3; Intercollegiate Stroke Working Party, 2008, NAT CLIN GUID STROK; Langhorne P, 2005, LANCET, V365, P501; Langhorne P, 2002, AGE AGEING, V31, P365, DOI 10.1093/ageing/31.5.365; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Langhorne P, 2009, LANCET NEUROL, V8, P308, DOI 10.1016/S1474-4422(09)70060-2; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; National Collaborating Centre for Chronic Conditions (UK), 2008, STROK NAT CLIN GUID; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Rothwell PM, 2003, STROKE, V34, P514, DOI 10.1161/01.STR.0000054671.71777.C7; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Saxena R., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000187.PUB2; Scottish Intercollegiate Guidelines Network, 2010, MAN PAT STROK ID MAN; Sherman DG, 2007, LANCET, V369, P1347, DOI 10.1016/S0140-6736(07)60633-3; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; Verro P, 2008, STROKE, V39, P1358, DOI 10.1161/STROKEAHA.107.496281	34	13	17	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2011	342								d2083	10.1136/bmj.d2083	http://dx.doi.org/10.1136/bmj.d2083			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749KG	21478239	Green Accepted			2022-12-28	WOS:000289464100003
J	Bhutto, ZA; Yakoob, MY; Lawn, JE; Rizvi, A; Friberg, IK; Weissman, E; Buchmann, E; Goldenberg, RL				Bhutto, Zulfiqar A.; Yakoob, Mohammad Yawar; Lawn, Joy E.; Rizvi, Arjumand; Friberg, Ingrid K.; Weissman, Eva; Buchmann, Eckhart; Goldenberg, Robert L.		Lancet's Stillbirths Series Steeri	Stillbirths 3 Stillbirths: what difference can we make and at what cost?	LANCET			English	Article							EMERGENCY OBSTETRIC CARE; REDUCING STILLBIRTHS; INTRAUTERINE GROWTH; PERINATAL-MORTALITY; NEONATAL-MORTALITY; PREGNANCY OUTCOMES; FOLIC-ACID; DEVELOPING-COUNTRIES; CONGENITAL-SYPHILIS; MATERNAL MORTALITY	Worldwide, 2.65 million (uncertainty range 2.08 million to 3.79 million) stillbirths occur yearly, of which 98% occur in countries of low and middle income. Despite the fact that more than 45% of the global burden of stillbirths occur intrapartum, the perception is that little is known about effective interventions, especially those that can be implemented in low-resource settings. We undertook a systematic review of randomised trials and observational studies of interventions which could reduce the burden of stillbirths, particularly in low-income and middle-income countries. We identified several interventions with sufficient evidence to recommend implementation in health systems, including periconceptional folic acid supplementation or fortification, prevention of malaria, and improved detection and management of syphilis during pregnancy in endemic areas. Basic and comprehensive emergency obstetric care were identified as key effective interventions to reduce intrapartum stillbirths. Broad-scale implementation of intervention packages across 68 countries listed as priorities in the Countdown to 2015 report could avert up to 45% of stillbirths according to a model generated from the Lives Saved Tool. The overall costs for these interventions are within the general estimates of cost-effective interventions for maternal care, especially in view of the effects on outcomes across maternal, fetal, and neonatal health.	[Bhutto, Zulfiqar A.; Yakoob, Mohammad Yawar; Rizvi, Arjumand] Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan; [Lawn, Joy E.] Save Children, Saving Newborn Lives, Cape Town, South Africa; [Lawn, Joy E.] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Lawn, Joy E.] Inst Child Hlth, London, England; [Friberg, Ingrid K.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Weissman, Eva] Futures Inst, New York, NY USA; [Buchmann, Eckhart] Chris Hani Baragwanath Hosp, Dept Obstet & Gynaecol, Johannesburg, South Africa; [Buchmann, Eckhart] Univ Witwatersrand, Johannesburg, South Africa; [Goldenberg, Robert L.] Drexel Univ, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA	Aga Khan University; Save the Children; University of London; University College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Witwatersrand; Drexel University	Bhutto, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Stadium Rd,POB 3500, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu	Flenady, Vicki Jane/O-9609-2014; Lawn, Joy/ABE-6382-2020; Yaqub, Muhammad Yawar/I-5052-2019	Flenady, Vicki Jane/0000-0001-8114-7677; Lawn, Joy/0000-0002-4573-1443; Froen Froen, Jahn Frederik/0000-0001-9390-8509	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	Some technical work and consultations for this report during 2010 were funded through a grant for the The Lancet's Series from the Bill & Melinda Gates Foundation to the International Stillbirth Alliance secretariat. JEL is funded by the Bill & Melinda Gates Foundation through Saving Newborn Lives/Save the Children. Additionally, the Partnership for Maternal, Newborn and Child Health and GAPPS supported travel for some members of the writing team (ZAB, JEL, EW, MYY) for technical consultations. The funding organisations had no role in the drafting or direction of this report. The findings and conclusions in this report are those of the authors and do not necessarily represent the official positions of their employers. The views expressed herein are solely those of the authors.	Abalos E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; Alfirevic Z, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007529.pub2; Alwan N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003395.pub2; American College of Obstetricians and Gynecologists Committee on Practice Bulletins--Obstetrics, 2001, Obstet Gynecol, V98, P525; Ananth CV, 2010, EPIDEMIOLOGY, V21, P118, DOI 10.1097/EDE.0b013e3181c297af; [Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD003755.PUB2; Bardia A, 2004, NATL MED J INDIA, V17, P207; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bhutta ZA, 2010, LANCET, V375, P1142, DOI 10.1016/S0140-6736(10)60324-8; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Blencowe H, 2010, INT J EPIDEMIOL, V39, P110, DOI 10.1093/ije/dyq028; Boschi-Pinto C, 2010, INT J EPIDEMIOL, V39, P3, DOI 10.1093/ije/dyq018; Carlo WA, 2010, PEDIATRICS, V126, pE1072, DOI 10.1542/peds.2010-1183; Carlo WA, 2010, NEW ENGL J MED, V362, P614, DOI 10.1056/NEJMsa0806033; Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786; Charles DHM, 2005, PAEDIATR PERINAT EP, V19, P112, DOI 10.1111/j.1365-3016.2005.00633.x; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Darmstadt GL, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S6; De Brouwere V, 2010, TROP MED INT HEALTH, V15, P901, DOI 10.1111/j.1365-3156.2010.02558.x; de Onis M, 1998, EUR J CLIN NUTR, V52, pS5; DOLEA C, 2003, GLOBAL BURDEN HYPERT; DULEY L, 2001, COCHRANE DB SYST REV, V1; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Garner P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub2; Gichangi P, 2004, East Afr Med J, V81, P589; Gill CJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d346; Gogia S, 2010, B WORLD HEALTH ORGAN, V88, P658, DOI 10.2471/BLT.09.069369; Goldenberg RL, 2007, ACTA OBSTET GYN SCAN, V86, P1303, DOI 10.1080/00016340701644876; Goldenberg RL, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S1; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Gomez L, 2003, AM J OBSTET GYNECOL, V189, pS179, DOI 10.1016/j.ajog.2003.10.435; GRANT A, 1989, LANCET, V2, P345; GREENBLATT ROBERT B., 1950, JOUR VENEREAL DIS INFORM, V31, P45; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haws RA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S5; Hoffman C, 2009, CURR OPIN OBSTET GYN, V21, P161, DOI 10.1097/GCO.0b013e3283292468; Hofmeyr GJ, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001059.pub2, 10.1002/14651858.CD001059.pub4, 10.1002/14651858.CD001059.pub5]; Hofmeyr GJ, 2009, INT J GYNECOL OBSTET, V107, pS21, DOI 10.1016/j.ijgo.2009.07.017; HOGBERG U, 1985, ACTA OBSTET GYN SCAN, V64, P583; Hussain AA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S5; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S4; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S18; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S1; INGRAHAM N R Jr, 1950, Acta Derm Venereol Suppl (Stockh), V31, P60; *INT DIAB FED, DIAB ATL REG OV; Ir P, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-1; Ishaque S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S3; Jabeen M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S6; Jehan I, 2009, B WORLD HEALTH ORGAN, V87, P130, DOI 10.2471/BLT.08.050963; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; King-Hele S, 2009, ARCH DIS CHILD-FETAL, V94, pF105, DOI 10.1136/adc.2007.135459; Kramer MS, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000032; Lassi ZS, 2010, COMMUNITY BASED INTE; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Lee ACC, 2009, INT J GYNECOL OBSTET, V107, pS65, DOI 10.1016/j.ijgo.2009.07.012; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Lu J, 2001, Zhonghua Fu Chan Ke Za Zhi, V36, P456; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; *MAN SCI HLTH, INT DRUG PRIC IND; Mandruzzato G, 2010, J PERINAT MED, V38, P111, DOI [10.1515/JPM.2010.057, 10.1515/jpm.2010.057]; MANGESI L, 2007, COCHRANE DB SYST REV, V1; Mavalankar D, 2009, INT J GYNECOL OBSTET, V107, P271, DOI 10.1016/j.ijgo.2009.09.008; McClure EM, 2007, INT J GYNECOL OBSTET, V96, P139, DOI 10.1016/j.ijgo.2006.10.010; Melve KK, 2010, AM J EPIDEMIOL, V172, P1123, DOI 10.1093/aje/kwq259; Menezes EV, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S4; Myer L, 2004, TROP MED INT HEALTH, V9, P1216, DOI 10.1111/j.1365-3156.2004.01330.x; Norwitz ER, 2007, CLIN OBSTET GYNECOL, V50, P547, DOI 10.1097/GRF.0b013e31804c9b11; Olesen AW, 2003, AM J OBSTET GYNECOL, V189, P222, DOI 10.1067/mob.2003.446; Pathmanathan I., 2003, INT BANK RECONSTRUCT; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Ratner PA, 2010, BMC NURS, V9, DOI 10.1186/1472-6955-9-15; Rogerson SJ, 2010, ADV EXP MED BIOL, V659, P139, DOI 10.1007/978-1-4419-0981-7_12; Rudan I, 2007, CROAT MED J, V48, P595; RUTGERS S, 1993, CENT AFR J MED, V39, P117; Schmid GP, 2007, SEX TRANSM DIS, V34, pS5, DOI 10.1097/01.olq.0000261456.09797.1b; Shea KM, 1998, EPIDEMIOLOGY, V9, P199, DOI 10.1097/00001648-199803000-00017; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; Signore LB, 2010, LANCET, V376, P624, DOI 10.1016/S0140-6736(10)60752-0; Sorensen BL, 2010, TROP MED INT HEALTH, V15, P894, DOI 10.1111/j.1365-3156.2010.02554.x; Southwick KL, 2007, INT J STD AIDS, V18, P392, DOI 10.1258/095646207781024748; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Stover J, 2006, SEX TRANSM INFECT, V82, pIII45, DOI 10.1136/sti.2006.020172; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; Syed M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S2; THOMSEN SG, 1990, J OBSTET GYNAECOL, V10, P189, DOI 10.3109/01443619009151155; Tikhonova L, 2003, SEX TRANSM INFECT, V79, P106, DOI 10.1136/sti.79.2.106; UNICEF, 2004, LOW BIRTHW COUNTR RE; UNICEF, SUPPL CAT; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35, DOI 10.4269/ajtmh.2004.71.35; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Walker G J, 2001, Cochrane Database Syst Rev, pCD001143, DOI 10.1002/14651858.CD001143; Walker GJA, 2007, SEMIN FETAL NEONAT M, V12, P198, DOI 10.1016/j.siny.2007.01.019; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; *WHO, 2010, CHOOSING INT AR COST; *WHO, COUNTD 2015 DEC REP; WHO, 2010, TRENDS MAT MORT 1990; Woods R, 2008, B WORLD HEALTH ORGAN, V86, P460, DOI 10.2471/BLT.07.043471; World Health Organization, 2006, NEON PER MORT COUNTR; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S7; Yakoob MY, 2010, SEMIN PERINATOL, V34, P387, DOI 10.1053/j.semperi.2010.09.010; Yakoob MY, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S3; BMC PREGNANCY CHIL S	113	154	156	1	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2011	377	9776					1523	1538		10.1016/S0140-6736(10)62269-6	http://dx.doi.org/10.1016/S0140-6736(10)62269-6			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761RX	21496906				2022-12-28	WOS:000290419400030
J	Murray, CJL; Anderson, B; Burstein, R; Leach-Kemon, K; Schneider, M; Tardif, A; Zhang, R				Murray, Christopher J. L.; Anderson, Brent; Burstein, Roy; Leach-Kemon, Katherine; Schneider, Matthew; Tardif, Annette; Zhang, Raymond			Development assistance for health: trends and prospects	LANCET			English	Editorial Material									[Murray, Christopher J. L.; Anderson, Brent; Burstein, Roy; Leach-Kemon, Katherine; Schneider, Matthew; Tardif, Annette; Zhang, Raymond] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	cjlm@uw.edu						[Anonymous], INT DRUG PRIC IND GU; [Anonymous], FIN GLOB HLTH 2010 D; BOEHNER J, 2010, BACKGROUND HOUSE REP; *I HLTH METR EV, 2010, FIN GLOB HLTH 2010 M; OSBORNE G, 2010, COMMUNICATION   1020; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; *THOMS REUT, 2010, PHYS DESK REF RED BO; *WORLD BANK, 2010, WORLD BANKS FUND POO	8	58	61	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 2	2011	378	9785					8	10		10.1016/S0140-6736(10)62356-2	http://dx.doi.org/10.1016/S0140-6736(10)62356-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791IU	21481450				2022-12-28	WOS:000292659700007
J	Kamakura, M				Kamakura, Masaki			Royalactin induces queen differentiation in honeybees	NATURE			English	Article							CULTURED RAT HEPATOCYTES; APIS-MELLIFERA; ENHANCES PROLIFERATION; CASTE DIFFERENTIATION; PROTHORACIC GLAND; REGULATES GROWTH; BODY-SIZE; DROSOPHILA; PROTEINS; FAMILY	The honeybee (Apis mellifera) forms two female castes: the queen and the worker. This dimorphism depends not on genetic differences, but on ingestion of royal jelly, although the mechanism through which royal jelly regulates caste differentiation has long remained unknown. Here I show that a 57-kDa protein in royal jelly, previously designated as royalactin, induces the differentiation of honeybee larvae into queens. Royalactin increased body size and ovary development and shortened developmental time in honeybees. Surprisingly, it also showed similar effects in the fruitfly (Drosophila melanogaster). Mechanistic studies revealed that royalactin activated p70 S6 kinase, which was responsible for the increase of body size, increased the activity of mitogen-activated protein kinase, which was involved in the decreased developmental time, and increased the titre of juvenile hormone, an essential hormone for ovary development. Knockdown of epidermal growth factor receptor (Egfr) expression in the fat body of honeybees and fruitflies resulted in a defect of all phenotypes induced by royalactin, showing that Egfr mediates these actions. These findings indicate that a specific factor in royal jelly, royalactin, drives queen development through an Egfr-mediated signalling pathway.	Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan	Toyama Prefectural University	Kamakura, M (corresponding author), Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan.	kamakura@pu-toyama.ac.jp	Kamakura, Masaki/E-7954-2011					BEETSMA J, 1979, BEE WORLD, V60, P24, DOI 10.1080/0005772X.1979.11097727; Belgacem YH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000187; Bilikova K, 2002, FEBS LETT, V528, P125, DOI 10.1016/S0014-5793(02)03272-6; Bloch Guy, 2002, P195; BOWNES M, 1994, BIOESSAYS, V16, P745, DOI 10.1002/bies.950161009; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; EBERT R, 1980, J COMP PHYSIOL, V137, P7, DOI 10.1007/BF00656912; Gilboa L, 2006, NATURE, V443, P97, DOI 10.1038/nature05068; GOEWIE EA, 1976, P K NED AKAD C BIOL, V79, P466; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Kamakura M, 2006, PROTEIN EXPRES PURIF, V45, P307, DOI 10.1016/j.pep.2005.08.004; Kamakura M, 2002, J BIOCHEM, V132, P911, DOI 10.1093/oxfordjournals.jbchem.a003304; Kamakura M, 2001, J NUTR SCI VITAMINOL, V47, P394, DOI 10.3177/jnsv.47.394; Kamakura M, 2001, BIOCHEM BIOPH RES CO, V282, P865, DOI 10.1006/bbrc.2001.4656; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; LeVea CM, 2004, EXP CELL RES, V297, P272, DOI 10.1016/j.yexcr.2004.03.026; McManus EJ, 2002, NAT CELL BIOL, V4, pE214, DOI 10.1038/ncb0902-e214; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Navolanic PM, 2003, INT J ONCOL, V22, P237; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; PATEL NG, 1960, NATURE, V186, P633, DOI 10.1038/186633a0; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; SHUEL R. W., 1960, INSECTES SOCIAUX, V7, P265, DOI 10.1007/BF02224497; Szathmary E, 1995, MAJOR TRANSITIONS EV; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; WEAVER NEVIN, 1957, ANN ENT SOC AMER, V50, P283; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; WIRTZ P, 1972, ENTOMOL EXP APPL, V15, P517, DOI 10.1007/BF00293616; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zinke I, 1999, DEVELOPMENT, V126, P5275	37	391	449	18	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					478	483		10.1038/nature10093	http://dx.doi.org/10.1038/nature10093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21516106	Green Submitted			2022-12-28	WOS:000290951300033
J	Ruediger, S; Vittori, C; Bednarek, E; Genoud, C; Strata, P; Sacchetti, B; Caroni, P				Ruediger, Sarah; Vittori, Claudia; Bednarek, Ewa; Genoud, Christel; Strata, Piergiorgio; Sacchetti, Benedetto; Caroni, Pico			Learning-related feedforward inhibitory connectivity growth required for memory precision	NATURE			English	Article							STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; CORTICAL CIRCUITS; HIPPOCAMPUS; CA3; CONSOLIDATION; CONTEXT; BRAIN; CELLS	In the adult brain, new synapses are formed and pre-existing ones are lost, but the function of this structural plasticity has remained unclear(1-5). Learning of new skills is correlated with formation of new synapses(6-8). These may directly encode new memories, but they may also have more general roles in memory encoding and retrieval processes(2). Here we investigated how mossy fibre terminal complexes at the entry of hippocampal and cerebellar circuits rearrange upon learning in mice, and what is the functional role of the rearrangements. We show that one-trial and incremental learning lead to robust, circuit-specific, long-lasting and reversible increases in the numbers of filopodial synapses onto fast-spiking interneurons that trigger feedforward inhibition. The increase in feedforward inhibition connectivity involved a majority of the presynaptic terminals, restricted the numbers of c-Fos-expressing postsynaptic neurons at memory retrieval, and correlated temporally with the quality of the memory. We then show that for contextual fear conditioning and Morris water maze learning, increased feedforward inhibition connectivity by hippocampal mossy fibres has a critical role for the precision of the memory and the learned behaviour. In the absence of mossy fibre long-term potentiation in Rab3a(-/-) mice(9), c-Fos ensemble reorganization and feedforward inhibition growth were both absent in CA3 upon learning, and the memory was imprecise. By contrast, in the absence of adducin 2 (Add2; also known as beta-adducin)(10) c-Fos reorganization was normal, but feedforward inhibition growth was abolished. In parallel, c-Fos ensembles in CA3 were greatly enlarged, and the memory was imprecise. Feedforward inhibition growth and memory precision were both rescued by re-expression of Add2 specifically in hippocampal mossy fibres. These results establish a causal relationship between learning-related increases in the numbers of defined synapses and the precision of learning and memory in the adult. The results further relate plasticity and feedforward inhibition growth at hippocampal mossy fibres to the precision of hippocampus-dependent memories.	[Ruediger, Sarah; Vittori, Claudia; Bednarek, Ewa; Genoud, Christel; Caroni, Pico] Friedrich Miescher Inst, CH-4058 Basel, Switzerland; [Vittori, Claudia; Strata, Piergiorgio; Sacchetti, Benedetto] Dept Neurosci, I-10125 Turin, Italy; [Vittori, Claudia; Strata, Piergiorgio; Sacchetti, Benedetto] Natl Inst Neurosci Italy, I-10125 Turin, Italy	Friedrich Miescher Institute for Biomedical Research	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	caroni@fmi.ch	Ruediger Lee, Sarah/ABG-6969-2021; Sacchetti, Benedetto/AAG-2916-2022; Sacchetti, Benedetto/AFK-4141-2022	Sacchetti, Benedetto/0000-0002-8695-8310; Ruediger, Sarah/0000-0001-6684-4693; Vittori, Claudia/0000-0002-3467-5984; Ruediger, Sarah/0000-0001-9140-872X; genoud, christel/0000-0002-0933-9911				Acsady L, 1998, J NEUROSCI, V18, P3386; BEDNAREK E, NEURON IN PRESS; Biedenkapp JC, 2007, LEARN MEMORY, V14, P200, DOI 10.1101/lm.499407; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Galimberti I, 2010, NEURON, V65, P627, DOI 10.1016/j.neuron.2010.02.016; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Knott GW, 2009, NAT PROTOC, V4, P1145, DOI 10.1038/nprot.2009.114; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005; Sacchetti B, 2004, NEURON, V42, P973, DOI 10.1016/j.neuron.2004.05.012; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907; Wiltgen BJ, 2010, CURR BIOL, V20, P1336, DOI 10.1016/j.cub.2010.06.068; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	30	186	187	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2011	473	7348					514	U258		10.1038/nature09946	http://dx.doi.org/10.1038/nature09946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	768QM	21532590	Green Submitted			2022-12-28	WOS:000290951300041
J	Calmy, AL; Ford, N				Calmy, Alexandra L.; Ford, Nathan			Improving treatment outcome for children with HIV	LANCET			English	Editorial Material							AFRICA		[Calmy, Alexandra L.; Ford, Nathan] Med Sans Frontieres, Campaign Access Essential Med, CH-1200 Geneva, Switzerland; [Calmy, Alexandra L.] Univ Hosp Geneva, Div Infect Dis, CH-1211 Geneva 14, Switzerland; [Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa	Doctors Without Borders; University of Geneva; University of Cape Town	Calmy, AL (corresponding author), Med Sans Frontieres, Campaign Access Essential Med, CH-1200 Geneva, Switzerland.	acalmy@gmail.com						Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Castro H, 2011, LANCET, V377, P1580, DOI 10.1016/S0140-6736(11)60208-0; Davies MA, 2011, JAIDS-J ACQ IMM DEF, V56, P270, DOI 10.1097/QAI.0b013e3182060610; Davies MA, 2009, AJAR-AFR J AIDS RES, V8, P329, DOI 10.2989/AJAR.2009.8.3.9.930; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Medecins Sans Frontieres, 2010, UNT WEB ANT PRIC RED; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Sohn AH, 2010, CURR OPIN HIV AIDS, V5, P54, DOI 10.1097/COH.0b013e3283339bd8; Vigano A, 2011, PHARMACOL RES, V64, P1, DOI 10.1016/j.phrs.2011.01.007; Waning B, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-74; Welch S, 2009, HIV MED, V10, P591, DOI 10.1111/j.1468-1293.2009.00759.x; WHO, 2011, PRIOR MED MOTH YOUNG	12	7	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1546	1548		10.1016/S0140-6736(11)60363-2	http://dx.doi.org/10.1016/S0140-6736(11)60363-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	763IJ	21511331				2022-12-28	WOS:000290549700005
J	Reganold, JP; Jackson-Smith, D; Batie, SS; Harwood, RR; Kornegay, JL; Bucks, D; Flora, CB; Hanson, JC; Jury, WA; Meyer, D; Schumacher, A; Sehmsdorf, H; Shennan, C; Thrupp, LA; Willis, P				Reganold, J. P.; Jackson-Smith, D.; Batie, S. S.; Harwood, R. R.; Kornegay, J. L.; Bucks, D.; Flora, C. B.; Hanson, J. C.; Jury, W. A.; Meyer, D.; Schumacher, A., Jr.; Sehmsdorf, H.; Shennan, C.; Thrupp, L. A.; Willis, P.			Transforming U.S. Agriculture	SCIENCE			English	Editorial Material									[Reganold, J. P.] Washington State Univ, Pullman, WA 99164 USA; [Jackson-Smith, D.] Utah State Univ, Logan, UT 84322 USA; [Batie, S. S.; Harwood, R. R.] Michigan State Univ, E Lansing, MI 48824 USA; [Kornegay, J. L.] N Carolina State Univ, Raleigh, NC 27695 USA; [Bucks, D.] Bucks Nat Resources Management, Elkridge, MD 21075 USA; [Flora, C. B.] Iowa State Univ, Ames, IA 50011 USA; [Hanson, J. C.] Univ Maryland, College Pk, MD 20742 USA; [Jury, W. A.] Univ Calif Riverside, Riverside, CA 92521 USA; [Meyer, D.] Univ Calif Davis, Davis, CA 95616 USA; [Schumacher, A., Jr.] SJH & Co, Washington, DC 20007 USA; [Sehmsdorf, H.] S&S Homestead Farm, Lopez Isl, WA 98261 USA; [Shennan, C.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Thrupp, L. A.] Fetzer Vineyards, Hopland, CA 95449 USA; [Willis, P.] Niman Pork Ranch Co, Thornton, IA 50479 USA	Washington State University; Utah System of Higher Education; Utah State University; Michigan State University; University of North Carolina; North Carolina State University; Iowa State University; University System of Maryland; University of Maryland College Park; University of California System; University of California Riverside; University of California System; University of California Davis; University of California System; University of California Santa Cruz	Reganold, JP (corresponding author), Washington State Univ, Pullman, WA 99164 USA.	reganold@wsu.edu	Jackson-Smith, Douglas/AAQ-8400-2021; Shennan, Carol/I-1694-2013	Jackson-Smith, Douglas/0000-0002-0671-5862; Shennan, Carol/0000-0001-6401-5007				Batie SS, 2009, FRONT ECOL ENVIRON, V7, P380, DOI 10.1890/080004; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Busch L., 2009, Natures Sciences Societes, V17, P241, DOI 10.1051/nss/2009041; Cox C., 2011, MANAGING AGR LANDSCA, P81; *DESCHUTTER O, 2010, REPORT SUBMITTED SPE; Dobbs TL, 2004, REV AGR ECON, V26, P220, DOI 10.1111/j.1467-9353.2004.00172.x; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Huffman W.E., 2006, SCI AGR LONG TERM PE, V2nd ed.; *INT ASS AGR SCI T, 2009, ARG CROSSR GLOB REP; MOLTKE J, 2010, CRS REP C; *NAT RES COUNC, 2010, SUST ARG SYST 21 CEN; Robertson GP, 2008, BIOSCIENCE, V58, P640, DOI 10.1641/B580711; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sachs J, 2010, NATURE, V466, P558, DOI 10.1038/466558a; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010	15	101	103	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					670	671		10.1126/science.1202462	http://dx.doi.org/10.1126/science.1202462			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	759RK	21551050				2022-12-28	WOS:000290265800027
J	Chen, Y; Graziano, JH; Parvez, F; Liu, ML; Slavkovich, V; Kalra, T; Argos, M; Islam, T; Ahmed, A; Rakibuz-Zaman, M; Hasan, R; Sarwar, G; Levy, D; van Geen, A; Ahsan, H				Chen, Yu; Graziano, Joseph H.; Parvez, Faruque; Liu, Mengling; Slavkovich, Vesna; Kalra, Tara; Argos, Maria; Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam; Levy, Diane; van Geen, Alexander; Ahsan, Habibul			Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOSE-RESPONSE RELATIONSHIP; PREMALIGNANT SKIN-LESIONS; ISCHEMIC-HEART-DISEASE; PERIPHERAL VASCULAR-DISEASE; CEREBROVASCULAR-DISEASE; HYPERENDEMIC VILLAGES; DIABETES-MELLITUS; BLADDER-CANCER; PULSE PRESSURE; LUNG-CANCER	Objective To evaluate the association between arsenic exposure and mortality from cardiovascular disease and to assess whether cigarette smoking influences the association. Design Prospective cohort study with arsenic exposure measured in drinking water from wells and urine. Setting General population in Araihazar, Bangladesh. Participants 11 746 men and women who provided urine samples in 2000 and were followed up for an average of 6. 6 years. Main outcome measure Death from cardiovascular disease. Results 198 people died from diseases of circulatory system, accounting for 43% of total mortality in the population. The mortality rate for cardiovascular disease was 214.3 per 100 000 person years in people drinking water containing <12.0 mu g/L arsenic, compared with 271.1 per 100 000 person years in people drinking water with >= 12.0 mu g/L arsenic. There was a dose-response relation between exposure to arsenic in well water assessed at baseline and mortality from ischaemic heart disease and other heart disease; the hazard ratios in increasing quarters of arsenic concentration in well water (0.1-12.0, 12.1-62.0, 62.1-148.0, and 148.1-864.0 mu g/L) were 1.00 (reference), 1.22 (0.65 to 2.32), 1.35 (0.71 to 2.57), and 1.92 (1.07 to 3.43) (P=0.0019 for trend), respectively, after adjustment for potential confounders including age, sex, smoking status, educational attainment, body mass index (BMI), and changes in urinary arsenic concentration since baseline. Similar associations were observed when baseline total urinary arsenic was used as the exposure variable and for mortality from ischaemic heart disease specifically. The data indicate a significant synergistic interaction between arsenic exposure and cigarette smoking in mortality from ischaemic heart disease and other heart disease. In particular, the hazard ratio for the joint effect of a moderate level of arsenic exposure (middle third of well arsenic concentration 25.3-114.0 mu g/L, mean 63.5 mu g/L) and cigarette smoking on mortality from heart disease was greater than the sum of the hazard ratios associated with their individual effect (relative excess risk for interaction 1.56, 0.05 to 3.14; P=0.010). Conclusions Exposure to arsenic in drinking water is adversely associated with mortality from heart disease, especially among smokers.	[Chen, Yu; Liu, Mengling] NYU, Sch Med, Dept Environm Med, New York, NY 10016 USA; [Graziano, Joseph H.; Parvez, Faruque; Slavkovich, Vesna; Levy, Diane] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Kalra, Tara; Argos, Maria; Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Kalra, Tara; Argos, Maria; Ahsan, Habibul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Kalra, Tara; Argos, Maria; Ahsan, Habibul] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Kalra, Tara; Argos, Maria; Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam] Columbia Univ Res Project Off, Dhaka, Bangladesh; [van Geen, Alexander] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA	New York University; Columbia University; University of Chicago; University of Chicago; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Columbia University	Chen, Y (corresponding author), NYU, Sch Med, Dept Environm Med, New York, NY 10016 USA.	yu.chen@nyumc.org; habib@uchicago.edu		Chen, Yu/0000-0002-1519-4894; Liu, Mengling/0000-0001-9758-8522	US National Institute of Health; National Institute of Environmental Health Sciences [P42ES010349, R01ES017541, R01CA102484, R01CA107431, R01ESO11601, P30ES09089, CA016087, ES000260, CA014599]; National Cancer Institute [P42ES010349, R01ES017541, R01CA102484, R01CA107431, R01ESO11601, P30ES09089, CA016087, ES000260, CA014599]; NATIONAL CANCER INSTITUTE [R01CA107431, R01CA102484, P30CA016087, P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, P30ES000260, R01ES017541, P42ES010349] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by US National Institute of Health funding. The National Institute of Environmental Health Sciences and the National Cancer Institute provide support under the following grants: P42ES010349, R01ES017541, R01CA102484, R01CA107431, R01ES017541, R01ESO11601, P30ES09089, CA016087, ES000260, and CA014599. The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Ahsan H, 2007, CANCER EPIDEM BIOMAR, V16, P1270, DOI 10.1158/1055-9965.EPI-06-0676; Ahsan H, 2006, AM J EPIDEMIOL, V163, P1138, DOI 10.1093/aje/kwj154; [Anonymous], 2007, MAN INT CLASS DIS IN; Argos M, 2007, AM J PUBLIC HEALTH, V97, P825, DOI 10.2105/AJPH.2005.078816; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; *BRIT GEOL SURV, 1999, GROUNDW STUD ARS CON; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Bunderson M, 2004, TOXICOL APPL PHARM, V201, P32, DOI 10.1016/j.taap.2004.04.008; Bunderson M, 2002, TOXICOL APPL PHARM, V184, P11, DOI 10.1006/taap.2002.9492; CHEN CJ, 1995, HYPERTENSION, V25, P53, DOI 10.1161/01.HYP.25.1.53; Chen CJ, 1996, ARTERIOSCL THROM VAS, V16, P504, DOI 10.1161/01.ATV.16.4.504; Chen CL, 2004, JAMA-J AM MED ASSOC, V292, P2984, DOI 10.1001/jama.292.24.2984; Chen Y, 2004, BRIT J NUTR, V92, P851, DOI 10.1079/BJN20041277; Chen Y, 2007, ENVIRON HEALTH PERSP, V115, P1415, DOI 10.1289/ehp.10277; Chen Y, 2007, ENVIRON HEALTH PERSP, V115, P917, DOI 10.1289/ehp.9833; Chen Y, 2007, AM J EPIDEMIOL, V165, P541, DOI 10.1093/aje/kwk037; Chen Y, 2006, EPIDEMIOLOGY, V17, P459, DOI 10.1097/01.ede.0000220554.50837.7f; Chen Y, 2010, ENVIRON HEALTH PERSP, V118, P1299, DOI 10.1289/ehp.0901559; Cheng Z, 2005, ENVIRON SCI TECHNOL, V39, P4759, DOI 10.1021/es048065f; Cheng Z, 2004, ANAL BIOANAL CHEM, V379, P512, DOI 10.1007/s00216-004-2618-x; Chiou HY, 1997, STROKE, V28, P1717, DOI 10.1161/01.STR.28.9.1717; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; ENGEL RR, 1994, ARCH ENVIRON HEALTH, V49, P418, DOI 10.1080/00039896.1994.9954996; Ferreccio C, 2000, EPIDEMIOLOGY, V11, P673, DOI 10.1097/00001648-200011000-00010; Gamble MV, 2005, ENVIRON HEALTH PERSP, V113, pA442, DOI 10.1289/ehp.113-a442a; GREENLAND S, 1994, AM J EPIDEMIOL, V139, P747, DOI 10.1093/oxfordjournals.aje.a117069; HopenhaynRich C, 1996, ENVIRON HEALTH PERSP, V104, P620, DOI 10.2307/3433091; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Hsueh YM, 1998, ATHEROSCLEROSIS, V141, P249, DOI 10.1016/S0021-9150(98)00178-6; Medrano MJ, 2010, ENVIRON RES, V110, P448, DOI 10.1016/j.envres.2009.10.002; Karagas MR, 2004, CANCER CAUSE CONTROL, V15, P465, DOI 10.1023/B:CACO.0000036452.55199.a3; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; Lindberg AL, 2010, ENVIRON HEALTH PERSP, V118, P533, DOI 10.1289/ehp.0900728; Meliker JR, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-4; Melkonian S, 2011, AM J EPIDEMIOL, V173, P183, DOI 10.1093/aje/kwq357; Mudur G, 2000, BRIT MED J, V320, P822; Navas-Acien A, 2005, AM J EPIDEMIOL, V162, P1037, DOI 10.1093/aje/kwi330; NIXON DE, 1991, CLIN CHEM, V37, P1575; Parvez F, 2006, ENVIRON HEALTH PERSP, V114, P355, DOI 10.1289/ehp.7903; Pierce BL, 2010, INT J EPIDEMIOL, V39, P1037, DOI 10.1093/ije/dyp364; Ronsmans C, 1998, INT J EPIDEMIOL, V27, P660, DOI 10.1093/ije/27.4.660; Rothman K, 1986, MODERN EPIDEMIOLOGY; Safar ME, 2003, CIRCULATION, V107, P2864, DOI 10.1161/01.CIR.0000069826.36125.B4; Simeonova PP, 2004, TOXICOL APPL PHARM, V198, P444, DOI 10.1016/j.taap.2003.10.018; Simeonova PP, 2003, ENVIRON HEALTH PERSP, V111, P1744, DOI 10.1289/ehp.6332; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; Srivastava S, 2009, TOXICOL APPL PHARM, V241, P90, DOI 10.1016/j.taap.2009.08.004; Steinmaus C, 2003, AM J EPIDEMIOL, V158, P1193, DOI 10.1093/aje/kwg281; Steinmaus C, 2009, EPIDEMIOLOGY, V20, P807, DOI 10.1097/EDE.0b013e3181b0fd29; Straub AC, 2009, AM J PATHOL, V174, P1949, DOI 10.2353/ajpath.2009.081016; Tseng CH, 2000, ENVIRON HEALTH PERSP, V108, P847, DOI 10.2307/3434992; Tseng CH, 1996, ATHEROSCLEROSIS, V120, P125, DOI 10.1016/0021-9150(95)05693-9; Tseng CH, 2003, TOXICOL LETT, V137, P15, DOI 10.1016/S0378-4274(02)00377-6; Tseng CH, 1997, ANGIOLOGY, V48, P321, DOI 10.1177/000331979704800405; *US EPA, 2009, 815F00015 EPA; van Geen A, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001617; van Geen A, 2002, B WORLD HEALTH ORGAN, V80, P732; Wang CH, 2002, CIRCULATION, V105, P1804, DOI 10.1161/01.CIR.0000015862.64816.B2; Wang CH, 2007, TOXICOL APPL PHARM, V222, P315, DOI 10.1016/j.taap.2006.12.022; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; WU MM, 1989, AM J EPIDEMIOL, V130, P1123, DOI 10.1093/oxfordjournals.aje.a115439; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238	70	260	268	4	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2011	342								d2431	10.1136/bmj.d2431	http://dx.doi.org/10.1136/bmj.d2431			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762MC	21546419	Green Published, hybrid			2022-12-28	WOS:000290481800003
J	West, S; Witt, J				West, Sophie; Witt, Johan			A PATIENT'S JOURNEY Bilateral developmental dysplasia of the hips	BRITISH MEDICAL JOURNAL			English	Editorial Material									[West, Sophie] London Deanery Sch Surg, London, England; [Witt, Johan] Univ Coll London Hosp, UCH Referrals Ctr, Orthopaed & Trauma Serv, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	West, S (corresponding author), London Deanery Sch Surg, London, England.	sophie.pinder@doctors.org.uk							0	3	3	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2011	342								d2152	10.1136/bmj.d2152	http://dx.doi.org/10.1136/bmj.d2152			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762MC	21546421	Bronze			2022-12-28	WOS:000290481800001
J	Umpierre, D; Ribeiro, PAB; Kramer, CK; Leitao, CB; Zucatti, ATN; Azevedo, MJ; Gross, JL; Ribeiro, JP; Schaan, BD				Umpierre, Daniel; Ribeiro, Paula A. B.; Kramer, Caroline K.; Leitao, Cristiane B.; Zucatti, Alessandra T. N.; Azevedo, Mirela J.; Gross, Jorge L.; Ribeiro, Jorge P.; Schaan, Beatriz D.			Physical Activity Advice Only or Structured Exercise Training and Association With HbA(1c) Levels in Type 2 Diabetes A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR RISK-FACTORS; LIFE-STYLE INTERVENTION; GLYCEMIC CONTROL; AEROBIC EXERCISE; METABOLIC-CONTROL; CARDIORESPIRATORY FITNESS; HEMOGLOBIN A(1C); PUBLICATION BIAS; BODY-MASS	Context Regular exercise improves glucose control in diabetes, but the association of different exercise training interventions on glucose control is unclear. Objective To conduct a systematic review and meta-analysis of randomized controlled clinical trials (RCTs) assessing associations of structured exercise training regimens (aerobic, resistance, or both) and physical activity advice with or without dietary cointervention on change in hemoglobin A(1c) (HbA(1c)) in type 2 diabetes patients. Data Sources MEDLINE, Cochrane-CENTRAL, EMBASE, ClinicalTrials.gov, LILACS, and SPORTDiscus databases were searched from January 1980 through February 2011. Study Selection RCTs of at least 12 weeks' duration that evaluated the ability of structured exercise training or physical activity advice to lower HbA(1c) levels as compared with a control group in patients with type 2 diabetes. Data Extraction Two independent reviewers extracted data and assessed quality of the included studies. Data Synthesis Of 4191 articles retrieved, 47 RCTs (8538 patients) were included. Pooled mean differences in HbA(1c) levels between intervention and control groups were calculated using a random-effects model. Overall, structured exercise training (23 studies) was associated with a decline in HbA(1c) level (-0.67%; 95% confidence interval [CI], -0.84% to -0.49%; I-2, 91.3%) compared with control participants. In addition, structured aerobic exercise (-0.73%; 95% CI, -1.06% to -0.40%; I-2, 92.8%), structured resistance training (-0.57%; 95% CI, -1.14% to -0.01%; I-2, 92.5%), and both combined (-0.51%; 95% CI, -0.79% to -0.23%; I-2, 67.5%) were each associated with declines in HbA(1c) levels compared with control participants. Structured exercise durations of more than 150 minutes per week were associated with HbA(1c) reductions of 0.89%, while structured exercise durations of 150 minutes or less per week were associated with HbA(1c) reductions of 0.36%. Overall, interventions of physical activity advice (24 studies) were associated with lower HbA(1c) levels (-0.43%; 95% CI, -0.59% to -0.28%; I-2, 62.9%) compared with control participants. Combined physical activity advice and dietary advice was associated with decreased HbA(1c) (-0.58%; 95% CI, -0.74% to -0.43%; I-2, 57.5%) as compared with control participants. Physical activity advice alone was not associated with HbA(1c) changes. Conclusions Structured exercise training that consists of aerobic exercise, resistance training, or both combined is associated with HbA(1c) reduction in patients with type 2 diabetes. Structured exercise training of more than 150 minutes per week is associated with greater HbA(1c) declines than that of 150 minutes or less per week. Physical activity advice is associated with lower HbA(1c), but only when combined with dietary advice. JAMA. 2011;305(17):1790-1799 www.jama.com	[Schaan, Beatriz D.] Hosp Clin Porto Alegre, Serv Endocrinol, Div Endocrinol, BR-90035003 Porto Alegre, RS, Brazil; [Umpierre, Daniel; Ribeiro, Paula A. B.; Ribeiro, Jorge P.] Hosp Clin Porto Alegre, Exercise Pathophysiol Res Lab, BR-90035003 Porto Alegre, RS, Brazil; [Ribeiro, Jorge P.] Hosp Clin Porto Alegre, Div Cardiol, BR-90035003 Porto Alegre, RS, Brazil; [Azevedo, Mirela J.; Gross, Jorge L.; Ribeiro, Jorge P.; Schaan, Beatriz D.] Univ Fed Rio Grande do Sul, Fac Med, Dept Internal Med, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Schaan, BD (corresponding author), Hosp Clin Porto Alegre, Serv Endocrinol, Div Endocrinol, Rua Ramior Barcelos 2350,Predio 12,4 Andar, BR-90035003 Porto Alegre, RS, Brazil.	beatrizschaan@gmail.com	Albertin, Paloma C/X-1093-2018; Umpierre, Daniel/G-9366-2013; Gross, Jorge L/G-9138-2012; Kramer, Caroline K/L-9093-2018; Azevedo, Mirela J/G-9018-2012; Schaan, Beatriz D./I-7518-2017	Umpierre, Daniel/0000-0001-6953-0163; Schaan, Beatriz D./0000-0002-2128-8387; Ribeiro, Paula/0000-0003-0513-5812; Leitao, Cristiane/0000-0002-2106-309X	Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp Dohme; Servier; Abbott; Aventis; Bioassist; Boehringer Ingelheim; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [576627/2008-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [PNPD 03021/09-2]	Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Merck Sharp Dohme(Merck & Company); Servier(Servier); Abbott(Abbott Laboratories); Aventis(Sanofi-Aventis); Bioassist; Boehringer Ingelheim(Boehringer Ingelheim); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gross reports having attended advisory board meetings, received research support, and undertaking clinical trials sponsored by Bristol-Myers Squibb; and delivered continuing medical educational programs sponsored by Bristol-Myers Squibb, GlaxoSmithKline, and Merck Sharp & Dohme. Dr Ribeiro reports having received consulting fees from Merck Sharp & Dohme and Servier; lecturing fees from Abbott, Aventis, Bioassist, Merck Sharp & Dohme, and Servier; and grant support from Boehringer Ingelheim, Bristol-Myers Squibb, Merck Sharp & Dohme, and Servier. The other authors reported no disclosures.; This study was partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grant 576627/2008-9 and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) PNPD 03021/09-2.	Aas AM, 2005, DIABETIC MED, V22, P316, DOI 10.1111/j.1464-5491.2005.01421.x; AgursCollins TD, 1997, DIABETES CARE, V20, P1503, DOI 10.2337/diacare.20.10.1503; Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Balducci S, 2004, DIABETES CARE, V27, P841, DOI 10.2337/diacare.27.3.841; Balducci S, 2010, ARCH INTERN MED, V170, P1794, DOI 10.1001/archinternmed.2010.380; Bjorgaas M, 2005, DIABETES OBES METAB, V7, P737, DOI 10.1111/j.1463-1326.2004.00464.x; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; Brun JF, 2008, DIABETES METAB, V34, P258, DOI 10.1016/j.diabet.2008.01.010; Castaneda C, 2002, DIABETES CARE, V25, P2335, DOI 10.2337/diacare.25.12.2335; Cheung NW, 2009, DIABETES RES CLIN PR, V83, P68, DOI DOI 10.1016/J.DIABRES.2008.12.009; Christian JG, 2008, ARCH INTERN MED, V168, P141, DOI 10.1001/archinternmed.2007.13; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Colberg SR, 2010, DIABETES CARE, V33, P2692, DOI [10.2337/dc10-1548, 10.2337/dc10-9990]; Cuff DJ, 2003, DIABETES CARE, V26, P2977, DOI 10.2337/diacare.26.11.2977; Dasgupta K, 2006, DIABETES RES CLIN PR, V72, P53, DOI 10.1016/j.diabres.2005.09.010; DeFronzo RA, 2010, DIABETIC MED, V27, P309, DOI 10.1111/j.1464-5491.2010.02941.x; Dela F, 2004, AM J PHYSIOL-ENDOC M, V287, pE1024, DOI 10.1152/ajpendo.00056.2004; Di Loreto C, 2003, DIABETES CARE, V26, P404, DOI 10.2337/diacare.26.2.404; Diedrich A, 2010, DIABETES EDUCATOR, V36, P132, DOI 10.1177/0145721709352382; Dunstan DW, 2002, DIABETES CARE, V25, P1729, DOI 10.2337/diacare.25.10.1729; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Ferrier KE, 2004, DIABETOLOGIA, V47, P630, DOI 10.1007/s00125-004-1373-z; Giannopoulou I, 2005, METABOLISM, V54, P866, DOI 10.1016/j.metabol.2005.01.033; Goldhaber-Fiebert JD, 2003, DIABETES CARE, V26, P24, DOI 10.2337/diacare.26.1.24; Gordon BA, 2009, DIABETES RES CLIN PR, V83, P157, DOI 10.1016/j.diabres.2008.11.024; Harbord R, 2009, METAANALYSIS STATA U, P70; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hordern MD, 2009, HEART, V95, P1343, DOI 10.1136/hrt.2009.165571; Indrayan A, 2008, MED BIOSTATISTICS; Jakicic JM, 2009, INT J OBESITY, V33, P305, DOI 10.1038/ijo.2008.280; Kadoglou NP, 2007, DIABETES CARE, V30, P719, DOI 10.2337/dc06-1149; Kadoglou NPE, 2007, EUR J CARDIOV PREV R, V14, P837, DOI 10.1097/HJR.0b013e3282efaf50; Kadoglou NPE, 2010, METABOLISM, V59, P599, DOI 10.1016/j.metabol.2009.09.002; Kim CJ, 2006, CIN-COMPUT INFORM NU, V24, P337, DOI 10.1097/00024665-200611000-00008; Kim SH, 2006, METABOLISM, V55, P1053, DOI 10.1016/j.metabol.2006.03.017; Kirk A, 2003, DIABETES CARE, V26, P1186, DOI 10.2337/diacare.26.4.1186; Kirk A, 2009, DIABETIC MED, V26, P293, DOI 10.1111/j.1464-5491.2009.02675.x; Krousel-Wood MA, 2008, DIABETES RES CLIN PR, V79, P230, DOI 10.1016/j.diabres.2007.08.028; Lambers S, 2008, CLIN REHABIL, V22, P483, DOI 10.1177/0269215508084582; Leehey DJ, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-62; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Ligtenberg PC, 1997, CLIN SCI, V93, P127, DOI 10.1042/cs0930127; Loimaala A, 2003, DIABETES, V52, P1837, DOI 10.2337/diabetes.52.7.1837; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Vancea DMM, 2009, ARQ BRAS CARDIOL, V92, P22, DOI 10.1590/S0066-782X2009000100005; Mayer-Davis EJ, 2004, AM J PUBLIC HEALTH, V94, P1736, DOI 10.2105/AJPH.94.10.1736; Menard Julie, 2005, CMAJ, V173, P1457, DOI 10.1503/cmaj.050054; Middlebrooke AR, 2006, DIABETOLOGIA, V49, P2263, DOI 10.1007/s00125-006-0361-x; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Phung OJ, 2010, JAMA-J AM MED ASSOC, V303, P1410, DOI 10.1001/jama.2010.405; RAZ I, 1994, ISRAEL J MED SCI, V30, P766; Ribeiro ICD, 2008, MED SCI SPORT EXER, V40, P779, DOI 10.1249/MSS.0b013e3181632d2d; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; RONNEMAA T, 1986, ACTA MED SCAND, V220, P219; Samaras K, 1997, DIABETES RES CLIN PR, V37, P121, DOI 10.1016/S0168-8227(97)00061-2; Sigal RJ, 2004, DIABETES CARE, V27, P2518, DOI 10.2337/diacare.27.10.2518; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317; Sridhar B, 2010, TOHOKU J EXP MED, V220, P107, DOI 10.1620/tjem.220.107; Tessier D, 2000, ARCH GERONTOL GERIAT, V31, P121, DOI 10.1016/S0167-4943(00)00076-5; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Tudor-Locke C, 2004, INT J OBESITY, V28, P113, DOI 10.1038/sj.ijo.0802485; van Rooijen AJ, 2004, QJM-INT J MED, V97, P343, DOI 10.1093/qjmed/hch061; VANNINEN E, 1992, DIABETOLOGIA, V35, P340, DOI 10.1007/BF00401201; VERITY LS, 1989, DIABETES RES CLIN PR, V6, P27, DOI 10.1016/0168-8227(89)90054-5; Wiebe N, 2006, J CLIN EPIDEMIOL, V59, P342, DOI 10.1016/j.jclinepi.2005.08.017; WING RR, 1988, DIABETOLOGIA, V31, P902	69	768	802	2	165	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1790	1799		10.1001/jama.2011.576	http://dx.doi.org/10.1001/jama.2011.576			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758HZ	21540423	Bronze			2022-12-28	WOS:000290156200020
J	Baldwin, DR; White, B; Schmidt-Hansen, M; Champion, AR; Melder, AM				Baldwin, D. R.; White, B.; Schmidt-Hansen, M.; Champion, A. R.; Melder, A. M.			Diagnosis and treatment of lung cancer: summary of updated NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Baldwin, D. R.; White, B.] Nottingham Univ Hosp NHS Trust, Nottingham NG5 1PB, England; [Schmidt-Hansen, M.; Champion, A. R.] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales; [Melder, A. M.] Ctr Clin Effectiveness, Clayton, Vic 3168, Australia	Nottingham University Hospital NHS Trust	Baldwin, DR (corresponding author), Univ Nottingham Hosp, David Evans Res Ctr, Resp Med Unit, City Campus,Hucknall Rd, Nottingham NG5 1PB, England.	david.baldwin@nuh.nhs.uk						[Anonymous], 2008, ERL TREATM NONSM CEL; Cancer Research UK, 2009, CANC MORT UK STAT; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Falcoz PE, 2007, J THORAC CARDIOV SUR, V133, P325, DOI 10.1016/j.jtcvs.2006.09.020; *NAT I HLTH CLIN, 2011, DIAGN TREATM LUNG CA; *NAT I HLTH CLIN E, 2009, TOP TREATM REL SMALL; *NAT I HLTH CLIN E, 2010, GEF 1 LIN TREATM LOC; National Institute for Health and Clinical Excellence, 2009, GUID MAN; National Institute for Health and Clinical Excellence, 2009, PEM 1 LIN TREATM NON; *NHS INF CTR, 2009, IC23090809 NHS INF C	10	53	54	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 27	2011	342								d2110	10.1136/bmj.d2110	http://dx.doi.org/10.1136/bmj.d2110			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759BT	21525094				2022-12-28	WOS:000290215600002
J	Donnelly, J				Donnelly, John			Profile Haja Zainab Bangura: Sierra Leone's tireless Minister of Health	LANCET			English	Biographical-Item												donnellyglobe@gmail.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 23	2011	377	9775					1399	1399		10.1016/S0140-6736(11)60562-X	http://dx.doi.org/10.1016/S0140-6736(11)60562-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UF	21515149				2022-12-28	WOS:000289963000012
J	Schneider, MD				Schneider, Michael D.			A Cardiac Nonproliferation Treaty	SCIENCE			English	Editorial Material							ZEBRAFISH HEART REGENERATION; PATHWAY; CARDIOMYOCYTES; PROLIFERATION; CATENIN; COMPLEX		Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, British Heart Fdn Ctr Res Excellence, London SW7 2AZ, England	Imperial College London	Schneider, MD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, British Heart Fdn Ctr Res Excellence, London SW7 2AZ, England.	m.d.schneider@imperial.ac.uk		Schneider, Michael/0000-0001-9645-1938				GONZALEZROSA JM, 2011, DEVELOPMENT; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Mercola M, 2011, GENE DEV, V25, P299, DOI 10.1101/gad.2018411; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007	15	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					426	427		10.1126/science.1205972	http://dx.doi.org/10.1126/science.1205972			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512022				2022-12-28	WOS:000289784900029
J	Pryor, WR; Rymer, AM; Mitchell, DG; Hill, TW; Young, DT; Saur, J; Jones, GH; Jacobsen, S; Cowley, SWH; Mauk, BH; Coates, AJ; Gustin, J; Grodent, D; Gerard, JC; Lamy, L; Nichols, JD; Krimigis, SM; Esposito, LW; Dougherty, MK; Jouchoux, AJ; Stewart, AIF; McClintock, WE; Holsclaw, GM; Ajello, JM; Colwell, JE; Hendrix, AR; Crary, FJ; Clarke, JT; Zhou, XY				Pryor, Wayne R.; Rymer, Abigail M.; Mitchell, Donald G.; Hill, Thomas W.; Young, David T.; Saur, Joachim; Jones, Geraint H.; Jacobsen, Sven; Cowley, Stan W. H.; Mauk, Barry H.; Coates, Andrew J.; Gustin, Jacques; Grodent, Denis; Gerard, Jean-Claude; Lamy, Laurent; Nichols, Jonathan D.; Krimigis, Stamatios M.; Esposito, Larry W.; Dougherty, Michele K.; Jouchoux, Alain J.; Stewart, A. Ian F.; McClintock, William E.; Holsclaw, Gregory M.; Ajello, Joseph M.; Colwell, Joshua E.; Hendrix, Amanda R.; Crary, Frank J.; Clarke, John T.; Zhou, Xiaoyan			The auroral footprint of Enceladus on Saturn	NATURE			English	Article							IO FLUX TUBE; CASSINI; ATMOSPHERE; MAGNETOSPHERE; SPECTROMETER; JUPITER; ORIGIN; PLASMA; PLUME	Although there are substantial differences between the magnetospheres of Jupiter and Saturn, it has been suggested that cryovolcanic activity at Enceladus(1-9) could lead to electrodynamic coupling between Enceladus and Saturn like that which links Jupiter with Io, Europa and Ganymede. Powerful field-aligned electron beams associated with the Io-Jupiter coupling, for example, create an auroral footprint in Jupiter's ionosphere(10,11). Auroral ultraviolet emission associated with Enceladus-Saturn coupling is anticipated to be just a few tenths of a kilorayleigh (ref. 12), about an order of magnitude dimmer than Io's footprint and below the observable threshold, consistent with its non-detection(13). Here we report the detection of magnetic-field-aligned ion and electron beams (offset several moon radii downstream from Enceladus) with sufficient power to stimulate detectable aurora, and the subsequent discovery of Enceladus-associated aurora in a few per cent of the scans of the moon's footprint. The footprint varies in emission magnitude more than can plausibly be explained by changes in magnetospheric parameters-and as such is probably indicative of variable plume activity.	[Rymer, Abigail M.; Mitchell, Donald G.; Mauk, Barry H.; Krimigis, Stamatios M.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Pryor, Wayne R.] Cent Arizona Coll, Dept Sci, Coolidge, AZ 85128 USA; [Pryor, Wayne R.] Space Environm Technol, Pacific Palisades, CA 90272 USA; [Hill, Thomas W.] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; [Young, David T.; Crary, Frank J.] SW Res Inst, Space Sci & Engn Div, San Antonio, TX 78238 USA; [Saur, Joachim; Jacobsen, Sven] Univ Cologne, Inst Geophys & Meteorol, D-50923 Cologne, Germany; [Jones, Geraint H.; Coates, Andrew J.] Univ Coll London, Mullard Space Sci Lab, Dept Space & Climate Phys, Dorking RH5 6NT, Surrey, England; [Jones, Geraint H.] Univ London Birkbeck Coll, Ctr Planetary Sci, London WC1E 6BT, England; [Cowley, Stan W. H.; Nichols, Jonathan D.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Gustin, Jacques; Grodent, Denis; Gerard, Jean-Claude] Univ Liege, Lab Phys Atmospher & Planetaire, Dept Astrophys Geophys & Oceanog, B-4000 Liege, Belgium; [Lamy, Laurent] Univ Paris Diderot, Univ Pierre & Marie Curie, Lab Etud Spatiales & Instrumentat Astrophys, Observ Paris,Ctr Natl Rech Sci, F-92195 Meudon, France; [Krimigis, Stamatios M.] Acad Athens, Athens 11527, Greece; [Esposito, Larry W.; Jouchoux, Alain J.; Stewart, A. Ian F.; McClintock, William E.; Holsclaw, Gregory M.] Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80303 USA; [Dougherty, Michele K.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England; [Ajello, Joseph M.; Hendrix, Amanda R.; Zhou, Xiaoyan] Jet Prop Lab, Pasadena, CA 91109 USA; [Colwell, Joshua E.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; [Clarke, John T.] Boston Univ, Dept Astron, Boston, MA 02215 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Rice University; Southwest Research Institute; University of Cologne; University of London; University College London; University of London; Birkbeck University London; University of Leicester; University of Liege; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Academy of Athens; University of Colorado System; University of Colorado Boulder; Imperial College London; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); State University System of Florida; University of Central Florida; Boston University	Rymer, AM (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	abigail.rymer@jhuapl.edu	Coates, Andrew/C-2396-2008; Saur, Joachim/V-6780-2019; ESPOSITO, LARRY W/AAB-3673-2021; Holsclaw, Greg/AAX-2486-2021; Rymer, Abigail/I-6206-2016; Krimigis, Stamatios/G-4591-2019; Jones, Geraint H./C-1682-2008; Jacobsen, Sven/K-1200-2013; Nichols, Jonathan/ABA-8695-2021; Clarke, John/C-8644-2013; Jacobsen, Sven/E-1763-2013; Mauk, Barry H/E-8420-2017; Nichols, Jonathan/F-5764-2010; Mitchell, Donald G/H-4601-2016; Colwell, Joshua/AAP-2692-2020	Coates, Andrew/0000-0002-6185-3125; Saur, Joachim/0000-0003-1413-1231; ESPOSITO, LARRY W/0000-0003-3381-2016; Holsclaw, Greg/0000-0002-9059-9437; Rymer, Abigail/0000-0002-4879-0748; Krimigis, Stamatios/0000-0003-2781-2386; Jones, Geraint H./0000-0002-5859-1136; Nichols, Jonathan/0000-0002-8004-6409; Mauk, Barry H/0000-0001-9789-3797; Nichols, Jonathan/0000-0002-8004-6409; Mitchell, Donald G/0000-0003-1960-2119; Colwell, Joshua/0000-0001-8269-6408; Cowley, Stanley/0000-0002-4041-0034; GERARD, Jean-Claude/0000-0002-8565-8746	NASA/ESA; NASA; Science and Technology Facilities Council [ST/H00260X/1, ST/I00212X/1, PP/E001076/1, PP/D005213/1, ST/H002480/1] Funding Source: researchfish; UK Space Agency [ST/I002642/1, PP/D00084X/1, ST/J00460X/1] Funding Source: researchfish; STFC [ST/H00260X/1, ST/I00212X/1, ST/H002480/1, PP/E001076/1, PP/D005213/1] Funding Source: UKRI	NASA/ESA(European Space AgencyNational Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We acknowledge support from the NASA/ESA Cassini Project and NASA's Cassini Data Analysis Program.	Bonfond B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032418; Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; Burton ME, 2009, PLANET SPACE SCI, V57, P1706, DOI 10.1016/j.pss.2009.04.008; Clarke JT, 2002, NATURE, V415, P997, DOI 10.1038/415997a; CONNERNEY JEP, 1993, SCIENCE, V262, P1035, DOI 10.1126/science.262.5136.1035; Connerney JEP, 1998, J GEOPHYS RES-SPACE, V103, P11929, DOI 10.1029/97JA03726; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; Dougherty MK, 2004, SPACE SCI REV, V114, P331, DOI 10.1007/s11214-004-1432-2; Esposito LW, 2004, SPACE SCI REV, V115, P299, DOI 10.1007/s11214-004-1455-8; Gerard JC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036554; GURNETT DA, 1981, J GEOPHYS RES-SPACE, V86, P717, DOI 10.1029/JA086iA02p00717; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Jacobsen S, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014753; Jia YD, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042948; Jones GH, 2006, SCIENCE, V311, P1412, DOI 10.1126/science.1121011; Kanani SJ, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014262; Krimigis SM, 2004, SPACE SCI REV, V114, P233, DOI 10.1007/s11214-004-1410-8; Nichols JD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041491; Persoon AM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027090; Pontius DH, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011674; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Saur J, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035811; Smith HT, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015184; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Tokar RL, 2006, SCIENCE, V311, P1409, DOI 10.1126/science.1121061; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; WAITE JH, 1983, J GEOPHYS RES-SPACE, V88, P6143, DOI 10.1029/JA088iA08p06143; Wannawichian S, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012899; Young DT, 2004, SPACE SCI REV, V114, P1, DOI 10.1007/s11214-004-1406-4	30	76	76	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					331	333		10.1038/nature09928	http://dx.doi.org/10.1038/nature09928			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21512570				2022-12-28	WOS:000289724600035
J	Wessely, S				Wessely, Simon			Commentary: A police officer's lot is not a happy one	BRITISH MEDICAL JOURNAL			English	Editorial Material							VETERANS; STRESS		Kings Coll London, Inst Psychiat, Dept Psychol Med, London WC2R 2LS, England	University of London; King's College London	Wessely, S (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychol Med, London WC2R 2LS, England.	simon.wessely@kcl.ac.uk	Wessely, Simon C/A-8713-2008	Wessely, Simon Charles/0000-0002-6743-9929				Collins PA, 2003, OCCUP MED-OXFORD, V53, P256, DOI 10.1093/occmed/kqg061; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Frueh BC, 2007, AM J PUBLIC HEALTH, V97, P2143, DOI 10.2105/AJPH.2007.115436; Hobsbawm Eric J., 1975, AGE CAPITAL 1848 187; Iversen A, 2005, EUR J PUBLIC HEALTH, V15, P175, DOI 10.1093/eurpub/cki128; Summerfield D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2127; Wainwright D., 2002, WORK STRESS MAKING M	7	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2011	342								d2252	10.1136/bmj.d2252	http://dx.doi.org/10.1136/bmj.d2252			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OI	21505223				2022-12-28	WOS:000289942200005
J	Dubach, P; Caversaccio, M				Dubach, Patrick; Caversaccio, Marco			Amalgam Tattoo	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dubach, Patrick; Caversaccio, Marco] Univ Bern, Inselspital, Dept Otorhinolaryngol Head & Neck Surg, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Dubach, P (corresponding author), Univ Bern, Inselspital, Dept Otorhinolaryngol Head & Neck Surg, CH-3010 Bern, Switzerland.	patrickdubach@insel.ch							0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					E29	E29		10.1056/NEJMicm1011669	http://dx.doi.org/10.1056/NEJMicm1011669			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LD	21488760	Green Published			2022-12-28	WOS:000289467200010
J	Bailey, CJ				Bailey, Clifford J.			The challenge of managing coexistent type 2 diabetes and obesity	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BARIATRIC SURGERY; RECEPTOR AGONIST; GLUCAGON; HYPERGLYCEMIA; THERAPEUTICS; MANAGEMENT; METFORMIN; THERAPY		Aston Univ, Birmingham B4 7ET, W Midlands, England	Aston University	Bailey, CJ (corresponding author), Aston Univ, Birmingham B4 7ET, W Midlands, England.	c.j.bailey@aston.ac.uk		Bailey, Clifford J/0000-0002-6998-6811	AstraZeneca; Sanofi-Aventis; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; Novo Nordisk; Merck Sharp Dohme	AstraZeneca(AstraZeneca); Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Merck Serono(Merck & Company); Novo Nordisk(Novo Nordisk); Merck Sharp Dohme(Merck & Company)	The author has completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declares: no support from any organisation for the submitted work; he has attended advisory board meetings or undertaken ad hoc consultancy for several companies (Bristol-Myers Squibb, AstraZeneca, Merck Sharp & Dohme, Novo Nordisk, GlaxoSmithKline, Sanofi-Aventis, Takeda, and Prosidion); received research grants from AstraZeneca and Sanofi-Aventis; delivered continuing medical educational programmes sponsored by Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline, Merck Serono, Novo Nordisk, and Merck Sharp & Dohme (these include BMJ Masterclasses); and received travel or accommodation reimbursement from GlaxoSmithKline and Bristol-Myers Squibb; no other relationships or activities that could appear to have influenced the submitted work.	[Anonymous], [No title captured]; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; Bailey Clifford J, 2007, Diab Vasc Dis Res, V4, P20, DOI 10.3132/dvdr.2007.002; Bailey CJ, 2011, TRENDS PHARMACOL SCI, V32, P63, DOI 10.1016/j.tips.2010.11.011; BEI B, 2009, CELL METAB, V9, P407; Billyard T, 2007, BEST PRACT RES CL EN, V21, P641, DOI 10.1016/j.beem.2007.07.006; Buse JB, 2010, DIABETES CARE, V33, P1255, DOI 10.2337/dc09-1914; *CONJ, PC DAC EX 4 CJC 1134; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Dixon JB, 2009, WORLD J SURG, V33, P2014, DOI 10.1007/s00268-009-0062-y; Flatt PR, 2008, DIABETIC MED, V25, P759, DOI 10.1111/j.1464-5491.2008.02455.x; Flatt PR, 2009, CURR DRUG METAB, V10, P125, DOI 10.2174/138920009787522124; Gregg EW, 2007, PREV MED, V45, P348, DOI 10.1016/j.ypmed.2007.07.020; Henness S, 2006, DRUGS, V66, P1625, DOI 10.2165/00003495-200666120-00012; International Diabetes Federation, 2009, DIAB ATL; Jones RM, 2009, EXPERT OPIN THER PAT, V19, P1339, DOI 10.1517/13543770903153878; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karra E, 2009, J PHYSIOL-LONDON, V587, P19, DOI 10.1113/jphysiol.2008.164269; Lam CKL, 2009, PHYSIOLOGY, V24, P159, DOI 10.1152/physiol.00003.2009; *LILL, 2011, DURATION 6 TOP LIN S; Ma X, 2009, DIABETES OBES METAB, V11, P953, DOI 10.1111/j.1463-1326.2009.01070.x; Madsen P, 2009, J MED CHEM, V52, P2989, DOI 10.1021/jm8016249; McCarthy MI, 2008, NAT GENET, V40, P1039, DOI 10.1038/ng0908-1039; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Pan CQ, 2006, J BIOL CHEM, V281, P12506, DOI 10.1074/jbc.M600127200; Pournaras DJ, 2010, INT J PEPT, V2010; Ratner RE, 2010, DIABETIC MED, V27, P1024, DOI 10.1111/j.1464-5491.2010.03020.x; Rosenstock J, 2010, DIABETES CARE, V33, P1516, DOI 10.2337/dc09-2315; Rosenstock J, 2009, DIABETES CARE, V32, P1880, DOI 10.2337/dc09-0366; Russell ST, 2010, ENDOCRINOLOGY, V151, P948, DOI 10.1210/en.2009-0827; Verspohl EJ, 2009, PHARMACOL THERAPEUT, V124, P113, DOI 10.1016/j.pharmthera.2009.06.002; Vetter ML, 2009, ANN INTERN MED, V150, P94, DOI 10.7326/0003-4819-150-2-200901200-00007; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Yu LF, 2010, CURR TOP MED CHEM, V10, P397, DOI 10.2174/156802610790980611	34	16	17	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2011	342								d1996	10.1136/bmj.d1996	http://dx.doi.org/10.1136/bmj.d1996			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752UX	21490051	Green Accepted			2022-12-28	WOS:000289721500003
J	Lawrence, C				Lawrence, Christopher			Historical keyword Blood	LANCET			English	Editorial Material												c.lawrence645@btinternet.com							0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1231	1231		10.1016/S0140-6736(11)60488-1	http://dx.doi.org/10.1016/S0140-6736(11)60488-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	751DI	21481693	Bronze			2022-12-28	WOS:000289597300014
J	Wang, ZN; Klipfell, E; Bennett, BJ; Koeth, R; Levison, BS; Dugar, B; Feldstein, AE; Britt, EB; Fu, XM; Chung, YM; Wu, YP; Schauer, P; Smith, JD; Allayee, H; Tang, WHW; DiDonato, JA; Lusis, AJ; Hazen, SL				Wang, Zeneng; Klipfell, Elizabeth; Bennett, Brian J.; Koeth, Robert; Levison, Bruce S.; Dugar, Brandon; Feldstein, Ariel E.; Britt, Earl B.; Fu, Xiaoming; Chung, Yoon-Mi; Wu, Yuping; Schauer, Phil; Smith, Jonathan D.; Allayee, Hooman; Tang, W. H. Wilson; DiDonato, Joseph A.; Lusis, Aldons J.; Hazen, Stanley L.			Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease	NATURE			English	Article							TRIMETHYLAMINE-N-OXIDE; CORONARY-HEART-DISEASE; GENE-EXPRESSION; CHLAMYDIA-PNEUMONIAE; MURINE MACROPHAGES; MASS-SPECTROMETRY; DNA METHYLATION; ATHEROSCLEROSIS; MOUSE; MICE	Metabolomics studies hold promise for the discovery of pathways linked to disease processes. Cardiovascular disease (CVD) represents the leading cause of death and morbidity worldwide. Here we used a metabolomics approach to generate unbiased small-molecule metabolic profiles in plasma that predict risk for CVD. Three metabolites of the dietary lipid phosphatidylcholine-choline, trimethylamine N-oxide (TMAO) and betaine-were identified and then shown to predict risk for CVD in an independent large clinical cohort. Dietary supplementation of mice with choline, TMAO or betaine promoted upregulation of multiple macrophage scavenger receptors linked to atherosclerosis, and supplementation with choline or TMAO promoted atherosclerosis. Studies using germ-free mice confirmed a critical role for dietary choline and gut flora in TMAO production, augmented macrophage cholesterol accumulation and foam cell formation. Suppression of intestinal microflora in atherosclerosis-prone mice inhibited dietary-choline-enhanced atherosclerosis. Genetic variations controlling expression of flavin monooxygenases, an enzymatic source of TMAO, segregated with atherosclerosis in hyperlipidaemic mice. Discovery of a relationship between gut-flora-dependent metabolism of dietary phosphatidylcholine and CVD pathogenesis provides opportunities for the development of new diagnostic tests and therapeutic approaches for atherosclerotic heart disease.	[Wang, Zeneng; Klipfell, Elizabeth; Koeth, Robert; Levison, Bruce S.; Dugar, Brandon; Feldstein, Ariel E.; Britt, Earl B.; Fu, Xiaoming; Chung, Yoon-Mi; Smith, Jonathan D.; Tang, W. H. Wilson; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Wang, Zeneng; Klipfell, Elizabeth; Levison, Bruce S.; Feldstein, Ariel E.; Britt, Earl B.; Fu, Xiaoming; Chung, Yoon-Mi; Tang, W. H. Wilson; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Bennett, Brian J.; Lusis, Aldons J.] Univ Calif Los Angeles, Ctr Hlth Sci BH 307, Div Cardiol, Dept Med, Los Angeles, CA 90095 USA; [Wu, Yuping] Cleveland State Univ, Dept Math, Cleveland, OH 44115 USA; [Schauer, Phil] Cleveland Clin, Bariatr & Metab Inst, Cleveland, OH 44195 USA; [Smith, Jonathan D.; Tang, W. H. Wilson; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Allayee, Hooman] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Allayee, Hooman] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90089 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California Los Angeles; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Southern California; University of Southern California	Hazen, SL (corresponding author), Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA.	hazens@ccf.org	Wang, Zeneng/AAK-6119-2021; Hazen, Stanley L/ABD-5845-2021; Tang, Wai Hong Wilson/I-1238-2013; Lorkiewicz, Pawel/A-2126-2011; Smith, Jonathan D./H-9723-2013	Lorkiewicz, Pawel/0000-0002-1755-9826; Schauer, Philip/0000-0002-4029-7537; Smith, Jonathan D./0000-0002-0415-386X; Tang, W. H. Wilson/0000-0002-8335-735X; bennett, brian/0000-0002-0766-3195; Levison, Bruce/0000-0002-1816-368X	National Institutes of Health [R01 HL103866, P01 HL098055, P01HL087018-020001, P01 HL28481, P01 HL30568, T32-DK07789]; Cleveland Clinic Foundation General Clinical Research Center of the Cleveland Clinic/Case Western Reserve University CTSA [1UL1RR024989]; Abbott Diagnostics;  [P01 HL076491-055328];  [R01 HL103931];  [R01 DK080732]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, P01HL087018, P01HL076491, R01HL103931, P01HL098055, P01HL028481, R01HL103866, R01HL098193, K99HL102223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080732, T32DK007789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Clinic Foundation General Clinical Research Center of the Cleveland Clinic/Case Western Reserve University CTSA; Abbott Diagnostics(Abbott Laboratories); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We wish to thank E. Sehayek for discussions, L. W. Castellani for help with lipoprotein profile analysis, and F. McNally, M. Berk and M. Pepoy for technical assistance. This research was supported by National Institutes of Health grants R01 HL103866, P01 HL098055, P01HL087018-020001, P01 HL28481 and P01 HL30568. B.J.B. was supported by NIH training grant T32-DK07789. The clinical study GeneBank was supported in part by P01 HL076491-055328, R01 HL103931 and the Cleveland Clinic Foundation General Clinical Research Center of the Cleveland Clinic/Case Western Reserve University CTSA (1UL1RR024989). Some of the laboratory studies (haemaglobin A1C, fasting glucose) in GeneBank were supported by R01 DK080732 and Abbott Diagnostics provided supplies for performance of some of the fasting lipid profile, glucose, creatinine, troponin I and hsCRP measured in GeneBank.	Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; ALWAIZ M, 1992, METABOLISM, V41, P135, DOI 10.1016/0026-0495(92)90140-6; Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baglione Julie, 2006, V129, P83; Bain MA, 2006, NEPHROL DIAL TRANSPL, V21, P1300, DOI 10.1093/ndt/gfk056; Barham Ann Hiott, 2009, Prev Cardiol, V12, P95, DOI 10.1111/j.1751-7141.2008.00019.x; Bidulescu Aurelian, 2007, BMC Cardiovasc Disord, V7, P20, DOI 10.1186/1471-2261-7-20; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Cannon CP, 2005, NEW ENGL J MED, V352, P1646, DOI 10.1056/NEJMoa043528; Cashman JR, 2003, CURR DRUG METAB, V4, P151, DOI 10.2174/1389200033489505; CHEN FCM, 1976, CAN J CHEM, V54, P3310, DOI 10.1139/v76-475; DACOSTA KA, 1990, ANAL BIOCHEM, V187, P234, DOI 10.1016/0003-2697(90)90449-J; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Danne O, 2007, CLIN CHIM ACTA, V383, P103, DOI 10.1016/j.cca.2007.05.001; de Vries TJ, 2009, J LEUKOCYTE BIOL, V85, P919, DOI 10.1189/jlb.0708402; Deichmann M, 1999, J CLIN ONCOL, V17, P1891, DOI 10.1200/JCO.1999.17.6.1891; Devlin GL, 2001, AM J RESP CELL MOL, V24, P727, DOI 10.1165/ajrcmb.24.6.4407; Dolphin CT, 1997, NAT GENET, V17, P491, DOI 10.1038/ng1297-491; Dong CM, 2002, J NUTR, V132, p2406S, DOI 10.1093/jn/132.8.2406S; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Epstein SE, 1996, LANCET, V348, pS13, DOI 10.1016/S0140-6736(96)98005-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; GADDIS ML, 1990, ANN EMERG MED, V19, P1462, DOI 10.1016/S0196-0644(05)82622-8; Gautam S, 1997, BIOMETRICS, V53, P1163, DOI 10.2307/2533575; GAUVREAU K, 1993, NUTRITION, V9, P386; GOODALL CM, 1986, J APPL TOXICOL, V6, P95, DOI 10.1002/jat.2550060206; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lang DH, 1998, BIOCHEM PHARMACOL, V56, P1005, DOI 10.1016/S0006-2952(98)00218-4; LeLeiko RM, 2009, AM J CARDIOL, V104, P638, DOI 10.1016/j.amjcard.2009.04.047; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; Miles EA, 2000, ATHEROSCLEROSIS, V152, P43, DOI 10.1016/S0021-9150(99)00446-3; Millward CA, 2009, MAMM GENOME, V20, P71, DOI 10.1007/s00335-008-9165-2; Mitchell SC, 2001, DRUG METAB DISPOS, V29, P517; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Nicholls SJ, 2010, J LIPID RES, V51, P3055, DOI 10.1194/jlr.M008961; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; PATEL P, 1995, BRIT MED J, V311, P711, DOI 10.1136/bmj.311.7007.711; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rasooly R, 2007, BRIT J NUTR, V97, P58, DOI 10.1017/S0007114507257745; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Rizzo ML, 2008, STAT COMPUTING R; Robinet P, 2010, J LIPID RES, V51, P3364, DOI 10.1194/jlr.D007336; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; SALMON WD, 1962, ARCH PATHOL, V73, P190; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Song JL, 2001, J BIOL CHEM, V276, P40241, DOI 10.1074/jbc.M107242200; Stoves J, 2002, NEPHROL DIAL TRANSPL, V17, P2036, DOI 10.1093/ndt/17.11.2036; Traissac P, 1999, REV EPIDEMIOL SANTE, V47, P593; Treberg JR, 2002, J EXP BIOL, V205, P1419; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; Wang SS, 2007, CIRC RES, V101, pE11, DOI 10.1161/CIRCRESAHA.107.152975; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Westendorf T, 2005, MOL CELL BIOCHEM, V277, P143, DOI 10.1007/s11010-005-5873-z; Wijnand HP, 2000, COMPUT METH PROG BIO, V63, P21, DOI 10.1016/S0169-2607(00)00058-4; Wright SD, 2000, J EXP MED, V191, P1437, DOI 10.1084/jem.191.8.1437; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zaina S, 2005, J NUTR, V135, P5, DOI 10.1093/jn/135.1.5; Zeisel SH, 2003, J NUTR, V133, P1302; Zhang AQ, 1999, FOOD CHEM TOXICOL, V37, P515, DOI 10.1016/S0278-6915(99)00028-9; Zhang J, 2006, DRUG METAB DISPOS, V34, P19, DOI 10.1124/dmd.105.006171; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	68	3224	3450	49	1324	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					57	U82		10.1038/nature09922	http://dx.doi.org/10.1038/nature09922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475195	Green Accepted, Green Submitted			2022-12-28	WOS:000289199400036
J	Khajetoorians, AA; Wiebe, J; Chilian, B; Wiesendanger, R				Khajetoorians, Alexander Ako; Wiebe, Jens; Chilian, Bruno; Wiesendanger, Roland			Realizing All-Spin-Based Logic Operations Atom by Atom	SCIENCE			English	Article							SCANNING TUNNELING MICROSCOPE; DOT CELLULAR-AUTOMATA; QUANTUM DOTS; GATE; SPECTROSCOPY; SURFACE; DEVICE; MEMORY	An ultimate goal of spintronic research is the realization of concepts for atomic-scale all-spin-based devices. We combined bottom-up atomic fabrication with spin-resolved scanning tunneling microscopy to construct and read out atomic-scale model systems performing logic operations. Our concept uses substrate-mediated indirect exchange coupling to achieve logical interconnection between individual atomic spins. Combined with spin frustration, this concept enables various logical operations between inputs, such as NOT and OR.	[Khajetoorians, Alexander Ako; Wiebe, Jens; Chilian, Bruno; Wiesendanger, Roland] Univ Hamburg, Inst Appl Phys, D-20355 Hamburg, Germany	University of Hamburg	Wiebe, J (corresponding author), Univ Hamburg, Inst Appl Phys, Jungiusstr 11, D-20355 Hamburg, Germany.	jwiebe@physnet.uni-hamburg.de	Wiebe, Jens/C-7580-2018; Khajetoorians, Alexander A/F-9698-2015; Wiesendanger, Roland/P-9726-2016; narasimhan, ganesh/D-6913-2017	Wiebe, Jens/0000-0003-1668-6142; Wiesendanger, Roland/0000-0002-0472-4183; narasimhan, ganesh/0000-0001-7682-256X	European Research Council; Deutsche Forschungsgemeinschaft [SFB668]; Graduiertenkolleg [1286]; Forschungs- und Wissenschaftsstiftung Hamburg	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduiertenkolleg(German Research Foundation (DFG)); Forschungs- und Wissenschaftsstiftung Hamburg	Financial support from the European Research Council Advanced Grant "FURORE" by the Deutsche Forschungsgemeinschaft via the SFB668, the Graduiertenkolleg 1286 "Functional Metal-Semiconductor Hybrid Systems," as well as from the Cluster of Excellence "Nanospintronics" funded by the Forschungs- und Wissenschaftsstiftung Hamburg is gratefully acknowledged. The authors thank S. Lounis, M. Potthoff, and R. Wieser for extensive discussions.	Allwood DA, 2005, SCIENCE, V309, P1688, DOI 10.1126/science.1108813; Amlani I, 1999, SCIENCE, V284, P289, DOI 10.1126/science.284.5412.289; Behin-Aein B, 2010, NAT NANOTECHNOL, V5, P266, DOI [10.1038/nnano.2010.31, 10.1038/NNANO.2010.31]; Brovko OO, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.036809; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Heinrich AJ, 2004, SCIENCE, V306, P466, DOI 10.1126/science.1101077; Heinrich AJ, 2002, SCIENCE, V298, P1381, DOI 10.1126/science.1076768; Hirjibehedin CF, 2006, SCIENCE, V312, P1021, DOI 10.1126/science.1125398; Hisamoto D, 2000, IEEE T ELECTRON DEV, V47, P2320, DOI 10.1109/16.887014; Imre A, 2006, SCIENCE, V311, P205, DOI 10.1126/science.1120506; Khajetoorians AA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.037205; Lent CS, 1997, P IEEE, V85, P541, DOI 10.1109/5.573740; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Meier F, 2008, SCIENCE, V320, P82, DOI 10.1126/science.1154415; Moon CR, 2009, NAT NANOTECHNOL, V4, P167, DOI [10.1038/NNANO.2008.415, 10.1038/nnano.2008.415]; Neumann P, 2010, NAT PHYS, V6, P249, DOI 10.1038/NPHYS1536; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Pietzsch O, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.057202; Ruess FJ, 2007, SMALL, V3, P563, DOI 10.1002/smll.200600680; Wiebe J, 2004, REV SCI INSTRUM, V75, P4871, DOI 10.1063/1.1794431; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Xu P, 2008, NAT NANOTECHNOL, V3, P97, DOI 10.1038/nnano.2008.1; Zhou LH, 2010, NAT PHYS, V6, P187, DOI 10.1038/NPHYS1514	24	289	296	3	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2011	332	6033					1062	1064		10.1126/science.1201725	http://dx.doi.org/10.1126/science.1201725			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21551029				2022-12-28	WOS:000290996700038
J	Thomas, PC				Thomas, Peter C.			Cold-Trapping Mars' Atmosphere	SCIENCE			English	Editorial Material							CARBON-DIOXIDE		Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA	Cornell University	Thomas, PC (corresponding author), Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA.	pthomas@astro.cornell.edu						Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; Fanale F.P., 1992, MARS, P1135; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; Mellon MT, 1996, ICARUS, V124, P268, DOI 10.1006/icar.1996.0203; MURRAY BC, 1972, ICARUS, V17, P328, DOI 10.1016/0019-1035(72)90004-8; NUNES DC, 2006, LUNAR PLANET SCI C, V37, P1450; Phillips RJ, 2011, SCIENCE, V332, P838, DOI 10.1126/science.1203091; PLAUT JJ, 2006, AGU FALL M; SAGAN C, 1973, J GEOPHYS RES, V78, P4250, DOI 10.1029/JB078i020p04250; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Thomas PC, 2009, ICARUS, V203, P352, DOI 10.1016/j.icarus.2009.05.014; Titus TN, 2003, SCIENCE, V299, P1048, DOI 10.1126/science.1080497	14	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					797	798		10.1126/science.1205169	http://dx.doi.org/10.1126/science.1205169			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21512000				2022-12-28	WOS:000290529900031
J	Clusella-Trullas, S; Chown, SL				Clusella-Trullas, Susana; Chown, Steven L.			Comment on "Erosion of Lizard Diversity by Climate Change and Altered Thermal Niches"	SCIENCE			English	Editorial Material							ANIMALS		[Clusella-Trullas, Susana; Chown, Steven L.] Univ Stellenbosch, Ctr Invas Biol, Dept Bot & Zool, ZA-7602 Stellenbosch, South Africa	Stellenbosch University	Clusella-Trullas, S (corresponding author), Univ Stellenbosch, Ctr Invas Biol, Dept Bot & Zool, ZA-7602 Stellenbosch, South Africa.	sct333@sun.ac.za	Chown, Steven/H-3347-2011	Chown, Steven/0000-0001-6069-5105				Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; GRANT BW, 1992, AM ZOOL, V32, P154; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; PORTER WP, 1973, OECOLOGIA, V13, P1, DOI 10.1007/BF00379617; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; Sears M, 2007, INTEGR COMP BIOL, V47, pE228; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695	8	42	42	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029								10.1126/science.1195193	http://dx.doi.org/10.1126/science.1195193			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527699	Green Published			2022-12-28	WOS:000289991100025
J	Kondrashov, N; Pusic, A; Stumpf, CR; Shimizu, K; Hsieh, AC; Xue, SF; Ishijima, J; Shiroishi, T; Barna, M				Kondrashov, Nadya; Pusic, Aya; Stumpf, Craig R.; Shimizu, Kunihiko; Hsieh, Andrew C.; Xue, Shifeng; Ishijima, Junko; Shiroishi, Toshihiko; Barna, Maria			Ribosome-Mediated Specificity in Hox mRNA Translation and Vertebrate Tissue Patterning	CELL			English	Article							AXIAL SKELETON; HOMEOBOX GENES; RETINOIC ACID; MOUSE; INITIATION; ACTIVATION; MUTATION; PROTEINS; IDENTITY; SUBUNIT	Historically, the ribosome has been viewed as a complex ribozyme with constitutive rather than regulatory capacity in mRNA translation. Here we identify mutations of the Ribosomal Protein L38 (Rpl38) gene in mice exhibiting surprising tissue-specific patterning defects, including pronounced homeotic transformations of the axial skeleton. In Rpl38 mutant embryos, global protein synthesis is unchanged; however the translation of a select subset of Homeobox mRNAs is perturbed. Our data reveal that RPL38 facilitates 80S complex formation on these mRNAs as a regulatory component of the ribosome to confer transcript-specific translational control. We further show that Rpl38 expression is markedly enriched in regions of the embryo where loss-of-function phenotypes occur. Unexpectedly, a ribosomal protein (RP) expression screen reveals dynamic regulation of individual RPs within the vertebrate embryo. Collectively, these findings suggest that RP activity may be highly regulated to impart a new layer of specificity in the control of gene expression and mammalian development.	[Kondrashov, Nadya; Pusic, Aya; Stumpf, Craig R.; Hsieh, Andrew C.; Xue, Shifeng; Barna, Maria] Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Hsieh, Andrew C.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94158 USA; [Shimizu, Kunihiko] Nihon Univ, Dept Pediat Dent, Sch Dent Matsudo, Chiba 2718587, Japan; [Shimizu, Kunihiko; Ishijima, Junko; Shiroishi, Toshihiko] Natl Inst Genet, Mammalian Genet Lab, Mishima, Shizuoka 4118540, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Nihon University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Barna, M (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	maria.barna@ucsf.edu	Stumpf, Craig/B-8703-2014	Stumpf, Craig/0000-0002-9946-8986; Xue, Shifeng/0000-0002-4668-5952	NICHD; UCSF; March of Dimes Basil O'Connor Scholar Research Award; MEXT, Japan; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008509] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UCSF; March of Dimes Basil O'Connor Scholar Research Award(March of Dimes); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are very grateful to Dr. Davide Ruggero for helpful discussions and CMV-HCV-IRES transgenic mice. We thank Katrina Cabaltera for technical assistance; Dr. Gail Martin and members of her lab, Drs. Davide Ruggero, Tom Kornberg, and Ross Metzger for critical reading of the manuscript; Drs. Rudi Balling and Toshio Uchiumi for discussion and comments; Dr. Lee Niswander for helpful discussions on neural tube patterning; Drs. Jens Schuster and Cristina Al-Khalili Szigyarto for the RPL38 antibody; and Dr. Lucie Jeannotte for the Hoxa5 antibody. We are grateful to Dr. Jean-Louis Guenet for providing Rbt and Dr. Tsutomu Hirasawa for providing Tss; Dr. Catherine Kirn-Safran for Rpl29<SUP>+/-</SUP> mice; Dr. Greg Barsh for Rps19<SUP>DSK3/+</SUP> and Rps20<SUP>DSK4/+</SUP> mice. The monoclonal antibodies against Shh, Nkx2.2, Isl1, Pax6, and Pax7 were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA, USA. This work was supported by the Program for Breakthrough Biomedical Research, UCSF (M.B.), the March of Dimes Basil O'Connor Scholar Research Award (M.B.), and Special coordination funds for promoting Science and Technology from the MEXT, Japan (T.S.).	Agmon I, 2009, INT J MOL SCI, V10, P2921, DOI 10.3390/ijms10072921; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Bellodi C, 2010, CANCER RES, V70, P6026, DOI 10.1158/0008-5472.CAN-09-4730; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; BURKE AC, 1995, DEVELOPMENT, V121, P333; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carpenter EM, 1997, DEVELOPMENT, V124, P4505; Chow CS, 2007, ACS CHEM BIOL, V2, P610, DOI 10.1021/cb7001494; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; DEOL MS, 1961, PROC R SOC SER B-BIO, V155, P78, DOI 10.1098/rspb.1961.0058; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; HORAN GSB, 1994, P NATL ACAD SCI USA, V91, P12644, DOI 10.1073/pnas.91.26.12644; Hustert E, 1996, MAMM GENOME, V7, P881, DOI 10.1007/s003359900261; Iimura T, 2009, CURR TOP DEV BIOL, V88, P201, DOI 10.1016/S0070-2153(09)88007-1; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; JEANNOTTE L, 1993, GENE DEV, V7, P2085, DOI 10.1101/gad.7.11.2085; Juan AH, 2003, DEVELOPMENT, V130, P4823, DOI 10.1242/dev.00672; Kirn-Safran CB, 2007, DEV DYNAM, V236, P447, DOI 10.1002/dvdy.21046; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; LABORATORY CSH, 2002, RIBOSOME, V66; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; LEMOUELLIC H, 1992, CELL, V69, P251, DOI 10.1016/0092-8674(92)90406-3; Lipton JM, 2010, CURR OPIN PEDIATR, V22, P12, DOI 10.1097/MOP.0b013e328334573b; Mauro VP, 2007, CELL CYCLE, V6, P2246, DOI 10.4161/cc.6.18.4739; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; MORGAN WC, 1950, J HERED, V41, P208, DOI 10.1093/oxfordjournals.jhered.a106131; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nishiyama T, 2007, NUCLEIC ACIDS RES, V35, P1514, DOI 10.1093/nar/gkl1121; OH SK, 1992, GENE DEV, V6, P1643, DOI 10.1101/gad.6.9.1643; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Oristian DS, 2009, J ORTHOP RES, V27, P28, DOI 10.1002/jor.20706; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; PINNEY DF, 1989, ENVIRON HEALTH PERSP, V80, P221, DOI 10.2307/3430747; RAMAGOPAL S, 1992, BIOCHEM CELL BIOL, V70, P738, DOI 10.1139/o92-113; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Sagliocco F A, 1996, Methods Mol Biol, V53, P297; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SIMEONE A, 1991, MECH DEVELOP, V33, P215, DOI 10.1016/0925-4773(91)90029-6; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thompson B, 2007, TRANSLATIONAL CONTRO, V48, P507; Tsukahara K, 2000, EXP ANIM TOKYO, V49, P131, DOI 10.1538/expanim.49.131; Uechi T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000037; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wellik DM, 2009, CURR TOP DEV BIOL, V88, P257, DOI 10.1016/S0070-2153(09)88009-5; Ye X, 1997, MOL CELL BIOL, V17, P1714, DOI 10.1128/MCB.17.3.1714; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; ZAPPAVIGNA V, 1991, EMBO J, V10, P4177, DOI 10.1002/j.1460-2075.1991.tb04996.x; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200	65	372	378	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					383	397		10.1016/j.cell.2011.03.028	http://dx.doi.org/10.1016/j.cell.2011.03.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529712	Bronze, Green Accepted			2022-12-28	WOS:000290022900008
J	Chiappini, C; Frischknecht, U; Meynet, G; Hirschi, R; Barbuy, B; Pignatari, M; Decressin, T; Maeder, A				Chiappini, Cristina; Frischknecht, Urs; Meynet, Georges; Hirschi, Raphael; Barbuy, Beatriz; Pignatari, Marco; Decressin, Thibaut; Maeder, Andre			Imprints of fast-rotating massive stars in the Galactic Bulge	NATURE			English	Article							METAL-POOR STARS; LOW-METALLICITY; EARLY GALAXY; S-PROCESS; EVOLUTION; ABUNDANCES; ELEMENTS; UNIVERSE; MODELS; YIELDS	The first stars that formed after the Big Bang were probably massive(1), and they provided the Universe with the first elements heavier than helium ('metals'), which were incorporated into low-mass stars that have survived to the present(2,3). Eight stars in the oldest globular cluster in the Galaxy, NGC 6522, were found to have surface abundances consistent with the gas from which they formed being enriched by massive stars(4) (that is, with higher alpha-element/Fe and Eu/Fe ratios than those of the Sun). However, the same stars have anomalously high abundances of Ba and La with respect to Fe(4), which usually arises through nucleosynthesis in low-mass stars(5) (via the slow-neutron-capture process, or s-process). Recent theory suggests that metal-poor fast-rotating massive stars are able to boost the s-process yields by up to four orders of magnitude(6), which might provide a solution to this contradiction. Here we report a reanalysis of the earlier spectra, which reveals that Y and Sr are also over-abundant with respect to Fe, showing a large scatter similar to that observed in extremely metal-poor stars(7), whereas C abundances are not enhanced. This pattern is best explained as originating in metal-poor fast-rotating massive stars, which might point to a common property of the first stellar generations and even of the 'first stars'.	[Chiappini, Cristina] Astrophys Inst Potsdam, D-14482 Potsdam, Germany; [Chiappini, Cristina; Meynet, Georges; Decressin, Thibaut; Maeder, Andre] Univ Geneva, Geneva Observ, CH-1290 Sauverny, Switzerland; [Chiappini, Cristina] Osserv Astron Trieste, Ist Nazl Astrofis, I-34143 Trieste, Italy; [Frischknecht, Urs; Pignatari, Marco] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland; [Frischknecht, Urs; Hirschi, Raphael] Keele Univ, Astrophys Grp, Keele ST5 5BG, Staffs, England; [Hirschi, Raphael] Univ Tokyo, IPMU, Chiba 2778582, Japan; [Barbuy, Beatriz] Univ Sao Paulo, IAG, BR-05508900 Sao Paulo, Brazil	University of Geneva; Istituto Nazionale Astrofisica (INAF); University of Basel; Keele University; University of Tokyo; Universidade de Sao Paulo	Chiappini, C (corresponding author), Astrophys Inst Potsdam, Sternwarte 16, D-14482 Potsdam, Germany.	cristina.chiappini@aip.de	Barbuy, Beatriz L. S./O-4665-2015; Pignatari, Marco/AAO-6015-2021; Frischknecht, Urs/C-5050-2008	Pignatari, Marco/0000-0002-9048-6010; Chiappini, Cristina/0000-0003-1269-7282	Swiss National Science Foundation (SNSF); NSF [PHY 02-16783]; FAPESP; CNPq (Brazil); ESF-EuroGENESIS; World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; STFC [ST/J000035/1, PP/F000057/1, ST/G002355/1, PP/D000955/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D000955/1, ST/J000035/1, PP/F000057/1, ST/G002355/1] Funding Source: researchfish	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); NSF(National Science Foundation (NSF)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ESF-EuroGENESIS; World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	C.C., U.F., G.M., T.D. and A. M. acknowledge support from the Swiss National Science Foundation (SNSF). M. P. acknowledges support from an Ambizione grant from the SNSF, and from NSF grant PHY 02-16783 (Joint Institute for Nuclear Astrophysics, JINA). B. B. acknowledges support from FAPESP and CNPq (Brazil). C. C. and T. D. acknowledge partial support from ESF-EuroGENESIS. R. H. acknowledges support from the World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan. This work is based on observations collected at the European Southern Observatory (ESO).	Barbuy B, 2009, ASTRON ASTROPHYS, V507, P405, DOI 10.1051/0004-6361/200912748; Beers TC, 2005, ANNU REV ASTRON ASTR, V43, P531, DOI 10.1146/annurev.astro.42.053102.134057; Bisterzo S, 2010, MON NOT R ASTRON SOC, V404, P1529, DOI 10.1111/j.1365-2966.2010.16369.x; Bromm V, 2009, NATURE, V459, P49, DOI 10.1038/nature07990; Chiappini C, 2008, ASTRON ASTROPHYS, V479, pL9, DOI 10.1051/0004-6361:20078698; Chiappini CC, 2006, ASTRON ASTROPHYS, V449, pL27, DOI 10.1051/0004-6361:20064866; Cowan JJ, 2006, NATURE, V440, P1151, DOI 10.1038/nature04807; Ekstrom S, 2008, ASTRON ASTROPHYS, V489, P685, DOI 10.1051/0004-6361:200809633; Farouqi K, 2009, ASTROPHYS J LETT, V694, pL49, DOI 10.1088/0004-637X/694/1/L49; Frebel A, 2010, ASTRON NACHR, V331, P474, DOI 10.1002/asna.201011362; Frischknecht U, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201014340; Karakas AI, 2010, MON NOT R ASTRON SOC, V403, P1413, DOI 10.1111/j.1365-2966.2009.16198.x; Martayan C, 2007, ASTRON ASTROPHYS, V472, P577, DOI 10.1051/0004-6361:20077390; Meyner G, 2006, ASTRON ASTROPHYS, V447, P623, DOI 10.1051/0004-6361:20053070; Pignatari M, 2008, ASTROPHYS J LETT, V687, pL95, DOI 10.1086/593350; Qian YZ, 2008, ASTROPHYS J, V687, P272, DOI 10.1086/591545; Sneden C, 2008, ANNU REV ASTRON ASTR, V46, P241, DOI 10.1146/annurev.astro.46.060407.145207; STACY A, MON NOT R A IN PRESS; Travaglio C, 2004, ASTROPHYS J, V601, P864, DOI 10.1086/380507; TRURAN JW, 1981, ASTRON ASTROPHYS, V97, P391	21	81	81	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					454	457		10.1038/nature10000	http://dx.doi.org/10.1038/nature10000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525928				2022-12-28	WOS:000289949600030
J	Hezelgrave, NL; Whitty, CJM; Shennan, AH; Chappell, LC				Hezelgrave, Natasha L.; Whitty, Christopher J. M.; Shennan, Andrew H.; Chappell, Lucy C.			Advising on travel during pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							EXPOSURE		[Hezelgrave, Natasha L.; Shennan, Andrew H.; Chappell, Lucy C.] Kings Coll London, Sch Med, Div Womens Hlth, London SE1 7EH, England; [Whitty, Christopher J. M.] London Sch Hyg & Trop Med, London WC1, England	University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	Chappell, LC (corresponding author), Kings Coll London, Sch Med, Div Womens Hlth, London SE1 7EH, England.	lucy.chappell@kcl.ac.uk	Whitty, Christopher/C-7740-2012	Shennan, Andrew/0000-0001-5273-3132; Whitty, Christopher/0000-0002-6076-5027	National Institute for Health Research [ACF-2009-17-019] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		*ACOG, 2003, OBSTET GYNECOLOGY, V101, P207; AGNEW CL, 1993, AM J PHYSIOL, V264, pR197, DOI 10.1152/ajpregu.1993.264.1.R197; [Anonymous], 2009, Obstet Gynecol, V114, P954, DOI 10.1097/AOG.0b013e3181bd1325; [Anonymous], 2004, OBSTET GYNECOL, V104, P647; Barish RJ, 2004, OBSTET GYNECOL, V103, P1326, DOI 10.1097/01.AOG.0000126947.90065.90; BARRY M, 1989, JAMA-J AM MED ASSOC, V261, P728, DOI 10.1001/jama.261.5.728; Breathnach F, 2004, Ir Med J, V97, P167; *CDCP, 1998, GUID VACC PREG WOM R; Diemert DJ, 2006, CLIN MICROBIOL REV, V19, P583, DOI 10.1128/CMR.00052-05; Dupont HL, 2009, ALIMENT PHARM THER, V30, P187, DOI 10.1111/j.1365-2036.2009.04028.x; Easa D, 1994, J Perinatol, V14, P264; *HLTH PROT AG, 2007, FOR TRAV ASS ILLN EN; HUCH R, 1986, AM J OBSTET GYNECOL, V154, P996, DOI 10.1016/0002-9378(86)90736-2; Kingman CE, 2003, J TRAVEL MED, V10, P330, DOI 10.2310/7060.2003.9353; Kuipers S, 2007, PLOS MED, V4, P1508, DOI 10.1371/journal.pmed.0040290; Lindsay S, 2000, LANCET, V355, P1972, DOI 10.1016/S0140-6736(00)02334-5; Magann EF, 2010, OBSTET GYNECOL SURV, V65, P396, DOI 10.1097/OGX.0b013e3181e572ae; McGready R, 2004, Travel Med Infect Dis, V2, P127, DOI 10.1016/j.tmaid.2004.03.008; National Institute for Health and Clinical Excellence, 2008, ANT CAR ROUT CAR HLT; *OFF NAT STAT, 2007, 1 13 LIV BIRTHS ENGL; Rodger MA, 2003, BEST PRACT RES CL HA, V16, P279, DOI 10.1016/S1521-6926(02)00093-2; *ROYAL COLL OBST G, 2010, 54B ROYAL COLL OBST; *ROYAL COLL OBST G, 2010, 54A ROYAL COLL OBST; *ROYAL COLL OBST G, 2008, AIR TRAV PREGN; Sotiriadis A, 2004, BMJ-BRIT MED J, V329, P152, DOI 10.1136/bmj.329.7458.152; Tannirandorn Y, 2003, INT J GYNECOL OBSTET, V81, P263, DOI 10.1016/S0020-7292(03)00076-6; Tongsong T, 1995, J Obstet Gynaecol (Tokyo 1995), V21, P331	27	15	16	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2011	342								d2506	10.1136/bmj.d2506	http://dx.doi.org/10.1136/bmj.d2506			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759BV	21527456	Green Accepted			2022-12-28	WOS:000290215900004
J	Levander, A; Schmandt, B; Miller, MS; Liu, K; Karlstrom, KE; Crow, RS; Lee, CTA; Humphreys, ED				Levander, A.; Schmandt, B.; Miller, M. S.; Liu, K.; Karlstrom, K. E.; Crow, R. S.; Lee, C. -T. A.; Humphreys, E. D.			Continuing Colorado plateau uplift by delamination-style convective lithospheric downwelling	NATURE			English	Article							FARALLON SLAB; MANTLE; BENEATH; PRESERVATION; GEOPHYSICS; MAGMATISM; EVOLUTION; CRUSTAL; RANGE; WAVES	The Colorado plateau is a large, tectonically intact, physiographic province in the southwestern North American Cordillera that stands at similar to 1,800-2,000 m elevation and has long been thought to be in isostatic equilibrium(1). The origin of these high elevations is unclear because unlike the surrounding provinces, which have undergone significant Cretaceous-Palaeogene compressional deformation followed by Neogene extensional deformation, the Colorado plateau is largely internally undeformed. Here we combine new seismic tomography(2) and receiver function images to resolve a vertical high-seismic-velocity anomaly beneath the west-central plateau that extends more than 200 km in depth. The upper surface of this anomaly is seismically defined by a dipping interface extending from the lower crust to depths of 70-90 km. The base of the continental crust above the anomaly has a similar shape, with an elevated Moho. We interpret these seismic structures as a continuing regional, delamination-style foundering of lower crust and continental lithosphere. This implies that Pliocene (2.6-5.3 Myr ago) uplift of the plateau and the magmatism on its margins are intimately tied to continuing deep lithospheric processes. Petrologic and geochemical observations indicate that late Cretaceous-Palaeogene (similar to 90-40 Myr ago) low-angle subduction hydrated and probably weakened much of the Proterozoic tecto-spheric mantle(3-5) beneath the Colorado plateau. We suggest that mid-Cenozoic (similar to 35-25 Myr ago) to Recent magmatic infiltration subsequently imparted negative compositional buoyancy to the base and sides of the Colorado plateau upper mantle, triggering downwelling. The patterns of magmatic activity suggest that previous such events have progressively removed the Colorado plateau lithosphere inward from its margins(6), and have driven uplift. Using Grand Canyon incision rates(7,8) and Pliocene basaltic volcanism patterns, we suggest that this particular event has been active over the past similar to 6 Myr.	[Levander, A.; Liu, K.; Lee, C. -T. A.] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; [Schmandt, B.; Humphreys, E. D.] Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA; [Miller, M. S.] Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; [Karlstrom, K. E.; Crow, R. S.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA	Rice University; University of Oregon; University of Southern California; University of New Mexico	Levander, A (corresponding author), Rice Univ, Dept Earth Sci, Houston, TX 77005 USA.	alan@rice.edu	Lee, Cin-Ty/AAV-8155-2021; Levander, Alan/A-3543-2011; Liu, Kaijian/I-4948-2014; Miller, Meghan S/A-2688-2011; Lee, Cin-Ty/A-5469-2008; Crow, Ryan/C-4103-2009	Lee, Cin-Ty/0000-0002-3586-0110; Levander, Alan/0000-0002-1048-0488; Miller, Meghan S/0000-0001-5494-2296; 	NSF [EAR-0844741, EAR-0844760, EAR-0911006]; Alexander von Humboldt Foundation; Directorate For Geosciences [0844760] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The USArray data are from the IRIS DMS. A. L., K. L., M. S. M., E. D. H. and B. S. were supported by NSF EarthScope grants EAR-0844741, EAR-0844760 and EAR-0911006. Part of this research was initiated at the CIDER 2008 workshop (A. L., M. S. M.), and part was initiated at the GFZ-Potsdam (A. L.). A. L. acknowledges an Alexander von Humboldt Foundation Research Prize.	Bassin C., 2000, EOS T AM GEOPHYS UN, V81, pF897; BENZ HM, 1994, GEOPHYS RES LETT, V21, P509, DOI 10.1029/93GL01660; BIRD P, 1988, SCIENCE, V239, P1501, DOI 10.1126/science.239.4847.1501; BIRD P, 1984, TECTONICS, V3, P741, DOI 10.1029/TC003i007p00741; BIRD P, 1979, J GEOPHYS RES, V84, P7561, DOI 10.1029/JB084iB13p07561; Buehler JS, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006874; Conrad CP, 1999, GEOPHYS J INT, V139, P51, DOI 10.1046/j.1365-246X.1999.00896.x; Crow R, 2011, GEOLOGY, V39, P27, DOI 10.1130/G31611.1; Ducea MN, 1996, J GEOPHYS RES-SOL EA, V101, P8229, DOI 10.1029/95JB03452; Dueker KG, 1997, J GEOPHYS RES-SOL EA, V102, P8313, DOI 10.1029/96JB03857; EHRENBERG SN, 1982, J PETROL, V23, P507, DOI 10.1093/petrology/23.4.507; Foley SF, 2009, LITHOS, V112, P274, DOI 10.1016/j.lithos.2009.03.020; Forsyth DW, 2005, GEOPHYS MONOGR SER, V157, P81, DOI 10.1029/156GM06; Henstock T.J., 1998, GSA TODAY, V8, P16; HENSTOCK TJ, 1998, GSA TODAY, V8, P1; Humphreys E, 2003, INT GEOL REV, V45, P575, DOI 10.2747/0020-6814.45.7.575; HUMPHREYS ED, 1995, GEOLOGY, V23, P987, DOI 10.1130/0091-7613(1995)023<0987:PLROTF>2.3.CO;2; Huntington KW, 2010, TECTONICS, V29, DOI 10.1029/2009TC002449; Karlstrom KE, 2008, GEOLOGY, V36, P835, DOI 10.1130/G25032A.1; KAY SM, 1994, J GEOPHYS RES-SOL EA, V99, P24323, DOI 10.1029/94JB00896; LANGSTON CA, 1977, B SEISMOL SOC AM, V67, P713; Lee CT, 2001, NATURE, V411, P69, DOI 10.1038/35075048; Li ZXA, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005540; LIPMAN PW, 1992, CORDILLERAN OROGEN C, P481; Liu KJ, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003611; LIVACCARI RF, 1993, GEOLOGY, V21, P719, DOI 10.1130/0091-7613(1993)021<0719:IEFPOC>2.3.CO;2; Menzies M, 2007, LITHOS, V96, P1, DOI 10.1016/j.lithos.2006.09.008; Morency C, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002414; Moucha R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039778; NELSON ST, 1992, GEOL SOC AM BULL, V104, P1547, DOI 10.1130/0016-7606(1992)104<1547:NADOCC>2.3.CO;2; Roy M, 2009, NATURE, V459, P978, DOI 10.1038/nature08052; Schmandt B, 2010, EARTH PLANET SC LETT, V297, P435, DOI 10.1016/j.epsl.2010.06.047; Schmandt B, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003042; Smith D, 2000, J GEOPHYS RES-SOL EA, V105, P16769, DOI 10.1029/2000JB900103; Spencer JE, 1996, J GEOPHYS RES-SOL EA, V101, P13595, DOI 10.1029/96JB00818; THOMPSON GA, 1979, TECTONOPHYSICS, V61, P149, DOI 10.1016/0040-1951(79)90296-8; van Wijk JW, 2010, GEOLOGY, V38, P611, DOI 10.1130/G31031.1; Yuan XH, 2006, GEOPHYS J INT, V165, P555, DOI 10.1111/j.1365-246X.2006.02885.x	38	227	231	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					461	U540		10.1038/nature10001	http://dx.doi.org/10.1038/nature10001			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525930				2022-12-28	WOS:000289949600032
J	Clementz, MT; Sewall, JO				Clementz, Mark T.; Sewall, Jacob O.			Latitudinal Gradients in Greenhouse Seawater delta O-18: Evidence from Eocene Sirenian Tooth Enamel	SCIENCE			English	Article							PALAEOCENE/EOCENE THERMAL MAXIMUM; STABLE-ISOTOPE ANALYSIS; MIDDLE EOCENE; TEMPERATURES; REGION; WATER	The Eocene greenhouse climate state has been linked to a more vigorous hydrologic cycle at mid-and high latitudes; similar information on precipitation levels at low latitudes is, however, limited. Oxygen isotopic fluxes track moisture fluxes and, thus, the delta O-18 values of ocean surface waters can provide insight into hydrologic cycle changes. The offset between tropical d18O values from sampled Eocene sirenian tooth enamel and modern surface waters is greater than the expected 1.0 per mil increase due to increased continental ice volume. This increased offset could result from suppression of surface-water delta O-18 values by a tropical, annual moisture balance substantially wetter than that of today. Results from an atmospheric general circulation model support this interpretation and suggest that Eocene low latitudes were extremely wet.	[Clementz, Mark T.] Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; [Clementz, Mark T.] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Sewall, Jacob O.] Kutztown State Univ, Dept Phys Sci, Kutztown, PA 19530 USA	University of Wyoming; University of Wyoming; Pennsylvania State System of Higher Education (PASSHE); Kutztown University - Pennsylvania	Clementz, MT (corresponding author), Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA.	mclemen1@uwyo.edu; sewall@kutztown.edu			American Chemical Society; NSF; Directorate For Geosciences [0847413] Funding Source: National Science Foundation	American Chemical Society(American Chemical Society); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank S. Bajpai, D. P. Domning, S. Sorbi, and the museums and institutions that made fossil specimens available for this study (a list of all institutions is provided in the SOM); P. Haselhorst and S. L. Peek for assistance with sample preparation; the University of Wyoming Stable Isotope Facility for stable isotope analyses; and E. Speelman. Funding for travel and analyses was provided by the American Chemical Society Petroleum Research Fund (M. T. C.) and the NSF (M. T. C.). Computation was supported by Virginia Tech Advanced Research Computing and the Department of Geosciences. We also thank two anonymous reviewers for critical and thoughtful comments that improved this manuscript.	[Anonymous], 1965, U RHODE ISLAND OCC P; Bice KL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000678; Bohaty SM, 2003, GEOLOGY, V31, P1017, DOI 10.1130/G19800.1; Bowen GJ, 2004, NATURE, V432, P495, DOI 10.1038/nature03115; Clementz MT, 2008, PALAIOS, V23, P574, DOI 10.2110/palo.2007.p07-054r; Clementz MT, 2009, GEOLOGY, V37, P307, DOI 10.1130/G25533A.1; Deutsch CJ, 2003, WILDLIFE MONOGR, P1; Jahren AH, 2003, GEOLOGY, V31, P463, DOI 10.1130/0091-7613(2003)031<0463:HEFTME>2.0.CO;2; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; Manabe S, 1997, AMBIO, V26, P47; McConnell MC, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002035; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pagani M, 2006, NATURE, V442, P671, DOI 10.1038/nature05043; Schmidt G. A., 1999, GLOBAL SEAWATER OXYG; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Sluijs A, 2009, NAT GEOSCI, V2, P777, DOI 10.1038/NGEO668; Speelman EN, 2010, EARTH PLANET SC LETT, V298, P57, DOI 10.1016/j.epsl.2010.07.026; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; YOSHIDA N, 1991, J GEOPHYS RES-OCEANS, V96, P815, DOI 10.1029/90JC01580; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266; Zanazzi A, 2007, NATURE, V445, P639, DOI 10.1038/nature05551	23	29	30	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					455	458		10.1126/science.1201182	http://dx.doi.org/10.1126/science.1201182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512030				2022-12-28	WOS:000289784900040
J	Hardcastle, MJ				Hardcastle, Martin J.			Revealing the Gamma-Ray Jet in a Black Hole Binary	SCIENCE			English	Editorial Material							CYGNUS X-1; POLARIZATION; RADIATION; SPECTRUM		Univ Hertfordshire, Sch Phys Astron & Math, Hatfield AL10 9AB, Herts, England	University of Hertfordshire	Hardcastle, MJ (corresponding author), Univ Hertfordshire, Sch Phys Astron & Math, Coll Lane, Hatfield AL10 9AB, Herts, England.	m.j.hardcastle@herts.ac.uk	Hardcastle, Martin/AAM-1395-2020; Hardcastle, Martin J/E-2264-2012	Hardcastle, Martin J/0000-0003-4223-1117				Albert J, 2007, ASTROPHYS J, V665, pL51, DOI 10.1086/521145; Bel MC, 2006, ASTRON ASTROPHYS, V446, P591, DOI 10.1051/0004-6361:20053068; BOWYER S, 1965, SCIENCE, V147, P394, DOI 10.1126/science.147.3656.394; Caballero-Nieves SM, 2009, ASTROPHYS J, V701, P1895, DOI 10.1088/0004-637X/701/2/1895; Fender RP, 2004, MON NOT R ASTRON SOC, V355, P1105, DOI 10.1111/j.1365-2966.2004.08384.x; Fender RP, 2006, MON NOT R ASTRON SOC, V369, P603, DOI 10.1111/j.1365-2966.2006.10193.x; Forot M, 2008, ASTROPHYS J LETT, V688, pL29, DOI 10.1086/593974; Gallo E, 2005, NATURE, V436, P819, DOI 10.1038/nature03879; Heinz S, 2006, ASTROPHYS J, V636, P316, DOI 10.1086/497954; Laurent P, 2011, SCIENCE, V332, P438, DOI 10.1126/science.1200848; MIRABEL IF, 1994, NATURE, V371, P46, DOI 10.1038/371046a0; POUTANEN J, 1994, ASTROPHYS J SUPPL S, V92, P607, DOI 10.1086/192024; Stirling AM, 2001, MON NOT R ASTRON SOC, V327, P1273, DOI 10.1046/j.1365-8711.2001.04821.x; Ziolkowski J, 2005, MON NOT R ASTRON SOC, V358, P851, DOI 10.1111/j.1365-2966.2005.08796.x	15	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					429	430		10.1126/science.1204074	http://dx.doi.org/10.1126/science.1204074			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512024	Green Submitted			2022-12-28	WOS:000289784900031
J	McCook, A				McCook, Alison			RETHINKING PHDS	NATURE			English	News Item																			0	22	22	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 21	2011	472	7343					280	282		10.1038/472280a	http://dx.doi.org/10.1038/472280a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21512549	Bronze			2022-12-28	WOS:000289724600011
J	Serwane, F; Zurn, G; Lompe, T; Ottenstein, TB; Wenz, AN; Jochim, S				Serwane, F.; Zuern, G.; Lompe, T.; Ottenstein, T. B.; Wenz, A. N.; Jochim, S.			Deterministic Preparation of a Tunable Few-Fermion System	SCIENCE			English	Article							ATOMIC MOTT INSULATOR; SINGLE-ATOM; OPTICAL LATTICE; DIPOLE TRAP; COLD ATOMS; GAS; TRANSITION; SUPERFLUID; PHYSICS	Systems consisting of few interacting fermions are the building blocks of matter, with atoms and nuclei being the most prominent examples. We have created a few-body quantum system with complete control over its quantum state using ultracold fermionic atoms in an optical dipole trap. Ground-state systems consisting of 1 to 10 particles are prepared with fidelities of similar to 90%. We can tune the interparticle interactions to arbitrary values using a Feshbach resonance and have observed the interaction-induced energy shift for a pair of repulsively interacting atoms. This work is expected to enable quantum simulation of strongly correlated few-body systems.	[Serwane, F.; Zuern, G.; Lompe, T.; Ottenstein, T. B.; Wenz, A. N.; Jochim, S.] Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; [Serwane, F.; Zuern, G.; Lompe, T.; Ottenstein, T. B.; Wenz, A. N.; Jochim, S.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Serwane, F.; Lompe, T.; Ottenstein, T. B.; Jochim, S.] GSI Helmholtzzentrum Schwerionenforsch, ExtreMe Matter Inst EMMI, D-64291 Darmstadt, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research	Serwane, F (corresponding author), Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany.	friedhelm.serwane@mpi-hd.mpg.de	Serwane, Friedhelm/A-6720-2018; Jochim, Selim/G-1287-2011; Serwane, Friedhelm/AAY-6057-2020	Serwane, Friedhelm/0000-0001-6943-8244; Jochim, Selim/0000-0001-6049-2658; Lompe, Thomas/0000-0002-7880-1639	Helmholtz Alliance [HA216/EMMI]; Heidelberg Center for Quantum Dynamics; IMPRS-QD	Helmholtz Alliance; Heidelberg Center for Quantum Dynamics; IMPRS-QD	We thank M. G. Raizen for inspiring discussions and M. Weidemuller for the loan of a fiber laser. This work was supported by the Helmholtz Alliance HA216/EMMI and the Heidelberg Center for Quantum Dynamics. We thank J. Ullrich and his group for their support. G.Z. and A.N.W. acknowledge support by the IMPRS-QD.	Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Busch T, 1998, FOUND PHYS, V28, P549, DOI 10.1023/A:1018705520999; Chuu CS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.260403; DEHEER WA, 1993, REV MOD PHYS, V65, P611, DOI 10.1103/RevModPhys.65.611; Frese D, 2000, PHYS REV LETT, V85, P3777, DOI 10.1103/PhysRevLett.85.3777; Grunzweig T, 2010, NAT PHYS, V6, P951, DOI 10.1038/NPHYS1778; Hayes D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.070501; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Ketterle W., 2008, P INT SCH PHYS ENR F; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; MIGDAL AB, 1959, NUCL PHYS, V13, P655, DOI 10.1016/0029-5582(59)90264-0; Muller T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.040401; Nascimbene S, 2010, NATURE, V463, P1057, DOI 10.1038/nature08814; Olshanii M, 1998, PHYS REV LETT, V81, P938, DOI 10.1103/PhysRevLett.81.938; Ottenstein T. B., 2010, THESIS U HEIDELBERG; Raizen MG, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.030302; Reimann SM, 2002, REV MOD PHYS, V74, P1283, DOI 10.1103/RevModPhys.74.1283; Sanner C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.040402; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Viverit L, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.033603; Weber M, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.043406; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827	27	380	381	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					336	338		10.1126/science.1201351	http://dx.doi.org/10.1126/science.1201351			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493855	Green Submitted			2022-12-28	WOS:000289516600040
J	Cypel, M; Yeung, JC; Liu, MY; Anraku, M; Chen, FS; Karolak, W; Sato, M; Laratta, J; Azad, S; Madonik, M; Chow, CW; Chaparro, C; Hutcheon, M; Singer, LG; Slutsky, AS; Yasufuku, K; de Perrot, M; Pierre, AF; Waddell, TK; Keshavjee, S				Cypel, Marcelo; Yeung, Jonathan C.; Liu, Mingyao; Anraku, Masaki; Chen, Fengshi; Karolak, Wojtek; Sato, Masaaki; Laratta, Jane; Azad, Sassan; Madonik, Mindy; Chow, Chung-Wai; Chaparro, Cecilia; Hutcheon, Michael; Singer, Lianne G.; Slutsky, Arthur S.; Yasufuku, Kazuhiro; de Perrot, Marc; Pierre, Andrew F.; Waddell, Thomas K.; Keshavjee, Shaf			Normothermic Ex Vivo Lung Perfusion in Clinical Lung Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY GRAFT DYSFUNCTION; EXTENDED DONOR CRITERIA; CARDIAC DEATH DONORS; ISHLT WORKING GROUP; SINGLE-CENTER; ALLOGRAFT-REJECTION; RISK-FACTORS; DONATION; PRESERVATION; EXPERIENCE	BACKGROUND More than 80% of donor lungs are potentially injured and therefore not considered suitable for transplantation. With the use of normothermic ex vivo lung perfusion (EVLP), the retrieved donor lung can be perfused in an ex vivo circuit, providing an opportunity to reassess its function before transplantation. In this study, we examined the feasibility of transplanting high-risk donor lungs that have undergone EVLP. METHODS In this prospective, nonrandomized clinical trial, we subjected lungs considered to be high risk for transplantation to 4 hours of EVLP. High-risk donor lungs were defined by specific criteria, including pulmonary edema and a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen (PO(2):FiO(2)) less than 300 mm Hg. Lungs with acceptable function were subsequently transplanted. Lungs that were transplanted without EVLP during the same period were used as controls. The primary end point was primary graft dysfunction 72 hours after transplantation. Secondary end points were 30-day mortality, bronchial complications, duration of mechanical ventilation, and length of stay in the intensive care unit and hospital. RESULTS During the study period, 136 lungs were transplanted. Lungs from 23 donors met the inclusion criteria for EVLP; in 20 of these lungs, physiological function remained stable during EVLP and the median PO(2):FiO(2) ratio increased from 335 mm Hg in the donor lung to 414 and 443 mm Hg at 1 hour and 4 hours of perfusion, respectively (P<0.001). These 20 lungs were transplanted; the other 116 lungs constituted the control group. The incidence of primary graft dysfunction 72 hours after transplantation was 15% in the EVLP group and 30% in the control group (P=0.11). No significant differences were observed for any secondary end points, and no severe adverse events were directly attributable to EVLP. CONCLUSIONS Transplantation of high-risk donor lungs that were physiologically stable during 4 hours of ex vivo perfusion led to results similar to those obtained with conventionally selected lungs.	[Cypel, Marcelo; Yeung, Jonathan C.; Liu, Mingyao; Anraku, Masaki; Chen, Fengshi; Karolak, Wojtek; Sato, Masaaki; Laratta, Jane; Azad, Sassan; Madonik, Mindy; Chow, Chung-Wai; Chaparro, Cecilia; Hutcheon, Michael; Singer, Lianne G.; Yasufuku, Kazuhiro; de Perrot, Marc; Pierre, Andrew F.; Waddell, Thomas K.; Keshavjee, Shaf] Univ Toronto, Toronto Lung Transplant Program, Toronto, ON, Canada; [Slutsky, Arthur S.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Cypel, Marcelo; Liu, Mingyao; Waddell, Thomas K.; Keshavjee, Shaf] Toronto Gen Res Inst, McEwen Ctr Regenerat Med, Toronto, ON, Canada; [Slutsky, Arthur S.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Keshavjee, S (corresponding author), Toronto Gen Hosp, 200 Elizabeth St,9N946, Toronto, ON M5G 2C4, Canada.	shaf.keshavjee@uhn.on.ca	Slutsky, Arthur/M-3325-2019; Chow, Chung-Wai/AAP-5533-2020; Singer, Lianne/E-9962-2019; Anraku, Masaki/Y-1246-2018	Chow, Chung-Wai/0000-0001-9344-8522; Singer, Lianne/0000-0002-2693-8676; Anraku, Masaki/0000-0002-2710-3486; Keshavjee, Shaf/0000-0003-4547-8094; de Perrot, Marc/0000-0003-2000-9427; Cypel, Marcelo/0000-0001-5652-1938; Yeung, Jonathan/0000-0001-5759-3028; Liu, Mingyao/0000-0002-9188-8417	Vitrolife	Vitrolife	Supported by Vitrolife.	Aigner C, 2005, EUR J CARDIO-THORAC, V27, P757, DOI 10.1016/j.ejcts.2005.01.024; Angel LF, 2006, AM J RESP CRIT CARE, V174, P710, DOI 10.1164/rccm.200603-432OC; Avlonitis VS, 2005, AM J TRANSPLANT, V5, P684, DOI 10.1111/j.1600-6143.2005.00755.x; Bharat A, 2008, ANN THORAC SURG, V86, P189, DOI 10.1016/j.athoracsur.2008.03.073; Bharat A, 2007, TRANSPLANTATION, V83, P150, DOI 10.1097/01.tp.0000250579.08042.b6; Botha P, 2006, J THORAC CARDIOV SUR, V131, P1154, DOI 10.1016/j.jtcvs.2005.12.037; Christie JD, 2010, J HEART LUNG TRANSPL, V29, P1231, DOI 10.1016/j.healun.2010.05.013; Christie JD, 2005, J HEART LUNG TRANSPL, V24, P1454, DOI 10.1016/j.healun.2004.11.049; Cypel M, 2009, AM J TRANSPLANT, V9, P2262, DOI 10.1111/j.1600-6143.2009.02775.x; Cypel M, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000266; Cypel M, 2009, J HEART LUNG TRANSPL, V28, P753, DOI 10.1016/j.healun.2009.05.009; Cypel M, 2008, J HEART LUNG TRANSPL, V27, P1319, DOI 10.1016/j.healun.2008.09.003; De Meester J, 2001, J HEART LUNG TRANSPL, V20, P518, DOI 10.1016/S1053-2498(01)00241-8; De Oliveira NC, 2010, J THORAC CARDIOV SUR, V139, P1306, DOI 10.1016/j.jtcvs.2010.02.004; de Perrot M, 2005, J HEART LUNG TRANSPL, V24, P1460, DOI 10.1016/j.healun.2005.02.017; de Perrot M, 2004, J THORAC CARDIOV SUR, V127, P1493, DOI 10.1016/j.jtcvs.2003.11.047; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; Erasmus ME, 2010, TRANSPLANTATION, V89, P452, DOI 10.1097/TP.0b013e3181c46a74; Fischer S, 2001, J THORAC CARDIOV SUR, V121, P594, DOI 10.1067/mtc.2001.109703; Ingemansson R, 2009, ANN THORAC SURG, V87, P255, DOI 10.1016/j.athoracsur.2008.09.049; JD P, 2007, AM J TRANSPLANT, V7, P1327; Kawut SM, 2005, TRANSPLANTATION, V79, P310, DOI 10.1097/01.TP.0000149504.53710.AE; KESHAVJEE SH, 1989, J THORAC CARDIOV SUR, V98, P529; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; Lederer DJ, 2006, AM J RESP CRIT CARE, V174, P659, DOI 10.1164/rccm.200604-520OC; Lee JC, 2010, SEMIN RESP CRIT CARE, V31, P161, DOI 10.1055/s-0030-1249111; Mason DP, 2008, J THORAC CARDIOV SUR, V136, P1061, DOI 10.1016/j.jtcvs.2008.04.023; Oto T, 2007, ANN THORAC SURG, V83, P257, DOI 10.1016/j.athoracsur.2006.07.040; Pierre AF, 2002, J THORAC CARDIOV SUR, V123, P421, DOI 10.1067/mtc.2002.120345; Puri V, 2009, ANN THORAC SURG, V88, P1609, DOI 10.1016/j.athoracsur.2009.06.039; Snell GI, 2008, AM J TRANSPLANT, V8, P1282, DOI 10.1111/j.1600-6143.2008.02231.x; SOUTHARD JH, 1995, ANNU REV MED, V46, P235; Van Raemdonck Dirk, 2009, Proc Am Thorac Soc, V6, P28, DOI 10.1513/pats.200808-098GO	33	718	754	2	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1431	1440		10.1056/NEJMoa1014597	http://dx.doi.org/10.1056/NEJMoa1014597			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LD	21488765				2022-12-28	WOS:000289467200007
J	Tronstein, E; Johnston, C; Huang, ML; Selke, S; Magaret, A; Warren, T; Corey, L; Wald, A				Tronstein, Elizabeth; Johnston, Christine; Huang, Meei-Li; Selke, Stacy; Magaret, Amalia; Warren, Terri; Corey, Lawrence; Wald, Anna			Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons With HSV-2 Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYPE-2 INFECTION; UNITED-STATES; TRANSMISSION; REACTIVATION; DNA; ACYCLOVIR; WOMEN; PREVALENCE; PREVENTION; DIAGNOSIS	Context Since herpes simplex virus type 2 (HSV-2) antibody tests have become commercially available, an increasing number of persons have learned that they have genital herpes through serologic testing. The course of natural history of HSV-2 in asymptomatic, seropositive persons is uncertain. Objective To evaluate the virologic and clinical course of HSV genital shedding among individuals with symptomatic and asymptomatic HSV-2 infection. Design, Setting, and Participants Cohort of 498 immunocompetent HSV-2-seropositive persons enrolled in prospective studies of genital HSV shedding at the University of Washington Virology Research Clinic, Seattle, and Westover Heights Clinic, Portland, Oregon, between March 1992 and April 2008. Each participant obtained daily self-collected swabs of genital secretions for at least 30 days. Main Outcome Measure The rate of viral shedding measured by quantitative realtime fluorescence polymerase chain reaction for HSV DNA from genital swabs. Results Herpes simplex virus type 2 was detected on 4753 of 23 683 days (20.1%; 95% confidence interval [CI], 18.3%-22.0%) in 410 persons with symptomatic genital HSV-2 infection compared with 519 of 5070 days (10.2%; 95% CI, 7.7%-13.6%) in 88 persons with asymptomatic infection (P < .001). Subclinical shedding rates were higher in persons with symptomatic infection compared with asymptomatic infection (2708 of 20 735 days [13.1%; 95% CI, 11.5%-14.6%) vs 434 of 4929 days [8.8%; 95% CI, 6.3%-11.5%]) (P < .001). However, the amount of HSV detected during subclinical shedding episodes was similar (median, 4.3 [interquartile range, 3.1-5.6] log(10) copies in the symptomatic infection group vs 4.2 [interquartile range, 2.9-5.5] in the asymptomatic infection group, P=.27). Days with lesions accounted for 2045 of 4753 days (43.0%; 95% CI, 39.8%-46.5%) with genital viral shedding among persons with symptomatic genital HSV-2 infection compared with 85 of 519 days (16.4%; 95% CI, 11.2%-23.9%) among persons with asymptomatic infection (P < .001). Conclusion Persons with asymptomatic HSV-2 infection shed virus in the genital tract less frequently than persons with symptomatic infection, but much of the difference is attributable to less frequent genital lesions because lesions are accompanied by frequent viral shedding. JAMA. 2011;305(14):1441-1449 www.jama.com	[Wald, Anna] Univ Washington, Virol Res Clin, Dept Med, Seattle, WA 98104 USA; [Huang, Meei-Li; Selke, Stacy; Magaret, Amalia; Corey, Lawrence; Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA; [Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Johnston, Christine; Huang, Meei-Li; Magaret, Amalia; Corey, Lawrence; Wald, Anna] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA; [Magaret, Amalia] Fred Hutchinson Canc Res Ctr, Program Biostat, Seattle, WA 98104 USA; [Warren, Terri] Westover Hts Clin, Portland, OR USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Wald, A (corresponding author), Univ Washington, Virol Res Clin, Dept Med, Box 359928,325 9th Ave, Seattle, WA 98104 USA.	annawald@u.washington.edu	Warren, Terri/AAJ-1650-2021; Wald, Anna/B-6272-2012; Corey, Lawrence/AAE-1796-2020	Wald, Anna/0000-0003-3486-6438; Corey, Lawrence/0000-0002-2179-2436; Johnston, Christine/0000-0002-3073-0843	National Institutes of Health (NIH) [P01AI030731, K23AI079394, K24AI071113, R37AI042528, PO1A1030731]; GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731, K24AI071113, K23AI079394, R37AI042528] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Ms Tronstein, Ms Selke, and Dr Huang all reported receiving research support from National Institutes of Health (NIH) P01AI030731. Dr Johnston reported receiving research support from NIH K23AI079394 and having received funding from GlaxoSmithKline and AiCuris. Dr Magaret reported receiving funding from NIH (P01AI030731 and K24AI071113) and consulting for Immune Design. Ms Warren reported having received research support from AiCuris and having served on the GlaxoSmithKline speakers' bureau. Dr Corey reported receiving research support from NIH (P01AI030731, R37AI042528) and consulting for AiCuris; he reports being listed as a coinventor on several patents describing antigens and epitopes to which T-cell responses to HSV-2 are directed (these proteins have the potential to be used in candidate vaccines against HSV), and he has received fees for serving as the head of the scientific advisory board of Immune Design, including equity shares that are less than 1% ownership. Dr Wald reported receiving research support from NIH (K24AI071113, P01AI030731) and GlaxoSmithKline and consulting for AiCuris.; This work was supported by NIH grants PO1A1030731 and K24 AI 071113.	ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Bochud PY, 2007, J INFECT DIS, V196, P505, DOI 10.1086/519693; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; CONE RW, 1994, JAMA-J AM MED ASSOC, V272, P792, DOI 10.1001/jama.272.10.792; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; COREY L, 1983, ANN INTERN MED, V98, P973, DOI 10.7326/0003-4819-98-6-973; COWAN FM, 1994, BRIT MED J, V309, P1325, DOI 10.1136/bmj.309.6965.1325; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Guerry SL, 2005, CLIN INFECT DIS, V40, P38, DOI 10.1086/426438; Leone P, 2010, CURR MED RES OPIN, V26, P653, DOI 10.1185/03007990903554471; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Magaret AS, 2009, SEX TRANSM INFECT, V85, P270, DOI 10.1136/sti.2008.034751; Magaret AS, 2007, J CLIN MICROBIOL, V45, P1618, DOI 10.1128/JCM.01405-06; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; Melville J, 2003, SEX TRANSM INFECT, V79, P280, DOI 10.1136/sti.79.4.280; MERTZ GJ, 1992, ANN INTERN MED, V116, P197, DOI 10.7326/0003-4819-116-3-197; Mertz GJ, 2008, J INFECT DIS, V198, P1098, DOI 10.1086/591914; Mertz KJ, 1998, J INFECT DIS, V178, P1795, DOI 10.1086/314502; Phipps W, 2011, J INFECT DIS, V203, P180, DOI 10.1093/infdis/jiq035; Ryncarz AJ, 1999, J CLIN MICROBIOL, V37, P1941, DOI 10.1128/JCM.37.6.1941-1947.1999; Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193; Sucato G, 1998, J INFECT DIS, V177, P1069, DOI 10.1086/515261; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Wald A, 2006, J INFECT DIS, V194, P42, DOI 10.1086/504717; Wald A, 1996, ANN INTERN MED, V124, P8, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00002; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Wald A, 2001, JAMA-J AM MED ASSOC, V285, P3100, DOI 10.1001/jama.285.24.3100; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792	34	182	190	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1441	1449		10.1001/jama.2011.420	http://dx.doi.org/10.1001/jama.2011.420			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486977	Green Accepted, Bronze			2022-12-28	WOS:000289424100021
J	Boehme, CC; Nicol, MP; Nabeta, P; Michael, JS; Gotuzzo, E; Tahirli, R; Gler, MT; Blakemore, R; Worodria, W; Gray, C; Huang, L; Caceres, T; Mehdiyev, R; Raymond, L; Whitelaw, A; Sagadevan, K; Alexander, H; Albert, H; Cobelens, F; Cox, H; Alland, D; Perkins, MD				Boehme, Catharina C.; Nicol, Mark P.; Nabeta, Pamela; Michael, Joy S.; Gotuzzo, Eduardo; Tahirli, Rasim; Gler, Ma Tarcela; Blakemore, Robert; Worodria, William; Gray, Christen; Huang, Laurence; Caceres, Tatiana; Mehdiyev, Rafail; Raymond, Lawrence; Whitelaw, Andrew; Sagadevan, Kalaiselvan; Alexander, Heather; Albert, Heidi; Cobelens, Frank; Cox, Helen; Alland, David; Perkins, Mark D.			Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study	LANCET			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INITIAL DEFAULT; TB DIAGNOSIS; PREVALENCE; INFECTION; RATES; ASSAY	Background The Xpert MTB/RIF test (Cepheid, Sunnyvale, CA, USA) can detect tuberculosis and its multidrug-resistant form with very high sensitivity and specificity in controlled studies, but no performance data exist from district and subdistrict health facilities in tuberculosis-endemic countries. We aimed to assess operational feasibility, accuracy, and effectiveness of implementation in such settings. Methods We assessed adults (>= 18 years) with suspected tuberculosis or multidrug-resistant tuberculosis consecutively presenting with cough lasting at least 2 weeks to urban health centres in South Africa, Peru, and India, drug-resistance screening facilities in Azerbaijan and the Philippines, and an emergency room in Uganda. Patients were excluded from the main analyses if their second sputum sample was collected more than 1 week after the first sample, or if no valid reference standard or MTB/RIF test was available. We compared one-off direct MTB/RIF testing in nine microscopy laboratories adjacent to study sites with 2-3 sputum smears and 1-3 cultures, dependent on site, and drug-susceptibility testing. We assessed indicators of robustness including indeterminate rate and between-site performance, and compared time to detection, reporting, and treatment, and patient dropouts for the techniques used. Findings We enrolled 6648 participants between Aug 11,2009, and June 26, 2010. One-off MTB/RIF testing detected 933 (90.3%) of 1033 culture-confirmed cases of tuberculosis, compared with 699 (67.1%) of 1041 for microscopy. MTB/RIF test sensitivity was 76.9% in smear-negative, culture-positive patients (296 of 385 samples), and 99.0% specific (2846 of 2876 non-tuberculosis samples). MTB/RIF test sensitivity for rifampicin resistance was 94.4% (236 of 250) and specificity was 98.3% (796 of 810). Unlike microscopy, MTB/RIF test sensitivity was not significantly lower in patients with HIV co-infection. Median time to detection of tuberculosis for the MTB/RIF test was 0 days (IQR 0-1), compared with 1 day (0-1) for microscopy, 30 days (23-43) for solid culture, and 16 days (13-21) for liquid culture. Median time to detection of resistance was 20 days (10-26) for line-probe assay and 106 days (30-124) for conventional drug-susceptibility testing. Use of the MTB/RIF test reduced median time to treatment for smear-negative tuberculosis from 56 days (39-81) to 5 days (2-8). The indeterminate rate of MTB/RIF testing was 2.4% (126 of 5321 samples) compared with 4.6% (441 of 9690) for cultures. Interpretation The MTB/RIF test can effectively be used in low-resource settings to simplify patients' access to early and accurate diagnosis, thereby potentially decreasing morbidity associated with diagnostic delay, dropout and mistreatment.	[Boehme, Catharina C.; Nabeta, Pamela; Gray, Christen; Alexander, Heather; Albert, Heidi; Perkins, Mark D.] Fdn Innovat New Diagnost, CH-1202 Geneva, Switzerland; [Nicol, Mark P.; Whitelaw, Andrew] Groote Schuur Hosp, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Nicol, Mark P.; Whitelaw, Andrew] Univ Cape Town, Dept Med Microbiol, ZA-7925 Cape Town, South Africa; [Nicol, Mark P.; Whitelaw, Andrew] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Michael, Joy S.; Sagadevan, Kalaiselvan] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Gotuzzo, Eduardo; Caceres, Tatiana] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Tahirli, Rasim] Special Treatment Inst, Baku, Azerbaijan; [Gler, Ma Tarcela] Trop Dis Fdn, Manila, Philippines; [Blakemore, Robert; Alland, David] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; [Blakemore, Robert; Alland, David] Univ Med & Dent New Jersey, Div Infect Dis, Newark, NJ 07103 USA; [Worodria, William] Makerere Univ, Fac Med, Dept Med, Kampala, Uganda; [Worodria, William] Uganda Minist Hlth, Kampala, Uganda; [Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA USA; [Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Mehdiyev, Rafail] Azerbaijan Minist Justice, Baku, Azerbaijan; [Raymond, Lawrence] Lung Ctr Philippines, Manila, Philippines; [Alexander, Heather] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Albert, Heidi] Fdn Innovat New Diagnost, Kampala, Uganda; [Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Cox, Helen] Med Sans Frontieres, Cape Town, South Africa	Foundation For Innovative New Diagnostics; University of Cape Town; University of Cape Town; University of Cape Town; Christian Medical College & Hospital (CMCH) Vellore; Universidad Peruana Cayetano Heredia; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Makerere University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Lung Center of the Philippines; Centers for Disease Control & Prevention - USA; Foundation For Innovative New Diagnostics; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Boehme, CC (corresponding author), Fdn Innovat New Diagnost, Ave Bude 16, CH-1202 Geneva, Switzerland.	catharina.boehme@finddiagnostics.org	Huang, Laurence/AAZ-7120-2021; Huang, Laurence/AAE-1590-2019; Nicol, Mark/W-4149-2019	Huang, Laurence/0000-0003-3888-2195; Nicol, Mark/0000-0002-1366-4805; Cobelens, Frank/0000-0002-4367-1133; Cox, Helen/0000-0002-6538-7192; Gray, Christen/0000-0002-9723-3032; Whitelaw, Andrew/0000-0001-9070-5247; CACERES, TATIANA/0000-0003-0516-5202	Foundation for Innovative New Diagnostics; Bill & Melinda Gates Foundation; European and Developing Countries Clinical Trials Partnership [TA2007.40200.009]; Wellcome Trust [085251/B/08/Z]; UK Department for International Development	Foundation for Innovative New Diagnostics; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); European and Developing Countries Clinical Trials Partnership; Wellcome Trust(Wellcome TrustEuropean Commission); UK Department for International Development	Foundation for Innovative New Diagnostics, Bill & Melinda Gates Foundation, European and Developing Countries Clinical Trials Partnership (TA2007.40200.009), Wellcome Trust (085251/B/08/Z), and UK Department for International Development.	Armand S, 2011, J CLIN MICROBIOL, V49, P1772, DOI 10.1128/JCM.02157-10; Asencios Luis, 2009, Rev. perú. med. exp. salud publica, V26, P278; Banada PP, 2010, J CLIN MICROBIOL, V48, P3551, DOI 10.1128/JCM.01053-10; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Bruchfeld J, 2000, T ROY SOC TROP MED H, V94, P677, DOI 10.1016/S0035-9203(00)90230-X; *CENTR TB DIV DIR, 2010, REV NAT TUB CONTR PR; *ENGL R INF MAN OF, 2008, BOL OV REG ANN HLTH; Farmer P, 1998, INT J TUBERC LUNG D, V2, P869; FISCHL MA, 1992, ANN INTERN MED, V117, P184, DOI 10.7326/0003-4819-117-3-184; Garin B, 1997, LANCET, V350, P1298, DOI 10.1016/S0140-6736(05)62475-0; Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7; Havlir DV, 1999, NEW ENGL J MED, V340, P367, DOI 10.1056/NEJM199902043400507; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1409; Khan MS, 2009, TROP MED INT HEALTH, V14, P1437, DOI 10.1111/j.1365-3156.2009.02406.x; Lanjewar D N, 2001, HIV Med, V2, P266, DOI 10.1046/j.1468-1293.2001.00079.x; Long Q, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-202; Lukoye D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016130; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Medecins Sans Frontieres, 2011, SCAL DIAGN TREATM DR; Mendoza Ticona Alberto, 2008, Acta méd. peruana, V25, P247; Millen SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001933; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Philippine Nationwide TB Drug Resi, 2009, INT J TUBERC LUNG D, V13, P500; Pronyk PM, 2004, INT J TUBERC LUNG D, V8, P796; Rao Nisar Ahmed, 2009, JPMA Journal of the Pakistan Medical Association, V59, P223; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; *STOP TB DEP WHO, ROADM ROLL OUT XPERT; *STOP TB DEP WHO E, 2010, ACC IMPL COLL TB HIV; *TROP DIS FDN DEP, 2007 NAT TUB PREV SU; Van Rie A, 2006, LANCET, V368, P1554, DOI 10.1016/S0140-6736(06)69575-5; *W CAP DEP HLTH ME, 2010, PROV HIV TB CAR PRIM; *WHO, SERV TUB CONTR 3; WHO, TUB COUNTR PROF; World Health Organization, MULT EXT DRUG RES TB; World Health Organization, 2010, GLOB TUB CONTR; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	42	735	769	5	233	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2011	377	9776					1495	1505		10.1016/S0140-6736(11)60438-8	http://dx.doi.org/10.1016/S0140-6736(11)60438-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761RX	21507477	Bronze, Green Published			2022-12-28	WOS:000290419400027
J	Bill-Axelson, A; Holmberg, L; Ruutu, M; Garmo, H; Stark, JR; Busch, C; Nordling, S; Haggman, M; Andersson, SO; Bratell, S; Spangberg, A; Palmgren, J; Steineck, G; Adami, HO; Johansson, JE				Bill-Axelson, Anna; Holmberg, Lars; Ruutu, Mirja; Garmo, Hans; Stark, Jennifer R.; Busch, Christer; Nordling, Stig; Haggman, Michael; Andersson, Swen-Olof; Bratell, Stefan; Spangberg, Anders; Palmgren, Juni; Steineck, Gunnar; Adami, Hans-Olov; Johansson, Jan-Erik		SPCG-4 Investigators	Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; RANDOMIZED-TRIAL; RADIOTHERAPY; RISK	BACKGROUND In 2008, we reported that radical prostatectomy, as compared with watchful waiting, reduces the rate of death from prostate cancer. After an additional 3 years of follow-up, we now report estimated 15-year results. METHODS From October 1989 through February 1999, we randomly assigned 695 men with early prostate cancer to watchful waiting or radical prostatectomy. Follow-up was complete through December 2009, with histopathological review of biopsy and radical-prostatectomy specimens and blinded evaluation of causes of death. Relative risks, with 95% confidence intervals, were estimated with the use of a Cox proportional-hazards model. RESULTS During a median of 12.8 years, 166 of the 347 men in the radical-prostatectomy group and 201 of the 348 in the watchful-waiting group died (P=0.007). In the case of 55 men assigned to surgery and 81 men assigned to watchful waiting, death was due to prostate cancer. This yielded a cumulative incidence of death from prostate cancer at 15 years of 14.6% and 20.7%, respectively (a difference of 6.1 percentage points; 95% confidence interval [CI], 0.2 to 12.0), and a relative risk with surgery of 0.62 (95% CI, 0.44 to 0.87; P=0.01). The survival benefit was similar before and after 9 years of follow-up, was observed also among men with low-risk prostate cancer, and was confined to men younger than 65 years of age. The number needed to treat to avert one death was 15 overall and 7 for men younger than 65 years of age. Among men who underwent radical prostatectomy, those with extracapsular tumor growth had a risk of death from prostate cancer that was 7 times that of men without extracapsular tumor growth (relative risk, 6.9; 95% CI, 2.6 to 18.4). CONCLUSIONS Radical prostatectomy was associated with a reduction in the rate of death from prostate cancer. Men with extracapsular tumor growth may benefit from adjuvant local or systemic treatment.	[Bill-Axelson, Anna; Haggman, Michael] Univ Uppsala Hosp, Dept Urol, S-75185 Uppsala, Sweden; [Holmberg, Lars; Garmo, Hans] Univ Uppsala Hosp, Reg Oncol Ctr, S-75185 Uppsala, Sweden; [Busch, Christer] Univ Uppsala Hosp, Dept Pathol, S-75185 Uppsala, Sweden; [Bill-Axelson, Anna; Steineck, Gunnar] Karolinska Inst, Dept Pathol & Oncol, Div Clin Canc Epidemiol, Stockholm, Sweden; [Palmgren, Juni; Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Stark, Jennifer R.; Andersson, Swen-Olof; Johansson, Jan-Erik] Dept Urol, Orebro, Sweden; [Johansson, Jan-Erik] Ctr Assessment Med Technol, Orebro, Sweden; [Bratell, Stefan] Boras Hosp, Dept Urol, Boras, Sweden; [Spangberg, Anders] Linkoping Univ Hosp, Dept Urol, S-58185 Linkoping, Sweden; [Steineck, Gunnar] Sahlgrens Acad, Div Clin Canc Epidemiol, Gothenburg, Sweden; [Holmberg, Lars; Garmo, Hans] Kings Coll London, Sch Med, Div Canc Studies, London, England; [Ruutu, Mirja] Univ Helsinki, Cent Hosp, Dept Urol, Helsinki, Finland; [Nordling, Stig] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Stark, Jennifer R.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Stark, Jennifer R.] Harvard Univ, Sch Med, Boston, MA USA; [Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Karolinska Institutet; Linkoping University; University of Gothenburg; University of London; King's College London; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Bill-Axelson, A (corresponding author), Univ Uppsala Hosp, Dept Urol, S-75185 Uppsala, Sweden.	anna.bill.axelson@akademiska.se	Rider, Jennifer/T-1272-2019; Björklund, Johan K/G-3097-2015; Steineck, Gunnar/W-1515-2019	Rider, Jennifer/0000-0002-2637-6036; Björklund, Johan K/0000-0003-3254-3993; Steineck, Gunnar/0000-0002-0787-3969; Garmo, Hans/0000-0001-7181-7083; Palmgren, Juni/0000-0002-9031-8615	Swedish Cancer Society [07 0512]; National Institutes of Health [1ROI CA 108746-01A1]; Astellas; NATIONAL CANCER INSTITUTE [R01CA108746] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Astellas(Astellas Pharmaceuticals); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the Swedish Cancer Society (07 0512, to Dr. Johansson) and the National Institutes of Health (1ROI CA 108746-01A1, to Dr. Steineck).; Dr. Spangberg reports serving on the advisory board of Pfizer and receiving lecture fees from Astellas. No other potential conflict of interest relevant to this article was reported.	Adami HO, 2010, ACTA ONCOL, V49, P298, DOI 10.3109/02841860903584945; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; BRENDLER CB, 1980, J UROLOGY, V124, P849, DOI 10.1016/S0022-5347(17)55696-7; Donovan J, 2003, Health Technol Assess, V7, P1; Eggener SE, 2011, J UROLOGY, V185, P869, DOI 10.1016/j.juro.2010.10.057; Gleason DF., 1977, HISTOLOGIC GRADING C; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; HARMER MH, 1978, TNM CLASSIFICATION M; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Johansson E, 2009, EUR UROL, V55, P422, DOI 10.1016/j.eururo.2008.08.054; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Klotz Laurence H, 2006, Can J Urol, V13 Suppl 1, P48; Rosenthal SA, 2009, INT J RADIAT ONCOL, V73, P672, DOI 10.1016/j.ijrobp.2008.05.020; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; WALSH PC, 1983, PROSTATE, V4, P473, DOI 10.1002/pros.2990040506; Widmark A, 2009, LANCET, V373, P1174; Widmark A, 2009, LANCET, V373, P301, DOI 10.1016/S0140-6736(08)61815-2; Wiegel T, 2009, J CLIN ONCOL, V27, P2924, DOI 10.1200/JCO.2008.18.9563; Wong YN, 2007, JAMA-J AM MED ASSOC, V297, P42	22	644	666	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1708	1717		10.1056/NEJMoa1011967	http://dx.doi.org/10.1056/NEJMoa1011967			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759DC	21542742				2022-12-28	WOS:000290219800007
J	Thoennessen, M; Sherrill, B				Thoennessen, Michael; Sherrill, Bradley			From isotopes to the stars	NATURE			English	Editorial Material									[Thoennessen, Michael; Sherrill, Bradley] Michigan State Univ, Natl Superconducting Cyclotron Lab, E Lansing, MI 48824 USA; [Thoennessen, Michael; Sherrill, Bradley] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Thoennessen, M (corresponding author), Michigan State Univ, Natl Superconducting Cyclotron Lab, E Lansing, MI 48824 USA.	thoennessen@nscl.msu.edu; sherrill@frib.msu.edu	Sherrill, Bradley M/B-3378-2011	Sherrill, Bradley M/0000-0002-5093-8190					0	39	43	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					25	26		10.1038/473025a	http://dx.doi.org/10.1038/473025a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	759CQ	21544125	Bronze			2022-12-28	WOS:000290218300012
J	Summerfield, D				Summerfield, Derek			FIRST PERSON Metropolitan Police blues: protracted sickness absence, ill health retirement, and the occupational psychiatrist	BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTTRAUMATIC-STRESS; DEPRESSION; STILL		Kings Coll London, Inst Psychiat, London SE5 8BB, England	University of London; King's College London	Summerfield, D (corresponding author), Kings Coll London, Inst Psychiat, London SE5 8BB, England.	derek.summerfield@slam.nhs.uk						BIGOS S, 1991, SPINE, V1, P1; Black C., 2008, WORKING HLTH TOMORRO; Brugha TS, 2004, BRIT J PSYCHIAT, V185, P378, DOI 10.1192/bjp.185.5.378; CANNING EC, 2003, THESIS U HULL; Cole J, 2008, BRIT J PSYCHIAT, V192, P83, DOI 10.1192/bjp.bp.107.039826; Dobson R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5688; Harvey SB, 2009, BRIT J PSYCHIAT, V194, P201, DOI 10.1192/bjp.bp.108.055111; Healthcare Commission, 2007, NO VOIC NO CHOIC JOI; Horton R, 2006, LANCET, V368, P1750, DOI 10.1016/S0140-6736(06)69641-4; Hussey S, 2004, BRIT MED J, V328, P88, DOI 10.1136/bmj.37949.656389.EE; Neal LA, 2004, BRIT J PSYCHIAT, V184, P247, DOI 10.1192/bjp.184.3.247; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Rosen GM, 2008, BRIT J PSYCHIAT, V192, P3, DOI 10.1192/bjp.bp.107.043083; Summerfield D, 2006, J ROY SOC MED, V99, P161, DOI 10.1258/jrsm.99.3.161; Summerfield D., 2004, POSTTRAUMATIC STRESS, P233, DOI [DOI 10.1002/9780470713570, 10.1002/9780470713570.ch12]; Waddell G., 2006, IS WORK GOOD YOUR HL; Waddell G., 2004, CONCEPTS REHABILITAT; Wainwright D., 2002, WORK STRESS MAKING M	18	20	20	1	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2011	342								d2127	10.1136/bmj.d2127	http://dx.doi.org/10.1136/bmj.d2127			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OI	21505221				2022-12-28	WOS:000289942200003
J	Gault, EJ; Perry, RJ; Cole, TJ; Casey, S; Paterson, WF; Hindmarsh, PC; Betts, P; Dunger, DB; Donaldson, MDC				Gault, Emma Jane; Perry, Rebecca J.; Cole, Tim J.; Casey, Sarah; Paterson, Wendy F.; Hindmarsh, Peter C.; Betts, Peter; Dunger, David B.; Donaldson, Malcolm D. C.		British Soc Paediat Endocrinology	Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GROWTH-HORMONE TREATMENT; ESTROGEN REPLACEMENT; GIRLS; THERAPY; MULTICENTER; NORMALIZATION; MANAGEMENT; STATURE; AGE	Objective To examine the effect of oxandrolone and the timing of pubertal induction on final height in girls with Turner's syndrome receiving a standard dose of growth hormone. Design Randomised, double blind, placebo controlled trial. Setting 36 paediatric endocrinology departments in UK hospitals. Participants Girls with Turner's syndrome aged 7-13 years at recruitment, receiving recombinant growth hormone therapy (10 mg/m(2)/week). Interventions Participants were randomised to oxandrolone (0.05 mg/kg/day, maximum 2.5 mg/day) or placebo from 9 years of age. Those with evidence of ovarian failure at 12 years were further randomised to oral ethinylestradiol (year 1, 2 mu g daily; year 2, 4 mu g daily; year 3, 4 months each of 6, 8, and 10 mu g daily) or placebo; participants who received placebo and those recruited after the age of 12.25 years started ethinylestradiol at age 14. Main outcome measure Final height. Results 106 participants were recruited, of whom 14 withdrew and 82/92 reached final height. Both oxandrolone and late pubertal induction increased final height: by 4.6 (95% confidence interval 1.9 to 7.2) cm (P=0.001, n=82) for oxandrolone and 3.8 (0.0 to 7.5) cm (P=0.05, n=48) for late pubertal induction with ethinylestradiol. In the 48 children who were randomised twice, the effects on final height (compared with placebo and early induction of puberty) of oxandrolone alone, late induction alone, and oxandrolone plus late induction were similar, averaging 7.1 (3.4 to 10.8) cm (P<0.001). No cases of virilisation were reported. Conclusion Oxandrolone had a positive effect on final height in girls with Turner's syndrome treated with growth hormone, as did late pubertal induction with ethinylestradiol at age 14 years. However, these effects were not additive, so using both had no advantage. Oxandrolone could, therefore, be offered as an alternative to late pubertal induction for increasing final height in Turner's syndrome.	[Gault, Emma Jane; Perry, Rebecca J.; Paterson, Wendy F.; Donaldson, Malcolm D. C.] Univ Glasgow, Royal Hosp Sick Children, Dept Child Hlth, Glasgow G3 8SJ, Lanark, Scotland; [Cole, Tim J.] UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England; [Casey, Sarah] Royal Hosp Sick Children, Dept Clin Trials, Dept Pharm, Glasgow G3 8SJ, Lanark, Scotland; [Hindmarsh, Peter C.] UCL Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Betts, Peter] Southampton Univ Hosp NHS Trust, Dept Paediat, Southampton, Hants, England; [Dunger, David B.] Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 2QQ, England	University of Glasgow; University of London; University College London; University of Glasgow; University of London; University College London; University of Southampton; University Hospital Southampton NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Donaldson, MDC (corresponding author), Univ Glasgow, Royal Hosp Sick Children, Dept Child Hlth, Glasgow G3 8SJ, Lanark, Scotland.	malcolm.donaldson@glasgow.ac.uk	Cole, Tim J/B-7883-2008	Cole, Tim J/0000-0001-5711-8200; Clayton, Peter/0000-0003-1225-4537; Dunger, Professor David/0000-0002-2566-9304; Davies, Justin/0000-0001-7560-6320; Acerini, Carlo/0000-0003-2121-5871	Scottish Executive Chief Scientist Office [K/MRS/50/C2713]; British Society for Paediatric Endocrinology and Diabetes; Child Growth Foundation; MRC [G0700961] Funding Source: UKRI; National Institute for Health Research [NF-SI-0508-10274] Funding Source: researchfish	Scottish Executive Chief Scientist Office; British Society for Paediatric Endocrinology and Diabetes; Child Growth Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding was provided by the Scottish Executive Chief Scientist Office (1999-2004) (K/MRS/50/C2713) and thereafter by the British Society for Paediatric Endocrinology and Diabetes, with a contribution to funding of pharmacy staff from the Child Growth Foundation	Bannink EMN, 2009, CLIN ENDOCRINOL, V70, P265, DOI 10.1111/j.1365-2265.2008.03446.x; Baxter L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003887.pub2; Blair J, 2001, J PEDIATR-US, V139, P724, DOI 10.1067/mpd.2001.118571; Cacciari E, 1999, J CLIN ENDOCR METAB, V84, P4510, DOI 10.1210/jc.84.12.4510; Carel JC, 1998, J CLIN ENDOCR METAB, V83, P1462, DOI 10.1210/jc.83.5.1462; Carel JC, 2006, J CLIN ENDOCR METAB, V91, P2972, DOI 10.1210/jc.2005-2652; Chernausek SD, 2000, J CLIN ENDOCR METAB, V85, P2439, DOI 10.1210/jc.85.7.2439; Chernausek SD, 1999, ACTA PAEDIATR, V88, P130, DOI 10.1111/j.1651-2227.1999.tb14422.x; Cole TJ, 2010, INT J EPIDEMIOL, V39, P1558, DOI 10.1093/ije/dyq115; Davenport ML, 2007, J CLIN ENDOCR METAB, V92, P3406, DOI 10.1210/jc.2006-2874; Davenport ML, 2008, ANN NY ACAD SCI, V1135, P126, DOI 10.1196/annals.1429.031; Evans S, 2004, MINIM ALLOCATION MIN; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gault EJ, 2003, ACTA PAEDIATR, V92, P1033, DOI 10.1080/08035250310004315; Haeusler G, 1996, ACTA PAEDIATR, V85, P1408; Hogler W, 2004, J CLIN ENDOCR METAB, V89, P193, DOI 10.1210/jc.2003-030799; Johnston DI, 2001, ARCH DIS CHILD, V84, P76, DOI 10.1136/adc.84.1.76; Karlberg J, 1989, Acta Paediatr Scand Suppl, V350, P70; LIPPE B, 1991, ENDOCRIN METAB CLIN, V20, P121, DOI 10.1016/S0889-8529(18)30284-6; Menke LA, 2010, J CLIN ENDOCR METAB, V95, P1151, DOI 10.1210/jc.2009-1821; Nathwani NC, 2000, CLIN ENDOCRINOL, V52, P363; Nilsson KO, 1996, J CLIN ENDOCR METAB, V81, P635, DOI 10.1210/jc.81.2.635; Plotnick L, 1998, PEDIATRICS, V102, P479; Reiter EO, 2001, J CLIN ENDOCR METAB, V86, P1936, DOI 10.1210/jc.86.5.1936; ROCHICCIOLI P, 1994, ACTA PAEDIATR, V83, P305, DOI 10.1111/j.1651-2227.1994.tb18099.x; ROCHICCIOLI P, 1995, HORM RES, V44, P172, DOI 10.1159/000184620; Rosenfeld RG, 1998, J PEDIATR-US, V132, P319, DOI 10.1016/S0022-3476(98)70452-4; Rosenfield RL, 1998, PEDIATRICS, V102, P486; Salerno M, 1999, EUR J PEDIATR, V158, P618, DOI 10.1007/s004310051163; Sas TC, 2000, CLIN ENDOCRINOL, V52, P531, DOI 10.1046/j.1365-2265.2000.00963.x; Sas TCJ, 1999, J CLIN ENDOCR METAB, V84, P4607, DOI 10.1210/jc.84.12.4607; Soriano-Guillen L, 2005, J CLIN ENDOCR METAB, V90, P5197, DOI 10.1210/jc.2005-0470; Stahnke N, 2002, J PEDIATR ENDOCR MET, V15, P129; Stephure DK, 2005, J CLIN ENDOCR METAB, V90, P3360, DOI 10.1210/jc.2004-2187; TAKANO K, 1995, HORM RES, V43, P141, DOI 10.1159/000184261; Tanner JM., 1983, ASSESSMENT SKELETAL	36	42	46	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2011	342								d1980	10.1136/bmj.d1980	http://dx.doi.org/10.1136/bmj.d1980			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752UZ	21493672	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-28	WOS:000289721700003
J	Oliver, A				Oliver, Adam			Is nudge an effective public health strategy to tackle obesity? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London London Sch Econ & Polit Sci, LSE Hlth, London WC2A 2AE, England	University of London; London School Economics & Political Science	Oliver, A (corresponding author), Univ London London Sch Econ & Polit Sci, LSE Hlth, Houghton St, London WC2A 2AE, England.	a.j.oliver@lse.ac.uk	Oliver, Adam/CAG-2031-2022					Cabinet Office, 2010, APPL BEH INS HLTH; Cassidy J, 2011, BMJ-BRIT MED J, V342, pd1648; Paul-Ebhohimhen V, 2008, OBES REV, V9, P355, DOI 10.1111/j.1467-789X.2007.00409.x; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804; PIANO STAIRS THEFUNT	5	21	21	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2011	342								d2168	10.1136/bmj.d2168	http://dx.doi.org/10.1136/bmj.d2168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752UZ	21493667				2022-12-28	WOS:000289721700005
J	Sutton, MA; Oenema, O; Erisman, JW; Leip, A; van Grinsven, H; Winiwarter, W				Sutton, Mark A.; Oenema, Oene; Erisman, Jan Willem; Leip, Adrian; van Grinsven, Hans; Winiwarter, Wilfried			Too much of a good thing	NATURE			English	Editorial Material									[Sutton, Mark A.] Ctr Ecol & Hydrol, Edinburgh EH26 0QB, Midlothian, Scotland; [Oenema, Oene] Alterra, NL-6700 AA Wageningen, Netherlands; [Sutton, Mark A.; Oenema, Oene; Erisman, Jan Willem] Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Leip, Adrian] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21027 Ispra, Italy; [van Grinsven, Hans] PBL Netherlands Environm Assessment Agcy, NL-3720 AH Bilthoven, Netherlands; [Winiwarter, Wilfried] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria	UK Centre for Ecology & Hydrology (UKCEH); Wageningen University & Research; Vrije Universiteit Amsterdam; European Commission Joint Research Centre; EC JRC ISPRA Site; International Institute for Applied Systems Analysis (IIASA)	Sutton, MA (corresponding author), Ctr Ecol & Hydrol, Edinburgh EH26 0QB, Midlothian, Scotland.	ms@ceh.ac.uk	Winiwarter, Wilfried/F-5073-2017	Winiwarter, Wilfried/0000-0001-7131-1496; Erisman, Jan Willem/0000-0001-5058-7012; Leip, Adrian/0000-0001-7616-5029	Natural Environment Research Council [ceh010023] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Amann M., 2011, 12011 CIAM IIASA; [Anonymous], 2010, DELHI DECLARATION; [Anonymous], 2009, BARSAC DECLARATION E; Erisman JW, 2008, NAT GEOSCI, V1, P636, DOI 10.1038/ngeo325; Howard C. M., 2011, EUROPEAN NITROGEN AS, DOI [10.1017/CBO9780511976988, DOI 10.1017/CBO9780511976988]; Magid J, 2006, ECOL ENG, V28, P44, DOI 10.1016/j.ecoleng.2006.03.009; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985	7	589	615	14	417	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					159	161		10.1038/472159a	http://dx.doi.org/10.1038/472159a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21478874	Green Accepted			2022-12-28	WOS:000289469100016
J	Foster, CB; Sabella, C				Foster, Charles B.; Sabella, Camille			Health Care-Associated Infections in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-STREAM INFECTIONS; INFANTS		[Foster, Charles B.; Sabella, Camille] Cleveland Clin Childrens Hosp, Ctr Pediat Infect Dis, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Sabella, C (corresponding author), Cleveland Clin Childrens Hosp, Ctr Pediat Infect Dis, 9500 Euclid Ave,Desk S-25, Cleveland, OH 44195 USA.	sabellc@ccf.org						Aly H, 2005, PEDIATRICS, V115, P1513, DOI 10.1542/peds.2004-1785; Bernstein HH, 2010, PEDIATRICS, V126, P809, DOI 10.1542/peds.2010-2376; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Grohskopf LA, 2002, J PEDIATR-US, V140, P432, DOI 10.1067/mpd.2002.122499; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Ingraham AM, 2010, J AM COLL SURGEONS, V211, P705, DOI 10.1016/j.jamcollsurg.2010.09.006; MACDONALD NE, 1982, NEW ENGL J MED, V307, P397, DOI 10.1056/NEJM198208123070702; Miller MR, 2010, PEDIATRICS, V125, P206, DOI 10.1542/peds.2009-1382; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Stulberg JJ, 2010, JAMA-J AM MED ASSOC, V303, P2479, DOI 10.1001/jama.2010.841	10	15	15	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1480	1481		10.1001/jama.2011.449	http://dx.doi.org/10.1001/jama.2011.449			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486980				2022-12-28	WOS:000289424100026
J	Goodman, A; Schorge, J; Greene, MF				Goodman, Annekathryn; Schorge, John; Greene, Michael F.			The Long-Term Effects of In Utero Exposures - The DES Story	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DIETHYLSTILBESTROL DES		[Goodman, Annekathryn; Schorge, John; Greene, Michael F.] Harvard Univ, Sch Med, Boston, MA 02163 USA; [Goodman, Annekathryn; Schorge, John; Greene, Michael F.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Goodman, A (corresponding author), Harvard Univ, Sch Med, Boston, MA 02163 USA.							Block K, 2000, FASEB J, V14, P1101, DOI 10.1096/fasebj.14.9.1101; Ma L, 2009, TRENDS ENDOCRIN MET, V20, P357, DOI 10.1016/j.tem.2009.03.009; SMITH OW, 1948, AM J OBSTET GYNECOL, V56, P821; Titus-Ernstoff L, 2008, EPIDEMIOLOGY, V19, P251, DOI 10.1097/EDE.0b013e318163152a; Troisi R, 2007, INT J CANCER, V121, P356, DOI 10.1002/ijc.22631	5	26	26	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22					2083	2084		10.1056/NEJMp1104409	http://dx.doi.org/10.1056/NEJMp1104409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	772AB	21506735				2022-12-28	WOS:000291200700002
J	Attwood, BK; Bourgognon, JM; Patel, S; Mucha, M; Schiavon, E; Skrzypiec, AE; Young, KW; Shiosaka, S; Korostynski, M; Piechota, M; Przewlocki, R; Pawlak, R				Attwood, Benjamin K.; Bourgognon, Julie-Myrtille; Patel, Satyam; Mucha, Mariusz; Schiavon, Emanuele; Skrzypiec, Anna E.; Young, Kenneth W.; Shiosaka, Sadao; Korostynski, Michal; Piechota, Marcin; Przewlocki, Ryszard; Pawlak, Robert			Neuropsin cleaves EphB2 in the amygdala to control anxiety	NATURE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; NMDA RECEPTORS; STRESS; BRAIN; GENE; POLYMORPHISMS; HIPPOCAMPAL; MODULATION; EXPRESSION; BEHAVIOR	A minority of individuals experiencing traumatic events develop anxiety disorders. The reason for the lack of correspondence between the prevalence of exposure to psychological trauma and the development of anxiety is unknown. Extracellular proteolysis contributes to fear-associated responses by facilitating neuronal plasticity at the neuron-matrix interface(1-4). Here we show in mice that the serine protease neuropsin is critical for stress-related plasticity in the amygdala by regulating the dynamics of the EphB2-NMDA-receptor interaction, the expression of Fkbp5 and anxiety-like behaviour. Stress results in neuropsin-dependent cleavage of EphB2 in the amygdala causing dissociation of EphB2 from the NR1 subunit of the NMDA receptor and promoting membrane turnover of EphB2 receptors. Dynamic EphB2-NR1 interaction enhances NMDA receptor current, induces Fkbp5 gene expression and enhances behavioural signatures of anxiety. On stress, neuropsin-deficient mice do not show EphB2 cleavage and its dissociation from NR1 resulting in a static EphB2-NR1 interaction, attenuated induction of the Fkbp5 gene and low anxiety. The behavioural response to stress can be restored by intra-amygdala injection of neuropsin into neuropsin-deficient mice and disrupted by the injection of either anti-EphB2 antibodies or silencing the Fkbp5 gene in the amygdala of wild-type mice. Our findings establish a novel neuronal pathway linking stress-induced proteolysis of EphB2 in the amygdala to anxiety.	[Attwood, Benjamin K.; Bourgognon, Julie-Myrtille; Patel, Satyam; Mucha, Mariusz; Schiavon, Emanuele; Skrzypiec, Anna E.; Pawlak, Robert] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Young, Kenneth W.] MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Shiosaka, Sadao] Nara Inst Sci & Technol, Div Struct Cell Biol, Nara 6300192, Japan; [Korostynski, Michal; Piechota, Marcin; Przewlocki, Ryszard] Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, PL-31343 Krakow, Poland	University of Leicester; University of Leicester; Nara Institute of Science & Technology; Polish Academy of Sciences	Pawlak, R (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Univ Rd, Leicester LE1 9HN, Leics, England.	rp135@le.ac.uk	Korostynski, Michal/AAS-2626-2021; Shiosaka, Sadao/B-1142-2008; Piechota, Marcin/G-9464-2011	Korostynski, Michal/0000-0002-4273-7401; Piechota, Marcin/0000-0003-2468-151X; Schiavon, Emanuele/0000-0002-4592-6961	Medical Research Council [G0500231/73852]; European Commission [MEXT-CT-2006-042265, LSHM-CT-2004-005166]; Medisearch Fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan [20300128]; Japan Science and Technology Agency; Ministry of Science and Higher Education of Poland [NN405 274137]; MRC [G0500231] Funding Source: UKRI; Medical Research Council [G0500231] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medisearch Fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council Project Grant (G0500231/73852), and a Marie Curie Excellence Grant (MEXT-CT-2006-042265 from the European Commission) to R. Pawlak, a Medisearch Fellowship to B.K.A., the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants-in-Aid, # 20300128) and Japan Science and Technology Agency (CREST program) to S.S., GENADDICT (LSHM-CT-2004-005166 from the European Commission) to R. Przewlocki, and NN405 274137 from the Ministry of Science and Higher Education of Poland to M.K. We are obliged to A. Kania, H. Castro and R. Fern for reagents. We are grateful to B. McEwen and A. Tobin for their comments on the manuscript and T. Gerdjikov, G. Mallucci and her laboratory members for advice.	Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bouvier D, 2008, J NEUROCHEM, V106, P682, DOI 10.1111/j.1471-4159.2008.05416.x; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Calo L, 2005, J NEUROSCI, V25, P2245, DOI 10.1523/JNEUROSCI.4956-04.2005; CHEN ZL, 1995, J NEUROSCI, V15, P5088; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Hirata A, 2001, MOL CELL NEUROSCI, V17, P600, DOI 10.1006/mcne.2000.0945; Horii Y, 2008, BEHAV NEUROSCI, V122, P498, DOI 10.1037/0735-7044.122.3.498; Huang YY, 2007, J NEUROSCI, V27, P3111, DOI 10.1523/JNEUROSCI.3908-06.2007; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Lin KT, 2008, J BIOL CHEM, V283, P28969, DOI 10.1074/jbc.M804401200; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; Matys T, 2004, P NATL ACAD SCI USA, V101, P16345, DOI 10.1073/pnas.0407355101; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Segman RH, 2005, MOL PSYCHIATR, V10, P500, DOI 10.1038/sj.mp.4001636; Shimizu C, 1998, J BIOL CHEM, V273, P11189, DOI 10.1074/jbc.273.18.11189; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Vyas A, 2002, J NEUROSCI, V22, P6810; WASHBURN MS, 1992, J NEUROSCI, V12, P4066	30	142	147	1	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					372	U553		10.1038/nature09938	http://dx.doi.org/10.1038/nature09938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21508957	Green Accepted			2022-12-28	WOS:000290722400048
J	Luz, PM; Vanni, T; Medlock, J; Paltiel, AD; Galvani, AP				Luz, Paula Mendes; Vanni, Tazio; Medlock, Jan; Paltiel, A. David; Galvani, Alison P.			Dengue vector control strategies in an urban setting: an economic modelling assessment	LANCET			English	Article							ADJUSTED LIFE YEARS; AEDES-AEGYPTI; COST-EFFECTIVENESS; INSECTICIDE; IMPACT; DISEASE; VIRUS; FEVER; POPULATIONS; CULICIDAE	Background An estimated 2.5 billion people are at risk of dengue. Incidence of dengue is especially high in resource-constrained countries, where control relies mainly on insecticides targeted at larval or adult mosquitoes. We did epidemiological and economic assessments of different vector control strategies. Methods We developed a dynamic model of dengue transmission that assesses the evolution of insecticide resistance and immunity in the human population, thus allowing for long-term evolutionary and immunological effects of decreased dengue transmission. We measured the dengue health burden in terms of disability-adjusted life-years (DALYs) lost. We did a cost-effectiveness analysis of 43 insecticide-based vector control strategies, including strategies targeted at adult and larval stages, at varying efficacies (high-efficacy [90% mortality], medium-efficacy [60% mortality], and low-efficacy [30% mortality]) and yearly application frequencies (one to six applications). To assess the effect of parameter uncertainty on the results, we did a probabilistic sensitivity analysis and a threshold analysis. Findings All interventions caused the emergence of insecticide resistance, which, with the loss of herd immunity, will increase the magnitude of future dengue epidemics. In our model, one or more applications of high-efficacy larval control reduced dengue burden for up to 2 years, whereas three or more applications of adult vector control reduced dengue burden for up to 4 years. The incremental cost-effectiveness ratios of the strategies for two high-efficacy adult vector control applications per year was US$615 per DALY saved and for six high-efficacy adult vector control applications per year was $1267 per DALY saved. Sensitivity analysis showed that if the cost of adult control was more than 8.2 times the cost of larval control then all strategies based on adult control became dominated. Interpretation Six high-efficacy adult vector control applications per year has a cost-effectiveness ratio that will probably meet WHO's standard for a cost-effective or very cost-effective intervention. Year-round larval control can be counterproductive, exacerbating epidemics in later years because of evolution of insecticide resistance and loss of herd immunity. We suggest the reassessment of vector control policies that are based on larval control only.	[Luz, Paula Mendes] Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, BR-21040360 Rio De Janeiro, Brazil; [Luz, Paula Mendes; Medlock, Jan; Paltiel, A. David; Galvani, Alison P.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Vanni, Tazio] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Medlock, Jan] Clemson Univ, Dept Math Sci, Clemson, SC USA	Fundacao Oswaldo Cruz; Yale University; University of London; London School of Hygiene & Tropical Medicine; Clemson University	Luz, PM (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, Ave Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.	paula.luz@ipec.fiocruz.br	Vanni, Tazio P./B-7925-2018	Paltiel, A. David/0000-0002-4861-3290; Luz, Paula/0000-0001-9746-719X	Fulbright Programme; CAPES (Brazilian federal agency for post-graduate education); Miriam Burnett trust; Notsew Orm Sands Foundation; National Science Foundation [SBE-0624117]; NIH MIDAS [UO1 GM087719-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719] Funding Source: NIH RePORTER	Fulbright Programme; CAPES (Brazilian federal agency for post-graduate education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Miriam Burnett trust; Notsew Orm Sands Foundation; National Science Foundation(National Science Foundation (NSF)); NIH MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	PML was funded by The Fulbright Programme, CAPES (Brazilian federal agency for post-graduate education), and the Miriam Burnett trust. APG was funded by Notsew Orm Sands Foundation and the Miriam Burnett trust. JM was supported by the National Science Foundation (grant SBE-0624117) and the Notsew Orm Sands Foundation. We gratefully acknowledge support from NIH MIDAS (grant UO1 GM087719-01).	Armien B, 2008, AM J TROP MED HYG, V79, P364, DOI 10.4269/ajtmh.2008.79.364; Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x; Bangs Michael J., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1103; Bartley LM, 2002, T ROY SOC TROP MED H, V96, P387, DOI 10.1016/S0035-9203(02)90371-8; Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667; Caldwell D, 2007, INT J EPIDEMIOL, V36, P476; Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786; Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128; da-Cunha MP, 2005, MEM I OSWALDO CRUZ, V100, P441, DOI 10.1590/S0074-02762005000400017; De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003; Donalísio Maria Rita, 2002, Rev. bras. epidemiol., V5, P259, DOI 10.1590/S1415-790X2002000300005; Drummond MF., 2005, METHODS EC EVALUATIO, P55; FENWICK E, 2009, ENCY MED DECISION MA, P1; Fernandez EA, 1998, ACTA TROP, V70, P171, DOI 10.1016/S0001-706X(98)00033-3; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Garg P, 2008, T ROY SOC TROP MED H, V102, P570, DOI 10.1016/j.trstmh.2008.02.015; Glasziou PP, 2001, DECISION MAKING HLTH; Gold MR, 1996, COST EFFECTIVENESS H; GRATZ NG, 1991, J AM MOSQUITO CONTR, V7, P353; GRATZ NG, 1994, AM J TROP MED HYG, V50, P11, DOI 10.4269/ajtmh.1994.50.6_Suppl.TM05006S0011; GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571, DOI 10.4269/ajtmh.1989.40.571; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; *INT MON FUND, DAT STAT; Jakubczyk M, 2010, HEALTH ECON, V19, P955, DOI 10.1002/hec.1534; Koenraadt CJM, 2007, J MED ENTOMOL, V44, P65, DOI 10.1603/0022-2585(2007)44[65:SATPIT]2.0.CO;2; Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; Lima José Bento Pereira, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P7, DOI 10.1590/S0036-46652005000100002; Luz PM, 2009, EPIDEMIOL INFECT, V137, P1203, DOI 10.1017/S0950268808001799; Luz PM, 2009, TROP MED INT HEALTH, V14, P237, DOI 10.1111/j.1365-3156.2008.02203.x; McConnell K. John, 2003, Rev Panam Salud Publica, V14, P9, DOI 10.1590/S1020-49892003000600003; McGuire A, 2001, EC EVALUATION HLTH C, P172; Medlock J, 2009, AM NAT, V174, P565, DOI 10.1086/605403; Meltzer MI, 1998, AM J TROP MED HYG, V59, P265, DOI 10.4269/ajtmh.1998.59.265; Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709; Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541; Pontes RJS, 2005, REV SOC BRAS MED TRO, V38, P316, DOI 10.1590/S0037-86822005000400007; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x; Teixeira M. da G., 2002, Dengue Bulletin, V26, P70; World Health Organization, 2001, MACR HLTH INV HLTH E	45	97	100	0	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2011	377	9778					1673	1680		10.1016/S0140-6736(11)60246-8	http://dx.doi.org/10.1016/S0140-6736(11)60246-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	766JF	21546076	Green Accepted, Green Published			2022-12-28	WOS:000290777700032
J	Massad, E; Coutinho, FAB				Massad, Eduardo; Bezerra Coutinho, Francisco Antonio			The cost of dengue control	LANCET			English	Editorial Material									[Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; Univ Sao Paulo, Fac Med, Hosp Clin, Lab Invest Med 01, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.	edmassad@dim.fm.usp.br	Coutinho, Francisco A B/H-5644-2011; Massad, Eduardo/B-1169-2012; Massad, Eduardo/H-6143-2011	Coutinho, Francisco A B/0000-0003-3127-3071; Massad, Eduardo/0000-0002-7200-2916; 				Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011; Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041; Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8; MACDONALD G, 1952, Trop Dis Bull, V49, P813; Reiter P., 2001, DENGUE DENGUE HEMORR, P425; Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; Taliberti H, 2010, REV PANAM SALUD PUBL, V27, P175, DOI 10.1590/S1020-49892010000300004; WHO, DENG DENG HAEM FEV F; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	12	28	29	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2011	377	9778					1630	1631		10.1016/S0140-6736(11)60470-4	http://dx.doi.org/10.1016/S0140-6736(11)60470-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	766JF	21546075				2022-12-28	WOS:000290777700006
J	Hah, N; Danko, CG; Core, L; Waterfall, JJ; Siepel, A; Lis, JT; Kraus, WL				Hah, Nasun; Danko, Charles G.; Core, Leighton; Waterfall, Joshua J.; Siepel, Adam; Lis, John T.; Kraus, W. Lee			A Rapid, Extensive, and Transient Transcriptional Response to Estrogen Signaling in Breast Cancer Cells	CELL			English	Article							DIVERGENT TRANSCRIPTION; ACTIVE PROMOTERS; GENE-EXPRESSION; RECEPTOR; RNA; ELEMENTS; ACTIVATION; DISEASE; ALPHA	We report the immediate effects of estrogen signaling on the transcriptome of breast cancer cells using global run-on and sequencing (GRO-seq). The data were analyzed using a new bioinformatic approach that allowed us to identify transcripts directly from the GRO-seq data. We found that estrogen signaling directly regulates a strikingly large fraction of the transcriptome in a rapid, robust, and unexpectedly transient manner. In addition to protein-coding genes, estrogen regulates the distribution and activity of all three RNA polymerases and virtually every class of noncoding RNA that has been described to date. We also identified a large number of previously undetected estrogen-regulated intergenic transcripts, many of which are found proximal to estrogen receptor binding sites. Collectively, our results provide the most comprehensive measurement of the primary and immediate estrogen effects to date and a resource for understanding rapid signal-dependent transcription in other systems.	[Hah, Nasun; Danko, Charles G.; Core, Leighton; Waterfall, Joshua J.; Lis, John T.; Kraus, W. Lee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Hah, Nasun; Lis, John T.; Kraus, W. Lee] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Danko, Charles G.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Basic Res Div, Dept Obstet & Gynecol, Dallas, TX 75390 USA	Cornell University; Cornell University; Cornell University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kraus, WL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	lee.kraus@utsouthwestern.edu		Danko, Charles/0000-0002-1999-7125; Hah, Nasun/0000-0003-1509-2799; Siepel, Adam/0000-0002-3557-7219; Waterfall, Joshua/0000-0002-3762-5050	NIH [T32HD052471, GM25232, HG04845]; PhRMA Foundation; NIH/NIDDK [DK058110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025232, R37GM025232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Andre Martins for helpful insights and suggestions and Xin Luo and Shrikanth Gadad for critical comments on this manuscript. This work was supported by an NIH training award (T32HD052471) and a postdoctoral fellowship from the PhRMA Foundation to C. G. D., grants from the NIH (GM25232 and HG04845) to J.T.L., and a grant from the NIH/NIDDK (DK058110) to W.L.K.	Acevedo ML, 2004, ESSAYS BIOCHEM, V40, P73, DOI 10.1042/bse0400073; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cheung E, 2010, ANNU REV PHYSIOL, V72, P191, DOI 10.1146/annurev-physiol-021909-135840; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Danko CG, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-31; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kininis Miltiadis, 2008, Nucl Recept Signal, V6, pe005, DOI 10.1621/nrs.06005; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Mitchison, 1998, BIOLOGICAL SEQUENCE; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruhl DD, 2009, PROG MOL BIOL TRANSL, V87, P137, DOI 10.1016/S1877-1173(09)87005-1; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Theodorou V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2470; Warner M, 1999, CURR OPIN OBSTET GYN, V11, P249, DOI 10.1097/00001703-199906000-00003; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568; WIDELITZ RB, 1987, EXP CELL RES, V168, P539, DOI 10.1016/0014-4827(87)90026-7	36	351	355	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					622	634		10.1016/j.cell.2011.03.042	http://dx.doi.org/10.1016/j.cell.2011.03.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21549415	Green Accepted, Bronze			2022-12-28	WOS:000290560800014
J	Phillips, RJ; Davis, BJ; Tanaka, KL; Byrne, S; Mellon, MT; Putzig, NE; Haberle, RM; Kahre, MA; Campbell, BA; Carter, LM; Smith, IB; Holt, JW; Smrekar, SE; Nunes, DC; Plaut, JJ; Egan, AF; Titus, TN; Seu, R				Phillips, Roger J.; Davis, Brian J.; Tanaka, Kenneth L.; Byrne, Shane; Mellon, Michael T.; Putzig, Nathaniel E.; Haberle, Robert M.; Kahre, Melinda A.; Campbell, Bruce A.; Carter, Lynn M.; Smith, Isaac B.; Holt, John W.; Smrekar, Suzanne E.; Nunes, Daniel C.; Plaut, Jeffrey J.; Egan, Anthony F.; Titus, Timothy N.; Seu, Roberto			Massive CO2 Ice Deposits Sequestered in the South Polar Layered Deposits of Mars	SCIENCE			English	Article							SOLID CO2; CIRCULATION; MODEL	Shallow Radar soundings from the Mars Reconnaissance Orbiter reveal a buried deposit of carbon dioxide (CO2) ice within the south polar layered deposits of Mars with a volume of 9500 to 12,500 cubic kilometers, about 30 times that previously estimated for the south pole residual cap. The deposit occurs within a stratigraphic unit that is uniquely marked by collapse features and other evidence of interior CO2 volatile release. If released into the atmosphere at times of high obliquity, the CO2 reservoir would increase the atmospheric mass by up to 80%, leading to more frequent and intense dust storms and to more regions where liquid water could persist without boiling.	[Phillips, Roger J.] SW Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA; [Phillips, Roger J.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Davis, Brian J.; Putzig, Nathaniel E.] SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; [Tanaka, Kenneth L.; Titus, Timothy N.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Byrne, Shane] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Mellon, Michael T.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Haberle, Robert M.] NASA, Ames Res Ctr, Space Sci & Astrobiol Div, Moffett Field, CA 94035 USA; [Kahre, Melinda A.] NASA, Ames Res Ctr, Bay Area Environm Res Inst, Moffett Field, CA 94035 USA; [Campbell, Bruce A.] Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20013 USA; [Carter, Lynn M.] NASA, Goddard Space Flight Ctr, Sci & Explorat Directorate, Greenbelt, MD 20771 USA; [Smith, Isaac B.; Holt, John W.] Univ Texas Austin, Jackson Sch Geosci, Inst Geophys, Austin, TX 78758 USA; [Smrekar, Suzanne E.; Nunes, Daniel C.; Plaut, Jeffrey J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Egan, Anthony F.] SW Res Inst, Dept Space Operat, Boulder, CO 80302 USA; [Seu, Roberto] Univ Roma La Sapienza, Dept Informat Engn Elect & Telecommun, I-00184 Rome, Italy	Washington University (WUSTL); United States Department of the Interior; United States Geological Survey; University of Arizona; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Smithsonian Institution; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Texas System; University of Texas Austin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Sapienza University Rome	Phillips, RJ (corresponding author), SW Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA.	roger@boulder.swri.edu	Smrekar, Suzanne/AAH-8074-2020; Byrne, Shane/B-8104-2012; Nunes, Daniel C/G-1279-2018; Holt, John/C-4896-2009; Mellon, Michael/C-3456-2016; Carter, Lynn/D-2937-2012	Smrekar, Suzanne/0000-0001-8775-075X; Carter, Lynn/0000-0002-6245-4142; Putzig, Nathaniel/0000-0003-4485-6321; Smith, Isaac/0000-0002-4331-913X; Nunes, Daniel/0000-0002-0937-7176	NASA	NASA(National Aeronautics & Space Administration (NASA))	K. Herkenhoff and C. Fortezzo provided useful comments on an earlier version of the paper. Remarks by three anonymous referees were exceedingly helpful. Funding for this work was provided by the NASA MRO project. The radar and imaging data are available through NASA's Planetary Data System.	Byrne S, 2003, SCIENCE, V299, P1051, DOI 10.1126/science.1080148; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Haberle RM, 2001, J GEOPHYS RES-PLANET, V106, P23317, DOI 10.1029/2000JE001360; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; Kolb E. J., 2006, 37 LUN PLAN SCI C LE; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Newman CE, 2005, ICARUS, V174, P135, DOI 10.1016/j.icarus.2004.10.023; Nunes DC, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002609; Pettinelli E, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001869; Phillips RJ, 2008, SCIENCE, V320, P1182, DOI 10.1126/science.1157546; Putzig NE, 2009, ICARUS, V204, P443, DOI 10.1016/j.icarus.2009.07.034; Seu R, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002745; Seu R, 2007, SCIENCE, V317, P1715, DOI 10.1126/science.1144120; SIMPSON RA, 1980, J GEOPHYS RES, V85, P5481, DOI 10.1029/JB085iB10p05481; Tanaka K. L., 2007, 7 INT C MARS PAS CA; Thomas PC, 2009, ICARUS, V203, P352, DOI 10.1016/j.icarus.2009.05.014; Weast R. C., 1974, CRC HDB CHEM PHYS	19	136	138	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2011	332	6031					838	841		10.1126/science.1203091	http://dx.doi.org/10.1126/science.1203091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21512003	Green Published			2022-12-28	WOS:000290529900045
J	Hopkins, TG; Maher, ER; Reid, E; Marciniak, SJ				Hopkins, Tom G.; Maher, Eamonn R.; Reid, Evan; Marciniak, Stefan J.			Recurrent pneumothorax	LANCET			English	Editorial Material							HOGG-DUBE-SYNDROME; FAMILIES		[Hopkins, Tom G.; Marciniak, Stefan J.] Addenbrookes Hosp NHS Fdn Trust, Dept Med, Div Resp Med, Cambridge CB2 0QQ, England; [Maher, Eamonn R.] Univ Birmingham, Dept Med & Mol Genet, Birmingham, W Midlands, England; [Reid, Evan; Marciniak, Stefan J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Reid, Evan] Univ Cambridge, Dept Med Genet, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Birmingham; University of Cambridge; University of Cambridge	Marciniak, SJ (corresponding author), Addenbrookes Hosp NHS Fdn Trust, Dept Med, Div Resp Med, Hills Rd, Cambridge CB2 0QQ, England.	sjm20@cam.ac.uk	Marciniak, Stefan J/F-1855-2010; Reid, Evan/F-3250-2010	Reid, Evan/0000-0003-1623-7304; Marciniak, Stefan/0000-0001-8472-7183	MRC [G0601840] Funding Source: UKRI; Medical Research Council [G0601840] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Pavlovich CP, 2002, AM J SURG PATHOL, V26, P1542, DOI 10.1097/00000478-200212000-00002; Sadikot RT, 1997, THORAX, V52, P805, DOI 10.1136/thx.52.9.805; Toro JR, 2008, J MED GENET, V45, P321, DOI 10.1136/jmg.2007.054304; Toro JR, 2007, AM J RESP CRIT CARE, V175, P1044, DOI 10.1164/rccm.200610-1483OC	5	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 7	2011	377	9777					1624	1624		10.1016/S0140-6736(11)60072-X	http://dx.doi.org/10.1016/S0140-6736(11)60072-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763IJ	21550484				2022-12-28	WOS:000290549700036
J	Mayer, C; Khoramnia, R				Mayer, Christian; Khoramnia, Ramin			Nearly an eye-catcher	LANCET			English	Editorial Material									[Mayer, Christian] Tech Univ Munich, Klinikum Rechts Isar, Eye Clin, D-81675 Munich, Germany; [Khoramnia, Ramin] Univ Heidelberg, Dept Ophthalmol, Heidelberg, Germany	Technical University of Munich; Ruprecht Karls University Heidelberg	Mayer, C (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Eye Clin, Ismaninger Str 22, D-81675 Munich, Germany.	christian.mayer@lrz.tu-muenchen.de	Khoramnia, Ramin/AAR-8358-2020	Khoramnia, Ramin/0000-0002-6237-7773					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 7	2011	377	9777					1599	1599		10.1016/S0140-6736(10)61118-X	http://dx.doi.org/10.1016/S0140-6736(10)61118-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	763IJ	21513973				2022-12-28	WOS:000290549700033
J	Kelly, WL				Kelly, Wendy L.			BIOCHEMISTRY Life imitates art	NATURE			English	Editorial Material							BIOSYNTHETIC GENE-CLUSTER; MACROPHOMATE SYNTHASE; SACCHAROPOLYSPORA-SPINOSA; POLYKETIDE SYNTHASE; REACTION-MECHANISM; DIELS-ALDERASE		Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Kelly, WL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	wendy.kelly@chemistry.gatech.edu						Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; Guimaraes CRW, 2005, J AM CHEM SOC, V127, P3577, DOI 10.1021/ja043905b; HUISGEN R, 1968, ANGEW CHEM INT EDIT, V7, P321, DOI 10.1002/anie.196803211; Kasahara K, 2010, CHEMBIOCHEM, V11, P1245, DOI 10.1002/cbic.201000173; Kim HJ, 2007, J AM CHEM SOC, V129, P14582, DOI 10.1021/ja076580i; Kim HJ, 2011, NATURE, V473, P109, DOI 10.1038/nature09981; Kim RR, 2010, J AM CHEM SOC, V132, P2983, DOI 10.1021/ja908395r; Kirst HA, 2010, J ANTIBIOT, V63, P101, DOI 10.1038/ja.2010.5; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Mergott DJ, 2004, P NATL ACAD SCI USA, V101, P11955, DOI 10.1073/pnas.0401247101; Serafimov JM, 2008, J AM CHEM SOC, V130, P7798, DOI 10.1021/ja8017994; Waldron C, 2001, CHEM BIOL, V8, P487, DOI 10.1016/S1074-5521(01)00029-1; Watanabe K, 2000, J BIOL CHEM, V275, P38393, DOI 10.1074/jbc.M003119200	13	11	11	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					35	36		10.1038/473035a	http://dx.doi.org/10.1038/473035a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544137				2022-12-28	WOS:000290218300023
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: bipolar II disorder	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	8	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2011	342								d2767	10.1136/bmj.d2767	http://dx.doi.org/10.1136/bmj.d2767			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MB	21543400				2022-12-28	WOS:000290481700009
J	Allemann, O; Duttwyler, S; Romanato, P; Baldridge, KK; Siegel, JS				Allemann, Oliver; Duttwyler, Simon; Romanato, Paola; Baldridge, Kim K.; Siegel, Jay S.			Proton-Catalyzed, Silane-Fueled Friedel-Crafts Coupling of Fluoroarenes	SCIENCE			English	Article							WEAKLY COORDINATING ANIONS; ARYL BOND FORMATION; PHENYL CATION; ACTIVATION; REACTIVITY; HYDRODEFLUORINATION; ELECTROPHILES; CARBORANES; CHEMISTRY; ARYLATION	The venerable Friedel-Crafts reaction appends alkyl or acyl groups to aromatic rings through alkyl or acyl cation equivalents typically generated by Lewis acids. We show that phenyl cation equivalents, generated from otherwise unreactive aryl fluorides, allow extension of the Friedel-Crafts reaction to intramolecular aryl couplings. The enabling feature of this reaction is the exchange of carbon-fluorine for silicon-fluorine bond enthalpies; the reaction is activated by an intermediate silyl cation. Catalytic quantities of protons or silyl cations paired with weakly coordinating carborane counterions initiate the reactions, after which proton transfer in the final aromatization step regenerates the active silyl cation species by protodesilylation of a quaternary silane. The methodology allows the high-yield formation of a range of tailored polycyclic aromatic hydrocarbons and graphene fragments.	[Allemann, Oliver; Duttwyler, Simon; Romanato, Paola; Baldridge, Kim K.; Siegel, Jay S.] Univ Zurich, Inst Organ Chem, CH-8057 Zurich, Switzerland	University of Zurich	Siegel, JS (corresponding author), Univ Zurich, Inst Organ Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jss@oci.unizh.ch	Siegel, Jay/E-6415-2011; Baldridge, Kim K/E-6422-2011	Siegel, Jay/0000-0002-3226-3521; Baldridge, Kim K/0000-0001-7171-3487	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank the Swiss National Science Foundation for financial support.	Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; Amii H, 2009, CHEM REV, V109, P2119, DOI 10.1021/cr800388c; Amsharov KY, 2009, EUR J ORG CHEM, V2009, P6328, DOI 10.1002/ejoc.200900976; Blanksby SJ, 2003, ACCOUNTS CHEM RES, V36, P255, DOI 10.1021/ar020230d; Bohm VPW, 2001, ANGEW CHEM INT EDIT, V40, P3387; Douglas TM, 2007, ORGANOMETALLICS, V26, P463, DOI 10.1021/om060975d; Douvris C, 2008, SCIENCE, V321, P1188, DOI 10.1126/science.1159979; Douvris C, 2010, J AM CHEM SOC, V132, P4946, DOI 10.1021/ja100605m; Duttwyler S, 2010, ANGEW CHEM INT EDIT, V49, P7519, DOI 10.1002/anie.201003762; EABORN C, 1953, J CHEM SOC, P3148, DOI 10.1039/jr9530003148; EABORN C, 1975, J ORGANOMET CHEM, V100, P43, DOI 10.1016/S0022-328X(00)88933-0; EABORN C, 1956, J CHEM SOC, P4858, DOI 10.1039/jr9560004858; Franck H.-G., 1988, IND AROMATIC CHEM; Hassan J, 2002, CHEM REV, V102, P1359, DOI 10.1021/cr000664r; HECK RF, 1968, J AM CHEM SOC, V90, P5518, DOI 10.1021/ja01022a034; Juhasz M, 2004, ANGEW CHEM INT EDIT, V43, P5352, DOI 10.1002/anie.200460005; Korbe S, 2006, CHEM REV, V106, P5208, DOI 10.1021/cr050548u; LAMBERT JB, 1988, J AM CHEM SOC, V110, P2201, DOI 10.1021/ja00215a033; LAMBERT JB, 1994, ORGANOMETALLICS, V13, P2430, DOI 10.1021/om00018a041; Luhmann N, 2010, APPL ORGANOMET CHEM, V24, P533, DOI 10.1002/aoc.1658; Luo Y-R., 2007, COMPREHENSIVE HDB CH, DOI [10.1201/9781420007282, DOI 10.1201/9781420007282]; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Nicolaides A, 1997, J AM CHEM SOC, V119, P8083, DOI 10.1021/ja970808s; OLAH GA, 1973, FRIEDELCRAFTS CHEM; Rappoport Z., 1997, DICOORDINATED CARBOC; Reed CA, 2005, CHEM COMMUN, P1669, DOI 10.1039/b415425h; Reed CA, 1998, ACCOUNTS CHEM RES, V31, P133, DOI 10.1021/ar970230r; REED CA, 1993, SCIENCE, V262, P402, DOI 10.1126/science.262.5132.402; Roberts R. M., 1984, FRIEDELCRAFTS ALKYLA; Scholl R, 1910, BER DTSCH CHEM GES, V43, P2202, DOI 10.1002/cber.191004302175; Scholl R, 1912, LIEBIGS ANN CHEM, V394, P111; SELIVANOV BA, 1980, ZH ORG KHIM+, V16, P1910	32	232	231	3	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					574	577		10.1126/science.1202432	http://dx.doi.org/10.1126/science.1202432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527709				2022-12-28	WOS:000289991100044
J	Hess, KL; Corda, CJ; Lanese, KM				Hess, Kenneth L.; Corda, Courtney J.; Lanese, Kristina M.			Science Buddies: Advancing Informal Science Education	SCIENCE			English	Editorial Material									[Hess, Kenneth L.; Corda, Courtney J.; Lanese, Kristina M.] Sci Buddies, Carmel, CA 93921 USA		Hess, KL (corresponding author), Sci Buddies, POB 5038, Carmel, CA 93921 USA.	khess@sciencebuddies.org						BOWLIN M, 2011, ARE WE THERE YET TES; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; National Academy of Engineering, ADV PERS LEARN; Thorup K, 2007, P NATL ACAD SCI USA, V104, P18115, DOI 10.1073/pnas.0704734104; YOUNG ER, 2011, WATER FUEL WATER FUE	5	1	1	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					550	551		10.1126/science.1196978	http://dx.doi.org/10.1126/science.1196978			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756DE	21527706				2022-12-28	WOS:000289991100036
J	Van Allen, EM				Van Allen, Eliezer M.			Paracentesis by Moonlight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												evanallen@partners.org		Van Allen, Eliezer/0000-0002-0201-4444					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1635	1636		10.1001/jama.2011.472	http://dx.doi.org/10.1001/jama.2011.472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521838				2022-12-28	WOS:000289890500001
J	Cram, P; Lu, X; Kaboli, PJ; Vaughan-Sarrazin, MS; Cai, XY; Wolf, BR; Li, Y				Cram, Peter; Lu, Xin; Kaboli, Peter J.; Vaughan-Sarrazin, Mary S.; Cai, Xueya; Wolf, Brian R.; Li, Yue			Clinical Characteristics and Outcomes of Medicare Patients Undergoing Total Hip Arthroplasty, 1991-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURGEON PROCEDURE VOLUME; TOTAL KNEE REPLACEMENT; LENGTH-OF-STAY; UNITED-STATES; RHEUMATOID-ARTHRITIS; ADMINISTRATIVE DATA; HEART-FAILURE; TRENDS; RATES; MORTALITY	Context Total hip arthroplasty is a common surgical procedure but little is known about longitudinal trends. Objective To examine demographics and outcomes of patients undergoing primary and revision total hip arthroplasty. Design, Setting, and Participants Observational cohort of 1 453 493 Medicare Part A beneficiaries who underwent primary total hip arthroplasty and 348 596 who underwent revision total hip arthroplasty. Participants were identified using International Classification of Diseases, Ninth Revision, Clinical Modification codes for primary and revision total hip arthroplasty between 1991 and 2008. Main Outcome Measures Changes in patient demographics and comorbidity, hospital length of stay (LOS), mortality, discharge disposition, and all-cause readmission rates. Results Between 1991 and 2008, the mean age for patients undergoing primary total hip arthroplasty increased from 74.1 to 75.1 years and for revision total hip arthroplasty from 75.8 to 77.3 years (P<.001). The mean number of comorbid illnesses per patient increased from 1.0 to 2.0 for primary total hip arthroplasty and 1.1 to 2.3 for revision (P<.001). For primary total hip arthroplasty, mean hospital LOS decreased from 9.1 days in 1991-1992 to 3.7 days in 2007-2008 (P=.002); unadjusted in-hospital and 30-day mortality decreased from 0.5% to 0.2% and from 0.7% to 0.4%, respectively (P<.001). The proportion of primary total hip arthroplasty patients discharged home declined from 68.0% to 48.2%; the proportion discharged to skilled care increased from 17.8% to 34.3%; and 30-day all-cause readmission increased from 5.9% to 8.5% (P<.001). For revision total hip arthroplasty, similar trends were observed in hospital LOS, in-hospital mortality, discharge disposition, and hospital readmission rates. Conclusion Among Medicare beneficiaries who underwent primary and revision hip arthroplasty between 1991 and 2008, there was a decrease in hospital LOS but an increase in the rates of discharge to postacute care and readmission. JAMA. 2011; 305(15): 1560-1567	[Cram, Peter; Lu, Xin; Kaboli, Peter J.; Vaughan-Sarrazin, Mary S.; Cai, Xueya; Li, Yue] Univ Iowa, Carver Coll Med, Dept Internal Med, Div Gen Internal Med, Iowa City, IA 52242 USA; [Wolf, Brian R.] Univ Iowa, Carver Coll Med, Dept Orthopaed Surg, Iowa City, IA 52242 USA; [Cram, Peter; Kaboli, Peter J.; Vaughan-Sarrazin, Mary S.] Iowa City Vet Adm Med Ctr, CADRE, Iowa City, IA USA; [Kaboli, Peter J.] Iowa City Vet Adm Med Ctr, VISN Midwest Rural Hlth Resource Ctr 23, Iowa City, IA USA	University of Iowa; University of Iowa	Cram, P (corresponding author), Univ Iowa, Carver Coll Med, Iowa City VA Med Ctr, Div Gen Med, Mail Stop 152, Iowa City, IA 52242 USA.	peter-cram@uiowa.edu	Cram, Peter/K-4472-2014	Cram, Peter/0000-0002-1910-346X; Vaughan Sarrazin, Mary/0000-0001-8717-1061; Kaboli, Peter/0000-0003-0993-0952; Wolf, Brian/0000-0002-2529-8056	National Center for Research Resources at the National Institutes of Health (NIH) [RR01997201]; Robert Wood Johnson Physician Faculty Scholars Program; National Heart, Lung, and Blood Institute at NIH [R01 HL085347-01A1, R01 AG033202]; Consumers Union; Vanguard Health Inc; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR019972] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033202, R01AG033035] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Robert Wood Johnson Physician Faculty Scholars Program(Robert Wood Johnson Foundation (RWJF)); National Heart, Lung, and Blood Institute at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Consumers Union; Vanguard Health Inc; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Cram was supported by a K23 career development award (RR01997201) from the National Center for Research Resources at the National Institutes of Health (NIH), and the Robert Wood Johnson Physician Faculty Scholars Program. The National Heart, Lung, and Blood Institute at NIH also provided support to Dr Cram (R01 HL085347-01A1) and Dr Li (R01 AG033202).; The authors report no conflicts of interest. Dr Cram reports having received consulting fees from The Consumers Union (publisher of Consumer Reports magazine) and Vanguard Health Inc for advice provided on quality improvement initiatives.	Baker DW, 2004, ARCH INTERN MED, V164, P538, DOI 10.1001/archinte.164.5.538; Birkmeyer JD, 2003, JAMA-J AM MED ASSOC, V290, P2703, DOI 10.1001/jama.290.20.2703; Birkmeyer NJO, 2000, ANN THORAC SURG, V70, P432, DOI 10.1016/S0003-4975(00)01456-9; Birrell F, 1999, ANN RHEUM DIS, V58, P569, DOI 10.1136/ard.58.9.569; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Buntin MB, 2009, HEALTH SERV RES, V44, P1188, DOI 10.1111/j.1475-6773.2009.00968.x; Chang RW, 1996, JAMA-J AM MED ASSOC, V275, P858, DOI 10.1001/jama.275.11.858; Chulis G S, 1991, Med Care Rev, V48, P167, DOI 10.1177/002570879104800203; Cram P, 2007, J BONE JOINT SURG AM, V89A, P1675, DOI 10.2106/JBJS.F.00873; DAVIS CK, 1988, HEALTH POLICY, V9, P117, DOI 10.1016/0168-8510(88)90029-2; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Escalante A, 2002, MED CARE, V40, P451, DOI 10.1097/00005650-200206000-00002; Hagen TP, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c165; Hausmann LRM, 2010, J GEN INTERN MED, V25, P982, DOI 10.1007/s11606-010-1399-5; Himanen AK, 2005, ACTA ORTHOP, V76, P85, DOI 10.1080/00016470510030373; Ho V, 2007, HEALTH ECON POLICY L, V2, P51, DOI 10.1017/S1744133106006256; Huo MH, 2008, J BONE JOINT SURG AM, V90A, P2043, DOI 10.2106/JBJS.H.00741; Jain NB, 2005, ARTHRITIS RHEUM-US, V52, P3928, DOI 10.1002/art.21420; Katz JN, 2004, J BONE JOINT SURG AM, V86A, P1909, DOI 10.2106/00004623-200409000-00008; Katz JN, 2001, J BONE JOINT SURG AM, V83A, P1622, DOI 10.2106/00004623-200111000-00002; Katz JN, 2003, ARTHRITIS RHEUM, V48, P560, DOI 10.1002/art.10754; Khatod M, 2008, ACTA ORTHOP, V79, P812, DOI 10.1080/17453670810016902; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441; Lie SA, 2000, ACTA ORTHOP SCAND, V71, P19, DOI 10.1080/00016470052943838; Liu K, 2001, HEALTH CARE FINANC R, V23, P1; Lohmander LS, 2006, ACTA ORTHOP, V77, P733, DOI 10.1080/17453670610012917; Losina E, 2004, ARTHRITIS RHEUM-US, V50, P1338, DOI 10.1002/art.20148; Mehrotra C, 2005, PUBLIC HEALTH REP, V120, P278, DOI 10.1177/003335490512000310; Merx H, 2003, ANN RHEUM DIS, V62, P222, DOI 10.1136/ard.62.3.222; MITCHELL JB, 1994, MED CARE, V32, pJS38; National Center for Health Statistics, HLTH US 2009 SPEC FE; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ricciardi R, 2008, ARCH SURG-CHICAGO, V143, P338, DOI 10.1001/archsurg.143.4.338; Robertsson O, 2000, ACTA ORTHOP SCAND, V71, P376, DOI 10.1080/000164700317393376; Ross JS, 2010, CIRC-HEART FAIL, V3, P97, DOI 10.1161/CIRCHEARTFAILURE.109.885210; Ryan J, 2009, CIRCULATION, V119, P952, DOI 10.1161/CIRCULATIONAHA.108.781138; Schrama JC, 2010, ARTHRIT CARE RES, V62, P473, DOI 10.1002/acr.20036; Shahian DM, 2005, ANN THORAC SURG, V80, P2106, DOI 10.1016/j.athoracsur.2005.06.078; Silverman E, 2004, J HEALTH ECON, V23, P369, DOI 10.1016/j.jhealeco.2003.09.007; Skinner J, 2003, NEW ENGL J MED, V349, P1350, DOI 10.1056/NEJMsa021569; SLOAN FA, 1988, MILBANK Q, V66, P191, DOI 10.2307/3350030; Venkitachalam L, 2009, CIRC-CARDIOVASC INTE, V2, P6, DOI 10.1161/CIRCINTERVENTIONS.108.825323; ZWANZIGER J, 1988, J HEALTH ECON, V7, P301, DOI 10.1016/0167-6296(88)90018-5	44	223	232	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1560	1567		10.1001/jama.2011.478	http://dx.doi.org/10.1001/jama.2011.478			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21505134	Green Accepted			2022-12-28	WOS:000289683000025
J	Moore, W				Moore, Wendy			PAST CARING What war is good for	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 20	2011	342								d2416	10.1136/bmj.d2416	http://dx.doi.org/10.1136/bmj.d2416			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755ON	21508047				2022-12-28	WOS:000289942900009
J	Oleksiuk, O; Jakovljevic, V; Vladimirov, N; Carvalho, R; Paster, E; Ryu, WS; Meir, Y; Wingreen, NS; Kollmann, M; Sourjik, V				Oleksiuk, Olga; Jakovljevic, Vladimir; Vladimirov, Nikita; Carvalho, Ricardo; Paster, Eli; Ryu, William S.; Meir, Yigal; Wingreen, Ned S.; Kollmann, Markus; Sourjik, Victor			Thermal Robustness of Signaling in Bacterial Chemotaxis	CELL			English	Article							ESCHERICHIA-COLI; COVALENT MODIFICATION; RECEPTOR COMPLEXES; TEMPERATURE; MECHANISM; BINDING; PRECISION; MOTOR; MODEL; TAR	Temperature is a global factor that affects the performance of all intracellular networks. Robustness against temperature variations is thus expected to be an essential network property, particularly in organisms without inherent temperature control. Here, we combine experimental analyses with computational modeling to investigate thermal robustness of signaling in chemotaxis of Escherichia coli, a relatively simple and well-established model for systems biology. We show that steady-state and kinetic pathway parameters that are essential for chemotactic performance are indeed temperature-compensated in the entire physiological range. Thermal robustness of steady-state pathway output is ensured at several levels by mutual compensation of temperature effects on activities of individual pathway components. Moreover, the effect of temperature on adaptation kinetics is counterbalanced by preprogrammed temperature dependence of enzyme synthesis and stability to achieve nearly optimal performance at the growth temperature. Similar compensatory mechanisms are expected to ensure thermal robustness in other systems.	[Oleksiuk, Olga; Jakovljevic, Vladimir; Vladimirov, Nikita; Carvalho, Ricardo; Sourjik, Victor] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany; [Paster, Eli; Ryu, William S.; Wingreen, Ned S.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Wingreen, Ned S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Meir, Yigal] Ben Gurion Univ Negev, Dept Phys, IL-84105 Beer Sheva, Israel; [Kollmann, Markus] Univ Dusseldorf, Dept Biol, D-40225 Dusseldorf, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Princeton University; Princeton University; Ben Gurion University; Heinrich Heine University Dusseldorf	Sourjik, V (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	v.sourjik@zmbh.uni-heidelberg.de	MEIR, YIGAL/F-1888-2012	Carvalho, Ricardo/0000-0002-5994-0094; Oleksiuk, Olga/0000-0002-6100-107X; Jakovljevic, Vladimir/0000-0002-6082-4867; Meir, Yigal/0000-0003-1606-8969	National Institutes of Health [GM082938]; Deutsche Forschungsgemeinschaft [SO 421/3-3, KO3442/3-1]; C.H.S.-Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); C.H.S.-Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Schwarz und A. Muller for help with cloning, L. Turner for sharing data, and R. Endres and M. Mayer for valuable discussions. This work was supported by grant GM082938 from the National Institutes of Health and in parts by grants SO 421/3-3 and KO3442/3-1 from the Deutsche Forschungsgemeinschaft and by the C.H.S.-Foundation.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; Andrews BW, 2006, PLOS COMPUT BIOL, V2, P1407, DOI 10.1371/journal.pcbi.0020154; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Endres RG, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.49; HASTINGS JW, 1957, P NATL ACAD SCI USA, V43, P804, DOI 10.1073/pnas.43.9.804; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; HUANG ZJ, 1995, SCIENCE, V267, P1169, DOI 10.1126/science.7855598; Jiang LL, 2009, BIOPHYS J, V97, P74, DOI 10.1016/j.bpj.2009.04.029; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P1786, DOI 10.1073/pnas.0507438103; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Li GY, 2000, CELL, V100, P357, DOI 10.1016/S0092-8674(00)80671-6; Lovdok L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000171; LOWE G, 1987, NATURE, V325, P637, DOI 10.1038/325637a0; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; MAEDA K, 1976, J BACTERIOL, V127, P1039, DOI 10.1128/JB.127.3.1039-1046.1976; Mehra A, 2009, CELL, V137, P749, DOI 10.1016/j.cell.2009.03.019; Meir Y, 2010, BIOPHYS J, V99, P2766, DOI 10.1016/j.bpj.2010.08.051; Mello BA, 2005, P NATL ACAD SCI USA, V102, P17354, DOI 10.1073/pnas.0506961102; MIZUNO T, 1984, J BACTERIOL, V159, P360, DOI 10.1128/JB.159.1.360-367.1984; Morton-Firth CJ, 1999, J MOL BIOL, V286, P1059, DOI 10.1006/jmbi.1999.2535; Nara T, 1996, J BIOL CHEM, V271, P17932, DOI 10.1074/jbc.271.30.17932; Neumann S, 2010, EMBO J, V29, P3484, DOI 10.1038/emboj.2010.224; Nishiyama SI, 1997, J BACTERIOL, V179, P6573, DOI 10.1128/jb.179.21.6573-6580.1997; Paster E, 2008, P NATL ACAD SCI USA, V105, P5373, DOI 10.1073/pnas.0709903105; Rajan K, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.022902; Salman H, 2007, NAT CELL BIOL, V9, P1098, DOI 10.1038/ncb1632; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; Sourjik V, 2010, EMBO J, V29, P2724, DOI 10.1038/emboj.2010.178; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Turner L, 1999, BIOPHYS J, V77, P597, DOI 10.1016/S0006-3495(99)76916-X; Virshup DM, 2009, CELL, V137, P602, DOI 10.1016/j.cell.2009.04.051; Vladimirov N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000717; Vladimirov N, 2009, BIOL CHEM, V390, P1097, DOI 10.1515/BC.2009.130; Vladimirov N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000242	46	57	62	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					312	321		10.1016/j.cell.2011.03.013	http://dx.doi.org/10.1016/j.cell.2011.03.013			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496648	Bronze, Green Accepted			2022-12-28	WOS:000289549900018
J	Short, J; Murray, S				Short, Jeffrey; Murray, Susan			A frozen hell	NATURE			English	Editorial Material									[Short, Jeffrey] JWS Consulting Out Juneau, Juneau, AK USA; [Murray, Susan] Advocacy Grp Oceana, Juneau, AK 99801 USA		Short, J (corresponding author), JWS Consulting Out Juneau, Juneau, AK USA.	jwsosc@gmail.com; smurray@oceana.org	Short, Jeffrey/AAZ-9241-2021						0	7	7	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					162	163		10.1038/472162a	http://dx.doi.org/10.1038/472162a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21490650				2022-12-28	WOS:000289469100017
J	Bartelds, GM; Krieckaert, CLM; Nurmohamed, MT; van Schouwenburg, PA; Lems, WF; Twisk, JWR; Dijkmans, AC; Aarden, L; Wolbink, GJ				Bartelds, Geertje M.; Krieckaert, Charlotte L. M.; Nurmohamed, Michael T.; van Schouwenburg, Pauline A.; Lems, Willem F.; Twisk, Jos W. R.; Dijkmans, A. C.; Aarden, Lucien; Wolbink, Gerrit Jan			Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RHEUMATOID-ARTHRITIS PATIENTS; CLINICAL-RESPONSE; CROHNS-DISEASE; IMMUNOGENICITY; INFLIXIMAB; THERAPY; COHORT	Context Short-term data on the immunogenicity of monoclonal antibodies showed associations between the development of antidrug antibodies and diminished serum drug levels, and a diminished treatment response. Little is known about the clinical relevance of antidrug antibodies against these drugs during long-term follow-up. Objective To examine the course of antidrug antibody formation against fully human monoclonal antibody adalimumab and its clinical relevance during long-term (3-year) follow-up of patients with rheumatoid arthritis (RA). Design, Setting, and Patients Prospective cohort study February 2004-September 2008; end of follow-up was September 2010. All 272 patients were diagnosed with RA and started treatment with adalimumab in an outpatient clinic. Main Outcome Measures Disease activity was monitored and trough serum samples were obtained at baseline and 8 time points to 156 weeks. Serum adalimumab concentrations and antiadalimumab antibody titers were determined after follow-up. Treatment discontinuation, minimal disease activity, and clinical remission were compared for patients with and without antiadalimumab antibodies. Results After 3 years, 76 of 272 patients (28%) developed antiadalimumab antibodies-51 of these (67%) during the first 28 weeks of treatment. Patients without antiadalimumab antibodies had much higher adalimumab concentrations (median, 12 mg/L; IQR, 9-16 mg/L) compared with patients with antibody titers from 13 to 100 AU/mL (median, 5 mg/L; IQR, 3-9 mg/L; regression coefficient, -4.5; 95% CI, -6.0 to -2.9; P < .001) and also those greater than 100 AU/mL (median, 0 mg/L; IQR, 0-3 mg/L; regression coefficient, -7.1; 95% CI, -8.4 to -5.8; P < .001). Patients with antiadalimumab antibodies more often discontinued participation due to treatment failure (n=29 [38%]; hazard ratio [HR], 3.0; 95% CI, 1.6-5.5; P < .001) compared with antiadalimumab antibody-negative ones (n=28 [14%]). Ninety-five of 196 patients (48%) without antiadalimumab antibodies had minimal disease activity vs 10 of 76 patients (13%) with antiadalimumab antibodies; patients with antiadalimumab antibodies less often had sustained minimal disease activity score in 28 joints (DAS28) (<3.2; HR, 3.6; 95% CI, 1.8-7.2; P < .001) compared with antiadalimumab antibody-negative ones. Three of 76 patients (4%) with antiadalimumab antibodies achieved sustained remission compared with 67 of 196 (34%) antiadalimumab antibody-negative ones; patients with antiadalimumab antibodies less often achieved remission (DAS28 <2.6; HR, -7.1; 95% CI, 2.1-23.4; P < .001) compared with antiadalimumab antibody-negative ones. Conclusion Among outpatients with RA in whom adalimumab was started over 3 years, the development of antidrug antibodies was associated with lower adalimumab concentration and lower likelihood of minimal disease activity or clinical remission. JAMA. 2011;305(14):1460-1468 www.jama.com	[Bartelds, Geertje M.; Krieckaert, Charlotte L. M.; Nurmohamed, Michael T.; Wolbink, Gerrit Jan] Jan van Breemen Res Inst, Amsterdam, Netherlands; [Nurmohamed, Michael T.; Lems, Willem F.; Twisk, Jos W. R.; Dijkmans, A. C.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [van Schouwenburg, Pauline A.; Aarden, Lucien; Wolbink, Gerrit Jan] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam	Wolbink, GJ (corresponding author), Reade Ctr Rehabil & Rheumatol, Div Rheumatol, Dr Jan van Breemenstr 2, NL-1056 AB Amsterdam, Netherlands.	g.wolbink@reade.nl		van Schouwenburg, Pauline/0000-0003-2779-1415; Nurmohamed, Michael/0000-0002-6274-1934; Wolbink, Gerrit Jan/0000-0003-1924-7460	Abbott; Roche; Pfizer; MSD; UCB; BMS; Wyeth; Schering-Plough; Wyeth Pharmaceuticals; Abbott Laboratories; Dutch Arthritis Foundation	Abbott(Abbott Laboratories); Roche(Roche Holding); Pfizer(Pfizer); MSD; UCB(UCB Pharma SA); BMS(Bristol-Myers Squibb); Wyeth(Wyeth); Schering-Plough(Merck & CompanySchering Plough Corporation); Wyeth Pharmaceuticals(Wyeth); Abbott Laboratories(Abbott Laboratories); Dutch Arthritis Foundation	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Nurmohamed reports having received consultancy fees from Abbott, Roche, Pfizer, MSD, UCB, BMS, and Wyeth; payment for lectures from Abbott, Roche, and Pfizer; and research grants from Abbott, Roche, and Pfizer. Dr Lems reports having received honoraria for lectures from Abbott, Roche, and Schering-Plough. Dr Dijkmans reports having received research grants from Schering-Plough, Abbott, and Wyeth. Dr Wolbink reports having received a research grant from Wyeth Pharmaceuticals and honoraria for lectures from Amgen and Pfizer. No other disclosures were reported.; Funding was provided by Abbott Laboratories and Wyeth Pharmaceuticals.; We are grateful to the Clinical Research Bureau of Reade, formerly the Jan van Breemen Institute, which receives support from the Dutch Arthritis Foundation, for help in the practical aspects of the cohort study. We thank the following research nurses for performing clinical assessments: Marga Kammeijer-Rippen, Anne-Marie Abrahams, Astrid Twisk, and Martine Kos, Department of Rheumatology, Jan van Breemen Research Institute; and for preparation and performing the assays, we thank Henk de Vrieze, MSc, and Kim van Houten, MSc, Sanquin Research; and Margret de Koning, MSc, Department of the Clinical Laboratory, Jan van Breemen Research Institute. None of the individuals listed in this acknowledgment received compensation for their work in association with this study.	Allez M, 2010, J CROHNS COLITIS, V4, P355, DOI 10.1016/j.crohns.2010.04.004; Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; Bartelds GM, 2010, ANN RHEUM DIS, V69, P817, DOI 10.1136/ard.2009.112847; Bartelds GM, 2009, ARTHRITIS RHEUM, V60, P2541, DOI 10.1002/art.24709; Bartelds GM, 2007, ANN RHEUM DIS, V66, P921, DOI 10.1136/ard.2006.065615; Bartelds GM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3208; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; Blom M, 2010, ARTHRIT CARE RES, V62, P1335, DOI 10.1002/acr.20211; Calabresi PA, 2007, NEUROLOGY, V69, P1391, DOI 10.1212/01.wnl.0000277457.17420.b5; Furst DE, 2007, ANN RHEUM DIS, V66, P2, DOI 10.1136/ard.2007.081430; Jamnitski A, 2011, ANN RHEUM DIS, V70, P284, DOI 10.1136/ard.2010.135111; Karmiris K, 2009, GASTROENTEROLOGY, V137, P1628, DOI 10.1053/j.gastro.2009.07.062; Krieckaert CLM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3147; Lecluse LLA, 2010, ARCH DERMATOL, V146, P127, DOI 10.1001/archdermatol.2009.347; Miyasaka N, 2008, MOD RHEUMATOL, V18, P252, DOI 10.1007/s10165-008-0045-0; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; van Kuijk AWR, 2010, ANN RHEUM DIS, V69, P624, DOI 10.1136/ard.2009.108787; van Schouwenburg PA, 2010, J IMMUNOL METHODS, V362, P82, DOI 10.1016/j.jim.2010.09.005; Vermeire S, 2007, GUT, V56, P1226, DOI 10.1136/gut.2006.099978; West RL, 2008, ALIMENT PHARM THER, V28, P1122, DOI 10.1111/j.1365-2036.2008.03828.x; Wolbink GJ, 2005, ANN RHEUM DIS, V64, P704, DOI 10.1136/ard.2004.030452; Wolbink GJ, 2006, ARTHRITIS RHEUM-US, V54, P711, DOI 10.1002/art.21671	23	568	608	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1460	1468		10.1001/jama.2011.406	http://dx.doi.org/10.1001/jama.2011.406			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486979	Bronze			2022-12-28	WOS:000289424100023
J	Wen, LS; Greysen, SR; Keszthelyi, D; Bracero, J; de Roos, PDG				Wen, Leana S.; Greysen, S. Ryan; Keszthelyi, Daniel; Bracero, Julio; de Roos, P. D. G.			Social accountability in health professionals' training	LANCET			English	Editorial Material							EDUCATION; SCHOOL; AREAS		[Wen, Leana S.] Massachusetts Gen Hosp, Brigham & Womens Hosp, Boston, MA 02115 USA; [Greysen, S. Ryan] Yale Univ, Sch Med, New Haven, CT USA; [Keszthelyi, Daniel] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Bracero, Julio] St Lukes Episcopal Hosp, Ponce, PR USA; [de Roos, P. D. G.] Ter Gooi Ziekenhuis, Blaricum, Netherlands	Harvard University; Brigham & Women's Hospital; Massachusetts General Hospital; Yale University; Maastricht University; Tergooi Blaricum	Wen, LS (corresponding author), Massachusetts Gen Hosp, Brigham & Womens Hosp, Boston, MA 02115 USA.	Wen.Leana@gmail.com	Dharamsi, Shafik/H-3165-2011; Keszthelyi, Daniel/H-7746-2019; Keszthelyi, Daniel/ABD-9496-2021	Keszthelyi, Daniel/0000-0001-9856-9980; de Roos, Paul/0000-0003-1079-2315; Wen, Leana/0000-0003-0259-0537				Agrawal JR, 2005, ACAD MED, V80, P484, DOI 10.1097/00001888-200505000-00017; Boelen C, 2009, MED EDUC, V43, P887, DOI 10.1111/j.1365-2923.2009.03413.x; Council on Graduate Medical Education, 2007, 18 COUNC GRAD MED ED; Flexner A., 1910, MEDICAL ED US CANADA; Frehywot S, 2010, B WORLD HEALTH ORGAN, V88, P364, DOI 10.2471/BLT.09.071605; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Hojat M, 2004, MED EDUC, V38, P934, DOI 10.1111/j.1365-2929.2004.01911.x; Huish R, 2008, PUBLIC HEALTH, V122, P552, DOI 10.1016/j.puhe.2008.03.001; Mullan F, 2010, ANN INTERN MED, V152, P804, DOI 10.7326/0003-4819-152-12-201006150-00009; Rabinowitz HK, 1999, JAMA-J AM MED ASSOC, V281, P255, DOI 10.1001/jama.281.3.255; *UN HLTH NETW, 2006, REASS REP REN MEMB; *WHO DIV DEV HUM R, 1995, DEF MEAS SOC ACC MED	12	7	7	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 3	2011	378	9807					E12	E13		10.1016/S0140-6736(10)62314-8	http://dx.doi.org/10.1016/S0140-6736(10)62314-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863AW	21477854				2022-12-28	WOS:000298136200001
J	Zhao, YF; Terry, DS; Shi, L; Quick, M; Weinstein, H; Blanchard, SC; Javitch, JA				Zhao, Yongfang; Terry, Daniel S.; Shi, Lei; Quick, Matthias; Weinstein, Harel; Blanchard, Scott C.; Javitch, Jonathan A.			Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue	NATURE			English	Article							BACTERIAL HOMOLOG; DOPAMINE TRANSPORTER; MOLECULAR-MECHANISM; SODIUM SYMPORTER; BINDING-SITE; LEUT; ION; CONFORMATION; STATE; IDENTIFICATION	Neurotransmitter/Na+ symporters (NSSs) terminate neuronal signalling by recapturing neurotransmitter released into the synapse in a co-transport (symport) mechanism driven by the Na+ electrochemical gradient(1-6). NSSs for dopamine, noradrenaline and serotonin are targeted by the psychostimulants cocaine and amphetamine(1), as well as by antidepressants(7). The crystal structure of LeuT, a prokaryotic NSS homologue, revealed an occluded conformation in which a leucine (Leu) and two Na+ are bound deep within the protein(8). This structure has been the basis for extensive structural and computational exploration of the functional mechanisms of proteins with a LeuT-like fold(9-22). Subsequently, an 'outward-open' conformation was determined in the presence of the inhibitor tryptophan(23), and the Na+-dependent formation of a dynamic outward-facing intermediate was identified using electron paramagnetic resonance spectroscopy(24). In addition, single-molecule fluorescence resonance energy transfer imaging has been used to reveal reversible transitions to an inward-open LeuT conformation, which involve the movement of transmembrane helix TM1a away from the transmembrane helical bundle(22). We investigated how substrate binding is coupled to structural transitions in LeuT during Na+-coupled transport. Here we report a process whereby substrate binding from the extracellular side of LeuT facilitates intracellular gate opening and substrate release at the intracellular face of the protein. In the presence of alanine, a substrate that is transported 10-fold faster than leucine(15,25), we observed alanine-induced dynamics in the intracellular gate region of LeuT that directly correlate with transport efficiency. Collectively, our data reveal functionally relevant and previously hidden aspects of the NSS transport mechanism that emphasize the functional importance of a second substrate (S2) binding site within the extracellular vestibule(15,20). Substrate binding in this S2 site appears to act cooperatively with the primary substrate (S1) binding site to control intracellular gating more than 30 angstrom away, in a manner that allows the Na+ gradient to power the transport mechanism.	[Zhao, Yongfang; Quick, Matthias; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Zhao, Yongfang; Quick, Matthias; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Zhao, Yongfang; Quick, Matthias; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Terry, Daniel S.; Shi, Lei; Weinstein, Harel; Blanchard, Scott C.] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Cornell University; Cornell University	Javitch, JA (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, 630 W 168th St, New York, NY 10032 USA.	scb2005@med.cornell.edu; jaj2@columbia.edu	Blanchard, Scott C./A-5804-2009; WEINSTEIN, HAREL/O-8245-2019; Zhao, Yongfang/B-5437-2010; Shi, Lei/AAV-1321-2020	Blanchard, Scott C./0000-0003-2717-9365; WEINSTEIN, HAREL/0000-0003-3473-9818; Shi, Lei/0000-0002-4137-096X; Javitch, Jonathan/0000-0001-7395-2967; Terry, Daniel/0000-0001-9021-0084	National Institutes of Health [DA17293, DA022413, DA12408, DA023694]; Irma T. Hirschl/Monique Weill-Caulier trusts; Lieber Center for Schizophrenia Research and Treatment; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, R00DA023694, R01DA017293, P01DA012408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl/Monique Weill-Caulier trusts; Lieber Center for Schizophrenia Research and Treatment; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Altman for assistance in preparing reagents for single-molecule experiments and F. Carvalho for the preparation of membranes. Molecular graphics were prepared with PyMOL. Computations were performed on Ranger at the Texas Advanced Computing Center (TG-MCB090022) and the David A. Cofrin computational infrastructure of the Institute for Computational Biomedicine at Weill Cornell Medical College. This work was supported in part by National Institutes of Health grants DA17293 and DA022413 (J.A.J.), DA12408 (H.W.), DA023694 (L.S.), the Irma T. Hirschl/Monique Weill-Caulier trusts (S.C.B.) and the Lieber Center for Schizophrenia Research and Treatment. D.S.T. is supported by the Tri-Institutional Training Program in Computational Biology and Medicine.	Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; GU H, 1994, J BIOL CHEM, V269, P7124; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krause S, 2005, MOL PHARMACOL, V68, P1728, DOI 10.1124/mol.105.013870; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Noskov SY, 2008, PROTEINS, V73, P851, DOI 10.1002/prot.22108; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Rudnick G., 2002, MECH BIOGENIC AMINE; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Sen N, 2005, NEUROPHARMACOLOGY, V49, P780, DOI 10.1016/j.neuropharm.2005.08.014; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, CHANNELS, V2, P380, DOI 10.4161/chan.2.5.6904; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sonders MS, 2005, CURR OPIN NEUROBIOL, V15, P296, DOI 10.1016/j.conb.2005.05.009; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	33	188	192	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					109	U11		10.1038/nature09971	http://dx.doi.org/10.1038/nature09971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21516104	Green Accepted			2022-12-28	WOS:000291156700048
J	Leung, AKW; Nagai, K; Li, J				Leung, Adelaine K. W.; Nagai, Kiyoshi; Li, Jade			Structure of the spliceosomal U4 snRNP core domain and its implication for snRNP biogenesis	NATURE			English	Article							AUTOMATED STRUCTURE SOLUTION; CRYSTAL-STRUCTURE; SM PROTEINS; U1 SNRNP; ELECTRON-MICROSCOPY; RNA-BINDING; COMPLEX; U5; U2; U6	The spliceosome is a dynamic macromolecular machine that assembles on pre-messenger RNA substrates and catalyses the excision of non-coding intervening sequences (introns)(1-3). Four of the five major components of the spliceosome, U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), contain seven Sm proteins (SmB/B9, SmD1, SmD2, SmD3, SmE, SmF and SmG) in common(4,5). Following export of the U1, U2, U4 and U5 snRNAs to the cytoplasm(6,7), the seven Sm proteins, chaperoned by the survival of motor neurons (SMN) complex, assemble around a single-stranded, U-rich sequence called the Sm site in each small nuclear RNA (snRNA), to form the core domain of the respective snRNP particle(8,9). Core domain formation is a prerequisite for re-import into the nucleus(10), where these snRNPs mature via addition of their particle-specific proteins. Here we present a crystal structure of the U4 snRNP core domain at 3.6 angstrom resolution, detailing how the Sm site heptad (AUUUUUG) binds inside the central hole of the heptameric ring of Sm proteins, interacting one-to-one with SmE-SmG-SmD3-SmB-SmD1-SmD2-SmF. An irregular backbone conformation of the Sm site sequence combined with the asymmetric structure of the heteromeric protein ring allows each base to interact in a distinct manner with four key residues at equivalent positions in the L3 and L5 loops of the Sm fold. A comparison of this structure with the U1 snRNP at 5.5 angstrom resolution(11,12) reveals snRNA-dependent structural changes outside the Sm fold, which may facilitate the binding of particle-specific proteins that are crucial to biogenesis of spliceosomal snRNPs.	[Leung, Adelaine K. W.; Nagai, Kiyoshi; Li, Jade] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Nagai, K (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	kn@mrc-lmb.cam.ac.uk; jl@mrc-lmb.cam.ac.uk	Leung, Adelaine/F-4132-2011; Leung, Adelaine/AAV-3357-2021	Leung, Adelaine/0000-0002-2849-4474; 	Medical Research Council of the UK; HFSP; NSERC; Sidney Sussex College, Cambridge University; Medical Research Council [MC_U105184330] Funding Source: researchfish; MRC [MC_U105184330] Funding Source: UKRI	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HFSP(Human Frontier Science Program); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sidney Sussex College, Cambridge University(University of Cambridge); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council of the UK and a HFSP grant. A.K.W.L. was supported by the Overseas Research Students Awards Scheme, Canada-Cambridge Commonwealth studentship, a postgraduate scholarship from NSERC and a Junior Research Fellowship from Sidney Sussex College, Cambridge University. We thank the European Synchrotron Radiation Facility and Daresbury beamline staff for their support. We thank M. Jinek, M. Kampmann and Y. Kondo for their help with crystallization. We also thank C. Kambach, J. Avis, R. Young, S. Walke and H. Teo for laying the foundation of this project, C. Oubridge and D. Pomeranz Krummel for sharing Sm proteins and providing help and advice throughout the project, and P. Zwart for advice on twinning.	Arnold E., 2001, INT TABLES CRYSTALLO, VF, P705; BRINGMANN P, 1986, EMBO J, V5, P3509, DOI 10.1002/j.1460-2075.1986.tb04676.x; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burge CB, 1999, RNA WORLD, P525; Collins BM, 2003, J BIOL CHEM, V278, P17291, DOI 10.1074/jbc.M211826200; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; DIAMOND R, 1992, PROTEIN SCI, V1, P1279, DOI 10.1002/pro.5560011006; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Draper DE, 2008, BIOPHYS J, V95, P5489, DOI 10.1529/biophysj.108.131813; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FISCHER U, 1993, EMBO J, V12, P573, DOI 10.1002/j.1460-2075.1993.tb05689.x; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Guthrie C., 2003, RNA, V9, P193; Hartmuth K, 1999, J MOL BIOL, V285, P133, DOI 10.1006/jmbi.1998.2300; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; HERMANN H, 1995, EMBO J, V14, P2076, DOI 10.1002/j.1460-2075.1995.tb07199.x; HINTERBERGER M, 1983, J BIOL CHEM, V258, P2604; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; KASTNER B, 1990, P NATL ACAD SCI USA, V87, P1710, DOI 10.1073/pnas.87.5.1710; KASTNER B, 1989, EMBO J, V8, P277, DOI 10.1002/j.1460-2075.1989.tb03374.x; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Leung AKW, 2010, J MOL BIOL, V402, P154, DOI 10.1016/j.jmb.2010.07.017; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; McConnell TS, 2003, RNA, V9, P193, DOI 10.1261/rna.2136103; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NELISSEN RLH, 1994, EMBO J, V13, P4113, DOI 10.1002/j.1460-2075.1994.tb06729.x; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Oubridge C, 2009, STRUCTURE, V17, P930, DOI 10.1016/j.str.2009.05.009; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Sauter C, 1999, J CRYST GROWTH, V196, P365, DOI 10.1016/S0022-0248(98)00852-5; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SERAPHIN B, 1995, EMBO J, V14, P2089, DOI 10.1002/j.1460-2075.1995.tb07200.x; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200; Toro I, 2002, J MOL BIOL, V320, P129, DOI 10.1016/S0022-2836(02)00406-0; Toro I, 2001, EMBO J, V20, P2293, DOI 10.1093/emboj/20.9.2293; Urlaub H, 2001, EMBO J, V20, P187, DOI 10.1093/emboj/20.1.187; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Will CL, 2006, COLD SPRING HARB MON, V43, P369; YU YT, 1999, RNA WORLD, V2, P487	56	94	103	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					536	U285		10.1038/nature09956	http://dx.doi.org/10.1038/nature09956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21516107	Green Accepted			2022-12-28	WOS:000290951300046
J	Gardner, AS; Moholdt, G; Wouters, B; Wolken, GJ; Burgess, DO; Sharp, MJ; Cogley, JG; Braun, C; Labine, C				Gardner, Alex S.; Moholdt, Geir; Wouters, Bert; Wolken, Gabriel J.; Burgess, David O.; Sharp, Martin J.; Cogley, J. Graham; Braun, Carsten; Labine, Claude			Sharply increased mass loss from glaciers and ice caps in the Canadian Arctic Archipelago	NATURE			English	Article							ELEVATION CHANGES; BALANCE; ISLAND; SHEET	Mountain glaciers and ice caps are contributing significantly to present rates of sea level rise and will continue to do so over the next century and beyond(1-5). The Canadian Arctic Archipelago, located off the northwestern shore of Greenland, contains one-third of the global volume of land ice outside the ice sheets(6), but its contribution to sea-level change remains largely unknown. Here we show that the Canadian Arctic Archipelago has recently lost 61 +/- 7 gigatonnes per year (Gt yr(-1)) of ice, contributing 0.17 +/- 0.02 mm yr(-1) to sea-level rise. Our estimates are of regional mass changes for the ice caps and glaciers of the Canadian Arctic Archipelago referring to the years 2004 to 2009 and are based on three independent approaches: surface mass-budget modelling plus an estimate of ice discharge (SMB+D), repeat satellite laser altimetry (ICESat) and repeat satellite gravimetry (GRACE). All three approaches show consistent and large mass-loss estimates. Between the periods 2004-2006 and 2007-2009, the rate of mass loss sharply increased from 31 +/- 8 Gt yr(-1) to 92 +/- 12 Gt yr(-1) in direct response to warmer summer temperatures, to which rates of ice loss are highly sensitive (64 +/- 14 Gt yr(-1) per 1 K increase). The duration of the study is too short to establish a long-term trend, but for 2007-2009, the increase in the rate of mass loss makes the Canadian Arctic Archipelago the single largest contributor to eustatic sea-level rise outside Greenland and Antarctica.	[Gardner, Alex S.; Sharp, Martin J.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Gardner, Alex S.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Moholdt, Geir] Univ Oslo, Dept Geosci, N-0316 Oslo, Norway; [Moholdt, Geir] Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA; [Wouters, Bert] Royal Netherlands Meteorol Inst, NL-3730 AE De Bilt, Netherlands; [Wolken, Gabriel J.] Alaska Dept Nat Resources, Div Geol & Geophys Surveys, Fairbanks, AK 99709 USA; [Burgess, David O.] Geol Survey Canada, Ottawa, ON K1A 0E8, Canada; [Cogley, J. Graham] Trent Univ, Dept Geog, Peterborough, ON K9J 7B8, Canada; [Braun, Carsten] Westfield State Univ, Dept Geog & Reg Planning, Westfield, MA 01086 USA; [Labine, Claude] Campbell Sci Canada Corp, Edmonton, AB T5M 1W7, Canada	University of Alberta; University of Michigan System; University of Michigan; University of Oslo; University of California System; University of California San Diego; Scripps Institution of Oceanography; Royal Netherlands Meteorological Institute; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; Trent University; Massachusetts System of Public Higher Education; Westfield State University	Gardner, AS (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada.	alexsg@umich.edu	Wouters, Bert/AAA-4254-2019; Wouters, Bert/A-5301-2017	Wouters, Bert/0000-0002-1086-2435; Wouters, Bert/0000-0002-1086-2435; Gardner, Alex/0000-0002-8394-8889	NSERC Canada; Alberta Ingenuity Fund; European Union [226375]; NSERC; CFCAS through the Polar Climate Stability Network	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity Fund; European Union(European Commission); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFCAS through the Polar Climate Stability Network	We thank A. Arendt for reviewing the manuscript and S. Luthcke and A. Arendt for providing the updated glacier mass anomalies for Alaska. We thank H. Blatter, W. Colgan, E. Dowdeswell, M. Huss, S. Marshall and D. Mueller for contributing observational data sets. We thank R. Riva and P. Stocchi for providing glacial isostatic adjustment models. This work was supported by funding to A.S.G. from NSERC Canada and the Alberta Ingenuity Fund, funding to G.M. by the European Union 7th Framework Program (grant number 226375) through the ice2sea programme (contribution number 017), and funding to M.J.S. from NSERC and CFCAS (through the Polar Climate Stability Network). The SMB modelling was conducted using the infrastructure and resources of AICT of the University of Alberta.	Abdalati W, 2004, J GEOPHYS RES-EARTH, V109, DOI 10.1029/2003JF000045; ALT BT, 1987, J CLIM APPL METEOROL, V26, P1605, DOI 10.1175/1520-0450(1987)026<1605:DSAFEM>2.0.CO;2; Arendt A, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000436; Bahr DB, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036309; BRADLEY RS, 1978, ARCTIC ALPINE RES, V10, P715, DOI 10.2307/1550739; BRAITHWAITE RJ, 1995, J GLACIOL, V41, P153, DOI 10.3189/S0022143000017846; Chen JL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031871; Cogley J. G., IACS CONTRI IN PRESS; Cogley JG, 1996, J GLACIOL, V42, P548, DOI 10.3189/S0022143000003531; De Woul M, 2005, ANN GLACIOL, V42, P217, DOI 10.3189/172756405781813096; Gardner AS, 2007, J CLIMATE, V20, P4586, DOI 10.1175/JCLI4268.1; Gardner AS, 2009, J CLIMATE, V22, P4281, DOI 10.1175/2009JCLI2845.1; Hock R, 2003, J HYDROL, V282, P104, DOI 10.1016/S0022-1694(03)00257-9; Hock R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037020; HOOKE RL, 1987, CAN J EARTH SCI, V24, P1550, DOI 10.1139/e87-151; Kaser G, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027511; Koerner RM, 2005, ANN GLACIOL-SER, V42, P417, DOI 10.3189/172756405781813122; Lotz J. R., 1962, GEOGR ANN, V44, P366; Luthcke SB, 2008, J GLACIOL, V54, P767, DOI 10.3189/002214308787779933; Meier MF, 2007, SCIENCE, V317, P1064, DOI 10.1126/science.1143906; Moholdt G, 2010, REMOTE SENS ENVIRON, V114, P2756, DOI 10.1016/j.rse.2010.06.008; Oerlemans J, 2005, ANN GLACIOL-SER, V42, P230, DOI 10.3189/172756405781812745; RADIC V, 2010, NAT GEOSCI, V115; Rignot E, 2003, SCIENCE, V302, P434, DOI 10.1126/science.1087393; Sole A, 2008, CRYOSPHERE, V2, P205, DOI 10.5194/tc-2-205-2008; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; Wouters B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034816; Zwally H.J., 2010, GLAS ICESAT L1B GLOB; Zwally HJ, 2002, J GEODYN, V34, P405, DOI 10.1016/S0264-3707(02)00042-X	29	226	232	3	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					357	360		10.1038/nature10089	http://dx.doi.org/10.1038/nature10089			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21508960				2022-12-28	WOS:000290722400044
J	Carlson, BA; Hasan, SM; Hollmann, M; Miller, DB; Harmon, LJ; Arnegard, ME				Carlson, Bruce A.; Hasan, Saad M.; Hollmann, Michael; Miller, Derek B.; Harmon, Luke J.; Arnegard, Matthew E.			Brain Evolution Triggers Increased Diversification of Electric Fishes	SCIENCE			English	Article							DIVERGENCE; MORMYRIDAE; SPECIATION; TELEOSTEI; RATES; MORMYROIDEA; RADIATION; DIVERSITY; DISCHARGE; SIGNALS	Communication can contribute to the evolution of biodiversity by promoting speciation and reinforcing reproductive isolation between existing species. The evolution of species-specific signals depends on the ability of individuals to detect signal variation, which in turn relies on the capability of the brain to process signal information. Here, we show that evolutionary change in a region of the brain devoted to the analysis of communication signals in mormyrid electric fishes improved detection of subtle signal variation and resulted in enhanced rates of signal evolution and species diversification. These results show that neural innovations can drive the diversification of signals and promote speciation.	[Carlson, Bruce A.; Hasan, Saad M.; Hollmann, Michael; Miller, Derek B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Harmon, Luke J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA; [Arnegard, Matthew E.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA	Washington University (WUSTL); Idaho; University of Idaho; Fred Hutchinson Cancer Center	Carlson, BA (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	carlson.bruce@wustl.edu	Hollmann, Michael/AAW-5574-2021; Harmon, Luke/A-8225-2012	Harmon, Luke/0000-0002-4985-5750; Hollmann, Michael/0000-0002-2209-2773	NSF [IOS-0818390, DEB-0919499]; Division Of Integrative Organismal Systems [0818390] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. D. Hopkins and J. R. Gallant for help with field work, J. P. Friel (Cornell University Museum of Vertebrates) for providing specimens, and S. Lavoue and J. P. Sullivan for providing cytb sequences (GenBank accession numbers provided in table S1). Supported by NSF IOS-0818390 (B.A.C.); L.J.H. was supported by NSF DEB-0919499.	Arnegard ME, 2006, J EXP BIOL, V209, P2182, DOI 10.1242/jeb.02239; Arnegard ME, 2010, AM NAT, V176, P335, DOI 10.1086/655221; Bass A.H., 1986, P13; BASS AH, 1982, J MORPHOL, V174, P313, DOI 10.1002/jmor.1051740306; Bell C.C., 1986, P375; Carlson Bruce, 2006, P805; Eschmeyer WN, 2010, CATALOG FISHES ELECT; Feulner PGD, 2007, J EVOLUTION BIOL, V20, P403, DOI 10.1111/j.1420-9101.2006.01181.x; Feulner PGD, 2009, BIOL LETTERS, V5, P225, DOI 10.1098/rsbl.2008.0566; HARDER W, 1968, Z VERGL PHYSIOL, V59, P272; HOPKINS CD, 1981, SCIENCE, V212, P85, DOI 10.1126/science.7209524; HOPKINS CD, 1981, AM ZOOL, V21, P211; Hoskin CJ, 2010, ECOL LETT, V13, P409, DOI 10.1111/j.1461-0248.2010.01448.x; Lavoue S, 2004, ZOOSYSTEMA, V26, P511; Lavoue S, 2003, BIOL J LINN SOC, V78, P273, DOI 10.1046/j.1095-8312.2003.00170.x; Lavoue S, 2010, ZOOTAXA, P1; Lavoue S, 2008, J PHYSIOL-PARIS, V102, P322, DOI 10.1016/j.jphysparis.2008.10.003; Machnik P, 2008, J EXP BIOL, V211, P1969, DOI 10.1242/jeb.016949; MOLLER P, 1989, ETHOLOGY, V82, P177; O'Meara BC, 2006, EVOLUTION, V60, P922; Post N, 1999, PHYSIOL BEHAV, V68, P115, DOI 10.1016/S0031-9384(99)00153-5; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; RYAN MJ, 1986, P NATL ACAD SCI USA, V83, P1379, DOI 10.1073/pnas.83.5.1379; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shumway CA, 2008, BRAIN BEHAV EVOLUT, V72, P123, DOI 10.1159/000151472; Sullivan JP, 2000, J EXP BIOL, V203, P665; Sylvester JB, 2010, P NATL ACAD SCI USA, V107, P9718, DOI 10.1073/pnas.1000395107; Terai Y, 2006, PLOS BIOL, V4, P2244, DOI 10.1371/journal.pbio.0040433; Xu-Friedman MA, 1999, J EXP BIOL, V202, P1311; Zakon H.H., 1986, P103	30	71	71	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029					583	586		10.1126/science.1201524	http://dx.doi.org/10.1126/science.1201524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527711				2022-12-28	WOS:000289991100047
J	Masui, O; Bonnet, I; Le Baccon, P; Brito, I; Pollex, T; Murphy, N; Hupe, P; Barillot, E; Belmont, AS; Heard, E				Masui, Osamu; Bonnet, Isabelle; Le Baccon, Patricia; Brito, Isabel; Pollex, Tim; Murphy, Niall; Hupe, Philippe; Barillot, Emmanuel; Belmont, Andrew S.; Heard, Edith			Live-Cell Chromosome Dynamics and Outcome of X Chromosome Pairing Events during ES Cell Differentiation	CELL			English	Article							WIDESPREAD MONOALLELIC EXPRESSION; XIST EXPRESSION; INACTIVATION CENTER; NONCODING RNA; HISTONE H3; STEM-CELLS; REGION; TSIX; CHOICE; TRANSCRIPTION	Random X inactivation represents a paradigm for monoallelic gene regulation during early ES cell differentiation. In mice, the choice of X chromosome to inactivate in XX cells is ensured by monoallelic regulation of Xist RNA via its antisense transcription unit Tsix/Xite. Homologous pairing events have been proposed to underlie asymmetric Tsix expression, but direct evidence has been lacking owing to their dynamic and transient nature. Here we investigate the live-cell dynamics and outcome of Tsix pairing in differentiating mouse ES cells. We find an overall increase in genome dynamics including the Xics during early differentiation. During pairing, however, Xic loci show markedly reduced movements. Upon separation, Tsix expression becomes transiently monoallelic, providing a window of opportunity for monoallelic Xist upregulation. Our findings reveal the spatiotemporal choreography of the X chromosomes during early differentiation and indicate a direct role for pairing in facilitating symmetry-breaking and monoallelic regulation of Xist during random X inactivation.	[Masui, Osamu; Bonnet, Isabelle; Le Baccon, Patricia; Brito, Isabel; Pollex, Tim; Murphy, Niall; Hupe, Philippe; Barillot, Emmanuel; Heard, Edith] Inst Curie, F-75248 Paris, France; [Masui, Osamu; Bonnet, Isabelle; Pollex, Tim; Murphy, Niall; Heard, Edith] CNRS, UMR3215, F-75248 Paris, France; [Masui, Osamu; Bonnet, Isabelle; Pollex, Tim; Murphy, Niall; Heard, Edith] INSERM, U934, F-75248 Paris, France; [Le Baccon, Patricia] CNRS, UMR218, F-75248 Paris, France; [Brito, Isabel; Hupe, Philippe; Barillot, Emmanuel] INSERM, U900, F-75248 Paris, France; [Brito, Isabel; Hupe, Philippe; Barillot, Emmanuel] Mines ParisTech, F-77300 Fontainebleau, France; [Hupe, Philippe] CNRS, UMR144, F-75248 Paris, France; [Belmont, Andrew S.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of Illinois System; University of Illinois Urbana-Champaign	Heard, E (corresponding author), Inst Curie, 26 Rue Ulm, F-75248 Paris, France.	edith.heard@curie.fr	Hupe, Philippe/T-8793-2017; Heard, Edith/D-7197-2017; Masui, Osamu/AAH-4111-2019	Hupe, Philippe/0000-0001-8468-3424; Heard, Edith/0000-0001-8052-7117; Pollex, Tim/0000-0001-5669-3940; Bonnet, Isabelle/0000-0003-2343-3784; BARILLOT, Emmanuel/0000-0003-2724-2002	Human Frontier Science Program; EU; ANR; FRM [SPF20080512397]; ERC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058460] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); EU(European Commission); ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Heard laboratory and John Sedat for helpful discussions; Michele Guggiari, Christel Picard, Matt Plutz, and Patricia Diabangouaya for technical assistance; Yohanns Bellaiche, Francois Graner, and Jennifer Chow for helpful advice and for critical reading of the manuscript. We thank Olivier Renaud and Olivier Leroy (PICT@BDD imaging facility), as well as Sebastian Huart for assistance with image analysis. This work was supported by the Human Frontier Science Program to E.H. and A.S.B.; the EU FP7 program HEROIC IP; ANR and FRM funding, and an ERC Advanced Investigator Award to E.H.; and the FRM to I. Bonnet (postdoc grant n degrees SPF20080512397).	Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Carmo-Fonseca M, 2002, TRENDS CELL BIOL, V12, P491, DOI 10.1016/S0962-8924(02)02387-5; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Chureau C, 2011, HUM MOL GENET, V20, P705, DOI 10.1093/hmg/ddq516; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Debrand E, 1999, MOL CELL BIOL, V19, P8513; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2010, BIOESSAYS, V32, P581, DOI 10.1002/bies.201000019; Nicodemi M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108104; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ohlsson R, 2007, SCIENCE, V318, P1077, DOI 10.1126/science.1150705; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Okamoto I, 2009, CHROMOSOME RES, V17, P659, DOI 10.1007/s10577-009-9057-7; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rajapakse I, 2009, P NATL ACAD SCI USA, V106, P6679, DOI 10.1073/pnas.0900986106; ROUGEULLE C, 1994, MAMM GENOME, V5, P416, DOI 10.1007/BF00357001; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Sado T, 2001, DEVELOPMENT, V128, P1275; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Scialdone A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000244; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5	44	101	103	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					447	458		10.1016/j.cell.2011.03.032	http://dx.doi.org/10.1016/j.cell.2011.03.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529716	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000290022900013
J	Schoggins, JW; Wilson, SJ; Panis, M; Murphy, MY; Jones, CT; Bieniasz, P; Rice, CM				Schoggins, John W.; Wilson, Sam J.; Panis, Maryline; Murphy, Mary Y.; Jones, Christopher T.; Bieniasz, Paul; Rice, Charles M.			A diverse range of gene products are effectors of the type I interferon antiviral response	NATURE			English	Article							HEPATITIS-C VIRUS; IDENTIFICATION; PROTEINS; REVEALS; RNA; CLASSIFICATION; REPLICATION; EXPRESSION; RESISTANCE; DISEASE	The type I interferon response protects cells against invading viral pathogens. The cellular factors that mediate this defence are the products of interferon-stimulated genes (ISGs). Although hundreds of ISGs have been identified since their discovery more than 25 years ago(1-3), only a few have been characterized with respect to antiviral activity. For most ISG products, little is known about their antiviral potential, their target specificity and their mechanisms of action. Using an overexpression screening approach, here we show that different viruses are targeted by unique sets of ISGs. We find that each viral species is susceptible to multiple antiviral genes, which together encompass a range of inhibitory activities. To conduct the screen, more than 380 human ISGs were tested for their ability to inhibit the replication of several important human and animal viruses, including hepatitis C virus, yellow fever virus, West Nile virus, chikungunya virus, Venezuelan equine encephalitis virus and human immunodeficiency virus type-1. Broadly acting effectors included IRF1, C6orf150 (also known as MB21D1), HPSE, RIG-I (also known as DDX58), MDA5 (also known as IFIH1) and IFITM3, whereas more targeted antiviral specificity was observed with DDX60, IFI44L, IFI6, IFITM2, MAP3K14, MOV10, NAMPT (also known as PBEF1), OASL, RTP4, TREX1 and UNC84B (also known as SUN2). Combined expression of pairs of ISGs showed additive antiviral effects similar to those of moderate type I interferon doses. Mechanistic studies uncovered a common theme of translational inhibition for numerous effectors. Several ISGs, including ADAR, FAM46C, LY6E and MCOLN2, enhanced the replication of certain viruses, highlighting another layer of complexity in the highly pleiotropic type I interferon system.	[Schoggins, John W.; Panis, Maryline; Murphy, Mary Y.; Jones, Christopher T.; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, Ctr Study Hepatitis C, New York, NY 10065 USA; [Wilson, Sam J.; Bieniasz, Paul] Rockefeller Univ, Howard Hughes Med Inst, Aaron Diamond AIDS Res Ctr, Lab Retrovirol, New York, NY 10016 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Rice, CM (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, Ctr Study Hepatitis C, New York, NY 10065 USA.	ricec@mail.rockefeller.edu		Wilson, Sam/0000-0002-6065-0895	New York State Department of Health (NYSDOH) [C023046]; National Institutes of Health [AI057158, AI064003]; Greenberg Medical Research Institute; Starr Foundation; Ronald A. Shellow, M. D. Memorial Fund; National Institute of Diabetes and Digestive and Kidney Diseases [DK082155, DK081193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI064003, U54AI057158, R01AI064003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK081193, F32DK082155] Funding Source: NIH RePORTER	New York State Department of Health (NYSDOH); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenberg Medical Research Institute; Starr Foundation; Ronald A. Shellow, M. D. Memorial Fund; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the following investigators for contributing viral molecular clones: C. Stoyanov (YFV), S. Higgs (CHIKV), I. Frolov (WNV and VEEV), M. MacDonald and J. Law (SINV(ts6) and SINV-Fluc), M. Heise (SINV and SINV-GFP). We thank E. Jouanguy and J.-L. Casanova for STAT1<SUP>-/-</SUP> fibroblasts. We acknowledge the support of C. Zhao, X. Wang and W. Zhang at The Rockefeller University Genomics Resource Center. For technical advice, we thank S. Mazel and C. Bare at The Rockefeller University Flow Cytometry Resource Center, supported by the Empire State Stem Cell Fund through the New York State Department of Health (NYSDOH) contract no. C023046; the opinions expressed here are solely those of the authors and do not necessarily reflect those of the Empire State Stem Cell Fund, the NYSDOH or the State of New York. We thank M. Holz, E. Castillo and A. Webson for laboratory support; C. Murray for critical reading and editing of the manuscript; and A. Ploss, M. Scull, M. T. Catanese and S. You for discussions. This work was supported in part by National Institutes of Health grants AI057158 (Northeast Biodefense Center-Lipkin) to C. M. R. and AI064003 to P. B. Additional funding was provided by the Greenberg Medical Research Institute, the Starr Foundation and the Ronald A. Shellow, M. D. Memorial Fund (C. M. R.). J. W. S. and C. T. J. were supported by National Research Service Awards DK082155 and DK081193, respectively, from the National Institute of Diabetes and Digestive and Kidney Diseases.	Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brodsky LI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000584; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Doria M, 2009, NUCLEIC ACIDS RES, V37, P5848, DOI 10.1093/nar/gkp604; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Frontini M, 2009, NUCLEIC ACIDS RES, V37, P1073, DOI 10.1093/nar/gkn1051; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Hilkens CMU, 2003, J IMMUNOL, V171, P5255, DOI 10.4049/jimmunol.171.10.5255; Hultcrantz M, 2007, VIROLOGY, V367, P92, DOI 10.1016/j.virol.2007.05.010; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; KNIGHT E, 1979, P NATL ACAD SCI USA, V76, P1824, DOI 10.1073/pnas.76.4.1824; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Lanford RE, 2006, HEPATOLOGY, V43, P961, DOI 10.1002/hep.21167; LARNER AC, 1984, P NATL ACAD SCI-BIOL, V81, P6733, DOI 10.1073/pnas.81.21.6733; Leaman DW, 2003, J INTERF CYTOK RES, V23, P745, DOI 10.1089/107999003772084860; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu HC, 2003, CYTOGENET GENOME RES, V102, P304, DOI 10.1159/000075767; McGee CE, 2010, VECTOR-BORNE ZOONOT, V10, P267, DOI 10.1089/vbz.2009.0067; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Petrakova O, 2005, J VIROL, V79, P7597, DOI 10.1128/JVI.79.12.7597-7608.2005; Rani MRS, 2007, J LEUKOCYTE BIOL, V82, P1353, DOI 10.1189/jlb.0507273; ROY S, 1990, SCIENCE, V247, P1216, DOI 10.1126/science.2180064; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Spindler KR, 2010, J IMMUNOL, V184, P3055, DOI 10.4049/jimmunol.0903363; Suthar MS, 2005, J VIROL, V79, P4219, DOI 10.1128/JVI.79.7.4219-4228.2005; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Toth AM, 2009, J BIOL CHEM, V284, P29350, DOI 10.1074/jbc.M109.045146; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang YJ, 2002, J VIROL, V76, P6332, DOI 10.1128/JVI.76.12.6332-6343.2002; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	42	1595	1643	4	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					481	U545		10.1038/nature09907	http://dx.doi.org/10.1038/nature09907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21478870	Green Accepted			2022-12-28	WOS:000289949600036
J	Bangalore, S; Kumar, S; Wetterslev, J; Messerli, FH				Bangalore, Sripal; Kumar, Sunil; Wetterslev, Jorn; Messerli, Franz H.			Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONVERTING-ENZYME-INHIBITORS; CHRONIC HEART-FAILURE; VENTRICULAR SYSTOLIC FUNCTION; HIGH CARDIOVASCULAR RISKS; CORONARY-ARTERY-DISEASE; HYPERTENSIVE PATIENTS; DIABETIC-NEPHROPATHY; EJECTION FRACTION; OPEN-LABEL; CANDESARTAN	Objectives To evaluate the cardiovascular outcomes and other outcomes associated with angiotensin receptor blockers. Design Systematic review of randomised controlled trials with meta-analysis and trial sequential analysis (TSA). Data sources and study selection Pubmed, Embase, and CENTRAL searches for randomised clinical trials, until August 2010, of angiotensin receptor blockers compared with controls (placebo/active treatment) that enrolled at least 100 participants and had a follow-up of at least one year. Data extraction Myocardial infarction, death, cardiovascular death, angina pectoris, stroke, heart failure, and new onset diabetes. Results 37 randomised clinical trials included 147 020 participants and had a total follow-up of 485 166 patient years. When compared with controls (placebo/active treatment), placebo, or active treatment, angiotensin receptor blockers were not associated with an increase in the risk of myocardial infarction (relative risk 0.99, 95% confidence interval 0.92 to 1.07), death, cardiovascular death, or angina pectoris. Compared with controls, angiotensin receptor blockers were associated with a reduction in the risk of stroke (0.90, 0.84 to 0.98), heart failure (0.87, 0.81 to 0.93), and new onset diabetes (0.85, 0.78 to 0.93), with similar results when compared with placebo or with active treatment. Based on trial sequential analysis, there is no evidence even for an average 5.0-7.5% (upper confidence interval 5-11%) relative increase in myocardial infarction (absolute increase of 0.3%), death, or cardiovascular death with firm evidence for relative risk reduction of stroke (at least 1%, average 10%) (compared with placebo only), heart failure (at least 5%, average 10%), and new onset diabetes (at least 4%, average 10%) with angiotensin receptor blockers compared with controls. Conclusions This large and comprehensive analysis produced firm evidence to refute the hypothesis that angiotensin receptor blockers increase the risk of myocardial infarction (ruling out even a 0.3% absolute increase). Compared with controls, angiotensin receptor blockers reduce the risk of stroke, heart failure, and new onset diabetes.	[Bangalore, Sripal] NYU, Sch Med, Leon H Charney Div Cardiol, Cardiac Catheterizat Lab, New York, NY 10016 USA; [Kumar, Sunil] Univ Nebraska, Omaha, NE 68182 USA; [Wetterslev, Jorn] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark; [Messerli, Franz H.] St Lukes Roosevelt Hosp, Hypertens Program, New York, NY 10025 USA; [Messerli, Franz H.] Columbia Univ, Hypertens Program, New York, NY USA	New York University; University of Nebraska System; Rigshospitalet; University of Copenhagen; Mount Sinai St. Luke's; Mount Sinai West; Columbia University	Bangalore, S (corresponding author), NYU, Sch Med, Leon H Charney Div Cardiol, Cardiac Catheterizat Lab, New York, NY 10016 USA.	sripalbangalore@gmail.com	Bangalore, Sripal/B-6246-2013; Wetterslev, Jørn/ABF-1251-2020; Messerli, Franz/AAR-4783-2021	Wetterslev, Jørn/0000-0001-7778-1771; Bangalore, Sripal/0000-0001-9485-0652	Novartis; Forest; Boehringer Ingelheim	Novartis(Novartis); Forest; Boehringer Ingelheim(Boehringer Ingelheim)	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available available on request from the corresponding author) and declare: no support from any organisation for the submitted work; FHM has been an occasional consultant/speaker for Novartis, Daiichi Sankyo, Sanofi, and Savient Pharmaceuticals and has received grants from Novartis, Forest, and Boehringer Ingelheim; no other relationships or activities that could appear to have influenced the submitted work.	Agodoa L, 2007, J HYPERTENS, V25, P951; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Berl T, 2003, ANN INTERN MED, V138, P542, DOI 10.7326/0003-4819-138-7-200304010-00010; Bilous R, 2009, ANN INTERN MED, V151, P11, DOI 10.7326/0003-4819-151-1-200907070-00120; Bradburn M, 1998, STATA TECH B REPRINT, V8, P86; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Chaturvedi N, 2008, LANCET, V372, P1394, DOI 10.1016/S0140-6736(08)61412-9; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dickstein K, 2002, LANCET, V360, P752, DOI 10.1016/S0140-6736(02)09895-1; Disertori M, 2009, NEW ENGL J MED, V360, P1606, DOI 10.1056/NEJMoa0805710; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hou FF, 2007, J AM SOC NEPHROL, V18, P1889, DOI 10.1681/ASN.2006121372; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kasanuki H, 2009, EUR HEART J, V30, P1203, DOI 10.1093/eurheartj/ehp101; Kondo J, 2003, AM HEART J, V146, DOI 10.1016/S0002-8703(03)00443-5; Levy BI, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000096609.73772.C5; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lindholm LH, 2003, J HYPERTENS, V21, P1563, DOI 10.1097/00004872-200308000-00022; LINZ W, 1995, PHARMACOL REV, V47, P25; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; McMurray J, 2006, J AM COLL CARDIOL, V47, P726, DOI 10.1016/j.jacc.2005.09.055; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; Messerli FH, 2009, CIRCULATION, V119, P371, DOI 10.1161/CIRCULATIONAHA.108.828897; Mochizuki S, 2007, LANCET, V369, P1431, DOI 10.1016/S0140-6736(07)60669-2; Nakamura T, 2005, HYPERTENS RES, V28, P415, DOI 10.1291/hypres.28.415; Ogihara T, 2008, HYPERTENSION, V51, P393, DOI 10.1161/HYPERTENSIONAHA.107.098475; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Pitt B, 1997, LANCET, V349, P747, DOI 10.1016/S0140-6736(97)01187-2; Sawada T, 2009, EUR HEART J, V30, P2461, DOI 10.1093/eurheartj/ehp363; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Suzuki H, 2005, HYPERTENS RES, V28, P307, DOI 10.1291/hypres.28.307; Suzuki H, 2008, AM J KIDNEY DIS, V52, P501, DOI 10.1053/j.ajkd.2008.04.031; Takahashi A, 2006, NEPHROL DIAL TRANSPL, V21, P2507, DOI 10.1093/ndt/gfl293; Verma S, 2004, BMJ-BRIT MED J, V329, P1248, DOI 10.1136/bmj.329.7477.1248; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Wright J.M, 2008, COCHRANE DB SYST REV, V2008, DOI [10.1002/14651858.CD003822.pub2., DOI 10.1002/14651858.CD003822.PUB2]; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zile MR, 2010, CIRCULATION, V121, P1393, DOI 10.1161/CIRCULATIONAHA.109.909614	54	98	101	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2011	342								d2234	10.1136/bmj.d2234	http://dx.doi.org/10.1136/bmj.d2234			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759BO	21521728	Green Published, hybrid			2022-12-28	WOS:000290215100002
J	Devereaux, PJ; Xavier, D; Pogue, J; Guyatt, G; Sigamani, A; Garutti, I; Leslie, K; Rao-Melacini, P; Chrolavicius, S; Yang, H; MacDonald, C; Avezum, A; Lanthier, L; Hu, WJ; Yusuf, S				Devereaux, P. J.; Xavier, Denis; Pogue, Janice; Guyatt, Gordon; Sigamani, Alben; Garutti, Ignacio; Leslie, Kate; Rao-Melacini, Purnima; Chrolavicius, Sue; Yang, Homer; MacDonald, Colin; Avezum, Alvaro; Lanthier, Luc; Hu, Weijiang; Yusuf, Salim		POISE Investigators	Characteristics and Short- Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; VASCULAR-SURGERY; POISE TRIAL; PREVENTION; METOPROLOL; ISCHEMIA; MEN	Background: Each year, millions of patients worldwide have a perioperative myocardial infarction (MI) after noncardiac surgery. Objective: To examine the characteristics and short-term outcome of perioperative MI. Design: Cohort study. (ClinicalTrials.gov registration number: NCT00182039) Setting: 190 centers in 23 countries. Patients: 8351 patients included in the POISE (PeriOperative ISchemic Evaluation) trial. Measurements: Four cardiac biomarker or enzyme assays were measured within 3 days of surgery. The definition of perioperative MI included either autopsy findings of acute MI or an elevated level of a cardiac biomarker or enzyme and at least 1 of the following defining features: ischemic symptoms, development of pathologic Q waves, ischemic changes on electrocardiography, coronary artery intervention, or cardiac imaging evidence of MI. Results: Within 30 days of random assignment, 415 patients (5.0%) had a perioperative MI. Most MIs (74.1%) occurred within 48 hours of surgery; 65.3% of patients did not experience ischemic symptoms. The 30-day mortality rate was 11.6% (48 of 415 patients) among patients who had a perioperative MI and 2.2% (178 of 7936 patients) among those who did not (P < 0.001). Among patients with a perioperative MI, mortality rates were elevated and similar between those with (9.7%; adjusted odds ratio, 4.76 [95% CI, 2.68 to 8.43]) and without (12.5%; adjusted odds ratio, 4.00 [CI, 2.65 to 6.06]) ischemic symptoms. Limitation: Cardiac markers were measured only until day 3 after surgery, and additional asymptomatic MIs may have been missed. Conclusion: Most patients with a perioperative MI will not experience ischemic symptoms. Data suggest that routine monitoring of troponin levels in at-risk patients is needed after surgery to detect most MIs, which have an equally poor prognosis regardless of whether they are symptomatic or asymptomatic.	McMaster Univ, Hamilton, ON, Canada; St Johns Med Coll, Bangalore, Karnataka, India; St Johns Res Inst, Bangalore, Karnataka, India; Hosp Gen Univ Gregorio Maranon, Madrid, Spain; Royal Melbourne Hosp, Melbourne, Vic, Australia; Univ Melbourne, Melbourne, Vic, Australia; Univ Ottawa, Ottawa, ON, Canada; Univ Alberta, Edmonton, AB, Canada; Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; Anshan Iron & Steel Min Co Hosp Gongchangling, Gongchangling, Peoples R China	McMaster University; St. John's National Academy of Health Sciences; St. John's Medical College; St. John's National Academy of Health Sciences; St. John's Research Institute; General University Gregorio Maranon Hospital; Royal Melbourne Hospital; University of Melbourne; University of Ottawa; University of Alberta; Instituto Dante Pazzanese de Cardiologia; University of Sherbrooke	Devereaux, PJ (corresponding author), Hamilton Gen Hosp, Populat Hlth Res Inst, David Braley Cardiac Vasc & Stroke Res Inst, Perioperat Med & Surg Res Unit, Room C1-116,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	philipj@mcmaster.ca	Devereaux, PJ/AAF-2862-2019; Avezum, Alvaro AA/K-6137-2016; Garutti, Ignacio/H-9035-2017; Sigamani, Alben/GQH-0406-2022; Avezum, Alvaro/AAP-7687-2020; Devereaux, PJ/AAY-1757-2021	Avezum, Alvaro AA/0000-0002-3073-6890; Garutti, Ignacio/0000-0001-8284-2903; Devereaux, PJ/0000-0003-2935-637X; Rao, Purnima/0000-0002-7537-9057; SIGAMANI, ALBEN/0000-0002-6927-1947; Yusuf, Salim/0000-0003-4776-5601; Leslie, Kate/0000-0001-8512-3517	Canadian Institutes of Health Research; Commonwealth Government of Australia's National Health and Medical Research Council; Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo) in Spain [PI071071]; British Heart Foundation; AstraZeneca	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Commonwealth Government of Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo) in Spain(Instituto de Salud Carlos III); British Heart Foundation(British Heart Foundation); AstraZeneca(AstraZeneca)	Grant Support: By the Canadian Institutes of Health Research, the Commonwealth Government of Australia's National Health and Medical Research Council, the Instituto de Salud Carlos III (PI071071, Ministerio de Sanidad y Consumo) in Spain, the British Heart Foundation, and AstraZeneca.	ASHTON CM, 1993, ANN INTERN MED, V118, P504, DOI 10.7326/0003-4819-118-7-199304010-00004; Badner NH, 1998, ANESTHESIOLOGY, V88, P572, DOI 10.1097/00000542-199803000-00005; Cohen MC, 1999, CARDIOVASC PATHOL, V8, P133, DOI 10.1016/S1054-8807(98)00032-5; Dawood MM, 1996, INT J CARDIOL, V57, P37, DOI 10.1016/S0167-5273(96)02769-6; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2006, AM HEART J, V152, P223, DOI 10.1016/j.ahj.2006.05.019; Devereaux PJ, 2005, CAN MED ASSOC J, V173, P779, DOI 10.1503/cmaj.050316; Devereaux PJ, 2009, EVIDENCE BASED CARDI, P47; Ellis SG, 1996, AM J CARDIOL, V77, P1126, DOI 10.1016/S0002-9149(96)00130-0; Landesberg G, 2001, J AM COLL CARDIOL, V37, P1839, DOI 10.1016/S0735-1097(01)01265-7; Le Manach Y, 2005, ANESTHESIOLOGY, V102, P885, DOI 10.1097/00000542-200505000-00004; MANGANO DT, 1990, NEW ENGL J MED, V323, P1781, DOI 10.1056/NEJM199012273232601; Simunovic N, 2010, CAN MED ASSOC J, V182, P1609, DOI 10.1503/cmaj.092220; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	16	435	460	1	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8					523	528		10.7326/0003-4819-154-8-201104190-00003	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-00003			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502650				2022-12-28	WOS:000289622000015
J	Elshaug, AG; Garber, AM				Elshaug, Adam G.; Garber, Alan M.			How CER Could Pay for Itself - Insights from Vertebral Fracture Treatments	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RANDOMIZED-TRIAL; VERTEBROPLASTY		[Elshaug, Adam G.] Commonwealth Fund, Int Program Hlth Policy & Practice, New York, NY 10021 USA; [Elshaug, Adam G.] Univ Adelaide, Sch Populat Hlth & Clin Practice, Adelaide, SA, Australia; [Garber, Alan M.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Garber, Alan M.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Garber, Alan M.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Commonwealth Fund; University of Adelaide; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Elshaug, AG (corresponding author), Commonwealth Fund, Int Program Hlth Policy & Practice, New York, NY 10021 USA.		Elshaug, Adam G/A-5714-2008	Elshaug, Adam/0000-0002-4939-5379				Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Food and Drug Administration, MAN US FAC DEV EXP D; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Weinstein JN, 2009, NEW ENGL J MED, V361, P619, DOI 10.1056/NEJMe0905889	4	19	20	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1390	1393		10.1056/NEJMp1101475	http://dx.doi.org/10.1056/NEJMp1101475			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	749LD	21488762	Green Published			2022-12-28	WOS:000289467200003
J	Heath, I				Heath, Iona			LIFE AND DEATH Who's complacent now? The King's Fund on general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Gen Practitioners, London, England		Heath, I (corresponding author), Royal Coll Gen Practitioners, London, England.	iona.heath22@yahoo.co.uk							0	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2011	342								d2254	10.1136/bmj.d2254	http://dx.doi.org/10.1136/bmj.d2254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752UX	21490040				2022-12-28	WOS:000289721500006
J	Diener, MK; Seiler, CM; Rossion, I; Kleeff, J; Glanemann, M; Butturini, G; Tomazic, A; Bruns, CJ; Busch, ORC; Farkas, S; Belyaev, O; Neoptolemos, JP; Halloran, C; Keck, T; Niedergethmann, M; Gellert, K; Witzigmann, H; Kollmar, O; Langer, P; Steger, U; Neudecker, J; Berrevoet, F; Ganzera, S; Heiss, MM; Luntz, SP; Bruckner, T; Kieser, M; Buchler, MW				Diener, Markus K.; Seiler, Christoph M.; Rossion, Inga; Kleeff, Joerg; Glanemann, Matthias; Butturini, Giovanni; Tomazic, Ales; Bruns, Christiane J.; Busch, Olivier R. C.; Farkas, Stefan; Belyaev, Orlin; Neoptolemos, John P.; Halloran, Christopher; Keck, Tobias; Niedergethmann, Marco; Gellert, Klaus; Witzigmann, Helmut; Kollmar, Otto; Langer, Peter; Steger, Ulrich; Neudecker, Jens; Berrevoet, Frederik; Ganzera, Silke; Heiss, Markus M.; Luntz, Steffen P.; Bruckner, Thomas; Kieser, Meinhard; Buechler, Markus W.			Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial	LANCET			English	Article							RISK-FACTORS; FISTULA; METAANALYSIS; MANAGEMENT; MORBIDITY; MORTALITY; LEAK	Background The ideal closure technique of the pancreas after distal pancreatectomy is unknown. We postulated that standardised closure with a stapler device would prevent pancreatic fistula more effectively than would a hand-sewn closure of the remnant. Methods This multicentre, randomised, controlled, parallel group-sequential superiority trial was done in 21 European hospitals. Patients with diseases of the pancreatic body and tail undergoing distal pancreatectomy were eligible and were randomly assigned by central randomisation before operation to either stapler or hand-sewn closure of the pancreatic remnant. Surgical performance was assessed with intraoperative photo documentation. The primary endpoint was the combination of pancreatic fistula and death until postoperative day 7. Patients and outcome assessors were masked to group assignment. Interim and final analysis were by intention to treat in all patients in whom a left resection was done. This trial is registered, ISRCTN18452029. Findings Between Nov 16, 2006, and July 3, 2009, 450 patients were randomly assigned to treatment groups (221 stapler; 229 hand-sewn closure), of whom 352 patients (177 stapler, 175 hand-sewn closure) were analysed. Pancreatic fistula rate or mortality did not differ between stapler (56 [32%] of 177) and hand-sewn closure (49 [28%] of 175; OR 0.84, 95% CI 0.53-1.33; p=0.56). One patient died within the first 7 days after surgery in the hand-sewn group; no deaths occurred in the stapler group. Serious adverse events did not differ between groups. Interpretation Stapler closure did not reduce the rate of pancreatic fistula compared with hand-sewn closure for distal pancreatectomy. New strategies, including innovative surgical techniques, need to be identified to reduce this adverse outcome.	[Diener, Markus K.; Seiler, Christoph M.; Rossion, Inga; Buechler, Markus W.] Univ Heidelberg, Dept Gen Visceral & Transplantat Surg, D-69120 Heidelberg, Germany; [Diener, Markus K.; Seiler, Christoph M.; Rossion, Inga] Univ Heidelberg, German Surg Soc, Study Ctr, D-69120 Heidelberg, Germany; [Kleeff, Joerg] Tech Univ Munich, Dept Gen Surg, Munich, Germany; [Glanemann, Matthias] Univ Med Berlin, Charite Campus Virchow Klinikum, Dept Gen Visceral & Transplantat Surg, Berlin, Germany; [Butturini, Giovanni] Verona Univ Hosp, Dept Surg, Verona, Italy; [Tomazic, Ales] Univ Med Ctr, Dept Surg, Ljubljana, Slovenia; [Bruns, Christiane J.] Univ Clin Munich, Dept Surg, Munich, Germany; [Busch, Olivier R. C.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Farkas, Stefan] Univ Hosp, Dept Surg, Regensburg, Germany; [Belyaev, Orlin] Ruhr Univ Bochum, St Josef Hosp, Dept Gen Surg, D-4630 Bochum, Germany; [Neoptolemos, John P.; Halloran, Christopher] Univ Liverpool, NIHR Pancreas Biomed Res Unit, Liverpool L69 3BX, Merseyside, England; [Neoptolemos, John P.; Halloran, Christopher] Univ Liverpool, Div Surg & Oncol, Liverpool L69 3BX, Merseyside, England; [Keck, Tobias] Univ Freiburg, Dept Gen & Visceral Surg, Freiburg, Germany; [Niedergethmann, Marco] Univ Heidelberg, Univ Med Ctr Mannheim, Dept Surg, D-6800 Mannheim, Germany; [Gellert, Klaus] Sana Klinikum Lichtenberg, Oskar Ziethen Krankenhaus, Dept Gen & Visceral Surg, Berlin, Germany; [Witzigmann, Helmut] Stadt Krankenhaus Dresden Friedrichstadt, Dept Gen & Visceral Surg, Dresden, Germany; [Kollmar, Otto] Saarland Univ Hosp, Dept Gen Visceral Vasc & Paediat Surg, Homburg, Germany; [Kollmar, Otto] Univ Saarland, Fac Med, D-6650 Homburg, Germany; [Langer, Peter] Univ Marburg, Univ Hosp Giessen, Dept Visceral Thorac & Vasc Surg, Marburg, Germany; [Langer, Peter] Univ Marburg, Marburg GmbH, Marburg, Germany; [Steger, Ulrich] Univ Hosp Wurzburg, Dept Gen Visceral Vasc & Paediat Surg, Wurzburg, Germany; [Neudecker, Jens] Campus Charite Mitte, Dept Gen Visceral Vasc & Thorac Surg, Berlin, Germany; [Berrevoet, Frederik] Ghent Univ Hosp, Dept Gen & Hepatobiliary Surg, Liver Transplantat Serv, B-9000 Ghent, Belgium; [Ganzera, Silke] Univ Witten Herdecke, Helios Hosp Wuppertal, Surg Ctr, Wuppertal, Germany; [Heiss, Markus M.] Univ Witten Herdecke, Merheim Med Ctr Cologne, Dept Visceral Vasc & Transplantat Surg, Cologne, Germany; [Heiss, Markus M.] Univ Witten Herdecke, Inst Res Operat Med, Cologne, Germany; [Luntz, Steffen P.] Univ Heidelberg Hosp, Coordinat Ctr Clin Trials KKS, Heidelberg, Germany; [Bruckner, Thomas; Kieser, Meinhard] Univ Heidelberg, Inst Med Biometry & Informat, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University Medical Centre Ljubljana; University of Munich; University of Amsterdam; Academic Medical Center Amsterdam; University of Regensburg; Ruhr University Bochum; University of Liverpool; University of Liverpool; University of Freiburg; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Municipal Hospital Dresden; Universitatsklinikum des Saarlandes; Saarland University; Philipps University Marburg; Philipps University Marburg; University Hospital of Giessen & Marburg; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ghent University; Ghent University Hospital; Witten Herdecke University; Witten Herdecke University; Witten Herdecke University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Buchler, MW (corresponding author), Univ Heidelberg, Dept Gen Visceral & Transplantat Surg, D-69120 Heidelberg, Germany.	markus.buechler@med.uni-heidelberg.de	Neoptolemos, John/HGU-7742-2022; Busch, Olivier/AAC-3650-2020; Kleeff, Jorg/B-2124-2009; Farkas, Stefan/AAG-5843-2020; Seiler, Christoph/AAG-7056-2021; Belyaev, Orlin/AAN-7658-2021; Berrevoet, Frederik/A-6117-2008; Belyaev, Orlin/E-4429-2013; Butturini, Giovanni/B-5567-2017	Kleeff, Jorg/0000-0003-3432-6669; Belyaev, Orlin/0000-0002-0595-2292; Berrevoet, Frederik/0000-0002-3575-5345; Butturini, Giovanni/0000-0002-9172-4885; Neoptolemos, John/0000-0002-6201-7399; Halloran, Christopher/0000-0002-5471-4178; Keck, Tobias/0000-0001-7651-6183	German Federal Ministry of Education and Research [Bundesministerium fur Bildung und Forschung (BMBF)] [01GH0606]; National Institute for Health Research [NF-SI-0510-10126] Funding Source: researchfish	German Federal Ministry of Education and Research [Bundesministerium fur Bildung und Forschung (BMBF)](Federal Ministry of Education & Research (BMBF)); National Institute for Health Research(National Institute for Health Research (NIHR))	This trial was funded by the German Federal Ministry of Education and Research [Bundesministerium fur Bildung und Forschung (BMBF); 01GH0606]. Staplers were provided by Johnson & Johnson Medical GmbH, Norderstedt, Germany. We thank Christina Klose for checking all numbers in the manuscript as well as accuracy of the wording and to Chris Halloran from Liverpool for correction of English language and proof reading of the report.	Andren-Sandberg A, 1999, DIGEST SURG, V16, P305, DOI 10.1159/000018740; Balzano G, 2005, J GASTROINTEST SURG, V9, P837, DOI 10.1016/j.gassur.2005.01.287; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Bassi C, 1999, HPB, V1, P203, DOI DOI 10.1016/S1365-182X(17)30671-8; Bilimoria MM, 2003, BRIT J SURG, V90, P190, DOI 10.1002/bjs.4032; Bruns H, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-58; Connor S, 2005, BRIT J SURG, V92, P1059, DOI 10.1002/bjs.5107; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diener MK, 2008, CLIN TRIALS, V5, P534, DOI 10.1177/1740774508096140; Fahy BN, 2002, AM J SURG, V183, P237, DOI 10.1016/S0002-9610(02)00790-0; Farrokhyar F, 2010, ANN SURG, V251, P409, DOI 10.1097/SLA.0b013e3181cf863d; Ferrone CR, 2008, J GASTROINTEST SURG, V12, P1691, DOI 10.1007/s11605-008-0636-2; Friess H, 1996, PANCREAS, V13, P202; Frozanpor F, 2010, J PANCREAS, V11, P439; Goh BKP, 2008, ARCH SURG-CHICAGO, V143, P956, DOI 10.1001/archsurg.143.10.956; Kajiyama Y, 1996, BRIT J SURG, V83, P1711, DOI 10.1002/bjs.1800831216; Knaebel HP, 2005, BRIT J SURG, V92, P539, DOI 10.1002/bjs.5000; Lillemoe KD, 1999, ANN SURG, V229, P693, DOI 10.1097/00000658-199905000-00012; Lorenz U, 2007, HPB (Oxford), V9, P302, DOI 10.1080/13651820701348621; Nathan H, 2009, ANN SURG, V250, P277, DOI 10.1097/SLA.0b013e3181ae34be; Okano K, 2008, J HEPATO-BILIARY-PAN, V15, P353, DOI 10.1007/s00534-008-1328-8; Pannegeon V, 2006, ARCH SURG-CHICAGO, V141, P1071, DOI 10.1001/archsurg.141.11.1071; Ridolfini MP, 2007, WORLD J GASTROENTERO, V13, P5096, DOI 10.3748/wjg.v13.i38.5096; Sheehan MK, 2002, AM SURGEON, V68, P264; Sledzianowski JF, 2005, SURGERY, V137, P180, DOI 10.1016/j.surg.2004.06.063; Takeuchi K, 2003, ANZ J SURG, V73, P922, DOI 10.1046/j.1445-2197.2003.02821.x; Zhao Yu-Pei, 2008, Zhonghua Wai Ke Za Zhi, V46, P24	27	357	375	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2011	377	9776					1514	1522		10.1016/S0140-6736(11)60237-7	http://dx.doi.org/10.1016/S0140-6736(11)60237-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761RX	21529927				2022-12-28	WOS:000290419400029
J	Kallmes, DF; Cloft, HJ; Molyneux, A; Burger, I; Brinjikji, W; Murphy, KP				Kallmes, David F.; Cloft, Harry J.; Molyneux, Andrew; Burger, Ingrid; Brinjikji, Waleed; Murphy, Kieren P.			Live case demonstrations: patient safety, ethics, consent, and conflicts	LANCET			English	Editorial Material									[Kallmes, David F.; Cloft, Harry J.; Brinjikji, Waleed] Mayo Clin, Rochester, MN 55902 USA; [Molyneux, Andrew] Univ Oxford, Oxford, England; [Burger, Ingrid] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Murphy, Kieren P.] Univ Toronto, Toronto, ON, Canada	Mayo Clinic; University of Oxford; University of California System; University of California San Francisco; University of Toronto	Kallmes, DF (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55902 USA.	kallmes.david@mayo.edu						ABEL DB, 2005, ENDOVASCULAR TOD JAN; CAMERON DE, SUGERY SPECTACLE; Darbari Anshuman, 2007, Indian J Surg, V69, P171, DOI 10.1007/s12262-007-0015-3; Dehmer GJ, 2010, J AM COLL CARDIOL, V56, P1267, DOI 10.1016/j.jacc.2010.08.599; Jones JW, 2008, J VASC SURG, V47, P476, DOI 10.1016/j.jvs.2007.12.001; Liao Z, 2009, AM J GASTROENTEROL, V104, P47, DOI 10.1038/ajg.2008.39; Misaki T, GUIDELINES LIVE PRES; Moore FD, 1999, ANN SURG, V229, P187, DOI 10.1097/00000658-199902000-00005; Neequaye SK, 2007, EUR J VASC ENDOVASC, V33, P525, DOI 10.1016/j.ejvs.2006.12.022; Sade RM, 2008, ANN THORAC SURG, V86, P357, DOI 10.1016/j.athoracsur.2008.05.066; Schmit A, 2005, ENDOSCOPY, V37, P695, DOI 10.1055/s-2005-870137; WEINTRAUB A, 2006, BUSINESS WEEK   1023; WOOD S, 2003, HEARTWIRE       1106	13	28	28	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2011	377	9776					1539	1541		10.1016/S0140-6736(11)60357-7	http://dx.doi.org/10.1016/S0140-6736(11)60357-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761RX	21531268				2022-12-28	WOS:000290419400031
J	Seo, JY; Yaneva, R; Hinson, ER; Cresswell, P				Seo, Jun-Young; Yaneva, Rakina; Hinson, Ella R.; Cresswell, Peter			Human Cytomegalovirus Directly Induces the Antiviral Protein Viperin to Enhance Infectivity	SCIENCE			English	Article							AMPHIPATHIC ALPHA-HELIX; ENDOPLASMIC-RETICULUM; ATP DEPLETION; ACTIN CYTOSKELETON; GENE-EXPRESSION; BETA-OXIDATION; MITOCHONDRIA; VIRUS; CELLS; REPLICATION	Viperin is an interferon-inducible protein that is directly induced in cells by human cytomegalovirus (HCMV) infection. Why HCMV would induce viperin, which has antiviral activity, is unknown. We show that HCMV-induced viperin disrupts cellular metabolism to enhance the infectious process. Viperin interaction with the viral protein vMIA resulted in viperin relocalization from the endoplasmic reticulum to the mitochondria. There, viperin interacted with the mitochondrial trifunctional protein that mediates beta-oxidation of fatty acids to generate adenosine triphosphate (ATP). This interaction with viperin, but not with a mutant lacking the viperin iron-sulfur cluster-binding motif, reduced cellular ATP generation, which resulted in actin cytoskeleton disruption and enhancement of infection. This function of viperin, which was previously attributed to vMIA, suggests that HCMV has coopted viperin to facilitate the infectious process.	[Seo, Jun-Young; Yaneva, Rakina; Hinson, Ella R.; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, 300 Cedar St, New Haven, CT 06520 USA.	peter.cresswell@yale.edu			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank C. Rahner in the Yale Center for Cell and Molecular Imaging for EM and the Keck Biotechnology Resource Laboratory for protein identification. The work was supported by the Howard Hughes Medical Institute. J.-Y.S. and P. C. conceived the study and designed experiments. J.-Y.S. performed experiments. R.Y. and E. R. H. performed assays and produced reagents. J.-Y.S. and P. C. analyzed and interpreted the data, and wrote the manuscript. All authors contributed to the final version of the manuscript.	AlBarazi HO, 1996, J VIROL, V70, P7198, DOI 10.1128/JVI.70.10.7198-7208.1996; BACALLAO R, 1994, J CELL SCI, V107, P3301; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Boudinot P, 2000, J GEN VIROL, V81, P2675, DOI 10.1099/0022-1317-81-11-2675; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Bresnahan WA, 2000, J VIROL, V74, P10816, DOI 10.1128/JVI.74.22.10816-10818.2000; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Colberg-Poley AM, 2000, J GEN VIROL, V81, P1779, DOI 10.1099/0022-1317-81-7-1779; Cudmore S, 1997, TRENDS MICROBIOL, V5, P142, DOI 10.1016/S0966-842X(97)01011-1; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Eaton S, 2000, BIOCHEM SOC T, V28, P177, DOI 10.1042/bst0280177; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Goldmacher VS, 2002, BIOCHIMIE, V84, P177, DOI 10.1016/S0300-9084(02)01367-6; Goldmacher VS, 1999, P NATL ACAD SCI USA, V96, P12536, DOI 10.1073/pnas.96.22.12536; GOLENHOFEN N, 1995, KIDNEY INT, V48, P1837, DOI 10.1038/ki.1995.482; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; JONES NL, 1986, EUR J CELL BIOL, V41, P304; Poncet D, 2006, J CELL BIOL, V174, P985, DOI 10.1083/jcb.200604069; Rivieccio MA, 2006, J IMMUNOL, V177, P4735, DOI 10.4049/jimmunol.177.7.4735; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Sharon-Friling R, 2006, P NATL ACAD SCI USA, V103, P19117, DOI 10.1073/pnas.0609353103; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Shelden EA, 2002, J AM SOC NEPHROL, V13, P2667, DOI 10.1097/01.ASN.0000033353.21502.31; Suh HS, 2007, J VIROL, V81, P9838, DOI 10.1128/JVI.00792-07; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Zhu H, 1997, P NATL ACAD SCI USA, V94, P13985, DOI 10.1073/pnas.94.25.13985	30	147	157	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1093	1097		10.1126/science.1202007	http://dx.doi.org/10.1126/science.1202007			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21527675				2022-12-28	WOS:000290996700047
J	Vons, C; Barry, C; Maitre, S; Pautrat, K; Leconte, M; Costaglioli, B; Karoui, M; Alves, A; Dousset, B; Valleur, P; Falissard, B; Franco, D				Vons, Corinne; Barry, Caroline; Maitre, Sophie; Pautrat, Karine; Leconte, Mahaut; Costaglioli, Bruno; Karoui, Mehdi; Alves, Arnaud; Dousset, Bertrand; Valleur, Patrice; Falissard, Bruno; Franco, Dominique			Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial	LANCET			English	Article							ANTIBIOTIC-THERAPY	Background Researchers have suggested that antibiotics could cure acute appendicitis. We assessed the efficacy of amoxicillin plus clavulanic acid by comparison with emergency appendicectomy for treatment of patients with uncomplicated acute appendicitis. Methods In this open-label, non-inferiority, randomised trial, adult patients (aged 18-68 years) with uncomplicated acute appendicitis, as assessed by CT scan, were enrolled at six university hospitals in France. A computer-generated randomisation sequence was used to allocate patients randomly in a 1:1 ratio to receive amoxicillin plus clavulanic acid (3 g per day) for 8-15 days or emergency appendicectomy. The primary endpoint was occurrence of postintervention peritonitis within 30 days of treatment initiation. Non-inferiority was shown if the upper limit of the two-sided 95% CI for the difference in rates was lower than 10 percentage points. Both intention-to-treat and per-protocol analyses were done. This trial is registered with ClinicalTrials.gov, number NCT00135603. Findings Of 243 patients randomised, 123 were allocated to the antibiotic group and 120 to the appendicectomy group. Four were excluded from analysis because of early dropout before receiving the intervention, leaving 239 (antibiotic group, 120; appendicectomy group, 119) patients for intention-to-treat analysis. 30-day postintervention peritonitis was significantly more frequent in the antibiotic group (8%, n=9) than in the appendicectomy group (2%, n=2; treatment difference 5.8; 95% CI 0.3-12.1). In the appendicectomy group, despite CT-scan assessment, 21 (18%) of 119 patients were unexpectedly identified at surgery to have complicated appendicitis with peritonitis. In the antibiotic group, 14 (12% [7.1-18.6]) of 120 underwent an appendicectomy during the first 30 days and 30 (29% [21.4-38.9]) of 102 underwent appendicectomy between 1 month and 1 year, 26 of whom had acute appendicitis (recurrence rate 26%; 18.0-34.7). Interpretation Amoxicillin plus clavulanic acid was not non-inferior to emergency appendicectomy for treatment of acute appendicitis. Identification of predictive markers on CT scans might enable improved targeting of antibiotic treatment.	[Vons, Corinne; Franco, Dominique] Hop Antoine Beclere, Assistance Publ Hop Paris, Clamart, France; [Vons, Corinne; Franco, Dominique] Univ Paris 11, Serv Chirurg, Clamart, France; [Maitre, Sophie] Univ Paris 11, Serv Radiol, Clamart, France; [Barry, Caroline; Falissard, Bruno] Univ Paris 11, INSERM, U669, Paris, France; [Barry, Caroline; Falissard, Bruno] Univ Paris 05, Paris, France; [Barry, Caroline; Falissard, Bruno] Hop Paul Brousse, AP HP, Villejuif, France; [Pautrat, Karine; Alves, Arnaud; Valleur, Patrice] Hop Lariboisiere, Assistance Publ Hop Paris, F-75475 Paris, France; [Pautrat, Karine; Alves, Arnaud; Valleur, Patrice] Univ Paris 07, Serv Chirurg, Paris, France; [Leconte, Mahaut; Dousset, Bertrand] Hop Cochin, Assistance Publ Hop Paris, F-75674 Paris, France; [Leconte, Mahaut; Dousset, Bertrand] Univ Paris 05, Serv Chirurg, Paris, France; [Costaglioli, Bruno] Hop Bicetre, Assistance Publ Hop Paris, Paris, France; [Costaglioli, Bruno] Univ Paris 11, Serv Chirurg, Paris, France; [Karoui, Mehdi] Le Kremlin Bicetre, Assistance Publ Hop Paris, Creteil, France; [Karoui, Mehdi] Univ Paris 12, Serv Chirurg, Creteil, France; [Karoui, Mehdi] Hop Henri Mondor, AP HP, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Vons, C (corresponding author), Hop Jean Verdier, Serv Chirurg, Ave 14 Juillet, F-93143 Bondy, France.	corinne.vons@jvr.aphp.fr	alves, arnaud/ABD-2113-2021; alves, arnaud/ABE-1469-2020	alves, arnaud/0000-0002-7280-8688; alves, arnaud/0000-0002-7242-0245; barry, caroline/0000-0001-6668-524X; Dousset, Bertrand/0000-0003-2526-7345	French Ministry of Health [AOR 02 063]; Assistance Publique-Hopitaux de Paris	French Ministry of Health; Assistance Publique-Hopitaux de Paris	We thank A Moschetto for help with identification of patients lost to follow-up; Solene Fabre for her contribution to data management; Laurent Becquemont for his constant support; and D Poussin, R Balzarotti, A Carloni, J M Proske, I Dagher, S Gueroult, J M Thillois, P Taleb, S Servadjian, J L Bouillot, I Lorand, F Gayral, A Laurent, and D Cherqui for their contributions to the study. This trial was supported by a grant from the Projet Hospitalier de Recherche Clinique of the French Ministry of Health (AOR 02 063) and Assistance Publique-Hopitaux de Paris.	Aguilo Javier, 2005, Cir Esp, V78, P312, DOI 10.1016/S0009-739X(05)70941-6; Altman DG., 2000, STAT CONFIDENCE CONF, V2nd, P171; Bixby SD, 2006, RADIOLOGY, V241, P780, DOI 10.1148/radiol.2413051896; de Kraker MEA, 2011, J ANTIMICROB CHEMOTH, V66, P398, DOI 10.1093/jac/dkq412; ERIKSSON S, 1995, BRIT J SURG, V82, P166, DOI 10.1002/bjs.1800820207; Fraser JD, 2010, J PEDIATR SURG, V45, P1198, DOI 10.1016/j.jpedsurg.2010.02.090; Hansson J, 2009, BRIT J SURG, V96, P473, DOI 10.1002/bjs.6482; Horton MD, 2000, AM J SURG, V179, P379, DOI 10.1016/S0002-9610(00)00372-X; Ingraham AM, 2010, SURGERY, V148, P625, DOI 10.1016/j.surg.2010.07.025; Konstantinidis KM, 2008, J LAPAROENDOSC ADV S, V18, P248, DOI 10.1089/lap.2006.0209; Leite NP, 2005, AM J ROENTGENOL, V185, P406, DOI 10.2214/ajr.185.2.01850406; Leung TTW, 2009, ANN SURG, V250, P51, DOI 10.1097/SLA.0b013e3181ad64a7; Lingreen R, 2010, PAIN PHYSICIAN, V13, P555; Livingston EH, 2007, ANN SURG, V245, P886, DOI 10.1097/01.sla.0000256391.05233.aa; Malik AA, 2009, J GASTROINTEST SURG, V13, P966, DOI 10.1007/s11605-009-0835-5; Ming PC, 2009, SURG LAPARO ENDO PER, V19, P244, DOI 10.1097/SLE.0b013e3181a4cda2; Parker MC, 2001, DIS COLON RECTUM, V44, P822, DOI 10.1007/BF02234701; Pelaez Nuria, 2006, Cir Esp, V80, P369; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pickhardt PJ, 2002, RADIOLOGY, V224, P775, DOI 10.1148/radiol.2243011545; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Schug-Pass C, 2010, INT J COLORECTAL DIS, V25, P751, DOI 10.1007/s00384-010-0899-4; Shindoh J, 2010, J GASTROINTEST SURG, V14, P309, DOI 10.1007/s11605-009-1094-1; Styrud J, 2006, WORLD J SURG, V30, P1033, DOI 10.1007/s00268-005-0304-6; Tsuboi M, 2008, RADIOLOGY, V246, P142, DOI 10.1148/radiol.2461051760; Varadhan KK, 2010, WORLD J SURG, V34, P199, DOI 10.1007/s00268-009-0343-5	26	388	401	2	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1573	1579		10.1016/S0140-6736(11)60410-8	http://dx.doi.org/10.1016/S0140-6736(11)60410-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763IJ	21550483				2022-12-28	WOS:000290549700030
J	Tracey, KJ				Tracey, Kevin J.			Ancient Neurons Regulate Immunity	SCIENCE			English	Editorial Material							INFLAMMATION		Feinstein Inst Med Res, Manhasset, NY 11030 USA	Northwell Health	Tracey, KJ (corresponding author), Feinstein Inst Med Res, Manhasset, NY 11030 USA.	kjtracey@nshs.edu		Tracey, Kevin J/0000-0003-1884-6314	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057226] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057226] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boettger MK, 2008, ARTHRITIS RHEUM-US, V58, P2368, DOI 10.1002/art.23608; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339	7	17	18	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					673	674		10.1126/science.1206353	http://dx.doi.org/10.1126/science.1206353			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551052	Green Accepted			2022-12-28	WOS:000290265800029
J	Gershenwald, JE; Ross, MI				Gershenwald, Jeffrey E.; Ross, Merrick I.			Sentinel-Lymph-Node Biopsy for Cutaneous Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN JOINT COMMITTEE; IN-TRANSIT METASTASES; SELECTIVE LYMPHADENECTOMY; STAGE-I; RECURRENCE; POSITIVITY; ACCURACY; PATTERNS; INCREASE; PREDICT	A 38-year-old woman presented to her dermatologist with a 2-month history of changes in a mole on her right upper back. The mole had been present for a few years, but recently the patient had noticed episodes of itching and observed blood on her blouse. On skin examination, this pigmented lesion was 8 mm in diameter and had irregular borders and variegated color. An excisional biopsy was performed; pathological examination revealed a superficial spreading melanoma, 2.8 mm thick (i.e., in depth), with ulceration and six mitotic figures per square millimeter. Subsequent examination of the patient revealed a healing biopsy site over the right upper back. There was no clinical adenopathy and no evidence of in-transit or satellite metastases. The patient had no specific symptoms indicative of metastatic disease. A surgical oncologist was consulted, who recommended that the patient undergo wide excision of the primary tumor and sentinel-lymph-node biopsy in the same operative setting.	[Gershenwald, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Unit 1484, Houston, TX 77230 USA	University of Texas System; UTMD Anderson Cancer Center	Gershenwald, JE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Unit 1484, POB 301402, Houston, TX 77230 USA.	jgershen@mdanderson.org	Gershenwald, Jeff/AAX-4367-2020	Gershenwald, Jeff/0000-0003-4519-5369	GlaxoSmithKline; Metamark Genetics; Imedex; Clinical Care Options; Schering; Genentech; Dava Oncology; Genomic Health	GlaxoSmithKline(GlaxoSmithKline); Metamark Genetics; Imedex; Clinical Care Options; Schering; Genentech(Roche HoldingGenentech); Dava Oncology; Genomic Health	Dr. Gershenwald reports receiving consulting fees from GlaxoSmithKline and Metamark Genetics, lecture fees from Imedex, fees for manuscript preparation from Clinical Care Options, royalties from Mercator Therapeutics, and fees for the development of educational presentations from Schering. Dr. Ross reports receiving consulting fees from GlaxoSmithKline and Genentech, lecture fees from Dava Oncology and Genomic Health, and travel reimbursement from Genentech. No other potential conflict of interest relevant to this article was reported.	Agnese DM, 2003, SURGERY, V134, P542, DOI 10.1016/S0039-6060(03)00275-7; Andtbacka RHI, 2009, J NATL COMPR CANC NE, V7, P308, DOI 10.6004/jnccn.2009.0023; Balch CM, 2010, J CLIN ONCOL, V28, P2452, DOI 10.1200/JCO.2009.27.1627; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; BALCH CM, 1980, CANCER-AM CANCER SOC, V45, P3012, DOI 10.1002/1097-0142(19800615)45:12<3012::AID-CNCR2820451223>3.0.CO;2-O; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Ballo NT, 2004, ONCOLOGY-NY, V18, P99; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; Cadili A, 2010, ANN SURG ONCOL, V17, P3015, DOI 10.1245/s10434-010-1145-6; Chao C, 2002, AM J SURG, V184, P520, DOI 10.1016/S0002-9610(02)01102-9; Choi EA, 2007, SURG ONCOL CLIN N AM, V16, P403, DOI 10.1016/j.soc.2007.03.004; Doeden K, 2009, J CUTAN PATHOL, V36, P772, DOI 10.1111/j.1600-0560.2008.01166.x; Estourgie SH, 2004, BRIT J SURG, V91, P1370, DOI 10.1002/bjs.4692; Faries MB, 2010, ANN SURG ONCOL, V17, P3324, DOI 10.1245/s10434-010-1203-0; Gajdos C, 2009, CANCER-AM CANCER SOC, V115, P5752, DOI 10.1002/cncr.24660; Gannon CJ, 2006, CANCER-AM CANCER SOC, V107, P2647, DOI 10.1002/cncr.22320; GERSHENWALD J, 2010, CANC MED, P1459; Gershenwald JE, 2000, ANN SURG ONCOL, V7, P160, DOI 10.1007/s10434-000-0160-4; Gershenwald JE, 1998, J CLIN ONCOL, V16, P2253, DOI 10.1200/JCO.1998.16.6.2253; Gershenwald JE, 1999, J CLIN ONCOL, V17, P976, DOI 10.1200/JCO.1999.17.3.976; Gershenwald JE, 2000, ANN SURG ONCOL, V7, P226, DOI 10.1007/BF02523658; Gershenwald JE, 2008, J CLIN ONCOL, V26, P4296, DOI 10.1200/JCO.2007.15.4179; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang JC, 2005, J CLIN ONCOL, V23, P4764, DOI 10.1200/JCO.2005.20.537; Kruper LL, 2006, CANCER-AM CANCER SOC, V107, P2436, DOI 10.1002/cncr.22295; Lee RJ, 2000, INT J RADIAT ONCOL, V46, P467, DOI 10.1016/S0360-3016(99)00431-9; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; McMasters KM, 2001, SURGERY, V130, P151, DOI 10.1067/msy.2001.115830; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Morton DL, 2005, ANN SURG, V242, P302, DOI 10.1097/01.sla.0000181092.50141.fa; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Morton Donald L, 2008, Nat Clin Pract Oncol, V5, P510, DOI 10.1038/ncponc1205; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; NCCN, 2011, NAT COMPR CANC NETW, V2; Paek SC, 2007, CANCER-AM CANCER SOC, V109, P100, DOI 10.1002/cncr.22382; Pawlik TM, 2005, ANN SURG ONCOL, V12, P587, DOI 10.1245/ASO.2005.05.025; Pawlik TM, 2005, J CLIN ONCOL, V23, P4588, DOI 10.1200/JCO.2005.12.245; Petersson F, 2009, J CUTAN PATHOL, V36, P1157, DOI 10.1111/j.1600-0560.2008.01242.x; REINTGEN D, 1994, ANN SURG, V220, P759, DOI 10.1097/00000658-199412000-00009; Ries LA, 2008, SEER CANC STAT REV 1; Rigel DS, 2010, CA-CANCER J CLIN, V60, P301, DOI 10.3322/caac.20074; ROSS MI, 1993, SEMIN SURG ONCOL, V9, P219; Rousseau DL, 2003, ANN SURG ONCOL, V10, P569, DOI 10.1245/ASO.2003.09.016; Sanki A, 2009, J CLIN ONCOL, V27, P5614, DOI 10.1200/JCO.2008.21.4882; Scoggins CR, 2010, ARCH SURG-CHICAGO, V145, P622, DOI 10.1001/archsurg.2010.115; Scolyer RA, 2005, J AM COLL SURGEONS, V201, P821, DOI 10.1016/j.jamcollsurg.2005.07.017; Scolyer RA, 2011, SURG ONCOL CLIN N AM, V20, P19, DOI 10.1016/j.soc.2010.09.006; Sondak VK, 2004, ANN SURG ONCOL, V11, P247, DOI 10.1245/ASO.2004.03.044; Thomas JM, 2004, EJSO-EUR J SURG ONC, V30, P686, DOI 10.1016/j.ejso.2004.04.004; THOMPSON JF, 1995, MELANOMA RES, V5, P255, DOI 10.1097/00008390-199508000-00008; Uren RF, 2003, J NUCL MED, V44, P570; Uren RF, 2009, ANN SURG ONCOL, V16, P1459, DOI 10.1245/s10434-009-0463-z; van Poll D, 2005, ANN SURG ONCOL, V12, P597, DOI 10.1245/ASO.2005.08.012; Voit C, 2010, J CLIN ONCOL, V28, P847, DOI 10.1200/JCO.2009.25.7428; Voit CA, 2009, J CLIN ONCOL, V27, P4994, DOI 10.1200/JCO.2008.19.0033; Wong SL, 2006, ANN SURG ONCOL, V13, P809, DOI 10.1245/ASO.2006.03.058; Wrightson WR, 2003, ANN SURG ONCOL, V10, P676, DOI 10.1245/ASO.2003.10.001; 2007, N ENGL J MED, V356, P418	58	89	92	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1738	1745		10.1056/NEJMct1002967	http://dx.doi.org/10.1056/NEJMct1002967			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759DC	21542744				2022-12-28	WOS:000290219800010
J	Neumann, PJ				Neumann, Peter J.			What Next for QALYs?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MAKERS		Tufts Univ, Sch Med, Inst Clin Res & Hlth Policy Studies, Ctr Evaluat Value & Risk Hlth,Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Neumann, PJ (corresponding author), Tufts Univ, Sch Med, Inst Clin Res & Hlth Policy Studies, Ctr Evaluat Value & Risk Hlth,Tufts Med Ctr, 800 Washington St, Boston, MA 02111 USA.	pneumann@tuftsmedicalcenter.org						Bridges JFP, 2010, EXPERT REV PHARM OUT, V10, P217, DOI 10.1586/ERP.10.31; Cohen JT, 2008, NEW ENGL J MED, V358, P661, DOI 10.1056/NEJMp0708558; *GERM I QUAL EFF H, 2009, GERM I QUAL EFF HLTH; Harris J, 2005, J MED ETHICS, V31, P373, DOI 10.1136/jme.2005.012906; KAHNEMAN D, 2007, QALYS VERSUS EXPERIE; McGregor M, 2006, PHARMACOECONOMICS, V24, P947, DOI 10.2165/00019053-200624100-00002; Neumann PJ, 2010, NEW ENGL J MED, V363, P1495, DOI 10.1056/NEJMp1007168; Nord E, 2009, VALUE HEALTH, V12, pS10, DOI 10.1111/j.1524-4733.2009.00516.x; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; *UK SECR STAT HLTH, 2010, NEW VAL BAS APPR PRI	10	35	35	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1806	1807		10.1001/jama.2011.566	http://dx.doi.org/10.1001/jama.2011.566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	758HZ	21540426				2022-12-28	WOS:000290156200024
J	Iglehart, JK				Iglehart, John K.			The ACO Regulations - Some Answers, More Questions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Berwick DM, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1103602; Guterman S, 2010, HEALTH AFFAIR, V29, P1188, DOI 10.1377/hlthaff.2010.0442; Iglehart JK, 2011, NEW ENGL J MED, V364, P198, DOI 10.1056/NEJMp1013896; Kastor JA, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1013221; Kocher R, 2011, NEW ENGL J MED, V364, P1790, DOI 10.1056/NEJMp1101959	5	13	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17								10.1056/NEJMp1103603	http://dx.doi.org/10.1056/NEJMp1103603			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755NW	21488758				2022-12-28	WOS:000289940400005
J	Buchanan, JA; Heard, K; Burbach, C; Wilson, ML; Dart, R				Buchanan, Jennie A.; Heard, Kennon; Burbach, Cynthia; Wilson, Michael L.; Dart, Richard			Prevalence of Levamisole in Urine Toxicology Screens Positive for Cocaine in an Inner-City Hospital	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Buchanan, Jennie A.] Denver Hlth & Hosp Author, Dept Emergency Med, Denver, CO USA; [Buchanan, Jennie A.; Heard, Kennon; Dart, Richard] Rocky Mt Poison & Drug Ctr, Denver, CO USA; [Burbach, Cynthia] Dept Publ Hlth, Denver, CO USA; [Wilson, Michael L.] Denver Hlth & Hosp Author, Dept Pathol, Denver, CO USA	Denver Health Medical Center; Denver Health Medical Center	Buchanan, JA (corresponding author), Denver Hlth & Hosp Author, Dept Emergency Med, Denver, CO USA.	jennie.buchanan3@dhha.org			NATIONAL INSTITUTE ON DRUG ABUSE [K08DA020573] Funding Source: NIH RePORTER; NIDA NIH HHS [K08 DA020573-05, K08DA020573, K08 DA020573] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		AMERY WKP, 1992, INT J IMMUNOPHARMACO, V14, P481, DOI 10.1016/0192-0561(92)90179-O; Chang A, 2010, CLIN PHARMACOL THER, V88, P408, DOI 10.1038/clpt.2010.156; *DRUG ENF ADM INT, 2010, DRUG INT BRIEF COC C; Rongioletti F, 1999, BRIT J DERMATOL, V140, P948, DOI 10.1046/j.1365-2133.1999.02833.x; Spector S, 1998, NEUROPSYCHOPHARMACOL, V19, P417, DOI 10.1016/S0893-133X(98)00034-7; Valentino AMM., 2005, MICROGRAM J, V3, P134	6	51	52	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1657	1658		10.1001/jama.2011.531	http://dx.doi.org/10.1001/jama.2011.531			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521846				2022-12-28	WOS:000289890500018
J	Wu, G; More, KL; Johnston, CM; Zelenay, P				Wu, Gang; More, Karren L.; Johnston, Christina M.; Zelenay, Piotr			High-Performance Electrocatalysts for Oxygen Reduction Derived from Polyaniline, Iron, and Cobalt	SCIENCE			English	Article							FUEL-CELL CATHODE; CARBON NANOTUBES; ACTIVE-SITES; CATALYSTS; ADSORPTION	The prohibitive cost of platinum for catalyzing the cathodic oxygen reduction reaction (ORR) has hampered the widespread use of polymer electrolyte fuel cells. We describe a family of non-precious metal catalysts that approach the performance of platinum-based systems at a cost sustainable for high-power fuel cell applications, possibly including automotive power. The approach uses polyaniline as a precursor to a carbon-nitrogen template for high-temperature synthesis of catalysts incorporating iron and cobalt. The most active materials in the group catalyze the ORR at potentials within similar to 60 millivolts of that delivered by state-of-the-art carbon-supported platinum, combining their high activity with remarkable performance stability for non-precious metal catalysts (700 hours at a fuel cell voltage of 0.4 volts) as well as excellent four-electron selectivity (hydrogen peroxide yield <1.0%).	[Wu, Gang; Johnston, Christina M.; Zelenay, Piotr] Los Alamos Natl Lab, Mat Phys & Applicat Div, Los Alamos, NM 87545 USA; [More, Karren L.] Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Zelenay, P (corresponding author), Los Alamos Natl Lab, Mat Phys & Applicat Div, Los Alamos, NM 87545 USA.	zelenay@lanl.gov	Wu, Gang/E-8536-2010; T, Maiyalagan/C-5716-2011; More, Karren L/A-8097-2016; Johnston, Christina/A-7344-2011; Wu, Gang/E-8536-2010	Wu, Gang/0000-0003-0885-6172; T, Maiyalagan/0000-0003-3528-3824; More, Karren L/0000-0001-5223-9097; Wu, Gang/0000-0003-4956-5208	Energy Efficiency and Renewable Energy Office of the U.S. Department of Energy (DOE); Los Alamos National Laboratory; DOE Office of Basic Energy Sciences	Energy Efficiency and Renewable Energy Office of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); DOE Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank R. Adzic, Y. S. Kim, J. Chlistunoff, F. Garzon, R. Mukundan, H. Chung, and S. Conradson for stimulating discussions. Supported by the Energy Efficiency and Renewable Energy Office of the U.S. Department of Energy (DOE) through the Fuel Cell Technologies Program, and by Los Alamos National Laboratory through the Laboratory-Directed Research and Development Program. Microscopy research was supported by the Oak Ridge National Laboratory's SHaRE User Facility, sponsored by the DOE Office of Basic Energy Sciences. The authors have filed a patent through Los Alamos National Laboratory on the catalysts described herein.	Baibarac M, 2003, CHEM MATER, V15, P4149, DOI 10.1021/cm021287x; Bashyam R, 2006, NATURE, V443, P63, DOI 10.1038/nature05118; Bonakdarpour A, 2008, ELECTROCHEM SOLID ST, V11, pB105, DOI 10.1149/1.2904768; Borup R, 2007, CHEM REV, V107, P3904, DOI 10.1021/cr050182l; Dodelet J. P., 2006, N4 MACROCYCLIC METAL, P83; Gojkovic SL, 1998, J ELECTROCHEM SOC, V145, P3493, DOI 10.1149/1.1838833; GUPTA S, 1989, J APPL ELECTROCHEM, V19, P19, DOI 10.1007/BF01039385; Hasche F, 2010, PHYS CHEM CHEM PHYS, V12, P15251, DOI 10.1039/c0cp00609b; Ikeda T, 2008, J PHYS CHEM C, V112, P14706, DOI 10.1021/jp806084d; Inaba M, 2004, ELECTROCHEM SOLID ST, V7, pA474, DOI 10.1149/1.1814595; James B., DOE EERE FUEL CELL T; Jaouen F, 2011, ENERG ENVIRON SCI, V4, P114, DOI 10.1039/c0ee00011f; Jaouen F, 2009, ACS APPL MATER INTER, V1, P1623, DOI 10.1021/am900219g; JASINSKI R, 1964, NATURE, V201, P1212, DOI 10.1038/2011212a0; Johnston C. M., 2009, HDB FUEL CELLS FUNDA, V5, P48; KINOSHITA K, 1973, CARBON, V11, P403, DOI 10.1016/0008-6223(73)90080-8; Koslowski UI, 2008, J PHYS CHEM C, V112, P15356, DOI 10.1021/jp802456e; Kothandaraman R, 2009, APPL CATAL B-ENVIRON, V92, P209, DOI 10.1016/j.apcatb.2009.07.005; LAVIRON E, 1974, J ELECTROANAL CHEM, V52, P395, DOI 10.1016/S0022-0728(74)80449-3; Maldonado S, 2004, J PHYS CHEM B, V108, P11375, DOI 10.1021/jp0496553; Matter PH, 2006, J CATAL, V239, P83, DOI 10.1016/j.jcat.2006.01.022; Nallathambi V, 2008, J POWER SOURCES, V183, P34, DOI 10.1016/j.jpowsour.2008.05.020; Schwartz V, 2002, J PHYS CHEM B, V106, P7210, DOI 10.1021/jp020870y; Sinha J., DOE EERE FUEL CELL T; Strelko VV, 2004, SURF SCI, V548, P281, DOI 10.1016/j.susc.2003.11.012; Thomas S, 1996, J PHYS CHEM-US, V100, P11726, DOI 10.1021/jp9606321; Wang H, 1999, J PHYS CHEM B, V103, P2042, DOI 10.1021/jp9821735; Wu G, 2008, LANGMUIR, V24, P3566, DOI 10.1021/la7029278; Wu G, 2009, ECS TRANSACTIONS, V25, P1299, DOI 10.1149/1.3210685; Wu G, 2008, ECS TRANSACTIONS, V16, P159, DOI 10.1149/1.2981852; Yang JB, 2008, CHEM COMMUN, P329, DOI 10.1039/b713096a; Zhang WM, 2010, ENERG ENVIRON SCI, V3, P1286, DOI 10.1039/c0ee00139b; Zheng J, 2000, J MATER CHEM, V10, P1039, DOI 10.1039/b000038h	33	3271	3350	88	3772	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					443	447		10.1126/science.1200832	http://dx.doi.org/10.1126/science.1200832			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512028				2022-12-28	WOS:000289784900037
J	Niinimaki, M; Suhonen, S; Mentula, M; Hemminki, E; Heikinheimo, O; Gissler, M				Niinimaki, Maarit; Suhonen, Satu; Mentula, Maarit; Hemminki, Elina; Heikinheimo, Oskari; Gissler, Mika			Comparison of rates of adverse events in adolescent and adult women undergoing medical abortion: population register based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK; TERMINATION; INFECTION	Objective To determine the risks of short term adverse events in adolescent and older women undergoing medical abortion. Design Population based retrospective cohort study. Setting Finnish abortion register 2000-6. Participants All women (n=27 030) undergoing medical abortion during 2000-6, with only the first induced abortion analysed for each woman. Main outcome measures Incidence of adverse events (haemorrhage, infection, incomplete abortion, surgical evacuation, psychiatric morbidity, injury, thromboembolic disease, and death) among adolescent (<18 years) and older (>= 18 years) women through record linkage of Finnish registries and genital Chlamydia trachomatis infections detected concomitantly with abortion and linked with data from the abortion register for 2004-6. Results During 2000-6, 3024 adolescents and 24 006 adults underwent at least one medical abortion. The rate of chlamydia infections was higher in the adolescent cohort (5.7% v 3.7%, P<0.001). The incidence of adverse events among adolescents was similar or lower than that among the adults. The risks of haemorrhage (adjusted odds ratio 0.87, 95% confidence interval 0.77 to 0.99), incomplete abortion (0.69, 0.59 to 0.82), and surgical evacuation (0.78, 0.67 to 0.90) were lower in the adolescent cohort. In subgroup analysis of primigravid women, the risks of incomplete abortion (0.68, 0.56 to 0.81) and surgical evacuation (0.75, 0.64 to 0.88) were lower in the adolescent cohort. In logistic regression, duration of gestation was the most important risk factor for infection, incomplete abortion, and surgical evacuation. Conclusions The incidence of adverse events after medical abortion was similar or lower among adolescents than among older women. Thus, medical abortion seems to be at least as safe in adolescents as it is in adults.	[Mentula, Maarit; Heikinheimo, Oskari] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Katiloopisto Hosp, Helsinki 00029, Finland; [Niinimaki, Maarit] Univ Hosp Oulu, Dept Obstet & Gynecol, Oulu, Finland; [Suhonen, Satu] City Helsinki Hlth Ctr, Unit Maternal & Child Hlth Care & Hlth Promot, Helsinki, Finland; [Hemminki, Elina; Gissler, Mika] Natl Inst Hlth & Welf, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden	University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare	Heikinheimo, O (corresponding author), Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Katiloopisto Hosp, POB 610, Helsinki 00029, Finland.	oskari.heikinheimo@helsinki.fi	Heikinheimo, Oskari/ABC-7792-2020; Niinimäki, Maarit/DIZ-1888-2022	Niinimäki, Maarit/0000-0003-0927-0472; Gissler, Mika/0000-0001-8254-7525; Heikinheimo, Oskari/0000-0002-8671-130X	Finnish Cultural Foundation; Helsinki University Central Hospital; University Hospital of Oulu; Concept Foundation	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Helsinki University Central Hospital; University Hospital of Oulu; Concept Foundation	This study was funded by Finnish Cultural Foundation (MN), Helsinki University Central Hospital Research Funds (OH, MN), and University Hospital of Oulu Research Funds (MN).; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: OH has lectured at an educational event organised by Nordic Drugs and has been principal investigator in clinical studies sponsored by the Concept Foundation; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work.	Deneux-Tharaux C, 2005, OBSTET GYNECOL, V106, P684, DOI 10.1097/01.AOG.0000174580.24281.e6; Department of Health, 2010, AB STAT ENGL WAL 200; *FINN GYN ASS TASK, 2001, DUODECIM, V117, P2084; Fjerstad M, 2009, NEW ENGL J MED, V361, P145, DOI 10.1056/NEJMoa0809146; GARDNER MJ, 1989, STAT CONFIDENCE CONF; Gewell-Danielsson K, 2008, REPROD HEALTH MATTER, V16, P162, DOI 10.1016/S0968-8080(08)31371-8; Gissler M, 1996, INT J EPIDEMIOL, V25, P376, DOI 10.1093/ije/25.2.376; Heikinheimo O, 2008, CONTRACEPTION, V78, P149, DOI 10.1016/j.contraception.2008.03.013; Jones Rachel K., 2010, CHARACTERISTICS US A; Lohr PA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006714.pub2; Munk-Olsen T, 2011, NEW ENGL J MED, V364, P332, DOI 10.1056/NEJMoa0905882; *NAT DEP INF DIS E, 2010, STAT DAT INF DIS REG; *NAT I HLTH WELF, 2010, IND AB; Niinimaki M, 2010, OBSTET GYNECOL, V115, P660, DOI 10.1097/AOG.0b013e3181d1b277; Niinimaki M, 2009, OBSTET GYNECOL, V113, P845, DOI 10.1097/AOG.0b013e31819cae06; *NORD CTR CLASS HL, 2010, NCSP NOMESCO CLASS S; Phelps RH, 2001, CONTRACEPTION, V64, P339, DOI 10.1016/S0010-7824(01)00296-7; *RCGP RCOG, 1985, J ROYAL COLL GEN PRA, V35, P175; Shannon C, 2004, CONTRACEPTION, V70, P183, DOI 10.1016/j.contraception.2004.04.009; Sihvo S, 2003, J EPIDEMIOL COMMUN H, V57, P601, DOI 10.1136/jech.57.8.601; *SOC, 2010, STAT; Soper DE, 2010, OBSTET GYNECOL, V116, P419, DOI 10.1097/AOG.0b013e3181e92c54; Teal SB, 2007, CONTRACEPTION, V75, P224, DOI 10.1016/j.contraception.2006.10.008; Warren JT, 2010, PERSPECT SEX REPRO H, V42, P230, DOI 10.1363/4223010; World Health Organization, 2010, INT CLASS DIS ICD	25	17	17	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2011	342								d2111	10.1136/bmj.d2111	http://dx.doi.org/10.1136/bmj.d2111			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755ON	21508042	Green Published, hybrid			2022-12-28	WOS:000289942900001
J	Spence, D				Spence, Des			FROM THE FRONTLINE The importance of mistrust: drugs of diversion	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 20	2011	342								d2465	10.1136/bmj.d2465	http://dx.doi.org/10.1136/bmj.d2465			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755ON	21508049				2022-12-28	WOS:000289942900011
J	Steinberg, DI				Steinberg, Daniel I.			Review: Risk prediction scales have different strengths and weaknesses for predicting mortality in community-acquired pneumonia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Yeshiva Univ, Albert Einstein Coll Med, Beth Israel Med Ctr, New York, NY 10033 USA	Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University	Steinberg, DI (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Beth Israel Med Ctr, New York, NY 10033 USA.								0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8							JC4-12	10.7326/0003-4819-154-8-201104190-02012	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502638				2022-12-28	WOS:000289622000011
J	Manavella, PA; Weigel, D; Wu, LA				Manavella, Pablo A.; Weigel, Detlef; Wu, Liang			Argonaute10 as a miRNA Locker	CELL			English	Editorial Material							ARABIDOPSIS DEVELOPMENT		[Manavella, Pablo A.; Weigel, Detlef; Wu, Liang] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Max Planck Society	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Manavella, Pablo/0000-0003-3589-4414				Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Lynn K, 1999, DEVELOPMENT, V126, P469; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Pouch-Pelissier MN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000096; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	9	17	19	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					173	174		10.1016/j.cell.2011.03.045	http://dx.doi.org/10.1016/j.cell.2011.03.045			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496638	Bronze			2022-12-28	WOS:000289549900006
J	Nagano, T; Fraser, P				Nagano, Takashi; Fraser, Peter			No-Nonsense Functions for Long Noncoding RNAs	CELL			English	Review							CHROMATIN; TRANSCRIPTION; COMPLEXES; CELLS		[Nagano, Takashi; Fraser, Peter] Babraham Inst, Nucl Dynam & Funct Lab, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Fraser, P (corresponding author), Babraham Inst, Nucl Dynam & Funct Lab, Babraham Res Campus, Cambridge CB22 3AT, England.	peter.fraser@bbsrc.ac.uk	Fraser, Peter/B-7549-2009	Fraser, Peter/0000-0002-0041-1227	BBSRC [BB/D014050/1, BBS/E/B/0000C151] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D014050/1, BBS/E/B/0000C151] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bond AM, 2009, NAT NEUROSCI, V12, P1020, DOI 10.1038/nn.2371; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chureau C, 2011, HUM MOL GENET, V20, P705, DOI 10.1093/hmg/ddq516; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lee JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003749; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Mao YTS, 2011, NAT CELL BIOL, V13, P95, DOI 10.1038/ncb2140; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Yan OY, 2005, BIOCHEM BIOPH RES CO, V337, P875, DOI 10.1016/j.bbrc.2005.09.122; Yao HJ, 2010, GENE DEV, V24, P2543, DOI 10.1101/gad.1967810; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	21	725	769	1	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					178	181		10.1016/j.cell.2011.03.014	http://dx.doi.org/10.1016/j.cell.2011.03.014			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496640	Bronze			2022-12-28	WOS:000289549900008
J	Greenwood, B; Targett, G				Greenwood, Brian; Targett, Geoffrey			The mysteries of immunity to malaria	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM; VACCINE		[Greenwood, Brian; Targett, Geoffrey] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Greenwood, B (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	Brian.Greenwood@lshtm.ac.uk						Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Sherman IW, 2009, ELUSIVE MALARIA VACC; Vaughan AM, 2010, HUM VACCINES, V6, P107, DOI 10.4161/hv.6.1.9654; Wilson AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016976	9	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 21	2011	377	9779					1729	1730		10.1016/S0140-6736(11)60515-1	http://dx.doi.org/10.1016/S0140-6736(11)60515-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	771AS	21514657				2022-12-28	WOS:000291130200009
J	Round, JL; Lee, SM; Li, J; Tran, G; Jabri, B; Chatila, TA; Mazmanian, SK				Round, June L.; Lee, S. Melanie; Li, Jennifer; Tran, Gloria; Jabri, Bana; Chatila, Talal A.; Mazmanian, Sarkis K.			The Toll-Like Receptor 2 Pathway Establishes Colonization by a Commensal of the Human Microbiota	SCIENCE			English	Article							REGULATORY T-CELLS; BACTERIA; DIFFERENTIATION; MATURATION; DIVERSITY	Mucosal surfaces constantly encounter microbes. Toll-like receptors (TLRs) mediate recognition of microbial patterns to eliminate pathogens. By contrast, we demonstrate that the prominent gut commensal Bacteroides fragilis activates the TLR pathway to establish host-microbial symbiosis. TLR2 on CD4(+) T cells is required for B. fragilis colonization of a unique mucosal niche in mice during homeostasis. A symbiosis factor (PSA, polysaccharide A) of B. fragilis signals through TLR2 directly on Foxp3(+) regulatory T cells to promote immunologic tolerance. B. fragilis lacking PSA is unable to restrain T helper 17 cell responses and is defective in niche-specific mucosal colonization. Therefore, commensal bacteria exploit the TLR pathway to actively suppress immunity. We propose that the immune system can discriminate between pathogens and the microbiota through recognition of symbiotic bacterial molecules in a process that engenders commensal colonization.	[Round, June L.; Lee, S. Melanie; Li, Jennifer; Tran, Gloria; Mazmanian, Sarkis K.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Jabri, Bana] Univ Chicago, Dept Med, Dept Pediat, Dept Pathol, Chicago, IL 60637 USA; [Chatila, Talal A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Immunol Allergy & Rheumatol, Los Angeles, CA 90095 USA	California Institute of Technology; University of Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Round, JL (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	jround@caltech.edu; sarkis@caltech.edu	Mazmanian, Sarkis/ABD-7729-2021	Mazmanian, Sarkis/0000-0003-2713-1513; Chatila, Talal/0000-0001-7439-2762	Crohn's and Colitis Foundation of America (CCFA) [2831, 2405]; NIH [AI 080002, DK 078938, DK 083633, AI 088626]; Damon Runyon Cancer Research Foundation; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088626, R01AI085090, R21AI080002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078938, R21DK083633, R56DK078938] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America (CCFA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. W. McBride and Y. Shen (California Institute for Technology) for help with bacterial colonization and germ-free studies. We are grateful to A. Rudensky [Memorial Sloan-Kettering Cancer Center and Howard Hughes Medical Institute (HHMI)] for the gift of Foxp3-DTR mice and L. Hooper (University of Texas Southwestern and HHMI) for germ-free Rag1<SUP>-/-</SUP> mice. We thank members of the Mazmanian laboratory for their critical review of the manuscript. B.J. acknowledges support from the Crohn's and Colitis Foundation of America (CCFA) (award 2831) and T.A.C acknowledges support from the NIH (grant AI 080002). J.L.R. is a Merck Fellow of the Jane Coffin Childs Memorial Fund. S.K.M. is a Searle Scholar. This work was supported by funding from the NIH (grants DK 078938, DK 083633, AI 088626), the Damon Runyon Cancer Research Foundation, and the CCFA (award 2405) to S.K.M. J.L.R. and S.K.M. have a patent application (PCT/US2008/082928) on the use of PSA as a therapy for inflammatory bowel disease. The authors have no competing financial interests related to this publication.	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Babu S, 2006, J IMMUNOL, V176, P3885, DOI 10.4049/jimmunol.176.7.3885; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fukata M, 2008, J IMMUNOL, V180, P1886, DOI 10.4049/jimmunol.180.3.1886; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439	24	1030	1130	11	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2011	332	6032					974	977		10.1126/science.1206095	http://dx.doi.org/10.1126/science.1206095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21512004	Green Accepted			2022-12-28	WOS:000290766600046
J	Dodd, LE; Wilkinson, RJ				Dodd, Lori Elizabeth; Wilkinson, Robert John			Isoniazid preventive therapy in HIV infection	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; TUBERCULOSIS		[Wilkinson, Robert John] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa; [Dodd, Lori Elizabeth] NIAID, Biostat Res Branch, Div Clin Res, Bethesda, MD 20892 USA; [Wilkinson, Robert John] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England; [Wilkinson, Robert John] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	University of Cape Town; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); MRC National Institute for Medical Research; Imperial College London	Wilkinson, RJ (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa.	r.j.wilkinson@imperial.ac.uk		Wilkinson, Robert/0000-0002-2753-1800	MRC [MC_U117588499] Funding Source: UKRI; Medical Research Council [MC_U117588499, U117588499(88499)] Funding Source: Medline; Wellcome Trust [088316] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P827; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Stop TB Department Department of HIV/AIDS WHO, 2011, GUID INT TUB CAS FIN	12	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1548	1550		10.1016/S0140-6736(11)60434-0	http://dx.doi.org/10.1016/S0140-6736(11)60434-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763IJ	21492928				2022-12-28	WOS:000290549700006
J	Jiao, YN; Wickett, NJ; Ayyampalayam, S; Chanderbali, AS; Landherr, L; Ralph, PE; Tomsho, LP; Hu, Y; Liang, HY; Soltis, PS; Soltis, DE; Clifton, SW; Schlarbaum, SE; Schuster, SC; Ma, H; Leebens-Mack, J; dePamphilis, CW				Jiao, Yuannian; Wickett, Norman J.; Ayyampalayam, Saravanaraj; Chanderbali, Andre S.; Landherr, Lena; Ralph, Paula E.; Tomsho, Lynn P.; Hu, Yi; Liang, Haiying; Soltis, Pamela S.; Soltis, Douglas E.; Clifton, Sandra W.; Schlarbaum, Scott E.; Schuster, Stephan C.; Ma, Hong; Leebens-Mack, Jim; dePamphilis, Claude W.			Ancestral polyploidy in seed plants and angiosperms	NATURE			English	Article							PHYLOGENETIC ANALYSIS; GENOME DUPLICATIONS; MAXIMUM-LIKELIHOOD; EVOLUTIONARY TREES; WHOLE-GENOME; GENE; ARABIDOPSIS; ORIGIN; LAND; PALEOPOLYPLOIDY	Whole-genome duplication (WGD), or polyploidy, followed by gene loss and diploidization has long been recognized as an important evolutionary force in animals, fungi and other organisms(1-3), especially plants. The success of angiosperms has been attributed, in part, to innovations associated with gene or whole-genome duplications(4-6), but evidence for proposed ancient genome duplications pre-dating the divergence of monocots and eudicots remains equivocal in analyses of conserved gene order. Here we use comprehensive phylogenomic analyses of sequenced plant genomes and more than 12.6 million new expressed-sequence-tag sequences from phylogenetically pivotal lineages to elucidate two groups of ancient gene duplications-one in the common ancestor of extant seed plants and the other in the common ancestor of extant angiosperms. Gene duplication events were intensely concentrated around 319 and 192 million years ago, implicating two WGDs in ancestral lineages shortly before the diversification of extant seed plants and extant angiosperms, respectively. Significantly, these ancestral WGDs resulted in the diversification of regulatory genes important to seed and flower development, suggesting that they were involved in major innovations that ultimately contributed to the rise and eventual dominance of seed plants and angiosperms.	[Jiao, Yuannian; Ma, Hong; dePamphilis, Claude W.] Penn State Univ, Intercoll Grad Degree Program Plant Biol, University Pk, PA 16802 USA; [Jiao, Yuannian; Wickett, Norman J.; Landherr, Lena; Ralph, Paula E.; Hu, Yi; Ma, Hong; dePamphilis, Claude W.] Penn State Univ, Inst Mol Evolutionary Genet, Dept Biol, University Pk, PA 16802 USA; [Jiao, Yuannian; Wickett, Norman J.; Landherr, Lena; Ralph, Paula E.; Hu, Yi; Ma, Hong; dePamphilis, Claude W.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Ayyampalayam, Saravanaraj; Leebens-Mack, Jim] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Chanderbali, Andre S.; Soltis, Douglas E.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Tomsho, Lynn P.; Schuster, Stephan C.] Penn State Univ, Ctr Infect Dis Dynam, Ctr Comparat Genom, University Pk, PA 16802 USA; [Liang, Haiying] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA; [Soltis, Pamela S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Clifton, Sandra W.] Washington Univ, Genome Ctr, St Louis, MO 63108 USA; [Schlarbaum, Scott E.] Univ Tennessee, Inst Agr, Dept Forestry Wildlife & Fisheries, Knoxville, TN 37996 USA; [Ma, Hong] Fudan Univ, Ctr Evolutionary Biol, Inst Plant Biol, Sch Life Sci,State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Ma, Hong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; University of Georgia; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Clemson University; State University System of Florida; University of Florida; Washington University (WUSTL); University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Fudan University; Fudan University	dePamphilis, CW (corresponding author), Penn State Univ, Intercoll Grad Degree Program Plant Biol, University Pk, PA 16802 USA.	cwd3@psu.edu	Soltis, Douglas/L-5957-2015; dePamphilis, Claude W/P-6652-2016; Jiao, Yuannian/H-8668-2012; Soltis, Pamela S/L-5184-2015; Leebens-Mack, James/AAF-6770-2019; Ma, Hong/W-5251-2018; Jiao, Yuannian/AAZ-7054-2021; Soltis, Pamela S/GNH-5557-2022; Wickett, Norman/AAV-8136-2021	Leebens-Mack, James/0000-0003-4811-2231; Ma, Hong/0000-0001-8717-4422; Jiao, Yuannian/0000-0002-8987-2782; Soltis, Pamela S/0000-0001-9310-8659; Wickett, Norman/0000-0003-0944-1956; Chanderbali, Andre/0000-0002-8728-6739	NSF [DEB 0638595]; Department of Biology; Huck Institutes of Life Sciences of the Pennsylvania State University; Fudan University; Direct For Biological Sciences [0830009] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0922742] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Department of Biology; Huck Institutes of Life Sciences of the Pennsylvania State University; Fudan University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported primarily by NSF Plant Genome Research Program (DEB 0638595, The Ancestral Angiosperm Genome Project) and in part by the Department of Biology and by the Huck Institutes of Life Sciences of the Pennsylvania State University. H. M. was also supported by funds from Fudan University. We thank J. Carlson, M. Frohlich, S. DiLoretto, L. Warg, S. Crutchfield, C. Johnson, N. Naznin, X. Zhou, J. Duarte, B. J. Bliss, J. Der and E. Wafula for help and discussion, D. Stevenson and C. Schultz for Zamia samples, J. McNeal, S. Kim and M. Axtell for photographs, and all the members of The Genome Center at Washington University production team, especially L. Fulton, K. Delehaunty and C. Fronick.	[Anonymous], 1991, POLLEN SPORES PATTER; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barker MS, 2009, GENOME BIOL EVOL, V1, P391, DOI 10.1093/gbe/evp040; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Buggs RJA, 2009, HEREDITY, V103, P73, DOI 10.1038/hdy.2009.24; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Dechaine JM, 2009, PLANT CELL ENVIRON, V32, P1297, DOI 10.1111/j.1365-3040.2009.01998.x; Devlin PF, 1998, PLANT CELL, V10, P1479, DOI 10.1105/tpc.10.9.1479; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; FELSENSTEIN J, 1978, SYST ZOOL, V27, P27, DOI 10.2307/2412810; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Hu W, 2008, J INTEGR PLANT BIOL, V50, P1031, DOI 10.1111/j.1744-7909.2008.00681.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kassahn KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/gr.086827.108; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lynch M, 2007, ORIGINS GENOME ARCHI; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Mathews S, 2003, MOL BIOL EVOL, V20, P1087, DOI 10.1093/molbev/msg123; McLachlan G.J., 1999, J STAT SOFTW, V4, DOI DOI 10.18637/JSS.V004.I02; Miller CN, 1999, BOT REV, V65, P239, DOI 10.1007/BF02857631; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Ohno S., 1970, EVOLUTION GENE DUPLI; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Prigge MJ, 2006, EVOL DEV, V8, P350, DOI 10.1111/j.1525-142X.2006.00107.x; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Solds DE, 2008, ANN NY ACAD SCI, V1133, P3, DOI 10.1196/annals.1438.005; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Vandepoele K, 2002, TRENDS GENET, V18, P606, DOI 10.1016/S0168-9525(02)02796-8; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	54	1353	1406	23	632	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					97	U113		10.1038/nature09916	http://dx.doi.org/10.1038/nature09916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21478875				2022-12-28	WOS:000290218300038
J	Adams, DK; McGillicuddy, DJ; Zamudio, L; Thurnherr, AM; Liang, XF; Rouxel, O; German, CR; Mullineaux, LS				Adams, Diane K.; McGillicuddy, Dennis J., Jr.; Zamudio, Luis; Thurnherr, Andreas M.; Liang, Xinfeng; Rouxel, Olivier; German, Christopher R.; Mullineaux, Lauren S.			Surface-Generated Mesoscale Eddies Transport Deep-Sea Products from Hydrothermal Vents	SCIENCE			English	Article							EAST PACIFIC RISE; TROPICAL PACIFIC; LARVAE; RIDGE; REPRODUCTION; TEHUANTEPEC; PATTERNS; FIELDS; PLUME; IRON	Atmospheric forcing, which is known to have a strong influence on surface ocean dynamics and production, is typically not considered in studies of the deep sea. Our observations and models demonstrate an unexpected influence of surface-generated mesoscale eddies in the transport of hydrothermal vent efflux and of vent larvae away from the northern East Pacific Rise. Transport by these deep-reaching eddies provides a mechanism for spreading the hydrothermal chemical and heat flux into the deep-ocean interior and for dispersing propagules hundreds of kilometers between isolated and ephemeral communities. Because the eddies interacting with the East Pacific Rise are formed seasonally and are sensitive to phenomena such as El Nino, they have the potential to introduce seasonal to interannual atmospheric variations into the deep sea.	[Adams, Diane K.; McGillicuddy, Dennis J., Jr.; Rouxel, Olivier; German, Christopher R.; Mullineaux, Lauren S.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Zamudio, Luis] Florida State Univ, Ctr Ocean Atmospher Predict Studies, Tallahassee, FL 32306 USA; [Thurnherr, Andreas M.; Liang, Xinfeng] Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Rouxel, Olivier] Univ Brest, Univ Europeenne Bretagne, UMR 6538, Inst Francais Rech Exploitat Mer IFREMER,IUEM, F-29280 Plouzane, France	Woods Hole Oceanographic Institution; State University System of Florida; Florida State University; Columbia University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ifremer; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Adams, DK (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.	dadams@whoi.edu	Adams, Diane/E-7831-2015; Rouxel, Olivier J/F-3954-2014; Liang, Xinfeng/B-4716-2014; Liang, Xinfeng/D-6366-2011	Adams, Diane/0000-0001-6638-5781; Rouxel, Olivier J/0000-0002-1431-222X; Liang, Xinfeng/0000-0002-5628-4896; Thurnherr, Andreas/0000-0002-1977-7122; Mullineaux, Lauren/0000-0002-8932-2625; McGillicuddy, Dennis/0000-0002-1437-2425	NSF [OCE-0424953, OCE-0425361, OCE-0647948]; Deep Ocean Exploration Institute; Ocean Venture Fund; National Defense Science and Engineering; WHOI Jannasch Chair for Excellence in Oceanography	NSF(National Science Foundation (NSF)); Deep Ocean Exploration Institute; Ocean Venture Fund; National Defense Science and Engineering; WHOI Jannasch Chair for Excellence in Oceanography	We are grateful for help at sea from S. Beaulieu, K. Buckman, D. Fornari, A. Fusaro, I. Garcia Berdeal, B. Govenar, B. Hogue, R. Jackson, S. Mills, C. Strasser, T. Shank, S. Worrilow, and to the Captains and crew, Alvin group, and Chief Scientists (M. Lilley and C. Vetriani) during Atlantis cruises AT11-20, 11-26, 15-12, and 15-26. Altimeter products were produced and distributed by AVISO (www.aviso.oceanobs.com/) as part of the Ssalto ground processing segment. V. Kosnyrev assisted in the analysis of altimetric data. M. Auro and S. Birdwhistell assisted with geochemical analysis. The LADDER group provided input during numerous discussions. HYCOM simulations were performed as part of the Office of Naval Research project Eddy Resolving Global Ocean Prediction Including Tides using challenge and nonchallenge time from the U. S. Department of Defense (DOD) High Performance Computing Modernization Office on Cray XT5 and IBM P6 computers at the Navy DOD Supercomputing Resource Center, Stennis Space Center. Support was provided by NSF grants OCE-0424953, OCE-0425361, and OCE-0647948; Woods Hole Oceanographic Institution (WHOI) grants from the Deep Ocean Exploration Institute and the Ocean Venture Fund; a National Defense Science and Engineering Graduate Fellowship to D.K.A.; and the WHOI Jannasch Chair for Excellence in Oceanography to L.S.M. Larval fluxes, chemical fluxes, and current records from 2004-2005 have been deposited in the Marine Geoscience Data System: RIDGE 2000 Data Portal. The authors declare no competing financial interests.	Adams DK, 2008, LIMNOL OCEANOGR, V53, P1945, DOI 10.4319/lo.2008.53.5.1945; Adams DK, 2010, DEEP-SEA RES PT I, V57, P1163, DOI 10.1016/j.dsr.2010.06.009; Baker ET, 2004, GEOPHYS MONOGR SER, V148, P245, DOI 10.1029/148GM10; Bennett SA, 2008, EARTH PLANET SC LETT, V270, P157, DOI 10.1016/j.epsl.2008.01.048; Chu NC, 2006, EARTH PLANET SC LETT, V245, P202, DOI 10.1016/j.epsl.2006.02.043; CRADDOCK C, 1995, MAR BIOL, V124, P137, DOI 10.1007/BF00349155; EDMOND JM, 1979, EARTH PLANET SC LETT, V46, P759; Fu LL, 2010, OCEANOGRAPHY, V23, P14, DOI 10.5670/oceanog.2010.02; German C.R., 2004, TREATISE GEOCHEMISTR, V6, p181?222; German CR, 2002, DEEP-SEA RES PT I, V49, P1921, DOI 10.1016/S0967-0637(02)00086-9; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; Jayne SR, 2002, J PHYS OCEANOGR, V32, P3328, DOI 10.1175/1520-0485(2002)032<3328:TOEHT>2.0.CO;2; Khripounoff A, 2008, DEEP-SEA RES PT I, V55, P532, DOI 10.1016/j.dsr.2008.01.001; Lavelle JW, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006426; Mackey DJ, 2002, DEEP-SEA RES PT I, V49, P877, DOI 10.1016/S0967-0637(01)00075-9; McGillicuddy DJ, 2010, DEEP-SEA RES PT I, V57, P880, DOI 10.1016/j.dsr.2010.04.003; Moore TS, 2009, DEEP-SEA RES PT II, V56, P1616, DOI 10.1016/j.dsr2.2009.05.008; Mullineaux LS, 2010, P NATL ACAD SCI USA, V107, P7829, DOI 10.1073/pnas.0913187107; Palacios DM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024324; Robinson A. R., 1983, EDDIES MARINE SCI; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Tagliabue A, 2010, NAT GEOSCI, V3, P252, DOI 10.1038/NGEO818; Thomson RE, 2003, NATURE, V424, P545, DOI 10.1038/nature01824; Toner BM, 2009, NAT GEOSCI, V2, P197, DOI 10.1038/NGEO433; Tunnicliffe V, 1998, ADV MAR BIOL, V34, P353, DOI 10.1016/S0065-2881(08)60213-8; Tyler PA, 1999, J MAR BIOL ASSOC UK, V79, P193, DOI 10.1017/S0025315499000235; Tyler PA, 2008, J SHELLFISH RES, V27, P107, DOI 10.2983/0730-8000(2008)27[107:ROGFVO]2.0.CO;2; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Willett CS, 2006, PROG OCEANOGR, V69, P218, DOI 10.1016/j.pocean.2006.03.010; Zamudio L, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003182	30	82	92	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					580	583		10.1126/science.1201066	http://dx.doi.org/10.1126/science.1201066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527710	Green Submitted, Green Published			2022-12-28	WOS:000289991100046
J	Wehbe, E; Hall, P				Wehbe, Edgard; Hall, Phillip			Diversion Stones	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wehbe, Edgard; Hall, Phillip] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Wehbe, E (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.	wehbee@ccf.org							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					E36	E36		10.1056/NEJMicm1008764	http://dx.doi.org/10.1056/NEJMicm1008764			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755NW	21524211				2022-12-28	WOS:000289940400013
J	Cartwright, N				Cartwright, Nancy			The Art of Medicine A philosopher's view of the long road from RCTs to effectiveness	LANCET			English	Editorial Material									[Cartwright, Nancy] Univ London London Sch Econ & Polit Sci, Dept Philosophy Log & Sci Method, London WC2A 2AE, England; [Cartwright, Nancy] Univ Calif San Diego, Dept Philosophy, La Jolla, CA 92093 USA	University of London; London School Economics & Political Science; University of California System; University of California San Diego	Cartwright, N (corresponding author), Univ London London Sch Econ & Polit Sci, Dept Philosophy Log & Sci Method, Houghton St, London WC2A 2AE, England.	R.Robinson1@lse.ac.uk			AHRC [AH/H007857/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/H007857/1] Funding Source: researchfish	AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))		Cartwright Nancy, 2011, CAUSALITY SCI; Mantzavinos C., 2009, PHILOS SOCIAL SCI PH; REISS J, 2010, SAGE HDB PHILOS SOCI; Worrall J, 2007, PHILOS COMPASS, V2, P981, DOI 10.1111/j.1747-9991.2007.00106.x; Worrall J, 2010, J EVAL CLIN PRACT, V16, P356, DOI 10.1111/j.1365-2753.2010.01400.x	5	110	110	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 23	2011	377	9775					1400	1401		10.1016/S0140-6736(11)60563-1	http://dx.doi.org/10.1016/S0140-6736(11)60563-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	755UF	21520508				2022-12-28	WOS:000289963000013
J	Nicholls, H				Nicholls, Henry			The art of conservation	NATURE			English	Editorial Material												henry@henrynicholls.com						Bonner R., 1993, HAND MAN PERIL HOPE; *CONS INT, 2010, NEW LOG NEW MISS CON; HUGHESEVANS D, 1981, ENVIRONMENTALIST, V1, P91; Schwarzenbach Alexis, 2011, SAVING WORLDS WILDLI; 1990, ORYX, V24, P118	5	8	8	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					287	289		10.1038/472287a	http://dx.doi.org/10.1038/472287a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752VW	21512551	Bronze			2022-12-28	WOS:000289724600013
J	Lipscombe, L				Lipscombe, Lorraine			HbA(1c) levels had low sensitivity but high specificity for screening for diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Womens Coll Hosp, Toronto, ON M5S 1B2, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital	Lipscombe, L (corresponding author), Womens Coll Hosp, Toronto, ON M5S 1B2, Canada.			Lipscombe, Lorraine/0000-0001-7412-7993				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bloomgarden Zachary T, 2009, Diabetes Care, V32, pe141, DOI 10.2337/dc09-zb12; Cavagnolli G, 2011, DIABETIC MED, V28, P31, DOI 10.1111/j.1464-5491.2010.03159.x; Selvin E, 2011, DIABETES CARE, V34, P84, DOI 10.2337/dc10-1235	4	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8							JC4-9	10.7326/0003-4819-154-8-201104190-02009	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502647				2022-12-28	WOS:000289622000008
J	Walker, N				Walker, Neff			Plausible estimates of stillbirth rates	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Walker, N (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	pneffwalker@yahoo.com						Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Darmstadt GL, 2008, HEALTH POLICY PLANN, V23, P101, DOI 10.1093/heapol/czn001; GARNETT GP, LANCET IN PRESS; OESTERGAARD MZ, 2011, NEONATAL MO IN PRESS; UNAIDS, UNAIDS REP GLOB AIDS; World Health Organization, GLOB BURD DIS	8	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1292	1294		10.1016/S0140-6736(10)62355-0	http://dx.doi.org/10.1016/S0140-6736(10)62355-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21496919				2022-12-28	WOS:000289962900005
J	Ang, YS; Tsai, SY; Lee, DF; Monk, J; Su, J; Ratnakumar, K; Ding, JJ; Ge, YC; Darr, H; Chang, B; Wang, JL; Rendl, M; Bernstein, E; Schaniel, C; Lemischka, IR				Ang, Yen-Sin; Tsai, Su-Yi; Lee, Dung-Fang; Monk, Jonathan; Su, Jie; Ratnakumar, Kajan; Ding, Junjun; Ge, Yongchao; Darr, Henia; Chang, Betty; Wang, Jianlong; Rendl, Michael; Bernstein, Emily; Schaniel, Christoph; Lemischka, Ihor R.			Wdr5 Mediates Self-Renewal and Reprogramming via the Embryonic Stem Cell Core Transcriptional Network	CELL			English	Article							CHROMATIN-STRUCTURE; DEVELOPMENTAL REGULATORS; HISTONE H3; POLYCOMB; GENES; PLURIPOTENT; BINDING; GENOME; RECOGNITION; METHYLATION	The embryonic stem (ES) cell transcriptional and chromatin-modifying networks are critical for self-renewal maintenance. However, it remains unclear whether these networks functionally interact and, if so, what factors mediate such interactions. Here, we show that WD repeat domain 5 (Wdr5), a core member of the mammalian Trithorax (trxG) complex, positively correlates with the undifferentiated state and is a regulator of ES cell self-renewal. We demonstrate that Wdr5, an "effector" of H3K4 methylation, interacts with the pluripotency transcription factor Oct4. Genome-wide protein localization and transcriptome analyses demonstrate overlapping gene regulatory functions between Oct4 and Wdr5. The Oct4-Sox2-Nanog circuitry and trxG cooperate in activating transcription of key self-renewal regulators, and furthermore, Wdr5 expression is required for the efficient formation of induced pluripotent stem (iPS) cells. We propose an integrated model of transcriptional and epigenetic control, mediated by select trxG members, for the maintenance of ES cell self-renewal and somatic cell reprogramming.	[Ang, Yen-Sin; Tsai, Su-Yi; Lee, Dung-Fang; Monk, Jonathan; Su, Jie; Ratnakumar, Kajan; Ding, Junjun; Darr, Henia; Chang, Betty; Wang, Jianlong; Rendl, Michael; Bernstein, Emily; Schaniel, Christoph; Lemischka, Ihor R.] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA; [Ang, Yen-Sin; Lee, Dung-Fang; Monk, Jonathan; Su, Jie; Darr, Henia; Chang, Betty; Schaniel, Christoph; Lemischka, Ihor R.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Ang, Yen-Sin; Tsai, Su-Yi; Lee, Dung-Fang; Su, Jie; Ding, Junjun; Darr, Henia; Chang, Betty; Wang, Jianlong; Rendl, Michael; Lemischka, Ihor R.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Ratnakumar, Kajan; Bernstein, Emily] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Tsai, Su-Yi; Ratnakumar, Kajan; Rendl, Michael; Bernstein, Emily] Mt Sinai Sch Med, Dept Dermatol, New York, NY 10029 USA; [Ge, Yongchao] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ang, YS (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA.	yen-sin.ang@mssm.edu; ihor.lemischka@mssm.edu	Schaniel, Chrisoph/C-9655-2012; Ding, Junjun/F-8618-2015; Ding, Junjun/C-4098-2012; Wang, Jianlong/AAG-9425-2020; Ge, Yongchao/AAG-9317-2021; Wang, Jianlong/GQR-1191-2022; Schaniel, Christoph/P-3836-2019	Ge, Yongchao/0000-0001-6448-5703; Wang, Jianlong/0000-0002-1317-6457; Schaniel, Christoph/0000-0002-1343-4858; TSAI, SU-YI/0000-0002-7423-645X; Rendl, Michael/0000-0001-6326-620X; Su, Jie/0000-0002-3071-7139; Ding, Junjun/0000-0002-9936-882X; Lee, Dung-Fang/0000-0003-2387-597X; Monk, Jonathan M./0000-0002-3895-8949	NIH [R01GM078465]; NYSTEM [C024410, C024285]; Dermatology Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD075735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; Dermatology Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C.D. Allis, C. Hughes, J. Wysocka, A. Sevilla, X. Carvajal-Vergara, F. Pereira, A. Waghray, S. Pardo, S. Mendez-Ferrer, W.L. Tam, B. Lim, C. Ren, H.A. Wu, J. Gingold, and V. Nair for technical assistance, materials, and advice. This work was supported by NIH (R01GM078465) to I.R.L.; NYSTEM (C024410) to I.R.L and C.S.; and NYSTEM (C024285) to E.B.D.F.L. is a NYSCF Fellow. M.R. is supported by a Dermatology Foundation Career Development Award.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Lairmore TC, 2009, ADV EXP MED BIOL, V668, P87; Landeira D, 2011, TRENDS CELL BIOL, V21, P74, DOI 10.1016/j.tcb.2010.10.004; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Pullirsch D, 2010, DEVELOPMENT, V137, P935, DOI 10.1242/dev.035956; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Taylor MD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000813; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Tsai SY, 2010, STEM CELLS, V28, P221, DOI 10.1002/stem.281; Tyagi S, 2009, EMBO J, V28, P3185, DOI 10.1038/emboj.2009.258; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zhu ED, 2008, J BIOL CHEM, V283, P7361, DOI 10.1074/jbc.M703304200	44	419	439	1	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					183	197		10.1016/j.cell.2011.03.003	http://dx.doi.org/10.1016/j.cell.2011.03.003			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21477851	Green Accepted, Bronze			2022-12-28	WOS:000289549900009
J	Grangier, P				Grangier, Philippe			Make It Quantum and Continuous	SCIENCE			English	Editorial Material							PODOLSKY-ROSEN CHANNELS; TELEPORTATION; STATES; LIGHT		Inst Opt, F-91127 Palaiseau, France	UDICE-French Research Universities; Universite Paris Saclay	Grangier, P (corresponding author), Inst Opt, F-91127 Palaiseau, France.	philippe.grangier@institutoptique.fr						Ban M, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.054304; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Gerrits T, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.031802; Grosshans F, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.010301; Lee N, 2011, SCIENCE, V332, P330, DOI 10.1126/science.1201034; Lvovsky AI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.050402; Neergaard-Nielsen JS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083604; Ourjoumtsev A, 2006, SCIENCE, V312, P83, DOI 10.1126/science.1122858; Ourjoumtsev A, 2007, NATURE, V448, P784, DOI 10.1038/nature06054; Ourjoumtsev A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.213601; Ourjoumtsev A, 2009, NAT PHYS, V5, P189, DOI 10.1038/NPHYS1199; Parigi V, 2007, SCIENCE, V317, P1890, DOI 10.1126/science.1146204; SLUSHER RE, 1985, PHYS REV LETT, V55, P2409, DOI 10.1103/PhysRevLett.55.2409; Takahashi H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.233605	17	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					313	314		10.1126/science.1204814	http://dx.doi.org/10.1126/science.1204814			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493849				2022-12-28	WOS:000289516600032
J	Huskins, WC; Huckabee, CM; O'Grady, NP; Murray, P; Kopetskie, H; Zimmer, L; Walker, ME; Sinkowitz-Cochran, RL; Jernigan, JA; Samore, M; Wallace, D; Goldmann, DA				Huskins, W. Charles; Huckabee, Charmaine M.; O'Grady, Naomi P.; Murray, Patrick; Kopetskie, Heather; Zimmer, Louise; Walker, Mary Ellen; Sinkowitz-Cochran, Ronda L.; Jernigan, John A.; Samore, Matthew; Wallace, Dennis; Goldmann, Donald A.		STAR ICU Trial Investigators	Intervention to Reduce Transmission of Resistant Bacteria in Intensive Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVENTING NOSOCOMIAL TRANSMISSION; STAPHYLOCOCCUS-AUREUS MRSA; ACTIVE SURVEILLANCE; NASAL CARRIAGE; GOWN-USE; ENTEROCOCCI; ACQUISITION; UNIT; IMPACT; CHLORHEXIDINE	BACKGROUND Intensive care units (ICUs) are high-risk settings for the transmission of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). METHODS In a cluster-randomized trial, we evaluated the effect of surveillance for MRSA and VRE colonization and of the expanded use of barrier precautions (intervention) as compared with existing practice (control) on the incidence of MRSA or VRE colonization or infection in adult ICUs. Surveillance cultures were obtained from patients in all participating ICUs; the results were reported only to ICUs assigned to the intervention. In intervention ICUs, patients who were colonized or infected with MRSA or VRE were assigned to care with contact precautions; all the other patients were assigned to care with universal gloving until their discharge or until surveillance cultures obtained at admission were reported to be negative. RESULTS During a 6-month intervention period, there were 5434 admissions to 10 intervention ICUs, and 3705 admissions to 8 control ICUs. Patients who were colonized or infected with MRSA or VRE were assigned to barrier precautions more frequently in intervention ICUs than in control ICUs (a median of 92% of ICU days with either contact precautions or universal gloving [51% with contact precautions and 43% with universal gloving] in intervention ICUs vs. a median of 38% of ICU days with contact precautions in control ICUs, P<0.001). In intervention ICUs, health care providers used clean gloves, gowns, and hand hygiene less frequently than required for contacts with patients assigned to barrier precautions; when contact precautions were specified, gloves were used for a median of 82% of contacts, gowns for 77% of contacts, and hand hygiene after 69% of contacts, and when universal gloving was specified, gloves were used for a median of 72% of contacts and hand hygiene after 62% of contacts. The mean (+/- SE) ICU-level incidence of events of colonization or infection with MRSA or VRE per 1000 patient-days at risk, adjusted for baseline incidence, did not differ significantly between the intervention and control ICUs (40.4 +/- 3.3 and 35.6 +/- 3.7 in the two groups, respectively; P = 0.35). CONCLUSIONS The intervention was not effective in reducing the transmission of MRSA or VRE, although the use of barrier precautions by providers was less than what was required.	[Huskins, W. Charles] Mayo Clin, Div Pediat Infect Dis, Rochester, MN 55905 USA; [Huckabee, Charmaine M.; Kopetskie, Heather; Zimmer, Louise; Wallace, Dennis] Rho Fed Syst Div, Chapel Hill, NC USA; [O'Grady, Naomi P.; Murray, Patrick] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Walker, Mary Ellen] Univ Alabama Birmingham, Birmingham, AL USA; [Sinkowitz-Cochran, Ronda L.; Jernigan, John A.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA USA; [Samore, Matthew] Univ Utah, Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Goldmann, Donald A.] Harvard Univ, Sch Med, Boston, MA USA; [Goldmann, Donald A.] Inst Healthcare Improvement, Cambridge, MA USA	Mayo Clinic; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Alabama System; University of Alabama Birmingham; Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; Institute for Healthcare Improvement	Huskins, WC (corresponding author), Mayo Clin, Div Pediat Infect Dis, 200 1st Ave SW, Rochester, MN 55905 USA.	huskins.charles@mayo.edu	Wallace, Dennis/AAR-7005-2021	Jernigan, John/0000-0001-8163-925X; Huskins, W. Charles/0000-0002-9989-175X	National Institute of Allergy and Infectious Diseases [N01 AI-15440, N01 AI-15441]; National Center for Research Resources [M01-RR-00585, UL1-RR024150, M01-RR-00039]; General Clinical Research Center at Emory University; Merck; Elan Pharmaceuticals; Roche Diagnostics; Kimberly Clark; Medegen; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150, M01RR000585, M01RR000039, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI015440] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL008080] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); General Clinical Research Center at Emory University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Merck(Merck & Company); Elan Pharmaceuticals; Roche Diagnostics; Kimberly Clark; Medegen; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER	Supported by contracts (N01 AI-15440 and N01 AI-15441) from the National Institute of Allergy and Infectious Diseases to the Bacteriology and Mycology Study Group clinical research network and the Bacteriology and Mycology Statistical and Operations Unit data coordinating center; by institutional grants (M01-RR-00585, UL1-RR024150, and M01-RR-00039) from the National Center for Research Resources to the Mayo Clinic Center for Translational Science Activities and the General Clinical Research Center at Emory University; and by Merck, Elan Pharmaceuticals, Roche Diagnostics, and Kimberly Clark.; Dr. Huskins reports receiving consulting fees from Roche Diagnostics and serving on an advisory board for GlaxoSmithKline; and Dr. Goldmann, receiving consulting fees from Medegen and serving on an advisory board for BioNeutral Group. No other potential conflict of interest relevant to this article was reported.	Acton DS, 2009, EUR J CLIN MICROBIOL, V28, P115, DOI 10.1007/s10096-008-0602-7; Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Ammerlaan HSM, 2009, CLIN INFECT DIS, V48, P922, DOI 10.1086/597291; Bearman GML, 2007, AM J INFECT CONTROL, V35, P650, DOI 10.1016/j.ajic.2007.02.011; Bootsma MCJ, 2006, P NATL ACAD SCI USA, V103, P5620, DOI 10.1073/pnas.0510077103; Climo MW, 2009, CRIT CARE MED, V37, P1858, DOI 10.1097/CCM.0b013e31819ffe6d; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Currie A, 2008, J CLIN MICROBIOL, V46, P3101, DOI 10.1128/JCM.00848-08; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Duckro AN, 2005, ARCH INTERN MED, V165, P302, DOI 10.1001/archinte.165.3.302; Fridkin SK, 1999, CLIN INFECT DIS, V29, P245, DOI 10.1086/520193; Garner JS, 1996, INFECT CONT HOSP EP, V17, P214; Golan Y, 2006, CLIN INFECT DIS, V42, P370, DOI 10.1086/498906; Grant J, 2006, INFECT CONT HOSP EP, V27, P191, DOI 10.1086/500623; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Hardy KJ, 2006, INFECT CONT HOSP EP, V27, P127, DOI 10.1086/500622; Hayden MK, 2006, CLIN INFECT DIS, V42, P1552, DOI 10.1086/503845; *HEALTHC INF CONTR, 2006, MAN MULT RES ORG HEA; Hidron AI, 2009, INFECT CONT HOSP EP, V30, DOI 10.1086/595954; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Huang SS, 2007, J INFECT DIS, V195, P330, DOI 10.1086/510622; Huang SS, 2007, J INFECT DIS, V195, P339, DOI 10.1086/510624; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Ieven M, 1999, J CLIN MICROBIOL, V37, P1436, DOI 10.1128/JCM.37.5.1436-1440.1999; Jernigan JA, 1996, AM J EPIDEMIOL, V143, P1079; Lee E. W., 1992, SURVIVAL ANAL STATE, P237, DOI [DOI 10.1007/978-94-015-7983-4_14, 10.1007/978-94-015-7983-4_14]; Loveday HP, 2006, J HOSP INFECT, V63, pS45, DOI 10.1016/j.jhin.2006.01.002; Lucet JC, 2005, INTENS CARE MED, V31, P1051, DOI 10.1007/s00134-005-2679-0; Muller A, 2006, J ANTIMICROB CHEMOTH, V58, P878, DOI 10.1093/jac/dkl343; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Ostrowsky BE, 2001, NEW ENGL J MED, V344, P1427, DOI 10.1056/NEJM200105103441903; Perencevich EN, 2004, CLIN INFECT DIS, V38, P1108, DOI 10.1086/382886; Puzniak LA, 2002, CLIN INFECT DIS, V35, P18, DOI 10.1086/340739; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Safdar N, 2003, J CLIN MICROBIOL, V41, P3163, DOI 10.1128/JCM.41.7.3163-3166.2003; Slaughter S, 1996, ANN INTERN MED, V125, P448, DOI 10.7326/0003-4819-125-6-199609150-00004; Srinivasan A, 2002, INFECT CONT HOSP EP, V23, P424, DOI 10.1086/502079; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; Vernon MO, 2006, ARCH INTERN MED, V166, P306, DOI 10.1001/archinte.166.3.306	39	272	281	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1407	1418		10.1056/NEJMoa1000373	http://dx.doi.org/10.1056/NEJMoa1000373			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LD	21488763	Green Accepted			2022-12-28	WOS:000289467200005
J	McQuatters-Gollop, A; Reid, PC; Edwards, M; Burkill, PH; Castellani, C; Batten, S; Gieskes, W; Beare, D; Bidigare, RR; Head, E; Johnson, R; Kahru, M; Koslow, JA; Pena, A				McQuatters-Gollop, Abigail; Reid, Philip C.; Edwards, Martin; Burkill, Peter H.; Castellani, Claudia; Batten, Sonia; Gieskes, Winfried; Beare, Doug; Bidigare, Robert R.; Head, Erica; Johnson, Rod; Kahru, Mati; Koslow, J. Anthony; Pena, Angelica			Is there a decline in marine phytoplankton?	NATURE			English	Letter							LONG-TERM; NORTHEAST ATLANTIC; OCEAN; CHLOROPHYLL; PLANKTON; BIOMASS; VARIABILITY		[McQuatters-Gollop, Abigail; Reid, Philip C.; Edwards, Martin; Burkill, Peter H.; Castellani, Claudia; Batten, Sonia] Sir Alister Hardy Fdn Ocean Sci, Plymouth PL1 2PB, Devon, England; [Gieskes, Winfried] Univ Groningen, ESRIG, Dept Ocean Ecosyst, NL-9747 AG Groningen, Netherlands; [Beare, Doug] Wageningen IMARES, Dept Fisheries, NL-1976 CP Ijmuiden, Netherlands; [Bidigare, Robert R.] Univ Hawaii, Ctr Marine Microbial Ecol & Divers, Honolulu, HI 96822 USA; [Head, Erica] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada; [Johnson, Rod] Bermuda Inst Ocean Sci, St Georges 01, Bermuda; [Kahru, Mati; Koslow, J. Anthony] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Pena, Angelica] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada	University of Groningen; Wageningen University & Research; University of Hawaii System; Bedford Institute of Oceanography; Fisheries & Oceans Canada; Bermuda Institute of Ocean Sciences; University of California System; University of California San Diego; Scripps Institution of Oceanography; Fisheries & Oceans Canada	McQuatters-Gollop, A (corresponding author), Sir Alister Hardy Fdn Ocean Sci, Citadel Hill, Plymouth PL1 2PB, Devon, England.	abiqua@sahfos.ac.uk	Beare, Doug/F-8299-2010	Beare, Doug/0000-0003-0609-3845; Edwards, Martin/0000-0002-5716-4714; McQuatters-Gollop, Abigail/0000-0002-6043-9563; castellani, claudia/0000-0002-2710-2360	Natural Environment Research Council [SAH01001] Funding Source: researchfish; NERC [SAH01001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Antoine D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002620; Batten SD, 2003, PROG OCEANOGR, V58, P193, DOI 10.1016/j.pocean.2003.08.004; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Edwards M, 2001, ICES J MAR SCI, V58, P39, DOI 10.1006/jmsc.2000.0987; Gregg WW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014689; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Head EJH, 2010, J PLANKTON RES, V32, P1633, DOI 10.1093/plankt/fbq090; Kahru M, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004979; Leterme SC, 2006, MAR ECOL PROG SER, V312, P57, DOI 10.3354/meps312057; McQuatters-Gollop A, 2007, LIMNOL OCEANOGR, V52, P635, DOI 10.4319/lo.2007.52.2.0635; McQuatters-Gollop A, 2009, ESTUAR COAST SHELF S, V82, P583, DOI 10.1016/j.ecss.2009.02.017; Raitsos DE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022484; Reid PC, 1998, NATURE, V391, P546, DOI 10.1038/35290; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; Saba VS, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003655	15	87	90	3	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					E6	E7		10.1038/nature09950	http://dx.doi.org/10.1038/nature09950			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21490625				2022-12-28	WOS:000289469100003
J	Sommer, A; Ku, M; Roati, G; Zwierlein, MW				Sommer, Ariel; Ku, Mark; Roati, Giacomo; Zwierlein, Martin W.			Universal spin transport in a strongly interacting Fermi gas	NATURE			English	Article							COULOMB DRAG; DIFFUSION; ATOMS	Transport of fermions, particles with half-integer spin, is central to many fields of physics. Electron transport runs modern technology, defining states of matter such as superconductors and insulators, and electron spin is being explored as a new carrier of information(1). Neutrino transport energizes supernova explosions following the collapse of a dying star(2), and hydrodynamic transport of the quark-gluon plasma governed the expansion of the early Universe(3). However, our understanding of non-equilibrium dynamics in such strongly interacting fermionic matter is still limited. Ultracold gases of fermionic atoms realize a pristine model for such systems and can be studied in real time with the precision of atomic physics(4). Even above the superfluid transition, such gases flow as an almost perfect fluid with very low viscosity when interactions are tuned to a scattering resonance(3,5-8). In this hydrodynamic regime, collective density excitations are weakly damped(6,7). Here we experimentally investigate spin excitations in a Fermi gas of (6)Li atoms, finding that, in contrast, they are maximally damped. A spin current is induced by spatially separating two spin components and observing their evolution in an external trapping potential. We demonstrate that interactions can be strong enough to reverse spin currents, with components of opposite spin reflecting off each other. Near equilibrium, we obtain the spin drag coefficient, the spin diffusivity and the spin susceptibility as a function of temperature on resonance and show that they obey universal laws at high temperatures. In the degenerate regime, the spin diffusivity approaches a value set by (h) over bar /m, the quantum limit of diffusion, where (h) over bar is Planck's constant divided by 2 pi and m the atomic mass. For repulsive interactions, our measurements seem to exclude a metastable ferromagnetic state(9-11).	[Sommer, Ariel; Ku, Mark; Zwierlein, Martin W.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Sommer, Ariel; Ku, Mark; Zwierlein, Martin W.] MIT, MIT Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA; [Sommer, Ariel; Ku, Mark; Zwierlein, Martin W.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Roati, Giacomo] Univ Florence, CNR, INO, I-50019 Sesto Fiorentino, Italy; [Roati, Giacomo] Univ Florence, LENS, I-50019 Sesto Fiorentino, Italy	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Florence; University of Florence	Sommer, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	atsommer@mit.edu	Roati, Giacomo/AFZ-0793-2022	Sommer, Ariel/0000-0003-3390-4455; /0000-0001-8120-8548; Ku, Mark Jen-Hao/0000-0003-3144-3069; /0000-0003-1391-0428	NSF; AFOSR-MURI; ARO-MURI; ONR; DARPA YFA; Army Research Office with DARPA OLE; David and Lucille Packard Foundation; Alfred P. Sloan Foundation	NSF(National Science Foundation (NSF)); AFOSR-MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); ARO-MURI(MURI); ONR(Office of Naval Research); DARPA YFA; Army Research Office with DARPA OLE; David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	We thank G. Bruun, C. Pethick, D. Huse, R. Duine and W. Zwerger for discussions, and A. Schirotzek for help with the early stages of the experiment. This work was supported by the NSF, AFOSR-MURI, ARO-MURI, ONR, DARPA YFA, a grant from the Army Research Office with funding from the DARPA OLE programme, the David and Lucille Packard Foundation and the Alfred P. Sloan Foundation.	ANDERSON AC, 1966, PHYS REV LETT, V17, P367, DOI 10.1103/PhysRevLett.17.367; Bruun GM, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/035005; Bruun GM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.240406; BURROWS A, 1990, ANNU REV NUCL PART S, V40, P181; Cao C, 2011, SCIENCE, V331, P58, DOI 10.1126/science.1195219; D'Amico I, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.085109; D'Amico I, 2000, PHYS REV B, V62, P4853, DOI 10.1103/PhysRevB.62.4853; DeMarco B, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.040405; Du X, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.150401; Duine RA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.220403; Enss T, 2011, ANN PHYS-NEW YORK, V326, P770, DOI 10.1016/j.aop.2010.10.002; Gaebler JP, 2010, NAT PHYS, V6, P569, DOI 10.1038/NPHYS1709; GARWIN RL, 1959, PHYS REV, V115, P1478, DOI 10.1103/PhysRev.115.1478; Gedik N, 2003, SCIENCE, V300, P1410, DOI 10.1126/science.1083038; Inguscio M., 2008, ULTRACOLD FERMI GASE; Jo GB, 2009, SCIENCE, V325, P1521, DOI 10.1126/science.1177112; KU M, 2010, B AM PHYS SOC, V55; Nascimbene S, 2010, NATURE, V463, P1057, DOI 10.1038/nature08814; Nascimbene S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.170402; O'Hara KM, 2002, SCIENCE, V298, P2179, DOI 10.1126/science.1079107; Parish MM, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.063605; Partridge GB, 2006, SCIENCE, V311, P503, DOI 10.1126/science.1122876; Perali A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.060402; Polini M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.266403; Riedl S, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.053609; Schafer T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126001; Shin Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.030401; Stringari S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.110406; Vichi L, 1999, PHYS REV A, V60, P4734, DOI 10.1103/PhysRevA.60.4734; Weber CP, 2005, NATURE, V437, P1330, DOI 10.1038/nature04206; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Zwierlein MW, 2006, SCIENCE, V311, P492, DOI 10.1126/science.1122318	32	215	216	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					201	204		10.1038/nature09989	http://dx.doi.org/10.1038/nature09989			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21490670	Green Submitted			2022-12-28	WOS:000289469100038
J	Neuzil, KM; Canh, DG; Thiem, VD; Janmohamed, A; Huong, VM; Tang, YX; Nguyen, TND; Tsu, V; LaMontagne, DS				Neuzil, Kathleen M.; Do Gia Canh; Vu Dinh Thiem; Janmohamed, Amynah; Vu Minh Huong; Tang, Yuxiao; Nguyen Thi Ngoc Diep; Tsu, Vivien; LaMontagne, D. Scott			Immunogenicity and Reactogenicity of Alternative Schedules of HPV Vaccine in Vietnam A Cluster Randomized Noninferiority Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-6; CERVICAL-CANCER PREVENTION; PARTICLE VACCINE; COST-EFFECTIVENESS; WOMEN; EFFICACY; ADOLESCENTS; COUNTRIES; BENEFITS; POLICY	Context Human papillomavirus (HPV) vaccine programs may decrease the morbidity and mortality due to cervical cancer seen among women in low-resource countries. However, the 3-dose schedule over a 6-month period is a potential barrier to vaccine introduction in such settings. Objective To determine the immunogenicity and reactogenicity of different dosing schedules of quadrivalent HPV vaccine in adolescent girls in Vietnam. Design, Setting, and Participants Open-label, cluster randomized, noninferiority study (conducted between October 2007 and January 2010) assessing 4 schedules of an HPV vaccine delivered in 21 schools to 903 adolescent girls (aged 11-13 years at enrollment) living in northwestern Vietnam. Intervention Intramuscular injection of 3 doses of quadrivalent HPV vaccine delivered on a standard dosing schedule (at 0, 2, and 6 months) and 3 alternative dosing schedules (at 0, 3, and 9 months; at 0, 6, and 12 months; or at 0, 12, and 24 months). Main Outcome Measures Serum anti-HPV geometric mean titers (GMT) measured 1 month after the third dose of the HPV vaccine was administered; GMT was determined by type-specific competitive immunoassay. Noninferiority of each alternative vaccination dosing schedule was achieved if the lower bound of the multiplicity-adjusted confidence interval (CI) of the type-specific GMT ratio for HPV-16 and HPV-18 was greater than 0.5 (primary outcome). Safety outcomes were immediate reactions, local reactions, fever within 7 days after each dose, and serious adverse events up to 30 days following the last dose. Results In the intention-to-treat analysis, 809 girls who received at least 1 HPV vaccine dose had valid serum measurements 1 month after the third dose. After the third dose, the GMTs for those in the standard schedule group who received doses at 0, 2, and 6 months were 5808.0 (95% CI, 4961.4-6799.0) for HPV-16 and 1729.9 (95% CI, 1504.0-1989.7) for HPV-18; 5368.5 (95% CI, 4632.4-6221.5) and 1502.3 (95% CI, 1302.1-1733.2), respectively, for those whose received doses at 0, 3, and 9 months; 5716.4 (95% CI, 4876.7-6700.6) and 1581.5 (95% CI, 1363.4-1834.6), respectively, for those who received doses at 0, 6, and 12 months; and 3692.5 (95% CI, 3145.3-4334.9) and 1335.7 (95% CI, 1191.6-1497.3), respectively, for those who received doses at 0, 12, and 24 months. Noninferiority criteria were met for the alternative schedule groups that received doses at 0, 3, and 9 months (HPV-16 GMT ratio: 0.92 [95% CI, 0.71-1.20]; HPV-18 GMT ratio: 0.87 [95% CI, 0.68-1.11]) and at 0, 6, and 12 months (HPV-16 GMT ratio: 0.98 [95% CI, 0.75-1.29]; HPV-18 GMT ratio: 0.91 [95% CI, 0.71-1.17]). Prespecified noninferiority criteria were not met for the alternative schedule group that received doses at 0, 12, and 24 months (HPV-16 GMT ratio: 0.64 [95% CI, 0.48-0.84]; HPV-18 GMT ratio: 0.77 [95% CI, 0.62-0.96]). Pain at the injection site was the most common adverse event. Conclusions Among adolescent girls in Vietnam, administration of the HPV vaccine on standard and alternative schedules was immunogenic and well tolerated. The use of 2 alternative dosing schedules (at 0, 3, and 9 months and at 0, 6, and 12 months) compared with a standard schedule (at 0, 2, and 6 months) did not result in inferior antibody concentrations.	[Neuzil, Kathleen M.; Janmohamed, Amynah; Tang, Yuxiao; Tsu, Vivien; LaMontagne, D. Scott] PATH, Seattle, WA 98108 USA; [Do Gia Canh; Vu Dinh Thiem] Minist Hlth, Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Vu Minh Huong; Nguyen Thi Ngoc Diep] PATH, Hanoi, Vietnam	National Institute of Hygiene & Epidemiology (NIHE)	Neuzil, KM (corresponding author), PATH, POB 900922, Seattle, WA 98108 USA.	kneuzil@path.org		Vu, Thiem/0000-0001-6168-4555; Nguyen, Diep Thi Ngoc/0000-0002-7103-7877	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded with a generous grant from the Bill & Melinda Gates Foundation. Merck & Co Inc provided the vaccine and the immunogenicity testing for no charge.	Anh PTH, 2003, INT J CANCER, V104, P213, DOI 10.1002/ijc.10936; [Anonymous], CERVICAL CANC VACCIN; [Anonymous], 2006, GARD QUADR HUM PAP T; Barr E, 2007, CLIN INFECT DIS, V45, P609, DOI 10.1086/520654; Biellik R, 2009, VACCINE, V27, P6203, DOI 10.1016/j.vaccine.2009.08.003; Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Dobson S, 2007, ADV COMM IMM PRACT D; DOBSON S, 2010, 26 INT PAP C JUL 3 M, DOI DOI 10.1016/J.VACCINE.2006.04.068; Ferlay J, 2010, INT J CANC; General Pharmaceutical Council, 2010, SURV ASS VIETN YOUTH, P5; Giuliano AR, 2007, J INFECT DIS, V196, P1153, DOI 10.1086/521679; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Goldie SJ, 2008, REPROD HEALTH MATTER, V16, P86, DOI 10.1016/S0968-8080(08)32409-4; Hernandez Brenda Y, 2008, Infect Agent Cancer, V3, P7, DOI 10.1186/1750-9378-3-7; Joura EA, 2008, VACCINE, V26, P6844, DOI 10.1016/j.vaccine.2008.09.073; Kim JJ, 2008, VACCINE, V26, P4015, DOI 10.1016/j.vaccine.2008.05.038; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Oliphant NP, 2010, FOOD NUTR BULL, V31, pS248, DOI 10.1177/15648265100313S304; Pan American Health Organization, 2010, PAHO REV FUND VACC S; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prabhu M, GOVT OFFERS CERVICAL; Quoc NM, 1998, INT J CANCER, V76, P472, DOI 10.1002/(SICI)1097-0215(19980518)76:4&lt;472::AID-IJC5&gt;3.0.CO;2-O; Reisinger KS, 2007, PEDIATR INFECT DIS J, V26, P201, DOI 10.1097/01.inf.0000253970.29190.5a; Schnorr JJ, 2001, VACCINE, V19, P1503, DOI 10.1016/S0264-410X(00)00349-2; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, J INFECT DIS, V196, P1438, DOI 10.1086/522864; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Villa LL, 2006, VACCINE, V24, P5571, DOI 10.1016/j.vaccine.2006.04.068; WHO, 2009, HUM PAP VACC; World Health Organization, 2009, COST CERVICAL CANC V, V84, P118; Zimmerman RK, 2010, J WOMENS HEALTH, V19, P1441, DOI 10.1089/jwh.2009.1753	33	62	67	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1424	1431		10.1001/jama.2011.407	http://dx.doi.org/10.1001/jama.2011.407			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486975	Bronze			2022-12-28	WOS:000289424100019
J	Shiels, MS; Pfeiffer, RM; Hall, HI; Li, JM; Goedert, JJ; Morton, LM; Hartge, P; Engels, EA				Shiels, Meredith S.; Pfeiffer, Ruth M.; Hall, H. Irene; Li, Jianmin; Goedert, James J.; Morton, Lindsay M.; Hartge, Patricia; Engels, Eric A.			Proportions of Kaposi Sarcoma, Selected Non-Hodgkin Lymphomas, and Cervical Cancer in the United States Occurring in Persons With AIDS, 1980-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INCIDENCE PATTERNS; SURVEILLANCE DATA; HIV; TRENDS; RISK; RECOMMENDATIONS; ADOLESCENTS; ADULTS; ASSOCIATION; SOCIETY	Context Given the higher risk of AIDS-defining malignancies that include Kaposi sarcoma (KS), certain non-Hodgkin lymphomas (NHLs), and cervical cancer in persons with human immunodeficiency virus (HIV) infection, the HIV epidemic has likely contributed to the overall numbers of these cancers in the United States. Objective To quantify the proportions of KS, AIDS-defining NHLs, and cervical cancer in the United States that occurred among persons with AIDS from 1980 to 2007. Design, Setting, and Participants The HIV/AIDS Cancer Match Study (19802007) linked data from 16 US HIV/AIDS and cancer registries to identify cases with and without AIDS for KS, AIDS-defining NHLs (ie, diffuse large B-cell lymphoma [DLBCL], Burkitt lymphoma [BL], and central nervous system [CNS] lymphoma), and cervical cancer. Using linked data, we derived cancer rates for persons with and without AIDS. To estimate national counts, the rates were applied to national AIDS surveillance and US Census data. Main Outcome Measure Proportion of AIDS-defining malignancies in the United States occurring in persons with AIDS. Results In the United States, an estimated 81.6% (95% confidence interval [CI], 81.2%-81.9%) of 83 252 KS cases, 6.0% (95% CI, 5.8%-6.1%) of 351 618 DLBCL cases, 19.9% (95% CI, 18.1%-21.7%) of 17 307 BL cases, 27.1% (95% CI, 26.1%-28.1%) of 27 265 CNS lymphoma cases, and 0.42% (95% CI, 0.37%-0.47%) of 375 452 cervical cancer cases occurred among persons with AIDS during 1980-2007. The proportion of KS and AIDS-defining NHLs in persons with AIDS peaked in the early 1990s (1990-1995: KS, 90.5% [95% CI, 90.2%-90.8%]; DLBCL, 10.2% [95% CI, 9.9%-10.5%]; BL, 27.8% [95% CI, 25.0%-30.5%]; and CNS lymphoma, 48.3% [95% CI, 46.7%-49.8%]; all P < .001 [compared with 1980-1989]) and then declined (2001-2007: KS, 70.5% [95% CI, 68.1%-73.0%]; DLBCL, 4.7% [95% CI, 4.3%-5.2%]; BL, 21.5% [95% CI, 17.7%-25.4%]; and CNS lymphoma, 12.9% [95% CI, 10.5%-15.3%]; all P < .001 [compared with 1990-1995]). The proportion of cervical cancers in persons with AIDS increased over time (1980-1989: 0.11% [95% CI, 0.09%-0.13%]; 2001-2007: 0.71% [95% CI, 0.51%-0.91%]; P < .001). Conclusions In the United States, the estimated proportions of AIDS-defining malignancies that occurred among persons with AIDS were substantial, particularly for KS and some NHLs. Except for cervical cancer, the proportions of AIDS-defining malignancies occurring among persons with AIDS peaked in the mid-1990s and then declined. JAMA. 2011;305(14):1450-1459 www.jama.com	[Shiels, Meredith S.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA; [Hall, H. Irene; Li, Jianmin] Ctr Dis Control & Prevent, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA	Shiels, MS (corresponding author), NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, 6120 Execut Blvd,EPS 7059, Rockville, MD 20892 USA.	shielsms@mail.nih.gov	Morton, Lindsay M/B-5234-2015; Morton, Lindsay/AAE-7495-2022	Morton, Lindsay M/0000-0001-9767-2310; Morton, Lindsay/0000-0001-9767-2310	National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010150] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Intramural Research Program of the National Cancer Institute.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2011, GUID US ANT AG HIV 1; [Anonymous], HIV AIDS STAT SURV; [Anonymous], 2007, HIV AIDS SURV REP US, V17; [Anonymous], 2011, SEER STAT DAT POP TO; BASHIR R, 1994, J NEURO-ONCOL, V20, P47, DOI 10.1007/BF01057960; Bedimo R, 2004, CLIN INFECT DIS, V39, P1380, DOI 10.1086/424883; Bellan C, 2003, ONCOGENE, V22, P6639, DOI 10.1038/sj.onc.1206815; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; Chiao EY, 2010, JAMA-J AM MED ASSOC, V304, P334, DOI 10.1001/jama.2010.752; Dunleavy K, 2010, BLOOD, V115, P3017, DOI 10.1182/blood-2009-11-253039; Eltom MA, 2002, J NATL CANCER I, V94, P1204, DOI 10.1093/jnci/94.16.1204; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Gatter KC, 2001, PATHOLOGY GENETICS T, P171; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Green TA, 1998, STAT MED, V17, P143, DOI 10.1002/(SICI)1097-0258(19980130)17:2&lt;143::AID-SIM757&gt;3.0.CO;2-Y; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harrison KM, 2008, PUBLIC HEALTH REP, V123, P618, DOI 10.1177/003335490812300512; Iscovich J, 2000, CANCER-AM CANCER SOC, V88, P500, DOI 10.1002/(SICI)1097-0142(20000201)88:3<500::AID-CNCR3>3.3.CO;2-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kadan-Lottick NS, 2002, CANCER, V95, P193, DOI 10.1002/cncr.10643; Larocca LM, 1998, BLOOD, V92, P1011; Levine AM, 2010, BLOOD, V115, P2986, DOI 10.1182/blood-2010-01-262717; Mbulaiteye SM, 2010, INT J CANCER, V126, P1732, DOI 10.1002/ijc.24934; National Cancer Institute, 2019, HIV AIDS CANC MATCH; National Cancer Institute, 2018, SEER STAT DAT INC SE; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Rouhani P, 2008, CANCER-AM CANCER SOC, V113, P616, DOI 10.1002/cncr.23571; Shiels M, 2010, 18 ANN INT AIDS C VI; Shiels MS, 2008, JAIDS-J ACQ IMM DEF, V48, P485, DOI 10.1097/QAI.0b013e31817dc42b; Sparano JA, 2010, BLOOD, V115, P3008, DOI 10.1182/blood-2009-08-231613; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004	37	104	107	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1450	1459		10.1001/jama.2011.396	http://dx.doi.org/10.1001/jama.2011.396			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486978	Green Accepted, Bronze			2022-12-28	WOS:000289424100022
J	Nomura, R; Ozawa, H; Tateno, S; Hirose, K; Hernlund, J; Muto, S; Ishii, H; Hiraoka, N				Nomura, Ryuichi; Ozawa, Haruka; Tateno, Shigehiko; Hirose, Kei; Hernlund, John; Muto, Shunsuke; Ishii, Hirofumi; Hiraoka, Nozomu			Spin crossover and iron-rich silicate melt in the Earth's deep mantle	NATURE			English	Article							ULTRALOW-VELOCITY ZONE; HIGH-PRESSURE; MAGMA OCEAN; PEROVSKITE; DYNAMICS; DENSITY; GPA; FE; GEOCHEMISTRY; SPECTROSCOPY	A melt has greater volume than a silicate solid of the same composition. But this difference diminishes at high pressure, and the possibility that a melt sufficiently enriched in the heavy element iron might then become more dense than solids at the pressures in the interior of the Earth (and other terrestrial bodies) has long been a source of considerable speculation(1,2). The occurrence of such dense silicate melts in the Earth's lowermost mantle would carry important consequences for its physical and chemical evolution and could provide a unifying model for explaining a variety of observed features in the core-mantle boundary region(3). Recent theoretical calculations(4) combined with estimates of iron partitioning between (Mg,Fe)SiO3 perovskite and melt at shallower mantle conditions(5-7) suggest that melt is more dense than solids at pressures in the Earth's deepest mantle, consistent with analysis of shockwave experiments(8). Here we extend measurements of iron partitioning over the entire mantle pressure range, and find a precipitous change at pressures greater than similar to 76 GPa, resulting in strong iron enrichment in melts. Additional X-ray emission spectroscopy measurements on (Mg0.95Fe0.05)SiO3 glass indicate a spin collapse around 70 GPa, suggesting that the observed change in iron partitioning could be explained by a spin crossover of iron (from high-spin to low-spin) in silicate melt. These results imply that (Mg,Fe)SiO3 liquid becomes more dense than coexisting solid at similar to 1,800 km depth in the lower mantle. Soon after the Earth's formation, the heat dissipated by accretion and internal differentiation could have produced a dense melt layer up to similar to 1,000 km in thickness underneath the solid mantle. We also infer that (Mg,Fe)SiO3 perovskite is on the liquidus at deep mantle conditions, and predict that fractional crystallization of dense magma would have evolved towards an iron-rich and silicon-poor composition, consistent with seismic inferences of structures in the core-mantle boundary region.	[Nomura, Ryuichi; Ozawa, Haruka; Tateno, Shigehiko; Hirose, Kei] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Nomura, Ryuichi] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ozawa, Haruka; Hirose, Kei] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan; [Hernlund, John] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Muto, Shunsuke] Nagoya Univ, Dept Mat Phys & Energy Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ishii, Hirofumi; Hiraoka, Nozomu] Natl Synchrotron Radiat Res Ctr, Hsinchu 30076, Taiwan	Tokyo Institute of Technology; University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of California System; University of California Berkeley; Nagoya University; National Synchrotron Radiation Research Center	Hirose, K (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan.	kei@geo.titech.ac.jp	Muto, Shunsuke/G-5741-2012; Hirose, Kei/C-2165-2009; Hernlund, John/A-8931-2014; Nomura, Ryuichi/B-9625-2015; Tateno, Shigehiko/D-4640-2011; Tateno, Haruka/N-7018-2014	Muto, Shunsuke/0000-0001-6275-0649; Hirose, Kei/0000-0003-4366-7721; Hernlund, John/0000-0003-1008-0182; Nomura, Ryuichi/0000-0003-4808-3709; Tateno, Haruka/0000-0002-1173-4021	National Science Foundation [NSFEAR0855737]	National Science Foundation(National Science Foundation (NSF))	We thank R. Sinmyo for support with TEM analyses and K. Shimizu for preparing the glass sample. Discussion with R. Caracas and comments from D. Frost were helpful. C.-C. Chen is acknowledged for XES measurements at BL12XU Taiwan Beamline, SPring-8. Some of the melting experiments were conducted at BL10XU (SPring-8 proposal no. 2009B0087). J.H. was supported by the National Science Foundation (NSFEAR0855737).	Agee CB, 1998, PHYS EARTH PLANET IN, V107, P63, DOI 10.1016/S0031-9201(97)00124-6; Akahama Y, 2004, J APPL PHYS, V96, P3748, DOI 10.1063/1.1778482; Auzende AL, 2008, EARTH PLANET SC LETT, V269, P164, DOI 10.1016/j.epsl.2008.02.001; Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Bengtson A, 2008, EARTH PLANET SC LETT, V265, P535, DOI 10.1016/j.epsl.2007.10.049; Cobden L, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006262; Corgne A, 2005, GEOCHIM COSMOCHIM AC, V69, P485, DOI 10.1016/j.gca.2004.06.041; de Koker NP, 2008, GEOCHIM COSMOCHIM AC, V72, P1427, DOI 10.1016/j.gca.2007.12.019; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Fialin M, 2009, PHYS CHEM MINER, V36, P183, DOI 10.1007/s00269-008-0268-9; Fiquet G, 2010, SCIENCE, V329, P1516, DOI 10.1126/science.1192448; Hernlund JW, 2008, EARTH PLANET SC LETT, V265, P423, DOI 10.1016/j.epsl.2007.10.042; Hernlund JW, 2010, EARTH PLANET SC LETT, V296, P1, DOI 10.1016/j.epsl.2010.04.027; Hier-Majumder S, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005662; Hirose K, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000597; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Irifune T, 2010, SCIENCE, V327, P193, DOI 10.1126/science.1181443; Ito E, 2004, PHYS EARTH PLANET IN, V143, P397, DOI 10.1016/j.pepi.2003.09.016; Jarrige I, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2966355; Jayasuriya KD, 2004, AM MINERAL, V89, P1597, DOI 10.2138/am-2004-11-1203; Karki BB, 2010, REV MINERAL GEOCHEM, V71, P355, DOI 10.2138/rmg.2010.71.17; Komabayashi T, 2010, EARTH PLANET SC LETT, V297, P691, DOI 10.1016/j.epsl.2010.07.025; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Liebske C, 2005, CONTRIB MINERAL PETR, V149, P113, DOI 10.1007/s00410-004-0641-8; Lundin S, 2008, PHYS EARTH PLANET IN, V168, P97, DOI 10.1016/j.pepi.2008.05.002; McCammon C, 1997, NATURE, V387, P694, DOI 10.1038/42685; Mosenfelder JL, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004364; Ozawa H, 2009, PHYS CHEM MINER, V36, P355, DOI 10.1007/s00269-008-0283-x; Presnall DC, 1998, PHYS EARTH PLANET IN, V107, P83, DOI 10.1016/S0031-9201(97)00126-X; Ricolleau A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036759; Sasano Y, 2008, J ELECTRON MICROSC, V57, P149, DOI 10.1093/jmicro/dfn014; Shen G, 1996, ADV MAT 96 NEW TREND, P149; Stixrude L, 2009, EARTH PLANET SC LETT, V278, P226, DOI 10.1016/j.epsl.2008.12.006; STOLPER E, 1981, J GEOPHYS RES, V86, P6261, DOI 10.1029/JB086iB07p06261; TAKAHASHI E, 1986, J GEOPHYS RES-SOLID, V91, P9367, DOI 10.1029/JB091iB09p09367; Tateno S, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3058760; Thorne MS, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003010; Tsuchiya T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.198501; van Aken PA, 1998, PHYS CHEM MINER, V25, P323, DOI 10.1007/s002690050122; Wicks JK, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043689; Williams Q, 1996, SCIENCE, V273, P1528, DOI 10.1126/science.273.5281.1528	41	181	185	3	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					199	+		10.1038/nature09940	http://dx.doi.org/10.1038/nature09940			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21516105				2022-12-28	WOS:000290487200035
J	Yoon, HS; Price, DC; Stepanauskas, R; Rajah, VD; Sieracki, ME; Wilson, WH; Yang, EC; Duffy, S; Bhattacharya, D				Yoon, Hwan Su; Price, Dana C.; Stepanauskas, Ramunas; Rajah, Veeran D.; Sieracki, Michael E.; Wilson, William H.; Yang, Eun Chan; Duffy, Siobain; Bhattacharya, Debashish			Single-Cell Genomics Reveals Organismal Interactions in Uncultivated Marine Protists	SCIENCE			English	Article							EUKARYOTES; PHYLOGENY; OCEAN; TIME	Whole-genome shotgun sequence data from three individual cells isolated from seawater, followed by analysis of ribosomal DNA, indicated that the cells represented three divergent clades of picobiliphytes. In contrast with the recent description of this phylum, we found no evidence of plastid DNA nor of nuclear-encoded plastid-targeted proteins, which suggests that these picobiliphytes are heterotrophs. Genome data from one cell were dominated by sequences from a widespread single-stranded DNA virus. This virus was absent from the other two cells, both of which contained non-eukaryote DNA derived from marine Bacteroidetes and large DNA viruses. By using shotgun sequencing of uncultured marine picobiliphytes, we revealed the distinct interactions of individual cells.	[Price, Dana C.; Rajah, Veeran D.; Duffy, Siobain; Bhattacharya, Debashish] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Yoon, Hwan Su; Stepanauskas, Ramunas; Sieracki, Michael E.; Wilson, William H.; Yang, Eun Chan] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME 04575 USA; [Yoon, Hwan Su] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea	Rutgers State University New Brunswick; Bigelow Laboratory for Ocean Sciences; Sungkyunkwan University (SKKU)	Bhattacharya, D (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA.	bhattacharya@aesop.rutgers.edu	Yoon, Hwan Su/A-2974-2013; t, lf/AAJ-4924-2020; Duffy, Siobain/A-9104-2009	Duffy, Siobain/0000-0003-0753-223X; Stepanauskas, Ramunas/0000-0003-4458-3108; Yoon, Hwan Su/0000-0001-9507-0105; Yang, Eun Chan/0000-0001-8211-8130	NSF [EF-0827023, DEB-0936884, OCE-0821374, OCE-0623288]; Rural Development Administration, South Korea	NSF(National Science Foundation (NSF)); Rural Development Administration, South Korea(Rural Development Administration (RDA), Republic of Korea)	This project was supported by NSF grants EF-0827023, DEB-0936884, OCE-0821374, and OCE-0623288, and by Nest Generation BioGreen 21 (SSAC, 2011), Rural Development Administration, South Korea. The authors thank J. Heywood and N. Poulton for technical support. The genome sequence of the MS584-5 virus is available in GenBank under the accession number HQ322117, whereas the 454 sequence data from SAG MS584-5 and 454 + Illumina reads from MS584-11 and MS584-22 are available at the NCBI Sequence Read Archive under the accession numbers SRR068243.1, SRR068244.2, and SRR068245.2, respectively. The assembled contigs for each SAG, the phylogenomic results (alignments and trees), singleton hit lists, annotations for the 8334 proteins in the MS584-11 joint assembly, protein alignments used for the trees presented in the paper, and the Paulinella caromatophora plastid sequence and Illumina genome data used to determine the frequency of plastid genes recovered from these reads are freely available at http://dbdata.rutgers.edu/data/pico.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; Bodaker I, 2010, ISME J, V4, P399, DOI 10.1038/ismej.2009.141; Cuvelier ML, 2008, ENVIRON MICROBIOL, V10, P1621, DOI 10.1111/j.1462-2920.2008.01580.x; Evans C, 2008, LIMNOL OCEANOGR, V53, P2035, DOI 10.4319/lo.2008.53.5.2035; Heywood JL, 2011, ISME J, V5, P674, DOI 10.1038/ismej.2010.155; Kim E, 2011, P NATL ACAD SCI USA, V108, P1496, DOI 10.1073/pnas.1013337108; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Moon DA, 1997, CURR GENET, V32, P132, DOI 10.1007/s002940050257; Moustafa A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-6; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Not F, 2007, SCIENCE, V315, P253, DOI 10.1126/science.1136264; Okamoto N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007080; Reyes-Prieto A, 2008, CURR BIOL, V18, P956, DOI 10.1016/j.cub.2008.05.042; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Shirai Y, 2008, APPL ENVIRON MICROB, V74, P4022, DOI 10.1128/AEM.00509-08; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	23	213	219	1	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					714	717		10.1126/science.1203163	http://dx.doi.org/10.1126/science.1203163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551060				2022-12-28	WOS:000290265800042
J	Sakaguchi, S; Wing, K				Sakaguchi, Shimon; Wing, Kajsa			Damping by Depletion	SCIENCE			English	Editorial Material							REGULATORY T-CELLS; CTLA-4; ACTIVATION		[Sakaguchi, Shimon] Osaka Univ, Expt Immunol Lab, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Wing, Kajsa] Karolinska Inst, Dept Med Biophys & Biochem, Sect Med Inflammat Res, Stockholm, Sweden	Osaka University; Karolinska Institutet	Sakaguchi, S (corresponding author), Osaka Univ, Expt Immunol Lab, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009	Wing, Kajsa/0000-0001-7744-4847				Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yokosuka T, 2010, IMMUNITY, V33, P326, DOI 10.1016/j.immuni.2010.09.006	14	7	7	2	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					542	543		10.1126/science.1206122	http://dx.doi.org/10.1126/science.1206122			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527700				2022-12-28	WOS:000289991100030
J	Peterson, PN; Shetterly, SM; Clarke, CL; Bekelman, DB; Chan, PS; Allen, LA; Matlock, DD; Magid, DJ; Masoudi, FA				Peterson, Pamela N.; Shetterly, Susan M.; Clarke, Christina L.; Bekelman, David B.; Chan, Paul S.; Allen, Larry A.; Matlock, Daniel D.; Magid, David J.; Masoudi, Frederick A.			Health Literacy and Outcomes Among Patients With Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIMITED LITERACY; CONTROLLED-TRIAL; HOSPITAL ADMISSION; IDENTIFY PATIENTS; SKILLS; RISK; POPULATION; QUESTIONS; ENROLLEES; MORTALITY	Context Little is known about the effects of low health literacy among patients with heart failure, a condition that requires self-management and frequent interactions with the health care system. Objective To evaluate the association between low health literacy and all-cause mortality and hospitalization among outpatients with heart failure. Design, Setting, and Patients Retrospective cohort study conducted at Kaiser Permanente Colorado, an integrated managed care organization. Outpatients with heart failure were identified between January 2001 and May 2008, were surveyed by mail, and underwent follow-up for a median of 1.2 years. Health literacy was assessed using 3 established screening questions and categorized as adequate or low. Responders were excluded if they did not complete at least 1 health literacy question or if they did not have at least 1 year of enrollment prior to the survey date. Main Outcome Measures All-cause mortality and all-cause hospitalization. Results Of the 2156 patients surveyed, 1547 responded (72% response rate). Of 1494 included responders, 262 (17.5%) had low health literacy. Patients with low health literacy were older, of lower socioeconomic status, less likely to have at least a high school education, and had higher rates of coexisting illnesses. In multivariable Cox regression, low health literacy was independently associated with higher mortality (unadjusted rate, 17.6% vs 6.3%; adjusted hazard ratio, 1.97 [95% confidence interval, 1.3-2.97]; P=.001) but not hospitalization (unadjusted rate, 30.5% vs 23.2%; adjusted hazard ratio, 1.05 [95% confidence interval, 0.8-1.37]; P=.73). Conclusion Among patients with heart failure in an integrated managed care organization, low health literacy was significantly associated with higher all-cause mortality. JAMA. 2011;305(16):1695-1701 www.jama.com	[Peterson, Pamela N.] Denver Hlth Med Ctr, Div Cardiol, Denver, CO 80204 USA; [Peterson, Pamela N.; Shetterly, Susan M.; Clarke, Christina L.; Magid, David J.; Masoudi, Frederick A.] Kaiser Permanente Colorado Inst Hlth Res, Denver, CO USA; [Peterson, Pamela N.; Bekelman, David B.; Allen, Larry A.; Matlock, Daniel D.; Magid, David J.; Masoudi, Frederick A.] Univ Colorado Denver, Aurora, CO USA; [Bekelman, David B.] Denver VA Med Ctr, Denver, CO USA; [Chan, Paul S.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Chan, Paul S.] Univ Missouri, Kansas City, MO 64110 USA	Denver Health Medical Center; Kaiser Permanente; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City	Peterson, PN (corresponding author), Denver Hlth Med Ctr, Div Cardiol, Mail Code 0960,777 Bannock St, Denver, CO 80204 USA.	pamela.peterson@ucdenver.edu	Masoudi, Frederick/Q-7467-2019; Allen, Larry/AAI-1323-2020	Matlock, Dan/0000-0001-9597-9642	American Heart Association [067001N]; National Heart, Lung, and Blood Institute [K23HL102224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Peterson is supported by American Heart Association Pharmaceutical Roundtable grant 067001N. Dr Chan is supported by a Career Development Grant Award (K23HL102224) from the National Heart, Lung, and Blood Institute. Dr Allen is supported by an American Heart Association Scientist Development Award.	Baker DW, 2007, ARCH INTERN MED, V167, P1503, DOI 10.1001/archinte.167.14.1503; Baker DW, 2006, J GEN INTERN MED, V21, P878, DOI 10.1111/j.1525-1497.2006.00540.x; Baker DW, 1998, J GEN INTERN MED, V13, P791, DOI 10.1046/j.1525-1497.1998.00242.x; Baker DW, 2002, AM J PUBLIC HEALTH, V92, P1278, DOI 10.2105/AJPH.92.8.1278; Cavanaugh K, 2009, DIABETES CARE, V32, P2149, DOI 10.2337/dc09-0563; Chew LD, 2004, FAM MED, V36, P588; Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5; COX DR, 1972, J R STAT SOC B, V34, P187; Davis T C, 1993, Fam Med, V25, P391; Davis TC, 2006, ANN INTERN MED, V145, P887, DOI 10.7326/0003-4819-145-12-200612190-00144; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; DeWalt DA, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-30; Eichler K, 2009, INT J PUBLIC HEALTH, V54, P313, DOI 10.1007/s00038-009-0058-2; Evangelista LS, 2010, J CARD FAIL, V16, P9, DOI 10.1016/j.cardfail.2009.10.026; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONAHA.105.577577; Institute of Medicine, 2004, PRESCR END CONF; Kripalani S, 2006, J GEN INTERN MED, V21, P852, DOI 10.1111/j.1525-1497.2006.00536.x; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Murray MD, 2009, CLIN PHARMACOL THER, V85, P651, DOI 10.1038/clpt.2009.7; Paasche-Orlow MK, 2006, J GEN INTERN MED, V21, P884, DOI 10.1111/j.1525-1497.2006.00544.x; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Powers BJ, 2010, JAMA-J AM MED ASSOC, V304, P76, DOI 10.1001/jama.2010.896; Riegel B, 2009, CIRCULATION, V120, P1141, DOI 10.1161/CIRCULATIONAHA.109.192628; Seligman HK, 2005, J GEN INTERN MED, V20, P1001, DOI 10.1111/j.1525-1497.2005.00189.x; Sudore RL, 2006, J GEN INTERN MED, V21, P806, DOI 10.1111/j.1525-1497.2006.00539.x; von Wagner C, 2009, HEALTH EDUC BEHAV, V36, P860, DOI 10.1177/1090198108322819; Wallace LS, 2007, J SURG RES, V140, P208, DOI 10.1016/j.jss.2007.01.029; Wallace LS, 2006, J GEN INTERN MED, V21, P874, DOI 10.1111/j.1525-1497.2006.00532.x; Weiss BD, 2006, J GEN INTERN MED, V21, P823, DOI 10.1111/j.1525-1497.2006.00531.x; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166	32	269	276	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1695	1701		10.1001/jama.2011.512	http://dx.doi.org/10.1001/jama.2011.512			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521851	Bronze, Green Accepted			2022-12-28	WOS:000289890500023
J	Sergeev, AG; Hartwig, JF				Sergeev, Alexey G.; Hartwig, John F.			Selective, Nickel-Catalyzed Hydrogenolysis of Aryl Ethers	SCIENCE			English	Article							N-HETEROCYCLIC CARBENES; CARBON-CARBON BONDS; MODEL COMPOUNDS; HYDROGENATION; OXYGEN; ACTIVATION; CHEMISTRY; CHEMICALS; CLEAVAGE; BIARYLS	Selective hydrogenolysis of the aromatic carbon-oxygen (C-O) bonds in aryl ethers is an unsolved synthetic problem important for the generation of fuels and chemical feedstocks from biomass and for the liquefaction of coal. Currently, the hydrogenolysis of aromatic C-O bonds requires heterogeneous catalysts that operate at high temperature and pressure and lead to a mixture of products from competing hydrogenolysis of aliphatic C-O bonds and hydrogenation of the arene. Here, we report hydrogenolyses of aromatic C-O bonds in alkyl aryl and diaryl ethers that form exclusively arenes and alcohols. This process is catalyzed by a soluble nickel carbene complex under just 1 bar of hydrogen at temperatures of 80 to 120 C; the relative reactivity of ether substrates scale as Ar-OAr>>Ar-OMe>ArCH(2)-OMe (Ar, Aryl; Me, Methyl). Hydrogenolysis of lignin model compounds highlights the potential of this approach for the conversion of refractory aryl ether biopolymers to hydrocarbons.	[Sergeev, Alexey G.; Hartwig, John F.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Hartwig, JF (corresponding author), Univ Illinois, Dept Chem, 600 S Matthews Ave, Urbana, IL 61801 USA.	jhartwig@illinois.edu	Sergeev, Alexey/H-4105-2013	Sergeev, Alexey/0000-0003-1587-2517	BP	BP	We thank the BP for financial support of this project through the Energy Biosciences Program and T. Rauchfuss for helpful discussions. A provisional patent has been filed on the methods presented herein.	Alvarez-Bercedo P, 2010, J AM CHEM SOC, V132, P17352, DOI 10.1021/ja106943q; Dabo P, 1999, CAN J CHEM, V77, P1225, DOI 10.1139/cjc-77-7-1225; Dankwardt JW, 2004, ANGEW CHEM INT EDIT, V43, P2428, DOI 10.1002/anie.200453765; Diez-Gonzalez S, 2009, CHEM REV, V109, P3612, DOI 10.1021/cr900074m; Dyson PJ, 2003, DALTON T, P2964, DOI 10.1039/b303250g; Ellsworth BA, 2008, BIOORG MED CHEM LETT, V18, P4770, DOI 10.1016/j.bmcl.2008.07.109; Furimsky E, 2000, APPL CATAL A-GEN, V199, P147, DOI 10.1016/S0926-860X(99)00555-4; Glorius F, 2007, TOP ORGANOMETAL CHEM, V21, P1, DOI 10.1007/3418_2006_059; Guan BT, 2008, CHEM COMMUN, P1437, DOI 10.1039/b718998b; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; HUUSKA MK, 1986, POLYHEDRON, V5, P233, DOI 10.1016/S0277-5387(00)84915-3; LEVINE DG, 1982, P NATL ACAD SCI USA, V79, P3365, DOI 10.1073/pnas.79.10.3365; MAERCKER A, 1987, ANGEW CHEM INT EDIT, V26, P972, DOI 10.1002/anie.198709721; Marshall AL, 2010, CHEM-EUR J, V16, P4970, DOI 10.1002/chem.200903028; POPPIUS K, 1984, ACTA CHEM SCAND B, V38, P611, DOI 10.3891/acta.chem.scand.38b-0611; Pu YQ, 2008, BIOFUEL BIOPROD BIOR, V2, P58, DOI 10.1002/bbb.48; Rylander P.N, 1985, HYDROGENATION METHOD, P157; SNIECKUS V, 1990, CHEM REV, V90, P879, DOI 10.1021/cr00104a001; STORK G, 1947, J AM CHEM SOC, V69, P576, DOI 10.1021/ja01195a034; Tobisu M, 2008, ANGEW CHEM INT EDIT, V47, P4866, DOI 10.1002/anie.200801447; Tobisu M, 2011, CHEM COMMUN, V47, P2946, DOI 10.1039/c0cc05169a; UTOH S, 1986, FUEL PROCESS TECHNOL, V14, P221, DOI 10.1016/0378-3820(86)90024-X; van der Boom ME, 1998, J AM CHEM SOC, V120, P6531, DOI 10.1021/ja9738889; Van Duzee EM, 1935, J AM CHEM SOC, V57, P147, DOI 10.1021/ja01304a040; WENKERT E, 1979, J AM CHEM SOC, V101, P2246, DOI 10.1021/ja00502a074; WENKERT E, 1984, J ORG CHEM, V49, P4894, DOI 10.1021/jo00199a030; Widegren JA, 2003, J MOL CATAL A-CHEM, V198, P317, DOI 10.1016/S1381-1169(02)00728-8; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u	28	628	644	13	707	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					439	443		10.1126/science.1200437	http://dx.doi.org/10.1126/science.1200437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512027				2022-12-28	WOS:000289784900036
J	Burnworth, M; Tang, LM; Kumpfer, JR; Duncan, AJ; Beyer, FL; Fiore, GL; Rowan, SJ; Weder, C				Burnworth, Mark; Tang, Liming; Kumpfer, Justin R.; Duncan, Andrew J.; Beyer, Frederick L.; Fiore, Gina L.; Rowan, Stuart J.; Weder, Christoph			Optically healable supramolecular polymers	NATURE			English	Article							HYDROGEN-BONDING INTERACTIONS; POLY(P-PHENYLENE ETHYNYLENE)S; POLYMERIZATION; ROUTE	Polymers with the ability to repair themselves after sustaining damage could extend the lifetimes of materials used in many applications(1). Most approaches to healable materials require heating the damaged area(2-4). Here we present metallosupramolecular polymers that can be mended through exposure to light. They consist of telechelic, rubbery, low-molecular-mass polymers with ligand end groups that are non-covalently linked through metal-ion binding. On exposure to ultraviolet light, the metal-ligand motifs are electronically excited and the absorbed energy is converted into heat. This causes temporary disengagement of the metal-ligand motifs and a concomitant reversible decrease in the polymers' molecular mass and viscosity(5), thereby allowing quick and efficient defect healing. Light can be applied locally to a damage site, so objects can in principle be healed under load. We anticipate that this approach to healable materials, based on supramolecular polymers and a light-heat conversion step, can be applied to a wide range of supramolecular materials that use different chemistries.	[Burnworth, Mark; Tang, Liming; Kumpfer, Justin R.; Rowan, Stuart J.; Weder, Christoph] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA; [Duncan, Andrew J.; Beyer, Frederick L.] USA, Res Lab, Aberdeen Proving Ground, MD 21005 USA; [Fiore, Gina L.; Weder, Christoph] Univ Fribourg, Adolphe Merkle Inst, CH-1700 Fribourg, Switzerland; [Fiore, Gina L.; Weder, Christoph] Univ Fribourg, Fribourg Ctr Nanomat, CH-1700 Fribourg, Switzerland	Case Western Reserve University; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); University of Fribourg; University of Fribourg	Rowan, SJ (corresponding author), Case Western Reserve Univ, Dept Macromol Sci & Engn, 2100 Adelbert Rd, Cleveland, OH 44106 USA.	stuart.rowan@case.edu; christoph.weder@unifr.ch	Weder, Christoph/K-7453-2012	Beyer, Frederick/0000-0003-0253-2134; Weder, Christoph/0000-0001-7183-1790; Merkle Institute, Adolphe/0000-0002-6220-424X; Rowan, Stuart/0000-0001-8176-0594	US Army Research Office [W911NF-09-1-0288, W911NF-06-1-0414]; National Science Foundation [CHE-0704026, DMR-0602869, MRI-0821515]; Adolphe Merkle Foundation; US Army Research Laboratory [ORISE-1120-1120-99]; US Department of Energy [ORISE-1120-1120-99]	US Army Research Office; National Science Foundation(National Science Foundation (NSF)); Adolphe Merkle Foundation; US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Department of Energy(United States Department of Energy (DOE))	This material is based on work supported by the US Army Research Office (W911NF-09-1-0288 and W911NF-06-1-0414); the National Science Foundation under grant numbers CHE-0704026, DMR-0602869 and MRI-0821515; the Adolphe Merkle Foundation; and the Postgraduate Research Participation Program at the US Army Research Laboratory, administered by the Oak Ridge Institute of Science and Education through an interagency agreement between the US Department of Energy and Army Research Laboratory (contract number ORISE-1120-1120-99). We thank S. Dellinger for the design and the fabrication of a device to introduce well-defined defects and Kraton Performance Polymers Inc for the donation of the hydroxyl-terminated poly(ethylene-co-butylene).	Beck JB, 2003, J AM CHEM SOC, V125, P13922, DOI 10.1021/ja038521k; Beck JB, 2005, MACROMOLECULES, V38, P5060, DOI 10.1021/ma050369e; Bergman SD, 2008, J MATER CHEM, V18, P41, DOI 10.1039/b713953p; Blaiszik BJ, 2010, ANNU REV MATER RES, V40, P179, DOI 10.1146/annurev-matsci-070909-104532; Bosman AW, 2004, MATER TODAY, V7, P34, DOI 10.1016/S1369-7021(04)00187-7; Burattini S, 2010, J AM CHEM SOC, V132, P12051, DOI 10.1021/ja104446r; Burattini S, 2009, CHEM COMMUN, P6717, DOI 10.1039/b910648k; Burnworth M, 2008, MACROMOLECULES, V41, P2157, DOI 10.1021/ma702712e; Burnworth M, 2007, J INORG ORGANOMET P, V17, P91, DOI 10.1007/s10904-006-9075-2; Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Crenshaw BR, 2007, MACROMOLECULES, V40, P2400, DOI 10.1021/ma062936j; Ghosh B, 2009, SCIENCE, V323, P1458, DOI 10.1126/science.1167391; Ilavsky J, 2009, J APPL CRYSTALLOGR, V42, P347, DOI 10.1107/S0021889809002222; Kautz H, 2006, MACROMOLECULES, V39, P4265, DOI 10.1021/ma060706z; KIM YH, 1983, MACROMOLECULES, V16, P1115, DOI 10.1021/ma00241a013; Knapton D, 2006, MACROMOLECULES, V39, P651, DOI 10.1021/ma0520747; Knapton D, 2006, ANGEW CHEM INT EDIT, V45, P5825, DOI 10.1002/anie.200601634; Knapton D, 2006, MACROMOLECULES, V39, P4069, DOI 10.1021/ma060500y; Kumpfer JR, 2010, J MATER CHEM, V20, P145, DOI 10.1039/b915490f; Kunzelman J, 2008, ADV MATER, V20, P119, DOI 10.1002/adma.200701772; Murphy EB, 2008, MACROMOLECULES, V41, P5203, DOI 10.1021/ma800432g; Murphy EB, 2010, PROG POLYM SCI, V35, P223, DOI 10.1016/j.progpolymsci.2009.10.006; Rowan SJ, 2005, FARADAY DISCUSS, V128, P43, DOI 10.1039/b403135k; Sivakova S, 2005, J AM CHEM SOC, V127, P18202, DOI 10.1021/ja055245w; Wojtecki RJ, 2011, NAT MATER, V10, P14, DOI [10.1038/nmat2891, 10.1038/NMAT2891]; Wool RP, 2008, SOFT MATTER, V4, P400, DOI 10.1039/b711716g	27	1336	1374	30	1114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					334	U230		10.1038/nature09963	http://dx.doi.org/10.1038/nature09963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21512571	Green Submitted			2022-12-28	WOS:000289724600036
J	Parkin, L; Sharples, K; Hernandez, RK; Jick, SS				Parkin, Lianne; Sharples, Katrina; Hernandez, Rohini K.; Jick, Susan S.			Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIPLE IMPUTATION; WOMEN; CYPROTERONE; THROMBOSIS	Objective To examine the risk of non-fatal idiopathic venous thromboembolism in current users of a combined oral contraceptive containing drospirenone, relative to current users of preparations containing levonorgestrel. Design Nested case-control study. Setting UK General Practice Research Database. Participants Women aged 15-44 years without major risk factors for venous thromboembolism who started a new episode of use of an oral contraceptive containing 30 mu g oestrogen in combination with either drospirenone or levonorgestrel between May 2002 and September 2009. Cases were women with a first diagnosis of venous thromboembolism; up to four controls, matched by age, duration of recorded information, and general practice, were randomly selected for each case. Main outcome measures Odds ratios and 95% confidence intervals estimated with conditional logistic regression; age adjusted incidence rate ratio estimated with Poisson regression. Results 61 cases of idiopathic venous thromboembolism and 215 matched controls were identified. In the case-control analysis, current use of the drospirenone contraceptive was associated with a threefold higher risk of non-fatal idiopathic venous thromboembolism compared with levonorgestrel use; the odds ratio adjusted for body mass index was 3.3 (95% confidence interval 1.4 to 7.6). Subanalyses suggested that referral, diagnostic, first time user, duration of use, and switching biases were unlikely explanations for this finding. The crude incidence rate was 23.0 (95% confidence interval 13.4 to 36.9) per 100 000 woman years in current users of drospirenone and 9.1 (6.6 to 12.2) per 100 000 woman years in current users of levonorgestrel oral contraceptives. The age adjusted incidence rate ratio was 2.7 (1.5 to 4.7). Conclusions These findings contribute to emerging evidence that the combined oral contraceptive containing drospirenone carries a higher risk of venous thromboembolism than do formulations containing levonorgestrel.	[Hernandez, Rohini K.; Jick, Susan S.] Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA; [Parkin, Lianne; Sharples, Katrina] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin 9054, New Zealand	Boston University; University of Otago	Jick, SS (corresponding author), Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, 11 Muzzey St, Lexington, MA 02421 USA.	sjick@bu.edu		Parkin, Lianne/0000-0002-6824-6176; Jick, Susan/0000-0002-2215-1067				AROWOJOLU AO, 2009, COCHRANE DB SYST REV, V1; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; Dinger JC, 2007, CONTRACEPTION, V75, P344, DOI 10.1016/j.contraception.2006.12.019; FARLEY TMM, 1995, LANCET, V346, P1582; GALLO MF, 2009, COCHRANE DB SYST REV, V1; Jick H, 2000, BMJ-BRIT MED J, V321, P1190, DOI 10.1136/bmj.321.7270.1190; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Jick H, 1998, LANCET, V352, P1767, DOI 10.1016/S0140-6736(98)04350-5; Jick SS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2151; Kemmeren JM, 2001, BRIT MED J, V323, P131, DOI 10.1136/bmj.323.7305.131; Lidegaard O, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2890; LOPEZ LM, 2009, COCHRANE DB SYST REV, V1; MAITRA NN, 2009, COCHRANE DB SYST REV, V1; Parkin L, 2000, LANCET, V355, P2133, DOI 10.1016/S0140-6736(00)02382-5; POULTER NR, 1995, LANCET, V346, P1575; Raghunathan T.E., 2001, SURV METHODOL, V27, P85; ROTHMAN KJ, 1988, INT J EPIDEMIOL, V17, P955, DOI 10.1093/ije/17.4.955; Royston P, 2005, STATA J, V5, P279, DOI 10.1177/1536867X0500500212; Seeger JD, 2007, OBSTET GYNECOL, V110, P587, DOI 10.1097/01.AOG.0000279448.62221.a8; Sheldon T, 2002, BRIT MED J, V324, P869, DOI 10.1136/bmj.324.7342.869; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tchaikovski SN, 2007, THROMB HAEMOSTASIS, V98, P1350, DOI 10.1160/TH07-07-0439; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Van Vliet HAAM, 2004, J THROMB HAEMOST, V2, P2060, DOI 10.1111/j.1538-7836.2004.00983.x; Vasilakis-Scaramozza C, 2001, LANCET, V358, P1427, DOI 10.1016/S0140-6736(01)06522-9; Vlieg AV, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2921; Winter M, 2005, CLIN LAB HAEMATOL, V27, P61, DOI 10.1111/j.1365-2257.2004.00660.x; 2005, EPISHEET SPREADSHEET	28	129	131	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2011	342								d2139	10.1136/bmj.d2139	http://dx.doi.org/10.1136/bmj.d2139			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755OR	21511804	Green Published, hybrid			2022-12-28	WOS:000289943400005
J	Redman, C; Duffy, S; Bromham, N; Francis, K				Redman, C.; Duffy, S.; Bromham, N.; Francis, K.			GUIDELINES Recognition and initial management of ovarian cancer: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Redman, C.] Univ Hosp N Staffordshire, Stoke On Trent ST4 6QG, Staffs, England; [Duffy, S.] Yorkshire Canc Network, Harrogate HG2 7RY, England; [Bromham, N.; Francis, K.] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales	Keele University	Redman, C (corresponding author), Univ Hosp N Staffordshire, Stoke On Trent ST4 6QG, Staffs, England.			Bromham, Nathan/0000-0003-2165-4188				JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Kirwan JMJ, 2002, BRIT MED J, V324, P148, DOI 10.1136/bmj.324.7330.148; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V61; *NAT I HLTH CLIN E, 2005, CLIN GUID NAT I HLTH, V27; *NAT I HLTH CLIN E, 2011, CLIN GUID NAT I HLTH, V122; National Institute for Health and Clinical Excellence, 2009, GUID MAN; Neilson JP, 2009, OBSTET GYNECOL, V113, P1157, DOI [10.1002/14651858.CD004706.pub2, 10.1097/AOG.0b013e3181a4b7e8]; Office for National Statistics, 2007, SURV RAT ENGL PAT DI; WALSH P, 2005, CANC ATLAS UK IRELAN, P193	9	17	17	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2011	342								d2073	10.1136/bmj.d2073	http://dx.doi.org/10.1136/bmj.d2073			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OR	21511784				2022-12-28	WOS:000289943400004
J	Taylor, MC				Taylor, Mark C.			Reform the PhD system or close it down	NATURE			English	Editorial Material																			0	40	43	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					261	261		10.1038/472261a	http://dx.doi.org/10.1038/472261a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752VW	21512530	Bronze			2022-12-28	WOS:000289724600004
J	Bastawrous, A; Silvester, A; Batterbury, M				Bastawrous, Andrew; Silvester, Alexander; Batterbury, Mark			Laser refractive eye surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Review							IN-SITU KERATOMILEUSIS; RISK-FACTORS; DRY EYE; MYOPIA		[Bastawrous, Andrew; Batterbury, Mark] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, St Pauls Eye Unit, Liverpool L7 8XP, Merseyside, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital	Bastawrous, A (corresponding author), Royal Liverpool & Broadgreen Univ Hosp NHS Trust, St Pauls Eye Unit, Liverpool L7 8XP, Merseyside, England.	andrew.bastawrous@gmail.com			Medical Research Council [G1001934] Funding Source: Medline; MRC [G1001934] Funding Source: UKRI; Fight for Sight [1310/11] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fight for Sight		Ahn H, 2011, J CATARACT REFR SURG, V37, P349, DOI 10.1016/j.jcrs.2010.08.042; Aj S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005135.pub2; *AM AC OPHTH, 2007, REFR SURG 2006 2007, P119; Ambrosio R, 2008, J REFRACT SURG, V24, P396, DOI 10.3928/1081597X-20080401-14; Chang MA, 2004, SURV OPHTHALMOL, V49, P269, DOI 10.1016/j.survophthal.2004.02.007; Cochrane GM, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1711; Cui M, 2008, CHINESE MED J-PEKING, V121, P2331, DOI 10.1097/00029330-200811020-00021; Dart JKG, 2008, OPHTHALMOLOGY, V115, P1647, DOI 10.1016/j.ophtha.2008.05.003; De Paiva CS, 2006, AM J OPHTHALMOL, V141, P438, DOI 10.1016/j.ajo.2005.10.006; Kasetsuwan N, 2001, CORNEA, V20, P41, DOI 10.1097/00003226-200101000-00008; Lindstrom R L, 1997, Trans Am Ophthalmol Soc, V95, P285; McGee HT, 2009, J CATARACT REFR SURG, V35, P1860, DOI 10.1016/j.jcrs.2009.05.047; *NAT I HLTH CLIN E, 2006, PHOT LAS SURG CORR R; *ROYAL COLL OPHTH, 2009, STAND LAS REFR SURG; Siganos D S, 1999, Oftalmologia, V47, P50; Solomon KD, 2009, OPHTHALMOLOGY, V116, P691, DOI 10.1016/j.ophtha.2008.12.037; Sugar A, 2002, OPHTHALMOLOGY, V109, P175, DOI 10.1016/S0161-6420(01)00966-6; *US FDA, LASIK; VRABEC MP, 1992, AM J OPHTHALMOL, V114, P96, DOI 10.1016/S0002-9394(14)77418-5; WARING GO, 1990, JAMA-J AM MED ASSOC, V263, P1083, DOI 10.1001/jama.263.8.1083	20	7	7	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2011	342								d2345	10.1136/bmj.d2345	http://dx.doi.org/10.1136/bmj.d2345			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755ON	21508060	Green Accepted			2022-12-28	WOS:000289942900006
J	Mostaghimi, A; Crotty, BH				Mostaghimi, Arash; Crotty, Bradley H.			Professionalism in the Digital Age	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								The increased use of social media by physicians, combined with the ease of finding information online, can blur personal and work identities, posing new considerations for physician professionalism in the information age. A professional approach is imperative in this digital age in order to maintain confidentiality, honesty, and trust in the medical profession. Although the ability of physicians to use online social networks, blogs, and media sites for personal and professional reasons should be preserved, a proactive approach is recommended that includes actively managing one's online presence and making informed choices about disclosure. The development of a "dual-citizenship" approach to online social media that separates public and private personae would allow physicians to both leverage networks for professional connections and maintain privacy in other aspects. Although social media posts by physicians enable direct communication with readers, all posts should be considered public and special consideration for patient privacy is necessary.	[Crotty, Bradley H.] Beth Israel Deaconess Med Ctr, Div Gen Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Crotty, BH (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med, 330 Brookline Ave, Boston, MA 02215 USA.	bcrotty@bidmc.harvard.edu	GAMBOA, THOMAS/A-4646-2011; Roundtree, Aimee/B-8838-2012; Crotty, Bradley/E-6332-2015	Crotty, Bradley/0000-0001-6271-4816; Mostaghimi, Arash/0000-0002-6084-5617	Institutional National Research Service [T32HP12706]; Division of General Medicine and Primary Care at Beth Israel Deaconess Medical Center	Institutional National Research Service; Division of General Medicine and Primary Care at Beth Israel Deaconess Medical Center	Grant Support: By an Institutional National Research Service Award T32HP12706 (Dr. Crotty) and the Division of General Medicine and Primary Care at Beth Israel Deaconess Medical Center.	*AM MED ASS, 2010, AMA POL PROF US SOC; Beach MC, 2004, J GEN INTERN MED, V19, P905, DOI 10.1111/j.1525-1497.2004.40040.x; Bennett E, HOSP SOCIAL NETWORK; Chretien KC, 2009, JAMA-J AM MED ASSOC, V302, P1309, DOI 10.1001/jama.2009.1387; Farnan JM, 2009, ACAD MED, V84, P1479, DOI 10.1097/ACM.0b013e3181bb17af; Greysen SR, 2010, J GEN INTERN MED, V25, P1227, DOI 10.1007/s11606-010-1447-1; HENNESSYFISKE M, 2010, LOS ANGELES TIM 0808; Jain SH, 2009, NEW ENGL J MED, V361, P649, DOI 10.1056/NEJMp0901277; Jain S, 2010, NEW ENGL J MED, V362, P6, DOI 10.1056/NEJMp0903473; Kind T, 2010, MED EDUC ONLINE, V15, DOI 10.3402/meo.v15i0.5324; Lagu T, 2008, J GEN INTERN MED, V23, P1642, DOI 10.1007/s11606-008-0726-6; Morse Diane S, 2008, Ann Intern Med, V149, P835; Mostaghimi A, 2010, J GEN INTERN MED, V25, P1152, DOI 10.1007/s11606-010-1425-7; TEVES O, 2008, ASSOCIATED PRES 0416; Thompson LA, 2008, J GEN INTERN MED, V23, P954, DOI 10.1007/s11606-008-0538-8; Ubink-Veltmaat LJ, 2004, DIABETES CARE, V27, P2560, DOI 10.2337/diacare.27.10.2560; *VAND U MED CTR, 2009, VUMC SOC MED POL; 2009, WISN MILWAUKEE  0225	18	74	76	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8					560	562		10.7326/0003-4819-154-8-201104190-00008	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-00008			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502653				2022-12-28	WOS:000289622000019
J	Atkinson, QD				Atkinson, Quentin D.			Phonemic Diversity Supports a Serial Founder Effect Model of Language Expansion from Africa	SCIENCE			English	Article							CULTURAL-EVOLUTION; POPULATION-SIZE; SOUTH-AFRICA; DISTANCE; PHYLOGENY; CLIMATE; HUMANS	Human genetic and phenotypic diversity declines with distance from Africa, as predicted by a serial founder effect in which successive population bottlenecks during range expansion progressively reduce diversity, underpinning support for an African origin of modern humans. Recent work suggests that a similar founder effect may operate on human culture and language. Here I show that the number of phonemes used in a global sample of 504 languages is also clinal and fits a serial founder-effect model of expansion from an inferred origin in Africa. This result, which is not explained by more recent demographic history, local language diversity, or statistical non-independence within language families, points to parallel mechanisms shaping genetic and linguistic diversity and supports an African origin of modern human languages.	[Atkinson, Quentin D.] Univ Auckland, Dept Psychol, Auckland, New Zealand; [Atkinson, Quentin D.] Univ Oxford, Inst Cognit & Evolutionary Anthropol, Oxford OX2 6PN, England	University of Auckland; University of Oxford	Atkinson, QD (corresponding author), Univ Auckland, Dept Psychol, Private Bag 92019, Auckland, New Zealand.	q.atkinson@auckland.ac.nz		Atkinson, Quentin/0000-0002-8499-7535				Atkinson QD, 2005, SYST BIOL, V54, P513, DOI 10.1080/10635150590950317; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Atkinson QD, 2008, SCIENCE, V319, P588, DOI 10.1126/science.1149683; BAKER AJ, 1987, ANIM BEHAV, V35, P1793, DOI 10.1016/S0003-3472(87)80072-6; Balloux F, 2009, P ROY SOC B-BIOL SCI, V276, P3447, DOI 10.1098/rspb.2009.0752; Betti L, 2009, P ROY SOC B-BIOL SCI, V276, P809, DOI 10.1098/rspb.2008.1563; Burnham KP., 2004, MODEL SELECTION MULT, V2, DOI 10.1007/b97636; CAVALLI-SFORZA L.L, 1981, CULTURAL TRANSMISSIO; de Boer B, 2000, J PHONETICS, V28, P441, DOI 10.1006/jpho.2000.0125; DIAMOND JM, 1978, NATURE, V273, P185, DOI 10.1038/273185a0; Dryer Matthew S., 2008, WORLD ATLAS LANGUAGE; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Hay J, 2007, LANGUAGE, V83, P388, DOI 10.1353/lan.2007.0071; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; KIRCH PV, 1987, CURR ANTHROPOL, V28, P431, DOI 10.1086/203547; Labov, 2001, PRINCIPLES LINGUISTI; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P553, DOI 10.1016/j.jas.2007.05.003; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rogers DS, 2009, P ROY SOC B-BIOL SCI, V276, P3835, DOI 10.1098/rspb.2009.1088; Tattersall I., P NATL ACAD SCI US, V106, P16018; Trudgill Peter, 2004, LINGUIST TYPOL, V8, P305, DOI DOI 10.1515/LITY.2004.8.3.305; Yang C., 2003, KNOWLEDGE LEARNING N	27	196	201	0	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					346	349		10.1126/science.1199295	http://dx.doi.org/10.1126/science.1199295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	750AT	21493858				2022-12-28	WOS:000289516600043
J	Porto, AMF; Coutinho, IC; Correia, JB; Amorim, MMR				Feitosa Porto, Ana Maria; Coutinho, Isabela Cristina; Correia, Jailson Barros; Ramos Amorim, Melania Maria			Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ELECTIVE CESAREAN-SECTION; DISTRESS-SYNDROME; TRANSIENT TACHYPNEA; GESTATIONAL-AGE; TERM NEWBORNS; PREVENTION; MORBIDITY; BIRTH; BETAMETHASONE; METAANALYSIS	Objectives To determine the effectiveness of corticosteroids in reducing respiratory disorders in infants born at 34-36 weeks' gestation. Design Randomised triple blind clinical trial. Setting A large tertiary teaching hospital in northeast of Brazil. Participants Women at 34-36 weeks of pregnancy at risk of imminent premature delivery. Interventions Betamethasone 12 mg or placebo intramuscularly for two consecutive days. Main outcomes measures Primary outcome was the incidence of respiratory disorders (respiratory distress syndrome and transient tachypnoea of the newborn). Secondary outcomes included the need for ventilatory support, neonatal morbidity, and duration of stay in hospital. Results 320 women were randomised, 163 of whom were assigned to the treatment group and 157 to the controls. Final analysis included 143 and 130 infants, respectively. The rate of respiratory distress syndrome was low (two (1.4%) in the corticosteroid group; one (0.8%) in the placebo group; P=0.54), while the rate of transient tachypnoea was high in both groups (34 (24%) v 29 (22%); P=0.77). There was no reduction in the risk of respiratory morbidity with corticosteroid use even after adjustment for subgroups of gestational age (34-34(+6) weeks, 35-35(+6) weeks, and >= 36 weeks). The adjusted risk of respiratory morbidity was 1.12 (95% confidence interval 0.74 to 1.70). The need for ventilatory support was around 20% in both groups. There was no difference in neonatal morbidity (88 (62%) v 93 (72%); P=0.08) or in the duration of stay in hospital between the two groups (5.12 v 5.22 days; P=0.87). Phototherapy for jaundice was required less often in babies whose mothers received corticosteroids (risk ratio 0.63, 0.44 to 0.91). Conclusions Antenatal treatment with corticosteroids at 34-36 weeks of pregnancy does not reduce the incidence of respiratory disorders in newborn infants.	[Feitosa Porto, Ana Maria] Inst Med Integral Prof Fernando Figueira, Med Residency Programme Gynaecol & Obstet, Recife, PE, Brazil; [Ramos Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira, Postgrad Programme Maternal & Child Hlth, Recife, PE, Brazil	Instituto de Medicina Integral Professor Fernando Figueira (IMIP); Instituto de Medicina Integral Professor Fernando Figueira (IMIP)	Amorim, MMR (corresponding author), Rua Neuza Borborema de Souza 300, BR-58406120 Campina Grande, PB, Brazil.	melamorim@uol.com.br	Correia, Jailson B./J-4331-2015; Amorim, Melania/C-5807-2013	Amorim, Melania/0000-0003-1047-2514; de Barros Correia, Jailson/0000-0002-0927-2219	Instituto de Medicina Integral Prof Fernando Figueira-IMIP, Recife, Pernambuco, Brazil	Instituto de Medicina Integral Prof Fernando Figueira-IMIP, Recife, Pernambuco, Brazil	This study was supported by the Instituto de Medicina Integral Prof Fernando Figueira-IMIP (www.imip.org.br), a private, not for profit healthcare organisation based in Recife, Pernambuco, Brazil, where the study was carried out. The institute did not interfere with study design or analysis and the funding covered all study expenses, including purchase of the drug and placebo.	Amorim MMR, 1999, AM J OBSTET GYNECOL, V180, P1283, DOI 10.1016/S0002-9378(99)70630-7; BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4; Bonanno C, 2009, AM J OBSTET GYNECOL, V200, P448, DOI 10.1016/j.ajog.2008.12.011; CROWLEY PA, 1995, AM J OBSTET GYNECOL, V173, P322, DOI 10.1016/0002-9378(95)90222-8; Davidoff MJ, 2006, SEMIN PERINATOL, V30, P8, DOI 10.1053/j.semperi.2006.01.009; Escobar GJ, 2006, SEMIN PERINATOL, V30, P28, DOI 10.1053/j.semperi.2006.01.005; Fuchs K, 2006, CLIN PERINATOL, V33, P793, DOI 10.1016/j.clp.2006.09.010; GAMSU HR, 1989, BRIT J OBSTET GYNAEC, V96, P401, DOI 10.1111/j.1471-0528.1989.tb02413.x; Guglani L, 2008, PEDIATR REV, V29, pE59, DOI 10.1542/pir.29-11-e59; Helve O, 2009, NEONATOLOGY, V95, P347, DOI 10.1159/000209300; Jain L, 2006, SEMIN PERINATOL, V30, P34, DOI 10.1053/j.semperi.2006.01.006; Jain L, 2008, AM J PERINAT, V25, P75, DOI 10.1055/s-2007-1022471; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Kurl S, 1997, CLIN PEDIATR, V36, P285, DOI 10.1177/000992289703600506; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Mac Bird T, 2010, PEDIATRICS, V126, pE311, DOI 10.1542/peds.2009-2869; Riskin A, 2005, AM J PERINAT, V22, P377, DOI 10.1055/s-2005-872594; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Santos IS, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-71; SINCLAIR JC, 1995, AM J OBSTET GYNECOL, V173, P335, DOI 10.1016/0002-9378(95)90223-6; Sotiriadis A, 2009, COCHRANE DB SYST REV, V4; Stutchfield P, 2005, BMJ-BRIT MED J, V331, P662, DOI 10.1136/bmj.38547.416493.06; Tomashek KM, 2006, SEMIN PERINATOL, V30, P61, DOI 10.1053/j.semperi.2006.02.003; Ventolini G, 2008, AM J PERINAT, V25, P79, DOI 10.1055/s-2007-1022470; Wang ML, 2004, PEDIATRICS, V114, P372, DOI 10.1542/peds.114.2.372; Young PC, 2007, PEDIATRICS, V119, pE659, DOI 10.1542/peds.2006-2486; Zanardo V, 2004, ACTA PAEDIATR, V93, P643, DOI [10.1080/08035250410026671, 10.1111/j.1651-2227.2004.tb02990.x]	27	96	102	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 12	2011	342								d1696	10.1136/bmj.d1696	http://dx.doi.org/10.1136/bmj.d1696			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752UV	21487057	Green Published, hybrid			2022-12-28	WOS:000289721300002
J	Macheboeuf, P; Buffalo, C; Fu, CY; Zinkernagel, AS; Cole, JN; Johnson, JE; Nizet, V; Ghosh, P				Macheboeuf, Pauline; Buffalo, Cosmo; Fu, Chi-yu; Zinkernagel, Annelies S.; Cole, Jason N.; Johnson, John E.; Nizet, Victor; Ghosh, Partho			Streptococcal M1 protein constructs a pathological host fibrinogen network	NATURE			English	Article							HEPARIN-BINDING PROTEIN; GROUP-A STREPTOCOCCI; OLIGOMERIZATION STATE; CRYSTAL-STRUCTURE; SURFACE-PROTEINS; COILED COILS; FRAGMENT-D; CRYSTALLOGRAPHY; PHAGOCYTOSIS; STABILITY	M1 protein, a major virulence factor of the leading invasive strain of group A Streptococcus, is sufficient to induce toxic-shock-like vascular leakage and tissue injury. These events are triggered by the formation of a complex between M1 and fibrinogen that, unlike M1 or fibrinogen alone, leads to neutrophil activation. Here we provide a structural explanation for the pathological properties of the complex formed between streptococcal M1 and human fibrinogen. A conformationally dynamic coiled-coil dimer of M1 was found to organize four fibrinogen molecules into a specific cross-like pattern. This pattern supported the construction of a supramolecular network that was required for neutrophil activation but was distinct from a fibrin clot. Disruption of this network into other supramolecular assemblies was not tolerated. These results have bearing on the pathophysiology of streptococcal toxic shock.	[Macheboeuf, Pauline; Buffalo, Cosmo; Ghosh, Partho] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Fu, Chi-yu; Johnson, John E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Zinkernagel, Annelies S.; Cole, Jason N.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Cole, Jason N.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Nizet, Victor] Univ Calif San Diego, Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego; University of Queensland; University of California System; University of California San Diego	Ghosh, P (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	pghosh@ucsd.edu	Zinkernagel, Annelies S/F-1780-2017; Johnson, Johnson/HDL-9124-2022; Nizet, Victor/AAF-3190-2019	Zinkernagel, Annelies S/0000-0003-4700-1118; Nizet, Victor/0000-0003-3847-0422; Buffalo, Cosmo/0000-0002-8187-4660; Macheboeuf, Pauline/0000-0003-4523-9923	NIH [R21 AI071167, T32 GM007240, R01 AI077780, R01 GM54076]; National Health and Medical Research Council of Australia [514639]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780, R37AI052453, R01AI052453, R21AI071167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240, R01GM054076] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Argonne Photon Source Laboratory GM/CA CAT staff for help with data collection, R. Doolittle and A. Royant for advice, and S. Mel and G. Ghosh for comments on the manuscript. This work was supported by NIH R21 AI071167 (P.G.), T32 GM007240 (C.B.), R01 AI077780 (V.N.), R01 GM54076 (J.E.J.), and a fellowship (J.N.C.) from the National Health and Medical Research Council of Australia (514639).	AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bowley SR, 2009, BLOOD, V113, P4425, DOI 10.1182/blood-2008-09-178178; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVERSE SJ, 1995, PROTEIN SCI, V4, P1013; Facklam RF, 2002, CLIN INFECT DIS, V34, P28, DOI 10.1086/324621; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Gautam N, 2000, J EXP MED, V191, P1829, DOI 10.1084/jem.191.11.1829; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Kahn F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000149; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; Linder A, 2009, CLIN INFECT DIS, V49, P1044, DOI 10.1086/605563; Lishko VK, 2002, BIOCHEMISTRY-US, V41, P12942, DOI 10.1021/bi026324c; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; Medved L, 1997, BIOCHEMISTRY-US, V36, P4685, DOI 10.1021/bi962795l; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Shannon O, 2007, MOL MICROBIOL, V65, P1147, DOI 10.1111/j.1365-2958.2007.05841.x; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Wagschal K, 1999, PROTEIN SCI, V8, P2312; WHITNACK E, 1985, J EXP MED, V162, P1983, DOI 10.1084/jem.162.6.1983; Yang Z, 2001, BIOCHEMISTRY-US, V40, P12515, DOI 10.1021/bi011394p	41	72	73	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					64	68		10.1038/nature09967	http://dx.doi.org/10.1038/nature09967			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475196	Green Accepted			2022-12-28	WOS:000289199400037
J	DESMET, J; DEMAEYER, M; HAZES, B; LASTERS, I				DESMET, J; DEMAEYER, M; HAZES, B; LASTERS, I			THE DEAD-END ELIMINATION THEOREM AND ITS USE IN PROTEIN SIDE-CHAIN POSITIONING	NATURE			English	Article							CONFORMATION	THE prediction of a protein's tertiary structure is still a considerable problem because the huge amount of possible conformational space' makes it computationally difficult. With regard to side-chain modelling, a solution has been attempted by the grouping of side-chain conformations into representative sets of rotamers 2-5. Nonetheless, an exhaustive combinatorial search is still limited to carefully identified packing units 5,6 containing a limited number of residues. For larger systems other strategies had to be developed, such as the Monte Carlo Procedure 6,7 and the genetic algorithm and clustering approach 8. Here we present a theorem, referred to as the 'dead-end elimination' theorem, which imposes a suitable condition to identify rotamers that cannot be members of the global minimum energy conformation. Application of this theorem effectively controls the computational explosion of the rotamer combinatorial problem, thereby allowing the determination of the global minimum energy conformation of a large collection of side chains.	CORVAS INT NV,B-9000 GHENT,BELGIUM; UNIV GRONINGEN,BIOSON RES INST,DEPT CHEM,9747 AG GRONINGEN,NETHERLANDS	University of Groningen	DESMET, J (corresponding author), KATHOLIEKE UNIV LEUVEN,INTERDISCIPLINARY RES CTR,CAMPUS KORTRIJK,B-8500 KORTRIJK,BELGIUM.							BERENSTEIN FC, 1977, J MOL BIOL, V112, P535; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; DELHAISE P, 1984, J MOL GRAPHICS, V2, P103, DOI 10.1016/0263-7855(84)80002-8; JAMES MNG, 1983, J MOL BIOL, V163, P299, DOI 10.1016/0022-2836(83)90008-6; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; LEE C, 1991, NATURE, V352, P448, DOI 10.1038/352448a0; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; MCGREGOR MJ, 1987, J MOL BIOL, V198, P295, DOI 10.1016/0022-2836(87)90314-7; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; TUFFERY P, 1991, J BIOMOL STRUCT DYN, V8, P1267, DOI 10.1080/07391102.1991.10507882	12	557	587	2	36	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 9	1992	356	6369					539	542		10.1038/356539a0	http://dx.doi.org/10.1038/356539a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN231	21488406				2022-12-28	WOS:A1992HN23100065
J	Garnett, GP; Cousens, S; Hallett, TB; Steketee, R; Walker, N				Garnett, Geoffrey P.; Cousens, Simon; Hallett, Timothy B.; Steketee, Richard; Walker, Neff			Mathematical models in the evaluation of health programmes	LANCET			English	Review							HUMAN-PAPILLOMAVIRUS VACCINATION; HIV PREVENTION INTERVENTIONS; CERVICAL-CANCER; COST-EFFECTIVENESS; PUBLIC-HEALTH; TRANSMISSION DYNAMICS; GLOBAL BURDEN; IMPACT; STRATEGIES; MORTALITY	Modelling is valuable in the planning and evaluation of interventions, especially when a controlled trial is ethically or logistically impossible. Models are often used to calculate the expected course of events in the absence of more formal assessments. They are also used to derive estimates of rare or future events from recorded intermediate points. When developing models, decisions are needed about the appropriate level of complexity to be represented and about model structure and assumptions. The degree of rigor in model development and assessment can vary greatly, and there is a danger that existing beliefs inappropriately influence judgments about model assumptions and results.	[Walker, Neff] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Garnett, Geoffrey P.; Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Cousens, Simon] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Steketee, Richard] PATH, Ferney Voltaire, France	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Walker, N (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	pneffwalker@yahoo.com	Garnett, Geoffrey P/A-9312-2008	Hallett, Timothy/0000-0002-9681-0424	Medical Research Council [G0600719B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Alonso D, 2007, J R SOC INTERFACE, V4, P575, DOI 10.1098/rsif.2006.0192; Amouzou A, 2010, INT J EPIDEMIOL, V39, P186, DOI 10.1093/ije/dyq034; ANDERSON R M, 1986, IMA Journal of Mathematics Applied in Medicine and Biology, V3, P229; ANDERSON R M, 1991; ANDERSON RM, 1986, J HYG-CAMBRIDGE, V96, P305, DOI 10.1017/S0022172400066079; Artzrouni M, 2002, AIDS, V16, pW1; Austin DJ, 1999, J INFECT DIS, V179, P883, DOI 10.1086/314682; Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Baussano I, 2010, EPIDEMICS-NETH, V2, P21, DOI 10.1016/j.epidem.2010.02.002; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Boily MC, 2007, SEX TRANSM INFECT, V83, P582, DOI 10.1136/sti.2007.027516; Boily MC, 2008, AIDS, V22, pS149, DOI 10.1097/01.aids.0000343773.59776.5b; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Chopra M, 2009, LANCET, V374, P835, DOI 10.1016/S0140-6736(09)61123-5; Cliff AD, 2008, INT J EPIDEMIOL, V37, P106, DOI 10.1093/ije/dym240; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Desai K, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-19; Desai KN, 1999, EPIDEMIOL INFECT, V123, P65, DOI 10.1017/S0950268899002642; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Ferguson NM, 1996, P NATL ACAD SCI USA, V93, P7231, DOI 10.1073/pnas.93.14.7231; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Friberg IK, 2010, INT J EPIDEMIOL, V39, P11, DOI 10.1093/ije/dyq017; Futures Institute, GOALS MOD VERS 3 0 E; Futures Institute, SPECTR AIDS IMP MOD; Garnett GP, 2006, VACCINE, V24, P178, DOI 10.1016/j.vaccine.2006.05.116; GARNETT GP, 1995, J ACQ IMMUN DEF SYND, V9, P500; Garnett GP, 2002, SEX TRANSM INFECT, V78, P7, DOI 10.1136/sti.78.1.7; Ghani AC, 1998, LANCET, V352, P1353, DOI [10.1016/S0140-6736(05)60744-1, 10.1016/S0140-6736(98)00046-4]; Ghani AC, 1997, SEX TRANSM DIS, V24, P45, DOI 10.1097/00007435-199701000-00009; Glass K, 2009, J R SOC INTERFACE, V6, P695, DOI 10.1098/rsif.2008.0404; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Goldie SJ, 2006, VACCINE, V24, P155, DOI 10.1016/j.vaccine.2006.05.112; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hallett TB, PAY CASH ON DELIVERY; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2007, SEX TRANSM INFECT, V83, pI55, DOI 10.1136/sti.2006.023663; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Hallett TB, 2008, PLOS MED, V5, P403, DOI 10.1371/journal.pmed.0050053; Halloran ME, 1999, EPIDEMIOL REV, V21, P73, DOI 10.1093/oxfordjournals.epirev.a017990; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Hazel E, 2010, INT J EPIDEMIOL, V39, P32, DOI 10.1093/ije/dyq019; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hu D, 2004, ANN INTERN MED, V141, P501, DOI 10.7326/0003-4819-141-7-200410050-00006; JACQUEZ JA, 1988, MATH BIOSCI, V92, P119, DOI 10.1016/0025-5564(88)90031-4; Johns Hopkins University, LIV SAV TOOL; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kim JJ, 2009, ANN INTERN MED, V151, P538, DOI 10.7326/0003-4819-151-8-200910200-00007; Kretzschmar M, 1996, AM J EPIDEMIOL, V144, P306; Lekone PE, 2006, BIOMETRICS, V62, P1170, DOI 10.1111/j.1541-0420.2006.00609.x; Macro International Inc, 2009, 5 YEAR EV GLOB FUND; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; Medical Research Council, 2008, DEV EV COMPL INT NEW; Medley GF, 2001, NAT MED, V7, P619, DOI 10.1038/87953; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226; Otten M, 2005, LANCET, V366, P832, DOI 10.1016/S0140-6736(05)67216-9; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; PLAISIER AP, 1990, COMPUT METH PROG BIO, V31, P43, DOI 10.1016/0169-2607(90)90030-D; Preston S., 2000, DEMOGRAPHY MEASURING; SEAHOLM SK, 1988, INT J BIOMED COMPUT, V23, P97, DOI 10.1016/0020-7101(88)90067-0; Stein CE, 2003, J INFECT DIS, V187, pS8, DOI 10.1086/368114; Susser M, 1996, AM J PUBLIC HEALTH, V86, P1713, DOI 10.2105/AJPH.86.12.1713; Van der Ploeg CPB, 1998, INTERFACES, V28, P84, DOI 10.1287/inte.28.3.84; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Walker N, 2004, LANCET, V363, P2180, DOI 10.1016/S0140-6736(04)16511-2; White RG, 2004, JAIDS-J ACQ IMM DEF, V37, P1500, DOI 10.1097/01.qai.0000127062.94627.31	71	148	151	0	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2011	378	9790					515	525		10.1016/S0140-6736(10)61505-X	http://dx.doi.org/10.1016/S0140-6736(10)61505-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809SO	21481448	Green Accepted			2022-12-28	WOS:000294077200031
J	Kelley, M				Kelley, Maureen			Counting stillbirths: women's health and reproductive rights	LANCET			English	Editorial Material									[Kelley, Maureen] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Kelley, Maureen] Seattle Childrens Hosp, Treuman Katz Ctr Pediat Bioeth, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital	Kelley, M (corresponding author), Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA.	mckelley@u.washington.edu		Kelley, Maureen/0000-0001-8230-5315				Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Jamison DT, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P427; Jutel A, 2006, PERSPECT BIOL MED, V49, P425, DOI 10.1353/pbm.2006.0040; Kelley M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S6; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021	7	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2011	377	9778					1636	1637		10.1016/S0140-6736(11)60279-1	http://dx.doi.org/10.1016/S0140-6736(11)60279-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	766JF	21496905				2022-12-28	WOS:000290777700010
J	Borissoff, JI; Spronk, HMH; ten Cate, H				Borissoff, Julian Ilcheff; Spronk, Henri M. H.; ten Cate, Hugo			MECHANISMS OF DISEASE The Hemostatic System as a Modulator of Atherosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FACTOR PATHWAY INHIBITOR; CORONARY-HEART-DISEASE; HEPARIN-COFACTOR-II; INTERCELLULAR-ADHESION MOLECULE-1; PERIPHERAL ARTERY-DISEASE; INTIMA-MEDIA THICKNESS; SMOOTH-MUSCLE-CELLS; ACTIVATED PROTEIN-C; LOW-DOSE ASPIRIN; TISSUE-FACTOR		[Borissoff, Julian Ilcheff; Spronk, Henri M. H.; ten Cate, Hugo] Maastricht Univ, Med Ctr,Cardiovasc Res Inst Maastricht, Lab Clin Thrombosis & Hemostasis, Dept Internal Med & Biochem, NL-6200 MD Maastricht, Netherlands	Maastricht University	ten Cate, H (corresponding author), Maastricht Univ, Med Ctr,Cardiovasc Res Inst Maastricht, Lab Clin Thrombosis & Hemostasis, Dept Internal Med & Biochem, Universiteitsingel 50,POB 616,Box 8, NL-6200 MD Maastricht, Netherlands.	h.tencate@maastrichtuniversity.nl	Cate, Hugo ten/AAM-4000-2021	ten Cate, Hugo/0000-0001-7796-4463; Spronk, Henri/0000-0002-3858-334X	European Commission [MEST-CT-2005-020706]	European Commission(European CommissionEuropean Commission Joint Research Centre)	Supported by a Marie Curie fellowship (MEST-CT-2005-020706) from the European Commission (to Dr. Borissoff).	AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; Aihara K, 2004, CIRCULATION, V109, P2761, DOI 10.1161/01.CIR.0000129968.46095.F3; Aihara K, 2007, J CLIN INVEST, V117, P1514, DOI 10.1172/JCI27095; Aleksic N, 2008, ATHEROSCLEROSIS, V198, P294, DOI 10.1016/j.atherosclerosis.2007.12.062; Anand S, 2007, NEW ENGL J MED, V357, P217; Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; ANNEX BH, 1995, CIRCULATION, V91, P619, DOI 10.1161/01.CIR.91.3.619; Antithrombotic Trialists' Collaboration, 2002, BMJ-BRIT MED J, V324, P141, DOI DOI 10.1136/BMJ.324.7330.141; Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; Ardissino D, 1997, LANCET, V349, P769, DOI 10.1016/S0140-6736(96)11189-2; Ardissino D, 2001, BLOOD, V98, P2726, DOI 10.1182/blood.V98.9.2726; Badimon JJ, 1999, CIRCULATION, V99, P1780, DOI 10.1161/01.CIR.99.14.1780; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bea F, 2006, ARTERIOSCL THROM VAS, V26, P2787, DOI 10.1161/01.ATV.0000246797.05781.ad; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; BINI A, 1989, ARTERIOSCLEROSIS, V9, P109, DOI 10.1161/01.ATV.9.1.109; Blann AD, 2000, ATHEROSCLEROSIS, V152, P29, DOI 10.1016/S0021-9150(99)00444-X; Borensztajn K, 2008, TRENDS MOL MED, V14, P429, DOI 10.1016/j.molmed.2008.08.001; Borissoff JI, 2010, CIRCULATION, V122, P821, DOI 10.1161/CIRCULATIONAHA.109.907121; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Burke AP, 2001, CIRCULATION, V103, P934; Byington RP, 1999, CIRCULATION, V100, pE14; Campeau L, 1997, NEW ENGL J MED, V336, P153; Caplice NM, 1998, CIRCULATION, V98, P1051, DOI 10.1161/01.CIR.98.11.1051; Castellino FJ, 2006, THROMB HAEMOSTASIS, V96, P794, DOI 10.1160/TH06-08-0430; Chen X, 2003, ATHEROSCLEROSIS, V169, P31, DOI 10.1016/S0021-9150(03)00105-9; Chiang N, 2006, ARTERIOSCL THROM VAS, V26, pE14, DOI 10.1161/01.ATV.0000196729.98651.bf; Chiodoni C, 2006, J EXP MED, V203, P2441, DOI 10.1084/jem.20060844; Cho YP, 2005, BRIT J RADIOL, V78, P601, DOI 10.1259/bjr/65615343; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cortellaro M, 1996, STROKE, V27, P450, DOI 10.1161/01.STR.27.3.450; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Crawley J, 2000, ARTERIOSCL THROM VAS, V20, P1362, DOI 10.1161/01.ATV.20.5.1362; Crawley JTB, 2007, J THROMB HAEMOST, V5, P95, DOI 10.1111/j.1538-7836.2007.02500.x; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; de Moerloose P, 2010, SEMIN THROMB HEMOST, V36, P7, DOI 10.1055/s-0030-1248720; Di Tullio MR, 2008, J AM COLL CARDIOL, V52, P855, DOI 10.1016/j.jacc.2008.04.062; Dicker HJ, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.006; Dielis AWJH, 2008, J THROMB HAEMOST, V6, P125; Eitzman DT, 2005, CIRCULATION, V111, P1822, DOI 10.1161/01.CIR.0000160854.75779.E8; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Ferroni P, 2003, CIRCULATION, V108, P1673, DOI 10.1161/01.CIR.0000094732.02060.27; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; Folsom AR, 2001, THROMB HAEMOSTASIS, V86, P366; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gailani D, 2007, J THROMB HAEMOST, V5, P1106, DOI 10.1111/j.1538-7836.2007.02446.x; Gailani D, 2007, ARTERIOSCL THROM VAS, V27, P2507, DOI 10.1161/ATVBAHA.107.155952; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gerdes VEA, 2004, J THROMB HAEMOST, V2, P200, DOI 10.1111/j.1538-7836.2004.0562f.x; Gertow K, 2009, ATHEROSCLEROSIS, V207, P168, DOI 10.1016/j.atherosclerosis.2009.04.040; Giri TK, 2005, ARTERIOSCL THROM VAS, V25, P2689, DOI 10.1161/01.ATV.0000193888.71297.f3; Gleissner CA, 2008, ARTERIOSCL THROM VAS, V28, P1920, DOI 10.1161/ATVBAHA.108.169417; Govers-Riemslag JWP, 2007, J THROMB HAEMOST, V5, P1896, DOI 10.1111/j.1538-7836.2007.02687.x; Green D, 2010, J THROMB HAEMOST, V8, P489, DOI 10.1111/j.1538-7836.2009.03727.x; Green DM, 2010, STROKE, V41, pE379; Hagedorn I, 2010, CIRCULATION, V121, P1510, DOI 10.1161/CIRCULATIONAHA.109.924761; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Holmes DR, 2009, J AM COLL CARDIOL, V54, P95, DOI 10.1016/j.jacc.2009.03.044; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; ISHIDA T, 1982, ATHEROSCLEROSIS, V44, P161, DOI 10.1016/0021-9150(82)90111-3; Iwaki T, 2006, BLOOD, V107, P3883, DOI 10.1182/blood-2005-09-3780; JANG YS, 1995, CIRCULATION, V92, P3041, DOI 10.1161/01.CIR.92.10.3041; Khallou-Laschet J, 2005, ARTERIOSCL THROM VAS, V25, P123, DOI 10.1161/01.ATV.0000171995.22284.9a; Knatterud GL, 2000, CIRCULATION, V102, P157, DOI 10.1161/01.CIR.102.2.157; Konings J, 2010, CLIN CARDIOGENETICS; Kopp CW, 2004, BLOOD, V103, P1653, DOI 10.1182/blood-2003-04-1148; Kramer MCA, 2010, J AM COLL CARDIOL, V55, P122, DOI 10.1016/j.jacc.2009.09.007; LaRusch GA, 2010, BLOOD, V115, P5111, DOI 10.1182/blood-2009-08-236430; Lentz SR, 2002, CIRCULATION, V106, P842, DOI 10.1161/01.CIR.0000024982.11646.25; Lepedda AJ, 2009, ATHEROSCLEROSIS, V203, P112, DOI 10.1016/j.atherosclerosis.2008.07.001; Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Liao D, 2009, BLOOD, V113, P165, DOI 10.1182/blood-2008-05-158048; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lievens D, 2009, THROMB HAEMOSTASIS, V102, P206, DOI 10.1160/TH09-01-0029; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JC135424, 10.1172/JCI35424]; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911; Mahmoodi BK, 2008, CIRCULATION, V118, P1659, DOI 10.1161/CIRCULATIONAHA.108.780759; Mann J, 1999, HEART, V82, P265, DOI 10.1136/hrt.82.3.265; Marmur JD, 1996, CIRCULATION, V94, P1226, DOI 10.1161/01.CIR.94.6.1226; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Matsumoto K, 2007, DIABETIC MED, V24, P1322, DOI 10.1111/j.1464-5491.2007.02289.x; Merlo C, 2002, ATHEROSCLEROSIS, V161, P261, DOI 10.1016/S0021-9150(01)00666-9; Methia N, 2001, BLOOD, V98, P1424, DOI 10.1182/blood.V98.5.1424; Mitchell CT, 2009, ATHEROSCLEROSIS, V207, P277, DOI 10.1016/j.atherosclerosis.2009.04.024; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; Monroe DM, 2007, J THROMB HAEMOST, V5, P1097, DOI 10.1111/j.1538-7836.2007.02435.x; Moreno PR, 1996, CIRCULATION, V94, P3090, DOI 10.1161/01.CIR.94.12.3090; Morris T, 2009, J IMMUNOL, V183, P2089, DOI 10.4049/jimmunol.0900477; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Muhlestein JB, 2010, THROMB HAEMOSTASIS, V103, P71, DOI 10.1160/TH09-03-0177; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Noto ATW, 2008, THROMB HAEMOSTASIS, V99, P602, DOI 10.1160/TH07-08-0493; Okajima K, 2001, IMMUNOL REV, V184, P258, DOI 10.1034/j.1600-065x.2001.1840123.x; Oltrona L, 1997, CIRCULATION, V96, P646; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pan SC, 2009, CIRC RES, V105, P713, DOI 10.1161/CIRCRESAHA.109.195016; Paramo JA, 2004, STROKE, V35, P1085, DOI 10.1161/01.STR.0000124927.38723.f2; Pardos-Gea J, 2008, THROMB RES, V121, P727, DOI 10.1016/j.thromres.2007.07.009; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Peter K, 1997, ARTERIOSCL THROM VAS, V17, P505, DOI 10.1161/01.ATV.17.3.505; Porcu P, 2004, ARTERIOSCL THROM VAS, V24, P1104, DOI 10.1161/01.ATV.0000128126.57688.a9; Randi AM, 2003, J THROMB HAEMOST, V1, P829, DOI 10.1046/j.1538-7836.2003.00113.x; Rennenberg RJMW, 2010, BLOOD, V115, P5121, DOI 10.1182/blood-2010-01-264598; Rittersma SZH, 2005, CIRCULATION, V111, P1160, DOI 10.1161/01.CIR.0000157141.00778.AC; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Rocken C, 2006, ARTERIOSCL THROM VAS, V26, P676, DOI 10.1161/01.ATV.0000201930.10103.be; Rosenberg RD, 1999, NEW ENGL J MED, V340, P1555, DOI 10.1056/NEJM199905203402007; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sakata T, 2004, ATHEROSCLEROSIS, V176, P355, DOI 10.1016/j.atherosclerosis.2004.05.017; Salomaa V, 1999, LANCET, V353, P1729, DOI 10.1016/S0140-6736(98)09057-6; Salomaa V, 2001, ATHEROSCLEROSIS, V157, P309, DOI 10.1016/S0021-9150(00)00729-2; Schmaier AH, 2008, J CLIN INVEST, V118, P3006, DOI 10.1172/JCI36617; Schulman S, 2003, NEW ENGL J MED, V349, P675, DOI 10.1056/NEJMcp025373; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Seehaus S, 2009, CIRCULATION, V120, P774, DOI 10.1161/CIRCULATIONAHA.109.849539; Semple JW, 2010, CELL MOL LIFE SCI, V67, P499, DOI 10.1007/s00018-009-0205-1; Siegerink B, 2010, CIRCULATION, V122, P1854, DOI 10.1161/CIRCULATIONAHA.110.943738; Sofi F, 2009, J THROMB HAEMOST, V7, P731, DOI 10.1111/j.1538-7836.2009.03325.x; Sofi F, 2007, THROMB HAEMOSTASIS, V98, P1114, DOI 10.1160/TH07-04-0300; Spronk HMH, 2003, J VASC RES, V40, P531, DOI 10.1159/000075344; Stone OA, 2009, ARTERIOSCL THROM VAS, V29, P657, DOI 10.1161/ATVBAHA.108.182139; Takamori N, 2004, CIRCULATION, V109, P481, DOI 10.1161/01.CIR.0000109695.39671.37; The Post Coronary Artery Bypass Graft Trial Investigators, 1997, NEW ENGL J MED, V336, P153; Thomas AC, 2004, ATHEROSCLEROSIS, V176, P73, DOI 10.1016/j.atherosclerosis.2004.05.006; Thome LM, 1998, CIRCULATION, V98, P2301, DOI 10.1161/01.CIR.98.21.2301; Tilley RE, 2006, ARTERIOSCL THROM VAS, V26, P555, DOI 10.1161/01.ATV.0000202028.62414.3c; Toschi V, 1997, CIRCULATION, V95, P594, DOI 10.1161/01.CIR.95.3.594; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; van der Meijden PEJ, 2009, BLOOD, V114, P881, DOI 10.1182/blood-2008-07-171066; Wang D, 2009, CIRC RES, V104, P1066, DOI 10.1161/CIRCRESAHA.109.196691; Waugh JM, 2000, CIRCULATION, V102, P332; Webb JH, 2002, J IMMUNOL, V169, P2580, DOI 10.4049/jimmunol.169.5.2580; Weber C, 2005, CIRC RES, V96, P612, DOI 10.1161/01.RES.0000160077.17427.57; Westrick RJ, 2001, CIRCULATION, V103, P3044, DOI 10.1161/hc2501.092492; Wu KK, 2003, CIRCULATION, V107, P1729, DOI 10.1161/01.CIR.0000064894.97094.4F; Xiao Q, 1998, J CLIN INVEST, V101, P1184, DOI 10.1172/JCI1461; Zhou D, 2007, CLIN EXP PHARMACOL P, V34, P185, DOI 10.1111/j.1440-1681.2007.04570.x; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386; Zito F, 2002, ATHEROSCLEROSIS, V165, P153, DOI 10.1016/S0021-9150(02)00196-X; Zoldhelyi P, 2001, P NATL ACAD SCI USA, V98, P4078, DOI 10.1073/pnas.061004098; Zorio E, 2006, J THROMB HAEMOST, V4, P1530, DOI 10.1111/j.1538-7836.2006.01996.x	149	387	399	1	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1746	1760		10.1056/NEJMra1011670	http://dx.doi.org/10.1056/NEJMra1011670			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759DC	21542745				2022-12-28	WOS:000290219800011
J	Cleland, K; Peipert, JF; Westhoff, C; Spear, S; Trussell, J				Cleland, Kelly; Peipert, Jeffrey F.; Westhoff, Carolyn; Spear, Scott; Trussell, James			Family Planning as a Cost-Saving Preventive Health Service	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cleland, Kelly; Trussell, James] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Peipert, Jeffrey F.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Westhoff, Carolyn] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA; [Westhoff, Carolyn] Columbia Univ, Dept Epidemiol, New York, NY USA; [Westhoff, Carolyn] Columbia Univ, Dept Populat & Family Hlth, New York, NY USA; [Spear, Scott] Planned Parenthood Texas Capital Reg, Austin, TX USA; [Spear, Scott] Planned Parenthood Cent Texas, Austin, TX USA; [Trussell, James] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England	Princeton University; Washington University (WUSTL); Columbia University; Columbia University; Columbia University; University of Hull; University of York - UK	Cleland, K (corresponding author), Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.		Potter, Joseph E/A-3122-2008	Cleland, Kelly/0000-0001-9966-1260	NICHD NIH HHS [R24 HD047879] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Brown S.S., 1995, BEST INTENTIONS UNIN; Frost JJ, 2008, PERSPECT SEX REPRO H, V40, P94, DOI 10.1363/4009408; Postlethwaite D, 2007, CONTRACEPTION, V76, P360, DOI 10.1016/j.contraception.2007.07.006; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Trussell J, 2010, CONTRACEPTION, V82, P391, DOI 10.1016/j.contraception.2010.04.008	5	66	69	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18								10.1056/NEJMp1104373	http://dx.doi.org/10.1056/NEJMp1104373			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759DC	21506736				2022-12-28	WOS:000290219800005
J	Colquhoun, D				Colquhoun, David			WELLBEING The A to Z of the wellbeing industry: from angelic reiki to patient centred care	BRITISH MEDICAL JOURNAL			English	Editorial Material							SURVIVAL		UCL, London WC1E 6BT, England	University of London; University College London	Colquhoun, D (corresponding author), UCL, London WC1E 6BT, England.	d.colquhoun@ucl.ac.uk	Colquhoun, David/C-1664-2008	Colquhoun, David/0000-0002-4263-017X				Coyne JC, 2007, PSYCHOL BULL, V133, P367, DOI 10.1037/0033-2909.133.3.367; *DEP BUS INN SKILL, MENT CAP WELLB PROJ; Epstein RM, 2011, ANN FAM MED, V9, P100, DOI 10.1370/afm.1239; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; MARMOT M, WORK STRESS HLTH WHI; Marmot M, 2010, FAIR SOC HLTH LIVES; Schofield P, 2004, CANCER-AM CANCER SOC, V100, P1276, DOI 10.1002/cncr.20076; Wilkinson Richard, 2009, SPIRIT LEVEL WHY MOR	8	1	1	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2011	342								d2711	10.1136/bmj.d2711	http://dx.doi.org/10.1136/bmj.d2711			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MB	21543407				2022-12-28	WOS:000290481700007
J	Topisirovic, I; Sonenberg, N				Topisirovic, Ivan; Sonenberg, Nahum			Translational Control by the Eukaryotic Ribosome	CELL			English	Editorial Material								The ribosome plays a universally conserved role in catalyzing protein synthesis. Kondrashov et al. (2011) now provide evidence that the loss of function of ribosomal protein L38 in mice leads to a selective reduction in the translation of Hox mRNAs, thus suggesting that ribosomal proteins play a critical role during embryonic development.	[Topisirovic, Ivan] McGill Univ, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H3T 1E2, Canada; [Topisirovic, Ivan] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Topisirovic, I (corresponding author), McGill Univ, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H3T 1E2, Canada.	ivan.topisirovic@mcgill.ca; nahum.sonenberg@mcgill.ca	Topisirovic, Ivan/A-9426-2008	Topisirovic, Ivan/0000-0002-5510-9762				Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; Fox GE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003483; Ganapathi KA, 2008, BRIT J HAEMATOL, V141, P376, DOI 10.1111/j.1365-2141.2008.07095.x; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stillman B, 2001, COLD SPRING HARB SYM, V66, pXVII; Uechi T, 2001, GENOMICS, V72, P223, DOI 10.1006/geno.2000.6470; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	10	21	23	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					333	334		10.1016/j.cell.2011.04.006	http://dx.doi.org/10.1016/j.cell.2011.04.006			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529706	Bronze, Green Submitted			2022-12-28	WOS:000290022900001
J	Vyazovskiy, VV; Olcese, U; Hanlon, EC; Nir, Y; Cirelli, C; Tononi, G				Vyazovskiy, Vladyslav V.; Olcese, Umberto; Hanlon, Erin C.; Nir, Yuval; Cirelli, Chiara; Tononi, Giulio			Local sleep in awake rats	NATURE			English	Article							SLOW-WAVE ACTIVITY; CORTICAL SYNCHRONIZATION; VISUAL-STIMULATION; THETA ACTIVITY; HOMEOSTASIS; EEG; NEURONS; WAKING; STATES; BRAIN	In an awake state, neurons in the cerebral cortex fire irregularly and electroencephalogram (EEG) recordings display low-amplitude, high-frequency fluctuations. During sleep, neurons oscillate between 'on' periods, when they fire as in an awake brain, and 'off' periods, when they stop firing altogether and the EEG displays high-amplitude slowwaves. However, what happens to neuronal firing after a long period of being awake is not known. Here we show that in freely behaving rats after a long period in an awake state, cortical neurons can go briefly 'offline' as in sleep, accompanied by slow waves in the local EEG. Neurons often go offline in one cortical area but not in another, and during these periods of 'local sleep', the incidence of which increases with the duration of the awake state, rats are active and display an 'awake' EEG. However, they are progressively impaired in a sugar pellet reaching task. Thus, although both the EEG and behaviour indicate wakefulness, local populations of neurons in the cortex may be falling asleep, with negative consequences for performance.	[Vyazovskiy, Vladyslav V.; Olcese, Umberto; Hanlon, Erin C.; Nir, Yuval; Cirelli, Chiara; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; [Olcese, Umberto] Scuola Super Sant Anna, PERCRO Lab, I-56217 Pisa, Italy	University of Wisconsin System; University of Wisconsin Madison; Scuola Superiore Sant'Anna	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	gtononi@wisc.edu		Vyazovskiy, Vladyslav/0000-0002-4336-6681; Nir, Yuval/0000-0002-5433-6349; Olcese, Umberto/0000-0001-6968-2503	NIMH [P20 MH077967]; NIH; AFOSR [FA9550-08-1-0244]; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH077967] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIMH P20 MH077967 (C. C.), NIH Director's Pioneer award (G. T.) and AFOSR FA9550-08-1-0244 (G. T.). We thank A. Nelson, M. Dash and U. Faraguna for help with the experiments, L. Krugner-Higby for advice about surgical procedures and P. Frumento for advice on statistical procedures.	Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Blaivas AJ, 2007, SLEEP MED, V8, P156, DOI 10.1016/j.sleep.2006.06.011; Borbely A. A., 2005, PRINCIPLES PRACTICE, P405; Chauvette S, 2010, CEREB CORTEX, V20, P2660, DOI 10.1093/cercor/bhq009; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Dang-Vu TT, 2010, SLEEP, V33, P1589, DOI 10.1093/sleep/33.12.1589; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; Ferrillo F, 2000, CLIN NEUROPHYSIOL, V111, P916, DOI 10.1016/S1388-2457(00)00246-7; Finelli LA, 2000, NEUROSCIENCE, V101, P523, DOI 10.1016/S0306-4522(00)00409-7; Hanlon EC, 2009, SLEEP, V32, P719, DOI 10.1093/sleep/32.6.719; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Laplante F, 2005, NEUROSCIENCE, V132, P501, DOI 10.1016/j.neuroscience.2004.11.059; Leemburg S, 2010, P NATL ACAD SCI USA, V107, P15939, DOI 10.1073/pnas.1002570107; Mahowald MW, 2005, NATURE, V437, P1279, DOI 10.1038/nature04287; Maquet P, 2000, J SLEEP RES, V9, P207; MARROCCO RT, 1987, J NEUROSCI, V7, P2756; MORUZZI G, 1966, FUNCTIONAL SIGNIFICA; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Nunez A, 1996, NEUROSCIENCE, V72, P757, DOI 10.1016/0306-4522(95)00582-X; Pigarev IN, 1997, NEUROREPORT, V8, P2557, DOI 10.1097/00001756-199707280-00027; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Terzaghi M, 2009, SLEEP, V32, P409, DOI 10.1093/sleep/32.3.409; Tirunahari VL, 2003, SLEEP MED, V4, P63, DOI 10.1016/S1389-9457(02)00250-2; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vyazovskiy VV, 2008, J NEUROPHYSIOL, V99, P969, DOI 10.1152/jn.01154.2007; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Vyazovskiy VV, 2009, J NEUROPHYSIOL, V101, P1921, DOI 10.1152/jn.91157.2008; Vyazovskiy VV, 2005, BRAIN RES, V1050, P64, DOI 10.1016/j.brainres.2005.05.022; Wu MF, 1999, NEUROSCIENCE, V91, P1389, DOI 10.1016/S0306-4522(98)00600-9	40	492	497	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					443	447		10.1038/nature10009	http://dx.doi.org/10.1038/nature10009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525926	Green Accepted			2022-12-28	WOS:000289949600028
J	Kachalia, A; Mello, MM				Kachalia, Allen; Mello, Michelle M.			New Directions in Medical Liability Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MALPRACTICE INSURANCE PREMIUMS; TORT REFORMS; DEFENSIVE MEDICINE; CLAIMS; IMPACT; PAYMENTS; CRISIS; COMPENSATION; LEGISLATION; LITIGATION		[Kachalia, Allen] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Kachalia, Allen] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Kachalia, A (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.			Mello, Michelle/0000-0003-2877-4270				Ambrose JM, 2007, J HEALTH POLIT POLIC, V32, P843, DOI 10.1215/03616878-2007-032; Avraham R, 2009, 15371 NBER; Avraham R, 2007, J LEGAL STUD, V36, pS183, DOI 10.1086/527332; BLACKMON G, 1991, TORT LAW PUBLIC INTE, P272; Boothman Richard C, 2009, J Health Life Sci Law, V2, P125; Born P, 2009, J RISK INSUR, V76, P197, DOI 10.1111/j.1539-6975.2009.01294.x; Bovbjerg RR, 2007, MILBANK Q, V85, P297, DOI 10.1111/j.1468-0009.2007.00488.x; CORRIGAN JM, 2002, FOSTERING RAPID ADV; Currie J, 2008, Q J ECON, V123, P795, DOI 10.1162/qjec.2008.123.2.795; DANZON P, 1984, J LAW ECON, V27, P115, DOI 10.1086/467060; DANZON PM, 1986, LAW CONTEMP PROBL, V49, P57, DOI 10.2307/1191415; DANZON PM, 2004, BROOKINGS WHARTON PA; Donohue III, 2007, J EMPIR LEGAL STUD, V4, P69; Helland E., 2006, IMPACT LIABILITY PHY; Hellinger FJ, 2006, AM J PUBLIC HEALTH, V96, P1375, DOI 10.2105/AJPH.2005.077883; Hyman D. A., 2009, J LEGAL ANAL, V1, P355, DOI DOI 10.4159/JLA.V1I1.16; Iglehart JK, 2009, NEW ENGL J MED, V360, P1693, DOI 10.1056/NEJMp0902651; Kachalia A, 2005, J LAW MED ETHICS, V33, P416, DOI 10.1111/j.1748-720X.2005.tb00509.x; Kachalia A, 2010, ANN INTERN MED, V153, P213, DOI 10.7326/0003-4819-153-4-201008170-00002; Kachalia AB, 2008, SOC SCI MED, V66, P387, DOI 10.1016/j.socscimed.2007.08.020; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; Kessler DP, 2005, JAMA-J AM MED ASSOC, V293, P2618, DOI 10.1001/jama.293.21.2618; Kilgore ML, 2006, INQUIRY-J HEALTH CAR, V43, P255, DOI 10.5034/inquiryjrnl_43.3.255; Klick J, 2007, J LEGAL STUD, V36, pS121, DOI 10.1086/520416; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; Matsa DA, 2007, J LEGAL STUD, V36, pS143, DOI 10.1086/519466; Mello M., 2006, MED MALPR IMP CRIS E; Mello M. M., 2006, 8 RW JOHNS FDN; Mello MM, 2006, MILBANK Q, V84, P459, DOI 10.1111/j.1468-0009.2006.00455.x; Mello MM, 2010, HEALTH AFFAIR, V29, P1569, DOI 10.1377/hlthaff.2009.0807; Mello MM, 2010, NEW ENGL J MED, V362, P1353, DOI 10.1056/NEJMp1001603; Mello MM, 2009, NEW ENGL J MED, V361, P1, DOI 10.1056/NEJMp0903765; Mello MM, 2003, NEW ENGL J MED, V348, P2281, DOI 10.1056/NEJMp030064; Mello MM, 2011, MED MALPRACTICE UPDA; Mello MM, 2010, EVALUATION OPTIONS M; MELLO MM, 2003, NEW ENGL J MED, V349, P1010; Morrisey MA, 2008, HEALTH SERV RES, V43, P2124, DOI 10.1111/j.1475-6773.2008.00869.x; SLOAN FA, 1985, J HEALTH POLIT POLIC, V9, P629, DOI 10.1215/03616878-9-4-629; SLOAN FA, 1989, J HEALTH POLIT POLIC, V14, P663, DOI 10.1215/03616878-14-4-663; Sloan FA, 2009, J HEALTH ECON, V28, P481, DOI 10.1016/j.jhealeco.2008.12.006; STROUB ML, 2002, RUTGERS LJ, V34, P279; STRUVE CT, 2003, EXPERTISE MED MALPRA; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Thorpe KE, 2004, HLTH AFF MILLWOOD S; Viscusi WK, 2005, J RISK INSUR, V72, P23, DOI 10.1111/j.0022-4367.2005.00114.x; VISCUSI WK, 1993, J RISK UNCERTAINTY, V6, P165, DOI 10.1007/BF01065357; Waters TM, 2007, HEALTH AFFAIR, V26, P500, DOI 10.1377/hlthaff.26.2.500; Weiler PC, 1993, MEASURE MALPRACTICE; White FJ, 2008, J EMPIR LEGAL STUD, V5, P375, DOI 10.1111/j.1740-1461.2008.00128.x; Yang YT, 2008, J EMPIR LEGAL STUD, V5, P21, DOI 10.1111/j.1740-1461.2007.00117.x; Yang YT, 2009, MED CARE, V47, P234, DOI 10.1097/MLR.0b013e31818475de; YANG YT, 2010, DOES TORT LAW IMPROV; Yoon Albert, 2004, AM L EC REV, V6, P95; ZUCKERMAN S, 1990, INQUIRY-J HEALTH CAR, V27, P167; 2010, PATIENT SAFETY MED L; 2006, MED MALPRACTICE TORT; 2010, MOMENT TRUTH REPORT; 2010, MED LIABILITY REFORM	59	82	82	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1564	1572		10.1056/NEJMhpr1012821	http://dx.doi.org/10.1056/NEJMhpr1012821			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752VH	21506746				2022-12-28	WOS:000289722700018
J	Williams, RS; Kunkel, TA				Williams, R. Scott; Kunkel, Thomas A.			FEN Nucleases: Bind, Bend, Fray, Cut	CELL			English	Editorial Material							REPAIR; MECHANISM		[Williams, R. Scott; Kunkel, Thomas A.] NIEHS, Struct Biol Lab, NIH, DHHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Williams, RS (corresponding author), NIEHS, Struct Biol Lab, NIH, DHHS, POB 12233, Res Triangle Pk, NC 27709 USA.	williamsrs@niehs.nih.gov; kunkel@niehs.nih.gov	Kunkel, Thomas A./D-5088-2019; Williams, R Scott/A-6059-2015	Kunkel, Thomas A./0000-0002-9900-1788; Williams, R Scott/0000-0002-4610-8397	Intramural NIH HHS [ZIA ES102765-01] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102765, ZIAES065089] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; DEPAMPHILIS M, 2006, COLD SPRING HARBOR M; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884	10	16	16	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					171	172		10.1016/j.cell.2011.03.039	http://dx.doi.org/10.1016/j.cell.2011.03.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496637	Green Accepted, Bronze			2022-12-28	WOS:000289549900005
J	Zhu, HL; Hu, FQ; Wang, RH; Zhou, X; Sze, SH; Liou, LW; Barefoot, A; Dickman, M; Zhang, XR				Zhu, Hongliang; Hu, Fuqu; Wang, Ronghui; Zhou, Xin; Sze, Sing-Hoi; Liou, Lisa Wen; Barefoot, Ashley; Dickman, Martin; Zhang, Xiuren			Arabidopsis Argonaute10 Specifically Sequesters miR166/165 to Regulate Shoot Apical Meristem Development	CELL			English	Article							LEAF POLARITY; SMALL RNAS; GENE; EXPRESSION; PATHWAY; ESTABLISHMENT; MICRORNAS; COMPLEXES; ROLES; SIRNA	The shoot apical meristem (SAM) comprises a group of undifferentiated cells that divide to maintain the plant meristem and also give rise to all shoot organs. SAM fate is specified by class III HOMEODOMAIN-LEUCINE ZIPPER (HD-ZIP III) transcription factors, which are targets of miR166/165. In Arabidopsis, AGO10 is a critical regulator of SAM maintenance, and here we demonstrate that AGO10 specifically interacts with miR166/165. The association is determined by a distinct structure of the miR166/165 duplex. Deficient loading of miR166 into AGO10 results in a defective SAM. Notably, the miRNA-binding ability of AGO10, but not its catalytic activity, is required for SAM development, and AGO10 has a higher binding affinity for miR166 than does AGO1, a principal contributor to miRNA-mediated silencing. We propose that AGO10 functions as a decoy for miR166/165 to maintain the SAM, preventing their incorporation into AGO1 complexes and the subsequent repression of HD-ZIP III gene expression.	[Zhu, Hongliang; Hu, Fuqu; Wang, Ronghui; Sze, Sing-Hoi; Liou, Lisa Wen; Barefoot, Ashley; Zhang, Xiuren] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Zhu, Hongliang; Hu, Fuqu; Wang, Ronghui; Zhou, Xin; Dickman, Martin; Zhang, Xiuren] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; [Sze, Sing-Hoi] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX 77843 USA; [Zhou, Xin] Washington Univ, Dept Genet, St Louis, MO 63108 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Washington University (WUSTL)	Zhang, XR (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	xiuren.zhang@tamu.edu	Zhu, Hongliang/I-7035-2019	Zhu, Hongliang/0000-0002-1484-2212	NSF [MCB-0951120]; Texas AM University; NSF-REU [MCB-1037884]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097570] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0951120] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Texas AM University; NSF-REU(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We are grateful to K. Barton for the ago10<SUP>pnh-2</SUP> mutant, T. Laux for the YFP-AGO10 lines, H. Vaucheret for the ago1-27 mutant, and D. Baulcombe for providing an anti-AGO1 antibody. We thank Drs. D. Shippen, G. Kapler, F. Qiao, T. Devarenne, and C. Kaplan for stimulating discussions and critical review of the manuscript. The work was supported by a grant from NSF (MCB-0951120) and a startup from Texas A&M University to X.Z. L.W.L. and A.B. were supported by NSF-REU (MCB-1037884).	Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Liu QL, 2009, PLANT J, V58, P27, DOI 10.1111/j.1365-313X.2008.03757.x; Lynn K, 1999, DEVELOPMENT, V126, P469; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Mallory AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000646; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Tucker MR, 2008, DEVELOPMENT, V135, P2839, DOI 10.1242/dev.023648; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Zhang XY, 2006, FASEB J, V20, pA122; Zhou GK, 2007, PLANT CELL PHYSIOL, V48, P391, DOI 10.1093/pcp/pcm008; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	35	311	349	8	125	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					242	256		10.1016/j.cell.2011.03.024	http://dx.doi.org/10.1016/j.cell.2011.03.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496644	Green Accepted, Bronze			2022-12-28	WOS:000289549900013
J	Zuccotti, G; Fontanarosa, PB				Zuccotti, Gianna; Fontanarosa, Phil B.			Progress in Infectious Disease and Immunology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												phil.fontanarosa@jama-archives.org						Angus DC, 2011, JAMA-J AM MED ASSOC, V305, P1469, DOI 10.1001/jama.2011.438; Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Foster CB, 2011, JAMA-J AM MED ASSOC, V305, P1480, DOI 10.1001/jama.2011.449; Hughes JM, 2011, JAMA-J AM MED ASSOC, V305, P1027, DOI 10.1001/jama.2011.279; Kim LT, 2011, JAMA-J AM MED ASSOC, V305, P1478, DOI 10.1001/jama.2011.447; Launay O, 2011, JAMA-J AM MED ASSOC, V305, P1432, DOI 10.1001/jama.2011.351; Lienhardt C, 2011, JAMA-J AM MED ASSOC, V305, P1415, DOI 10.1001/jama.2011.436; Neuzil KM, 2011, JAMA-J AM MED ASSOC, V305, P1424, DOI 10.1001/jama.2011.407; Perencevich EN, 2011, JAMA-J AM MED ASSOC, V305, P1482, DOI 10.1001/jama.2011.450; Shiels MS, 2011, JAMA-J AM MED ASSOC, V305, P1450, DOI 10.1001/jama.2011.396; Stein RA, 2011, JAMA-J AM MED ASSOC, V305, P1484, DOI 10.1001/jama.2011.446; Tronstein E, 2011, JAMA-J AM MED ASSOC, V305, P1441, DOI 10.1001/jama.2011.420; WHO, WORLD HLTH STAT 2010; Zuccotti G, 2010, JAMA-J AM MED ASSOC, V304, P1126, DOI 10.1001/jama.2010.1305	14	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1486	1487		10.1001/jama.2011.452	http://dx.doi.org/10.1001/jama.2011.452			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486983				2022-12-28	WOS:000289424100029
J	Schleiss, MR				Schleiss, Mark R.			A cytomegalovirus vaccine tames the troll of transplantation	LANCET			English	Editorial Material							RECIPIENTS; DISEASE; INFECTION; PROPHYLAXIS; IMMUNITY		Univ Minnesota, Sch Med, Ctr Infect Dis & Microbiol Translat Res, Div Pediat Infect Dis,Dept Pediat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Schleiss, MR (corresponding author), Univ Minnesota, Sch Med, Ctr Infect Dis & Microbiol Translat Res, Div Pediat Infect Dis,Dept Pediat, Minneapolis, MN 55455 USA.	schleiss@umn.edu	Schleiss, Mark/ABI-8450-2020	Schleiss, Mark/0000-0002-2108-9433	NICHD NIH HHS [HD044864, HD038416] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044864] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038416] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADLER SP, 1995, J INFECT DIS, V171, P26, DOI 10.1093/infdis/171.1.26; [Anonymous], COCHRANE DATABASE SY; BALFOUR HH, 1979, ARCH INTERN MED, V139, P279, DOI 10.1001/archinte.139.3.279; Griffiths PD, 2011, LANCET, V377, P1256, DOI 10.1016/S0140-6736(11)60136-0; Hodson EM, 2005, LANCET, V365, P2105, DOI 10.1016/S0140-6736(05)66553-1; Legendre C, 2008, CLIN INFECT DIS, V46, P732, DOI 10.1086/527397; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; PLOTKIN SA, 1991, ANN INTERN MED, V114, P525, DOI 10.7326/0003-4819-114-7-525; SNYDMAN DR, 1993, ANN INTERN MED, V119, P984, DOI 10.7326/0003-4819-119-10-199311150-00004; Torres-Madriz G, 2008, CLIN INFECT DIS, V47, P702, DOI 10.1086/590934; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085	12	1	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1216	1218		10.1016/S0140-6736(11)60435-2	http://dx.doi.org/10.1016/S0140-6736(11)60435-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751DI	21481691				2022-12-28	WOS:000289597300006
J	Narita, M; Young, ARJ; Arakawa, S; Samarajiwa, SA; Nakashima, T; Yoshida, S; Hong, SK; Berry, LS; Reichelt, S; Ferreira, M; Tavare, S; Inoki, K; Shimizu, S; Narita, M				Narita, Masako; Young, Andrew R. J.; Arakawa, Satoko; Samarajiwa, Shamith A.; Nakashima, Takayuki; Yoshida, Sei; Hong, Sungki; Berry, Lorraine S.; Reichelt, Stefanie; Ferreira, Manuela; Tavare, Simon; Inoki, Ken; Shimizu, Shigeomi; Narita, Masashi			Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes	SCIENCE			English	Article							RAG GTPASES; PROTEIN; COMPLEX	Protein synthesis and autophagic degradation are regulated in an opposite manner by mammalian target of rapamycin (mTOR), whereas under certain conditions it would be beneficial if they occurred in unison to handle rapid protein turnover. We observed a distinct cellular compartment at the trans side of the Golgi apparatus, the TOR-autophagy spatial coupling compartment (TASCC), where (auto)lysosomes and mTOR accumulated during Ras-induced senescence. mTOR recruitment to the TASCC was amino acid-and Rag guanosine triphosphatase-dependent, and disruption of mTOR localization to the TASCC suppressed interleukin-6/8 synthesis. TASCC formation was observed during macrophage differentiation and in glomerular podocytes; both displayed increased protein secretion. The spatial coupling of cells' catabolic and anabolic machinery could augment their respective functions and facilitate the mass synthesis of secretory proteins.	[Narita, Masako; Young, Andrew R. J.; Samarajiwa, Shamith A.; Nakashima, Takayuki; Berry, Lorraine S.; Reichelt, Stefanie; Ferreira, Manuela; Tavare, Simon; Narita, Masashi] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Arakawa, Satoko; Shimizu, Shigeomi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol & Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Samarajiwa, Shamith A.; Tavare, Simon] Univ Cambridge, Dept Oncol, Cambridge CB2 0RE, England; [Yoshida, Sei; Hong, Sungki; Inoki, Ken] Univ Michigan, Dept Mol & Integrat Physiol & Internal Med, Inst Life Sci, Ann Arbor, MI 48109 USA	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Tokyo Medical & Dental University (TMDU); University of Cambridge; University of Michigan System; University of Michigan	Narita, M (corresponding author), Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	masashi.narita@cancer.org.uk; masashi.narita@cancer.org.uk	Arakawa, Satoko/AAM-9638-2020; Samarajiwa, Shamith/B-1601-2013; Ferreira, Manuela/AAF-5299-2020; Ferreira, Manuela/I-7904-2018	Arakawa, Satoko/0000-0002-4375-1643; Samarajiwa, Shamith/0000-0003-1046-0601; Ferreira, Manuela/0000-0001-9498-8061; Ferreira, Manuela/0000-0001-9498-8061; Ferreira, Manuela/0000-0002-0075-2400; Young, Andrew/0000-0002-7522-5525; Narita, Masako/0000-0002-9774-4908; Narita, Masashi/0000-0001-7764-577X; Yoshida, Sei/0000-0002-4771-3900; Reichelt, Stefanie/0000-0003-4151-0712	Univ. of Cambridge; Cancer Research UK; Hutchison Whampoa; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Biomedical Innovation; Juvenile Diabetes Research Foundation; NIH [DK083491]; Grants-in-Aid for Scientific Research [23657084, 22770054] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083491] Funding Source: NIH RePORTER; Cancer Research UK [19556] Funding Source: researchfish	Univ. of Cambridge; Cancer Research UK(Cancer Research UK); Hutchison Whampoa; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Research UK(Cancer Research UK)	We thank K. Ryan, N. Mizushima, F. Watt, and R. Rios for reagents; R. Rios, D. Tuveson, T. Kanaseki, I. Mills, N. Dolman, and members of Narita lab for helpful discussion; L. Blackburn for editing; CRI's Genomics, Bioinformatics, Microscopy (J. Harris), and Histopathology facilities for technical support; and the Gurdon Institute's microscopy facility (A. Sossick) for optical microscopy experimental. This work was supported by the Univ. of Cambridge; Cancer Research UK; Hutchison Whampoa; Grants-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology of Japan; the Program for Promotion of Fundamental Studies in the National Institute of Biomedical Innovation (S.A. and S.S.); and Juvenile Diabetes Research Foundation Award and NIH grant DK083491 (K.I.). Expression data are available at the National Center for Biotechnology Information Gene Expression Omnibus under accession number GSE28464.	Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	13	370	381	4	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					966	970		10.1126/science.1205407	http://dx.doi.org/10.1126/science.1205407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21512002	Green Accepted			2022-12-28	WOS:000290766600044
J	Wilensky, GR				Wilensky, Gail R.			Reforming Medicare - Toward a Modified Ryan Plan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Project HOPE, Bethesda, MD USA		Wilensky, GR (corresponding author), Project HOPE, Bethesda, MD USA.							Debt Reduction Task Force, REST AM FUT; *GOP GOV, PATH PROSP REST AM P; SUMMARY CMS PROPOSED	3	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2011	364	20					1890	1892		10.1056/NEJMp1104425	http://dx.doi.org/10.1056/NEJMp1104425			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	765PJ	21524207				2022-12-28	WOS:000290720700003
J	Good, MC; Zalatan, JG; Lim, WA				Good, Matthew C.; Zalatan, Jesse G.; Lim, Wendell A.			Scaffold Proteins: Hubs for Controlling the Flow of Cellular Information	SCIENCE			English	Review							FUS3 MAP KINASE; SIGNALING SPECIFICITY; BINDING DOMAIN; STE5; COMPLEX; ACTIVATION; SUBSTRATE; RECEPTOR; MECHANISM; PATHWAYS	The spatial and temporal organization of molecules within a cell is critical for coordinating the many distinct activities carried out by the cell. In an increasing number of biological signaling processes, scaffold proteins have been found to play a central role in physically assembling the relevant molecular components. Although most scaffolds use a simple tethering mechanism to increase the efficiency of interaction between individual partner molecules, these proteins can also exert complex allosteric control over their partners and are themselves the target of regulation. Scaffold proteins offer a simple, flexible strategy for regulating selectivity in pathways, shaping output behaviors, and achieving new responses from preexisting signaling components. As a result, scaffold proteins have been exploited by evolution, pathogens, and cellular engineers to reshape cellular behavior.	[Good, Matthew C.; Zalatan, Jesse G.; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu	Good, Matthew C/GLS-0964-2022	Zalatan, Jesse/0000-0002-1458-0654; Good, Matthew/0000-0002-6367-1034	Miller Fellowship; Damon Runyon Fellowship; NIH [RO1GM055040, RO1GM062583, PN2EY016546, P50GM081879]; NSF Synthetic Biology and Engineering Research Center; Packard Foundation; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040, R01GM062583, P50GM081879] Funding Source: NIH RePORTER	Miller Fellowship; Damon Runyon Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Synthetic Biology and Engineering Research Center; Packard Foundation(The David & Lucile Packard Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Pryciak, A. Weiss, R. Nicoll, R. Phillips, N. Pierce, J. Iwasa, J. Dueber, A. Remenyi, M. Borovinskaya, S. Peisajovich, J. Garbarino, A. Won, C. Bashor, N. Helman, S. H. Park, S. Coyle, P. Wei, J. Toettcher, and other members of the Lim lab for helpful discussions and comments. Supported by a Miller Fellowship (M.C.G.), a Damon Runyon Fellowship (J.G.Z.), NIH grants RO1GM055040, RO1GM062583, PN2EY016546, and P50GM081879 (W.A.L.), the NSF Synthetic Biology and Engineering Research Center (W.A.L.), the Packard Foundation (W.A.L.), and the Howard Hughes Medical Institute (W.A.L.).	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Chapman SA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.73; CHOI KY, 1994, CELL, V78, P499; DeLisa MP, 2009, NAT BIOTECHNOL, V27, P728, DOI 10.1038/nbt0809-728; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Elliott J, 2007, J VIROL, V81, P3428, DOI 10.1128/JVI.02303-06; FINKELSTEIN AV, 1989, PROTEIN ENG, V3, P1, DOI 10.1093/protein/3.1.1; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Garrenton LS, 2006, GENE DEV, V20, P1946, DOI 10.1101/gad.1413706; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Inouye C, 1997, GENETICS, V147, P479; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lin J, 2001, J BIOL CHEM, V276, P29588, DOI 10.1074/jbc.M102221200; Locasale JW, 2007, P NATL ACAD SCI USA, V104, P13307, DOI 10.1073/pnas.0706311104; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; McCoy MW, 2010, INFECT IMMUN, V78, P2584, DOI 10.1128/IAI.00141-10; McDonald C, 2003, J BIOL CHEM, V278, P18514, DOI 10.1074/jbc.M301226200; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Patterson JC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001275; PRINTEN JA, 1994, GENETICS, V138, P609; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Schwartz MA, 2006, CURR GENET, V49, P351, DOI 10.1007/s00294-006-0061-6; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6305, DOI 10.1021/bi970503q; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YB, 2001, BIOPHYS J, V81, P1632, DOI 10.1016/S0006-3495(01)75817-1; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	57	587	613	9	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					680	686		10.1126/science.1198701	http://dx.doi.org/10.1126/science.1198701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551057	Green Accepted			2022-12-28	WOS:000290265800034
J	White, DB; Brody, B				White, Douglas B.; Brody, Baruch			Would Accommodating Some Conscientious Objections by Physicians Promote Quality in Medical Care?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[White, Douglas B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Program Eth & Decis Making Crit Illness, Pittsburgh, PA 15261 USA; [Brody, Baruch] Rice Univ, Dept Philosophy, Houston, TX USA; [Brody, Baruch] Baylor Coll Med, Ctr Eth, Houston, TX 77030 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rice University; Baylor College of Medicine	White, DB (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Program Eth & Decis Making Crit Illness, 3550 Terrace St,Scaife Hall,Room 608,HPU010604, Pittsburgh, PA 15261 USA.	whitedb@upmc.edu						Beauchamp Tom L., 2019, PRINCIPLES BIOMEDICA, V8th; Benjamin Martin, 1990, SPLITTING DIFFERENCE; Cherniss C., 1995, BEYOND BURNOUT; Glasberg AL, 2007, J ADV NURS, V57, P392, DOI 10.1111/j.1365-2648.2007.04111.x; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Lynch, 2010, CONFLICTS CONSCIENCE; Rawls John, 2005, POLITICAL LIBERALISM; Rentmeester CA, 2008, J MED PHILOS, V33, P27, DOI 10.1093/jmp/jhm006; Savulescu J, 2006, BRIT MED J, V332, P294, DOI 10.1136/bmj.332.7536.294; Schavel M., 2011, SUPERVISION SOCIAL S	10	17	19	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1804	1805		10.1001/jama.2011.575	http://dx.doi.org/10.1001/jama.2011.575			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	758HZ	21540425				2022-12-28	WOS:000290156200023
J	Hanania, NA; Alpan, O; Hamilos, DL; Condemi, JJ; Reyes-Rivera, I; Zhu, J; Rosen, KE; Eisner, MD; Wong, DA; Busse, W				Hanania, Nicola A.; Alpan, Oral; Hamilos, Daniel L.; Condemi, John J.; Reyes-Rivera, Irmarie; Zhu, Jin; Rosen, Karin E.; Eisner, Mark D.; Wong, Dennis A.; Busse, William			Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; ANTIBODY OMALIZUMAB; PERSISTENT ASTHMA; MONTELUKAST; EFFICACY; RHINITIS; DISEASE	Background: Inhaled corticosteroids (ICS) and long-acting beta(2)-agonists (LABAs) are recommended in patients with asthma that is not well-controlled; however, many patients continue to have inadequately controlled asthma despite this therapy. Objective: To evaluate the efficacy and safety of omalizumab in patients with inadequately controlled severe asthma who are receiving high-dose ICS and LABAs, with or without additional controller therapy. Design: Prospective, multicenter, randomized, parallel-group, double-blind, placebo-controlled trial. (ClinicalTrials. gov registration number: NCT00314575) Setting: 193 investigational sites in the United States and 4 sites in Canada. Patients: 850 patients aged 12 to 75 years who had inadequately controlled asthma despite treatment with high-dose ICS plus LABAs, with or without other controllers. Intervention: Omalizumab (n = 427) or placebo (n = 423) was added to existing medication regimens for 48 weeks. Measurements: The primary end point was the rate of protocol-defined exacerbations over the study period. Secondary efficacy end points included the change from baseline to week 48 in mean daily number of puffs of albuterol, mean total asthma symptom score, and mean overall score on the standardized version of the Asthma Quality of Life Questionnaire (AQLQ[S]). Safety end points included the frequency and severity of treatment-emergent adverse events. Results: During 48 weeks, the rate of protocol-defined asthma exacerbations was significantly reduced for omalizumab compared with placebo (0.66 vs. 0.88 per patient; P = 0.006), representing a 25% relative reduction (incidence rate ratio, 0.75 [95% CI, 0.61 to 0.92]). Omalizumab improved mean AQLQ(S) scores (0.29 point [CI, 0.15 to 0.43]), reduced mean daily albuterol puffs (-0.27 puff/d [CI, -0.49 to -0.04 puff/d]), and decreased mean asthma symptom score (-0.26 [CI, -0.42 to -0.10]) compared with placebo during the 48-week study period. The incidence of adverse events (80.4% vs. 79.5%) and serious adverse events (9.3% vs. 10.5%) were similar in the omalizumab and placebo groups, respectively. Limitations: The results are limited by early patient discontinuation (20.8%). The study was not powered to detect rare safety events or the treatment effect in the oral corticosteroid subgroup. Conclusion: In this study, omalizumab provided additional clinical benefit for patients with severe allergic asthma that is inadequately controlled with high-dose ICS and LABA therapy.	[Eisner, Mark D.] Genentech Inc, Product Dev Inflammat & Resp, San Francisco, CA 94080 USA; Baylor Coll Med, Houston, TX 77030 USA; O&O Alpan, Bethesda, MD USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; AAIR Res Ctr, Rochester, NY USA; Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA	Roche Holding; Genentech; Baylor College of Medicine; Harvard University; Massachusetts General Hospital; University of Wisconsin System; University of Wisconsin Madison	Eisner, MD (corresponding author), Genentech Inc, Product Dev Inflammat & Resp, 1 DNA Way, San Francisco, CA 94080 USA.	eisner.mark@gene.com	Hanania, Nicola A/C-5875-2016; Wong, Dennis A/AAH-2958-2020	Hanania, Nicola A/0000-0003-3087-9530; 	Genentech; Novartis Pharmaceuticals	Genentech(Roche HoldingGenentech); Novartis Pharmaceuticals(Novartis)	Primary Funding Source: Genentech and Novartis Pharmaceuticals.	Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Broder MS, 2010, ALLERGY ASTHMA PROC, V31, P60, DOI 10.2500/aap.2010.31.3302; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Chan ISF, 1999, BIOMETRICS, V55, P1202, DOI 10.1111/j.0006-341X.1999.01202.x; Global Initiative for Asthma, 1995, NIH PUBL; Holgate ST, 2004, CLIN EXP ALLERGY, V34, P632, DOI 10.1111/j.1365-2222.2004.1916.x; Humbert M, 2005, ALLERGY, V60, P309, DOI 10.1111/j.1398-9995.2004.00772.x; Irvin CG, 2007, AM J RESP CRIT CARE, V175, P235, DOI 10.1164/rccm.200603-416OC; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; Nathan RA, 2005, CHEST, V128, P1910, DOI 10.1378/chest.128.4.1910; National Heart Lung and Blood Institute National Asthma Education and Prevention Program, 2007, 3 NIH NAT HEART LUNG; Robinson DS, 2001, LANCET, V357, P2007, DOI 10.1016/S0140-6736(00)05113-8; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; SIGNORINI DF, 1993, STAT MED, V12, P2343, DOI 10.1002/sim.4780122410; SIGNORINI DF, 1991, BIOMETRIKA, V78, P446; Soler M, 2001, EUR RESPIR J, V18, P254, DOI 10.1183/09031936.01.00092101; Vignola AM, 2004, ALLERGY, V59, P709, DOI 10.1111/j.1398-9995.2004.00550.x; Walsh LJ, 2001, THORAX, V56, P279, DOI 10.1136/thorax.56.4.279	19	377	395	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					573	582		10.7326/0003-4819-154-9-201105030-00002	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21536936				2022-12-28	WOS:000290112300001
J	Green, RA; Kao, HL; Audhya, A; Arur, S; Mayers, JR; Fridolfsson, HN; Schulman, M; Schloissnig, S; Niessen, S; Laband, K; Wang, SH; Starr, DA; Hyman, AA; Schedl, T; Desai, A; Piano, F; Gunsalus, KC; Oegema, K				Green, Rebecca A.; Kao, Huey-Ling; Audhya, Anjon; Arur, Swathi; Mayers, Jonathan R.; Fridolfsson, Heidi N.; Schulman, Monty; Schloissnig, Siegfried; Niessen, Sherry; Laband, Kimberley; Wang, Shaohe; Starr, Daniel A.; Hyman, Anthony A.; Schedl, Tim; Desai, Arshad; Piano, Fabio; Gunsalus, Kristin C.; Oegema, Karen			A High-Resolution C. elegans Essential Gene Network Based on Phenotypic Profiling of a Complex Tissue	CELL			English	Article							FUNCTIONAL GENOMIC ANALYSIS; WIDE RNAI SCREENS; NUCLEAR-ENVELOPE; INTERACTOME NETWORK; CELL-DIVISION; CHROMOSOME-I; KINETOCHORE; MICROSCOPY; OVARY; MAP	High-content screening for gene profiling has generally been limited to single cells. Here, we explore an alternative approach-profiling gene function by analyzing effects of gene knockdowns on the architecture of a complex tissue in a multicellular organism. We profile 554 essential C. elegans genes by imaging gonad architecture and scoring 94 phenotypic features. To generate a reference for evaluating methods for network construction, genes were manually partitioned into 102 phenotypic classes, predicting functions for uncharacterized genes across diverse cellular processes. Using this classification as a benchmark, we developed a robust computational method for constructing gene networks from high-content profiles based on a network context-dependent measure that ranks the significance of links between genes. Our analysis reveals that multi-parametric profiling in a complex tissue yields functional maps with a resolution similar to genetic interaction-based profiling in unicellular eukaryotes-pinpointing subunits of macromolecular complexes and components functioning in common cellular processes.	[Kao, Huey-Ling; Schulman, Monty; Piano, Fabio; Gunsalus, Kristin C.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Green, Rebecca A.; Laband, Kimberley; Wang, Shaohe; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Green, Rebecca A.; Laband, Kimberley; Wang, Shaohe; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Audhya, Anjon; Mayers, Jonathan R.] Univ Wisconsin, Dept Biomol Chem, Madison Med Sch, Madison, WI 53706 USA; [Arur, Swathi] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Fridolfsson, Heidi N.; Starr, Daniel A.] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA; [Schedl, Tim] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Schloissnig, Siegfried; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Niessen, Sherry] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Niessen, Sherry] Scripps Res Inst, Dept Physiol Chem, Ctr Physiol Prote, La Jolla, CA 92037 USA; [Piano, Fabio; Gunsalus, Kristin C.] New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates	New York University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Davis; Washington University (WUSTL); Max Planck Society; Scripps Research Institute; Scripps Research Institute	Gunsalus, KC (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, 12 Waverly Pl,8th Floor, New York, NY 10003 USA.	kcg1@nyu.edu; koegema@ucsd.edu	Hyman, Tony/F-1923-2011; Wang, Shaohe/J-6456-2019; Hyman, Anthony A/B-3917-2017	Wang, Shaohe/0000-0001-9522-2359; Hyman, Anthony A/0000-0003-3664-154X; Schloissnig, Siegfried/0000-0003-4574-8330; Laband, Kimberley/0000-0002-8535-2050; Starr, Daniel/0000-0001-7339-6606; Green, Rebecca/0000-0002-4528-011X	American Cancer Society [PF-06-254-01-CCG]; Helen Hay Whitney Foundation; NIH [R01 GM074207, R01 HD046236, R01 GM085503, R01 GM085150, R01 GM088151, R01 GM073874]; Ludwig Institute for Cancer Research; NIH National Center for Research Resources, for strains; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085503, R01GM088151, R01GM074207, R01GM085150, R01GM073874] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NIH National Center for Research Resources, for strains(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the American Cancer Society (PF-06-254-01-CCG, to RG), the Helen Hay Whitney Foundation (to A. A.), and the NIH R01 GM074207 to K.O., R01 HD046236 to K.C.G. and FP; R01 GM085503 to K.C.G.; R01 GM085150 to TS; R01 GM088151 to A.A.; R01 GM073874 to D.A.S.) and by funding from the Ludwig Institute for Cancer Research to KO and AD. We thank Kahn Rhrissorrakrai for the MINE algorithm, Michael Volkmer for movie formatting, and the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources, for strains. Author Contributions: Conceived and designed the experiments: KO, AD, RG, AA. Performed the experiments: RG, AA, SN, SA, TS, SW, HF, DS, JM. Scored the data: AA, RG, KO. Manually partitioned the genes into classes: RG, KO. Reworked Phenobank to include the gonad morphology data: SS, RG, KO, AH. Developed N-Browse: HK, MS, FP, KG. Developed CSI: KO, RG, HK, MS, FP, KG. Conceptualized and performed network analysis: HK, FP, KG. Contributed reagents/materials/analysis tools: KO, RG, AA, SN, KL, SA, TS, AD, HK, MS, KG, FP, HF, DS.	[Anonymous], 2008, CURR PROTOC BIOINFOR; [Anonymous], WORMBOOK C ELEGANS R; Arur S, 2009, P NATL ACAD SCI USA, V106, P4776, DOI 10.1073/pnas.0812285106; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2009, NAT METHODS, V6, P721, DOI 10.1038/nmeth1009-721; Conrad C, 2010, J CELL BIOL, V188, P453, DOI 10.1083/jcb.200910105; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Essex A, 2009, MOL BIOL CELL, V20, P1252, DOI 10.1091/mbc.E08-10-1047; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fridolfsson HN, 2010, J CELL BIOL, V191, P115, DOI 10.1083/jcb.201004118; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Gunsalus Kristin C, 2008, J Biol, V7, P8, DOI 10.1186/jbiol70; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; Kimble Judith, 2005, WormBook, P1; Kops GJPL, 2010, J CELL SCI, V123, P1623, DOI 10.1242/jcs.061549; Lee MH, 2007, GENETICS, V177, P2039, DOI 10.1534/genetics.107.081356; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r26; MADURO M, 1995, GENETICS, V141, P977; Mathey-Prevot B, 2006, COLD SPRING HARB SYM, V71, P141, DOI 10.1101/sqb.2006.71.027; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Praitis V, 2001, GENETICS, V157, P1217; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shi AB, 2010, MOL BIOL CELL, V21, P2930, DOI 10.1091/mbc.E10-02-0149; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Starr DA, 2001, DEVELOPMENT, V128, P5039; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Zhou K, 2009, J CELL BIOL, V186, P229, DOI 10.1083/jcb.200902101; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	49	142	144	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					470	482		10.1016/j.cell.2011.03.037	http://dx.doi.org/10.1016/j.cell.2011.03.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529718	Green Accepted, Bronze			2022-12-28	WOS:000290022900015
J	Merritt, DJ; Dixon, KW				Merritt, David J.; Dixon, Kingsley W.			Restoration Seed Banks-A Matter of Scale	SCIENCE			English	Editorial Material							ECOLOGICAL RESTORATION		[Merritt, David J.; Dixon, Kingsley W.] Kings Pk & Bot Gardens, Perth, WA 6005, Australia; [Merritt, David J.; Dixon, Kingsley W.] Univ Western Australia, Fac Nat & Agr Sci, Sch Plant Biol, Crawley, WA 6009, Australia	University of Western Australia	Merritt, DJ (corresponding author), Kings Pk & Bot Gardens, Perth, WA 6005, Australia.	david.merritt@bgpa.wa.gov.au	Dixon, Kingsley W/A-8133-2016; Merritt, David J/G-9376-2011; Dixon, Kingsley W/B-1042-2011	Dixon, Kingsley W/0000-0001-5989-2929; Merritt, David J/0000-0002-3250-6861; 				*BHP BILL IR OR, 2006, JIMB WHEEL HILL MIN; BOWERS K, RHIZOME; Broadhurst LM, 2008, EVOL APPL, V1, P587, DOI 10.1111/j.1752-4571.2008.00045.x; Crane PR, 2009, TRENDS PLANT SCI, V14, P575, DOI 10.1016/j.tplants.2009.09.007; CUNNINGHAM S, 2008, REWEALTHL; DELANGE JH, 1990, S AFR J BOT, V59, P145; Dixon KW, 2009, ACTA HORTIC, V813, P155; *GREAT BAS RES CTR, SEED WAR; Hardwick KA, 2011, CONSERV BIOL, V25, P265, DOI 10.1111/j.1523-1739.2010.01632.x; Higgs E, 2005, RESTOR ECOL, V13, P159, DOI 10.1111/j.1526-100X.2005.00020.x; *KEW, BREATH PLAN PROGR; Koch JM, 2007, RESTOR ECOL, V15, pS26, DOI 10.1111/j.1526-100X.2007.00290.x; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Li DZ, 2009, TRENDS PLANT SCI, V14, P614, DOI 10.1016/j.tplants.2009.09.005; MERRITT DJ, 2005, P 5 AUSTR WORKSH NAT, P69; Mortlock BW., 2000, ECOLOGICAL MANAGEMEN, V1, P93, DOI [10.1046/j.1442-8903.2000.00029.x, DOI 10.1046/J.1442-8903.2000.00029.X]; Nelleman C, 2010, DEAD PLANET LIVING P; OMAR SAS, 2009, HDB ENV CHEM, V3, P141; Rokich DP, 2007, AUST J BOT, V55, P375, DOI 10.1071/BT06108; *SECR CONV BIOL DI, 2010, CBD PUBL; Smith P, 2011, SEED SCI RES, V21, P1, DOI 10.1017/S0960258510000309; SMITH RD, 2003, SEED CONSERVATION TU, pCH56; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Wehi PM, 2009, ECOL APPL, V19, P267, DOI 10.1890/07-1693.1; Wijdeven SMJ, 2000, RESTOR ECOL, V8, P414, DOI 10.1046/j.1526-100x.2000.80056.x; Williams MI, 2002, RESTOR ECOL, V10, P385, DOI 10.1046/j.1526-100X.2002.01025.x	26	222	230	4	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					424	425		10.1126/science.1203083	http://dx.doi.org/10.1126/science.1203083			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512021				2022-12-28	WOS:000289784900028
J	Cain, LE; Logan, R; Robins, JM; Sterne, JAC; Sabin, C; Bansi, L; Justice, A; Goulet, J; van Sighem, A; de Wolf, F; Bucher, HC; von Wyl, V; Esteve, A; Casabona, J; del Amo, J; Moreno, S; Seng, R; Meyer, L; Perez-Hoyos, S; Muga, R; Lodi, S; Lanoy, E; Costagliola, D; Hernan, MA				Cain, Lauren E.; Logan, Roger; Robins, James M.; Sterne, Jonathan A. C.; Sabin, Caroline; Bansi, Loveleen; Justice, Amy; Goulet, Joseph; van Sighem, Ard; de Wolf, Frank; Bucher, Heiner C.; von Wyl, Viktor; Esteve, Anna; Casabona, Jordi; del Amo, Julia; Moreno, Santiago; Seng, Remonie; Meyer, Laurence; Perez-Hoyos, Santiago; Muga, Roberto; Lodi, Sara; Lanoy, Emilie; Costagliola, Dominique; Hernan, Miguel A.		HIV-CAUSAL Collaboration	When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; CONTROLLED-TRIAL; BASE-LINE; DEATH; INDIVIDUALS; PROGNOSIS; SURVIVAL; DISEASE	Background: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell counts below 0.350 x 10(9) cells/L initiate combined antiretroviral therapy (cART), but the optimal CD4 cell count at which cART should be initiated remains a matter of debate. Objective: To identify the optimal CD4 cell count at which cART should be initiated. Design: Prospective observational data from the HIV-CAUSAL Collaboration and dynamic marginal structural models were used to compare cART initiation strategies for CD4 thresholds between 0.200 and 0.500 x 10(9) cells/L. Setting: HIV clinics in Europe and the Veterans Health Administration system in the United States. Patients: 20 971 HIV-infected, therapy-naive persons with baseline CD4 cell counts at or above 0.500 x 10(9) cells/L and no previous AIDS-defining illnesses, of whom 8392 had a CD4 cell count that decreased into the range of 0.200 to 0.499 x 10(9) cells/L and were included in the analysis. Measurements: Hazard ratios and survival proportions for all-cause mortality and a combined end point of AIDS-defining illness or death. Results: Compared with initiating cART at the CD4 cell count threshold of 0.500 x 10(9) cells/L, the mortality hazard ratio was 1.01 (95% CI, 0.84 to 1.22) for the 0.350 threshold and 1.20 (CI, 0.97 to 1.48) for the 0.200 threshold. The corresponding hazard ratios were 1.38 (CI, 1.23 to 1.56) and 1.90 (CI, 1.67 to 2.15), respectively, for the combined end point of AIDS-defining illness or death. Limitations: CD4 cell count at cART initiation was not randomized. Residual confounding may exist. Conclusion: Initiation of cART at a threshold CD4 count of 0.500 x 10(9) cells/L increases AIDS-free survival. However, mortality did not vary substantially with the use of CD4 thresholds between 0.300 and 0.500 x 10(9) cells/L.	[Cain, Lauren E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Bristol, Bristol, Avon, England; UCL, Sch Med, London W1N 8AA, England; MRC, London, England; Yale Univ, Sch Med, New Haven, CT USA; Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; Univ Amsterdam, Amsterdam, Netherlands; Univ Spital Basel, Basel, Switzerland; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Univ Zurich, Zurich, Switzerland; Hosp Badalona Germans Trias & Pujol, Badalona, Spain; Inst Salud Carlos III, Madrid, Spain; Hosp Ramon & Cajal, Madrid, Spain; Hop Bicetre, Le Kremlin Bicetre, France; Barcelona Ctr Int Hlth Res, Barcelona, Spain; Hosp Clin Barcelona, Barcelona, Spain; Univ Paris 06, INSERM, U943, Paris, France; Hop La Pitie Salpetriere, Paris, France	Harvard University; Harvard T.H. Chan School of Public Health; University of Bristol; University of London; University College London; UCL Medical School; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Amsterdam; University of Basel; University of Zurich; University Zurich Hospital; University of Zurich; Hospital Germans Trias i Pujol; Instituto de Salud Carlos III; Hospital Universitario Ramon y Cajal; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Cain, LE (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	lcain@hsph.harvard.edu	Perez-Hoyos, Santiago/E-2370-2012; van der Ven, A.J.A.M./H-8102-2014; Costagliola, Dominique/H-5849-2011; Guevara, Marcela/B-4473-2015; Sabin, Caroline/C-2464-2008; Oteo, Jose A./AAB-3134-2020; Guiguet, Marguerite/L-8480-2018; Muga, Roberto/AAY-8655-2021; Cuellar, Sandra/I-3069-2015; Boucherit, Soraya/I-1704-2017; Mahamat, Aba/V-7888-2019; , Felipe/F-4242-2014; Sobrino-Vegas, Paz/E-1741-2015; Sterne, Jonathan/Z-3106-2019; Cepeda, Concepción/D-7728-2016; Lanoy, Emilie/A-8541-2011; Victor, Moreno-Cuerda/G-3851-2016; TISSOT-DUPONT, Hervé/P-5808-2016; Perez Hoyos, Santiago/O-1075-2019; Pantaleo, Giuseppe/K-6163-2016; Pulido, Federico/B-8417-2009; DEL AMO VALERO, JULIA/M-7020-2015; Bergmann, Jean-Francois/L-6044-2017; Soriano, Vicente/O-5730-2018; Matheron, Sophie/D-7420-2017; Lopez.Cortes, Luis Fernando/S-5625-2018	Perez-Hoyos, Santiago/0000-0001-9797-4917; van der Ven, A.J.A.M./0000-0003-1833-3391; Costagliola, Dominique/0000-0003-0765-0869; Guevara, Marcela/0000-0001-9242-6364; Sabin, Caroline/0000-0001-5173-2760; Oteo, Jose A./0000-0001-7080-6542; Muga, Roberto/0000-0001-6301-431X; Boucherit, Soraya/0000-0002-8819-7594; Mahamat, Aba/0000-0001-8755-0424; , Felipe/0000-0001-7658-5832; Sobrino-Vegas, Paz/0000-0002-0775-1558; Sterne, Jonathan/0000-0001-8496-6053; Cepeda, Concepción/0000-0002-9197-9589; Lanoy, Emilie/0000-0002-4789-7770; Victor, Moreno-Cuerda/0000-0003-0262-8216; Perez Hoyos, Santiago/0000-0001-9797-4917; Pulido, Federico/0000-0002-7414-8812; DEL AMO VALERO, JULIA/0000-0002-3104-540X; delpech, valerie/0000-0002-9952-8109; De Lazzari, Elisa/0000-0003-2614-6545; Montoliu, Alexandra/0000-0002-4251-7062; Hervas Gomez, Rafael/0000-0002-2840-8839; Bergmann, Jean-Francois/0000-0001-6861-9748; Rijnders, Bart/0000-0003-3343-9610; Cabie, Andre/0000-0003-0117-3061; Arvieux, Cedric/0000-0003-2332-2507; Sanchez-Hellin, Victoria/0000-0002-4101-0120; ABEL, Sylvie/0000-0002-3351-0547; Cabellos, Carmen/0000-0001-7392-7382; /0000-0001-7808-5479; Goulet, Joseph Lucien/0000-0002-0842-804X; Vargas Laguna, Montserrat/0000-0001-7650-0587; von Wyl, Viktor/0000-0002-8754-9797; Leen, Clifford/0000-0001-8439-7719; Gayet-Ageron, Angele/0000-0002-6164-9693; Soriano, Vicente/0000-0002-4624-5199; Casabona-Barbara, Jordi/0000-0003-4816-5536; Matheron, Sophie/0000-0001-7879-6553; Bernal, Enrique/0000-0002-4041-0579; JARRIN, INMA/0000-0002-7485-2252; Easterbrook, Philippa/0000-0002-2603-5418; Hernan, Miguel/0000-0003-1619-8456; Negredo, Eugenia/0000-0001-5298-1734; Gerschenson, Mariana/0000-0002-8615-5964; Gnatiuc Friedrichs, Louisa/0000-0002-0641-2220; Kozal, Michael/0000-0002-3100-8254; Taffe, Patrick/0000-0002-2049-6651; Fidler, Sarah/0000-0003-1676-7583; Galinier, Anne/0000-0003-2454-5681; Vilades, Consuelo/0000-0002-2991-9593; Lopez.Cortes, Luis Fernando/0000-0002-3804-3458	National Institutes of Health [R01-AI073127, U10-AA013566]; Medical Research Council [G0700820]; MRC [G0100221, G0900274, G0700820, MC_U122886351] Funding Source: UKRI; Medical Research Council [MC_U122886351, G0100221, G0900274] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032475, R01AI073127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020794, U10AA013566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Grant Support: By the National Institutes of Health (grants R01-AI073127 and U10-AA013566) and the Medical Research Council (grant G0700820).	ANGLARET X, EARLY ANTIRETROVIRAL; [Anonymous], [No title captured]; BERAL V, 1996, EPIDEMIOL INFECT, V117, P305; Cain LE, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1212; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Desquilbet L, 2004, AIDS, V18, P2361; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; European AIDS Clinical Society, 2009, GUID CLIN MAN TREATM; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hernan MA, 2006, BASIC CLIN PHARMACOL, V98, P237, DOI 10.1111/j.1742-7843.2006.pto_329.x; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernan MA, 2009, NEW ENGL J MED, V361, P822; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Lima VD, 2008, AIDS, V22, P2371, DOI 10.1097/QAD.0b013e328315cdd3; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Orellana L, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1200; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Perez-Hoyos S, 2003, AIDS, V17, P353, DOI 10.1097/00002030-200302140-00009; Phillips AN, 2007, AIDS, V21, P1717; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Robins J, 2008, STAT MED, V27, P4678, DOI 10.1002/sim.3301; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; van der Laan Mark J, 2007, Int J Biostat, V3, P3, DOI 10.2202/1557-4679.1022; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; World Health Organization, 2009, RAP ADV ANT THER HIV; 2009, STRATEGIC TIMING ANT	44	171	176	0	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8					509	515		10.7326/0003-4819-154-8-201104190-00001	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-00001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502648				2022-12-28	WOS:000289622000013
J	Orans, J; McSweeney, EA; Iyer, RR; Hast, MA; Hellinga, HW; Modrich, P; Beese, LS				Orans, Jillian; McSweeney, Elizabeth A.; Iyer, Ravi R.; Hast, Michael A.; Hellinga, Homme W.; Modrich, Paul; Beese, Lorena S.			Structures of Human Exonuclease 1 DNA Complexes Suggest a Unified Mechanism for Nuclease Family	CELL			English	Article							HUMAN FLAP ENDONUCLEASE-1; HUMAN MISMATCH REPAIR; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; POLYMERASE-I; CANCER SUSCEPTIBILITY; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; ACTIVE-SITE; RESECT DNA	Human exonuclease 1 (hExo1) plays important roles in DNA repair and recombination processes that maintain genomic integrity. It is a member of the 50 structure-specific nuclease family of exonucleases and endonucleases that includes FEN-1, XPG, and GEN1. We present structures of hExo1 in complex with a DNA substrate, followed by mutagenesis studies, and propose a common mechanism by which this nuclease family recognizes and processes diverse DNA structures. hExo1 induces a sharp bend in the DNA at nicks or gaps. Frayed 50 ends of nicked duplexes resemble flap junctions, unifying the mechanisms of endo- and exonucleolytic processing. Conformational control of a mobile region in the catalytic site suggests a mechanism for allosteric regulation by binding to protein partners. The relative arrangement of substrate binding sites in these enzymes provides an elegant solution to a complex geometrical puzzle of substrate recognition and processing.	[Orans, Jillian; McSweeney, Elizabeth A.; Iyer, Ravi R.; Hast, Michael A.; Hellinga, Homme W.; Modrich, Paul; Beese, Lorena S.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Beese, LS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	lb12@duke.edu	Classen, Scott/AAY-8176-2020	Modrich, Paul/0000-0001-8708-9885	National Institutes of Health [R01 GM091487, R01 GM45190, P01 CA092584]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; DOE with the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM091487, R01GM045190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE with the U.S. Department of Energy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Anita Changela, Shannon Kelly, and Miaw-Sheue Tsai for assistance with cloning and purification. This work was supported by National Institutes of Health grants R01 GM091487 to L.S.B., R01 GM45190 to P.M., and P01 CA092584 to L.S.B. and P.M. P.M. is an Investigator of the Howard Hughes Medical Institute. Use of the Advanced Photon Source was supported, in part, by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number W-31-109-Eng-38. Use of the SIBYLS beamline at the Advanced Light Source, Lawrence Berkeley National Laboratory, was supported, in part, by the DOE program Integrated Diffraction Analysis Technologies (IDAT) and the DOE program Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE) under contract number DE-AC02-05CH11231 with the U.S. Department of Energy.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allawi HT, 2003, J MOL BIOL, V328, P537, DOI 10.1016/S0022-2836(03)00351-6; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Barnes CJ, 1996, J BIOL CHEM, V271, P29624, DOI 10.1074/jbc.271.47.29624; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Brautigam CA, 1998, J MOL BIOL, V277, P363, DOI 10.1006/jmbi.1997.1586; Brautigam CA, 1999, BIOCHEMISTRY-US, V38, P696, DOI 10.1021/bi981537g; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Dervan JJ, 2002, P NATL ACAD SCI USA, V99, P8542, DOI 10.1073/pnas.082241699; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Doherty KM, 2005, J BIOL CHEM, V280, P28085, DOI 10.1074/jbc.M500265200; Dore AS, 2006, NUCLEIC ACIDS RES, V34, P4515, DOI 10.1093/nar/gkl623; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FANG WH, 1993, J BIOL CHEM, V268, P11838; Feng M, 2004, NAT STRUCT MOL BIOL, V11, P450, DOI 10.1038/nsmb754; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Genschel J, 2009, J BIOL CHEM, V284, P21536, DOI 10.1074/jbc.M109.021287; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hohl M, 2007, NUCLEIC ACIDS RES, V35, P3053, DOI 10.1093/nar/gkm092; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; KOLODNER RD, 1995, TRENDS BIOCHEM SCI, V20, P397, DOI 10.1016/S0968-0004(00)89087-8; Lee B, 2002, NUCLEIC ACIDS RES, V30, P942, DOI 10.1093/nar/30.4.942; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Liberti SE, 2011, DNA REPAIR, V10, P73, DOI 10.1016/j.dnarep.2010.09.023; Matsui E, 2002, J BIOL CHEM, V277, P37840, DOI 10.1074/jbc.M205235200; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; OTWINOWSKI Z, 1998, DENZO SCALEPACK PROG; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Schmutte C, 1998, CANCER RES, V58, P4537; Schmutte C, 2001, J BIOL CHEM, V276, P33011, DOI 10.1074/jbc.M102670200; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Sengerova B, 2010, BIOCHEMISTRY-US, V49, P8085, DOI 10.1021/bi100895j; Sharma S, 2003, J BIOL CHEM, V278, P23487, DOI 10.1074/jbc.M212798200; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Shen BH, 1996, J BIOL CHEM, V271, P9173, DOI 10.1074/jbc.271.16.9173; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Tomlinson CG, 2010, BIOCHEM SOC T, V38, P433, DOI 10.1042/BST0380433; Vallur AC, 2010, J BIOL CHEM, V285, P28514, DOI 10.1074/jbc.M110.132738; Vallur AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008908; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	63	121	123	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					212	223		10.1016/j.cell.2011.03.005	http://dx.doi.org/10.1016/j.cell.2011.03.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496642	Bronze, Green Accepted			2022-12-28	WOS:000289549900011
J	Carlet, J; Collignon, P; Goldmann, D; Goossens, H; Gyssens, IC; Harbarth, S; Jarlier, V; Levy, SB; N'Doye, B; Pittet, D; Richtmann, R; Seto, WH; van der Meer, JWM; Voss, A				Carlet, Jean; Collignon, Peter; Goldmann, Don; Goossens, Herman; Gyssens, Inge C.; Harbarth, Stephan; Jarlier, Vincent; Levy, Stuart B.; N'Doye, Babacar; Pittet, Didier; Richtmann, Rosana; Seto, Wing H.; van der Meer, Jos W. M.; Voss, Andreas			Society's failure to protect a precious resource: antibiotics	LANCET			English	Editorial Material							RESISTANCE; EMERGENCE		[Carlet, Jean] WHO, African Partnership Patient Safety Programme, Paris, France; [Collignon, Peter] Canberra Hosp, Infect Dis Unit, Woden, ACT, Australia; [Collignon, Peter] Canberra Hosp, Dept Microbiol, Woden, ACT, Australia; [Collignon, Peter] Australian Natl Univ, Sch Clin Med, Woden, ACT, Australia; [Goldmann, Don] Inst Healthcare Improvement, Cambridge, MA USA; [Goldmann, Don] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Goldmann, Don] Harvard Univ, Sch Med, Boston, MA USA; [Goossens, Herman] Univ Antwerp, Lab Med Microbiol, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium; [Gyssens, Inge C.; van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med & Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Gyssens, Inge C.; Voss, Andreas] Hasselt Univ, Diepenbeek, Belgium; [Harbarth, Stephan; Pittet, Didier] Univ Hosp Geneva, Infect Control Program, Geneva, Switzerland; [Harbarth, Stephan; Pittet, Didier] Univ Hosp Geneva, WHO Collaborating Ctr Patient Safety, Geneva, Switzerland; [Harbarth, Stephan; Pittet, Didier] Univ Geneva, Fac Med, Geneva, Switzerland; [Jarlier, Vincent] UPMC Univ Paris, Bacteriol Hyg Pitie Salpetriere Hosp, AP HP, Paris, France; [Levy, Stuart B.] Tufts Univ, Sch Med, Ctr Adaptat Genet & Drug Resistance, Boston, MA 02111 USA; [Levy, Stuart B.] Tufts Univ, Sch Med, Dept Mol Biol Microbiol, Boston, MA 02111 USA; [Levy, Stuart B.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [N'Doye, Babacar] Minist Sante & Prevent, Programme Natl Lutte Infect Nosocomiales PRONALIN, Dakar, Senegal; [Richtmann, Rosana] Emilio Ribas Infect Dis Inst, Dept Infect Dis, Sao Paulo, Brazil; [Seto, Wing H.] Hong Kong Hosp Author, Dept Qual & Safety, Hong Kong, Hong Kong, Peoples R China	World Health Organization; Australian National University; Canberra Hospital; Australian National University; Canberra Hospital; Australian National University; Institute for Healthcare Improvement; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Antwerp; Radboud University Nijmegen; Hasselt University; University of Geneva; University of Geneva; World Health Organization; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Tufts University; Tufts University; Tufts University	Carlet, J (corresponding author), 9 Rue Terrasse, F-94000 Creteil, France.	jeancarlet@gmail.com	van der Meer, Jos W.M./C-8521-2013; Gyssens, Inge C.J./L-4343-2015; Voss, A./H-8111-2014; Gyssens, Inge/ABB-9031-2021; Collignon, Peter/U-4846-2019	van der Meer, Jos W.M./0000-0001-5120-3690; Gyssens, Inge/0000-0002-9226-0752; Collignon, Peter/0000-0001-8648-9203; Seto, Wing Hong/0000-0002-1139-9200				Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Chisholm SA, 2010, J ANTIMICROB CHEMOTH, V65, P2141, DOI 10.1093/jac/dkq289; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Earnshaw S, 2010, EUROSURVEILLANCE, V14, P23; European Centre for Disease Prevention and Control, ECDC EMEA JOINT TECH; European Centre for Disease Prevention and Control, EARS NET DAT; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grave K, 2010, J ANTIMICROB CHEMOTH, V65, P2037, DOI 10.1093/jac/dkq247; Hughes JM, 2011, JAMA-J AM MED ASSOC, V305, P1027, DOI 10.1001/jama.2011.279; Hulscher MEJL, 2010, LANCET INFECT DIS, V10, P167, DOI 10.1016/S1473-3099(10)70027-X; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; *INF DIS SOC AM, BAD BUGS NO DRUGS; Jajoo M, 2011, PEDIATR INFECT DIS J, V30, P218, DOI 10.1097/INF.0b013e3182064bfe; Johnson PDR, 2010, J INFECT DIS, V202, P1278, DOI 10.1086/656319; Kennedy K, 2010, EUR J CLIN MICROBIOL, V29, P1501, DOI 10.1007/s10096-010-1031-y; Koo SH, 2010, KOREAN J LAB MED, V30, P498, DOI 10.3343/kjlm.2010.30.5.498; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; KUNIN CM, 1973, ANN INTERN MED, V79, P555, DOI 10.7326/0003-4819-79-4-555; Li JY, 2010, FOODBORNE PATHOG DIS, V7, P1387, DOI 10.1089/fpd.2010.0581; Ofner-Agostini M., 2009, CAN J INFECT DIS MED, V20, P43; Seto WH, 2010, INFECT CONT HOSP EP, V31, P948, DOI 10.1086/655833; Uma B, 2010, INDIAN J GASTROENTER, V29, P201, DOI 10.1007/s12664-010-0044-x; Union. CotE, 2002, OJ L, V45, P13; United States Centers for Disease Prevention and Control, GET SMART PROGR; van Hal SJ, 2011, EUR J CLIN MICROBIOL, V30, P603, DOI 10.1007/s10096-010-1128-3	26	210	226	2	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					369	371		10.1016/S0140-6736(11)60401-7	http://dx.doi.org/10.1016/S0140-6736(11)60401-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XL	21477855				2022-12-28	WOS:000293615800035
J	Specht, HP; Nolleke, C; Reiserer, A; Uphoff, M; Figueroa, E; Ritter, S; Rempe, G				Specht, Holger P.; Nolleke, Christian; Reiserer, Andreas; Uphoff, Manuel; Figueroa, Eden; Ritter, Stephan; Rempe, Gerhard			A single-atom quantum memory	NATURE			English	Article							ENTANGLEMENT; PHOTON; CAVITY; QUBIT	The faithful storage of a quantum bit (qubit) of light is essential for long-distance quantum communication, quantum networking and distributed quantum computing(1). The required optical quantum memory must be able to receive and recreate the photonic qubit; additionally, it must store an unknown quantum state of light better than any classical device. So far, these two requirements have been met only by ensembles of material particles that store the information in collective excitations(2-7). Recent developments, however, have paved the way for an approach in which the information exchange occurs between single quanta of light and matter(8-13). This single-particle approach allows the material qubit to be addressed, which has fundamental advantages for realistic implementations. First, it enables a heralding mechanism that signals the successful storage of a photon by means of state detection(14-16); this can be used to combat inevitable losses and finite efficiencies. Second, it allows for individual qubit manipulations, opening up avenues for in situ processing of the stored quantum information. Here we demonstrate the most fundamental implementation of such a quantum memory, by mapping arbitrary polarization states of light into and out of a single atom trapped inside an optical cavity. The memory performance is tested with weak coherent pulses and analysed using full quantum process tomography. The average fidelity is measured to be 93%, and low decoherence rates result in qubit coherence times exceeding 180 microseconds. This makes our system a versatile quantum node with excellent prospects for applications in optical quantum gates(17) and quantum repeaters(18).	[Specht, Holger P.; Nolleke, Christian; Reiserer, Andreas; Uphoff, Manuel; Figueroa, Eden; Ritter, Stephan; Rempe, Gerhard] Max Planck Inst Quantum Opt, D-85748 Garching, Germany	Max Planck Society	Ritter, S (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	stephan.ritter@mpq.mpg.de	Ritter, Stephan/F-1579-2010; Reiserer, Andreas/G-4980-2017; Reiserer, Andreas/J-3243-2014	Ritter, Stephan/0000-0001-9002-7407; Reiserer, Andreas/0000-0001-9595-7363; Reiserer, Andreas/0000-0001-9595-7363	Deutsche Forschungsgemeinschaft [635]; European Union; Bundesministerium fur Bildung und Forschung; Alexander von Humboldt Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank N. Kiesel for discussions and A. Neuzner for experimental assistance. This work was supported by the Deutsche Forschungsgemeinschaft (Research Unit 635), by the European Union (Collaborative Project AQUTE) and by the Bundesministerium fur Bildung und Forschung via IKT 2020 (QK_QuOReP). E.F. acknowledges support from the Alexander von Humboldt Foundation.	Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Bochmann J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.203601; Boozer AD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.193601; Bowdrey MD, 2002, PHYS LETT A, V294, P258, DOI 10.1016/S0375-9601(02)00069-5; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Choi KS, 2008, NATURE, V452, P67, DOI 10.1038/nature06670; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Clausen C, 2011, NATURE, V469, P508, DOI 10.1038/nature09662; Curty M, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.062301; Gorshkov AV, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.033804; Hennrich M, 2000, PHYS REV LETT, V85, P4872, DOI 10.1103/PhysRevLett.85.4872; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Jin X.-M., 2010, QUANTUM INTERFACE FR; Kampschulte T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.153603; Keller M, 2004, NATURE, V431, P1075, DOI 10.1038/nature02961; Lloyd S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.167903; Lvovsky AI, 2009, NAT PHOTONICS, V3, P706, DOI 10.1038/nphoton.2009.231; MASSAR S, 1995, PHYS REV LETT, V74, P1259, DOI 10.1103/PhysRevLett.74.1259; Matsukevich DN, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030405; Mucke M, 2010, NATURE, V465, P755, DOI 10.1038/nature09093; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Piro N, 2011, NAT PHYS, V7, P17, DOI 10.1038/NPHYS1805; Radnaev AG, 2010, NAT PHYS, V6, P894, DOI [10.1038/NPHYS1773, 10.1038/nphys1773]; Saglamyurek E, 2011, NATURE, V469, P512, DOI 10.1038/nature09719; Tanji H, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.043601; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Vasilev GS, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/063024; Volz J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030404; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835; Zhao B, 2009, NAT PHYS, V5, P95, DOI 10.1038/NPHYS1153; Zhao R, 2009, NAT PHYS, V5, P100, DOI 10.1038/NPHYS1152	32	286	292	4	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					190	193		10.1038/nature09997	http://dx.doi.org/10.1038/nature09997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21532588	Green Submitted			2022-12-28	WOS:000290487200033
J	Bendall, SC; Simonds, EF; Qiu, P; Amir, EAD; Krutzik, PO; Finck, R; Bruggner, RV; Melamed, R; Trejo, A; Ornatsky, OI; Balderas, RS; Plevritis, SK; Sachs, K; Pe'er, D; Tanner, SD; Nolan, GP				Bendall, Sean C.; Simonds, Erin F.; Qiu, Peng; Amir, El-ad D.; Krutzik, Peter O.; Finck, Rachel; Bruggner, Robert V.; Melamed, Rachel; Trejo, Angelica; Ornatsky, Olga I.; Balderas, Robert S.; Plevritis, Sylvia K.; Sachs, Karen; Pe'er, Dana; Tanner, Scott D.; Nolan, Garry P.			Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum	SCIENCE			English	Article							TYROSINE KINASE INHIBITOR; FLOW-CYTOMETRY; SIGNALING NETWORKS; QUANTITATIVE-ANALYSIS; MYELOGENOUS LEUKEMIA; STEM-CELLS; IDENTIFICATION; LYMPHOCYTE; DASATINIB; ACTIVATION	Flow cytometry is an essential tool for dissecting the functional complexity of hematopoiesis. We used single-cell "mass cytometry" to examine healthy human bone marrow, measuring 34 parameters simultaneously in single cells (binding of 31 antibodies, viability, DNA content, and relative cell size). The signaling behavior of cell subsets spanning a defined hematopoietic hierarchy was monitored with 18 simultaneous markers of functional signaling states perturbed by a set of ex vivo stimuli and inhibitors. The data set allowed for an algorithmically driven assembly of related cell types defined by surface antigen expression, providing a superimposable map of cell signaling responses in combination with drug inhibition. Visualized in this manner, the analysis revealed previously unappreciated instances of both precise signaling responses that were bounded within conventionally defined cell subsets and more continuous phosphorylation responses that crossed cell population boundaries in unexpected manners yet tracked closely with cellular phenotype. Collectively, such single-cell analyses provide system-wide views of immune signaling in healthy human hematopoiesis, against which drug action and disease can be compared for mechanistic studies and pharmacologic intervention.	[Bendall, Sean C.; Simonds, Erin F.; Krutzik, Peter O.; Finck, Rachel; Bruggner, Robert V.; Trejo, Angelica; Sachs, Karen; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Qiu, Peng; Plevritis, Sylvia K.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Amir, El-ad D.; Melamed, Rachel; Pe'er, Dana] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Ornatsky, Olga I.; Tanner, Scott D.] Univ Toronto, Toronto, ON M5S 3H6, Canada; [Ornatsky, Olga I.; Tanner, Scott D.] DVS Sci, Markham, ON L3R 6E7, Canada; [Balderas, Robert S.] BD Biosci, San Diego, CA 95131 USA; [Bruggner, Robert V.] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Columbia University; University of Toronto; Stanford University	Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Nolan, Garry/AAE-7903-2019; Bendall, Sean/AGG-0126-2022	Altan-Bonnet, Gregoire/0000-0002-7283-3162; Nolan, Garry/0000-0002-8862-9043; Simonds, Erin/0000-0002-3497-4861; Bendall, Sean/0000-0003-1341-2453; Pe'er, Dana/0000-0002-9259-8817; Melamed, Rachel/0000-0003-3089-9806	Damon Runyon Cancer Research Foundation [DRG-2017-09]; NIH [U19 AI057229, P01 CA034233, 272200700038C, 1R01CA130826, U54 CA149145, 5U54 CA143907, RB2-01592, PN2 EY018228, NOI-HV-00242]; European Commission [HEALTH.2010.1.2-1]; California Institute for Regenerative Medicine [RB2-01592, DR-01477]; Genome Canada via the Ontario Genomics Institute for Cancer Research; Ontario Research Fund [ORF-GL2-01-003]; Burroughs Wellcome Fund; Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE [U54CA149145, R01CA130826, P01CA034233, U54CA143907] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Genome Canada via the Ontario Genomics Institute for Cancer Research; Ontario Research Fund; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors thank W. J. Fantl for critical reading of the. manuscript. S.C.B. is supported by the Damon Runyon Cancer Research Foundation Fellowship (DRG-2017-09). This work was supported by NIH grants, U19 AI057229, P01 CA034233, 272200700038C, 1R01CA130826, U54 CA149145, 5U54 CA143907, RB2-01592, PN2 EY018228, NOI-HV-00242, and HEALTH.2010.1.2-1 (European Commission grant to the Sweden Diatools Consortium), as well as California Institute for Regenerative Medicine (DR-01477, RB2-01592) to G.P.N. G.P.N. is supported by an endowed chair from Rachtford and Carlota A. Harris. S.D.T. was supported by Genome Canada via the Ontario Genomics Institute for Cancer Research and by the Ontario Research Fund ORF-GL2-01-003. D.P. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and Packard Fellowship for Science and Engineering. Some antibodies were a gift from Becton Dickinson Biosciences. B.B. is a paid employee of Becton Dickinson, and G.P.N. and P.K. are paid consultants for Becton Dickinson Biosciences. G.P.N. is a member of the Board of Directors and a consultant for DVS Sciences. O.O., G.P.N., and S.T. have equity holdings in DVS Biosciences, and S.T. is an employee of DVS Sciences A patent has been applied for on the SPADE algorithm on behalf of Stanford University. Raw data and SPADE trees can be downloaded open access at www.cytobank.org/nolanlab.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Autissier P, 2010, CYTOM PART A, V77A, P410, DOI 10.1002/cyto.a.20859; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Dohse M, 2010, DRUG METAB DISPOS, V38, P1371, DOI 10.1124/dmd.109.031302; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Fraser IDC, 2009, NAT IMMUNOL, V10, P327, DOI 10.1038/ni.1711; Frisa PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007064; FULWYLER MJ, 1965, SCIENCE, V150, P910, DOI 10.1126/science.150.3698.910; Gibbs KD, 2011, BLOOD, V117, P4226, DOI 10.1182/blood-2010-07-298232; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; HERZENBERG LA, 1973, J EXP MED, V137, P1311, DOI 10.1084/jem.137.6.1311; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; KONDO M, 2003, Nat Med, V21, P2; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; KRASNOW MA, 1991, SCIENCE, V251, P81, DOI 10.1126/science.1898782; Krutzik PO, 2008, NAT CHEM BIOL, V4, P132, DOI 10.1038/nchembio.2007.59; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Lemischka IR, 2005, ANN NY ACAD SCI, V1044, P132, DOI 10.1196/annals.1349.017; Lindauer M, 2010, RECENT RESULTS CANC, V184, P83, DOI 10.1007/978-3-642-01222-8_7; Lou XD, 2007, ANGEW CHEM INT EDIT, V46, P6111, DOI 10.1002/anie.200700796; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Nam S, 2007, MOL CANCER THER, V6, P1400, DOI 10.1158/1535-7163.MCT-06-0446; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Oh ST, 2010, BLOOD, V116, P988, DOI 10.1182/blood-2010-02-270108; Ornatsky OI, 2008, ANAL CHEM, V80, P2539, DOI 10.1021/ac702128m; Ornatsky O, 2010, J IMMUNOL METHODS, V361, P1, DOI 10.1016/j.jim.2010.07.002; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Quintas-Cardama A, 2009, BLOOD, V114, P261, DOI 10.1182/blood-2008-09-180604; Robinson JP, 2005, CYTOM PART A, V67A, P61, DOI 10.1002/cyto.a.20183; Roederer M, 1997, Semin Immunol, V9, P389, DOI 10.1006/smim.1997.0097; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013543; Russwurm G, 2010, BLOOD, V116, P2617, DOI 10.1182/blood-2010-04-279786; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Schade AE, 2008, BLOOD, V111, P1366, DOI 10.1182/blood-2007-04-084814; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Sillaber C, 2009, EUR J CLIN INVEST, V39, P1098, DOI 10.1111/j.1365-2362.2009.02206.x; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takano K, 2000, INT J HEMATOL, V72, P48; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tarnok A, 2010, CYTOM PART A, V77A, P6, DOI 10.1002/cyto.a.20844; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; Yang C, 2008, LEUKEMIA, V22, P1755, DOI 10.1038/leu.2008.163	54	1580	1661	30	657	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					687	696		10.1126/science.1198704	http://dx.doi.org/10.1126/science.1198704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551058	Green Submitted, Green Accepted			2022-12-28	WOS:000290265800035
J	Kotler, S; Akerman, N; Glickman, Y; Keselman, A; Ozeri, R				Kotler, Shlomi; Akerman, Nitzan; Glickman, Yinnon; Keselman, Anna; Ozeri, Roee			Single-ion quantum lock-in amplifier	NATURE			English	Article							METROLOGY; DIAMOND; MEMORY; SPIN	Quantum metrology(1) uses tools from quantum information science to improve measurement signal-to-noise ratios. The challenge is to increase sensitivity while reducing susceptibility to noise, tasks that are often in conflict. Lock-in measurement is a detection scheme designed to overcome this difficulty by spectrally separating signal from noise. Here we report on the implementation of a quantum analogue to the classical lock-in amplifier. All the lock-in operations-modulation, detection and mixing-are performed through the application of non-commuting quantum operators to the electronic spin state of a single, trapped Sr(+) ion. We significantly increase its sensitivity to external fields while extending phase coherence by three orders of magnitude, to more than one second. Using this technique, we measure frequency shifts with a sensitivity of 0.42 Hz Hz(-1/2) (corresponding to a magnetic field measurement sensitivity of 15 pT Hz(-1/2)), obtaining an uncertainty of less than 10 mHz (350 fT) after 3,720 seconds of averaging. These sensitivities are limited by quantum projection noise and improve on other single-spin probe technologies(2,3) by two orders of magnitude. Our reported sensitivity is sufficient for the measurement of parity non-conservation(4), as well as the detection of the magnetic field of a single electronic spin one micrometre from an ion detector with nanometre resolution. As a first application, we perform light shift spectroscopy of a narrow optical quadrupole transition. Finally, we emphasize that the quantum lock-in technique is generic and can potentially enhance the sensitivity of any quantum sensor.	[Kotler, Shlomi; Akerman, Nitzan; Glickman, Yinnon; Keselman, Anna; Ozeri, Roee] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Kotler, S (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, POB 26, IL-76100 Rehovot, Israel.	shlomi.kotler@weizmann.ac.il	Kotler, Shlomi/I-4393-2014	Kotler, Shlomi/0000-0002-0191-5777	ISF; Crown Photonics Center; Minerva Foundation	ISF(Israel Science Foundation); Crown Photonics Center; Minerva Foundation	We thank G. Bensky, G. Gordon and G. Kurizki for discussions. We acknowledge the support by the ISF Morasha program, the Crown Photonics Center and the Minerva Foundation.	Andre A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.230801; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Biercuk MJ, 2009, NATURE, V458, P996, DOI 10.1038/nature07951; de Lange G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.080802; Degen C, 2008, NAT NANOTECHNOL, V3, P643, DOI 10.1038/nnano.2008.328; DREVER RWP, 1983, APPL PHYS B-PHOTO, V31, P97, DOI 10.1007/BF00702605; FORTSON N, 1993, PHYS REV LETT, V70, P2383, DOI 10.1103/PhysRevLett.70.2383; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Gordon G, 2007, J PHYS B-AT MOL OPT, V40, pS75, DOI 10.1088/0953-4075/40/9/S04; Hall LT, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.045208; Huelga SF, 1997, PHYS REV LETT, V79, P3865, DOI 10.1103/PhysRevLett.79.3865; Kielpinski D, 2001, SCIENCE, V291, P1013, DOI 10.1126/science.1057357; Knunz S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.013004; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Leibfried D, 2004, SCIENCE, V304, P1476, DOI 10.1126/science.1097576; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Oskay WH, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.163001; Riley W. J., 2008, NIST SPEC PUBL, V1065; Roos CF, 2006, NATURE, V443, P316, DOI 10.1038/nature05101; Roos CF, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.220402; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Sagi Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053201; Schmid S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.133202; Uys H, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.040501; Zipkes C, 2010, NATURE, V464, P388, DOI 10.1038/nature08865	27	136	137	4	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					61	65		10.1038/nature10010	http://dx.doi.org/10.1038/nature10010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544142	Green Submitted			2022-12-28	WOS:000290218300030
J	Ware, JH; Hamel, MB				Ware, James H.; Hamel, Mary Beth			STATISTICS IN MEDICINE Pragmatic Trials - Guides to Better Patient Care?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ware, James H.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Ware, JH (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624	3	191	194	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1685	1687		10.1056/NEJMp1103502	http://dx.doi.org/10.1056/NEJMp1103502			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759DC	21542739				2022-12-28	WOS:000290219800001
J	Levinson, W; Pizzo, PA				Levinson, Wendy; Pizzo, Philip A.			Patient-Physican Communication It's About Time	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; CULTURE		[Levinson, Wendy] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada; [Pizzo, Philip A.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Pizzo, Philip A.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	University of Toronto; Stanford University; Stanford University	Levinson, W (corresponding author), Univ Toronto, Dept Med, Ste 3-805,R Fraser Elliot Bldg,190 Elizabeth St, Toronto, ON M5G 2C4, Canada.	wendy.levinson@utoronto.ca						ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Institute of Medicine (US) Committee on Quality of Health Care in America, 2014, CROSSING QUALITY CHA; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Levinson W, 2010, HEALTH AFFAIR, V29, P1310, DOI 10.1377/hlthaff.2009.0450; Lockyer Jocelyn, 2003, J Contin Educ Health Prof, V23, P4, DOI 10.1002/chp.1340230103; O'Malley AJ, 2005, HEALTH SERV RES, V40, P2162, DOI 10.1111/j.1475-6773.2005.00470.x; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; Rao JK, 2007, MED CARE, V45, P340, DOI 10.1097/01.mlr.0000254516.04961.d5; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461	9	60	61	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1802	1803		10.1001/jama.2011.556	http://dx.doi.org/10.1001/jama.2011.556			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	758HZ	21540424				2022-12-28	WOS:000290156200022
J	McCarthy, MA; Liu, B; Donoghue, EP; Kravchenko, I; Kim, DY; So, F; Rinzler, AG				McCarthy, M. A.; Liu, B.; Donoghue, E. P.; Kravchenko, I.; Kim, D. Y.; So, F.; Rinzler, A. G.			Low-Voltage, Low-Power, Organic Light-Emitting Transistors for Active Matrix Displays	SCIENCE			English	Article							THIN-FILM TRANSISTORS; FIELD-EFFECT TRANSISTORS; DEPENDENCE; DEVICE; SI	Intrinsic nonuniformity in the polycrystalline-silicon backplane transistors of active matrix organic light-emitting diode displays severely limits display size. Organic semiconductors might provide an alternative, but their mobility remains too low to be useful in the conventional thin-film transistor design. Here we demonstrate an organic channel light-emitting transistor operating at low voltage, with low power dissipation, and high aperture ratio, in the three primary colors. The high level of performance is enabled by a single-wall carbon nanotube network source electrode that permits integration of the drive transistor and the light emitter into an efficient single stacked device. The performance demonstrated is comparable to that of polycrystalline-silicon backplane transistor-driven display pixels.	[McCarthy, M. A.; Liu, B.; Donoghue, E. P.; Rinzler, A. G.] Univ Florida, Dept Phys, Gainesville, FL 32611 USA; [McCarthy, M. A.; Kim, D. Y.; So, F.] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA; [Kravchenko, I.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37830 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences	Rinzler, AG (corresponding author), Univ Florida, Dept Phys, Gainesville, FL 32611 USA.	rinzler@phys.ufl.edu	, Do Young Kim/B-9147-2012; Kravchenko, Ivan/K-3022-2015; So, Franky/F-2942-2019	Kravchenko, Ivan/0000-0003-4999-5822; So, Franky/0000-0002-8310-677X	Oak Ridge National Laboratory by the Scientific User Facilities Division, U.S. Department of Energy; NSF [ECCS-0824157]; Nanoholdings LLC; Div Of Electrical, Commun & Cyber Sys [0824157] Funding Source: National Science Foundation	Oak Ridge National Laboratory by the Scientific User Facilities Division, U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Nanoholdings LLC; Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank J. R. Reynolds (University of Florida) for useful discussions. We thank K. Takimiya (Hiroshima University) and E. Kanoh (Nippon Kayaku Co., Ltd.) for supplying the DNTT, and the University of Florida Nanoscale Research Facility for use of equipment and technical support. A portion of this research was conducted at the Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Scientific User Facilities Division, U.S. Department of Energy. We acknowledge support from the NSF (ECCS-0824157) and Nanoholdings LLC. The University of Florida has filed patent applications for the CN-VOLET architecture and for its use in AMOLED displays.	Adachi C, 2001, ORG ELECTRON, V2, P37, DOI 10.1016/S1566-1199(01)00010-6; Chang CP, 2009, IEEE ELECTR DEVICE L, V30, P1176, DOI 10.1109/LED.2009.2031130; Gu G, 1998, IEEE J SEL TOP QUANT, V4, P83, DOI 10.1109/2944.669473; Iechi H, 2005, SYNTHETIC MET, V154, P149, DOI 10.1016/j.synthmet.2005.07.038; Jung MH, 2008, JPN J APPL PHYS, V47, P8275, DOI 10.1143/JJAP.47.8275; Kimura M, 1999, IEEE T ELECTRON DEV, V46, P2282, DOI 10.1109/16.808054; Kudo K, 2005, CURR APPL PHYS, V5, P337, DOI 10.1016/j.cap.2003.11.095; LIN PS, 1994, IEEE ELECTR DEVICE L, V15, P138, DOI 10.1109/55.285404; Liu B, 2008, ADV MATER, V20, P3605, DOI 10.1002/adma.200800601; Liu B, 2010, ADV FUNCT MATER, V20, P3440, DOI 10.1002/adfm.201001175; Matsushima T, 2008, J APPL PHYS, V103, DOI 10.1063/1.2836972; McCarthy MA, 2011, ACS NANO, V5, P291, DOI 10.1021/nn102721v; McCarthy MA, 2010, NANO LETT, V10, P3467, DOI 10.1021/nl101589x; Nakamura K, 2008, JPN J APPL PHYS, V47, P1889, DOI 10.1143/JJAP.47.1889; Nathan A, 2005, J DISP TECHNOL, V1, P267, DOI 10.1109/JDT.2005.858913; Oh SY, 2006, MOL CRYST LIQ CRYST, V458, P247, DOI 10.1080/15421400600932439; Ohta S, 2005, JPN J APPL PHYS 1, V44, P3678, DOI 10.1143/JJAP.44.3678; Park B, 2004, APPL PHYS LETT, V85, P1280, DOI 10.1063/1.1784044; Park YJ, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.03CD01; POWELL MJ, 1989, APPL PHYS LETT, V54, P1323, DOI 10.1063/1.100704; POWELL MJ, 1989, IEEE T ELECTRON DEV, V36, P2753, DOI 10.1109/16.40933; Tokito S, 1996, J PHYS D APPL PHYS, V29, P2750, DOI 10.1088/0022-3727/29/11/004; Tsujioka T, 2001, JPN J APPL PHYS 1, V40, P2523, DOI 10.1143/JJAP.40.2523; Xu Z, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2778751; Yamamoto T, 2007, J AM CHEM SOC, V129, P2224, DOI 10.1021/ja068429z; Yamauchi H, 2007, JPN J APPL PHYS 1, V46, P2678, DOI 10.1143/JJAP.46.2678	26	368	381	14	396	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029					570	573		10.1126/science.1203052	http://dx.doi.org/10.1126/science.1203052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527708				2022-12-28	WOS:000289991100043
J	Ensrud, KE; Schousboe, JT				Ensrud, Kristine E.; Schousboe, John T.			Vertebral Fractures	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							X-RAY ABSORPTIOMETRY; LOW BONE-DENSITY; QUALITY-OF-LIFE; POSTMENOPAUSAL WOMEN; COMPRESSION FRACTURES; RANDOMIZED-TRIAL; PERCUTANEOUS VERTEBROPLASTY; NONVERTEBRAL FRACTURES; STRONTIUM RANELATE; PREVENT FRACTURES	A 72-year-old woman presents with a 2-month history of increasing pain in her lower back, which has not improved with ibuprofen and is causing difficulty with walking and dressing. On questioning, she reports having lost about 5 cm (2 in.) of height since she was a young woman. On examination, there is mild kyphosis in her lower thoracic spine but no point tenderness. A lateral spine radiograph reveals that the L2 vertebra is biconcave in appearance, a finding that is consistent with a vertebral fracture (Fig. 1). How should this case be managed?	[Ensrud, Kristine E.; Schousboe, John T.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Vet Affairs Med Ctr, Dept Med, Minneapolis, MN 55417 USA; [Schousboe, John T.] Pk Nicollet Inst, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Ensrud, KE (corresponding author), 1 Vet Dr 111-0, Minneapolis, MN USA.	ensru001@umn.edu		Ensrud, Kristine/0000-0002-9069-3036	Roche; Hologic; Eli Lilly	Roche(Roche Holding); Hologic; Eli Lilly(Eli Lilly)	Dr. Ensrud reports receiving travel support from Pfizer, Merck, and the Croatian Osteoporosis Society; and Dr. Schousboe, receiving consulting fees from Roche and grant support from Hologic and Eli Lilly. No other potential conflict of interest relevant to this article was reported.	Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Burge R, 2002, VALUE HEALTH, V5, P301, DOI 10.1046/j.1524-4733.2002.54126.x; Cauley JA, 2008, J BONE MINER RES, V23, P1458, DOI 10.1359/JBMR.080411; COOPER C, 1992, J BONE MINER RES, V7, pS174; CUMMINGS SR, 1995, J BONE MINER RES, V10, P518; Cummings SR, 2010, NEW ENGL J MED, V362, P686, DOI 10.1056/NEJMoa0808692; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Donaldson MG, 2009, J BONE MINER RES, V24, P1793, DOI 10.1359/jbmr.090511; Dusdal K, 2011, OSTEOPOROSIS INT, V22, P755, DOI 10.1007/s00198-010-1497-6; Ensrud KE, 2000, J AM GERIATR SOC, V48, P241, DOI 10.1111/j.1532-5415.2000.tb02641.x; ETTINGER B, 1992, J BONE MINER RES, V7, P449; Fink HA, 2005, J BONE MINER RES, V20, P1216, DOI 10.1359/JBMR.050314; Fink HA, 2003, OSTEOPOROSIS INT, V14, P69, DOI 10.1007/s00198-002-1314-y; Freitas SS, 2008, OSTEOPOROSIS INT, V19, P615, DOI 10.1007/s00198-007-0510-1; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Gray DT, 2008, SPINE, V33, P1905, DOI 10.1097/BRS.0b013e31817bb0a4; Greenspan SL, 2007, ANN INTERN MED, V146, P326, DOI 10.7326/0003-4819-146-5-200703060-00005; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jergas M, 1997, CALCIFIED TISSUE INT, V61, P351, DOI 10.1007/s002239900347; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P1103, DOI 10.1007/s00198-008-0599-x; KIEL D, 1995, J BONE MINER RES, V10, P605; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Knopp JA, 2005, OSTEOPOROSIS INT, V16, P1281, DOI 10.1007/s00198-004-1798-8; Krueger A, 2009, EUR SPINE J, V18, P1257, DOI 10.1007/s00586-009-1073-y; Laredo JD, 2004, SKELETAL RADIOL, V33, P493, DOI 10.1007/s00256-004-0776-8; Lee B, 2009, EUR J CANCER, V45, P1597, DOI 10.1016/j.ejca.2009.01.021; Lewiecki EM, 2006, J CLIN ENDOCR METAB, V91, P4215, DOI 10.1210/jc.2006-1178; Lips P, 2010, CLIN ENDOCRINOL, V73, P277, DOI 10.1111/j.1365-2265.2009.03701.x; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Majumdar SR, 2005, ARCH INTERN MED, V165, P905, DOI 10.1001/archinte.165.8.905; MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007/BF01623271; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Mudano AS, 2009, OSTEOPOROSIS INT, V20, P819, DOI 10.1007/s00198-008-0745-5; *NAT OST FDN, 2010, NOF CLIN GUID PREV T; Nevitt MC, 2005, J BONE MINER RES, V20, P131, DOI 10.1359/JBMR.041003; Nevitt MC, 1998, ANN INTERN MED, V128, P793, DOI 10.7326/0003-4819-128-10-199805150-00001; ONeill TW, 1996, J BONE MINER RES, V11, P1010; ONeill TW, 1997, J RHEUMATOL, V24, P1208; Pfeifer M, 2004, AM J PHYS MED REHAB, V83, P177, DOI 10.1097/01.PHM.0000113403.16617.93; Prather H, 2007, INJURY, V38, P40, DOI 10.1016/j.injury.2007.08.010; Qaseem A, 2008, ANN INTERN MED, V149, P404, DOI 10.7326/0003-4819-149-6-200809160-00007; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Rousing R, 2010, SPINE, V35, P478, DOI 10.1097/BRS.0b013e3181b71bd1; Schneider DL, 2004, J RHEUMATOL, V31, P747; Schousboe JT, 2008, J CLIN DENSITOM, V11, P92, DOI 10.1016/j.jocd.2007.12.008; Schousboe JT, 2006, J CLIN DENSITOM, V9, P133, DOI 10.1016/j.jocd.2005.11.004; Schousboe JT, 2006, OSTEOPOROSIS INT, V17, P281, DOI 10.1007/s00198-005-2010-5; Schousboe JT, 2002, J CLIN DENSITOM, V5, P239, DOI 10.1385/JCD:5:3:239; Silverman SL, 2001, ARTHRITIS RHEUM, V44, P2611, DOI 10.1002/1529-0131(200111)44:11<2611::AID-ART441>3.0.CO;2-N; Silverman SL, 2008, J BONE MINER RES, V23, P1923, DOI 10.1359/JBMR.080710; Stadhouder A, 2009, J ORTHOP TRAUMA, V23, P588, DOI 10.1097/BOT.0b013e3181a18728; Stevenson M, 2005, HEALTH TECHNOL ASSES, V9, P1; Taylor RS, 2007, EUR SPINE J, V16, P1085, DOI 10.1007/s00586-007-0308-z; Trout AT, 2006, AM J NEURORADIOL, V27, P217; Uetani M, 2004, CLIN RADIOL, V59, P124, DOI 10.1016/j.crad.2003.07.005; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6; Xu L, 2000, J BONE MINER RES, V15, P2019, DOI 10.1359/jbmr.2000.15.10.2019; Zampini JM, 2010, CLIN ORTHOP RELAT R, V468, P1773, DOI 10.1007/s11999-010-1279-7	62	122	128	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1634	1642		10.1056/NEJMcp1009697	http://dx.doi.org/10.1056/NEJMcp1009697			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755NW	21524214				2022-12-28	WOS:000289940400010
J	Fitzpatrick, K				Fitzpatrick, Kevin			Should the law on assisted dying be changed? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									Not Dead Yet UK, Reynoldston, Wales		Fitzpatrick, K (corresponding author), Not Dead Yet UK, Reynoldston, Wales.	kevin@inclusion21.org						CAMPBELL J, 2006, HMV UK M ST THOM HOS; O'Neill O, 2010, AUTONOMY ASSISTED SU; Tiernan E, 2002, J ROY SOC MED, V95, P386, DOI 10.1258/jrsm.95.8.386; Wittgenstein Ludwig., 1974, TRACTATUS LOGICO PHI	4	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2011	342								d1883	10.1136/bmj.d1883	http://dx.doi.org/10.1136/bmj.d1883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OR	21511803				2022-12-28	WOS:000289943400001
J	Dunn, A				Dunn, Andrew			Apixaban reduced stroke and systemic embolism compared with aspirin in adults with AF for whom VKA therapy was unsuitable	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ATRIAL-FIBRILLATION		Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Dunn, A (corresponding author), Mt Sinai Sch Med, New York, NY 10029 USA.							Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Lopes RD, 2010, AM HEART J, V159, P331, DOI 10.1016/j.ahj.2009.07.035; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527	4	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8							JC4-3	10.7326/0003-4819-154-8-201104190-02003	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502641				2022-12-28	WOS:000289622000002
J	Lu, W; Du, JA; Wacker, T; Gerbig-Smentek, E; Andrade, SLA; Einsle, O				Lue, Wei; Du, Juan; Wacker, Tobias; Gerbig-Smentek, Elke; Andrade, Susana L. A.; Einsle, Oliver			pH-Dependent Gating in a FocA Formate Channel	SCIENCE			English	Article							ESCHERICHIA-COLI K-12; NUCLEOTIDE-SEQUENCE; MEMBRANE-PROTEINS; NITRATE; IDENTIFICATION; DEHYDROGENASE; TRANSPORTER; METABOLISM; MECHANISM; BACTERIA	The formate transporter FocA was described to switch its mode of operation from a passive export channel at high external pH to a secondary active formate/H+ importer at low pH. The crystal structure of Salmonella typhimurium FocA at pH 4.0 shows that this switch involves a major rearrangement of the amino termini of individual protomers in the pentameric channel. The amino-terminal helices open or block transport in a concerted, cooperative action that indicates how FocA is gated in a pH-dependent way. Electrophysiological studies show that the protein acts as a specific formate channel at pH 7.0 and that it closes upon a shift of pH to 5.1.	[Lue, Wei; Du, Juan; Wacker, Tobias; Gerbig-Smentek, Elke; Andrade, Susana L. A.; Einsle, Oliver] Univ Freiburg, Lehrstuhl Biochem, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	University of Freiburg	Einsle, O (corresponding author), Univ Freiburg, Lehrstuhl Biochem, Inst Organ Chem & Biochem, Albertstr 21, D-79104 Freiburg, Germany.	einsle@biochemie.uni-freiburg.de	Andrade, Susana L. A./D-5119-2012; Du, Juan/AAQ-5466-2020	Andrade, Susana L. A./0000-0003-2267-8499; Einsle, Oliver/0000-0001-8722-2893	Deutsche Forschungsgemeinschaft [Ei-520/3, An-676/1, IRTG 1478]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the staff at beamline X06SA at the Swiss Light Source, in particular T. Tomizaki, for assistance with data collection and W. Hardt (ETH Zurich) for genomic DNA of S. typhimurium. R. Dutzler (University of Zurich) is acknowledged for helpful discussions. This work was supported by Deutsche Forschungsgemeinschaft (Ei-520/3 to O.E., An-676/1 to S. L. A. A., and IRTG 1478). The structural model and structure factors have been deposited with the Protein Data Bank (accession code 3Q7K).	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Aveyard R., 1973, INTRO PRINCIPLES SUR; BERG BL, 1991, J BIOL CHEM, V266, P22380; Clegg S, 2002, MOL MICROBIOL, V44, P143, DOI 10.1046/j.1365-2958.2002.02858.x; Cole J, 1996, FEMS MICROBIOL LETT, V136, P1; Hakobyan M, 2005, BIOPHYS CHEM, V118, P135, DOI 10.1016/j.bpc.2005.09.012; KNAPPE J, 1990, FEMS MICROBIOL LETT, V75, P383, DOI 10.1111/j.1574-6968.1990.tb04108.x; Leonhartsberger S, 2002, J MOL MICROB BIOTECH, V4, P269; MACY J, 1976, J BACTERIOL, V125, P423, DOI 10.1128/JB.125.2.423-428.1976; ROSSMANN R, 1991, MOL MICROBIOL, V5, P2807, DOI 10.1111/j.1365-2958.1991.tb01989.x; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; Sawers RG, 1994, ANTON LEEUW INT J G, V66, P57; STANKOWSKI S, 1991, BIOPHYS J, V60, P341, DOI 10.1016/S0006-3495(91)82059-8; Stroud RM, 2003, ADV PROTEIN CHEM, V63, P291; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Waight AB, 2010, NAT STRUCT MOL BIOL, V17, P31, DOI 10.1038/nsmb.1740; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; WHITE WB, 1992, J BACTERIOL, V174, P4997, DOI 10.1128/JB.174.15.4997-5004.1992; WIMPENNY JW, 1967, BIOCHIM BIOPHYS ACTA, V148, P233, DOI 10.1016/0304-4165(67)90298-X	21	60	60	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					352	354		10.1126/science.1199098	http://dx.doi.org/10.1126/science.1199098			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493860				2022-12-28	WOS:000289516600045
J	Horsburgh, CR; Rubin, EJ				Horsburgh, C. Robert, Jr.; Rubin, Eric J.			Latent Tuberculosis Infection in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GAMMA RELEASE ASSAY; DRUG-USERS; ACTIVE TUBERCULOSIS; PREDICTIVE-VALUE; SKIN-TESTS; RISK; PREVALENCE; RIFAMPIN; TB; TRANSMISSION	A healthy 43-year-old woman presents for a pre-employment physical examination. She is originally from Ghana and came to the United States 18 months ago. Her employer, a hospital, requires a tuberculosis test. She reports having no known exposure to tuberculosis and no cough, fevers, or weight loss. Her physical examination is unremarkable. What screening test would you recommend, and how would you decide whether treatment is needed?	[Rubin, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Horsburgh, C. Robert, Jr.] Boston Univ, Sch Publ Hlth, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Boston University	Rubin, EJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 200 Longwood Ave, Boston, MA 02115 USA.	erubin@hsph.harvard.edu		Horsburgh, C./0000-0001-6838-7895; Rubin, Eric/0000-0001-5120-962X	Novartis; Otsuka Pharmaceutical	Novartis(Novartis); Otsuka Pharmaceutical(Otsuka Pharmaceutical)	Dr. Rubin reports serving on an unpaid scientific advisory board for the Global Alliance for TB Drug Development and receiving consulting fees and travel reimbursement from Novartis; and Dr. Horsburgh, receiving consulting fees from Otsuka Pharmaceutical. No other potential conflict of interest relevant to this article was reported.	Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; [Anonymous], 2010, Can Commun Dis Rep, V36, P1, DOI [10.14745/ccdr.v36i00as2, 10.14745/ccdr.v36i00a05, 10.14745/ccdr.v36i00as3]; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2008, Canada Communicable Disease Report, V34, P1; Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Belknap R, 2009, 105 INT C AM THOR SO; Bennett DE, 2008, AM J RESP CRIT CARE, V177, P348, DOI 10.1164/rccm.200701-057OC; Brassard P, 2004, INT J TUBERC LUNG D, V8, P988; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Clark SA, 2007, CLIN EXP IMMUNOL, V150, P238, DOI 10.1111/j.1365-2249.2007.03477.x; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Ena J, 2005, CLIN INFECT DIS, V40, P670, DOI 10.1086/427802; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; GIRLING DJ, 1992, AM REV RESPIR DIS, V145, P36; Grimes CZ, 2007, INT J TUBERC LUNG D, V11, P1183; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Jasmer RM, 2002, ANN INTERN MED, V137, P640, DOI 10.7326/0003-4819-137-8-200210150-00007; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; Kik SV, 2010, EUR RESPIR J, V35, P1346, DOI 10.1183/09031936.00098509; Kong PM, 2002, EMERG INFECT DIS, V8, P1280; Linas BP, 2009, AM J RESP CRIT CARE, V179; Lobato MN, 2003, AM J PREV MED, V24, P249, DOI 10.1016/S0749-3797(02)00583-4; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Matteelli A, 1999, INT J TUBERC LUNG D, V3, P1043; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Menzies D, 2004, AM J RESP CRIT CARE, V170, P445, DOI 10.1164/rccm.200404-478OC; Menzies D, 2008, ANN INTERN MED, V149, DOI 10.7326/0003-4819-149-8-200810210-02015; Moss AR, 2000, AM J RESP CRIT CARE, V162, P460, DOI 10.1164/ajrccm.162.2.9910055; National Institute for Health and Clinical Excellence, 2011, TUB CLIN DIAGN MAN T, V117; Ozuah PO, 1999, CHEST, V116, P104, DOI 10.1378/chest.116.1.104; PablosMendez A, 1997, AM J PUBLIC HEALTH, V87, P574, DOI 10.2105/AJPH.87.4.574; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; PALMER CE, 1957, AM REV TUBERC PULM, V76, P517; Pollock NR, 2008, INFECT CONT HOSP EP, V29, P878, DOI 10.1086/590262; Riley ED, 2002, J URBAN HEALTH, V79, P113, DOI 10.1093/jurban/79.1.113; Salomon N, 2000, INT J TUBERC LUNG D, V4, P47; Sarrazin H, 2009, J INFECT DIS, V199, P702, DOI 10.1086/596735; Schechter M, 2006, AM J RESP CRIT CARE, V173, P922, DOI 10.1164/rccm.200512-1953OC; Spigelman MK, 2007, J INFECT DIS, V196, pS28, DOI 10.1086/518663; Todryk SM, 2009, IMMUNOLOGY, V128, P83, DOI 10.1111/j.1365-2567.2009.03073.x; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201	48	195	201	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1441	1448		10.1056/NEJMcp1005750	http://dx.doi.org/10.1056/NEJMcp1005750			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LD	21488766				2022-12-28	WOS:000289467200008
J	[Anonymous]				[Anonymous]			Rational reform to medical education in India	LANCET			English	Editorial Material																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 9	2011	377	9773					1212	1212						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	751DI	21495274				2022-12-28	WOS:000289597300003
J	Copley, A; Avouac, JP; Wernicke, BP				Copley, Alex; Avouac, Jean-Philippe; Wernicke, Brian P.			Evidence for mechanical coupling and strong Indian lower crust beneath southern Tibet	NATURE			English	Article							COLLISION ZONE; PLATEAU; HIMALAYA; FLOW; TECTONICS; EXTENSION; DYNAMICS; DEFORMATION; LITHOSPHERE; KINEMATICS	How surface deformation within mountain ranges relates to tectonic processes at depth is not well understood. The upper crust of the Tibetan Plateau is generally thought to be poorly coupled to the underthrusting Indian crust because of an intervening low-viscosity channel(1). Here, however, we show that the contrast in tectonic regime between primarily strike-slip faulting in northern Tibet and dominantly normal faulting in southern Tibet requires mechanical coupling between the upper crust of southern Tibet and the underthrusting Indian crust. Such coupling is inconsistent with the presence of active 'channel flow' beneath southern Tibet, and suggests that the Indian crust retains its strength as it underthrusts the plateau. These results shed new light on the debates regarding the mechanical properties of the continental lithosphere(2-4), and the deformation of Tibet(1,5-10).	[Copley, Alex; Avouac, Jean-Philippe; Wernicke, Brian P.] CALTECH, Div Geol & Planetary Sci, Tecton Observ, Pasadena, CA 91125 USA	California Institute of Technology	Copley, A (corresponding author), Univ Cambridge, Dept Earth Sci, Bullard Labs, Cambridge CB3 0EZ, England.	acc41@cam.ac.uk	NCEO, COMET+`/A-3443-2013; Copley, Alex/M-9689-2018; Avouac, Jean-Philippe/B-5699-2015	Avouac, Jean-Philippe/0000-0002-3060-8442; Copley, Alex/0000-0003-0362-0494	Gordon and Betty Moore Foundation through the Caltech Tectonics Observatory; Pembroke College in the University of Cambridge; NERC [come20001] Funding Source: UKRI; Natural Environment Research Council [come20001, earth010007] Funding Source: researchfish	Gordon and Betty Moore Foundation through the Caltech Tectonics Observatory; Pembroke College in the University of Cambridge; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Gordon and Betty Moore Foundation for support through the Caltech Tectonics Observatory, and Pembroke College in the University of Cambridge for financial support to A.C. This work benefited from a review by L. Flesch. This is Caltech Tectonics Observatory contribution number 145.	ARGAND E, 1924, P 13 INT GEOL C, V7, P170; ARMIJO R, 1986, J GEOPHYS RES-SOLID, V91, P13803, DOI 10.1029/JB091iB14p13803; Beaumont C, 2001, NATURE, V414, P738, DOI 10.1038/414738a; Bendick R, 2007, GEOLOGY, V35, P895, DOI 10.1130/G23714A.1; Bettinelli P, 2006, J GEODESY, V80, P567, DOI 10.1007/s00190-006-0030-3; Bollinger L, 2006, EARTH PLANET SC LETT, V244, P58, DOI 10.1016/j.epsl.2006.01.045; Cattin R, 2001, GEOPHYS J INT, V147, P381, DOI 10.1046/j.0956-540x.2001.01541.x; Clark MK, 2000, GEOLOGY, V28, P703, DOI 10.1130/0091-7613(2000)28<703:TOBTEM>2.0.CO;2; Copley A, 2008, GEOPHYS J INT, V174, P1081, DOI 10.1111/j.1365-246X.2008.03853.x; Copley A, 2007, GEOPHYS J INT, V169, P683, DOI 10.1111/j.1365-246X.2007.03343.x; Copley A, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006634; DeCelles PG, 2002, TECTONICS, V21, DOI 10.1029/2001TC001322; ENGLAND P, 1989, J GEOPHYS RES-SOLID, V94, P17561, DOI 10.1029/JB094iB12p17561; England P, 1997, SCIENCE, V278, P647, DOI 10.1126/science.278.5338.647; Flesch LM, 2001, J GEOPHYS RES-SOL EA, V106, P16435, DOI 10.1029/2001JB000208; FRANCHETEAU J, 1984, NATURE, V307, P32, DOI 10.1038/307032a0; Grujic D, 2002, EARTH PLANET SC LETT, V198, P177, DOI 10.1016/S0012-821X(02)00482-X; Hetenyi G, 2007, EARTH PLANET SC LETT, V264, P226, DOI 10.1016/j.epsl.2007.09.036; Huang WC, 2000, J GEOPHYS RES-SOL EA, V105, P27979, DOI 10.1029/2000JB900339; Jackson J, 2002, GEOPHYS J INT, V148, P214, DOI 10.1046/j.1365-246X.2002.01588.x; Jackson J, 2008, J GEOL SOC LONDON, V165, P453, DOI 10.1144/0016-76492007-109; Nabelek J, 2009, SCIENCE, V325, P1371, DOI 10.1126/science.1167719; Nelson KD, 1996, SCIENCE, V274, P1684, DOI 10.1126/science.274.5293.1684; Priestley K, 2008, GEOPHYS J INT, V172, P345, DOI [10.1111/j.1365-246X.2007.03636.x, 10.1111/j.1365-246X.2007.03636.X]; TAPPONNIER P, 1977, J GEOPHYS RES, V82, P2905, DOI 10.1029/JB082i020p02905; Taylor M, 2003, TECTONICS, V22, DOI 10.1029/2002TC001361; Tseng TL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040457; Watts AB, 2003, EARTH PLANET SC LETT, V213, P113, DOI 10.1016/S0012-821X(03)00289-9; Wittlinger G, 2004, EARTH PLANET SC LETT, V221, P117, DOI 10.1016/S0012-821X(03)00723-4; Zhang PZ, 2004, GEOLOGY, V32, P809, DOI 10.1130/G20554.1	30	127	133	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					79	81		10.1038/nature09926	http://dx.doi.org/10.1038/nature09926			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475198				2022-12-28	WOS:000289199400040
J	Kirby, T				Kirby, Tony			Profile Colin Sullivan: inventive pioneer of sleep medicine	LANCET			English	Biographical-Item												tony.kirby@lancet.com							0	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2011	377	9776					1485	1485		10.1016/S0140-6736(11)60589-8	http://dx.doi.org/10.1016/S0140-6736(11)60589-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761RX	21531260	Bronze			2022-12-28	WOS:000290419400014
J	Banks, JA; Nishiyama, T; Hasebe, M; Bowman, JL; Gribskov, M; dePamphilis, C; Albert, VA; Aono, N; Aoyama, T; Ambrose, BA; Ashton, NW; Axtell, MJ; Barker, E; Barker, MS; Bennetzen, JL; Bonawitz, ND; Chapple, C; Cheng, CY; Correa, LGG; Dacre, M; DeBarry, J; Dreyer, I; Elias, M; Engstrom, EM; Estelle, M; Feng, L; Finet, C; Floyd, SK; Frommer, WB; Fujita, T; Gramzow, L; Gutensohn, M; Harholt, J; Hattori, M; Heyl, A; Hirai, T; Hiwatashi, Y; Ishikawa, M; Iwata, M; Karol, KG; Koehler, B; Kolukisaoglu, U; Kubo, M; Kurata, T; Lalonde, S; Li, KJ; Li, Y; Litt, A; Lyons, E; Manning, G; Maruyama, T; Michael, TP; Mikami, K; Miyazaki, S; Morinaga, S; Murata, T; Mueller-Roeber, B; Nelson, DR; Obara, M; Oguri, Y; Olmstead, RG; Onodera, N; Petersen, BL; Pils, B; Prigge, M; Rensing, SA; Riano-Pachon, DM; Roberts, AW; Sato, Y; Scheller, HV; Schulz, B; Schulz, C; Shakirov, EV; Shibagaki, N; Shinohara, N; Shippen, DE; Sorensen, I; Sotooka, R; Sugimoto, N; Sugita, M; Sumikawa, N; Tanurdzic, M; Theissen, G; Ulvskov, P; Wakazuki, S; Weng, JK; Willats, WWGT; Wipf, D; Wolf, PG; Yang, LX; Zimmer, AD; Zhu, QH; Mitros, T; Hellsten, U; Loque, D; Otillar, R; Salamov, A; Schmutz, J; Shapiro, H; Lindquist, E; Lucas, S; Rokhsar, D; Grigoriev, IV				Banks, Jo Ann; Nishiyama, Tomoaki; Hasebe, Mitsuyasu; Bowman, John L.; Gribskov, Michael; dePamphilis, Claude; Albert, Victor A.; Aono, Naoki; Aoyama, Tsuyoshi; Ambrose, Barbara A.; Ashton, Neil W.; Axtell, Michael J.; Barker, Elizabeth; Barker, Michael S.; Bennetzen, Jeffrey L.; Bonawitz, Nicholas D.; Chapple, Clint; Cheng, Chaoyang; Correa, Luiz Gustavo Guedes; Dacre, Michael; DeBarry, Jeremy; Dreyer, Ingo; Elias, Marek; Engstrom, Eric M.; Estelle, Mark; Feng, Liang; Finet, Cedric; Floyd, Sandra K.; Frommer, Wolf B.; Fujita, Tomomichi; Gramzow, Lydia; Gutensohn, Michael; Harholt, Jesper; Hattori, Mitsuru; Heyl, Alexander; Hirai, Tadayoshi; Hiwatashi, Yuji; Ishikawa, Masaki; Iwata, Mineko; Karol, Kenneth G.; Koehler, Barbara; Kolukisaoglu, Uener; Kubo, Minoru; Kurata, Tetsuya; Lalonde, Sylvie; Li, Kejie; Li, Ying; Litt, Amy; Lyons, Eric; Manning, Gerard; Maruyama, Takeshi; Michael, Todd P.; Mikami, Koji; Miyazaki, Saori; Morinaga, Shin-ichi; Murata, Takashi; Mueller-Roeber, Bernd; Nelson, David R.; Obara, Mari; Oguri, Yasuko; Olmstead, Richard G.; Onodera, Naoko; Petersen, Bent Larsen; Pils, Birgit; Prigge, Michael; Rensing, Stefan A.; Mauricio Riano-Pachon, Diego; Roberts, Alison W.; Sato, Yoshikatsu; Scheller, Henrik Vibe; Schulz, Burkhard; Schulz, Christian; Shakirov, Eugene V.; Shibagaki, Nakako; Shinohara, Naoki; Shippen, Dorothy E.; Sorensen, Iben; Sotooka, Ryo; Sugimoto, Nagisa; Sugita, Mamoru; Sumikawa, Naomi; Tanurdzic, Milos; Theissen, Guenter; Ulvskov, Peter; Wakazuki, Sachiko; Weng, Jing-Ke; Willats, William W. G. T.; Wipf, Daniel; Wolf, Paul G.; Yang, Lixing; Zimmer, Andreas D.; Zhu, Qihui; Mitros, Therese; Hellsten, Uffe; Loque, Dominique; Otillar, Robert; Salamov, Asaf; Schmutz, Jeremy; Shapiro, Harris; Lindquist, Erika; Lucas, Susan; Rokhsar, Daniel; Grigoriev, Igor V.			The Selaginella Genome Identifies Genetic Changes Associated with the Evolution of Vascular Plants	SCIENCE			English	Article							SMALL RNAS; MESSENGER-RNAS; ARABIDOPSIS; MOELLENDORFFII; MECHANISM; LAND; PERSPECTIVE; SIRNAS	Vascular plants appeared similar to 410 million years ago, then diverged into several lineages of which only two survive: the euphyllophytes (ferns and seed plants) and the lycophytes. We report here the genome sequence of the lycophyte Selaginella moellendorffii (Selaginella), the first nonseed vascular plant genome reported. By comparing gene content in evolutionarily diverse taxa, we found that the transition from a gametophyte- to a sporophyte-dominated life cycle required far fewer new genes than the transition from a nonseed vascular to a flowering plant, whereas secondary metabolic genes expanded extensively and in parallel in the lycophyte and angiosperm lineages. Selaginella differs in posttranscriptional gene regulation, including small RNA regulation of repetitive elements, an absence of the trans-acting small interfering RNA pathway, and extensive RNA editing of organellar genes.	[Banks, Jo Ann] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Nishiyama, Tomoaki] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa 9200934, Japan; [Nishiyama, Tomoaki; Hasebe, Mitsuyasu; Cheng, Chaoyang; Hirai, Tadayoshi; Ishikawa, Masaki; Iwata, Mineko; Kubo, Minoru; Kurata, Tetsuya; Obara, Mari; Oguri, Yasuko; Onodera, Naoko; Sato, Yoshikatsu; Shinohara, Naoki; Sugimoto, Nagisa; Wakazuki, Sachiko] Japan Sci & Technol Agcy, ERATO, Okazaki, Aichi 4448585, Japan; [Hasebe, Mitsuyasu; Aono, Naoki; Aoyama, Tsuyoshi; Hiwatashi, Yuji; Miyazaki, Saori; Morinaga, Shin-ichi; Murata, Takashi; Sumikawa, Naomi] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Hasebe, Mitsuyasu; Aoyama, Tsuyoshi; Hiwatashi, Yuji; Murata, Takashi] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Sci, Okazaki, Aichi 4448585, Japan; [Bowman, John L.; Floyd, Sandra K.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia; [Bowman, John L.] Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA; [Gribskov, Michael; Li, Kejie; Li, Ying] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [dePamphilis, Claude; Axtell, Michael J.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [dePamphilis, Claude; Axtell, Michael J.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [dePamphilis, Claude] Penn State Univ, Grad Program Plant Biol, University Pk, PA 16802 USA; [dePamphilis, Claude] Penn State Univ, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA; [Albert, Victor A.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Ambrose, Barbara A.; Karol, Kenneth G.; Litt, Amy] New York Bot Garden, Bronx, NY 10458 USA; [Ashton, Neil W.; Barker, Elizabeth] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada; [Barker, Michael S.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Bennetzen, Jeffrey L.; DeBarry, Jeremy; Yang, Lixing; Zhu, Qihui] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Bonawitz, Nicholas D.; Chapple, Clint; Weng, Jing-Ke] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Correa, Luiz Gustavo Guedes; Koehler, Barbara] Univ Potsdam, Dept Mol Biol, D-14476 Potsdam, Germany; [Dacre, Michael; Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA; [Dreyer, Ingo] Univ Potsdam, Heisenberg Grp Biophys & Mol Plant Biol, D-14476 Potsdam, Germany; [Elias, Marek] Charles Univ Prague, Dept Bot, Fac Sci, Prague 12801 2, Czech Republic; [Elias, Marek] Univ Prague, Fac Sci, Ostrava 71000, Czech Republic; [Engstrom, Eric M.] Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; [Estelle, Mark; Prigge, Michael] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Feng, Liang] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Finet, Cedric] Ecole Normale Super Lyon, Lab Reprod & Dev Plantes, F-69364 Lyon, France; [Frommer, Wolf B.; Lalonde, Sylvie] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Fujita, Tomomichi] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan; [Gramzow, Lydia; Theissen, Guenter] Univ Jena, Dept Genet, D-07743 Jena, Germany; [Gutensohn, Michael; Schulz, Burkhard] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Gutensohn, Michael] Univ Halle Wittenberg, Inst Biol, D-06120 Halle, Germany; [Harholt, Jesper; Petersen, Bent Larsen; Sorensen, Iben; Ulvskov, Peter; Willats, William W. G. T.] Univ Copenhagen, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg C, Denmark; [Hattori, Mitsuru; Sugita, Mamoru] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648602, Japan; [Hattori, Mitsuru] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Heyl, Alexander] Free Univ Berlin, Dahlem Ctr Plant Sci, Inst Biol Appl Genet, D-14195 Berlin, Germany; [Hirai, Tadayoshi] Univ Tsukuba, Ctr Gene Res, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kolukisaoglu, Uener] Univ Rostock, Ctr Life Sci Automat, D-18119 Rostock, Germany; [Kolukisaoglu, Uener] Univ Tubingen, Studiengangskoordinat Nanosci, D-72076 Tubingen, Germany; [Kurata, Tetsuya] Nara Inst Sci & Technol, Grad Sch Biol Sci, Plant Global Educ Project, Nara 6300192, Japan; [Li, Ying] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Lyons, Eric; Scheller, Henrik Vibe] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Maruyama, Takeshi] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Michael, Todd P.] Rutgers State Univ, Dept Plant Biol & Pathol, Piscataway, NJ 08854 USA; [Michael, Todd P.] Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Michael, Todd P.] Monsanto Co, Genome Anal Ctr, St Louis, MO 63167 USA; [Mikami, Koji] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Miyazaki, Saori] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Morinaga, Shin-ichi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan; [Mueller-Roeber, Bernd] Bernd Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Nelson, David R.] Univ Tennessee, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Obara, Mari] Japan Sci & Technol Agcy, Sapporo, Hokkaido 0600819, Japan; [Olmstead, Richard G.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Onodera, Naoko] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Pils, Birgit] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Pils, Birgit] Sias AG, CH-8634 Hombrechtikon, Switzerland; [Rensing, Stefan A.; Zimmer, Andreas D.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Rensing, Stefan A.] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Rensing, Stefan A.] Univ Freiburg, Freiburg Initiat Syst Biol FRISYS, D-79104 Freiburg, Germany; [Mauricio Riano-Pachon, Diego] Max Planck Inst Mol Plant Physiol, Bioinformat Grp, GabiPD Team, D-14476 Potsdam, Germany; [Mauricio Riano-Pachon, Diego] Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia; [Roberts, Alison W.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Scheller, Henrik Vibe; Loque, Dominique] Joint BioEnergy Inst, Feedstocks Div, Emeryville, CA 94608 USA; [Schulz, Christian] Ruhr Univ Bochum, Dept Evolut & Biodivers Plants, D-44780 Bochum, Germany; [Shakirov, Eugene V.; Shippen, Dorothy E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Shibagaki, Nakako] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Shinohara, Naoki; Sotooka, Ryo] Hokkaido Univ, Sch Sci, Sapporo, Hokkaido 0600810, Japan; [Sorensen, Iben] Cornell Univ, Dept Plant Biol, Ithaca, NY 14850 USA; [Tanurdzic, Milos] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Weng, Jing-Ke] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Wipf, Daniel] Univ Bourgogne, INRA, UMR 1088, CNRS 5184, F-21065 Dijon, France; [Wolf, Paul G.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Mitros, Therese; Rokhsar, Daniel] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Hellsten, Uffe; Otillar, Robert; Salamov, Asaf; Schmutz, Jeremy; Shapiro, Harris; Lindquist, Erika; Lucas, Susan; Rokhsar, Daniel; Grigoriev, Igor V.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Kanazawa University; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Monash University; University of California System; University of California Davis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; New York Botanical Garden; University of Regina; University of Arizona; University System of Georgia; University of Georgia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Potsdam; Salk Institute; University of Potsdam; Charles University Prague; William & Mary; University of California System; University of California San Diego; University System of Georgia; University of Georgia; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Carnegie Institution for Science; Hokkaido University; Friedrich Schiller University of Jena; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Martin Luther University Halle Wittenberg; University of Copenhagen; Nagoya University; University of Tokyo; Free University of Berlin; University of Tsukuba; University of Rostock; Eberhard Karls University of Tubingen; Nara Institute of Science & Technology; Mayo Clinic; University of California System; University of California Berkeley; Hokkaido University; Rutgers State University New Brunswick; Monsanto; Hokkaido University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo; Max Planck Society; University of Tennessee System; University of Tennessee Health Science Center; Japan Science & Technology Agency (JST); University of Washington; University of Washington Seattle; Dalhousie University; University of Oxford; Wellcome Centre for Human Genetics; University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society; Universidad de los Andes (Colombia); University of Rhode Island; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Ruhr University Bochum; Texas A&M University System; Texas A&M University College Station; Osaka University; Hokkaido University; Cornell University; Cold Spring Harbor Laboratory; Salk Institute; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Bourgogne; Utah System of Higher Education; Utah State University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Banks, JA (corresponding author), Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA.	banksj@purdue.edu	Riaño-Pachón, Diego M/A-1755-2010; Li, Kejie/D-3595-2013; Manning, Gerard/C-8308-2009; Riaño-Pachón, Diego Mauricio/B-4891-2014; Weng, Jing-Ke/V-5934-2019; Heyl, Alexander/ABD-2145-2020; Harholt, Jesper/F-3760-2011; Barker, Mike/AAE-7891-2019; Petersen, Bent/H-9437-2014; Sato, Yoshikatsu/I-6129-2014; dePamphilis, Claude W/P-6652-2016; Elias, Marek/D-6851-2014; Frommer, Wolf B/K-5042-2017; Loque, Dominique/A-8153-2008; Chapple, Clint CS/Q-5456-2017; Kubo, Minoru/AAH-1689-2019; Weng, Jing-Ke/E-7343-2013; Schmutz, Jeremy/N-3173-2013; Dacre, Michael/C-1131-2008; Tanurdzic, Milos/A-5712-2012; Feng, Liang/I-5010-2014; Harholt, Jesper/F-6865-2014; Ishikawa, Masaki/AAC-8162-2022; Dreyer, Ingo/N-4747-2014; Ulvskov, Peter/I-1228-2014; Estelle, Mark/ABD-6742-2021; Weng, Jing-Ke/A-6900-2015; Wolf, Paul/F-7664-2010; Mikami, Koji/A-9825-2012; Mueller-Roeber, Bernd/Z-4052-2019; Yang, Lixing/A-7073-2013; Ye, Mingli/G-4909-2012; Scheller, Henrik/AAH-4770-2020; Zhu, Qihui/N-2625-2013; Shakirov, Eugene V/A-1363-2012; Gribskov, Michael/AAH-5905-2021; Frommer, Wolf B/A-8256-2008; Kolukisaoglu, Üner/J-8831-2014; Ishikawa, Masaki/Q-7598-2018	Riaño-Pachón, Diego M/0000-0001-9803-3465; Riaño-Pachón, Diego Mauricio/0000-0001-9803-3465; Weng, Jing-Ke/0000-0003-3059-0075; Barker, Mike/0000-0001-7173-1319; Petersen, Bent/0000-0002-2004-9077; Elias, Marek/0000-0003-0066-6542; Frommer, Wolf B/0000-0001-6465-0115; Chapple, Clint CS/0000-0002-5195-562X; Kubo, Minoru/0000-0001-8691-6252; Weng, Jing-Ke/0000-0003-1079-3668; Schmutz, Jeremy/0000-0001-8062-9172; Dacre, Michael/0000-0002-5561-1656; Tanurdzic, Milos/0000-0002-7564-0868; Harholt, Jesper/0000-0002-7984-0066; Ishikawa, Masaki/0000-0002-6491-5539; Dreyer, Ingo/0000-0002-2781-0359; Ulvskov, Peter/0000-0003-3776-818X; Weng, Jing-Ke/0000-0003-3059-0075; Wolf, Paul/0000-0002-4317-6976; Mikami, Koji/0000-0003-3811-0072; Scheller, Henrik/0000-0002-6702-3560; Shakirov, Eugene V/0000-0003-2689-7410; Frommer, Wolf B/0000-0001-6465-0115; Kolukisaoglu, Üner/0000-0002-8656-5963; Ishikawa, Masaki/0000-0002-6491-5539; Gramzow, Lydia/0000-0003-1919-6077; Nelson, David/0000-0003-0583-5421; Rokhsar, Daniel/0000-0002-8704-2224; Prigge, Michael/0000-0003-0671-2538; Shinohara, Naoki/0000-0002-4029-239X; Sorensen, Iben/0000-0002-9768-620X; DeBarry, Jeremy/0000-0001-5718-2675; Schulz, Christian/0000-0002-2708-0632; Wipf, Daniel/0000-0001-7197-5612; Bowman, John/0000-0001-7347-3691; Hasebe, Mitsuyasu/0000-0001-7425-8758; Lyons, Eric/0000-0002-3348-8845; Michael, Todd/0000-0001-6272-2875; Aoyama, Tsuyoshi/0000-0002-4184-167X; Gribskov, Michael/0000-0002-1718-0242; HIWATASHI, YUJI/0000-0002-3996-0549; Zimmer, Andreas/0000-0002-5595-9388; Grigoriev, Igor/0000-0002-3136-8903; Nishiyama, Tomoaki/0000-0003-1279-7806; Willats, William/0000-0003-2064-4025; Manning, Gerard/0000-0002-5087-9151	Office of Science of the U.S. DOE [DE-AC02-05CH11231]; NSF [0844413, 0515435, 0519970, 0638595, 0922742, 1020443, 0607123, 0744800, 1020660, 1036466, 0735191, 0228660, 0421604]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Australian Research Council [FF0561326]; Lewis B and Dorothy Cullman Program; Natural Sciences and Engineering Research Council of Canada (NSERC) [2982]; NIH [GM84051, T32 GM007757, T32-HG00035, GM065383]; Life Sciences Research Foundation; National Human Genome Research Institute (NHGRI) [HG004164]; German Science Foundation (Deutsche Forschungsgemeinschaft, DFG) [DR 430/4-2]; Czech Ministry of Education [21620828]; Jeffress Memorial Trust [J-938]; DOE [DE-FG02-04ER15542]; Danish Council for Independent Research, Technology and Production Sciences [009-066624/274-09-0314]; Villum Kann Rasmussen Foundation; U.S. Department of Agriculture (USDA) [DE-FG02-08ER64630]; Danish Council for Strategic Research [09-063090]; Marie Curie FP6 RTN ZOONET; DFG [RE 837/10-2, BMBF FRISYS 0313921]; Bundesministerium fuer Bildung und Forschung, Germany [0315046]; USDA NRI [2007-35318-18389]; Burgundy Regional Council [20100112095254682-1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004164, T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065383, T32GM007757, R01GM043644, R01GM084051] Funding Source: NIH RePORTER; Direct For Biological Sciences [1020443] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0922742, 0844413] Funding Source: National Science Foundation; Villum Fonden [00007173] Funding Source: researchfish	Office of Science of the U.S. DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Australian Research Council(Australian Research Council); Lewis B and Dorothy Cullman Program; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); German Science Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Jeffress Memorial Trust; DOE(United States Department of Energy (DOE)); Danish Council for Independent Research, Technology and Production Sciences(Det Frie Forskningsrad (DFF)); Villum Kann Rasmussen Foundation(Villum Fonden); U.S. Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Marie Curie FP6 RTN ZOONET(European Commission); DFG(German Research Foundation (DFG)); Bundesministerium fuer Bildung und Forschung, Germany; USDA NRI(United States Department of Agriculture (USDA)); Burgundy Regional Council(Region Bourgogne-Franche-Comte); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Villum Fonden(Villum Fonden)	Selaginella sequences were deposited at GenBank with the accession numbers GL377566 to GL378322.1 and HM173080. Genome sequencing and analysis were performed by the U.S. Department of Energy (DOE), Joint Genome Institute, supported by the Office of Science of the U.S. DOE, Contract DE-AC02-05CH11231 (I.V.G., U.H., D.L., E.L., S.L., T.M., R.O., D.R., A.S., J.S., H.V.S.). Support was provided by NSF 0844413 (J.A.B.); Japan Society for the Promotion of Science (M.H., T.N., T.F., K.M., T.M., M.S.); Ministry of Education, Culture, Sports, Science, and Technology, Japan (M.H., T.N., T.F.); NSF 0515435 and Australian Research Council FF0561326 (J.L.B.); NSF 0519970 (M.G.); NSF 0638595 (C.D.); NSF 0922742 (V.A.A.); The Lewis B and Dorothy Cullman Program (B.A.A., A.L.); NSF 1020443 (B.A.A.); Natural Sciences and Engineering Research Council of Canada (NSERC) 2982 (N.W.A.); NIH GM84051 (M.J.A.); NSERC (E.I.B.); NIH T32 GM007757 and NSERC PGS-D (M.S.B.); NSF 0607123 (J.L.B.); Life Sciences Research Foundation (NDB); National Human Genome Research Institute (NHGRI) HG004164 (M.D.); German Science Foundation (Deutsche Forschungsgemeinschaft, DFG) DR 430/4-2 (I.D.); Czech Ministry of Education 21620828 (M.E.); Jeffress Memorial Trust J-938 (E.M.E.); NSF 0744800 (M.E. and M.P.); DOE DE-FG02-04ER15542 (W.B.F. and S.L.); The Danish Council for Independent Research, Technology and Production Sciences 009-066624/274-09-0314 (J.H.); The Villum Kann Rasmussen Foundation (J.H., I.S., B.P., P.U., W.W.); NIH T32-HG00035, NSF 1020660, and NSF 1036466 (K.G.K.); NSF 0735191 (E.L.); NHGRI HG004164 (G.M); U.S. Department of Agriculture (USDA) DE-FG02-08ER64630 (T.P.M.); NSF 0228660 (R.G.O.); The Danish Council for Strategic Research 09-063090 (B.L.P. and P.U.); Marie Curie FP6 RTN ZOONET (B.P.); DFG RE 837/10-2, BMBF FRISYS 0313921 (S.A.R.); Bundesministerium fuer Bildung und Forschung, Germany, GABI-FUTURE grant 0315046 (D.M.R.); USDA NRI 2007-35318-18389 (A.W.R.); NSF 0421604 (C.S.); NIH GM065383 (D.E.S.); Burgundy Regional Council 20100112095254682-1 (D.W.); and DFG RE 837/10-2 (A.D.Z.). K. Wall, D. Hurley, and S. Hentel provided computational assistance.	Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Barker MS, 2009, GENOME BIOL EVOL, V1, P391, DOI 10.1093/gbe/evp040; Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Bourc'his D, 2010, SCIENCE, V330, P617, DOI 10.1126/science.1194776; Cao Y, 2010, FITOTERAPIA, V81, P253, DOI 10.1016/j.fitote.2009.09.007; Chen DJ, 2010, BIOINFORMATICS, V26, P1391, DOI 10.1093/bioinformatics/btq150; Chitwood DH, 2009, GENE DEV, V23, P549, DOI 10.1101/gad.1770009; Cho SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000314; Demura T, 2007, TRENDS PLANT SCI, V12, P64, DOI 10.1016/j.tplants.2006.12.006; Floyd SK, 2006, CURR BIOL, V16, P1911, DOI 10.1016/j.cub.2006.07.067; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grewe F, 2011, NUCLEIC ACIDS RES, V39, P2890, DOI 10.1093/nar/gkq1227; Harrison CJ, 2005, NATURE, V434, P509, DOI 10.1038/nature03410; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tsuji S, 2007, J PLANT RES, V120, P281, DOI 10.1007/s10265-006-0055-y; Wang WM, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-10; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yasumura Y, 2007, CURR BIOL, V17, P1225, DOI 10.1016/j.cub.2007.06.037	25	583	653	5	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					960	963		10.1126/science.1203810	http://dx.doi.org/10.1126/science.1203810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21551031	Green Accepted			2022-12-28	WOS:000290766600042
J	Kim, BH; Shenoy, AR; Kumar, P; Das, R; Tiwari, S; MacMicking, JD				Kim, Bae-Hoon; Shenoy, Avinash R.; Kumar, Pradeep; Das, Rituparna; Tiwari, Sangeeta; MacMicking, John D.			A Family of IFN-gamma-Inducible 65-kD GTPases Protects Against Bacterial Infection	SCIENCE			English	Article							BINDING; IMMUNITY; AUTOPHAGY	Immune interferon gamma (IFN-gamma) is essential for mammalian host defense against intracellular pathogens. IFN-gamma induces nearly 2000 host genes, yet few have any assigned function. Here, we examined a complete mouse 65-kilodalton (kD) guanylate-binding protein (Gbp) gene family as part of a 43-member IFN-gamma-inducible guanosine triphosphatase (GTPase) superfamily in mouse and human genomes. Family-wide loss-of-function analysis found that at least four Gbps-Gbp1, Gbp6, Gbp7, and Gbp10-conferred cell-autonomous immunity to listerial or mycobacterial infection within macrophages and gene-deficient animals. These Gbps solicited host defense proteins, including the phagocyte oxidase, antimicrobial peptides, and autophagy effectors, to kill intracellular bacteria. Thus, specific 65-kD Gbps coordinate a potent oxidative and vesicular trafficking program to protect the host from infection.	[Kim, Bae-Hoon; Shenoy, Avinash R.; Kumar, Pradeep; Das, Rituparna; Tiwari, Sangeeta; MacMicking, John D.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06510 USA; [Das, Rituparna] Yale Univ, Sch Med, Dept Internal Med, Div Infect Dis, New Haven, CT 06510 USA	Yale University; Yale University	MacMicking, JD (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06510 USA.	john.macmicking@yale.edu	hongbo, yi/G-9615-2011; Tiwari, Sangeeta/GWV-0350-2022; Kim, Bae-Hoon/A-8847-2014; Kim, Bae-Hoon/F-3289-2012; tiwari, sangeeta/T-5810-2019	Shenoy, Avinash/0000-0001-6228-9303; Kim, Bae-Hoon/0000-0001-6866-7248	NIH National Institute of Allergy and Infectious Diseases [R01 AI068041-01A1]; Burroughs Wellcome Fund; Searle Scholars Program; Cancer Research Institute; W.W. Winchester Foundation; Browne-Cox Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068041] Funding Source: NIH RePORTER	NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Searle Scholars Program; Cancer Research Institute; W.W. Winchester Foundation; Browne-Cox Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Matsuura (NS34A DN cells); S. Ivanov (Ub-K63-GFP cells); R. Medzhitov (MyD88<SUP>-/-</SUP> Trif<SUP>-/-</SUP> mice); M. Pypaert (electron microscopy); and P. Cresswell, W. Mothes, C. Roy, G. Superti-Furga, T. Yoshimori, and H. Zhu (plasmids and antibodies). Supported by NIH National Institute of Allergy and Infectious Diseases (R01 AI068041-01A1), Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award, Searle Scholars Program, Cancer Research Institute Investigator Award, W.W. Winchester Foundation (to J.D.M.) and Browne-Cox Fellowship (to A.R.S.).	Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Modiano N, 2005, P NATL ACAD SCI USA, V102, P8680, DOI 10.1073/pnas.0503227102; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Olszewski MA, 2006, J INTERF CYTOK RES, V26, P328, DOI 10.1089/jir.2006.26.328; Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Rupper AC, 2008, INFECT IMMUN, V76, P2304, DOI 10.1128/IAI.01437-07; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x	24	320	333	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					717	721		10.1126/science.1201711	http://dx.doi.org/10.1126/science.1201711			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551061				2022-12-28	WOS:000290265800043
J	Giuseppone, N; Lutz, JF				Giuseppone, Nicolas; Lutz, Jean-Francois			MATERIALS CHEMISTRY Catalytic accordions	NATURE			English	Editorial Material							ENCAPSULATION; SYSTEMS		[Giuseppone, Nicolas] Univ Strasbourg, Fac Chem, F-67034 Strasbourg, France; [Giuseppone, Nicolas] CNRS, Inst Charles Sadron, UPR22, F-67034 Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Giuseppone, N (corresponding author), Univ Strasbourg, Fac Chem, F-67034 Strasbourg, France.	giuseppone@unistra.fr; jflutz@unistra.fr	Giuseppone, Nicolas/J-1300-2016; Lutz, Jean-François/C-3264-2009	Giuseppone, Nicolas/0000-0003-4093-3000; Lutz, Jean-François/0000-0002-3893-2458				Badi N, 2009, CHEM SOC REV, V38, P3383, DOI 10.1039/b806413j; BRESLOW R, 1982, SCIENCE, V218, P532, DOI 10.1126/science.7123255; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; Dwars T, 2005, ANGEW CHEM INT EDIT, V44, P7174, DOI 10.1002/anie.200501365; Hecht S, 2001, ANGEW CHEM INT EDIT, V40, P74, DOI 10.1002/1521-3773(20010105)40:1<74::AID-ANIE74>3.0.CO;2-C; Kang JM, 1997, NATURE, V385, P50, DOI 10.1038/385050a0; Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j; Ouchi M, 2009, CHEM REV, V109, P4963, DOI 10.1021/cr900234b; Terashima T, 2011, J AM CHEM SOC, V133, P4742, DOI 10.1021/ja2004494	9	37	37	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					40	41		10.1038/473040a	http://dx.doi.org/10.1038/473040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544141				2022-12-28	WOS:000290218300026
J	Springgate, BF; Brook, RH				Springgate, Benjamin F.; Brook, Robert H.			Accountable Care Organizations and Community Empowerment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Springgate, Benjamin F.; Brook, Robert H.] RAND Corp, Santa Monica, CA 90401 USA; [Springgate, Benjamin F.] Tulane Univ, Sch Med, New Orleans, LA 70112 USA	RAND Corporation; Tulane University	Springgate, BF (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	bspringg@rand.org						American Academy of Family Physicians American Academy of Pediatrics American College of Physicians American Osteopathic Association, JOINT PRINC PAT CTR; [Anonymous], 1999, DEV FREEDOM; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Centers for Medicare & Medicaid Services, MED ACC CAR ORG SHAR; Connor E, 1983, COMMUNITY ORIENTED P; Emanuel EJ, 1997, J HEALTH POLIT POLIC, V22, P147, DOI 10.1215/03616878-22-1-147; *NAT COMM QUAL ASS, ACC CAR ORG ACO DRAF; National Committee for Quality Assurance, PAT CTR MED HOM	8	15	15	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1800	1801		10.1001/jama.2011.547	http://dx.doi.org/10.1001/jama.2011.547			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758HZ	21505120				2022-12-28	WOS:000290156200021
J	Crowe, SE				Crowe, Sheila E.			Celiac Disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GLIADIN PEPTIDE ANTIBODY; TERM-FOLLOW-UP; TISSUE TRANSGLUTAMINASE; UNITED-STATES; AT-RISK; PREVALENCE; POPULATION; MANAGEMENT; MORTALITY; DIAGNOSIS											Abdulkarim AS, 2002, AM J GASTROENTEROL, V97, P2016; Ackerman Z, 1996, AM J GASTROENTEROL, V91, P2099; Akobeng AK, 2006, ARCH DIS CHILD, V91, P39, DOI 10.1136/adc.2005.082016; [Anonymous], 2006, GASTROENTEROLOGY, V131, P1977, DOI 10.1053/j.gastro.2006.10.003; Askling J, 2002, GASTROENTEROLOGY, V123, P1428, DOI 10.1053/gast.2002.36585; Biagi F, 2010, NAT REV GASTRO HEPAT, V7, P158, DOI 10.1038/nrgastro.2010.2; Bonamico M, 2002, J CLIN ENDOCR METAB, V87, P5495, DOI 10.1210/jc.2002-020855; Bushara KO, 2005, GASTROENTEROLOGY, V128, pS92, DOI 10.1053/j.gastro.2005.02.018; Campanella J, 2008, SCAND J GASTROENTERO, V43, P1311, DOI 10.1080/00365520802200036; Catassi C, 2005, GASTROENTEROLOGY, V128, pS79, DOI 10.1053/j.gastro.2005.02.027; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; Catassi C, 2007, AM J GASTROENTEROL, V102, P1454, DOI 10.1111/j.1572-0241.2007.01173.x; Cellier C, 2000, LANCET, V356, P203, DOI 10.1016/S0140-6736(00)02481-8; Dickey W, 1997, J CLIN GASTROENTEROL, V25, P328, DOI 10.1097/00004836-199707000-00006; FARTHING MJG, 1983, GUT, V24, P127, DOI 10.1136/gut.24.2.127; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Ford AC, 2009, ARCH INTERN MED, V169, P651, DOI 10.1001/archinternmed.2009.22; GARLOCH JJ, 1994, BRIT J DERMATOL, V131, P541; Goldstein NS, 2004, AM J CLIN PATHOL, V121, P546, DOI 10.1309/10FCNCTC56NMN0YE; Green PHR, 2009, CLIN GASTROENTEROL H, V7, P1210, DOI 10.1016/j.cgh.2009.07.011; Guandalini Stefano, 2005, J Pediatr Gastroenterol Nutr, V41, P366, DOI 10.1097/01.mpg.0000177313.88694.e5; Hadithi M, 2007, ANN INTERN MED, V147, P294, DOI 10.7326/0003-4819-147-5-200709040-00003; Haines ML, 2008, ALIMENT PHARM THER, V28, P1042, DOI 10.1111/j.1365-2036.2008.03820.x; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001; Hopper AD, 2008, ENDOSCOPY, V40, P219, DOI 10.1055/s-2007-995361; IVARSSON A, 2002, AM J CLIN NUTR, V91, P39; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Kaukinen K, 2007, SCAND J GASTROENTERO, V42, P1428, DOI 10.1080/00365520701452217; Korponay-Szabo IR, 2003, GUT, V52, P1567, DOI 10.1136/gut.52.11.1567; Leffler DA, 2007, CLIN GASTROENTEROL H, V5, P445, DOI 10.1016/j.cgh.2006.12.006; Lewis NR, 2009, ALIMENT PHARM THER, V31, P73, DOI 10.1111/j.1365-2036.2009.04110.x; Ludvigsson JF, 2005, GASTROENTEROLOGY, V129, P454, DOI 10.1053/j.gastro.2005.05.065; Ludvigsson JF, 2009, JAMA-J AM MED ASSOC, V302, P1171, DOI 10.1001/jama.2009.1320; Malamut G, 2009, GASTROENTEROLOGY, V136, P81, DOI 10.1053/j.gastro.2008.09.069; Matysiak-Budnik T, 2007, GUT, V56, P1379, DOI 10.1136/gut.2006.100511; Mohn A, 2001, J PEDIATR GASTR NUTR, V32, P37, DOI 10.1097/00005176-200101000-00012; NISIHARA, 2005, J PEDIAT, V81, P373; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; Oxentenko AS, 2002, AM J GASTROENTEROL, V97, P933; Pietzak MM, 2009, CLIN GASTROENTEROL H, V7, P966, DOI 10.1016/j.cgh.2009.05.028; PRIMIGNANI M, 1987, RES CLIN LAB, V17, P243; Richter D, 2004, PEDIATR ALLERGY IMMU, V15, P191, DOI 10.1046/j.1399-3038.2003.00120.x; Rostom A, 2005, GASTROENTEROLOGY, V128, pS38, DOI 10.1053/j.gastro.2005.02.028; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Rubio-Tapia A, 2010, AM J GASTROENTEROL, V105, P1412, DOI 10.1038/ajg.2010.10; Rubio-Tapia A, 2010, GUT, V59, P547, DOI 10.1136/gut.2009.195131; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V136, P99, DOI 10.1053/j.gastro.2008.10.013; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Sander HW, 2003, LANCET, V362, P1548, DOI 10.1016/S0140-6736(03)14743-5; Soni S, 2010, J REPROD MED, V55, P3; Tata LJ, 2005, GASTROENTEROLOGY, V128, P849, DOI 10.1053/j.gastro.2005.02.017; van der Windt DAWM, 2010, JAMA-J AM MED ASSOC, V303, P1738, DOI 10.1001/jama.2010.549; Vazquez H, 2000, AM J GASTROENTEROL, V95, P183	53	6	8	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9							ITC5	10.7326/0003-4819-154-9-201105030-01005	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-01005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21536935				2022-12-28	WOS:000290112300015
J	Alegre-Cebollada, J; Kosuri, P; Fernandez, JM				Alegre-Cebollada, Jorge; Kosuri, Pallav; Fernandez, Julio M.			Protease Power Strokes Force Proteins to Unfold	CELL			English	Editorial Material							UBIQUITIN	ATP-dependent proteases degrade proteins in the cytosol of cells. Two recent articles, by Aubin-Tam et al. (2011) and Maillard et al. (2011 [this issue]), use single-molecule optical tweezers to show directly that these molecular machines use the energy derived from ATP hydrolysis to mechanically unfold and translocate its substrates into the proteolytic chamber.	[Alegre-Cebollada, Jorge; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Kosuri, Pallav] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA	Columbia University; Columbia University	Fernandez, JM (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jfernandez@columbia.edu	Kosuri, Pallav/J-8279-2012; Alegre-Cebollada, Jorge/I-4301-2014	Kosuri, Pallav/0000-0002-7025-3543; Alegre-Cebollada, Jorge/0000-0003-0542-0170	NHLBI NIH HHS [R01 HL061228, R01 HL066030] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066030, R01HL061228] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Dougan L, 2009, P NATL ACAD SCI USA, V106, P12605, DOI 10.1073/pnas.0900678106; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Furuike S, 2001, FEBS LETT, V498, P72, DOI 10.1016/S0014-5793(01)02497-8; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10534, DOI 10.1073/pnas.0901213106; Hochstrasser M, 2001, NAT STRUCT BIOL, V8, P294, DOI 10.1038/86153; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101	10	3	3	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					339	340		10.1016/j.cell.2011.04.007	http://dx.doi.org/10.1016/j.cell.2011.04.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529709	Bronze, Green Accepted			2022-12-28	WOS:000290022900004
J	Salinga, M; Wuttig, M				Salinga, Martin; Wuttig, Matthias			Phase-Change Memories on a Diet	SCIENCE			English	Editorial Material									[Salinga, Martin] Rhein Westfal TH Aachen, D-52056 Aachen, Germany; JARA FIT, Phys Inst IA 1, D-52056 Aachen, Germany	RWTH Aachen University	Salinga, M (corresponding author), Rhein Westfal TH Aachen, D-52056 Aachen, Germany.	wuttig@physik.rwth-aachen.de	Salinga, Martin S/B-6796-2011; Wuttig, Matthias/A-8860-2012	Salinga, Martin S/0000-0002-2228-6244; Wuttig, Matthias/0000-0003-1498-1025				Bruns G, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3191670; Descartes R., 1909, DISCOURSE METHOD RIG; Im DH, 2008, INT EL DEVICES MEET, P211; Pirovano A., 2003, IEEE IEDM, V29, P1; Wang W. J., 2008, APPL PHYS LETT, V93, P3; Wong HSP, 2010, P IEEE, V98, P2201, DOI 10.1109/JPROC.2010.2070050; Wuttig M, 2007, NAT MATER, V6, P824, DOI 10.1038/nmat2009; Xiong F, 2011, SCIENCE, V332, P568, DOI 10.1126/science.1201938	8	112	112	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029					543	544		10.1126/science.1204093	http://dx.doi.org/10.1126/science.1204093			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527701				2022-12-28	WOS:000289991100031
J	Larson, DR; Zenklusen, D; Wu, B; Chao, JA; Singer, RH				Larson, Daniel R.; Zenklusen, Daniel; Wu, Bin; Chao, Jeffrey A.; Singer, Robert H.			Real-Time Observation of Transcription Initiation and Elongation on an Endogenous Yeast Gene	SCIENCE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; SINGLE CELLS; LIVING YEAST; LIVE CELLS; DYNAMICS; ASSOCIATION; RECRUITMENT; ACTIVATION; EXPRESSION; BINDING	Cellular messenger RNA levels are achieved by the combinatorial complexity of factors controlling transcription, yet the small number of molecules involved in these pathways fluctuates stochastically. It has not yet been experimentally possible to observe the activity of single polymerases on an endogenous gene to elucidate how these events occur in vivo. Here, we describe a method of fluctuation analysis of fluorescently labeled RNA to measure dynamics of nascent RNA-including initiation, elongation, and termination-at an active yeast locus. We find no transcriptional memory between initiation events, and elongation speed can vary by threefold throughout the cell cycle. By measuring the abundance and intranuclear mobility of an upstream transcription factor, we observe that the gene firing rate is directly determined by trans-activating factor search times.	[Larson, Daniel R.; Zenklusen, Daniel; Wu, Bin; Chao, Jeffrey A.; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Larson, Daniel R.; Wu, Bin; Singer, Robert H.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Larson, Daniel R.; Singer, Robert H.] Howard Hughes Med Inst, Transcript Imaging Consortium, Ashburn, VA 20147 USA; [Zenklusen, Daniel] Univ Montreal, Dept Biochim, Montreal, PQ H3T 1J4, Canada	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Universite de Montreal	Singer, RH (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA.	robert.singer@einstein.yu.edu	Larson, Daniel R/B-9829-2008; Zenklusen, Daniel/C-4503-2008	Larson, Daniel R/0000-0001-9253-3055; Zenklusen, Daniel/0000-0002-0067-0093; Chao, Jeffrey/0000-0002-5895-9156	NIH National Institute of General Medical Sciences [57071, 86217]; NATIONAL CANCER INSTITUTE [ZIABC011383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086217, R01GM057071] Funding Source: NIH RePORTER	NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the following for critical reading of the manuscript: D. Grunwald, T. Lionnet, T. Trcek, J. Yao, X. Darzacq, R. Tjian, and M. Larson. D. R. L. thanks W. Zipfel, S. Hess, J. Atilgan, and M. Nicholas for discussions about fluctuation analysis. S. Silverman provided the fkh1fkh2 deletion strain. B. Slaughter provided the NLS-GFP strain and J. Vogel the Mbp-GFP strain. We thank E. Gruss Lipper for her gift founding the Gruss Lipper Biophotonics Center that provided the equipment used in this study. Supported by NIH National Institute of General Medical Sciences grants 57071 and 86217 to R. H. S. There is a patent (no. 6,586,240) associated with the methods for visualization of RNA in living cells as presented in this manuscript.	BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Boireau S, 2007, J CELL BIOL, V179, P291, DOI 10.1083/jcb.200706018; Chao JA, 2008, NAT STRUCT MOL BIOL, V15, P103, DOI 10.1038/nsmb1327; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Keaveney M, 1998, MOL CELL, V1, P917, DOI 10.1016/S1097-2765(00)80091-X; Larson DR, 2005, P NATL ACAD SCI USA, V102, P15453, DOI 10.1073/pnas.0504812102; Michelman-Ribeiro A, 2009, BIOPHYS J, V97, P337, DOI 10.1016/j.bpj.2009.04.027; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; PIZZAGALLI A, 1992, CURR GENET, V21, P183, DOI 10.1007/BF00336839; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	27	412	420	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					475	478		10.1126/science.1202142	http://dx.doi.org/10.1126/science.1202142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512033	Green Accepted			2022-12-28	WOS:000289784900046
J	Pertel, T; Hausmann, S; Morger, D; Zuger, S; Guerra, J; Lascano, J; Reinhard, C; Santoni, FA; Uchil, PD; Chatel, L; Bisiaux, A; Albert, ML; Strambio-De-Castillia, C; Mothes, W; Pizzato, M; Grutter, MG; Luban, J				Pertel, Thomas; Hausmann, Stephane; Morger, Damien; Zueger, Sara; Guerra, Jessica; Lascano, Josefina; Reinhard, Christian; Santoni, Federico A.; Uchil, Pradeep D.; Chatel, Laurence; Bisiaux, Aurelie; Albert, Matthew L.; Strambio-De-Castillia, Caterina; Mothes, Walther; Pizzato, Massimo; Gruetter, Markus G.; Luban, Jeremy			TRIM5 is an innate immune sensor for the retrovirus capsid lattice	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; UNANCHORED POLYUBIQUITIN CHAINS; CYCLOPHILIN-A; TRIM5-ALPHA PROTEIN; HUMAN-CELLS; HIV-1; RESISTANCE; INFECTION; RESTRICTION; RECOGNITION	TRIM5 is a RING domain-E3 ubiquitin ligase that restricts infection by human immunodeficiency virus (HIV)-1 and other retroviruses immediately following virus invasion of the target cell cytoplasm(1,2). Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice(3,4) and several reports indicate that TRIM5 has a role in signal transduction(5-7), but the precise mechanism of restriction is unknown(8). Here we demonstrate that TRIM5 promotes innate immune signalling and that this activity is amplified by retroviral infection and interaction with the capsid lattice. Acting with the heterodimeric, ubiquitin-conjugating enzyme UBC13-UEV1A (also known as UBE2N-UBE2V1), TRIM5 catalyses the synthesis of unattached K63-linked ubiquitin chains that activate the TAK1 (also known as MAP3K7) kinase complex and stimulate AP-1 and NF kappa B signalling. Interaction with the HIV-1 capsid lattice greatly enhances the UBC13-UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NF-kappa B-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid. Finally, TAK1 and UBC13-UEV1A contribute to capsid-specific restriction by TRIM5. Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signalling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.	[Pertel, Thomas; Hausmann, Stephane; Guerra, Jessica; Lascano, Josefina; Reinhard, Christian; Santoni, Federico A.; Strambio-De-Castillia, Caterina; Pizzato, Massimo; Luban, Jeremy] Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Morger, Damien; Zueger, Sara; Gruetter, Markus G.] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Uchil, Pradeep D.; Mothes, Walther] Yale Univ, Sect Microbial Pathogenesis, Sch Med, New Haven, CT 06536 USA; [Chatel, Laurence] Novimmune SA, CH-1228 Geneva, Switzerland; [Bisiaux, Aurelie; Albert, Matthew L.] Inst Pasteur, INSERM, U818, F-75724 Paris, France	University of Geneva; University of Zurich; Yale University; NovImmune SA; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Luban, J (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland.	jeremy.luban@unige.ch	Albert, Matthew L/C-9782-2009; Pizzato, Massimo/AFL-0051-2022	Pizzato, Massimo/0000-0002-9491-1483; Santoni, Federico/0000-0002-3258-4747; Luban, Jeremy/0000-0001-5650-4054; Uchil, Pradeep/0000-0002-7236-858X; Strambio De Castillia, Caterina/0000-0002-1069-1816; Bisiaux, Aurelie/0000-0002-2447-3393; Pertel, Thomas/0000-0002-2286-6011	NIH [RO1AI59159, R21AI087467]; Swiss National Science Foundation [3100A0-128655, 3100A0-122342]; UZH Forschungskredit [54041402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087467, R01AI059159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UZH Forschungskredit; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Baltimore, M. J. Birrer, J. Brojatsch, A. Cimarelli, A. Delaco, S. Elledge, M. Emerman, W. Ferlin, D. Garcin, S. Ghosh, O. Haller, T. Hatziioannou, J. Hiscott, A. Iwasaki, D. Kolakofsky, M. Kosco-Vilbois, H. Malik, R. Medzhitov, M. R. Neagu, G. Napolitani, P. Palese, D. Pinschewer, O. Pornillos, L. Roux, O. Schwartz, M. Strubin, V. Studer, W. Sundquist, G. Towers, D. Trono, J. Tschopp, M. Yeager, M. Zufferey, and the Functional Genomics Center (Zurich), for ideas, technical assistance, and reagents. This work was supported by NIH grant RO1AI59159 to J. L., NIH grant R21AI087467 to W. M., Swiss National Science Foundation grant 3100A0-128655 to J. L. and 3100A0-122342 to M. G. and UZH Forschungskredit 54041402 to S.Z.	Berthoux L, 2005, P NATL ACAD SCI USA, V102, P14849, DOI 10.1073/pnas.0505659102; Berthoux L, 2003, J VIROL, V77, P3167, DOI 10.1128/JVI.77.5.3167-3180.2003; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; KORNBLUTH RS, 1989, J EXP MED, V169, P1137, DOI 10.1084/jem.169.3.1137; Langelier CR, 2008, J VIROL, V82, P11682, DOI 10.1128/JVI.01562-08; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Medzhitov R, 2008, NATURE, V455, P591, DOI 10.1038/455591a; Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Sebastian S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-40; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tareen SU, 2011, VIROLOGY, V409, P113, DOI 10.1016/j.virol.2010.09.018; Ulm JW, 2007, VIROLOGY, V363, P245, DOI 10.1016/j.virol.2006.09.048; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yin Q, 2009, BIOCHEMISTRY-US, V48, P10558, DOI 10.1021/bi901462e; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	27	471	491	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					361	365		10.1038/nature09976	http://dx.doi.org/10.1038/nature09976			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21512573	Green Accepted			2022-12-28	WOS:000289724600042
J	Claridge, LC; Armstrong, MJ; Booth, C; Gill, PS				Claridge, Lee C.; Armstrong, Matthew J.; Booth, Caroline; Gill, Paramjit S.			10-MINUTE CONSULTATION Gilbert's syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS		[Claridge, Lee C.; Armstrong, Matthew J.] Univ Birmingham, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England; [Booth, Caroline] York Hosp NHS Trust, York YO31 8HE, N Yorkshire, England; [Gill, Paramjit S.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Claridge, LC (corresponding author), Univ Birmingham, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England.	l.c.claridge@bham.ac.uk		Armstrong, Matthew/0000-0002-3425-1161				BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Esteban A, 1999, EUR J DRUG METAB PH, V24, P9, DOI 10.1007/BF03190005; FOULK WT, 1959, MEDICINE, V38, P25, DOI 10.1097/00005792-195902000-00002; OWENS D, 1975, J MED GENET, V12, P152, DOI 10.1136/jmg.12.2.152; Prueksaritanont T, 2002, DRUG METAB DISPOS, V30, P1280, DOI 10.1124/dmd.30.11.1280; Rotger M, 2005, J INFECT DIS, V192, P1381, DOI 10.1086/466531; SIEG A, 1987, DEUT MED WOCHENSCHR, V112, P1206, DOI 10.1055/s-2008-1068222; SIEG A, 1986, CLIN CHIM ACTA, V154, P41, DOI 10.1016/0009-8981(86)90086-0; THOMSEN HF, 1981, SCAND J GASTROENTERO, V16, P699, DOI 10.3109/00365528109182033	9	17	19	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2011	342								d2293	10.1136/bmj.d2293	http://dx.doi.org/10.1136/bmj.d2293			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755ON	21508045				2022-12-28	WOS:000289942900005
J	Kalil, AC; Sandkovsky, US				Kalil, Andre C.; Sandkovsky, Uriel S.			Daily emtricitabine plus tenofovir disoproxil fumarate reduced risk for HIV infection in men who have sex with men	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kalil, Andre C.; Sandkovsky, Uriel S.] Univ Nebraska Med Ctr, Omaha, NE 68131 USA	University of Nebraska System; University of Nebraska Medical Center	Kalil, AC (corresponding author), Univ Nebraska Med Ctr, Omaha, NE 68131 USA.							Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65	2	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8							JC4-2	10.7326/0003-4819-154-8-201104190-02002	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502640				2022-12-28	WOS:000289622000001
J	Abanin, DA; Morozov, SV; Ponomarenko, LA; Gorbachev, RV; Mayorov, AS; Katsnelson, MI; Watanabe, K; Taniguchi, T; Novoselov, KS; Levitov, LS; Geim, AK				Abanin, D. A.; Morozov, S. V.; Ponomarenko, L. A.; Gorbachev, R. V.; Mayorov, A. S.; Katsnelson, M. I.; Watanabe, K.; Taniguchi, T.; Novoselov, K. S.; Levitov, L. S.; Geim, A. K.			Giant Nonlocality Near the Dirac Point in Graphene	SCIENCE			English	Article							TRANSPORT	Transport measurements have been a powerful tool for discovering electronic phenomena in graphene. We report nonlocal measurements performed in the Hall bar geometry with voltage probes far away from the classical path of charge flow. We observed a large nonlocal response near the Dirac point in fields as low as 0.1 tesla, which persisted up to room temperature. The nonlocality is consistent with the long-range flavor currents induced by the lifting of spin/valley degeneracy. The effect is expected to contribute strongly to all magnetotransport phenomena near the neutrality point.	[Levitov, L. S.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Abanin, D. A.; Morozov, S. V.; Ponomarenko, L. A.; Gorbachev, R. V.; Mayorov, A. S.; Novoselov, K. S.; Geim, A. K.] Univ Manchester, Manchester Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England; [Abanin, D. A.] Princeton Univ, Princeton Ctr Theoret Sci, Princeton, NJ 08544 USA; [Abanin, D. A.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Katsnelson, M. I.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Morozov, S. V.] Russian Acad Sci, Inst Microelect Technol, Chernogolovka 142432, Russia	Massachusetts Institute of Technology (MIT); University of Manchester; Princeton University; Princeton University; Radboud University Nijmegen; National Institute for Materials Science; Russian Academy of Sciences	Levitov, LS (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	levitov@mit.edu; geim@man.ac.uk	Novoselov, Kostya S/G-9581-2014; Mayorov, Alexander/P-4737-2015; Gorbachev, Roman/I-2512-2013; TANIGUCHI, Takashi/H-2718-2011; Geim, Andre K/J-7888-2012; Katsnelson, Mikhail I./D-4359-2012; WATANABE, Kenji/H-2825-2011; Ponomarenko, Leonid/AAF-1731-2021; Watanabe, Kenji/ABB-2135-2021; Abanin, Dmitry/ABD-6660-2021; Morozov, Sergey V/H-3171-2014	Novoselov, Kostya S/0000-0003-4972-5371; Mayorov, Alexander/0000-0003-4558-3425; Gorbachev, Roman/0000-0003-3604-5617; Geim, Andre K/0000-0003-2861-8331; WATANABE, Kenji/0000-0003-3701-8119; Watanabe, Kenji/0000-0003-3701-8119; Morozov, Sergey V/0000-0003-3075-7787; Levitov, Leonid/0000-0002-4268-731X; hai yan, he/0000-0003-0366-6185	Engineering and Physical Research Council (UK); Royal Society; U.S. Office of Naval Research; U.S. Air Force Office of Scientific Research; Korber Foundation; EPSRC [EP/G035954/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G035954/1] Funding Source: researchfish	Engineering and Physical Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); U.S. Office of Naval Research(Office of Naval Research); U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Korber Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by the Engineering and Physical Research Council (UK), the Royal Society, U.S. Office of Naval Research, U.S. Air Force Office of Scientific Research, and the Korber Foundation. We thank D. Elias, P. Blake, E. Hill, F. Schedin, S. Anissimova, and I. Grigorieva for their help.	Abanin DA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196806; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Checkelsky JG, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115434; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Du X, 2009, NATURE, V462, P192, DOI 10.1038/nature08522; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Gorbachev RV, 2011, SMALL, V7, P465, DOI 10.1002/smll.201001628; HAUG RJ, 1993, SEMICOND SCI TECH, V8, P131, DOI 10.1088/0268-1242/8/2/001; Heersche HB, 2007, NATURE, V446, P56, DOI 10.1038/nature05555; Jedema FJ, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.085319; Jiang Z, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.106802; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; MCEUEN PL, 1990, PHYS REV LETT, V64, P2062, DOI 10.1103/PhysRevLett.64.2062; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Song YJ, 2010, NATURE, V467, P185, DOI 10.1038/nature09330; Tombros N, 2007, NATURE, V448, P571, DOI 10.1038/nature06037; Tserkovnyak Y, 2005, REV MOD PHYS, V77, P1375, DOI 10.1103/RevModPhys.77.1375; van der Pauw LJ, 1958, PHILLIPS TECHNICAL R, V20, P220, DOI DOI 10.4236/JMP.2013.411179; WASHBURN S, 1992, REP PROG PHYS, V55, P1311, DOI 10.1088/0034-4885/55/8/004; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204; Young AF, 2009, NAT PHYS, V5, P222, DOI 10.1038/NPHYS1198	22	201	207	4	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					328	330		10.1126/science.1199595	http://dx.doi.org/10.1126/science.1199595			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493852	Green Submitted			2022-12-28	WOS:000289516600037
J	Lienhardt, C; Cook, SV; Burgos, M; Yorke-Edwards, V; Rigouts, L; Anyo, G; Kim, SJ; Jindani, A; Enarson, DA; Nunn, AJ				Lienhardt, Christian; Cook, Sharlette V.; Burgos, Marcos; Yorke-Edwards, Victoria; Rigouts, Leen; Anyo, Gladys; Kim, Sang-Jae; Jindani, Amina; Enarson, Don A.; Nunn, Andrew J.		Study C Trial Grp	Efficacy and Safety of a 4-Drug Fixed-Dose Combination Regimen Compared With Separate Drugs for Treatment of Pulmonary Tuberculosis The Study C Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHEMOTHERAPY; BIOAVAILABILITY; PYRAZINAMIDE; RIFAMPIN; TB	Context Fixed-dose combinations (FDCs) of drugs for treatment of tuberculosis have been advocated to prevent the emergence of drug resistance. Objective To assess the efficacy and safety of a 4-drug FDC for the treatment of tuberculosis. Design, Setting, and Patients The Study C trial, a parallel-group, open-label, noninferiority, randomized controlled trial conducted in 11 sites in Africa, Asia, and Latin America between 2003 and 2008. Patients were 1585 adults with newly diagnosed smear-positive pulmonary tuberculosis. Interventions Patients were randomized to receive daily treatment with 4 drugs (rifampicin, isoniazid, pyrazinamide, ethambutol) given as an FDC (n=798 patients) or separately (n=787) in the 8-week intensive phase of treatment. Main Outcome Measure Favorable treatment outcome, defined as negative culture result at 18 months post randomization and not having already been classified as unfavorable. Noninferiority was dependent on consistent results from a per-protocol and modified intention-to-treat analysis, using 2 different models for the latter, classifying all changes of treatment or refusal to continue treatment (eg, bacteriological failure/relapse, adverse event, default, drug resistance) as unfavorable (model 1) and classifying changes of treatment for reasons other than therapeutic outcomes according to their 18-month bacteriological outcome if available (post hoc model 2). The prespecified noninferiority margin was 4%. Results In the per-protocol analysis, 555 of 591 patients (93.9%) had a favorable outcome in the FDC group vs 548 of 579 (94.6%) in the separate-drugs group (risk difference, -0.7% [90% confidence interval {CI}, -3.0% to 1.5%]). In the model 1 analysis, 570 of 684 patients (83.3%) had a favorable outcome in the FDC group vs 563 of 664 (84.8%) in the separate-drugs group (risk difference, -1.5% [90% CI, -4.7% to 1.8%]). In the post hoc model 2 analysis, 591 of 658 patients (89.8%) in the FDC group and 589 of 647 (91.0%) in the separate-drugs group had a favorable outcome (risk difference, -1.2% [90% CI, -3.9% to 1.5%]). Adverse events related to trial drugs were similarly distributed among treatment groups. Conclusions Compared with a regimen of separately administered drugs, a 4-drug FDC regimen for treatment of tuberculosis satisfied prespecified noninferiority criteria in 2 of 3 analyses. Although the results do not demonstrate full noninferiority of the FDCs compared with single drugs given separately using the strict definition applied in this trial, use of FDCs is preferred because of potential advantages associated with the administration of FDCs compared with separate-drug formulations.	[Lienhardt, Christian; Cook, Sharlette V.; Enarson, Don A.] Int Union TB & Lung Dis, Clin Trial Div, Paris, France; [Burgos, Marcos] Univ New Mexico, Dept Internal Med, Div Infect Dis, Albuquerque, NM 87131 USA; [Yorke-Edwards, Victoria; Nunn, Andrew J.] MRC, Clin Trials Unit, London, England; [Rigouts, Leen; Anyo, Gladys] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Kim, Sang-Jae] Int TB Res Ctr, Seoul, South Korea; [Jindani, Amina] Univ London, Dept Cellular & Mol Med, London, England	University of New Mexico; Medical Research Council Clinical Trials Unit; Institute of Tropical Medicine (ITM); University of London	Lienhardt, C (corresponding author), WHO, Stop TB Partnership, Desk D4 6017,20 Ave Appia, CH-1211 Geneva 27, Switzerland.	lienhardtc@who.int	Gutiérrez, Jose Muñoz/X-5917-2018; Ferro, Beatriz Eugenia/F-7144-2016; Lienhardt, Christian/AAU-4969-2021; Yorke-Edwards, Victoria/AAA-2942-2019; Gutierrez, Jose Muñoz/AAH-6954-2020	Gutiérrez, Jose Muñoz/0000-0002-0945-1735; Ferro, Beatriz Eugenia/0000-0001-6045-1610; Lienhardt, Christian/0000-0003-0233-893X; Yorke-Edwards, Victoria/0000-0002-6465-7330; Gutierrez, Jose Muñoz/0000-0002-0945-1735; Jindani, Amina/0000-0002-7110-5286; Hernandez Lopez, Edna Lorena/0000-0001-7507-6067; Nunn, Andrew/0000-0002-9158-4595; Tran Ngoc, Buu/0000-0003-3554-1176	United States Agency for International Development (USAID) [GHS-A-00-03-00045-00]; MRC [MC_U122888469] Funding Source: UKRI; Medical Research Council [MC_U122888469] Funding Source: researchfish	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by United States Agency for International Development (USAID) cooperative agreement GHS-A-00-03-00045-00.	ACOCELLA G, 1988, AM REV RESPIR DIS, V138, P882, DOI 10.1164/ajrccm/138.4.882; [Anonymous], 2007, EMEACHMPEWP122355200; [Anonymous], 2009, M ANT DRUGS ADV COMM; Bartacek A, 2009, INT J TUBERC LUNG D, V13, P760; Blomberg B, 2001, B WORLD HEALTH ORGAN, V79, P61; ELLARD GA, 1986, AM REV RESPIR DIS, V133, P1076; Europe Middle East Africa., 2005, CPMPEWP215899; Forget EJ, 2006, EXPERT OPIN DRUG SAF, V5, P231, DOI 10.1517/14740338.5.2.231; Geiter L J, 1987, Tubercle, V68, P41, DOI 10.1016/S0041-3879(87)80021-1; Girling D. J., 1991, American Review of Respiratory Disease, V143, P707; Gravendeel JMT, 2003, TUBERCULOSIS, V83, P183, DOI 10.1016/S1472-9792(02)00053-7; [Hong Kong Chest Service British Medical Research Council], 1989, AM REV RESPIR DIS, V140, P1618; *INT UN TUB LUNG D, 1988, B INT UNION TUBERC L, V63, P60; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; KUDOH S, 1974, B WORLD HEALTH ORGAN, V51, P71; Lienhardt C, 2010, CURR OPIN PULM MED, V16, P186, DOI 10.1097/MCP.0b013e328337580c; Lin Y, 2009, PAC HLTH SUMM SEATTL; Machin D., 1987, STAT TABLES DESIGN C; Nunn AJ, 2008, TUBERCULOSIS, V88, pS85, DOI 10.1016/S1472-9792(08)70039-8; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Raviglione MC, 2006, INT J TUBERC LUNG D, V10, P238; StataCorp L, 2007, STAT DAT AN STAT SOF; Stop TB Partnership, GLOB DRUG FAC; Su WJ, 2002, INT J TUBERC LUNG D, V6, P1029; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; WHO, 2009, TREATM TUB GUID; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	27	71	78	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1415	1423		10.1001/jama.2011.436	http://dx.doi.org/10.1001/jama.2011.436			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486974	Bronze			2022-12-28	WOS:000289424100018
J	Stewart, A; Ubee, SS; Davies, H				Stewart, A.; Ubee, S. S.; Davies, H.			10-MINUTE CONSULTATION Epididymo-orchitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Stewart, A.] Royal Liverpool & Broadgreen Univ Hosp Trust, Liverpool L7 8XP, Merseyside, England; [Ubee, S. S.] Heart England NHS Fdn Trust, Birmingham B9 5SS, W Midlands, England; [Davies, H.] Green Lane Med Ctr, Liverpool L13 7DY, Merseyside, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; University of Liverpool; Heart of England NHS Foundation Trust	Stewart, A (corresponding author), Royal Liverpool & Broadgreen Univ Hosp Trust, Liverpool L7 8XP, Merseyside, England.	a.j.stewart@doctors.org.uk		Ubee, Sarvpreet/0000-0002-6718-6415	National Institute for Health Research [ACF-2011-07-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	5	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2011	342								d1543	10.1136/bmj.d1543	http://dx.doi.org/10.1136/bmj.d1543			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752UX	21490048				2022-12-28	WOS:000289721500002
J	Weinberger, DM; Malley, R; Lipsitch, M				Weinberger, Daniel M.; Malley, Richard; Lipsitch, Marc			Serotype replacement in disease after pneumococcal vaccination	LANCET			English	Review							STREPTOCOCCUS-PNEUMONIAE SEROTYPES; CARE-CENTER ATTENDEES; ACUTE OTITIS-MEDIA; CONJUGATE VACCINE; NASOPHARYNGEAL CARRIAGE; INVASIVE DISEASE; TEMPORAL TRENDS; ANTIMICROBIAL RESISTANCE; CHANGING EPIDEMIOLOGY; HAEMOPHILUS-INFLUENZAE	Vaccination with heptavalent pneumococcal conjugate vaccine (PCV7) has significantly reduced the burden of pneumococcal disease and has had an important public health benefit. Because this vaccine targets only seven of the more than 92 pneumococcal serotypes, concerns have been raised that non-vaccine serotypes (NVTs) could increase in prevalence and reduce the benefits of vaccination. Indeed, among asymptomatic carriers, the prevalence of NVTs has increased substantially, and consequently, there has been little or no net change in the bacterial carriage prevalence. In many populations, pneumococcal disease caused by NVT has increased, but in most cases this increase has been less than the increase in NVT carriage. We review the evidence for serotype replacement in carriage and disease, and address the surveillance biases that might affect these findings. We then discuss possible reasons for the discrepancy between near-complete replacement in carriage and partial replacement for disease, including differences in invasiveness between vaccine serotypes. We contend that the magnitude of serotype replacement in disease can be attributed, in part, to a combination of lower invasiveness of the replacing serotypes, biases in the pre-vaccine carriage data (unmasking), and biases in the disease surveillance systems that could underestimate the true amount of replacement. We conclude by discussing the future potential for serotype replacement in disease and the need for continuing surveillance.	[Weinberger, Daniel M.; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Ctr Communicable Dis Dynam, Sch Publ Hlth, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA 02115 USA; [Malley, Richard] Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Malley, Richard] Harvard Univ, Sch Med, Boston, MA USA; [Weinberger, Daniel M.] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Weinberger, DM (corresponding author), NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bldg 16,Room 37, Bethesda, MD 20892 USA.	weinbergerdm@mail.nih.gov		Weinberger, Daniel/0000-0003-1178-8086; Lipsitch, Marc/0000-0003-1504-9213	Pfizer; Novartis; NIH [R01 AI048935, R01 AI066013]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066013, R01AI048935] Funding Source: NIH RePORTER	Pfizer(Pfizer); Novartis(Novartis); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	DMW has no conflicts of interest to declare. RM is a member of the Scientific Advisory Board of Genocea Biosciences. ML has accepted honoraria or consulting fees from Pfizer and Novartis.; We thank Anthony Scott and Elizabeth Miller for helpful discussions, particularly on the topics of surveillance artifacts (EM) and design of surveillance in low-resource areas (AS), and for crucial feedback on the manuscript. This study was supported by NIH research grant R01 AI048935 to ML and R01 AI066013 to RM.	Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x; Alexandre C, 2010, ACTA PAEDIATR, V99, P1686, DOI 10.1111/j.1651-2227.2010.01914.x; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Aristegui J, 2007, EUR J CLIN MICROBIOL, V26, P303, DOI 10.1007/s10096-007-0294-4; Benito-Fernandez J, 2007, PEDIATR INFECT DIS J, V26, P667, DOI 10.1097/INF.0b013e3180f610b3; Bettinger JA, 2010, VACCINE, V28, P2130, DOI 10.1016/j.vaccine.2009.12.026; Bingen E, 2008, EUR J CLIN MICROBIOL, V27, P191, DOI 10.1007/s10096-007-0417-y; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Black S, 2010, PEDIATR INFECT DIS J, V29, P301, DOI 10.1097/INF.0b013e3181c391fb; Black S, 2007, PEDIATR INFECT DIS J, V26, P771, DOI 10.1097/INF.0b013e318124a494; Bogaert D, 2010, VACCINE, V28, P681, DOI 10.1016/j.vaccine.2009.10.085; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Calbo E, 2006, CLIN MICROBIOL INFEC, V12, P867, DOI 10.1111/j.1469-0691.2006.1502_1.x; Casado-Flores J, 2008, PEDIATR INFECT DIS J, V27, P1020, DOI 10.1097/INF.0b013e31817bd2dc; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; Chibuk TK, 2010, EUR J PEDIATR, V169, P1123, DOI 10.1007/s00431-010-1195-6; Choi EH, 2008, EMERG INFECT DIS, V14, P275, DOI 10.3201/eid1402.070807; Cohen R, 2010, VACCINE, V28, P6114, DOI 10.1016/j.vaccine.2009.05.037; Crisinel PA, 2010, EUR J PEDIATR, V169, P1311, DOI 10.1007/s00431-010-1214-7; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525; Dagan R, 1996, J INFECT DIS, V174, P1271, DOI 10.1093/infdis/174.6.1271; Dagan R, 2009, J INFECT DIS, V199, P776, DOI 10.1086/597044; Dias R, 2007, FEMS IMMUNOL MED MIC, V51, P35, DOI 10.1111/j.1574-695X.2007.00283.x; Doit C, 2010, DIAGN MICR INFEC DIS, V66, P332, DOI 10.1016/j.diagmicrobio.2009.10.012; Dunais B, 2008, PEDIATR INFECT DIS J, V27, P1033, DOI 10.1097/INF.0b013e31817bb8cf; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Fenoll A, 2009, J ANTIMICROB CHEMOTH, V64, P1338, DOI 10.1093/jac/dkp376; Foster D, 2010, J MED MICROBIOL, DOI jmm.0.023135-0; Frazao N, 2010, VACCINE, V28, P3445, DOI 10.1016/j.vaccine.2010.02.070; Ghaffar F, 2004, CLIN INFECT DIS, V39, P930, DOI 10.1086/423379; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Grivea IN, 2008, PEDIATR INFECT DIS J, V27, P519, DOI 10.1097/INF.0b013e318168d28a; Guevara M, 2009, CLIN MICROBIOL INFEC, V15, P1013, DOI 10.1111/j.1469-0691.2009.02904.x; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; Hanage WP, 2010, EPIDEMICS-NETH, V2, P80, DOI 10.1016/j.epidem.2010.03.005; Hanage WP, 2005, INFECT IMMUN, V73, P431, DOI 10.1128/IAI.73.1.431-435.2005; Hanna JN, 2008, MED J AUSTRALIA, V189, P43, DOI 10.5694/j.1326-5377.2008.tb01897.x; Harboe ZB, 2010, VACCINE, V28, P2642, DOI 10.1016/j.vaccine.2010.01.017; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Hsieh YC, 2009, VACCINE, V27, P5513, DOI 10.1016/j.vaccine.2009.06.091; Hsu KK, 2010, PEDIATR INFECT DIS J, V29, P289, DOI 10.1097/INF.0b013e3181c15471; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Hyams C, 2010, INFECT IMMUN, V78, P716, DOI 10.1128/IAI.01056-09; Jacobs MR, 2008, CLIN INFECT DIS, V47, P1388, DOI 10.1086/592972; Jaffar S, 1999, VACCINE, V18, P633, DOI 10.1016/S0264-410X(99)00277-7; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaltoft MS, 2008, J MICROBIOL METH, V75, P540, DOI 10.1016/j.mimet.2008.08.010; Kaplan SL, 2010, PEDIATRICS, V125, P429, DOI 10.1542/peds.2008-1702; Kellner JD, 2009, CLIN INFECT DIS, V49, P205, DOI 10.1086/599827; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lacapa R, 2008, CLIN INFECT DIS, V47, P476, DOI 10.1086/590001; Lehmann D, 2010, CLIN INFECT DIS, V50, P1477, DOI 10.1086/652440; Lepoutre A, 2008, Euro Surveill, V13; Levy C, 2011, PEDIATR INFECT DIS J, V30, P168, DOI 10.1097/INF.0b013e3181f4cf69; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Lipsitch M, 2001, AM J EPIDEMIOL, V154, P85, DOI 10.1093/aje/154.1.85; Lipsitch M, 2007, J INFECT DIS, V196, P1221, DOI 10.1086/521831; Lipsitch M, 2009, EPIDEMICS-NETH, V1, P2, DOI 10.1016/j.epidem.2008.07.001; Lucero MG, 2009, PEDIATR INFECT DIS J, V28, P455, DOI 10.1097/INF.0b013e31819637af; Maraki S, 2010, EUR J CLIN MICROBIOL, V29, P1449, DOI 10.1007/s10096-010-1005-0; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; McCormick AW, 2003, NAT MED, V9, P424, DOI 10.1038/nm839; Messina AF, 2007, PEDIATR INFECT DIS J, V26, P461, DOI 10.1097/INF.0b013e31805cdbeb; Miller E, 2010, P 7 INT S PNEUM PNEU; Moore MR, 2008, CLIN INFECT DIS, V46, P183, DOI 10.1086/524661; Moore MR, 2009, J INFECT DIS, V199, P771, DOI 10.1086/597045; Moulton LH, 2001, CONTROL CLIN TRIALS, V22, P438, DOI 10.1016/S0197-2456(01)00132-5; MOXON ER, 1978, P NATL ACAD SCI USA, V75, P1534, DOI 10.1073/pnas.75.3.1534; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; Perez A, 2008, EUR J CLIN MICROBIOL, V27, P717, DOI 10.1007/s10096-008-0498-2; Perez-Trallero E, 2009, EUR J CLIN MICROBIOL, V28, P731, DOI 10.1007/s10096-008-0693-1; Pilishvili T, 2010, PEDIATRICS, V126, pE9, DOI 10.1542/peds.2009-2150; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Rivera-Olivero IA, 2009, J MED MICROBIOL, V58, P584, DOI 10.1099/jmm.0.006726-0; Rodenburg GD, 2010, EMERG INFECT DIS, V16, P816, DOI 10.3201/eid1605.091223; Ruckinger S, 2009, VACCINE, V27, P4136, DOI 10.1016/j.vaccine.2009.04.057; Ruckinger S, 2009, PEDIATR INFECT DIS J, V28, P118, DOI 10.1097/INF.0b013e318187e215; Sa-Leao R, 2009, CLIN MICROBIOL INFEC, V15, P1002, DOI 10.1111/j.1469-0691.2009.02775.x; Salleras L, 2009, CLIN MICROBIOL INFEC, V15, P997, DOI 10.1111/j.1469-0691.2009.02938.x; Scott JAG, 2007, VACCINE, V25, P2398, DOI 10.1016/j.vaccine.2006.09.008; Scott JAG, 2010, P 7 INT S PNEUM PNEU; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Song JH, 2009, DIAGN MICR INFEC DIS, V63, P271, DOI 10.1016/j.diagmicrobio.2008.11.015; Spratt BG, 2000, LANCET, V356, P1210, DOI 10.1016/S0140-6736(00)02779-3; Steenhoff AP, 2006, CLIN INFECT DIS, V42, P907, DOI 10.1086/500941; Techasaensiri C, 2010, PEDIATR INFECT DIS J, V29, P294, DOI 10.1097/INF.0b013e3181c2a229; Trotter CL, 2010, J INFECTION, V60, P200, DOI 10.1016/j.jinf.2009.12.008; Tsigrelis C, 2009, MAYO CLIN PROC, V84, P871, DOI 10.1016/S0025-6196(11)60504-1; Tsigrelis C, 2009, J INFECTION, V59, P188, DOI 10.1016/j.jinf.2009.07.004; Tyrrell GJ, 2009, VACCINE, V27, P3553, DOI 10.1016/j.vaccine.2009.03.063; UK Health Protection Agency, 2004, CUM WEEKL NUMB REP I; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; Vestrheim DF, 2010, VACCINE, V28, P2214, DOI 10.1016/j.vaccine.2009.12.054; Vestrheim DF, 2010, CLIN VACCINE IMMUNOL, V17, P325, DOI 10.1128/CVI.00435-09; Weatherholtz R, 2010, CLIN INFECT DIS, V50, P1238, DOI 10.1086/651680; Weinberger DM, 2011, EPIDEMIOLOGY, V22, P199, DOI 10.1097/EDE.0b013e3182087634; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Wenger JD, 2010, PEDIATR INFECT DIS J, V29, P251, DOI 10.1097/INF.0b013e3181bdbed5; Zemlickova H, 2010, J MED MICROBIOL, V59, P1079, DOI 10.1099/jmm.0.018390-0	108	631	648	1	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2011	378	9807					1962	1973		10.1016/S0140-6736(10)62225-8	http://dx.doi.org/10.1016/S0140-6736(10)62225-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863AW	21492929	Green Accepted, Green Submitted			2022-12-28	WOS:000298136200030
J	van't Hof, AE; Edmonds, N; Dalikova, M; Marec, F; Saccheri, IJ				van't Hof, Arjen E.; Edmonds, Nicola; Dalikova, Martina; Marec, Frantisek; Saccheri, Ilik J.			Industrial Melanism in British Peppered Moths Has a Singular and Recent Mutational Origin	SCIENCE			English	Article							BLACK-AND-WHITE; LINKAGE DISEQUILIBRIUM; HELICONIUS BUTTERFLIES; SELECTION	The rapid spread of a novel black form (known as carbonaria) of the peppered moth Biston betularia in 19th-century Britain is a textbook example of how an altered environment may produce morphological adaptation through genetic change. However, the underlying genetic basis of the difference between the wild-type (light-colored) and carbonaria forms has remained unknown. We have genetically mapped the carbonaria morph to a 200-kilobase region orthologous to a segment of silkworm chromosome 17 and show that there is only one core sequence variant associated with the carbonaria morph, carrying a signature of recent strong selection. The carbonaria region coincides with major wing-patterning loci in other lepidopteran systems, suggesting the existence of basal color-patterning regulators in this region.	[van't Hof, Arjen E.; Edmonds, Nicola; Saccheri, Ilik J.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Dalikova, Martina; Marec, Frantisek] Acad Sci Czech Republic, Inst Entomol, CR-37005 Ceske Budejovice, Czech Republic; [Dalikova, Martina; Marec, Frantisek] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	University of Liverpool; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Saccheri, IJ (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	saccheri@liv.ac.uk	Van 't Hof, Arjen/AAE-8044-2022; Dalikova, Martina/J-5722-2015; Marec, Frantisek/G-7943-2014	Dalikova, Martina/0000-0002-0266-8894; Marec, Frantisek/0000-0002-6745-5603	Natural Environment Research Council [NE/C003101/1]; Grant Agency of the Academy of Sciences of the Czech Republic [IAA600960925]; Entomology Institute [Z50070508]; Grant Agency of the Czech Republic [521/08/H042]; NERC [NE/H024352/1] Funding Source: UKRI; Natural Environment Research Council [NE/H024352/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Entomology Institute; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by Natural Environment Research Council grant NE/C003101/1 to I.J.S. Cytogenetic experiments were financed by Grant Agency of the Academy of Sciences of the Czech Republic grant IAA600960925, Entomology Institute project Z50070508, and Grant Agency of the Czech Republic 521/08/H042 grants to F.M. and M.D. Specimens for the UK-wide survey were made available by several museums and private collectors, listed in table S4. J. Delf produced fig. S3. GenBank accession numbers are listed in table S1.	Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Cook Laurence M., 2003, Entomologist's Gazette, V54, P211; Cook LM, 2005, J HERED, V96, P522, DOI 10.1093/jhered/esi082; Cook LM, 2003, Q REV BIOL, V78, P399, DOI 10.1086/378925; GOLDSMITH MR, 1995, MOL MODEL SYSTEMS LE; Hedrick P, 2001, EUR J HUM GENET, V9, P969, DOI 10.1038/sj.ejhg.5200735; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; Kronforst MR, 2006, GENETICS, V174, P535, DOI 10.1534/genetics.106.059527; Lees D. R., 1981, GENETIC CONSEQUENCES, P129; Majerus M, 1998, MELANISM EVOLUTION A; Majerus MEN, 2003, TRENDS GENET, V19, P585, DOI 10.1016/j.tig.2003.09.003; Papa R, 2008, CURR OPIN GENET DEV, V18, P559, DOI 10.1016/j.gde.2008.11.007; Pfaffelhuber P, 2008, GENETICS, V179, P527, DOI 10.1534/genetics.107.081497; Saccheri IJ, 2008, P NATL ACAD SCI USA, V105, P16212, DOI 10.1073/pnas.0803785105; Stern D. L., 2010, EVOLUTION DEV PREDIC; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; van't Hof AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010889; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X	18	101	104	4	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					958	960		10.1126/science.1203043	http://dx.doi.org/10.1126/science.1203043			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21493823				2022-12-28	WOS:000290766600041
J	Flenady, V; Middleton, P; Smith, GC; Duke, W; Erwich, JJ; Khong, TY; Neilson, J; Ezzati, M; Koopmans, L; Ellwood, D; Fretts, R; Froen, JF				Flenady, Vicki; Middleton, Philippa; Smith, Gordon C.; Duke, Wes; Erwich, Jan Jaap; Khong, T. Yee; Neilson, Jim; Ezzati, Majid; Koopmans, Laura; Ellwood, David; Fretts, Ruth; Froen, J. Frederik		Lancet's Stillbirths Series Steeri	Stillbirths 5 Stillbirths: the way forward in high-income countries	LANCET			English	Article							PERINATAL-MORTALITY; GESTATIONAL-AGE; FETAL-DEATH; PERIODONTAL-DISEASE; AVOIDABLE MORTALITY; ALCOHOL-CONSUMPTION; NEONATAL DEATHS; AUTOPSY RATES; PRENATAL-CARE; BIRTH-WEIGHT	Stillbirth rates in high-income countries declined dramatically from about 1940, but this decline has slowed or stalled over recent times. The present variation in stillbirth rates across and within high-income countries indicates that further reduction in stillbirth is possible. Large disparities (linked to disadvantage such as poverty) in stillbirth rates need to be addressed by providing more educational opportunities and improving living conditions for women. Placental pathologies and infection associated with preterm birth are linked to a substantial proportion of stillbirths. The proportion of unexplained stillbirths associated with under investigation continues to impede efforts in stillbirth prevention. Overweight, obesity, and smoking are important modifiable risk factors for stillbirth, and advanced maternal age is also an increasingly prevalent risk factor. Intensified efforts are needed to ameliorate the effects of these factors on stillbirth rates. Culturally appropriate preconception care and quality antenatal care that is accessible to all women has the potential to reduce stillbirth rates in high-income countries. Implementation of national perinatal mortality audit programmes aimed at improving the quality of care could substantially reduce stillbirths. Better data on numbers and causes of stillbirth are needed, and international consensus on definition and classification related to stillbirth is a priority. All parents should be offered a thorough investigation including a high-quality autopsy and placental histopathology. Parent organisations are powerful change agents and could have an important role in raising awareness to prevent stillbirth. Future research must focus on screening and interventions to reduce antepartum stillbirth as a result of placental dysfunction. Identification of ways to reduce maternal overweight and obesity is a high priority for high-income countries.	[Flenady, Vicki] Mater Med Res Inst, Mater Hlth Serv, Brisbane, Qld 4101, Australia; [Flenady, Vicki] Univ Queensland, Brisbane, Qld, Australia; [Flenady, Vicki] Int Stillbirth Alliance, Baltimore, MD USA; [Middleton, Philippa] Univ Adelaide, Adelaide, SA, Australia; [Smith, Gordon C.] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Duke, Wes] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [Erwich, Jan Jaap] Univ Groningen, Dept Obstet, Utrecht, Netherlands; [Erwich, Jan Jaap] Fdn Perinatal Audit Netherlands, Utrecht, Netherlands; [Khong, T. Yee] Womens & Childrens Hosp, SA Pathol, Adelaide, SA, Australia; [Neilson, Jim] Univ Liverpool, Cochrane Pregnancy & Childbirth Grp, Liverpool L69 3BX, Merseyside, England; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Ellwood, David] Canberra Hosp, Canberra, ACT, Australia; [Ellwood, David] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Fretts, Ruth] Harvard Vanguard Med Associates, Wellesley, MA USA; [Froen, J. Frederik] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway	Mater Health Services; Mater Research; University of Queensland; University of Adelaide; University of Cambridge; Centers for Disease Control & Prevention - USA; University of Groningen; SA Pathology; Womens & Childrens Hospital Australia; University of Liverpool; Imperial College London; Australian National University; Canberra Hospital; Australian National University; Harvard Vanguard Medical Associates; Norwegian Institute of Public Health (NIPH)	Flenady, V (corresponding author), Mater Med Res Inst, Mater Hlth Serv, Brisbane, Qld 4101, Australia.	Vicki.Flenady@mmri.mater.org.au	Flenady, Vicki Jane/O-9609-2014; Lawn, Joy/ABE-6382-2020; Smith, Gordon/A-8070-2008; Frøen, J. Frederik/C-3271-2009; Ellwood, David Alan/GNW-4485-2022	Flenady, Vicki Jane/0000-0001-8114-7677; Lawn, Joy/0000-0002-4573-1443; Smith, Gordon/0000-0003-2124-0997; Ellwood, David Alan/0000-0003-4512-6443; Froen Froen, Jahn Frederik/0000-0001-9390-8509	Bill & Melinda Gates Foundation; International Stillbirth Alliance; Norwegian Institute of Public Health; Medical Research Council [G0801056B] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); International Stillbirth Alliance; Norwegian Institute of Public Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Bill & Melinda Gates Foundation for a grant to support this work to the International Stillbirth Alliance administered by the Mater Medical Research Institute, Brisbane, QLD, Australia. Additionally, we thank the International Stillbirth Alliance and the Norwegian Institute of Public Health for seed funding to support meetings of the steering committee. We thank the following for technical support: Dominique Rossouw, Madeleine Elder, and, Elizabeth Flenady for literature searching and reference management, Kristen Gibbons for statistical advice, and Glenda Hawley, Teresa Walsh, Shelley Wilkinson, and Ann Kingsbury for providing feedback on the report. We thank Janet Scott of Sands UK, Sue Hale of Sands UK and ISA Parent Advisory Committee, and Liz Conway Sands Australia and the ISA Parent Advisory Committee for their comments and contributions to the report. We thank the following for their contributions to the research priority component: Justus Hofmeyr for his assistance with the development of the research priority questions, review of interventions, and comment of drafts of the report; Eckhart Buchmann for development of the initial drafts of all the research questions; Igor Rudan for guidance and support; and Ibinabo Ibiebele for data analysis. We thank all those who scored the stillbirth research priorities: Adrian Charles, Paul Colditz, Linda Dodds, Lelia Duley, Jason Gardosi, Sanne Gordijn, Grace Guyon, Justus Hofmeyr, Alex Heazell, Robyn Kennare, Russell Kirby, Wolfgang Kuenzel, Kassam Mahomed, Luigi Matturri, Elizabeth M McClure, Lesley McCowan, Giorgio Mello, Ayman el Mohandes, Halit Pinar, Ingela Radestad, Uma M Reddy, Birgit Reime, Bob Silver, and Bert Timmer, and members of the GAPPS Basic Biology Working Group: Craig Rubens, Michael Gravett, Gordon Smith, Leslie Myatt, Oslem Equils, Roger Smith, and Sarah England.	Acolet D, 2005, PEDIATRICS, V116, P1457, DOI 10.1542/peds.2004-2691; Alderliesten ME, 2008, EUR J OBSTET GYN R B, V137, P141, DOI 10.1016/j.ejogrb.2007.06.002; Alfirevic Z, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007529.pub2; Aliyu MH, 2008, ALCOHOL, V42, P369, DOI 10.1016/j.alcohol.2008.04.003; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2007, DIAB PREGN AR WE PRO; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Bateman BT, 2006, AM J OBSTET GYNECOL, V194, P840, DOI 10.1016/j.ajog.2005.08.038; Bergsjo P, 2003, ACTA OBSTET GYN SCAN, V82, P780, DOI 10.1034/j.1600-0412.2003.00224.x; BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Bolling K, 2007, INFANT FEEDING SURVE; Breeze ACG, 2008, ULTRASOUND OBST GYN, V31, P187, DOI 10.1002/uog.5199; Brookes JS, 2006, J MAGN RESON IMAGING, V24, P1221, DOI 10.1002/jmri.20770; Bryant AS, 2010, AM J OBSTET GYNECOL, V202, P335, DOI 10.1016/j.ajog.2009.10.864; Burnley H, 2005, J CLIN PATHOL, V58, P93, DOI 10.1136/jcp.2004.020636; *CCOPMM, 2007, ANN REP YEAR 2007 IN; *CESDI, 2001, 8 CESDI; Chan A, 2004, J PAEDIATR CHILD H, V40, P340, DOI 10.1111/j.1440-1754.2004.00398.x; *CMACE, 2010, CTR MAT CHILD ENQ PE; Cnattingius S, 1998, BRIT MED J, V316, P1483, DOI 10.1136/bmj.316.7143.1483; Cogswell ME, 1999, OBSTET GYNECOL, V94, P616, DOI 10.1016/S0029-7844(99)00375-0; Cohen MC, 2008, PEDIATR DEVEL PATHOL, V11, P1, DOI 10.2350/07-01-0213.1; Corabian P, 2007, J OBSTET GYNAECOL CA, V29, P560, DOI 10.1016/S1701-2163(16)32500-2; Crowther CA, 1999, AUST NZ J OBSTET GYN, V39, P12, DOI 10.1111/j.1479-828X.1999.tb03434.x; d'Espaignet ET, 2008, FORENSIC SCI MED PAT, V4, P83, DOI 10.1007/s12024-007-9011-y; Darmstadt GL, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S6; De Lange TE, 2008, AUST NZ J OBSTET GYN, V48, P50, DOI 10.1111/j.1479-828X.2007.00801.x; De Reu PAOM, 2000, EUR J OBSTET GYN R B, V88, P65, DOI 10.1016/S0301-2115(99)00135-9; De Reu P, 2009, ACTA OBSTET GYN SCAN, V88, P1201, DOI 10.3109/00016340903280990; De Reu PAOM, 2010, J PERINAT MED, V38, P311, DOI [10.1515/JPM.2010.027, 10.1515/jpm.2010.027]; Dodd JM, 2010, BJOG-INT J OBSTET GY, V117, P1316, DOI 10.1111/j.1471-0528.2010.02540.x; Doumit G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000125.pub3; Doyle LW, 2000, LANCET, V355, P2093, DOI 10.1016/S0140-6736(00)02373-4; Dudley DJ, 2010, OBSTET GYNECOL, V116, P254, DOI 10.1097/AOG.0b013e3181e7d975; Duke W, 2010, WOMEN HEALTH ISS, V20, P366, DOI 10.1016/j.whi.2010.06.004; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Essen B, 2002, BJOG-INT J OBSTET GY, V109, P677, DOI 10.1016/S1470-0328(02)01077-7; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flenady V, 2010, AUST NZ J OBSTET GYN, V50, P138, DOI 10.1111/j.1479-828X.2009.01125.x; Flenady V, 2010, STILLBIRTH UNDERSTAN; FLENADY V, 2010, J PAEDIATR CHILD H, V46, P46; Flenady V., 2009, CLIN PRACTICE GUIDEL; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Floyd RL, 2007, AM J PREV MED, V32, P1, DOI 10.1016/j.amepre.2006.08.028; Floyd RL, 1999, AM J PREV MED, V17, P101, DOI 10.1016/S0749-3797(99)00059-8; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-58; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-22; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; Froen JF, 2004, J PERINAT MED, V32, P13, DOI 10.1515/JPM.2004.003; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Getahun D, 2005, OBSTET GYNECOL, V106, P81, DOI 10.1097/01.AOG.0000165274.06811.86; Gissler M, 2010, INFORM HEALTH SOC CA, V35, P64, DOI 10.3109/17538157.2010.492923; Goldenberg R L, 2004, J Matern Fetal Neonatal Med, V16, P79; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Gordijn SJ, 2007, EUR J OBSTET GYN R B, V132, P3, DOI 10.1016/j.ejogrb.2006.10.031; Gordijn SJ, 2002, PEDIATR DEVEL PATHOL, V5, P480, DOI 10.1007/s10024-002-0008-y; Gulmezoglu AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945; Haavaldsen C, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.014; Hagmann CF, 2007, ARCH DIS CHILD-FETAL, V92, pF215, DOI 10.1136/fnn.2005.092387; HALL MH, 1980, LANCET, V2, P78; HARVEY SM, 1993, FAM PLANN PERSPECT, V25, P32, DOI 10.2307/2135990; Haws RA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S5; Hawthorne G, 1997, BRIT MED J, V315, P279, DOI 10.1136/bmj.315.7103.279; Henderson-Smart DJ, 2003, CLIN PERINATOL, V30, P333, DOI 10.1016/S0095-5108(03)00026-5; Herring Sharon J, 2008, BMC Pregnancy Childbirth, V8, P54, DOI 10.1186/1471-2393-8-54; Hofmeyr GJ, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001059.pub2, 10.1002/14651858.CD001059.pub4, 10.1002/14651858.CD001059.pub5]; Holt J, 2002, ACTA OBSTET GYN SCAN, V81, P899, DOI 10.1034/j.1600-0412.2002.811001.x; Huisman Thierry A G M, 2004, Semin Neonatol, V9, P347, DOI 10.1016/j.siny.2003.09.004; Hutcheon JA, 2011, PAEDIATR PERINAT EP, V25, P11, DOI 10.1111/j.1365-3016.2010.01155.x; *I MED NAT RES COU, 2009, WEIGHT GAIN PREGN RE; *INT STILLB ALL, 2009, ISA POS STAT FET MOV; Jack BW, 2008, AM J OBSTET GYNECOL, V199, pS266, DOI 10.1016/j.ajog.2008.07.067; Jorgensen T, 2008, SCAND J PUBLIC HEALT, V36, P635, DOI 10.1177/1403494808089653; Kenyon S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001058.pub2; Khong TY, 2006, J PAEDIATR CHILD H, V42, P366, DOI 10.1111/j.1440-1754.2006.00874.x; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Khong TY, 2003, PEDIATR DEVEL PATHOL, V6, P54, DOI 10.1007/s10024-001-0263-3; Khong TY, 1996, PAEDIATR PERINAT EP, V10, P97, DOI 10.1111/j.1365-3016.1996.tb00030.x; Khong TY., 2006, CURR DIAG PATHOL, V12, P61, DOI 10.1016/j.cdip.2006.03.001; KHONG TY, 2009, STILLBIRTH UNDERSTAN, P91; Korteweg FJ, 2008, PLACENTA, V29, P71, DOI 10.1016/j.placenta.2007.07.003; Korteweg FJ, 2006, BJOG-INT J OBSTET GY, V113, P393, DOI 10.1111/j.1471-0528.2006.00881.x; Korteweg FJ, 2010, OBSTET GYNECOL, V116, P355, DOI 10.1097/AOG.0b013e3181e66d58; Krebs L, 2002, J PERINAT MED, V30, P220, DOI 10.1515/JPM.2002.030; Laing Ian A, 2004, Semin Neonatol, V9, P247, DOI 10.1016/j.siny.2003.11.004; Lauenborg J, 2003, DIABETES CARE, V26, P1385, DOI 10.2337/diacare.26.5.1385; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Laws P, 2009, PERINATAL STAT SERIE; Loftin Ryan W, 2010, Rev Obstet Gynecol, V3, P10; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; Luo ZC, 2010, CAN MED ASSOC J, V182, P235, DOI 10.1503/cmaj.082042; Macdorman Marian F, 2009, NCHS Data Brief, P1; Macones GA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.892; MANGESI L, 2007, COCHRANE DB SYST REV, V1; McDonnell KA, 2004, MATERN CHILD HLTH J, V8, P231, DOI 10.1023/B:MACI.0000047421.93207.51; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Menezes EV, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S4; Michalowicz BS, 2006, NEW ENGL J MED, V355, P1885, DOI 10.1056/NEJMoa062249; *NAT I HLTH CLIN E, 2010, NICE CLIN GUID, V107; *NAT I HLTH CLIN E, 2010, QUITT SMOK PREGN FOL, V26; National Collaborating Centre for Women's and Children's Health (UK), 2008, DIAB PREGN MAN DIAB; National Institute for Health and Clinical Excellence, 2010, WEIGHT MAN PREGN, V27; NEILSON JP, 2000, COCHRANE DB SYST REV, V2; Newnham JP, 2009, OBSTET GYNECOL, V114, P1239, DOI 10.1097/AOG.0b013e3181c15b40; Orentlicher D, 2010, HASTINGS CENT REP, V40, P12; Pattinson RC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002961.pub2; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Pinar H, 2010, CLIN OBSTET GYNECOL, V53, P656, DOI 10.1097/GRF.0b013e3181eb68fe; *PMMRC, 2010, 4 PMMRC MIN HLTH; PRESTON P, 2010, J PAEDIAT CHILD H S3, V46, P45; Ravelli ACJ, 2011, J EPIDEMIOL COMMUN H, V65, P696, DOI 10.1136/jech.2009.095406; Richardus J H, 2003, J Matern Fetal Neonatal Med, V14, P267, DOI 10.1080/713606659; Roberts CL, 2000, AUST NZ J PUBL HEAL, V24, P291, DOI 10.1111/j.1467-842X.2000.tb01571.x; Robson S, 2006, AUST NZ J OBSTET GYN, V46, P305, DOI 10.1111/j.1479-828X.2006.00597.x; Rotter T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006632.pub2; *ROYAL COLL PAED C, 2002, FUT PAED PATH SERV F; Saastad E, 2007, ACTA OBSTET GYN SCAN, V86, P444, DOI 10.1080/00016340701207724; Salihu H, 2004, OBSTET GYNECOL, V104, P734, DOI 10.1097/01.AOG.0000139944.15133.e3; Salihu HM, 2003, OBSTET GYNECOL, V102, P1006, DOI 10.1016/S0029-7844(03)00739-7; Silver RM, 2007, OBSTET GYNECOL, V109, P153, DOI 10.1097/01.AOG.0000248537.89739.96; Silver RM, 2007, AM J OBSTET GYNECOL, V196, P433, DOI 10.1016/j.ajog.2006.11.041; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Smith GCS, 2010, JAMA-J AM MED ASSOC, V303, P561, DOI 10.1001/jama.2010.102; Stade BC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004228.pub2; Stock SJ, 2010, EUR J OBSTET GYN R B, V153, P148, DOI 10.1016/j.ejogrb.2010.07.022; Streuling I, 2010, AM J CLIN NUTR, V92, P678, DOI 10.3945/ajcn.2010.29363; Sun CCJ, 2002, ARCH PATHOL LAB MED, V126, P706; Tan K. H., 1999, SMJ, V40, P251; Thomas LH, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000349, DOI 10.1002/14651858.CD000349]; Thornton CM, 1998, BRIT J OBSTET GYNAEC, V105, P18, DOI 10.1111/j.1471-0528.1998.tb09344.x; Tieu J, 2010, COCHRANE DB SYST REV, V12; TUGWELL P, 1985, J CHRON DIS, V38, P339, DOI 10.1016/0021-9681(85)90080-3; Tveit JVH, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-32; Van Diem M, 2010, ACTA OBSTET GYN SCAN, V89, P1168, DOI 10.3109/00016349.2010.500468; VERKERK PH, 1993, EARLY HUM DEV, V32, P121, DOI 10.1016/0378-3782(93)90006-G; Vintzileos AM, 2002, OBSTET GYNECOL, V99, P483, DOI 10.1016/S0029-7844(01)01758-6; Vredevoogd C B, 2001, Ned Tijdschr Geneeskd, V145, P482; VUJANIC GM, 1995, J CLIN PATHOL, V48, P998, DOI 10.1136/jcp.48.11.998; *W MIDL PER I, 2009, W MIDL KEY HLTH DAT, pCH13; Whitworth M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007058.pub2; Whitworth M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007536.pub2; WIGGLESWORTH JS, 1987, ARCH DIS CHILD, V62, P1207, DOI 10.1136/adc.62.12.1207; Willinger M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.057; Wolleswinkel-van den Bosch JH, 2002, ACTA OBSTET GYN SCAN, V81, P17, DOI 10.1034/j.1600-0412.2002.810104.x; Woods R, 2008, B WORLD HEALTH ORGAN, V86, P460, DOI 10.2471/BLT.07.043471; Wright C, 1998, BRIT J OBSTET GYNAEC, V105, P24, DOI 10.1111/j.1471-0528.1998.tb09345.x; Wylie BJ, 2010, OBSTET GYNECOL, V115, P1039, DOI 10.1097/AOG.0b013e3181da7929; Yakoob MY, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S3; YUDKIN PL, 1987, LANCET, V1, P1192; [No title captured]	155	301	309	3	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2011	377	9778					1703	1717		10.1016/S0140-6736(11)60064-0	http://dx.doi.org/10.1016/S0140-6736(11)60064-0			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	766JF	21496907				2022-12-28	WOS:000290777700035
J	Huismans, R; Beaumont, C				Huismans, Ritske; Beaumont, Christopher			Depth-dependent extension, two-stage breakup and cratonic underplating at rifted margins	NATURE			English	Article							CONTINENTAL-CRUST; UPPER-MANTLE; LITHOSPHERIC MANTLE; DEEP-STRUCTURE; EVOLUTION; WAVE; ARCHITECTURE; CONSTRAINTS; MODELS; ORIGIN	Uniform lithospheric extension(1) predicts basic properties of nonvolcanic rifted margins but fails to explain other important characteristics(2,3). Significant discrepancies are observed at 'type I' margins (such as the Iberia-Newfoundland conjugates), where large tracts of continental mantle lithosphere are exposed at the sea floor(4), and 'type II' margins (such as some ultrawide central South Atlantic margins), where thin continental crust spans wide regions below which continental lower crust and mantle lithosphere have apparently been removed(5,6). Neither corresponds to uniform extension. Instead, either crust or mantle lithosphere has been preferentially removed. Using dynamical models, we demonstrate that these margins are opposite end members: in type I, depth-dependent extension results in crustal-necking breakup before mantle-lithosphere breakup and in type II, the converse is true. These two-layer, two-stage breakup behaviours explain the discrepancies and have implications for the styles of the associated sedimentary basins. Laterally flowing lower-mantle cratonic lithosphere may underplate some type II margins, thereby contributing to their anomalous characteristics.	[Huismans, Ritske] Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway; [Beaumont, Christopher] Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada	University of Bergen; Dalhousie University	Huismans, R (corresponding author), Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway.	ritske.huismans@geo.uib.no	Huismans, Ritske/C-3938-2013	Huismans, Ritske S./0000-0003-0548-6591	Department of Earth Science, University of Bergen, Norway; Canada Research Chair in Geodynamics	Department of Earth Science, University of Bergen, Norway; Canada Research Chair in Geodynamics(Canada Research Chairs)	R.H. acknowledges support of the Department of Earth Science, University of Bergen, Norway. C.B. acknowledges support of the Canada Research Chair in Geodynamics. We thank G. Karner for comments on the manuscript.	Aslanian D, 2009, TECTONOPHYSICS, V468, P98, DOI 10.1016/j.tecto.2008.12.016; Begg GC, 2009, GEOSPHERE, V5, P23, DOI 10.1130/GES00179.1; Contrucci I, 2004, GEOPHYS J INT, V158, P529, DOI 10.1111/j.1365-246X.2004.02303.x; DAVIS M, 2004, P NSF RIFTED MARGINS, V1, P92; Dupre S, 2007, MAR PETROL GEOL, V24, P151, DOI 10.1016/j.marpetgeo.2006.11.003; Fishwick S, 2008, TECTONICS, V27, DOI 10.1029/2007TC002116; Fraser SI, 2007, PETROL GEOSCI, V13, P99, DOI 10.1144/1354-079307-749; FULLSACK P, 1995, GEOPHYS J INT, V120, P1, DOI 10.1111/j.1365-246X.1995.tb05908.x; GLEASON GC, 1995, TECTONOPHYSICS, V247, P1, DOI 10.1016/0040-1951(95)00011-B; Griffin WL, 2009, J PETROL, V50, P1185, DOI 10.1093/petrology/egn033; HALLIDAY AN, 1988, J PETROL, V29, P181, DOI 10.1093/petrology/29.1.181; Huismans RS, 2007, GEOL SOC SPEC PUBL, V282, P111, DOI 10.1144/SP282.6; Huismans RS, 2008, GEOLOGY, V36, P163, DOI 10.1130/G24231A.1; Huismans RS, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002026; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; Karner GD, 2007, GEOL SOC SPEC PUBL, V285, P15, DOI 10.1144/SP285.2; Karner GD, 1999, GEOL SOC SPEC PUBL, V164, P271, DOI 10.1144/GSL.SP.1999.164.01.14; King SD, 2005, EARTH PLANET SC LETT, V234, P1, DOI 10.1016/j.epsl.2005.03.007; MCKENZIE D, 1978, EARTH PLANET SC LETT, V40, P25, DOI 10.1016/0012-821X(78)90071-7; McKenzie D, 2008, LITHOS, V102, P1, DOI 10.1016/j.lithos.2007.05.005; Moulin M, 2005, GEOPHYS J INT, V162, P793, DOI 10.1111/j.1365-246X.2005.02668.x; O'Reilly SY, 2009, LITHOS, V112, P1043, DOI 10.1016/j.lithos.2009.04.028; Peron-Pinvidic G, 2007, TECTONICS, V26, DOI 10.1029/2006TC001970; Peron-Pinvidic G, 2009, INT J EARTH SCI, V98, P1581, DOI 10.1007/s00531-008-0337-9; Rankenburg K, 2005, J PETROL, V46, P169, DOI 10.1093/petrology/egh067; Regelous M, 2009, LITHOS, V112, P57, DOI 10.1016/j.lithos.2008.10.012; Reston T, 2007, GEOLOGY, V35, P367, DOI 10.1130/G23213A.1; Ritsema J, 2000, GEOLOGY, V28, P63, DOI 10.1130/0091-7613(2000)028<0063:NSMOTU>2.3.CO;2; ROYDEN L, 1980, EARTH PLANET SC LETT, V51, P343, DOI 10.1016/0012-821X(80)90216-2; Sebai A, 2006, PHYS EARTH PLANET IN, V155, P48, DOI 10.1016/j.pepi.2005.09.009; Simons FJ, 1999, LITHOS, V48, P17, DOI 10.1016/S0024-4937(99)00041-9; Sleep NH, 2005, ANNU REV EARTH PL SC, V33, P369, DOI 10.1146/annurev.earth.33.092203.122643; Van Avendonk HJA, 2009, TECTONOPHYSICS, V468, P131, DOI 10.1016/j.tecto.2008.05.030; WERNICKE B, 1985, CAN J EARTH SCI, V22, P108, DOI 10.1139/e85-009; Whitmarsh RB, 2001, NATURE, V413, P150, DOI 10.1038/35093085; Willett SD, 1999, TECTONOPHYSICS, V305, P419, DOI 10.1016/S0040-1951(99)00034-7	36	375	399	2	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					74	U85		10.1038/nature09988	http://dx.doi.org/10.1038/nature09988			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544144				2022-12-28	WOS:000290218300033
J	Stolarz-Skrzypek, K; Kuznetsova, T; Thijs, L; Tikhonoff, V; Seidlerova, J; Richart, T; Jin, Y; Olszanecka, A; Malyutina, S; Casiglia, E; Filipovsky, J; Kawecka-Jaszcz, K; Nikitin, Y; Staessen, JA				Stolarz-Skrzypek, Katarzyna; Kuznetsova, Tatiana; Thijs, Lutgarde; Tikhonoff, Valerie; Seidlerova, Jitka; Richart, Tom; Jin, Yu; Olszanecka, Agnieszka; Malyutina, Sofia; Casiglia, Edoardo; Filipovsky, Jan; Kawecka-Jaszcz, Kalina; Nikitin, Yuri; Staessen, Jan A.		European Project Genes Hypertensio	Fatal and Nonfatal Outcomes, Incidence of Hypertension, and Blood Pressure Changes in Relation to Urinary Sodium Excretion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REDUCED DIETARY-SODIUM; CARDIOVASCULAR-DISEASE; SALT INTAKE; NATIONAL-HEALTH; POTASSIUM; MORTALITY; RISK; POPULATION; METAANALYSIS; CONSUMPTION	Context Extrapolations from observational studies and short-term intervention trials suggest that population-wide moderation of salt intake might reduce cardiovascular events. Objective To assess whether 24-hour urinary sodium excretion predicts blood pressure (BP) and health outcomes. Design, Setting, and Participants Prospective population study, involving 3681 participants without cardiovascular disease (CVD) who are members of families that were randomly enrolled in the Flemish Study on Genes, Environment, and Health Outcomes (1985-2004) or in the European Project on Genes in Hypertension (1999-2001). Of 3681 participants without CVD, 2096 were normotensive at baseline and 1499 had BP and sodium excretion measured at baseline and last follow-up (2005-2008). Main Outcome Measures Incidence of mortality and morbidity and association between changes in BP and sodium excretion. Multivariable-adjusted hazard ratios (HRs) express the risk in tertiles of sodium excretion relative to average risk in the whole study population. Results Among 3681 participants followed up for a median 7.9 years, CVD deaths decreased across increasing tertiles of 24-hour sodium excretion, from 50 deaths in the low (mean, 107 mmol), 24 in the medium (mean, 168 mmol), and 10 in the high excretion group (mean, 260 mmol; P<.001), resulting in respective death rates of 4.1% (95% confidence interval [CI], 3.5%-4.7%), 1.9% (95% CI, 1.5%-2.3%), and 0.8% (95% CI, 0.5%-1.1%). In multivariable-adjusted analyses, this inverse association retained significance (P=.02): the HR in the low tertile was 1.56 (95% CI, 1.02-2.36; P=.04). Baseline sodium excretion predicted neither total mortality (P=.10) nor fatal combined with nonfatal CVD events (P=.55). Among 2096 participants followed up for 6.5 years, the risk of hypertension did not increase across increasing tertiles (P=.93). Incident hypertension was 187 (27.0%; HR, 1.00; 95% CI, 0.87-1.16) in the low, 190 (26.6%; HR, 1.02; 95% CI, 0.89-1.16) in the medium, and 175 (25.4%; HR, 0.98; 95% CI, 0.86-1.12) in the high sodium excretion group. In 1499 participants followed up for 6.1 years, systolic blood pressure increased by 0.37 mm Hg per year (P<.001), whereas sodium excretion did not change (-0.45 mmol per year, P=.15). However, in multivariable-adjusted analyses, a 100-mmol increase in sodium excretion was associated with 1.71 mm Hg increase in systolic blood pressure (P.<001) but no change in diastolic BP. Conclusions In this population-based cohort, systolic blood pressure, but not diastolic pressure, changes over time aligned with change in sodium excretion, but this association did not translate into a higher risk of hypertension or CVD complications. Lower sodium excretion was associated with higher CVD mortality. JAMA. 2011;305(17):1777-1785 www.jama.com	[Staessen, Jan A.] Katholieke Univ Leuven, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, Dept Cardiovasc Dis,Lab Hypertens, BE-3000 Louvain, Belgium; [Stolarz-Skrzypek, Katarzyna; Olszanecka, Agnieszka; Kawecka-Jaszcz, Kalina] Jagiellonian Univ, Coll Med, Dept Cardiol & Hypertens 1, Krakow, Poland; [Tikhonoff, Valerie; Casiglia, Edoardo] Univ Padua, Dept Clin & Expt Med, Padua, Italy; [Seidlerova, Jitka; Filipovsky, Jan] Charles Univ Prague, Fac Med Pilsen, Plzen, Czech Republic; [Malyutina, Sofia; Nikitin, Yuri] Inst Internal Med, Novosibirsk, Russia; [Richart, Tom; Staessen, Jan A.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands	KU Leuven; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Padua; Charles University Prague; Maastricht University	Staessen, JA (corresponding author), Katholieke Univ Leuven, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, Dept Cardiovasc Dis,Lab Hypertens, Campus Sint Rafael,Kapucijnenvoer 35,Block D,POB, BE-3000 Louvain, Belgium.	jan.staessen@med.kuleuven.be	Seidlerova, Jitka/P-1188-2017; Malyutina, Sofia/J-1651-2018; Kuznetsova, Tatiana/ABI-5662-2020; Staessen, Jan A/A-1065-2011; Tikhonoff, Valerie/AAC-3728-2019; Nikitin, Yuri/D-2774-2018; Stolarz-Skrzypek, Katarzyna/E-1589-2011	Seidlerova, Jitka/0000-0002-2731-4961; Malyutina, Sofia/0000-0001-6539-0466; Kuznetsova, Tatiana/0000-0003-4293-4576; Staessen, Jan A/0000-0002-3026-1637; Tikhonoff, Valerie/0000-0001-7846-0101; Nikitin, Yuri/0000-0002-3932-2299; Thijs, Lutgarde/0000-0002-8108-2356; Casiglia, Edoardo/0000-0002-0003-3289; Olszanecka, Agnieszka/0000-0001-7020-9641	European Union [IC15-CT98-0329-EPOGH, LSHM-CT-2006-037093]; Studies Coordinating Centre (Leuven, Belgium) [HEALTH-F4-2007-201550]; studies in Pilsen (Czech Republic); studies in Pilsen, Padova (Italy); studies in Pilsen, Krakow (Poland); Novosibirsk (Russian Federation); Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0575.06, G.0734.09]; Katholieke Universiteit Leuven, Belgium [OT/00/25, OT/05/49]; Polish Ministry for Science and Higher Education; Czech Society of Hypertension	European Union(European Commission); Studies Coordinating Centre (Leuven, Belgium); studies in Pilsen (Czech Republic)(Czech Republic Government); studies in Pilsen, Padova (Italy); studies in Pilsen, Krakow (Poland); Novosibirsk (Russian Federation)(Russian Federation); Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium(FWO); Katholieke Universiteit Leuven, Belgium(KU Leuven); Polish Ministry for Science and Higher Education(Ministry of Science and Higher Education, Poland); Czech Society of Hypertension	The European Union grants IC15-CT98-0329-EPOGH, LSHM-CT-2006-037093. InGenious HyperCare, and HEALTH-F4-2007-201550 HyperGenes supported the Studies Coordinating Centre (Leuven, Belgium) and the studies in Pilsen (Czech Republic), Padova (Italy), Krakow (Poland), and Novosibirsk (Russian Federation). The Studies Coordinating Centre also received grants G.0575.06 and G.0734.09 from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium, and the grants OT/00/25 and OT/05/49 from the Katholieke Universiteit Leuven, Belgium. The Polish Ministry for Science and Higher Education supported the fellowship of Dr Stolarz-Skrzypek in Leuven. The Czech Society of Hypertension provided additional funding to Dr Seidlerova.	ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144; Alderman MH, 1998, LANCET, V351, P781, DOI 10.1016/S0140-6736(97)09092-2; Alderman MH, 2010, JAMA-J AM MED ASSOC, V303, P448, DOI 10.1001/jama.2010.69; Bernstein AM, 2010, AM J CLIN NUTR, V92, P1172, DOI 10.3945/ajcn.2010.29367; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Campese VM, 1999, NUTR METAB CARDIOVAS, V9, P143; Chien KL, 2008, J HYPERTENS, V26, P1750, DOI 10.1097/HJH.0b013e328306a0a7; CLELAND JGF, 1987, BRIT HEART J, V58, P230; Cohen HW, 2008, J GEN INTERN MED, V23, P1297, DOI 10.1007/s11606-008-0645-6; Cohen HW, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.042; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; ELLIOTT P, 1988, BRIT MED J, V297, P319; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Franklin SS, 1997, CIRCULATION, V96, P308; Gavin JR, 1999, DIABETES CARE, V22, pS5; GELEIJNSE JM, 1990, BMJ-BRIT MED J, V300, P899, DOI 10.1136/bmj.300.6729.899; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Hansen TW, 2010, HYPERTENSION, V55, P1049, DOI [10.1161/HYPERTENSIONAHA.109.140798, 10.1161/HYP.0b013e3181dfc0ad]; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; He JA, 2000, HYPERTENSION, V35, P544, DOI 10.1161/01.HYP.35.2.544; He JA, 1999, JAMA-J AM MED ASSOC, V282, P2027, DOI 10.1001/jama.282.21.2027; HOSMER DW, 1989, APPL LOGISTIC REGRES; KAGAN A, 1985, STROKE, V16, P390, DOI 10.1161/01.STR.16.3.390; Kuznetsova T, 2002, BLOOD PRESS MONIT, V7, P215, DOI 10.1097/00126097-200208000-00003; LEVER AF, 1981, BRIT MED J, V283, P463, DOI 10.1136/bmj.283.6289.463; Li Y, 2007, HYPERTENSION, V49, P1291, DOI 10.1161/HYPERTENSIONAHA.106.085498; LUFT FC, 1982, HYPERTENSION, V4, P805, DOI 10.1161/01.HYP.4.6.805; McCarron DA, 2009, CLIN J AM SOC NEPHRO, V4, P1878, DOI 10.2215/CJN.04660709; Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590; Morris RC, 1999, HYPERTENSION, V33, P18, DOI 10.1161/01.HYP.33.1.18; Palar K, 2009, AM J HEALTH PROMOT, V24, P49, DOI 10.4278/ajhp.080826-QUAN-164; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Schmidlin O, 1999, HYPERTENSION, V33, P633, DOI 10.1161/01.HYP.33.2.633; SMITH WCS, 1988, BRIT MED J, V297, P329, DOI 10.1136/bmj.297.6644.329; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; STAESSEN J, 1983, AM J EPIDEMIOL, V117, P676, DOI 10.1093/oxfordjournals.aje.a113601; STAESSEN J, 1988, J HYPERTENS, V6, P965, DOI 10.1097/00004872-198812000-00003; Staessen JA, 2001, J HYPERTENS, V19, P1349, DOI 10.1097/00004872-200108000-00002; Staessen JA, 1997, AM J CLIN NUTR, V65, P661; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; TunstallPedoe H, 1997, BRIT MED J, V315, P722, DOI 10.1136/bmj.315.7110.722; Tuomilehto J, 2001, LANCET, V357, P848, DOI 10.1016/S0140-6736(00)04199-4; Umesawa M, 2008, AM J CLIN NUTR, V88, P195, DOI 10.1093/ajcn/88.1.195; *WORLD MED ASS DEC, 1997, JAMA-J AM MED ASSOC, V277, P925, DOI DOI 10.1001/JAMA.1997.03540350075038	45	417	429	0	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1777	1785		10.1001/jama.2011.574	http://dx.doi.org/10.1001/jama.2011.574			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758HZ	21540421	Green Published, Bronze			2022-12-28	WOS:000290156200018
J	Kippenberg, TJ; Holzwarth, R; Diddams, SA				Kippenberg, T. J.; Holzwarth, R.; Diddams, S. A.			Microresonator-Based Optical Frequency Combs	SCIENCE			English	Review							MODE-LOCKED LASERS; PHASE-CONTROL; SPECTROSCOPY; GENERATION; METROLOGY; CHIP; ION	The series of precisely spaced, sharp spectral lines that form an optical frequency comb is enabling unprecedented measurement capabilities and new applications in a wide range of topics that include precision spectroscopy, atomic clocks, ultracold gases, and molecular fingerprinting. A new optical frequency comb generation principle has emerged that uses parametric frequency conversion in high resonance quality factor (Q) microresonators. This approach provides access to high repetition rates in the range of 10 to 1000 gigahertz through compact, chip-scale integration, permitting an increased number of comb applications, such as in astronomy, microwave photonics, or telecommunications. We review this emerging area and discuss opportunities that it presents for novel technologies as well as for fundamental science.	[Kippenberg, T. J.] Swiss Fed Inst Technol Lausanne EPFL, CH-1015 Lausanne, Switzerland; [Holzwarth, R.] Menlo Syst GmbH, Martinsried, Germany; [Kippenberg, T. J.; Holzwarth, R.] Max Planck Inst Quantentopt, Garching, Germany; [Diddams, S. A.] NIST, Boulder, CO 80305 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Menlo Systems GmbH; Max Planck Society; National Institute of Standards & Technology (NIST) - USA	Kippenberg, TJ (corresponding author), Swiss Fed Inst Technol Lausanne EPFL, CH-1015 Lausanne, Switzerland.	tobias.kippenberg@epfl.ch; scott.diddams@nist.gov	Kippenberg, T. J./B-3133-2013; Diddams, Scott A/L-2819-2013	Kippenberg, T. J./0000-0002-3408-886X; Diddams, Scott A/0000-0002-2144-0764	Marie Curie Industry-Academia Partnerships and Pathways; Swiss National Science Foundation; National Centre of Competence in Research (NCCR) of Quantum Photonics; NCCR NanoTera; T.W. Hansch; NIST	Marie Curie Industry-Academia Partnerships and Pathways; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research (NCCR) of Quantum Photonics(Swiss National Science Foundation (SNSF)); NCCR NanoTera; T.W. Hansch; NIST(National Institute of Standards & Technology (NIST) - USA)	The authors thank P. Del Haye and D. Heinecke for comments and preparation of the figures and A. Gaeta, L. Maleki, A. Matsko, and D. Moss for providing data and images. We further appreciate the thoughtful comments of S. Papp and D. Leibfried. T.J.K. and R.H. acknowledge support by a Marie Curie Industry-Academia Partnerships and Pathways, and T.J.K. acknowledges further support by the Swiss National Science Foundation, the National Centre of Competence in Research (NCCR) of Quantum Photonics, and the NCCR NanoTera. T.J.K. thanks T.W. Hansch for support. S.A.D. acknowledges support from NIST.	Agha IH, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.043837; Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Bartels A, 2009, SCIENCE, V326, P681, DOI 10.1126/science.1179112; Blatt S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.140801; BRAGINSKY VB, 1989, PHYS LETT A, V137, P393, DOI 10.1016/0375-9601(89)90912-2; Braje D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.193902; Chou CW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070802; Coddington I, 2009, NAT PHOTONICS, V3, P351, DOI 10.1038/NPHOTON.2009.94; Coddington I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013902; Cundiff ST, 2003, REV MOD PHYS, V75, P325, DOI 10.1103/RevModPhys.75.325; Del'Haye P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.053903; Del'Haye P, 2007, NATURE, V450, P1214, DOI 10.1038/nature06401; Diddams SA, 2001, SCIENCE, V293, P825, DOI 10.1126/science.1061171; Diddams SA, 2007, NATURE, V445, P627, DOI 10.1038/nature05524; Foster MA, 2006, NATURE, V441, P960, DOI 10.1038/nature04932; Gohle C, 2005, NATURE, V436, P234, DOI 10.1038/nature03851; Huang CB, 2008, LASER PHOTONICS REV, V2, P227, DOI 10.1002/lpor.200810001; Ilchenko VS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.043903; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; Jones RJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.193201; Keilmann F, 2004, OPT LETT, V29, P1542, DOI 10.1364/OL.29.001542; Keller U, 2003, NATURE, V424, P831, DOI 10.1038/nature01938; Kippenberg TJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.083904; Leuthold J, 2010, NAT PHOTONICS, V4, P535, DOI [10.1038/NPHOTON.2010.185, 10.1038/nphoton.2010.185]; Levy JS, 2010, NAT PHOTONICS, V4, P37, DOI 10.1038/NPHOTON.2009.259; Li CH, 2008, NATURE, V452, P610, DOI 10.1038/nature06854; McFerran JJ, 2005, ELECTRON LETT, V41, P650, DOI 10.1049/el:20050505; Razzari L, 2010, NAT PHOTONICS, V4, P41, DOI 10.1038/NPHOTON.2009.236; Reichert J, 1999, OPT COMMUN, V172, P59, DOI 10.1016/S0030-4018(99)00491-5; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Savchenkov AA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.243905; Savchenkov AA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.093902; Steinmetz T, 2008, SCIENCE, V321, P1335, DOI 10.1126/science.1161030; Stowe MC, 2008, ADV ATOM MOL OPT PHY, V55, P1, DOI 10.1016/S1049-250X(07)55001-9; Telle HR, 1999, APPL PHYS B-LASERS O, V69, P327, DOI 10.1007/s003400050813; Thorpe MJ, 2006, SCIENCE, V311, P1595, DOI 10.1126/science.1123921; Udem T, 2002, NATURE, V416, P233, DOI 10.1038/416233a; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939	38	1412	1458	48	791	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029					555	559		10.1126/science.1193968	http://dx.doi.org/10.1126/science.1193968			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527707				2022-12-28	WOS:000289991100039
J	Koenig, J; Linder, AN; Leutgeb, JK; Leutgeb, S				Koenig, Julie; Linder, Ashley N.; Leutgeb, Jill K.; Leutgeb, Stefan			The Spatial Periodicity of Grid Cells Is Not Sustained During Reduced Theta Oscillations	SCIENCE			English	Article							ENTORHINAL CORTEX; PLACE CELLS; UNIT-ACTIVITY; HIPPOCAMPUS; NEURONS; INTERFERENCE; NAVIGATION; FREQUENCY; SEPTUM; PHASE	Grid cells in parahippocampal cortices fire at vertices of a periodic triangular grid that spans the entire recording environment. Such precise neural computations in space have been proposed to emerge from equally precise temporal oscillations within cells or within the local neural circuitry. We found that grid-like firing patterns in the entorhinal cortex vanished when theta oscillations were reduced after intraseptal lidocaine infusions in rats. Other spatially modulated cells in the same cortical region and place cells in the hippocampus retained their spatial firing patterns to a larger extent during these periods without well-organized oscillatory neuronal activity. Precisely timed neural activity within single cells or local networks is thus required for periodic spatial firing but not for single place fields.	[Leutgeb, Stefan] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, San Diego, CA 92103 USA; Univ Calif San Diego, Ctr Neural Circuits & Behav, Div Biol Sci, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Leutgeb, S (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, San Diego, CA 92103 USA.	sleutgeb@ucsd.edu	koenig, julie/O-7865-2016	koenig, julie/0000-0003-0516-6627; Leutgeb, Jill/0000-0002-2014-842X	NSF/NIH/Bundesministerium fur Bildung und Forschung [1010463]; Ellison Medical Foundation [AG-NS-0724-10]; Alfred P. Sloan Foundation; Alzheimer's Association [NIRG-09-133414]	NSF/NIH/Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Alzheimer's Association(Alzheimer's Association)	The authors thank T. Solstad and E. Mankin for Matlab scripts and M. Hasselmo, L. Squire, and M. Scanziani for comments and discussions. Supported by the Walter F. Heiligenberg Professorship, NSF/NIH/Bundesministerium fur Bildung und Forschung grant 1010463, Ellison Medical Foundation grant AG-NS-0724-10, the Alfred P. Sloan Foundation, and Alzheimer's Association grant NIRG-09-133414.	Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Brazhnik E, 2004, J NEUROSCI, V24, P9313, DOI 10.1523/JNEUROSCI.1618-04.2004; Burgess N, 1996, HIPPOCAMPUS, V6, P749; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Dickson CT, 2000, ANN NY ACAD SCI, V911, P127; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; JEFFERY KJ, 1995, NEUROREPORT, V6, P2166, DOI 10.1097/00001756-199511000-00017; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; MIZUMORI SJY, 1989, J NEUROSCI, V9, P3915; MIZUMORI SJY, 1989, BRAIN RES, V500, P99, DOI 10.1016/0006-8993(89)90303-X; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; PETSCHE H, 1962, ELECTROEN CLIN NEURO, V14, P202, DOI 10.1016/0013-4694(62)90030-5; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; TAUBE JS, 1990, J NEUROSCI, V10, P420; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	27	278	280	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					592	595		10.1126/science.1201685	http://dx.doi.org/10.1126/science.1201685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527713				2022-12-28	WOS:000289991100050
J	Poisson, J; McCudden, C				Poisson, Jessica; McCudden, Christopher			Digital Gangrene	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Poisson, Jessica; McCudden, Christopher] Univ N Carolina, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Poisson, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.			McCudden, Christopher/0000-0002-4172-4641					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					E34	E34		10.1056/NEJMicm1006821	http://dx.doi.org/10.1056/NEJMicm1006821			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21506739				2022-12-28	WOS:000289722700013
J	West-Eberhard, MJ; Smith, JAC; Winter, K				West-Eberhard, Mary Jane; Smith, J. Andrew C.; Winter, Klaus			Photosynthesis, Reorganized	SCIENCE			English	Editorial Material							CRASSULACEAN ACID METABOLISM; EVOLUTIONARY; EXPRESSION; ORIGINS		[West-Eberhard, Mary Jane] Univ Costa Rica, Smithsonian Trop Res Inst, Escuela Biol, San Pedro, Costa Rica; [Smith, J. Andrew C.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Winter, Klaus] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Costa Rica; University of Oxford; Smithsonian Institution; Smithsonian Tropical Research Institute	West-Eberhard, MJ (corresponding author), Univ Costa Rica, Smithsonian Trop Res Inst, Escuela Biol, San Pedro, Costa Rica.	mjwe@sent.com; andrew.smith@plants.ox.ac.uk; winterk@si.edu	Smith, J.A.C./M-3338-2014	Smith, J.A.C./0000-0001-9188-0258				Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Boxall SF, 2005, PLANT PHYSIOL, V137, P969, DOI 10.1104/pp.104.054577; Brown NJ, 2011, SCIENCE, V331, P1436, DOI 10.1126/science.1201248; Christin PA, 2010, TRENDS GENET, V26, P400, DOI 10.1016/j.tig.2010.06.005; Crayn DM, 2004, P NATL ACAD SCI USA, V101, P3703, DOI 10.1073/pnas.0400366101; Cushman JC, 1997, PLANT PHYSIOL, V113, P667, DOI 10.1104/pp.113.3.667; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Hibberd JM, 2010, ANNU REV PLANT BIOL, V61, P181, DOI 10.1146/annurev-arplant-042809-112238; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Silvera K, 2009, PLANT PHYSIOL, V149, P1838, DOI 10.1104/pp.108.132555; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; West-Eberhard Mary Jane, 2003, pi; Winter K, 1996, CRASSULACEAN ACID ME; Winter K, 2007, PLANT PHYSIOL, V143, P98, DOI 10.1104/pp.106.088922	15	43	49	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					311	312		10.1126/science.1205336	http://dx.doi.org/10.1126/science.1205336			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493847				2022-12-28	WOS:000289516600030
J	[Anonymous]				[Anonymous]			PERSONAL VIEW Junior doctors don't get enough teaching	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 13	2011	342								d2246	10.1136/bmj.d2246	http://dx.doi.org/10.1136/bmj.d2246			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752UX	21490039				2022-12-28	WOS:000289721500005
J	Sliwa, K; Stewart, S				Sliwa, Karen; Stewart, Simon			A low-cost solar-powered blood-pressure device	LANCET			English	Editorial Material							DISEASES CHRONIC DISEASES; HEART-DISEASE; SOWETO; HYPERTENSION; INSIGHTS		[Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Inst Cardiovasc Res Africa, ZA-7935 Cape Town, Western Cape, South Africa; [Stewart, Simon] Baker IDI, Melbourne, Vic, Australia	University of Cape Town; Baker Heart and Diabetes Institute	Sliwa, K (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Inst Cardiovasc Res Africa, ZA-7935 Cape Town, Western Cape, South Africa.	sliwa-hahnlek@mdh-africa.org	Stewart, Simon/M-3316-2016	Stewart, Simon/0000-0001-9032-8998; Sliwa, Karen/0000-0002-8272-0911				Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Lock K, 2010, LANCET, V376, P1699, DOI 10.1016/S0140-6736(10)61352-9; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mendis S, 2004, J HYPERTENS, V22, P59, DOI 10.1097/00004872-200401000-00013; Parati G, 2010, HYPERTENSION, V56, P1047, DOI 10.1161/HYPERTENSIONAHA.110.160408; Sliwa K, 2010, EUR HEART J, V31, P719, DOI 10.1093/eurheartj/ehp530; Stewart S, 2011, EUR HEART J, V32, P492, DOI 10.1093/eurheartj/ehq439; Stewart S, 2011, INT J CARDIOL, V146, P22, DOI 10.1016/j.ijcard.2009.05.061; Stewart S, 2009, NAT REV CARDIOL, V6, P489, DOI 10.1038/nrcardio.2009.79	9	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 20	2011	378	9792					647	648		10.1016/S0140-6736(11)60131-1	http://dx.doi.org/10.1016/S0140-6736(11)60131-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815EW	21513974				2022-12-28	WOS:000294509900008
J	Hughes, SA; Wedemeyer, H; Harrison, PM				Hughes, Sarah A.; Wedemeyer, Heiner; Harrison, Phillip M.			Hepatitis delta virus	LANCET			English	Article							B SURFACE-ANTIGEN; FRAGMENT-LENGTH-POLYMORPHISM; LIVER-TRANSPLANTATION; GENOTYPE-II; RNA-POLYMERASE; PEGYLATED INTERFERON; COMBINATION THERAPY; FULMINANT-HEPATITIS; GENETIC-VARIABILITY; VANISHING DISEASE	Hepatitis delta virus (HDV) is a small, defective RNA virus that can infect only individuals who have hepatitis B virus (HBV); worldwide more than 15 million people are co-infected. There are eight reported genotypes of HDV with unexplained variations in their geographical distribution and pathogenicity. The hepatitis D virion is composed of a coat of HBV envelope proteins surrounding the nucleocapsid, which consists of a single-stranded, circular RNA genome complexed with delta antigen, the viral protein. HDV is clinically important because although it suppresses HBV replication, it causes severe liver disease with rapid progression to cirrhosis and hepatic decompensation. The range of clinical presentation is wide, varying from mild disease to fulminant liver failure. The prevalence of HDV is declining in some endemic areas but increasing in northern and central Europe because of immigration. Treatment of HDV is with pegylated interferon alfa; however, response rates are poor. Increased understanding of the molecular virology of HDV will identify novel therapeutic targets for this most severe form of chronic viral hepatitis.	[Harrison, Phillip M.] Kings Coll London, London SE5 9PJ, England; [Hughes, Sarah A.] Kings Coll Hosp London, Inst Liver Studies, London, England; [Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Hannover Medical School	Harrison, PM (corresponding author), Kings Coll London, Denmark Hill Campus, London SE5 9PJ, England.	phillip.harrison@kcl.ac.uk	Harrison, Phillip M/D-5374-2009		Gilead; Bristol-Myers Squibb; Phytopharm; Schering Plough; Novartis; Roche	Gilead(Gilead Sciences); Bristol-Myers Squibb(Bristol-Myers Squibb); Phytopharm; Schering Plough(Merck & CompanySchering Plough Corporation); Novartis(Novartis); Roche(Roche Holding)	PMH has received payment for board membership from Roche; consultancy fees from Gilead, Bristol-Myers Squibb, and Phytopharm; and payment for participation in a speakers' bureau from Gilead and Bristol-Myers Squibb. HW has received payment for board membership from Roche, Gilead, Bristol-Myers Squibb, and Schering Plough; consultancy fees from Roche and Novartis: grant support from Roche and Gilead; payment for participation in a speakers' bureau from Roche, Gilead, Bristol-Myers Squibb, Schering Plough, and Novartis; and payment for developing educational presentations from Roche. SAH declares that she has no conflicts of interest	Abbas Z, 2010, WORLD J GASTROENTERO, V16, P554, DOI 10.3748/wjg.v16.i5.554; Abou-Jaoude G, 2007, J VIROL, V81, P13057, DOI 10.1128/JVI.01495-07; Abou-Jaoude G, 2007, VIROLOGY, V365, P204, DOI 10.1016/j.virol.2007.03.030; ACTIS GC, 1987, DIGESTION, V37, P51, DOI 10.1159/000199487; Aslan N, 2006, J VIRAL HEPATITIS, V13, P505, DOI 10.1111/j.1365-2893.2006.00723.x; Aslan N, 2003, J HEPATOL, V38, P15, DOI 10.1016/S0168-8278(03)80457-9; Barrera A, 2005, J VIROL, V79, P9786, DOI 10.1128/JVI.79.15.9786-9798.2005; Bordier BB, 2003, J CLIN INVEST, V112, P407, DOI 10.1172/JCI200317704; Borresen ML, 2010, J VIRAL HEPATITIS, V17, P162, DOI 10.1111/j.1365-2893.2009.01159.x; Boyd A, 2010, J VIRAL HEPATITIS, V17, P65, DOI 10.1111/j.1365-2893.2009.01153.x; BRANCH AD, 1989, SCIENCE, V243, P649, DOI 10.1126/science.2492676; Canbakan B, 2006, J GASTROEN HEPATOL, V21, P657, DOI 10.1111/j.1440-1746.2006.04082.x; Casey JL, 1996, J INFECT DIS, V174, P920, DOI 10.1093/infdis/174.5.920; CASEY JL, 1993, P NATL ACAD SCI USA, V90, P9016, DOI 10.1073/pnas.90.19.9016; Castelnau C, 2006, HEPATOLOGY, V44, P728, DOI 10.1002/hep.21325; Chakraborty P, 2005, INDIAN J MED RES, V122, P254; CHANG MF, 1994, J VIROL, V68, P646, DOI 10.1128/JVI.68.2.646-653.1994; Chen YS, 2008, J VIROL, V82, P9345, DOI 10.1128/JVI.00656-08; COLOMBO M, 1983, GASTROENTEROLOGY, V85, P235; Cross TJS, 2008, J MED VIROL, V80, P277, DOI 10.1002/jmv.21078; Degertekin H, 2008, LIVER INT, V28, P494, DOI 10.1111/j.1478-3231.2008.01673.x; Deny P, 2006, CURR TOP MICROBIOL, V307, P151; DiMarco V, 1996, J VIRAL HEPATITIS, V3, P123; Engelke M, 2006, HEPATOLOGY, V43, P750, DOI 10.1002/hep.21112; Erhardt A, 2006, LIVER INT, V26, P805, DOI 10.1111/j.1478-3231.2006.01279.x; FARCI P, 1983, GASTROENTEROLOGY, V85, P669; Farci P, 2003, J HEPATOL, V39, pS212, DOI 10.1016/S0168-8278(03)00331-3; Farci P, 2004, GASTROENTEROLOGY, V126, P1740, DOI 10.1053/j.gastro.2004.03.017; Fattovich G, 2000, GUT, V46, P420, DOI 10.1136/gut.46.3.420; FATTOVICH G, 1987, J INFECT DIS, V155, P931, DOI 10.1093/infdis/155.5.931; Flodgren E, 2000, J CLIN MICROBIOL, V38, P3311, DOI 10.1128/JCM.38.9.3311-3316.2000; Gaeta GB, 2000, HEPATOLOGY, V32, P824, DOI 10.1053/jhep.2000.17711; Gaeta GB, 2007, HEPATOLOGY, V46, P1312, DOI 10.1002/hep.21816; GARRIPOLI A, 1994, LIVER, V14, P154; Glebe D, 2005, GASTROENTEROLOGY, V129, P234, DOI 10.1053/j.gastro.2005.03.090; GLENN JS, 1992, SCIENCE, V256, P1331, DOI 10.1126/science.1598578; Gordien E, 2001, J VIROL, V75, P2684, DOI 10.1128/JVI.75.6.2684-2691.2001; GOVINDARAJAN S, 1984, GASTROENTEROLOGY, V86, P1417; GOVINDARAJAN S, 1983, GASTROENTEROLOGY, V85, P160; Greco-Stewart VS, 2009, VIROLOGY, V386, P12, DOI 10.1016/j.virol.2009.02.007; Gripon P, 2005, J VIROL, V79, P1613, DOI 10.1128/JVI.79.3.1613-1622.2005; Gudima S, 2002, J VIROL, V76, P3709, DOI 10.1128/JVI.76.8.3709-3719.2002; GUILHOT S, 1994, J VIROL, V68, P1052, DOI 10.1128/JVI.68.2.1052-1058.1994; Gunsar F, 2005, ANTIVIR THER, V10, P721; HADLER SC, 1984, ANN INTERN MED, V100, P339, DOI 10.7326/0003-4819-100-3-339; HADZIYANNIS SJ, 1991, J HEPATOL, V13, pS21, DOI 10.1016/0168-8278(91)91716-T; Heidrich B, 2009, J VIRAL HEPATITIS, V16, P883, DOI 10.1111/j.1365-2893.2009.01144.x; Hong SY, 2010, J VIROL, V84, P1430, DOI 10.1128/JVI.02083-09; Hsu SC, 2000, HEPATOLOGY, V32, P1111, DOI 10.1053/jhep.2000.19257; Hsu SC, 2002, HEPATOLOGY, V35, P665, DOI 10.1053/jhep.2002.31777; Huang C, 2007, J VIROL, V81, P5985, DOI 10.1128/JVI.02809-06; Huang C, 2009, J VIROL, V83, P12314, DOI 10.1128/JVI.01044-09; Huang YH, 2004, J GEN VIROL, V85, P3089, DOI 10.1099/vir.0.80183-0; Huo TI, 1997, J GASTROEN HEPATOL, V12, P747, DOI 10.1111/j.1440-1746.1997.tb00364.x; IMAZEKI F, 1990, J VIROL, V64, P5594, DOI 10.1128/JVI.64.11.5594-5599.1990; Ivaniushina V, 2001, J GEN VIROL, V82, P2709, DOI 10.1099/0022-1317-82-11-2709; Jayan GC, 2002, J VIROL, V76, P12399, DOI 10.1128/JVI.76.23.12399-12404.2002; Kaymakoglu S, 2005, ANTIMICROB AGENTS CH, V49, P1135, DOI 10.1128/AAC.49.3.1135-1138.2005; Khan A, 2008, J MED VIROL, V80, P268, DOI 10.1002/jmv.21057; Kiesslich D, 2009, J INFECT DIS, V199, P1608, DOI 10.1086/598955; KOS A, 1986, NATURE, V323, P558, DOI 10.1038/323558a0; Krushkal J, 1995, J MOL EVOL, V41, P721; Lai MMC, 2005, J VIROL, V79, P7951, DOI 10.1128/JVI.79.13.7951-7958.2005; Lau DTY, 1999, GASTROENTEROLOGY, V117, P1229, DOI 10.1016/S0016-5085(99)70409-9; Lau DTY, 1999, HEPATOLOGY, V30, P546, DOI 10.1002/hep.510300217; Le Gal F, 2005, J CLIN MICROBIOL, V43, P2363, DOI 10.1128/JCM.43.5.2363-2369.2005; Le Gal F, 2007, HEPATOLOGY, V45, P1332, DOI 10.1002/hep.21652; Le Gal F, 2006, EMERG INFECT DIS, V12, P1447, DOI 10.3201/eid1209.060112; Lerut JP, 1999, J HEPATOL, V30, P706, DOI 10.1016/S0168-8278(99)80203-7; Lesbordes J L, 1987, Prog Clin Biol Res, V234, P451; Li YJ, 2006, J VIROL, V80, P6478, DOI 10.1128/JVI.02650-05; Li YJ, 2004, J VIROL, V78, P13325, DOI 10.1128/JVI.78.23.13325-13334.2004; Makuwa M, 2009, J CLIN MICROBIOL, V47, P2265, DOI 10.1128/JCM.02012-08; Manock SR, 2000, AM J TROP MED HYG, V63, P209, DOI 10.4269/ajtmh.2000.63.209; Mansour W, 2010, J CLIN VIROL, V47, P97, DOI 10.1016/j.jcv.2009.09.027; Mathurin P, 2000, J VIRAL HEPATITIS, V7, P15; Mederacke I, 2010, J CLIN MICROBIOL, V48, P2022, DOI 10.1128/JCM.00084-10; Mederacke I, 2009, HEPATOLOGY, V50, p547A; Monesis EK, 2007, ANTIVIR THER, V12, P381; Mulyanto, 2009, ARCH VIROL, V154, P1047, DOI 10.1007/s00705-009-0406-9; Nakano T, 2001, J GEN VIROL, V82, P2183, DOI 10.1099/0022-1317-82-9-2183; NAVASCUES CA, 1995, AM J GASTROENTEROL, V90, P1981; Nguyen VTT, 2007, J GASTROEN HEPATOL, V22, P2093, DOI 10.1111/j.1440-1746.2007.05010.x; Niro GA, 2005, ALIMENT PHARM THERAP, V22, P227, DOI 10.1111/j.1365-2036.2005.02542.x; Niro GA, 1997, HEPATOLOGY, V25, P728, DOI 10.1002/hep.510250339; Niro GA, 2001, LIVER, V21, P254, DOI 10.1034/j.1600-0676.2001.021004254.x; Niro GA, 2006, HEPATOLOGY, V44, P713, DOI 10.1002/hep.21296; Nisini R, 1997, J VIROL, V71, P2241, DOI 10.1128/JVI.71.3.2241-2251.1997; Nwokediuko SC, 2009, NIGER J CLIN PRACT, V12, P439; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Onder FO, 2009, HEPATOLOGY, V50, p735A; Parana R, 2006, AM J TROP MED HYG, V75, P475, DOI 10.4269/ajtmh.2006.75.475; Piccolo P, 2010, EUR J PUBLIC HEALTH, V20, P711, DOI 10.1093/eurpub/ckp168; PONZETTO A, 1987, J INFECT DIS, V155, P72, DOI 10.1093/infdis/155.1.72; Radjef N, 2004, J VIROL, V78, P2537, DOI 10.1128/JVI.78.5.2537-2544.2004; Raimondo G, 2006, HEPATOLOGY, V43, P100, DOI 10.1002/hep.20944; RIZZETTO M, 1990, VACCINE, V8, pS10, DOI 10.1016/0264-410X(90)90207-3; RIZZETTO M, 1983, ANN INTERN MED, V98, P437, DOI 10.7326/0003-4819-98-4-437; RIZZETTO M, 1977, GUT, V18, P997, DOI 10.1136/gut.18.12.997; RIZZETTO M, 1980, P NATL ACAD SCI-BIOL, V77, P6124, DOI 10.1073/pnas.77.10.6124; Rizzetto M, 2009, J HEPATOL, V50, P1043, DOI 10.1016/j.jhep.2009.01.004; Romeo R, 2009, GASTROENTEROLOGY, V136, P1629, DOI 10.1053/j.gastro.2009.01.052; Rosenau J, 2007, J HEPATOL, V46, P635, DOI 10.1016/j.jhep.2006.11.022; ROSENBLUM L, 1992, JAMA-J AM MED ASSOC, V267, P2477, DOI 10.1001/jama.267.18.2477; Sagnelli E, 1997, J HEPATOL, V26, P20, DOI 10.1016/S0168-8278(97)80004-9; Sagnelli E, 2000, HEPATOLOGY, V32, P1106, DOI 10.1053/jhep.2000.19288; Sakugawa H, 1999, J MED VIROL, V58, P366, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;366::AID-JMV8&gt;3.0.CO;2-X; SAKUGAWA H, 1995, J MED VIROL, V45, P312, DOI 10.1002/jmv.1890450313; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308; Salisse J, 2009, J VIROL, V83, P9321, DOI 10.1128/JVI.00678-09; SAMUEL D, 1995, HEPATOLOGY, V21, P333, DOI 10.1016/0270-9139(95)90089-6; SARACCO G, 1987, J HEPATOL, V5, P274, DOI 10.1016/S0168-8278(87)80032-6; Schaper M, 2010, J HEPATOL, V52, P658, DOI 10.1016/j.jhep.2009.10.036; Schulze A, 2010, J VIROL, V84, P1989, DOI 10.1128/JVI.01902-09; Seetlani Naresh Kumar, 2009, JPMA Journal of the Pakistan Medical Association, V59, P434; Shakil AO, 1997, VIROLOGY, V234, P160, DOI 10.1006/viro.1997.8644; Sheldon J, 2008, ANTIVIR THER, V13, P97; Shih HH, 2008, J VIROL, V82, P2250, DOI 10.1128/JVI.02155-07; Shih HH, 2010, J GEN VIROL, V91, P1004, DOI 10.1099/vir.0.017541-0; SMEDILE A, 1983, AM J EPIDEMIOL, V117, P223, DOI 10.1093/oxfordjournals.aje.a113533; Smedile A, 1998, HEPATOLOGY, V27, P1723, DOI 10.1002/hep.510270636; SMITH HM, 1992, J EPIDEMIOL COMMUN H, V46, P144, DOI 10.1136/jech.46.2.144; Somi MH, 2009, TROP DOCT, V39, P154, DOI 10.1258/td.2009.080365; Su CW, 2006, GASTROENTEROLOGY, V130, P1625, DOI 10.1053/j.gastro.2006.01.035; Sureau C, 2006, CURR TOP MICROBIOL, V307, P113; Taylor JM, 2006, CURR TOP MICROBIOL, V307, P1; Taylor J, 2010, FUTURE MICROBIOL, V5, P393, DOI 10.2217/FMB.10.15; Tsatsralt-Od B, 2006, J MED VIROL, V78, P542, DOI 10.1002/jmv.20574; Tsatsralt-Od B, 2005, J MED VIROL, V77, P491, DOI 10.1002/jmv.20482; Tseng CH, 2010, J VIROL, V84, P918, DOI 10.1128/JVI.01034-09; VERME G, 1986, HEPATOLOGY, V6, P1303, DOI 10.1002/hep.1840060613; Viana S, 2005, AM J TROP MED HYG, V73, P808, DOI 10.4269/ajtmh.2005.73.808; Vietheer PTK, 2005, J VIROL, V79, P6570, DOI 10.1128/JVI.79.10.6570-6573.2005; WANG CJ, 1991, J VIROL, V65, P6630, DOI 10.1128/JVI.65.12.6630-6636.1991; WANG KS, 1986, NATURE, V323, P508, DOI 10.1038/323508a0; Wang YC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-31; Watanabe H, 2003, J GEN VIROL, V84, P3275, DOI 10.1099/vir.0.19499-0; Wedemeyer H, 2007, J HEPATOL, V46, pS13, DOI 10.1016/S0168-8278(07)61625-0; Wedemeyer H, 2007, HEPATOLOGY, V45, P1331, DOI 10.1002/hep.21590; Wedemeyer H, 2011, NEW ENGL J MED, V364, P322, DOI 10.1056/NEJMoa0912696; WEINER AJ, 1988, J VIROL, V62, P594, DOI 10.1128/JVI.62.2.594-599.1988; Williams V, 2009, J GEN VIROL, V90, P2759, DOI 10.1099/vir.0.011239-0; Wolters LMM, 2000, J VIRAL HEPATITIS, V7, P428, DOI 10.1046/j.1365-2893.2000.00254.x; WU HN, 1989, P NATL ACAD SCI USA, V86, P1831, DOI 10.1073/pnas.86.6.1831; Wu JC, 2006, CURR TOP MICROBIOL, V307, P173; WU JC, 1995, GASTROENTEROLOGY, V108, P796, DOI 10.1016/0016-5085(95)90453-0; Wu JC, 1995, HEPATOLOGY, V22, P1656, DOI 10.1016/0270-9139(95)90187-6; Wu JC, 1998, J GEN VIROL, V79, P1105, DOI 10.1099/0022-1317-79-5-1105; WU JC, 1995, LANCET, V346, P939, DOI 10.1016/S0140-6736(95)91558-3; XIA YP, 1992, J VIROL, V66, P914, DOI 10.1128/JVI.66.2.914-921.1992; Yamaguchi Y, 2001, SCIENCE, V293, P124, DOI 10.1126/science.1057925; Yurdaydin C, 2008, J VIRAL HEPATITIS, V15, P314, DOI 10.1111/j.1365-2893.2007.00936.x; Yurdaydin C, 2007, J VIRAL HEPATITIS, V14, P812, DOI 10.1111/j.1365-2893.2007.00875.x; Yurdaydin C, 2002, J HEPATOL, V37, P266, DOI 10.1016/S0168-8278(02)00162-9; Yurdaydin C, 2009, HEPATOLOGY, V50, p736A; Zachou K, 2010, LIVER INT, V30, P430, DOI 10.1111/j.1478-3231.2009.02140.x	156	337	367	1	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2011	378	9785					73	85		10.1016/S0140-6736(10)61931-9	http://dx.doi.org/10.1016/S0140-6736(10)61931-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791IU	21511329				2022-12-28	WOS:000292659700036
J	Benowitz, NL; Samet, JM				Benowitz, Neal L.; Samet, Jonathan M.			The Threat of Menthol Cigarettes to U.S. Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Benowitz, Neal L.] San Francisco Gen Hosp, Med Ctr, Med Serv, Div Clin Pharmacol & Expt Therapeut, San Francisco, CA 94110 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Therapeut Sci, San Francisco, CA 94143 USA; [Samet, Jonathan M.] USC, Dept Prevent Med, Keck Sch Med, Los Angeles, CA USA; [Samet, Jonathan M.] Univ So Calif, USC Inst Global Hlth, Los Angeles, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California; University of Southern California Keck Hospital; University of Southern California	Benowitz, NL (corresponding author), San Francisco Gen Hosp, Med Ctr, Med Serv, Div Clin Pharmacol & Expt Therapeut, San Francisco, CA 94110 USA.							Tobacco Products Scientific Advisory Committee (TPSAC), 2011, MENTH CIG PUBL HLTH; US Dep Health Educ Welfare (DHEW), 1964, DHEW PUBL	2	26	27	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2179	2181		10.1056/NEJMp1103610	http://dx.doi.org/10.1056/NEJMp1103610			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	774NA	21542737				2022-12-28	WOS:000291392100002
J	Wenzel, DM; Lissounov, A; Brzovic, PS; Klevit, RE				Wenzel, Dawn M.; Lissounov, Alexei; Brzovic, Peter S.; Klevit, Rachel E.			UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids	NATURE			English	Article							UBIQUITIN-CONJUGATING ENZYME; CRYSTAL-STRUCTURE; PROTEIN; LIGASE; RING; EXPRESSION; ACTIVATION; RESIDUES; INSIGHTS; COMPLEX	Although the functional interaction between ubiquitin-conjugating enzymes (E2s) and ubiquitin ligases (E3s) is essential in ubiquitin (Ub) signalling, the criteria that define an active E2-E3 pair are not well established. The human E2 UBCH7 (also known as UBE2L3) shows broad specificity for HECT-type E3s(1), but often fails to function with RING E3s in vitro despite forming specific complexes(2-4). Structural comparisons of inactive UBCH7-RING complexes with active UBCH5-RING complexes reveal no defining differences(3,4), highlighting a gap in our understanding of Ub transfer. Here we show that, unlike many E2s that transfer Ub with RINGs, UBCH7 lacks intrinsic, E3-independent reactivity with lysine, explaining its preference for HECTs. Despite lacking lysine reactivity, UBCH7 exhibits activity with the RING-inbetween-RING (RBR) family of E3s that includes parkin (also known as PARK2) and human homologue of ariadne (HHARI; also known as ARIH1)(5,6). Found in all eukaryotes(7), RBRs regulate processes such as translation(8) and immune signalling(9). RBRs contain a canonical C3HC4-type RING, followed by two conserved Cys/His-rich Zn2+-binding domains, in-between-RING (IBR) and RING2 domains, which together define this E3 family(7). We show that RBRs function like RING/HECT hybrids: they bind E2s via a RING domain, but transfer Ub through an obligate thioester-linked Ub (denoted Ub), requiring a conserved cysteine residue in RING2. Our results define the functional cadre of E3s for UBCH7, an E2 involved in cell proliferation(10) and immune function(11), and indicate a novel mechanism for an entire class of E3s.	[Wenzel, Dawn M.; Lissounov, Alexei; Brzovic, Peter S.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Klevit, RE (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	klevit@u.washington.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X	National Institute of General Medical Sciences [5R01 GM088055, T32 GM07270]; National Science Foundation [MCB0615632]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM088055] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Stoll, M. Schwartz and N. Zheng for critical reading of the manuscript and discussions and V. Vittal, K. Stoll and P. Littlefield for technical help. We thank K. Borden, E. Fon, B. Schulman, L. Boyd, J. Chen and A. Merz for expression vectors for HHARI, parkin, E6-AP, Ubc18, human E1 and GST pull-down reagents, respectively. We acknowledge support from the National Institute of General Medical Sciences in the form of 5R01 GM088055 (R.E.K.) and T32 GM07270 (D.M.W.), and the National Science Foundation in the form of MCB0615632 (R.E.K.)	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Ardley HC, 2001, J BIOL CHEM, V276, P19640, DOI 10.1074/jbc.M011028200; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diao J, 2008, NAT STRUCT MOL BIOL, V15, P65, DOI 10.1038/nsmb1346; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Huang A, 2009, J MOL BIOL, V385, P507, DOI 10.1016/j.jmb.2008.10.044; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones D, 2002, GENOME BIOL, V3; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Maruyama M, 2000, ANN NEUROL, V48, P245, DOI 10.1002/1531-8249(200008)48:2<245::AID-ANA15>3.0.CO;2-2; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tan NGS, 2003, FEBS LETT, V554, P501, DOI 10.1016/S0014-5793(03)01235-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Whitcomb EA, 2009, MOL BIOL CELL, V20, P1, DOI 10.1091/mbc.E08-01-0036; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	35	370	386	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					105	U136		10.1038/nature09966	http://dx.doi.org/10.1038/nature09966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21532592	Green Accepted			2022-12-28	WOS:000291156700047
J	Williams, K; Christensen, J; Pedersen, MT; Johansen, JV; Cloos, PAC; Rappsilber, J; Helin, K				Williams, Kristine; Christensen, Jesper; Pedersen, Marianne Terndrup; Johansen, Jens V.; Cloos, Paul A. C.; Rappsilber, Juri; Helin, Kristian			TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity	NATURE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; 5-HYDROXYMETHYLCYTOSINE; WIDE; PLURIPOTENT; CONVERSION; COMPLEX; GENES; MAPS	Enzymes catalysing the methylation of the 5-position of cytosine (mC) have essential roles in regulating gene expression and maintaining cellular identity. Recently, TET1 was found to hydroxylate the methyl group of mC, converting it to 5-hydroxymethyl cytosine (hmC). Here we show that TET1 binds throughout the genome of embryonic stem cells, with the majority of binding sites located at transcription start sites (TSSs) of CpG-rich promoters and within genes. The hmC modification is found in gene bodies and in contrast to mC is also enriched at CpG-rich TSSs. We provide evidence further that TET1 has a role in transcriptional repression. TET1 binds a significant proportion of Polycomb group target genes. Furthermore, TET1 associates and colocalizes with the SIN3A co-repressor complex. We propose that TET1 fine-tunes transcription, opposes aberrant DNA methylation at CpG-rich sequences and thereby contributes to the regulation of DNA methylation fidelity.	[Williams, Kristine; Christensen, Jesper; Pedersen, Marianne Terndrup; Johansen, Jens V.; Cloos, Paul A. C.; Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Williams, Kristine; Christensen, Jesper; Pedersen, Marianne Terndrup; Cloos, Paul A. C.; Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; [Johansen, Jens V.] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Edinburgh	Helin, K (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	kristian.helin@bric.ku.dk	Rappsilber, Juri/ABF-3328-2020; Williams, Kristine/AAA-5662-2022; Rappsilber, Juri/B-7265-2015; Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022	Williams, Kristine/0000-0002-1198-6552; Rappsilber, Juri/0000-0001-5999-1310; Helin, Kristian/0000-0003-1975-6097; Vilstrup Johansen, Jens/0000-0001-7094-6801; Cloos, Paul/0000-0001-5863-0054; Pedersen, Marianne Terndrup/0000-0003-3808-0352	Danish Cancer Society; University of Copenhagen; Danish National Research Foundation; Lundbeck foundation; Novo Nordisk Foundation; Danish Medical Research Council	Danish Cancer Society(Danish Cancer Society); University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank U. Toftegaard for excellent technical help, M. Okano for the donation of TKO ES cells, and members of the Helin lab for discussions. M.T.P. was supported by a fellowship from the Danish Cancer Society. J.R. is a senior research fellow of the Wellcome Trust. The work in the Helin lab was supported by grants from the Excellence Program of the University of Copenhagen, the Danish National Research Foundation, the Danish Cancer Society, the Lundbeck foundation, the Novo Nordisk Foundation, and the Danish Medical Research Council.	Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; ERLANGER BF, 1964, P NATL ACAD SCI USA, V52, P68, DOI 10.1073/pnas.52.1.68; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohamedali AM, 2009, J CLIN ONCOL, V27, P4002, DOI 10.1200/JCO.2009.22.6985; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	29	760	798	1	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					343	U472		10.1038/nature10066	http://dx.doi.org/10.1038/nature10066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21490601	Green Accepted			2022-12-28	WOS:000290722400041
J	Jost, TS				Jost, Timothy Stoltzfus			Consensus and Conflict in Health System Reform - The Republican Budget Plan and the ACA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.							[Anonymous], 2011, LONG TERM AN BUDG PR; Kaiser Family Foundation, 2011, WHAT ACT VAL AFF CAR; ROWLAND D, 2009, MED BASICS; RYAN P, HLTH CARE ROADMAP AM	4	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2011	364	19								10.1056/NEJMP1104806	http://dx.doi.org/10.1056/NEJMP1104806			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MM	21524209				2022-12-28	WOS:000290483000006
J	Markel, H				Markel, Howard			John Harvey Kellogg and the Pursuit of Wellness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Michigan, Sch Med, Ctr Hist Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Sch Med, Ctr Hist Med, 100 Simpson Mem Inst,Box 0725,102 Observ, Ann Arbor, MI 48109 USA.	howard@umich.edu						[Anonymous], 1982, CRUSADERS FITNESS HI; Carson Gerald, 1957, CORNFLAKE CRUSADE PU; GREEN H, 1986, FIT AMERICA HLTH FIT; Kellogg J. H., 1886, PLAIN FACTS OLD YOUN; KELLOGG JH, 1922, TOBACCOISM; KELLOGG JH, 1891, MAN THE MASTERPIECE; KELLOGG JH, 1924, BATTLE CREEK SANITAR; Kellogg John H., 1918, ITINERARY BREAKFAST; Numbers R. L., 2008, PROPHETESS HLTH STUD, V3rd; SCHWARZ RW, 2006, JH KELLOGG PIONEERIN	10	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1814	1815		10.1001/jama.2011.557	http://dx.doi.org/10.1001/jama.2011.557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758HZ	21540428				2022-12-28	WOS:000290156200027
J	Badouel, C; McNeill, H				Badouel, Caroline; McNeill, Helen			SnapShot: The Hippo Signaling Pathway	CELL			English	Editorial Material							SIZE CONTROL		[Badouel, Caroline; McNeill, Helen] Univ Toronto, Samuel Lunenfeld Res Inst, Dept Mol Genet, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Badouel, C (corresponding author), Univ Toronto, Samuel Lunenfeld Res Inst, Dept Mol Genet, Mt Sinai Hosp, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.		McNeill, Helen/E-4579-2013	McNeill, Helen/0000-0003-1126-5154				Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	6	71	75	3	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					484	U162	484.e1	10.1016/j.cell.2011.04.009	http://dx.doi.org/10.1016/j.cell.2011.04.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529719	Bronze			2022-12-28	WOS:000290022900017
J	Simon, J; Bakr, WS; Ma, RC; Tai, ME; Preiss, PM; Greiner, M				Simon, Jonathan; Bakr, Waseem S.; Ma, Ruichao; Tai, M. Eric; Preiss, Philipp M.; Greiner, Markus			Quantum simulation of antiferromagnetic spin chains in an optical lattice	NATURE			English	Article							ATOMIC MOTT INSULATOR; ULTRACOLD ATOMS; TRAPPED IONS; GAS; TRANSITION; SUPERFLUID; CRITICALITY; SYMMETRY; PHYSICS; STATE	Understanding exotic forms of magnetism in quantum mechanical systems is a central goal of modern condensed matter physics, with implications for systems ranging from high-temperature superconductors to spintronic devices. Simulating magnetic materials in the vicinity of a quantum phase transition is computationally intractable on classical computers, owing to the extreme complexity arising from quantum entanglement between the constituent magnetic spins. Here we use a degenerate Bose gas of rubidium atoms confined in an optical lattice to simulate a chain of interacting quantum Ising spins as they undergo a phase transition. Strong spin interactions are achieved through a site-occupation to pseudo-spin mapping. As we vary a magnetic field, quantum fluctuations drive a phase transition from a paramagnetic phase into an antiferromagnetic phase. In the paramagnetic phase, the interaction between the spins is overwhelmed by the applied field, which aligns the spins. In the antiferromagnetic phase, the interaction dominates and produces staggered magnetic ordering. Magnetic domain formation is observed through both in situ site-resolved imaging and noise correlation measurements. By demonstrating a route to quantum magnetism in an optical lattice, this work should facilitate further investigations of magnetic models using ultracold atoms, thereby improving our understanding of real magnetic materials.	[Simon, Jonathan; Bakr, Waseem S.; Ma, Ruichao; Tai, M. Eric; Preiss, Philipp M.; Greiner, Markus] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Greiner, M (corresponding author), Harvard Univ, Dept Phys, 17 Oxford St, Cambridge, MA 02138 USA.	greiner@physics.harvard.edu	Greiner, Markus/A-8502-2010; Greiner, Markus/E-9512-2017; Ma, Ruichao/P-3604-2014	Ma, Ruichao/0000-0003-4516-874X; Simon, Jonathan/0000-0001-7854-4647	Army Research Office DARPA OLE; AFOSR MURI; NSF	Army Research Office DARPA OLE; AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); NSF(National Science Foundation (NSF))	We thank E. Demler, W. Ketterle, T. Kitagawa, M. D. Lukin, S. Pielawa and S. Sachdev for discussions. This work was supported by the Army Research Office DARPA OLE programme, an AFOSR MURI programme, and by grants from the NSF.	Altman E, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.013603; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Banuls MC, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.050405; BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Buchler HP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.060404; Capogrosso-Sansone B, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.053622; Coldea R, 2010, SCIENCE, V327, P177, DOI 10.1126/science.1180085; Duan LM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090402; Dziarmaga J, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.064416; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Folling S, 2007, NATURE, V448, P1029, DOI 10.1038/nature06112; Folling S, 2005, NATURE, V434, P481, DOI 10.1038/nature03500; Friedenauer A, 2008, NAT PHYS, V4, P757, DOI 10.1038/nphys1032; Garcia-Ripoll JJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.250405; Hung CL, 2011, NATURE, V470, P236, DOI 10.1038/nature09722; IMRY Y, 1975, PHYS REV LETT, V35, P1399, DOI 10.1103/PhysRevLett.35.1399; Jo GB, 2009, SCIENCE, V325, P1521, DOI 10.1126/science.1177112; Kim K, 2010, NATURE, V465, P590, DOI 10.1038/nature09071; Kitaev A, 2006, ANN PHYS-NEW YORK, V321, P2, DOI 10.1016/j.aop.2005.10.005; Lee PJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.020402; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Lukin MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037901; MCKAY D, 2010, COOLING STRONGLY COR; MEDLEY P, 2010, SPIN GRADIENT DEMAGN; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; NOVOTNY MA, 1986, J MAGN MAGN MATER, V54-7, P685, DOI 10.1016/0304-8853(86)90210-6; Ovchinnikov AA, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.214406; PIELAWA S, 2010, CORRELATED PHASES BO; Plotz P, 2011, EUR PHYS J D, V63, P47, DOI 10.1140/epjd/e2010-10554-7; Ruegg C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.205701; Sachdev S, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.075128; Sachdev S., 2001, QUANTUM PHASE TRANSI; Sachdev S, 2008, NAT PHYS, V4, P173, DOI 10.1038/nphys894; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Soltan-Panahi P, 2011, NAT PHYS, V7, P434, DOI [10.1038/nphys1916, 10.1038/NPHYS1916]; Sorensen AS, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.061603; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Vidal G, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.227902; Weimer H, 2010, NAT PHYS, V6, P382, DOI 10.1038/NPHYS1614; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Weld DM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.245301; ZHANG X, 2010, EXPLORING QUANTUM CR	49	667	673	2	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					307	U200		10.1038/nature09994	http://dx.doi.org/10.1038/nature09994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21490600	Green Submitted			2022-12-28	WOS:000289724600031
J	Postow, M				Postow, Michael			The Ice Cream Man	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												postowm@mskcc.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1518	1518		10.1001/jama.2011.371	http://dx.doi.org/10.1001/jama.2011.371			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21505122				2022-12-28	WOS:000289683000001
J	Ismail-Beigi, F; Moghissi, E; Tiktin, M; Hirsch, IB; Inzucchi, SE; Genuth, S				Ismail-Beigi, Faramarz; Moghissi, Etie; Tiktin, Margaret; Hirsch, Irl B.; Inzucchi, Silvio E.; Genuth, Saul			Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GLUCOSE CONTROL; CARDIOVASCULAR-DISEASE; HEMOGLOBIN A(1C); MORTALITY; HYPOGLYCEMIA; ASSOCIATION; ADULTS; HEALTH; COMPLICATIONS; PROGRESSION	One of the first steps in the management of patients with type 2 diabetes mellitus is setting glycemic goals. Professional organizations advise setting specific hemoglobin A(1c) (HbA(1c)) targets for patients, and individualization of these goals has more recently been emphasized. However, the operational meaning of glycemic goals, and specific methods for individualizing them, have not been well-described. Choosing a specific HbA(1c) target range for a given patient requires taking several factors into consideration, including an assessment of the patient's risk for hyperglycemia-related complications versus the risks of therapy, all in the context of the overall clinical setting. Comorbid conditions, psychological status, capacity for self-care, economic considerations, and family and social support systems also play a key role in the intensity of therapy. The individualization of HbA(1c) targets has gained more traction after recent clinical trials in older patients with established type 2 diabetes mellitus failed to show a benefit from intensive glucose-lowering therapy on cardiovascular disease (CVD) outcomes. The limited available evidence suggests that near-normal glycemic targets should be the standard for younger patients with relatively recent onset of type 2 diabetes mellitus and little or no micro-or macrovascular complications, with the aim of preventing complications over the many years of life. However, somewhat higher targets should be considered for older patients with long-standing type 2 diabetes mellitus and evidence of CVD (or multiple CVD risk factors). This review explores these issues further and proposes a framework for considering an appropriate and safe HbA(1c) target range for each patient.	[Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Med, Cleveland, OH 44122 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ Washington, Seattle, WA 98195 USA; Yale Univ, New Haven, CT USA	Case Western Reserve University; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Yale University	Ismail-Beigi, F (corresponding author), Case Western Reserve Univ, Dept Med, 10900 Euclid Ave, Cleveland, OH 44122 USA.	fxi2@case.edu	Oliveira, Claudia DL/G-8618-2011; Inzucchi, Silvio/ABF-4121-2021					Alencar RC, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-10; August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022; BLICKEM C, 2010, HLTH SOC CARE COMMUN; Bonds Denise E, 2010, BMJ, V340, pb4909, DOI 10.1136/bmj.b4909; Calles-Escandon J, 2010, DIABETES CARE, V33, P721, DOI 10.2337/dc09-1471; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; de Galan BE, 2009, DIABETOLOGIA, V52, P2328, DOI 10.1007/s00125-009-1484-7; Desouza C, 2003, DIABETES CARE, V26, P1485, DOI 10.2337/diacare.26.5.1485; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Kalyani RR, 2010, DIABETES CARE, V33, P1055, DOI 10.2337/dc09-1597; Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Lipscombe LL, 2010, CAN MED ASSOC J, V182, pE1, DOI 10.1503/cmaj.090495; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Peyrot M, 2006, DIABETOLOGIA, V49, P279, DOI 10.1007/s00125-005-0048-8; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012; Reaven PD, 2009, DIABETES, V58, P2642, DOI 10.2337/db09-0618; Saydah S, 2009, DIABETES CARE, V32, P1440, DOI 10.2337/dc09-0117; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *US DEP VET AFF, 2010, MAN DIAB MELL PRIM C; Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460; Wolever RQ, 2010, DIABETES EDUCATOR, V36, P629, DOI 10.1177/0145721710371523; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	30	248	267	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8					554	559		10.7326/0003-4819-154-8-201104190-00007	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-00007			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502652				2022-12-28	WOS:000289622000018
J	Lee, N; Benichi, H; Takeno, Y; Takeda, S; Webb, J; Huntington, E; Furusawa, A				Lee, Noriyuki; Benichi, Hugo; Takeno, Yuishi; Takeda, Shuntaro; Webb, James; Huntington, Elanor; Furusawa, Akira			Teleportation of Nonclassical Wave Packets of Light	SCIENCE			English	Article							SQUEEZED STATES; QUANTUM	We report on the experimental quantum teleportation of strongly nonclassical wave packets of light. To perform this full quantum operation while preserving and retrieving the fragile nonclassicality of the input state, we have developed a broadband, zero-dispersion teleportation apparatus that works in conjunction with time-resolved state preparation equipment. Our approach brings within experimental reach a whole new set of hybrid protocols involving discrete-and continuous-variable techniques in quantum information processing for optical sciences.	[Lee, Noriyuki; Benichi, Hugo; Takeno, Yuishi; Takeda, Shuntaro; Furusawa, Akira] Univ Tokyo, Dept Appl Phys, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Webb, James; Huntington, Elanor] Univ New S Wales, Ctr Quantum Computat & Commun Technol, Sch Engn & Informat Technol, Univ Coll, Canberra, ACT 2600, Australia	University of Tokyo; Australian Defense Force Academy; University of New South Wales Sydney	Furusawa, A (corresponding author), Univ Tokyo, Dept Appl Phys, Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	akiraf@ap.t.u-tokyo.ac.jp	Huntington, Elanor/G-4081-2010; Takeda, Shuntaro/A-3318-2015; Furusawa, Akira/P-5787-2014	Huntington, Elanor/0000-0002-7154-0042; Furusawa, Akira/0000-0002-6176-6742	Ministry of Education, Culture, Sports, Science and Technology of Japan; Academy of Sciences of the Czech Republic; Japanese Society for the Promotion of Science; Australian Research Council, Center of Excellence [CE11E0096]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Australian Research Council, Center of Excellence(Australian Research Council)	Supported by the Strategic Information and Communications R&D Promotion (SCOPE) program of the Ministry of Internal Affairs and Communications of Japan, Special Coordination Funds for Promoting Science and Technology, Grants-in-Aid for Scientific Research, Global Center of Excellence, Advanced Photon Science Alliance, and Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) commissioned by the Ministry of Education, Culture, Sports, Science and Technology of Japan, Academy of Sciences of the Czech Republic, Japanese Society for the Promotion of Science, and the Australian Research Council, Center of Excellence (grant CE11E0096).	Ban M, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.054304; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Braunstein SL, 1998, PHYS REV LETT, V80, P869, DOI 10.1103/PhysRevLett.80.869; Dakna M, 1997, PHYS REV A, V55, P3184, DOI 10.1103/PhysRevA.55.3184; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Grosshans F, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.010301; HILLERY M, 1984, PHYS REP, V106, P121, DOI 10.1016/0370-1573(84)90160-1; Jeong H, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.013801; Lund AP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.030503; Lvovsky A. I., 2004, J OPT B-QUANTUM S O, V54, pS556; Mista L, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.012322; Neergaard-Nielsen JS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083604; Neergaard-Nielsen JS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053602; Ourjoumtsev A, 2006, SCIENCE, V312, P83, DOI 10.1126/science.1122858; Ourjoumtsev A, 2007, NATURE, V448, P784, DOI 10.1038/nature06054; SMITHEY DT, 1993, PHYS REV LETT, V70, P1244, DOI 10.1103/PhysRevLett.70.1244; Takahashi H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.233605; Wakui K, 2007, OPT EXPRESS, V15, P3568, DOI 10.1364/OE.15.003568; Yoshikawa J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.060301; Yukawa M, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.022314	22	149	151	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					330	333		10.1126/science.1201034	http://dx.doi.org/10.1126/science.1201034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493853	Green Submitted			2022-12-28	WOS:000289516600038
J	Jain, R; Kralovic, SM; Evans, ME; Ambrose, M; Simbartl, LA; Obrosky, DS; Render, ML; Freyberg, RW; Jernigan, JA; Muder, RR; Miller, LJ; Roselle, GA				Jain, Rajiv; Kralovic, Stephen M.; Evans, Martin E.; Ambrose, Meredith; Simbartl, Loretta A.; Obrosky, D. Scott; Render, Marta L.; Freyberg, Ron W.; Jernigan, John A.; Muder, Robert R.; Miller, LaToya J.; Roselle, Gary A.			Veterans Affairs Initiative to Prevent Methicillin-Resistant Staphylococcus aureus Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE-UNIT; BLOOD-STREAM INFECTIONS; NOSOCOMIAL TRANSMISSION; COLONIZATION PRESSURE; HOSPITAL ADMISSION; MRSA; SURVEILLANCE; RISK; PRECAUTIONS; PREVALENCE	BACKGROUND Health care-associated infections with methicillin-resistant Staphylococcus aureus (MRSA) have been an increasing concern in Veterans Affairs (VA) hospitals. METHODS A "MRSA bundle" was implemented in 2007 in acute care VA hospitals nationwide in an effort to decrease health care-associated infections with MRSA. The bundle consisted of universal nasal surveillance for MRSA, contact precautions for patients colonized or infected with MRSA, hand hygiene, and a change in the institutional culture whereby infection control would become the responsibility of everyone who had contact with patients. Each month, personnel at each facility entered into a central database aggregate data on adherence to surveillance practice, the prevalence of MRSA colonization or infection, and health care-associated transmissions of and infections with MRSA. We assessed the effect of the MRSA bundle on health care-associated MRSA infections. RESULTS From October 2007, when the bundle was fully implemented, through June 2010, there were 1,934,598 admissions to or transfers or discharges from intensive care units (ICUs) and non-ICUs (ICUs, 365,139; non-ICUs, 1,569,459) and 8,318,675 patient-days (ICUs, 1,312,840; and non-ICUs, 7,005,835). During this period, the percentage of patients who were screened at admission increased from 82% to 96%, and the percentage who were screened at transfer or discharge increased from 72% to 93%. The mean (+/- SD) prevalence of MRSA colonization or infection at the time of hospital admission was 13.6 +/- 3.7%. The rates of health care-associated MRSA infections in ICUs had not changed in the 2 years before October 2007 (P = 0.50 for trend) but declined with implementation of the bundle, from 1.64 infections per 1000 patient-days in October 2007 to 0.62 per 1000 patient-days in June 2010, a decrease of 62% (P<0.001 for trend). During this same period, the rates of health care-associated MRSA infections in non-ICUs fell from 0.47 per 1000 patient-days to 0.26 per 1000 patient-days, a decrease of 45% (P<0.001 for trend). CONCLUSIONS A program of universal surveillance, contact precautions, hand hygiene, and institutional culture change was associated with a decrease in health care-associated transmissions of and infections with MRSA in a large health care system.	[Jain, Rajiv; Evans, Martin E.; Ambrose, Meredith; Miller, LaToya J.] Vet Affairs Cent Off, Patient Care Serv, Vet Hlth Adm MRSA Program Off, Pittsburgh, PA USA; [Jain, Rajiv; Evans, Martin E.; Ambrose, Meredith; Miller, LaToya J.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Jain, Rajiv; Muder, Robert R.] VA Pittsburgh Healthcare Syst, Dept Internal Med, Pittsburgh, PA USA; [Jain, Rajiv; Muder, Robert R.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Obrosky, D. Scott] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA; [Kralovic, Stephen M.; Simbartl, Loretta A.; Roselle, Gary A.] VA Cent Off, Patient Care Serv, Natl Infect Dis Program Off, Cincinnati, OH USA; [Kralovic, Stephen M.; Simbartl, Loretta A.; Roselle, Gary A.] Cincinnati VA Med Ctr, Cincinnati, OH USA; [Kralovic, Stephen M.; Render, Marta L.; Roselle, Gary A.] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH USA; [Render, Marta L.; Freyberg, Ron W.] VA Inpatient Evaluat Ctr, Cincinnati, OH USA; [Evans, Martin E.] Univ Kentucky, Sch Med, Dept Internal Med, Lexington, KY 40506 USA; [Jernigan, John A.] Ctr Dis Control & Prevent, Prevent & Response Branch, Div Healthcare Qual Promot, Atlanta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; University of Kentucky; Centers for Disease Control & Prevention - USA	Evans, ME (corresponding author), Lexington VAMC, VHA MDRO Program, 1101 Vet Dr,11I-CDD, Lexington, KY 40502 USA.	martin.evans@va.gov		Jernigan, John/0000-0001-8163-925X				[Anonymous], 2009, VHA HDB; [Anonymous], ID HEALTHC ASS INF H; Boyce JM, 2004, INFECT CONT HOSP EP, V25, P395, DOI 10.1086/502412; Boyce JM, 1997, INFECT CONT HOSP EP, V18, P622; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; Chang S, 2009, CLIN INFECT DIS, V48, P1423, DOI 10.1086/598505; Chowers MY, 2009, INFECT CONT HOSP EP, V30, P778, DOI 10.1086/599019; Clancy M, 2006, INFECT CONT HOSP EP, V27, P1009, DOI 10.1086/507915; Croft CA, 2009, AM SURGEON, V75, P458; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Harbarth S, 2000, J HOSP INFECT, V46, P43, DOI 10.1053/jhin.2000.0798; Hidron AI, 2009, INFECT CONT HOSP EP, V30, DOI 10.1086/595954; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lee BY, 2010, INFECT CONT HOSP EP, V31, P598, DOI 10.1086/652524; Lucet JC, 2003, ARCH INTERN MED, V163, P181, DOI 10.1001/archinte.163.2.181; Lucet JC, 2005, INTENS CARE MED, V31, P1051, DOI 10.1007/s00134-005-2679-0; Merrer J, 2000, INFECT CONT HOSP EP, V21, P718, DOI 10.1086/501721; Muder RR, 2008, INFECT CONT HOSP EP, V29, P702, DOI 10.1086/589981; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Nyman JA, 2011, AM J INFECT CONTROL, V39, P27, DOI 10.1016/j.ajic.2010.09.006; Pan A, 2005, INFECT CONT HOSP EP, V26, P127, DOI 10.1086/502515; Pujol M, 1996, AM J MED, V100, P509, DOI 10.1016/S0002-9343(96)00014-9; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Robicsek A, 2009, INFECT CONT HOSP EP, V30, P623, DOI 10.1086/597550; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Vos MC, 2009, INFECT CONT HOSP EP, V30, P977, DOI 10.1086/605921; Williams VR, 2009, AM J INFECT CONTROL, V37, P106, DOI 10.1016/j.ajic.2008.05.007; Wolk DM, 2009, J CLIN MICROBIOL, V47, P758, DOI 10.1128/JCM.01714-08; World Health Organization, 2009, WHO GUID HAND HYG HL	34	377	400	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1419	1430		10.1056/NEJMoa1007474	http://dx.doi.org/10.1056/NEJMoa1007474			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LD	21488764				2022-12-28	WOS:000289467200006
J	Cardinale, BJ				Cardinale, Bradley J.			Biodiversity improves water quality through niche partitioning	NATURE			English	Article							PLANT DIVERSITY; STREAM PERIPHYTON; PATCH DYNAMICS; NITROGEN; EUTROPHICATION; PRODUCTIVITY; DISTURBANCE; ECOLOGY; NITRATE; RESPONSES	Excessive nutrient loading of water bodies is a leading cause of water pollution worldwide(1,2), and controlling nutrient levels in watersheds is a primary objective of most environmental policy(3). Over the past two decades, much research has shown that ecosystems with more species are more efficient at removing nutrients from soil and water than are ecosystems with fewer species(4-7). This has led some to suggest that conservation of biodiversity might be a useful tool for managing nutrient uptake and storage(7-10), but this suggestion has been controversial, in part because the specific biological mechanisms by which species diversity influences nutrient uptake have not been identified(10-12). Here I use a model system of stream biofilms to show that niche partitioning among species of algae can increase the uptake and storage of nitrate, a nutrient pollutant of global concern. I manipulated the number of species of algae growing in the biofilms of 150 stream mesocosms that had been set up to mimic the variety of flow habitats and disturbance regimes that are typical of natural streams. Nitrogen uptake rates, as measured by using N-15-labelled nitrate, increased linearly with species richness and were driven by niche differences among species. As different forms of algae came to dominate each unique habitat in a stream, the more diverse communities achieved a higher biomass and greater N-15 uptake. When these niche opportunities were experimentally removed by making all of the habitats in a stream uniform, diversity did not influence nitrogen uptake, and biofilms collapsed to a single dominant species. These results provide direct evidence that communities with more species take greater advantage of the niche opportunities in an environment, and this allows diverse systems to capture a greater proportion of biologically available resources such as nitrogen. One implication is that biodiversity may help to buffer natural ecosystems against the ecological impacts of nutrient pollution.	Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Cardinale, BJ (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.	bradcard@umich.edu	Cardinale, Bradley J/I-7076-2013		US National Science Foundation [DEB 0614428, DEB 1046121]; Division Of Environmental Biology [1046121] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Byrnes, W. Dodds, J. Levine and A. Steinman for comments that improved the manuscript. D. Bennett, K. Matulich, L. Power and J. Weis helped to set up and run the experiment. M. Potapova provided images of the algae in Fig. 2. This work was funded by grants from the US National Science Foundation (DEB 0614428 and DEB 1046121).	Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Andersen R. A., 2005, ALGAL CULTURING TECH; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Biggs BJF, 1998, ARCH HYDROBIOL, V143, P21; BIGGS BJF, 1995, J PHYCOL, V31, P233, DOI 10.1111/j.0022-3646.1995.00233.x; Biggs BJF, 1998, J PHYCOL, V34, P598, DOI 10.1046/j.1529-8817.1998.340598.x; Bracken MES, 2006, ECOLOGY, V87, P2397, DOI 10.1890/0012-9658(2006)87[2397:SDENUV]2.0.CO;2; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Cardinale BJ, 2009, ECOLOGY, V90, P1227, DOI 10.1890/08-1038.1; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Carroll I. T., ECOLOGY IN PRESS; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cooper SD, 1997, J N AM BENTHOL SOC, V16, P174, DOI 10.2307/1468250; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dodds WK, 2006, LIMNOL OCEANOGR, V51, P671, DOI 10.4319/lo.2006.51.1_part_2.0671; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; FRY B., 2006, STABLE ISOTOPE ECOLO; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hubbell SP, 2008, P NATL ACAD SCI USA, V105, P11498, DOI 10.1073/pnas.0801915105; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Legendre L, 1997, J PLANKTON RES, V19, P263, DOI 10.1093/plankt/19.2.263; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Nusch E.A., 1980, ARCH HYDROBIOLOGIE B, V14, P14; Passy SI, 2001, J PHYCOL, V37, P370, DOI 10.1046/j.1529-8817.2001.037003370.x; PETERSON CG, 1992, ECOLOGY, V73, P1445, DOI 10.2307/1940689; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; PRINGLE CM, 1988, J N AM BENTHOL SOC, V7, P503, DOI 10.2307/1467303; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Scherer-Lorenzen M, 2003, ECOLOGY, V84, P1539, DOI 10.1890/0012-9658(2003)084[1539:TROPDA]2.0.CO;2; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; STEINMAN AD, 1986, J PHYCOL, V22, P352, DOI 10.1111/j.1529-8817.1986.tb00035.x; Steinman Alan D., 1996, P295; Stevenson R. Jan, 1996, P321; STEVENSON RJ, 1983, ECOLOGY, V64, P1514, DOI 10.2307/1937506; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Townsend CR, 1998, ECOL LETT, V1, P200; TOWNSEND CR, 1989, J N AM BENTHOL SOC, V8, P36, DOI 10.2307/1467400; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VOGEL S, 1978, BIOSCIENCE, V28, P638, DOI 10.2307/1307394	49	456	481	24	933	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					86	U113		10.1038/nature09904	http://dx.doi.org/10.1038/nature09904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475199				2022-12-28	WOS:000289199400042
J	Mendes, R; Kruijt, M; de Bruijn, I; Dekkers, E; van der Voort, M; Schneider, JHM; Piceno, YM; DeSantis, TZ; Andersen, GL; Bakker, PAHM; Raaijmakers, JM				Mendes, Rodrigo; Kruijt, Marco; de Bruijn, Irene; Dekkers, Ester; van der Voort, Menno; Schneider, Johannes H. M.; Piceno, Yvette M.; DeSantis, Todd Z.; Andersen, Gary L.; Bakker, Peter A. H. M.; Raaijmakers, Jos M.			Deciphering the Rhizosphere Microbiome for Disease-Suppressive Bacteria	SCIENCE			English	Article							PATHOGENS	Disease-suppressive soils are exceptional ecosystems in which crop plants suffer less from specific soil-borne pathogens than expected owing to the activities of other soil microorganisms. For most disease-suppressive soils, the microbes and mechanisms involved in pathogen control are unknown. By coupling PhyloChip-based metagenomics of the rhizosphere microbiome with culture-dependent functional analyses, we identified key bacterial taxa and genes involved in suppression of a fungal root pathogen. More than 33,000 bacterial and archaeal species were detected, with Proteobacteria, Firmicutes, and Actinobacteria consistently associated with disease suppression. Members of the gamma-Proteobacteria were shown to have disease-suppressive activity governed by nonribosomal peptide synthetases. Our data indicate that upon attack by a fungal root pathogen, plants can exploit microbial consortia from soil for protection against infections.	[Mendes, Rodrigo; Kruijt, Marco; de Bruijn, Irene; Dekkers, Ester; van der Voort, Menno; Raaijmakers, Jos M.] Wageningen Univ, Phytopathol Lab, NL-6700 EE Wageningen, Netherlands; [Schneider, Johannes H. M.] Inst Sugar Beet Res, NL-4611 HL Bergen Op Zoom, Netherlands; [Piceno, Yvette M.; DeSantis, Todd Z.; Andersen, Gary L.] Lawrence Berkeley Natl Lab, Dept Ecol, Berkeley, CA 94720 USA; [DeSantis, Todd Z.] Second Genome Inc, San Francisco, CA 94158 USA; [Bakker, Peter A. H. M.] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands	Wageningen University & Research; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Utrecht University	Raaijmakers, JM (corresponding author), Wageningen Univ, Phytopathol Lab, Droevendaalsesteeg 1, NL-6700 EE Wageningen, Netherlands.	jos.raaijmakers@wur.nl	Mendes, Rodrigo/F-1534-2010; Raaijmakers, Jos M/D-1574-2014; Piceno, Yvette/I-6738-2016; Andersen, Gary/G-2792-2015; rolshausen, philippe/F-7999-2011; Mendes, Rodrigo/AAV-6490-2020; de Bruijn, Irene/A-7437-2014; Bakker, Peter A.H.M./B-9355-2011	Mendes, Rodrigo/0000-0002-9817-4118; Raaijmakers, Jos M/0000-0003-1608-6614; Piceno, Yvette/0000-0002-7915-4699; Andersen, Gary/0000-0002-1618-9827; Mendes, Rodrigo/0000-0002-9817-4118; de Bruijn, Irene/0000-0002-4889-3253; 	Netherlands Science Organisation (NWO) [838.06.101]; Netherlands Genomics Initiative-Ecogenomics, Netherlands; Lawrence Berkeley National Laboratory (LBNL) [DE-AC02-05CH11231]; U.S. Department of Energy	Netherlands Science Organisation (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative-Ecogenomics, Netherlands(Netherlands Government); Lawrence Berkeley National Laboratory (LBNL); U.S. Department of Energy(United States Department of Energy (DOE))	We thank T. Bisseling for critical reading and valuable suggestions. We acknowledge assistance by L. Sibbel-Wagemakers, N. Pangesti, M. de Milliano, N. Sharma, R. de Vries, P. M. S. van Oorschot, A. H. L. Schoone, and Y. Bakker. This work was financially supported by grants from Netherlands Science Organisation (NWO)-ERGO (#838.06.101) and Netherlands Genomics Initiative-Ecogenomics, Netherlands. Additional work was performed at Lawrence Berkeley National Laboratory (LBNL) (contract DE-AC02-05CH11231 with the U.S. Department of Energy). The 16S rDNA sequences are available on GenBank under accessions HQ848634 to HQ848643, and the thaABCD sequences under accession HQ888764. LBNL has a patent on the PhyloChip assay and Second Genome has licensed this assay from LBNL. Although the G3 PhyloChip is under patent (and under exclusive license to Second Genome), the data generated from the use of the chip are not patented or restricted. T.Z.dS. owns stock in Second Genome valued at under $10,000.	Bisseling T, 2009, SCIENCE, V324, P691, DOI 10.1126/science.1174404; COOK RJ, 1995, P NATL ACAD SCI USA, V92, P4197, DOI 10.1073/pnas.92.10.4197; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Garbeva P, 2011, ISME J; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Postma J, 2010, SOIL BIOL BIOCHEM, V42, P804, DOI 10.1016/j.soilbio.2010.01.017; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010	14	1357	1475	86	1149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1097	1100		10.1126/science.1203980	http://dx.doi.org/10.1126/science.1203980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21551032	Green Published			2022-12-28	WOS:000290996700048
J	Helander, MG; Wang, ZB; Qiu, J; Greiner, MT; Puzzo, DP; Liu, ZW; Lu, ZH				Helander, M. G.; Wang, Z. B.; Qiu, J.; Greiner, M. T.; Puzzo, D. P.; Liu, Z. W.; Lu, Z. H.			Chlorinated Indium Tin Oxide Electrodes with High Work Function for Organic Device Compatibility	SCIENCE			English	Article							LIGHT-EMITTING DEVICES; HIGH-EFFICIENCY; ELECTROLUMINESCENT DEVICE; OPERATING-VOLTAGE; DIODES; LAYERS	In organic light-emitting diodes (OLEDs), a stack of multiple organic layers facilitates charge flow from the low work function [similar to 4.7 electron volts (eV)] of the transparent electrode (tin-doped indium oxide, ITO) to the deep energy levels (similar to 6 eV) of the active light-emitting organic materials. We demonstrate a chlorinated ITO transparent electrode with a work function of >6.1 eV that provides a direct match to the energy levels of the active light-emitting materials in state-of-the art OLEDs. A highly simplified green OLED with a maximum external quantum efficiency (EQE) of 54% and power efficiency of 230 lumens per watt using outcoupling enhancement was demonstrated, as were EQE of 50% and power efficiency of 110 lumens per watt at 10,000 candelas per square meter.	[Helander, M. G.; Wang, Z. B.; Qiu, J.; Greiner, M. T.; Puzzo, D. P.; Liu, Z. W.; Lu, Z. H.] Univ Toronto, Dept Mat Sci & Engn, Toronto, ON M5S 3E4, Canada; [Lu, Z. H.] Yunnan Univ, Dept Phys, Kunming 650091, Yunnan, Peoples R China	University of Toronto; Yunnan University	Helander, MG (corresponding author), Univ Toronto, Dept Mat Sci & Engn, 184 Coll St, Toronto, ON M5S 3E4, Canada.	michael.helander@utoronto.ca; zhibin.wang@utoronto.ca; zhiwei.liu@utoronto.ca; zhenghong.lu@utoronto.ca	Wang, Zhibin/E-7408-2013		Natural Sciences and Engineering Research Council (NSERC) of Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Z.H.L. is a Canada Research Chair in Organic Optoelectronics, Tier I. We acknowledge funding for this research from the Natural Sciences and Engineering Research Council (NSERC) of Canada. We are grateful to T. P. Bender and G. A. Ozin (University of Toronto) for helpful discussions.	Armstrong NR, 2009, ACCOUNTS CHEM RES, V42, P1748, DOI 10.1021/ar900096f; Aziz H, 1999, SCIENCE, V283, P1900, DOI 10.1126/science.283.5409.1900; Baldo MA, 2000, NATURE, V403, P750, DOI 10.1038/35001541; Carter SA, 1997, APPL PHYS LETT, V70, P2067, DOI 10.1063/1.118953; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; He GF, 2004, APPL PHYS LETT, V85, P3911, DOI 10.1063/1.1812378; HERRING C, 1949, REV MOD PHYS, V21, P185, DOI 10.1103/RevModPhys.21.185; KIDO J, 1995, SCIENCE, V267, P1332, DOI 10.1126/science.267.5202.1332; Koo WH, 2010, NAT PHOTONICS, V4, P222, DOI [10.1038/NPHOTON.2010.7, 10.1038/nphoton.2010.7]; Mladenovski S, 2009, OPT EXPRESS, V17, P7562, DOI 10.1364/OE.17.007562; Muller CD, 2003, NATURE, V421, P829, DOI 10.1038/nature01390; NEFEDOV VI, 1977, J STRUCT CHEM+, V18, P549, DOI 10.1007/BF00745292; Oswald S, 2006, SURF INTERFACE ANAL, V38, P590, DOI 10.1002/sia.2216; Reineke S, 2009, NATURE, V459, P234, DOI 10.1038/nature08003; Sekitani T, 2009, NAT MATER, V8, P494, DOI [10.1038/NMAT2459, 10.1038/nmat2459]; Shen ZL, 1997, SCIENCE, V276, P2009, DOI 10.1126/science.276.5321.2009; Su SJ, 2010, ADV MATER, V22, P3311, DOI 10.1002/adma.200904249; Sun XH, 2003, CHEM PHYS LETT, V370, P425, DOI 10.1016/S0009-2614(03)00135-0; Sun YR, 2006, NATURE, V440, P908, DOI 10.1038/nature04645; Tanaka D, 2007, JPN J APPL PHYS 2, V46, pL10, DOI 10.1143/JJAP.46.L10; Tokito S, 1996, J PHYS D APPL PHYS, V29, P2750, DOI 10.1088/0022-3727/29/11/004; VanSlyke SA, 1996, APPL PHYS LETT, V69, P2160, DOI 10.1063/1.117151; Wang ZB, 2010, J APPL PHYS, V108, DOI 10.1063/1.3456513; Watanabe S, 2007, JPN J APPL PHYS 1, V46, P1186, DOI 10.1143/JJAP.46.1186; Zhou X, 2001, APPL PHYS LETT, V78, P410, DOI 10.1063/1.1343849	25	533	543	5	392	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					944	947		10.1126/science.1202992	http://dx.doi.org/10.1126/science.1202992			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21493822				2022-12-28	WOS:000290766600037
J	Agakishiev, H; Aggarwal, MM; Ahammed, Z; Alakhverdyants, AV; Alekseev, I; Alford, J; Anderson, BD; Anson, CD; Arkhipkin, D; Averichev, GS; Balewski, J; Beavis, DR; Behera, NK; Bellwied, R; Betancourt, MJ; Betts, RR; Bhasin, A; Bhati, AK; Bichsel, H; Bielcik, J; Bielcikova, J; Biritz, B; Bland, LC; Bordyuzhin, IG; Borowski, W; Bouchet, J; Braidot, E; Brandin, AV; Bridgeman, A; Brovko, SG; Bruna, E; Bueltmann, S; Bunzarov, I; Burton, TP; Cai, XZ; Caines, H; Calderon, M; Cebra, D; Cendejas, R; Cervantes, MC; Chajecki, Z; Chaloupka, P; Chattopadhyay, S; Chen, HF; Chen, JH; Chen, JY; Chen, L; Cheng, J; Cherney, M; Chikanian, A; Choi, KE; Christie, W; Chung, P; Codrington, MJM; Corliss, R; Cramer, JG; Crawford, HJ; Leyva, AD; De Silva, LC; Debbe, RR; Dedovich, TG; Derevschikov, AA; de Souza, RD; Didenko, L; Djawotho, P; Dogra, SM; Dong, X; Drachenberg, JL; Draper, JE; Dunlop, C; Efimov, LG; Elnimr, M; Engelage, J; Eppley, G; Estienne, M; Eun, L; Evdokimov, O; Fatemi, R; Fedorisin, J; Fersch, RG; Filip, P; Finch, E; Fine, V; Fisyak, Y; Gagliardi, CA; Gangadharan, DR; Geurts, F; Ghosh, P; Gorbunov, YN; Gordon, A; Grebenyuk, OG; Grosnick, D; Guertin, SM; Gupta, A; Gupta, S; Guryn, W; Haag, B; Hajkova, O; Hamed, A; Han, LX; Harris, JW; Hays-Wehle, JP; Heinz, M; Heppelmann, S; Hirsch, A; Hjort, E; Hoffmann, GW; Hofman, DJ; Huang, B; Huang, HZ; Humanic, TJ; Huo, L; Igo, G; Jacobs, P; Jacobs, W; Jena, C; Jin, F; Joseph, J; Judd, EG; Kabana, S; Kang, K; Kapitan, J; Kauder, K; Ke, HW; Keane, D; Kechechyan, A; Kettler, D; Kikola, DP; Kiryluk, J; Kisiel, A; Kizka, V; Klein, SR; Knospe, AG; Koetke, DD; Kollegger, T; Konzer, J; Koralt, I; Koroleva, L; Korsch, W; Kotchenda, L; Kouchpil, V; Kravtsov, P; Krueger, K; Krus, M; Kumar, L; Kurnadi, P; Lamont, MAC; Landgraf, JM; LaPointe, S; Lauret, J; Lebedev, A; Lednicky, R; Lee, JH; Leight, W; LeVine, MJ; Li, C; Li, L; Li, N; Li, W; Li, X; Li, X; Li, Y; Li, ZM; Lisa, MA; Liu, F; Liu, H; Liu, J; Ljubicic, T; Llope, WJ; Longacre, RS; Love, WA; Lu, Y; Lukashov, EV; Luo, X; Ma, GL; Ma, YG; Mahapatra, DP; Majka, R; Mall, OI; Manweiler, R; Margetis, S; Markert, C; Masui, H; Matis, HS; Matulenko, YA; McDonald, D; McShane, TS; Meschanin, A; Milner, R; Minaev, NG; Mioduszewski, S; Mitrovski, MK; Mohammed, Y; Mohanty, B; Mondal, MM; Morozov, B; Morozov, DA; Munhoz, MG; Mustafa, MK; Naglis, M; Nandi, BK; Nayak, TK; Netrakanti, PK; Nogach, LV; Nurushev, SB; Odyniec, G; Ogawa, A; Oh, K; Ohlson, A; Okorokov, V; Oldag, EW; Olson, D; Pachr, M; Page, BS; Pal, SK; Pandit, Y; Panebratsev, Y; Pawlak, T; Pei, H; Peitzmann, T; Perkins, C; Peryt, W; Pile, P; Planinic, M; Ploskon, MA; Pluta, J; Plyku, D; Poljak, N; Porter, J; Poskanzer, AM; Potukuchi, BVKS; Powell, CB; Prindle, D; Pruneau, C; Pruthi, NK; Pujahari, PR; Putschke, J; Qiu, H; Raniwala, R; Raniwala, S; Ray, RL; Redwine, R; Reed, R; Ritter, HG; Roberts, JB; Rogachevskiy, OV; Romero, JL; Ruan, L; Rusnak, J; Sahoo, NR; Sakrejda, I; Salur, S; Sandweiss, J; Sangaline, E; Sarkar, A; Schambach, J; Scharenberg, RP; Schmah, AM; Schmitz, N; Schuster, TR; Seele, J; Seger, J; Selyuzhenkov, I; Seyboth, P; Shah, N; Shahaliev, E; Shao, M; Sharma, M; Shi, SS; Shou, QY; Sichtermann, EP; Simon, F; Singaraju, RN; Skoby, MJ; Smirnov, N; Solanki, D; Sorensen, P; Spinka, HM; Srivastava, B; Stanislaus, TDS; Staszak, D; Steadman, SG; Stevens, JR; Stock, R; Strikhanov, M; Stringfellow, B; Suaide, AAP; Suarez, MC; Subba, NL; Sumbera, M; Sun, XM; Sun, Y; Sun, Z; Surrow, B; Svirida, DN; Symons, TJM; de Toledo, AS; Takahashi, J; Tang, AH; Tang, Z; Tarini, LH; Tarnowsky, T; Thein, D; Thomas, JH; Tian, J; Timmins, AR; Tlusty, D; Tokarev, M; Trainor, TA; Trentalange, S; Tribble, RE; Tribedy, P; Tsai, OD; Ullrich, T; Underwood, DG; Van Buren, G; van Nieuwenhuizen, G; Vanfossen, JA; Varma, R; Vasconcelos, GMS; Vasiliev, AN; Videbaek, F; Viyogi, YP; Vokal, S; Voloshin, SA; Wada, M; Walker, M; Wang, F; Wang, G; Wang, H; Wang, JS; Wang, Q; Wang, XL; Wang, Y; Webb, G; Webb, JC; Westfall, GD; Whitten, C; Wieman, H; Wissink, SW; Witt, R; Witzke, W; Wu, YF; Xiao, Z; Xie, W; Xu, H; Xu, N; Xu, QH; Xu, W; Xu, Y; Xu, Z; Xue, L; Yang, Y; Yang, Y; Yepes, P; Yip, K; Yoo, IK; Zawisza, M; Zbroszczyk, H; Zhan, W; Zhang, JB; Zhang, S; Zhang, WM; Zhang, XP; Zhang, Y; Zhang, ZP; Zhao, F; Zhao, J; Zhong, C; Zhou, W; Zhu, X; Zhu, YH; Zoulkarneev, R; Zoulkarneeva, Y				Agakishiev, H.; Aggarwal, M. M.; Ahammed, Z.; Alakhverdyants, A. V.; Alekseev, I.; Alford, J.; Anderson, B. D.; Anson, C. D.; Arkhipkin, D.; Averichev, G. S.; Balewski, J.; Beavis, D. R.; Behera, N. K.; Bellwied, R.; Betancourt, M. J.; Betts, R. R.; Bhasin, A.; Bhati, A. K.; Bichsel, H.; Bielcik, J.; Bielcikova, J.; Biritz, B.; Bland, L. C.; Bordyuzhin, I. G.; Borowski, W.; Bouchet, J.; Braidot, E.; Brandin, A. V.; Bridgeman, A.; Brovko, S. G.; Bruna, E.; Bueltmann, S.; Bunzarov, I.; Burton, T. P.; Cai, X. Z.; Caines, H.; Calderon, M.; Cebra, D.; Cendejas, R.; Cervantes, M. C.; Chajecki, Z.; Chaloupka, P.; Chattopadhyay, S.; Chen, H. F.; Chen, J. H.; Chen, J. Y.; Chen, L.; Cheng, J.; Cherney, M.; Chikanian, A.; Choi, K. E.; Christie, W.; Chung, P.; Codrington, M. J. M.; Corliss, R.; Cramer, J. G.; Crawford, H. J.; Leyva, A. Davila; De Silva, L. C.; Debbe, R. R.; Dedovich, T. G.; Derevschikov, A. A.; Derradi de Souza, R.; Didenko, L.; Djawotho, P.; Dogra, S. M.; Dong, X.; Drachenberg, J. L.; Draper, J. E.; Dunlop, C.; Efimov, L. G.; Elnimr, M.; Engelage, J.; Eppley, G.; Estienne, M.; Eun, L.; Evdokimov, O.; Fatemi, R.; Fedorisin, J.; Fersch, R. G.; Filip, P.; Finch, E.; Fine, V.; Fisyak, Y.; Gagliardi, C. A.; Gangadharan, D. R.; Geurts, F.; Ghosh, P.; Gorbunov, Y. N.; Gordon, A.; Grebenyuk, O. G.; Grosnick, D.; Guertin, S. M.; Gupta, A.; Gupta, S.; Guryn, W.; Haag, B.; Hajkova, O.; Hamed, A.; Han, L-X.; Harris, J. W.; Hays-Wehle, J. P.; Heinz, M.; Heppelmann, S.; Hirsch, A.; Hjort, E.; Hoffmann, G. W.; Hofman, D. J.; Huang, B.; Huang, H. Z.; Humanic, T. J.; Huo, L.; Igo, G.; Jacobs, P.; Jacobs, W.; Jena, C.; Jin, F.; Joseph, J.; Judd, E. G.; Kabana, S.; Kang, K.; Kapitan, J.; Kauder, K.; Ke, H. W.; Keane, D.; Kechechyan, A.; Kettler, D.; Kikola, D. P.; Kiryluk, J.; Kisiel, A.; Kizka, V.; Klein, S. R.; Knospe, A. G.; Koetke, D. D.; Kollegger, T.; Konzer, J.; Koralt, I.; Koroleva, L.; Korsch, W.; Kotchenda, L.; Kouchpil, V.; Kravtsov, P.; Krueger, K.; Krus, M.; Kumar, L.; Kurnadi, P.; Lamont, M. A. C.; Landgraf, J. M.; LaPointe, S.; Lauret, J.; Lebedev, A.; Lednicky, R.; Lee, J. H.; Leight, W.; LeVine, M. J.; Li, C.; Li, L.; Li, N.; Li, W.; Li, X.; Li, X.; Li, Y.; Li, Z. M.; Lisa, M. A.; Liu, F.; Liu, H.; Liu, J.; Ljubicic, T.; Llope, W. J.; Longacre, R. S.; Love, W. A.; Lu, Y.; Lukashov, E. V.; Luo, X.; Ma, G. L.; Ma, Y. G.; Mahapatra, D. P.; Majka, R.; Mall, O. I.; Manweiler, R.; Margetis, S.; Markert, C.; Masui, H.; Matis, H. S.; Matulenko, Yu A.; McDonald, D.; McShane, T. S.; Meschanin, A.; Milner, R.; Minaev, N. G.; Mioduszewski, S.; Mitrovski, M. K.; Mohammed, Y.; Mohanty, B.; Mondal, M. M.; Morozov, B.; Morozov, D. A.; Munhoz, M. G.; Mustafa, M. K.; Naglis, M.; Nandi, B. K.; Nayak, T. K.; Netrakanti, P. K.; Nogach, L. V.; Nurushev, S. B.; Odyniec, G.; Ogawa, A.; Oh, K.; Ohlson, A.; Okorokov, V.; Oldag, E. W.; Olson, D.; Pachr, M.; Page, B. S.; Pal, S. K.; Pandit, Y.; Panebratsev, Y.; Pawlak, T.; Pei, H.; Peitzmann, T.; Perkins, C.; Peryt, W.; Pile, P.; Planinic, M.; Ploskon, M. A.; Pluta, J.; Plyku, D.; Poljak, N.; Porter, J.; Poskanzer, A. M.; Potukuchi, B. V. K. S.; Powell, C. B.; Prindle, D.; Pruneau, C.; K. Pruthi, N.; Pujahari, P. R.; Putschke, J.; Qiu, H.; Raniwala, R.; Raniwala, S.; Ray, R. L.; Redwine, R.; Reed, R.; Ritter, H. G.; Roberts, J. B.; Rogachevskiy, O. V.; Romero, J. L.; Ruan, L.; Rusnak, J.; Sahoo, N. R.; Sakrejda, I.; Salur, S.; Sandweiss, J.; Sangaline, E.; Sarkar, A.; Schambach, J.; Scharenberg, R. P.; Schmah, A. M.; Schmitz, N.; Schuster, T. R.; Seele, J.; Seger, J.; Selyuzhenkov, I.; Seyboth, P.; Shah, N.; Shahaliev, E.; Shao, M.; Sharma, M.; Shi, S. S.; Shou, Q. Y.; Sichtermann, E. P.; Simon, F.; Singaraju, R. N.; Skoby, M. J.; Smirnov, N.; Solanki, D.; Sorensen, P.; Spinka, H. M.; Srivastava, B.; Stanislaus, T. D. S.; Staszak, D.; Steadman, S. G.; Stevens, J. R.; Stock, R.; Strikhanov, M.; Stringfellow, B.; Suaide, A. A. P.; Suarez, M. C.; Subba, N. L.; Sumbera, M.; Sun, X. M.; Sun, Y.; Sun, Z.; Surrow, B.; Svirida, D. N.; Symons, T. J. M.; Szanto de Toledo, A.; Takahashi, J.; Tang, A. H.; Tang, Z.; Tarini, L. H.; Tarnowsky, T.; Thein, D.; Thomas, J. H.; Tian, J.; Timmins, A. R.; Tlusty, D.; Tokarev, M.; Trainor, T. A.; Trentalange, S.; Tribble, R. E.; Tribedy, P.; Tsai, O. D.; Ullrich, T.; Underwood, D. G.; Van Buren, G.; van Nieuwenhuizen, G.; Vanfossen, J. A., Jr.; Varma, R.; Vasconcelos, G. M. S.; Vasiliev, A. N.; Videbaek, F.; Viyogi, Y. P.; Vokal, S.; Voloshin, S. A.; Wada, M.; Walker, M.; Wang, F.; Wang, G.; Wang, H.; Wang, J. S.; Wang, Q.; Wang, X. L.; Wang, Y.; Webb, G.; Webb, J. C.; Westfall, G. D.; Whitten, C., Jr.; Wieman, H.; Wissink, S. W.; Witt, R.; Witzke, W.; Wu, Y. F.; Xiao, Z.; Xie, W.; Xu, H.; Xu, N.; Xu, Q. H.; Xu, W.; Xu, Y.; Xu, Z.; Xue, L.; Yang, Y.; Yang, Y.; Yepes, P.; Yip, K.; Yoo, I-K.; Zawisza, M.; Zbroszczyk, H.; Zhan, W.; Zhang, J. B.; Zhang, S.; Zhang, W. M.; Zhang, X. P.; Zhang, Y.; Zhang, Z. P.; Zhao, F.; Zhao, J.; Zhong, C.; Zhou, W.; Zhu, X.; Zhu, Y. H.; Zoulkarneev, R.; Zoulkarneeva, Y.		STAR Collaboration	Observation of the antimatter helium-4 nucleus	NATURE			English	Article							QUARK-GLUON PLASMA; ANTIPROTONS; COLLISIONS; ELECTRON	High-energy nuclear collisions create an energy density similar to that of the Universe microseconds after the Big Bang(1); in both cases, matter and antimatter are formed with comparable abundance. However, the relatively short-lived expansion in nuclear collisions allows antimatter to decouple quickly from matter, and avoid annihilation. Thus, a high-energy accelerator of heavy nuclei provides an efficient means of producing and studying antimatter. The antimatter helium-4 nucleus ((4)(He) over bar), also known as the anti-alpha ((alpha) over bar), consists of two antiprotons and two antineutrons (baryon number B = -4). It has not been observed previously, although the alpha-particle was identified a century ago by Rutherford and is present in cosmic radiation at the ten per cent level(2). Antimatter nuclei with B -1 have been observed only as rare products of interactions at particle accelerators, where the rate of antinucleus production in high-energy collisions decreases by a factor of about 1,000 with each additional antinucleon(3-5). Here we report the observation of (4)<(He) over bar, the heaviest observed antinucleus to date. In total, 18 (4)(He) over bar counts were detected at the STAR experiment at the Relativistic Heavy Ion Collider (RHIC; ref. 6) in 10(9) recorded gold-on-gold (Au+Au) collisions at centre-of-mass energies of 200 GeV and 62 GeV per nucleon-nucleon pair. The yield is consistent with expectations from thermodynamic(7) and coalescent nucleosynthesis(8) models, providing an indication of the production rate of even heavier antimatter nuclei and a benchmark for possible future observations of (4)(He) over bar in cosmic radiation.	[Agakishiev, H.; Alakhverdyants, A. V.; Averichev, G. S.; Bunzarov, I.; Dedovich, T. G.; Efimov, L. G.; Fedorisin, J.; Filip, P.; Kechechyan, A.; Kizka, V.; Lednicky, R.; Panebratsev, Y.; Rogachevskiy, O. V.; Shahaliev, E.; Tokarev, M.; Vokal, S.; Zoulkarneev, R.; Zoulkarneeva, Y.] Joint Inst Nucl Res, Dubna 141980, Russia; [Aggarwal, M. M.; Bhati, A. K.; K. Pruthi, N.] Panjab Univ, Chandigarh 160014, India; [Ahammed, Z.; Dong, X.; Grebenyuk, O. G.; Hjort, E.; Jacobs, P.; Kiryluk, J.; Klein, S. R.; Masui, H.; Matis, H. S.; Naglis, M.; Odyniec, G.; Olson, D.; Ploskon, M. A.; Porter, J.; Poskanzer, A. M.; Powell, C. B.; Ritter, H. G.; Sakrejda, I.; Schmah, A. M.; Sichtermann, E. P.; Sun, X. M.; Symons, T. J. M.; Thomas, J. H.; Wieman, H.; Zhang, Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Alekseev, I.; Bordyuzhin, I. G.; Koroleva, L.; Morozov, B.; Svirida, D. N.] Alikhanov Inst Theoret & Expt Phys, Moscow 117218, Russia; [Alford, J.; Anderson, B. D.; Bouchet, J.; Joseph, J.; Keane, D.; Kumar, L.; Margetis, S.; Pandit, Y.; Subba, N. L.; Vanfossen, J. A., Jr.; Zhang, W. M.] Kent State Univ, Kent, OH 44242 USA; [Anson, C. D.; Chajecki, Z.; Humanic, T. J.; Lisa, M. A.] Ohio State Univ, Columbus, OH 43210 USA; [Arkhipkin, D.; Beavis, D. R.; Bland, L. C.; Burton, T. P.; Christie, W.; Debbe, R. R.; Didenko, L.; Dunlop, C.; Fine, V.; Fisyak, Y.; Gordon, A.; Guryn, W.; Lamont, M. A. C.; Landgraf, J. M.; Lauret, J.; Lebedev, A.; Lee, J. H.; LeVine, M. J.; Ljubicic, T.; Longacre, R. S.; Love, W. A.; Mitrovski, M. K.; Ogawa, A.; Pile, P.; Ruan, L.; Sorensen, P.; Tang, A. H.; Ullrich, T.; Van Buren, G.; Videbaek, F.; Webb, J. C.; Xu, Z.; Yip, K.] Brookhaven Natl Lab, Upton, NY 11973 USA; [Balewski, J.; Betancourt, M. J.; Corliss, R.; Hays-Wehle, J. P.; Leight, W.; Milner, R.; Redwine, R.; Seele, J.; Steadman, S. G.; Surrow, B.; van Nieuwenhuizen, G.; Walker, M.] MIT, Cambridge, MA 02139 USA; [Behera, N. K.; Nandi, B. K.; Pujahari, P. R.; Sarkar, A.; Varma, R.] Indian Inst Technol, Bombay 400076, Maharashtra, India; [Bellwied, R.; De Silva, L. C.; Timmins, A. R.] Univ Houston, Houston, TX 77204 USA; [Betts, R. R.; Evdokimov, O.; Hofman, D. J.; Kauder, K.; Pei, H.; Suarez, M. C.] Univ Illinois, Chicago, IL 60607 USA; [Bhasin, A.; Dogra, S. M.; Gupta, A.; Gupta, S.; Potukuchi, B. V. K. S.] Univ Jammu, Jammu 180001, India; [Bichsel, H.; Cramer, J. G.; Kettler, D.; Prindle, D.; Trainor, T. A.] Univ Washington, Seattle, WA 98195 USA; [Bielcik, J.; Hajkova, O.; Krus, M.; Pachr, M.] Czech Tech Univ, FNSPE, Prague 11519, Czech Republic; [Bielcikova, J.; Chaloupka, P.; Chung, P.; Kapitan, J.; Kouchpil, V.; Rusnak, J.; Sumbera, M.; Tlusty, D.] Nucl Phys Inst AS CR, Rez 25068, Czech Republic; [Biritz, B.; Cendejas, R.; Gangadharan, D. R.; Guertin, S. M.; Huang, H. Z.; Igo, G.; Kurnadi, P.; Shah, N.; Staszak, D.; Trentalange, S.; Tsai, O. D.; Wang, G.; Whitten, C., Jr.; Xu, W.; Zhao, F.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Borowski, W.; Estienne, M.; Kabana, S.] SUBATECH, F-44307 Nantes, France; [Braidot, E.; Peitzmann, T.] NIKHEF, NL-1098 XG Amsterdam, Netherlands; [Braidot, E.; Peitzmann, T.] Univ Utrecht, NL-1098 XG Amsterdam, Netherlands; [Brandin, A. V.; Kotchenda, L.; Kravtsov, P.; Lukashov, E. V.; Okorokov, V.; Strikhanov, M.] Moscow Engn Phys Inst, Moscow 115409, Russia; [Bridgeman, A.; Krueger, K.; Spinka, H. M.; Underwood, D. G.] Argonne Natl Lab, Argonne, IL 60439 USA; [Brovko, S. G.; Calderon, M.; Cebra, D.; Draper, J. E.; Haag, B.; Liu, H.; Mall, O. I.; Reed, R.; Romero, J. L.; Salur, S.; Sangaline, E.] Univ Calif Davis, Davis, CA 95616 USA; [Bruna, E.; Caines, H.; Chikanian, A.; Finch, E.; Harris, J. W.; Heinz, M.; Knospe, A. G.; Majka, R.; Ohlson, A.; Putschke, J.; Sandweiss, J.; Smirnov, N.] Yale Univ, New Haven, CT 06520 USA; [Bueltmann, S.; Koralt, I.; Plyku, D.] Old Dominion Univ, Norfolk, VA 23529 USA; [Cai, X. Z.; Chen, J. H.; Han, L-X.; Jin, F.; Li, W.; Ma, G. L.; Ma, Y. G.; Shou, Q. Y.; Tian, J.; Xue, L.; Zhang, S.; Zhao, J.; Zhong, C.; Zhu, Y. H.] Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China; [Bhasin, A.; Cervantes, M. C.; Codrington, M. J. M.; Djawotho, P.; Drachenberg, J. L.; Gagliardi, C. A.; Hamed, A.; Huo, L.; Mioduszewski, S.; Mohammed, Y.; Pal, S. K.; Tribble, R. E.] Texas A&M Univ, College Stn, TX 77843 USA; [Bhasin, A.; Chattopadhyay, S.; Ghosh, P.; Mohanty, B.; Mondal, M. M.; Nayak, T. K.; Sahoo, N. R.; Singaraju, R. N.; Tribedy, P.; Viyogi, Y. P.] Variable Energy Cyclotron Ctr, Kolkata 700064, India; [Chen, H. F.; Huang, B.; Li, C.; Lu, Y.; Luo, X.; Shao, M.; Sun, Y.; Tang, Z.; Wang, X. L.; Xu, Y.; Zhang, Z. P.] Univ Sci & Technol China, Hefei 230026, Peoples R China; [Chen, J. Y.; Chen, L.; Ke, H. W.; Li, N.; Li, Z. M.; Liu, F.; Shi, S. S.; Wu, Y. F.; Xu, N.; Yang, Y.; Zhang, J. B.] CCNU HZNU, Inst Particle Phys, Wuhan 430079, Peoples R China; [Cheng, J.; Kang, K.; Li, Y.; Wang, Y.; Xiao, Z.; Zhang, X. P.; Zhu, X.] Tsinghua Univ, Beijing 100084, Peoples R China; [Cherney, M.; Gorbunov, Y. N.; McShane, T. S.; Seger, J.] Creighton Univ, Omaha, NE 68178 USA; [Choi, K. E.; Oh, K.; Yoo, I-K.] Pusan Natl Univ, Pusan 609735, South Korea; [Leyva, A. Davila; Hoffmann, G. W.; Li, L.; Markert, C.; Oldag, E. W.; Ray, R. L.; Schambach, J.; Thein, D.; Wada, M.] Univ Texas Austin, Austin, TX 78712 USA; [Derevschikov, A. A.; Matulenko, Yu A.; Meschanin, A.; Minaev, N. G.; Morozov, D. A.; Nogach, L. V.; Nurushev, S. B.; Vasiliev, A. N.] Inst High Energy Phys, Protvino 142281, Russia; [Derradi de Souza, R.; Takahashi, J.; Vasconcelos, G. M. S.] Univ Estadual Campinas, BR-13083859 Sao Paulo, Brazil; [Elnimr, M.; LaPointe, S.; Pruneau, C.; Sharma, M.; Tarini, L. H.; Voloshin, S. A.] Wayne State Univ, Detroit, MI 48201 USA; [Eppley, G.; Geurts, F.; Llope, W. J.; McDonald, D.; Roberts, J. B.; Yepes, P.] Rice Univ, Houston, TX 77251 USA; [Eun, L.; Heppelmann, S.] Penn State Univ, University Pk, PA 16802 USA; [Fatemi, R.; Fersch, R. G.; Korsch, W.; Webb, G.; Witzke, W.] Univ Kentucky, Lexington, KY 40506 USA; [Grosnick, D.; Koetke, D. D.; Manweiler, R.; Stanislaus, T. D. S.] Valparaiso Univ, Valparaiso, IN 46383 USA; [Hirsch, A.; Kikola, D. P.; Konzer, J.; Li, X.; Mustafa, M. K.; Netrakanti, P. K.; Scharenberg, R. P.; Skoby, M. J.; Srivastava, B.; Stringfellow, B.; Wang, F.; Wang, Q.; Xie, W.] Purdue Univ, W Lafayette, IN 47907 USA; [Jacobs, W.; Page, B. S.; Selyuzhenkov, I.; Stevens, J. R.; Wissink, S. W.] Indiana Univ, Bloomington, IN 47408 USA; [Jena, C.; Mahapatra, D. P.] Inst Phys, Bhubaneswar 751005, Orissa, India; [Kisiel, A.; Pawlak, T.; Peryt, W.; Pluta, J.; Zawisza, M.; Zbroszczyk, H.] Warsaw Univ Technol, PL-00661 Warsaw, Poland; [Kollegger, T.; Schuster, T. R.; Stock, R.; Zhou, W.] Goethe Univ Frankfurt, D-60325 Frankfurt, Germany; [Li, X.; Xu, Q. H.] Shandong Univ, Jinan 250100, Shandong, Peoples R China; [Munhoz, M. G.; Suaide, A. A. P.; Szanto de Toledo, A.] Univ Sao Paulo, BR-05508090 Sao Paulo, Brazil; [Planinic, M.; Poljak, N.] Univ Zagreb, HR-10002 Zagreb, Croatia; [Qiu, H.; Sun, Z.; Wang, J. S.; Xu, H.; Yang, Y.; Zhan, W.] Inst Modern Phys, Lanzhou 730000, Peoples R China; [Raniwala, R.; Raniwala, S.; Solanki, D.] Univ Rajasthan, Jaipur 302004, Rajasthan, India; [Schmitz, N.; Seyboth, P.; Simon, F.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Tarnowsky, T.; Wang, H.; Westfall, G. D.] Michigan State Univ, E Lansing, MI 48824 USA; [Witt, R.] USN Acad, Annapolis, MD 21402 USA	Joint Institute for Nuclear Research - Russia; Panjab University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Ohio State University; United States Department of Energy (DOE); Brookhaven National Laboratory; Massachusetts Institute of Technology (MIT); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Houston System; University of Houston; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Jammu; University of Washington; University of Washington Seattle; Czech Technical University Prague; Czech Academy of Sciences; Nuclear Physics Institute of the Czech Academy of Sciences; University of California System; University of California Los Angeles; IMT - Institut Mines-Telecom; IMT Atlantique; FOM National Institute for Subatomic Physics; Utrecht University; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); United States Department of Energy (DOE); Argonne National Laboratory; University of California System; University of California Davis; Yale University; Old Dominion University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Texas A&M University System; Texas A&M University College Station; Variable Energy Cyclotron Centre; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Central China Normal University; Tsinghua University; Creighton University; Pusan National University; University of Texas System; University of Texas Austin; National Research Centre - Kurchatov Institute; Institute of High Energy Physics - IHEP; Universidade Estadual de Campinas; Wayne State University; Rice University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Kentucky; Valparaiso University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Institute of Physics Bhubaneswar (IOPB); Warsaw University of Technology; Goethe University Frankfurt; Shandong University; Universidade de Sao Paulo; University of Zagreb; Chinese Academy of Sciences; Institute of Modern Physics, CAS; University of Rajasthan; Max Planck Society; Michigan State University; United States Department of Defense; United States Navy; United States Naval Academy			Sahoo, Nihar Ranjan/ABF-3516-2021; Li, Xuan/K-6034-2017; Takahashi, Jun/B-2946-2012; Okorokov, Vitaly/C-4800-2017; Kabana, Sonia/ABF-5974-2020; Bordyuzhin, Igor/AGX-2537-2022; Krůs, Miroslav/Q-5779-2018; Vasiliev, Alexander N/N-4742-2017; Dogra, Sunil/B-5330-2013; Behera, Nirbhay Kumar/AAG-3409-2019; Yoo, In-Kwon/J-6222-2012; Munhoz, Marcelo Gameiro/C-7939-2013; Hamed, Ahmed Abdeen/AAF-4658-2020; Xu, Wenqin/H-7553-2014; Strikhanov, Mikhail N/P-7393-2014; Lednicky, Richard/K-4164-2013; Bielcikova, Jana/AAB-4862-2020; Voloshin, Sergei A/I-4122-2013; Yip, Kin/D-6860-2013; Shi, Shusu/ABC-6567-2021; Raniwala, Rashmi/AAA-3747-2022; Huang, Bingchu/H-6343-2015; Li, Xuan/D-2549-2018; Sumbera, Michal/O-7497-2014; Bielcikova, Jana/G-9342-2014; Selyuzhenkov, Ilya/AAH-8322-2019; de Souza, Rafael Derradi/M-4791-2013; Rusnak, Jan/G-8462-2014; Kumar, Lokesh/A-6154-2010; Alekseev, Igor G/J-8070-2014; Matis, Howard/AAO-2082-2021; Witt, Richard/H-3560-2012; Selyuzhenkov, Ilya/AAD-6163-2020; Peitzmann, Thomas/K-2206-2012; Svirida, Dmitry N/R-4909-2016; mohammed, yasser/P-1462-2016; Pandit, Yadav/I-2170-2013; Bhasin, Anju/AAS-4745-2021; Bruna, Elena/C-4939-2014; Planinic, Mirko/E-8085-2012; Suaide, Alexandre A P/L-6239-2016; Ma, Yu-Gang/M-8122-2013; Wang, Xin/AAN-8435-2021; Poljak, Nikola/AAI-4178-2020; Okorokov, Vitaly/AFM-5721-2022; XIAO, Zhi Gang/C-9460-2016; Chaloupka, Petr/E-5965-2012; wang, xl/Y-8251-2019; Xue, Liang/F-8077-2013; Kisiel, Adam/O-8754-2015; CAI, Xiangzhou/N-8768-2013; Fisyak, Yuri/K-2142-2017	Sahoo, Nihar Ranjan/0000-0003-4518-6630; Li, Xuan/0000-0002-3167-8629; Takahashi, Jun/0000-0002-4091-1779; Okorokov, Vitaly/0000-0002-7162-5345; Kabana, Sonia/0000-0003-0568-5750; Krůs, Miroslav/0000-0002-8595-3139; Behera, Nirbhay Kumar/0000-0002-1999-9876; Munhoz, Marcelo Gameiro/0000-0003-3695-3180; Xu, Wenqin/0000-0002-5976-4991; Strikhanov, Mikhail N/0000-0003-2586-0405; Lednicky, Richard/0000-0001-6887-1804; Yip, Kin/0000-0002-8576-4311; Shi, Shusu/0000-0003-2032-0848; Huang, Bingchu/0000-0002-3253-3210; Li, Xuan/0000-0002-3167-8629; Sumbera, Michal/0000-0002-0639-7323; Selyuzhenkov, Ilya/0000-0002-8042-4924; de Souza, Rafael Derradi/0000-0002-2084-7001; Rusnak, Jan/0000-0002-4738-7869; Kumar, Lokesh/0000-0002-2746-9840; Alekseev, Igor G/0000-0003-3358-9635; Peitzmann, Thomas/0000-0002-7116-899X; Svirida, Dmitry N/0000-0002-0334-7304; mohammed, yasser/0000-0001-8399-3017; Pandit, Yadav/0000-0003-2809-7943; Bruna, Elena/0000-0001-5427-1461; Planinic, Mirko/0000-0001-6760-2514; Suaide, Alexandre A P/0000-0003-2847-6556; Ma, Yu-Gang/0000-0002-0233-9900; Wang, Xin/0000-0002-4457-7376; Okorokov, Vitaly/0000-0002-7162-5345; XIAO, Zhi Gang/0000-0001-9534-5981; Xue, Liang/0000-0002-2321-9019; Kisiel, Adam/0000-0001-8322-9510; Luo, Xiaofeng/0000-0002-4919-303X; OH, Kunsu/0000-0002-8342-9747; Bhasin, Anju/0000-0002-3687-8179; Evdokimov, Olga/0000-0002-1250-8931; pruneau, claude/0000-0002-0458-538X; Leight, William/0000-0002-2968-7841; CAI, Xiangzhou/0000-0002-7108-2344; Thomas, James/0000-0002-6256-4536; Poljak, Nikola/0000-0002-4512-9620; Zhao, Jie/0000-0001-6408-2314; Anson, Christopher/0000-0001-6244-4713; Vanfossen, Joseph/0000-0002-7915-1455; Ke, Hongwei/0000-0003-1463-7291; M. Hamed, Ahmed/0000-0003-1732-8443; Fisyak, Yuri/0000-0002-3151-8377; Finch, Evan/0000-0002-6150-8612; Klein, Spencer/0000-0003-2841-6553; Simon, Frank/0000-0002-5978-0289; Pujahari, Prabhat Ranjan/0000-0002-0994-7212; Sorensen, Paul/0000-0001-5056-9391; Kikola, Daniel/0000-0001-6896-6475; Dogra, Sunil Manohar/0000-0002-0812-0758	RHIC Operations Group; RACF at BNL; NERSC Center at LBNL; Open Science Grid consortium; Offices of NP and HEP within the US DOE Office of Science; US NSF; Sloan Foundation; DFG cluster of excellence 'Origin and Structure of the Universe' of Germany; CNRS/IN2P3; FAPESP; CNPq of Brazil; Ministry of Education and Science of the Russian Federation; NNSFC; CAS; MoST; MoE of China; GA and MSMT of the Czech Republic; FOM and NWO of the Netherlands; DAE, DST and CSIR of India; Polish Ministry of Science and Higher Education; Korea Research Foundation; Ministry of Science, Education and Sports of Croatia; RosAtom of Russia	RHIC Operations Group; RACF at BNL; NERSC Center at LBNL; Open Science Grid consortium; Offices of NP and HEP within the US DOE Office of Science(United States Department of Energy (DOE)); US NSF(National Science Foundation (NSF)); Sloan Foundation(Alfred P. Sloan Foundation); DFG cluster of excellence 'Origin and Structure of the Universe' of Germany(German Research Foundation (DFG)); CNRS/IN2P3(Centre National de la Recherche Scientifique (CNRS)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); NNSFC(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); MoST; MoE of China(Ministry of Education, China); GA and MSMT of the Czech Republic; FOM and NWO of the Netherlands(FOM (The Netherlands)); DAE, DST and CSIR of India(Department of Science & Technology (India)Department of Atomic Energy (DAE)); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Korea Research Foundation(National Research Foundation of Korea); Ministry of Science, Education and Sports of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); RosAtom of Russia	We thank the RHIC Operations Group and RACF at BNL, the NERSC Center at LBNL and the Open Science Grid consortium for providing resources and support. This work was supported in part by the Offices of NP and HEP within the US DOE Office of Science, the US NSF, the Sloan Foundation, the DFG cluster of excellence 'Origin and Structure of the Universe' of Germany, CNRS/IN2P3, FAPESP, CNPq of Brazil, the Ministry of Education and Science of the Russian Federation, NNSFC, CAS, MoST and MoE of China, GA and MSMT of the Czech Republic, FOM and NWO of the Netherlands, DAE, DST and CSIR of India, the Polish Ministry of Science and Higher Education, the Korea Research Foundation, the Ministry of Science, Education and Sports of Croatia, and RosAtom of Russia.	Abelev BI, 2010, SCIENCE, V328, P58, DOI 10.1126/science.1183980; ABELEV BI, 2009, YIELDS ELLIPTIC FLOW; AHLEN S, 1994, NUCL INSTRUM METH A, V350, P351, DOI 10.1016/0168-9002(94)91184-3; Anderson CD, 1933, PHYS REV, V43, P491, DOI 10.1103/PhysRev.43.491; Anderson M, 2003, NUCL INSTRUM METH A, V499, P659, DOI 10.1016/S0168-9002(02)01964-2; Andronic A, 2011, PHYS LETT B, V697, P203, DOI 10.1016/j.physletb.2011.01.053; Antipov Yu. M., 1970, Yadernaya Fizika, V12, P311; Armstrong TA, 1999, PHYS REV LETT, V83, P5431, DOI 10.1103/PhysRevLett.83.5431; Arsene I, 2005, NUCL PHYS A, V757, P1, DOI 10.1016/j.nuclphysa.2005.02.130; Baur G, 1996, PHYS LETT B, V368, P251, DOI 10.1016/0370-2693(96)00005-6; Bichsel H, 2006, NUCL INSTRUM METH A, V562, P154, DOI 10.1016/j.nima.2006.03.009; Bonner B, 2003, NUCL INSTRUM METH A, V508, P181, DOI 10.1016/S0168-9002(03)01347-0; Braun-Munzinger P, 2007, NATURE, V448, P302, DOI 10.1038/nature06080; BUTLER ST, 1961, PHYS REV LETT, V7, P69, DOI 10.1103/PhysRevLett.7.69; CHAMBERLAIN O, 1955, PHYS REV, V100, P947, DOI 10.1103/PhysRev.100.947; CORK B, 1956, PHYS REV, V104, P1193, DOI 10.1103/PhysRev.104.1193; Dirac PAM, 1928, P R SOC LOND A-CONTA, V117, P610, DOI 10.1098/rspa.1928.0023; DORFAN DE, 1965, PHYS REV LETT, V14, P1003, DOI 10.1103/PhysRevLett.14.1003; Greiner W, 1996, INT J MOD PHYS E, V5, P1, DOI 10.1142/S0218301396000025; Harrison M, 2003, NUCL INSTRUM METH A, V499, P235, DOI 10.1016/S0168-9002(02)01937-X; HEINZ U, 1986, J PHYS G NUCL PARTIC, V12, P1237, DOI 10.1088/0305-4616/12/11/013; LEE TD, 1975, REV MOD PHYS, V47, P267, DOI 10.1103/RevModPhys.47.267; Lemaitre G., 1927, ANN SOC SCI BRUX, VA47, P49; LIU H, 2007, THESIS U SCI TECHNOL; MASSAM T, 1965, NUOVO CIMENTO, V39, P10, DOI 10.1007/BF02814251; SATO H, 1981, PHYS LETT B, V98, P153, DOI 10.1016/0370-2693(81)90976-X; Tang ZB, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.051901; Vishnevskii N. K., 1974, Yadernaya Fizika, V20, P694; Wiebel-Sooth B, 1998, ASTRON ASTROPHYS, V330, P389; Zhou J., 2009, THESIS RICE U	30	113	116	6	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					353	356		10.1038/nature10079	http://dx.doi.org/10.1038/nature10079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21516103	Green Submitted, Green Published			2022-12-28	WOS:000290722400043
J	Martin, DF; Maguire, MG; Ying, GS; Grunwald, JE; Fine, SL; Jaffe, GJ				Martin, Daniel F.; Maguire, Maureen G.; Ying, Gui-shuang; Grunwald, Juan E.; Fine, Stuart L.; Jaffe, Glenn J.		CATT Res Grp	Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background Clinical trials have established the efficacy of ranibizumab for the treatment of neovascular age-related macular degeneration (AMD). In addition, bevacizumab is used off-label to treat AMD, despite the absence of similar supporting data. Methods In a multicenter, single-blind, noninferiority trial, we randomly assigned 1208 patients with neovascular AMD to receive intravitreal injections of ranibizumab or bevacizumab on either a monthly schedule or as needed with monthly evaluation. The primary outcome was the mean change in visual acuity at 1 year, with a noninferiority limit of 5 letters on the eye chart. Results Bevacizumab administered monthly was equivalent to ranibizumab administered monthly, with 8.0 and 8.5 letters gained, respectively. Bevacizumab administered as needed was equivalent to ranibizumab as needed, with 5.9 and 6.8 letters gained, respectively. Ranibizumab as needed was equivalent to monthly ranibizumab, although the comparison between bevacizumab as needed and monthly bevacizumab was inconclusive. The mean decrease in central retinal thickness was greater in the ranibizumab-monthly group (196 mu m) than in the other groups (152 to 168 mu m, P = 0.03 by analysis of variance). Rates of death, myocardial infarction, and stroke were similar for patients receiving either bevacizumab or ranibizumab (P>0.20). The proportion of patients with serious systemic adverse events (primarily hospitalizations) was higher with bevacizumab than with ranibizumab (24.1% vs. 19.0%; risk ratio, 1.29; 95% confidence interval, 1.01 to 1.66), with excess events broadly distributed in disease categories not identified in previous studies as areas of concern. Conclusions At 1 year, bevacizumab and ranibizumab had equivalent effects on visual acuity when administered according to the same schedule. Ranibizumab given as needed with monthly evaluation had effects on vision that were equivalent to those of ranibizumab administered monthly. Differences in rates of serious adverse events require further study. (Funded by the National Eye Institute; ClinicalTrials. gov number, NCT00593450.)	[Maguire, Maureen G.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Martin, Daniel F.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Fine, Stuart L.] Univ Colorado Denver, Aurora, CO USA; [Jaffe, Glenn J.] Duke Univ, Durham, NC USA	University of Pennsylvania; Pennsylvania Medicine; Cleveland Clinic Foundation; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University	Maguire, MG (corresponding author), Univ Penn, Scheie Eye Inst, 3535 Market St,Suite 700, Philadelphia, PA 19104 USA.	maguirem@mail.med.upenn.edu	Barresi, Luca/B-4622-2013; Ciulla, Thomas/AAA-1299-2020	Barresi, Luca/0000-0002-3788-145X; Ciulla, Thomas/0000-0001-5557-6777; Vavvas, Demetrios/0000-0002-8622-6478; Folk, James/0000-0002-6271-2906; Losordo, Douglas/0000-0002-6857-7506; Pistilli, Maxwell/0000-0002-4266-4150; Stinnett, Sandra/0000-0001-7192-0195	National Eye Institute, National Institutes of Health, Department of Health and Human Services [U10-EY017823, U10-EY017825, U10-EY017826, U10-EY017828]; Glaxo-SmithKline; Neurotech; SurModics; NATIONAL EYE INSTITUTE [U10EY017828, U10EY017823, U10EY017825, U10EY017826] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Glaxo-SmithKline(GlaxoSmithKline); Neurotech; SurModics; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by cooperative agreements (U10-EY017823, U10-EY017825, U10-EY017826, and U10-EY017828) from the National Eye Institute, National Institutes of Health, Department of Health and Human Services.; Dr. Grunwald reports receiving consulting fees from Glaxo-SmithKline; and Dr. Jaffe, consulting fees from Neurotech and SurModics. No other potential conflict of interest relevant to this article was reported.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 2010, COMP AGERELATED MACU, P10; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; Avery RL, 2006, OPHTHALMOLOGY, V113, P363, DOI 10.1016/j.ophtha.2005.11.019; Beck RW, 2003, AM J OPHTHALMOL, V135, P194, DOI 10.1016/S0002-9394(02)01825-1; Boyer DS, 2009, OPHTHALMOLOGY, V116, P1731, DOI 10.1016/j.ophtha.2009.05.024; Brechner RJ, 2011, AM J OPHTHALMOL, V151, P887, DOI 10.1016/j.ajo.2010.11.017; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; COX DR, 1972, J R STAT SOC B, V34, P187; Curtis LH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI 10.1001/archophthalmol.2010.223; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Fung AE, 2007, AM J OPHTHALMOL, V143, P566, DOI 10.1016/j.ajo.2007.01.028; Genentech, AV LAB TEXT FDA APPR; Martin DF, 2010, NEW ENGL J MED, V363, P105, DOI 10.1056/NEJMp1001201; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2005, OPHTHAL SURG LAS IM, V36, P331, DOI 10.3928/1542-8877-20050701-14; Rosner B, 2003, BIOMETRICS, V59, P1089, DOI 10.1111/j.0006-341X.2003.00125.x; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Schmidt-Erfurth U, 2010, OPHTHALMOLOGY   1209; The European Agency for the Evaluation of Medicinal Products Committee for Proprietary Medicinal Products (CPMP), 2000, CMPEWP48299 EUR AG E; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	23	1935	2002	0	138	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2011	364	20					1897	1908		10.1056/NEJMoa1102673	http://dx.doi.org/10.1056/NEJMoa1102673			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765PJ	21526923	Green Accepted			2022-12-28	WOS:000290720700005
J	O'Neill, LA				O'Neill, Luke A.			Jurg Tschopp (1951-2011) RETROSPECTIVE	SCIENCE			English	Biographical-Item									Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LA (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748					0	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					679	679		10.1126/science.1207046	http://dx.doi.org/10.1126/science.1207046			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551056				2022-12-28	WOS:000290265800033
J	Dominguez, G; Wilkins, G; Thiemens, MH				Dominguez, Gerardo; Wilkins, Gautam; Thiemens, Mark H.			The Soret effect and isotopic fractionation in high-temperature silicate melts	NATURE			English	Article							THERMAL-DIFFUSION; MOLECULAR-DYNAMICS; EVAPORATION; LIQUIDS; SYSTEMS; SIO2	Diffusion in condensed phases is a ubiquitous but poorly understood phenomenon. For example, chemical diffusion, which is the transport of matter associated with chemical concentration gradients (Fick's law), is treated as a separate process from thermal transport (the Soret effect), which is mass transport induced by temperature gradients. In the past few years, large variations in the proportions of isotopes of Mg, Ca, Fe, Si and O found in silicate melts subject to thermal gradients have been found(1-3), but no physical mechanism has been proposed. Here we present a model of diffusion in natural condensed systems that explains both the chemical and isotopic fractionation of Mg, Ca and Fe in high-temperature geochemical melts. Despite the high temperatures associated with these melts (T > 1,000 degrees C), we find that consideration of the quantum-mechanical zero-point energy of diffusing species is essential for understanding diffusion at the isotopic level. Our model explains thermal and chemical mass transport as manifestations of the same underlying diffusion mechanism. This work promises to provide insights into mass-transport phenomena (diffusion and evaporation) and associated isotopic fractionations in a wide range of natural condensed systems, including the atmospheric water cycle(1,2), geological and geochemical systems(3-6) and the early Solar System(4). This work might also be relevant to studies of mass transport in biological(7,8) and nanotechnological condensed systems(9).	[Dominguez, Gerardo; Thiemens, Mark H.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Wilkins, Gautam] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA	University of California System; University of California San Diego; University of California System; University of California Berkeley	Dominguez, G (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	gdominguez@ucsd.edu			University of California; NASA [NNX07AM66G, NNX08AI15G]	University of California(University of California System); NASA(National Aeronautics & Space Administration (NASA))	We thank Frank Richter for introducing us to this problem. We thank C. Lundstrom, E. Schauble, S. Chakraborty, A. Fnu and R. Shaheen for discussions. G. D. acknowledges support from the University of California President's Fellowship and NASA grants NNX07AM66G and NNX08AI15G.	Astumian RD, 2007, P NATL ACAD SCI USA, V104, P3, DOI 10.1073/pnas.0609754104; Braun D, 2004, PHYS BIOL, V1, pP1, DOI 10.1088/1478-3967/1/1/P01; Chakraborty S, 2008, ANNU REV EARTH PL SC, V36, P153, DOI 10.1146/annurev.earth.36.031207.124125; Duhr S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.168301; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Huang F, 2010, NATURE, V464, P396, DOI 10.1038/nature08840; Huang F, 2009, GEOCHIM COSMOCHIM AC, V73, P729, DOI 10.1016/j.gca.2008.11.012; Huang F, 2009, CHEM GEOL, V268, P15, DOI 10.1016/j.chemgeo.2009.07.003; Korkotian E, 2006, CELL CALCIUM, V40, P441, DOI 10.1016/j.ceca.2006.08.008; KUBICKI JD, 1988, AM MINERAL, V73, P941; LANDSBERG PT, 1984, J APPL PHYS, V56, P1119, DOI 10.1063/1.334083; LaTourrette T, 1996, GEOCHIM COSMOCHIM AC, V60, P1329, DOI 10.1016/0016-7037(96)00015-4; LESHER CE, 1986, GEOCHIM COSMOCHIM AC, V50, P1397, DOI 10.1016/0016-7037(86)90313-3; Luz B, 2009, GEOCHIM COSMOCHIM AC, V73, P6697, DOI 10.1016/j.gca.2009.08.008; Pathria R. K., 1972, STAT MECH; Richter FM, 2008, GEOCHIM COSMOCHIM AC, V72, P206, DOI 10.1016/j.gca.2007.10.016; Richter FM, 2007, GEOCHIM COSMOCHIM AC, V71, P5544, DOI 10.1016/j.gca.2007.09.005; Richter FM, 2009, GEOCHIM COSMOCHIM AC, V73, P4250, DOI 10.1016/j.gca.2009.04.011; Richter FM, 2009, CHEM GEOL, V258, P92, DOI 10.1016/j.chemgeo.2008.06.011; Roselieb K, 1997, GEOCHIM COSMOCHIM AC, V61, P3101, DOI 10.1016/S0016-7037(97)00153-1; Soret C., 1879, ARCH SCI PHYS NAT, V2, P48; Truhlar DG, 1996, J PHYS CHEM-US, V100, P12771, DOI 10.1021/jp953748q; Uemura R, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041960; van Milligen BP, 2005, EUR J PHYS, V26, P913, DOI 10.1088/0143-0807/26/5/023; VASHISHTA P, 1990, PHYS REV B, V41, P12197, DOI 10.1103/PhysRevB.41.12197; WALKER D, 1982, CONTRIB MINERAL PETR, V79, P231, DOI 10.1007/BF00371514; Watson EB, 2007, EARTH PLANET SC LETT, V253, P307, DOI 10.1016/j.epsl.2006.11.015; WERT C, 1949, PHYS REV, V76, P1169, DOI 10.1103/PhysRev.76.1169	30	54	56	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					70	U134		10.1038/nature09911	http://dx.doi.org/10.1038/nature09911			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21508959				2022-12-28	WOS:000290218300032
J	Ko, H; Hofer, SB; Pichler, B; Buchanan, KA; Sjostrom, PJ; Mrsic-Flogel, TD				Ko, Ho; Hofer, Sonja B.; Pichler, Bruno; Buchanan, Katherine A.; Sjoestroem, P. Jesper; Mrsic-Flogel, Thomas D.			Functional specificity of local synaptic connections in neocortical networks	NATURE			English	Article							PRIMARY VISUAL-CORTEX; IN-VIVO; HORIZONTAL CONNECTIONS; INTRACORTICAL CIRCUITS; NEURONAL NETWORKS; CORTICAL NETWORKS; STRIATE CORTEX; SIMPLE CELLS; CAT; INHIBITION	Neuronal connectivity is fundamental to information processing in the brain. Therefore, understanding the mechanisms of sensory processing requires uncovering how connection patterns between neurons relate to their function. On a coarse scale, long-range projections can preferentially link cortical regions with similar responses to sensory stimuli(1-4). But on the local scale, where dendrites and axons overlap substantially, the functional specificity of connections remains unknown. Here we determine synaptic connectivity between nearby layer 2/3 pyramidal neurons in vitro, the response properties of which were first characterized in mouse visual cortex in vivo. We found that connection probability was related to the similarity of visually driven neuronal activity. Neurons with the same preference for oriented stimuli connected at twice the rate of neurons with orthogonal orientation preferences. Neurons responding similarly to naturalistic stimuli formed connections at much higher rates than those with uncorrelated responses. Bidirectional synaptic connections were found more frequently between neuronal pairs with strongly correlated visual responses. Our results reveal the degree of functional specificity of local synaptic connections in the visual cortex, and point to the existence of fine-scale subnetworks dedicated to processing related sensory information.	[Ko, Ho; Hofer, Sonja B.; Pichler, Bruno; Buchanan, Katherine A.; Sjoestroem, P. Jesper; Mrsic-Flogel, Thomas D.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6DE, England	University of London; University College London	Mrsic-Flogel, TD (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, 21 Univ St, London WC1E 6DE, England.	t.mrsic-flogel@ucl.ac.uk	Ko, Ho/I-7513-2016; Ko, Ho/AAH-2755-2020; Sjöström, Per Jesper/B-9696-2019	Ko, Ho/0000-0002-0254-3274; Ko, Ho/0000-0002-0254-3274; Sjöström, Per Jesper/0000-0001-7085-2223; Hofer, Sonja/0000-0003-4921-8521; Mrsic-Flogel, Tom/0000-0002-8947-408X	Wellcome Trust; European Research Council; European Molecular Biology Organisation; Medical Research Council [243914]; Overseas Research Students Award; UCL; MRC [G0700188] Funding Source: UKRI; Medical Research Council [G0700188] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organisation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Overseas Research Students Award; UCL; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Margrie for discussions about the project and the manuscript, and J. Vogelstein for the spike inference algorithm. This work was supported by the Wellcome Trust (T.D.M.-F.), the European Research Council (T.D.M.-F.), the European Molecular Biology Organisation (S.B.H.), the Medical Research Council and FP7 grant #243914 (K.A.B., P.J.S.), the Overseas Research Students Award Scheme and UCL studentship (H.K.).	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Agresti A, 2003, CATEGORICAL DATA ANA; Alitto HJ, 2010, CURR OPIN NEUROBIOL, V20, P340, DOI 10.1016/j.conb.2010.02.012; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Bosking WH, 1997, J NEUROSCI, V17, P2112; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Debanne D, 2008, NAT PROTOC, V3, P1559, DOI 10.1038/nprot.2008.147; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Roerig B, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0002.1999; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Thomson AM, 2002, PHILOS T R SOC B, V357, P1781, DOI 10.1098/rstb.2002.1163; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; VOGELSTEIN JT, 2010, J NEUROPHYSIOL; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	38	502	505	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					87	U100		10.1038/nature09880	http://dx.doi.org/10.1038/nature09880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21478872	Green Accepted			2022-12-28	WOS:000290218300036
J	Yamada, K; Frouws, TD; Angst, B; Fitzgerald, DJ; DeLuca, C; Schimmele, K; Sargent, DF; Richmond, TJ				Yamada, Kazuhiro; Frouws, Timothy D.; Angst, Brigitte; Fitzgerald, Daniel J.; DeLuca, Carl; Schimmele, Kyoko; Sargent, David F.; Richmond, Timothy J.			Structure and mechanism of the chromatin remodelling factor ISW1a	NATURE			English	Article							NUCLEOSOME CORE PARTICLE; HIGH-RESOLUTION; CRYSTAL-STRUCTURE; DNA COMPLEX; ORGANIZATION; EXPRESSION; POSITION; PROTEIN; DOMAIN; VISUALIZATION	Site-specific recognition of DNA in eukaryotic organisms depends on the arrangement of nucleosomes in chromatin. In the yeast Saccharomyces cerevisiae, ISW1a and related chromatin remodelling factors are implicated in establishing the nucleosome repeat during replication and altering nucleosome position to affect gene activity. Here we have solved the crystal structures of S. cerevisiae ISW1a lacking its ATPase domain both alone and with DNA bound at resolutions of 3.25 angstrom and 3.60 angstrom, respectively, and we have visualized two different nucleosome-containing remodelling complexes using cryo-electron microscopy. The composite X-ray and electron microscopy structures combined with site-directed photocrosslinking analyses of these complexes suggest that ISW1a uses a dinucleosome substrate for chromatin remodelling. Results from a remodelling assay corroborate the dinucleosome model. We show how a chromatin remodelling factor could set the spacing between two adjacent nucleosomes acting as a 'protein ruler'.	[Yamada, Kazuhiro; Frouws, Timothy D.; Angst, Brigitte; Fitzgerald, Daniel J.; DeLuca, Carl; Schimmele, Kyoko; Sargent, David F.; Richmond, Timothy J.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Richmond, TJ (corresponding author), ETH, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	richmond@mol.biol.ethz.ch						Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bellizzi JJ, 1999, STRUCTURE, V7, pR263, DOI 10.1016/S0969-2126(00)80020-9; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; BIENIOSSEK C, 2008, CURR PROT PROTEIN SC; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Corona DFV, 2004, BBA-GENE STRUCT EXPR, V1677, P113, DOI 10.1016/j.bbaexp.2003.09.018; Cuperus G, 2002, GENETICS, V162, P633; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flaus A, 1996, P NATL ACAD SCI USA, V93, P1370, DOI 10.1073/pnas.93.4.1370; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Gangaraju VK, 2007, MOL CELL BIOL, V27, P3217, DOI 10.1128/MCB.01731-06; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Horton JR, 2007, PROTEINS, V67, P1198, DOI 10.1002/prot.21352; Hu DL, 2000, J BIOL CHEM, V275, P2705, DOI 10.1074/jbc.275.4.2705; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mellor J, 2004, BBA-GENE STRUCT EXPR, V1677, P100, DOI 10.1016/j.bbaexp.2003.10.014; Mizuguchi G, 1997, MOL CELL, V1, P141, DOI 10.1016/S1097-2765(00)80015-5; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinskaya M, 2009, MOL CELL BIOL, V29, P2419, DOI 10.1128/MCB.01050-08; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Unser M, 2005, J STRUCT BIOL, V149, P243, DOI 10.1016/j.jsb.2004.10.011; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; Vary JC, 2003, MOL CELL BIOL, V23, P80, DOI 10.1128/MCB.23.1.80-91.2003; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Wang JP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000175	55	126	128	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					448	U536		10.1038/nature09947	http://dx.doi.org/10.1038/nature09947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525927				2022-12-28	WOS:000289949600029
J	Nair, G; Raj, A				Nair, Gautham; Raj, Arjun			Time-Lapse Transcription	SCIENCE			English	Editorial Material							GENE		[Nair, Gautham; Raj, Arjun] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania	Nair, G (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	rajlaboratory@gmail.com		Raj, Arjun/0000-0002-2915-6960				Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Dieci G, 2003, TRENDS BIOCHEM SCI, V28, P202, DOI 10.1016/S0968-0004(03)00054-9; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Octavio LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000673; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817	9	1	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					431	432		10.1126/science.1205995	http://dx.doi.org/10.1126/science.1205995			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512026				2022-12-28	WOS:000289784900033
J	Dixit, V				Dixit, Vishva			Jurg Tschopp (1951-2011) OBITUARY	NATURE			English	Biographical-Item									[Dixit, Vishva] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Dixit, V (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	dixit.vishva@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326					0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					296	296		10.1038/472296a	http://dx.doi.org/10.1038/472296a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21512562	Bronze			2022-12-28	WOS:000289724600023
J	Yank, V; Tuohy, CV; Logan, AC; Bravata, DM; Staudenmayer, K; Eisenhut, R; Sundaram, V; McMahon, D; Olkin, I; McDonald, KM; Owens, DK; Stafford, RS				Yank, Veronica; Tuohy, C. Vaughan; Logan, Aaron C.; Bravata, Dena M.; Staudenmayer, Kristan; Eisenhut, Robin; Sundaram, Vandana; McMahon, Donal; Olkin, Ingram; McDonald, Kathryn M.; Owens, Douglas K.; Stafford, Randall S.			Systematic Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications	ANNALS OF INTERNAL MEDICINE			English	Review							ACTIVATED FACTOR-VII; ORTHOTOPIC LIVER-TRANSPLANTATION; CARDIAC-SURGERY; INTRACEREBRAL HEMORRHAGE; TRANSFUSION REQUIREMENTS; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE ANALYSIS; COAGULOPATHIC PATIENTS; ADJUNCTIVE THERAPY; RANDOMIZED-TRIALS	Background: Recombinant factor VIIa (rFVIIa), a hemostatic agent approved for hemophilia, is increasingly used for off-label indications. Purpose: To evaluate the benefits and harms of rFVIIa use for 5 off-label, in-hospital indications: intracranial hemorrhage, cardiac surgery, trauma, liver transplantation, and prostatectomy. Data Sources: Ten databases (including PubMed, EMBASE, and the Cochrane Library) queried from inception through December 2010. Articles published in English were analyzed. Study Selection: Two reviewers independently screened titles and abstracts to identify clinical use of rFVIIa for the selected indications and identified all randomized, controlled trials (RCTs) and observational studies for full-text review. Data Extraction: Two reviewers independently assessed study characteristics and rated study quality and indication-wide strength of evidence. Data Synthesis: 16 RCTs, 26 comparative observational studies, and 22 noncomparative observational studies met inclusion criteria. Identified comparators were limited to placebo (RCTs) or usual care (observational studies). For intracranial hemorrhage, mortality was not improved with rFVIIa use across a range of doses. Arterial thromboembolism was increased with medium-dose rFVIIa use (risk difference [RD], 0.03 [95% CI, 0.01 to 0.06]) and high-dose rFVIIa use (RD, 0.06 [CI, 0.01 to 0.11]). For adult cardiac surgery, there was no mortality difference, but there was an increased risk for thromboembolism (RD, 0.05 [CI, 0.01 to 0.10]) with rFVIIa. For body trauma, there were no differences in mortality or thromboembolism, but there was a reduced risk for the acute respiratory distress syndrome (RD, -0.05 [CI, -0.02 to -0.08]). Mortality was higher in observational studies than in RCTs. Limitations: The amount and strength of evidence were low for most outcomes and indications. Publication bias could not be excluded. Conclusion: Limited available evidence for 5 off-label indications suggests no mortality reduction with rFVIIa use. For some indications, it increases thromboembolism.	[Yank, Veronica] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94304 USA; Stanford Sch Med, Stanford, CA USA; Palo Alto Med Fdn Res Inst, Palo Alto, CA USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Castlight Hlth, San Francisco, CA USA	Stanford University; Stanford University; Palo Alto Medical Foundation Research Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Pennsylvania	Yank, V (corresponding author), Stanford Univ, Stanford Prevent Res Ctr, Med Sch Off Bldg X312,251 Campus Dr, Stanford, CA 94304 USA.	vyank@stanford.edu	Logan, Aaron C/ADJ-7526-2022; Stafford, Randall/F-3974-2017	Logan, Aaron C/0000-0002-1179-5879; Stafford, Randall/0000-0003-1805-1271	Agency for Healthcare Research and Quality, U. S. Department of Health and Human Services [290-02-0017]; U.S. Department of Veterans Affairs; National Heart, Lung, and Blood Institute [K24HL086703]; Palo Alto Medical Foundation Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL086703] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality, U. S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Palo Alto Medical Foundation Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: By the Agency for Healthcare Research and Quality, U. S. Department of Health and Human Services, under contract 290-02-0017. Dr. Owens was supported by the U.S. Department of Veterans Affairs. This research also was supported by training grants from the National Heart, Lung, and Blood Institute (RSS, K24HL086703) and the Palo Alto Medical Foundation Research Institute.	*AG HEALTC RES QUL, 2011, METH REF GUID EFF CO; Aggarwal Anita, 2004, Thromb J, V2, P9, DOI 10.1186/1477-9560-2-9; Bartal C, 2007, J TRAUMA, V63, P725, DOI 10.1097/TA.0b013e318031ccca; Birchall J, 2008, TRANSFUS MED REV, V22, P177, DOI 10.1016/j.tmrv.2008.02.007; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Bowman LJ, 2008, ANN THORAC SURG, V85, P1669, DOI 10.1016/j.athoracsur.2008.01.089; Brody DL, 2005, NEUROCRIT CARE, V2, P263, DOI 10.1385/NCC:2:3:263; Brown CVR, 2010, J TRAUMA, V68, P348, DOI 10.1097/TA.0b013e3181bbfb6b; Bruckner BA, 2009, J HEART LUNG TRANSPL, V28, P785, DOI 10.1016/j.healun.2009.04.028; Cameron P, 2007, INJURY, V38, P1030, DOI 10.1016/j.injury.2007.05.003; De Gasperi A, 2005, INTENS CARE MED, V31, P315, DOI 10.1007/s00134-004-2525-9; Deeks J J, 2003, Health Technol Assess, V7, piii; DEMENTEVA II, 2004, ANESTEZIOL REANIMAT, V5, P11; Dementyeva II, 2005, GEMATOL TRANSFUZIOL, V50, P12; Diprose P, 2005, BRIT J ANAESTH, V95, P596, DOI 10.1093/bja/aei244; Duchesne JC, 2008, AM SURGEON, V74, P1159; Dunning J, 2008, EUR J CARDIO-THORAC, V34, P73, DOI 10.1016/j.ejcts.2008.02.024; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Felfernig M, 2007, J R Army Med Corps, V153, P32; Filsoufi F, 2006, ANN THORAC SURG, V82, P1779, DOI 10.1016/j.athoracsur.2006.05.076; Flower O, 2010, BLOOD COAGUL FIBRIN, V21, P207, DOI 10.1097/MBC.0b013e3283333589; Fox CJ, 2009, J TRAUMA, V66, pS112, DOI 10.1097/TA.0b013e31819ce240; Friederich PW, 2003, LANCET, V361, P201, DOI 10.1016/S0140-6736(03)12268-4; Friedrich JO, 2005, NEW ENGL J MED, V352, P2133; Gandhi MJ, 2007, J CARDIOTHORAC SURG, V2, DOI 10.1186/1749-8090-2-32; Garcia E, 2008, TRAFFIC, V9, P200, DOI 10.1111/j.1600-0854.2007.00678.x; Gelsomino S, 2008, EUR J CARDIO-THORAC, V33, P64, DOI 10.1016/j.ejcts.2007.10.004; Gill R, 2009, CIRCULATION, V120, P21, DOI 10.1161/CIRCULATIONAHA.108.834275; GLESER L. J., 2009, HDB RES SYNTHESIS ME, P357; Gong Zhi-yun, 2008, Zhonghua Wai Ke Za Zhi, V46, P1497; Grintescu Ioana, 2006, Chirurgia (Bucur), V101, P615; Hallevi H, 2008, STROKE, V39, P473, DOI 10.1161/STROKEAHA.107.497651; Harrison TD, 2005, J TRAUMA, V59, P150, DOI 10.1097/01.TA.0000171470.39742.8E; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; HEDGES L, 1985, STAT METHODS METAANA, P166; Hendriks HGD, 2001, TRANSPLANTATION, V71, P402, DOI 10.1097/00007890-200102150-00011; Howes Jeremy L, 2009, Am J Surg, V198, P895, DOI 10.1016/j.amjsurg.2009.05.026; Hsia CC, 2009, TRANSFUSION MED, V19, P43, DOI 10.1111/j.1365-3148.2009.00913.x; Hsia CC, 2008, ANN SURG, V248, P61, DOI 10.1097/SLA.0b013e318176c4ec; Hyllner M, 2005, EUR J CARDIO-THORAC, V28, P254, DOI 10.1016/j.ejcts.2005.04.021; Ityas C, 2008, J CLIN ANESTH, V20, P276, DOI 10.1016/j.jclinane.2007.12.012; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jarosz K, 2009, TRANSPL P, V41, P3088, DOI 10.1016/j.transproceed.2009.07.099; Johansson PI, 2008, VOX SANG, V95, P1, DOI 10.1111/j.1423-0410.2008.01063.x; Kalicinski P, 2005, PEDIATR TRANSPLANT, V9, P299, DOI 10.1111/j.1399-3046.2005.00309.x; Karkouti K, 2005, TRANSFUSION, V45, P26, DOI 10.1111/j.1537-2995.2005.04216.x; Karkouti K, 2008, CIRCULATION, V118, P331, DOI 10.1161/CIRCULATIONAHA.108.764308; Karkouti K, 2007, CAN J ANAESTH, V54, P573, DOI 10.1007/BF03022322; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Knudson MM, 2011, J AM COLL SURGEONS, V212, P87, DOI 10.1016/j.jamcollsurg.2010.08.020; Kranzler HR, 2001, ALCOHOL CLIN EXP RES, V25, P1335, DOI 10.1097/00000374-200109000-00014; Levi M, 2010, NEW ENGL J MED, V363, P1791, DOI 10.1056/NEJMoa1006221; Lin YL, 2011, CAN MED ASSOC J, V183, pE9, DOI 10.1503/cmaj.100408; LIU J, 2009, TISSUE ENG RES, V13, P3580; Lodge JPA, 2005, LIVER TRANSPLANT, V11, P973, DOI 10.1002/lt.20470; Logan AC, 2011, ANN INTERN MED, V154, P516, DOI 10.7326/0003-4819-154-8-201104190-00002; MA B, 2006, DIER JUNYI DAXUE XUE, V27, P1110; Martinowitz U, 2005, J THROMB HAEMOST, V3, P640, DOI 10.1111/j.1538-7836.2005.01203.x; Masud F, 2009, J CARDIOTHOR VASC AN, V23, P28, DOI 10.1053/j.jvca.2008.08.003; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2005, STROKE, V36, P74, DOI 10.1161/01.STR.0000149628.80251.b8; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Mayer SA, 2006, NEUROCRIT CARE, V4, P206, DOI 10.1385/NCC:4:3:206; McCall P, 2006, CAN J ANAESTH, V53, P926, DOI 10.1007/BF03022836; McQuay N, 2009, J NEUROSURG, V111, P666, DOI 10.3171/2009.4.JNS081611; *MED EC, 2009, PHYS DES REF; Millan C, 2009, REV ESP ANEST REANIM, V56, P485, DOI 10.1016/S0034-9356(09)70439-6; Mitra B, 2010, ANAESTH INTENS CARE, V38, P671, DOI 10.1177/0310057X1003800409; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Niemann CU, 2006, TRANSFUSION MED, V16, P93, DOI 10.1111/j.1365-3148.2006.00653.x; Nishijima DK, 2010, ACAD EMERG MED, V17, P244, DOI 10.1111/j.1553-2712.2010.00666.x; Nishijima DK, 2009, ANN EMERG MED, V54, P737, DOI 10.1016/j.annemergmed.2009.01.027; Novak V, 2008, SRP ARK CELOK LEK, V136, P193, DOI 10.2298/SARH08S3193N; Nussbaum ES, 2009, NEUROCRIT CARE, V10, P55, DOI 10.1007/s12028-008-9149-9; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Patanwala AE, 2008, AM J HEALTH-SYST PH, V65, P1616, DOI 10.2146/ajhp080008; Perel P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007877.pub2; Pickard JD, 2000, BLOOD COAGUL FIBRIN, V11, pS117, DOI 10.1097/00001721-200004001-00022; Planinsic RM, 2005, LIVER TRANSPLANT, V11, P895, DOI 10.1002/lt.20458; POHAR S, 2009, RECOMBINANT ACTIVATE; Pugliese F, 2007, TRANSPL P, V39, P1883, DOI 10.1016/j.transproceed.2007.05.062; Raivio P, 2005, ANN THORAC SURG, V80, P66, DOI 10.1016/j.athoracsur.2005.02.044; Rizoli SB, 2006, J TRAUMA, V61, P1419, DOI 10.1097/01.ta.0000243045.56579.74; Robinson MT, 2010, STROKE, V41, P1459, DOI 10.1161/STROKEAHA.110.581538; Rucker G, 2009, STAT MED, V28, P721, DOI 10.1002/sim.3511; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Squizzato A, 2007, CURR DRUG SAF, V2, P155, DOI 10.2174/157488607780598278; Stanworth SJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005011.pub2; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Sutherland CS, 2008, CAN J NEUROL SCI, V35, P567, DOI 10.1017/S0317167100009343; Tatoulis James, 2009, Interact Cardiovasc Thorac Surg, V9, P459, DOI 10.1510/icvts.2009.204735; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tritapepe L, 2007, CRIT CARE MED, V35, P1685, DOI 10.1097/01.CCM.0000269033.89428.B3; Trowbridge Cody, 2008, J Extra Corpor Technol, V40, P89; Vandenbroucke JP, 2008, JAMA-J AM MED ASSOC, V300, P2417, DOI 10.1001/jama.2008.723; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; von Heymann C, 2005, CRIT CARE MED, V33, P2241, DOI 10.1097/01.CCM.0000181527.47749.57; Wade CE, 2010, J TRAUMA, V69, P353, DOI 10.1097/TA.0b013e3181e49059; Warren O, 2007, ANN THORAC SURG, V83, P707, DOI 10.1016/j.athoracsur.2006.10.033; Woodruff SI, 2010, EMERG MED J, V27, P121, DOI 10.1136/emj.2008.060657; YANK V, 2011, COMP EFFECTIVENESS R; You H, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005951.pub2; Yuan ZH, 2010, J CLIN NEUROSCI, V17, P685, DOI 10.1016/j.jocn.2009.11.020; Zangrillo A, 2009, J CARDIOTHOR VASC AN, V23, P34, DOI 10.1053/j.jvca.2008.09.017	108	168	173	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8					529	540		10.7326/0003-4819-154-8-201104190-00004	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502651	Green Accepted			2022-12-28	WOS:000289622000016
J	Zhang, JM; Wang, Y; Chi, ZK; Keuss, MJ; Pai, YME; Kang, HC; Shin, JH; Bugayenko, A; Wang, H; Xiong, YL; Pletnikov, MV; Mattson, MP; Dawson, TM; Dawson, VL				Zhang, Jianmin; Wang, Yue; Chi, Zhikai; Keuss, Matthew J.; Pai, Ying-Min Emily; Kang, Ho Chul; Shin, Joo-Ho; Bugayenko, Artem; Wang, Hong; Xiong, Yulan; Pletnikov, Mikhail V.; Mattson, Mark P.; Dawson, Ted M.; Dawson, Valina L.			The AAA(+) ATPase Thorase Regulates AMPA Receptor-Dependent Synaptic Plasticity and Behavior	CELL			English	Article							TRANSGENIC MICE; GLUR2; SYNAPSES; MEMORY; NMDA; TRAFFICKING; SUBUNIT; COMPLEX; BINDING; PROTEIN	The synaptic insertion or removal of AMPA receptors (AMPAR) plays critical roles in the regulation of synaptic activity reflected in the expression of long-term potentiation (LTP) and long-term depression (LTD). The cellular events underlying this important process in learning and memory are still being revealed. Here we describe and characterize the AAA(+) ATPase Thorase, which regulates the expression of surface AMPAR. In an ATPase-dependent manner Thorase mediates the internalization of AMPAR by disassembling the AMPAR-GRIP1 complex. Following genetic deletion of Thorase, the internalization of AMPAR is substantially reduced, leading to increased amplitudes of miniature excitatory postsynaptic currents, enhancement of LTP, and elimination of LTD. These molecular events are expressed as deficits in learning and memory in Thorase null mice. This study identifies an AAA(+) ATPase that plays a critical role in regulating the surface expression of AMPAR and thereby regulates synaptic plasticity and learning and memory.	[Zhang, Jianmin; Keuss, Matthew J.; Pai, Ying-Min Emily; Kang, Ho Chul; Shin, Joo-Ho; Bugayenko, Artem; Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Neuroregenerat & Stem Cell Programs, Inst Cell Engn, Baltimore, MD 21205 USA; [Zhang, Jianmin; Chi, Zhikai; Pai, Ying-Min Emily; Kang, Ho Chul; Shin, Joo-Ho; Bugayenko, Artem; Xiong, Yulan; Pletnikov, Mikhail V.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Chi, Zhikai; Wang, Hong; Mattson, Mark P.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Pletnikov, Mikhail V.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Keuss, Matthew J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21205 USA; [Wang, Yue; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Neuroregenerat & Stem Cell Programs, Inst Cell Engn, Baltimore, MD 21205 USA.	tdawson@jhmi.edu; vdawson@jhmi.edu	Pletnikov, Mikhail V/G-8709-2012; Dawson, Valina/Y-9757-2019; Mattson, Mark P/F-6038-2012; Shin, Joo-Ho/P-1417-2018	Pletnikov, Mikhail V/0000-0002-8819-6559; Dawson, Valina/0000-0002-2915-3970	National Institute on Aging, USPHS [AG029368, DA00266]; Simon's Foundation Autism Research Initiative; McKnight Endowment for the Neuroscience; American Heart Association [0725470U]; NATIONAL INSTITUTE ON AGING [ZIAAG000312, ZIAAG000317, R01AG029368, ZIAAG000330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	National Institute on Aging, USPHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)United States Public Health Service); Simon's Foundation Autism Research Initiative; McKnight Endowment for the Neuroscience; American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We apologize that, due to space limitations, we were not able to cite all the primary papers on AMPAR trafficking, LTD, and LTP. We thank all of our colleagues who generously contributed reagents as noted in the Supplemental Information and Dr. Richard Huganir for the generous gift of monoclonal anti-GluR1 N-terminal antibody. Research was supported by the Intramural Research Program of the National Institute on Aging, USPHS grants AG029368 and DA00266, the Simon's Foundation Autism Research Initiative, McKnight Endowment for the Neuroscience, and an American Heart Association Postdoctoral Fellowship to J.Z. (0725470U). We thank the Comparative Medicine Section of NIA for technical support. T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases.	Besancon E, 2008, TRENDS PHARMACOL SCI, V29, P268, DOI 10.1016/j.tips.2008.02.003; Biou V, 2008, P NATL ACAD SCI USA, V105, P1038, DOI 10.1073/pnas.0711412105; Dai C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015008; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Singer HS, 2009, J NEUROIMMUNOL, V211, P39, DOI 10.1016/j.jneuroim.2009.03.011; Sudhof TC, 2008, NEURON, V60, P469, DOI 10.1016/j.neuron.2008.10.011; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wang Y, 2009, NEUROBIOL AGING, V30, P1061, DOI 10.1016/j.neurobiolaging.2007.10.009; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x	32	68	75	3	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					284	299		10.1016/j.cell.2011.03.016	http://dx.doi.org/10.1016/j.cell.2011.03.016			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496646	Green Accepted, Bronze			2022-12-28	WOS:000289549900016
J	Meng, J; Wang, YQ; Li, CK				Meng, Jin; Wang, Yuanqing; Li, Chuankui			Transitional mammalian middle ear from a new Cretaceous Jehol eutriconodont	NATURE			English	Article							OSSIFIED MECKELS CARTILAGE; EVOLUTIONARY DEVELOPMENT; ORIGIN; DIDELPHIDAE	The transference of post-dentary jaw elements to the cranium of mammals as auditory ossicles is one of the central topics in evolutionary biology of vertebrates. Homologies of these bones among jawed vertebrates have long been demonstrated by developmental studies; but fossils illuminating this critical transference are sparse and often ambiguous. Here we report the first unambiguous ectotympanic (angular), malleus (articular and prearticular) and incus (quadrate) of an Early Cretaceous eutriconodont mammal from the Jehol Biota, Liaoning, China. The ectotympanic and malleus have lost their direct contact with the dentary bone but still connect the ossified Meckel's cartilage (OMC); we hypothesize that the OMC serves as a stabilizing mechanism bridging the dentary and the detached ossicles during mammalian evolution. This transitional mammalian middle ear narrows the morphological gap between the mandibular middle ear in basal mammaliaforms and the definitive mammalian middle ear (DMME) of extant mammals; it reveals complex changes contributing to the detachment of ear ossicles during mammalian evolution.	[Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Meng, Jin; Wang, Yuanqing; Li, Chuankui] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China	American Museum of Natural History (AMNH); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Meng, J (corresponding author), Amer Museum Nat Hist, Div Paleontol, Cent Pk W & 79th St, New York, NY 10024 USA.	jmeng@amnh.org			Ministry of Science and Technology, China [2006CB806400]; National Science Foundation of China [40121202]; Chinese Academy of Sciences; National Science Foundation of USA [EF-0629811]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of USA(National Science Foundation (NSF))	We thank X.-L. Wang of the Institute of Vertebrate Paleontology and Paleoanthropology for collecting the specimen; S.-H. Xie for preparing the specimen; J. Zhang, W. Gao, X. Jin, F.-C. Zhang and S.-B. Wang for photographs; W.-D. Zhang for scanning electron microscope and X-ray images; and E. Allin, G. Rougier and M. Takechi for discussion. The study was supported by the Major Basic Research Project of the Ministry of Science and Technology, China (2006CB806400), the National Science Foundation of China (40121202), the Special Fund for Fossil Excavation and Preparation of the Chinese Academy of Sciences, and the National Science Foundation of USA (EF-0629811 to J.M.).	Allin E.F., 1986, P283; ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; ALLIN EF, 1975, J MORPHOL, V147, P403, DOI 10.1002/jmor.1051470404; Barghusen H.R., 1986, P253; Bensley, 1902, U TORONTO STUDIES BI, V3, P75, DOI DOI 10.5962/BHL.TITLE.66541; Clack JA, 2004, SPR HDB AUD, V22, P128; CLARK CT, 1993, J MORPHOL, V215, P119, DOI 10.1002/jmor.1052150203; Crompton A.W., 1972, P231; FILAN SL, 1991, J ZOOL, V225, P577, DOI 10.1111/j.1469-7998.1991.tb04326.x; FLEISCHER G, 1973, Saeugetierkundliche Mitteilungen, V21, P131; Fleischer G., 1978, Advances in Anatomy Embryology and Cell Biology, V55, P1; Gaupp E., 1913, ARCH ANATOMIE ENTWIC, P1; Goodrich ES., 1930, STUDIES STRUCTURE DE, DOI [DOI 10.5962/BHL.TITLE.82144, 10.5962/bhl.title.82144]; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020792; Henson V.W. Jr., 1974, P39; HOPSON JA, 1966, AM ZOOL, V6, P437; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Ji Q, 1999, NATURE, V398, P326; Ji Q, 2009, SCIENCE, V326, P278, DOI 10.1126/science.1178501; KERMACK K A, 1983, Acta Palaeontologica Polonica, V28, P147; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Krebs B, 1971, ZOOLOGICAL J LINN S1, V50, P89; Li CK, 2003, CHINESE SCI BULL, V48, P1129, DOI 10.1360/02wd0134; Li J-L, 2000, CHINESE SCI BULL, V45, P2545; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; MAIER W, 1990, NETH J ZOOL, V40, P55, DOI 10.1163/156854289X00183; Mallo M, 2001, DEV BIOL, V231, P410, DOI 10.1006/dbio.2001.0154; McClain JA, 1938, J MORPHOL, V64, P211; MENG J, 1995, NATURE, V377, P141, DOI 10.1038/377141a0; Meng J, 2003, ZOOL J LINN SOC-LOND, V138, P431, DOI 10.1046/j.1096-3642.2003.00064.x; Meng Jin, 2005, Vertebrata Palasiatica, V43, P1; Presley R., 1984, S ZOOL SOC LOND, V52, P127; Reichert C., 1837, ARCH ANAT PHYSL WISS, V1837, P120; Rougier Guillermo W., 1996, American Museum Novitates, V3187, P1; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Sanchez-Villagra MR, 2002, J MORPHOL, V251, P219, DOI 10.1002/jmor.1085; SHUTE CCD, 1956, J ANAT, V90, P261; Takechi M., 2010, J EXPT ZOOLOGY B, V314, P1; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; WATSON DMS, 1953, EVOLUTION, V7, P159, DOI 10.1111/j.1558-5646.1953.tb00074.x; WESTOLL TS, 1945, NATURE, V155, P114, DOI 10.1038/155114a0; Zeller U., 1989, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, P1; ZELLER U, 1993, MAMMAL PHYLOGENY, P95	46	102	109	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					181	185		10.1038/nature09921	http://dx.doi.org/10.1038/nature09921			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21490668				2022-12-28	WOS:000289469100034
J	Rayner, G; Lang, T				Rayner, Geof; Lang, Tim			Is nudge an effective public health strategy to tackle obesity? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rayner, Geof; Lang, Tim] City Univ London, Ctr Food Policy, London EC1V 0HB, England	City University London	Rayner, G (corresponding author), City Univ London, Ctr Food Policy, London EC1V 0HB, England.	mail@rayner.uk.com						BOSELEY S, 2011, GUARDIAN        0217; Cabinet Office and Behavioural Insights Team, 2010, APPL BEH INS HLTH BE; *CHILDR FOOD CAMP, 2011, GREAT SWAP RIP OFF; *CONS PART, RESP DEAL 2 WORK BUS; *DEP HLTH, 2010, CM7895; Elias N., 1978, CIVILIZING PROCESS; Gilmore AB, 2011, J PUBLIC HEALTH-UK, V33, P2, DOI 10.1093/pubmed/fdr008; Government Office for Science, 2007, FOR TACKL OB FUT CHO; *HOUS LORDS SEL CO, 2011, INQ BEH CHANG EV SES; Kopelman P.G, 2009, CLIN OBESITY ADULTS; STODELL H, 2011, GROCER          0204; Thaler R., 2010, GRAD COUNC LECT 20 O; Thaler RH., 2021, NUDGE FINAL EDITION; WHO European Region, 2006, EUR CHART COUNT OB; Wise J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d580	15	20	20	0	22	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 14	2011	342								d2177	10.1136/bmj.d2177	http://dx.doi.org/10.1136/bmj.d2177			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752UZ	21493668	Green Accepted			2022-12-28	WOS:000289721700006
J	Rykaczewski, RR; Dunne, JP				Rykaczewski, Ryan R.; Dunne, John P.			A measured look at ocean chlorophyll trends	NATURE			English	Letter							COLOR		[Rykaczewski, Ryan R.] Univ Corp Atmospher Res, Boulder, CO 80307 USA; [Rykaczewski, Ryan R.; Dunne, John P.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA	National Center Atmospheric Research (NCAR) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Rykaczewski, RR (corresponding author), Univ Corp Atmospher Res, Boulder, CO 80307 USA.	rrykacze@ucar.edu	Rykaczewski, Ryan/A-8625-2016; Dunne, John P/F-8086-2012	Rykaczewski, Ryan/0000-0001-8893-872X; Dunne, John P/0000-0002-8794-0489				Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; McClain CR, 1998, SEA TECHNOL, V39, P10; MOREL A, 1977, LIMNOL OCEANOGR, V22, P709, DOI 10.4319/lo.1977.22.4.0709; SATHYENDRANATH S, 1989, INT J REMOTE SENS, V10, P1373, DOI 10.1080/01431168908903974	4	50	51	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					E5	E6		10.1038/nature09952	http://dx.doi.org/10.1038/nature09952			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21490624	Green Published			2022-12-28	WOS:000289469100002
J	Davies, RH; Rees, BI				Davies, Rhodri H.; Rees, Brian I.			PICTURE QUIZ Abdominal trauma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NONOPERATIVE MANAGEMENT; SPLENIC INJURIES; ORGAN INJURY; INFECTION; SPLEEN; LIVER; COMPLICATIONS; EMBOLIZATION; POPULATION; RISK		[Davies, Rhodri H.; Rees, Brian I.] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales	Cardiff University	Davies, RH (corresponding author), Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales.	daviesrh2@cardiff.ac.uk						BAILEY H, 2000, H BAILEYS EMERGENCY; Bee TK, 2001, J TRAUMA, V50, P230, DOI 10.1097/00005373-200102000-00007; Bisharat N, 2001, J INFECTION, V43, P182, DOI 10.1053/jinf.2001.0904; Cadeddu M, 2006, CAN J SURG, V49, P386; Cadili A, 2008, AM J MED, V121, P371, DOI 10.1016/j.amjmed.2008.02.014; Cavill I, 1996, BRIT MED J, V312, P430; Cocanour CS, 1998, ARCH SURG-CHICAGO, V133, P619, DOI 10.1001/archsurg.133.6.619; COGBILL TH, 1989, J TRAUMA, V29, P1312, DOI 10.1097/00005373-198910000-00002; Davies JM, 2002, CLIN MED, V2, P440, DOI 10.7861/clinmedicine.2-5-440; Dent D, 2004, J TRAUMA, V56, P1063, DOI 10.1097/01.TA.0000123037.66867.F2; DICKERMAN JD, 1976, J TRAUMA, V16, P662, DOI 10.1097/00005373-197608000-00012; Farahmand N, 2005, RADIOLOGY, V235, P436, DOI 10.1148/radiol.2352040583; Haaga J., 2008, CT MRI WHOLE BODY, V5th ed; Hawkins ML, 1998, AM SURGEON, V64, P552; Kool DR, 2007, EMERG RADIOL, V14, P135, DOI 10.1007/s10140-007-0633-x; Lynch AM, 1996, INFECT DIS CLIN N AM, V10, P693, DOI 10.1016/S0891-5520(05)70322-6; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; MOORE EE, 1995, J TRAUMA, V38, P323, DOI 10.1097/00005373-199503000-00001; Nakae H, 2009, J TRAUMA, V67, P557, DOI 10.1097/TA.0b013e3181af6ca9; Ochsner MG, 2001, WORLD J SURG, V25, P1393, DOI 10.1007/s00268-001-0138-9; ORWIG D, 1989, AM J ROENTGENOL, V153, P747, DOI 10.2214/ajr.153.4.747; Pachter HL, 1998, ANN SURG, V227, P708, DOI 10.1097/00000658-199805000-00011; ROSSE WF, 1987, NEW ENGL J MED, V317, P704, DOI 10.1056/NEJM198709103171110; RUTLEDGE R, 1995, ANN SURG, V222, P311, DOI 10.1097/00000658-199509000-00009; Schwab CW, 2001, WORLD J SURG, V25, P1389, DOI 10.1007/s00268-001-0137-x; Stamou KM, 2006, ARCH SURG-CHICAGO, V141, P663, DOI 10.1001/archsurg.141.7.663; SUTTON D, 1992, TXB RADIOLOGY IMAGIN; Velmahos GC, 2000, ARCH SURG-CHICAGO, V135, P674, DOI 10.1001/archsurg.135.6.674; Wallis A, 2010, WORLD J EMERG SURG, V5, DOI 10.1186/1749-7922-5-18; Yanar H, 2008, J TRAUMA, V64, P943, DOI 10.1097/TA.0b013e3180342023	30	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2011	342								d882	10.1136/bmj.d882	http://dx.doi.org/10.1136/bmj.d882			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752UX	21490047				2022-12-28	WOS:000289721500018
J	Christodouleas, JP; Forrest, RD; Ainsley, CG; Tochner, Z; Hahn, SM; Glatstein, E				Christodouleas, John P.; Forrest, Robert D.; Ainsley, Christopher G.; Tochner, Zelig; Hahn, Stephen M.; Glatstein, Eli			Short-Term and Long-Term Health Risks of Nuclear-Power-Plant Accidents	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SOLID CANCER INCIDENCE; CHERNOBYL EMERGENCY WORKERS; ATOMIC-BOMB SURVIVORS; IN-UTERO EXPOSURE; THYROID-CANCER; RADIATION RISKS; INFANT LEUKEMIA; BRYANSK REGION; BREAST-CANCER; FOLLOW-UP	ON MARCH 11, 2011, A 9.0-MAGNITUDE EARTHQUAKE STRUCK THE EAST cost of Japan. The total number of people who died in the earthquake and the tsunami that it generated is still being assessed, but the official estimation already exceeds 14,000.(1) The natural disaster also caused substantial damage to the Fukushima Daiichi nuclear power plant, the consequences of which are still unclear. The purpose of this review is to put the emergency at the Japanese power plant, even as it is evolving, into the context of the extensive literature on nuclear-reactor accidents by analyzing the mechanisms and major short-term and long-term health risks of radiation exposure. In addition, we briefly discuss the accidents at Three Mile Island in Pennsylvania in 1979 and at Chernobyl in Ukraine in 1986 because they illustrate the broad range of potential outcomes.	[Christodouleas, John P.; Ainsley, Christopher G.; Tochner, Zelig; Hahn, Stephen M.; Glatstein, Eli] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Forrest, Robert D.] Univ Penn, Dept Radiat Safety, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Glatstein, E (corresponding author), Univ Penn, Dept Radiat Oncol, 2 Donner,3400 Spruce St, Philadelphia, PA 19104 USA.	glatstein@uphs.upenn.edu	Ley, Sarah/Y-9216-2019					[Anonymous], 1998, Ann ICRP, V28, P1; [Anonymous], 2006, HLTH EFF CHERN ACC S, P182; Armed Forces Radiobiology Research Institute, 2010, MED MAN RAD CAS; BARANOV A, 1989, NEW ENGL J MED, V321, P205, DOI 10.1056/NEJM198907273210401; BARANOV A, 1990, NEW ENGL J MED, V322, P280; Bogdanova NV, 2010, CLIN GENET, V78, P364, DOI 10.1111/j.1399-0004.2010.01473.x; BRENNER AV, 2011, ENV HLTH PERSPE 0314; Cardis E, 2005, JNCI-J NATL CANCER I, V97, P724, DOI 10.1093/jnci/dji129; Feng Ying-jin, 2002, Space Med Med Eng (Beijing), V15, P265; Fliedner TM, 2008, BLOOD, V111, P5757, DOI 10.1182/blood-2008-04-150243; *FOOD DRUG ADM, 2001, POT IOD THYR BLOCK A; FRIEDBERG W, 2003, NTIS PUBLICATION; Friesecke I, 2000, RADIAT ENVIRON BIOPH, V39, P213, DOI 10.1007/s004110000056; HALL EJ, 2000, RADIOBIOLOGY RADIOLO, P208; Hatch M, 2009, J CLIN ENDOCR METAB, V94, P899, DOI 10.1210/jc.2008-2049; HATCH MC, 1991, AM J PUBLIC HEALTH, V81, P719, DOI 10.2105/AJPH.81.6.719; *HPS, 2010, HPS PUBL; *INT AT EN AG, 2002, IAEA PUBL; *INT AT EN AG, 1998, SAF SER INT AT EN AG, V2; *INT AT EN AG, 2006, IAEA PUBL; Ivanov V, 2004, J RADIAT RES, V45, P41, DOI 10.1269/jrr.45.41; Ivanov VK, 2008, RADIAT ENVIRON BIOPH, V47, P463, DOI 10.1007/s00411-008-0177-9; Ivanov VK, 2004, RADIAT ENVIRON BIOPH, V43, P35, DOI 10.1007/s00411-003-0223-6; Ivanov VK, 2003, HEALTH PHYS, V84, P46, DOI 10.1097/00004032-200301000-00004; Ivanov VK, 2002, RADIAT ENVIRON BIOPH, V41, P195, DOI 10.1007/s00411-002-0163-6; Kemeny J, 1980, REPORT PRESIDENTS CO; Kesminiene A, 2008, RADIAT RES, V170, P721, DOI 10.1667/RR1231.1; Konogorov Andrei P., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P143; Korschunov VM, 1996, J MED MICROBIOL, V44, P70, DOI 10.1099/00222615-44-1-70; Levin RJ, 2008, LARYNGOSCOPE, V118, P618, DOI 10.1097/MLG.0b013e3181613ad2; Mettler FA, 2007, HEALTH PHYS, V93, P462, DOI 10.1097/01.HP.0000278843.27969.74; *NAT LIB MED, 2011, RAD EM MED MAN; *NAT POL AG JAP EM, 2011, DAM SIT POL COUNT ME; NAUMAN J, 1993, AM J MED, V94, P524, DOI 10.1016/0002-9343(93)90089-8; Noshchenko AG, 2002, INT J CANCER, V99, P609, DOI 10.1002/ijc.10406; *NUCL EN AG ORG EC, 2003, CHERN ASS RAD HLTH I; Parkin DM, 1996, BRIT J CANCER, V73, P1006, DOI 10.1038/bjc.1996.197; Petridou E, 1996, NATURE, V382, P352, DOI 10.1038/382352a0; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; PRESTON DL, 1994, RADIAT RES, V137, pS68, DOI 10.2307/3578893; PRESTON DL, 1994, RADIAT RES, V139, P129; Pukkala E, 2006, INT J CANCER, V119, P651, DOI 10.1002/ijc.21885; Romanenko AY, 2008, RADIAT RES, V170, P711, DOI 10.1667/RR1404.1; Shakhtarin VV, 2003, INT J EPIDEMIOL, V32, P584, DOI 10.1093/ije/dyg205; Shibata Y, 2001, LANCET, V358, P1965, DOI 10.1016/S0140-6736(01)06971-9; Steiner M, 1998, RADIAT ENVIRON BIOPH, V37, P87, DOI 10.1007/s004110050099; Talbott EO, 2003, ENVIRON HEALTH PERSP, V111, P341, DOI 10.1289/ehp.5662; TALBOTT EO, 2003, ENV HLTH PERSPECT, V111, pA453; TOCHNER ZA, 2008, HARRISONS PRINCIPLES, P1358; Tronko MD, 2006, JNCI-J NATL CANCER I, V98, P897, DOI 10.1093/jnci/djj244; United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation, 2000, SOURC EFF ION RAD UN; Weinstock DM, 2008, BLOOD, V111, P5440, DOI 10.1182/blood-2008-01-134817; Zablotska LB, 2011, BRIT J CANCER, V104, P181, DOI 10.1038/sj.bjc.6605967; Zanzonico PB, 2000, HEALTH PHYS, V78, P660, DOI 10.1097/00004032-200006000-00008	54	112	116	3	135	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2334	2341		10.1056/NEJMra1103676	http://dx.doi.org/10.1056/NEJMra1103676			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777RZ	21506737				2022-12-28	WOS:000291643800011
J	Carpenter, SR; Cole, JJ; Pace, ML; Batt, R; Brock, WA; Cline, T; Coloso, J; Hodgson, JR; Kitchell, JF; Seekell, DA; Smith, L; Weidel, B				Carpenter, S. R.; Cole, J. J.; Pace, M. L.; Batt, R.; Brock, W. A.; Cline, T.; Coloso, J.; Hodgson, J. R.; Kitchell, J. F.; Seekell, D. A.; Smith, L.; Weidel, B.			Early Warnings of Regime Shifts: A Whole-Ecosystem Experiment	SCIENCE			English	Article							TROPHIC CASCADES; ECOLOGICAL-SYSTEMS; PLANKTON; PHYTOPLANKTON; INDICATORS; PATTERNS; SIGNALS; CHAOS; FISH	Catastrophic ecological regime shifts may be announced in advance by statistical early warning signals such as slowing return rates from perturbation and rising variance. The theoretical background for these indicators is rich, but real-world tests are rare, especially for whole ecosystems. We tested the hypothesis that these statistics would be early warning signals for an experimentally induced regime shift in an aquatic food web. We gradually added top predators to a lake over 3 years to destabilize its food web. An adjacent lake was monitored simultaneously as a reference ecosystem. Warning signals of a regime shift were evident in the manipulated lake during reorganization of the food web more than a year before the food web transition was complete, corroborating theory for leading indicators of ecological regime shifts.	[Carpenter, S. R.; Batt, R.; Cline, T.; Kitchell, J. F.; Smith, L.; Weidel, B.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Cole, J. J.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Pace, M. L.; Coloso, J.; Seekell, D. A.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Brock, W. A.] Univ Wisconsin, Dept Econ, Madison, WI 53706 USA; [Hodgson, J. R.] St Norbert Coll, Dept Biol, De Pere, WI 54115 USA	University of Wisconsin System; University of Wisconsin Madison; Cary Institute of Ecosystem Studies; University of Virginia; University of Wisconsin System; University of Wisconsin Madison	Carpenter, SR (corresponding author), Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA.	srcarpen@wisc.edu	Carpenter, Stephen/AAQ-6404-2020; Cole, Jonathan Jay/G-4566-2011; Batt, Ryan/D-7690-2013	Cole, Jonathan Jay/0000-0003-4633-7402; Carpenter, Stephen/0000-0001-8097-8700; Batt, Ryan/0000-0002-7267-5395; Pace, Michael/0000-0001-5945-6131	NSF	NSF(National Science Foundation (NSF))	This research was supported by the NSF. C. Brousseau, M. Dougherty, A. Farrell, R. Johnson, S. Klobucar, J. Kurtzweil, K. Lee, T. Matthys, K. McDonnell, H. Pack, T. Walsworth, and L. Zinn provided technical help. We thank the staff of the University of Notre Dame Environmental Research Center for assistance.	[Anonymous], 2005, EC HUM WELL BEING OU; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Brock WA, 2010, ECOL MONOGR, V80, P353, DOI 10.1890/09-1824.1; Brock W.A., 1996, ECONOMET REV, V15, P197, DOI [10.1080/07474939608800353, DOI 10.1080/07474939608800353]; Carpenter SR, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00016.1; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; Carpenter S. R., 1993, TROPHIC CASCADES LAK; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Carpenter SR, 2001, ECOL MONOGR, V71, P163, DOI 10.1890/0012-9615(2001)071[0163:TCNALP]2.0.CO;2; Contamin R, 2009, ECOL APPL, V19, P799, DOI 10.1890/08-0109.1; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; DOVERI F, 1993, THEOR POPUL BIOL, V43, P159, DOI 10.1006/tpbi.1993.1008; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Estes J.A., 2010, TROPHIC CASCADES; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kleinen T., 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; Kuwahara VS, 2008, J OCEANOGR, V64, P691, DOI 10.1007/s10872-008-0058-5; Litzow MA, 2008, ECOL APPL, V18, P1331, DOI 10.1890/07-0998.1; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, HYDROBIOLOGIA, V491, P9, DOI 10.1023/A:1024404804748; Scheffer M, 2000, CAN J FISH AQUAT SCI, V57, P1208, DOI 10.1139/cjfas-57-6-1208; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Weston K, 2008, J SEA RES, V60, P262, DOI 10.1016/j.seares.2008.09.003	30	583	604	13	598	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2011	332	6033					1079	1082		10.1126/science.1203672	http://dx.doi.org/10.1126/science.1203672			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21527677				2022-12-28	WOS:000290996700043
J	DiMaio, F; Terwilliger, TC; Read, RJ; Wlodawer, A; Oberdorfer, G; Wagner, U; Valkov, E; Alon, A; Fass, D; Axelrod, HL; Das, D; Vorobiev, SM; Iwai, H; Pokkuluri, PR; Baker, D				DiMaio, Frank; Terwilliger, Thomas C.; Read, Randy J.; Wlodawer, Alexander; Oberdorfer, Gustav; Wagner, Ulrike; Valkov, Eugene; Alon, Assaf; Fass, Deborah; Axelrod, Herbert L.; Das, Debanu; Vorobiev, Sergey M.; Iwai, Hideo; Pokkuluri, P. Raj; Baker, David			Improved molecular replacement by density- and energy-guided protein structure optimization	NATURE			English	Article							CRYSTALLOGRAPHIC REFINEMENT; PREDICTION; ACCURACY; SOFTWARE	Molecular replacement(1-4) procedures, which search for placements of a starting model within the crystallographic unit cell that best account for the measured diffraction amplitudes, followed by automatic chain tracing methods(5-8), have allowed the rapid solution of large numbers of protein crystal structures. Despite extensive work(9-14), molecular replacement or the subsequent rebuilding usually fail with more divergent starting models based on remote homologues with less than 30% sequence identity. Here we show that this limitation can be substantially reduced by combining algorithms for protein structure modelling with those developed for crystallographic structure determination. An approach integrating Rosetta structure modelling with Autobuild chain tracing yielded high-resolution structures for 8 of 13 X-ray diffraction data sets that could not be solved in the laboratories of expert crystallographers and that remained unsolved after application of an extensive array of alternative approaches. We estimate that the new method should allow rapid structure determination without experimental phase information for over half the cases where current methods fail, given diffraction data sets of better than 3.2 angstrom resolution, four or fewer copies in the asymmetric unit, and the availability of structures of homologous proteins with >20% sequence identity.	[Terwilliger, Thomas C.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [DiMaio, Frank; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [DiMaio, Frank; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Read, Randy J.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Wlodawer, Alexander] NCI, Macromol Crystallog Lab, Frederick, MD 21702 USA; [Oberdorfer, Gustav; Wagner, Ulrike] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Valkov, Eugene] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Alon, Assaf; Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Axelrod, Herbert L.; Das, Debanu] SLAC Natl Accelerator Lab, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA; [Axelrod, Herbert L.; Das, Debanu] SLAC Natl Accelerator Lab, SSRL, Menlo Pk, CA 94025 USA; [Vorobiev, Sergey M.] Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA; [Iwai, Hideo] Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland; [Pokkuluri, P. Raj] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Graz; University of Cambridge; Weizmann Institute of Science; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Columbia University; University of Helsinki; United States Department of Energy (DOE); Argonne National Laboratory	Terwilliger, TC (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	terwilliger@lanl.gov; dabaker@u.washington.edu	Iwaï, Hideo/A-6416-2009; Read, Randy J/L-1418-2013; Terwilliger, Thomas/AAM-4079-2020; Valkov, Eugene/AAA-1735-2020; Terwilliger, Thomas/AEF-4827-2022; Baker, David/K-8941-2012; Valkov, Eugene/C-1554-2010; Terwilliger, Thomas C/K-4109-2012	Iwaï, Hideo/0000-0001-7376-5264; Read, Randy J/0000-0001-8273-0047; Terwilliger, Thomas/0000-0001-6384-0320; Valkov, Eugene/0000-0002-3721-1739; Baker, David/0000-0001-7896-6217; Terwilliger, Thomas C/0000-0001-6384-0320; Oberdorfer, Gustav/0000-0002-6144-9114; Alon, Assaf/0000-0001-8102-5290	NIH [5R01GM092802, P41RR002250]; Wellcome Trust; HHMI; Israel Science Foundation; DK Molecular Enzymology [W901]; Austrian Science Fund [P19858]; NIH, National Cancer Institute, Center for Cancer Research; academy of Finland [1131413]; Protein Structure Initiative of National Institute of General Medical Sciences [U54 GM074958]; US Department of Energy's Office of Science, Biological and Environmental Research [DE-AC02-06CH11357]; NIH, National Institutes of General Medical Sciences, Protein Structure Initiative [U54 GM094586, GM074898]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586, U54GM094597, U54GM074898, U54GM074958, P01GM063210, R01GM092802] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); HHMI(Howard Hughes Medical Institute); Israel Science Foundation(Israel Science Foundation); DK Molecular Enzymology(Austrian Science Fund (FWF)); Austrian Science Fund(Austrian Science Fund (FWF)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); academy of Finland(Academy of Finland); Protein Structure Initiative of National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy's Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Institutes of General Medical Sciences, Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.J.R., T.C.T. and D.B. thank the NIH (5R01GM092802), the Wellcome Trust (R.J.R.), and HHMI (D.B.) for funding this research. F.D. acknowledges the NIH (P41RR002250) and HHMI. D.F. and A.A. acknowledge support from the Israel Science Foundation. G.O. thanks DK Molecular Enzymology (FWF-project W901) and the Austrian Science Fund (FWF-project P19858). The work of A.W. was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. H.I. acknowledges support from the academy of Finland (1131413). S.M.V. was supported by a grant from the Protein Structure Initiative of National Institute of General Medical Sciences (U54 GM074958). The work of P.R.P. at Argonne National Laboratory was supported by the US Department of Energy's Office of Science, Biological and Environmental Research GTL programme under contract DE-AC02-06CH11357. We thank all members of the JCSG for their general contributions to the protein production and structural work. The JCSG is supported by the NIH, National Institutes of General Medical Sciences, Protein Structure Initiative (U54 GM094586 and GM074898).	ABE H, 1984, COMPUT CHEM, V8, P239, DOI 10.1016/0097-8485(84)85015-9; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; [Anonymous], 2006, CURRENT PROTOCOLS BI, DOI DOI 10.1002/0471250953.BI0506S15; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DePristo MA, 2005, STRUCTURE, V13, P1311, DOI 10.1016/j.str.2005.06.008; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rodriguez DD, 2009, NAT METHODS, V6, P651, DOI [10.1038/NMETH.1365, 10.1038/nmeth.1365]; Rossmann M. G., 1972, MOL REPLACEMENT METH; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Suhre K, 2004, ACTA CRYSTALLOGR D, V60, P796, DOI 10.1107/S0907444904001982; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vitkup D, 2001, NAT STRUCT BIOL, V8, P559, DOI 10.1038/88640; WEIS WI, 1990, J MOL BIOL, V212, P737, DOI 10.1016/0022-2836(90)90234-D	29	188	189	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					540	U149		10.1038/nature09964	http://dx.doi.org/10.1038/nature09964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21532589	Green Accepted			2022-12-28	WOS:000290951300047
J	Kang, SM; Polvani, LM; Fyfe, JC; Sigmond, M				Kang, S. M.; Polvani, L. M.; Fyfe, J. C.; Sigmond, M.			Impact of Polar Ozone Depletion on Subtropical Precipitation	SCIENCE			English	Article							SOUTHERN ANNULAR MODE; GLOBAL PRECIPITATION; PART II; TRENDS	Over the past half-century, the ozone hole has caused a poleward shift of the extratropical westerly jet in the Southern Hemisphere. Here, we argue that these extratropical circulation changes, resulting from ozone depletion, have substantially contributed to subtropical precipitation changes. Specifically, we show that precipitation in the southern subtropics in austral summer increases significantly when climate models are integrated with reduced polar ozone concentrations. Furthermore, the observed patterns of subtropical precipitation change, from 1979 to 2000, are very similar to those in our model integrations, where ozone depletion alone is prescribed. In both climate models and observations, the subtropical moistening is linked to a poleward shift of the extratropical westerly jet. Our results highlight the importance of polar regions for the subtropical hydrological cycle.	[Kang, S. M.; Polvani, L. M.] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA; [Polvani, L. M.] Columbia Univ, Dept Earth & Environm Sci, New York, NY USA; [Fyfe, J. C.] Environm Canada, Canadian Ctr Climate Modelling & Anal, Victoria, BC, Canada; [Sigmond, M.] Univ Toronto, Dept Phys, Toronto, ON, Canada	Columbia University; Columbia University; Environment & Climate Change Canada; Canadian Centre for Climate Modelling & Analysis (CCCma); University of Toronto	Kang, SM (corresponding author), Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA.	smk2182@columbia.edu	, Sarah/CAA-3536-2022; Kang, Sarah M./F-9117-2011; , Sarah/AFG-5973-2022; Polvani, Lorenzo M/E-5949-2011; Sigmond, Michael/K-3169-2012; , Sarah/AAF-1498-2022; Sigmond, Michael/Q-7202-2019	, Sarah/0000-0003-4635-275X; , Sarah/0000-0003-4635-275X; Sigmond, Michael/0000-0003-2191-9756; , Sarah/0000-0003-4635-275X; Sigmond, Michael/0000-0003-2191-9756	U.S. National Science Foundation; Canadian Foundation for Climate Atmospheric Sciences	U.S. National Science Foundation(National Science Foundation (NSF)); Canadian Foundation for Climate Atmospheric Sciences	We are grateful to I. Held, D. Frierson, I.-S. Kang, A. Sobel, G. Flato, B. Merryfield, and N. Gillett for comments on early versions of this work, and to G. Correa for helping with the CAM3 model integrations. L.M.P. and S.M.K. are supported in part by a grant from the U.S. National Science Foundation to Columbia University. M.S. is a member of the Canadian Stratospheric Processes and their Role in Climate (CSPARC) network and gratefully acknowledges the support of the Canadian Foundation for Climate Atmospheric Sciences.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; [Anonymous], 2010, J GEOPHYS RES-ATMOS, DOI [DOI 10.1029/2010JD014271, DOI 10.1029/2010jd014271]; Arblaster JM, 2006, J CLIMATE, V19, P2896, DOI 10.1175/JCLI3774.1; Archer CL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033614; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Fogt RL, 2009, J CLIMATE, V22, P5346, DOI 10.1175/2009JCLI2786.1; Gillett NP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020876; Gillett NP, 2003, SCIENCE, V302, P273, DOI 10.1126/science.1087440; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Perlwitz J, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033317; Polvani LM, 2011, J CLIMATE, V24, P795, DOI 10.1175/2010JCLI3772.1; Previdi M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031243; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Scinocca JF, 2008, ATMOS CHEM PHYS, V8, P7055, DOI 10.5194/acp-8-7055-2008; Sen Gupta A, 2006, J CLIMATE, V19, P4457, DOI 10.1175/JCLI3843.1; Sigmond M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043773; Son SW, 2008, SCIENCE, V320, P1486, DOI 10.1126/science.1155939; Son SW, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038671; Thompson DWJ, 2000, J CLIMATE, V13, P1018, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025	26	182	188	5	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2011	332	6032					951	954		10.1126/science.1202131	http://dx.doi.org/10.1126/science.1202131			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21512001	Green Submitted			2022-12-28	WOS:000290766600039
J	Rosenthal, MB				Rosenthal, Meredith B.			Hard Choices - Alternatives for Reining In Medicare and Medicaid Spending	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Rosenthal, MB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.			Rosenthal, Meredith/0000-0003-3410-0184				Congressional Budget Office, 2008, TECHN CHANG GROWTH H; Congressional Budget Office, 2011, RED DEF SPEND REV OP; *HJ KAIS FAM FDN, 2011, PUBL HJ KAIS FAM FDN, V8129; *HJ KAIS FAM FDN, 2011, PUBL HJ KAIS FAM FDN, V8124; Newhouse JP, 1993, FREE ALL LESSONS RAN	5	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2011	364	20					1887	1890		10.1056/NEJMp1104428	http://dx.doi.org/10.1056/NEJMp1104428			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	765PJ	21506734				2022-12-28	WOS:000290720700002
J	Mattison, MLP; Zeidel, M				Mattison, Melissa L. P.; Zeidel, Mark			Navigating the Challenges of In-flight Emergencies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mattison, Melissa L. P.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Mattison, MLP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, 330 Brookline Ave, Boston, MA 02215 USA.	mmattiso@bidmc.harvard.edu						Gendreau MA, 2002, NEW ENGL J MED, V346, P1067, DOI 10.1056/NEJMra012774; Sand M, 2009, CRIT CARE, V13, DOI 10.1186/cc7690; Shaner DM, 2010, NEW ENGL J MED, V363, P1988, DOI 10.1056/NEJMp1006331; Silverman D, 2009, LANCET, V373, P2067, DOI 10.1016/S0140-6736(09)60209-9; *US FED AV ADM, 12133B US FED AV ADM; *US FED AV ADM, 12134B US FED AV ADM; *US FED AV ADM, COMM AIR CARR FAT RA; NO US AIRLINE FATALI; THERES DOCTOR BOARD	9	13	13	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2011	305	19					2003	2004		10.1001/jama.2011.618	http://dx.doi.org/10.1001/jama.2011.618			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764WO	21540410				2022-12-28	WOS:000290665500024
J	Guarani, V; Deflorian, G; Franco, CA; Kruger, M; Phng, LK; Bentley, K; Toussaint, L; Dequiedt, F; Mostoslavsky, R; Schmidt, MHH; Zimmermann, B; Brandes, RP; Mione, M; Westphal, CH; Braun, T; Zeiher, AM; Gerhardt, H; Dimmeler, S; Potente, M				Guarani, Virginia; Deflorian, Gianluca; Franco, Claudio A.; Krueger, Marcus; Phng, Li-Kun; Bentley, Katie; Toussaint, Louise; Dequiedt, Franck; Mostoslavsky, Raul; Schmidt, Mirko H. H.; Zimmermann, Barbara; Brandes, Ralf P.; Mione, Marina; Westphal, Christoph H.; Braun, Thomas; Zeiher, Andreas M.; Gerhardt, Holger; Dimmeler, Stefanie; Potente, Michael			Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase	NATURE			English	Article							NEGATIVE REGULATOR; ANGIOGENESIS; CELLS; DLL4; DIFFERENTIATION; ZEBRAFISH; GROWTH; ACTS	Notch signalling is a key intercellular communication mechanism that is essential for cell specification and tissue patterning, and which coordinates critical steps of blood vessel growth(1-3). Although subtle alterations in Notch activity suffice to elicit profound differences in endothelial behaviour and blood vessel formation(2,3), little is known about the regulation and adaptation of endothelial Notch responses. Here we report that the NAD1-dependent deacetylase SIRT1 acts as an intrinsic negative modulator of Notch signalling in endothelial cells. We show that acetylation of the Notch1 intracellular domain (NICD) on conserved lysines controls the amplitude and duration of Notch responses by altering NICD protein turnover. SIRT1 associates with NICD and functions as a NICD deacetylase, which opposes the acetylation-induced NICD stabilization. Consequently, endothelial cells lacking SIRT1 activity are sensitized to Notch signalling, resulting in impaired growth, sprout elongation and enhanced Notch target gene expression in response to DLL4 stimulation, thereby promoting a non-sprouting, stalk-cell-like phenotype. In vivo, inactivation of Sirt1 in zebrafish and mice causes reduced vascular branching and density as a consequence of enhanced Notch signalling. Our findings identify reversible acetylation of the NICD as a molecular mechanism to adapt the dynamics of Notch signalling, and indicate that SIRT1 acts as rheostat to fine-tune endothelial Notch responses.	[Guarani, Virginia; Zimmermann, Barbara; Dimmeler, Stefanie] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany; [Deflorian, Gianluca; Mione, Marina] FIRC Inst Mol Oncol, IFOM, I-20139 Milan, Italy; [Franco, Claudio A.; Phng, Li-Kun; Bentley, Katie; Gerhardt, Holger] London Res Inst Canc Res UK, Vasc Biol Lab, London WC2A 3LY, England; [Krueger, Marcus; Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Toussaint, Louise; Dequiedt, Franck] GxABT, Lab Prot Signaling & Interact, B-5030 Gembloux, Belgium; [Toussaint, Louise; Dequiedt, Franck] Univ Liege, Interdisciplinary Cluster Appl Genoprote GIGA R, B-4000 Sart Tilman Par Liege, Belgium; [Mostoslavsky, Raul] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Schmidt, Mirko H. H.] Goethe Univ Frankfurt, Edinger Inst, Inst Neurol, D-60590 Frankfurt, Germany; [Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Cardiovasc Physiol, Vasc Res Ctr, D-60590 Frankfurt, Germany; [Westphal, Christoph H.] Sirtris, Cambridge, MA 02139 USA; [Zeiher, Andreas M.; Potente, Michael] Goethe Univ Frankfurt, Dept Cardiol, D-60590 Frankfurt, Germany; [Gerhardt, Holger] VIB, Vesalius Res Ctr, Vasc Patterning Lab, Consultant Grp, B-3000 Louvain, Belgium	Goethe University Frankfurt; IFOM - FIRC Institute of Molecular Oncology; University of London; Institute of Cancer Research - UK; Max Planck Society; University of Liege; Harvard University; Harvard Medical School; Massachusetts General Hospital; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Flanders Institute for Biotechnology (VIB)	Potente, M (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany.	potente@em.uni-frankfurt.de	Franco, Claudio A/D-8117-2015; Braun, Thomas/B-2310-2008; Franco, Claudio A/B-1060-2013; Brandes, Ralf P/L-3058-2017; Mione, Maria Caterina/I-3073-2013; Mione, Maria Caterina/ABG-9926-2021; Phng, Li-Kun/L-7346-2013; Schmidt, Mirko H. H./ABI-6650-2020; Gerhardt, Holger/G-4610-2011; Gerhardt, Holger/G-4610-2011	Franco, Claudio A/0000-0002-2861-3883; Franco, Claudio A/0000-0002-2861-3883; Brandes, Ralf P/0000-0002-8035-0048; Schmidt, Mirko H. H./0000-0001-7411-8835; Gerhardt, Holger/0000-0002-3030-0384; Dimmeler, Stefanie/0000-0002-1045-2436; Bentley, Katie/0000-0002-9391-659X; Potente, Michael/0000-0002-5689-0036; Dequiedt, Franck/0000-0003-1234-7477; Gerhardt, Holger/0000-0001-9228-7472; Braun, Thomas/0000-0002-6165-4804; Mione, Maria Caterina/0000-0002-9040-3705	DFG [PO1306/1-1, SFB 834/A6, Exc 147/1]; Interuniversity Attraction Poles Program-Belgian Science Policy [IUAP-BELSPO PVI/28]; Sidney Kimmel Cancer Research Foundation; Massachusetts Life Sciences Center; NIH [R01DK088190-01A1, R01GM093072-01]; Cancer Research UK; European Molecular Biology Organisation; Lister Institute of Preventive Medicine; Fondation Leducq Transatlantic Network of Excellence ARTEMIS; Marie Curie FP7 People initiative; AIRC (Associazione Italiana per la Ricerca sul Cancro); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Interuniversity Attraction Poles Program-Belgian Science Policy(Belgian Federal Science Policy Office); Sidney Kimmel Cancer Research Foundation; Massachusetts Life Sciences Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); European Molecular Biology Organisation; Lister Institute of Preventive Medicine; Fondation Leducq Transatlantic Network of Excellence ARTEMIS; Marie Curie FP7 People initiative; AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are thankful to F. W. Alt, R. Kopan, Z. Lou, E. Seto, S. L. Berger, S. Diane Hayward, S. McMahon, G. Thurston and N. D. Lawson for reagents and to I. Dikic for comments. This work was supported by grants from the DFG (PO1306/1-1, SFB 834/A6 and Exc 147/1). F.D. was supported by the Interuniversity Attraction Poles Program-Belgian Science Policy (IUAP-BELSPO PVI/28). R.M. is supported by the Sidney Kimmel Cancer Research Foundation, a New Investigator Grant from the Massachusetts Life Sciences Center, an AFAR Research Grant and NIH grants (R01DK088190-01A1 and R01GM093072-01). H.G. is supported by Cancer Research UK, the European Molecular Biology Organisation Young Investigator Programme, and The Lister Institute of Preventive Medicine. H.G. and K.B. are supported by the Fondation Leducq Transatlantic Network of Excellence ARTEMIS. C.A.F. is supported by the Marie Curie FP7 People initiative. G.D. and M.M. thank F. Pezzimenti for fish care and technical help, and AIRC (Associazione Italiana per la Ricerca sul Cancro) for financial support.	Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim MY, 2007, MOL CELL BIOL, V27, P6506, DOI 10.1128/MCB.01515-06; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095	36	273	285	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					234	+		10.1038/nature09917	http://dx.doi.org/10.1038/nature09917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21499261	Green Accepted			2022-12-28	WOS:000290487200043
J	Bers, DM; Harris, SP				Bers, Donald M.; Harris, Samantha P.			TRANSLATIONAL MEDICINE To the rescue of the failing heart	NATURE			English	Editorial Material							FAILURE		[Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Harris, Samantha P.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Bers, DM (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	dmbers@ucdavis.edu	Bers, Donald M/C-4507-2012	Bers, Donald/0000-0002-2237-9483	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080367] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL080367] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407; Kawase Y, 2011, J AM COLL CARDIOL, V57, P1169, DOI 10.1016/j.jacc.2010.11.023; Kushnir A, 2010, ADV PHARMACOL, V59, P1, DOI 10.1016/S1054-3589(10)59001-X; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Tang WHW, 2010, J AM COLL CARDIOL, V55, P688, DOI 10.1016/j.jacc.2009.10.028	6	10	11	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					36	39		10.1038/473036a	http://dx.doi.org/10.1038/473036a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544138				2022-12-28	WOS:000290218300024
J	Moynihan, R				Moynihan, Ray			MEDICALISATION A new deal on disease definition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ASSOCIATION; PANEL		Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Brotto L, 2009, ARCH SEXUAL BEHAV; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clayton A, 2009, J SEXUAL MED; Cosgrove L, 2006, PSYCHOTHER PSYCHOSOM, V75, P154, DOI 10.1159/000091772; Cosgrove L, 2009, NEW ENGL J MED, V360, P2035, DOI 10.1056/NEJMc0810237; Frances A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1168; Godlee F, 2010, BMJ-BRIT MED J, V341, pc4766; Institute of Medicine, 2009, CONFL INT MED RES ED; Kaplan RM, 2007, ANNU REV PUBL HEALTH, V28, P321, DOI 10.1146/annurev.publhealth.28.021406.144141; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Moynihan R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4442; *NIH, CONS DEV PROGR; NIH State of the Science Conference, 2009, NIH STAT SCI C DIAGN; Rodbard HW, 2009, ENDOCR PRACT, V15, P540, DOI 10.4158/EP.15.6.540; Ryan EA, 2011, DIABETOLOGIA, V54, P480, DOI 10.1007/s00125-010-2005-4; US Department of Health and Human Services Food and Drug Administration, 2008, FDA GUID; Welch G, 2011, DIAGNOSED MAKING PEO; WHO, REP WHO COMM SOC DET; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z	19	26	27	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2011	342								d2548	10.1136/bmj.d2548	http://dx.doi.org/10.1136/bmj.d2548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MA	21540259				2022-12-28	WOS:000290481600008
J	Brandon, MP; Bogaard, AR; Libby, CP; Connerney, MA; Gupta, K; Hasselmo, ME				Brandon, Mark P.; Bogaard, Andrew R.; Libby, Christopher P.; Connerney, Michael A.; Gupta, Kishan; Hasselmo, Michael E.			Reduction of Theta Rhythm Dissociates Grid Cell Spatial Periodicity from Directional Tuning	SCIENCE			English	Article							FREELY MOVING RATS; ENTORHINAL CORTEX; PHASE PRECESSION; REPRESENTATION; MEMORY; HIPPOCAMPUS; MODULATION; WORKING	Grid cells recorded in the medial entorhinal cortex of freely moving rats exhibit firing at regular spatial locations and temporal modulation with theta rhythm oscillations (4 to 11 hertz). We analyzed grid cell spatial coding during reduction of network theta rhythm oscillations caused by medial septum (MS) inactivation with muscimol. During MS inactivation, grid cells lost their spatial periodicity, whereas head-direction cells maintained their selectivity. Conjunctive grid-by-head-direction cells lost grid cell spatial periodicity but retained head-direction specificity. All cells showed reduced rhythmicity in autocorrelations and cross-correlations. This supports the hypothesis that spatial coding by grid cells requires theta oscillations, and dissociates the mechanisms underlying the generation of entorhinal grid cell periodicity and head-direction selectivity.	[Brandon, Mark P.; Bogaard, Andrew R.; Libby, Christopher P.; Connerney, Michael A.; Gupta, Kishan; Hasselmo, Michael E.] Boston Univ, Dept Psychol, Ctr Memory & Brain, Grad Program Neurosci, Boston, MA 02215 USA	Boston University	Brandon, MP (corresponding author), Boston Univ, Dept Psychol, Ctr Memory & Brain, Grad Program Neurosci, 2 Cummington St, Boston, MA 02215 USA.	markpb68@bu.edu; hasselmo@bu.edu		Hasselmo, Michael/0000-0002-9925-6377	National Institute of Mental Health [R01 MH60013, MH61492]; Office of Naval Research Multidisciplinary University Research Initiative [N00014-10-1-0936]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061492, R01MH060013] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of Naval Research Multidisciplinary University Research Initiative(MURIOffice of Naval Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Thanks to C. Stern, S. Leutgeb, H. Eichenbaum, N. Schultheiss, E. Newman, C. Monaghan, J. Climer, and E. Zilli for advice and comments and to T. Ware for technical assistance. The research was supported by National Institute of Mental Health grants R01 MH60013 and MH61492 and Office of Naval Research Multidisciplinary University Research Initiative grant N00014-10-1-0936.	Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CHROBAK JJ, 1989, BEHAV NEURAL BIOL, V52, P357, DOI 10.1016/S0163-1047(89)90472-X; Deshmukh SS, 2010, J NEUROPHYSIOL, V104, P994, DOI 10.1152/jn.01141.2009; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; GIVENS B, 1994, J NEUROSCI, V14, P3578; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; JEFFERY KJ, 1995, NEUROREPORT, V6, P2166, DOI 10.1097/00001756-199511000-00017; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Martin MM, 2007, PHYSIOL BEHAV, V90, P412, DOI 10.1016/j.physbeh.2006.10.007; MITCHELL SJ, 1982, J NEUROSCI, V2, P292; MIZUMORI SJY, 1989, J NEUROSCI, V9, P3915; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Moser EI, 2008, HIPPOCAMPUS, V18, P1142, DOI 10.1002/hipo.20483; Navratilova Z., 2011, HIPPOCAMPUS, DOI 10.1002/hipo.20939; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pang KCH, 1999, BEHAV NEUROSCI, V113, P265, DOI 10.1037/0735-7044.113.2.265; RAWLINS JNP, 1979, EXP BRAIN RES, V37, P49, DOI 10.1007/BF01474253; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; TAUBE JS, 1990, J NEUROSCI, V10, P420; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646	28	285	285	4	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					595	599		10.1126/science.1201652	http://dx.doi.org/10.1126/science.1201652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527714	Green Accepted			2022-12-28	WOS:000289991100051
J	Guo, JU; Su, YJ; Zhong, C; Ming, GL; Song, HJ				Guo, Junjie U.; Su, Yijing; Zhong, Chun; Ming, Guo-li; Song, Hongjun			Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain	CELL			English	Article							SINGLE-STRANDED-DNA; METHYLATION; GLYCOSYLASE; GENOME; 5-HYDROXYMETHYLCYTOSINE; INHIBITOR; DEAMINASE; QUANTIFICATION; MECHANISMS; CONVERSION	Cytosine methylation is the major covalent modification of mammalian genomic DNA and plays important roles in transcriptional regulation. The molecular mechanism underlying the enzymatic removal of this epigenetic mark, however, remains elusive. Here, we show that 5-methylcytosine (5mC) hydroxylase TET1, by converting 5mCs to 5-hydroxymethylcytosines (5hmCs), promotes DNA demethylation in mammalian cells through a process that requires the base excision repair pathway. Though expression of the 12 known human DNA glycosylases individually did not enhance removal of 5hmCs in mammalian cells, demethylation of both exogenously introduced and endogenous 5hmCs is promoted by the AID (activation-induced deaminase)/APOBEC (apolipoprotein B mRNA-editing enzyme complex) family of cytidine deaminases. Furthermore, Tet1 and Apobec1 are involved in neuronal activity-induced, region-specific, active DNA demethylation and subsequent gene expression in the dentate gyrus of the adult mouse brain in vivo. Our study suggests a TET1-induced oxidation-deamination mechanism for active DNA demethylation in mammals.	[Guo, Junjie U.; Su, Yijing; Zhong, Chun; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Guo, Junjie U.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Su, Yijing; Zhong, Chun; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	shongju1@jhmi.edu	Erlitzki, Noa/AHC-5346-2022; Ming, Guo-li/J-7880-2013; liyue, shi/G-4890-2011	Ming, Guo-li/0000-0002-2517-6075	AMRF; NIH [HD069184, NS048271, NS047344, AG024984, MH087874]; FARMS; MSCRF; NARSAD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087874, R21MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047344, R56NS047344, R01NS048271, R01NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	AMRF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FARMS; MSCRF; NARSAD(NARSAD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D.K.Ma and K. Christian for comments; members of Song and Ming laboratories for discussion; Y. Gao for RNA-seq; H.C. Kang, J.S. Jeong, N.Y. Jung and J. Shin for help with molecular cloning; and Q. Hussaini, Y. Cai, and L. Liu for technical support. This work was supported by AMRF and NIH (HD069184 and NS048271) to G.-I.M., by NIH (NS047344, AG024984, and MH087874) and NARSAD to H.J.S., and by fellowships from FARMS to J.U.G, AMRF to Y.S., and MSCRF to C.Z.	Baker D, 2002, CHEM RES TOXICOL, V15, P33, DOI 10.1021/tx010113b; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Feng J, 2009, INT REV NEUROBIOL, V89, P67, DOI 10.1016/S0074-7742(09)89004-1; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zhang QM, 2005, DNA REPAIR, V4, P71, DOI 10.1016/j.dnarep.2004.08.002; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	55	998	1065	0	159	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					423	434		10.1016/j.cell.2011.03.022	http://dx.doi.org/10.1016/j.cell.2011.03.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21496894	Bronze, Green Accepted			2022-12-28	WOS:000290022900011
J	Goodridge, HS; Reyes, CN; Becker, CA; Katsumoto, TR; Ma, J; Wolf, AJ; Bose, N; Chan, ASH; Magee, AS; Danielson, ME; Weiss, A; Vasilakos, JP; Underhill, DM				Goodridge, Helen S.; Reyes, Christopher N.; Becker, Courtney A.; Katsumoto, Tamiko R.; Ma, Jun; Wolf, Andrea J.; Bose, Nandita; Chan, Anissa S. H.; Magee, Andrew S.; Danielson, Michael E.; Weiss, Arthur; Vasilakos, John P.; Underhill, David M.			Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'	NATURE			English	Article							BETA-GLUCAN RECOGNITION; CANDIDA-ALBICANS; LECTIN RECEPTORS; DENDRITIC CELLS; MACROPHAGES; KINASE; CD148; CLEC-2; CD45	Innate immune cells must be able to distinguish between direct binding to microbes and detection of components shed from the surface of microbes located at a distance. Dectin-1 (also known as CLEC7A) is a pattern-recognition receptor expressed by myeloid phagocytes (macrophages, dendritic cells and neutrophils) that detects beta-glucans in fungal cell walls and triggers direct cellular antimicrobial activity, including phagocytosis and production of reactive oxygen species (ROS)(1,2). In contrast to inflammatory responses stimulated upon detection of soluble ligands by other pattern-recognition receptors, such as Toll-like receptors (TLRs), these responses are only useful when a cell comes into direct contact with a microbe and must not be spuriously activated by soluble stimuli. In this study we show that, despite its ability to bind both soluble and particulate beta-glucan polymers, Dectin-1 signalling is only activated by particulate beta-glucans, which cluster the receptor in synapse-like structures from which regulatory tyrosine phosphatases CD45 and CD148 (also known as PTPRC and PTPRJ, respectively) are excluded (Supplementary Fig. 1). The 'phagocytic synapse' now provides a model mechanism by which innate immune receptors can distinguish direct microbial contact from detection of microbes at a distance, thereby initiating direct cellular antimicrobial responses only when they are required.	[Goodridge, Helen S.; Reyes, Christopher N.; Becker, Courtney A.; Ma, Jun; Wolf, Andrea J.; Underhill, David M.] Cedars Sinai Med Ctr, IBD & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Goodridge, Helen S.] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA; [Goodridge, Helen S.; Underhill, David M.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Katsumoto, Tamiko R.; Weiss, Arthur] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Bose, Nandita; Chan, Anissa S. H.; Magee, Andrew S.; Danielson, Michael E.; Vasilakos, John P.] Biothera, Eagan, MN 55121 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Underhill, DM (corresponding author), Cedars Sinai Med Ctr, IBD & Immunobiol Res Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	david.underhill@csmc.edu	Katsumoto, Tamiko/V-4086-2019; UNDERHILL, DAVID/ABE-2185-2021	Underhill, David/0000-0002-2989-658X; Katsumoto, Tamiko/0000-0002-7978-0315	NIH [AI071116, AI066120]; American Heart Association; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066120, R01AI071116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Wawrowsky for help with confocal microscopy, and G. D. Brown for Dectin-1-deficient mice. This study was funded by grants from the NIH (AI071116 and AI066120 to D. M. U. and A. W., respectively) and the American Heart Association (D. M. U.). H. S. G. held a Research Fellowship Award from the Crohn's and Colitis Foundation of America. D. M. U. holds the Janis and William Wetsman Family Chair in Inflammatory Bowel Disease at Cedars-Sinai Medical Center.	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; CZOP JK, 1985, J IMMUNOL, V134, P2588; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Feng D, 2007, J NEUROSCI, V27, P12757, DOI 10.1523/JNEUROSCI.2846-07.2007; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Lavigne LM, 2006, J IMMUNOL, V177, P8667, DOI 10.4049/jimmunol.177.12.8667; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	24	532	553	2	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					471	U541		10.1038/nature10071	http://dx.doi.org/10.1038/nature10071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525931	Green Submitted, Green Accepted			2022-12-28	WOS:000289949600034
J	Cyranoski, D; Gilbert, N; Ledford, H; Nayar, A; Yahia, M				Cyranoski, David; Gilbert, Natasha; Ledford, Heidi; Nayar, Anjali; Yahia, Mohammed			THE PHD FACTORY	NATURE			English	News Item																			0	258	269	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 21	2011	472	7343					276	279		10.1038/472276a	http://dx.doi.org/10.1038/472276a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21512548	Bronze			2022-12-28	WOS:000289724600010
J	Allison, JE; Fraser, CG				Allison, James E.; Fraser, Callum G.			Fecal immunochemical tests had better sensitivity for detecting colorectal neoplasia in aspirin users than in nonusers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Allison, James E.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Fraser, Callum G.] Univ Dundee, Dundee, Scotland	University of California System; University of California San Francisco; University of Dundee	Allison, JE (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							Hundt S, 2009, ANN INTERN MED, V150, P162, DOI 10.7326/0003-4819-150-3-200902030-00005; Levi Z, 2009, AM J GASTROENTEROL, V104, P933, DOI 10.1038/ajg.2009.14; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7	3	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8							JC4-10	10.7326/0003-4819-154-8-201104190-02010	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502636				2022-12-28	WOS:000289622000009
J	Kiel, DP				Kiel, Douglas P.			Review: Exercise/physical therapy and vitamin D each reduce risk for falls in older community-dwelling adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kiel, Douglas P.] Inst Aging Res Hebrew SeniorLife, Boston, MA 02131 USA; [Kiel, Douglas P.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Hebrew SeniorLife; Harvard University; Harvard Medical School	Kiel, DP (corresponding author), Inst Aging Res Hebrew SeniorLife, Boston, MA 02131 USA.			Kiel, Douglas/0000-0001-8474-0310				Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x	2	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8							JC4-5	10.7326/0003-4819-154-8-201104190-02005	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502643				2022-12-28	WOS:000289622000004
J	Nesrallah, GE				Nesrallah, Gihad E.			Increased frequency of hemodialysis reduced adverse clinical outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Western Ontario, London, ON, Canada	Western University (University of Western Ontario)	Nesrallah, GE (corresponding author), Univ Western Ontario, London, ON, Canada.		Nesrallah, Gihad/AAY-7534-2020					Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Rocco MV, 2011, AM J KIDNEY DIS, V57, P90, DOI 10.1053/j.ajkd.2010.08.024	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8							JC4-6	10.7326/0003-4819-154-8-201104190-02006	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502644				2022-12-28	WOS:000289622000005
J	Habashi, JP; Doyle, JJ; Holm, TM; Aziz, H; Schoenhoff, F; Bedja, D; Chen, YC; Modiri, AN; Judge, DP; Dietz, HC				Habashi, Jennifer P.; Doyle, Jefferson J.; Holm, Tammy M.; Aziz, Hamza; Schoenhoff, Florian; Bedja, Djahida; Chen, YiChun; Modiri, Alexandra N.; Judge, Daniel P.; Dietz, Harry C.			Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism	SCIENCE			English	Article							SMOOTH-MUSCLE-CELLS; MARFAN-SYNDROME; MOUSE MODEL; BLOCKADE; GROWTH; PATHOGENESIS; CONTRIBUTES; MECHANISM; ACTIVATION; EXPRESSION	Angiotensin II (AngII) mediates progression of aortic aneurysm, but the relative contribution of its type 1 (AT1) and type 2 (AT2) receptors remains unknown. We show that loss of AT2 expression accelerates the aberrant growth and rupture of the aorta in a mouse model of Marfan syndrome (MFS). The selective AT1 receptor blocker (ARB) losartan abrogated aneurysm progression in the mice; full protection required intact AT2 signaling. The angiotensin-converting enzyme inhibitor (ACEi) enalapril, which limits signaling through both receptors, was less effective. Both drugs attenuated canonical transforming growth factor-beta (TGF beta) signaling in the aorta, but losartan uniquely inhibited TGF beta-mediated activation of extracellular signal-regulated kinase (ERK), by allowing continued signaling through AT2. These data highlight the protective nature of AT2 signaling and potentially inform the choice of therapies in MFS and related disorders.	[Habashi, Jennifer P.; Doyle, Jefferson J.; Holm, Tammy M.; Aziz, Hamza; Schoenhoff, Florian; Chen, YiChun; Modiri, Alexandra N.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Habashi, Jennifer P.; Doyle, Jefferson J.; Holm, Tammy M.; Aziz, Hamza; Schoenhoff, Florian; Chen, YiChun; Modiri, Alexandra N.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Habashi, Jennifer P.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Div Pediat Cardiol, Dept Pediat, Baltimore, MD 21205 USA; [Bedja, Djahida] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Judge, Daniel P.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	hdietz@jhmi.edu	Doyle, Jefferson/C-3156-2013; Chen, Yi-Chun/H-4468-2013; Chen, Yichun/AAI-3892-2020	Chen, Yichun/0000-0002-9092-7189; Schoenhoff, Florian/0000-0002-3311-4595; Judge, Daniel/0000-0002-3407-0248	NIH; Howard Hughes Medical Institute; National Marfan Foundation; Johns Hopkins School of Medicine; Smilow Center for Marfan Syndrome Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698, R01AR041135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Marfan Foundation; Johns Hopkins School of Medicine(Johns Hopkins University); Smilow Center for Marfan Syndrome Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the NIH (H. C. D., D.P.J.); Howard Hughes Medical Institute (H. C. D.); the National Marfan Foundation (H. C. D., J.P.H., J.J.D.); the Cellular and Molecular Medicine Training Program, Johns Hopkins School of Medicine (J.J.D.); and the Smilow Center for Marfan Syndrome Research (H. C. D.). We thank T. Inagami for the AT2KO mice. Johns Hopkins University and the authors (H. C. D., J.P.H., D.P.J.) have filed a patent relating to the use of TGF beta antagonists, including AT1 receptor blockers, for the treatment of Marfan syndrome.	Ahimastos AA, 2007, JAMA-J AM MED ASSOC, V298, P1539, DOI 10.1001/jama.298.13.1539; Akishita M, 1999, J CLIN INVEST, V103, P63, DOI 10.1172/JCI5182; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; Fukuda N, 2000, AM J HYPERTENS, V13, P191, DOI 10.1016/S0895-7061(99)00152-1; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Jones ES, 2004, J MOL CELL CARDIOL, V37, P1023, DOI 10.1016/j.yjmcc.2004.08.004; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Nagashima H, 2002, J VASC SURG, V36, P818, DOI 10.1067/mva.2002.126091; Nagashima H, 2001, CIRCULATION, V104, pI282; Naito T, 2004, AM J PHYSIOL-RENAL, V286, pF278, DOI 10.1152/ajprenal.00139.2003; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Patten RD, 2003, CLIN SCI, V104, P109, DOI 10.1042/CS20020219; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Sakurabayashi-Kitade S, 2009, ATHEROSCLEROSIS, V206, P54, DOI 10.1016/j.atherosclerosis.2009.01.039; Siragy HM, 1999, P NATL ACAD SCI USA, V96, P6506, DOI 10.1073/pnas.96.11.6506; Ulmasov B, 2009, AM J PHYSIOL-GASTR L, V296, pG284, DOI 10.1152/ajpgi.90409.2008; Wolf G, 1999, J MOL MED-JMM, V77, P556, DOI 10.1007/s001099900028; Yetman AT, 2005, AM J CARDIOL, V95, P1125, DOI 10.1016/j.amjcard.2005.01.032	23	318	324	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					361	365		10.1126/science.1192152	http://dx.doi.org/10.1126/science.1192152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493863	Green Accepted			2022-12-28	WOS:000289516600048
J	Mackas, DL				Mackas, David L.			Does blending of chlorophyll data bias temporal trend?	NATURE			English	Letter									Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada	Fisheries & Oceans Canada	Mackas, DL (corresponding author), Fisheries & Oceans Canada, Inst Ocean Sci, POB 6000, Sidney, BC V8L 4B2, Canada.	Dave.Mackas@dfo-mpo.gc.ca						Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; FALKOWSKI PG, 1992, NATURE, V358, P741, DOI 10.1038/358741a0; Siegel DA, 2010, NATURE, V466, P569, DOI 10.1038/466569a	3	42	42	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					E4	E5		10.1038/nature09951	http://dx.doi.org/10.1038/nature09951			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21490623				2022-12-28	WOS:000289469100001
J	Bonner, L				Bonner, Laura			The Walk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												bonnerlauram@gmail.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1393	1393		10.1001/jama.2011.368	http://dx.doi.org/10.1001/jama.2011.368			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486965				2022-12-28	WOS:000289424100030
J	Ito, T; Simons, M				Ito, Takeo; Simons, Mark			Probing Asthenospheric Density, Temperature, and Elastic Moduli Below the Western United States	SCIENCE			English	Article							AMERICA; MODEL	Periodic ocean tides continually provide a cyclic load on Earth's surface, the response to which can be exploited to provide new insights into Earth's interior structure. We used geodetic observations of surface displacements induced by ocean tidal loads to constrain a depth-dependent model for the crust and uppermost mantle that provides independent estimates of density and elastic moduli below the western United States and nearby offshore regions. Our observations require strong gradients in both density and elastic shear moduli at the top and bottom of the asthenosphere but no discrete structural discontinuity at a depth of 220 kilometers. The model indicates that the asthenosphere has a low-density anomaly of similar to 50 kilograms per cubic meter; a temperature anomaly of similar to 300 degrees C can simultaneously explain this density anomaly and inferred colocated minima in elastic moduli.	[Ito, Takeo; Simons, Mark] CALTECH, Div Geol & Planetary Sci, Seismol Lab, Pasadena, CA 91125 USA; [Ito, Takeo] Nagoya Univ, Res Ctr Seismol Volcanol & Disaster Mitigat, Aichi 4648602, Japan	California Institute of Technology; Nagoya University	Ito, T (corresponding author), CALTECH, Div Geol & Planetary Sci, Seismol Lab, Pasadena, CA 91125 USA.	takeo_ito@nagoya-u.jp	Ito, Takeo/S-1271-2019; Ito, Takeo/D-7027-2012; Simons, Mark/N-4397-2015	Ito, Takeo/0000-0003-1661-9943; Ito, Takeo/0000-0003-1661-9943; Simons, Mark/0000-0003-1412-6395	NSF [EAR-0350028, EAR-0732947]; Ministry of Education, Culture, Sports, Science & Technology of Japan [20740254]; JSPS; Gordon and Betty Moore Foundation	NSF(National Science Foundation (NSF)); Ministry of Education, Culture, Sports, Science & Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	We thank H. Kanamori, D. L. Anderson, M. Gurnis, and two reviewers for informative discussions and helpful reviews of early versions of this work. This material is based on raw data provided by the Plate Boundary Observatory operated by UNAVCO for EarthScope (www.earthscope.org). Supported by NSF grants EAR-0350028 and EAR-0732947, Ministry of Education, Culture, Sports, Science & Technology of Japan grant-in-aid for scientific research 20740254, JSPS Postdoctoral Fellowships for Research Abroad, and the Gordon and Betty Moore Foundation. Data are available from UNAVCO Archive collections (http://facility.unavco.org/data/). This paper is Caltech Tectonics Observatory contribution 150 and Seismolab contribution 10056. We thank T. Takasu for providing us his GPS analysis codes (GPS Tools, version 0.6.4).	BURDICK LJ, 1978, J GEOPHYS RES, V83, P1699, DOI 10.1029/JB083iB04p01699; Darwin G. H., 1899, TIDES KINDRED PHENOM; Dziewonski A.M., 2007, TREATISE GEOPHYS, V1; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Dziewonski AM, 1997, EARTHS DEEP INTERIOR, P11; Fu GY, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004512; Fuji N, 2010, PHYS EARTH PLANET IN, V180, P118, DOI 10.1016/j.pepi.2009.10.004; GRAND SP, 1984, GEOPHYS J ROY ASTR S, V76, P399, DOI 10.1111/j.1365-246X.1984.tb05053.x; HAGER BH, 1989, MANTLE CONVECTION, P657; Hart RHG, 1996, J GEOPHYS RES-SOL EA, V101, P25553, DOI 10.1029/96JB02273; Ito T, 2009, J GEODYN, V48, P253, DOI 10.1016/j.jog.2009.09.012; Jackson JM, 2007, PHYS EARTH PLANET IN, V161, P1, DOI 10.1016/j.pepi.2006.11.002; KENNETT BLN, 1991, GEOPHYS J INT, V105, P429, DOI 10.1111/j.1365-246X.1991.tb06724.x; King MA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032252; Kustowski B, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005169; Latychev K, 2009, EARTH PLANET SC LETT, V277, P86, DOI 10.1016/j.epsl.2008.10.008; Lyard F, 2006, OCEAN DYNAM, V56, P394, DOI 10.1007/s10236-006-0086-x; Mantovani MSM, 2005, EARTH PLANET SC LETT, V230, P397, DOI 10.1016/j.epsl.2004.12.007; Moucha R, 2008, EARTH PLANET SC LETT, V271, P101, DOI 10.1016/j.epsl.2008.03.056; PARIISKY NN, 1965, TECTONOPHYSICS, V1, P439; Penna NT, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004047; Roeloffs E, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006407; Ruan YY, 2010, GEOPHYS J INT, V181, P479, DOI 10.1111/j.1365-246X.2010.04514.x; Spasojevic S, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002345; Stein S., 2003, INTRO SEISMOLOGY EAR; Tan Y, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004853; Vergnolle M, 2008, GEOPHYS J INT, V173, P444, DOI 10.1111/j.1365-246X.2008.03734.x; Vergnolle M, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006852	28	34	35	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					947	951		10.1126/science.1202584	http://dx.doi.org/10.1126/science.1202584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21493821				2022-12-28	WOS:000290766600038
J	Brennand, KJ; Simone, A; Jou, J; Gelboin-Burkhart, C; Tran, N; Sangar, S; Li, Y; Mu, YL; Chen, G; Yu, D; McCarthy, S; Sebat, J; Gage, FH				Brennand, Kristen J.; Simone, Anthony; Jou, Jessica; Gelboin-Burkhart, Chelsea; Tran, Ngoc; Sangar, Sarah; Li, Yan; Mu, Yangling; Chen, Gong; Yu, Diana; McCarthy, Shane; Sebat, Jonathan; Gage, Fred H.			Modelling schizophrenia using human induced pluripotent stem cells	NATURE			English	Article							RABIES VIRUS; RECEPTORS; PATHOGENESIS; PATHWAYS; PATIENT	Schizophrenia (SCZD) is a debilitating neurological disorder with a world-wide prevalence of 1%; there is a strong genetic component, with an estimated heritability of 80-85%(1). Although post-mortem studies have revealed reduced brain volume, cell size, spine density and abnormal neural distribution in the prefrontal cortex and hippocampus of SCZD brain tissue(2) and neuropharmacological studies have implicated dopaminergic, glutamatergic and GABAergic activity in SCZD(3), the cell types affected in SCZD and the molecular mechanisms underlying the disease state remain unclear. To elucidate the cellular and molecular defects of SCZD, we directly reprogrammed fibroblasts from SCZD patients into human induced pluripotent stem cells (hiPSCs) and subsequently differentiated these disorder-specific hiPSCs into neurons (Supplementary Fig. 1). SCZD hiPSC neurons showed diminished neuronal connectivity in conjunction with decreased neurite number, PSD95-protein levels and glutamate receptor expression. Gene expression profiles of SCZD hiPSC neurons identified altered expression of many components of the cyclic AMP and WNT signalling pathways. Key cellular and molecular elements of the SCZD phenotype were ameliorated following treatment of SCZD hiPSC neurons with the antipsychotic loxapine. To date, hiPSC neuronal pathology has only been demonstrated in diseases characterized by both the loss of function of a single gene product and rapid disease progression in early childhood(4-6). We now report hiPSC neuronal phenotypes and gene expression changes associated with SCZD, a complex genetic psychiatric disorder.	[Brennand, Kristen J.; Simone, Anthony; Jou, Jessica; Gelboin-Burkhart, Chelsea; Tran, Ngoc; Sangar, Sarah; Li, Yan; Mu, Yangling; Yu, Diana; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Chen, Gong] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [McCarthy, Shane] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Sebat, Jonathan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Salk Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cold Spring Harbor Laboratory; University of California System; University of California San Diego; University of California System; University of California San Diego	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Brennand, Kristen J/J-8704-2012; Brennand, Kristen J/U-5470-2019	Brennand, Kristen J/0000-0003-0993-5956; Sebat, Jonathan/0000-0002-9087-526X; Chen JNU, Gong/0000-0002-1857-3670	California Institute for Regenerative Medicine; CIRM [RL1-00649-1]; Lookout and Mathers Foundation; Helmsley Foundation; Sanofi-Aventis; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS028121, P30NS072031] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); CIRM(California Institute for Regenerative Medicine); Lookout and Mathers Foundation; Helmsley Foundation; Sanofi-Aventis(Sanofi-Aventis); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	L. Moore, B. Miller, K. Stecker, J. Jepsen, D. Sepp, S. Larkin and L. Johnson provided technical assistance. T. Berggren directs, and M. Lutz manages, the Salk Stem Cell facility. D. Gibbs directs the Salk Viral Vector Core. J. Nguyen and L. Ouyang provided gene expression support. D. Chambers and J. Barrie provided FACS support. E. Callaway and I. Wickersham provided rabies trans-neuronal tracing viruses and invaluable advice and scientific feedback. M. Lawson provided assistance with statistical analysis. Thanks to G. Yeo, M. McConnell, S. Aigner, C. Marchetto and L. Boyer for advice and conversation. K.J.B. is supported by a training grant from the California Institute for Regenerative Medicine. The Gage Laboratory, and this project, is partially funded by CIRM Grant RL1-00649-1, The Lookout and Mathers Foundation, the Helmsley Foundation as well as Sanofi-Aventis.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Cannon TD, 2006, ANNU REV CLIN PSYCHO, V2, P267, DOI 10.1146/annurev.clinpsy.2.022305.095232; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Higgs BW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-70; Jaaro-Peled H, 2010, SCHIZOPHRENIA BULL, V36, P301, DOI 10.1093/schbul/sbp133; Javitt DC, 2008, NAT REV DRUG DISCOV, V7, P68, DOI 10.1038/nrd2463; Kapur S, 1997, AM J PSYCHIAT, V154, P1525, DOI 10.1176/ajp.154.11.1525; Karayiorgou M, 2004, MOL BRAIN RES, V132, P95, DOI 10.1016/j.molbrainres.2004.09.029; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Ugolini G, 2008, DEV BIOLOGICALS, V131, P493; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang XD, 2008, INT J NEUROPSYCHOPH, V11, P553, DOI 10.1017/S1461145707008371; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wong AHC, 2003, NEUROSCI BIOBEHAV R, V27, P269, DOI 10.1016/S0149-7634(03)00035-6	25	950	983	3	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					221	+		10.1038/nature09915	http://dx.doi.org/10.1038/nature09915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21490598	Green Accepted			2022-12-28	WOS:000290487200040
J	Scott, P				Scott, Phillip			Leishmania - A Parasitized Parasite	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Scott, P (corresponding author), Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA.							BARRAL A, 1992, AM J TROP MED HYG, V47, P587, DOI 10.4269/ajtmh.1992.47.587; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Liese J, 2008, IMMUNOBIOLOGY, V213, P377, DOI 10.1016/j.imbio.2007.12.005; Salinas G, 1996, AM J TROP MED HYG, V54, P425, DOI 10.4269/ajtmh.1996.54.425; STUART KD, 1992, P NATL ACAD SCI USA, V89, P8596, DOI 10.1073/pnas.89.18.8596	5	15	16	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1773	1774		10.1056/NEJMcibr1101694	http://dx.doi.org/10.1056/NEJMcibr1101694			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759DC	21542750				2022-12-28	WOS:000290219800017
J	Yun, SJ; Kim, SJ				Yun, Sook Jung; Kim, Seong-Jin			Hutchinson's Nail Sign	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yun, Sook Jung; Kim, Seong-Jin] Chonnam Natl Univ, Sch Med, Kwangju, South Korea	Chonnam National University	Yun, SJ (corresponding author), Chonnam Natl Univ, Sch Med, Kwangju, South Korea.	sjyun@chonnam.ac.kr							0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					E38	E38		10.1056/NEJMicm1009305	http://dx.doi.org/10.1056/NEJMicm1009305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759DC	21542738				2022-12-28	WOS:000290219800013
J	Epstein, AJ; Polsky, D; Yang, FF; Yang, L; Groeneveld, PW				Epstein, Andrew J.; Polsky, Daniel; Yang, Feifei; Yang, Lin; Groeneveld, Peter W.			Coronary Revascularization Trends in the United States, 2001-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR DATA REGISTRY; AMERICAN-COLLEGE; ELUTING STENTS; THROMBOSIS	Context Coronary revascularization is among the most common hospital-based major interventional procedures performed in the United States. It is uncertain how new revascularization technologies, new clinical evidence from trials, and updated clinical guidelines have influenced the volume and distribution of coronary revascularizations over the past decade. Objective To examine national time trends in the rates and types of coronary revascularizations. Design, Setting, and Patients A serial cross-sectional study with time trends of patients undergoing coronary artery bypass graft (CABG) surgery or percutaneous coronary interventions (PCIs) between 2001 and 2008 at US hospitals in the Healthcare Cost and Utilization Project's Nationwide Inpatient Sample, which reports inpatient coronary revascularizations. These data were supplemented by Medicare outpatient hospital claims. Main Outcome Measures Annual procedure rates of coronary revascularizations, CABG surgery, and PCI. Results A 15% decrease (P<.001) in the annual rate of coronary revascularizations was observed from 2001-2002 to 2007-2008. The annual CABG surgery rate decreased steadily from 1742 (95% confidence interval [CI], 1663-1825) CABG surgeries per million adults per year in 2001-2002 to 1081 (95% CI, 1032-1133) CABG surgeries per million adults per year in 2007-2008 (P<.001), but PCI rates did not significantly change (3827 [95% CI, 3578-4092] PCI per million adults per year in 2001-2002 vs 3667 [95% CI, 3429-3922] PCI per million adults per year in 2007-2008, P=.74). Between 2001 and 2008, the number of hospitals in the Nationwide Inpatient Sample providing CABG surgery increased by 12% (212 in 2001 vs 241 in 2008, P=.03), and the number of PCI hospitals increased by 26% (246 in 2001 vs 331 in 2008, P<.001). The median CABG surgery caseload per hospital decreased by 28% (median [interquartile range], 253 [161-458] in 2001 vs 183 [98-292] in 2008; P<.001) and the number of CABG surgery hospitals providing fewer than 100 CABG surgeries per year increased from 23 (11%) in 2001 to 62 (26%) in 2008 (P<.001). Conclusions In US hospitals between 2001 and 2008, a substantial decrease in CABG surgery utilization rates was observed, but PCI utilization rates remained unchanged. JAMA. 2011;305(17):1769-1776 www.jama.com	[Epstein, Andrew J.; Polsky, Daniel; Yang, Feifei; Yang, Lin; Groeneveld, Peter W.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Epstein, Andrew J.; Groeneveld, Peter W.] Philadelphia Vet Affairs Med Ctr, Dept Vet Affairs, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Epstein, Andrew J.; Polsky, Daniel; Groeneveld, Peter W.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania	Groeneveld, PW (corresponding author), Univ Penn, Sch Med, Dept Med, 1229 Blockley Hall,423 Serv Dr, Philadelphia, PA 19104 USA.	petergro@mail.med.upenn.edu		Epstein, Andrew/0000-0001-5078-6564; Groeneveld, Peter/0000-0002-7374-4292	National Heart, Lung, and Blood Institute [1R01HL086919]; Agency for Healthcare Research and Quality [1R01HS018403]; Pennsylvania Department of Health; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018403] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086919] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Pennsylvania Department of Health; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants 1R01HL086919 from the National Heart, Lung, and Blood Institute and 1R01HS018403 from the Agency for Healthcare Research and Quality. This work was also funded in part under a grant from the Pennsylvania Department of Health.	Agency for Healthcare Research and Quality, 2008, HEALTHC COST UT PROJ; Anderson HV, 2002, J AM COLL CARDIOL, V39, P1096, DOI 10.1016/S0735-1097(02)01733-3; BODEN WE, 2007, PHYS REV LETT, V356, P1503; Cohen M M, 1997, Cost Qual Q J, V3, P48; *CTR MED MED SERV, INP HOSP PAYM INF VA; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; DeFrances CJ, 2008, 2006 NATL HOSP DISCH; Dunlay Shannon M, 2009, Curr Treat Options Cardiovasc Med, V11, P61; EAGLE KA, 1999, PHYS REV LETT, V34, P1262; Eagle Kim A, 2004, J Am Coll Cardiol, V44, pe213; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; FRUTKIN AD, 2009, PHYS REV LETT, V2, P614; GOGO PB, 2007, PHYS REV LETT, V99, P1222; GROENEVELD PW, 2008, PHYS REV LETT, V51, P2017; Harrison Jeffrey P, 2004, J Med Syst, V28, P411, DOI 10.1023/B:JOMS.0000041168.28200.8c; Hernandez AF, 2009, AM HEART J, V158, P47, DOI 10.1016/j.ahj.2009.05.014; Krone RJ, 2010, JACC-CARDIOVASC INTE, V3, P902, DOI 10.1016/j.jcin.2010.06.014; LI Z, 2008, PHYS REV LETT, V156, P1095; MOSES JW, 2003, PHYS REV LETT, V349, P1315; PATEL MR, 2009, PHYS REV LETT, V53, P530; RATHORE SS, 2004, PHYS REV LETT, V239, P110; ROE MT, 2009, PHYS REV LETT, V2, P414; SERRUYS PW, 2009, PHYS REV LETT, V360, P961; Shuchman M, 2006, NEW ENGL J MED, V355, P1949, DOI 10.1056/NEJMp068234; SMITH SC, 2001, PHYS REV LETT, V37, P2215; SMITH SC, 2006, PHYS REV LETT, V47, P216; STONE GW, 2004, PHYS REV LETT, V350, P221; *US BUR CENS, NCEST200902 US CENS; VAUGHANSARRAZIN MS, 2002, PHYS REV LETT, V288, P1859	29	395	425	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1769	1776		10.1001/jama.2011.551	http://dx.doi.org/10.1001/jama.2011.551			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758HZ	21540420	Green Accepted, Bronze			2022-12-28	WOS:000290156200017
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING PCORI: odd name, important job, potential trouble	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Elshaug AG, 2011, NEW ENGL J MED, V364, P1390, DOI 10.1056/NEJMp1101475; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Kamerow D, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2432; 2011, WALL STREET J   0318	4	7	7	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2011	342								d2635	10.1136/bmj.d2635	http://dx.doi.org/10.1136/bmj.d2635			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MB	21543406				2022-12-28	WOS:000290481700004
J	Moore, KJ; Tabas, I				Moore, Kathryn J.; Tabas, Ira			Macrophages in the Pathogenesis of Atherosclerosis	CELL			English	Review							LOW-DENSITY-LIPOPROTEIN; ENDOPLASMIC-RETICULUM STRESS; FOAM CELL-FORMATION; PROMOTES COLLAGEN ACCUMULATION; APOPTOTIC CELLS; DENDRITIC CELLS; ACCELERATED ATHEROSCLEROSIS; IMMUNE-RESPONSES; CHOLESTEROL; MICE	In atherosclerosis, the accumulation of apolipoprotein B-lipoproteins in the matrix beneath the endothelial cell layer of blood vessels leads to the recruitment of monocytes, the cells of the immune system that give rise to macrophages and dendritic cells. Macrophages derived from these recruited monocytes participate in a maladaptive, nonresolving inflammatory response that expands the subendothelial layer due to the accumulation of cells, lipid, and matrix. Some lesions subsequently form a necrotic core, triggering acute thrombotic vascular disease, including myocardial infarction, stroke, and sudden cardiac death. This Review discusses the central roles of macrophages in each of these stages of disease pathogenesis.	[Tabas, Ira] Columbia Univ, Dept Med, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Moore, Kathryn J.] NYU, Dept Med, Med Ctr, New York, NY 10016 USA; [Moore, Kathryn J.] NYU, Dept Cell Biol, Med Ctr, New York, NY 10016 USA	Columbia University; Columbia University; Columbia University; New York University; New York University	Tabas, I (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	iat1@columbia.edu	Moore, Kathryn/ABE-6416-2020	Moore, Kathryn/0000-0003-2505-2547	NIH [P01-HL054591, R01-HL075662, R01-HL057560, R01-AG20255, P01-HL087123]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106019, P01HL087123, R01HL057560, R01HL075662, P01HL054591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020255] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants P01-HL054591, R01-HL075662, R01-HL057560, R01-AG20255, and P01-HL087123. The authors acknowledge invaluable discussions with members of their laboratories and colleagues in the field.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Abi-Younes S, 2000, CIRC RES, V86, P131, DOI 10.1161/01.RES.86.2.131; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Babaev VR, 2008, CELL METAB, V8, P492, DOI 10.1016/j.cmet.2008.09.005; Baetta R, 2010, ATHEROSCLEROSIS, V210, P1, DOI 10.1016/j.atherosclerosis.2009.10.028; Becker L, 2010, CELL METAB, V11, P125, DOI 10.1016/j.cmet.2010.01.003; Bergmark C, 2008, J LIPID RES, V49, P2230, DOI 10.1194/jlr.M800174-JLR200; Bobryshev YV, 2005, EUR HEART J, V26, P1700, DOI 10.1093/eurheartj/ehi282; Boyle JJ, 2003, ARTERIOSCL THROM VAS, V23, P1553, DOI 10.1161/01.ATV.0000086961.44581.B7; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1980, J BIOL CHEM, V255, P9344; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Chan JM, 2010, P NATL ACAD SCI USA, V107, P2213, DOI 10.1073/pnas.0914585107; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Coller BS, 2005, ARTERIOSCL THROM VAS, V25, P658, DOI 10.1161/01.ATV.0000156877.94472.a5; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; Curtiss LK, 2009, J LIPID RES, V50, pS340, DOI 10.1194/jlr.R800056-JLR200; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; Deguchi J, 2006, CIRCULATION, V114, P55, DOI 10.1161/CIRCULATIONAHA.106.619056; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Fryburg DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002029; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Goel R, 2008, ARTERIOSCL THROM VAS, V28, DOI 10.1161/ATVBAHA.108.172270; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Han XB, 2010, FASEB J, V24, P2869, DOI 10.1096/fj.09-148155; Harry BL, 2008, ARTERIOSCL THROM VAS, V28, P2003, DOI 10.1161/ATVBAHA.108.164707; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Jerome WG, 2006, REJUV RES, V9, P245, DOI 10.1089/rej.2006.9.245; Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kamei M, 2010, CURR OPIN HEMATOL, V17, P43, DOI 10.1097/MOH.0b013e3283333949; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Leon B, 2005, SEMIN IMMUNOL, V17, P313, DOI 10.1016/j.smim.2005.05.013; Li SZ, 2009, CIRC RES, V105, P1072, DOI 10.1161/CIRCRESAHA.109.199570; Liu J, 2005, ARTERIOSCL THROM VAS, V25, P174, DOI 10.1161/01.ATV.0000148548.47755.22; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Lotta LA, 2010, EUR J INTERN MED, V21, P74, DOI 10.1016/j.ejim.2009.11.003; Lusis AJ, 2007, ARTERIOSCL THROM VAS, V27, P2100, DOI 10.1161/ATVBAHA.107.147918; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mehta NN, 2011, EUR HEART J, V32, P963, DOI 10.1093/eurheartj/ehr091; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Nakano K, 2007, ATHEROSCLEROSIS, V194, P309, DOI 10.1016/j.atherosclerosis.2006.10.029; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Rigamonti E, 2008, ARTERIOSCL THROM VAS, V28, P1050, DOI 10.1161/ATVBAHA.107.158998; Rosenfeld Michael E, 2002, Curr Atheroscler Rep, V4, P238, DOI 10.1007/s11883-002-0025-3; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; Sadeghi MM, 2010, J NUCL MED, V51, p51S, DOI 10.2967/jnumed.109.068163; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Schiller NK, 2001, ARTERIOSCL THROM VAS, V21, P1674, DOI 10.1161/hq1001.096724; Schneider F, 2008, CIRCULATION, V117, P931, DOI 10.1161/CIRCULATIONAHA.107.707448; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; Schulte S, 2008, AM J PATHOL, V172, P1500, DOI 10.2353/ajpath.2008.070776; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Seimon TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012772; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shaposhnik Z, 2007, ARTERIOSCL THROM VAS, V27, P621, DOI 10.1161/01.ATV.0000254673.55431.e6; Shibata N, 2009, J LIPID RES, V50, pS277, DOI 10.1194/jlr.R800063-JLR200; Smith JD, 2001, ANN NY ACAD SCI, V947, P247; SMITH JD, 2001, ANN NY ACAD SCI, V947, P252; Steinberg D, 2008, CIRCULATION, V118, P672, DOI 10.1161/CIRCULATIONAHA.107.753152; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Sun HJ, 2002, J BIOL CHEM, V277, P47486, DOI 10.1074/jbc.M205814200; TABAS I, 1993, J BIOL CHEM, V268, P20419; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Tabas I, 2010, CIRC RES, V106, P58, DOI 10.1161/CIRCRESAHA.109.208488; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Tarling EJ, 2010, ARTERIOSCL THROM VAS, V30, P1174, DOI 10.1161/ATVBAHA.110.205617; Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Tsukano H, 2010, ARTERIOSCL THROM VAS, V30, P1925, DOI 10.1161/ATVBAHA.110.206094; Virmani Renu, 2002, J Interv Cardiol, V15, P439, DOI 10.1111/j.1540-8183.2002.tb01087.x; Wilensky RL, 2009, CURR OPIN LIPIDOL, V20, P415, DOI 10.1097/MOL.0b013e3283307c16; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Williams KJ, 2005, CURR OPIN CLIN NUTR, V8, P139, DOI 10.1097/00075197-200503000-00006; Witztum JL, 2001, TRENDS CARDIOVAS MED, V11, P93, DOI 10.1016/S1050-1738(01)00111-6; Yancey PG, 2010, ARTERIOSCL THROM VAS, V30, P787, DOI 10.1161/ATVBAHA.109.202051; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Yvan-Charvet L, 2010, CIRC RES, V106, P1861, DOI 10.1161/CIRCRESAHA.110.217281; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	113	1717	1806	15	456	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					341	355		10.1016/j.cell.2011.04.005	http://dx.doi.org/10.1016/j.cell.2011.04.005			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529710	Bronze, Green Accepted			2022-12-28	WOS:000290022900005
J	Scott, J				Scott, Janet			Stillbirths: breaking the silence of a hidden grief	LANCET			English	Editorial Material									Sands Stillbirth & Neonatal Death Charity, London W1B 1LY, England		Scott, J (corresponding author), Sands Stillbirth & Neonatal Death Charity, London W1B 1LY, England.	janet.scott@uk-sands.org							0	32	33	2	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 23	2011	377	9775					1386	1388		10.1016/S0140-6736(11)60107-4	http://dx.doi.org/10.1016/S0140-6736(11)60107-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UF	21496914				2022-12-28	WOS:000289963000007
J	Takada, T; Ikusaka, M; Ohira, Y; Noda, K; Tsukamoto, T				Takada, Toshihiko; Ikusaka, Masatomi; Ohira, Yoshiyuki; Noda, Kazutaka; Tsukamoto, Tomoko			Paroxysmal hip pain	LANCET			English	Editorial Material							STRANGULATED OBTURATOR HERNIA		[Takada, Toshihiko] Chiba Univ Hosp, Dept Gen Med, Chuo Ku, Chiba, Japan		Takada, T (corresponding author), Chiba Univ Hosp, Dept Gen Med, Chuo Ku, 1-8-1 Inohana, Chiba, Japan.	ttakada@water.ocn.ne.jp	Ohira, Yohiyuki/K-4310-2019					BJORK KJ, 1988, SURG GYNECOL OBSTET, V167, P217; GRAY SW, 1974, SURGERY, V75, P20; Green BT, 2001, SOUTH MED J, V94, P81; Igari K, 2010, HERNIA, V14, P409, DOI 10.1007/s10029-010-0658-z; YIP AWC, 1993, SURGERY, V113, P266	5	5	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 23	2011	377	9775					1464	1464		10.1016/S0140-6736(10)62298-2	http://dx.doi.org/10.1016/S0140-6736(10)62298-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UF	21515165				2022-12-28	WOS:000289963000035
J	Ochiai, M; Miyamoto, K; Kaneaki, T; Hayashi, S; Nakanishi, W				Ochiai, Masahito; Miyamoto, Kazunori; Kaneaki, Takao; Hayashi, Satoko; Nakanishi, Waro			Highly Regioselective Amination of Unactivated Alkanes by Hypervalent Sulfonylimino-lambda(3)-Bromane	SCIENCE			English	Article							SINGLE-ELECTRON TRANSFER; INTERMOLECULAR AMINATION; AMIDATION; OXYFUNCTIONALIZATION; FUNCTIONALIZATION; AZIRIDINATION; MECHANISM; BONDS	Amination of alkanes has generally required metal catalysts and/or high temperatures. Here we report that simple exposure of a broad range of alkanes to N-triflylimino-lambda(3)-bromane 1 at ambient temperature results in C-H insertion of the nitrogen functionality to afford triflyl-substituted amines in moderate to high yields. Marked selectivity for tertiary over secondary C-H bonds was observed; primary (methyl) C-H bonds were inert. Addition of hexafluoroisopropanol to inhibit decomposition of 1 dramatically improved the C-H amination efficiencies. Second-order kinetics, activation parameters (negative activation entropy), deuterium isotope effects, and theoretical calculations suggest a concerted asynchronous bimolecular transition state for the metal-free C-H amination event.	[Ochiai, Masahito; Miyamoto, Kazunori; Kaneaki, Takao] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan; [Hayashi, Satoko; Nakanishi, Waro] Wakayama Univ, Fac Syst Engn, Dept Chem & Mat Sci, Wakayama 6408510, Japan	Tokushima University; Wakayama University	Ochiai, M (corresponding author), Univ Tokushima, Grad Sch Pharmaceut Sci, 1-78 Shomachi, Tokushima 7708505, Japan.	mochiai@ph.tokushima-u.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (B) (Japan Society for the Promotion of Science). We thank Central Glass Co., Japan, for a generous gift of BrF<INF>3</INF>.	Au SM, 1999, J AM CHEM SOC, V121, P9120, DOI 10.1021/ja9913481; Badiei YM, 2008, ANGEW CHEM INT EDIT, V47, P9961, DOI 10.1002/anie.200804304; BRESLOW DS, 1969, J AM CHEM SOC, V91, P2273, DOI 10.1021/ja01037a016; BRESLOW R, 1982, J CHEM SOC CHEM COMM, P1400, DOI 10.1039/c39820001400; Chen KH, 2009, OPT ENG, V48, DOI 10.1117/1.3121987; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; DESMARTEAU DD, 1993, J AM CHEM SOC, V115, P4897, DOI 10.1021/ja00064a063; Farooq U, 2009, ANGEW CHEM INT EDIT, V48, P1018, DOI 10.1002/anie.200805027; Fiori KW, 2007, J AM CHEM SOC, V129, P562, DOI 10.1021/ja0650450; Fokin AA, 2000, J AM CHEM SOC, V122, P7317, DOI 10.1021/ja000193q; Fructos MR, 2006, J AM CHEM SOC, V128, P11784, DOI 10.1021/ja0627850; Glukhovtsev MN, 1998, J AM CHEM SOC, V120, P10528, DOI 10.1021/ja9813156; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; Gomez-Emeterio BP, 2008, ORGANOMETALLICS, V27, P4126, DOI 10.1021/om800218d; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Li ZG, 2007, ANGEW CHEM INT EDIT, V46, P5184, DOI 10.1002/anie.200700760; Liang CG, 2008, J AM CHEM SOC, V130, P343, DOI 10.1021/ja076519d; Lide D.R., 1992, CRC HDB CHEM PHYS, V73; Lin XF, 2007, CHEM-ASIAN J, V2, P1101, DOI 10.1002/asia.200700068; MELLO R, 1989, J AM CHEM SOC, V111, P6749, DOI 10.1021/ja00199a039; Nakamura E, 2002, J AM CHEM SOC, V124, P7181, DOI 10.1021/ja017823o; Ochiai M, 2008, J AM CHEM SOC, V130, P2118, DOI 10.1021/ja074624h; Ochiai M, 2007, J AM CHEM SOC, V129, P12938, DOI 10.1021/ja075811i; Ochiai M, 2010, CHEM COMMUN, V46, P511, DOI 10.1039/b922033j; Ochiai M, 2009, SYNLETT, P159, DOI 10.1055/s-0028-1087355; OKUYAMA T, 1995, J AM CHEM SOC, V117, P3360, DOI 10.1021/ja00117a006; Reichardt C., 2003, SOLVENTS SOLVENT EFF, V3rd; Schreiner PR, 2004, CHEM REC, V3, P247, DOI 10.1002/tcr.10070; Stang P. J., 1979, VINYL CATIONS	29	130	131	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					448	451		10.1126/science.1201686	http://dx.doi.org/10.1126/science.1201686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512029				2022-12-28	WOS:000289784900038
J	Jick, SS; Hernandez, RK				Jick, Susan S.; Hernandez, Rohini K.			Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HORMONAL CONTRACEPTIVES; TRANSDERMAL PATCH; ETHINYL ESTRADIOL; NORGESTIMATE; DISEASE; USERS; THROMBOSIS	Objective To compare the risk of non-fatal venous thromboembolism in women receiving oral contraceptives containing drospirenone with that in women receiving oral contraceptives containing levonorgestrel. Design Nested case-control and cohort study. Setting The study was based on information from PharMetrics, a United States based company that collects information on claims paid by managed care plans. Participants The study encompassed all women aged 15 to 44 years who received an oral contraceptive containing either drospirenone or levonorgestrel after 1 January 2002. Cases were women with current use of a study oral contraceptive and a diagnosis of venous thromboembolism in the absence of identifiable clinical risk factors (idiopathic venous thromboembolism). Up to four controls were matched to each case by age and calendar time. Main outcome measures Odds ratios comparing the risk of non-fatal venous thromboembolism in users of the two contraceptives; incidence rates and rate ratios of non-fatal venous thromboembolism for users of each of the study contraceptives. Results 186 newly diagnosed, idiopathic cases of venous thromboembolism were identified in the study population and matched with 681 controls. In the case-control analysis, the conditional odds ratio for venous thromboembolism comparing use of oral contraceptives containing drospirenone with use of those containing levonorgestrel was 2.3 (95% confidence interval 1.6 to 3.2). The incidence rates for venous thromboembolism in the study population were 30.8 (95% confidence interval 25.6 to 36.8) per 100 000 woman years among users of oral contraceptives containing drospirenone and 12.5 (9.61 to 15.9) per 100 000 woman years among users of oral contraceptives containing levonorgestrel. The age adjusted incidence rate ratio for venous thromboembolism for current use of oral contraceptives containing drospirenone compared with those containing levonorgestrel was 2.8 (2.1 to 3.8). Conclusions The risk of non-fatal venous thromboembolism among users of oral contraceptives containing drospirenone seems to be around twice that of users of oral contraceptives containing levonorgestrel, after the effects of potential confounders and prescribing biases have been taken into account.	[Jick, Susan S.; Hernandez, Rohini K.] Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA	Boston University	Jick, SS (corresponding author), Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, 11 Muzzey St, Lexington, MA 02421 USA.	sjick@bu.edu		Jick, Susan/0000-0002-2215-1067				Dinger JC, 2007, CONTRACEPTION, V75, P344, DOI 10.1016/j.contraception.2006.12.019; Farmer RDT, 2000, BRIT J CLIN PHARMACO, V49, P580, DOI 10.1046/j.1365-2125.2000.00198.x; Gomes MPV, 2004, ARCH INTERN MED, V164, P1965, DOI 10.1001/archinte.164.18.1965; Jick H, 2000, BMJ-BRIT MED J, V321, P1190, DOI 10.1136/bmj.321.7270.1190; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Jick SS, 2006, CONTRACEPTION, V73, P223, DOI 10.1016/j.contraception.2006.01.001; Jick S, 2007, CONTRACEPTION, V76, P4, DOI 10.1016/j.contraception.2007.03.003; Jick SS, 2007, PHARMACOTHERAPY, V27, P218, DOI 10.1592/phco.27.2.218; Jick SS, 2006, CONTRACEPTION, V74, P290, DOI 10.1016/j.contraception.2006.05.071; Jick SS, 2006, CONTRACEPTION, V73, P566, DOI 10.1016/j.contraception.2006.02.002; Kemmeren JM, 2001, BRIT MED J, V323, P131, DOI 10.1136/bmj.323.7305.131; Lidegaard O, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2890; Parkin L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2139; PORTER JB, 1985, OBSTET GYNECOL, V66, P1; POULTER NR, 1995, LANCET, V346, P1575; ROTHMAN KJ, 1988, INT J EPIDEMIOL, V17, P955, DOI 10.1093/ije/17.4.955; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Seeger JD, 2007, OBSTET GYNECOL, V110, P587, DOI 10.1097/01.AOG.0000279448.62221.a8; Spitzer WO, 1996, BRIT MED J, V312, P83; Vasilakis-Scaramozza C, 2001, LANCET, V358, P1427, DOI 10.1016/S0140-6736(01)06522-9; Vlieg AV, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2921; 2005, EPISHEET SPREADSHEET	22	152	155	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2011	342								d2151	10.1136/bmj.d2151	http://dx.doi.org/10.1136/bmj.d2151			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755OR	21511805	hybrid, Green Published			2022-12-28	WOS:000289943400006
J	Giugliano, D; Esposito, K				Giugliano, Dario; Esposito, Katherine			Clinical Inertia as a Clinical Safeguard	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-PRESSURE CONTROL; PREVENTION		[Giugliano, Dario; Esposito, Katherine] Univ Naples 2, Dept Geriatr & Metab Dis, I-80138 Naples, Italy	Universita della Campania Vanvitelli	Giugliano, D (corresponding author), Univ Naples 2, Dept Geriatr & Metab Dis, Piazza L Miraglia 2, I-80138 Naples, Italy.	dario.giugliano@unina2.it	Esposito, Katherine/AHE-2564-2022; Maiorino, Maria Ida/AHE-9986-2022	Esposito, Katherine/0000-0002-3652-5154; Maiorino, Maria Ida/0000-0003-4659-7546; Giugliano, Dario/0000-0002-9377-873X				Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Garfinkel D, 2010, ARCH INTERN MED, V170, P1648, DOI 10.1001/archinternmed.2010.355; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; National Center for Health Statistics, 2010, HLTH US 2009 SPEC FE; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Skyler JS, 2009, DIABETES CARE, V32, P187, DOI 10.2337/dc08-9026; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z	10	61	63	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1591	1592		10.1001/jama.2011.490	http://dx.doi.org/10.1001/jama.2011.490			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21505139				2022-12-28	WOS:000289683000031
J	Tangri, N; Stevens, LA; Griffith, J; Tighiouart, H; Djurdjev, O; Naimark, D; Levin, A; Levey, AS				Tangri, Navdeep; Stevens, Lesley A.; Griffith, John; Tighiouart, Hocine; Djurdjev, Ognjenka; Naimark, David; Levin, Adeera; Levey, Andrew S.			A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; RENAL RISK SCORES; CARDIOVASCULAR-DISEASE; IGA NEPHROPATHY; CLINICAL-TRIAL; HEART-DISEASE; UNITED-STATES; FOLLOW-UP; ALL-CAUSE; POPULATION	Context Chronic kidney disease (CKD) is common. Kidney disease severity can be classified by estimated glomerular filtration rate (GFR) and albuminuria, but more accurate information regarding risk for progression to kidney failure is required for clinical decisions about testing, treatment, and referral. Objective To develop and validate predictive models for progression of CKD. Design, Setting, and Participants Development and validation of prediction models using demographic, clinical, and laboratory data from 2 independent Canadian cohorts of patients with CKD stages 3 to 5 (estimated GFR, 10-59 mL/min/1.73 m(2)) who were referred to nephrologists between April 1, 2001, and December 31, 2008. Models were developed using Cox proportional hazards regression methods and evaluated using C statistics and integrated discrimination improvement for discrimination, calibration plots and Akaike Information Criterion for goodness of fit, and net reclassification improvement (NRI) at 1, 3, and 5 years. Main Outcome Measure Kidney failure, defined as need for dialysis or preemptive kidney transplantation. Results The development and validation cohorts included 3449 patients (386 with kidney failure [11%]) and 4942 patients (1177 with kidney failure [24%]), respectively. The most accurate model included age, sex, estimated GFR, albuminuria, serum calcium, serum phosphate, serum bicarbonate, and serum albumin (C statistic, 0.917; 95% confidence interval [CI], 0.901-0.933 in the development cohort and 0.841; 95% CI, 0.825-0.857 in the validation cohort). In the validation cohort, this model was more accurate than a simpler model that included age, sex, estimated GFR, and albuminuria (integrated discrimination improvement, 3.2%; 95% CI, 2.4%-4.2%; calibration [Nam and D'Agostino chi(2) statistic, 19 vs 32]; and reclassification for CKD stage 3 [NRI, 8.0%; 95% CI, 2.1%-13.9%] and for CKD stage 4 [NRI, 4.1%; 95% CI, -0.5% to 8.8%]). Conclusion A model using routinely obtained laboratory tests can accurately predict progression to kidney failure in patients with CKD stages 3 to 5.	[Tangri, Navdeep; Stevens, Lesley A.; Levey, Andrew S.] Tufts Med Ctr, Dept Med, Boston, MA 02111 USA; [Griffith, John; Tighiouart, Hocine] Tufts Med Ctr, Tufts Clin & Translat Sci Inst, Biostat Res Ctr, Boston, MA 02111 USA; [Djurdjev, Ognjenka; Levin, Adeera] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Djurdjev, Ognjenka; Levin, Adeera] British Columbia Prov Renal Agcy, Vancouver, BC, Canada; [Naimark, David] Univ Toronto, Sunnybrook Hosp, Dept Med, Toronto, ON, Canada	Tufts Medical Center; Tufts Medical Center; University of British Columbia; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Tangri, N (corresponding author), Tufts Med Ctr, Dept Med, 800 Washington St,POB 391, Boston, MA 02111 USA.	ntangri@tuftsmedicalcenter.org		Naimark, David Malcolm Joseph/0000-0002-0621-0637; Tangri, Navdeep/0000-0002-5075-6370	KRESCENT postdoctoral fellowship award; William B. Schwartz Nephrology Fund; Change Foundation of Ontario	KRESCENT postdoctoral fellowship award(Canadian Institutes of Health Research (CIHR)); William B. Schwartz Nephrology Fund; Change Foundation of Ontario	This work was supported by the KRESCENT postdoctoral fellowship award and William B. Schwartz Nephrology Fund. The KRESCENT award is a joint initiative of the Kidney Foundation of Canada, the Canadian Institute of Health Research, and the Canadian Society of Nephrology. Dr Naimark was supported by an operating grant from the Change Foundation of Ontario.	Batsis JA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-29; Blantz RC, 2007, CLIN J AM SOC NEPHRO, V2, P193, DOI 10.2215/CJN.00100107; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; D'Agostino RB, 2004, EVALUATION PERFORMAN, P1; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; Geddes CC, 1998, NEPHROL DIAL TRANSPL, V13, P67, DOI 10.1093/ndt/13.1.67; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P1151, DOI 10.1001/jama.2010.303; Jain AK, 2009, KIDNEY INT, V76, P318, DOI 10.1038/ki.2009.158; Johnson ES, 2008, AM J KIDNEY DIS, V52, P653, DOI 10.1053/j.ajkd.2008.04.026; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kent D, 2008, NEW ENGL J MED, V358, P1199; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Lasser KE, 2006, AM J PUBLIC HEALTH, V96, P1300, DOI 10.2105/AJPH.2004.059402; Leslie WD, 2010, ANN INTERN MED, V153, P580, DOI 10.7326/0003-4819-153-9-201011020-00007; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levin A, 2008, AM J KIDNEY DIS, V52, P661, DOI 10.1053/j.ajkd.2008.06.023; Mackinnon B, 2008, NEPHRON CLIN PRACT, V109, pC148, DOI 10.1159/000145458; Manns B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5869; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Muller-Riemenschneider F, 2010, ARCH INTERN MED, V170, P719, DOI 10.1001/archinternmed.2010.66; O'Hare AM, 2007, KIDNEY INT, V71, P555, DOI 10.1038/sj.ki.5002078; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; POZEN MW, 1984, NEW ENGL J MED, V310, P1273, DOI 10.1056/NEJM198405173102001; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Sarnak MJ, 2000, AM J KIDNEY DIS, V35, pS117, DOI 10.1016/S0272-6386(00)70239-3; Sarnak MJ, 2005, ANN INTERN MED, V142, P342, DOI 10.7326/0003-4819-142-5-200503010-00009; Schwarz S, 2006, CLIN J AM SOC NEPHRO, V1, P825, DOI 10.2215/CJN.02101205; Selker HP, 1998, ANN INTERN MED, V129, P845, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00002; Steyerberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Taal MW, 2008, KIDNEY INT, V73, P1216, DOI 10.1038/ki.2008.36; Taal MW, 2006, KIDNEY INT, V70, P1694, DOI 10.1038/sj.ki.5001794; van Steenkiste B, 2004, SCAND J PRIM HEALTH, V22, P32, DOI 10.1080/02813430310004489; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wilson PWF, 2008, CIRC-CARDIOVASC QUAL, V1, P92, DOI 10.1161/CIRCOUTCOMES.108.831198; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	43	673	692	4	50	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1553	1559		10.1001/jama.2011.451	http://dx.doi.org/10.1001/jama.2011.451			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21482743	Bronze			2022-12-28	WOS:000289683000024
J	Ezard, THG; Aze, T; Pearson, PN; Purvis, A				Ezard, Thomas H. G.; Aze, Tracy; Pearson, Paul N.; Purvis, Andy			Interplay Between Changing Climate and Species' Ecology Drives Macroevolutionary Dynamics	SCIENCE			English	Article							RED QUEEN; FOSSIL RECORD; COURT JESTER; EXTINCTION; DIVERSITY; TIME; FORAMINIFERA; ORIGINATION; EVOLUTION; MODELS	Ecological change provokes speciation and extinction, but our knowledge of the interplay among the biotic and abiotic drivers of macroevolution remains limited. Using the unparalleled fossil record of Cenozoic macroperforate planktonic foraminifera, we demonstrate that macroevolutionary dynamics depend on the interaction between species' ecology and the changing climate. This interplay drives diversification but differs between speciation probability and extinction risk: Speciation was more strongly shaped by diversity dependence than by climate change, whereas the reverse was true for extinction. Crucially, no single ecology was optimal in all environments, and species with distinct ecologies had significantly different probabilities of speciation and extinction. The ensuing macroevolutionary dynamics depend fundamentally on the ecological structure of species' assemblages.	[Ezard, Thomas H. G.; Purvis, Andy] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Ezard, Thomas H. G.] Univ Surrey, Dept Math, Fac Engn & Phys Sci, Surrey GU2 7XH, England; [Aze, Tracy; Pearson, Paul N.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, S Glam, Wales	Imperial College London; University of Surrey; Cardiff University	Ezard, THG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	t.ezard@surrey.ac.uk	Pearson, Paul N/B-2276-2009; Purvis, Andy/A-7529-2008	Pearson, Paul N/0000-0003-4628-9818; Purvis, Andy/0000-0002-8609-6204; Ezard, Thomas/0000-0001-8305-6605; Aze, Tracy/0000-0002-4201-7105	Natural Environment Research Council (UK) [NE/E015956/1]; NERC [NE/E015956/1, NE/E018165/1] Funding Source: UKRI; Natural Environment Research Council [NE/E018165/1, NE/E015956/1] Funding Source: researchfish	Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Natural Environment Research Council (UK) for funding (grant NE/E015956/1 to A. P. and P.N.P.) and G. Mace, T. Barraclough, N. Bunnefeld, L.-M. Chevin, T. Coulson, L. McInnes, I. Owens, A. Phillimore, G. Thomas, and two anonymous reviewers for insightful comments that improved our work. The data we analyzed are deposited as online appendices to (13).	Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Aze T, 2011, BIOL REV, V86, P900, DOI 10.1111/j.1469-185X.2011.00178.x; Barnosky AD, 2001, J VERTEBR PALEONTOL, V21, P172, DOI 10.1671/0272-4634(2001)021[0172:DTEOTR]2.0.CO;2; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; BERGGREN WA, 1995, SEPM SPEC P, pR5; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; De Roos AM, 2008, ECOL LETT, V11, P1, DOI 10.1111/j.1461-0248.2007.01121.x; Doran NA, 2006, PALAIOS, V21, P571, DOI 10.2110/palo.2006.p06-055r; Foote M, 1999, NATURE, V398, P415, DOI 10.1038/18872; Foote M, 2000, PALEOBIOLOGY, V26, P578, DOI 10.1666/0094-8373(2000)026<0578:OAECOT>2.0.CO;2; Hemleben C., 1991, Geologisches Jahrbuch Reihe A, V128, P117; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; NORRIS RD, 1992, PALAEOGEOGR PALAEOCL, V95, P1, DOI 10.1016/0031-0182(92)90161-W; Norris RD, 1996, PALEOBIOLOGY, V22, P461, DOI 10.1017/S0094837300016468; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Quental TB, 2010, TRENDS ECOL EVOL, V25, P434, DOI 10.1016/j.tree.2010.05.002; Sharpe FR, 1911, PHILOS MAG, V21, P435, DOI 10.1080/14786440408637050; Simpson G.G., 1961, PRINCIPLES ANIMAL TA, DOI DOI 10.7312/SIMP92414; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; VALENTINE JW, 1980, PALEOBIOLOGY, V6, P444, DOI 10.1017/S0094837300003614; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; Venditti C, 2010, NATURE, V463, P349, DOI 10.1038/nature08630; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	28	220	221	6	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					349	351		10.1126/science.1203060	http://dx.doi.org/10.1126/science.1203060			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493859	Green Submitted			2022-12-28	WOS:000289516600044
J	Han, DR; Pal, S; Nangreave, J; Deng, ZT; Liu, Y; Yan, H				Han, Dongran; Pal, Suchetan; Nangreave, Jeanette; Deng, Zhengtao; Liu, Yan; Yan, Hao			DNA Origami with Complex Curvatures in Three-Dimensional Space	SCIENCE			English	Article							NANOSCALE SHAPES; FOLDING DNA; FLEXIBILITY; DESIGN	We present a strategy to design and construct self-assembling DNA nanostructures that define intricate curved surfaces in three-dimensional (3D) space using the DNA origami folding technique. Double-helical DNA is bent to follow the rounded contours of the target object, and potential strand crossovers are subsequently identified. Concentric rings of DNA are used to generate in-plane curvature, constrained to 2D by rationally designed geometries and crossover networks. Out-of-plane curvature is introduced by adjusting the particular position and pattern of crossovers between adjacent DNA double helices, whose conformation often deviates from the natural, B-form twist density. A series of DNA nanostructures with high curvature-such as 2D arrangements of concentric rings and 3D spherical shells, ellipsoidal shells, and a nanoflask-were assembled.	[Han, Dongran; Pal, Suchetan; Nangreave, Jeanette; Deng, Zhengtao; Liu, Yan; Yan, Hao] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Han, Dongran; Pal, Suchetan; Nangreave, Jeanette; Deng, Zhengtao; Liu, Yan; Yan, Hao] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Han, DR (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	dongran.han@asu.edu; yan_liu@asu.edu; hao.yan@asu.edu	Deng, Zhengtao/F-8581-2010; Pal, Suchetan/D-3653-2012; Liu, Yan/K-1999-2014; Pal, Suchetan/R-5525-2019	Deng, Zhengtao/0000-0002-8428-8982; Pal, Suchetan/0000-0001-8291-2844; Liu, Yan/0000-0003-0906-2606; Pal, Suchetan/0000-0002-6323-7502	Office of Naval Research; Army Research Office; National Science Foundation; Department of Energy; National Institutes of Health; Sloan Research Foundation; Arizona State University; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001016]	Office of Naval Research(Office of Naval Research); Army Research Office; National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Research Foundation; Arizona State University; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank the AFM applications group at Bruker Nanosurfaces for assistance in acquiring some of the high-resolution AFM images, using Peak Force Tapping with ScanAsyst on the MultiMode 8. This research was partly supported by grants from the Office of Naval Research, Army Research Office, National Science Foundation, Department of Energy, and National Institutes of Health to H.Y. and Y.L. and from the Sloan Research Foundation to H.Y. Y.L. and H.Y. were supported by the Technology and Research Initiative Fund from Arizona State University and as part of the Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC0001016.	Aldaye FA, 2007, J AM CHEM SOC, V129, P13376, DOI 10.1021/ja075966q; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Lin C, 2009, BIOCHEMISTRY-US, V48, P1663, DOI 10.1021/bi802324w; Mathieu F, 2005, NANO LETT, V5, P661, DOI 10.1021/nl050084f; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105	20	854	906	31	785	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					342	346		10.1126/science.1202998	http://dx.doi.org/10.1126/science.1202998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493857				2022-12-28	WOS:000289516600042
J	Tang, YQ; Cohen, AE				Tang, Yiqiao; Cohen, Adam E.			Enhanced Enantioselectivity in Excitation of Chiral Molecules by Superchiral Light	SCIENCE			English	Article							DETECTED CIRCULAR-DICHROISM; PLASMON-RESONANCE; OPTICAL-ACTIVITY; FIELDS	A molecule or larger body is chiral if it cannot be superimposed on its mirror image (enantiomer). Electromagnetic fields may be chiral, too, with circularly polarized light (CPL) as the paradigmatic example. A recently introduced measure of the local degree of chiral dissymmetry in electromagnetic fields suggested the existence of optical modes more selective than circularly polarized plane waves in preferentially exciting single enantiomers in certain regions of space. By probing induced fluorescence intensity, we demonstrated experimentally an 11-fold enhancement over CPL in discrimination of the enantiomers of a biperylene derivative by precisely sculpted electromagnetic fields. This result, which agrees to within 15% with theoretical predictions, establishes that optical chirality is a fundamental and tunable property of light, with possible applications ranging from plasmonic sensors to absolute asymmetric synthesis.	[Tang, Yiqiao; Cohen, Adam E.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Cohen, Adam E.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Cohen, AE (corresponding author), Harvard Univ, Dept Phys, 12 Oxford St, Cambridge, MA 02138 USA.	cohen@chemistry.harvard.edu			Nano-Enabled Technology Initiative of MITRE Corporation; Defense Advanced Research Projects Agency; Office of Naval Research; Harvard Center for Nanoscale Systems	Nano-Enabled Technology Initiative of MITRE Corporation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research(Office of Naval Research); Harvard Center for Nanoscale Systems	We thank H. Langhals for the chiral biperylene compound and L. Men for help with the figures. Financial support was provided by the Nano-Enabled Technology Initiative of MITRE Corporation, a Defense Advanced Research Projects Agency Young Faculty Award, the Office of Naval Research Young Investigator Program, and the Harvard Center for Nanoscale Systems.	Aeschlimann M, 2007, NATURE, V446, P301, DOI 10.1038/nature05595; Autschbach J, 2002, J CHEM PHYS, V116, P6930, DOI 10.1063/1.1436466; Barron L. D., 2004, MOL LIGHT SCATTERING, V2nd; BARRON LD, 1972, NATURE, V238, P17, DOI 10.1038/238017a0; Berova N., 2000, CIRCULAR DICHROISM P, DOI DOI 10.1038/natrevmats.2016.21; Drachev VP, 2001, J OPT SOC AM B, V18, P1896, DOI 10.1364/JOSAB.18.001896; Fedotov VA, 2007, NANO LETT, V7, P1996, DOI 10.1021/nl0707961; Hendry E, 2010, NAT NANOTECHNOL, V5, P783, DOI [10.1038/nnano.2010.209, 10.1038/NNANO.2010.209]; KIBBLE TWB, 1965, J MATH PHYS, V6, P1022, DOI 10.1063/1.1704363; Langhals H, 1997, LIEBIGS ANN-RECL, P1151; Lieberman I, 2008, ANGEW CHEM INT EDIT, V47, P4855, DOI 10.1002/anie.200800231; LIPKIN DM, 1964, J MATH PHYS, V5, P696, DOI 10.1063/1.1704165; MASON SF, 1982, MOL OPTICAL ACTIVITY; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Rosenfeld L., 1928, Z PHYS, V52, P161, DOI DOI 10.1007/BF01342393; Shapiro M, 2003, REP PROG PHYS, V66, P859, DOI 10.1088/0034-4885/66/6/201; STEPHENS PJ, 1985, J PHYS CHEM-US, V89, P748, DOI 10.1021/j100251a006; Tang YQ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.163901; Tang YQ, 2009, J PHYS CHEM A, V113, P6213, DOI 10.1021/jp903598t; TURNER DH, 1974, J AM CHEM SOC, V96, P4340, DOI 10.1021/ja00820a057; Yang N, 2011, J PHYS CHEM B, V115, P5304, DOI 10.1021/jp1092898; Yang N, 2009, NANO TODAY, V4, P269, DOI 10.1016/j.nantod.2009.05.001	22	460	468	24	397	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					333	336		10.1126/science.1202817	http://dx.doi.org/10.1126/science.1202817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493854				2022-12-28	WOS:000289516600039
J	Ross, JJ; Rogal, SS; Ukomadu, C				Ross, John J; Rogal, Shari S; Ukomadu, Chinweike			A Sweet Source of Abdominal Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					E30	E30		10.1056/NEJMimc1013484	http://dx.doi.org/10.1056/NEJMimc1013484			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LD	21488761				2022-12-28	WOS:000289467200043
J	Hawkins, WG; Alseidi, A				Hawkins, William G.; Alseidi, Adnan			DISPACT trial: what do we learn from equivalency?	LANCET			English	Editorial Material							INTERNATIONAL STUDY-GROUP; PANCREATIC FISTULA; METAANALYSIS		[Hawkins, William G.; Alseidi, Adnan] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA	Washington University (WUSTL)	Hawkins, WG (corresponding author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.	hawkinsw@wustl.edu		alseidi, adnan/0000-0002-0365-1955				Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Connor S, 2005, BRIT J SURG, V92, P1059, DOI 10.1002/bjs.5107; Diener MK, 2011, LANCET, V377, P1514, DOI 10.1016/S0140-6736(11)60237-7; Knaebel HP, 2005, BRIT J SURG, V92, P539, DOI 10.1002/bjs.5000; Pratt WB, 2007, ANN SURG, V245, P443, DOI 10.1097/01.sla.0000251708.70219.d2; Thaker RI, 2007, J GASTROINTEST SURG, V11, P59, DOI 10.1007/s11605-006-0042-6; Zhou W, 2010, AM J SURG, V200, P529, DOI 10.1016/j.amjsurg.2009.12.022	7	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2011	377	9776					1470	1471		10.1016/S0140-6736(11)60514-X	http://dx.doi.org/10.1016/S0140-6736(11)60514-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761RX	21529929				2022-12-28	WOS:000290419400006
J	Hambleton, S; Salem, S; Bustamante, J; Bigley, V; Boisson-Dupuis, S; Azevedo, J; Fortin, A; Haniffa, M; Ceron-Gutierrez, L; Bacon, CM; Menon, G; Trouillet, C; McDonald, D; Carey, P; Ginhoux, F; Alsina, L; Zumwalt, TJ; Kong, XF; Kumararatne, D; Butler, K; Hubeau, M; Feinberg, J; Al-Muhsen, S; Cant, A; Abel, L; Chaussabel, D; Doffinger, R; Talesnik, E; Grumach, A; Duarte, A; Abarca, K; Moraes-Vasconcelos, D; Burk, D; Berghuis, A; Geissmann, F; Collin, M; Casanova, JL; Gros, P				Hambleton, Sophie; Salem, Sandra; Bustamante, Jacinta; Bigley, Venetia; Boisson-Dupuis, Stephanie; Azevedo, Joana; Fortin, Anny; Haniffa, Muzlifah; Ceron-Gutierrez, Lourdes; Bacon, Chris M.; Menon, Geetha; Trouillet, Celine; McDonald, David; Carey, Peter; Ginhoux, Florent; Alsina, Laia; Zumwalt, Timothy J.; Kong, Xiao-Fei; Kumararatne, Dinakantha; Butler, Karina; Hubeau, Marjorie; Feinberg, Jacqueline; Al-Muhsen, Saleh; Cant, Andrew; Abel, Laurent; Chaussabel, Damien; Doffinger, Rainer; Talesnik, Eduardo; Grumach, Anete; Duarte, Alberto; Abarca, Katia; Moraes-Vasconcelos, Dewton; Burk, David; Berghuis, Albert; Geissmann, Frederic; Collin, Matthew; Casanova, Jean-Laurent; Gros, Philippe			IRF8 Mutations and Human Dendritic-Cell Immunodeficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGULATORY FACTOR-8; MOUSE; ICSBP; TUBERCULOSIS; MACROPHAGES; RESPONSES; IMMUNITY; REVEALS; BINDING; MICE	BACKGROUND The genetic analysis of human primary immunodeficiencies has defined the contribution of specific cell populations and molecular pathways in the host defense against infection. Disseminated infection caused by bacille Calmette-Guerin (BCG) vaccines is an early manifestation of primary immunodeficiencies, such as severe combined immunodeficiency. In many affected persons, the cause of disseminated BCG disease is unexplained. METHODS We evaluated an infant presenting with features of severe immunodeficiency, including early-onset disseminated BCG disease, who required hematopoietic stem-cell transplantation. We also studied two otherwise healthy subjects with a history of disseminated but curable BCG disease in childhood. We characterized the monocyte and dendritic-cell compartments in these three subjects and sequenced candidate genes in which mutations could plausibly confer susceptibility to BCG disease. RESULTS We detected two distinct disease-causing mutations affecting interferon regulatory factor 8 (IRF8). Both K108E and T80A mutations impair IRF8 transcriptional activity by disrupting the interaction between IRF8 and DNA. The K108E variant was associated with an autosomal recessive severe immunodeficiency with a complete lack of circulating monocytes and dendritic cells. The T80A variant was associated with an autosomal dominant, milder immunodeficiency and a selective depletion of CD11c+CD1c+ circulating dendritic cells. CONCLUSIONS These findings define a class of human primary immunodeficiencies that affect the differentiation of mononuclear phagocytes. They also show that human IRF8 is critical for the development of monocytes and dendritic cells and for antimycobacterial immunity. (Funded by the Medical Research Council and others.)	[Hambleton, Sophie; Bigley, Venetia; Haniffa, Muzlifah; McDonald, David; Cant, Andrew; Collin, Matthew] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bacon, Chris M.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bacon, Chris M.; Menon, Geetha] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Cellular Pathol, Newcastle Upon Tyne, Tyne & Wear, England; [Carey, Peter] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Haematol, Newcastle Upon Tyne, Tyne & Wear, England; [Azevedo, Joana; Trouillet, Celine; Ginhoux, Florent] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England; [Ceron-Gutierrez, Lourdes; McDonald, David; Doffinger, Rainer] Addenbrookes Hosp, Dept Clin Immunol, Cambridge, England; [Salem, Sandra; Fortin, Anny; Burk, David; Berghuis, Albert; Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Bustamante, Jacinta; Boisson-Dupuis, Stephanie; Haniffa, Muzlifah; Feinberg, Jacqueline; Abel, Laurent; Casanova, Jean-Laurent] INSERM, U980, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [Bustamante, Jacinta; Boisson-Dupuis, Stephanie; Haniffa, Muzlifah; Feinberg, Jacqueline; Abel, Laurent; Casanova, Jean-Laurent] Univ Paris 05, Necker Med Sch, Paris, France; [Boisson-Dupuis, Stephanie; Kong, Xiao-Fei; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA; [Ginhoux, Florent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Alsina, Laia; Zumwalt, Timothy J.; Chaussabel, Damien] Baylor Inst Immunol Res, Dallas, TX USA; [Alsina, Laia; Zumwalt, Timothy J.; Chaussabel, Damien] Baylor Res Inst, Dallas, TX USA; [Alsina, Laia] Univ Barcelona, Allergy & Clin Immunol Dept, Hosp St Joan Deu, Barcelona, Spain; [Zumwalt, Timothy J.] Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA; [Butler, Karina] Our Ladys Childrens Hosp, Dublin, Ireland; [Al-Muhsen, Saleh; Casanova, Jean-Laurent] King Saud Univ, Coll Med, Dept Pediat, Prince Naif Ctr Immunol Res, Riyadh 11461, Saudi Arabia; [Talesnik, Eduardo; Abarca, Katia] Pontificia Univ Catolica Chile, Santiago, Chile; [Grumach, Anete; Duarte, Alberto; Moraes-Vasconcelos, Dewton] Univ Sao Paulo, Dept Dermatol, Sch Med, Lab Invest Dermatol & Immunodeficiencies, Sao Paulo, Brazil	Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Baylor Scott & White Health; Baylor Scott & White Health; Baylor University Medical Center; University of Barcelona; Baylor University; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; King Saud University; Pontificia Universidad Catolica de Chile; Universidade de Sao Paulo	Collin, M (corresponding author), Newcastle Univ, Inst Cellular Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	matthew.collin@newcastle.ac.uk; casanova@rockefeller.edu; philippe.gros@mcgill.ca	Rivet, Catherine A/M-7978-2014; Moraes-Vasconcelos, Dewton/G-2209-2012; Bigley, Venetia/AAU-9738-2020; Al-muhsen, saleh/E-9315-2014; Berghuis, Albert M/A-6495-2008; Alsina, Laia/AID-4372-2022; ABARCA, KATIA/HDM-9351-2022; Chaussabel, Damien/AAX-1909-2020; Bustamante, Jacinta/H-7877-2017; KONG, Xiao-Fei/G-3437-2011; Abel, Laurent/H-8888-2017; Grumach, Anete S/I-3430-2014; Boisson-Dupuis, Stephanie/AAF-5066-2021; Boisson-Dupuis, Stéphanie/I-2040-2017; Casanova, Jean-Laurent/I-3418-2017; Alsina, Laia/GQI-3516-2022	Moraes-Vasconcelos, Dewton/0000-0002-3930-3354; Bigley, Venetia/0000-0002-3017-2474; Al-muhsen, saleh/0000-0003-3698-9968; Bustamante, Jacinta/0000-0002-3439-2482; Abel, Laurent/0000-0001-7016-6493; Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Chaussabel, Damien/0000-0002-6131-7242; Grumach, Anete/0000-0002-9803-0309; Kong, Xiao-Fei/0000-0001-9983-2373; Bacon, Chris/0000-0002-8268-2812; Casanova, Jean-Laurent/0000-0002-7782-4169; geissmann, frederic/0000-0001-5029-2468; Berghuis, Albert/0000-0002-2663-025X; Alsina, Laia/0000-0002-3559-0018	Medical Research Council [G0701897, G0800358, G0900867]; National Institutes of Health [AI035237, AI089970]; Canadian Institutes of Health Research [MOP106424]; Agence Nationale de la Recherche (ANR); St. Giles Foundation; Jeffrey Modell Foundation; Talecris Biotherapeutics; Rockefeller University Center for Clinical and Translational Science [5UL1RR024143-03]; European Union [HOMITB-CEE E08153KK, NEOTIM 018736]; March of Dimes [RO5050KK]; Wellcome Trust [WT088555MA]; Leukaemia and Lymphoma Research Fund [LRF060169]; Arthritis Research UK Chair in Inflammation Biology; Medical Research Council; European Research Council [ERC 2010-StG 261299]; Fundacao Calouste Gulbenkian; Fundacao Champalimaud; Ministerio da Saude e Fundacao para a Ciencia e Tecnologia, Portugal; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089970, R37AI095983, R01AI035237] Funding Source: NIH RePORTER; MRC [G0900867, G0800358, G0701897] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); St. Giles Foundation; Jeffrey Modell Foundation; Talecris Biotherapeutics; Rockefeller University Center for Clinical and Translational Science; European Union(European Commission); March of Dimes(March of Dimes); Wellcome Trust(Wellcome Trust); Leukaemia and Lymphoma Research Fund; Arthritis Research UK Chair in Inflammation Biology(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Fundacao Calouste Gulbenkian(European Commission); Fundacao Champalimaud; Ministerio da Saude e Fundacao para a Ciencia e Tecnologia, Portugal; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by fellowships from the Medical Research Council (G0701897, to Dr. Hambleton, and G0800358, to Dr. Bigley); by grants from the National Institutes of Health (AI035237, to Dr. Gros) and the Canadian Institutes of Health Research (MOP106424, to Dr. Gros); by institutional grants to Institut National de la Sante et de la Recherche Medicale (INSERM) U980 and Rockefeller University; by grants from the Agence Nationale de la Recherche (ANR), the St. Giles Foundation, the Jeffrey Modell Foundation, Talecris Biotherapeutics, the Rockefeller University Center for Clinical and Translational Science (5UL1RR024143-03), the European Union (HOMITB-CEE E08153KK) and (NEOTIM 018736), the March of Dimes (RO5050KK), and the National Institutes of Health (AI089970, to Dr. Casanova); a Wellcome Trust fellowship (WT088555MA, to Dr. Haniffa); a grant from the Leukaemia and Lymphoma Research Fund (LRF060169, to Dr. Collin); an Arthritis Research UK Chair in Inflammation Biology (to Dr. Geissmann); a program grant (G0900867) from the Medical Research Council, and a European Research Council investigator award (ERC 2010-StG 261299, to Dr. Geissmann); and a grant from the Gulbenkian Programme for Advanced Medical Education, sponsored by Fundacao Calouste Gulbenkian, Fundacao Champalimaud, Ministerio da Saude e Fundacao para a Ciencia e Tecnologia, Portugal (to Dr. Azevedo).	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Alter-Koltunoff M, 2008, J BIOL CHEM, V283, P2724, DOI 10.1074/jbc.M707704200; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; CASANOVA JL, 1995, LANCET, V346, P581, DOI 10.1016/S0140-6736(95)91421-8; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; Fischer A, 2007, IMMUNITY, V27, P835, DOI 10.1016/j.immuni.2007.11.012; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fortier A, 2009, INFECT IMMUN, V77, P4794, DOI 10.1128/IAI.01546-08; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kubosaki A, 2010, MOL IMMUNOL, V47, P2295, DOI 10.1016/j.molimm.2010.05.289; Marquis JF, 2009, J IMMUNOL, V182, P3008, DOI 10.4049/jimmunol.0800680; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Merad M, 2003, NAT IMMUNOL, V4, P92, DOI 10.1038/ni0103-92; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Turcotte K, 2007, J IMMUNOL, V179, P2467, DOI 10.4049/jimmunol.179.4.2467; Ulrichs T, 2003, INFECT IMMUN, V71, P3076, DOI 10.1128/IAI.71.6.3076-3087.2003; Vinh DC, 2010, BLOOD, V115, P1519, DOI 10.1182/blood-2009-03-208629	34	420	426	3	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					127	138		10.1056/NEJMoa1100066	http://dx.doi.org/10.1056/NEJMoa1100066			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SP	21524210	Green Accepted			2022-12-28	WOS:000292685500009
J	Coriat, R; Mir, O; Ropert, S; Clerc, J; Goldwasser, F				Coriat, Romain; Mir, Olivier; Ropert, Stanislas; Clerc, Jerome; Goldwasser, Francois			A painful cranial bulge	LANCET			English	Editorial Material									[Coriat, Romain; Mir, Olivier; Ropert, Stanislas; Goldwasser, Francois] Univ Paris 05, Hop Cochin, Dept Med Oncol, Ctr Res Angiogenesis Inhibitors CERIA, Paris, France; [Clerc, Jerome] Univ Paris 05, Hop Cochin, Dept Nucl Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Coriat, R (corresponding author), Univ Paris 05, Cochin Teaching Hosp, Dept Med Oncol, Ctr Res Angiogenesis Inhibitors CERIA, Paris, France.	romain.coriat@cch.aphp.fr	Coriat, Romain/O-7902-2017; Mir, Olivier/GNP-7828-2022; Goldwasser, François/P-4861-2017	Mir, Olivier/0000-0002-6761-4002; clerc, jerome/0000-0002-9089-3628					0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 21	2011	377	9779					1777	1777		10.1016/S0140-6736(10)61089-6	http://dx.doi.org/10.1016/S0140-6736(10)61089-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771AS	21481926				2022-12-28	WOS:000291130200036
J	Goldenberg, RL; McClure, EM; Bhutta, ZA; Belizan, JM; Reddy, UM; Rubens, CE; Mabeya, H; Flenady, V; Darmstadt, GL				Goldenberg, Robert L.; McClure, Elizabeth M.; Bhutta, Zulfiqar A.; Belizan, Jose M.; Reddy, Uma M.; Rubens, Craig E.; Mabeya, Hillary; Flenady, Vicki; Darmstadt, Gary L.		Lancet's Stillbirths Series Steeri	Stillbirths 6 Stillbirths: the vision for 2020	LANCET			English	Article							MATERNAL MORTALITY; NEONATAL DEATHS; OBSTETRIC CARE; BIRTH; PREVENTION	Stillbirth is a common adverse pregnancy outcome, with nearly 3 million third-trimester stillbirths occurring worldwide each year. 98% occur in low-income and middle-income countries, and more than 1 million stillbirths occur in the intrapartum period, despite many being preventable. Nevertheless, stillbirth is practically unrecognised as a public health issue and few data are reported. In this final paper in the Stillbirths Series, we call for inclusion of stillbirth as a recognised outcome in all relevant international health reports and initiatives. We ask every country to develop and implement a plan to improve maternal and neonatal health that includes a reduction in stillbirths, and to count stillbirths in their vital statistics and other health outcome surveillance systems. We also ask for increased investment in stillbirth-related research, and especially research aimed at identifying and addressing barriers to the aversion of stillbirths within the maternal and neonatal health systems of low-income and middle-income countries. Finally, we ask all those interested in reducing stillbirths to join with advocates for the improvement of other pregnancy-related outcomes, for mothers and their offspring, so that a united front for improved pregnancy and neonatal care for all will become a reality.	[Goldenberg, Robert L.] Drexel Univ, Coll Med, Dept Obstet & Gynecol, Philadelphia, PA 19102 USA; [McClure, Elizabeth M.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Bhutta, Zulfiqar A.] Aga Khan Univ, Div Women & Child Hlth, Karachi, Pakistan; [Belizan, Jose M.] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Reddy, Uma M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Rubens, Craig E.] Global Alliance Prevent Prematur & Stillbirth, Seattle, WA USA; [Mabeya, Hillary] Moi Univ, Eldoret, Kenya; [Flenady, Vicki] Mater Med Res Inst, Brisbane, Qld, Australia; [Flenady, Vicki] Int Stillbirth Alliance, Baltimore, MD USA; [Flenady, Vicki] Univ Queensland, Brisbane, Qld, Australia; [Darmstadt, Gary L.] Bill & Melinda Gates Fdn, Global Hlth Program, Family Hlth Div, Seattle, WA USA	Drexel University; University of North Carolina; University of North Carolina Chapel Hill; Aga Khan University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Moi University; Mater Research; University of Queensland; Bill & Melinda Gates Foundation	Goldenberg, RL (corresponding author), Drexel Univ, Coll Med, Dept Obstet & Gynecol, 245 N 15th St,17th Floor,Room 17113, Philadelphia, PA 19102 USA.	rgoldenb@drexelmed.edu	Frøen, J. Frederik/C-3271-2009; Darmstadt, Gary/AAU-7488-2020; Flenady, Vicki Jane/O-9609-2014; Lawn, Joy/ABE-6382-2020; Mabeya, Hillary/HHC-7512-2022	Flenady, Vicki Jane/0000-0001-8114-7677; Lawn, Joy/0000-0002-4573-1443; McClure, Elizabeth/0000-0001-8659-5444; Froen Froen, Jahn Frederik/0000-0001-9390-8509; Darmstadt, Gary/0000-0002-7522-5824; Belizan, Jose/0000-0002-8412-3010	Bill & Melinda Gates Foundation; Global Alliance to Prevent Prematurity and Stillbirth; International Stillbirth Alliance; Partnership for Maternal, Newborn and Child Health; National Institute of Child Health and Human Development Global Network; Research Triangle Institute, Research Triangle Park, NC, USA	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Global Alliance to Prevent Prematurity and Stillbirth; International Stillbirth Alliance; Partnership for Maternal, Newborn and Child Health; National Institute of Child Health and Human Development Global Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Research Triangle Institute, Research Triangle Park, NC, USA	We thank Joy E Lawn, Robert Pattinson, and J Frederik Froen for their extensive contributions to this article, and the Bill & Melinda Gates Foundation, the Global Alliance to Prevent Prematurity and Stillbirth, the International Stillbirth Alliance, and the Partnership for Maternal, Newborn and Child Health for their financial support to The Lancet's Stillbirths Series. CER has received funding from the Bill & Melinda Gates Foundation, and support for RLG and EMM was provided by the National Institute of Child Health and Human Development Global Network, and the Maternal and Neonatal Directed Assessment of Technology project of the Research Triangle Institute, Research Triangle Park, NC, USA.	[Anonymous], 1996, GLOBAL BURDEN DIS CO; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Darmstadt GL, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S6; Darmstadt GL, 2009, INT J GYNECOL OBSTET, V107, pS89, DOI 10.1016/j.ijgo.2009.07.010; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P417, DOI 10.1111/j.1365-3016.2008.00962.x; Engmann C, 2009, TROP MED INT HEALTH, V14, P1496, DOI 10.1111/j.1365-3156.2009.02395.x; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Fretts RC, 2005, AM J OBSTET GYNECOL, V193, P1923, DOI 10.1016/j.ajog.2005.03.074; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; GOLDENBERG RL, 1987, OBSTET GYNECOL, V70, P831; Goldenberg RL, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S1; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Jehan I, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.012; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Luo ZC, 2008, PAEDIATR PERINAT EP, V22, P341, DOI 10.1111/j.1365-3016.2008.00938.x; McClure EM, 2007, INT J GYNECOL OBSTET, V96, P139, DOI 10.1016/j.ijgo.2006.10.010; McClure EM, 2009, J MATERN-FETAL NEO M, V22, P183, DOI 10.1080/14767050802559129; O'Rourke K, 1998, Rev Panam Salud Publica, V3, P9; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Sibley L, 2004, SOC SCI MED, V59, P1757, DOI 10.1016/j.socscimed.2004.02.009; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; Sibley LM, 2006, J HEALTH POPUL NUTR, V24, P472; Silver RM, 2007, AM J OBSTET GYNECOL, V196, P433, DOI 10.1016/j.ajog.2006.11.041; Sloan NL, 2005, J MIDWIFERY WOM HEAL, V50, P315, DOI 10.1016/j.jmwh.2004.08.018; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Tebeu PM, 2009, INT J GYNECOL OBSTET, V107, P12, DOI 10.1016/j.ijgo.2009.05.019; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; Walker R, 2002, BIRTH-ISS PERINAT C, V29, P28, DOI 10.1046/j.1523-536X.2002.00153.x; *WHO, 2004, ICD 10 INT STAT CLAS, V2; WHO UNICEF, 2010, COUNTD 2015 DEC REP; Willinger M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.057; Woods R, 2008, B WORLD HEALTH ORGAN, V86, P460, DOI 10.2471/BLT.07.043471; World Health Organization (WHO), 2007, NEON PER MORT COUNTR; YUDKIN PL, 1987, LANCET, V1, P1192	43	110	118	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2011	377	9779					1798	1805		10.1016/S0140-6736(10)62235-0	http://dx.doi.org/10.1016/S0140-6736(10)62235-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771AS	21496912				2022-12-28	WOS:000291130200038
J	Roestenberg, M; Teirlinck, AC; McCall, MBB; Teelen, K; Makamdop, KN; Wiersma, J; Arens, T; Beckers, P; van Gemert, G; van de Vegte-Bolmer, M; van der Ven, AJAM; Luty, AJF; Hermsen, CC; Sauerwein, RW				Roestenberg, Meta; Teirlinck, Anne C.; McCall, Matthew B. B.; Teelen, Karina; Makamdop, Krystelle Nganou; Wiersma, Jorien; Arens, Theo; Beckers, Pieter; van Gemert, GeertJan; van de Vegte-Bolmer, Marga; van der Ven, Andre J. A. M.; Luty, Adrian J. F.; Hermsen, Cornelus C.; Sauerwein, Robert W.			Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study	LANCET			English	Article							PLASMODIUM-FALCIPARUM MALARIA; VON-WILLEBRAND-FACTOR; VACCINE DEVELOPMENT; BLOOD-STAGE; INFECTION; RESPONSES; IMMUNITY; CHALLENGE; MEMORY	Background We have shown that immunity to infection with Plasmodium falciparum can be induced experimentally in malaria-naive volunteers through immunisation by bites of infected mosquitoes while simultaneously preventing disease with chloroquine prophylaxis. This immunity was associated with parasite-specific production of interferon gamma and interleukin 2 by pluripotent effector memory cells in vitro. We aim to explore the persistence of protection and immune responses in the same volunteers. Methods In an open-label study at the Radboud University Nijmegen Medical Centre (Nijmegen, Netherlands), from November to December, 2009, we rechallenged previously immune volunteers (28 months after immunisation) with the bites of five mosquitoes infected with P falciparum. Newly recruited malaria-naive volunteers served as infection controls. Our primary outcome was the detection of blood-stage parasitaemia by microscopy. We assessed the kinetics of parasitaemia with real-time quantitative PCR (rtPCR) and recorded clinical signs and symptoms. In-vitro production of interferon gamma and interleukin 2 by effector memory T cells was studied after stimulation with sporozoites and red blood cells infected with P falciparum. Differences in cellular immune responses between the study groups were assessed with the Mann-Whitney test. This study is registered with ClinicalTrials.gov, number NCT00757887. Findings Four of six immune volunteers were microscopically negative after rechallenge. rtPCR-based detection of blood-stage parasites in these individuals was negative throughout follow-up. Patent parasitaemia was delayed in the remaining two immunised volunteers. In-vitro assays showed the long-term persistence of parasite-specific pluripotent effector memory T-cell responses in protected volunteers. The four protected volunteers reported several mild to moderate adverse events, of which the most commonly reported symptom was headache (one to three episodes per volunteer). The two patients with delayed patency had adverse events similar to those in the control group. Interpretation Artificially induced immunity lasts longer than generally recorded after natural exposure; providing a new avenue of research into the mechanisms of malaria immunity.	[Roestenberg, Meta; Teirlinck, Anne C.; McCall, Matthew B. B.; Teelen, Karina; Makamdop, Krystelle Nganou; Wiersma, Jorien; Beckers, Pieter; van Gemert, GeertJan; van de Vegte-Bolmer, Marga; Luty, Adrian J. F.; Hermsen, Cornelus C.; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; [van der Ven, Andre J. A. M.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Sauerwein, RW (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	r.sauerwein@mmb.umcn.nl	Luty, Adrian/CAH-2547-2022; Sauerwein, Robert/C-8519-2013; Hermsen, C.C./L-4368-2015; van der Ven, A.J.A.M./H-8102-2014; Roestenberg, Meta/AAP-9413-2021	van der Ven, A.J.A.M./0000-0003-1833-3391; Roestenberg, Meta/0000-0002-5052-2830; McCall, Matthew/0000-0002-5738-1401; Luty, Adrian John Frederick/0000-0001-8830-3425	European Malaria Vaccine Development Association; European Union; Netherlands Organisation for Scientific Research	European Malaria Vaccine Development Association; European Union(European Commission); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	ACT is funded by the European Malaria Vaccine Development Association, MBBM was supported by a European Union FP6 Network of Excellence (BioMalPar) fellowship, KNM was funded by a Mozaiek grant from the Netherlands Organisation for Scientific Research. We thank the trial volunteers and the staff from the Clinical Research Centre Nijmegen who made this study possible. We thank the following individuals for their assistance during the trial: Laura Pelser, Jolanda Klaassen, Astrid Pouwelsen, and Jacqueline Kuhnen for the mosquito infection and dissection work, Wendy Arts, Nanny Huiberts, Chantal Siebes, Marlou Kooreman, Paul Daemen, and Ella Driessen for reading many thick smears. We acknowledge Alexander Rennings for his help with monitoring volunteer safety and Gheorghe Pop and Marc Brouwer for their cardiac monitoring of the trial volunteers. We acknowledge Richard Huijbens for the cytokine measurements by Luminex. We thank Rob Woestenenk for use and support of the flow cytotneter.	Achtman AH, 2005, CURR TOP MICROBIOL, V297, P71; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Bejon P, 2007, J IMMUNOL, V179, P4193, DOI 10.4049/jimmunol.179.6.4193; Bousema JT, 2006, AM J TROP MED HYG, V74, P425; Broen K, 2007, MOL BIOCHEM PARASIT, V151, P1, DOI 10.1016/j.molbiopara.2006.10.001; Claus RA, 2010, CURR MOL MED, V10, P236, DOI 10.2174/156652410790963367; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; de Mast Q, 2007, J INFECT DIS, V196, P622, DOI 10.1086/519844; DELORON P, 1992, PARASITOL TODAY, V8, P375, DOI 10.1016/0169-4758(92)90174-Z; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; JEFFERY GM, 1966, B WORLD HEALTH ORGAN, V35, P873; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; Morel CM, 2005, BMJ-BRIT MED J, V331, P1299, DOI 10.1136/bmj.38639.702384.AE; Nieman AE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-277; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Sauerwein RW, 2010, CURR OPIN IMMUNOL, V22, P367, DOI 10.1016/j.coi.2010.04.001; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713; WHO Global Malaria Programme, 2010, WORLD MAL REP 2010	28	203	209	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 21	2011	377	9779					1770	1776		10.1016/S0140-6736(11)60360-7	http://dx.doi.org/10.1016/S0140-6736(11)60360-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771AS	21514658				2022-12-28	WOS:000291130200035
J	Eddy, DM; Adler, J; Patterson, B; Lucas, D; Smith, KA; Morris, M				Eddy, David M.; Adler, Joshua; Patterson, Bradley; Lucas, Don; Smith, Kurt A.; Morris, Macdonald			Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-PRACTICE GUIDELINES; CARDIOVASCULAR-DISEASE; STATIN TREATMENT; PREVENTION; ARCHIMEDES; RISK; CARE; OUTCOMES; PROFILE; IMPACT	Background: Current guidelines focus on a particular risk factor and specify criteria for categorizing persons into a small number of treatment groups. Objective: To compare current guidelines with individualized guidelines (that use readily available characteristics from each person to calculate the risk reduction expected from treatment and to identify persons for treatment in ranked order of decreasing expected benefit), in the context of blood pressure management. Design: Analysis of person-specific, longitudinal data. Setting: The ARIC (Atherosclerosis Risk in Communities) Study. Participants: Persons aged 45 to 64 years without preexisting cardiovascular disease who currently do not receive antihypertensive treatment. Intervention: Treatment according to the criteria of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7 guidelines); individualized guidelines, or treatment in decreasing order of expected benefit; and random care, or treatment of persons selected at random. Measurements: Number of myocardial infarctions (MIs) and strokes and medical costs. Results: Compared with treating people according to random care, individualized guidelines could prevent the same number of MIs and strokes as JNC 7 guidelines at savings that are 67% greater than using JNC 7 guidelines, or it could prevent 43% more MIs and strokes for the same cost as treatment according to JNC 7 guidelines. The superiority of individualized guidelines was not sensitive to a wide range of assumptions about costs, treatment effectiveness, level of risk for cardiovascular disease in the population, or effects on workflow. The degree of superiority was sensitive to the accuracy of the method used to rank patients and to its span (the proportion of the population for whom all of the outcomes of interest can be calculated). Limitations: Specific results apply to the effects of blood pressure management on MI and stroke in the ARIC Study population. The methods for calculating individual benefits require quantitative evidence about the relationships among risk factors, long-term outcomes, and treatment effects. Conclusion: Use of individualized guidelines can help to increase the quality and reduce the cost of care.	[Eddy, David M.; Adler, Joshua; Patterson, Bradley; Lucas, Don; Smith, Kurt A.; Morris, Macdonald] Archimedes, San Francisco, CA USA		Eddy, DM (corresponding author), 201 Mission St,29th Floor, San Francisco, CA 94105 USA.	author@archimedesmodel.com			National Heart, Lung, and Blood Institute; ARIC study investigators	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ARIC study investigators	The ARIC Study is conducted and supported by the National Heart, Lung, and Blood Institute in collaboration with the ARIC study investigators. This article was prepared using a limited-access data set and does not necessarily reflect the opinions or views of the ARIC Study investigators or the National Heart, Lung, and Blood Institute.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Bash LD, 2009, AM J EPIDEMIOL, V170, P414, DOI 10.1093/aje/kwp151; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Bundorf MK, 2004, HEALTH SERV RES, V39, P131; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Eddy DM, 2003, DIABETES CARE, V26, P3102, DOI 10.2337/diacare.26.11.3102; Eddy DM, 2003, DIABETES CARE, V26, P3093, DOI 10.2337/diacare.26.11.3093; EDDY DM, 1982, NEW ENGL J MED, V307, P343, DOI 10.1056/NEJM198208053070604; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P877; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; *FRAM HEART STUD, STORK; Framingham Heart Study, HARD COR HEART DIS 1; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Genest J, 2003, CAN MED ASSOC J, V169, P921; Halfhill TR, TOMS INFLATION CALCU; Hayward RA, 2010, ANN INTERN MED, V152, P69, DOI 10.7326/0003-4819-152-2-201001190-00004; *HEART FDN, QUICK REF GUID HLTH; Honaker J, AMELIA 2 PROGRAM MIS; Kahn R, 2008, CIRCULATION, V118, P576, DOI 10.1161/CIRCULATIONAHA.108.190186; Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197; Manuel DG, 2006, BMJ-BRIT MED J, V332, P1419, DOI 10.1136/bmj.38849.487546.DE; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; *NAT I HLTH CLIN E, STAT PREV CARD EV PA; National Heart Lung and Blood Institute, BIOL SPEC DAT REP IN; New Zealand Guidelines Group, ASS MAN CARD RISK; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Samsa GP, 1999, STROKE, V30, P338, DOI 10.1161/01.STR.30.2.338; Schlessinger L, 2002, J BIOMED INFORM, V35, P37, DOI 10.1016/S1532-0464(02)00006-0; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15; Tonkin Andrew, 2005, Heart Lung Circ, V14, P275; U.S. Department of Health and Human Services (National Heart Lung and Blood Institute, 7 US DEP HLTH HUM SE; U.S. Department of Health and Human Services National Institutes of Health, 3 US DEP HLTH HUM SE; *WIK, PERS MED; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; ARIC ATHEROSCLEROSIS	39	90	90	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					627	634		10.7326/0003-4819-154-9-201105030-00008	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21536939				2022-12-28	WOS:000290112300006
J	West, AP; Brodsky, IE; Rahner, C; Woo, DK; Erdjument-Bromage, H; Tempst, P; Walsh, MC; Choi, Y; Shadel, GS; Ghosh, S				West, A. Phillip; Brodsky, Igor E.; Rahner, Christoph; Woo, Dong Kyun; Erdjument-Bromage, Hediye; Tempst, Paul; Walsh, Matthew C.; Choi, Yongwon; Shadel, Gerald S.; Ghosh, Sankar			TLR signalling augments macrophage bactericidal activity through mitochondrial ROS	NATURE			English	Article							SALMONELLA-TYPHIMURIUM; REACTIVE OXYGEN; PHAGOSOME MATURATION; ECSIT; ASSOCIATION; HOMEOSTASIS; UBIQUITIN; MEMBRANE; COMPLEX; PROTEIN	Reactive oxygen species (ROS) are essential components of the innate immune response against intracellular bacteria and it is thought that professional phagocytes generate ROS primarily via the phagosomal NADPH oxidase machinery(1). However, recent studies have suggested that mitochondrial ROS (mROS) also contribute to mouse macrophage bactericidal activity, although the mechanisms linking innate immune signalling to mitochondria for mROS generation remain unclear(2-4). Here we demonstrate that engagement of a subset of Toll-like receptors (TLR1, TLR2 and TLR4) results in the recruitment of mitochondria to macrophage phagosomes and augments mROS production. This response involves translocation of a TLR signalling adaptor, tumour necrosis factor receptor-associated factor 6 (TRAF6), to mitochondria, where it engages the protein ECSIT (evolutionarily conserved signalling intermediate in Toll pathways), which is implicated in mitochondrial respiratory chain assembly(5). Interaction with TRAF6 leads to ECSIT ubiquitination and enrichment at the mitochondrial periphery, resulting in increased mitochondrial and cellular ROS generation. ECSIT-and TRAF6-depleted macrophages have decreased levels of TLR-induced ROS and are significantly impaired in their ability to kill intracellular bacteria. Additionally, reducing macrophage mROS levels by expressing catalase in mitochondria results in defective bacterial killing, confirming the role of mROS in bactericidal activity. These results reveal a novel pathway linking innate immune signalling to mitochondria, implicate mROS as an important component of antibacterial responses and further establish mitochondria as hubs for innate immune signalling.	[Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [West, A. Phillip; Brodsky, Igor E.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Rahner, Christoph] Yale Univ, Dept Cell Biol, Sch Med, New Haven, CT 06520 USA; [Woo, Dong Kyun; Shadel, Gerald S.] Yale Univ, Dept Pathol, Sch Med, New Haven, CT 06520 USA; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Walsh, Matthew C.; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Columbia University; Yale University; Yale University; Yale University; Memorial Sloan Kettering Cancer Center; University of Pennsylvania	Ghosh, S (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA.	sg2715@columbia.edu	West, A. Phillip/A-7867-2009; West, A. Phillip/W-8171-2019	West, A. Phillip/0000-0003-2884-6895; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NIH [R37-AI33443, NS-056206]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033443, R37AI033443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank C. Schindler, B. Reizis and L. Ciaccia for comments on the manuscript. We also thank P. Rabinovitch for MCAT mice, J. Cotney for technical assistance, Z. Zhang for animal maintenance and M. Graham and K. Zichichi for assistance with immuno-electron microscopy. This work was supported by NIH grants to S. G. (R37-AI33443) and G. S. S. (NS-056206).	Adachi Y, 2006, J IMMUNOL, V176, P5033, DOI 10.4049/jimmunol.176.8.5033; Arnoult D, 2009, SEMIN IMMUNOL, V21, P223, DOI 10.1016/j.smim.2009.05.009; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Brodsky IE, 2005, MOL MICROBIOL, V55, P954, DOI 10.1111/j.1365-2958.2004.04444.x; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chong A, 2009, INFECT IMMUN, V77, P4724, DOI 10.1128/IAI.00150-09; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; MATSUMOTO A, 1991, J ELECTRON MICROSC, V40, P356; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Remer KA, 2005, CLIN EXP IMMUNOL, V140, P73, DOI 10.1111/j.1365-2249.2005.02740.x; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Sinai AP, 1997, J CELL SCI, V110, P2117; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; Vazquez-Torres A, 2001, MICROBES INFECT, V3, P1313, DOI 10.1016/S1286-4579(01)01492-7; Vazquez-Torres A, 2001, TRENDS MICROBIOL, V9, P29, DOI 10.1016/S0966-842X(00)01897-7; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Werling D, 2004, IMMUNOLOGY, V111, P41, DOI 10.1111/j.1365-2567.2004.01781.x; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Xiao CC, 2003, GENE DEV, V17, P2933, DOI 10.1101/gad.1145603	36	993	1026	9	261	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					476	U543		10.1038/nature09973	http://dx.doi.org/10.1038/nature09973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525932	Green Accepted			2022-12-28	WOS:000289949600035
J	Modi, AC; Rausch, JR; Glauser, TA				Modi, Avani C.; Rausch, Joseph R.; Glauser, Tracy A.			Patterns of Nonadherence to Antiepileptic Drug Therapy in Children With Newly Diagnosed Epilepsy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; TREATMENT ADHERENCE; REPORTED ADHERENCE; PEDIATRIC-PATIENTS; CYSTIC-FIBROSIS; ASTHMA; TRAJECTORIES; MEDICATION; ADOLESCENTS; DEFINITION	Context Because of epilepsy's common occurrence, the narrow therapeutic and safety margins of antiepileptic medications, and the recognized complications of medication nonadherence in adults with epilepsy, identifying the rates, patterns, and predictors of nonadherence in children with epilepsy is imperative. The onset and evolution of antiepileptic drug nonadherence in children with newly diagnosed epilepsy remains unknown. Objectives To identify and characterize trajectories of adherence in children with newly diagnosed epilepsy over the first 6 months of therapy and to determine sociodemographic and epilepsy-specific predictors of adherence trajectories. Design, Setting, and Patients Prospective, longitudinal observational study of antiepileptic drug adherence in a consecutive cohort of 124 children (2-12 years old) with newly diagnosed epilepsy at Cincinnati Children's Hospital Medical Center. Patients were recruited from April 2006 through March 2009, and final data collection occurred in September 2009. Main Outcome Measure Objective adherence measured using electronic monitors. Results Fifty-eight percent of children with newly diagnosed epilepsy demonstrated persistent nonadherence during the first 6 months of therapy. Group-based trajectory models identified 5 differential adherence patterns (Bayesian information criterion=-23611.8): severe early nonadherence (13%; 95% confidence interval [CI], 8%-20%), severe delayed nonadherence (7%; 95% CI, 3%-12%), moderate nonadherence (13%; 95% CI, 8%-20%), mild nonadherence (26%; 95% CI, 19%-34%), and near-perfect adherence (42%; 95% CI, 33%-50%). The adherence pattern of most patients was established by the first month of therapy. Socioeconomic status was the sole predictor of adherence trajectory group status (chi(2)(4)=19.3 [n=115]; P<.001; partial r(2)=0.25), with lower socioeconomic status associated with higher nonadherence. Conclusion Five trajectory patterns were identified that captured the spectrum of nonadherence to antiepileptic drugs among children with newly diagnosed epilepsy; the patterns were significantly associated with socioeconomic status. JAMA. 2011;305(16):1669-1676 www.jama.com	[Modi, Avani C.; Rausch, Joseph R.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Glauser, Tracy A.] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Modi, AC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, 3333 Burnet Ave,MLC 7039 Adherence Ctr, Cincinnati, OH 45229 USA.	avani.modi@cchmc.org	Rausch, Joseph R/E-8107-2018	Modi, Avani/0000-0002-7580-3751	National Institutes of Health [K23HD057333]; ucb Pharma; Eisai; Upsher-Smith; Lundbeck; Sunovion; Supernus; Questcor; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD057333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ucb Pharma(UCB Pharma SA); Eisai(Eisai Co Ltd); Upsher-Smith; Lundbeck(Lundbeck Corporation); Sunovion; Supernus; Questcor; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Modi reports that she has been a consultant for Novartis Pharmaceuticals Inc, which has an interest in antiepileptic drugs. Dr Glauser reports that he is an advisor to, a speaker for, and has received research grants from companies with interests in antiepileptic drugs, including ucb Pharma, Eisai, Upsher-Smith, Lundbeck, Sunovion, Supernus, and Questcor. No other disclosures were reported.; This research was funded by grant K23HD057333 from the National Institutes of Health awarded to Dr Modi.	Adams CD, 2004, CURR ALLERGY ASTHM R, V4, P425, DOI 10.1007/s11882-004-0007-3; Al-Faris EA, 2002, SAUDI MED J, V23, P969; Asadi-Pooya AA, 2005, SEIZURE-EUR J EPILEP, V14, P393, DOI 10.1016/j.seizure.2005.05.003; Asato MR, 2009, J CHILD NEUROL, V24, P562, DOI 10.1177/0883073809332396; Bassili A, 2002, INT J QUAL HEALTH C, V14, P277, DOI 10.1093/intqhc/14.4.277; Berquist RK, 2006, PEDIATR TRANSPLANT, V10, P304, DOI 10.1111/j.1399-3046.2005.00451.x; Cohen J., 2002, APPL MULTIPLE REGRES, V3rd, DOI 10.4324/9780203774441; Conklin CA, 2005, NICOTINE TOB RES, V7, P533, DOI 10.1080/14622200500185371; Ettinger AB, 2009, EPILEPSY BEHAV, V14, P324, DOI 10.1016/j.yebeh.2008.10.021; Faught E, 2008, NEUROLOGY, V71, P1572, DOI 10.1212/01.wnl.0000319693.10338.b9; Fiese BH, 2005, J PEDIATR-US, V146, P171, DOI 10.1016/j.jpeds.2004.08.083; Glass TR, 2010, JAIDS-J ACQ IMM DEF, V54, P197, DOI 10.1097/QAI.0b013e3181ca48bf; Glauser T, 2006, EPILEPSIA, V47, P1094, DOI 10.1111/j.1528-1167.2006.00585.x; Graves MM, 2007, CURR ALLERGY ASTHM R, V7, P427, DOI 10.1007/s11882-007-0065-4; HAYNES RB, 1976, LANCET, V1, P1265; Irvine L, 2002, EUR RESPIR J, V20, P1464, DOI 10.1183/09031936.02.00302102; Kahana S, 2008, J PEDIATR PSYCHOL, V33, P590, DOI 10.1093/jpepsy/jsm128; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Kyngas H, 2000, SEIZURE-EUR J EPILEP, V9, P598, DOI 10.1053/seiz.2000.0470; LEESTMA JE, 1989, ANN NEUROL, V26, P195, DOI 10.1002/ana.410260203; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; LUND L, 1974, ARCH NEUROL-CHICAGO, V31, P289, DOI 10.1001/archneur.1974.00490410037002; MATSUI D, 1994, J CLIN PHARMACOL, V34, P944, DOI 10.1002/j.1552-4604.1994.tb04009.x; Mitchell WG, 2000, EPILEPSIA, V41, P1616; Modi AC, 2011, SOC BEHAV EPILEPSY, P175; Modi AC, 2008, PEDIATRICS, V121, pE961, DOI 10.1542/peds.2007-1690; Modi AC, 2006, J PEDIATR PSYCHOL, V31, P846, DOI 10.1093/jpepsy/jsj096; Modi AC, 2011, J PEDIATR PSYCHOL, V36, P466, DOI 10.1093/jpepsy/jsq114; Modi AC, 2011, EPILEPSIA, V52, P370, DOI 10.1111/j.1528-1167.2010.02789.x; Modi AC, 2010, J PEDIATR PSYCHOL, V35, P1028, DOI 10.1093/jpepsy/jsq015; Modi AC, 2010, EPILEPSY BEHAV, V18, P94, DOI 10.1016/j.yebeh.2010.03.009; Modi AC, 2009, CHILD HEALTH CARE, V38, P107, DOI 10.1080/02739610902813245; MUELLER CW, 1981, CHILD DEV, V52, P13, DOI 10.2307/1129211; Mulvaney S, 2006, J AM ACAD CHILD PSY, V45, P737, DOI 10.1097/10.chi.0000214192.57993.06; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 2005, GROUP BASED MODELING; NEUSPIEL DR, 1985, JAMA-J AM MED ASSOC, V254, P1321, DOI 10.1001/jama.254.10.1321; Pai ALH, 2010, PEDIATR TRANSPLANT, V14, P993, DOI 10.1111/j.1399-3046.2010.01391.x; Riekert KA, 2002, J CLIN PSYCHOL MED S, V9, P25, DOI 10.1023/A:1014131928789; Schurman JV, 2011, J PEDIATR PSYCHOL, V36, P116, DOI 10.1093/jpepsy/jsq046; Schwebel DC, 2007, J DEV BEHAV PEDIATR, V28, P245, DOI 10.1097/01.DBP.0000268561.80204.2a; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9	43	160	162	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1669	1676		10.1001/jama.2011.506	http://dx.doi.org/10.1001/jama.2011.506			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	754XG	21521848	Green Accepted			2022-12-28	WOS:000289890500020
J	Pollack, CE; Armstrong, K				Pollack, Craig Evan; Armstrong, Katrina			Accountable Care Organizations and Health Care Disparities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RACIAL DISPARITIES; MEDICARE		[Pollack, Craig Evan] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Pollack, Craig Evan] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Pollack, Craig Evan; Armstrong, Katrina] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Armstrong, Katrina] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; University of Pennsylvania	Pollack, CE (corresponding author), Johns Hopkins Sch Med, Div Gen Internal Med, 2024 E Monument St,Rm 2-615, Baltimore, MD 21287 USA.	cpollac2@jhmi.edu			NATIONAL CANCER INSTITUTE [U54CA091409] Funding Source: NIH RePORTER; NCI NIH HHS [5U54CA091409-10, P30 CA006973, U54 CA091409] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; Devers K, 2009, CAN ACCOUNTABLE CARE; Groeneveld PW, 2005, MED CARE, V43, P320, DOI 10.1097/01.mlr.0000156849.15166.ec; Jha AK, 2007, ARCH INTERN MED, V167, P1177, DOI 10.1001/archinte.167.11.1177; Pear Robert, 2010, N Y TIMES; Shortell SM, 2010, HEALTH AFFAIR, V29, P1293, DOI 10.1377/hlthaff.2010.0453; Smith DB, 1998, AM J PUBLIC HEALTH, V88, P461, DOI 10.2105/AJPH.88.3.461; Werner RM, 2010, ANN INTERN MED, V153, P340, DOI 10.7326/0003-4819-153-5-201009070-00010	9	49	49	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1706	1707		10.1001/jama.2011.533	http://dx.doi.org/10.1001/jama.2011.533			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	754XG	21521853	Green Accepted			2022-12-28	WOS:000289890500026
J	Cousens, S; Blencowe, H; Stanton, C; Chou, D; Ahmed, S; Steinhardt, L; Creanga, AA; Tuncalp, O; Balsara, ZP; Gupta, S; Say, L; Lawn, JE				Cousens, Simon; Blencowe, Hannah; Stanton, Cynthia; Chou, Doris; Ahmed, Saifuddin; Steinhardt, Laura; Creanga, Andreea A.; Tuncalp, Oezge; Balsara, Zohra Patel; Gupta, Shivam; Say, Lale; Lawn, Joy E.			National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis	LANCET			English	Article							COUNTRIES; MORTALITY	Background Stillbirths do not count in routine worldwide data-collating systems or for the Millennium Development Goals. Two sets of national stillbirth estimates for 2000 produced similar worldwide totals of 3.2 million and 3.3 million, but rates differed substantially for some countries. We aimed to develop more reliable estimates and a time series from 1995 for 193 countries, by increasing input data, using recent data, and applying improved modelling approaches. Methods For international comparison, stillbirth is defined as fetal death in the third trimester (>= 1000 g birthweight or >= 28 completed weeks of gestation). Several sources of stillbirth data were identified and assessed against prespecified inclusion criteria: vital registration data; nationally representative surveys; and published studies identified through systematic literature searches, unpublished studies, and national data identified through a WHO country consultation process. For 2009, reported rates were used for 33 countries and model-based estimates for 160 countries. A regression model of log stillbirth rate was developed and used to predict national stillbirth rates from 1995 to 2009. Uncertainty ranges were obtained with a bootstrap approach. The final model included log(neonatal mortality rate) (cubic spline), log(low birthweight rate) (cubic spline), log(gross national income purchasing power parity) (cubic spline), region, type of data source, and definition of stillbirth. Findings Vital registration data from 79 countries, 69 nationally representative surveys from 39 countries, and 113 studies from 42 countries met inclusion criteria. The estimated number of global stillbirths was 2.64 million (uncertainty range 2.14 million to 3.82 million) in 2009 compared with 3.03 million (uncertainty range 2.37 million to 4.19 million) in 1995. Worldwide stillbirth rate has declined by 14.5%, from 22.1 stillbirths per 1000 births in 1995 to 18.9 stillbirths per 1000 births in 2009. In 2009,76.2% of stillbirths occurred in south Asia and sub-Saharan Africa. Interpretation This study draws attention to the dearth of reliable data in regions where most stillbirths occur. The estimated trend in stillbirth rate reduction is slower than that for maternal mortality and lags behind the increasing progress in reducing deaths in children younger than 5 years. Improved data and improved use of data are crucial to ensure that stillbirths count in global and national policy.	[Cousens, Simon; Blencowe, Hannah] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Stanton, Cynthia; Ahmed, Saifuddin; Steinhardt, Laura; Creanga, Andreea A.; Tuncalp, Oezge; Balsara, Zohra Patel; Gupta, Shivam] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Chou, Doris; Say, Lale] WHO, CH-1211 Geneva, Switzerland; [Lawn, Joy E.] Saving Newborn Lives Save Children, Cape Town, South Africa	University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; Save the Children	Cousens, S (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	simon.cousens@lshtm.ac.uk	Blencowe, Hannah/K-7415-2012; , lalesay/AAG-1912-2021; Tunçalp, Ӧzge/Y-2724-2018; Lawn, Joy/ABE-6382-2020	Tunçalp, Ӧzge/0000-0002-5370-682X; Lawn, Joy/0000-0002-4573-1443; Blencowe, Hannah/0000-0003-1556-3159	Bill & Melinda Gates Foundation through the Global Alliance to Prevent Prematurity and Stillbirth, Saving Newborn Lives/Save the Children; International Stillbirth Alliance; Department of Reproductive Health and Research, WHO; WHO; World Bank; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation through the Global Alliance to Prevent Prematurity and Stillbirth, Saving Newborn Lives/Save the Children; International Stillbirth Alliance; Department of Reproductive Health and Research, WHO(World Health Organization); WHO(World Health Organization); World Bank(The World Bank India); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Bill & Melinda Gates Foundation through the Global Alliance to Prevent Prematurity and Stillbirth, Saving Newborn Lives/Save the Children, and the International Stillbirth Alliance. The Department of Reproductive Health and Research, WHO, through the UN Development Programme, UN Population Fund, WHO, and World Bank Special Programme of Research, Development and Research Training in Human Reproduction.	*AUSTR I HLTH WELF, NAT PER STAT UN; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001006; Efron B., 1994, MONOGRAPHS STAT APPL; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-58; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; *I NAT STAT ET EC, 1994, NES VIV ENF SANS VIE; *INF GES BUND, FED HLTH MON; Joint United Nations Programme on HIV/AIDS, UNAIDS REP GLOB AIDS; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; OESTERGAARD MZ, WORLD HLTH IN PRESS; *ORC MACR, DEM HLTH SURV; *ORC MACR, 2001, MOD A QUEST HIGH CON; *PLOS COLL, GLOB HLTH EST; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Scott J, 2011, LANCET, V377, P1386, DOI 10.1016/S0140-6736(11)60107-4; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; UNICEF, 2009, STAT WORLDS CHILDR; United Nations Children's Fund (UNICEF), MULT IND CLUST SURV; WHO, 1993, INT STAT CLASS DIS R, V2; WHO, COUNTD 2015 MAT NEWB; Woods R, 2008, B WORLD HEALTH ORGAN, V86, P460, DOI 10.2471/BLT.07.043471; World Bank, WORLD DEV IND 2008; World Health Organization, 2010, TRENDS MAT MORT 1990, P18; World Health Organization, 2006, NEON PER MORT YEAR 2	32	413	424	1	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1319	1330		10.1016/S0140-6736(10)62310-0	http://dx.doi.org/10.1016/S0140-6736(10)62310-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UE	21496917	Green Accepted			2022-12-28	WOS:000289962900033
J	Holm, TM; Habashi, JP; Doyle, JJ; Bedja, D; Chen, YC; van Erp, C; Lindsay, ME; Kim, D; Schoenhoff, F; Cohn, RD; Loeys, BL; Thomas, CJ; Patnaik, S; Marugan, JJ; Judge, DP; Dietz, HC				Holm, Tammy M.; Habashi, Jennifer P.; Doyle, Jefferson J.; Bedja, Djahida; Chen, YiChun; van Erp, Christel; Lindsay, Mark E.; Kim, David; Schoenhoff, Florian; Cohn, Ronald D.; Loeys, Bart L.; Thomas, Craig J.; Patnaik, Samarjit; Marugan, Juan J.; Judge, Daniel P.; Dietz, Harry C.			Noncanonical TGF beta Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice	SCIENCE			English	Article							N-TERMINAL KINASE; MOUSE MODEL; NOONANS-SYNDROME; ACTIVATION; RECEPTOR; CELLS; PATHOGENESIS; INHIBITOR; MUTATIONS; VALSALVA	Transforming growth factor-beta (TGF beta) signaling drives aneurysm progression in multiple disorders, including Marfan syndrome (MFS), and therapies that inhibit this signaling cascade are in clinical trials. TGF beta can stimulate multiple intracellular signaling pathways, but it is unclear which of these pathways drives aortic disease and, when inhibited, which result in disease amelioration. Here we show that extracellular signal-regulated kinase (ERK) 1 and 2 and Smad2 are activated in a mouse model of MFS, and both are inhibited by therapies directed against TGF beta. Whereas selective inhibition of ERK1/2 activation ameliorated aortic growth, Smad4 deficiency exacerbated aortic disease and caused premature death in MFS mice. Smad4-deficient MFS mice uniquely showed activation of Jun N-terminal kinase-1 (JNK1), and a JNK antagonist ameliorated aortic growth in MFS mice that lacked or retained full Smad4 expression. Thus, noncanonical (Smad-independent) TGF beta signaling is a prominent driver of aortic disease in MFS mice, and inhibition of the ERK1/2 or JNK1 pathways is a potential therapeutic strategy for the disease.	[Holm, Tammy M.; Habashi, Jennifer P.; Doyle, Jefferson J.; Chen, YiChun; van Erp, Christel; Lindsay, Mark E.; Kim, David; Schoenhoff, Florian; Cohn, Ronald D.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Holm, Tammy M.; Habashi, Jennifer P.; Doyle, Jefferson J.; Chen, YiChun; van Erp, Christel; Lindsay, Mark E.; Kim, David; Schoenhoff, Florian; Cohn, Ronald D.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Habashi, Jennifer P.; Lindsay, Mark E.; Cohn, Ronald D.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Baltimore, MD 21205 USA; [Bedja, Djahida] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Loeys, Bart L.] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Thomas, Craig J.; Patnaik, Samarjit; Marugan, Juan J.] NIH, Chem Genom Ctr, Rockville, MD 20850 USA; [Judge, Daniel P.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Ghent University; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Johns Hopkins University	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	hdietz@jhmi.edu	Loeys, Bart/B-3236-2017; Doyle, Jefferson/C-3156-2013; Cohn, Ronald/AAC-5835-2021; Chen, Yi-Chun/H-4468-2013	Loeys, Bart/0000-0003-3703-9518; Judge, Daniel/0000-0002-3407-0248; Schoenhoff, Florian/0000-0002-3311-4595; Thomas, Craig/0000-0001-9386-9001	National Institutes of Health; Howard Hughes Medical Institute; National Marfan Foundation; Cellular and Molecular Medicine Training Program; National Human Genome Research Institute; Smilow Center for Marfan Syndrome Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041135, P01AR049698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Marfan Foundation; Cellular and Molecular Medicine Training Program; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Smilow Center for Marfan Syndrome Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the National Institutes of Health (H. C. D. and D.P.J), Howard Hughes Medical Institute (H. C. D.), National Marfan Foundation (H. C. D., J.P.H., and J.J.D.), Cellular and Molecular Medicine Training Program (J.J.D.), National Human Genome Research Institute Intramural Research Program and the NIH Therapeutics for Rare and Neglected Diseases Program (C.J.T., S. P., and J.J.M.), and the Smilow Center for Marfan Syndrome Research (H. C. D.). We thank Dr. C. Deng for the Smad4-targeted mice. Johns Hopkins University and the authors (H. C. D., J.P.H., D.P.J., and R. C.) have filed a patent relating to the use of TGF beta antagonists, including angiotensin II type 1 receptor blockers, for the treatment of Marfan syndrome.	Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dietz HC, 2010, J CLIN INVEST, V120, P403, DOI 10.1172/JCI42014; Fukuda N, 2000, AM J HYPERTENS, V13, P191, DOI 10.1016/S0895-7061(99)00152-1; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Huang JB, 2010, CIRC RES, V106, P583, DOI 10.1161/CIRCRESAHA.109.207852; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Iverson C, 2009, CANCER RES, V69, P6839, DOI 10.1158/0008-5472.CAN-09-0679; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; MORGAN JM, 1989, EUR HEART J, V10, P190, DOI 10.1093/oxfordjournals.eurheartj.a059462; Naito T, 2004, AM J PHYSIOL-RENAL, V286, pF278, DOI 10.1152/ajprenal.00139.2003; Nakamura T, 2007, J CLIN INVEST, V117, P2123, DOI 10.1172/JCI30756; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Purnell R, 2005, EUR J CARDIO-THORAC, V28, P346, DOI 10.1016/j.ejcts.2005.05.004; Wolf G, 1999, J MOL MED-JMM, V77, P556, DOI 10.1007/s001099900028; Xu XL, 2000, ONCOGENE, V19, P1868, DOI 10.1038/sj.onc.1203504; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335	26	338	351	4	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					358	361		10.1126/science.1192149	http://dx.doi.org/10.1126/science.1192149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493862	Green Accepted			2022-12-28	WOS:000289516600047
J	Hoffert, M				Hoffert, Marty			Governments must pay for clean-energy innovation	NATURE			English	Editorial Material									NYU, New York, NY 10003 USA	New York University	Hoffert, M (corresponding author), NYU, New York, NY 10003 USA.	marty.hoffert@nyu.edu						Hoffert MI, 1998, NATURE, V395, P881, DOI 10.1038/27638	1	3	4	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					137	137		10.1038/472137a	http://dx.doi.org/10.1038/472137a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	749LR	21490630	Bronze			2022-12-28	WOS:000289469100008
J	Stein, RA				Stein, Richard A.			Epigenetics-The Link Between Infectious Diseases and Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CELLS		Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Stein, RA (corresponding author), Princeton Univ, Dept Mol Biol, 1 Washington Rd,LTL 320, Princeton, NJ 08544 USA.	ras2@princeton.edu						DEBUSTROS A, 1988, P NATL ACAD SCI USA, V85, P5693; Fernandez AF, 2010, ONCOGENE, V29, P1405, DOI 10.1038/onc.2009.517; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Malfertheiner P, 2005, AM J GASTROENTEROL, V100, P2100, DOI 10.1111/j.1572-0241.2005.41688.x; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397; Westra WH, 2009, HEAD NECK PATHOL, V3, P78, DOI 10.1007/s12105-009-0100-y; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	10	29	29	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1484	1485		10.1001/jama.2011.446	http://dx.doi.org/10.1001/jama.2011.446			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486982				2022-12-28	WOS:000289424100028
J	Fournier, PE; Thuny, F; Grisoli, D; Lepidi, H; Vitte, J; Casalta, JP; Weiller, PJ; Habib, G; Raoult, D				Fournier, Pierre-Edouard; Thuny, Franck; Grisoli, Dominique; Lepidi, Hubert; Vitte, Joanna; Casalta, Jean-Paul; Weiller, Pierre-Jean; Habib, Gilbert; Raoult, Didier			A deadly aversion to pork	LANCET			English	Editorial Material							VALVE		[Raoult, Didier] Univ Aix Marseille 2, Fac Med, Unite Rech Malad Infect & Trop Emergentes, IRD,CNRS,UMR 6236, F-13385 Marseille, France; [Thuny, Franck; Habib, Gilbert] Hop La Timone, Serv Cardiol, Marseille, France; [Lepidi, Hubert] Hop La Timone, Lab Anatomopathol, Marseille, France; [Grisoli, Dominique] Hop La Timone, Serv Chirurg Cardiaque, Marseille, France; [Weiller, Pierre-Jean] Hop La Timone, Serv Med Interne, Marseille, France; [Vitte, Joanna] Hop Conception, Immunol Lab, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Raoult, D (corresponding author), Univ Aix Marseille 2, Fac Med, Unite Rech Malad Infect & Trop Emergentes, IRD,CNRS,UMR 6236, F-13385 Marseille, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; Fournier, Pierre-Edouard/AAC-6155-2021; Thuny, Franck/GSD-2668-2022; Vitte, Joana/G-2572-2013; Thuny, Franck/ABC-7157-2020; Thuny, Franck/ABB-2408-2021	RAOULT, Didier/0000-0002-0633-5974; Fournier, Pierre-Edouard/0000-0001-8463-8885; Thuny, Franck/0000-0002-8727-7154; Vitte, Joana/0000-0002-3344-9408; Thuny, Franck/0000-0002-8727-7154				Cooper HL, 2008, QJM-INT J MED, V101, P67, DOI 10.1093/qjmed/hcm107; Fournier PE, 2010, CLIN INFECT DIS, V51, P131, DOI 10.1086/653675; Gudmundsson GS, 2003, ARCH PATHOL LAB MED, V127, P606; Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311; ZEMAN AZJ, 1993, SURG NEUROL, V40, P75, DOI 10.1016/0090-3019(93)90175-Z	5	14	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2011	377	9776					1542	1542		10.1016/S0140-6736(11)60021-4	http://dx.doi.org/10.1016/S0140-6736(11)60021-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761RX	21531269				2022-12-28	WOS:000290419400032
J	Wolfe, D; Carrieri, MP; Dasgupta, N; Wodak, A; Newman, R; Bruce, RD				Wolfe, Daniel; Carrieri, M. Patrizia; Dasgupta, Nabarun; Wodak, Alex; Newman, Robert; Bruce, R. Douglas			Concerns about injectable naltrexone for opioid dependence	LANCET			English	Editorial Material							HEROIN DEPENDENCE; PHARMACOTHERAPIES; BUPRENORPHINE		[Wolfe, Daniel] Open Soc Inst, Int Harm Reduct Dev Program, New York, NY 10019 USA; [Carrieri, M. Patrizia] INSERM, U912, SE4S, F-13258 Marseille, France; [Carrieri, M. Patrizia] ORS PACA, Marseille, France; [Carrieri, M. Patrizia] Univ Aix Marseille, IRD, UMR S912, Marseille, France; [Dasgupta, Nabarun] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Wodak, Alex] St Vincents Hosp, Alcohol & Drug Serv, Darlinghurst, NSW 2010, Australia; [Newman, Robert] Beth Israel Deaconess Med Ctr, Baron Edmond de Rothschild Chem Dependency Inst, New York, NY 10003 USA; [Bruce, R. Douglas] Yale Univ, AIDS Programme, New Haven, CT USA	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of North Carolina; University of North Carolina Chapel Hill; St Vincents Hospital Sydney; Harvard University; Beth Israel Deaconess Medical Center; Yale University	Wolfe, D (corresponding author), Open Soc Inst, Int Harm Reduct Dev Program, New York, NY 10019 USA.	dwolfe@sorosny.org		Carrieri, Patrizia/0000-0002-6794-4837; Dasgupta, Nabarun/0000-0002-4098-605X; Bruce, Robert/0000-0003-4184-8748				*ALK INC, 2010, FDA PSYCH DRUGS ADV; Digiusto E, 2004, ADDICTION, V99, P450, DOI 10.1111/j.1360-0443.2004.00654.x; Gibson AE, 2007, DRUG ALCOHOL REV, V26, P405, DOI 10.1080/09595230701373834; GUNNE LM, 1981, DRUG ALCOHOL DEPEN, V7, P249, DOI 10.1016/0376-8716(81)90096-X; Kakko J, 2003, LANCET, V361, P662, DOI 10.1016/S0140-6736(03)12600-1; Krupitsky E, 2011, LANCET, V377, P1506, DOI 10.1016/S0140-6736(11)60358-9; Krupitsky E, 2010, CURR PSYCHIAT REP, V12, P448, DOI 10.1007/s11920-010-0135-5; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Lewis JA, 2002, LANCET, V359, P1337, DOI 10.1016/S0140-6736(02)08277-6; Miotto K, 1997, DRUG ALCOHOL DEPEN, V45, P131, DOI 10.1016/S0376-8716(97)01348-3; Schottenfeld RS, 2008, LANCET, V371, P2192, DOI 10.1016/S0140-6736(08)60954-X; *US FDA, Q DAT FDA ADV EV REP	12	29	29	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2011	377	9776					1468	1470		10.1016/S0140-6736(10)62056-9	http://dx.doi.org/10.1016/S0140-6736(10)62056-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761RX	21529930				2022-12-28	WOS:000290419400005
J	Volk, ML; Lieber, SR; Kim, SY; Ubel, PA; Schneider, CE				Volk, Michael L.; Lieber, Sarah R.; Kim, Scott Y.; Ubel, Peter A.; Schneider, Carl E.			Contracts with patients in clinical practice	LANCET			English	Editorial Material							CARE		[Volk, Michael L.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Lieber, Sarah R.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Kim, Scott Y.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Schneider, Carl E.] Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA; [Ubel, Peter A.] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Duke University	Volk, ML (corresponding author), Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA.	mvolk@med.umich.edu		Lieber, Sarah/0000-0001-8304-4479	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK085204] Funding Source: NIH RePORTER; NIDDK NIH HHS [K23 DK085204-03, K23 DK085204] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BLOOM H, 1989, Psychiatric Quarterly (New York), V60, P317, DOI 10.1007/BF01064355; Bosch-Capblanch X, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004808.pub3; Garvey KA, 2009, J AM ACAD PSYCHIATRY, V37, P363; Hariharan J, 2007, J GEN INTERN MED, V22, P485, DOI 10.1007/s11606-006-0084-1; Harris PS, 1999, J CLIN ETHIC, V10, P242; Kelly KT, 2000, ARCH FAM MED, V9, P1119, DOI 10.1001/archfami.9.10.1119; Payne R, AM J BIOETH, V10, P5; QUILL TE, 1983, ANN INTERN MED, V98, P228, DOI 10.7326/0003-4819-98-2-228; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; Rollnick S., 2008, MOTIVATIONAL INTERVI; Sacopulos M, 2009, CLIN ORTHOP RELAT R, V467, P427, DOI 10.1007/s11999-008-0619-3; Starrels JL, 2010, ANN INTERN MED, V152, P712, DOI 10.7326/0003-4819-152-11-201006010-00004	12	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2012	379	9810					7	9		10.1016/S0140-6736(11)60170-0	http://dx.doi.org/10.1016/S0140-6736(11)60170-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	873WC	21497394	Green Accepted			2022-12-28	WOS:000298913000009
J	Benoist, C; Hacohen, N				Benoist, Christophe; Hacohen, Nir			Flow Cytometry, Amped Up	SCIENCE			English	Editorial Material							PROTEIN-LEVELS; VARIABILITY; NETWORKS; CELLS		[Benoist, Christophe] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Benoist, Christophe; Hacohen, Nir] Broad Inst, Cambridge, MA 02142 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital	Benoist, C (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	cb@hms.harvard.edu; nhacohen@partners.org						Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Herzenberg LA, 2002, CLIN CHEM, V48, P1819; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002	10	24	26	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					677	678		10.1126/science.1206351	http://dx.doi.org/10.1126/science.1206351			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551055				2022-12-28	WOS:000290265800032
J	Burns, DM; D'Ambrogio, A; Nottrott, S; Richter, JD				Burns, David M.; D'Ambrogio, Andrea; Nottrott, Stephanie; Richter, Joel D.			CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation	NATURE			English	Article							MEDIATED CYTOPLASMIC POLYADENYLATION; RIBOSOMAL-PROTEIN L26; CELLULAR SENESCENCE; SYNAPTIC PLASTICITY; MICRORNAS; GLD-2; STABILIZATION; MOUSE; CELLS; MICE	Cytoplasmic polyadenylation-induced translation controls germ cell development(1,2), neuronal synaptic plasticity(3-5) and cellular senescence(6,7), a tumour-suppressor mechanism that limits the replicative lifespan of cells(8,9). The cytoplasmic polyadenylation element binding protein (CPEB) promotes polyadenylation by nucleating a group of factors including defective in germline development 2 (Gld2), a non-canonical poly(A) polymerase(10-12), on specific messenger RNA (mRNA) 3' untranslated regions (UTRs). Because CPEB regulation of p53 mRNA polyadenylation/translation is necessary for cellular senescence in primary human diploid fibroblasts(6), we surmised that Gld2 would be the enzyme responsible for poly(A) addition. Here we show that depletion of Gld2 surprisingly promotes rather than inhibits p53 mRNA polyadenylation/translation, induces premature senescence and enhances the stability of CPEB mRNA. The CPEB 3' UTR contains two miR-122 binding sites, which when deleted, elevate mRNA translation, as does an antagomir of miR-122. Although miR-122 is thought to be liver specific, it is present in primary fibroblasts and destabilized by Gld2 depletion. Gld4, a second non-canonical poly(A) polymerase, was found to regulate p53 mRNA polyadenylation/translation in a CPEB-dependent manner. Thus, translational regulation of p53 mRNA and cellular senescence is coordinated by Gld2/miR-122/CPEB/Gld4.	[Burns, David M.; D'Ambrogio, Andrea; Nottrott, Stephanie; Richter, Joel D.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	joel.richter@umassmed.edu	D'Ambrogio, Andrea/D-3729-2013		Max Planck Society; European Molecular Biology Organization [ALTF 995-2004]; National Institutes of Health [AG30323]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD037267] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030323] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank V. Ambros, J. Steitz, T. Kowalik and R. Davis for comments. S.N. was supported by a fellowship of the Max Planck Society and by European Molecular Biology Organization fellowship ALTF 995-2004. This work was supported by National Institutes of Health grant AG30323. Additional core support from the Diabetes Endocrinology Research Center (DK32520) is acknowledged.	Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; Holst LM, 2010, EXP DERMATOL, V19, pE201, DOI 10.1111/j.1600-0625.2009.01049.x; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim JH, 2007, GENE DEV, V21, P2571, DOI 10.1101/gad.1593007; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Santos SDM, 2008, NATURE, V454, P288, DOI 10.1038/454288a; Schmid M, 2009, GENE DEV, V23, P824, DOI 10.1101/gad.494009; Schulte JH, 2009, CANCER LETT, V274, P10, DOI 10.1016/j.canlet.2008.06.010; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008	27	145	153	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					105	U125		10.1038/nature09908	http://dx.doi.org/10.1038/nature09908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21478871	Green Accepted			2022-12-28	WOS:000290218300040
J	Umena, Y; Kawakami, K; Shen, JR; Kamiya, N				Umena, Yasufumi; Kawakami, Keisuke; Shen, Jian-Ren; Kamiya, Nobuo			Crystal structure of oxygen-evolving photosystem II at a resolution of 1.9 angstrom	NATURE			English	Article							DIFFRACTION DATA; WATER; BINDING; PROTEIN; MECHANISM; OXIDATION; MANGANESE; CHANNELS; CLUSTER; CRYSTALLOGRAPHY	Photosystem II is the site of photosynthetic water oxidation and contains 20 subunits with a total molecular mass of 350 kDa. The structure of photosystem II has been reported at resolutions from 3.8 to 2.9 angstrom. These resolutions have provided much information on the arrangement of protein subunits and cofactors but are insufficient to reveal the detailed structure of the catalytic centre of water splitting. Here we report the crystal structure of photosystem II at a resolution of 1.9 angstrom. From our electron density map, we located all of the metal atoms of the Mn4CaO5 cluster, together with all of their ligands. We found that five oxygen atoms served as oxo bridges linking the five metal atoms, and that four water molecules were bound to the Mn4CaO5 cluster; some of them may therefore serve as substrates for dioxygen formation. We identified more than 1,300 water molecules in each photosystem II monomer. Some of them formed extensive hydrogen-bonding networks that may serve as channels for protons, water or oxygen molecules. The determination of the high-resolution structure of photosystem II will allow us to analyse and understand its functions in great detail.	[Kawakami, Keisuke; Shen, Jian-Ren] Okayama Univ, Fac Sci, Grad Sch Nat Sci & Technol, Div Biosci, Okayama 7008530, Japan; [Umena, Yasufumi; Kamiya, Nobuo] Osaka City Univ, Grad Sch Sci, Dept Chem, Osaka 5588585, Japan	Okayama University; Osaka Metropolitan University	Shen, JR (corresponding author), Okayama Univ, Fac Sci, Grad Sch Nat Sci & Technol, Div Biosci, Okayama 7008530, Japan.	shen@cc.okayama-u.ac.jp; nkamiya@sci.osaka-cu.ac.jp	Umena, Yasufumi/AAD-5472-2019; Shen, Jian-Ren/B-2558-2011	Kamiya, Nobuo/0000-0002-9056-7558	Ministry of Education, Culture, Sports, Science and Technology of Japan; Yamada Science foundation; Grants-in-Aid for Scientific Research [10J02491] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The X-ray diffraction data was taken at beamlines BL44XU, BL41XU and BL38B1 at SPring-8. We thank E. Yamashita, N. Shimizu, S. Baba and N. Mizuno for their help in using the beamlines. J.-R.S. thanks Y. Inoue for his support in the initiation of this work. This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (Structures of Biological Macromolecular Assemblies), a Grant-in-Aid for Creative Scientific Research, a GCOE programme on Pico-biology at the University of Hyogo, a Grant-in-Aid for Scientific Research (C), from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a research grant from the Yamada Science foundation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Broser M, 2010, J BIOL CHEM, V285, P26255, DOI 10.1074/jbc.M110.127589; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURRELL JWK, 1959, P CHEM SOC LONDON, P263; Carrell TG, 2002, J BIOL INORG CHEM, V7, P2, DOI 10.1007/s00775-001-0305-3; CHU HA, 1995, BIOCHEMISTRY-US, V34, P5839, DOI 10.1021/bi00017a016; CRABBE P, 1959, P CHEM SOC LONDON, P264; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; DAOPIN S, 1994, ACTA CRYSTALLOGR D, V50, P85, DOI 10.1107/S090744499300808X; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; DEPAULA JC, 1986, J AM CHEM SOC, V108, P4002, DOI 10.1021/ja00274a025; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hays AMA, 1999, BIOCHEMISTRY-US, V38, P11851, DOI 10.1021/bi990716a; Ho FM, 2008, BBA-BIOENERGETICS, V1777, P140, DOI 10.1016/j.bbabio.2007.08.009; Hoganson CW, 1997, SCIENCE, V277, P1953, DOI 10.1126/science.277.5334.1953; Hwang HJ, 2007, BIOCHEMISTRY-US, V46, P11987, DOI 10.1021/bi701387b; Joliot P, 2003, PHOTOSYNTH RES, V76, P65, DOI 10.1023/A:1024946610564; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kawakami K, 2007, FEBS LETT, V581, P4983, DOI 10.1016/j.febslet.2007.09.036; Kawakami K, 2009, P NATL ACAD SCI USA, V106, P8567, DOI 10.1073/pnas.0812797106; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Murray JW, 2007, J STRUCT BIOL, V159, P228, DOI 10.1016/j.jsb.2007.01.016; Murray JW, 2008, ENERG ENVIRON SCI, V1, P161, DOI 10.1039/b810067p; NIXON PJ, 1994, BIOCHEM SOC T, V22, P338, DOI 10.1042/bst0220338; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Robblee JH, 2001, BBA-BIOENERGETICS, V1503, P7, DOI 10.1016/S0005-2728(00)00217-6; Service RJ, 2010, BIOCHEMISTRY-US, V49, P6655, DOI 10.1021/bi100730d; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Tommos C, 2000, BBA-BIOENERGETICS, V1458, P199, DOI 10.1016/S0005-2728(00)00069-4; Vasil'ev S, 2001, P NATL ACAD SCI USA, V98, P8602, DOI 10.1073/pnas.141239598; VINCENT JB, 1987, INORG CHIM A-BIOINOR, V136, pL41, DOI 10.1016/S0020-1693(00)81142-1; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Zein S, 2008, PHILOS T R SOC B, V363, P1167, DOI 10.1098/rstb.2007.2212; Zhang CX, 2007, BBA-BIOENERGETICS, V1767, P493, DOI 10.1016/j.bbabio.2006.12.008; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	40	2871	2950	33	1246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					55	U65		10.1038/nature09913	http://dx.doi.org/10.1038/nature09913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21499260	Green Submitted			2022-12-28	WOS:000290218300029
J	Ferreira, A; Marguti, I; Bechmann, I; Jeney, V; Chora, A; Palha, NR; Rebelo, S; Henri, A; Beuzard, Y; Soares, MP				Ferreira, Ana; Marguti, Ivo; Bechmann, Ingo; Jeney, Viktoria; Chora, Angelo; Palha, Nuno R.; Rebelo, Sofia; Henri, Annie; Beuzard, Yves; Soares, Miguel P.			Sickle Hemoglobin Confers Tolerance to Plasmodium Infection	CELL			English	Article							HEME OXYGENASE-1; CELL-DISEASE; FALCIPARUM-MALARIA; MOUSE MODEL; PROTECTION; TRAIT; INDUCTION; PATHOGENESIS; RESISTANCE; MECHANISM	Sickle human hemoglobin (Hb) confers a survival advantage to individuals living in endemic areas of malaria, the disease caused by Plasmodium infection. As demonstrated hereby, mice expressing sickle Hb do not succumb to experimental cerebral malaria (ECM). This protective effect is exerted irrespectively of parasite load, revealing that sickle Hb confers host tolerance to Plasmodium infection. Sickle Hb induces the expression of heme oxygenase-1 (HO-1) in hematopoietic cells, via a mechanism involving the transcription factor NF-E2-related factor 2 (Nrf2). Carbon monoxide (CO), a byproduct of heme catabolism by HO-1, prevents further accumulation of circulating free heme after Plasmodium infection, suppressing the pathogenesis of ECM. Moreover, sickle Hb inhibits activation and/or expansion of pathogenic CD8(+) T cells recognizing antigens expressed by Plasmodium, an immunoregulatory effect that does not involve Nrf2 and/or HO-1. Our findings provide insight into molecular mechanisms via which sickle Hb confers host tolerance to severe forms of malaria.	[Ferreira, Ana; Marguti, Ivo; Jeney, Viktoria; Chora, Angelo; Palha, Nuno R.; Rebelo, Sofia; Soares, Miguel P.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Bechmann, Ingo] Univ Leipzig, Inst Anat, D-04103 Leipzig, Germany; [Bechmann, Ingo] Goethe Univ Frankfurt, Inst Clin Neuroanat, D-60596 Frankfurt, Germany; [Henri, Annie; Beuzard, Yves] Univ Paris 07, Inst Univ Hematol, F-75221 Paris 05, France; [Henri, Annie; Beuzard, Yves] CEA, Inst Emerging Dis & Innovat Therapies, Fontenay Aux Roses, France; [Henri, Annie; Beuzard, Yves] INSERM, F-75654 Paris 13, France; [Henri, Annie; Beuzard, Yves] Univ Paris 11, Paris, France	Instituto Gulbenkian de Ciencia; Leipzig University; Goethe University Frankfurt; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Soares, MP (corresponding author), Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal.	mpsoares@igc.gulbenkian.pt	Soares, Miguel P/G-4188-2011; Ferreira Chora, Angelo/AAZ-6503-2021; Jeney, Viktória/AAF-5355-2019; Jeney, Viktoria/A-6779-2011	Ferreira Chora, Angelo/0000-0002-7941-7196; Soares, Miguel/0000-0002-9314-4833; Rebelo, Sofia/0000-0001-8399-0262; Jeney, Viktoria/0000-0003-4942-7091; Ferreira, Ana/0000-0002-9171-6068	"Fundacao para a Ciencia e a Tecnologia'', Portugal [PTDC/SAU-MII/71140/2006, SFRH/BPD/21707/2005, SFHR/BD/33218/2007, PTDC/BIA-BCM/101311/2008, PTDC/SAU-FCF/100762/2008]; GEMI Fund Linde Healthcare; European Community; DFG; BMBF; Dr. Senckenberg-Stiftung; Kassel-Stiftung; Messer-Stiftung, Germany; Paris VII University; Commissariat a l'Energie Atomique; Agence Nationale de la Recherche Scientifique, France;  [LSH-2005-1.2.5-1];  [FP7-PEOPLE-2007-2-1-IEF]	"Fundacao para a Ciencia e a Tecnologia'', Portugal(Portuguese Foundation for Science and Technology); GEMI Fund Linde Healthcare; European Community(European Commission); DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Dr. Senckenberg-Stiftung; Kassel-Stiftung; Messer-Stiftung, Germany; Paris VII University; Commissariat a l'Energie Atomique(French Atomic Energy Commission); Agence Nationale de la Recherche Scientifique, France(French National Research Agency (ANR)); ; 	We thank Ruslan Medzhitov for intellectual support and encouragement by means of many insightful discussions, Thiago Carvalho (Instituto Gulbenkian de Cie ncia) and Rui Costa Fundacao Champalimaud as well as Marcelo Bozza (Universidade Federal do Rio De Janeiro), Robert P. Hebbel and Gregory Vercellotti (University of Minnesota, USA) for critical review of the manuscript, Nuno Sepulveda for support in statistical analysis, Tim M. Townes and Tom M. Ryan (University of Alabama at Birmingham) for providing the HbA/A mice. Silvia Cardoso and Matteo Villa for mouse breeding and genotyping. This work was supported by "Fundacao para a Ciencia e a Tecnologia'', Portugal grants PTDC/SAU-MII/71140/2006 and SFRH/BPD/21707/2005 (AF), SFHR/BD/33218/2007 (IM), PTDC/SAU-MII/71140/2006, PTDC/BIA-BCM/101311/2008, PTDC/SAU-FCF/100762/2008, GEMI Fund Linde Healthcare, European Community and LSH-2005-1.2.5-1 (MPS), FP7-PEOPLE-2007-2-1-IEF (VJ). I. B. is supported by the DFG, BMBF, Dr. Senckenberg-Stiftung, Kassel-Stiftung and Messer-Stiftung, Germany. Annie Henri is supported by INSERM and Yves Beuzard by Paris VII University, Commissariat a l'Energie Atomique and Agence Nationale de la Recherche Scientifique, France.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Bains SK, 2010, ARTERIOSCL THROM VAS, V30, P305, DOI 10.1161/ATVBAHA.109.196360; BALLA G, 1992, J BIOL CHEM, V267, P18148; BEET E A, 1947, East Afr Med J, V24, P212; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Berberat PO, 2003, FASEB J, V17, P1724, DOI 10.1096/fj.03-0229fje; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Clark IA, 2004, CLIN MICROBIOL REV, V17, P509, DOI 10.1128/CMR.17.3.509-539.2004; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; EISENSTEIN RS, 1991, P NATL ACAD SCI USA, V88, P688, DOI 10.1073/pnas.88.3.688; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; FRIEDMAN MJ, 1978, P NATL ACAD SCI USA, V75, P1994, DOI 10.1073/pnas.75.4.1994; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; HEBBEL RP, 1988, P NATL ACAD SCI USA, V85, P237, DOI 10.1073/pnas.85.1.237; Hood AT, 1996, BLOOD, V87, P1600, DOI 10.1182/blood.V87.4.1600.bloodjournal8741600; Hutagalung R, 1999, J INFECT DIS, V179, P283, DOI 10.1086/314561; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; JALLOW M, 2009, GENOME WIDE FINE RES; Jison ML, 2004, BLOOD, V104, P270, DOI 10.1182/blood-2003-08-2760; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; LIVINGSTONE FB, 1971, ANNU REV GENET, V5, P33, DOI 10.1146/annurev.ge.05.120171.000341; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; MOTULSKY AG, 1966, AM J HUM GENET, V18, P514; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Nath KA, 2001, AM J PATHOL, V158, P893, DOI 10.1016/S0002-9440(10)64037-0; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Sabaa N, 2008, J CLIN INVEST, V118, P1924, DOI 10.1172/JCI33308; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Sears DA, 2001, AM J MED SCI, V322, P345, DOI 10.1097/00000441-200112000-00007; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; SHEAR HL, 1993, BLOOD, V81, P222; Soares MP, 2009, TRENDS MOL MED, V15, P50, DOI 10.1016/j.molmed.2008.12.004; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; TRUDEL M, 1994, BLOOD, V84, P3189; TRUDEL M, 1991, EMBO J, V10, P3157, DOI 10.1002/j.1460-2075.1991.tb04877.x; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163	55	213	217	2	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					398	409		10.1016/j.cell.2011.03.049	http://dx.doi.org/10.1016/j.cell.2011.03.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529713	Bronze			2022-12-28	WOS:000290022900009
J	Meinwald, J				Meinwald, Jerrold			Thomas Eisner (1929-2011) RETROSPECTIVE	SCIENCE			English	Biographical-Item									Cornell Univ, Ithaca, NY 14853 USA	Cornell University	Meinwald, J (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	circe@cornell.edu							0	0	1	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					549	549		10.1126/science.1206758	http://dx.doi.org/10.1126/science.1206758			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527705				2022-12-28	WOS:000289991100035
J	Venkitaraman, AR				Venkitaraman, Ashok R.			Does Metabolite Deficiency Mark Oncogenic Cell Cycles?	CELL			English	Editorial Material							DNA-DAMAGE RESPONSE; GENOMIC INSTABILITY; SENESCENCE	Genome instability occurs early in the development of most cancers. Bester et al. now provide evidence that oncogenic signals trigger cell division without coordinate nucleotide synthesis, engendering aberrant DNA replication and damage that could promote carcinogenesis. A mismatch between proliferation and metabolite production may characterize oncogenic cell cycles.	Univ Cambridge, Med Res Council Canc Cell Unit, Hutchison MRC Res Ctr, Cambridge CB2 0XZ, England	University of Cambridge	Venkitaraman, AR (corresponding author), Univ Cambridge, Med Res Council Canc Cell Unit, Hutchison MRC Res Ctr, Hills Rd, Cambridge CB2 0XZ, England.	arv22@hutchison-mrc.cam.ac.uk			Medical Research Council [G0700651, G0600332, MC_U105359877, G9900064] Funding Source: Medline; MRC [MC_U105359877, G9900064, G0700651, G0600332] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Venkitaraman AR, 2005, NATURE, V434, P829, DOI 10.1038/434829a	10	3	4	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					337	338		10.1016/j.cell.2011.04.003	http://dx.doi.org/10.1016/j.cell.2011.04.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529708	Bronze			2022-12-28	WOS:000290022900003
J	Esfandbod, M				Esfandbod, Mohsen			Tuberculoid Leprosy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Esfandbod, Mohsen] Univ Tehran Med Sci, Tehran, Iran	Tehran University of Medical Sciences	Esfandbod, M (corresponding author), Univ Tehran Med Sci, Tehran, Iran.	sfandbod@sina.tums.ac.ir		Esfandbod, Mohsen/0000-0002-6497-2306					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1657	1657		10.1056/NEJMicm1011992	http://dx.doi.org/10.1056/NEJMicm1011992			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755NW	21524216				2022-12-28	WOS:000289940400012
J	Shrank, WH				Shrank, William H.			Our Bulging Medicine Cabinets - The Other Side of Medication Nonadherence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shrank, William H.] Brigham & Womens Hosp, Dept Med, Div Pharmacoeidemiol & Pharmacoecon, Boston, MA 02115 USA; [Shrank, William H.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shrank, WH (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoeidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.							Benotti MJ, 2009, ENVIRON SCI TECHNOL, V43, P597, DOI 10.1021/es801845a; Catalano RF, 2011, ADDICT BEHAV, V36, P79, DOI 10.1016/j.addbeh.2010.08.028; *FOOD DRUG ADM, DISP FLUSH CERT UN M; McCabe SE, 2009, ARCH PEDIAT ADOL MED, V163, P739, DOI 10.1001/archpediatrics.2009.120; Richman PB, 2001, AM J EMERG MED, V19, P57, DOI 10.1053/ajem.2001.20035	5	26	26	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1591	1593		10.1056/NEJMp1011624	http://dx.doi.org/10.1056/NEJMp1011624			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755NW	21524212				2022-12-28	WOS:000289940400004
J	Jenkins, M				Jenkins, Michael			PERSONAL VIEW We need leaders, not leadership fads	BRITISH MEDICAL JOURNAL			English	Editorial Material									Riverbank Med Ctr, Weston Super Mare, England		Jenkins, M (corresponding author), Riverbank Med Ctr, Weston Super Mare, England.	mrjmjenkins@yahoo.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 27	2011	342								d2552	10.1136/bmj.d2552	http://dx.doi.org/10.1136/bmj.d2552			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759BT	21525096				2022-12-28	WOS:000290215600006
J	Marshall, BDL; Milloy, MJ; Wood, E; Montaner, JSG; Kerr, T				Marshall, Brandon D. L.; Milloy, M-J; Wood, Evan; Montaner, Julio S. G.; Kerr, Thomas			Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study	LANCET			English	Article							NEW-YORK-CITY; DRUG-USERS; COHORT; VANCOUVER; RISK; ATTENDANCE; PATTERNS; TRENDS; IMPACT; DEATH	Background Overdose from illicit drugs is a leading cause of premature mortality in North America. Internationally, more than 65 supervised injecting facilities (SIFs), where drug users can inject pre-obtained illicit drugs, have been opened as part of various strategies to reduce the harms associated with drug use. We sought to determine whether the opening of an SIF in Vancouver, BC, Canada, was associated with a reduction in overdose mortality. Methods We examined population-based overdose mortality rates for the period before (Jan 1, 2001, to Sept 20, 2003) and after (Sept 21, 2003, to Dec 31, 2005) the opening of the Vancouver SIF. The location of death was determined from provincial coroner records. We compared overdose fatality rates within an a priori specified 500 m radius of the SIF and for the rest of the city. Findings Of 290 decedents, 229 (79.0%) were male, and the median age at death was 40 years (IQR 32-48 years). A third (89, 30.7%) of deaths occurred in city blocks within 500 m of the SIF. The fatal overdose rate in this area decreased by 35.0% after the opening of the SIF, from 253.8 to 165.1 deaths per 100000 person-years (p=0.048). By contrast, during the same period, the fatal overdose rate in the rest of the city decreased by only 9.3%, from 7.6 to 6.9 deaths per 100 000 person-years (p=0.490). There was a significant interaction of rate differences across strata (p=0.049). Interpretation SIFs should be considered where injection drug use is prevalent, particularly in areas with high densities of overdose.	[Marshall, Brandon D. L.; Milloy, M-J; Wood, Evan; Montaner, Julio S. G.; Kerr, Thomas] Univ British Columbia, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V5Z 1M9, Canada; [Wood, Evan; Montaner, Julio S. G.; Kerr, Thomas] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Milloy, M-J] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Marshall, Brandon D. L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia; University of British Columbia; Columbia University	Kerr, T (corresponding author), St Pauls Hosp, BC Ctr Excellence HIV AIDS, Urban Hlth Res Initiat, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	uhri-tk@cfenet.ubc.ca	Marshall, Brandon/B-4895-2010; Milloy, M-J/AAY-3618-2020; Montaner, Julio/K-7621-2012	Marshall, Brandon/0000-0002-0134-7052; 	Abbott Laboratories; Agouron Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Borean Pharma AS; Bristol-Myers Squibb; DuPont Pharma; Gilead Sciences; GlaxoSmithKline; Hoffmann-La Roche; Immune Response Corporation; Incyte; Janssen-Ortho Inc; Kucera Pharmaceutical Company; Merck Frosst Laboratories; Pfizer Canada; Sanofi Pasteur; Shire Biochem; Tibotec Pharmaceuticals; Trimeris; Health Canada; Canadian Institutes of Health Research (CIHR); Vancouver Coastal Health; Michael Smith Foundation for Health Research (MSFHR)	Abbott Laboratories(Abbott Laboratories); Agouron Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals(Boehringer Ingelheim); Borean Pharma AS; Bristol-Myers Squibb(Bristol-Myers Squibb); DuPont Pharma; Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Hoffmann-La Roche(Hoffmann-La Roche); Immune Response Corporation; Incyte; Janssen-Ortho Inc; Kucera Pharmaceutical Company; Merck Frosst Laboratories; Pfizer Canada(Pfizer); Sanofi Pasteur; Shire Biochem; Tibotec Pharmaceuticals; Trimeris; Health Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Vancouver Coastal Health; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	JSGM has received educational grants from, serves as an ad hoc adviser to, or speaks at various events sponsored by Abbott Laboratories, Agouron Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Borean Pharma AS, Bristol-Myers Squibb, DuPont Pharma, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Immune Response Corporation, Incyte, Janssen-Ortho Inc, Kucera Pharmaceutical Company, Merck Frosst Laboratories, Pfizer Canada, Sanofi Pasteur, Shire Biochem, Tibotec Pharmaceuticals, and Trimeris. No other authors declared any conflicts of interest.; We gratefully acknowledge the invaluable assistance of the Chief Coroner and other officials of the British Columbia Coroners Service, in particular Sara Weinstein and Tej Sidhu. We thank Daniel Kane, Deborah Graham, and Tricia Collingham of the British Columbia Centre for Excellence in HIV/AIDS for their research and administrative assistance. The SIF assessment was originally funded by a contribution from Health Canada, although the views expressed in this analysis do not represent the official policies of Health Canada. The study is now supported by the Canadian Institutes of Health Research (CIHR) and Vancouver Coastal Health. TK is supported by a CIHR New Investigator Award and a Michael Smith Foundation for Health Research (MSFHR) Scholar Award. BDLM and MJM are supported by Canada Graduate Scholarships from CIHR; BDLM is supported by a Senior Graduate Trainee Award from Michael Smith Foundation for Health Research.	*ANG REID, CAN AR SUPP INS OPP; Apparicio P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-7; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Bohnert ASB, 2010, ADDICTION, V105, P1049, DOI 10.1111/j.1360-0443.2009.02887.x; Bohnert ASB, 2009, ANN EMERG MED, V54, P618, DOI 10.1016/j.annemergmed.2009.05.004; Bow C Jennifer D, 2004, Int J Health Geogr, V3, P5, DOI 10.1186/1476-072X-3-5; Brugal MT, 2005, ADDICTION, V100, P981, DOI 10.1111/j.1360-0443.2005.01089.x; BUXTON JA, VANCOUVER DRUG USE E; Cameron AC, 1997, J ECONOMETRICS, V77, P329; *CDCP, UN DRUG POIS US; Crandall CG, 2002, ANN INTERN MED, V136, P785, DOI 10.7326/0003-4819-136-11-200206040-00006; Darke S, 2003, J URBAN HEALTH, V80, P189, DOI 10.1093/jurban/jtg022; DeBeck K, 2008, SUBST ABUSE TREAT PR, V3, DOI 10.1186/1747-597X-3-11; Fairbairn N, 2008, SOC SCI MED, V67, P817, DOI 10.1016/j.socscimed.2008.05.012; Fielden Sarah J, 2007, Harm Reduct J, V4, P10, DOI 10.1186/1477-7517-4-10; Fischer B, 2006, CAN J PUBLIC HEALTH, V97, P384, DOI 10.1007/BF03405347; Galai N, 2003, AM J EPIDEMIOL, V158, P695, DOI 10.1093/aje/kwg209; Galea S, 2003, J URBAN HEALTH, V80, P201, DOI 10.1093/jurban/jtg023; Hall W, 2005, LANCET, V366, P271, DOI 10.1016/S0140-6736(05)66476-8; HEDRICH D, EUROPEAN REPORT DRUG; Hulse GK, 1999, ADDICTION, V94, P221, DOI 10.1046/j.1360-0443.1999.9422216.x; Kaye S, 2004, ADDICTION, V99, P1315, DOI 10.1111/j.1360-0443.2004.00875.x; Kerr T, 2006, BRIT MED J, V332, P220, DOI 10.1136/bmj.332.7535.220; Kerr T, 2005, LANCET, V366, P316, DOI 10.1016/S0140-6736(05)66475-6; Kerr T, 2008, LANCET, V372, P354, DOI 10.1016/S0140-6736(08)61138-1; Kerr T, 2007, AM J PUBLIC HEALTH, V97, P1228, DOI 10.2105/AJPH.2006.086256; Kerr T, 2006, INT J DRUG POLICY, V17, P436, DOI 10.1016/j.drugpo.2006.05.008; Kimber J, 2003, DRUG ALCOHOL REV, V22, P227, DOI 10.1080/095952301000116951; Lloyd-Smith E, 2009, DRUG ALCOHOL DEPEN, V99, P176, DOI 10.1016/j.drugalcdep.2008.07.003; Milloy MJ, 2010, ADDICTION, V105, P1962, DOI 10.1111/j.1360-0443.2010.03077.x; *MSIC EV COMM, FIN REP EV SYDN MED; Petrar S, 2007, ADDICT BEHAV, V32, P1088, DOI 10.1016/j.addbeh.2006.07.013; Rachlis BS, 2008, HEALTH PLACE, V14, P536, DOI 10.1016/j.healthplace.2007.10.006; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Small W, 2008, DRUG ALCOHOL DEPEN, V98, P159, DOI 10.1016/j.drugalcdep.2008.05.014; Small W, 2007, INT J DRUG POLICY, V18, P27, DOI 10.1016/j.drugpo.2006.11.019; Spittal PM, 2006, AIDS CARE, V18, P101, DOI 10.1080/09540120500159292; *STAT CAN, 2003, POP FAM EST METH STA; Statistics Canada, 2007, POST COD CONV FIL PC; Stoove MA, 2008, DRUG ALCOHOL DEPEN, V96, P281, DOI 10.1016/j.drugalcdep.2008.03.006; Strathdee SA, 1997, AIDS, V11, pF59, DOI 10.1097/00002030-199708000-00001; Tyndall MW, 2006, DRUG ALCOHOL DEPEN, V83, P193, DOI 10.1016/j.drugalcdep.2005.11.011; *VANC COAST HLTH, INJ DRUG US DTES; Werb D, 2010, DRUG ALCOHOL REV, V29, P271, DOI 10.1111/j.1465-3362.2009.00145.x; White JM, 1999, ADDICTION, V94, P961, DOI 10.1046/j.1360-0443.1999.9479612.x; Wood E, 2006, NEW ENGL J MED, V354, P2512, DOI 10.1056/NEJMc052939; Wood E, 2006, AM J PUBLIC HEALTH, V96, P770, DOI 10.2105/AJPH.2004.057828; Wood E, 2006, ADDICTION, V101, P689, DOI 10.1111/j.1360-0443.2006.01385.x; Wood E, 2005, AM J PREV MED, V29, P126, DOI 10.1016/j.amepre.2005.04.011; Wood E, 2004, LANCET INFECT DIS, V4, P301, DOI 10.1016/S1473-3099(04)01006-0; Wood E, 2008, INT J DRUG POLICY, V19, P220, DOI 10.1016/j.drugpo.2007.11.001; Wood E, 2008, AM J PUBLIC HEALTH, V98, P515, DOI 10.2105/AJPH.2007.114595; Wood E, 2006, CAN MED ASSOC J, V175, P1399, DOI 10.1503/cmaj.060863; Wood Evan, 2004, Harm Reduct J, V1, P9, DOI 10.1186/1477-7517-1-9; DOWNTOWN EASTSIDE CO	55	275	275	3	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2011	377	9775					1429	1437		10.1016/S0140-6736(10)62353-7	http://dx.doi.org/10.1016/S0140-6736(10)62353-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UF	21497898				2022-12-28	WOS:000289963000032
J	Kesselheim, A				Kesselheim, Aaron			Safety, Supply, and Suits - Litigation and the Vaccine Industry	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kesselheim, Aaron] Harvard Univ, Sch Med, Div Pharmacoepidemiol, Boston, MA 02115 USA; [Kesselheim, Aaron] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kesselheim, A (corresponding author), Harvard Univ, Sch Med, Div Pharmacoepidemiol, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				[Anonymous], 1995, FED REGISTER, V60, P7678; [Anonymous], 1965, RESTATEMENT 2 TORTS, V682	2	7	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1485	1487		10.1056/NEJMp1102182	http://dx.doi.org/10.1056/NEJMp1102182			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752VH	21506740				2022-12-28	WOS:000289722700001
J	Logan, AC; Yank, V; Stafford, RS				Logan, Aaron C.; Yank, Veronica; Stafford, Randall S.			Off-Label Use of Recombinant Factor VIIa in US Hospitals: Analysis of Hospital Records	ANNALS OF INTERNAL MEDICINE			English	Article							ACTIVATED FACTOR-VII; THROMBOEMBOLIC ADVERSE EVENTS; INTRACEREBRAL HEMORRHAGE; CONTROLLED-TRIALS; CARDIAC-SURGERY; CLINICAL-TRIALS; SAFETY; EFFICACY; HEMOPHILIA; TRANSFUSION	Background: Recombinant factor VIIa (rFVIIa) is approved for treatment of bleeding in patients who have hemophilia with inhibitors but has been applied to a wide range of off-label indications. Objective: To estimate patterns of off-label rFVIIa use in U. S. hospitals. Design: Retrospective database analysis. Setting: Data were extracted from the Premier Perspectives database (Premier, Charlotte, North Carolina), which contains discharge records from a sample of academic and nonacademic U. S. hospitals. Patients: 12 644 hospitalizations for patients who received rFVIIa during a hospital stay. Measurements: Hospital diagnoses and patient dispositions from 1 January 2000 to 31 December 2008. Statistical weights for each hospital were used to provide national estimates of rFVIIa use. Results: From 2000 to 2008, off-label use of rFVIIa in hospitals increased more than 140-fold, such that in 2008, 97% (95% CI, 96% to 98%) of 18 311 in-hospital uses were off-label. In contrast, in-hospital use for hemophilia increased less than 4-fold and accounted for 2.7% (CI, 1.9% to 3.5%) of use in 2008. Adult and pediatric cardiovascular surgery (29% [CI, 21% to 33%]), body and brain trauma (29% [CI, 19% to 38%]), and intracranial hemorrhage (11% [CI, 7.7% to 14%]) were the most common indications for rFVIIa use. Across all indications, in-hospital mortality was 27% (CI, 19% to 34%) and 43% (CI, 26% to 59%) of patients were discharged to home. Limitation: Accuracy and completeness of the discharge diagnoses and patient medication records in the database sample cannot be verified. Conclusion: Off-label use of rFVIIa in the hospital setting far exceeds use for approved indications. These patterns raise concern about the application of rFVIIa to conditions for which strong supporting evidence is lacking.	[Stafford, Randall S.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA	Stanford University	Stafford, RS (corresponding author), Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Off Bldg X312,251 Campus Dr, Palo Alto, CA 94304 USA.	rstafford@stanford.edu	Logan, Aaron C/ADJ-7526-2022; Stafford, Randall/F-3974-2017	Logan, Aaron C/0000-0002-1179-5879; Stafford, Randall/0000-0003-1805-1271	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [290-02-0017]; National Heart, Lung, and Blood Institute [K24HL086703]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL086703] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: By the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, under contract 290-02-0017. Dr. Stafford also was supported by a National Heart, Lung, and Blood Institute mentoring award (RSS, K24HL086703).	Aledort LM, 2004, J THROMB HAEMOST, V2, P1700, DOI 10.1111/j.1538-7836.2004.00944.x; Aledort LM, 2010, NEW ENGL J MED, V363, P1853, DOI 10.1056/NEJMe1008857; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Carcao MD, 2008, SEMIN HEMATOL, V45, pS68, DOI 10.1053/j.seminhematol.2008.03.003; Diprose P, 2005, BRIT J ANAESTH, V95, P596, DOI 10.1093/bja/aei244; Diringer MN, 2008, STROKE, V39, P850, DOI 10.1161/STROKEAHA.107.493601; Diringer MN, 2010, STROKE, V41, P48, DOI 10.1161/STROKEAHA.109.561712; Ganguly S, 2006, CLIN LAB HAEMATOL, V28, P309, DOI 10.1111/j.1365-2257.2006.00815.x; Gill R, 2009, CIRCULATION, V120, P21, DOI 10.1161/CIRCULATIONAHA.108.834275; Goodnough LT, 2004, TRANSFUSION, V44, P1325, DOI 10.1111/j.1537-2995.2004.04052.x; Goodnough LT, 2002, INTENS CARE MED, V28, pS221, DOI 10.1007/s00134-002-1468-2; Hardy JF, 2008, ANN THORAC SURG, V86, P1038, DOI 10.1016/j.athoracsur.2008.05.013; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hedner U, 2008, THROMB HAEMOSTASIS, V100, P557, DOI 10.1160/TH08-07-0434; Heller M, 2008, PEDIATR BLOOD CANCER, V50, P1013, DOI 10.1002/pbc.21375; Howes Jeremy L, 2009, Am J Surg, V198, P895, DOI 10.1016/j.amjsurg.2009.05.026; Hsia CC, 2009, TRANSFUSION MED, V19, P43, DOI 10.1111/j.1365-3148.2009.00913.x; Hsia CC, 2008, ANN SURG, V248, P61, DOI 10.1097/SLA.0b013e318176c4ec; Levi M, 2010, NEW ENGL J MED, V363, P1791, DOI 10.1056/NEJMoa1006221; MacLaren R, 2005, TRANSFUSION, V45, P1434, DOI 10.1111/j.1537-2995.2005.00548.x; MAGNETTI S, 2007, P & T, V32, P218; Mayer SA, 2003, STROKE, V34, P224, DOI 10.1161/01.STR.0000046458.67968.E4; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; Roberts HR, 2004, BLOOD, V104, P3858, DOI 10.1182/blood-2004-06-2223; Roberts HR, 2004, SEMIN HEMATOL, V41, P101, DOI 10.1053/j.seminhematol.2003.11.019; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; Thomas GOR, 2007, J TRAUMA, V62, P564, DOI 10.1097/TA.0b013e318031afc2; Webert KE, 2007, HAEMOPHILIA, V13, P518, DOI 10.1111/j.1365-2516.2007.01490.x; YANK V, 2010, COMP EFFECTIVENESS R; Yank V, 2011, ANN INTERN MED, V154, P529, DOI 10.7326/0003-4819-154-8-201104190-00004	31	99	104	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8					516	522		10.7326/0003-4819-154-8-201104190-00002	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-00002			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502649	Green Accepted			2022-12-28	WOS:000289622000014
J	Griffiths, PD; Stanton, A; McCarrell, E; Smith, C; Osman, M; Harber, M; Davenport, A; Jones, G; Wheeler, DC; O'Beirne, J; Thorburn, D; Patch, D; Atkinson, CE; Pichon, S; Sweny, P; Lanzman, M; Woodford, E; Rothwell, E; Old, N; Kinyanjui, R; Haque, T; Atabani, S; Luck, S; Prideaux, S; Milne, RSB; Emery, VC; Burroughs, AK				Griffiths, Paul D.; Stanton, Anna; McCarrell, Erin; Smith, Colette; Osman, Mohamed; Harber, Mark; Davenport, Andrew; Jones, Gareth; Wheeler, David C.; O'Beirne, James; Thorburn, Douglas; Patch, David; Atkinson, Claire E.; Pichon, Sylvie; Sweny, Paul; Lanzman, Marisa; Woodford, Elizabeth; Rothwell, Emily; Old, Natasha; Kinyanjui, Ruth; Haque, Tanzina; Atabani, Sowsan; Luck, Suzanne; Prideaux, Steven; Milne, Richard S. B.; Emery, Vincent C.; Burroughs, Andrew K.			Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial	LANCET			English	Article							LIVER-TRANSPLANTATION; RENAL-TRANSPLANTATION; PREEMPTIVE THERAPY; DISEASE; VALGANCICLOVIR; PROPHYLAXIS; INFECTION; LOAD; VIRUS; PREVENTION	Background Cytomegalovirus end-organ disease can be prevented by giving ganciclovir when viraemia is detected in allograft recipients. Values of viral load correlate with development of end-organ disease and are moderated by preexisting natural immunity. Our aim was to determine whether vaccine-induced immunity could do likewise. Methods We undertook a phase-2 randomised placebo controlled trial in adults awaiting kidney or liver transplantation at the Royal Free Hospital, London, UK. Exclusion criteria were pregnancy, receipt of blood products (except albumin) in the previous 3 months, and simultaneous multiorgan transplantation. 70 patients seronegative and 70 seropositive for cytomegalovirus were randomly assigned from a scratch-oft randomisation code in a 1:1 ratio to receive either cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant or placebo, each given at baseline, 1 month and 6 months later. If a patient was transplanted, no further vaccinations were given and serial blood samples were tested for cytomegalovirus DNA by real-time quantitative PCR (rtqPCR). Any patient with one blood sample containing more than 3000 cytomegalovirus genomes per mL received ganciclovir until two consecutive undetectable cytomegalovirus DNA measurements. Safety and immunogenicity were coprimary endpoints and were assessed by intention to treat in patients who received at least one dose of vaccine or placebo. This trial is registered with ClinicalTrials.gov, NCT00299260. Findings 67 patients received vaccine and 73 placebo, all of whom were evaluable. Glycoprotein-B antibody titres were significantly increased in both seronegative (geometric mean titre 12 537 (95% CI 6593-23 840) versus 86 (63-118) in recipients of placebo recipients; p<0.0001) and seropositive (118 395; 64 503-217 272) versus 24 682 (17 909-34017); p<0.0001) recipients of vaccine. In those who developed viraemia after transplantation, glycoprotein-B antibody titres correlated inversely with duration of viraemia (p=0.0022). In the seronegative patients with seropositive donors, the duration of viraemia (p=0.0480) and number of days of ganciclovir treatment (p=0.0287) were reduced in vaccine recipients. Interpretation Although cytomegalovirus disease occurs in the context of suppressed cell-mediated immunity post-transplantation, humoral immunity has a role in reduction of cytomegalovirus viraemia. Vaccines containing cytomegalovirus glycoprotein B merit further assessment in transplant recipients.	[Griffiths, Paul D.; Stanton, Anna; McCarrell, Erin; Osman, Mohamed; Atkinson, Claire E.; Rothwell, Emily; Haque, Tanzina; Atabani, Sowsan; Luck, Suzanne; Prideaux, Steven; Milne, Richard S. B.; Emery, Vincent C.] Sheila Sherlock Liver Ctr, Ctr Virol, London, England; [Harber, Mark; Davenport, Andrew; Jones, Gareth; Wheeler, David C.; Sweny, Paul; Kinyanjui, Ruth] Sheila Sherlock Liver Ctr, Ctr Nephrol, London, England; [O'Beirne, James; Thorburn, Douglas; Patch, David; Burroughs, Andrew K.] Royal Free NHS Trust, Univ Dept Surg, London, England; [Smith, Colette] UCL Med Sch, Dept Infect & Populat Hlth, London NW3 2PF, England; [Lanzman, Marisa; Woodford, Elizabeth] Royal Free NHS Trust, Dept Pharm, London, England; [Pichon, Sylvie] Sanofi Pasteur, Clin Dev, Marcy Letoile, France	University of London; University College London; University of London; University College London; University of London; University College London; Sanofi-Aventis; Sanofi France	Griffiths, PD (corresponding author), UCL Med Sch, Ctr Virol, Rowland Hill St, London NW3 2PF, England.	p.griffiths@medsch.ucl.ac.uk	Burroughs, Andrew K/C-5645-2009; O'Beirne, James/I-8251-2019; o'beirne, james p/C-5701-2009; Emery, Vincent/G-8928-2013	Burroughs, Andrew K/0000-0001-6527-457X; O'Beirne, James/0000-0003-3400-2816; o'beirne, james p/0000-0001-8590-396X; Old, Natasha/0000-0003-3387-8904; Smith, Colette/0000-0003-2847-3355; Emery, Vincent/0000-0001-5893-9756	Amgen; Shire; Roche; Viropharma; National Institute of Allergy and Infectious Diseases [R01A1051355]; Wellcome Trust [078332]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051355] Funding Source: NIH RePORTER	Amgen(Amgen); Shire; Roche(Roche Holding); Viropharma; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	PDG has been a member of advisory boards for Viropharma, Chimerix, Astellas, and Boehringer-Ingelheirn. DCW has received consulting fees from Amgen and lecture payments from Amgen and Shire. PS has been a member of advisory boards from Wyeth, Novartis, Roche, and Astellas. VCE has acted as a member of the advisory board, received consulting fees and lecture fees from Roche and Viropharma. SPi is an employee of Sanofi Pasteur. All other authors declare that they have no conflicts of interest.; This study was financed by grant R01A1051355 from the National Institute of Allergy and Infectious Diseases. We thank the patients who volunteered for the study and the clinicians responsible for their day-to-day clinical care; Walla Dempsey and Christopher Beisel for their advice about grant administration, with support from Wellcome Trust grant 078332; Sanofi Pasteur staff for their long-term advice; all the staff of the renal transplant and liver transplant units for their enthusiastic collaboration and Graham Shining and Joyce Grant for LA data; and the members of the Data Safety Committee (Prof Stephen Mackinnon, Michael Jacobs, Prof Caroline Sabin) for their expert advice. The study products, composed of Sanofi Pasteur's glycoprotein-B and Novartis Vaccines' proprietary MF59 adjuvant, were provided by Sanofi Pasteur.	Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999; Boeckh M, 2009, BLOOD, V113, P5711, DOI 10.1182/blood-2008-10-143560; Cope AV, 1997, J INFECT DIS, V176, P1484, DOI 10.1086/514145; Cope AV, 1997, J MED VIROL, V52, P200, DOI 10.1002/(SICI)1096-9071(199706)52:2<200::AID-JMV14>3.0.CO;2-O; Emery VC, 2000, P NATL ACAD SCI USA, V97, P8039, DOI 10.1073/pnas.140123497; Emery VC, 2000, LANCET, V355, P2032, DOI 10.1016/S0140-6736(00)02350-3; Emery VC, 1999, J EXP MED, V190, P177, DOI 10.1084/jem.190.2.177; Emery VC, 2002, J INFECT DIS, V185, P1723, DOI 10.1086/340653; Frey SE, 1999, J INFECT DIS, V180, P1700, DOI 10.1086/315060; Gor D, 1998, BONE MARROW TRANSPL, V21, P597, DOI 10.1038/sj.bmt.1701139; GRUNDY JE, 1988, LANCET, V2, P132; Hackett DJ, 2010, CLIN VACCINE IMMUNOL, V17, P836, DOI 10.1128/CVI.00422-09; Humar A, 2010, AM J TRANSPLANT, V10, P1228, DOI 10.1111/j.1600-6143.2010.03074.x; Jung C, 2001, TRANSPLANT P, V33, P3621, DOI 10.1016/S0041-1345(01)02558-1; Khoury JA, 2006, AM J TRANSPLANT, V6, P2134, DOI 10.1111/j.1600-6143.2006.01413.x; Kotton CN, 2010, TRANSPLANTATION, V89, P779, DOI 10.1097/TP.0b013e3181cee42f; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Mattes FM, 2005, J INFECT DIS, V191, P89, DOI 10.1086/425905; Mitchell DK, 2002, PEDIATR INFECT DIS J, V21, P133, DOI 10.1097/00006454-200202000-00009; Pass RF, 1999, J INFECT DIS, V180, P970, DOI 10.1086/315022; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; PLOTKIN SA, 1994, TRANSPLANTATION, V58, P1176, DOI 10.1097/00007890-199412270-00006; Reischig T, 2008, AM J TRANSPLANT, V8, P69, DOI 10.1111/j.1600-6143.2007.02031.x; Ross SA, 2010, J INFECT DIS, V201, P386, DOI 10.1086/649903; Schleiss MR, 2005, EXPERT REV VACCINES, V4, P381, DOI 10.1586/14760584.4.3.381; Singh N, 2006, REV MED VIROL, V16, P281, DOI 10.1002/rmv.513; Snydman DR, 2006, REV MED VIROL, V16, P289, DOI 10.1002/rmv.514; SNYDMAN DR, 1993, ANN INTERN MED, V119, P984, DOI 10.7326/0003-4819-119-10-199311150-00004; Stratton KR, 2001, VACCINES 21 CENTURY, P1; Sun HY, 2008, AM J TRANSPLANT, V8, P2111, DOI 10.1111/j.1600-6143.2008.02369.x	30	281	298	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1256	1263		10.1016/S0140-6736(11)60136-0	http://dx.doi.org/10.1016/S0140-6736(11)60136-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751DI	21481708	Green Published			2022-12-28	WOS:000289597300032
